Citrus Sinensis ID: 036229

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980--
Protein Sequence
MERVHSLSMMSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNYY
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHcccccccccccccccccccccccEEEEEccccccEEEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEccHHHHcccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEEcccccccccccccEEccccEEEEcccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEccccccEEEccHHHHHccccccEEEccccEEEEcccHHHHccccccEEEccccEEEccccccccccccccEEEccccccccccccccccHHccccccccEEEcccccccccccccccccccccccEEEEEccEEEEEcccccccccccccEEcccccccccccccccccccccEEEcccccccccccHHHHcccccccEEccccccccccccccccccccccEEccccccccccHHHHccccccccccccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEccccccccccccHHHHcccccccEEcccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEccccccEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEcccccccccccccccccccccccccEEEccccccccccEEEEcccccEEEEEEEEEcccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHcccccccccccccccccccccEEEEEEcccccEEEEEEEEEEcEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEccccccccccHHHcccHHHcEEEcEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHccHcccEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEcccccccccccccccHHHccccccEEEEEccccccccccHHHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEcccccccccccHHHHcccccEEEEcccccccccccHHHcccccccEEEccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccEEEEEcccccccccccHHHHHHHcccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEcHHHHHHHHccccHHcEEEcccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccHHEccccccccccccccccccccHHHcccccEEEEEccccEEEEEEEEEcccccc
Coil and Loop (DISEMBL)
mervhslsMMSRFLFLHCLILISLLTAAAtantssitTDQDALLALKAHithdptnflaknwntstpvcnwtgvtcdvhsHRVKVLNIshlnltgtipsqlwnlsslqslnlgfnrlsgsipsaIFTLYTLKYVnfrgnqlsgafpsfifnksslqhLDFSynalsgeipanicsnlpflesISLSQnmfhgripsalsnckYLEILSLSINNLLGAIPKEIGNLTKLKELYlgysglqgeiprefgNLAELELMALQVSnlqgeipqelanlTGLEVLKlgknfltgeippeihnlhnlklldlshnklvgavpatiFNMStltglglqsnslsgslssiadvqlpnleeLRLWsnnfsgtiprfiFNASKLSVLELGrnsfsgfipntfgnlrNLRLMTLHYNYLTSSNLELSFLssfsncksltyiglsnnpldgilprmsmgnlshsleyfdmsycnvsggfpkeigNLTNLIGIYlggnklngsipitLGKLQklqglhlednklegpipddicRLTKLYELglsgnklsgsipacfsnlaslgtlslgsnkltsiplTIWNLKGMLYLnfssnfftgplpldignLKVLIGidfstnnfsdvipTVIGGLTNLQYLFLGYnrlqgsisesFGDLIslkslnlsnnnlsrsipisleklsyleDLDLSFNKlkgeipkggsfgnfsaksfegnellcgspnlqvppcktsihhksrKNVLLLGIVLPLSTIFIIVVILLIVRYRkrvkqppndanmppiatcRRFSYLELCRATnrfsennligrggfgsVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYmphgslekslyssnYILDIFQRLNIMVDVATTLEylhfgysapvihcdlkpsnvllddnmvahLSDFGIAklligedqsitQTQTLAtigymapglFHVKYILFVVNFLTSYSFLMIFIGRGNYY
Flexible Loop (DISEMBL)
MERVHSLSMMSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEdnklegpipdDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKrvkqppndanmppiaTCRRFSYLELCRATnrfsennligrggFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNYY
Low Complexity Region (SEG)
MERVHSLSMMSRflflhclilislltaaatantssittDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPsqlwnlsslqslnlGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEilslsinnllGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMstltglglqsnslsgslssIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTssnlelsflssfsnCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITlgklqklqglHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDlislkslnlsnnnlsrsipislEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTifiivvillivRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNYY
Disordered region (IsUnstruct)
********MMSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRVK*******MPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG***
Disordered Region (DISOPRED)
***********RFLFLHCLILISLLTAAATAN****TTDQDALLALKAHITH*********WNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP*********************LGIVLPLSTIFIIVVILLIVR*********************RFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED***TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG***
Disordered Region (DISEMBL)
********MMSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNYY
Disordered Region (DISPRO)
*ERVHSLSMMSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRV*******NMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG**Y
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiii
Transmembrane Helix (MEMSAT)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooo
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MERVHSLSMMSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNYY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	982	2.2.26 [Sep-21-2011]
Q9FL28	1173	LRR receptor-like serine/	yes	no	0.925	0.774	0.354	1e-143
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.807	0.785	0.396	1e-140
C0LGT6	1031	LRR receptor-like serine/	no	no	0.854	0.813	0.348	1e-137
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.928	0.730	0.331	1e-125
Q9SD62	1025	Putative receptor-like pr	no	no	0.872	0.836	0.351	1e-121
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.829	0.650	0.335	1e-119
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.905	0.850	0.324	1e-117
Q9FZ59	1088	Leucine-rich repeat recep	no	no	0.908	0.819	0.333	1e-116
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.928	0.828	0.324	1e-115
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.939	0.837	0.335	1e-113

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  508 bits (1309), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 366/1033 (35%), Positives = 548/1033 (53%), Gaps = 124/1033 (12%)

Query: 41   DALLALKAHITHDPTNFLAKNWNT--STPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIP 98
            +AL + K  I++DP   L+ +W    S   CNWTG+TCD   H V V ++    L G + 
Sbjct: 32   EALKSFKNGISNDPLGVLS-DWTIIGSLRHCNWTGITCDSTGHVVSV-SLLEKQLEGVLS 89

Query: 99   SQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHL 158
              + NL+ LQ L+L  N  +G IP+ I  L  L  +    N  SG+ PS I+   ++ +L
Sbjct: 90   PAIANLTYLQVLDLTSNSFTGKIPAEIGKLTELNQLILYLNYFSGSIPSGIWELKNIFYL 149

Query: 159  DFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAI 218
            D   N LSG++P  IC     L  I    N   G+IP  L +  +L++   + N+L G+I
Sbjct: 150  DLRNNLLSGDVPEEICKT-SSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSI 208

Query: 219  PKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEV 278
            P  IG L  L +L L  + L G+IPR+FGNL  L+ + L  + L+G+IP E+ N + L  
Sbjct: 209  PVSIGTLANLTDLDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQ 268

Query: 279  LKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSL 338
            L+L  N LTG+IP E+ NL  L+ L +  NKL  ++P+++F ++ LT LGL  N L G +
Sbjct: 269  LELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPI 328

Query: 339  SSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLR 398
            S      L +LE L L SNNF+G  P+ I N   L+VL +G N+ SG +P   G L NLR
Sbjct: 329  SEEIGF-LESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLR 387

Query: 399  LMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPR---------MSMG--- 446
             ++ H N LT         SS SNC  L  + LS+N + G +PR         +S+G   
Sbjct: 388  NLSAHDNLLTGP-----IPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNH 442

Query: 447  -----------------------NLS----------HSLEYFDMSYCNVSGGFPKEIGNL 473
                                   NL+            L    +SY +++G  P+EIGNL
Sbjct: 443  FTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNL 502

Query: 474  TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNK 533
             +L  +YL  N   G IP  +  L  LQGL +  N LEGPIP+++  +  L  L LS NK
Sbjct: 503  KDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNK 562

Query: 534  LSGSIPACFSNLASLGTLSLGSNKLT-SIPLTI-------------------------WN 567
             SG IPA FS L SL  LSL  NK   SIP ++                          +
Sbjct: 563  FSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLAS 622

Query: 568  LKGM-LYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP---------------- 610
            LK M LYLNFS+N  TG +P ++G L+++  ID S N FS  IP                
Sbjct: 623  LKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQ 682

Query: 611  ---------TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL 661
                      V  G+  +  L L  N   G I +SFG++  L SL+LS+NNL+  IP SL
Sbjct: 683  NNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESL 742

Query: 662  EKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPC---KTSIHH 718
              LS L+ L L+ N LKG +P+ G F N +A    GN  LCGS    + PC   + S H 
Sbjct: 743  ANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHF 801

Query: 719  KSRKNVLL--LGIVLPLSTIFIIVVILLIVRYRKRVKQPPNDANMPPIATC---RRFSYL 773
              R  V+L  LG    L  + ++V+IL   + +++  +  +++++P + +    +RF   
Sbjct: 802  SKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPK 861

Query: 774  ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMK 831
            EL +AT+ F+  N+IG     +VYK ++ +G  +AVKV +L+     + K F  E + + 
Sbjct: 862  ELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLS 921

Query: 832  SIRHRNLIKVIS-SCSTEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATT 889
             ++HRNL+K++  +  + + KAL+L +M +G+LE +++ S+  I  + +++++ V +A+ 
Sbjct: 922  QLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASG 981

Query: 890  LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTL--ATI 946
            ++YLH GY  P++HCDLKP+N+LLD + VAH+SDFG A++L   ED S T + +    TI
Sbjct: 982  IDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTI 1041

Query: 947  GYMAPGLFHVKYI 959
            GY+AP   +++ +
Sbjct: 1042 GYLAPEFAYMRKV 1054

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  501 bits (1289), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 328/827 (39%), Positives = 463/827 (55%), Gaps = 34/827 (4%)

Query: 155 LQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNL 214
           + HL+     L G I  +I  NL FL S+ L +N F G IP  +     LE L + IN L
Sbjct: 68  VTHLELGRLQLGGVISPSI-GNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYL 126

Query: 215 LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLT 274
            G IP  + N ++L  L L  + L G +P E G+L  L  + L  +N++G++P  L NLT
Sbjct: 127 RGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLT 186

Query: 275 GLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSL 334
            LE L L  N L GEIP ++  L  +  L L  N   G  P  ++N+S+L  LG+  N  
Sbjct: 187 LLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHF 246

Query: 335 SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNL 394
           SG L     + LPNL    +  N F+G+IP  + N S L  L +  N+ +G IP TFGN+
Sbjct: 247 SGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNV 305

Query: 395 RNLRLMTLHYNYLTS-SNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLE 453
            NL+L+ LH N L S S+ +L FL+S +NC  L  +G+  N L G LP +S+ NLS  L 
Sbjct: 306 PNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLV 364

Query: 454 YFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGP 513
             D+    +SG  P +IGNL NL  + L  N L+G +P +LGKL  L+ L L  N+L G 
Sbjct: 365 TLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGG 424

Query: 514 IPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGML 572
           IP  I  +T L  L LS N   G +P    N + L  L +G NKL  +IPL I  ++ +L
Sbjct: 425 IPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLL 484

Query: 573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS 632
            L+ S N   G LP DIG L+ L  +    N  S  +P  +G    ++ LFL  N   G 
Sbjct: 485 RLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGD 544

Query: 633 ISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSA 692
           I +  G L+ +K ++LSNN+LS SIP      S LE L+LSFN L+G++P  G F N + 
Sbjct: 545 IPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATT 603

Query: 693 KSFEGNELLCGS-PNLQVPPCKTSI-----HHKSRKNVLLLGIVLPLS---TIFIIVVIL 743
            S  GN  LCG     Q+ PC +        H SR   +++G+ + ++    +F+  V L
Sbjct: 604 VSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTL 663

Query: 744 LIVRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKA-RIG 802
           + +R RK+ K+  N           + SY +L  ATN FS +N++G G FG+VYKA  + 
Sbjct: 664 IWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLT 723

Query: 803 EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST-----EEFKALILEY 857
           E   VAVKV ++Q   A KSF  ECE +K IRHRNL+K++++CS+      EF+ALI E+
Sbjct: 724 EKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEF 783

Query: 858 MPHGSLE--------KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPS 909
           MP+GSL+        + ++  +  L + +RLNI +DVA+ L+YLH     P+ HCDLKPS
Sbjct: 784 MPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPS 843

Query: 910 NVLLDDNMVAHLSDFGIAKLLIGEDQ-----SITQTQTLATIGYMAP 951
           NVLLDD++ AH+SDFG+A+LL+  D+      ++      TIGY AP
Sbjct: 844 NVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAP 890

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  489 bits (1260), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 330/946 (34%), Positives = 486/946 (51%), Gaps = 107/946 (11%)

Query: 38  TDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTI 97
           TD  ALL  K+ ++ +    +  +WN S+P CNW GVTC     RV              
Sbjct: 30  TDMQALLEFKSQVSENNKREVLASWNHSSPFCNWIGVTCGRRRERVI------------- 76

Query: 98  PSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQH 157
                      SLNLG  +L+G I  +I  L  L+ +N   N      P  +     LQ+
Sbjct: 77  -----------SLNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQY 125

Query: 158 LDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGA 217
           L+                         +S N+  GRIPS+LSNC  L  + LS N+L   
Sbjct: 126 LN-------------------------MSYNLLEGRIPSSLSNCSRLSTVDLSSNHLGHG 160

Query: 218 IPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLE 277
           +P E+G+L+K                        L ++ L  +NL G  P  L NLT L+
Sbjct: 161 VPSELGSLSK------------------------LAILDLSKNNLTGNFPASLGNLTSLQ 196

Query: 278 VLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGS 337
            L    N + GEIP E+  L  +    ++ N   G  P  ++N+S+L  L L  NS SG+
Sbjct: 197 KLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGN 256

Query: 338 LSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNL 397
           L +     LPNL  L L +N F+G IP+ + N S L   ++  N  SG IP +FG LRNL
Sbjct: 257 LRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNL 316

Query: 398 RLMTLH-YNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFD 456
             + +   +   +S+  L F+ + +NC  L Y+ +  N L G LP  S+ NLS +L    
Sbjct: 317 WWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLF 375

Query: 457 MSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPD 516
           +    +SG  P +IGNL +L  + L  N L+G +P++ GKL  LQ + L  N + G IP 
Sbjct: 376 LGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPS 435

Query: 517 DICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLN 575
               +T+L +L L+ N   G IP        L  L + +N+L  +IP  I  +  + Y++
Sbjct: 436 YFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYID 495

Query: 576 FSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISE 635
            S+NF TG  P ++G L++L+G+  S N  S  +P  IGG  ++++LF+  N   G+I +
Sbjct: 496 LSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD 555

Query: 636 SFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSF 695
               L+SLK+++ SNNNLS  IP  L  L  L +L+LS NK +G +P  G F N +A S 
Sbjct: 556 -ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSV 614

Query: 696 EGNELLCGS-PNLQVPPCKTSIHHKSRKNV-----LLLGIVLPLSTIFIIVVILLIVRYR 749
            GN  +CG    +Q+ PC      + RK +     ++ GI + ++++ +I+++  +  + 
Sbjct: 615 FGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFM 674

Query: 750 KRVKQPPNDANMPPIATC-----RRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG-E 803
           KR K+       P  +T       + SY EL  AT+RFS  NLIG G FG+V+K  +G E
Sbjct: 675 KRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPE 734

Query: 804 GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST-----EEFKALILEYM 858
              VAVKV +L    A KSF  ECE  K IRHRNL+K+I+ CS+      +F+AL+ E+M
Sbjct: 735 NKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFM 794

Query: 859 PHGSLE--------KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSN 910
           P GSL+        + +   +  L   ++LNI +DVA+ LEYLH     PV HCD+KPSN
Sbjct: 795 PKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSN 854

Query: 911 VLLDDNMVAHLSDFGIAKLLIGEDQ-----SITQTQTLATIGYMAP 951
           +LLDD++ AH+SDFG+A+LL   D+       +      TIGY AP
Sbjct: 855 ILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  449 bits (1154), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 369/1114 (33%), Positives = 526/1114 (47%), Gaps = 202/1114 (18%)

Query: 36   ITTDQDALLALKAHITHDPT-NFLAKNWNTST-PVCNWTGVTCD-VHSHRVKVLNISHLN 92
            I  D   LL +K  +  +P  +   + WN+     C+WTGVTCD     RV  LN++ L 
Sbjct: 23   INNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLG 82

Query: 93   LTGTI------------------------PSQLWNLSSLQSLNLGFNRLSGSIPSAIFTL 128
            LTG+I                        P+ L NL+SL+SL L  N+L+G IPS + +L
Sbjct: 83   LTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSL 142

Query: 129  YTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN 188
              ++ +    N+L G  P  + N  +LQ L  +   L+G IP+ +   L  ++S+ L  N
Sbjct: 143  VNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQL-GRLVRVQSLILQDN 201

Query: 189  MFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGN 248
               G IP+ L NC  L + + + N L G IP E+G L  L+ L L  + L GEIP + G 
Sbjct: 202  YLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGE 261

Query: 249  LAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNL----------- 297
            +++L+ ++L  + LQG IP+ LA+L  L+ L L  N LTGEIP E  N+           
Sbjct: 262  MSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANN 321

Query: 298  --------------------------------------HNLKLLDLSHNKLVGAVPATIF 319
                                                   +LK LDLS+N L G++P  +F
Sbjct: 322  HLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALF 381

Query: 320  NMSTLTGLGLQSNSLSGSLS-SIADV---------------QLPN-------LEELRLWS 356
             +  LT L L +N+L G+LS SI+++               +LP        LE L L+ 
Sbjct: 382  ELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYE 441

Query: 357  NNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYL--------- 407
            N FSG IP+ I N + L ++++  N F G IP + G L+ L L+ L  N L         
Sbjct: 442  NRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLG 501

Query: 408  ----------TSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP-------RMSMGNLSH 450
                        + L  S  SSF   K L  + L NN L G LP        ++  NLSH
Sbjct: 502  NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSH 561

Query: 451  --------------SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGK 496
                          S   FD++        P E+GN  NL  + LG N+L G IP TLGK
Sbjct: 562  NRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGK 621

Query: 497  LQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN 556
            +++L  L +  N L G IP  +    KL  + L+ N LSG IP     L+ LG L L SN
Sbjct: 622  IRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSN 681

Query: 557  K-LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGG 615
            + + S+P  ++N   +L L+   N   G +P +IGNL  L  ++   N FS  +P  +G 
Sbjct: 682  QFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGK 741

Query: 616  LTNLQYLFLGYNRLQGSISESFGDLISLKS-LNLSNNNLSRSIPISLEKLSYLEDLDLSF 674
            L+ L  L L  N L G I    G L  L+S L+LS NN +  IP ++  LS LE LDLS 
Sbjct: 742  LSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSH 801

Query: 675  NKLKGEIPK------------------GG----SFGNFSAKSFEGNELLCGSPNLQVPPC 712
            N+L GE+P                   GG     F  + A SF GN  LCGSP  +    
Sbjct: 802  NQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRV 861

Query: 713  KTSIHHK--SRKNVLLLGIVLPLSTI-FIIVVILLIVRYR----KRVKQPPN-------- 757
            +++   +  S ++V+++  +  L+ I  +I+VI L  + R    K+V             
Sbjct: 862  RSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSS 921

Query: 758  -DANMPPI----ATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF 812
              A   P+    A+     + ++  AT+  SE  +IG GG G VYKA +  G  VAVK  
Sbjct: 922  SQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI 981

Query: 813  ----DLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFKALILEYMPHGSLEKS 866
                DL      KSF  E + +  IRHR+L+K++  CS+  E    LI EYM +GS+   
Sbjct: 982  LWKDDLMSN---KSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDW 1038

Query: 867  LYSSNYIL-------DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 919
            L+    +L       D   RL I V +A  +EYLH     P++H D+K SNVLLD NM A
Sbjct: 1039 LHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEA 1098

Query: 920  HLSDFGIAKLLIGEDQSITQTQTL--ATIGYMAP 951
            HL DFG+AK+L     + T + T    + GY+AP
Sbjct: 1099 HLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  436 bits (1122), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 342/974 (35%), Positives = 504/974 (51%), Gaps = 117/974 (12%)

Query: 19  LILISLLTAAATANTSSIT----------TDQDALLALKAHITHDPTNFLAKNWNTSTPV 68
           LIL+S L  + +   S +           TD+ ALL  K+ ++ + +  +  +WN S P+
Sbjct: 10  LILVSALLVSVSLEHSDMVCAQTIRLTEETDKQALLEFKSQVS-ETSRVVLGSWNDSLPL 68

Query: 69  CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTL 128
           C+WTGV C           + H  +TG                                 
Sbjct: 69  CSWTGVKC----------GLKHRRVTG--------------------------------- 85

Query: 129 YTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN 188
                V+  G +L+G    F+                          NL FL S++L+ N
Sbjct: 86  -----VDLGGLKLTGVVSPFV-------------------------GNLSFLRSLNLADN 115

Query: 189 MFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGN 248
            FHG IPS + N   L+ L++S N   G IP  + N + L  L L  + L+  +P EFG+
Sbjct: 116 FFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNCSSLSTLDLSSNHLEQGVPLEFGS 175

Query: 249 LAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHN 308
           L++L L++L  +NL G+ P  L NLT L++L    N + GEIP +I  L  +    ++ N
Sbjct: 176 LSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALN 235

Query: 309 KLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
           K  G  P  I+N+S+L  L +  NS SG+L       LPNL+ L +  N+F+GTIP  + 
Sbjct: 236 KFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLS 295

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS-SNLELSFLSSFSNCKSLT 427
           N S L  L++  N  +G IP +FG L+NL L+ L+ N L + S+ +L FL + +NC  L 
Sbjct: 296 NISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQ 355

Query: 428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
           Y+ +  N L G LP + + NLS  L    +    +SG  P  IGNL +L  + LG N L 
Sbjct: 356 YLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLT 414

Query: 488 GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLAS 547
           G +P +LG+L +L+ + L  N L G IP  +  ++ L  L L  N   GSIP+   + + 
Sbjct: 415 GKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSY 474

Query: 548 LGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
           L  L+LG+NKL  SIP  +  L  ++ LN S N   GPL  DIG LK L+ +D S N  S
Sbjct: 475 LLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLS 534

Query: 607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY 666
             IP  +    +L++L L  N   G I +  G L  L+ L+LS NNLS +IP  +   S 
Sbjct: 535 GQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSK 593

Query: 667 LEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGS-PNLQVPPCKTSI---HHKSRK 722
           L++L+LS N   G +P  G F N SA S  GN  LCG  P+LQ+ PC   +   H   RK
Sbjct: 594 LQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRK 653

Query: 723 NVLLLGIVLPLSTIFIIVVILLIVRYRKRVKQP-----PNDANMPPIAT-CRRFSYLELC 776
            + +    +  + + + + ++ +  Y+ RVK        ND +  P+ +   + SY EL 
Sbjct: 654 IITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELY 713

Query: 777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
           + T  FS +NLIG G FG+V+K  +G +   VA+KV +L    A KSF  ECE +  IRH
Sbjct: 714 KTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRH 773

Query: 836 RNLIKVISSCSTE-----EFKALILEYMPHGSLEKSLYSS--------NYILDIFQRLNI 882
           RNL+K+++ CS+      +F+AL+ E+MP+G+L+  L+          +  L +F RLNI
Sbjct: 774 RNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNI 833

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ- 941
            +DVA+ L YLH     P+ HCD+KPSN+LLD ++ AH+SDFG+A+LL+  D+     Q 
Sbjct: 834 AIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQF 893

Query: 942 ----TLATIGYMAP 951
                  TIGY AP
Sbjct: 894 SSAGVRGTIGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  429 bits (1104), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 317/944 (33%), Positives = 476/944 (50%), Gaps = 129/944 (13%)

Query: 93   LTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNK 152
            L G++P++L  L +LQ+LNLG N  SG IPS +  L +++Y+N  GNQL G  P  +   
Sbjct: 228  LNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTEL 287

Query: 153  SSLQHLDFS------------------------YNALSGEIPANICSNLPFLESISLSQN 188
            ++LQ LD S                         N LSG +P  ICSN   L+ + LS+ 
Sbjct: 288  ANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSET 347

Query: 189  MFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGN 248
               G IP+ +SNC+ L++L LS N L G IP  +  L +L  LYL  + L+G +     N
Sbjct: 348  QLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISN 407

Query: 249  LAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHN 308
            L  L+   L  +NL+G++P+E+  L  LE++ L +N  +GE+P EI N   L+ +D   N
Sbjct: 408  LTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGN 467

Query: 309  KLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
            +L G +P++I  +  LT L L+ N L G+                         IP  + 
Sbjct: 468  RLSGEIPSSIGRLKDLTRLHLRENELVGN-------------------------IPASLG 502

Query: 369  NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY 428
            N  +++V++L  N  SG IP++FG L  L L  ++ N     +L+ +   S  N K+LT 
Sbjct: 503  NCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNN-----SLQGNLPDSLINLKNLTR 557

Query: 429  IGLSNNPLDGILPRMSMGNLSHSLEY--FDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKL 486
            I  S+N  +G     S+  L  S  Y  FD++     G  P E+G  TNL  + LG N+ 
Sbjct: 558  INFSSNKFNG-----SISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQF 612

Query: 487  NGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLA 546
             G IP T GK+ +L  L +  N L G IP ++    KL  + L+ N LSG IP     L 
Sbjct: 613  TGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLP 672

Query: 547  SLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNF 605
             LG L L SNK   S+P  I++L  +L L    N   G +P +IGNL+ L  ++   N  
Sbjct: 673  LLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQL 732

Query: 606  SDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKS-LNLSNNNLSRSIPISLEKL 664
            S  +P+ IG L+ L  L L  N L G I    G L  L+S L+LS NN +  IP ++  L
Sbjct: 733  SGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTL 792

Query: 665  SYLEDLDLSFNKLKGEIPK----------------------GGSFGNFSAKSFEGNELLC 702
              LE LDLS N+L GE+P                          F  + A +F GN  LC
Sbjct: 793  PKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLC 852

Query: 703  GSPNLQVPPCKTSIHHKSR----KNVLLLGIVLPLSTIFIIVVILLIVRYR-----KRVK 753
            GSP   +  C  +     R    K V+++  +  L+ I ++V+++++   +     K+V+
Sbjct: 853  GSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVR 909

Query: 754  -------------QPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR 800
                         Q P  +N    +  +   + ++  AT+  +E  +IG GG G VYKA 
Sbjct: 910  GGNSAFSSNSSSSQAPLFSNGGAKSDIK---WDDIMEATHYLNEEFMIGSGGSGKVYKAE 966

Query: 801  IGEGMEVAVKVF----DLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE--FKALI 854
            +  G  +AVK      DL      KSF+ E + + +IRHR+L+K++  CS++      LI
Sbjct: 967  LKNGETIAVKKILWKDDLMSN---KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLI 1023

Query: 855  LEYMPHGSLEKSLYSSN-----YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPS 909
             EYM +GS+   L+++       +L    RL I + +A  +EYLH+    P++H D+K S
Sbjct: 1024 YEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSS 1083

Query: 910  NVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL--ATIGYMAP 951
            NVLLD N+ AHL DFG+AK+L G   + T++ T+   + GY+AP
Sbjct: 1084 NVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAP 1127

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  423 bits (1088), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 326/1006 (32%), Positives = 494/1006 (49%), Gaps = 117/1006 (11%)

Query: 16  LHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNW---NTSTPVCNWT 72
           L  L++IS++ + + A  S+   + +ALL  K+  T+  ++    +W   NTS+   +W 
Sbjct: 28  LQVLLIISIVLSCSFA-VSATVEEANALLKWKSTFTNQTSSSKLSSWVNPNTSSFCTSWY 86

Query: 73  GVTCDVHSHRVKVLNISHLNLTGTIPS-QLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTL 131
           GV C + S  +  LN+++  + GT       +L +L  ++L  NR SG+I          
Sbjct: 87  GVACSLGS--IIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTI---------- 134

Query: 132 KYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
                  + L G F       S L++ D S N L GEIP  +  +L  L+++ L +N  +
Sbjct: 135 -------SPLWGRF-------SKLEYFDLSINQLVGEIPPEL-GDLSNLDTLHLVENKLN 179

Query: 192 GRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAE 251
           G IPS +     +  +++  N L G IP   GNLTKL  LYL  + L G IP E GNL  
Sbjct: 180 GSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPN 239

Query: 252 LELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLV 311
           L  + L  +NL G+IP    NL  + +L + +N L+GEIPPEI N+  L  L L  NKL 
Sbjct: 240 LRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLT 299

Query: 312 GAVPATIFNMSTLTGLGLQSNSLSGS-------LSSIADVQ----------------LPN 348
           G +P+T+ N+ TL  L L  N L+GS       + S+ D++                L  
Sbjct: 300 GPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTA 359

Query: 349 LEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTF---GNLRNLRLMTLHYN 405
           LE L L  N  SG IP  I N+++L+VL+L  N+F+GF+P+T    G L NL L   H+ 
Sbjct: 360 LEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHF- 418

Query: 406 YLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG 465
                  E     S  +CKSL  +    N   G +   + G +  +L + D+S  N  G 
Sbjct: 419 -------EGPVPKSLRDCKSLIRVRFKGNSFSGDISE-AFG-VYPTLNFIDLSNNNFHGQ 469

Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLY 525
                     L+   L  N + G+IP  +  + +L  L L  N++ G +P+ I  + ++ 
Sbjct: 470 LSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRIS 529

Query: 526 ELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPL 585
           +L L+GN+LSG IP+    L +L                        YL+ SSN F+  +
Sbjct: 530 KLQLNGNRLSGKIPSGIRLLTNLE-----------------------YLDLSSNRFSSEI 566

Query: 586 PLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKS 645
           P  + NL  L  ++ S N+    IP  +  L+ LQ L L YN+L G IS  F  L +L+ 
Sbjct: 567 PPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLER 626

Query: 646 LNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP 705
           L+LS+NNLS  IP S + +  L  +D+S N L+G IP   +F N    +FEGN+ LCGS 
Sbjct: 627 LDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSV 686

Query: 706 NLQ--VPPCKTSIHHKSRKNV-LLLGIVLPLSTIFIIVVIL--LIVRYRKRVKQPPNDAN 760
           N    + PC  +   KS K+  L++ I++P+    II+ +   + + +RKR KQ     +
Sbjct: 687 NTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTD 746

Query: 761 -------MPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFD 813
                  +   +   +  Y E+ +AT  F    LIG GG G VYKA++   + +AVK  +
Sbjct: 747 SESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLN 805

Query: 814 LQCGRAF------KSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSL 867
                +       + F  E   +  IRHRN++K+   CS      L+ EYM  GSL K L
Sbjct: 806 ETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVL 865

Query: 868 YSSNYI--LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
            + +    LD  +R+N++  VA  L Y+H   S  ++H D+   N+LL ++  A +SDFG
Sbjct: 866 ENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFG 925

Query: 926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSF 971
            AKLL  +  S   +    T GY+AP L    Y + V      YSF
Sbjct: 926 TAKLL--KPDSSNWSAVAGTYGYVAPEL---AYAMKVTEKCDVYSF 966

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1

 Score =  420 bits (1079), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 338/1015 (33%), Positives = 493/1015 (48%), Gaps = 123/1015 (12%)

Query: 10  MSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNW--NTS-T 66
           M     L   +L SL       + SS+ +D  ALL+L  H    P   +A  W  NTS T
Sbjct: 1   MRNLGLLEITLLCSLFVYFRIDSVSSLNSDGLALLSLLKHFDKVPLE-VASTWKENTSET 59

Query: 67  PVCN--WTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSA 124
             CN  W GV CD+  + V+ LN+S   L+G + S++  L SL +L+L  N  SG +PS 
Sbjct: 60  TPCNNNWFGVICDLSGNVVETLNLSASGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPST 119

Query: 125 IFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDF------------------------ 160
           +    +L+Y++   N  SG  P  IF   SLQ+L F                        
Sbjct: 120 LGNCTSLEYLDLSNNDFSGEVPD-IF--GSLQNLTFLYLDRNNLSGLIPASVGGLIELVD 176

Query: 161 ---SYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL------------------- 198
              SYN LSG IP  +  N   LE ++L+ N  +G +P++L                   
Sbjct: 177 LRMSYNNLSGTIPE-LLGNCSKLEYLALNNNKLNGSLPASLYLLENLGELFVSNNSLGGR 235

Query: 199 -----SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELE 253
                SNCK L  L LS N+  G +P EIGN + L  L +    L G IP   G L ++ 
Sbjct: 236 LHFGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVS 295

Query: 254 LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGA 313
           ++ L  + L G IPQEL N + LE LKL  N L GEIPP +  L  L+ L+L  NKL G 
Sbjct: 296 VIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGE 355

Query: 314 VPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKL 373
           +P  I+ + +LT + + +N+L+G L  +   QL +L++L L++N F G IP  +     L
Sbjct: 356 IPIGIWKIQSLTQMLVYNNTLTGELP-VEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSL 414

Query: 374 SVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSN 433
             ++L  N F+G IP    + + LRL  L  N L          +S   CK+L  + L +
Sbjct: 415 EEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGK-----IPASIRQCKTLERVRLED 469

Query: 434 NPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPIT 493
           N L G+LP       S SL Y ++   +  G  P+ +G+  NL+ I L  NKL G IP  
Sbjct: 470 NKLSGVLPEFPE---SLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPE 526

Query: 494 LGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL 553
           LG LQ L  L+L  N LEGP+P  +    +L    +  N L+GSIP+ F +  SL TL L
Sbjct: 527 LGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVL 586

Query: 554 GSNK-LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVL-IGIDFSTNNFSDVIPT 611
             N  L +IP  +  L  +  L  + N F G +P  +G LK L  G+D S N F+  IPT
Sbjct: 587 SDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPT 646

Query: 612 VIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLD 671
            +G L NL                        + LN+SNN L+  + + L+ L  L  +D
Sbjct: 647 TLGALINL------------------------ERLNISNNKLTGPLSV-LQSLKSLNQVD 681

Query: 672 LSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPP--------CKTSIHHKSRKN 723
           +S+N+  G IP   +  + S+K F GN  LC   +  V          CK  +   + K 
Sbjct: 682 VSYNQFTGPIPV--NLLSNSSK-FSGNPDLCIQASYSVSAIIRKEFKSCKGQVKLSTWKI 738

Query: 724 VLLLGIVLPLSTIFIIVVILLIVRYRKRVKQPPNDANMPPIATCRRFSYL--ELCRATNR 781
            L+           +  + L++ R ++  K    DAN   I      S L  ++  AT+ 
Sbjct: 739 ALIAAGSSLSVLALLFALFLVLCRCKRGTKT--EDAN---ILAEEGLSLLLNKVLAATDN 793

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVK--VFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
             +  +IGRG  G VY+A +G G E AVK  +F     RA ++   E E +  +RHRNLI
Sbjct: 794 LDDKYIIGRGAHGVVYRASLGSGEEYAVKKLIFAEHI-RANQNMKREIETIGLVRHRNLI 852

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNY---ILDIFQRLNIMVDVATTLEYLHFG 896
           ++      +E   ++ +YMP+GSL   L+  N    +LD   R NI + ++  L YLH  
Sbjct: 853 RLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHHD 912

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              P+IH D+KP N+L+D +M  H+ DFG+A++L  +D +++      T GY+AP
Sbjct: 913 CHPPIIHRDIKPENILMDSDMEPHIGDFGLARIL--DDSTVSTATVTGTTGYIAP 965

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  417 bits (1072), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 336/1035 (32%), Positives = 496/1035 (47%), Gaps = 123/1035 (11%)

Query: 18  CLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNT--STPVCNWTGVT 75
           C + I +L + +     S+  +   LL  KA + +D   +LA +WN   S P CNWTG+ 
Sbjct: 6   CFLAIVILCSFSFILVRSLNEEGRVLLEFKAFL-NDSNGYLA-SWNQLDSNP-CNWTGIA 62

Query: 76  CDVHSHRVKVLNISHLNLTGT------------------------IPSQLWNLSSLQSLN 111
           C  H   V  ++++ +NL+GT                        IP  L    SL+ L+
Sbjct: 63  C-THLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLD 121

Query: 112 LGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPA 171
           L  NR  G IP  +  + TLK +    N L G+ P  I N SSLQ L    N L+G IP 
Sbjct: 122 LCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPP 181

Query: 172 NICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKEL 231
           ++ + L  L  I   +N F G IPS +S C+ L++L L+ N L G++PK++  L  L +L
Sbjct: 182 SM-AKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDL 240

Query: 232 YLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIP 291
            L  + L GEIP   GN++ LE++AL  +   G IP+E+  LT ++ L L  N LTGEIP
Sbjct: 241 ILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIP 300

Query: 292 PEIHNL----------------------H--NLKLLDLSHNKLVGAVPATIFNMSTLTGL 327
            EI NL                      H  NLKLL L  N L+G +P  +  ++ L  L
Sbjct: 301 REIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKL 360

Query: 328 GLQSNSLSGSLSSIADVQ-LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGF 386
            L  N L+G++    ++Q LP L +L+L+ N   G IP  I   S  SVL++  NS SG 
Sbjct: 361 DLSINRLNGTIPQ--ELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGP 418

Query: 387 IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMG 446
           IP  F   + L L++L  N L+ +            CKSLT + L +N L G LP + + 
Sbjct: 419 IPAHFCRFQTLILLSLGSNKLSGN-----IPRDLKTCKSLTKLMLGDNQLTGSLP-IELF 472

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
           NL  +L   ++    +SG    ++G L NL  + L  N   G IP  +G L K+ G ++ 
Sbjct: 473 NL-QNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNIS 531

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTI 565
            N+L G IP ++     +  L LSGNK SG I      L  L  L L  N+LT  IP + 
Sbjct: 532 SNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSF 591

Query: 566 WNLKGMLYLNFSSNFFTGPLPLDIGNLKVL-IGIDFSTNNFSDVIPTVIGGLTNLQYLFL 624
            +L  ++ L    N  +  +P+++G L  L I ++ S NN S  IP  +G L  L+ L+L
Sbjct: 592 GDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYL 651

Query: 625 GYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG 684
             N+L G I  S G+L+SL   N+SNNNL                         G +P  
Sbjct: 652 NDNKLSGEIPASIGNLMSLLICNISNNNLV------------------------GTVPDT 687

Query: 685 GSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHK----------SRKNVLLLGIVLPLS 734
             F    + +F GN  LC S   Q   C+  + H           S++  +L    + + 
Sbjct: 688 AVFQRMDSSNFAGNHGLCNS---QRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIG 744

Query: 735 TIFIIVVILLIVRYRKRVKQPP----NDANMPPIATC-----RRFSYLELCRATNRFSEN 785
           ++F+I  + L    ++R  +P      D   P +        + F+Y  L  AT  FSE+
Sbjct: 745 SVFLITFLGLCWTIKRR--EPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSED 802

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDL--QCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
            ++GRG  G+VYKA +  G  +AVK  +   +   +  SF  E   +  IRHRN++K+  
Sbjct: 803 VVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYG 862

Query: 844 SCSTEEFKALILEYMPHGSLEKSLY--SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
            C  +    L+ EYM  GSL + L     N +LD   R  I +  A  L YLH      +
Sbjct: 863 FCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQI 922

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILF 961
           +H D+K +N+LLD+   AH+ DFG+AK LI    S + +    + GY+AP      Y + 
Sbjct: 923 VHRDIKSNNILLDERFQAHVGDFGLAK-LIDLSYSKSMSAVAGSYGYIAP---EYAYTMK 978

Query: 962 VVNFLTSYSFLMIFI 976
           V      YSF ++ +
Sbjct: 979 VTEKCDIYSFGVVLL 993

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  411 bits (1057), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 334/997 (33%), Positives = 490/997 (49%), Gaps = 74/997 (7%)

Query: 33  TSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPV-CNWTGVTCDVHSH---------- 81
           T+ +  +   LL +K+       N   +NWN++  V C WTGV C  +S           
Sbjct: 24  TTGLNLEGQYLLEIKSKFVDAKQNL--RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLS 81

Query: 82  ----------------RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAI 125
                            +K L++S+  L+G IP ++ N SSL+ L L  N+  G IP  I
Sbjct: 82  SMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEI 141

Query: 126 FTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISL 185
             L +L+ +    N++SG+ P  I N  SL  L    N +SG++P +I  NL  L S   
Sbjct: 142 GKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSI-GNLKRLTSFRA 200

Query: 186 SQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE 245
            QNM  G +PS +  C+ L +L L+ N L G +PKEIG L KL ++ L  +   G IPRE
Sbjct: 201 GQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPRE 260

Query: 246 FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDL 305
             N   LE +AL  + L G IP+EL +L  LE L L +N L G IP EI NL     +D 
Sbjct: 261 ISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDF 320

Query: 306 SHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPR 365
           S N L G +P  + N+  L  L L  N L+G++  +    L NL +L L  N  +G IP 
Sbjct: 321 SENALTGEIPLELGNIEGLELLYLFENQLTGTI-PVELSTLKNLSKLDLSINALTGPIPL 379

Query: 366 FIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
                  L +L+L +NS SG IP   G   +L ++ +  N+L  S    S+L   SN   
Sbjct: 380 GFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHL--SGRIPSYLCLHSN--- 434

Query: 426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNK 485
           +  + L  N L G +P  +      +L    ++  N+ G FP  +    N+  I LG N+
Sbjct: 435 MIILNLGTNNLSGNIP--TGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNR 492

Query: 486 LNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNL 545
             GSIP  +G    LQ L L DN   G +P +I  L++L  L +S NKL+G +P+   N 
Sbjct: 493 FRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNC 552

Query: 546 ASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN 604
             L  L +  N  + ++P  + +L  +  L  S+N  +G +P+ +GNL  L  +    N 
Sbjct: 553 KMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNL 612

Query: 605 FSDVIPTVIGGLTNLQY-LFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEK 663
           F+  IP  +G LT LQ  L L YN+L G I     +L+ L+ L L+NNNLS  IP S   
Sbjct: 613 FNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFAN 672

Query: 664 LSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP---NLQVPPCKTSIH--- 717
           LS L   + S+N L G IP      N S  SF GNE LCG P    +Q  P   S     
Sbjct: 673 LSSLLGYNFSYNSLTGPIPL---LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGK 729

Query: 718 ---HKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRV-------KQPPN---DANMPPI 764
               +S K + +   V+   ++ +I +I+ ++R   R         QP     D   PP 
Sbjct: 730 PGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPK 789

Query: 765 ATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF--DLQCG---RA 819
                F++ +L  AT+ F E+ ++GRG  G+VYKA +  G  +AVK    + + G     
Sbjct: 790 ---EGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNV 846

Query: 820 FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQR 879
             SF  E   + +IRHRN++K+   C+ +    L+ EYMP GSL + L+  +  LD  +R
Sbjct: 847 DNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKR 906

Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
             I +  A  L YLH      + H D+K +N+LLDD   AH+ DFG+AK +I    S + 
Sbjct: 907 FKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPHSKSM 965

Query: 940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFI 976
           +    + GY+AP      Y + V      YS+ ++ +
Sbjct: 966 SAIAGSYGYIAP---EYAYTMKVTEKSDIYSYGVVLL 999

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	982
359483198	1087	PREDICTED: probable LRR receptor-like se	0.938	0.848	0.484	0.0
255572272	1089	serine-threonine protein kinase, plant-t	0.926	0.835	0.470	0.0
224116832	1061	predicted protein [Populus trichocarpa]	0.909	0.841	0.495	0.0
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.901	0.846	0.472	0.0
224139658	1019	predicted protein [Populus trichocarpa]	0.898	0.865	0.464	0.0
449465016	1092	PREDICTED: probable LRR receptor-like se	0.935	0.841	0.461	0.0
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.869	0.587	0.475	0.0
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.926	0.798	0.440	0.0
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.883	0.699	0.474	0.0
255578886	1043	serine-threonine protein kinase, plant-t	0.922	0.868	0.481	0.0

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  788 bits (2036), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 464/958 (48%), Positives = 601/958 (62%), Gaps = 36/958 (3%)

Query: 27  AAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVL 86
           +A  A + S  TDQ +LLALKAHIT DP + LA NW+T T  C W GV+C+    RV  L
Sbjct: 20  SACVAMSLSNFTDQSSLLALKAHITLDPHHVLAGNWSTKTSFCEWIGVSCNAQQQRVIAL 79

Query: 87  NISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFP 146
           ++S+L L GTIP  L NLS L SL+L  N   G +P  +  L +L  +N + N LSG  P
Sbjct: 80  DLSNLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNLQYNLLSGQIP 139

Query: 147 SFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEI 206
               N + LQ L    N+ +G IP +I  N+  LE++ L  N   G IP  +     ++I
Sbjct: 140 PSFGNLNRLQSLFLGNNSFTGTIPPSI-GNMSMLETLGLGGNHLQGNIPEEIGKLSTMKI 198

Query: 207 LSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGN------------------ 248
           L +  N L+GAIP  I N++ L+E+ L Y+ L G++P    N                  
Sbjct: 199 LDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTG 258

Query: 249 --------LAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNL 300
                     EL+ + L  +   G IP+ + +LT L +L L  N L+GE+P EI +L  L
Sbjct: 259 PIPSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTL 318

Query: 301 KLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS 360
            +L++  N L G +P  IFN+S++    L  N+LSG+L       LPNLE L L  N  S
Sbjct: 319 NVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLENLILEINWLS 378

Query: 361 GTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNL--ELSFLS 418
           G IP  I NASKL  L+ G N  +G IP+  G+LR L  + L  N L   +   ELSFL+
Sbjct: 379 GIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLT 438

Query: 419 SFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG 478
           S +NCK L  + LS NPL GILP +S+GNLS SL+ F+ + C + G  P EIGNL+NL  
Sbjct: 439 SLTNCKRLRILYLSFNPLIGILP-ISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYL 497

Query: 479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSI 538
           + L  N L G+IP ++G+LQKLQGL+L  NKL+G IP+DIC+L  L EL L+ N+LSGSI
Sbjct: 498 LSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSI 557

Query: 539 PACFSNLASLGTLSLGSNKLTS-IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIG 597
           PAC   L  L  L LGSNKL S IP T+W+L  +L L+ SSNF  G LP D+GNLKVL+ 
Sbjct: 558 PACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVK 617

Query: 598 IDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSI 657
           ID S N  S  IP+ IGGL +L  L L +NR +G I  SF +L SL+ ++LS+N L   I
Sbjct: 618 IDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEI 677

Query: 658 PISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIH 717
           P SLE L YL+ LD+SFN L GEIP  G F NFSA+SF  N+ LCGSP L++PPC+T   
Sbjct: 678 PKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTR 737

Query: 718 HKSRKNVLLLGIVLP--LSTIFIIVVILLIVRYRKRVKQPPNDANMPPIATCRRFSYLEL 775
             +  + LLL  +LP  LST+  + +I +  R RKR    P  +     AT RR SY E+
Sbjct: 738 WSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRISYQEI 797

Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
            +ATN FS  NL+GRG  GSVY+  + +G   A+KVF+LQ   AFKSFD ECE+M  IRH
Sbjct: 798 FQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRH 857

Query: 836 RNLIKVISSCSTE--EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RNLIK++SSCS    +FKAL+LEY+P+GSLE+ LYS NY LDI QRLNIM+DVA  +EYL
Sbjct: 858 RNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYL 917

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H G S PV+HCDLKPSN+LLD++   H+ DFGIAKLL  E++SI +TQTLATIGYMAP
Sbjct: 918 HHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLL-REEESIRETQTLATIGYMAP 974

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  786 bits (2031), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 445/945 (47%), Positives = 611/945 (64%), Gaps = 35/945 (3%)

Query: 38  TDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTI 97
           TD  ALL LK H   DP  F++KNW+++T  C+W GVTC    +RV  L +S++ + G +
Sbjct: 30  TDLSALLVLKEHSNFDP--FMSKNWSSATSFCHWYGVTCSERHNRVVALTLSNMGIKGIV 87

Query: 98  PSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSF--------- 148
           P  + NLS L  +++  N  SG +P+ +  L+ LK++NF  N   G  PS          
Sbjct: 88  PPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFMNFSNNSFVGEIPSSLAMLPKLQH 147

Query: 149 --------------IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI 194
                         IFN ++L  LD + N L G I  NI  NL  L+ +++  N   G  
Sbjct: 148 LLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILDNIGGNLSNLQVLNMGLNQLSGSF 207

Query: 195 PSALSNCKYLEILSLSINNLLGAIPKEIGNL-TKLKELYLGYSGLQGEIPREFGNLAELE 253
           P  + +   L+ + L +NNL G + + + N  +KL+ L L  + L G+IP +     EL 
Sbjct: 208 PPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQLLNLAGNQLYGQIPSDLYKCKELR 267

Query: 254 LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGA 313
            +AL  +   G IP+ + NLT L+ L LG+N LTG IP EI NL NL+++ LS N L G+
Sbjct: 268 SLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPLEIGNLQNLQIVHLSFNNLNGS 327

Query: 314 VPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKL 373
           +P  +FN+ST+  + + SN+L G+L +   + LPNL  L L  N  SG IP +I NASKL
Sbjct: 328 IPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWLYLGINKLSGPIPSYISNASKL 387

Query: 374 SVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS--SNLELSFLSSFSNCKSLTYIGL 431
           ++LEL  NSF+GFIP++ G+LRNL+ + L  N L+S  ++ EL+  SS  NC++L Y+ L
Sbjct: 388 TILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQELTIFSSLKNCQNLKYLWL 447

Query: 432 SNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP 491
           S NPLDG LP  S+GNLS+SLE F  S   + G   + IGNL++L  + LG N L G IP
Sbjct: 448 SYNPLDGYLPH-SVGNLSNSLESFLASDGLIKGSVHESIGNLSSLTRLNLGNNDLTGRIP 506

Query: 492 ITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTL 551
            T+G L+ LQGL+L  N L+G IP ++C L  LY L L+GNKLSGSIP CFSNL SL  L
Sbjct: 507 TTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKLSGSIPTCFSNLTSLRNL 566

Query: 552 SLGSNKLTS-IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP 610
            L SN+  S I  T+W LK +L +N +SN+ TG LP +I NL+ +  I+ S N  S  IP
Sbjct: 567 FLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLRAVYMINISKNQLSGEIP 626

Query: 611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDL 670
             IGGL +L  L+L  N+LQG I +S GD+ SL+ L+LS+NNLS  IP SL+ L YL+  
Sbjct: 627 ISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNLSGMIPKSLDNLLYLKYF 686

Query: 671 DLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCK--TSIHHKSRKNVLLLG 728
           ++SFN L+GEIP+GGSF NFSA+SF GNE LCGS  LQV PCK   S   ++  + ++L 
Sbjct: 687 NVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCKDDNSRATETPGSKIVLR 746

Query: 729 IVLP--LSTIFIIVVILLIVRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENN 786
            VLP  +  +F++  ++++ RY +R  +   + +   + T RR SY EL  ATN F E+N
Sbjct: 747 YVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRRISYHELQLATNGFQESN 806

Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
            +G G FGSVYK  + +G  +A KVF+LQ  RAFKSFD ECE+++++RHRNL+K+I+SCS
Sbjct: 807 FLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECEVLRNLRHRNLVKIITSCS 866

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
              FKAL+LE+MP+ SLEK LYS +Y L+  QRLNIM+DVA+ LEYLH GY+ P+ HCD+
Sbjct: 867 GPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVASVLEYLHHGYTIPMAHCDI 926

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           KPSNVLL+++MVA L+DFGI+KLL GE+ S+ QT TLATIGYMAP
Sbjct: 927 KPSNVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLATIGYMAP 970

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  783 bits (2023), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 460/929 (49%), Positives = 594/929 (63%), Gaps = 36/929 (3%)

Query: 78  VHSHRVKVLNISHLNLTGTIPSQLWN-LSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNF 136
            H HR+K +N+++ N  G IPS  +  L  LQ L L  N L+GSIPS++F +  L+ +N 
Sbjct: 36  THLHRLKDMNLAYNNFAGDIPSSWFAMLPQLQHLFLTNNSLAGSIPSSLFNVTALETLNL 95

Query: 137 RGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIP---------------AN--------- 172
            GN + G     I N S+L+ LD  +N  SG I                AN         
Sbjct: 96  EGNFIEGNISEEIRNLSNLKILDLGHNHFSGVISPILFNMPSLRLINLRANSLSGILQVV 155

Query: 173 -ICSNLP-FLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKE 230
            I SN+P  LE ++L  N  HGRIPS L  C  L +L L  N   G+IPKEI  LTKLKE
Sbjct: 156 MIMSNIPSTLEVLNLGYNQLHGRIPSNLHKCTELRVLDLESNRFTGSIPKEICTLTKLKE 215

Query: 231 LYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEI 290
           LYLG + L G+IP E   L  LE + L+V+ L G IP+E+ N T L  + +  N LTG I
Sbjct: 216 LYLGKNNLTGQIPGEIARLVSLEKLGLEVNGLNGNIPREIGNCTYLMEIHVENNNLTGVI 275

Query: 291 PPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLE 350
           P E+ NLH L+ LDL  N + G++P+T FN S L  + +  N LSG L S   + LPNLE
Sbjct: 276 PNEMGNLHTLQELDLGFNNITGSIPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLE 335

Query: 351 ELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSS 410
           EL L  N  SG IP  I NASKL VL+L  NSFSG IP+  GNLRNL+ + L  N LTS 
Sbjct: 336 ELYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSK 395

Query: 411 NLELSFLSSFS--NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPK 468
           +L        S  NC+SL Y+  + NPL G LP +S+GNLS SLE      C + G  P+
Sbjct: 396 SLRSELSFLSSLSNCRSLAYLRFNGNPLRGRLP-VSIGNLSASLEELYAFDCRIIGNIPR 454

Query: 469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELG 528
            IGNL+NLIG+ L  N+L G+IP  +G+L+ LQ   L  NKL+G IP++IC L +L  L 
Sbjct: 455 GIGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLY 514

Query: 529 LSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLD 588
           L  N  SGS+PAC SN+ SL  L LGSN+ TSIP T W+LK +L +N S N  TG LPL+
Sbjct: 515 LLENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLE 574

Query: 589 IGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNL 648
           IGNLKV+  IDFS+N  S  IPT I  L NL +  L  NR+QG I  SFGDL+SL+ L+L
Sbjct: 575 IGNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDL 634

Query: 649 SNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQ 708
           S N+LS +IP SLEKL +L+  ++SFN+L+GEI  GG F NFS +SF  NE LCG   +Q
Sbjct: 635 SRNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQ 694

Query: 709 VPPCKT-SIHHKS-RKNVLLLGIVLPLSTIFIIVVILLIVRYRKRVKQPPNDANMP-PIA 765
           VPPCK+ S H +S R    ++  ++P     I+V+ L ++ +R+  K+  +    P P A
Sbjct: 695 VPPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPA 754

Query: 766 TCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDV 825
           T R+ SY EL RAT  F+E NL+G G  GSVYK  + +G+ +AVKVF LQ       FD 
Sbjct: 755 TWRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDS 814

Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           ECE+++ +RHRNL+K+ISSC   +FKALILE++PHGSLEK LYS NY LDI QRLNIM+D
Sbjct: 815 ECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMID 874

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           VA+ LEYLH G + PV+HCDLKPSNVL++++MVAH+SDFGI++LL GE  ++TQT TLAT
Sbjct: 875 VASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLL-GEGDAVTQTLTLAT 933

Query: 946 IGYMAPGLFHVKYILFVVNFLTSYS-FLM 973
           IGYMAP  + ++ I+ V   + SY  FLM
Sbjct: 934 IGYMAPE-YGLEGIVSVKGDVYSYGIFLM 961

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  768 bits (1982), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/956 (47%), Positives = 600/956 (62%), Gaps = 71/956 (7%)

Query: 38  TDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTI 97
            D+ AL+ALKAHIT+D    LA NW+T +  CNW G++C+    RV  +N+S++ L GTI
Sbjct: 8   VDEFALIALKAHITYDSQGILATNWSTKSSYCNWYGISCNAPQQRVSAINLSNMGLEGTI 67

Query: 98  PSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQH 157
             Q+ NLS L SL+L +N                          +G+ P+ I N   LQ 
Sbjct: 68  APQVGNLSFLVSLDLTYN------------------------DFTGSIPNGIGNLVELQR 103

Query: 158 LDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGA 217
           L    N+L+GEIP+N+ S+   L  +SLS N F G IP A+ +   LE L L+ N L G 
Sbjct: 104 LSLRNNSLTGEIPSNL-SHCRELRGLSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGG 162

Query: 218 IPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE----LANL 273
           IP+EIGNL+ L  L LG +G+ G IP E   ++ L+ +    ++L G +P +    L NL
Sbjct: 163 IPREIGNLSNLNILQLGSNGISGPIPAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNL 222

Query: 274 TGLEV---------------------LKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG 312
            GL +                     L L  N  TG IP EI NL  L+ +DLS N L+G
Sbjct: 223 QGLYLSQNHLSGQLPTTLSLCRELLSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIG 282

Query: 313 AVPATI----------FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT 362
           ++P +           FN+S L  LGL  N LSGSL S     LP+LE L +  N FSGT
Sbjct: 283 SIPTSFGNLMTLKFLSFNISKLQTLGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGT 342

Query: 363 IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLE--LSFLSSF 420
           IP  I N SKL+VL L  NSF+G +P    NL  L+ + L YN LT  +L   + FL+S 
Sbjct: 343 IPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSL 402

Query: 421 SNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY 480
           +NCK L  + +  NPL G LP  S+GNL  +LE F  S C   G  P  IGNLTNLI + 
Sbjct: 403 TNCKFLRNLWIGYNPLTGTLPN-SLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLD 461

Query: 481 LGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA 540
           LG N L GSIP TLG+LQKLQ L +  N++ G IP+D+C L  L  L LS NKLSGSIP+
Sbjct: 462 LGANDLTGSIPTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPS 521

Query: 541 CFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGID 599
           CF +L +L  LSL SN L  +IP++ W+L+ +L LN SSNF TG LP ++GN+K +  +D
Sbjct: 522 CFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLD 581

Query: 600 FSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI 659
            S N  S  IP+ +G L NL  L L  N+LQG I   FGDL+SL+SL+LS NNLS +IP 
Sbjct: 582 LSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPK 641

Query: 660 SLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHK 719
           +LE L YL+ L++SFNKL+GEIP GG F  F+A+SF  NE LCG+P+ QV  C  +   +
Sbjct: 642 TLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQ 701

Query: 720 S--RKNVLLLGIVLPL-STIFIIVVILLIVRYRKRVKQP-PNDANMPPIATCRRFSYLEL 775
           S   K+ +L  I+LP+ ST+ ++V I+L +R R  ++ P P D+ +P   T  + S+ +L
Sbjct: 702 SWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GTHEKISHQQL 759

Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
             ATN F E+NLIG+G  G VYK  +  G+ VA+KVF+L+   A +SF+ ECE+M+ IRH
Sbjct: 760 LYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRH 819

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           RNL+++I+ CS  +FKAL+L+YMP+GSLEK LYS  Y LD+ QRLNIM+DVA+ LEYLH 
Sbjct: 820 RNLVRIITCCSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHH 879

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S+ V+HCDLKPSNVLLDD+MVAH++DFGIAKLL  E +S+ QT+TL+TIGYMAP
Sbjct: 880 DCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLT-ETESMQQTKTLSTIGYMAP 934

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  767 bits (1980), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/942 (46%), Positives = 575/942 (61%), Gaps = 60/942 (6%)

Query: 20  ILISLLTAAATANTSSITT----DQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVT 75
           IL+S+L  +      SI T    DQ ALLA K HIT DP N L  +W++ T  CNW GV+
Sbjct: 8   ILVSMLLMSLPKKCISIPTSNFTDQSALLAFKDHITFDPQNMLTHSWSSKTSFCNWMGVS 67

Query: 76  CDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVN 135
           C +   RV  L++S + L GTIP QL NLS LQ                        Y+ 
Sbjct: 68  CSLRRQRVTALDLSSMGLLGTIPPQLGNLSFLQ------------------------YLI 103

Query: 136 FRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP 195
              N   G  PS I N   LQ +D   N LS  I      NL  LE +    N   G IP
Sbjct: 104 LYNNSFHGDLPSEIGNLRRLQVMDIGSNKLSLVIVPESFGNLHRLEELRFDGNNLTGTIP 163

Query: 196 SALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELEL 254
           S + N   L++L L  N L G++PK +  +L +L+ L L  + L G+IP +     EL+L
Sbjct: 164 STIFNISSLKVLDLMFNGLFGSLPKNMCDHLPRLEMLLLSSNQLSGQIPSDLFKCRELQL 223

Query: 255 MALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAV 314
           + L  +N  G IP+EL  L  LEVL LG N L+G++P                       
Sbjct: 224 LWLPYNNFTGVIPEELGFLPMLEVLNLGVNMLSGDLP----------------------- 260

Query: 315 PATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLS 374
             +IFNM++L  + +  N+LSGS+     + LPNLEEL+L  N  +G++PRF+ N S+L 
Sbjct: 261 -RSIFNMTSLRTMQICCNNLSGSIPQENSIDLPNLEELQLNLNGITGSMPRFLGNMSRLE 319

Query: 375 VLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS--SNLELSFLSSFSNCKSLTYIGLS 432
           +L+L  N  +G +   FGNLR L++++L  N  T+  S+  L+F++S +N + L  + + 
Sbjct: 320 ILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHPSSQTLNFITSLTNSRQLKELHIG 379

Query: 433 NNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI 492
           +NPLDG+LP  S+GNLS  L  F +    + G  P EIGNL+NLI + L  N L G IP 
Sbjct: 380 DNPLDGMLPN-SVGNLSSFLTKFYVYASKLKGNIPGEIGNLSNLIVLSLEENSLMGPIPT 438

Query: 493 TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS 552
           T+G L+K+Q L+L  N L G IP DIC   +L ++ L+ N LSG IP+C  NL SL  L 
Sbjct: 439 TVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITLNNNVLSGEIPSCIGNLTSLRNLY 498

Query: 553 LGSNKLTS-IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPT 611
           L  N L+S IP+ +W+LK +L LN  SNF  G LP  +G ++  IGI  S+N  S  IP+
Sbjct: 499 LHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQVGEMEAAIGIRLSSNQLSGNIPS 558

Query: 612 VIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLD 671
            IG L NL    L  N  QGSI E+FG L+SL+ L+LS NNLS  IP SLE L YLE   
Sbjct: 559 TIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDLSQNNLSGEIPKSLEALRYLEFFS 618

Query: 672 LSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVL 731
           +SFN L+GEIP+GG F NF+A+SF  N+ LCG   LQVPPC       S+    LL   L
Sbjct: 619 VSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQVPPCSIESRKDSKTKSRLLRFSL 678

Query: 732 PL--STIFIIVVILLIVRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIG 789
           P   S + ++  I L++  R+R ++ P    +P  A  RR SYLEL  ATN F E+NL+G
Sbjct: 679 PTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAIQRRISYLELLHATNEFHESNLLG 738

Query: 790 RGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE 849
            G FGSVY+ R+ +G+ VAVK+F+LQ  RAF+SFD ECE+M++IRHRNL+K+I SCS  +
Sbjct: 739 IGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLD 798

Query: 850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPS 909
           FKAL+LEYMP GSLEK LYS NY LDI QR+NIM+DVA+ LEYLH GY +PV+HCDLKPS
Sbjct: 799 FKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPS 858

Query: 910 NVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           NVLLD++MVAH+ DFGIAKLL GE++S  QT+TLATIGYMAP
Sbjct: 859 NVLLDEDMVAHVCDFGIAKLL-GENESFAQTRTLATIGYMAP 899

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  759 bits (1959), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/980 (46%), Positives = 611/980 (62%), Gaps = 61/980 (6%)

Query: 31  ANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISH 90
           A   +ITTDQ ALLAL+AHIT DP      NW+ +T VCNW G+ C V   RV  LN S 
Sbjct: 2   AFAQNITTDQAALLALRAHITSDPFGITTNNWSATTSVCNWVGIICGVKHKRVTSLNFSF 61

Query: 91  LNLTGTIPSQ------------------------LWNLSSLQSLNLGFNRLSGSIPSAIF 126
           + LTGT P +                        L NL  L+ ++LG N  SG IP+ I 
Sbjct: 62  MGLTGTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSGEIPTWIG 121

Query: 127 TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
            L  ++ +   GNQ SG  P+ +FN +SL  L+   N LSG IP  I  NL  L+ + L+
Sbjct: 122 RLPRMEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREI-GNLTLLQDLYLN 180

Query: 187 QN-----------------------MFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI- 222
            N                       +F G IP  + N   L IL LS NN +G +P +I 
Sbjct: 181 SNQLTEIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLPDDIC 240

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
            +L  L  LYL Y+ L G++P        LE +AL  +   G IP+ + NLT ++ + LG
Sbjct: 241 EDLPSLGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQIFLG 300

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIA 342
            N+L+GEIP E+  L NL+ L +  N   G +P TIFN+S L  + L  N LSG+L +  
Sbjct: 301 VNYLSGEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTLPADL 360

Query: 343 DVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL 402
            V LPNL +L L  N  +GTIP  I N+S L++ ++G NSFSG IPN FG   NLR + L
Sbjct: 361 GVGLPNLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLRWINL 420

Query: 403 HYNYLTSSN--LELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYC 460
             N  T+ +   E    S  +N  SL  + LS+NPL+  LP   + N S S +Y  M   
Sbjct: 421 ELNNFTTESPPSERGIFSFLTNLTSLVRLELSHNPLNIFLPSSFV-NFSSSFQYLSMVNT 479

Query: 461 NVSGGFPKEIGN-LTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC 519
            + G  PK+IGN L +LI + +  N++ G+IP ++GKL++LQGLHL +N LEG IP +IC
Sbjct: 480 GIKGMIPKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPAEIC 539

Query: 520 RLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTS-IPLTIWNLKGMLYLNFSS 578
           +L  L EL L+ NKLSG+IP CF NL++L TLSLGSN L S +P ++W+L  +L+LN SS
Sbjct: 540 QLENLDELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLNLSS 599

Query: 579 NFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFG 638
           N   G LP++IGNL+V++ ID S N  S  IP+ IGGL NL  L L +N L+GSI +SFG
Sbjct: 600 NSLRGSLPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPDSFG 659

Query: 639 DLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGN 698
           +L++L+ L+LS+NNL+  IP SLEKLS+LE  ++SFN+L+GEIP GG F NFSA+SF  N
Sbjct: 660 NLVNLEILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSFISN 719

Query: 699 ELLC-GSPNLQVPPCKTSIHH----KSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRVK 753
             LC  S   QV PC T        K+ K V +L  +L      I++++ +  R+RK+ +
Sbjct: 720 IGLCSASSRFQVAPCTTKTSQGSGRKTNKLVYILPSILLAMLSLILLLLFMTYRHRKK-E 778

Query: 754 QPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFD 813
           Q   D  +P     RR +Y EL +AT+ FSE+NLIGRG FGSVYKA + +G   AVK+FD
Sbjct: 779 QVREDTPLPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAVKIFD 838

Query: 814 LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI 873
           L    A KSF++ECE++ +IRHRNL+K+I+SCS+ +FKALILEYMP+G+L+  LY+ +  
Sbjct: 839 LLTQDANKSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDMWLYNHDCG 898

Query: 874 LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L++ +RL+I++DVA  L+YLH GY  P++HCDLKP+N+LLD +MVAHL+DFGI+KLL G 
Sbjct: 899 LNMLERLDIVIDVALALDYLHNGYGKPIVHCDLKPNNILLDGDMVAHLTDFGISKLLGGG 958

Query: 934 DQSITQTQTLATIGYMAPGL 953
           D SITQT TLAT+GYMAP L
Sbjct: 959 D-SITQTITLATVGYMAPEL 977

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  758 bits (1957), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/941 (47%), Positives = 577/941 (61%), Gaps = 87/941 (9%)

Query: 94   TGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKS 153
            TG IP    NL++LQ L L  N + G+IPS +  L  L+Y+    N L+G  P  IFN S
Sbjct: 406  TGNIPPSFGNLTALQVLELAENNIPGNIPSELGNLINLQYLKLSANNLTGIIPEAIFNIS 465

Query: 154  SLQHLDFSYNALSGEIPANICS---NLPFLESISLSQNMFHGRIPSALSNCKYLEILSLS 210
            SLQ +DFS N+LSG +P +IC    +LP LE I LS N   G IPS+LS+C +L  LSLS
Sbjct: 466  SLQEIDFSNNSLSGCLPMDICKHLPDLPKLEFIDLSSNQLKGEIPSSLSHCPHLRGLSLS 525

Query: 211  INNLLGAIPKEIGNLTKLKELYL------------------------GYSGLQGEIPREF 246
            +N   G IP+ IG+L+ L+ELYL                        G SG+ G IP E 
Sbjct: 526  LNQFTGGIPQAIGSLSNLEELYLAYNNLVGGIPREIGNLSNLNILDFGSSGISGPIPPEI 585

Query: 247  GNLAELELMAL---------------QVSNLQ---------------------------- 263
             N++ L++  L                + NLQ                            
Sbjct: 586  FNISSLQIFDLTDNSLLGSLPMDIYKHLPNLQELYLSWNKLSGQLPSTLSLCGQLQSLSL 645

Query: 264  ------GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPAT 317
                  G IP    NLT L+ L+LG N + G IP E+ NL NL+ L LS N L G +P  
Sbjct: 646  WGNRFTGNIPPSFGNLTALQDLELGDNNIQGNIPNELGNLINLQNLKLSENNLTGIIPEA 705

Query: 318  IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLE 377
            IFN+S L  L L  N  SGSL S    QLP+LE L +  N FSG IP  I N S+L+ L+
Sbjct: 706  IFNISKLQSLSLAQNHFSGSLPSSLGTQLPDLEGLAIGRNEFSGIIPMSISNMSELTELD 765

Query: 378  LGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS--SNLELSFLSSFSNCKSLTYIGLSNNP 435
            +  N F+G +P   GNLR L  + L  N LT   S  E+ FL+S +NC  L  + + +NP
Sbjct: 766  IWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDEHSASEVGFLTSLTNCNFLRTLWIEDNP 825

Query: 436  LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLG 495
            L GILP  S+GNLS SLE FD S C   G  P  IGNLT+LI + LG N L G IP TLG
Sbjct: 826  LKGILPN-SLGNLSISLESFDASACQFRGTIPTGIGNLTSLISLELGDNDLTGLIPTTLG 884

Query: 496  KLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS 555
            +L+KLQ L +  N+L G IP+D+CRL  L  L LS N+L+GSIP+C   L  L  L L S
Sbjct: 885  QLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFLSSNQLTGSIPSCLGYLPPLRELYLHS 944

Query: 556  NKLTS-IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
            N L S IP ++W L+G+L LN SSNF TG LP ++GN+K +  +D S N  S  IP  +G
Sbjct: 945  NALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPEVGNIKSIRTLDLSKNQVSGHIPRTLG 1004

Query: 615  GLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF 674
             L NL+ L L  NRLQG I   FGDL+SLK L+LS NNLS  IP SL+ L+YL+ L++SF
Sbjct: 1005 ELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDLSQNNLSGVIPKSLKALTYLKYLNVSF 1064

Query: 675  NKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKS-RKNVLLLGIVLP- 732
            NKL+GEIP GG F NF+A+SF  NE LCG+P+ QV  C  S   +S R  + +L  +LP 
Sbjct: 1065 NKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQVIACDKSTRSRSWRTKLFILKYILPP 1124

Query: 733  -LSTIFIIVVILLIVRYRKRVKQP-PNDANMPPIATCRRFSYLELCRATNRFSENNLIGR 790
             +S I ++V ++L +R RK ++ P P D+ +P   +  + S+ +L  ATN F E+NLIG+
Sbjct: 1125 VISIITLVVFLVLWIRRRKNLEVPTPIDSWLP--GSHEKISHQQLLYATNYFGEDNLIGK 1182

Query: 791  GGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF 850
            G    VYK  +  G+ VAVKVF+L+   AF+SFD ECE+M+SIRHRNL+K+I+ CS  +F
Sbjct: 1183 GSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDF 1242

Query: 851  KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSN 910
            KAL+LEYMP GSL+K LYS NY LD+ QRLNIM+DVA+ LEYLH    + V+HCDLKP+N
Sbjct: 1243 KALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNN 1302

Query: 911  VLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +LLDD+MVAH+ DFGIA+LL  E +S+ QT+TL TIGYMAP
Sbjct: 1303 ILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLGTIGYMAP 1342

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  756 bits (1953), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/1025 (44%), Positives = 608/1025 (59%), Gaps = 115/1025 (11%)

Query: 38   TDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTI 97
             D+ AL+ALKAHIT+D    LA NW+T +P C+W G++C+     V  +N+S++ L GTI
Sbjct: 8    VDEFALIALKAHITYDSQGILATNWSTKSPHCSWIGISCNAPQQSVSAINLSNMGLEGTI 67

Query: 98   ------------------------------------------------PSQLWNLSSLQS 109
                                                            P  + NLS L+ 
Sbjct: 68   APQVGNLSFLVSLDLSDNYFHGSLPKDIGKCKELQQLNLFNNKLVGGIPEAICNLSKLEE 127

Query: 110  LNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEI 169
            L LG N+L G IP  +  L  LK ++F  N L+G+ P+ IFN SSL ++  S N LSG +
Sbjct: 128  LYLGNNQLIGEIPKKMNHLQNLKVLSFPMNNLTGSIPATIFNISSLLNISLSNNNLSGSL 187

Query: 170  PANICSNLPFLES------------------------ISLSQNMFHGRIPSALSN----- 200
            P ++C   P L+                         ISL+ N F G IPS + N     
Sbjct: 188  PMDMCYANPKLKELNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIDNLVELQ 247

Query: 201  --------------------------CKYLEILSLSINNLLGAIPKEI-GNLTKLKELYL 233
                                         L++++ + N+L G++PK+I  +L  L+ L L
Sbjct: 248  RLSLQNNSFTAFKDISKALLFAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLSL 307

Query: 234  GYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE 293
              + L G++P       EL  ++L  +  +G IP+E+ NL+ LE + LG N L G IP  
Sbjct: 308  SQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEEIYLGTNSLIGSIPTS 367

Query: 294  IHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELR 353
              NL  LK L+L  N L G VP  IFN+S L  L +  N LSGSL S     LP+LE L 
Sbjct: 368  FGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDLEGLF 427

Query: 354  LWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNL- 412
            +  N FSG IP  I N SKL+VL L  NSF+G +P   GNL  L+++ L  N LT  ++ 
Sbjct: 428  IAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVA 487

Query: 413  -ELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIG 471
             E+ FL+S +NCK L  + + N P  G LP  S+GNL  +LE F  S C   G  P  IG
Sbjct: 488  SEVGFLTSLTNCKFLKNLWIGNIPFKGTLPN-SLGNLPIALESFIASACQFRGTIPTGIG 546

Query: 472  NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG 531
            NLTNLI + LG N L GSIP TLG+LQKLQ L++  N++ G IP+D+C L  L  L LS 
Sbjct: 547  NLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSS 606

Query: 532  NKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIG 590
            NKLSGSIP+CF +L +L  L L SN L  +IP ++W+L+ +L LN SSNF TG LP ++G
Sbjct: 607  NKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVG 666

Query: 591  NLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSN 650
            N+K +  +D S N  S  IP+ +G L +L  L L  NRLQG I   FGDL+SL+SL+LS 
Sbjct: 667  NMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQ 726

Query: 651  NNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVP 710
            NNLS +IP SLE L YL+ L++S NKL+GEIP GG F NF+A+SF  NE LCG+P+ QV 
Sbjct: 727  NNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVM 786

Query: 711  PCKTSIHHKS--RKNVLLLGIVLPLSTIFIIVV-ILLIVRYRKRVKQP-PNDANMPPIAT 766
             C  +   +S   K+ +L  I+LP+ +I  +VV I+L +R R  ++ P P D+ +P   T
Sbjct: 787  ACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GT 844

Query: 767  CRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVE 826
              + S+ +L  ATN F E+NLIG+G  G VYK  +  G+ VA+KVF+L+   A +SFD E
Sbjct: 845  HEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSE 904

Query: 827  CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
            CE+M+ IRHRNL+++I+ CS  +FKAL+LEYMP+GSLEK LYS NY LD+ QRLNIM+DV
Sbjct: 905  CEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDV 964

Query: 887  ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
            A+ LEYLH   S+ V+HCDLKP+NVLLDD+MVAH++DFGI KLL  + +S+ QT+TL TI
Sbjct: 965  ASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKTLGTI 1023

Query: 947  GYMAP 951
            GYMAP
Sbjct: 1024 GYMAP 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  749 bits (1933), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 441/929 (47%), Positives = 580/929 (62%), Gaps = 61/929 (6%)

Query: 79   HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRG 138
            H   ++ L++S    TG IP  + +L +L+ L L FN+L+G IP  I  L  L  +    
Sbjct: 206  HCRELRGLSLSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSKLNILQLSS 265

Query: 139  NQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL 198
            N +SG  P+ IFN SSLQ +DFS N+L+GEIP+N+ S+   L  +SLS N F G IP A+
Sbjct: 266  NGISGPIPTEIFNISSLQEIDFSNNSLTGEIPSNL-SHCRELRVLSLSFNQFTGGIPQAI 324

Query: 199  SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELEL---- 254
             +   LE L LS N L G IP+EIGNL+ L  L LG +G+ G IP E  N++ L++    
Sbjct: 325  GSLSNLEGLYLSYNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNISSLQIIDFS 384

Query: 255  ---------------------------------------------MALQVSNLQGEIPQE 269
                                                         ++L V+  +G IP+E
Sbjct: 385  NNSLSGSLPMDICKHLPNLQGLYLLQNHLSGQLPTTLSLCGELLYLSLAVNKFRGSIPRE 444

Query: 270  LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGL 329
            + NL+ LE + L  N L G IP    NL  LK LDL  N L G VP  IFN+S L  L L
Sbjct: 445  IGNLSKLEDISLRSNSLVGSIPTSFGNLMALKYLDLGMNFLTGTVPEAIFNISELQILVL 504

Query: 330  QSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN 389
              N LSGSL       LP+LE L + SN FSGTIP  I N SKL  L++  NSF+G +P 
Sbjct: 505  VQNHLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSISNMSKLIQLQVWDNSFTGNVPK 564

Query: 390  TFGNLRNLRLMTLHYNYLTSSNLE--LSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGN 447
              GNL  L ++ L  N LT+ +L   + FL+S +NCK L ++ + +NP  G LP  S+GN
Sbjct: 565  DLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKFLRHLWIDDNPFKGTLPN-SLGN 623

Query: 448  LSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLED 507
            L  +LE F  S C   G  P  IGNLTNLI + LG N L  SIP TLG+LQKLQ LH+  
Sbjct: 624  LPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDLTRSIPTTLGRLQKLQRLHIAG 683

Query: 508  NKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIW 566
            N++ G IP+D+C L  L  L L  NKLSGSIP+CF +L +L  L L SN L  +IP ++W
Sbjct: 684  NRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLW 743

Query: 567  NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGY 626
            +L+ +L LN SSNF TG LP ++GN+K +  +D S N  S  IP  +G   NL  L L  
Sbjct: 744  SLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQ 803

Query: 627  NRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGS 686
            NRLQG I   FGDL+SL+SL+LS NNLS +IP SLE L YL+ L++S NKL+GEIP GG 
Sbjct: 804  NRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGP 863

Query: 687  FGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKS--RKNVLLLGIVLPL-STIFIIVVIL 743
            F NF+A+SF  NE LCG+P+ QV  C  +   +S   K+ +L  I+LP+ STI ++V I+
Sbjct: 864  FXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIV 923

Query: 744  LIVRYRKRVK-QPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG 802
            L +R R  ++   P D+ +P   T  + S+ +L  ATN F E+NLIG+G  G VYK  + 
Sbjct: 924  LWIRRRDNMEIXTPIDSWLP--GTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLS 981

Query: 803  EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGS 862
             G+ VA+KVF+L+   A +SFD ECE+M+ IRHRNL+++I+ CS  +FKAL+L+YMP+GS
Sbjct: 982  NGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGS 1041

Query: 863  LEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 922
            LEK LYS NY LD+ QRLNIM+DVA+ LEYLH   S+ V+HCDLKPSNVLLDDBMVAH++
Sbjct: 1042 LEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDBMVAHVT 1101

Query: 923  DFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DFGIAKLL  + +S+ QT+TL TIGYMAP
Sbjct: 1102 DFGIAKLLT-KTESMQQTKTLGTIGYMAP 1129

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255578886|ref|XP_002530297.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223530195|gb|EEF32104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  747 bits (1929), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 457/950 (48%), Positives = 602/950 (63%), Gaps = 44/950 (4%)

Query: 14  LFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTG 73
           L +  ++L S   + A   T+ I +DQDALLALK  I  DP N LA NW+ +T VC W G
Sbjct: 10  LCMKIILLYSFFVSIADGVTN-IASDQDALLALKVRIIRDPNNLLAANWSITTSVCTWVG 68

Query: 74  VTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKY 133
           VTC     RV  L++S + LTGTIP  L NLS L  ++   NR  GS+P  +  L  +K 
Sbjct: 69  VTCGARHGRVTALDLSDMGLTGTIPPHLGNLSFLAFISFYNNRFHGSLPDELSKLRRIKA 128

Query: 134 VNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR 193
                N  SG  PS+I + + LQ L                         SLS N F G 
Sbjct: 129 FGMSTNYFSGEIPSWIGSFTQLQRL-------------------------SLSSNKFTGL 163

Query: 194 IPSALSN--CKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLA 250
           +P+ L+N     L +L    NNL G +P  I  +L  L+ LYL  +   G IP       
Sbjct: 164 LPAILANNTISSLWLLDFGTNNLTGRLPPNIFTHLANLRALYLNSNLFNGPIPSTLMACQ 223

Query: 251 ELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL 310
           +L+L+AL  ++ +G I +++ NLT L+ L LG N  +G IP EI +L +L+ + L+ N L
Sbjct: 224 QLKLLALSFNHFEGSIHKDIGNLTMLQELYLGGNNFSGTIPDEIGDLAHLEEIILNVNGL 283

Query: 311 VGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA 370
            G VP+ I+N S +T +GL  N LSG L S ++  LPNLE   +  NNF+G IP  +FNA
Sbjct: 284 SGLVPSGIYNASKMTAIGLALNQLSGYLPSSSN--LPNLEFFIIEDNNFTGPIPVSLFNA 341

Query: 371 SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLT--SSNLELSFLSSFSNCKSLTY 428
           SKL  ++LG NSF G IP+  GNL++L + +   N+LT  SS+  LS  SS + CK L  
Sbjct: 342 SKLGNIDLGWNSFYGPIPDELGNLKSLEVFSFWVNHLTVKSSSSGLSLFSSLTKCKHLRR 401

Query: 429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
             LSNNPL+G LP +S+GNLS SLE  ++  C ++G  PKEIGNL++L  + LG N L G
Sbjct: 402 FDLSNNPLNGNLP-ISVGNLSSSLEVVEIFDCGITGTIPKEIGNLSSLSWLDLGANDLRG 460

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
           +IP T+ KL KLQ L L  N+LEG  P ++C L  L  L L  N LSG IP+C  N+ SL
Sbjct: 461 TIPTTIRKLGKLQELKLHYNRLEGSFPYELCDLQSLAYLYLEVNALSGQIPSCLGNVNSL 520

Query: 549 GTLSLGSNKLTS-IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSD 607
            TLS+G NK +S IP T+W L  +L LN SSN  +G L +DIGNLK +  ID S N  S 
Sbjct: 521 RTLSMGMNKFSSTIPSTLWRLADILELNLSSNSLSGSLAVDIGNLKAVTLIDLSGNQLSG 580

Query: 608 VIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYL 667
            IP+ IGGL  L  L L  NRL+GSI + FGD ISL+ L+LSNNNLS  IP SLE+L YL
Sbjct: 581 HIPSSIGGLKTLLNLSLAVNRLEGSIPQLFGDAISLQLLDLSNNNLSGEIPKSLEELRYL 640

Query: 668 EDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKSR---KNV 724
              ++SFN+L+GEIP G +F N SAKSF GN+ LCG+  LQV PC+TS H  S+   K  
Sbjct: 641 TYFNVSFNELQGEIPNGRAFINLSAKSFMGNKGLCGAAKLQVQPCETSTHQGSKAASKLA 700

Query: 725 LLLGIVLPLSTIFIIVVILLI-VRYRKRVKQPPNDANMPPIATCRRFSYLELCRATNRFS 783
           L  G++    TI  +  + +I +R RKR  +      + P+AT +R SY EL +AT++F+
Sbjct: 701 LRYGLMATGLTILAVAAVAIIFIRSRKRNMRITE--GLLPLATLKRISYRELEQATDKFN 758

Query: 784 ENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           E NL+GRG FGSVYK    +G  VAVKVF+LQ   AFKSFDVECE+++ IRHRNL+K+I+
Sbjct: 759 EMNLLGRGSFGSVYKGTFSDGSSVAVKVFNLQVEGAFKSFDVECEVLRMIRHRNLVKIIT 818

Query: 844 SCS--TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
           SCS    +FKAL+LE+MP+ SLEK L S  + L++ +RLNIM+DVA+ +EYLH GY+ P+
Sbjct: 819 SCSDINIDFKALVLEFMPNYSLEKWLCSPKHFLELLERLNIMLDVASAVEYLHHGYAMPI 878

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +HCDLKPSN+LLD+NMVAH++DFGIAKLL G++ S  QT TLAT+GYMAP
Sbjct: 879 VHCDLKPSNILLDENMVAHVTDFGIAKLL-GDEHSFIQTITLATVGYMAP 927

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	982
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.692	0.659	0.315	9.1e-126
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.821	0.787	0.347	2.3e-117
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.892	0.746	0.312	3.5e-107
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.724	0.703	0.343	7.8e-94
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.712	0.682	0.336	2.4e-92
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.772	0.688	0.288	2.7e-98
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.643	0.504	0.312	1.4e-95
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.795	0.625	0.300	6.3e-80
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.720	0.700	0.315	1.3e-82
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.688	0.831	0.333	2.1e-93

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 846 (302.9 bits), Expect = 9.1e-126, Sum P(2) = 9.1e-126
 Identities = 220/697 (31%), Positives = 326/697 (46%)

Query:   165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEIGN 224
             L+G I  +I  NL FL  ++L+ N F   IP  +     L+          G IP  + N
Sbjct:    85 LTGVISPSI-GNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSN 143

Query:   225 LTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKN 284
              ++L  + L  + L   +P E G+L++L ++ L  +NL G  P  L NLT L+ L    N
Sbjct:   144 CSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYN 203

Query:   285 FLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADV 344
              + GEIP E+  L  +    ++ N   G  P  ++N+                       
Sbjct:   204 QMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFGY 263

Query:   345 QLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHY 404
              LPNL  L L +N F+G IP+ + N S L   ++  N  SG IP +FG LRNL  + +  
Sbjct:   264 LLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRN 323

Query:   405 NYL-TXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVS 463
             N L                C  L Y+ +  N L G LP  S+ NLS +L    +    +S
Sbjct:   324 NSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPA-SIANLSTTLTSLFLGQNLIS 382

Query:   464 GGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICRLTK 523
             G  P +IGNL +L  + L  N L+G +P++           L  N + G IP     +T+
Sbjct:   383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442

Query:   524 LYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFT 582
             L +L L+ N   G IP        L  L + +N+L  +IP  I  +  + Y++ S+NF T
Sbjct:   443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLT 502

Query:   583 GPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDXXX 642
             G  P ++G L++L+G+  S N  S  +P  IGG  ++++LF+  N   G+I +       
Sbjct:   503 GHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVS 561

Query:   643 XXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLC 702
                                  L  L +L+LS NK +G +P  G F N +A S  GN  +C
Sbjct:   562 LKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNIC 621

Query:   703 GSPN-LQVPPCKTSIHHKSRKNV-----LLLGIVLPLSTXXXXXXXXXXXRYRKRVKQP- 755
             G    +Q+ PC      + RK +     ++ GI + +++            + KR K+  
Sbjct:   622 GGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNN 681

Query:   756 PNDANMPPIATCRRF----SYLELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVK 810
              +D N     T   F    SY EL  AT+RFS  NLIG G FG+V+K  +G E   VAVK
Sbjct:   682 ASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVK 741

Query:   811 VFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
             V +L    A KSF  ECE  K IRHRNL+K+I+ CS+
Sbjct:   742 VLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSS 778

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1156 (412.0 bits), Expect = 2.3e-117, P = 2.3e-117
 Identities = 291/837 (34%), Positives = 424/837 (50%)

Query:   165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEIGN 224
             LSG I  ++  NL FL  + L  N   G IP  LS    L+          G+IP  IG 
Sbjct:    91 LSGIISPSL-GNLSFLRELDLGDNYLSGEIPPELSRLSRLQLLELSDNSIQGSIPAAIGA 149

Query:   225 LTKLKELYLGYSGLQGEIPREFG-NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGK 283
              TKL  L L ++ L+G IPRE G +L  L  + L  + L GEIP  L NLT L+   L  
Sbjct:   150 CTKLTSLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSF 209

Query:   284 NFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIAD 343
             N L+G IP  +  L +L  ++L  N L G +P +I+N+                    A 
Sbjct:   210 NRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAF 269

Query:   344 VQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLH 403
               L  LE + + +N F G IP  + NAS L+V+++  N FSG I + FG LRNL  + L 
Sbjct:   270 KTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLW 329

Query:   404 YN-YLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNV 462
              N + T              C  L  + L  N L G+LP  S  NLS SL +  +    +
Sbjct:   330 RNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPN-SFSNLSTSLSFLALELNKI 388

Query:   463 SGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICRLT 522
             +G  PK+IGNL  L  +YL  N   GS+P +             +N L G IP  I  LT
Sbjct:   389 TGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLT 448

Query:   523 KLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTS-IPLTIWNLKGM-LYLNFSSNF 580
             +L  L L  NK SG IP   SNL +L +L L +N L+  IP  ++N++ + + +N S N 
Sbjct:   449 ELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNN 508

Query:   581 FTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDX 640
               G +P +IG+LK L+     +N  S  IP  +G    L+YL+L  N L GSI  + G  
Sbjct:   509 LEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQL 568

Query:   641 XXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNEL 700
                                    ++ L  L+LSFN   GE+P  G+F   S  S +GN  
Sbjct:   569 KGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAK 628

Query:   701 LCGS-PNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTXXXXXXXXXXXRYRKRVKQPPNDA 759
             LCG  P+L +P C   + ++    VL + + L  +             +++  K  P+  
Sbjct:   629 LCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRT 688

Query:   760 NMP--PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG 817
             +M   P+      SY +L +AT+ F+  NL+G G FGSVYK ++     VAVKV  L+  
Sbjct:   689 SMKGHPLV-----SYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENP 743

Query:   818 RAFKSFDVECEMMKSIRHRNLIKVISSCST-----EEFKALILEYMPHGSLEKSLY---- 868
             +A KSF  ECE ++++RHRNL+K+++ CS+      +FKA++ ++MP+GSLE  ++    
Sbjct:   744 KALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETN 803

Query:   869 --SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 926
               +    L++ +R+ I++DVA  L+YLH     PV+HCD+K SNVLLD +MVAH+ DFG+
Sbjct:   804 DQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGL 863

Query:   927 AKLLIGEDQSITQTQT----LATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG 979
             A++L+     I Q+ +    + TIGY AP  + V  I      + SY  L++ I  G
Sbjct:   864 ARILVDGTSLIQQSTSSMGFIGTIGYAAPE-YGVGLIASTHGDIYSYGILVLEIVTG 919

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
 Identities = 285/911 (31%), Positives = 450/911 (49%)

Query:    85 VLNISHLNLTGTIPXXXXXXXXXXXXXXGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGA 144
             ++   + NLTG IP                N L+GSIP +I TL  L  ++  GNQL+G 
Sbjct:   172 LIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGK 231

Query:   145 FPSFIFNKSSLQHLDFSYNALSGEIPANI--CSNLPFLESISLSQNMFHGRIPSALSNCK 202
              P    N  +LQ L  + N L G+IPA I  CS+L  LE   L  N   G+IP+ L N  
Sbjct:   232 IPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLE---LYDNQLTGKIPAELGNLV 288

Query:   203 YLEXXXXXXXXXXGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
              L+           +IP  +  LT+L  L L  + L G I  E G L  LE++ L  +N 
Sbjct:   289 QLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNF 348

Query:   263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMX 322
              GE PQ + NL  L VL +G N ++GE+P ++  L NL+ L    N L G +P++I N  
Sbjct:   349 TGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCT 408

Query:   323 XXXXXXXXXXXXXXXXXXIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
                                      NL  + +  N+F+G IP  IFN S L  L +  N+
Sbjct:   409 GLKLLDLSHNQMTGEIPR--GFGRMNLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNN 466

Query:   383 FSGFIPNTFGNLRNLRLMTLHYNYLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPR 442
              +G +    G L+ LR++ + YN LT               K L  + L +N   G +PR
Sbjct:   467 LTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNL-----KDLNILYLHSNGFTGRIPR 521

Query:   443 MSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXX 502
               M NL+  L+   M   ++ G  P+E+ ++  L  + L  NK +G IP           
Sbjct:   522 -EMSNLT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTY 579

Query:   503 XHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGT-LSLGSNKLT- 559
               L+ NK  G IP  +  L+ L    +S N L+G+IP    ++L ++   L+  +N LT 
Sbjct:   580 LSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTG 639

Query:   560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPT-VIGGLTN 618
             +IP  +  L+ +  ++ S+N F+G +P  +   K +  +DFS NN S  IP  V  G+  
Sbjct:   640 TIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDM 699

Query:   619 LQYLFLGYNRLQGSISESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLK 678
             +  L L  N   G I +SFG+                        LS L+ L L+ N LK
Sbjct:   700 IISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLK 759

Query:   679 GEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPC---KTSIHHKSRKNVLL--LGIVLPL 733
             G +P+ G F N +A    GN  LCGS    + PC   + S H   R  V+L  LG    L
Sbjct:   760 GHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAAL 818

Query:   734 STXXXXXXXXXXXRYRKRVKQPPNDANMPPIATC---RRFSYLELCRATNRFSENNLIGR 790
                          + +++  +  +++++P + +    +RF   EL +AT+ F+  N+IG 
Sbjct:   819 LLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGS 878

Query:   791 GGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVIS-SCST 847
                 +VYK ++ +G  +AVKV +L+     + K F  E + +  ++HRNL+K++  +  +
Sbjct:   879 SSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWES 938

Query:   848 EEFKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
              + KAL+L +M +G+LE +++ S   I  + +++++ V +A+ ++YLH GY  P++HCDL
Sbjct:   939 GKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDL 998

Query:   907 KPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTL--ATIGYMAPGLFHVKYILFVV 963
             KP+N+LLD + VAH+SDFG A++L   ED S T + +    TIGY+AP   +++ +    
Sbjct:   999 KPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKA 1058

Query:   964 NFLTSYSFLMI 974
             +   S+  +M+
Sbjct:  1059 DVF-SFGIIMM 1068

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
 Identities = 253/737 (34%), Positives = 356/737 (48%)

Query:   151 NKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXX 210
             NK  + HL+     L G I  +I  NL FL S+ L +N F G IP  +     LE     
Sbjct:    65 NKR-VTHLELGRLQLGGVISPSI-GNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMG 122

Query:   211 XXXXXGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQEL 270
                  G IP  + N ++L  L L  + L G +P E G+L  L  + L  +N++G++P  L
Sbjct:   123 INYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSL 182

Query:   271 ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXX 330
              NLT LE L L  N L GEIP ++  L  +  L L  N   G  P  ++N+         
Sbjct:   183 GNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIG 242

Query:   331 XXXXXXXXXXIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNT 390
                          + LPNL    +  N F+G+IP  + N S L  L +  N+ +G IP T
Sbjct:   243 YNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-T 301

Query:   391 FGNLRNLRLMTLHYNYL-TXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLS 449
             FGN+ NL+L+ LH N L +              C  L  +G+  N L G LP +S+ NLS
Sbjct:   302 FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLS 360

Query:   450 HSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNK 509
               L   D+    +SG  P +IGNL NL  + L  N L+G +P +           L  N+
Sbjct:   361 AKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNR 420

Query:   510 LEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNL 568
             L G IP  I  +T L  L LS N   G +P    N + L  L +G NKL  +IPL I  +
Sbjct:   421 LSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKI 480

Query:   569 KGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR 628
             + +L L+ S N   G LP DIG L+ L  +    N  S  +P  +G    ++ LFL  N 
Sbjct:   481 QQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNL 540

Query:   629 LQGSISESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFG 688
               G I +  G                          S LE L+LSFN L+G++P  G F 
Sbjct:   541 FYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFE 599

Query:   689 NFSAKSFEGNELLCGS-PNLQVPPCKT---SI--HHKSRKNVLLLGIVLPLSTXXXXXXX 742
             N +  S  GN  LCG     Q+ PC +   S+   H SR   +++G+ + ++        
Sbjct:   600 NATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMA 659

Query:   743 XXXXRY-RKRVKQPPNDANMPPIATCR----RFSYLELCRATNRFSENNLIGRGGFGSVY 797
                  + RKR K    + N P  +T      + SY +L  ATN FS +N++G G FG+VY
Sbjct:   660 SVTLIWLRKRKKN--KETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVY 717

Query:   798 KARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST-----EEFK 851
             KA +  E   VAVKV ++Q   A KSF  ECE +K IRHRNL+K++++CS+      EF+
Sbjct:   718 KALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFR 777

Query:   852 ALILEYMPHGSLEKSLY 868
             ALI E+MP+GSL+  L+
Sbjct:   778 ALIYEFMPNGSLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 920 (328.9 bits), Expect = 2.4e-92, P = 2.4e-92
 Identities = 243/723 (33%), Positives = 353/723 (48%)

Query:   165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEIGN 224
             L+G +   +  NL FL S++L+ N FHG IPS + N   L+          G IP  + N
Sbjct:    93 LTGVVSPFV-GNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSN 151

Query:   225 LTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKN 284
              + L  L L  + L+  +P EFG+L++L L++L  +NL G+ P  L NLT L++L    N
Sbjct:   152 CSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYN 211

Query:   285 FLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADV 344
              + GEIP +I  L  +    ++ NK  G  P  I+N+                       
Sbjct:   212 QIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGS 271

Query:   345 QLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHY 404
              LPNL+ L +  N+F+GTIP  + N S L  L++  N  +G IP +FG L+NL L+ L+ 
Sbjct:   272 LLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNN 331

Query:   405 NYL-TXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVS 463
             N L                C  L Y+ +  N L G LP + + NLS  L    +    +S
Sbjct:   332 NSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP-VFIANLSTQLTELSLGGNLIS 390

Query:   464 GGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICRLTK 523
             G  P  IGNL +L  + LG N L G +P +           L  N L G IP  +  ++ 
Sbjct:   391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450

Query:   524 LYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFT 582
             L  L L  N   GSIP+   + + L  L+LG+NKL  SIP  +  L  ++ LN S N   
Sbjct:   451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510

Query:   583 GPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDXXX 642
             GPL  DIG LK L+ +D S N  S  IP  +    +L++L L  N   G I +  G    
Sbjct:   511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTG 569

Query:   643 XXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLC 702
                                   S L++L+LS N   G +P  G F N SA S  GN  LC
Sbjct:   570 LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629

Query:   703 GS-PNLQVPPCKTSI--HHKSRKNVLLLGIVLPLSTXXXXXXXXXXXR-YRKRVKQP--- 755
             G  P+LQ+ PC   +   H S + ++ + +   ++              Y+ RVK     
Sbjct:   630 GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689

Query:   756 --PNDANMPPIATC-RRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKV 811
                ND +  P+ +   + SY EL + T  FS +NLIG G FG+V+K  +G +   VA+KV
Sbjct:   690 NNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749

Query:   812 FDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEF-----KALILEYMPHGSLEK 865
              +L C R A KSF  ECE +  IRHRNL+K+++ CS+ +F     +AL+ E+MP+G+L+ 
Sbjct:   750 LNL-CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDM 808

Query:   866 SLY 868
              L+
Sbjct:   809 WLH 811

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 715 (256.8 bits), Expect = 2.7e-98, Sum P(2) = 2.7e-98
 Identities = 233/808 (28%), Positives = 345/808 (42%)

Query:    43 LLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVL--NISHLNLTGTIPXX 100
             LL +K+       N    N N S P C WTGV C  +S   +VL  N+S + L+G +   
Sbjct:    34 LLEIKSKFVDAKQNLRNWNSNDSVP-CGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPS 92

Query:   101 XXXXXXXXXXXXGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDF 160
                          +N LSG IP  I    +L+ +    NQ  G  P  I    SL++L  
Sbjct:    93 IGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLII 152

Query:   161 SYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPK 220
               N +SG +P  I + L   + ++ S N+  G++P ++ N K L           G++P 
Sbjct:   153 YNNRISGSLPVEIGNLLSLSQLVTYSNNI-SGQLPRSIGNLKRLTSFRAGQNMISGSLPS 211

Query:   221 EIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLK 280
             EIG    L  L L  + L GE+P+E G L +L  + L  +   G IP+E++N T LE L 
Sbjct:   212 EIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLA 271

Query:   281 LGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXX-X 339
             L KN L G IP E+ +L +L+ L L  N L G +P  I N+                   
Sbjct:   272 LYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPL 331

Query:   340 XIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRL 399
              + +++   LE L L+ N  +GTIP  +     LS L+L  N+ +G IP  F  LR L +
Sbjct:   332 ELGNIE--GLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFM 389

Query:   400 MTLHYNYLTXXX-----------------XXXXXXXXXXXC--KSLTYIGLSNNPLDGIL 440
             + L  N L+                               C   ++  + L  N L G +
Sbjct:   390 LQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNI 449

Query:   441 PRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXX 500
             P         +L    ++  N+ G FP  +    N+  I LG N+  GSIP         
Sbjct:   450 PTGI--TTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSAL 507

Query:   501 XXXHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT- 559
                 L DN   G +P +I  L++L  L +S NKL+G +P+   N   L  L +  N  + 
Sbjct:   508 QRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSG 567

Query:   560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
             ++P  + +L  +  L  S+N  +G +P+ +GNL  L  +    N F+  IP  +G LT L
Sbjct:   568 TLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGL 627

Query:   620 QY-LFLGYNRLQGSISESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLK 678
             Q  L L YN+L G I     +                        LS L   + S+N L 
Sbjct:   628 QIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLT 687

Query:   679 GEIPKGGSFGNFSAKSFEGNELLCGSP-N--LQVPPCKTSIHH------KSRKNVLLLGI 729
             G IP      N S  SF GNE LCG P N  +Q  P   S         +S K + +   
Sbjct:   688 GPIPL---LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAA 744

Query:   730 VLP-LSTXXXXXXXXXXXRYRKRVKQPPNDANMPPIATC------RRFSYLELCRATNRF 782
             V+  +S            R  + V     D     ++          F++ +L  AT+ F
Sbjct:   745 VIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNF 804

Query:   783 SENNLIGRGGFGSVYKARIGEGMEVAVK 810
              E+ ++GRG  G+VYKA +  G  +AVK
Sbjct:   805 DESFVVGRGACGTVYKAVLPAGYTLAVK 832

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 680 (244.4 bits), Expect = 1.4e-95, Sum P(2) = 1.4e-95
 Identities = 203/649 (31%), Positives = 291/649 (44%)

Query:    39 DQDALLALK-AHITHDPTNFLAKNWNTSTP-VCNWTGVTCDVHSHRVKVLNISHLNLTGT 96
             D   LL LK + IT+     + ++WN+ +P  CNWTGVTC      +  LN+S L LTG+
Sbjct:    29 DLQTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGVTCG--GREIIGLNLSGLGLTGS 86

Query:    97 IPXXXXXXXXXXXXXXGFNRLSGSIPSAIFTLYT-LKYVNFRGNQLSGAFPSFIFNKSSL 155
             I                 NRL G IP+ +  L + L+ ++   N LSG  PS + +  +L
Sbjct:    87 ISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNL 146

Query:   156 QHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXX 215
             + L    N L+G IP     NL  L+ ++L+     G IPS       L+          
Sbjct:   147 KSLKLGDNELNGTIPETF-GNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELE 205

Query:   216 GAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTG 275
             G IP EIGN T L      ++ L G +P E   L  L+ + L  ++  GEIP +L +L  
Sbjct:   206 GPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVS 265

Query:   276 LEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXX 335
             ++ L L  N L G IP  +  L NL+ LDLS N L G +    + M              
Sbjct:   266 IQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLS 325

Query:   336 XXXXXIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLR 395
                         +L++L L     SG IP  I N   L +L+L  N+ +G IP++   L 
Sbjct:   326 GSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLV 385

Query:   396 NLRLMTLHYNYLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYF 455
              L  + L+ N L                 +L    L +N L+G +P+  +G L   LE  
Sbjct:   386 ELTNLYLNNNSLEGTLSSSISNLT-----NLQEFTLYHNNLEGKVPK-EIGFLG-KLEIM 438

Query:   456 DMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIP 515
              +     SG  P EIGN T L  I   GN+L+G IP +          HL +N+L G IP
Sbjct:   439 YLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIP 498

Query:   516 DDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYL 574
               +    ++  + L+ N+LSGSIP+ F  L +L    + +N L  ++P ++ NLK +  +
Sbjct:   499 ASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRI 558

Query:   575 NFSSNFFTGPL-PLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI 633
             NFSSN F G + PL  G+   L   D + N F   IP  +G  TNL  L LG N+  G I
Sbjct:   559 NFSSNKFNGSISPL-CGSSSYL-SFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRI 616

Query:   634 SESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIP 682
               +FG                            L  +DL+ N L G IP
Sbjct:   617 PRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIP 665

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 809 (289.8 bits), Expect = 6.3e-80, P = 6.3e-80
 Identities = 249/829 (30%), Positives = 383/829 (46%)

Query:    83 VKVLNISHLNLTGTIPXXXXXXXXXXXXXXGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
             +++LN+++ +LTG IP                N+L G IP ++  L  L+ ++   N L+
Sbjct:   241 LEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLT 300

Query:   143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCK 202
             G  P   +N S L  L  + N LSG +P +ICSN   LE + LS     G IP  LS C+
Sbjct:   301 GEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQ 360

Query:   203 YLEXXXXXXXXXXGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
              L+          G+IP+ +  L +L +LYL  + L+G +     NL  L+ + L  +NL
Sbjct:   361 SLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNL 420

Query:   263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMX 322
             +G++P+E++ L  LEVL L +N  +GEIP EI N  +LK++D+  N   G +P +I  + 
Sbjct:   421 EGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLK 480

Query:   323 XXXXXXXXXXXXXXXX-XXIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRN 381
                                + +    N+  L L  N  SG+IP        L  L L  N
Sbjct:   481 ELNLLHLRQNELVGGLPASLGNCHQLNI--LDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538

Query:   382 SFSGFIPNTFGNLRNLRLMTLHYNYLTXXXXXXXXXXXXXXCKSLTYIG--LSNNPLDGI 439
             S  G +P++  +LRNL  + L +N L               C S +Y+   ++NN  +  
Sbjct:   539 SLQGNLPDSLISLRNLTRINLSHNRLNGTIHPL--------CGSSSYLSFDVTNNGFEDE 590

Query:   440 LPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXX 499
             +P + +GN S +L+   +    ++G  P  +G +  L  + +  N L G+IP+       
Sbjct:   591 IP-LELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKK 648

Query:   500 XXXXHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT 559
                  L +N L GPIP  + +L++L EL LS N+   S+P    N   L  LSL  N L 
Sbjct:   649 LTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLN 708

Query:   560 -SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTN 618
              SIP  I NL  +  LN   N F+G LP  +G L  L  +  S N+ +  IP  IG L +
Sbjct:   709 GSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQD 768

Query:   619 LQY-LFLGYNRLQGSISESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKL 677
             LQ  L L YN   G I  + G                         +  L  L++SFN L
Sbjct:   769 LQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNL 828

Query:   678 KGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHK--SRKNVLLLGIVLPLST 735
              G++ K   F  + A SF GN  LCGSP  +    +++   +  S ++V+++  +  L+ 
Sbjct:   829 GGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTA 886

Query:   736 XXXXXXXXXXX-RYR----KRV---------KQPPNDANMPPI----ATCRRFSYLELCR 777
                         + R    K+V             + A   P+    A+     + ++  
Sbjct:   887 IGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIME 946

Query:   778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF----DLQCGRAFKSFDVECEMMKSI 833
             AT+  SE  +IG GG G VYKA +  G  VAVK      DL      KSF  E + +  I
Sbjct:   947 ATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSN---KSFSREVKTLGRI 1003

Query:   834 RHRNLIKVISSCST--EEFKALILEYMPHGSLEKSLYSSNYILDIFQRL 880
             RHR+L+K++  CS+  E    LI EYM +GS+   L+    +L+  ++L
Sbjct:  1004 RHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKL 1052

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 828 (296.5 bits), Expect = 1.3e-82, P = 1.3e-82
 Identities = 230/730 (31%), Positives = 342/730 (46%)

Query:   157 HLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXG 216
             HL+     L G +  +I  N+ FL S+ LS N F G IP  + N   LE          G
Sbjct:    70 HLNLGGLQLGGIVSPSI-GNVSFLISLDLSDNAFGGIIPREVGNLFRLEHLYMAFNSLEG 128

Query:   217 AIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGL 276
              IP  + N ++L  L L  + L+  +P E G+L +L ++ L  +NL+G++P+ L NLT L
Sbjct:   129 GIPATLSNCSRLLNLDLYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSL 188

Query:   277 EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXX 336
             + L    N + GE+P E+  L  +  L LS NK  G  P  I+N+               
Sbjct:   189 KSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSG 248

Query:   337 XXXXIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRN 396
                      LPN+ EL L  N+  G IP  + N S L    + +N  +G I   FG + +
Sbjct:   249 SLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGKVPS 308

Query:   397 LRLMTLHYNYL-TXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYF 455
             L+ + L  N L +              C  L  + +    L G LP  S+ N+S  L   
Sbjct:   309 LQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPT-SIANMSTELISL 367

Query:   456 DMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIP 515
             ++   +  G  P++IGNL  L  + LG N L G +P +           L  N++ G IP
Sbjct:   368 NLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIP 427

Query:   516 DDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYL 574
               I  LT+L  L LS N   G +P      + +  L +G NKL  +IP  I  +  ++ L
Sbjct:   428 SFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLVNL 487

Query:   575 NFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSIS 634
             +   N  +G LP DIG+L+ L+ +    N FS  +P  +G    ++ LFL  N   G+I 
Sbjct:   488 SMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIP 547

Query:   635 ESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKS 694
                G                          S LE L+LS N   G++P  G+F N +   
Sbjct:   548 NIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVF 606

Query:   695 FEGNELLCGS-PNLQVPPC-----KTSIHHKS--RKNVLLLGIVLPLSTXXXXXXXXXXX 746
               GN+ LCG   +L++ PC          H S  +K  +L+ I + L             
Sbjct:   607 VFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCW 666

Query:   747 RYRKRVKQPPNDANMPPIATC--RRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG-E 803
              +RKR K    +  +P        + SY +L  ATN FS +N++G G FG+V+KA +  E
Sbjct:   667 -FRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTE 725

Query:   804 GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC-STE----EFKALILEYM 858
                VAVKV ++Q   A KSF  ECE +K  RHRNL+K++++C ST+    EF+ALI EY+
Sbjct:   726 SKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYL 785

Query:   859 PHGSLEKSLY 868
             P+GS++  L+
Sbjct:   786 PNGSVDMWLH 795

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 930 (332.4 bits), Expect = 2.1e-93, P = 2.1e-93
 Identities = 234/701 (33%), Positives = 343/701 (48%)

Query:   186 SQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEIGNLTKLKELYLGYSGLQGEIPRE 245
             S N+  G I  +L N  +L           G IP+E+  L++L++L L ++ L GEIP  
Sbjct:    87 SSNLA-GIISPSLGNLSFLRTLQLSDNHLSGKIPQELSRLSRLQQLVLNFNSLSGEIPAA 145

Query:   246 FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDL 305
              GNL  L ++ L  + L G IP  L  LTGL  L L +N L+G IP     L  L  L L
Sbjct:   146 LGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSL 205

Query:   306 SHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLPNLEELRLWSNNFSGTIPR 365
             + N L GA+P  I+N+                    A   LP+L+E+ ++ N F G IP 
Sbjct:   206 AFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPA 265

Query:   366 FIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTXXXXXX-XXXXXXXXCK 424
              I NAS +S+  +G NSFSG +P   G +RNL+ + L                     C 
Sbjct:   266 SIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCS 325

Query:   425 SLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGN 484
             +L  + L      G+LP  S+ NLS SL    +    +SG  P++IGNL NL  + L  N
Sbjct:   326 NLQEVELGGCKFGGVLPD-SVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLANN 384

Query:   485 KLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSN 544
              L GS+P +           +++NKL G +P  I  LT+L  + +  N   G+IP+   N
Sbjct:   385 SLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGN 444

Query:   545 LASLGTLSLGSNK-LTSIPLTIWNLKGML-YLNFSSNFFTGPLPLDIGNLKVLIGIDFST 602
             L  L  ++LG N  +  IP+ I+++  +   L+ S N   G +P +IG LK ++     +
Sbjct:   445 LTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADS 504

Query:   603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDXXXXXXXXXXXXXXXXXXXXXXE 662
             N  S   P+ IG    LQ+LFL  N L GSI  +                          
Sbjct:   505 NKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLG 564

Query:   663 KLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGS-PNLQVPPCKTSIHHKSR 721
              +  L  L+LSFN   GE+P  G F N S    +GN  +CG  P L +P C      K +
Sbjct:   565 DMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKK 624

Query:   722 KNVLLLGIVLPL-STXXXXXXXXXXXR-YRKRVKQPPNDANMP--PIATCRRFSYLELCR 777
               +LLL +V+ L ST             +++R K+ P   +M   P+ T     Y +L +
Sbjct:   625 HQILLLVVVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQGHPMIT-----YKQLVK 679

Query:   778 ATNRFSENNLIGRGGFGSVYKARI----GEGME-VAVKVFDLQCGRAFKSFDVECEMMKS 832
             AT+ FS ++L+G G FGSVYK       GE    VAV+V  L+  +A KSF  ECE +++
Sbjct:   680 ATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRN 739

Query:   833 IRHRNLIKVISSCST-----EEFKALILEYMPHGSLEKSLY 868
              RHRNL+K+++ CS+      +FKA++ ++MP+GSLE  L+
Sbjct:   740 TRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLH 780

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00110705 hypothetical protein (1061 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	982
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-117
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-37
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-17
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-13
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-11
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	7e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	9e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.001
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	0.001
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
PLN03210	1153	PLN03210, PLN03210, Resistant to P	0.002
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.002
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.003
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.003
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	0.004
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.004
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  381 bits (980), Expect = e-117
 Identities = 290/895 (32%), Positives = 425/895 (47%), Gaps = 120/895 (13%)

Query: 43  LLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLW 102
           LL+ K+ I +DP  +L+ NWN+S  VC W G+TC+ +S RV  +++S  N++G I S ++
Sbjct: 34  LLSFKSSI-NDPLKYLS-NWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIF 90

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTL-YTLKYVNFRGNQLSGAFPS-FIFNKSSLQHLDF 160
            L  +Q++NL  N+LSG IP  IFT   +L+Y+N   N  +G+ P   I N   L+ LD 
Sbjct: 91  RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN---LETLDL 147

Query: 161 SYNALSGEIPANI--CSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAI 218
           S N LSGEIP +I   S+L  L+   L  N+  G+IP++L+N   LE L+L+ N L+G I
Sbjct: 148 SNNMLSGEIPNDIGSFSSLKVLD---LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQI 204

Query: 219 PKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEV 278
           P+E+G +  LK +YLGY+ L GEIP E G L  L  + L  +NL G IP  L NL  L+ 
Sbjct: 205 PRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264

Query: 279 LKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSL 338
           L L +N L+G IPP I +L  L  LDLS N L G +P  +                    
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-------------------- 304

Query: 339 SSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLR 398
                +QL NLE L L+SNNF+G IP  + +  +L VL+L  N FSG IP   G   NL 
Sbjct: 305 -----IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL- 358

Query: 399 LMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMS 458
                                       T + LS N L G +P                 
Sbjct: 359 ----------------------------TVLDLSTNNLTGEIPE---------------G 375

Query: 459 YCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDI 518
            C+         GNL  LI   L  N L G IP +LG  + L+ + L+DN   G +P + 
Sbjct: 376 LCSS--------GNLFKLI---LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424

Query: 519 CRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSS 578
            +L  +Y L +S N L G I +   ++ SL  LSL  NK        +  K +  L+ S 
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484

Query: 579 NFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFG 638
           N F+G +P  +G+L  L+ +  S N  S  IP  +     L  L L +N+L G I  SF 
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544

Query: 639 DLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGN 698
           ++  L  L+LS N LS  IP +L  +  L  +++S N L G +P  G+F   +A +  GN
Sbjct: 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGN 604

Query: 699 ELLCGSPNLQ-VPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYR----KRVK 753
             LCG      +PPCK      S    +   +   L    +    + I        KRV+
Sbjct: 605 IDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE 664

Query: 754 QPPNDANMPPIAT--CRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK 810
                  +    +   +  +  ++  +     E N+I RG  G+ YK + I  GM+  VK
Sbjct: 665 NEDGTWELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVK 721

Query: 811 VFDLQCGRAFKSFDVECEM----MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKS 866
                        +         M  ++H N++K+I  C +E+   LI EY+   +L + 
Sbjct: 722 --------EINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV 773

Query: 867 LYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 921
           L +    L   +R  I + +A  L +LH   S  V+  +L P  +++D     HL
Sbjct: 774 LRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  139 bits (353), Expect = 2e-37
 Identities = 60/167 (35%), Positives = 87/167 (52%), Gaps = 8/167 (4%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           +G GGFG+VY AR    G +VA+K+   +      +    E E++K + H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
             E    L++EY   GSL+  L  +   L   + L I++ +   LEYLH   S  +IH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 906 LKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           LKP N+LLD DN    L+DFG++KLL            + T  YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  137 bits (347), Expect = 4e-36
 Identities = 58/169 (34%), Positives = 86/169 (50%), Gaps = 13/169 (7%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV----ECEMMKSIRHRNLIKVI 842
           +G G FG+VYKA+  G G  VAVK+   +        D     E  +++ + H N++++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            +   ++   L++EY   G L     S    L   +   I + +   LEYLH   S  +I
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDL-FDYLSRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP N+LLD+N V  ++DFG+AK L+    S   T    T  YMAP
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSS-LTTFV-GTPWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  136 bits (345), Expect = 6e-36
 Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 11/169 (6%)

Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHRNLIKVIS 843
             +G G FG VY AR    G  VA+KV   +  +   +    E +++K ++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
               E+   L++EY   G L   L      L   +    +  + + LEYLH   S  ++H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDL-FDLLKKRGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
            DLKP N+LLD++    L+DFG+A+ L        +  T   T  YMAP
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  120 bits (304), Expect = 2e-30
 Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 10/173 (5%)

Query: 785 NNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNL 838
              +G G FG VYK ++      + +EVAVK           + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++  C+ EE   +++EYM  G L   L  +   L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              IH DL   N L+ +N+V  +SDFG+++  + +D    +      I +MAP
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  118 bits (297), Expect = 2e-29
 Identities = 53/174 (30%), Positives = 86/174 (49%), Gaps = 11/174 (6%)

Query: 785 NNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNL 838
              +G G FG VYK  +     G+ +EVAVK        +  + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSL-YSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           +K++  C+ EE   +++EYMP G L   L  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           S   IH DL   N L+ +N+V  +SDFG+++  + +D           I +MAP
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (295), Expect = 3e-29
 Identities = 50/170 (29%), Positives = 81/170 (47%), Gaps = 9/170 (5%)

Query: 788 IGRGGFGSVYKARI-----GEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG VYK  +     G   +VAVK           + F  E  +MK + H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
           +  C+  E   ++ EYMP G L   L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +H DL   N L+ +N+V  +SDFG+++ +  +D    +      I +MAP
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  116 bits (294), Expect = 5e-29
 Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 23/183 (12%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRA--FKSFDVECEMMKSIRHRN 837
            ++   L+GRG FGSVY A   + G  +AVK  +L        ++ + E  ++ S++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 838 LIKVISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATT 889
           +++   S   EE   L   LEY+  GSL         +L  F +L   V       +   
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEG 113

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGY 948
           L YLH   S  ++H D+K +N+L+D + V  L+DFG AK  +G+ ++   T ++  T  +
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYW 169

Query: 949 MAP 951
           MAP
Sbjct: 170 MAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (268), Expect = 1e-25
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 22/182 (12%)

Query: 786 NLIGRGGFGSVYKARI----GEGMEVAVKV----FDLQCGRAFKSFDVECEMMKSIRHRN 837
             +G G FG VYK ++    G+  EVAVK        +  + F     E  +MK + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL--------YSSNYILDIFQRLNIMVDVATT 889
           +++++  C+ EE   L+LEYM  G L   L              L +   L+  + +A  
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           +EYL    S   +H DL   N L+ +++V  +SDFG+++ +  +D    +T     I +M
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174

Query: 950 AP 951
           AP
Sbjct: 175 AP 176

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 56/165 (33%), Positives = 86/165 (52%), Gaps = 7/165 (4%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG+GGFG VYKAR    G EVA+KV  L+     +    E +++K  +H N++K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            ++   +++E+   GSL+  L S+N  L   Q   +  ++   LEYLH   S  +IH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           K +N+LL  +    L DFG++  L       T    + T  +MAP
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 96.0 bits (240), Expect = 7e-22
 Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 19/182 (10%)

Query: 786 NLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCG------RAFKSFDVECEMMKSIRHRNL 838
             IG+G FG VY  R    G    +K  DL          A      E +++K + H N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF---QRLNIMVDVATTLEYLHF 895
           IK   S   +    +++EY   G L + +         F   Q L+  V +   L+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
             S  ++H D+KP N+ L  N +  L DFGI+K+L      + +T  + T  Y++P L  
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLSPELCQ 176

Query: 956 VK 957
            K
Sbjct: 177 NK 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 59/180 (32%), Positives = 85/180 (47%), Gaps = 21/180 (11%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRN 837
            +   +LIGRG FG VYK    E G  VA+K   L+     A KS   E +++K+++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------IMVDVATTLE 891
           ++K I S  T +   +ILEY  +GSL +       I+  F           +  V   L 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLA 113

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YLH      VIH D+K +N+L   + V  L+DFG+A  L    +         T  +MAP
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 11/153 (7%)

Query: 786 NLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLI 839
             +G G FG V   R        G +VAVK  +       +S F+ E E+++++ H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 840 KVISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           K    C     ++  LI+EY+P GSL   L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           S   IH DL   N+L++   +  +SDFG+AK+L
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 8/145 (5%)

Query: 787 LIGRGGFGSVYKARIGEGMEVAVK---VFDLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
            IG+G FG VYK  +    EVAVK          +    F  E E++K   H N++K+I 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIG 59

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
            C  ++   +++E +P GSL   L      L + + L + +D A  +EYL    S   IH
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIH 116

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAK 928
            DL   N L+ +N V  +SDFG+++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 88.3 bits (217), Expect = 2e-18
 Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH-RNLIKVI 842
            +G G FG VY AR  +   VA+KV   +     +  + F  E +++ S+ H  N++K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 843 SSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
                E    L++EY+  GSLE  L        L   + L I+  + + LEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 901 VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLA----TIGYMAPGLFH 955
           +IH D+KP N+LLD D  V  L DFG+AKLL     + +     +    T GYMAP +  
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 956 VKYILFVVNFLTSYSFLMIFI 976
              + +  +    +S  +   
Sbjct: 182 GLSLAYASSSSDIWSLGITLY 202

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 49/144 (34%), Positives = 76/144 (52%), Gaps = 8/144 (5%)

Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSC 845
            IG+G FG V       G +VAVK   L+    A ++F  E  +M ++RH NL++++   
Sbjct: 13  TIGKGEFGDVMLG-DYRGQKVAVKC--LKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 846 STEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
                  ++ EYM  GSL   L S    ++ + Q+L   +DV   +EYL        +H 
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAK 928
           DL   NVL+ +++VA +SDFG+AK
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 51/187 (27%), Positives = 80/187 (42%), Gaps = 29/187 (15%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V+           +   VAVK         A K F+ E E++ + +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSN-------------YILDIFQRLNIMVDVA 887
               C+  +   ++ EYM HG L K L S                 L + Q L I V +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 888 TTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           + + YL   HF      +H DL   N L+  ++V  + DFG+++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 945 TIGYMAP 951
            I +M P
Sbjct: 187 PIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 5e-18
 Identities = 58/171 (33%), Positives = 82/171 (47%), Gaps = 16/171 (9%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEM-----MKSIRHRNLIKV 841
           +G+G FG V   R    G   A+KV  L+  +  K  +VE  +     +  I H  ++K+
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
             +  TEE   L+LEY P G L   L       +   R     ++   LEYLH   S  +
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGI 114

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           I+ DLKP N+LLD +    L+DFG+AK L  E     +T T   T  Y+AP
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 85.3 bits (212), Expect = 5e-18
 Identities = 48/144 (33%), Positives = 69/144 (47%), Gaps = 5/144 (3%)

Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G VYKA     G EVA+K   L+     +    E  +MK  +H N++    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  VIH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLL 930
           K  N+LL  +    L+DFG A  L
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQL 166

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 83.7 bits (208), Expect = 3e-17
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 24/185 (12%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVK----VFD--LQCGRAFKSFDVECEMMKSI 833
           R+     IG G +G V  A     G +VA+K    VFD  +   R  +    E ++++ +
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHL 56

Query: 834 RHRNLIK---VISSCSTEEFKALIL--EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           RH N+I    ++   S E+F  + +  E M    L K + S   + D   +   +  +  
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILR 114

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT--LATI 946
            L+YLH   SA VIH DLKPSN+L++ N    + DFG+A+  +  D+      T  + T 
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVDPDEDEKGFLTEYVVTR 170

Query: 947 GYMAP 951
            Y AP
Sbjct: 171 WYRAP 175

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 55/166 (33%), Positives = 81/166 (48%), Gaps = 14/166 (8%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD-LQCGRAFKSFDVECE---MMKSIRHRNLIKV 841
           +IG G F +V  A+      E A+K+ D  Q  +  K   V+ E   + +   H  +IK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
             +   EE    +LEY P+G L + +  Y S   LD         ++   LEYLH   S 
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SK 121

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
            +IH DLKP N+LLD +M   ++DFG AK+L   + S    +  AT
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDAT 166

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 15/149 (10%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV----ECEMMKSIRHRNLIKVI 842
           IG G +G VYKAR    G  VA+K   ++  +  + F +    E ++++ +RH N++++ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 843 SSCSTEEFKA---LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
               T + K    ++ EYM H  L   L S        Q    M  +   L+YLH   S 
Sbjct: 65  EIV-TSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SN 119

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            ++H D+K SN+L++++ V  L+DFG+A+
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 49/171 (28%), Positives = 77/171 (45%), Gaps = 11/171 (6%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G    VY A  +    +VA+K  DL +C  +      E + M    H N++K  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV---DVATTLEYLHFGYSAPVI 902
              +   L++ Y+  GSL   +  S+Y         I     +V   LEYLH   S   I
Sbjct: 69  VVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLI--GEDQSITQTQTLATIGYMAP 951
           H D+K  N+LL ++    ++DFG++  L   G+     +   + T  +MAP
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 57/177 (32%), Positives = 92/177 (51%), Gaps = 13/177 (7%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+        +VAVK   L+ G  + ++F  E ++MK +RH  L+++ + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L S     L + Q +++   +A  + YL    S   IH D
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-----GLFHVK 957
           L   N+L+ +N+V  ++DFG+A+ LI +D+   +      I + AP     G F +K
Sbjct: 129 LAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 35/210 (16%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSI 833
           F    +IG+G FG V    I +  +   K+F ++           + ++   E  +++ +
Sbjct: 2   FELLRVIGKGAFGKV---CIVQKRDTK-KMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57

Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------IMVDVA 887
            H  L+ +  S   EE   L+++ +  G L        Y L    + +       + ++ 
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIV 110

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             LEYLH   S  +IH D+KP N+LLD+    H++DF IA  +  +  +   T T  T G
Sbjct: 111 LALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPG 164

Query: 948 YMAPGLFHVKYILFVVNF----LTSYSFLM 973
           YMAP +   +     V++    +T+Y  L 
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLR 194

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 55/178 (30%), Positives = 83/178 (46%), Gaps = 32/178 (17%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G +G VYKAR I  G  VA+KV  L+ G  F+    E  M+K  RH N++    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN----------IMVDVATTLEYLHFG 896
             +   +++EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
                IH D+K +N+LL ++    L+DFG++  L     +I + ++   IG   +MAP
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 20/165 (12%)

Query: 787 LIGRGGFGSVYKARI----GEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           ++G G FGSV + ++    G  ++VAVK    D+      + F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 841 VISSCSTEEFKA------LILEYMPHGSLEKSLYSSN-----YILDIFQRLNIMVDVATT 889
           +I  C             +IL +M HG L   L  S        L +   L  MVD+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           +EYL    +   IH DL   N +L ++M   ++DFG++K +   D
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 62/182 (34%), Positives = 86/182 (47%), Gaps = 21/182 (11%)

Query: 781 RFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGR--AFKSFDVECEMMKSIRHRN 837
           R+   N IG G FG VY A  +  G  +AVK   +Q       K    E ++++ ++H N
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 838 LIKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT-----LE 891
           L+K          K  I +EY   G+LE  L     ILD       ++ V T      L 
Sbjct: 61  LVKYYG-VEVHREKVYIFMEYCSGGTLE-ELLEHGRILD-----EHVIRVYTLQLLEGLA 113

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI-TQTQTLA-TIGYM 949
           YLH   S  ++H D+KP+N+ LD N V  L DFG A  L     ++  + Q+LA T  YM
Sbjct: 114 YLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 950 AP 951
           AP
Sbjct: 171 AP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 4/150 (2%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           F+    +G G FG V++      + VA+K+         + F  E + +K +RH++LI +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAP 900
            + CS  E   +I E M  GSL   L S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            IH DL   N+L+ +++V  ++DFG+A+L+
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 27/176 (15%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSC 845
           +G+G  G VYK R    G   A+K   +     F K    E + ++S     ++K   + 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT---------LEYLHFG 896
             E   +++LEYM  GSL           D+ +++  + +             L+YLH  
Sbjct: 69  YKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDYLH-- 116

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
               +IH D+KPSN+L++      ++DFGI+K+L   + ++ Q  T + T+ YM+P
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 24/180 (13%)

Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDL-QCGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           IG+G FG+V K  R  +G  +  K  D        K   V E  +++ ++H N+++    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 845 CSTEEFKAL--ILEYMPHGSL---------EKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
                 + L  ++EY   G L         E+      +I  I  +L         L   
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL------LLALYEC 121

Query: 894 HFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H        V+H DLKP+N+ LD N    L DFG+AK+L G D S  +T  + T  YM+P
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 11/178 (6%)

Query: 788 IGRGGFGSVYKAR-IGEG----MEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG+VYK   I EG    + VA+KV   +    A K    E  +M S+ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
           +  C + +   LI + MP G L   + +    +     LN  V +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-GLFHVKY 958
           +H DL   NVL+       ++DFG+AKLL  +++          I +MA   + H  Y
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 53/166 (31%), Positives = 85/166 (51%), Gaps = 8/166 (4%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V++        VAVK   L+ G    K F  E ++MK +RH  LI++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKT--LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ E M +GSL + L       L + Q +++   VA+ + YL    +   IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           L   NVL+ +N +  ++DFG+A+ +I ED    +      I + AP
Sbjct: 129 LAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 17/171 (9%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQ------CGRAFKSFDVECEMMKSIRHRNLIK 840
           IG G +G VYKAR    G  VA+K   L+         A +    E +++K + H N+IK
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           ++     +    L+ E+M    L K +      L      + +  +   L + H   S  
Sbjct: 63  LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           ++H DLKP N+L++   V  L+DFG+A+           T  + T  Y AP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 8/162 (4%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKS 832
           E+ R     +  + +G G +G VY+    +  + VAVK    +     + F  E  +MK 
Sbjct: 2   EMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 58

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLE 891
           I+H NL++++  C+ E    +I E+M +G+L   L   N   ++    L +   +++ +E
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           YL        IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 119 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 52/149 (34%), Positives = 74/149 (49%), Gaps = 13/149 (8%)

Query: 788 IGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKV 841
           +G G FG V          G G  VAVK    +CG+   S +  E  ++K++ H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              CS +  K   LI+EY+P GSL   L      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             IH DL   NVLLD++ +  + DFG+AK
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 1e-14
 Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 29/178 (16%)

Query: 574 LNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI 633
           L   +    G +P DI  L+ L  I+ S N+    IP  +G +T+L+ L L YN   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 634 SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAK 693
            ES G L SL+ LNL+ N+LS  +P +                L G +    SF      
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA----------------LGGRLLHRASF------ 520

Query: 694 SFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKR 751
           +F  N  LCG P L    C   +   ++     +GI   +S  F+ +VI  +  +++R
Sbjct: 521 NFTDNAGLCGIPGL--RACGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 31/186 (16%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDL----QCGR-AFKSFDVECEMMKSIR 834
           R+ +  L+G G FGSVY+    + G   AVK   L    Q G+ A K  + E  ++  ++
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT----- 889
           H N+++ + +   E+   + LE +P GSL K       +L  +      V    T     
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAK-------LLKKYGSFPEPVIRLYTRQILL 113

Query: 890 -LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG- 947
            LEYLH       +H D+K +N+L+D N V  L+DFG+AK      Q +  +   +  G 
Sbjct: 114 GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGS 164

Query: 948 --YMAP 951
             +MAP
Sbjct: 165 PYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 53/170 (31%), Positives = 83/170 (48%), Gaps = 20/170 (11%)

Query: 782 FSENNLIGRGGFGSVYKARI----GEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRH 835
           F+   ++G+G FGSV +A++    G   +VAVK+   D+      + F  E   MK   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 836 RNLIKVISSCSTEEFKA------LILEYMPHGSLEKSLYSSN-----YILDIFQRLNIMV 884
            N+IK+I        K       +IL +M HG L   L  S      + L +   +  M+
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           D+A+ +EYL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 27/200 (13%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQ---CGRAFKSFDVE 826
           E+  +  RF E   +G G FG VYK  +          +V +  L+     +  + F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN--------------- 871
            E+M  ++H N++ ++  C+ E+   ++ EY+ HG L + L  ++               
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 872 YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 931
             LD    L+I + +A  +EYL    S   +H DL   N L+ + +   +SDFG+++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 932 GEDQSITQTQTLATIGYMAP 951
             D    Q+++L  + +M P
Sbjct: 176 SADYYRVQSKSLLPVRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 14/174 (8%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           I +G +G V+ A+    G   A+KV    D+           E +++   +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
           S   ++   L++EY+P G L   L +    LD       + ++   LEYLH   S  +IH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKL-LIGE--DQSITQTQTLATIG---YMAP 951
            DLKP N+L+D N    L+DFG++K+ L+    + +  + +    +G   Y+AP
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 5/167 (2%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG G FG V+     E  +VA+K    +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
                L+ E+M HG L   L +          L + +DV   + YL    S+ VIH DL 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLA 127

Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             N L+ +N V  +SDFG+ + ++ +DQ  + T T   + + +P +F
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVF 173

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 26/185 (14%)

Query: 786 NLIGRGGFGSVYKARI---GEGMEVAVKVF-DLQCGRAFKSFDVECEMM-KSIRHRNLIK 840
           ++IG G FG V +A I   G  M  A+K+  +       + F  E E++ K   H N+I 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------------LDIFQRLNIMVD 885
           ++ +C    +  + +EY P+G+L   L  S  +               L   Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           VAT ++YL        IH DL   NVL+ +N+ + ++DFG+++   GE+  + +T     
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 946 IGYMA 950
           + +MA
Sbjct: 182 VRWMA 186

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 6/165 (3%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E G+  A K+  ++     + F VE +++   +H N++ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            E    +++E+   G+L+  +      L   Q   +   +   L +LH   S  VIH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           K  N+LL  +    L+DFG++       Q   +   + T  +MAP
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 72.3 bits (178), Expect = 7e-14
 Identities = 52/184 (28%), Positives = 76/184 (41%), Gaps = 34/184 (18%)

Query: 782 FSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           F     +G G +GSVYKA   E G  VA+KV  +      +    E  ++K      ++K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN----------IMVDVATTL 890
              S        +++EY   GS          + DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG--- 947
           EYLH   S   IH D+K  N+LL++   A L+DFG++  L       T  +    IG   
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPF 164

Query: 948 YMAP 951
           +MAP
Sbjct: 165 WMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 8/166 (4%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSC 845
           +G G  G V K      G  +AVK   L+   A  K    E +++       ++    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
                 ++ +EYM  GSL+K L      +       I V V   L YLH  +   +IH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +KPSN+L++      L DFG++  L+    S+ +T    T  YMAP
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 72.6 bits (179), Expect = 1e-13
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 14/181 (7%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDL------QCGRAFKSFDVECEMMKSI 833
           R+ +   +G G +  VYKAR  E G  VA+K   L      + G  F +   E ++++ +
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59

Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           +H N+I ++     +    L+ E+M    LEK +   + +L      + M+     LEYL
Sbjct: 60  KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H  +   ++H DLKP+N+L+  + V  L+DFG+A+   G        Q + T  Y AP L
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQ-VVTRWYRAPEL 173

Query: 954 F 954
            
Sbjct: 174 L 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 7/161 (4%)

Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIKVISSC 845
           L+G+G FG V+K  + +   VAVK       +  K  F  E  ++K   H N++K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           +  +   +++E +P G     L      L   Q +   +D A  + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
           L   N L+ +N V  +SDFG+++    ED  I  +  L  I
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQI 156

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 12/173 (6%)

Query: 785 NNLIGRGGFGSVYKA----RIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLI 839
              IG G FG VY+        E + VAVK        + +  F  E  +M+   H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K+I    TE    +++E  P G L   L  + Y LD+   +     ++T L YL    S 
Sbjct: 71  KLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI-TQTQTLATIGYMAP 951
             +H D+   NVL+       L DFG+++ L  ED+S    ++    I +MAP
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAP 177

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 29/187 (15%)

Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSN---YILD-----------IFQRLNIMVDVA 887
              C+      ++ EYM HG L + L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 888 TTLEY---LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           + + Y   LHF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 945 TIGYMAP 951
            I +M P
Sbjct: 187 PIRWMPP 193

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 26/185 (14%)

Query: 786 NLIGRGGFGSVYKARI---GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRNLIK 840
           ++IG G FG V KARI   G  M+ A+K + +       + F  E E++  +  H N+I 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------------LDIFQRLNIMVD 885
           ++ +C    +  L +EY PHG+L   L  S  +               L   Q L+   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T     
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186

Query: 946 IGYMA 950
           + +MA
Sbjct: 187 VRWMA 191

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 12/175 (6%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVA---VKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG+G F  VYKA  + +G  VA   V++F++   +A +    E +++K + H N+IK ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 844 SCSTEEFKALILEYMPHGSLE---KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           S        ++LE    G L    K       ++         V + + LE++H   S  
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR 126

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
           ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+P   H
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIH 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 47/183 (25%), Positives = 93/183 (50%), Gaps = 20/183 (10%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG------RAFKSFDVECEMMKSIRH 835
           +++  ++G+G +G+VY     +G  +AVK  +L         + ++    E +++KS++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI-FQRL--NIMVDVATTLEY 892
            N+++ + +C  +   ++ +E++P GS+   L     + +  F +    I+  VA    Y
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----Y 117

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG----Y 948
           LH   +  V+H D+K +NV+L  N +  L DFG A+ L       T +  L ++     +
Sbjct: 118 LH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 949 MAP 951
           MAP
Sbjct: 175 MAP 177

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 13/168 (7%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G +G VYKAR +  G   A+KV  L+ G  F     E  MMK  +H N++    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   + +E+   GSL+  +Y   ++        I      TL+ L++ +S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQ-DIY---HVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
           K +N+LL DN    L+DFG++  +     + T  +  + IG   +MAP
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 46/144 (31%), Positives = 80/144 (55%), Gaps = 12/144 (8%)

Query: 788 IGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+V +   GE  G +VAVK  +++C    ++F  E  +M  + H+NL++++   
Sbjct: 14  IGEGEFGAVLQ---GEYTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 846 STEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
                  +++E M  G+L   L +    ++ + Q L   +DVA  +EYL    S  ++H 
Sbjct: 69  LHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAK 928
           DL   N+L+ ++ VA +SDFG+A+
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 23/182 (12%)

Query: 781 RFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIRHRN 837
            F     +G+G +GSVYK  R+ +    A+K  DL      +  D   E  ++ S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 838 LIKVISSCSTEEF-----KALILEYMPHGSLEKSLYSSNYILDIFQR---LNIMVDVATT 889
           +I        E F       +++EY P G L K++        +        I + +   
Sbjct: 61  II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           L+ LH      ++H DLK +N+LL  N +  + D GI+K+L    +++ +TQ   T  YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYM 168

Query: 950 AP 951
           AP
Sbjct: 169 AP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 26/171 (15%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IG-----EGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI 833
           R +    +G G FG V KA  +G     E   VAVK+  D    +       E EMMK I
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 834 -RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS-------SNYILDIFQRLNI-MV 884
            +H+N+I ++  C+ E    +++EY  HG+L   L +       ++          +   
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 885 D-------VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           D       VA  +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 133 DLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)

Query: 782 FSENN---LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
           + EN    ++G+G +G VY AR +   + +A+K    +  R  +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYS------SNYILDIFQRLNIMVDVATTLE 891
           +++ + S S   F  + +E +P GSL   L S       N    IF    I+      L+
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           YLH      ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177

Query: 951 P 951
           P
Sbjct: 178 P 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 69.8 bits (172), Expect = 6e-13
 Identities = 48/153 (31%), Positives = 72/153 (47%), Gaps = 25/153 (16%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECE-----------MMKSIRH 835
           +G G +G VYKAR    G  VA+K   L         D E E           ++K ++H
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRL---------DNEEEGIPSTALREISLLKELKH 57

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
            N++K++    TE    L+ EY     L+K L      L      +IM  +   L Y H 
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             S  ++H DLKP N+L++ + V  L+DFG+A+
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 53/178 (29%), Positives = 92/178 (51%), Gaps = 16/178 (8%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP     G F +K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 51/156 (32%), Positives = 77/156 (49%), Gaps = 18/156 (11%)

Query: 787 LIGRGGFGSVY---KARIGEGMEVAVKVFDL------QCGRAFKSFDV---ECEMMKSIR 834
           LIG G FGSVY    A  GE M  AVK  +L         R     D    E  ++K ++
Sbjct: 7   LIGSGSFGSVYLGMNASSGELM--AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H N+++ + S    +   + LEY+P GS+   L +     +   R N +  +   L YLH
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH 123

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
              +  +IH D+K +N+L+D+     +SDFGI+K L
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 9/166 (5%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VYKAR +  G   AVK+  L+ G  F     E  M+K  +H N++    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
           + E   + +EY   GSL+  +Y   ++      L I      TL+ L + +S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQ-DIY---HVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDI 132

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
           K +N+LL DN    L+DFG+A  +     +I + ++ + T  +MAP
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 8/156 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKS---FDVECEMMKSIR 834
           +  ++  +IG G FG V++   ++    EVAV +  L+ G   K    F  E  +M    
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H N+I++    +  +   +I EYM +G+L+K L   +     +Q + ++  +A  ++YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                  +H DL   N+L++ N+   +SDFG++++L
Sbjct: 125 ---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 54/168 (32%), Positives = 83/168 (49%), Gaps = 17/168 (10%)

Query: 788 IGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG+G FG V    +G+  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 846 STEEFKALIL-EYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
             E+    I+ EYM  GSL   L S    +L     L   +DV   +EYL    +   +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 30/188 (15%)

Query: 788 IGRGGFGSVYKAR------IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYS---------------SNYILDIFQRLNIMVDV 886
              C   +   ++ EYM HG L K L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 887 ATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
           A+ + YL   HF      +H DL   N L+  N++  + DFG+++ +   D       T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 944 ATIGYMAP 951
             I +M P
Sbjct: 187 LPIRWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 16/181 (8%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV------ECEMMKS 832
           N++    ++G G +G V K R    G  VA+K F      +    DV      E ++++ 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK----ESEDDEDVKKTALREVKVLRQ 56

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +RH N++ +  +   +    L+ EY+    LE  L +S   L      + +  +   + Y
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAY 115

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPG 952
            H   S  +IH D+KP N+L+ ++ V  L DFG A+ L     S   T  +AT  Y AP 
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPE 171

Query: 953 L 953
           L
Sbjct: 172 L 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 19/176 (10%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVF-----DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           L+G+G FG VY    +  G E+AVK         +  +   + + E +++K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
                  +E  ++ +EYMP GS++  L +   + +   R      +   +EYLH   S  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNM 124

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-----LATIGYMAP 951
           ++H D+K +N+L D      L DFG +K L    Q+I  + T       T  +M+P
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 56/182 (30%), Positives = 81/182 (44%), Gaps = 35/182 (19%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVF-----DLQCGR-AFKSFDVECEMMKSIRHRNLIK 840
           IG G +G V+K R  E G  VA+K F     D    + A +    E  M+K ++H NL+ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64

Query: 841 VISSCSTEEFKA-----LILEYMPHGSLEKSLYSSNYILDIFQR----LNIMVDVATTLE 891
           +I     E F+      L+ EY  H  L +        L+   R      I   +  TL+
Sbjct: 65  LI-----EVFRRKRKLHLVFEYCDHTVLNE--------LEKNPRGVPEHLIKKIIWQTLQ 111

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            ++F +    IH D+KP N+L+       L DFG A++L G       T  +AT  Y AP
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAP 169

Query: 952 GL 953
            L
Sbjct: 170 EL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 10/170 (5%)

Query: 787 LIGRGGFGSVYKA-RIGEG----MEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIK 840
           L+G G FG+V+K   I EG    + VA+K    + GR  F+        M S+ H  +++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           ++  C     + L+ +  P GSL   +      LD  + LN  V +A  + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           ++H +L   N+LL  + +  ++DFG+A LL  +D+    ++    I +MA
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 37/198 (18%)

Query: 786 NLIGRGGFGSVYKAR------IGEG-MEVAVKVFDLQCG---RAFKSFDVECEMMKSIRH 835
           N +G G FG VY+         G G + VAVK   L+ G   +  K F  E  +M +  H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT--LRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNY------ILDIFQRLNIMVDVATT 889
            N++K++  C   E + +I+E M  G L   L  +        +L + + L+I +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 890 LEYL---HFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
             YL   HF      IH DL   N L+     D + V  + DFG+A+ +   D    + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 942 TLATIGYMAP-----GLF 954
            L  + +MAP     G F
Sbjct: 173 GLLPVRWMAPESLLDGKF 190

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 30/180 (16%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD-------VECEMMKSIRHRNLI 839
           IG G  G V+KA+    G  VA+K       R  +           E + +++ +H  ++
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALK---KVALR--RLEGGIPNQALREIKALQACQHPYVV 62

Query: 840 KVI------SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           K++      S         L++EYMP   L + L      L   Q  + M  +   + Y+
Sbjct: 63  KLLDVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   +  ++H DLKP+N+L+  + V  ++DFG+A+L   E++    +  +AT  Y AP L
Sbjct: 116 H---ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 3e-12
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 31/185 (16%)

Query: 780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
             F+    IG+G FG VYKA        VA+KV DL+        ++E ++ +       
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQE------ 49

Query: 839 IKVISSCS-----------TEEFK-ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
           I+ +S C             +  K  +I+EY   GS    L      LD      I+ +V
Sbjct: 50  IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREV 107

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
              LEYLH       IH D+K +N+LL +     L+DFG++  L        +   + T 
Sbjct: 108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162

Query: 947 GYMAP 951
            +MAP
Sbjct: 163 FWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 9/170 (5%)

Query: 787 LIGRGGFGSVYKARIGE-GMEVAVKVF-DLQCGRAFKSFDV-ECEMMKSIRHRNLIKVIS 843
           L+G G +G V K +  E G  VA+K F + +  +  K   + E  M+K +RH NL+ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
               ++   L+ E++ H  L+  L      LD  +    +  +   +E+ H   S  +IH
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIH 123

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+L+  + V  L DFG A+ L    +    T  +AT  Y AP L
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 6/172 (3%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V+  +    ++VA+K+   +   +   F  E ++M  + H NL+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    ++ EYM +G L   L      L     L++  DV   +EYL    S   IH DL 
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127

Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF-HVKY 958
             N L+ ++ V  +SDFG+A+ ++ +DQ  +   T   + +  P +F + ++
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRF 178

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E G   A KV + +     + + VE E++ +  H  ++K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            +    +++E+ P G+++  +   +  L       I V     LE L + +S  +IH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 907 KPSNVLLDDNMVAHLSDFGIA----KLLIGEDQSITQTQTLATIGYMAP 951
           K  NVLL  +    L+DFG++    K L   D  I       T  +MAP
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 5/168 (2%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    ++ EYM +G L   L          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
             N L+DD     +SDFG+++ ++ +D+  +   +   + +  P +  
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLL 174

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 22/175 (12%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH---RN 837
           LIGRG +G+VY+ + +  G  VA+K+ +L         DV     E  ++  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + K   S        +I+EY   GS+ ++L  +  I + +  + I+ +V   L+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY-MAP 951
              VIH D+K +N+L+ +     L DFG+A LL   +Q+ ++  T     Y MAP
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 55/192 (28%), Positives = 87/192 (45%), Gaps = 35/192 (18%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKVFDL---QCGR-------AFKSFDVECEMMKSIRH 835
           LIG+G +G VY A  +  G  +AVK  +L     GR         K+   E E +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL----------EKSLYSSNYILDIFQRLNIMVD 885
            N+++ +   +TEE+ ++ LEY+P GS+          E+ L                  
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-----------FTEQ 116

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           V   L YLH   S  ++H DLK  N+L+D + +  +SDFGI+K       +        +
Sbjct: 117 VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 946 IGYMAPGLFHVK 957
           + +MAP + H  
Sbjct: 174 VFWMAPEVIHSY 185

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 46/172 (26%), Positives = 68/172 (39%), Gaps = 11/172 (6%)

Query: 787 LIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
            +G G FG V    +    G+ + VAVK     +       F  E  +M S+ H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAP 900
                T     ++ E  P GSL   L         I    +  V +A  + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLIGEDQSITQTQTLATIGYMAP 951
            IH DL   N+LL  +    + DFG+ + L   ED  + +        + AP
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 23/178 (12%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           ++GRG FG V+   R  +   V +K   ++        +   EC+++K + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY-------LHFG 896
           +   ++   +++EY P G+L +          I +R N ++D  T L +       LH  
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEY---------IQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 897 YSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           ++  ++H DLK  N+LLD + MV  + DFGI+K+L  + ++ T    + T  Y++P L
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 1e-11
 Identities = 57/188 (30%), Positives = 91/188 (48%), Gaps = 32/188 (17%)

Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R+   + IG G +G V  A     G++VA+K    F+ Q  C R  +    E ++++  +
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFK 61

Query: 835 HRNLIK---VISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILD-----IFQRLNIMV 884
           H N+I    +I   S E F    ++ E M    L K + + +   D     ++Q L    
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR--- 117

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTL 943
                L+Y+H   SA V+H DLKPSN+LL+ N    + DFG+A++     D +   T+ +
Sbjct: 118 ----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170

Query: 944 ATIGYMAP 951
           AT  Y AP
Sbjct: 171 ATRWYRAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 10/177 (5%)

Query: 787 LIGRGGFGSVYKA-RIGEG----MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIK 840
           ++G G FG+VYK   + EG    + VA+K+ +   G +A   F  E  +M S+ H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           ++  C +   + L+ + MPHG L   ++     +     LN  V +A  + YL       
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           ++H DL   NVL+       ++DFG+A+LL G+++          I +MA    H +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 10/156 (6%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+        +VAVK   L+ G  + +SF  E ++MK +RH  L+++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKT--LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 847 TEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L +   +++   VA  + Y+        IH D
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ D +V  ++DFG+A+L+  ED   T  Q
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI--EDNEYTARQ 161

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 19/163 (11%)

Query: 788 IGRGGFGSVYKARIGEG---MEVAVKVFDLQ-CGRA-FKSFDVECEMMKSIRHRNLIKVI 842
           +G G FGSV + ++ +    ++VAVK   +  C R+  + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 843 SSC----STEEFKA--LILEYMPHGSLEKSLYSSNY-----ILDIFQRLNIMVDVATTLE 891
             C     +E + +  +IL +M HG L   L  S        L     +  M D+A+ +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           YL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 9/106 (8%)

Query: 231 LYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEI 290
           L L   GL+G IP +   L  L+ + L  ++++G IP  L ++T LEVL L  N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 291 PPEIHNLHNLKLLDLSHNKLVGAVPA---------TIFNMSTLTGL 327
           P  +  L +L++L+L+ N L G VPA           FN +   GL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 2e-11
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 5/107 (4%)

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-S 560
           GL L++  L G IP+DI +L  L  + LSGN + G+IP    ++ SL  L L  N    S
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 561 IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSD 607
           IP ++  L  +  LN + N  +G +P  +G   +L    F   NF+D
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGR-LLHRASF---NFTD 524

Length = 623

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 32/197 (16%)

Query: 777 RATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV----ECEMMK 831
           R  ++F     IG G +G VYKAR  + G  VA+K   L   +  + F +    E ++++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILR 61

Query: 832 SIRHRNLIK----VISSCSTEEFKA------LILEYMPH---GSLEKSL--YSSNYILDI 876
            + HRN++     V       +FK       L+ EYM H   G LE  L  +S ++I   
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
            ++L         LE L++ +    +H D+K SN+LL++     L+DFG+A+L   E+  
Sbjct: 122 MKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 937 ITQTQTLATIGYMAPGL 953
              T  + T+ Y  P L
Sbjct: 173 -PYTNKVITLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 10/150 (6%)

Query: 787 LIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKV 841
           +IG G FG V   R+      E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-FGYSAP 900
               +  +   ++ EYM +GSL+  L   +    + Q + ++  +A+ ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +H DL   N+L++ N+V  +SDFG++++L
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 54/178 (30%), Positives = 91/178 (51%), Gaps = 16/178 (8%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+        +VA+K   L+ G    ++F  E ++MK +RH  L+ + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 847 TEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ E+M  GSL   L   +   L + Q +++   +A  + Y+        IH D
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +N+L+ DN+V  ++DFG+A+L+  ED   T  Q     I + AP     G F +K
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 3e-11
 Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 1/90 (1%)

Query: 158 LDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGA 217
           L      L G IP +I S L  L+SI+LS N   G IP +L +   LE+L LS N+  G+
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 218 IPKEIGNLTKLKELYLGYSGLQGEIPREFG 247
           IP+ +G LT L+ L L  + L G +P   G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 49/177 (27%), Positives = 90/177 (50%), Gaps = 13/177 (7%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+        +VAVK   L+ G  + ++F  E  +MK+++H  L+++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL-NIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   +I EYM  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-----GLFHVK 957
           L+ +NVL+ ++++  ++DFG+A+ +I +++   +      I + AP     G F +K
Sbjct: 129 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.8 bits (163), Expect = 4e-11
 Identities = 28/79 (35%), Positives = 51/79 (64%)

Query: 262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM 321
           L+G IP +++ L  L+ + L  N + G IPP + ++ +L++LDLS+N   G++P ++  +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 322 STLTGLGLQSNSLSGSLSS 340
           ++L  L L  NSLSG + +
Sbjct: 490 TSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 4e-11
 Identities = 33/77 (42%), Positives = 45/77 (58%)

Query: 464 GGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTK 523
           G  P +I  L +L  I L GN + G+IP +LG +  L+ L L  N   G IP+ + +LT 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 524 LYELGLSGNKLSGSIPA 540
           L  L L+GN LSG +PA
Sbjct: 492 LRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 21/182 (11%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + + VAVK        A K F  E E++ +++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSN------------YILDIFQRLNIMVDVATT 889
              C   +   ++ EYM HG L K L +                L   Q L+I   +A  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 950 AP 951
            P
Sbjct: 190 PP 191

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 21/193 (10%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV----ECEMM 830
           C   +++ +   IG+G FG V+KAR       VA+K   +      + F +    E +++
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKIL 65

Query: 831 KSIRHRNLIKVISSCSTE-----EFKA---LILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
           + ++H N++ +I  C T+      +K    L+ E+  H  L   L + N    + +   +
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLIGEDQSITQT 940
           M  +   L Y+H      ++H D+K +N+L+  + +  L+DFG+A+   L    +    T
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 941 QTLATIGYMAPGL 953
             + T+ Y  P L
Sbjct: 182 NRVVTLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 31/202 (15%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIG-EGME----VAVKVF-DLQCGRAFKSFDVEC 827
           EL  +  RF E   +G   FG +YK  +   GM+    VA+K   D+   + +  F  E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 828 EMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY----------SSN------ 871
            +M  + H N++ ++   + E+   ++ EY+  G L + L           SS+      
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 872 YILDIFQRLNIMVDVATTLEYL--HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
             LD    L+I + +A  +EYL  HF      +H DL   N+L+ + +   +SD G+++ 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 930 LIGEDQSITQTQTLATIGYMAP 951
           +   D    Q ++L  I +M P
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 48/208 (23%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVF------DLQCGRAFKSFDVECEMMKSIRH 835
           IG+G FG V++AR            VAVK+       D+Q       F  E  +M    H
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-----ADFQREAALMAEFDH 67

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSL--------------------YSSNYI-L 874
            N++K++  C+  +   L+ EYM +G L + L                       N + L
Sbjct: 68  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127

Query: 875 DIFQRLNIMVDVATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 931
              ++L I   VA  + YL    F      +H DL   N L+ +NMV  ++DFG+++ + 
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 932 GEDQSITQTQTLATIGYMAP-GLFHVKY 958
             D           I +M P  +F+ +Y
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRY 209

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 19/172 (11%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVK------VFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G GGFG V   +   +    A+K      + +        S   E E+++   H  ++K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  +   +++  +++EY   G L   L       D +     +  V    EYLH   +  
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRG 113

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
           +I+ DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+AP
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.8 bits (158), Expect = 5e-11
 Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 22/160 (13%)

Query: 785 NNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL---------------QCGRAFKSFDVECE 828
              +G G +G V KA     G  VA+K   +                CG  F +   E +
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR-ELK 72

Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           +M  I+H N++ ++      +F  L+++ M    L+K +      L   Q   I++ +  
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILN 130

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            L  LH  Y    +H DL P+N+ ++   +  ++DFG+A+
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 54/190 (28%), Positives = 87/190 (45%), Gaps = 44/190 (23%)

Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDV---------ECEMMKSIRHRN 837
           IG G +G V  A     G +VA+K       +   +FDV         E ++++  +H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 838 L--IKVISSCSTEEFKA--LILEYMPHGSLEKSLYSS--------NYILDIFQRLNIMVD 885
           +  I+ I      +FK   ++++ M    L   ++S          Y L  +Q L     
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFL--YQLLR---- 118

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG--EDQSITQTQTL 943
               L+Y+H   SA VIH DLKPSN+L++++    + DFG+A+ L     +     T+ +
Sbjct: 119 ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 944 ATIGYMAPGL 953
           AT  Y AP L
Sbjct: 173 ATRWYRAPEL 182

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.0 bits (156), Expect = 6e-11
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 17/162 (10%)

Query: 782 FSENNLI-----GRGGFGSVYKAR---IGE--GMEVAVKVFDLQCGRAFKSFDVECEMMK 831
           F E +L      G+G FGSV   R   + +  G  VAVK          + F+ E E++K
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 832 SIRHRNLIK---VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           S++H N++K   V  S      + L++EY+P+GSL   L      LD  + L     +  
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICK 119

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +EYL    S   +H DL   N+L++      + DFG+ K+L
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 26/185 (14%)

Query: 786 NLIGRGGFGSVYKARI---GEGMEVAVKVF-DLQCGRAFKSFDVECEMM-KSIRHRNLIK 840
           ++IG G FG V KARI   G  M+ A+K   +       + F  E E++ K   H N+I 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------------LDIFQRLNIMVD 885
           ++ +C    +  L +EY PHG+L   L  S  +               L   Q L+   D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T     
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 946 IGYMA 950
           + +MA
Sbjct: 175 VRWMA 179

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.2 bits (156), Expect = 6e-11
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 8/165 (4%)

Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG+G  G+VY A  +  G EVA+K  +LQ     +    E  +M+  +H N++  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   S  VIH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 40/188 (21%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR------HRNLI 839
            +G G F S Y+AR +  G  +AVK        + +  +V   + K IR      H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 840 KVI-SSCSTEEFKALILEYMPHGSLEKSLY---------SSNYILDIFQRLNIMVDVATT 889
           +++ ++C    F  L +E+M  GS+   L            NY   + +           
Sbjct: 67  RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------G 115

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSIT-----QTQTL 943
           L YLH      +IH D+K +N+L+D       ++DFG A  L       T     Q Q L
Sbjct: 116 LSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLL 169

Query: 944 ATIGYMAP 951
            TI +MAP
Sbjct: 170 GTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 60/197 (30%), Positives = 90/197 (45%), Gaps = 29/197 (14%)

Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 943 LATIGYMAP-GLFHVKY 958
              + +MAP  LF   Y
Sbjct: 200 RLPVKWMAPEALFDRVY 216

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 57.7 bits (140), Expect = 7e-11
 Identities = 21/41 (51%), Positives = 29/41 (70%), Gaps = 2/41 (4%)

Query: 38 TDQDALLALKAHITHDPTNFLAKNWNTSTPV-CNWTGVTCD 77
           D+DALLA K+ +  DP+  L+ +WN S+   C+WTGVTCD
Sbjct: 3  DDRDALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 9e-11
 Identities = 32/82 (39%), Positives = 43/82 (52%)

Query: 478 GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGS 537
           G+ L    L G IP  + KL+ LQ ++L  N + G IP  +  +T L  L LS N  +GS
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 538 IPACFSNLASLGTLSLGSNKLT 559
           IP     L SL  L+L  N L+
Sbjct: 482 IPESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 2/88 (2%)

Query: 206 ILSLSINN--LLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
           I  L ++N  L G IP +I  L  L+ + L  + ++G IP   G++  LE++ L  ++  
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIP 291
           G IP+ L  LT L +L L  N L+G +P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.5 bits (155), Expect = 1e-10
 Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 24/185 (12%)

Query: 782 FSENNL-----IGRGGFGSVYKARIGE-GMEVAVKVFDLQC-GRAFKSFDVECE-MMKSI 833
           F+  +L     IGRG FG+V K      G  +AVK        +  K   ++ + +M+S 
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL---NIM--VDVAT 888
               ++K   +   E    + +E M   SL+K  Y   Y+ ++ + +    I+  + VAT
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDK-FY--KYVYEVLKSVIPEEILGKIAVAT 116

Query: 889 --TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
              L YL       +IH D+KPSN+LLD N    L DFGI+  L+    SI +T+     
Sbjct: 117 VKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCR 171

Query: 947 GYMAP 951
            YMAP
Sbjct: 172 PYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 24/187 (12%)

Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVK---VFDLQCGRAFKSFDVECEMMKSIRHRN 837
           F     IGRG F  VY+A  + +G+ VA+K   +FDL   +A      E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 838 LIKVISSCSTEEFKALILEYMPHGSL---------EKSLYSSNYILDIFQRLNIMVDVAT 888
           +IK  +S   +    ++LE    G L         +K L     +   F      V + +
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF------VQLCS 117

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            LE++H   S  V+H D+KP+NV +    V  L D G+ +      ++      + T  Y
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 172

Query: 949 MAPGLFH 955
           M+P   H
Sbjct: 173 MSPERIH 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 12/150 (8%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKV--FDLQCGRAFKSFD-VECE--MMKSIRHRNLIK 840
           L+GRG FG VY       G E+AVK   FD       K  + +ECE  ++K++RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 841 VISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
                   E K L   +EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             ++H D+K +N+L D      L DFG +K
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 24/155 (15%)

Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FGSV    Y  + G+ +EVAVK      +  G+  K F  E  +M  + H  +++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYL---HF 895
           +I  C  E    L++E  P G L K L       + D+     +   VA  + YL   HF
Sbjct: 61  LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF 116

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                 +H DL   NVLL +   A +SDFG+++ L
Sbjct: 117 ------VHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 10/152 (6%)

Query: 785 NNLIGRGGFGSVYKARIGEGME----VAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLI 839
             +IG G FG V + R+    +    VA+K        +    F  E  +M    H N+I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL-HFGYS 898
           ++    +      +I EYM +GSL+K L  ++    + Q + ++  +A+ ++YL    Y 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
              +H DL   N+L++ N+V  +SDFG+++ L
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 2e-10
 Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 29/132 (21%)

Query: 71  WTGVTCDVHSHR----VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIF 126
           W+G  C   S +    +  L + +  L G IP+ +  L  LQS+NL  N + G+IP ++ 
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 127 TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
           ++                        +SL+ LD SYN+ +G IP ++   L  L  ++L+
Sbjct: 464 SI------------------------TSLEVLDLSYNSFNGSIPESL-GQLTSLRILNLN 498

Query: 187 QNMFHGRIPSAL 198
            N   GR+P+AL
Sbjct: 499 GNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 42/141 (29%), Positives = 73/141 (51%), Gaps = 4/141 (2%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E G+  A KV D +     + + VE +++ S  H N++K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            E    +++E+   G+++  +      L   Q   I V    TLE L++ +   +IH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQ---IRVVCKQTLEALNYLHENKIIHRDL 129

Query: 907 KPSNVLLDDNMVAHLSDFGIA 927
           K  N+L   +    L+DFG++
Sbjct: 130 KAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 47/177 (26%), Positives = 83/177 (46%), Gaps = 19/177 (10%)

Query: 787 LIGRGGFGSVYKARIGEG--MEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIK- 840
           +IG G FG V + R+      E+ V +  L+ G   +  + F  E  +M    H N+I  
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 841 ---VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
              V  S        +I E+M +G+L+  L  ++    + Q + ++  +A  ++YL    
Sbjct: 71  EGVVTKSRPV----MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS--- 123

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA---TIGYMAP 951
               +H DL   N+L++ N+V  +SDFG+++ L  +    T T +L     I + AP
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 42/162 (25%)

Query: 788 IGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMM---KSIR----HRNLI 839
           +G G FGSVY AR  E  E VA+K       + F S++ EC  +   KS+R    H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 840 KVISSCSTEEFKA-----LILEYMPHGSLEKSLYSSNYILDIFQRL-------NIMVDVA 887
           K+      E F+       + EYM     E +LY    + D   +        +I+  + 
Sbjct: 62  KLK-----EVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQIL 109

Query: 888 TTLEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             L ++H  G+     H DLKP N+L+    V  ++DFG+A+
Sbjct: 110 QGLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 3e-10
 Identities = 30/92 (32%), Positives = 52/92 (56%)

Query: 179 FLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGL 238
           F++ + L      G IP+ +S  ++L+ ++LS N++ G IP  +G++T L+ L L Y+  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 239 QGEIPREFGNLAELELMALQVSNLQGEIPQEL 270
            G IP   G L  L ++ L  ++L G +P  L
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 5/143 (3%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSC 845
           IGRG FG V+  R+  +   VAVK          K+ F  E  ++K   H N++++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           + ++   +++E +  G     L +    L + + + ++ + A  +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 906 LKPSNVLLDDNMVAHLSDFGIAK 928
           L   N L+ +  V  +SDFG+++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 11/174 (6%)

Query: 788 IGRGGFGSVYKARIGEGMEVA-VKVFDLQCGRAFKS---FDVECEMMKSIRHRNLIKVIS 843
           IG G FG V    +  G   A V V +L+   + +    F  E +  +S++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            C+      L++E+ P G L+  L S         D      +  ++A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             IH DL   N LL  ++   + D+G++     ED  +T  Q    + ++AP L
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 21/182 (11%)

Query: 782 FSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQ-CGRAFKSFDV-ECEMMKSIRHRNL 838
           F   N IG+G FG V+K  R  +    A+K  DL    R  +   + E  ++  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYS-------SNYILDIFQRLNIMVDVATTLE 891
           I+   S   +    +++EY  +G L K L          + +   F      + +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +LH   S  ++H D+K  N+ LD      + D G+AKLL   D +      + T  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170

Query: 952 GL 953
            L
Sbjct: 171 EL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 59/190 (31%), Positives = 81/190 (42%), Gaps = 36/190 (18%)

Query: 780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVF------DLQCGRAFKSFDVECEMMKS 832
            +  E + +G G  GSV K R+   GM  A+K        DLQ     K    E E+ KS
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-----KQILRELEINKS 55

Query: 833 IRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYS---------SNYILDIFQRLN 881
            +   ++K   +   E      + +EY   GSL+ S+Y             +L       
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKKVKKRGGRIGEKVL-----GK 109

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           I   V   L YLH   S  +IH D+KPSN+LL       L DFG++  L+    S+  T 
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTF 163

Query: 942 TLATIGYMAP 951
           T  T  YMAP
Sbjct: 164 T-GTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.8 bits (151), Expect = 5e-10
 Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 47/189 (24%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVK-VF-------DLQCGRAFKSFDVECEMM--KSIR-H 835
           +G+G +G V+KA        VA+K +F       D Q  R F+      E+M  + +  H
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR------EIMFLQELGDH 66

Query: 836 RNLIKVISSCSTEEFKA-------LILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVD 885
            N++K+++       KA       L+ EYM     E  L++   +N + D+ +R  IM  
Sbjct: 67  PNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQ 115

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI---GEDQSITQTQT 942
           +   L+Y+H   S  VIH DLKPSN+LL+ +    L+DFG+A+ L       ++   T  
Sbjct: 116 LLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 943 LATIGYMAP 951
           +AT  Y AP
Sbjct: 173 VATRWYRAP 181

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 47/176 (26%), Positives = 89/176 (50%), Gaps = 12/176 (6%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V+        +VA+K    Q   + ++F  E  +MK ++H  L++ + +  T
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVR-LYAVVT 71

Query: 848 EEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
           +E   +I EYM +GSL   L +   I L I + +++   +A  + ++        IH DL
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-----GLFHVK 957
           + +N+L+ + +   ++DFG+A+ LI +++   +      I + AP     G F +K
Sbjct: 129 RAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 55/181 (30%), Positives = 84/181 (46%), Gaps = 30/181 (16%)

Query: 787 LIGRGGFGSVYKARIGEG--------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           ++G+GG+G V++ R   G        M+V  K   ++  +       E  ++++++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT--------TL 890
           + +I +  T     LILEY+  G L   L        IF     M D A          L
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IF-----MEDTACFYLSEISLAL 113

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           E+LH      +I+ DLKP N+LLD      L+DFG+ K  I E  ++T T    TI YMA
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYMA 168

Query: 951 P 951
           P
Sbjct: 169 P 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 8e-10
 Identities = 39/180 (21%), Positives = 79/180 (43%), Gaps = 19/180 (10%)

Query: 788 IGRGGFGSVYK---ARIGEG---MEVAVK-VFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG VY+     + +G     VA+K V +    R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYS--------SNY-ILDIFQRLNIMVDVATTLE 891
           ++   ST +   +++E M  G L+  L S               + + + +  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YL    +   +H DL   N ++ +++   + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 60.6 bits (147), Expect = 9e-10
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 11/169 (6%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           +G+GGFG V   ++   G   A K  D   L+  +  +    E ++++ +  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
           +  T++   L++  M  G L+  +Y+         + +     +   LE+LH      ++
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           + DLKP NVLLDD+    +SD G+A  L G            T GYMAP
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.3 bits (146), Expect = 9e-10
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 15/176 (8%)

Query: 788 IGRGGFGSVYKARIGEGMEVA-VKVFDLQCGRAFK---SFDVECEMMKSIRHRNLIKVIS 843
           IG G FG V       GM  A V V +L+          F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYIL------DIFQRLNIMVDVATTLEYLHFGY 897
            C       L+LE+ P G L+  L S+  ++      D+ QR+    +VA+ L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            A  IH DL   N  L  ++   + D+G+A     ED  IT+      + ++AP L
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 22/181 (12%)

Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAKG 121

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  +++          I +M
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 950 A 950
           A
Sbjct: 179 A 179

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 45/216 (20%)

Query: 755 PPNDANMPPIATCRRFSYLELCRATNRFSE---NNLIGRGGFGSVYKAR-IGEGMEVAVK 810
           PP  ++    ++    +      A    SE    N IG G  G+VYK      G   A+K
Sbjct: 48  PPPSSSSSSSSSSS--ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK 105

Query: 811 VF--------DLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGS 862
           V           Q  R       E E+++ + H N++K            ++LE+M  GS
Sbjct: 106 VIYGNHEDTVRRQICR-------EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158

Query: 863 LE-KSLYSSNYILDI-FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 920
           LE   +    ++ D+  Q L+        + YLH      ++H D+KPSN+L++      
Sbjct: 159 LEGTHIADEQFLADVARQILS-------GIAYLH---RRHIVHRDIKPSNLLINSAKNVK 208

Query: 921 LSDFGIAKLLIGEDQSITQT-----QTLATIGYMAP 951
           ++DFG++++L        QT      ++ TI YM+P
Sbjct: 209 IADFGVSRIL-------AQTMDPCNSSVGTIAYMSP 237

Length = 353

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 40/170 (23%), Positives = 80/170 (47%), Gaps = 5/170 (2%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V+  +    ++VA+K  + +   + + F  E ++M  + H  L+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           ++   ++ E+M +G L   L      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
             N L+    V  +SDFG+ + ++ +D+  + +     + +  P +F+  
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFS 176

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 33/186 (17%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV---------ECE 828
           TNR+ +   +G G FG V  AR    G  VA+K       +  K F           E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61

Query: 829 MMKSIRHRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           ++K +RH N+I    +  S   + +   + E +  G+    L +S  +   F +   +  
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIY--FVTELL--GTDLHRLLTSRPLEKQFIQY-FLYQ 116

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           +   L+Y+H   SA V+H DLKPSN+L+++N    + DFG+A++     Q    T  ++T
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168

Query: 946 IGYMAP 951
             Y AP
Sbjct: 169 RYYRAP 174

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 54/175 (30%), Positives = 82/175 (46%), Gaps = 15/175 (8%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEM------MKSIRHRNLIK 840
           IG+G FG V  A+   +G   AVKV  LQ     K  + +  M      +K+++H  L+ 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  S  T +    +L+Y+  G L   L       +   R     ++A+ L YLH   S  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
           +I+ DLKP N+LLD      L+DFG+ K   G + S T +    T  Y+AP +  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLR 169

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 32/87 (36%), Positives = 50/87 (57%), Gaps = 2/87 (2%)

Query: 429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
           +GL N  L G +P   +  L H L+  ++S  ++ G  P  +G++T+L  + L  N  NG
Sbjct: 423 LGLDNQGLRGFIPN-DISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIP 515
           SIP +LG+L  L+ L+L  N L G +P
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 31/183 (16%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           F++   IG+G FG V+K       +V A+K+ DL+        + E E+ + I+    I 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54

Query: 841 VISSCSTEEFKA------------LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           V+S C +                 +I+EY+  GS    L +  +  D FQ   ++ ++  
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILK 112

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  I +   + T  +
Sbjct: 113 GLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFW 167

Query: 949 MAP 951
           MAP
Sbjct: 168 MAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 2e-09
 Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 39/181 (21%)

Query: 788 IGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFD---VECEMMKSIRHRNLIKVIS 843
           +G G FG V   R     +  A+K+         K  +    E  +++SIRH  L+ +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM------------VDVATTLE 891
           S   +    L++EY+P G             ++F  L                 V   LE
Sbjct: 69  SFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMA 950
           YLH   S  +++ DLKP N+LLD +    ++DFG AK + G      +T TL  T  Y+A
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLA 166

Query: 951 P 951
           P
Sbjct: 167 P 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 18/158 (11%)

Query: 781 RFSENNLIGRGGFGSVYKARIGEGME-VAVKVFDL---QCGRAFKSFDVECEMMKSIRHR 836
            F++   IG G FG+VY AR     E VA+K       Q    ++    E   ++ +RH 
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 837 NLIKVISSCSTEEFKA-LILEYMPHGSLEKSLYSSNYILDI----FQRLNIMVDVATTLE 891
           N I+    C   E  A L++EY         L S++ IL++     Q + I       L+
Sbjct: 76  NTIE-YKGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQ 126

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
            L + +S   IH D+K  N+LL +     L+DFG A L
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 31/211 (14%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFD 824
           EL R   R +    +G G FG V         K +  + + VAVK+  D    +      
Sbjct: 8   ELSRT--RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 825 VECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILD--- 875
            E EMMK I +H+N+I ++ +C+ +    +++EY   G+L + L +      +Y  D   
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 876 ------IFQRL-NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
                  F+ L +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 929 LLIGEDQSITQTQTLATIGYMAP-GLFHVKY 958
            +   D     T     + +MAP  LF   Y
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 11/149 (7%)

Query: 788 IGRGGFGSVYKARI-----GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V   R        G +VAVK    +  G        E E+++++ H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C+ +      LI+E++P GSL++ L  +   +++ Q+L   V +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             +H DL   NVL++      + DFG+ K
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 3e-09
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 30/182 (16%)

Query: 788 IGRGGFG---SVYKARIGEGMEVAVK----VFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           IG G FG   SV   R  +G  VA+K    VF   + C R F+    E +M+   +H N+
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNV 61

Query: 839 IKVIS-------SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE 891
           +  +            E +  ++ E M    L K + S   +     ++  +  +   L+
Sbjct: 62  LSALDILQPPHIDPFEEIY--VVTELM-QSDLHKIIVSPQPLSSDHVKV-FLYQILRGLK 117

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YLH   SA ++H D+KP N+L++ N V  + DFG+A++    D+S   TQ + T  Y AP
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQYYRAP 173

Query: 952 GL 953
            +
Sbjct: 174 EI 175

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 31/198 (15%)

Query: 788 IGRGGFGSVYKARIGEGME---------VAVKVF-DLQCGRAFKSFDVECEMMKSI-RHR 836
           +G G FG V +A    G++         VAVK+  D    +       E E+MK I +H+
Sbjct: 20  LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-N 881
           N+I ++  C+ E    +I+EY   G+L + L +      +Y  DI         F+ L +
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
               VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     + 
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 942 TLATIGYMAP-GLFHVKY 958
               + +MAP  LF   Y
Sbjct: 196 GRLPVKWMAPEALFDRVY 213

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 46/175 (26%), Positives = 87/175 (49%), Gaps = 11/175 (6%)

Query: 782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRHRN 837
           F +  ++G+GGFG V   ++   G   A K  + +  +  K   +   E ++++ +  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFG 896
           ++ +  +  T++   L+L  M  G L+  +Y       +  + +    ++   LE LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               +++ DLKP N+LLDD+    +SD G+A + + E Q+I     + T+GYMAP
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 59.6 bits (144), Expect = 4e-09
 Identities = 71/234 (30%), Positives = 101/234 (43%), Gaps = 6/234 (2%)

Query: 468 KEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYEL 527
               +    + +       +      L  L  L  L L  N+L   I  ++  LT L  L
Sbjct: 63  PSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSL 121

Query: 528 GLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPL 587
            L  N ++   P      ++L  L L  NK+ S+P  + NL  +  L+ S N  +  LP 
Sbjct: 122 DLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSD-LPK 180

Query: 588 DIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLN 647
            + NL  L  +D S N  SD +P  I  L+ L+ L L  N +   +  S  +L +L  L 
Sbjct: 181 LLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLE 238

Query: 648 LSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELL 701
           LSNN L   +P S+  LS LE LDLS N++   I   GS  N       GN L 
Sbjct: 239 LSNNKL-EDLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLS 290

Length = 394

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.9 bits (143), Expect = 4e-09
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 13/184 (7%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGEGME-VAVKV--FDLQCGRAFKSFDVECEMMKS 832
           CR+   F + N IG G +G VY+AR     E VA+K    D +      S   E  ++ +
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62

Query: 833 IRHRN---LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           +RH N   L +V+     +    L++EY     L   L +        Q   +M+ +   
Sbjct: 63  LRHPNIVELKEVVVGKHLDSI-FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           L+YLH  +   +IH DLK SN+LL D     ++DFG+A+      + +  T  + T+ Y 
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYR 175

Query: 950 APGL 953
           AP L
Sbjct: 176 APEL 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.6 bits (141), Expect = 5e-09
 Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 24/174 (13%)

Query: 788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G G + +VYK +    G  VA+KV  LQ   G  F +   E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 845 CSTEEFKALILEYMPHGSLEK-------SLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
             T+E   L+ EY+ H  L +        L+  N  L +FQ L         L Y+H  Y
Sbjct: 72  IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY 123

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              ++H DLKP N+L+ D     L+DFG+A+       S T +  + T+ Y  P
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPP 172

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 15/170 (8%)

Query: 787 LIGRGGFGSVYKARIGEGME-VAVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
            +G G FG V+  R        A+KV    ++   +  +    E  ++K + H  +I++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            +   + F  +++EY+P G L   L +S    +         ++   LEYLH   S  ++
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SKEIV 123

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
           + DLKP N+LLD      L+DFG AK L        +T TL  T  Y+AP
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTWTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 15/152 (9%)

Query: 786 NLIGRGGFGSVYKARI----GEGMEVAVK----VFDLQCGRAFKSFDVECEMMKSIRHRN 837
            +IG+G FG VY   +    G+ +  AVK    + DL+     + F  E  +MK   H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE---EVEQFLKEGIIMKDFSHPN 57

Query: 838 LIKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           ++ ++  C   E   L+ L YM HG L   + S  +   +   +   + VA  +EYL   
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-- 115

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            S   +H DL   N +LD++    ++DFG+A+
Sbjct: 116 -SKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 10/152 (6%)

Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIKVI 842
           +G G FG V    YK R  + ++VA+KV   +  ++ +     E E+M  + +  ++++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
             C  E    L++E    G L K L      + +   + +M  V+  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.5 bits (142), Expect = 7e-09
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 40/191 (20%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV------ECEMMKS 832
           +R+   + +G G +G V  A   + G +VA+K       R F+S         E  ++K 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKH 70

Query: 833 IRHRNLIKVIS----SCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLN----- 881
           + H N+I ++     + S E+F+   L+   M        L +   I+   Q+L+     
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-----GADLNN---IVK-CQKLSDDHIQ 121

Query: 882 -IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
            ++  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T
Sbjct: 122 FLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MT 173

Query: 941 QTLATIGYMAP 951
             +AT  Y AP
Sbjct: 174 GYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.8 bits (139), Expect = 7e-09
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 8/172 (4%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
             + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   S 
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SN 135

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            VIH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 51/177 (28%), Positives = 92/177 (51%), Gaps = 14/177 (7%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+ A   +  +VAVK   ++ G  + ++F  E  +MK+++H  L+K + +  
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVK-LHAVV 70

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL-EYLHFGYSAPVIHCD 905
           T+E   +I E+M  GSL   L S        Q L  ++D +  + E + F      IH D
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-----GLFHVK 957
           L+ +N+L+  ++V  ++DFG+A+ +I +++   +      I + AP     G F +K
Sbjct: 128 LRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.8 bits (139), Expect = 8e-09
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 8/172 (4%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           +++    IG+G  G+V+ A  +  G EVA+K  +LQ     +    E  +MK +++ N++
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
             + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   + 
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---AN 134

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            VIH D+K  NVLL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 39/187 (20%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           F++   IG+G FG VYK       EV A+K+ DL+        + E E+ + I+    I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--------EAEDEI-EDIQQE--IT 54

Query: 841 VISSCS----TEEFKA--------LILEYMPHGS----LEKSLYSSNYILDIFQRLNIMV 884
           V+S C     T  + +        +I+EY+  GS    L+       YI  I +      
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------ 108

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           ++   L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  I +   + 
Sbjct: 109 EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVG 163

Query: 945 TIGYMAP 951
           T  +MAP
Sbjct: 164 TPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (140), Expect = 8e-09
 Identities = 56/195 (28%), Positives = 83/195 (42%), Gaps = 37/195 (18%)

Query: 778 ATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RH 835
            T  F    +IG G +G VYKAR  + G  VA+K+ D+      +    E  +++    H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62

Query: 836 RNL-------IKVISSCSTEEFKALILEYMPHGS---LEKSLYSSNYILDIFQRLN---- 881
            N+       IK     + ++   L++E    GS   L K L          +RL     
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKG------KRLKEEWI 115

Query: 882 --IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
             I+ +    L YLH      VIH D+K  N+LL  N    L DFG++  L   D ++ +
Sbjct: 116 AYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGR 169

Query: 940 TQTLATIG---YMAP 951
             T   IG   +MAP
Sbjct: 170 RNT--FIGTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.7 bits (142), Expect = 1e-08
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 1/92 (1%)

Query: 561 IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQ 620
           IP  I  L+ +  +N S N   G +P  +G++  L  +D S N+F+  IP  +G LT+L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 621 YLFLGYNRLQGSISESFGD-LISLKSLNLSNN 651
            L L  N L G +  + G  L+   S N ++N
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 48/175 (27%), Positives = 87/175 (49%), Gaps = 11/175 (6%)

Query: 782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRHRN 837
           F +  ++G+GGFG V   ++   G   A K  + +  +  K   +   E ++++ +  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFG 896
           ++ +  +  T++   L+L  M  G L+  +Y+  N   +  + L    ++   LE LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                ++ DLKP N+LLDD     +SD G+A + I E +SI     + T+GYMAP
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESI--RGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 24/181 (13%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVK---VFDLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IGRG F  VY+A  + +   VA+K   +F++   +A +    E +++K + H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 844 SCSTEEFKALILEYMPHGSL---------EKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           S   +    ++LE    G L         +K L     +   F      V + + +E++H
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF------VQLCSAVEHMH 123

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
              S  V+H D+KP+NV +    V  L D G+ +      ++      + T  YM+P   
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERI 178

Query: 955 H 955
           H
Sbjct: 179 H 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 15/171 (8%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQ-----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G+GGFG V   ++   G   A K  D +      G   K   +E E+++ +    ++ +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE--KMALLEKEILEKVNSPFIVNL 58

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAP 900
             +  ++    L++  M  G L+  +Y+     L++ + ++    +   + +LH   S  
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMD 115

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +++ D+KP NVLLDD     LSD G+A + + + ++ITQ     T GYMAP
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRA--GTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 27/200 (13%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARI-----GEGME-VAVKVF-DLQCGRAFKSFDVE 826
           E+  +T RF E   +G   FG VYK  +     GE  + VA+K   D   G   + F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY---------------SSN 871
             M   ++H N++ ++   + E+  ++I  Y  H  L + L                +  
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 872 YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 931
             L+    ++I+  +A  +E+L    S  V+H DL   NVL+ D +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 932 GEDQSITQTQTLATIGYMAP 951
             D       +L  I +M+P
Sbjct: 176 AADYYKLMGNSLLPIRWMSP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 44/144 (30%), Positives = 75/144 (52%), Gaps = 7/144 (4%)

Query: 788 IGRGGFGSVYKARIGEGME-VAVKVFDLQ-CGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           IG G +G+V+KA+  E  E VA+K   L        S  + E  ++K ++H+N++++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             +++   L+ EY     L+K   S N  +D     + M  +   L + H   S  V+H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAK 928
           DLKP N+L++ N    L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 27/191 (14%)

Query: 788 IGRGGFGSVYKARIGE--GM----EVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIK 840
           +G G FG V KA      G      VAVK+       +  +    E  ++K + H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYI----LDIFQRLNIMVDVATTLEYLHFG 896
           +  +CS +    LI+EY  +GSL   L  S  +    L      N           L  G
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 897 --------------YSA--PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
                         Y A   ++H DL   NVL+ +     +SDFG+++ +  ED  + ++
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 941 QTLATIGYMAP 951
           +    + +MA 
Sbjct: 188 KGRIPVKWMAI 198

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 25/188 (13%)

Query: 786 NLIGRGGFGSVYKA----RIGEG--MEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNL 838
             +G G FG VY+     R G+   ++VAVK     C    +S F +E  +M    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSN------YILDIFQRLNIMVDVATTLEY 892
           +++I        + ++LE M  G L+  L  +         L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 893 L---HFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
           L   HF      IH D+   N LL       VA ++DFG+A+ +          + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 947 GYMAPGLF 954
            +M P  F
Sbjct: 186 KWMPPEAF 193

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 8/172 (4%)

Query: 781 RFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           +++    IG+G  G+VY A  I  G EVA+K  +LQ     +    E  +M+  ++ N++
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
             + S    +   +++EY+  GSL   +  +   +D  Q   +  +    L++LH   S 
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SN 134

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            VIH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 9/172 (5%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLI 839
           F++   IG+G FG V+K       +V A+K+ DL+      +    E  ++       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K   S   +    +I+EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             IH D+K +NVLL ++    L+DFG+A  L   D  I +   + T  +MAP
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 23/173 (13%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGR------AFKSFDVECE 828
           C     +     +G G FG VYKAR I  G  VA+K   +   +      A +    E +
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIK 59

Query: 829 MMKSIRHRNLIKVI------SSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRL 880
           ++K ++H N++ +I         S  +  +  ++  YM H  L   L + +  L   Q  
Sbjct: 60  ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK 118

Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
             M+ +   + YLH      ++H D+K +N+L+D+  +  ++DFG+A+   G 
Sbjct: 119 CYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 16/164 (9%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKV--FDL---QCGRAFKSFDVECEMMKSIRHRNLIK 840
           L+G+G FG VY    +  G E+A K   FD    +  +   + + E +++K+++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 841 VISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
                     K L   +EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
             ++H D+K +N+L D      L DFG +K L    Q+I  + T
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICMSGT 164

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 28/189 (14%)

Query: 788 IGRGGFGSVYKAR-IGEGME-------VAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V  A  IG   E       VAVK+       +       E EMMK I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSN------YILDIFQRLNI 882
           +I ++ +C+ +    +I+EY   G+L + L         Y  N        L     ++ 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 203 RLPVKWMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 56/172 (32%), Positives = 81/172 (47%), Gaps = 15/172 (8%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEM------MKSIRHRNLI 839
           +IG+G FG V  A R  +G   AVKV  LQ     K  +    M      +K+++H  L+
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +  S  T E    +L+Y+  G L   L      L+   R     +VA+ + YLH   S 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +I+ DLKP N+LLD      L+DFG+ K   G +   T +    T  Y+AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 26/176 (14%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECE-----------MMKSIRH 835
           IG G +G VYKAR    G  VA+K   L         D E E           ++K + H
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL---------DTETEGVPSTAIREISLLKELNH 58

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
            N++K++    TE    L+ E++ H  L+K + +S  +  I   L I   +   L+ L F
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASP-LSGIPLPL-IKSYLFQLLQGLAF 115

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +S  V+H DLKP N+L++      L+DFG+A+   G     T T  + T+ Y AP
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVR-TYTHEVVTLWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)

Query: 782 FSENNL-----IGRGGFGSVYKA------RIGEGMEVAVKVFDLQCGRAFK-SFDVECEM 829
           F  NNL     +G G FG V +A      +    M+VAVK+       + + +   E ++
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 830 MKSI-RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVA 887
           M  +  H N++ ++ +C+      +I EY  +G L   L       L +   L+    VA
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + +L    S   IH DL   NVLL    +  + DFG+A+ ++ +   + +      + 
Sbjct: 152 KGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 948 YMAP-GLFHVKYILFVVNFLTSYSFLM--IFIGRGNYY 982
           +MAP  +F+  Y     + + SY  L+  IF    N Y
Sbjct: 209 WMAPESIFNCVYT--FESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 46/169 (27%), Positives = 86/169 (50%), Gaps = 15/169 (8%)

Query: 788 IGRGGFGSVYKARIGEGME-VAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           +G+GG+G V+ A+  +  E VA+K      L      +    E +++ + +   L+K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-FGYSAPVI 902
           +   +E+  L +EY+P G   ++L ++  +L        M ++   ++ LH  GY    I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP N L+D +    L+DFG++K ++    S+     + +  YMAP
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 4e-08
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 3/87 (3%)

Query: 279 LKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSL 338
           L L    L G IP +I  L +L+ ++LS N + G +P ++ ++++L  L L  NS +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 339 -SSIADVQLPNLEELRLWSNNFSGTIP 364
             S+   QL +L  L L  N+ SG +P
Sbjct: 483 PESLG--QLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 4e-08
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 14/149 (9%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKV---FDL--QCGRAFKSFDVECEMMKSIRHRNLIK 840
           +IGRG FG V+  R  +  +V A+KV    D+  +   A      E +++       ++K
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADADSPWIVK 65

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-FGYSA 899
           +  S   EE   L++EYMP G L   L   +   +   R  I  ++   L+ +H  G+  
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYI-AELVLALDSVHKLGF-- 122

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             IH D+KP N+L+D +    L+DFG+ K
Sbjct: 123 --IHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 20/172 (11%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKV--FDLQCGRAFKSFD-VECE--MMKSIRHRNLIK 840
           L+G+G FG VY       G E+AVK   FD +     K  + +ECE  ++K++ H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 841 VISSC--STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
                    E   ++ +E+MP GS++  L S   + +   R          LE + + +S
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY----TRQILEGVSYLHS 124

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
             ++H D+K +N+L D      L DFG +K L        QT  L+  G  +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRL--------QTICLSGTGMKS 168

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 42/169 (24%), Positives = 77/169 (45%), Gaps = 15/169 (8%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSIRHR-NLIKVI 842
           I +G FGSVY A+    G   A+KV    D+       +   E  +M        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            S  ++++  L++EY+  G     + +   + + + +   + +V   +E LH      +I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H D+KP N+L+D      L+DFG+++   G        + + T  Y+AP
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR--NGL----ENKKFVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 30/189 (15%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGME-VAVKVF-DLQCGRAFKSFDV-ECEMMKSIRHR 836
           N+F    ++G G +G V K R  E  E VA+K F D +     K   + E +M+++++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 837 NLIKVISSCSTEEFKALILEY-----------MPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           N++++  +        L+ EY           MP+G   + + S  Y L           
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
               ++ +H+ +   ++H D+KP N+L+  N V  L DFG A+ L  E  +   T+ +AT
Sbjct: 110 ----IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVAT 164

Query: 946 IGYMAPGLF 954
             Y +P L 
Sbjct: 165 RWYRSPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.3 bits (134), Expect = 4e-08
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 55/200 (27%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR--AFKSFDV-------------E 826
           + E   IG G +G+VYKAR            DL  GR  A K   V             E
Sbjct: 1   YEELAEIGEGAYGTVYKAR------------DLNTGRFVALKKVRVPLSEEGIPLSTLRE 48

Query: 827 CEMMKSIR---HRNLIKVISSC----STEEFK-ALILEYMP---HGSLEK---SLYSSNY 872
             ++K +    H N+++++  C    +  E K  L+ E++       L K          
Sbjct: 49  IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET 108

Query: 873 ILDI-FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 931
           I D+  Q L         +++LH   S  ++H DLKP N+L+  +    ++DFG+A++  
Sbjct: 109 IKDLMRQLLR-------GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY- 157

Query: 932 GEDQSITQTQTLATIGYMAP 951
             + ++  T  + T+ Y AP
Sbjct: 158 SFEMAL--TSVVVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 10/175 (5%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G+G +G V   R   +G +  +K  +L+    R  K+ + E +++  ++H N++    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 845 CSTEE-FKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              E+    +++ +   G L   L      +L   Q +   V +A  L+YLH      ++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           H DLK  NV L    +  + D GIA++L  E+Q    +  + T  YM+P LF  K
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNK 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.7 bits (134), Expect = 5e-08
 Identities = 96/327 (29%), Positives = 132/327 (40%), Gaps = 45/327 (13%)

Query: 244 REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLH-NLKL 302
            E               N       EL  LT L  L L  N +T +IPP I  L  NLK 
Sbjct: 86  SENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKE 144

Query: 303 LDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT 362
           LDLS NK+  ++P+ + N+  L  L L  N LS     +++  L NL  L L  N  S  
Sbjct: 145 LDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSN--LSNLNNLDLSGNKIS-D 200

Query: 363 IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN 422
           +P  I   S L  L+L                              S+N  +  LSS SN
Sbjct: 201 LPPEIELLSALEELDL------------------------------SNNSIIELLSSLSN 230

Query: 423 CKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLG 482
            K+L+ + LSNN L       S+GNLS +LE  D+S   +S      +G+LTNL  + L 
Sbjct: 231 LKNLSGLELSNNKL--EDLPESIGNLS-NLETLDLSNNQIS--SISSLGSLTNLRELDLS 285

Query: 483 GNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACF 542
           GN L+ ++P+    L  L  L L        +   +  +     +  +G     S P   
Sbjct: 286 GNSLSNALPLIA-LLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGE---TSSPEAL 341

Query: 543 SNLASLGTLSLGSNKLTSIPLTIWNLK 569
           S L SL  L    N L    L  + +K
Sbjct: 342 SILESLNNLWTLDNALDESNLNRYIVK 368

Length = 394

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.0 bits (133), Expect = 6e-08
 Identities = 42/197 (21%), Positives = 79/197 (40%), Gaps = 24/197 (12%)

Query: 767 CRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG---RAFKSF 823
             +F  + LC A     + +        +     +     VAVKV  L+      A + F
Sbjct: 15  EGQFGEVHLCEADG-LQDFSEKAFAENDNADAPVL-----VAVKV--LRPDASDNAREDF 66

Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILD 875
             E +++  +   N+ +++  C+ +    +I+EYM +G L + L          +     
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 876 IFQR--LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           +     L +   +A+ + YL    S   +H DL   N L+  N    ++DFG+++ L   
Sbjct: 127 LSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183

Query: 934 DQSITQTQTLATIGYMA 950
           D    Q +    I +MA
Sbjct: 184 DYYRVQGRAPLPIRWMA 200

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.0 bits (132), Expect = 8e-08
 Identities = 57/176 (32%), Positives = 83/176 (47%), Gaps = 15/176 (8%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEM------MKSIRHRNLI 839
           +IG+G FG V  AR   E    AVKV  LQ     K  + +  M      +K+++H  L+
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +  S  T +    +L+Y+  G L   L      L+   R     ++A+ L YLH   S 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
            +++ DLKP N+LLD      L+DFG+ K  I E    T T    T  Y+AP + H
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTST-FCGTPEYLAPEVLH 169

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 31/70 (44%), Positives = 39/70 (55%), Gaps = 5/70 (7%)

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           I V +   LEYLH   S  VIH D+KPSNVL++ N    L DFGI+  L+    S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 942 TLATIGYMAP 951
                 YMAP
Sbjct: 163 DAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.6 bits (134), Expect = 1e-07
 Identities = 31/84 (36%), Positives = 51/84 (60%), Gaps = 3/84 (3%)

Query: 326 GLGLQSNSLSGSLSSIADV-QLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFS 384
           GLGL +  L G + +  D+ +L +L+ + L  N+  G IP  + + + L VL+L  NSF+
Sbjct: 422 GLGLDNQGLRGFIPN--DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 385 GFIPNTFGNLRNLRLMTLHYNYLT 408
           G IP + G L +LR++ L+ N L+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 42/257 (16%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
            L++L SL+L  N ++   P        LK ++   N++  + PS + N  +L++LD S+
Sbjct: 114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
           N LS                           +P  LSN   L  L LS  N +  +P EI
Sbjct: 173 NDLS--------------------------DLPKLLSNLSNLNNLDLS-GNKISDLPPEI 205

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
             L+ L+EL L  + +  E+     NL  L  + L  +N   ++P+ + NL+ LE L L 
Sbjct: 206 ELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLS 263

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIA 342
            N ++      + +L NL+ LDLS N L  A+P             L    L   L+ + 
Sbjct: 264 NNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIA----------LLLLLLELLLNLLL 311

Query: 343 DVQLPNLEELRLWSNNF 359
            ++   L+   +  NN 
Sbjct: 312 TLKALELKLNSILLNNN 328

Length = 394

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 37/197 (18%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           R+ +   +G G  G V+ A   +    VAVK   L   ++ K    E ++++ + H N++
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 840 KVI------SSCSTEEFKAL--------ILEYMP---HGSLEKSLYSSNYI-LDIFQRLN 881
           KV        S  TE+  +L        + EYM       LE+   S  +  L ++Q L 
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQ- 939
                   L+Y+H   SA V+H DLKP+NV ++ +++V  + DFG+A+++   D   +  
Sbjct: 126 -------GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHK 172

Query: 940 ---TQTLATIGYMAPGL 953
              ++ L T  Y +P L
Sbjct: 173 GYLSEGLVTKWYRSPRL 189

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 34/205 (16%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGME----------------VAVKVFDLQCG 817
           E  R   R  E   +G G FG V+     EG+                 VAVK+      
Sbjct: 1   EFPRQQLRLKEK--LGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT 57

Query: 818 R-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYS-- 869
           + A   F  E ++M  +++ N+I+++  C +++   +I EYM +G L     ++ + S  
Sbjct: 58  KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF 117

Query: 870 --SNYI--LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
             +N I  + I   L + V +A+ ++YL    S   +H DL   N L+ ++    ++DFG
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFG 174

Query: 926 IAKLLIGEDQSITQTQTLATIGYMA 950
           +++ L   D    Q + +  I +MA
Sbjct: 175 MSRNLYSGDYYRIQGRAVLPIRWMA 199

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 50/189 (26%), Positives = 90/189 (47%), Gaps = 16/189 (8%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           +G+GGFG V   ++   G   A K  +   L+  + ++   VE  ++  +  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  T+    L++  M  G L   +Y+    N      +       + + LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLIGEDQSITQTQTLA-TIGYMAPGLFHVKY 958
           +I+ DLKP NVLLD++    +SD G+A +L  G+    ++T+  A T G+MAP L   + 
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ----SKTKGYAGTPGFMAPELLQGEE 173

Query: 959 ILFVVNFLT 967
             F V++  
Sbjct: 174 YDFSVDYFA 182

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 19/151 (12%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC-GRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           IG G +G VYK R    G  VA+K   L+       S  + E  ++K ++H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-------FGY 897
              E    LI E++    L+K L S              +D      YL+       F +
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMDAELVKSYLYQILQGILFCH 118

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           S  V+H DLKP N+L+D+  V  L+DFG+A+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 11/170 (6%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKVFDLQC---GRAFKSFDVECE-MMKSIRHRNLIKV 841
           +IG+G FG V  A R  +G   AVKV   +     +  K    E   ++K+++H  L+ +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
             S  T E    +L+++  G L   L       +   R     ++A+ L YLH   S  +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYA-AEIASALGYLH---SINI 117

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           ++ DLKP N+LLD      L+DFG+ K   G  QS T T    T  Y+AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 2e-07
 Identities = 30/78 (38%), Positives = 47/78 (60%), Gaps = 2/78 (2%)

Query: 418 SSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLI 477
           +  S  + L  I LS N + G +P  S+G+++ SLE  D+SY + +G  P+ +G LT+L 
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIP-PSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 478 GIYLGGNKLNGSIPITLG 495
            + L GN L+G +P  LG
Sbjct: 494 ILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 33/183 (18%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVK----VFD--LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           IGRG +G V  A+  E   +VA+K     FD  +   R  +    E ++++ + H N+I 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68

Query: 841 ---VISSCSTEEFKALILEY-MPHGSLEKSLYSSNYILD------IFQRLNIMVDVATTL 890
              ++     E F  + + Y +    L + + SS  + D      ++Q L         L
Sbjct: 69  IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GL 121

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +Y+H   SA V+H DLKPSN+LL+ N    + DFG+A+    +   +  T+ + T  Y A
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYRA 176

Query: 951 PGL 953
           P L
Sbjct: 177 PEL 179

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 26/172 (15%)

Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSC 845
           +G G  G+VYKA  +     +AVKV  L       K    E E++       +I    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL------NIMVDVATTLEYLHFGYSA 899
             E   ++  E+M  GSL           D+++++       I V V   L YL   +S 
Sbjct: 69  FVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL---WSL 114

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            ++H D+KPSN+L++      L DFG++  L+    SI +T  + T  YMAP
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 54/180 (30%), Positives = 90/180 (50%), Gaps = 24/180 (13%)

Query: 774 ELCRATNR-FSENNLIGRGGFGSVYKAR-IGEGMEVAVK--VFDLQCGRAFKSFDVECEM 829
           ++ R+ N+ +   N+IG G FG VY+A  I    +VA+K  + D Q    +K  + E  +
Sbjct: 59  DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YK--NRELLI 112

Query: 830 MKSIRHRNLIKVISSCSTEEFKA--------LILEYMPHGSLEKSLYSS--NYILDIFQR 879
           MK++ H N+I +     TE FK         +++E++P    +   + +  N+ L +F  
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172

Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQSIT 938
                 +   L Y+H   S  + H DLKP N+L+D N     L DFG AK L+   +S++
Sbjct: 173 KLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229

Length = 440

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 24/152 (15%)

Query: 788 IGRGGFGSVYK--ARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVIS 843
           +G G + +VYK  +RI  G  VA+KV  ++   G  F +   E  ++K ++H N++ +  
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 844 SCSTEEFKALILEYMPHGSLEK-------SLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
              T+E    + EYM H  L +        L+  N  L +FQ L         L Y+H  
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQ 122

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           +   ++H DLKP N+L+       L+DFG+A+
Sbjct: 123 H---ILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 10/166 (6%)

Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  AR    G +VAVK+ DL+  +  +    E  +M+  +H+N++++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             E   +++E++  G+L   +  S   L+  Q   +   V   L YLH   S  VIH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY-MAP 951
           K  ++LL  +    LSDFG    +    + + + ++L    Y MAP
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 17/173 (9%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMM-KSI-----RHRNLI 839
           ++G+G FG V  A +    E+ AVKV  L+     +  DVEC M  K +     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           ++ S   T++    ++EY+  G L   +  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
            +I+ DLK  NVLLD      ++DFG+ K  I    +   T T   T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 48.3 bits (116), Expect = 2e-07
 Identities = 26/60 (43%), Positives = 32/60 (53%)

Query: 618 NLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKL 677
           NL+ L L  NRL      +F  L +LK L+LS NNL+   P +   L  L  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 11/175 (6%)

Query: 782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRHRN 837
           F    ++G+GGFG V   ++   G   A K  + +  +  K   +   E  +++ +  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFG 896
           ++ +  +  T++   L+L  M  G L+  +Y+  N   D  + +    ++   LE L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ-- 119

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               +++ DLKP N+LLDD     +SD G+A + I E +++     + T+GYMAP
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETV--RGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 29/179 (16%)

Query: 787 LIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISS- 844
           +IGRGGFG VY  R  + G   A+K  D       K   ++     ++  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 845 ------CSTEEFKA-----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
                 C T  F        IL+ M  G L   L       +   R     ++   LE++
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLATIGYMAP 951
           H  +   V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T GYMAP
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 39/139 (28%), Positives = 69/139 (49%), Gaps = 6/139 (4%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  A     G +VAVK  DL+  +  +    E  +M+  +H N++++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++E++  G+L   +  +   ++  Q   + + V   L +LH   +  VIH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 907 KPSNVLLDDNMVAHLSDFG 925
           K  ++LL  +    LSDFG
Sbjct: 142 KSDSILLTSDGRVKLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 8/145 (5%)

Query: 788 IGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISSC 845
           +G G + +VYK R     E VA+K   L       S  + E  +MK ++H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 846 STEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
            TE    L+ EYM    L+K +  +     LD     +    +   L+ + F +   V+H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL---LKGIAFCHENRVLH 123

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAK 928
            DLKP N+L++      L+DFG+A+
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 29/179 (16%)

Query: 787 LIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISS- 844
           +IGRGGFG VY  R  + G   A+K  D       K   ++     ++  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 845 ------CSTEEFK-----ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
                 C +  F      + IL+ M  G L   L S + +    +      ++   LE++
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLATIGYMAP 951
           H  +   V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T GYMAP
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMK------SIRHRNLI 839
           ++G+G FG V  A +    EV A+KV  L+     +  DV+C M +      + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +     T++    ++EY+  G L   +  S    +   R     +V   L +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            VI+ DLK  N+LLD      L+DFG+ K  I     +T T    T  Y+AP
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 39/164 (23%), Positives = 67/164 (40%), Gaps = 24/164 (14%)

Query: 783 SENNLIGRGGFGSVYKARIGEGME------VAVKVF----DLQCGRAFKSFDVECEMMKS 832
            E   +GRG FG V+ A+     E      V VK      D      F+    E +M + 
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRK 64

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLE--------KSLYSSNYILDIFQRLNIMV 884
           + H+N+++++  C   E   +ILEY   G L+        K        L   Q++ +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            +A  +++L    +A  +H DL   N L+       +S   ++K
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 24/183 (13%)

Query: 781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN 837
           R+     IG G FG +Y A+   +     +K  DL     +  ++   E  ++  ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKS-------LYSSNYILDIFQRLNIMVDVATTL 890
           ++   +S        +++EY   G L K        L+S + IL  F      V ++  L
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGL 114

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGY 948
           +++H      ++H D+K  N+ L  N MVA L DFGIA+ L   + S+    T   T  Y
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYY 168

Query: 949 MAP 951
           ++P
Sbjct: 169 LSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 14/173 (8%)

Query: 788 IGRGGFGSVYKARIGEG--------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN-L 838
           +G G +G V+  R   G        M+V  K   +Q  +  +    E ++++++R    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           + +  +  T+    LIL+Y+  G L   LY   +  +   R+ I  ++   L++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI-AEIVLALDHLH---Q 123

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +I+ D+K  N+LLD      L+DFG++K  + E++    +    TI YMAP
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 27/70 (38%), Positives = 38/70 (54%), Gaps = 5/70 (7%)

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           + V +   L YL   +   VIH D+KPSN+LLD +    L DFGI+  L+    S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173

Query: 942 TLATIGYMAP 951
           +     YMAP
Sbjct: 174 SAGCAAYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.2 bits (113), Expect = 5e-07
 Identities = 27/63 (42%), Positives = 33/63 (52%), Gaps = 3/63 (4%)

Query: 591 NLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSN 650
           NLK L   D S N  + +      GL NL+ L L  N L     E+F  L SL+SL+LS 
Sbjct: 1   NLKSL---DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57

Query: 651 NNL 653
           NNL
Sbjct: 58  NNL 60

Length = 60

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 51/189 (26%), Positives = 89/189 (47%), Gaps = 32/189 (16%)

Query: 788 IGRGGFGSVY-----KARIGEGMEV--AVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG+VY     KA   E ++V   + V +L      ++ + E +++  + H  ++K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLNIMVDVATTLE 891
             +S    +   +I EY     L+  L          S N + + F +L + V       
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH------ 120

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQTLATIGYMA 950
           Y+H      ++H DLK  N+ L +N++  + DFG+++LL+G  D + T T    T  YM+
Sbjct: 121 YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMS 173

Query: 951 P-GLFHVKY 958
           P  L H  Y
Sbjct: 174 PEALKHQGY 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 5e-07
 Identities = 46/174 (26%), Positives = 81/174 (46%), Gaps = 14/174 (8%)

Query: 787 LIGRGGFGSVYKARIGEG--------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN- 837
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E  +++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           L+ +  +  TE    LIL+Y+  G +   LY  +   +   R     ++   LE+LH   
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +++ D+K  N+LLD      L+DFG++K  + E++  T +    TI YMAP
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.0 bits (124), Expect = 8e-07
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 40/190 (21%)

Query: 781 RFSENNLIGRGGFGSV---YKARIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMK 831
           R+     +G G +GSV   Y  R+ +  +VAVK    +  R F+S         E  ++K
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLK 69

Query: 832 SIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------ 881
            ++H N+I ++     + S E F  + L     G+        N I+   Q+L+      
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQF 122

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           ++  +   L+Y+H   SA +IH DLKPSNV ++++    + DFG+A+    E      T 
Sbjct: 123 LIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTG 174

Query: 942 TLATIGYMAP 951
            +AT  Y AP
Sbjct: 175 YVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.4 bits (123), Expect = 8e-07
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 17/178 (9%)

Query: 782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFK------SFDVECEMMKSIR 834
           F    ++G+GGFG V   ++   G   A K   L+  R  K      + + E ++++ + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALN-EKQILEKVN 58

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYL 893
            R ++ +  +  T++   L+L  M  G L+  +Y+  N   D  + +    ++   LE L
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H      +++ DLKP N+LLDD     +SD G+A + I E ++I     + T+GYMAP
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI--RGRVGTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.0 bits (124), Expect = 8e-07
 Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 24/182 (13%)

Query: 781 RFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKSI 833
           R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K +
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 834 RHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           +H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +   
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRG 132

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y 
Sbjct: 133 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 184

Query: 950 AP 951
           AP
Sbjct: 185 AP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 52.5 bits (126), Expect = 1e-06
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 16/160 (10%)

Query: 804 GMEVAVKVF--DLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-FKALILEYMP 859
           G EVA+K+   D          F  E  +   + H N++ ++ S          + EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDN 916
             +L + L +++  L   +   +M+ V   L   H   +  ++H DLKP N+++      
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 917 MVAHLSDFGIAKLLIGEDQSITQTQTLAT--IG---YMAP 951
             A + DFGI  LL G   +   T T  T  +G   Y AP
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 18/158 (11%)

Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL---QCGRAFKSFDVECEMMKSIRHRN 837
           FS+   IG G FG+VY AR +     VA+K       Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 838 LIKVISSCSTEEFKA-LILEYMPHGSLEKSLYSSNYILDI----FQRLNIMVDVATTLEY 892
            I+    C   E  A L++EY         L S++ +L++     Q + I       L+ 
Sbjct: 77  TIQY-RGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           L + +S  +IH D+K  N+LL +  +  L DFG A ++
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 54/172 (31%), Positives = 87/172 (50%), Gaps = 17/172 (9%)

Query: 788 IGRGGFGSVYKARIGEGME-VAVKVFDL-QCGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           IG G +G VYKAR     E +A+K   L Q      S  + E  ++K ++H N++++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
             +E+   L+ EY+    L+K + SS ++  +   RL I   +   L  + + +S  V+H
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKN--PRL-IKTYLYQILRGIAYCHSHRVLH 125

Query: 904 CDLKPSNVLLDDNMVA-HLSDFGIAKLLIGEDQSI---TQTQTLATIGYMAP 951
            DLKP N+L+D    A  L+DFG+A+        I   T T  + T+ Y AP
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAF-----GIPVRTFTHEVVTLWYRAP 172

Length = 294

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 47/192 (24%), Positives = 85/192 (44%), Gaps = 33/192 (17%)

Query: 788 IGRGGFGSVYKARIGEGME------------------VAVKVFDLQCGR-AFKSFDVECE 828
           +G G FG V+     EGME                  VAVK+      + A   F  E +
Sbjct: 13  LGEGQFGEVHLCEA-EGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL---------EKSLYSSNYILDIFQR 879
           +M  ++  N+I++++ C T +   +I EYM +G L         +++   ++ +   +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 880 LNIM-VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
           L  M   +A+ ++YL    S   +H DL   N L+  N    ++DFG+++ L   D    
Sbjct: 132 LIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 939 QTQTLATIGYMA 950
           Q + +  I +M+
Sbjct: 189 QGRAVLPIRWMS 200

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 46/183 (25%), Positives = 83/183 (45%), Gaps = 24/183 (13%)

Query: 788 IGRGGFGS--VYKARIGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG   +Y+ R  +   V  K  +L      +  D   E  ++  ++H N+I   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 844 SCSTEEFKALILEYMPHGSL-------EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
               +    + +EY   G+L       +  L+    +L        +  + + + Y+H  
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSAVSYIH-- 118

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH- 955
             A ++H D+K  N+ L    +  L DFGI+K+L G + S+ +T  + T  YM+P L   
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQG 175

Query: 956 VKY 958
           VKY
Sbjct: 176 VKY 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 1e-06
 Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 55/200 (27%)

Query: 788 IGRGGFGSVYKARIGEGM---EVAVKVFDLQCGRAFKSFDV--------ECEMMKSIRHR 836
           IGRG +G VYKA+   G    E A+K F     +  K            E  +++ ++H 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62

Query: 837 NLIKVISSCSTEEFKA--LILEYMPHGSLE--------KSLYSSNYILD--IFQRLNIMV 884
           N++ ++        K+  L+ +Y  H   +        K +     ++   ++Q LN   
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN--- 119

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA-------KLLIGE 933
                + YLH   S  V+H DLKP+N+L+     +  V  + D G+A       K L   
Sbjct: 120 ----GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 934 DQSITQTQTLATIGYMAPGL 953
           D  +       TI Y AP L
Sbjct: 173 DPVVV------TIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 46/173 (26%), Positives = 84/173 (48%), Gaps = 17/173 (9%)

Query: 787 LIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMK------SIRHRNLI 839
           ++G+G FG V+ A + G     A+K   L+        DVEC M++      +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +  +  T+E    ++EY+  G L   + S  +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LIGEDQSITQTQTLATIGYMAP 951
            +++ DLK  N+LLD +    ++DFG+ K  ++G+ ++ T      T  Y+AP
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 18/157 (11%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDL---QCGRAFKSFDVECEMMKSIRHRN 837
           F++   IG G FG+VY AR     EV A+K       Q    ++    E + ++ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 838 LIKVISSCSTEEFKA-LILEYMPHGSLEKSLYSSNYILDI----FQRLNIMVDVATTLEY 892
            I+    C   E  A L++EY         L S++ +L++     Q + I       L+ 
Sbjct: 87  SIEY-KGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQG 137

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
           L + +S  +IH D+K  N+LL +     L+DFG A +
Sbjct: 138 LAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 16/175 (9%)

Query: 787 LIGRGGFGSVYKARIGEG--------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN- 837
           ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV-DVATTLEYLHFG 896
           L+ +  +  T+    LIL+Y+  G L   L       +  Q + I   ++   LE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLH-- 122

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               +I+ D+K  N+LLD N    L+DFG++K    ED+         TI YMAP
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 29/181 (16%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIR---HRNLIKV 841
           IG G +G+VYKAR    G  VA+K   +Q            E  ++K +    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 842 ISSCST----EEFK-ALILEYMPH---GSLEKSL---YSSNYILDIFQRLNIMVDVATTL 890
           +  C+T     E K  L+ E++       L+K       +  I D+ ++          L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF------LRGL 121

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           ++LH      ++H DLKP N+L+       L+DFG+A++       +  T  + T+ Y A
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRA 175

Query: 951 P 951
           P
Sbjct: 176 P 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 19/176 (10%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISS 844
           L+G G +G VYK R +  G   A+KV D+  G   +    E  M+K    HRN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 845 C------STEEFKALILEYMPHGSLEKSLYSS--NYILDIFQRLNIMVDVATTLEYLHFG 896
                    ++   L++E+   GS+   + ++  N + + +    I  ++   L +LH  
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH-- 128

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
               VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 28/159 (17%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC-------GRAFKSFDVECEMMKSIRHRNL 838
           L+G+G  G V+  R  G G   A+KV D +         R       E E++ ++ H  L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATLDHPFL 63

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEY 892
             + +S  TE +  L+++Y P G L + L          + L+  V      +V   LEY
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLLALEY 118

Query: 893 LH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           LH  G     ++ DLKP N+LL ++    LSDF ++K  
Sbjct: 119 LHLLGI----VYRDLKPENILLHESGHIMLSDFDLSKQS 153

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 14/147 (9%)

Query: 788 IGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           +G G + +VYK R  + + + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILD---IFQRLNIMVDVATTLEYLHFGYSAPV 901
             TE+   L+ EY     L+K L    Y+ D        N+ + +   L  L++ +   V
Sbjct: 73  IHTEKSLTLVFEY-----LDKDL--KQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           +H DLKP N+L+++     L+DFG+A+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 15/78 (19%)

Query: 863 LEKSLYSSNYILDIFQRL---------NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL 913
           LEK + ++    +IF+R+         NIM D+ TTLEY+H      + H D+KP N+++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159

Query: 914 DDNMVAHLSDFGIAKLLI 931
           D N   ++ D+GIA   I
Sbjct: 160 DGNNRGYIIDYGIASHFI 177

Length = 294

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 43/214 (20%)

Query: 774 ELCRATNRFSENNLIGRGGFGSV-----------------YKARIGEGMEVAVKVFDLQC 816
           +  R    F E   +G G FG V                 +  R G  + VAVK+     
Sbjct: 1   KFPRGHLLFKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA 58

Query: 817 GR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD 875
            + A   F  E +++  ++  N+I+++  C  E+   +I EYM +G L + L SS+++ D
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDD 117

Query: 876 IFQR-------------------LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN 916
             +                    L++ + +A+ ++YL    S   +H DL   N L+ +N
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGEN 174

Query: 917 MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +   ++DFG+++ L   D    Q + +  I +MA
Sbjct: 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 52/167 (31%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR--AFKSFDVECE-------------MMKS 832
           IG G +G VYKAR            D   G   A K   +E E             ++K 
Sbjct: 7   IGEGTYGVVYKAR------------DKLTGEIVALKKIRLETEDEGVPSTAIREISLLKE 54

Query: 833 IRHRNLIKVISSCSTEEFKALILEYM-----------PHGSLEKSLYSSNYILDIFQRLN 881
           + H N+++++    +E    L+ E++           P   L+  L  S Y+  + Q + 
Sbjct: 55  LNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS-YLYQLLQGIA 113

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
                     Y H   S  V+H DLKP N+L+D      L+DFG+A+
Sbjct: 114 ----------YCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 38/184 (20%)

Query: 787 LIGRGGFGSVYKAR--IGE--GMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLI 839
           ++G+G FG V+  R   G   G   A+KV     L+     ++  +E +++  + H  ++
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIV 61

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------------DVA 887
           K+  +  TE    LIL+++  G             D+F RL+  V            ++A
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELA 108

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             L++LH   S  +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ 
Sbjct: 109 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVE 163

Query: 948 YMAP 951
           YMAP
Sbjct: 164 YMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVI-- 842
           ++G G +G VYK R +  G   A+KV D+      +   +E  M+K    HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 843 ----SSCSTEEFKALILEYMPHGS---LEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
               S    ++   L++E+   GS   L K+   +    D      I  ++   L +LH 
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH- 138

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
             +  VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 10/150 (6%)

Query: 787 LIGRGGFGSVYK---ARIGEGME--VAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           ++G G FG+VYK      GE ++  VA+KV  +    +A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           ++  C T   + L+ + MP+G L   +  +   +     LN  V +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           ++H DL   NVL+       ++DFG+A+LL
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 32/148 (21%), Positives = 64/148 (43%), Gaps = 19/148 (12%)

Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECE--MMKSIRHRNLI--KVI 842
           L+  G    VY     +  +  +K+         K  D E E  +++ +  + L   KV+
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKIN----PSREKGADREREVAILQLLARKGLPVPKVL 59

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV- 901
           +S  ++ +  L++E++   +L++        +   ++ +I   +A  L  LH      V 
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLLVL 110

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
            H DL P N+L+DD  +  + D+  A  
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.8 bits (119), Expect = 5e-06
 Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 33/160 (20%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKS--------- 832
           F    +IGRG FG V   R     + + +V+ ++    F       EM+K          
Sbjct: 45  FDVIKVIGRGAFGEVQLVR----HKSSKQVYAMKLLSKF-------EMIKRSDSAFFWEE 93

Query: 833 ---IRHRN---LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
              + H N   ++++  +   +++  +++EYMP G L  +L S+  I + + R     +V
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTA-EV 151

Query: 887 ATTLEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
              L+ +H  G+    IH D+KP N+LLD +    L+DFG
Sbjct: 152 VLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 49.1 bits (118), Expect = 5e-06
 Identities = 49/188 (26%), Positives = 95/188 (50%), Gaps = 19/188 (10%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV----ECEMM 830
           CR+ + + + N I  G +G VY+AR    G  VA+K   L+  +  + F +    E  ++
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINIL 58

Query: 831 KSIRHRNLIKV--ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
             ++H N++ V  +   S  +   +++EY+ H  L+  + +        +   +M+ + +
Sbjct: 59  LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ--TQTLATI 946
            + +LH  +   ++H DLK SN+LL++  +  + DFG+A+    E  S  +  TQ + T+
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR----EYGSPLKPYTQLVVTL 170

Query: 947 GYMAPGLF 954
            Y AP L 
Sbjct: 171 WYRAPELL 178

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMK------SIRHRNLI 839
           ++G+G FG V  AR+ E   + AVKV  L+     +  DVEC M +      +  H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           ++     T +    ++E++  G L   +  S    +   R     ++ + L +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +I+ DLK  NVLLD      L+DFG+ K  I      T +    T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.9 bits (116), Expect = 6e-06
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 18/173 (10%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRHRNLIKVI 842
           L+G+G FG V   R    G   A+K+   +   A         E  ++K+ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            S  T++    ++EY+  G L   L       +   R     ++ + L+YLH   S  ++
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGKIV 117

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI----GYMAP 951
           + DLK  N++LD +    ++DFG+ K      + IT   T+ T      Y+AP
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 48.3 bits (115), Expect = 9e-06
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 18/172 (10%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSC 845
           +G+G +GSVYK      G+ +A+K   L+   + F    +E +++       ++    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 846 STEEFKALILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
             E    + +EYM  GSL+K LY    +   +       I   V   L++L   ++  +I
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
           H D+KP+NVL++ N    L DFG++  L+    S+ +T     IG   YMAP
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 9e-06
 Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 46/172 (26%)

Query: 781 RFSENNLIGRGGFGSVYKA---RIGEGMEVAVKVF------DLQCGRAFKSFDVECEMMK 831
           R++    +G G +GSV  A   R GE  +VA+K        ++   RA++    E  ++K
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGE--KVAIKKLSRPFQSEIFAKRAYR----ELTLLK 69

Query: 832 SIRHRNLIKVI----SSCSTEEFKA--LILEYM---------PHGSLEKSLYSSNYILDI 876
            ++H N+I ++    S+ S +EF+   L++ YM            S +K  Y       +
Sbjct: 70  HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL------V 123

Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           +Q L         L+Y+H   SA +IH DLKP N+ ++++    + DFG+A+
Sbjct: 124 YQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 40/147 (27%), Positives = 74/147 (50%), Gaps = 14/147 (9%)

Query: 788 IGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           +G G + +V+K R  + E + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILD---IFQRLNIMVDVATTLEYLHFGYSAPV 901
             T++   L+ EY     L+K L    Y+ D   I    N+ + +   L  L + +   V
Sbjct: 73  VHTDKSLTLVFEY-----LDKDL--KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           +H DLKP N+L+++     L+DFG+A+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 23/185 (12%)

Query: 782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRHRN 837
           F     +G G FG V  A+  G G   A+K    +     K       E  ++  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS----NYILDIFQRLNIMVDVATTLEYL 893
           ++ ++ S   E     +LE++  G L   L  +    N +   +       ++    EYL
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAPG 952
           H   S  +I+ DLKP N+LLD+     ++DFG AK      +   +T TL  T  Y+AP 
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAPE 185

Query: 953 LFHVK 957
           +   K
Sbjct: 186 VIQSK 190

Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 787 LIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMK----SIRHRN--LI 839
           ++G+G FG V  A + G+G   AVK   L+        DVEC M++    ++   N  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +  +  T+E    ++E++  G L   +       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LIGEDQSITQTQTLATIGYMAPGLFHVKY 958
            +I+ DLK  NV+LD +    ++DFG+ K  + G++++ T      T  Y+AP +     
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLK 172

Query: 959 ILFVVNFLTSYSFLM--IFIGRGNYY 982
             F V++  S+  L+  + IG+  ++
Sbjct: 173 YTFSVDWW-SFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 26/153 (16%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G G + +VYK R    G  VA+K   L+   G  F +   E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDI 71

Query: 845 CSTEEFKALILEYM---------PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             T++   L+ EY+           G     L   N  L +FQ L         L Y H 
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLR-------GLAYCH- 120

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
                V+H DLKP N+L+ +     L+DFG+A+
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 30/182 (16%)

Query: 788 IGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDVECEM-----MKSIRHRNLIK 840
           IG G +G V+KAR     G  VA+K   +Q G          E+     +++  H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 841 VISSCST-----EEFKALILEYMPHG---SLEKSL---YSSNYILDIFQRLNIMVDVATT 889
           +   C+      E    L+ E++       L+K       +  I D      +M  +   
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD------MMFQLLRG 122

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           L++LH   S  V+H DLKP N+L+  +    L+DFG+A+  I   Q    T  + T+ Y 
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMAL-TSVVVTLWYR 176

Query: 950 AP 951
           AP
Sbjct: 177 AP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 69/242 (28%), Positives = 113/242 (46%), Gaps = 12/242 (4%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL 141
            +K L++S   +  ++PS L NL +L++L+L FN LS  +P  +  L  L  ++  GN++
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNC 201
           S   P  I   S+L+ LD S N++   + +   SNL  L  + LS N     +P ++ N 
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSIIELLSS--LSNLKNLSGLELS-NNKLEDLPESIGNL 254

Query: 202 KYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN 261
             LE L LS NN + +I   +G+LT L+EL L  + L   +P     L  LEL+   +  
Sbjct: 255 SNLETLDLS-NNQISSISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312

Query: 262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM 321
           L+    +  + L    +L  G+       P  +  L +L  L    N L  +        
Sbjct: 313 LKALELKLNSILLNNNILSNGE----TSSPEALSILESLNNLWTLDNALDESNLNRYIVK 368

Query: 322 ST 323
           + 
Sbjct: 369 NP 370

Length = 394

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 48/182 (26%), Positives = 77/182 (42%), Gaps = 23/182 (12%)

Query: 787 LIGRGGFGSVYKARI--GEGMEVAVK---VFDLQCGRAFKSFD-------VECEMMK-SI 833
            +G G FG VYK R        +A+K   V +   G+  +  D        E  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 834 RHRNLIKVISSCSTEEFKALIL----EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           RH N+++   +   E  +  I+    E  P G    SL          +  NI V +   
Sbjct: 67  RHPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           L YLH      ++H DL P+N++L ++    ++DFG+AK    +      T  + TI Y 
Sbjct: 126 LRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYS 180

Query: 950 AP 951
            P
Sbjct: 181 CP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 48/173 (27%), Positives = 86/173 (49%), Gaps = 18/173 (10%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKV---FDL--QCGRAFKSFDVECEMMKSIRHRNLIK 840
           +IGRG FG V   R     +V A+K+   F++  +   AF  F  E ++M       +++
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 107

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN--IMVDVATTLEYLHFGYS 898
           +  +   +++  +++EYMP G L   +  SNY  D+ ++       +V   L+ +H   S
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLALDAIH---S 160

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +IH D+KP N+LLD +    L+DFG   + + E   +     + T  Y++P
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 788 IGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           +G G + +V+K R  + E + VA+K   L+         + E  ++K+++H N++ +   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             TE    L+ EY+    L++ L +   ++ +      M  +   L Y H      ++H 
Sbjct: 72  IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAK 928
           DLKP N+L+++     L+DFG+A+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 24/161 (14%)

Query: 781 RFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVF------DLQCGRAFKSFDVECEMMKSI 833
           R+ +   IG G  G V  A     G+ VAVK             RA++    E  ++K +
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR----ELVLLKCV 77

Query: 834 RHRNLIKVIS----SCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVA 887
            H+N+I +++      S EEF+   L++E M   +L + ++     LD  +   ++  + 
Sbjct: 78  NHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQML 133

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             +++LH   SA +IH DLKPSN+++  +    + DFG+A+
Sbjct: 134 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 18/60 (30%), Positives = 26/60 (43%)

Query: 348 NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYL 407
           NL+ L L +N  +            L VL+L  N+ +   P  F  L +LR + L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 22/65 (33%), Positives = 30/65 (46%), Gaps = 5/65 (7%)

Query: 372 KLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGL 431
            L  L+L  N  +      F  L NL+++ L  N LTS + E     +FS   SL  + L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55

Query: 432 SNNPL 436
           S N L
Sbjct: 56  SGNNL 60

Length = 60

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 37/186 (19%)

Query: 788 IGRGGFGSVYKAR---IGEGMEVAVK----VFD--LQCGRAFKSFDVECEMMKSIR-HRN 837
           +G+G +G V  AR     E   VA+K    VF   +   RA +    E ++++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 838 LIKVISS--CSTEEFKALIL-EYMPHGSLEKSLYSSNYILD------IFQRLNIMVDVAT 888
           +  +          F  L L E +    L + + S   + D      I+Q L        
Sbjct: 64  ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL-------C 116

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ---TQTLAT 945
            L+Y+H   SA V+H DLKP N+L++ +    + DFG+A+    E+        T+ +AT
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVAT 172

Query: 946 IGYMAP 951
             Y AP
Sbjct: 173 RWYRAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.1 bits (112), Expect = 3e-05
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 35/199 (17%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVK----VFD--LQCGRAFKSFDVECEMMKSI 833
           R+    +IG+G +G V  A     G +VA+K    VF+      R  +    E ++++ +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR----EIKLLRLL 56

Query: 834 RHRNLIKVIS---SCSTEEFKAL--ILEYMP---HGSLEKS--LYSSNYILDIFQRLNIM 883
           RH +++++       S  EFK +  + E M    H  ++ +  L   ++   ++Q L   
Sbjct: 57  RHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR-- 114

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-ITQTQT 942
                 L+Y+H   +A V H DLKP N+L + +    + DFG+A++   +  + I  T  
Sbjct: 115 -----ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166

Query: 943 LATIGYMAP---GLFHVKY 958
           +AT  Y AP   G F  KY
Sbjct: 167 VATRWYRAPELCGSFFSKY 185

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 24/152 (15%)

Query: 788 IGRGGFGSVYKARIGEGME-VAVKVFDL---QCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG G FG+VY A      E VAVK       Q    ++    E + ++ ++H N I+   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY-K 87

Query: 844 SCSTEEFKA-LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT-------LEYLHF 895
            C  +E  A L++EY         L S++ +L++ ++    V++A         L YLH 
Sbjct: 88  GCYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH- 138

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
             S  +IH D+K  N+LL +     L+DFG A
Sbjct: 139 --SHNMIHRDIKAGNILLTEPGQVKLADFGSA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 20/174 (11%)

Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKS--------FDVECEMMKSIRHRNL 838
           +IGRG FG V   R     +   KV+ ++    F+         F  E ++M       +
Sbjct: 50  VIGRGAFGEVQLVR----HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGY 897
           +++  +   + +  +++EYMP G L   +  SNY + + + R     +V   L+ +H   
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH--- 159

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           S   IH D+KP N+LLD +    L+DFG   + + ++  +     + T  Y++P
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 4e-05
 Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 22/153 (14%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNL------ 838
           +IGRG FG V   +    G   A+K          KS  +E E +  +R  R++      
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60

Query: 839 ---IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  S   E +  LI+EY+P G +   L       D F        +A T+  +  
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDS 116

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            +    IH D+KP N+LLD      LSDFG+  
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 11/167 (6%)

Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSC 845
           +G G  GSV K   I  G  +A KV  +    +  K    E ++M   R   ++    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             E    + +E+M  GSL++       I ++I  +  I V V   L YL+      ++H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           D+KPSN+L++      L DFG++  LI    SI  T  + T  YM+P
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 8/167 (4%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  A +   G  VAVK  DL+  +  +    E  +M+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++E++  G+L   +  +   ++  Q   + + V   L  LH   +  VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP L
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEL 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.2 bits (110), Expect = 6e-05
 Identities = 40/141 (28%), Positives = 73/141 (51%), Gaps = 22/141 (15%)

Query: 818 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSTEEFKA--LILEYMPHGSLEKSLYSSN 871
           RA++       +MK + H+N+I +++      S EEF+   L++E M   +L + +    
Sbjct: 61  RAYREL----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVI---Q 112

Query: 872 YILDIFQRLNIMV-DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
             LD  +R++ ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+  
Sbjct: 113 MDLD-HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168

Query: 931 IGEDQSITQTQTLATIGYMAP 951
                S   T  + T  Y AP
Sbjct: 169 GT---SFMMTPYVVTRYYRAP 186

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 10/166 (6%)

Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  A     G +VAVK  DL+  +  +    E  +M+   H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++E++  G+L   +  +   ++  Q   + + V   L YLH   +  VIH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY-MAP 951
           K  ++LL  +    LSDFG    +  E   + + ++L    Y MAP
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKE---VPKRKSLVGTPYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 15/162 (9%)

Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIRHRNLIKV 841
           +G G FG+V    YK +  E   VAVK+            ++  E  +M+ + +  ++++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV-DVATTLEYLHFGYSAP 900
           I  C  E +  L++E    G L K L  + ++ +  + +  +V  V+  ++YL       
Sbjct: 62  IGICEAESW-MLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYLE---ETN 115

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
            +H DL   NVLL     A +SDFG++K L G D++  + +T
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKT 156

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 18/173 (10%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRHRNLIKVI 842
           L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            +  T +    ++EY   G L   L       +   R     ++ + LEYLH   S  V+
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRDVV 117

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI----GYMAP 951
           + D+K  N++LD +    ++DFG+ K      + I+   T+ T      Y+AP
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.0 bits (109), Expect = 7e-05
 Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 8/176 (4%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEV-AVKVFD---LQCGRAFKSFDVECEMMKSIRH 835
             F   +L+GRG FG V   R     ++ A+KV     L        F+ E +++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             + ++  +   ++   L++EY P G L   L   N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +    +H D+KP NVL+D      L+DFG A  L   ++ +     + T  Y+AP
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 8e-05
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 31/165 (18%)

Query: 781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVKVF------DLQCGRAFKSFDVECEMMKSI 833
           R+ +   +G G +G+V  A     G +VA+K        +L   RA++    E  ++K +
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHM 71

Query: 834 RHRNLIKVI----SSCSTEEFKALILEYMPH-----GSLEKSLYSSNYILDIFQRLNIMV 884
           +H N+I ++       S + F    L  MP      G L K    S        R+  +V
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYL-VMPFMGTDLGKLMKHEKLSE------DRIQFLV 124

Query: 885 -DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             +   L+Y+H   +A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 125 YQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 8e-05
 Identities = 42/158 (26%), Positives = 74/158 (46%), Gaps = 22/158 (13%)

Query: 788 IGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMKSIR-HRN-------- 837
           I RG FG VY  R     ++ AVKV         K+  +   M+  ++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERDALALSKSP 64

Query: 838 -LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
            ++ +  S  +     L++EY+  G ++  L+   Y  D    +  + +VA  L+YLH  
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-- 121

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
               +IH DLKP N+L+ +     L+DFG++K+ +  +
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.4 bits (108), Expect = 9e-05
 Identities = 35/147 (23%), Positives = 59/147 (40%), Gaps = 15/147 (10%)

Query: 787 LIGR----GGFGSVYKARIGEGMEVAVKVFDL--QCGRAFKSFDVECEMMKSIRHRNLIK 840
           LIG+         + K +      VAVK  +L        K    E    + ++H N++ 
Sbjct: 5   LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL---NIMVDVATTLEYLHFGY 897
            ++S   +    ++   M +GS E  L    +  +    L    I+ DV   L+Y+H   
Sbjct: 64  YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH--- 118

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDF 924
           S   IH  +K S++LL  +    LS  
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 24/61 (39%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 275 GLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNS 333
            L+ L L  N LT  IP      L NLK+LDLS N L    P     + +L  L L  N+
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 334 L 334
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 33/145 (22%), Positives = 67/145 (46%), Gaps = 10/145 (6%)

Query: 787 LIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFK---SFDVECEMMKSIRHRNLIKV 841
           ++G G FG + +   ++    E+ V +  L+ G + K    F  E   +    H N++++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL-HFGYSAP 900
               +      ++ EYM +G+L+  L      L   Q + ++  +A+ ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFG 925
            +H  L    VL++ ++V  +S F 
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.5 bits (108), Expect = 2e-04
 Identities = 53/210 (25%), Positives = 76/210 (36%), Gaps = 63/210 (30%)

Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAF----------------KSFDVECEMM 830
           LIG+GG G VY A            +D  C R                  K F  E ++ 
Sbjct: 9   LIGKGGMGEVYLA------------YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIA 56

Query: 831 KSIRHRNLIKVISSCSTEEFKALILEYMPH--GSLEKSLYSSNYILDIFQR--------- 879
             + H  ++ V S CS  +    +   MP+  G   KSL  S +  +   +         
Sbjct: 57  ADLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113

Query: 880 --LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE---- 933
             L+I   +  T+EY+H   S  V+H DLKP N+LL       + D+G A     E    
Sbjct: 114 AFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170

Query: 934 -DQSITQTQTL-----------ATIGYMAP 951
            D  + +                T  YMAP
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAP 200

Length = 932

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 36/135 (26%), Positives = 63/135 (46%), Gaps = 13/135 (9%)

Query: 788 IGRGGFGSVYKA---RIGEG-----MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           +G+G F  ++K     +G+       EV +KV D       +SF     MM  + H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY-LHFGYS 898
                C   +   ++ EY+  GSL+  L  +  +++I  +L    +VA  L + LHF   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL----EVAKQLAWALHFLED 118

Query: 899 APVIHCDLKPSNVLL 913
             + H ++   NVLL
Sbjct: 119 KGLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 38/157 (24%), Positives = 71/157 (45%), Gaps = 21/157 (13%)

Query: 788 IGRGGFGSVYKAR---------IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIRHRN 837
           +G+G F ++YK           +G G EV+V +  L    R   +F     +M  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           L+K+   C  +E   ++ EY+  G L+  L+     + +  +L++   +A+ L YL    
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118

Query: 898 SAPVIHCDLKPSNVLL---DDNM----VAHLSDFGIA 927
              ++H ++   N+L+     N        LSD GI 
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.9 bits (106), Expect = 2e-04
 Identities = 49/196 (25%), Positives = 79/196 (40%), Gaps = 27/196 (13%)

Query: 755 PPNDANMPPIATCRRFSYL------ELCRATNRFSENNLIGRGGFGSV-YKARIGEGMEV 807
              DA +  +  CR F                ++  + ++G G  G+V    R+ +G   
Sbjct: 3   ASGDAMIGRV--CRTFPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPF 60

Query: 808 AVKVFDLQ------CGRAFKSFDVECEM---MKSIR--HRNLIKVISSCSTEE---FKAL 853
           AVKV D++        RA    +V C +     SI   H +  K        E     AL
Sbjct: 61  AVKVVDMEGMSEADKNRA--QAEVCCLLNCDFFSIVKCHEDFAK--KDPRNPENVLMIAL 116

Query: 854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL 913
           +L+Y   G L + + S       F+     +     L  +H  +S  +IH D+K +N+LL
Sbjct: 117 VLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL 176

Query: 914 DDNMVAHLSDFGIAKL 929
             N +  L DFG +K+
Sbjct: 177 CSNGLVKLGDFGFSKM 192

Length = 496

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 27/178 (15%)

Query: 788 IGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVIS--- 843
           IG+G FG VY+ R  +   + A+KV   +   A K      E+  +I  RN++       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 844 ---------SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
                    S  T+    L+ +YM  G L   L       +   +  I  ++   LE+LH
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYI-AELVLALEHLH 113

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
                 +++ DLKP N+LLD      L DFG++K  + ++++   T T   T  Y+AP
Sbjct: 114 ---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 20/58 (34%), Positives = 25/58 (43%), Gaps = 1/58 (1%)

Query: 523 KLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL-TIWNLKGMLYLNFSSN 579
            L  L LS N+L+      F  L +L  L L  N LTSI       L  +  L+ S N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 22/173 (12%)

Query: 788 IGRGGFGSVYKARIGEG--MEVAVKVFDLQCGRAFKSFD---VECEMMKSIRHRNLIKVI 842
           +G G FG V  A         VA+K F+       K  D    E +++  I H   + + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYI---LDIFQRLNIMVDVATTLEYLHFGYSA 899
            S   E +  L+LE++  G     L  +      +  F    I++      EYL    S 
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQ---SL 150

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
            +++ DLKP N+LLD +    ++DFG AK++       T+T TL  T  Y+AP
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEYIAP 197

Length = 340

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 43.2 bits (102), Expect = 4e-04
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 17/173 (9%)

Query: 787 LIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMK------SIRHRNLI 839
           ++G+G FG V  A + G     A+K   L+     +  DVEC M++      +  H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +  +  T+E    ++EY+  G L   + SS    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
            +I+ DLK  NVLLD +    ++DFG+ K  +  +    +  T   T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 30/145 (20%)

Query: 818 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSTEEFKA--LILEYMPHG-----SLEKS 866
           RA++    E  +MK + H+N+I +++      S EEF+   L++E M         +E  
Sbjct: 62  RAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD 117

Query: 867 LYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 926
               +Y+L  +Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+
Sbjct: 118 HERMSYLL--YQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165

Query: 927 AKLLIGEDQSITQTQTLATIGYMAP 951
           A+       S   T  + T  Y AP
Sbjct: 166 ART---AGTSFMMTPYVVTRYYRAP 187

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 30/145 (20%)

Query: 818 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSTEEFKAL--ILEYMPHG-----SLEKS 866
           RA++    E  +MK + H+N+I +++      S EEF+ +  ++E M         +E  
Sbjct: 69  RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 124

Query: 867 LYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 926
               +Y+L  +Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+
Sbjct: 125 HERMSYLL--YQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 172

Query: 927 AKLLIGEDQSITQTQTLATIGYMAP 951
           A+       S   T  + T  Y AP
Sbjct: 173 ART---AGTSFMMTPYVVTRYYRAP 194

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 58/244 (23%), Positives = 89/244 (36%), Gaps = 46/244 (18%)

Query: 131 LKYVNFRGNQLSGAFPSFIFN----KSSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
           L+ +   GN L       + +    + SL+ L  S N   G IP  + S L  L      
Sbjct: 25  LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQGLTKGCGL 83

Query: 187 QNMFH----------GRIPSALSNCKYLEILSLSINNLLG--AIPKEIGNLT----KLKE 230
           Q +            G + S L +   L+ L L+ NN LG   +      L      L++
Sbjct: 84  QELDLSDNALGPDGCGVLESLLRS-SSLQELKLN-NNGLGDRGLRLLAKGLKDLPPALEK 141

Query: 231 LYLGYSGLQGEIPREFGNLA----ELELMALQVSNLQGE----IPQELANLTGLEVLKLG 282
           L LG + L+G              +L+ + L  + +       + + L     LEVL L 
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201

Query: 283 KNFLT-------GEIPPEIHNLHNLKLLDLSHNKL--VGA---VPATIFNMSTLTGLGLQ 330
            N LT        E       L +L++L+L  N L   GA     A +    +L  L L 
Sbjct: 202 NNGLTDEGASALAETLAS---LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLS 258

Query: 331 SNSL 334
            N +
Sbjct: 259 CNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 9e-04
 Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 8/106 (7%)

Query: 825 VECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--LDIFQRLNI 882
           +E  +++++ H ++I++  +  +     ++L   PH S +   Y +     L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
              +   L YLH   +  +IH D+K  N+ ++D     + D G A+
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 15/174 (8%)

Query: 787 LIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMK------SIRHRNLI 839
           ++G+G FG V  A R G     A+K+  L+     +  DVEC M++      S +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           ++ S   T +    ++EY+  G L   +Y    +   F+  + +   A     L F +S 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            +I+ DLK  NV+LD      ++DFG+ K  + +   +T      T  Y+AP +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 42.0 bits (99), Expect = 0.001
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 7/97 (7%)

Query: 855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD 914
           +E+M  GSL++ L  +  I +      I + V   L YL   +   ++H D+KPSN+L++
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134

Query: 915 DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                 L DFG++  LI    S+  +  + T  YM+P
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 39/173 (22%), Positives = 71/173 (41%), Gaps = 10/173 (5%)

Query: 788 IGRGGFGSVYKARIGEGMEVA-VKVFDLQCGRAFK---SFDVECEMMKSIRHRNLIKVIS 843
           IG G FG V  + I     VA V V +L+   + K    F  + +  + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYIL---DIFQRLNIMVDVATTLEYLHFGYSAP 900
            C       L+ EY   G L+  L    +      +     +  ++A  + ++H      
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            +H DL   N  L  ++   + D+GI      ED   T+      + ++AP L
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
           NLK LDLS+N+L          +  L  L L  N+L+ S+S  A   LP+L  L L  NN
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 359 F 359
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 0.002
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 20/155 (12%)

Query: 782 FSENNLIGRGGFGSVYKARIGE-GMEVAVKVF---DL----QCG--RAFKSFDVECEMMK 831
           F    +IGRG FG V   +  + G   A+K+    D+    Q G  RA +   VE + + 
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE 891
                 ++K+  S   +    LI+E++P G +   L   + + +   +  I   V     
Sbjct: 63  ------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 926
               G+    IH D+KP N+LLD      LSDFG+
Sbjct: 117 IHQLGF----IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 26/186 (13%)

Query: 788 IGRGGFGSVYKARIGEGM---EVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLI---K 840
           +GRG +G VYKA+  +G    E A+K  +   G     S   E  +++ ++H N+I   K
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE---GTGISMSACREIALLRELKHPNVIALQK 65

Query: 841 VISSCSTEEFKALILEYMPHG-----SLEKSLYSSNYILDIFQRL--NIMVDVATTLEYL 893
           V  S S  +   L+ +Y  H         ++  ++   + + + +  +++  +   + YL
Sbjct: 66  VFLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 894 HFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLATIGY 948
           H  +   V+H DLKP+N+L+     +     ++D G A+L     + +      + T  Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 949 MAPGLF 954
            AP L 
Sbjct: 182 RAPELL 187

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.2 bits (96), Expect = 0.002
 Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 22/156 (14%)

Query: 782 FSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN--- 837
           F    +IGRG FG V   +  + G   A+K+         K+  +E E +  IR      
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERDIL 55

Query: 838 -------LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
                  ++K+  S   +    LI+E++P G +   L   + + +   +  I   V    
Sbjct: 56  VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 926
                G+    IH D+KP N+LLD      LSDFG+
Sbjct: 116 AIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 41.8 bits (98), Expect = 0.002
 Identities = 67/256 (26%), Positives = 110/256 (42%), Gaps = 46/256 (17%)

Query: 198 LSNCKYLEILSLSIN-------NLLGAIP-KEIGNL-TKLKELYLGYSGLQGEIPREF-- 246
           +S C+ LEIL   IN       NL G    K   ++ T +  L L  + ++ E P     
Sbjct: 688 MSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRL 746

Query: 247 GNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTG-----EIPPEIHNLHNLK 301
            NL EL L  ++   L   + Q L  L  +    L + FL+      E+P  I NLH L+
Sbjct: 747 ENLDELILCEMKSEKLWERV-QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLE 805

Query: 302 LLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG 361
            L++ +   +  +P  I N+ +L  L L   S    L +  D+   N+ +L L   + +G
Sbjct: 806 HLEIENCINLETLPTGI-NLESLESLDLSGCS---RLRTFPDIS-TNISDLNL---SRTG 857

Query: 362 T--IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS 419
              +P +I   S LS L++   +             NL+ ++L+      S L+      
Sbjct: 858 IEEVPWWIEKFSNLSFLDMNGCN-------------NLQRVSLNI-----SKLKHLETVD 899

Query: 420 FSNCKSLTYIGLSNNP 435
           FS+C +LT    + +P
Sbjct: 900 FSDCGALTEASWNGSP 915

syringae 6; Provisional. Length = 1153

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 41.2 bits (97), Expect = 0.002
 Identities = 50/177 (28%), Positives = 77/177 (43%), Gaps = 26/177 (14%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVE---CE-----MMKSIRHRNL 838
           +GRG FG V  A     G   A+K   L+ G      +VE   CE        S RH  L
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM---VDVATTLEYLHF 895
           + + +   TE+    ++EY   G L   +++     D+F     +     V   L+YLH 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
                +++ DLK  N+LLD      ++DFG+ K  +G      +T T   T  ++AP
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAP 170

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 72/353 (20%), Positives = 113/353 (32%), Gaps = 99/353 (28%)

Query: 346 LPNLEELRLWSNNFSGTIPRFIFNASK---------LSVLELGRN-SFSGFIPNTFGNLR 395
           L  L+ LRL  N       + + +A +         LS+ E GR       +        
Sbjct: 22  LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81

Query: 396 NLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM---SMGNLSHSL 452
            L+ + L  N L         L S     SL  + L+NN L     R+    + +L  +L
Sbjct: 82  GLQELDLSDNALGPDGCG--VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139

Query: 453 EYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEG 512
           E   +    + G   + +                       L   + L+ L+L +N +  
Sbjct: 140 EKLVLGRNRLEGASCEALAKA--------------------LRANRDLKELNLANNGIGD 179

Query: 513 PIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGML 572
                +         GL  N              +L  L L +N LT         +G  
Sbjct: 180 AGIRALAE-------GLKANC-------------NLEVLDLNNNGLTD--------EGAS 211

Query: 573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS 632
            L              + +L+VL   +   NN +D       G   L             
Sbjct: 212 AL--------AETLASLKSLEVL---NLGDNNLTDA------GAAAL---------ASAL 245

Query: 633 ISESFGDLISLKSLNLSNNNLSRSIPISL-----EKLSYLEDLDLSFNKLKGE 680
           +S +    ISL +L+LS N+++      L     EK S L +LDL  NK   E
Sbjct: 246 LSPN----ISLLTLSLSCNDITDDGAKDLAEVLAEKES-LLELDLRGNKFGEE 293

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 39/181 (21%), Positives = 81/181 (44%), Gaps = 21/181 (11%)

Query: 788 IGRGGFGSVYKARIGEGM-------EVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLI 839
           +G+G FG VY+  I +G+        VA+K  +     R    F  E  +MK     +++
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYS------SNYIL---DIFQRLNIMVDVATTL 890
           +++   S  +   +I+E M  G L+  L S      +N +     + + + +  ++A  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
            YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 951 P 951
           P
Sbjct: 190 P 190

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 30/180 (16%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVF---------DLQCGRAFKSFDV--ECEMMKSIR 834
           +IGRG FG V   ++     + A+K+          +  C R  ++  V  +C+ + ++ 
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNI--MVDVATTLE 891
           +        +   E +  L+++Y   G L   L    + + +   R  I  MV    ++ 
Sbjct: 68  Y--------AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            LH+      +H D+KP NVLLD N    L+DFG + L + +D ++  +  + T  Y++P
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.004
 Identities = 18/60 (30%), Positives = 30/60 (50%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL 141
            +K L++S+  LT         L +L+ L+L  N L+   P A   L +L+ ++  GN L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 40.2 bits (94), Expect = 0.004
 Identities = 28/112 (25%), Positives = 53/112 (47%), Gaps = 16/112 (14%)

Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEK-------SLYSSNYILDIFQ 878
           E  ++ +++H N+++   S        ++++Y   G L K        L+  + ILD F 
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF- 107

Query: 879 RLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                V +   L+++H      ++H D+K  N+ L  +    L DFGIA++L
Sbjct: 108 -----VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 40.2 bits (94), Expect = 0.004
 Identities = 49/189 (25%), Positives = 75/189 (39%), Gaps = 42/189 (22%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC- 845
           IG G +G VYKAR    G  VA+K       +     D E     ++R  +L++++S   
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 846 ---------STEEFKA-----LILEYMPHGSLEKSLYSSNY-----ILDIFQRLNIMVDV 886
                      EE        L+ EY+   S  K    SN       L      + M  +
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYL--DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSI---TQTQT 942
              + + H      V+H DLKP N+L+D    +  ++D G     +G   SI   + T  
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG-----LGRAFSIPVKSYTHE 171

Query: 943 LATIGYMAP 951
           + T+ Y AP
Sbjct: 172 IVTLWYRAP 180

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 41/167 (24%), Positives = 80/167 (47%), Gaps = 11/167 (6%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISSC 845
           +G G  G V K +    G+ +A K+  L+   A ++  + E +++       ++    + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            ++   ++ +E+M  GSL++ L  +  I  +I  +++I V     L YL   +   ++H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGLAYLREKHQ--IMHR 128

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           D+KPSN+L++      L DFG++  LI           + T  YM+P
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	982
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.98
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.98
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.98
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.98
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.98
KOG0605	550	consensus NDR and related serine/threonine kinases	99.98
KOG0198	313	consensus MEKK and related serine/threonine protei	99.98
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
KOG0610	459	consensus Putative serine/threonine protein kinase	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.96
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.96
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.96
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.95
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
KOG0586	596	consensus Serine/threonine protein kinase [General	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.95
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.95
PTZ00267	478	NIMA-related protein kinase; Provisional	99.95
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.95
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.94
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
PHA03212	391	serine/threonine kinase US3; Provisional	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.94
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.94
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
PHA03211	461	serine/threonine kinase US3; Provisional	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
KOG0584	632	consensus Serine/threonine protein kinase [General	99.94
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.93
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.93
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.93
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.93
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.93
PHA03207	392	serine/threonine kinase US3; Provisional	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.93
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.93
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.93
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.93
PHA03209	357	serine/threonine kinase US3; Provisional	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
PTZ00036	440	glycogen synthase kinase; Provisional	99.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.93
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.93
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.93
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.93
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.93
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.93
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.93
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.93
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.93
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.93
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.93
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.93
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.93
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.93
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.93
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.92
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.92
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.92
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.92
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.92
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.92
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.92
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.92
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.92
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.92
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.92
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.92
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.92
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.92
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.92
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.92
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.92
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.92
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.92
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.92
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.92
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.92
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.92
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.92
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.92
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.92
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.92
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.92
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.92
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.92
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.92
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.92
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.92
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.92
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.92
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.92
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.92
PTZ00284	467	protein kinase; Provisional	99.92
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.92
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.92
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.92
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.92
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.92
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.92
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.92
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.92
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.92
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.91
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.91
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.91
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.91
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.91
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.91
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.91
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.91
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.91
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.91
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.91
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.91
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.91
PHA03210	501	serine/threonine kinase US3; Provisional	99.91
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.91
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.91
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.91
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.91
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.91
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.91
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.91
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.91
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.91
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.91
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.91
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.91
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.91
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.91
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.91
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.91
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.9
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.9
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.9
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.9
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.9
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.9
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.9
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.9
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.9
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.9
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.9
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.9
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.9
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.9
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.9
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.9
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.9
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.9
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.9
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.9
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.9
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.89
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.89
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.89
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.89
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.89
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.89
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.89
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.89
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.89
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.89
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.89
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.89
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.89
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.89
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.89
PHA02882	294	putative serine/threonine kinase; Provisional	99.89
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.89
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.89
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.89
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.89
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.89
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.88
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.88
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.88
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.88
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.88
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.88
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.88
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.88
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.87
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.87
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.87
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.87
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.87
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.87
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.87
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.83
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.83
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.81
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.8
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
smart00090	237	RIO RIO-like kinase.	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
PRK12274	218	serine/threonine protein kinase; Provisional	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
PLN03150	623	hypothetical protein; Provisional	99.66
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
PLN00181	793	protein SPA1-RELATED; Provisional	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
PLN03150	623	hypothetical protein; Provisional	99.6
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.44
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.39
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.38
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.36
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.28
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.25
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.23
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.22
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.21
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.16
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.16
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.16
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.15
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.13
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.13
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.08
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.07
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.07
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.06
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.05
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.9
KOG1243	690	consensus Protein kinase [General function predict	98.84
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.84
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.84
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.83
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.83
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.75
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.74
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.68
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.58
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.57
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.52
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.5
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.47
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.43
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.39
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.31
PRK09902	216	hypothetical protein; Provisional	98.3

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-107  Score=1038.49  Aligned_cols=828  Identities=34%  Similarity=0.563  Sum_probs=649.7

Q ss_pred             ChhHHHHHHHHHHHhcCCCCccccCCCCCCCCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCC
Q 036229           36 ITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFN  115 (982)
Q Consensus        36 ~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n  115 (982)
                      .++|++||++||+++.+  +.+.+.+|+..++||.|.||+|+ ..++|+.|+|++++++|.+|+.+..+++|+.|||++|
T Consensus        27 ~~~~~~~l~~~~~~~~~--~~~~~~~w~~~~~~c~w~gv~c~-~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         27 HAEELELLLSFKSSIND--PLKYLSNWNSSADVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN  103 (968)
T ss_pred             CHHHHHHHHHHHHhCCC--CcccCCCCCCCCCCCcCcceecC-CCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence            67899999999999954  44567999988899999999998 5679999999999999999999999999999999999


Q ss_pred             CccccCcchhh-hccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeeccc
Q 036229          116 RLSGSIPSAIF-TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI  194 (982)
Q Consensus       116 ~~~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~  194 (982)
                      +++|.+|..++ .+++|++|+|++|++++.+|.  +.+++|++|||++|.+++.+|..+ +++++|++|+|++|.+.+.+
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~-~~l~~L~~L~L~~n~l~~~~  180 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI-GSFSSLKVLDLGGNVLVGKI  180 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHH-hcCCCCCEEECccCcccccC
Confidence            99999999877 899999999999999988886  468899999999999988888877 78899999999999988888


Q ss_pred             CCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccC
Q 036229          195 PSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLT  274 (982)
Q Consensus       195 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~  274 (982)
                      |..|+++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|+.|++++|++.+.+|..+++++
T Consensus       181 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~  260 (968)
T PLN00113        181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK  260 (968)
T ss_pred             ChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence            88888899999999999988888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEc
Q 036229          275 GLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRL  354 (982)
Q Consensus       275 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  354 (982)
                      +|++|++++|++++.+|..+.++++|++|+|++|.+.+.+|..+.++++|                         ++|++
T Consensus       261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------------------~~L~l  315 (968)
T PLN00113        261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL-------------------------EILHL  315 (968)
T ss_pred             CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCC-------------------------cEEEC
Confidence            88888888888888888888888888888888888887777776665555                         55555


Q ss_pred             cCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCC
Q 036229          355 WSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNN  434 (982)
Q Consensus       355 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N  434 (982)
                      ++|.+.+..|..+..+++|+.|++++|.+++.+|..++.+++|+                             .|++++|
T Consensus       316 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~-----------------------------~L~Ls~n  366 (968)
T PLN00113        316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT-----------------------------VLDLSTN  366 (968)
T ss_pred             CCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCc-----------------------------EEECCCC
Confidence            55555556666666667777777777776666555554444443                             3333333


Q ss_pred             CCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCC
Q 036229          435 PLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPI  514 (982)
Q Consensus       435 ~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  514 (982)
                                                ++++..|..+..+++|+.|++++|++.+.+|..+..+++|+.|+|++|++++.+
T Consensus       367 --------------------------~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~  420 (968)
T PLN00113        367 --------------------------NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL  420 (968)
T ss_pred             --------------------------eeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeEC
Confidence                                      333344555666666777777777777777777777777777777777777777


Q ss_pred             CcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccc-ccccccccccCceEEecCCCcccCCCcccccccc
Q 036229          515 PDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLK  593 (982)
Q Consensus       515 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  593 (982)
                      |..|..+++|+.|++++|++++.+|..+..+++|+.|+|++|++. .+|. .+..++|+.|++++|++++.+|..+.+++
T Consensus       421 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~-~~~~~~L~~L~ls~n~l~~~~~~~~~~l~  499 (968)
T PLN00113        421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSRNQFSGAVPRKLGSLS  499 (968)
T ss_pred             ChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCc-ccccccceEEECcCCccCCccChhhhhhh
Confidence            777777777777777777777777777777777777777777776 3443 34557889999999999999999999999


Q ss_pred             ccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecC
Q 036229          594 VLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLS  673 (982)
Q Consensus       594 ~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls  673 (982)
                      +|+.|++++|++++.+|..++.+++|++|+|++|++++.+|..|.++++|+.|||++|+++|.+|..+..+++|+.|+++
T Consensus       500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls  579 (968)
T PLN00113        500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS  579 (968)
T ss_pred             ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCCCCCCCCCCcccccCcccCCCCC-CCCCCCCcccccccccceeEeeeehhhHHHHHHHHHhhheeecccc
Q 036229          674 FNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPN-LQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVILLIVRYRKRV  752 (982)
Q Consensus       674 ~N~l~~~~p~~~~~~~~~~~~~~gn~~lc~~~~-~~~~~c~~~~~~~~~~~~~i~~i~~~~~~~~~~v~~~~~~~~r~~~  752 (982)
                      +|+++|.+|..+++..+.+.++.||+++||.+. ...++|...  .+.....++++++++++++++++++++++++||+.
T Consensus       580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  657 (968)
T PLN00113        580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV--RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNN  657 (968)
T ss_pred             CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc--cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhc
Confidence            999999999999999999999999999998642 234566532  11122222222222222222222222222222221


Q ss_pred             CC-CCCCC---CCCCC----cccccCCHHHHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhH
Q 036229          753 KQ-PPNDA---NMPPI----ATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSF  823 (982)
Q Consensus       753 ~~-~~~~~---~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~  823 (982)
                      ++ +....   .....    .....+++   ......|...+.||+|+||.||+|+. .+++.||||+++....    ..
T Consensus       658 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~  730 (968)
T PLN00113        658 LELKRVENEDGTWELQFFDSKVSKSITI---NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IP  730 (968)
T ss_pred             ccccccccccccccccccccccchhhhH---HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----cc
Confidence            11 11110   00000    00112223   33345678889999999999999986 5689999999864322    22


Q ss_pred             HHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 036229          824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH  903 (982)
Q Consensus       824 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  903 (982)
                      ..|++++++++||||++++++|.+++..++||||+++|+|.++++.    ++|.++.+++.|+++|++|||..++++|+|
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  806 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVV  806 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence            3568899999999999999999999999999999999999999953    789999999999999999999666779999


Q ss_pred             cCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       904 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |||||+||+++.++.+++. ||.+.....      .....+|+.|||||++.+..++.   .+|+|++|+
T Consensus       807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~---~sDv~S~Gv  866 (968)
T PLN00113        807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITE---KSDIYGFGL  866 (968)
T ss_pred             CCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCc---ccchhhHHH
Confidence            9999999999998888876 666543311      12346889999999997766553   456666663

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.2e-63  Score=632.10  Aligned_cols=517  Identities=38%  Similarity=0.590  Sum_probs=457.7

Q ss_pred             CCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCcccc-CcCCCCccccccCcccccCchhhhcCCCCCCee
Q 036229          105 SSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIF-NKSSLQHLDFSYNALSGEIPANICSNLPFLESI  183 (982)
Q Consensus       105 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L  183 (982)
                      .+++.|||++|.++|.+|..+..+++|++|+|++|+++|.+|..+. ++++|++|||++|.++|.+|.   +.+++|++|
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L  145 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETL  145 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEE
Confidence            4688999999999999999999999999999999999999998765 899999999999999988886   458899999


Q ss_pred             eecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccC
Q 036229          184 SLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ  263 (982)
Q Consensus       184 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  263 (982)
                      +|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|+.|++++|++.
T Consensus       146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence            99999999889999999999999999999999889999999999999999999999888999999999999999999998


Q ss_pred             CcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCcccc
Q 036229          264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIAD  343 (982)
Q Consensus       264 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  343 (982)
                      +.+|..++++++|++|++++|++++.+|..|.++++|++|+|++|++++..|..+.++++|                   
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L-------------------  286 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-------------------  286 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCc-------------------
Confidence            8888888889999999999999888888888888888888888888888777777665555                   


Q ss_pred             ccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCC
Q 036229          344 VQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNC  423 (982)
Q Consensus       344 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l  423 (982)
                            ++|++++|++.+.+|..+.++++|++|++++|.+++..|..+..+++|+                         
T Consensus       287 ------~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~-------------------------  335 (968)
T PLN00113        287 ------ISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ-------------------------  335 (968)
T ss_pred             ------CEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCC-------------------------
Confidence                  6777777777777888888888899999999888877776655555444                         


Q ss_pred             ccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeE
Q 036229          424 KSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGL  503 (982)
Q Consensus       424 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  503 (982)
                          .|++++|                          ++++.+|..++.+++|+.|++++|++++.+|.++..+++|+.|
T Consensus       336 ----~L~L~~n--------------------------~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L  385 (968)
T PLN00113        336 ----VLQLWSN--------------------------KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL  385 (968)
T ss_pred             ----EEECcCC--------------------------CCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence                5555555                          4444567778889999999999999999999999999999999


Q ss_pred             EeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccc-ccccccccccCceEEecCCCccc
Q 036229          504 HLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFT  582 (982)
Q Consensus       504 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~Ls~N~l~  582 (982)
                      ++++|++++.+|..+..+++|+.|++++|++++..|..|.++++|+.|++++|+++ .+|..++.+++|++|++++|++.
T Consensus       386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~  465 (968)
T PLN00113        386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF  465 (968)
T ss_pred             ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceee
Confidence            99999999999999999999999999999999999999999999999999999999 57777889999999999999999


Q ss_pred             CCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccc
Q 036229          583 GPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLE  662 (982)
Q Consensus       583 ~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  662 (982)
                      +.+|..++ .++|+.||+++|++++.+|..+.++++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..+.
T Consensus       466 ~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  544 (968)
T PLN00113        466 GGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS  544 (968)
T ss_pred             eecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHh
Confidence            99988764 58999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccceeecCCCcccccCCCCC-CCCCCCCcccccCcccCCCC
Q 036229          663 KLSYLEDLDLSFNKLKGEIPKGG-SFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       663 ~l~~L~~l~ls~N~l~~~~p~~~-~~~~~~~~~~~gn~~lc~~~  705 (982)
                      .+++|++|||++|+++|.+|... .+.........+|+..+.-|
T Consensus       545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  588 (968)
T PLN00113        545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP  588 (968)
T ss_pred             CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence            99999999999999999999753 23344556667777665433

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.4e-47  Score=392.01  Aligned_cols=498  Identities=27%  Similarity=0.411  Sum_probs=333.5

Q ss_pred             cccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCC
Q 036229          100 QLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPF  179 (982)
Q Consensus       100 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~  179 (982)
                      ..|.-..|+.|++++|.+. .+-+.+.++..|..|++++|+++ .+|++++.+.+++.|+.|+|++. .+|..+ ..+++
T Consensus        40 ~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i-~s~~~  115 (565)
T KOG0472|consen   40 NWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQI-GSLIS  115 (565)
T ss_pred             hhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHH-hhhhh
Confidence            4555666777777777776 44455667777777777777777 67777777777777777777777 777777 66777


Q ss_pred             CCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccc
Q 036229          180 LESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQV  259 (982)
Q Consensus       180 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  259 (982)
                      |+.|+.++|.+. ..|+.++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++...|+.+. ++.|+.+|+..
T Consensus       116 l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~  192 (565)
T KOG0472|consen  116 LVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNS  192 (565)
T ss_pred             hhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccch
Confidence            777777777776 46666777777777777777776 5677777777777777777777755554444 66677777666


Q ss_pred             cccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcC
Q 036229          260 SNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLS  339 (982)
Q Consensus       260 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  339 (982)
                      |-+. .+|+.++.+.+|+.|+|.+|+|. ..| .|.++..|++|+++.|+|. .+|+..+                    
T Consensus       193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~--------------------  248 (565)
T KOG0472|consen  193 NLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHL--------------------  248 (565)
T ss_pred             hhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHh--------------------
Confidence            6665 55666666667777777777766 344 6666666666666666665 4444433                    


Q ss_pred             ccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCccccccccc
Q 036229          340 SIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS  419 (982)
Q Consensus       340 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  419 (982)
                          ..++++..|||.+|+++ ..|+.++-+.+|++||+|+|.|++. |..++++ .|+.|.+.+|.+..+..++.....
T Consensus       249 ----~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT  321 (565)
T KOG0472|consen  249 ----KHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-PYSLGNL-HLKFLALEGNPLRTIRREIISKGT  321 (565)
T ss_pred             ----cccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccC-Ccccccc-eeeehhhcCCchHHHHHHHHcccH
Confidence                23444566777777776 6777788888888888888888854 5667777 788788888877665544322111


Q ss_pred             CCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCC
Q 036229          420 FSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQK  499 (982)
Q Consensus       420 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  499 (982)
                      -.-++.|+. ...+-.++..     -+.             .-+  -+                -...+..| ....+.+
T Consensus       322 ~~vLKyLrs-~~~~dglS~s-----e~~-------------~e~--~~----------------t~~~~~~~-~~~~~i~  363 (565)
T KOG0472|consen  322 QEVLKYLRS-KIKDDGLSQS-----EGG-------------TET--AM----------------TLPSESFP-DIYAIIT  363 (565)
T ss_pred             HHHHHHHHH-hhccCCCCCC-----ccc-------------ccc--cC----------------CCCCCccc-chhhhhh
Confidence            111222221 0000000000     000             000  00                00001111 2234456


Q ss_pred             CCeEEeeccCCCCCCCcccCCCcc---ccEEEccCCcCCcCCCccccCCCccc-ccccCCCcccccccccccccCceEEe
Q 036229          500 LQGLHLEDNKLEGPIPDDICRLTK---LYELGLSGNKLSGSIPACFSNLASLG-TLSLGSNKLTSIPLTIWNLKGMLYLN  575 (982)
Q Consensus       500 L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~ip~~~~~l~~L~~L~  575 (982)
                      .+.|++++=+++ .+|+......+   .+..+++.|++. .+|..+..++.+. .+.+++|.+..+|..+..+++|..|+
T Consensus       364 tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~  441 (565)
T KOG0472|consen  364 TKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLD  441 (565)
T ss_pred             hhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeee
Confidence            777777777777 45554333333   667777888876 5676666666543 46677777777777777788888888


Q ss_pred             cCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCC
Q 036229          576 FSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR  655 (982)
Q Consensus       576 Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  655 (982)
                      |++|.+. .+|.+++.+..|+.||+|+|+|. .+|..+..+..|+.+-.++|++....|+.++++.+|+.|||.+|.+. 
T Consensus       442 L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-  518 (565)
T KOG0472|consen  442 LSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-  518 (565)
T ss_pred             cccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-
Confidence            8877776 67777888888888888888884 57777777777777777789998666777999999999999999997 


Q ss_pred             CCCcccccccccceeecCCCccc
Q 036229          656 SIPISLEKLSYLEDLDLSFNKLK  678 (982)
Q Consensus       656 ~~p~~l~~l~~L~~l~ls~N~l~  678 (982)
                      .+|+.++++++|++|++++|+|+
T Consensus       519 ~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  519 QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hCChhhccccceeEEEecCCccC
Confidence            68889999999999999999997

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.2e-46  Score=387.02  Aligned_cols=490  Identities=29%  Similarity=0.371  Sum_probs=326.5

Q ss_pred             EEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCcccccc
Q 036229           83 VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY  162 (982)
Q Consensus        83 v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  162 (982)
                      ...+.+++|.+. .+.+.+-++..|+.|++++|+++ ..|++++.+..++.|+.|+|+++ .+|++++++.+|.+||.++
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            456888999998 77788999999999999999998 89999999999999999999999 8999999999999999999


Q ss_pred             CcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCch
Q 036229          163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEI  242 (982)
Q Consensus       163 N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  242 (982)
                      |.+. ++|+++ +.+..|..|+..+|++. ..|+.++++.+|..|++.+|+++...|..+ +++.|++||...|-++ .+
T Consensus       124 n~~~-el~~~i-~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tl  198 (565)
T KOG0472|consen  124 NELK-ELPDSI-GRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TL  198 (565)
T ss_pred             ccee-ecCchH-HHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cC
Confidence            9998 899998 78999999999999998 688899999999999999999995544444 5999999999999997 78


Q ss_pred             hhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCC
Q 036229          243 PREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS  322 (982)
Q Consensus       243 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  322 (982)
                      |..++.+.+|+.|+|..|++. .+| +|.+++.|++|+++.|+|.....+...+++++.+|||..|+++ ..|+.++-+.
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLr  275 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLR  275 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhh
Confidence            999999999999999999998 566 8999999999999999999544445569999999999999998 7888888888


Q ss_pred             CCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCC--cccee
Q 036229          323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLR--NLRLM  400 (982)
Q Consensus       323 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~--~L~~L  400 (982)
                      +|.+||+++|.|++...                          .++++ .|+.|-+.+|.+..+-.+.+..-+  -|++|
T Consensus       276 sL~rLDlSNN~is~Lp~--------------------------sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyL  328 (565)
T KOG0472|consen  276 SLERLDLSNNDISSLPY--------------------------SLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYL  328 (565)
T ss_pred             hhhhhcccCCccccCCc--------------------------ccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHH
Confidence            88666666666654433                          34444 444444444444322111111000  01111


Q ss_pred             cccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccc--cccce
Q 036229          401 TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNL--TNLIG  478 (982)
Q Consensus       401 ~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l--~~L~~  478 (982)
                      .-   ++++......     ++ .+-+.-++.    .+..+..   ....+.+.|+++.-+++..+...|..-  .-...
T Consensus       329 rs---~~~~dglS~s-----e~-~~e~~~t~~----~~~~~~~---~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~  392 (565)
T KOG0472|consen  329 RS---KIKDDGLSQS-----EG-GTETAMTLP----SESFPDI---YAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTS  392 (565)
T ss_pred             HH---hhccCCCCCC-----cc-cccccCCCC----CCcccch---hhhhhhhhhcccccccccCCHHHHHHhhhcceEE
Confidence            00   0100000000     00 000000000    0000000   011233445555555553222222211  12455


Q ss_pred             EEecCCCCCCCCCccccCcCCCC-eEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCc
Q 036229          479 IYLGGNKLNGSIPITLGKLQKLQ-GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNK  557 (982)
Q Consensus       479 L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  557 (982)
                      .++++|++. .+|..+..++.++ .+.+++|.++ .+|..++.+++|..|+|++|-+. .+|..++.+..|+.||++.|+
T Consensus       393 VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~Nr  469 (565)
T KOG0472|consen  393 VNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNR  469 (565)
T ss_pred             EecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccc
Confidence            666666665 4555555444433 3344444443 56666666666666666666665 556666666666666666666


Q ss_pred             ccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccc
Q 036229          558 LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESF  637 (982)
Q Consensus       558 l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  637 (982)
                      +..+|.++..+..++.+-.++                        |++..+.|+.+++|.+|..|||.+|.+. .+|..+
T Consensus       470 Fr~lP~~~y~lq~lEtllas~------------------------nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~L  524 (565)
T KOG0472|consen  470 FRMLPECLYELQTLETLLASN------------------------NQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPIL  524 (565)
T ss_pred             cccchHHHhhHHHHHHHHhcc------------------------ccccccChHHhhhhhhcceeccCCCchh-hCChhh
Confidence            666666655554444444444                        4444444444555555555555555555 455556


Q ss_pred             cCCCCCCeeeCCCCcCC
Q 036229          638 GDLISLKSLNLSNNNLS  654 (982)
Q Consensus       638 ~~l~~L~~L~Ls~N~l~  654 (982)
                      +++++|+.|+|++|.|.
T Consensus       525 gnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  525 GNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccccceeEEEecCCccC
Confidence            66666666666666664

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-43  Score=373.37  Aligned_cols=369  Identities=24%  Similarity=0.287  Sum_probs=289.6

Q ss_pred             CCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeee
Q 036229          106 SLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISL  185 (982)
Q Consensus       106 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L  185 (982)
                      .-+.||+++|.++..-+..|.++++|++++|.+|.++ .+|........|+.|+|.+|.|+ ++...-.+.++.|++|||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDL  156 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDL  156 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhh
Confidence            3467999999999777888899999999999999998 78988777778999999999998 565555588999999999


Q ss_pred             cceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCc
Q 036229          186 SQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGE  265 (982)
Q Consensus       186 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  265 (982)
                      |.|.|+.+.-.+|..-.++++|+|++|+|+......|.++.+|..|.|+.|+++...+..|.+|++|+.|+|..|++.-.
T Consensus       157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv  236 (873)
T KOG4194|consen  157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV  236 (873)
T ss_pred             hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence            99999977777888878999999999999988888999999999999999999988888999999999999999998755


Q ss_pred             CChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCcccccc
Q 036229          266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQ  345 (982)
Q Consensus       266 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  345 (982)
                      .--.|.+|++|+.|.|..|.|+....+.|..+.++++|+|+.|+++..-..+++++++|                     
T Consensus       237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L---------------------  295 (873)
T KOG4194|consen  237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSL---------------------  295 (873)
T ss_pred             hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchh---------------------
Confidence            45678999999999999999998888889999999999999999987777777777766                     


Q ss_pred             CCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCcc
Q 036229          346 LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS  425 (982)
Q Consensus       346 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~  425 (982)
                          +.|+||+|.|+.+-++.+...++|++|+|++|+|+...++.|..+..|+.|.|++|.++.+...     +|..+++
T Consensus       296 ----~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~-----af~~lss  366 (873)
T KOG4194|consen  296 ----EQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEG-----AFVGLSS  366 (873)
T ss_pred             ----hhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhh-----HHHHhhh
Confidence                5666666666666667777777888888888888888888888888888888888777766544     3677777


Q ss_pred             ccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEe
Q 036229          426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHL  505 (982)
Q Consensus       426 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  505 (982)
                      |+.|||++|.++....+                       -...|..++.|+.|.|.+|+|+.+...+|.+++.|++|||
T Consensus       367 L~~LdLr~N~ls~~IED-----------------------aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL  423 (873)
T KOG4194|consen  367 LHKLDLRSNELSWCIED-----------------------AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDL  423 (873)
T ss_pred             hhhhcCcCCeEEEEEec-----------------------chhhhccchhhhheeecCceeeecchhhhccCcccceecC
Confidence            77777777766543222                       1123445566666666666666555556666666666666


Q ss_pred             eccCCCCCCCcccCCCccccEEEcc
Q 036229          506 EDNKLEGPIPDDICRLTKLYELGLS  530 (982)
Q Consensus       506 s~N~l~~~~p~~~~~l~~L~~L~Ls  530 (982)
                      .+|.|..+.|++|..+ +|++|.++
T Consensus       424 ~~NaiaSIq~nAFe~m-~Lk~Lv~n  447 (873)
T KOG4194|consen  424 GDNAIASIQPNAFEPM-ELKELVMN  447 (873)
T ss_pred             CCCcceeecccccccc-hhhhhhhc
Confidence            6666665666666655 55555443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=368.22  Aligned_cols=366  Identities=26%  Similarity=0.318  Sum_probs=284.1

Q ss_pred             CCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhcc
Q 036229          155 LQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLG  234 (982)
Q Consensus       155 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  234 (982)
                      -+.||+|+|++. .+....|.++++|+.+++..|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.||||
T Consensus        80 t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   80 TQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             eeeeeccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            345777777776 565566677777777777777776 466665666678888888888886667778888888888888


Q ss_pred             CCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccC
Q 036229          235 YSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAV  314 (982)
Q Consensus       235 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  314 (982)
                      .|.|+.+.-.+|..=.+++.|+|++|+|+......|.++.+|..|.|+.|+|+...+..|.++++|+.|||..|+|....
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            88888665567777677888888888887777777888888888888888888777778888888888888888887544


Q ss_pred             cccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccC
Q 036229          315 PATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNL  394 (982)
Q Consensus       315 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  394 (982)
                      -.+|.++++|+.|.|..|.|. .+.+.+|..+.++++|+|+.|+++..-..|++++++|+.|+||+|.|..+.++...-.
T Consensus       238 ~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft  316 (873)
T KOG4194|consen  238 GLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT  316 (873)
T ss_pred             hhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence            567777888888888888876 4555666677888888888888887777888888888888888888888888888888


Q ss_pred             CccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCccccccc
Q 036229          395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLT  474 (982)
Q Consensus       395 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~  474 (982)
                      ++|++|+|++|+|++++.+     +|..+.+|++|+|++|.++.+                          -...|..++
T Consensus       317 qkL~~LdLs~N~i~~l~~~-----sf~~L~~Le~LnLs~Nsi~~l--------------------------~e~af~~ls  365 (873)
T KOG4194|consen  317 QKLKELDLSSNRITRLDEG-----SFRVLSQLEELNLSHNSIDHL--------------------------AEGAFVGLS  365 (873)
T ss_pred             ccceeEeccccccccCChh-----HHHHHHHhhhhcccccchHHH--------------------------HhhHHHHhh
Confidence            8888888888888877655     367777777777777765533                          234567778


Q ss_pred             ccceEEecCCCCCCCCC---ccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccccc
Q 036229          475 NLIGIYLGGNKLNGSIP---ITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTL  551 (982)
Q Consensus       475 ~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  551 (982)
                      +|+.|+|++|.|+..+.   ..|.++++|+.|+|.+|+|..+...+|.++..|++|||.+|.|..+.|.+|..+ .|+.|
T Consensus       366 sL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~L  444 (873)
T KOG4194|consen  366 SLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKEL  444 (873)
T ss_pred             hhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhh
Confidence            88888888888876654   357788888888888888886666788888888888888888888888888888 88877


Q ss_pred             ccCC
Q 036229          552 SLGS  555 (982)
Q Consensus       552 ~L~~  555 (982)
                      .+..
T Consensus       445 v~nS  448 (873)
T KOG4194|consen  445 VMNS  448 (873)
T ss_pred             hhcc
Confidence            7654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-41  Score=377.85  Aligned_cols=506  Identities=29%  Similarity=0.338  Sum_probs=381.6

Q ss_pred             EEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcc-hhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCc
Q 036229           86 LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPS-AIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA  164 (982)
Q Consensus        86 L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  164 (982)
                      +|+++.++. .||..+..-..++.|+++.|.+- ..|- ++...-+|+.||||+|+++ ..|..+..++.|+.|+++.|.
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~   79 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY   79 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence            577778887 88988888888999999999775 3332 3344556999999999998 899999999999999999999


Q ss_pred             ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhh
Q 036229          165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPR  244 (982)
Q Consensus       165 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  244 (982)
                      |. .+|.++ +++.+|+.|+|.+|++. ..|..+..+.+|++||+|.|++. .+|..+..++.++.+..++|......  
T Consensus        80 i~-~vp~s~-~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l--  153 (1081)
T KOG0618|consen   80 IR-SVPSSC-SNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL--  153 (1081)
T ss_pred             Hh-hCchhh-hhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh--
Confidence            98 889887 89999999999999997 68999999999999999999997 88999999999999999999322222  


Q ss_pred             hcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCC
Q 036229          245 EFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTL  324 (982)
Q Consensus       245 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  324 (982)
                        +... .+.+++..|.+.+.++..+..++.  .|||++|.+..   ..+..+++|+.|....|++....    -..++|
T Consensus       154 --g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~----~~g~~l  221 (1081)
T KOG0618|consen  154 --GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELE----ISGPSL  221 (1081)
T ss_pred             --cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEE----ecCcch
Confidence              2222 788899999999988888887777  79999999872   35678889999999999987432    235688


Q ss_pred             ceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccc
Q 036229          325 TGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHY  404 (982)
Q Consensus       325 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  404 (982)
                      +.|..+.|.+......   ....+|++++++.|++++ +|+|+..+.+|+.++..+|+++ ..|..+...++|+.+.+.+
T Consensus       222 ~~L~a~~n~l~~~~~~---p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~  296 (1081)
T KOG0618|consen  222 TALYADHNPLTTLDVH---PVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAY  296 (1081)
T ss_pred             heeeeccCcceeeccc---cccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhh
Confidence            9999999998722221   234578999999999984 5699999999999999999996 5677777888899999999


Q ss_pred             cccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCC
Q 036229          405 NYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGN  484 (982)
Q Consensus       405 N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N  484 (982)
                      |.+..++..      ...+++|++|+|..|+|...++ .++.-...++                        ..|+.+.|
T Consensus       297 nel~yip~~------le~~~sL~tLdL~~N~L~~lp~-~~l~v~~~~l------------------------~~ln~s~n  345 (1081)
T KOG0618|consen  297 NELEYIPPF------LEGLKSLRTLDLQSNNLPSLPD-NFLAVLNASL------------------------NTLNVSSN  345 (1081)
T ss_pred             hhhhhCCCc------ccccceeeeeeehhccccccch-HHHhhhhHHH------------------------HHHhhhhc
Confidence            988776643      3557888888888887766544 2222222223                        44444444


Q ss_pred             CCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccc
Q 036229          485 KLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLT  564 (982)
Q Consensus       485 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~  564 (982)
                      ++....--.=..++.|+.|++.+|+++...-+.+.+..+|+.|+|++|+|.......+.++..|++|+||+|+|+.+|.+
T Consensus       346 ~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~t  425 (1081)
T KOG0618|consen  346 KLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDT  425 (1081)
T ss_pred             cccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHH
Confidence            44422211112345577777777777766666677777777777777777644445567777777777777777777777


Q ss_pred             cccccCceEEecCCCcccCCCccccccccccceeecccccccccc-cccccCccCcceEecccccccCCccccccCCCCC
Q 036229          565 IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVI-PTVIGGLTNLQYLFLGYNRLQGSISESFGDLISL  643 (982)
Q Consensus       565 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  643 (982)
                      +..+..|++|...+|++. ..| ++..+++|+.+|+|.|+|+... |..... ++|++|||++|.=....-..|..+.++
T Consensus       426 va~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l  502 (1081)
T KOG0618|consen  426 VANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSL  502 (1081)
T ss_pred             HHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhh
Confidence            777777777777777776 344 7777888888888888887543 333322 789999999997332445567777777


Q ss_pred             CeeeCCCC
Q 036229          644 KSLNLSNN  651 (982)
Q Consensus       644 ~~L~Ls~N  651 (982)
                      ...+++-|
T Consensus       503 ~~~~i~~~  510 (1081)
T KOG0618|consen  503 SQMDITLN  510 (1081)
T ss_pred             hheecccC
Confidence            77777766

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-39  Score=332.51  Aligned_cols=186  Identities=26%  Similarity=0.428  Sum_probs=162.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..++|...+.||+|+||+||+|+.+ ++.+||||.+.+.  ..+..+.+..|+++++.++|||||++++++..++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4578999999999999999999854 5899999999766  556678889999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC------CcEEEEeecCce
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN------MVAHLSDFGIAK  928 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~------~~~kL~DFGla~  928 (982)
                      ||||.||+|.++++.++ .+++..++.++.|++.|+++||   +++||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999998765 5899999999999999999999   9999999999999999754      468999999999


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .+...   ......+|+|.|||||++..+.|+..   .|.|++|.
T Consensus       164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAK---ADLWSiG~  202 (429)
T KOG0595|consen  164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAK---ADLWSIGT  202 (429)
T ss_pred             hCCch---hHHHHhhCCccccCHHHHHhccccch---hhHHHHHH
Confidence            87432   23456899999999999977777644   44555553

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=374.09  Aligned_cols=507  Identities=28%  Similarity=0.321  Sum_probs=405.2

Q ss_pred             EEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecce
Q 036229          109 SLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN  188 (982)
Q Consensus       109 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N  188 (982)
                      .+|.+..++. .||..+..-..|+.|++++|.+-..--+++.+.-+|+.||+|+|.+. ..|..+ ..+++|+.|++++|
T Consensus         2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~i-t~l~~L~~ln~s~n   78 (1081)
T KOG0618|consen    2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQI-TLLSHLRQLNLSRN   78 (1081)
T ss_pred             CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchh-hhHHHHhhcccchh
Confidence            3577777776 78888877666999999999876322344555666999999999997 889888 67999999999999


Q ss_pred             eeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCCh
Q 036229          189 MFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQ  268 (982)
Q Consensus       189 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~  268 (982)
                      .|. ..|.+..++.+|++|.|.+|++. ..|.++..+.+|++|++++|++. .+|..+..++.++.+..++|...    .
T Consensus        79 ~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~----~  151 (1081)
T KOG0618|consen   79 YIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKI----Q  151 (1081)
T ss_pred             hHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhh----h
Confidence            998 57788899999999999999987 88999999999999999999997 78999999999999999999322    2


Q ss_pred             hhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCC
Q 036229          269 ELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPN  348 (982)
Q Consensus       269 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~  348 (982)
                      .++... ++.++|..|.+.+.++..+..+..  .|||++|++.   -..+.++.+|+.|....|++...     ....++
T Consensus       152 ~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l-----~~~g~~  220 (1081)
T KOG0618|consen  152 RLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL-----EISGPS  220 (1081)
T ss_pred             hhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE-----EecCcc
Confidence            233333 899999999999988888887776  7999999986   23567788899999999988632     223567


Q ss_pred             ccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccE
Q 036229          349 LEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY  428 (982)
Q Consensus       349 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~  428 (982)
                      |+.|+.++|.+....+.  ....+|+++|+++|++++.+ ++.+.+.+|+.+.+.+|+++.++.+.      ....+|+.
T Consensus       221 l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~lp~ri------~~~~~L~~  291 (1081)
T KOG0618|consen  221 LTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVALPLRI------SRITSLVS  291 (1081)
T ss_pred             hheeeeccCcceeeccc--cccccceeeecchhhhhcch-HHHHhcccceEecccchhHHhhHHHH------hhhhhHHH
Confidence            89999999998844332  23568999999999999764 99999999999999999987776553      33455666


Q ss_pred             EEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCC-CCeEEeec
Q 036229          429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQK-LQGLHLED  507 (982)
Q Consensus       429 L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~  507 (982)
                      |.+..|.++.                           +|.....++.|++|+|..|+|...++..|..... |+.|+.+.
T Consensus       292 l~~~~nel~y---------------------------ip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~  344 (1081)
T KOG0618|consen  292 LSAAYNELEY---------------------------IPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSS  344 (1081)
T ss_pred             HHhhhhhhhh---------------------------CCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhh
Confidence            6666665443                           3455666888999999999998555545555444 88999999


Q ss_pred             cCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccccccccc-ccccCceEEecCCCcccCCCc
Q 036229          508 NKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTI-WNLKGMLYLNFSSNFFTGPLP  586 (982)
Q Consensus       508 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~-~~l~~L~~L~Ls~N~l~~~~~  586 (982)
                      |++.......=.....|+.|++.+|+++...-..+.+.++|+.|+|++|+|.++|+.. .++..|+.|+||+|+++ .+|
T Consensus       345 n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp  423 (1081)
T KOG0618|consen  345 NKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLP  423 (1081)
T ss_pred             ccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhh
Confidence            9998443222234678999999999999877677899999999999999999999864 57999999999999999 678


Q ss_pred             cccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccc
Q 036229          587 LDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY  666 (982)
Q Consensus       587 ~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  666 (982)
                      ..+.++..|++|..-+|++. ..| ++..++.|+.+|+|.|+|+...-..-...++|++|||++|.-.-.--..|..+.+
T Consensus       424 ~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~  501 (1081)
T KOG0618|consen  424 DTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKS  501 (1081)
T ss_pred             HHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhh
Confidence            99999999999999999996 466 8999999999999999998554333333389999999999743233455666777


Q ss_pred             cceeecCCC
Q 036229          667 LEDLDLSFN  675 (982)
Q Consensus       667 L~~l~ls~N  675 (982)
                      +...++.-|
T Consensus       502 l~~~~i~~~  510 (1081)
T KOG0618|consen  502 LSQMDITLN  510 (1081)
T ss_pred             hhheecccC
Confidence            777777666

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-36  Score=313.37  Aligned_cols=191  Identities=24%  Similarity=0.390  Sum_probs=161.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccc-------hhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCG-------RAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      ..+.|.+.+.+|+|+||.|-+|. .++|+.||||++.....       .....+++|+++|++++|||||+++++++.++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34678889999999999999997 55799999999975411       12234679999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecC
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGI  926 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGl  926 (982)
                      ..||||||++||+|.+.+-..+ .+.+...+.+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999987654 4777788999999999999999   9999999999999999755   7899999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      |+...   +.....+.+|||.|.|||++.++.+....+..|+||+|+++
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvL  371 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVL  371 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceE
Confidence            99863   34456779999999999999777655555556666666443

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=331.04  Aligned_cols=205  Identities=43%  Similarity=0.682  Sum_probs=177.8

Q ss_pred             ccccCCHHHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeee
Q 036229          766 TCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC  845 (982)
Q Consensus       766 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  845 (982)
                      ..+.|++.++..+|++|...+.||+|+||.||+|..++++.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            46779999999999999999999999999999999988999999988755432145699999999999999999999999


Q ss_pred             cCCC-eeEEEEEeccCCChHHHHhcCCC-cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          846 STEE-FKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       846 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                      .+.+ +.++|+||+++|+|+++++.... .++|..+.+||.++|+||+|||+.+...||||||||+|||+|+++.+||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999997765 889999999999999999999987777899999999999999999999999


Q ss_pred             ecCceeecCCCCceeeccc-ccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          924 FGIAKLLIGEDQSITQTQT-LATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ||+|+..+......  ... .||.+|+|||++..+   ..+.++|+|+||+++
T Consensus       221 FGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g---~lt~KsDVySFGVvl  268 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTG---KLTEKSDVYSFGVVL  268 (361)
T ss_pred             ccCcccCCccccce--eeecCCCCccCChhhhccC---CcCcccccccchHHH
Confidence            99997643211111  112 799999999999664   345678899999755

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=314.89  Aligned_cols=198  Identities=29%  Similarity=0.428  Sum_probs=168.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||+||.++. ++++.+|+|++++.   .....+...+|..++.+++||+||+++-.|++++.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            356899999999999999999985 45999999999755   23456778899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |+||+.||.|..++++.+ .+++..++-++.+|+.||.|||   ++||||||+||+|||+|.+|+++|+|||+|+.... 
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-  177 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-  177 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence            999999999999997654 4899999999999999999999   99999999999999999999999999999996422 


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee--ecccCCCC
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI--FIGRGNYY  982 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~--l~~~~~f~  982 (982)
                       ........+||+.|||||++.+..|+.+.|| |+.|+.++  ++|..|||
T Consensus       178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDW-WsLGillYeML~G~pPF~  226 (357)
T KOG0598|consen  178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDW-WSLGILLYEMLTGKPPFY  226 (357)
T ss_pred             -CCCccccccCCccccChHHHhcCCCCcccch-HhHHHHHHHHhhCCCCCc
Confidence             2233445899999999999999888877554 45555544  44455664

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-36  Score=307.95  Aligned_cols=193  Identities=24%  Similarity=0.325  Sum_probs=165.5

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC-eeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-FKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~E~  857 (982)
                      +.+..+.||+|..|+||+|+++ +++.+|+|++... +....+++.+|++++++.+||+||++||+|..++ ..+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4455678999999999999864 6999999999544 4456789999999999999999999999999998 59999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      |++|+|+++++.. +.+++....+++.+|++||.|||.  +++||||||||+|||++..|+|||||||.++.+.+.    
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            9999999998765 458999999999999999999993  499999999999999999999999999999987433    


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccCCC
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNY  981 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~~f  981 (982)
                      ....++||..|||||.+.+..|+.. .|+|.+|+.++.++.|.|
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~Grf  275 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRF  275 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCC
Confidence            3456899999999999999877755 333455555778888855

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.3e-37  Score=331.00  Aligned_cols=367  Identities=29%  Similarity=0.426  Sum_probs=189.3

Q ss_pred             CCCCCeeeecceeee-cccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceE
Q 036229          177 LPFLESISLSQNMFH-GRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELM  255 (982)
Q Consensus       177 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  255 (982)
                      ||..+-.|+++|.|+ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+...++.|+.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            334444445555544 334555555555555555555554 45555555555555555555554 233333333333333


Q ss_pred             eccccccCC-cCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcC
Q 036229          256 ALQVSNLQG-EIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSL  334 (982)
Q Consensus       256 ~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  334 (982)
                      .+..|++.. -+|+.+..+..|..||||+|+++ ..|..+..-.++-.|+||+|+|. .+|..                 
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~-----------------  144 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNS-----------------  144 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCch-----------------
Confidence            333333321 12333333444444444444443 33333333344444444444443 22211                 


Q ss_pred             CCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccc
Q 036229          335 SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLEL  414 (982)
Q Consensus       335 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  414 (982)
                             .+..+..|-+||||+|++. .+|+.+..+..|++|+|++|.+....-..+                       
T Consensus       145 -------lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQL-----------------------  193 (1255)
T KOG0444|consen  145 -------LFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQL-----------------------  193 (1255)
T ss_pred             -------HHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcC-----------------------
Confidence                   1122233344555555554 344444455555555555555443211111                       


Q ss_pred             cccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccc
Q 036229          415 SFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITL  494 (982)
Q Consensus       415 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  494 (982)
                            ..+++|+.|.+++.+                         +-...+|.++..+.+|..++||.|++. ..|+.+
T Consensus       194 ------PsmtsL~vLhms~Tq-------------------------RTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl  241 (1255)
T KOG0444|consen  194 ------PSMTSLSVLHMSNTQ-------------------------RTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL  241 (1255)
T ss_pred             ------ccchhhhhhhccccc-------------------------chhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence                  122233344444331                         111235556666666666666666665 566666


Q ss_pred             cCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEE
Q 036229          495 GKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL  574 (982)
Q Consensus       495 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L  574 (982)
                      .++++|+.|+||+|+|+ ...-......+|++|+||+|+++ ..|++++.|+.|+.|++.+|+|+.              
T Consensus       242 y~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F--------------  305 (1255)
T KOG0444|consen  242 YKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF--------------  305 (1255)
T ss_pred             hhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc--------------
Confidence            66666666666666666 33333444555666666666665 555666666666666666665551              


Q ss_pred             ecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcC
Q 036229          575 NFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNL  653 (982)
Q Consensus       575 ~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  653 (982)
                              .-+|..++++.+|+.+..++|.+ ...|+.+..+..|+.|.|++|++- ..|+++.-|+.|+.|||..|.=
T Consensus       306 --------eGiPSGIGKL~~Levf~aanN~L-ElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  306 --------EGIPSGIGKLIQLEVFHAANNKL-ELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             --------cCCccchhhhhhhHHHHhhcccc-ccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence                    12344455555555556666666 456777777888888888888876 6777777788888888877753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.9e-36  Score=296.58  Aligned_cols=193  Identities=25%  Similarity=0.298  Sum_probs=161.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|+...++|+|+||+||+|+.+ +|+.||||++...  ++...+-..+|++++++++|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            56888899999999999999954 5999999998533  33445667899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      ||+. ++.+-+......++...++++++|++.|+.|+|   ++++|||||||+||||+.+|.+||||||+|+.+...  .
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--g  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--G  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--c
Confidence            9987 555566666667899999999999999999999   999999999999999999999999999999988543  2


Q ss_pred             eeecccccccccccCceeeee-eeeeEEeeEeeeeeeeeecccC
Q 036229          937 ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ...+.++.|.+|+|||.+-+. .|..+ .+.|+.|+.+..+.+|
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~p-VDiWAiGCv~aEl~~G  198 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKP-VDIWAIGCVFAELLTG  198 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCc-ccchhhhHHHHHHhcC
Confidence            344678999999999999774 45544 4444555555555554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-35  Score=319.05  Aligned_cols=195  Identities=28%  Similarity=0.428  Sum_probs=168.6

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .+|..++.||+|+|+.||+++. .+|+.||+|++++.   .....+.+.+||+|.+.++|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 78999999999763   4556788999999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+|+.++|..+++ .++.+++.++..+++||+.|+.|||   +.+|+|||||..|++++++.++||+|||+|..+..++ 
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            9999999999987 5667999999999999999999999   9999999999999999999999999999999885432 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee--eecccCCC
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM--IFIGRGNY  981 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~--~l~~~~~f  981 (982)
                       ....+.+|||.|+|||++....+++..|. |+.|+++  +++|.-||
T Consensus       173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDi-WSlGcvmYtLL~G~PPF  218 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDI-WSLGCVMYTLLVGRPPF  218 (592)
T ss_pred             -cccceecCCCcccChhHhccCCCCCchhh-hhhhhHHHhhhhCCCCc
Confidence             34456899999999999987777766333 3333333  34444454

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=6e-37  Score=329.90  Aligned_cols=369  Identities=28%  Similarity=0.418  Sum_probs=260.3

Q ss_pred             hhhhhccCCCCC-CchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEcc
Q 036229          228 LKELYLGYSGLQ-GEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLS  306 (982)
Q Consensus       228 L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  306 (982)
                      .+-.|+++|.++ +..|..+..+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-+.+..++.|+.+++.
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence            344566666666 345555555555555555555554 44555555555555555555554 233344444455555555


Q ss_pred             Cccccc-cCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCcc
Q 036229          307 HNKLVG-AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG  385 (982)
Q Consensus       307 ~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~  385 (982)
                      +|++.. -+|..++.+.                         .|+.||||+|++. ..|..+...+++-+|+||+|+|..
T Consensus        87 ~N~LKnsGiP~diF~l~-------------------------dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Iet  140 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIFRLK-------------------------DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIET  140 (1255)
T ss_pred             ccccccCCCCchhcccc-------------------------cceeeecchhhhh-hcchhhhhhcCcEEEEcccCcccc
Confidence            544431 1232333222                         3355555555554 455555555566666666666654


Q ss_pred             ccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccC
Q 036229          386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG  465 (982)
Q Consensus       386 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~  465 (982)
                      ++...|-++                             ..|-+||||+|++..                           
T Consensus       141 IPn~lfinL-----------------------------tDLLfLDLS~NrLe~---------------------------  164 (1255)
T KOG0444|consen  141 IPNSLFINL-----------------------------TDLLFLDLSNNRLEM---------------------------  164 (1255)
T ss_pred             CCchHHHhh-----------------------------HhHhhhccccchhhh---------------------------
Confidence            444444444                             444455555554432                           


Q ss_pred             CCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCC-CCCCcccCCCccccEEEccCCcCCcCCCccccC
Q 036229          466 FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLE-GPIPDDICRLTKLYELGLSGNKLSGSIPACFSN  544 (982)
Q Consensus       466 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  544 (982)
                      +|+.+..+.+|++|.|++|.+...--..+.++++|+.|++++.+=+ ..+|.++..+.+|..+|||.|.+. +.|.++.+
T Consensus       165 LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~  243 (1255)
T KOG0444|consen  165 LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYK  243 (1255)
T ss_pred             cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhh
Confidence            3444555666677777777665443444556778888888876533 468888999999999999999998 88999999


Q ss_pred             CCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccccccc-ccccccccCccCcceEe
Q 036229          545 LASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS-DVIPTVIGGLTNLQYLF  623 (982)
Q Consensus       545 l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~-~~~p~~~~~l~~L~~L~  623 (982)
                      +++|+.|+||+|+|+++..+.....+++.|+||.|+++ .+|.++.+++.|+.|.+.+|+++ .-+|+.++.|.+|+.+.
T Consensus       244 l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~  322 (1255)
T KOG0444|consen  244 LRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFH  322 (1255)
T ss_pred             hhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHH
Confidence            99999999999999998888888889999999999998 78999999999999999999886 44899999999999999


Q ss_pred             cccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC
Q 036229          624 LGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       624 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                      .++|.+. ..|+.+..+..|+.|.|++|++- .+|+++.-++.|+.|||..|+=--.+|+.
T Consensus       323 aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP  381 (1255)
T KOG0444|consen  323 AANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKP  381 (1255)
T ss_pred             hhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCc
Confidence            9999997 89999999999999999999997 68999999999999999999865566654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-36  Score=299.13  Aligned_cols=196  Identities=24%  Similarity=0.383  Sum_probs=164.4

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEe-eecCCCe-eEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVIS-SCSTEEF-KAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~l  853 (982)
                      ..+|++.++||+|+||+||++. ..+|..||.|.+..+  +.+..++...|+.+|++++|||||++++ .+.++.. .++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            3468889999999999999997 568999999998744  4566778899999999999999999998 4444444 899


Q ss_pred             EEEeccCCChHHHHh---cCCCcCCHHHHHHHHHHHHHHHHHHHccCC--CC--eEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          854 ILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDVATTLEYLHFGYS--AP--VIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       854 v~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~--~~--ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      |||||++|+|.+.++   +.++.+++..+++++.|++.||..+|   .  ..  |+||||||.||+++.+|.|||+|||+
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH---~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH---SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh---ccccccceeeccCcchheEEcCCCceeeccchh
Confidence            999999999999887   34567999999999999999999999   5  44  89999999999999999999999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee----eecccCCCC
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM----IFIGRGNYY  982 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~----~l~~~~~f~  982 (982)
                      ++.+...  .......+|||+||+||.+....|++.   +|+|++|+    +...+.|||
T Consensus       175 ~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~k---SDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  175 GRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFK---SDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             HhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcc---hhHHHHHHHHHHHHhcCCCcc
Confidence            9987433  233457899999999999999888866   55566663    445566765

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=289.52  Aligned_cols=194  Identities=28%  Similarity=0.373  Sum_probs=168.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|+..+.+|.|+||.|.+++.+ +|..+|+|+++++.   .+..+...+|..+++.+.||+++++++.+.+.+..|||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            457888999999999999999854 58999999997653   34456678899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||++||.|..++++.+ .+++..++.++.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+...+. 
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999998765 4899999999999999999999   999999999999999999999999999999987322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecc--cCCCC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIG--RGNYY  982 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~--~~~f~  982 (982)
                          .-+.+|||.|+|||++..+.+..+.| ||++|+.++.|.  ..|||
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavD-WWalGVLIYEMlaG~pPF~  242 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVD-WWALGVLIYEMLAGYPPFY  242 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchh-HHHHHHHHHHHHcCCCCCc
Confidence                34689999999999999999987754 567777765554  44665

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.8e-34  Score=281.94  Aligned_cols=197  Identities=26%  Similarity=0.392  Sum_probs=164.3

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|...+++|+|.||.||+|++ .+|+.||||+++....  .......+|++.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5788899999999999999984 5699999999986532  224567889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++. +|+..++.....++..+++.++.++++|++|+|   ++.|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9976 999999998889999999999999999999999   999999999999999999999999999999988655443


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeee-eeecccCCCC
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL-MIFIGRGNYY  982 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~-~~l~~~~~f~  982 (982)
                      .  +..+-|.+|+|||.+.|...+....+.|+.|+. ..++...|||
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f  202 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF  202 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence            3  344889999999998766443333333333333 3445555654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-34  Score=305.08  Aligned_cols=191  Identities=29%  Similarity=0.375  Sum_probs=162.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCC--CeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~  852 (982)
                      ..+.|+..++||+|+||.||+|+ ..+|+.||+|++..+.  .....-..+||.||++++||||+++.+...+.  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            34668888999999999999998 4579999999998654  34455678899999999999999999988766  6899


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +|+|||++ ||.-++....-.+++.+++.+++|++.||+|+|   .+||+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            99999987 998888877778999999999999999999999   99999999999999999999999999999998754


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .. ....+..+.|.+|+|||.+.|...+....+.|+.|+++
T Consensus       271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl  310 (560)
T KOG0600|consen  271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCIL  310 (560)
T ss_pred             CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHH
Confidence            43 33467788999999999998875444444444444443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=309.81  Aligned_cols=189  Identities=30%  Similarity=0.472  Sum_probs=159.3

Q ss_pred             CCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCC-eeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-FKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~E~  857 (982)
                      .....+.+|+|+||+||+|.+.....||||++.....  ...++|.+|+.+|++++|||||+++|+|..+. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3445566999999999999996555599999975432  22569999999999999999999999998887 79999999


Q ss_pred             ccCCChHHHHhc-CCCcCCHHHHHHHHHHHHHHHHHHHccCCCC-eEEcCCCCCCEEEcCCC-cEEEEeecCceeecCCC
Q 036229          858 MPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAP-VIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGED  934 (982)
Q Consensus       858 ~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~-ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~  934 (982)
                      +++|+|.++++. .+..+++..+.+++.|||+||.|||   +++ |||||+||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999988 4678999999999999999999999   888 99999999999999997 99999999998753221


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                        ...+...||+.|||||++.+. ....+.++|+||||+++
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~-~~~~~~K~DvySFgIvl  236 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGE-KSPYTEKSDVYSFGIVL  236 (362)
T ss_pred             --ccccCCCCCccccChhhhcCC-CCcCCccchhhhHHHHH
Confidence              333447899999999999854 33344668888888543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=1.5e-33  Score=289.91  Aligned_cols=196  Identities=22%  Similarity=0.317  Sum_probs=171.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .-+|++.+.+|+|.||+|-+|+. ..|+.||||.++++   +.++.-.+.+|++||..++||||+++|++|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            34788899999999999999984 67999999999754   445566789999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||..+|.|.+|+.+++ .+++.++..+++||+.|+.|+|   .+++||||+|.+|||+|+++.+||+|||++-.+.+  
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--  205 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence            99999999999998765 4899999999999999999999   99999999999999999999999999999987632  


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee--ecccCCC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI--FIGRGNY  981 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~--l~~~~~f  981 (982)
                       .....+++|+|-|.+||++.+.+|.....++|+.|+.+|  ..|+.||
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF  253 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF  253 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc
Confidence             233457899999999999999999888777766666544  3455555

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.98  E-value=3.4e-33  Score=299.86  Aligned_cols=198  Identities=28%  Similarity=0.420  Sum_probs=166.5

Q ss_pred             HHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCee
Q 036229          777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  851 (982)
                      +...+|..++.||+|+|++||+|+ ..++++||||++.+.   ..+..+.+.+|-.+|.+| .||.|++++..|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            445789999999999999999998 456999999998754   234456678899999999 899999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      |+|+||+++|+|.++|++.+ .+++..++.++.||+.|++|||   ++|||||||||+|||+|++|++||+|||.|+.+.
T Consensus       150 YFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            99999999999999998764 4899999999999999999999   9999999999999999999999999999999886


Q ss_pred             CCCCc---------eee--cccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          932 GEDQS---------ITQ--TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       932 ~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      +....         ...  ..++||..|.+||++.....++..| .|++||.+|-|..|
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sD-iWAlGCilyQmlaG  283 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSD-LWALGCILYQMLAG  283 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccc-hHHHHHHHHHHhcC
Confidence            43211         111  4589999999999998877765533 34555555555444

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.5e-34  Score=301.84  Aligned_cols=186  Identities=25%  Similarity=0.333  Sum_probs=158.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhh-hhHHHHHHHhhhcC-CccceeEEeeecCCC-eeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIR-HRNLIKVISSCSTEE-FKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~l  853 (982)
                      ..++|...++||.|+||.||+|+ ..+++.||||.++.+-.... -.=.+|++.+++++ ||||+++.+++.+.+ ..|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45789999999999999999998 55699999999976533222 22367999999998 999999999998887 9999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |||||+. +|.++++.+++.+++.+++.|+.||++||+|+|   ++|+.|||+||||||+.....+||+|||+|+.+.  
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--  161 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR--  161 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc--
Confidence            9999965 999999999999999999999999999999999   9999999999999999988899999999999873  


Q ss_pred             CCceeecccccccccccCceee-eeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFH-VKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~d~~~~~~  973 (982)
                       .....++++.|.+|+|||++. ...|+..   .|+|++|+
T Consensus       162 -SkpPYTeYVSTRWYRAPEvLLrs~~Ys~p---vD~wA~Gc  198 (538)
T KOG0661|consen  162 -SKPPYTEYVSTRWYRAPEVLLRSGYYSSP---VDMWAVGC  198 (538)
T ss_pred             -cCCCcchhhhcccccchHHhhhccccCCc---hHHHHHHH
Confidence             334567899999999999984 4455544   33444443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.98  E-value=1.9e-33  Score=301.02  Aligned_cols=195  Identities=28%  Similarity=0.442  Sum_probs=166.7

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|.+.+.||+|+||.||||+. .+.+.||+|.+++.  .++..+.+.+|++++++++||||+.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5788999999999999999984 46899999999754  34556789999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+.| +|..++...+ .+++.++..++.|++.||.|||   +.+|+|||+||.|||++..|.+|+||||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9976 9999997654 5899999999999999999999   99999999999999999999999999999998633  33


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccCCCC
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRGNYY  982 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~~f~  982 (982)
                      ...+...|||.|||||.+.+.+|+...|. |+.|+.  .++.|+-|||
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDl-WslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDL-WSLGCILYELYVGQPPFY  201 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhH-HHHHHHHHHHhcCCCCch
Confidence            44567889999999999998888866443 233333  3445666776

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=304.09  Aligned_cols=197  Identities=23%  Similarity=0.330  Sum_probs=166.5

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc----cc-hhhhhHHHHHHHhhhcC-CccceeEEeeecCCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ----CG-RAFKSFDVECEMMKSIR-HRNLIKVISSCSTEE  849 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~  849 (982)
                      ...++|...+.||+|+||+|+.|+. .+++.||+|+++.+    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3467899999999999999999974 46899999987654    11 33556778999999998 999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCce
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAK  928 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~  928 (982)
                      ..|+||||+.||+|.+++.+ ...+.+.++.++++|++.|++|+|   ++||+||||||+||+++.+ +.+||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999988 566888999999999999999999   9999999999999999998 999999999999


Q ss_pred             eecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeeeeeecccC
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ...  .........+||+.|+|||++.+.. |.....+.|++|+.++.+.+|
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G  219 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCG  219 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhC
Confidence            763  2233456789999999999998877 665555544444444544444

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.98  E-value=1.1e-32  Score=296.56  Aligned_cols=200  Identities=25%  Similarity=0.350  Sum_probs=166.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|+..+.||+|+||.||+|+. .+|..+|+|++++.   .....+.+..|..+|....+|+||++|-.|++.+++|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            467899999999999999999984 46999999999765   34456778899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||++||++..++...+ .+++..++.++.+++.|++.+|   +.|+|||||||+|+|||..|++||+|||++.-+...
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999997654 5899999999999999999999   999999999999999999999999999998643210


Q ss_pred             ---------------------CCce-----e-------------------ecccccccccccCceeeeeeeeeEEeeEee
Q 036229          934 ---------------------DQSI-----T-------------------QTQTLATIGYMAPGLFHVKYILFVVNFLTS  968 (982)
Q Consensus       934 ---------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~  968 (982)
                                           .+..     .                   ....+|||.|||||++.++.|+...| ||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD-wWS  373 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD-WWS  373 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc-HHH
Confidence                                 0000     0                   01358999999999999998886655 445


Q ss_pred             eeeee--eecccCCCC
Q 036229          969 YSFLM--IFIGRGNYY  982 (982)
Q Consensus       969 ~~~~~--~l~~~~~f~  982 (982)
                      .|+++  +++|..|||
T Consensus       374 LG~ImyEmLvGyPPF~  389 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFC  389 (550)
T ss_pred             HHHHHHHHHhCCCCCC
Confidence            55554  456666775

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=5.5e-32  Score=286.65  Aligned_cols=198  Identities=30%  Similarity=0.427  Sum_probs=163.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC--eeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE--FKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~  855 (982)
                      ..+|...+.||+|+||.||++... +|+..|||.+........+.+.+|+++|++++|||||+++|.....+  ..+++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            456888999999999999999864 48999999998664444677899999999999999999999854444  688999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceeecC-C
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIG-E  933 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~-~  933 (982)
                      ||+++|+|.+++...+..+++..++++.+||++||+|||   ++|||||||||+|||++. ++.+||+|||+|+.... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999876657899999999999999999999   999999999999999999 79999999999997643 1


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ..........||+.|||||++..+.......|+|+.|+.++.|.||
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg  218 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTG  218 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCC
Confidence            1122334578999999999998533332234455666667777776

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=287.55  Aligned_cols=204  Identities=25%  Similarity=0.349  Sum_probs=160.2

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc--------------hhhhhHHHHHHHhhhcCCccce
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG--------------RAFKSFDVECEMMKSIRHRNLI  839 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~nIv  839 (982)
                      -....++|++.+.||+|.||.|-+|+. .+++.||||++++...              ...+++.+||.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            344568899999999999999999985 4599999999964311              1125789999999999999999


Q ss_pred             eEEeeecCC--CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          840 KVISSCSTE--EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       840 ~l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      +++++..+.  +.+|||+|||..|.+.. ....+..+++.++++|+++++.||+|||   .+|||||||||+|+|++++|
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            999998765  58999999999988743 2222223889999999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCceeecCC---CCceeecccccccccccCceeeeee-eeeEEeeEeeeeee----eeecccCCCC
Q 036229          918 VAHLSDFGIAKLLIGE---DQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL----MIFIGRGNYY  982 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~----~~l~~~~~f~  982 (982)
                      +|||+|||.+......   +........+|||.|||||...++. ..+.....|+|++|    ++++|+-||+
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            9999999999876322   1112224478999999999997632 23333344555555    4566777775

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=301.93  Aligned_cols=195  Identities=24%  Similarity=0.316  Sum_probs=167.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|...++||+|+||+|+++..+ +++.+|||+++++   .+++.+..+.|.+|+... +||+++.++.+|+++++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999854 5889999999876   345667788899998877 5999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+.||++..+.  ....+++..+.-|+..|+.||+|||   ++||||||+|.+|||+|.+|++||+|||+++.-..
T Consensus       446 fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            999999999954443  3345899999999999999999999   99999999999999999999999999999997432


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccCC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGN  980 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~~  980 (982)
                        ......+++|||.|||||++.+..|+.+ .+||++|+.+|.|..|.
T Consensus       521 --~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq  565 (694)
T KOG0694|consen  521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGE  565 (694)
T ss_pred             --CCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCC
Confidence              3335678999999999999999988866 55678888876666553

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=1.3e-32  Score=277.99  Aligned_cols=189  Identities=24%  Similarity=0.304  Sum_probs=158.4

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecC--CCe
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCST--EEF  850 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~  850 (982)
                      ++..+.|+..++|++|+||.||+|+++ +++.||+|+++.+..  ...-...+||.++.+++|||||.+-.+...  -+.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            345567888999999999999999954 589999999976532  223456889999999999999999887643  457


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      +|+|||||+. +|...+...++.+...+++.++.|+++|++|||   .+.|+|||+||+|+|+...|.+||+|||+|+.+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999999987 999999988888999999999999999999999   999999999999999999999999999999988


Q ss_pred             cCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      ...  ....+..+.|.+|+|||.+.+.. |+.+   +|+|++|+
T Consensus       228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~---iDMWSvGC  266 (419)
T KOG0663|consen  228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTA---VDMWSVGC  266 (419)
T ss_pred             cCC--cccCcceEEEeeecCHHHhcCCcccCcc---hhhhhHHH
Confidence            443  33456788999999999997653 4433   34455554

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=293.74  Aligned_cols=184  Identities=27%  Similarity=0.384  Sum_probs=163.7

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ...|..-++||+|+.|.||.|+ ..+++.||||.+........+-+.+|+.+|+..+|+|||.+++.|...+..|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4568888999999999999997 556899999999988777778899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++||+|.+.+....  +++.++..|++++++||+|||   .+||+|||||.+|||++.+|.+||+|||++..+..+..  
T Consensus       352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            99999999986544  899999999999999999999   99999999999999999999999999999998754433  


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .....+|||+|||||++..+.|++.   .|+|++|
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~K---VDIWSLG  456 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPK---VDIWSLG  456 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCcc---ccchhhh
Confidence            3456789999999999988888855   4455555

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=294.76  Aligned_cols=190  Identities=29%  Similarity=0.485  Sum_probs=162.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .+.+...+.||+|-||+||.|+++....||+|.++.. ....++|.+|+++|++++|++||+++++|..++.+|||||||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            3445567899999999999999988889999999854 334578889999999999999999999999988999999999


Q ss_pred             cCCChHHHHhc-CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +.|+|.++++. .+..+...+.+.++.||++|++||+   ++++|||||.++||||+++..+||+|||+|+.+ .++...
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~  359 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYT  359 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCcee
Confidence            99999999996 5667888999999999999999999   999999999999999999999999999999954 333444


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeeeec
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFI  976 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~  976 (982)
                      ......-+..|.|||++....++   .++||||||++++
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS---~kSDVWSFGVlL~  395 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFS---SKSDVWSFGVLLW  395 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcc---cccceeehhhhHH
Confidence            44444556789999999766555   5577888886553

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=279.82  Aligned_cols=192  Identities=25%  Similarity=0.350  Sum_probs=162.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..+.|+..+.||.|..++||+|+ .+.++.||||++..+. ....+.+++|+..|+.++||||++++..|..+...|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            45689999999999999999998 5678999999998663 344689999999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      .||.+|++.++++.. ...+++..+..|.+++++||.|||   .+|.||||||+.||||+.+|.|||+|||.+..+.+.+
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999853 345899999999999999999999   9999999999999999999999999999987765443


Q ss_pred             Cce-ee-cccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSI-TQ-TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~-~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ... .. ...+||+.|||||++..... ..+.++|+|+||+
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~-GYdfKaDIwSfGI  220 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLH-GYDFKADIWSFGI  220 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhccc-CccchhhhhhhhH
Confidence            221 12 56789999999999643322 2335566777774

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=294.73  Aligned_cols=203  Identities=25%  Similarity=0.404  Sum_probs=171.7

Q ss_pred             CHHHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC
Q 036229          771 SYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       771 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      +..+++...+.+...+.||+|+||+||+|+|.  ..||||++..+  .....+.|+.|+.++++-+|.||+-+.|||..+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34666677778889999999999999999984  36999999755  345678999999999999999999999999988


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      .. .+|+.+|+|.+|..+++..+..++..+...||+||++|+.|||   .++|||||+|..||++.++++|||+|||++.
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence            87 8999999999999999988888999999999999999999999   9999999999999999999999999999987


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee--eecccC
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM--IFIGRG  979 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~--~l~~~~  979 (982)
                      .-.............|...|||||+++.+...+.+..+|||+||+  |.+.+|
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg  589 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG  589 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence            643322223334556888999999997766666667788888884  444444

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.8e-31  Score=290.79  Aligned_cols=194  Identities=23%  Similarity=0.307  Sum_probs=165.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .+-|+.++.||+|+-|.|..|+. .+|+.+|||++.+.   .......+.+|+.+|+-+.|||++++|++|++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            35688899999999999999984 57999999999755   233456789999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      .||++||.|.+++..++ .+++.++.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+.+||+|||+|..-   .
T Consensus        91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~  163 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE---V  163 (786)
T ss_pred             EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence            99999999999998765 4788899999999999999999   999999999999999999999999999999863   2


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ......+.||+|.|+|||++.|.+|.....+.|.+|++++.+.+|
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG  208 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTG  208 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhC
Confidence            233445689999999999999998877665544444444444444

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=3.7e-31  Score=274.46  Aligned_cols=187  Identities=27%  Similarity=0.344  Sum_probs=156.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCcc-ceeEEeeecCCC-----
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN-LIKVISSCSTEE-----  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~-----  849 (982)
                      ...|+..++||+|+||+||+|+. .+|+.||+|++..+.+  .......+|+.++++++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45577788999999999999984 5689999999986643  35567789999999999999 999999998777     


Q ss_pred             -eeEEEEEeccCCChHHHHhcCC---CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          850 -FKALILEYMPHGSLEKSLYSSN---YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       850 -~~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                       ..++|+||++. +|.+++....   ..++...++.+++|++.|++|||   +++|+||||||+||+|+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             88999999955 9999998765   45777889999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMI  974 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~  974 (982)
                      +|+.+.-+  ....+..++|.+|+|||++.+. .|+..   .|+||+|++
T Consensus       166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~---vDiWs~GcI  210 (323)
T KOG0594|consen  166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTS---VDIWSLGCI  210 (323)
T ss_pred             hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCC---cchHhHHHH
Confidence            99965322  2234567899999999999776 33333   345555543

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-31  Score=278.46  Aligned_cols=191  Identities=28%  Similarity=0.404  Sum_probs=159.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhh--cCCccceeEEeeecCCC----eeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKS--IRHRNLIKVISSCSTEE----FKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~  852 (982)
                      ....+..+.||+|+||.||+|++ +++.||||++..   +..+.|+.|.+|++.  ++|+||++++++-....    ..+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            34456678999999999999998 459999999974   445678889888876  48999999999875554    789


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc------CCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~------~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      +|+||.+.|+|.++++..  .++|.+..+|+..+++||+|||+.      ++.+|+|||||++||||..|+++.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999999754  589999999999999999999953      477999999999999999999999999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeee---EEeeEeeeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILF---VVNFLTSYSFLMIF  975 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~~~~d~~~~~~~l  975 (982)
                      |.++............+||.+|||||++.+...-.   +--..|+|++|+++
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL  414 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL  414 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence            99987665555556689999999999997652221   22346788888654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=1.5e-30  Score=295.97  Aligned_cols=199  Identities=28%  Similarity=0.462  Sum_probs=167.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      ...+....+.||+|+||+||+|+.      ++.+.||||.++..... ...+|++|++++..++|||||+++|+|..++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            345566778999999999999974      23567999999876554 78999999999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcC-------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          851 KALILEYMPHGSLEKSLYSS-------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      .+||+|||..|||.+++...             +..++..+.+.||.|||.||+||-   ++.+|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence            99999999999999999842             123778899999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee-----ecccCCCC
Q 036229          918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI-----FIGRGNYY  982 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~-----l~~~~~f~  982 (982)
                      .|||+|||+++.+...+.+.......-..+|||||.+..+.++   ..+|||++|++     -+|.-|||
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT---teSDVWs~GVvLWEIFsyG~QPy~  707 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT---TESDVWSFGVVLWEIFSYGKQPYY  707 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc---chhhhhhhhhhhhhhhccccCccc
Confidence            9999999999987666655554455667899999999777666   44666777743     34566665

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-32  Score=262.18  Aligned_cols=194  Identities=22%  Similarity=0.430  Sum_probs=162.6

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .+.|++.+.||+|.|+.||++. .++|+.+|+|++...  .....+++.+|++|.+.++||||+++.+.+...+..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            4678899999999999999997 457999999998643  3346788999999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~~  932 (982)
                      |++.|++|..-+-++ ..+++..+-.+++||++|+.|+|   .+||||||+||+|+++.   ....+|++|||+|..+. 
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999997666544 45788899999999999999999   99999999999999995   34479999999999885 


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee----eecccCCCC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM----IFIGRGNYY  982 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~----~l~~~~~f~  982 (982)
                        ........+|||+|||||++...+|+.+.   |+|++|+    ++.|.-|||
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpv---DiW~cGViLfiLL~G~~PF~  213 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPV---DIWACGVILYILLVGYPPFW  213 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcc---hhhhhhHHHHHHHhCCCCCC
Confidence              22334568899999999999998888773   3455553    344566665

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=7.5e-31  Score=271.04  Aligned_cols=180  Identities=28%  Similarity=0.417  Sum_probs=143.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC-----eeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-----FKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~l  853 (982)
                      -.|+..+.+|.|+||.||+|+.. ++++||||++-.+.+    --.+|.++|+.++|||||++.-+|....     +..+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35777899999999999999854 479999999864422    2246999999999999999988874322     3458


Q ss_pred             EEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCcee
Q 036229          854 ILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKL  929 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~  929 (982)
                      ||||++. +|.+.++.   .+..++...++-+.+|+.+|+.|||   +.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999976 99998874   2456788888999999999999999   9999999999999999965 9999999999998


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYS  970 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~  970 (982)
                      +.....   ...+..|..|+|||.+.+........|.|+.|
T Consensus       176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaG  213 (364)
T KOG0658|consen  176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAG  213 (364)
T ss_pred             eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhh
Confidence            854433   24577899999999996653333333333333

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.6e-31  Score=255.14  Aligned_cols=194  Identities=26%  Similarity=0.356  Sum_probs=163.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++++.||+|.||.||.|+. +++-.||+|++.+.   ......++.+|++|-+.++||||.++|++|.+....|+
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            356899999999999999999984 46889999998644   23445788999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          854 ILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ++||...|++...+... ...+++.....++.|+|.|+.|+|   .+++|||||||+|+|++.++.+||+|||-+..-+ 
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999999843 335888889999999999999999   9999999999999999999999999999988642 


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee----eeecccCCC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL----MIFIGRGNY  981 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~----~~l~~~~~f  981 (982)
                         .......+||..|.|||+..+..++..   .|+|++|    .++.|..||
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~---Vd~w~lgvl~yeflvg~ppF  222 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKF---VDLWSLGVLCYEFLVGLPPF  222 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccch---hhHHHHHHHHHHHHhcCCch
Confidence               223356789999999999988877644   4555555    344455555

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-31  Score=282.21  Aligned_cols=186  Identities=27%  Similarity=0.335  Sum_probs=158.9

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..|+..+.||.|+||.||-|++ .+.+.||||++....   ...+.++.+|++++++++|||++.+-|+|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            3467778999999999999985 468889999987543   334677889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||- |+-.|++.-.++++.+.++..|..+.+.||.|||   +.+.||||||+.|||+++.|.|||+|||.|....    
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----  177 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----  177 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence            9995 5888888877788999999999999999999999   9999999999999999999999999999998652    


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                        +...++|||+|||||++....-+..++..|+|++|+.+
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITC  215 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC  215 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchh
Confidence              23468999999999998544334445667777777543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=5.6e-30  Score=266.93  Aligned_cols=199  Identities=22%  Similarity=0.322  Sum_probs=165.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .+.|+..+.||+|.-|+||+|+..+ +..+|+|+++++   ..+...+++.|.+||+.++||+++.+|+.++.+.+.|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3467788999999999999999654 689999999865   344556788899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC-
Q 036229          855 LEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG-  932 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~-  932 (982)
                      ||||+||+|....+++ .+.+++..++.++.+++-||+|||   -.|||+||+||+||||.++|++-|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999988754 457899999999999999999999   99999999999999999999999999998764311 


Q ss_pred             --------------------------------CCC---------------------ceeecccccccccccCceeeeeee
Q 036229          933 --------------------------------EDQ---------------------SITQTQTLATIGYMAPGLFHVKYI  959 (982)
Q Consensus       933 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  959 (982)
                                                      ...                     ......++||-.|.|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                     011234679999999999999888


Q ss_pred             eeEEeeEeeeeeee--eecccCCC
Q 036229          960 LFVVNFLTSYSFLM--IFIGRGNY  981 (982)
Q Consensus       960 ~~~~~~~d~~~~~~--~l~~~~~f  981 (982)
                      +.+ .+||.+|+.+  +++|+.||
T Consensus       313 gsA-VDWWtfGIflYEmLyG~TPF  335 (459)
T KOG0610|consen  313 GSA-VDWWTFGIFLYEMLYGTTPF  335 (459)
T ss_pred             Cch-hhHHHHHHHHHHHHhCCCCc
Confidence            866 4455666654  55566665

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-30  Score=285.15  Aligned_cols=196  Identities=24%  Similarity=0.426  Sum_probs=165.3

Q ss_pred             CCCccceeeeeceEEEEEEEeCC----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ...+.++||.|.||+||+|+++.    ...||||.++.. ..+.+.+|..|+.||.++.||||+++.|+.......++|+
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            44678999999999999998642    466999999865 4566789999999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||++|+|+.++++....+++.+...++++|+.|++||-   +.++|||||.++|||++.+..+|++|||+++.+.++.+
T Consensus       710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999999998888999999999999999999999   99999999999999999999999999999998754432


Q ss_pred             c-eeecccccccccccCceeeeeeeeeEEeeEeeeeee-----eeecccCCCC
Q 036229          936 S-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL-----MIFIGRGNYY  982 (982)
Q Consensus       936 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~-----~~l~~~~~f~  982 (982)
                      . .+...-.-..+|.|||.+....++.+   +|+||+|     ++-+|++|||
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsA---SDVWSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSA---SDVWSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCch---hhccccceEEEEecccCCCccc
Confidence            1 12122223468999999977777655   4455555     3457888886

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-30  Score=273.99  Aligned_cols=189  Identities=24%  Similarity=0.405  Sum_probs=163.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .+...+.++||+|.||+|.+|....+..||||..+.... ....+|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            345678899999999999999987789999999986644 4458999999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcC-CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSNYIL-DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~-~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++|+|.+++.+...+. +.....+|+.||+.|++||.   +-++||||+.++|+|+|.++++||+|||+++.+...+.+
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999998764333 55566789999999999999   999999999999999999999999999999977666666


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......+-..+|||||.+..+..+.+   +|+|+||+
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFtta---SDvWafgv  727 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTA---SDVWAFGV  727 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccch---hhhhhhHH
Confidence            66666777889999999976666644   56677764

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-29  Score=277.91  Aligned_cols=191  Identities=27%  Similarity=0.404  Sum_probs=157.1

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEeCC--C---eEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeec
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARIGE--G---MEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCS  846 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  846 (982)
                      ++...++....++||+|+||.||+|++..  +   ..||||..+..   ......++.+|+++|++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34445566667999999999999998532  2   23899998752   3566788999999999999999999999999


Q ss_pred             CCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       847 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      .+...++|||+|.||+|.+++++.+..++..++.+++.+.|.||+|||   ++++|||||.++|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            999999999999999999999988777999999999999999999999   99999999999999999999999999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++.-.  ..........-...|+|||.+....+++.   +|+|+||+
T Consensus       309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~k---TDV~sfGV  350 (474)
T KOG0194|consen  309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFK---TDVWSFGV  350 (474)
T ss_pred             ccCCc--ceeeccccccCcceecChhhhccCccccc---cchhheee
Confidence            88531  11111112235678999999988766655   44445553

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=281.93  Aligned_cols=195  Identities=29%  Similarity=0.457  Sum_probs=163.2

Q ss_pred             CCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC------eeE
Q 036229          781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------FKA  852 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~  852 (982)
                      -|...+.||+|+||.||+|+ ..+|+.||||.++.. .....+.+.+|++++++++|||||++++.-++..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            45667899999999999999 556999999999754 3445678899999999999999999998765543      567


Q ss_pred             EEEEeccCCChHHHHhcC--CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCC--cEEEEeecC
Q 036229          853 LILEYMPHGSLEKSLYSS--NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFGI  926 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kL~DFGl  926 (982)
                      +|||||.||||...+.+.  ...+++.+...+..+++.||.|||   ++|||||||||.||++-  .+|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999999854  346899999999999999999999   99999999999999984  333  679999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccCCC
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNY  981 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~~f  981 (982)
                      |+.+.++.   .....+||+.|.|||++....++.++.|.|++|+.+|..+||.+
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l  222 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL  222 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence            99874333   45678999999999999854444466777778887888888865

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=261.69  Aligned_cols=187  Identities=28%  Similarity=0.323  Sum_probs=155.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEee--cccchhhhhHHHHHHHhhhcCCccceeEEeeecC-----CC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST-----EE  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~  849 (982)
                      ...+|...+.||+|+||.|+.|.. .+|+.||||++.  .+.....++..+|+++++.++|+||+.+.+.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            445677789999999999999985 468999999987  4455567888999999999999999999998865     34


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..|+|+|+| +.+|.+.++..+ .++...+..+++|+++||+|+|   +.+|+|||+||+|++++.+..+||+|||+|+.
T Consensus       100 DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence            789999999 559999997654 4888899999999999999999   99999999999999999999999999999998


Q ss_pred             ecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFL  972 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~  972 (982)
                      ..........++++.|.+|.|||++.. ..|+.+   +|+||+|
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~a---iDiWSvG  215 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKA---IDIWSVG  215 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccch---hhhhhhh
Confidence            754333444578899999999999843 344433   3445555

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=265.60  Aligned_cols=191  Identities=26%  Similarity=0.430  Sum_probs=154.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhh--cCCccceeEEeeecCCC----eeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKS--IRHRNLIKVISSCSTEE----FKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~  852 (982)
                      ..+....+.||+|.||+||+|+| .|+.||||++...   +...+.+|.+|++.  ++|+||..+++.-..++    .+|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            45677889999999999999999 6899999999743   34567889999876  49999999998754432    689


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHc-----cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF-----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~-----~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      +|++|.+.|||.|++.+  ..++.....+++..+|.||++||.     ..+..|.|||||++||||..++.+.|+|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            99999999999999976  468999999999999999999993     34778999999999999999999999999999


Q ss_pred             eeecCCCC--ceeecccccccccccCceeeeee---eeeEEeeEeeeeeeeee
Q 036229          928 KLLIGEDQ--SITQTQTLATIGYMAPGLFHVKY---ILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       928 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~d~~~~~~~l  975 (982)
                      ........  .......+||.+|||||++...-   ....-...|+|+||+++
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl  416 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL  416 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence            98754422  23346789999999999985431   11111345677777544

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-30  Score=272.25  Aligned_cols=191  Identities=30%  Similarity=0.404  Sum_probs=163.4

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..|+..+.||+|+||.||+|.+ .+++.||+|+++.+ .....+++++|+.++.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577789999999999999985 45899999999866 345568899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      |.||++.+.++... .+++..+.-++++++.|+.|+|   .++.+|||||+.||++..+|.+|++|||.+..+.....  
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            99999999997654 3477788889999999999999   99999999999999999999999999999998754332  


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ....++|||.|||||++.+..|+..   .|+||+|  .+.+++|
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~K---ADIWSLGITaiEla~G  207 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTK---ADIWSLGITAIELAKG  207 (467)
T ss_pred             ccccccccccccchhhhccccccch---hhhhhhhHHHHHHhcC
Confidence            2267899999999999997667655   4445555  5666665

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.96  E-value=8.4e-29  Score=279.66  Aligned_cols=174  Identities=22%  Similarity=0.333  Sum_probs=149.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++..   .......+.+|+++++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4578999999999999999999864 5889999998643   22234567889999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+|......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999998654  4788899999999999999999   999999999999999999999999999999876322


Q ss_pred             CCceeecccccccccccCceeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVK  957 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~  957 (982)
                      . ........||+.|||||++.+.
T Consensus       196 ~-~~~~~~~~gt~~Y~aPE~~~~~  218 (370)
T cd05621         196 G-MVRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             C-ceecccCCCCcccCCHHHHhcc
Confidence            2 1222456799999999999654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=5.4e-29  Score=281.54  Aligned_cols=186  Identities=24%  Similarity=0.330  Sum_probs=155.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|+..+.||+|+||+||+|+.. +++.||+|+++...   ......+..|++++++++||+|+++++++.++...|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999854 58999999997532   233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999997643 5889999999999999999999   99999999999999999999999999999876432110


Q ss_pred             c---------------------------------eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 S---------------------------------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .                                 ......+||+.|+|||++.+..++..   +|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~---~DvwSlG  223 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL---CDWWSLG  223 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc---hhhhhhH
Confidence            0                                 00123579999999999987766644   4455555

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=7.5e-29  Score=263.05  Aligned_cols=189  Identities=26%  Similarity=0.396  Sum_probs=155.1

Q ss_pred             cceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          785 NNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      .+.+|.|.||+||-|+. ++|+.||||++++.  ..+...++++|+.|++.+.||.||.+...|++.+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            58999999999999984 56999999999754  2344578999999999999999999999999999999999999654


Q ss_pred             ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecCceeecCCCCcee
Q 036229          862 SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       862 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      =|+-++...+..+++...+.+..||+.||.|||   -++|||+|+||+|||+...   ..+||||||+|+.+..   ...
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksF  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSF  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hhh
Confidence            444445556667899888999999999999999   9999999999999999633   4899999999998732   223


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccCC
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGN  980 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~~  980 (982)
                      ....+|||.|.|||+++.+.|.+.-|+| ..|+.+|....|-
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMW-SVGVIiYVsLSGT  763 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMW-SVGVIIYVSLSGT  763 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccce-eeeEEEEEEeccc
Confidence            3568899999999999999888775543 3444444444443

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.96  E-value=7e-30  Score=250.72  Aligned_cols=200  Identities=27%  Similarity=0.391  Sum_probs=161.4

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeeccc--------chhhhhHHHHHHHhhhc-CCccceeEEeee
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSI-RHRNLIKVISSC  845 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  845 (982)
                      ...-.+|...+.+|.|..++|.+|. ..+|+++|+|++....        ....+.-.+|+.|++++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3445678899999999999999986 4568999999986431        12234567799999998 799999999999


Q ss_pred             cCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       846 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      +.+...++|+|.|+.|.|.|++.+.- .+++....+|++|+..|++|||   .++|||||+||+|||+|++..+||+|||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999997643 5889999999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeee---eeEEeeEeeeeeeee----ecccCCCC
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYI---LFVVNFLTSYSFLMI----FIGRGNYY  982 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~d~~~~~~~----l~~~~~f~  982 (982)
                      +|+.+..+   ......+|||+|.|||.+.-.-+   .......|.|++|++    +.|..|||
T Consensus       169 Fa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  169 FACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             eeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            99987443   33467899999999999853311   111122345555543    34566775

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=279.99  Aligned_cols=195  Identities=23%  Similarity=0.295  Sum_probs=156.7

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+. .+++.||||++...   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4789999999999999999985 46899999998643   2234567888999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.+.....
T Consensus        81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            999999999998754 35788899999999999999999   99999999999999999999999999999964321100


Q ss_pred             c---------------------------------------------eeecccccccccccCceeeeeeeeeEEeeEeeee
Q 036229          936 S---------------------------------------------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYS  970 (982)
Q Consensus       936 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~  970 (982)
                      .                                             ......+||+.|+|||++.+..++... ++|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-DiwSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC-DWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce-eeEecc
Confidence            0                                             000124699999999999777666442 233444


Q ss_pred             eeeeecccC
Q 036229          971 FLMIFIGRG  979 (982)
Q Consensus       971 ~~~~l~~~~  979 (982)
                      +.++.+.+|
T Consensus       236 vil~elltG  244 (377)
T cd05629         236 AIMFECLIG  244 (377)
T ss_pred             hhhhhhhcC
Confidence            444444444

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-29  Score=273.98  Aligned_cols=194  Identities=24%  Similarity=0.368  Sum_probs=164.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc---hhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  852 (982)
                      ....|+..+.||+|.||.||+|+.+ +|+.+|+|++++...   ...+.+.+|+++|+++. ||||+++++++++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567899999999999999999865 499999999976533   24468999999999998 999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC----CCcEEEEeecCce
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDFGIAK  928 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kL~DFGla~  928 (982)
                      +|||+|.||.|.+.+.+.  .+++..+..++.|++.|++|+|   +.||+|||+||+|+|+..    ++.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999876  3899999999999999999999   999999999999999963    3589999999999


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee----eeecccCCCC
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL----MIFIGRGNYY  982 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~----~~l~~~~~f~  982 (982)
                      ....   .......+||++|+|||++....|+..   .|+|++|    +++.|..|||
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~---~DiWS~Gvi~yiLL~G~~PF~  239 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDE---VDVWSIGVILYILLSGVPPFW  239 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcc---cchhHHHHHHHHHhhCCCCCc
Confidence            8744   334567899999999999987766655   4455555    3344444765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.7e-30  Score=273.05  Aligned_cols=175  Identities=26%  Similarity=0.409  Sum_probs=150.0

Q ss_pred             CCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          781 RFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      .....+-+|.|+.|.||+|++ .++.||||+++.       .-..+|+-|++++||||+.+.|+|.....+|||||||+.
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             HhhhhhhhccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            344568899999999999998 578999998762       224578889999999999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |-|...++..+ .+.......|..+||.|+.|||   .+.|||||+|.-||||..+..|||+|||.++...+   ..+..
T Consensus       197 GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkM  269 (904)
T KOG4721|consen  197 GQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKM  269 (904)
T ss_pred             ccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhh
Confidence            99999998765 4677778899999999999999   99999999999999999999999999999997632   24556


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .++||..|||||++++++..   .+.|+|+||+
T Consensus       270 SFaGTVaWMAPEvIrnePcs---EKVDIwSfGV  299 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCS---EKVDIWSFGV  299 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcc---cccceehhHH
Confidence            78999999999999887655   4455666664

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=1.7e-28  Score=279.24  Aligned_cols=195  Identities=20%  Similarity=0.268  Sum_probs=156.5

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999854 58999999986432   233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC-
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED-  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-  934 (982)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|..+.... 
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999997643 5788888999999999999999   9999999999999999999999999999985321000 


Q ss_pred             ----------------------------------------CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          935 ----------------------------------------QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       935 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                                                              ........+||+.|||||++.+..++... ++|++|+.++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC-DWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce-eeeeccceee
Confidence                                                    00011235799999999999877666442 3334444454


Q ss_pred             ecccC
Q 036229          975 FIGRG  979 (982)
Q Consensus       975 l~~~~  979 (982)
                      .+.+|
T Consensus       236 ell~G  240 (376)
T cd05598         236 EMLVG  240 (376)
T ss_pred             ehhhC
Confidence            44444

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.96  E-value=1.1e-28  Score=275.01  Aligned_cols=182  Identities=24%  Similarity=0.317  Sum_probs=155.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367899999999999999999864 58999999997532   23446788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++..... 
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            99999999999987643 4788889999999999999999   999999999999999999999999999999875322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                          .....||+.|+|||++.+..++..   +|+|++|
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  202 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKA---VDWWTMG  202 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCc---ceeechH
Confidence                123579999999999987766543   4455555

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-31  Score=260.57  Aligned_cols=191  Identities=24%  Similarity=0.330  Sum_probs=164.1

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      -|.+.+++|+|+||.||+|.. ..|+.||||.+..+  ...+++.+|+.+|++++.|++|++||.|......|+|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            467788999999999999975 46999999998754  346788999999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      .|+..++++.+++++.+.++..+++..++||+|||   ...-||||||+.|||+..+|.+|++|||.|..+.+.  ....
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR  186 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence            99999999999999999999999999999999999   788899999999999999999999999999987433  3334


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ....|||.|||||++..-.|...+| +|+.|+..+.++.|
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~AD-IWSLGITaIEMAEG  225 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKAD-IWSLGITAIEMAEG  225 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhh-HhhhcchhhhhhcC
Confidence            5678999999999997776665533 23444445666655

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=279.17  Aligned_cols=186  Identities=24%  Similarity=0.338  Sum_probs=154.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...   ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999864 58999999997532   233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987644 5899999999999999999999   99999999999999999999999999999876532110


Q ss_pred             ce------------------------------------eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SI------------------------------------TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ..                                    .....+||+.|+|||++.+..++..   +|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlG  226 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---CDWWSLG  226 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe---eeeecch
Confidence            00                                    0112469999999999977666544   4445555

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.96  E-value=1.3e-28  Score=275.00  Aligned_cols=189  Identities=23%  Similarity=0.270  Sum_probs=156.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC--CeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE--GMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+...  +..||+|++...   .....+.+.+|+++++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999997533  468999998643   22345678889999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999997654 5889999999999999999999   999999999999999999999999999999875321


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                           .....||+.|||||++.+..++..   +|+|++|  ++.+.+|
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlGvil~ell~G  224 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKA---ADWWTLGIFIYEILVG  224 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCcc---ccccchhhHHHHHhcC
Confidence                 234579999999999977655543   3445555  4444333

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=1.7e-28  Score=279.22  Aligned_cols=145  Identities=21%  Similarity=0.336  Sum_probs=130.6

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .|+..+.||+|+||+||+|+. .+++.||+|+++...   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999985 458999999997542   2345678899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999987644 4788889999999999999999   99999999999999999999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.8e-30  Score=294.77  Aligned_cols=203  Identities=24%  Similarity=0.336  Sum_probs=171.1

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      ++.-..++|.+.+.||+|+||.|..++. .+++.||+|++.+.   ......-|..|.++|..-+.+-|++++-+|+++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            3444567899999999999999999985 46899999998753   2334567888999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      +.|+|||||+||+|-.++.+.. .+++..++.|+.+|+.||.-+|   +.|+|||||||+|||+|..|++||+|||.+..
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999998776 6899999999999999999999   99999999999999999999999999999988


Q ss_pred             ecCCCCceeecccccccccccCceee----e-eeeeeEEeeEeeeeee--eeecccCCCC
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFH----V-KYILFVVNFLTSYSFL--MIFIGRGNYY  982 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~~~~d~~~~~--~~l~~~~~f~  982 (982)
                      +..++ .......+|||.|++||++.    + +.|+...||| +.|+.  .+++|+.|||
T Consensus       225 m~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW-SlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  225 MDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW-SLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             cCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchh-hhHHHHHHHHcCCCcch
Confidence            75443 34456789999999999984    2 3455454443 33333  5678999998

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=2.3e-28  Score=271.87  Aligned_cols=185  Identities=24%  Similarity=0.316  Sum_probs=152.2

Q ss_pred             ceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          786 NLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.||+|+||.||+|+. .+++.||+|+++...   ......+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4799999999999985 468999999997542   233456788999999999999999999999999999999999999


Q ss_pred             ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecc
Q 036229          862 SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ  941 (982)
Q Consensus       862 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  941 (982)
                      +|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....  ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence            9999887543 5789999999999999999999   999999999999999999999999999998853221  122234


Q ss_pred             cccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          942 TLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       942 ~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ..||+.|+|||++.+..++..   +|+|++|  ++.+.+|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~---~DiwSlG~il~elltg  191 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCG  191 (323)
T ss_pred             eecCccccChhhhcCCCCCcc---ccCcccchhhhhhhcC
Confidence            679999999999987766644   3444444  4444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-29  Score=254.34  Aligned_cols=197  Identities=24%  Similarity=0.311  Sum_probs=167.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|...+.+|+|.||+|.+|+- .+++.+|+|+++++.   +.....-..|-++++..+||++..+--.|+..++.|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            46788899999999999999984 569999999998663   33344556799999999999999999899999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+.||.|.-++.+. +.+++..+..+..+|+.||.|||   +++||.||+|.+|.++|.+|++||+|||+++.-  ..
T Consensus       247 MeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IK  320 (516)
T ss_pred             EEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc--cc
Confidence            9999999998888654 45888888899999999999999   999999999999999999999999999999853  23


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee--ecccCCCC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI--FIGRGNYY  982 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~--l~~~~~f~  982 (982)
                      ...+...++|||.|.|||++....|..+.| ||+.|++||  +.|+-|||
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVD-WWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVD-WWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceee-hhhhhHHHHHHHhccCccc
Confidence            444567899999999999999888887644 556666654  44556776

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=3e-29  Score=271.95  Aligned_cols=186  Identities=24%  Similarity=0.359  Sum_probs=162.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCe-eEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF-KALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv  854 (982)
                      .++|...+.+|+|+||.++.++.+ +++.||+|.+...  ....+....+|+.++++++|||||.+.+.|..++. .++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367899999999999999999743 5788999999755  34445578899999999999999999999999887 9999


Q ss_pred             EEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          855 LEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |+||+||++.+.+.+.+ ..+++..+..++.|++.|+.|||   +++|+|||||+.||+++.++.|||+|||+|+.+..+
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998765 67899999999999999999999   999999999999999999999999999999988544


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .  ......+||+.||+||++.+.+|....|   +|++|
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSD---iWsLG  193 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSD---IWSLG  193 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCc---chhhc
Confidence            3  2345688999999999999999886644   44444

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.95  E-value=6.9e-29  Score=278.32  Aligned_cols=191  Identities=25%  Similarity=0.391  Sum_probs=153.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCC-
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE-  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-  848 (982)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|+++... ....+.+.+|+++++.+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            457899999999999999999963      235689999987442 23456788999999999 899999999988764 


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------------------------------------------------------
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------------------------------------------------------  871 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------  871 (982)
                      +..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46889999999999999987432                                                         


Q ss_pred             ----CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccc
Q 036229          872 ----YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG  947 (982)
Q Consensus       872 ----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  947 (982)
                          ..+++.++..++.|+++||+|||   ++||+||||||+||++++++.+||+|||+++...............+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                23677788899999999999999   99999999999999999999999999999987543322222233456788


Q ss_pred             cccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          948 YMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       948 y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |||||++.+..++.   .+|+|++|++
T Consensus       242 y~aPE~~~~~~~~~---~sDiwslG~i  265 (338)
T cd05102         242 WMAPESIFDKVYTT---QSDVWSFGVL  265 (338)
T ss_pred             ccCcHHhhcCCCCc---ccCHHHHHHH
Confidence            99999997765553   4566777754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=2.9e-28  Score=275.64  Aligned_cols=194  Identities=22%  Similarity=0.267  Sum_probs=157.6

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCC
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      .+.....++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344456689999999999999999999865 5889999998642   223345577899999999999999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      +..++||||+++|+|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            9999999999999999998654  3788888999999999999999   9999999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeee-eeEEeeEeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYI-LFVVNFLTSYSFL  972 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~d~~~~~  972 (982)
                      ...... ........||+.|||||++.+... ...+..+|+|++|
T Consensus       191 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlG  234 (371)
T cd05622         191 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG  234 (371)
T ss_pred             EcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehh
Confidence            763322 122245679999999999865421 1122334555555

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.95  E-value=2.8e-28  Score=277.90  Aligned_cols=145  Identities=21%  Similarity=0.350  Sum_probs=130.5

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      +|+..+.||+|+||.||+|+. .+++.||+|++....   ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            688999999999999999985 458899999987542   2345678899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+|||+|..
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999987643 5788889999999999999999   99999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-29  Score=264.28  Aligned_cols=195  Identities=24%  Similarity=0.288  Sum_probs=169.3

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .+-|...+.||+|.|++|-+|+ .-+|+.||||++++.  +......+.+|++.|+-++|||||++|++......+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4568888999999999999997 458999999999865  3344567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~  934 (982)
                      |.-++|+|.+||-+....+.+.-+++++.||+.|+.|+|   +..+||||+||+||++- .-|-|||.|||++-.+.+. 
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-  172 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-  172 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence            999999999999988888999999999999999999999   99999999999999875 6689999999999887433 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                        ...+..+|+..|.|||++.+..|+.++.++|..|+++|++.+|
T Consensus       173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCG  215 (864)
T KOG4717|consen  173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCG  215 (864)
T ss_pred             --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhC
Confidence              3446789999999999999998888877766666665554443

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=5.3e-28  Score=270.11  Aligned_cols=172  Identities=24%  Similarity=0.363  Sum_probs=150.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|+.+++.++||+|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999854 58999999997542   234566888999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876567899999999999999999999   99999999999999999999999999999987643322


Q ss_pred             ceeecccccccccccCceee
Q 036229          936 SITQTQTLATIGYMAPGLFH  955 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~  955 (982)
                       .......||+.|+|||++.
T Consensus       158 -~~~~~~~gt~~y~aPE~~~  176 (330)
T cd05601         158 -VNSKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             -eeeecccCCccccCHHHhc
Confidence             2223457899999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=4.6e-28  Score=273.79  Aligned_cols=195  Identities=24%  Similarity=0.319  Sum_probs=158.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...   ......+..|++++..++||+|+++++++.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999864 58999999997432   234567788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987543 4789999999999999999999   99999999999999999999999999999875422110


Q ss_pred             c---------------------------------eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          936 S---------------------------------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       936 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      .                                 ......+||+.|+|||++.+..++... ++|++|+.++.+.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~-DiwSlGvilyel~tG  232 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC-DWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcc-eeccccceeeecccC
Confidence            0                                 001235799999999999877666543 334445545555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=3.2e-28  Score=272.10  Aligned_cols=182  Identities=25%  Similarity=0.405  Sum_probs=155.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999865 58999999997542   234467888999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||+|.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997543 5788899999999999999999   99999999999999999999999999999986532   


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~---~DvwslG~  186 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFT---VDYWSLGC  186 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCc---cceecchH
Confidence              2235679999999999987755544   45566553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.7e-29  Score=271.08  Aligned_cols=182  Identities=26%  Similarity=0.355  Sum_probs=155.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999865 58999999987432   234566888999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999997654 5788899999999999999999   999999999999999999999999999999865321  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....||+.|+|||++.+..++.   .+|+|++|+
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~  186 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNK---AVDWWALGI  186 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCc---hhhHHHHHH
Confidence               12356899999999997766553   355666663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=2.2e-28  Score=268.21  Aligned_cols=195  Identities=28%  Similarity=0.375  Sum_probs=168.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ....|.+.+.||+|.|++|..|+. .++..||||.+++..  ......+.+|+++|+.++|||||+++.+.+.+...|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            457899999999999999999984 469999999998653  23345588999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+.+|.+++++.+.+. ..+..+..++.|++.|++|+|   +++|||||||++||+++.+..+||+|||++..+.   
T Consensus       134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---  206 (596)
T ss_pred             EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---
Confidence            999999999999987765 445888999999999999999   9999999999999999999999999999999874   


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ........+|++.|+|||++.+..|.....+.|+.++.+|.+..|
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~G  251 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEG  251 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeec
Confidence            233445689999999999999998877766666666666655554

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=269.30  Aligned_cols=190  Identities=27%  Similarity=0.393  Sum_probs=162.6

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChH
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLE  864 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~  864 (982)
                      -++|+|.||+||-|++. +...+|||.+...+....+-+..|+.+-++++|.|||+++|.+..++++-+.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            47999999999999954 46779999998777777788899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcC--CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCceeecCCCCceeecc
Q 036229          865 KSLYSSNYIL--DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQ  941 (982)
Q Consensus       865 ~~l~~~~~~~--~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~  941 (982)
                      ++++..-+++  .+.+.-.+.+||++||+|||   ++.|||||||-+||||+ -.|.+||+|||.++.+.+-..  ...+
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccc
Confidence            9999876666  77888889999999999999   99999999999999996 689999999999998743322  2345


Q ss_pred             cccccccccCceeeee-eeeeEEeeEeeeeeeeeecccCC
Q 036229          942 TLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMIFIGRGN  980 (982)
Q Consensus       942 ~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~l~~~~~  980 (982)
                      +.||..|||||++..+ .....+.++|++|+.++.|+||.
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGr  775 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGR  775 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCC
Confidence            7799999999999544 33334456667777788888774

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=6.4e-28  Score=268.63  Aligned_cols=178  Identities=24%  Similarity=0.333  Sum_probs=149.3

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.||+|+||.||+|+.. +++.||+|++...   .......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999854 5899999999754   2234567788999999999999999999999999999999999999


Q ss_pred             ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecc
Q 036229          862 SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ  941 (982)
Q Consensus       862 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  941 (982)
                      +|.+++... ..+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            999888654 35889999999999999999999   999999999999999999999999999998853221  122234


Q ss_pred             cccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          942 TLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       942 ~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ..||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~---~DiwslG  182 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRA---VDWWGLG  182 (328)
T ss_pred             ccCCcCccChhhhcCCCCCcc---CCccccc
Confidence            679999999999977665543   4455555

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5e-28  Score=269.95  Aligned_cols=190  Identities=22%  Similarity=0.281  Sum_probs=155.6

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+.+++.++|++|+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999854 5899999999742   2233456788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.+....+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999765666899999999999999999999   99999999999999999999999999999986533221


Q ss_pred             ceeecccccccccccCceeeeee--eeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~~  973 (982)
                       .......||+.|||||++....  ....+..+|+|++|+
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~  196 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGV  196 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhh
Confidence             1223356999999999986321  111223355566653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=5.7e-28  Score=263.85  Aligned_cols=184  Identities=24%  Similarity=0.380  Sum_probs=154.3

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .|+..+.||+|+||.||+|.. .+++.||+|++....   ......+.+|++++++++|++|+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999985 568999999987442   2233467789999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++... ...+++..+..++.|++.|++|||   ++||+||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999998887643 335889999999999999999999   9999999999999999999999999999998753221 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......||+.|||||++.+..++..   +|+|++|+
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~---~DvwslGv  189 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFS---PDWWGLGC  189 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcc---cCchhHHH
Confidence              2234579999999999987766544   45666663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=5.8e-28  Score=273.25  Aligned_cols=189  Identities=22%  Similarity=0.280  Sum_probs=154.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++..   .....+.+..|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999864 5899999999643   12234457789999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999998654  3788888999999999999999   999999999999999999999999999999875322


Q ss_pred             CCceeecccccccccccCceeeeee-eeeEEeeEeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL  972 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~  972 (982)
                      . ........||+.|||||++.+.. ....+..+|+|++|
T Consensus       196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlG  234 (370)
T cd05596         196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG  234 (370)
T ss_pred             C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehh
Confidence            2 11223467999999999986532 11122345556665

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=9.3e-28  Score=267.83  Aligned_cols=173  Identities=21%  Similarity=0.313  Sum_probs=149.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+..|+.+++.++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999864 5888999998642   2233455788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|+|   ++||+||||||+||+++.++.+||+|||++..+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875566889999999999999999999   99999999999999999999999999999987643222


Q ss_pred             ceeecccccccccccCceeee
Q 036229          936 SITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~  956 (982)
                       .......||+.|+|||++.+
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~  177 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQA  177 (331)
T ss_pred             -eeeccccCCcccCCHHHHhc
Confidence             22234579999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=1.2e-27  Score=266.47  Aligned_cols=187  Identities=24%  Similarity=0.299  Sum_probs=151.3

Q ss_pred             ceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          786 NLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.||+|+||.||+|+. .+++.||+|+++...   ......+..|+++++.++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999997542   233456778999999999999999999999999999999999999


Q ss_pred             ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          862 SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       862 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      +|.+++...+ .+++..+..++.|++.||+|||   + +||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            9998886543 5889999999999999999999   7 799999999999999999999999999988542221  1223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ...||+.|||||++.+..++... ++|++|+.++.+.+|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~-DiwslG~il~el~tG  192 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAV-DWWGLGVVMYEMMCG  192 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCcc-ccccccceeeeeccC
Confidence            45799999999999777665442 233344444444444

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=3.8e-28  Score=268.10  Aligned_cols=191  Identities=24%  Similarity=0.387  Sum_probs=155.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-----------------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCcccee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-----------------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIK  840 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~  840 (982)
                      .++|.+.++||+|+||.||+|.++                 ++..||+|++.... .....++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            357899999999999999999753                 23479999987543 334567899999999999999999


Q ss_pred             EEeeecCCCeeEEEEEeccCCChHHHHhcCC------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeE
Q 036229          841 VISSCSTEEFKALILEYMPHGSLEKSLYSSN------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVI  902 (982)
Q Consensus       841 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~iv  902 (982)
                      +++++.+.+..++||||+++|+|.+++....                  ..+++..+.+++.|++.||.|||   +.||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999886421                  23577888999999999999999   99999


Q ss_pred             EcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       903 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ||||||+||++++++.+||+|||+++...............++..|||||++.+..++.   ..|+|++|+++
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~~l  230 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT---ASDVWAFGVTL  230 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCc---hhhhHHHHHHH
Confidence            99999999999999999999999998764333222233445678999999987665553   45667777543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.95  E-value=8.7e-28  Score=268.60  Aligned_cols=191  Identities=24%  Similarity=0.333  Sum_probs=154.4

Q ss_pred             CCCccceeeeeceEEEEEEEe----CCCeEEEEEEeecc----cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCee
Q 036229          781 RFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  851 (982)
                      +|++.+.||+|+||.||+|+.    .+++.||+|+++..    .....+.+..|+++++.+ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999974    35889999998743    223345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++|+|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987543 4889999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeee--eeecccC
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .... .......||+.|||||++.+.. ++..   .|+|++|  ++.+.+|
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~---~DiwslG~il~elltg  203 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTG  203 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhcCCCCCCCc---cccccchhhhhhhhcC
Confidence            3222 1223467999999999997643 3322   3445555  4444443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=3.3e-28  Score=268.34  Aligned_cols=186  Identities=24%  Similarity=0.334  Sum_probs=153.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999865 689999999874422 233467789999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++ +++.+++......+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||++.......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            995 6888888766666889999999999999999999   9999999999999999999999999999998542221  


Q ss_pred             eeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      .......||+.|+|||++.+.. ++   ..+|+|++|+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~---~~~DiwslG~  192 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYS---TCLDMWGVGC  192 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCC---cHHHHHHHHH
Confidence            2223456899999999986542 33   2345566663

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=3e-28  Score=266.47  Aligned_cols=192  Identities=22%  Similarity=0.348  Sum_probs=156.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999999854 68999999987442 2334567889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++ +|.+++......+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++......  
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9975 999988776666789999999999999999999   9999999999999999999999999999998643221  


Q ss_pred             eeecccccccccccCceeeee-eeeeEEeeEeeeeee--eeecccC
Q 036229          937 ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .......+++.|+|||++.+. .++.   ..|+|++|  ++.+.+|
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~---~~DiwslG~~l~~l~~g  200 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYST---PIDMWGVGCILYEMATG  200 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCc---HHHHHHHHHHHHHHHhC
Confidence            122345689999999998653 3332   34556555  4444443

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=6.4e-28  Score=268.12  Aligned_cols=178  Identities=24%  Similarity=0.325  Sum_probs=149.1

Q ss_pred             ceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          786 NLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.||+|+||.||+|+. .+++.||+|+++..   .......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4799999999999985 46899999999754   2234456778999999999999999999999999999999999999


Q ss_pred             ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecc
Q 036229          862 SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ  941 (982)
Q Consensus       862 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  941 (982)
                      +|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9998886543 5789999999999999999999   9999999999999999999999999999987532221  22234


Q ss_pred             cccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          942 TLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       942 ~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ..||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~---~DiwSlG  182 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRA---VDWWGLG  182 (323)
T ss_pred             ccCCcCcCCcccccCCCCCch---hchhhhH
Confidence            679999999999977665543   4556655

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=226.66  Aligned_cols=186  Identities=25%  Similarity=0.337  Sum_probs=156.5

Q ss_pred             cCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .+|...++||+|.||+||+|+ +++++.||+|.++.++  +.......+|+.+++.++|.|||++++....+....+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            357778999999999999998 5568999999997653  3446678999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      ||. .+|.++...-++.++...+..++.|+++|+.|+|   ++++.|||+||.|.+|..+|+.|++|||+|+.+.-  ..
T Consensus        82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgi--pv  155 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PV  155 (292)
T ss_pred             Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ce
Confidence            995 4999999888888999999999999999999999   99999999999999999999999999999997632  22


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......+.|.+|.+|.++.+......+  +|+|+.|+
T Consensus       156 rcysaevvtlwyrppdvlfgakly~ts--idmwsagc  190 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTS--IDMWSAGC  190 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccc--hHhhhcch
Confidence            233556789999999999765433332  33444443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=245.53  Aligned_cols=194  Identities=24%  Similarity=0.364  Sum_probs=158.7

Q ss_pred             HHHHHHHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCC
Q 036229          772 YLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE  849 (982)
Q Consensus       772 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  849 (982)
                      +.+.-.-+     .+.+|+|+||.|--|. ..++.++|||++++.....+.++.+|++++.+. .|+||++++++|+++.
T Consensus        75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            45554444     3789999999999987 678999999999988778889999999999999 5999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecC
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGI  926 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGl  926 (982)
                      .+|+|||-|.||+|..+|.+++ .+++.++.++.++|+.||+|||   .+||.|||+||+|||-.+..   .+|||||.+
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecccc
Confidence            9999999999999999998754 5899999999999999999999   99999999999999997543   689999988


Q ss_pred             ceeecC--CCC---ceeecccccccccccCceee--eeeeeeEEeeEeeeeeeee
Q 036229          927 AKLLIG--EDQ---SITQTQTLATIGYMAPGLFH--VKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       927 a~~~~~--~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~~~d~~~~~~~  974 (982)
                      +.-+.-  +..   .......+|+..|||||+..  .....+.+...|.|++|++
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvI  280 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVI  280 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHH
Confidence            764321  111   12224578999999999963  2233344555677777743

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.95  E-value=1.2e-27  Score=267.03  Aligned_cols=172  Identities=21%  Similarity=0.326  Sum_probs=147.9

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+..|+.++..++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999865 4788999998642   1223345788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.+....+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999875566899999999999999999999   99999999999999999999999999999986533221


Q ss_pred             ceeecccccccccccCceee
Q 036229          936 SITQTQTLATIGYMAPGLFH  955 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~  955 (982)
                       .......||+.|||||++.
T Consensus       158 -~~~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQ  176 (332)
T ss_pred             -ceecccccCccccCHHHHh
Confidence             2223457999999999985

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.6e-28  Score=265.97  Aligned_cols=176  Identities=25%  Similarity=0.298  Sum_probs=148.3

Q ss_pred             eeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ||+|+||.||+|+.. +++.||+|+++..   .......+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999864 5889999998743   233456778899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccc
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL  943 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  943 (982)
                      .+++.... .+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99987643 5889999999999999999999   9999999999999999999999999999998542221  2223467


Q ss_pred             cccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          944 ATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       944 gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ||+.|+|||++.+..++..   +|+|++|
T Consensus       155 gt~~y~aPE~~~~~~~~~~---~DvwslG  180 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKA---VDWWTLG  180 (312)
T ss_pred             CCcccCCHHHHcCCCCCCc---cceechh
Confidence            9999999999987766544   4555555

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.8e-28  Score=270.89  Aligned_cols=186  Identities=25%  Similarity=0.380  Sum_probs=157.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999865 68999999997542   234567888999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC-
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED-  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-  934 (982)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999765 45889999999999999999999   9999999999999999999999999999998754322 


Q ss_pred             --------------------------CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 --------------------------QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                                                .........||+.|+|||++.+..++..   +|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlG  217 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE---CDWWSLG  217 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc---eeeEecc
Confidence                                      0112234579999999999987755543   4455555

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=271.42  Aligned_cols=191  Identities=24%  Similarity=0.314  Sum_probs=160.9

Q ss_pred             cCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      +.|.+...+|.|+||.||+|..++ +-..|.|++........+++..||+||..+.||+||++++.|..++.+|+..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            345666789999999999998554 5556889998887888899999999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      .||-.+.++-.-+..+.+.++..+++|++.||.|||   +++|||||+|+.|||++-+|.++|+|||.+....  .....
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK  186 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence            999999998887888999999999999999999999   9999999999999999999999999999987542  22233


Q ss_pred             ecccccccccccCceeeee--eeeeEEeeEeeeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVK--YILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~--~~~~~~~~~d~~~~~~~l  975 (982)
                      ...+.|||+|||||+....  ...+.+-.+|+|++|+.+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITL  225 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITL  225 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHH
Confidence            4568999999999997432  222233345667777543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=2.1e-27  Score=264.12  Aligned_cols=179  Identities=28%  Similarity=0.387  Sum_probs=148.6

Q ss_pred             ceeeeeceEEEEEEEe----CCCeEEEEEEeeccc----chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          786 NLIGRGGFGSVYKARI----GEGMEVAVKVFDLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +.||+|+||.||+|+.    .+++.||+|+++...    ......+..|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999975    357899999987431    23345677899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++...+ .+.+..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            99999999987644 4778888899999999999999   9999999999999999999999999999988542222  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......||+.|+|||++.+..++.   ..|+|++|+
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~  188 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGK---AVDWWSLGA  188 (323)
T ss_pred             cccccCCCccccChhhccCCCCCC---cceecccHH
Confidence            223457999999999997765543   355666663

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=258.01  Aligned_cols=194  Identities=25%  Similarity=0.353  Sum_probs=165.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .+.|..-++||+|+||.||-|+. .+|+.+|.|+++++   ..+......+|..++++++.++||.+--+|++++..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            34577889999999999999984 46999999988643   234455678899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          855 LEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      +..|.||+|.-+|...+ ..+++..+..++.+|+.||++||   +.+||.||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999988887643 46899999999999999999999   999999999999999999999999999999988543


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      .   .....+||.+|||||++.++.|++.. +||+.|+.+|.|..|
T Consensus       341 ~---~~~~rvGT~GYMAPEvl~ne~Y~~s~-Dwf~lGCllYemi~G  382 (591)
T KOG0986|consen  341 K---PIRGRVGTVGYMAPEVLQNEVYDFSP-DWFSLGCLLYEMIAG  382 (591)
T ss_pred             C---ccccccCcccccCHHHHcCCcccCCc-cHHHHHhHHHHHHcc
Confidence            3   33456999999999999998888664 456777766655443

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-28  Score=236.61  Aligned_cols=202  Identities=25%  Similarity=0.326  Sum_probs=170.7

Q ss_pred             HHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCC-----Ce
Q 036229          777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EF  850 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~  850 (982)
                      ...++|.+.+.+|+|||+.||.++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            346789999999999999999998 667899999999877777888999999999999999999999987443     35


Q ss_pred             eEEEEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          851 KALILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      .|++++|+..|+|.+.+..   ++..+++.+++.|+.++++||++||   +..  ++||||||.||++.+++.+++.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEecc
Confidence            8999999999999998874   3446899999999999999999999   777  9999999999999999999999999


Q ss_pred             CceeecCC----CC---ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee----eecccCCC
Q 036229          926 IAKLLIGE----DQ---SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM----IFIGRGNY  981 (982)
Q Consensus       926 la~~~~~~----~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~----~l~~~~~f  981 (982)
                      .+....-.    .+   .+.......|..|+|||.+.-+.+...+...|+|++|+    ++++..||
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf  241 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF  241 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence            98764211    00   01123445788999999998888888888899999984    56667766

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.2e-27  Score=279.44  Aligned_cols=186  Identities=22%  Similarity=0.278  Sum_probs=156.7

Q ss_pred             CCCccceeeeeceEEEEEEEeC-C-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-E-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .|...+.||+|++|.||+|... + ++.||+|.+..........+..|+++++.++||||+++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999743 3 6789999876655555567788999999999999999999999999999999999


Q ss_pred             cCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          859 PHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       859 ~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ++|+|.++++.   ....+++.++..++.|++.||+|+|   ++||+||||||+||+++.++.+||+|||+|+.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999988764   2345788899999999999999999   99999999999999999999999999999997644332


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .......+||+.|+|||++.+..++..   +|+|++|
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Dv~slG  258 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKK---ADMWSLG  258 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcH---HhHHHHH
Confidence            223345679999999999977655533   4566666

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.95  E-value=2.1e-27  Score=264.37  Aligned_cols=183  Identities=23%  Similarity=0.250  Sum_probs=151.2

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCc-cceeEEeeecCCCeeEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHR-NLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~  855 (982)
                      +|++.+.||+|+||.||+|+.. +++.||+|+++..   .....+.+..|+++++.++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999864 5789999999754   233456678899999999765 6888999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999999886543 4788999999999999999999   9999999999999999999999999999987532111 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                       .......||+.|+|||++.+..++..   +|+|++|
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  188 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKS---VDWWAFG  188 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcc---cchhhhH
Confidence             12234679999999999987766543   4455555

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=4.4e-27  Score=261.14  Aligned_cols=187  Identities=27%  Similarity=0.370  Sum_probs=152.0

Q ss_pred             ceeeeeceEEEEEEEe----CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          786 NLIGRGGFGSVYKARI----GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      +.||+|+||.||+++.    .+++.||+|+++...  ......+..|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    358999999997542  2234567789999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +|+|.+++.+. ..+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            99999998654 35899999999999999999999   9999999999999999999999999999998653221  222


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ....||+.|+|||++.+..++.. .+.|++|+.++.+.+|
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg  194 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTG  194 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccC
Confidence            34679999999999977655543 2233444445555544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=9.7e-28  Score=271.92  Aligned_cols=192  Identities=24%  Similarity=0.389  Sum_probs=155.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  849 (982)
                      ..++|++.+.||+|+||.||+|++      .++..||||+++... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            456799999999999999999963      236789999986432 33456788999999999 8999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCC----------------------------------------------------------
Q 036229          850 FKALILEYMPHGSLEKSLYSSN----------------------------------------------------------  871 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------  871 (982)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999886432                                                          


Q ss_pred             ----------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          872 ----------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       872 ----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                                      ..+++..+..++.||+.||+|||   ++||+||||||+||++++++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                            13677888999999999999999   99999999999999999999999999999987643322


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ........++..|+|||++.+..++..   +|+|++|+++
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~---sDi~slG~~l  306 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFE---SDVWSYGILL  306 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCC---CCHHHHHHHH
Confidence            222223345678999999977665543   5667777543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=2.3e-27  Score=264.42  Aligned_cols=178  Identities=23%  Similarity=0.294  Sum_probs=148.6

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999864 58999999997542   23345678899999988 799999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence            9999888654 35899999999999999999999   999999999999999999999999999998753211  11223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   .|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  183 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFS---VDWWALG  183 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCc---cceechH
Confidence            4679999999999987766544   4455555

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=2.8e-27  Score=263.21  Aligned_cols=190  Identities=22%  Similarity=0.271  Sum_probs=153.9

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      +|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999864 57899999987542   22334567788888777 5899999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++.....  
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence            9999999999886543 4788999999999999999999   999999999999999999999999999999854221  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ........||+.|+|||++.+..++..   +|+|++|  ++.+.+|
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlGvil~elltg  197 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAG  197 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCc---cchhchhHHHHHHHhC
Confidence            122335679999999999987766544   4455555  4444333

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=4.1e-27  Score=261.79  Aligned_cols=178  Identities=28%  Similarity=0.351  Sum_probs=144.4

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHH-HhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECE-MMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999864 58899999987432   222344555554 57889999999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+.+... ..+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS  154 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence            9998888654 35788888999999999999999   999999999999999999999999999998753221  12233


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   .|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  183 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRT---VDWWCLG  183 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCc---Ccccccc
Confidence            4679999999999977665543   4555555

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=3.9e-27  Score=262.46  Aligned_cols=178  Identities=24%  Similarity=0.302  Sum_probs=147.9

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++..   .....+.+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999864 5889999999754   223445677899888776 899999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++... ..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            9999888654 35889999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  183 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFS---VDWWALG  183 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCc---cceeccc
Confidence            4679999999999987766544   4455555

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=5.1e-28  Score=277.15  Aligned_cols=196  Identities=26%  Similarity=0.341  Sum_probs=156.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCC-eEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeee-cC---C---C
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEG-MEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSC-ST---E---E  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~-~~---~---~  849 (982)
                      .-++++.+.|.+|||+.||.|+...+ .+||+|++-..+....+.+.+|+++|+.|+ |+|||.+++.. ..   .   -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34577889999999999999997655 999999987777788889999999999996 99999999932 11   1   2


Q ss_pred             eeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          850 FKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      +.++.||||+||.|-+++..+ ...+++.++++|+.|+++|+.+|| .++..|||||||-||||++.+|..||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            567999999999999999854 234899999999999999999999 445679999999999999999999999999987


Q ss_pred             eecCCCC-cee------ecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          929 LLIGEDQ-SIT------QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       929 ~~~~~~~-~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ....... ...      .-...-|+.|+|||++.--..-..+.++|+|++|+++
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclL  248 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLL  248 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHH
Confidence            5432211 100      0123468999999998544344456777888888654

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=2e-27  Score=264.49  Aligned_cols=181  Identities=24%  Similarity=0.331  Sum_probs=149.1

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHh---hhcCCccceeEEeeecCCCeeEEE
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMM---KSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      |++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999854 58999999997542   23345666776665   566899999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|..++..  ..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            999999999988854  35899999999999999999999   9999999999999999999999999999987542221


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        .......|++.|||||++.+..++..   +|+|++|
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~---~DiwslG  188 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRA---VDWWGLG  188 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcc---cchhhHH
Confidence              22234679999999999977665543   4556655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=4.9e-27  Score=261.51  Aligned_cols=186  Identities=28%  Similarity=0.332  Sum_probs=147.1

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHH-HhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECE-MMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||+||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999854 58999999997542   223345555655 46778999999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|..++... ..+++..+..++.||+.||+|||   ++||+||||||+||++++++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (325)
T cd05604          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT  154 (325)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence            9999888654 35889999999999999999999   999999999999999999999999999998753221  12234


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeeeeeccc
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGR  978 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~  978 (982)
                      ...||+.|||||++.+..++... ++|++|+.++.+.+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~-DvwslG~il~el~~  191 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTV-DWWCLGAVLYEMLY  191 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcC-ccccccceehhhhc
Confidence            56799999999999877665442 23333433444433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=4.7e-27  Score=261.66  Aligned_cols=178  Identities=29%  Similarity=0.365  Sum_probs=143.4

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHH-HhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECE-MMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999864 57889999997432   122234444444 56788999999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++.... .+.+..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+......  ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcc
Confidence            99999887643 4778888889999999999999   9999999999999999999999999999998542221  2234


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|||||++.+..++..   +|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  183 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRT---VDWWCLG  183 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCc---ccccccc
Confidence            5679999999999987766644   3445554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=3.7e-27  Score=267.76  Aligned_cols=193  Identities=23%  Similarity=0.384  Sum_probs=156.6

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcC-CccceeEEeeecCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSTE  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  848 (982)
                      ...++|++.+.||+|+||.||+|+..      .+..||||+++... ....+.+.+|+++++++. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            34678999999999999999999742      24579999997543 234567899999999996 99999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------------------------------------------------------
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------------------------------------------------------  871 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------  871 (982)
                      +..|+||||+++|+|.+++....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999999886421                                                         


Q ss_pred             --------------------------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          872 --------------------------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       872 --------------------------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                                                            ..+++..+..++.|++.|++|||   +++|+||||||+||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEE
Confidence                                                  23677788899999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ++++.+||+|||+++...............+++.|+|||++.+..++.   ..|+|++|+++
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwSlGvil  329 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT---LSDVWSYGILL  329 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc---hhhHHHHHHHH
Confidence            999999999999998764333322333445778899999997765554   35667777543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=1.8e-27  Score=269.51  Aligned_cols=192  Identities=23%  Similarity=0.385  Sum_probs=154.3

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  848 (982)
                      ...++|++.+.||+|+||.||+|+..      +++.||+|+++... ....+.+.+|+++++.+ +||||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34568999999999999999998731      24579999997542 33456788999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------------------------------------------------------
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------------------------------------------------------  871 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------  871 (982)
                      +..++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999999886421                                                         


Q ss_pred             ------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          872 ------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       872 ------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                                  ..+++.++.+++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++...........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        23677888999999999999999   999999999999999999999999999999876433222222


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....++..|||||++.+..++..   .|+|++|++
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~---~DvwSlGvi  303 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQ---SDVWSYGIL  303 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCcc---ccHHHHHHH
Confidence            23345678999999976655544   556666643

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=3.4e-27  Score=261.50  Aligned_cols=178  Identities=24%  Similarity=0.335  Sum_probs=146.2

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+....|.+++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999864 58899999997542   23344556677777654 899999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999887644 5888999999999999999999   9999999999999999999999999999998643222  2233


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DvwslG  183 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNES---VDWWSFG  183 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCc---ccchhHH
Confidence            5679999999999977665543   4556666

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-28  Score=251.85  Aligned_cols=195  Identities=23%  Similarity=0.266  Sum_probs=161.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  852 (982)
                      ...+|....+||+|+||+|.+|.. .+.+.+|||+++++.   ....+--..|.++|..- +-|++++++.+|++-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            345789999999999999999974 457789999987652   22334445677777766 6789999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+.||+|.-.+++-+ .+.+..+..+|.+|+-||-|||   ++|||.||+|.+||++|.+|++||+|||+++.-. 
T Consensus       427 FVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-  501 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-  501 (683)
T ss_pred             eEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence            9999999999988887654 3777888899999999999999   9999999999999999999999999999998632 


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                       -...+....+|||.|+|||++...+|..+ .+||+||+.++.|..|
T Consensus       502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaG  546 (683)
T KOG0696|consen  502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAG  546 (683)
T ss_pred             -cCCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcC
Confidence             23445567899999999999999988865 5567888886655443

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.94  E-value=2.5e-27  Score=262.99  Aligned_cols=187  Identities=23%  Similarity=0.339  Sum_probs=155.8

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-C-----ccceeEEeeecCCCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-H-----RNLIKVISSCSTEEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~  852 (982)
                      .+|++.+.||+|+||.|-+|.+ ++++.||||+++.+ .....+...|+.+|..++ |     -|+|+++++|...++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            3899999999999999999985 56999999999854 345567788999999996 4     38999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC--CcEEEEeecCcee
Q 036229          853 LILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN--MVAHLSDFGIAKL  929 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~  929 (982)
                      +|+|.++ .+|.++++..+ ..++...++.++.||+.||.+||   +.||||+||||||||+.+.  ..+||+|||.|..
T Consensus       265 iVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999995 49999998653 45889999999999999999999   9999999999999999743  3899999999996


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ..     .....++-+..|+|||++.|.+|+.+   +|+||+|  +..+.+|
T Consensus       341 ~~-----q~vytYiQSRfYRAPEVILGlpY~~~---IDmWSLGCIlAEL~tG  384 (586)
T KOG0667|consen  341 ES-----QRVYTYIQSRFYRAPEVILGLPYDTA---IDMWSLGCILAELFTG  384 (586)
T ss_pred             cC-----CcceeeeeccccccchhhccCCCCCc---cceeehhhhHHhHhcC
Confidence            42     12226778999999999999988866   4444444  4444443

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=6.2e-27  Score=260.44  Aligned_cols=178  Identities=29%  Similarity=0.372  Sum_probs=144.9

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHH-HhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECE-MMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||+||+|+.. +++.||+|++....   .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999864 68999999997532   222344455554 46789999999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++... ..+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (323)
T cd05575          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS  154 (323)
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence            9999988754 35788899999999999999999   999999999999999999999999999998753221  12233


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   .|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DvwslG  183 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRT---VDWWCLG  183 (323)
T ss_pred             cccCChhhcChhhhcCCCCCcc---ccccccc
Confidence            4679999999999987766544   4455555

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=282.85  Aligned_cols=189  Identities=27%  Similarity=0.453  Sum_probs=159.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeCC--C----eEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGE--G----MEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ++.+..+.||+|+||.||+|...+  +    ..||||.++.. +.+...+|.+|..+|+.++|||||+++|.|.+.+..+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            445667899999999999998533  3    34899988755 4566789999999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcC------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          853 LILEYMPHGSLEKSLYSS------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      +++|||+||+|..++++.      ...+...+...++.|||+|++||+   ++++|||||.++|+|++....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999987      567889999999999999999999   99999999999999999999999999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |+.+.+.+.........-...|||||.+....++   .++|+|+||++
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt---skSDvWsFGVl  893 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT---SKSDVWSFGVL  893 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccc---cccchhhhHHH
Confidence            9976555544443333455789999999776555   44667777754

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=3.7e-27  Score=261.62  Aligned_cols=178  Identities=25%  Similarity=0.317  Sum_probs=147.6

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++..   .....+.+..|.++++.. +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999864 5889999998753   223445667888888876 699999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccc
Confidence            99999887554 5889999999999999999999   999999999999999999999999999998854221  12233


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  183 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPS---VDWWAMG  183 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCc---cchhhhH
Confidence            4679999999999977665543   4555555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=3.2e-27  Score=255.32  Aligned_cols=189  Identities=19%  Similarity=0.317  Sum_probs=155.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            457889999999999999999742    36789999987543 2334678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++......+++.++..++.|++.|++|||   ++|++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999987653221


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      . ........++..|+|||.+.+..++.   .+|+|++|++
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  197 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSS---ASDVWSFGIV  197 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccc---hhHHHHHHHH
Confidence            1 11112234567899999987765553   4566776643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=5.9e-27  Score=260.39  Aligned_cols=178  Identities=25%  Similarity=0.304  Sum_probs=147.7

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.++++.+ +||+|+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999864 58899999997542   23345677888888866 799999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|..++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            99998887543 5788899999999999999999   9999999999999999999999999999988643222  2223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DvwslG  183 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPS---VDWWALG  183 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCc---cceechh
Confidence            4679999999999977666544   4555555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.94  E-value=2.5e-28  Score=244.35  Aligned_cols=191  Identities=24%  Similarity=0.303  Sum_probs=153.6

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC---C--CeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecC-C
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG---E--GMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCST-E  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~  848 (982)
                      +....|+....||+|.||.||+|...   +  .+.+|+|.++.+.+  ..-...-+|+.+++.++|||++.+..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            34567999999999999999999532   2  34799999975422  223456789999999999999999999877 7


Q ss_pred             CeeEEEEEeccCCChHHHHhcC----CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC----CcEE
Q 036229          849 EFKALILEYMPHGSLEKSLYSS----NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAH  920 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~k  920 (982)
                      ...++++||.+. +|.++|+-.    .+.++...++.|++||+.|+.|||   ++-|+|||+||.|||+..+    |.||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence            789999999987 998988732    245788899999999999999999   9999999999999999877    8999


Q ss_pred             EEeecCceeecCCCCce-eecccccccccccCceeeeeeeeeEEeeEeeeee
Q 036229          921 LSDFGIAKLLIGEDQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSF  971 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~  971 (982)
                      |+|||+|+.+...-... .....+.|.+|+|||.+.+......+.+.|+.||
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC  228 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC  228 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence            99999999886543332 3456778999999999987755545444443333

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=4.4e-27  Score=261.43  Aligned_cols=183  Identities=21%  Similarity=0.267  Sum_probs=150.5

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      +|+..+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999854 58999999997542   233456778888888885 577888999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++.....  
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--
Confidence            9999999999886543 4889999999999999999999   999999999999999999999999999998854222  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ........||+.|+|||++.+..++..   .|+|++|
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  188 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKS---VDWWAYG  188 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCc---cchhhhH
Confidence            122234569999999999977665543   4555555

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=6.3e-27  Score=260.66  Aligned_cols=178  Identities=24%  Similarity=0.312  Sum_probs=148.6

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999854 58899999997542   23445678899999888 699999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99998886543 5899999999999999999999   9999999999999999999999999999988532211  2223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  183 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFS---VDWWALG  183 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCch---heeehhH
Confidence            5679999999999987766543   4555655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=4.6e-27  Score=260.40  Aligned_cols=178  Identities=24%  Similarity=0.362  Sum_probs=146.8

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++...   .........|.+++... +||+|+++++++.+++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999865 58899999997542   23345567788888754 899999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            9999988764 35788999999999999999999   9999999999999999999999999999987532111  1234


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   .|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  183 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFS---VDWWSFG  183 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcc---cchhhhH
Confidence            5679999999999987766544   4455555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=2.8e-27  Score=268.70  Aligned_cols=186  Identities=21%  Similarity=0.229  Sum_probs=152.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+|++.+.||+|+||.||+|+. .+++.||+|+..      ...+.+|++++++++||||+++++++..+...++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            46799999999999999999985 458999999753      23567899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +. ++|.+++.... .+++.+++.++.|++.||+|||   ++|||||||||+||+++.++.+||+|||+|+...... ..
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            95 68888886543 4789999999999999999999   9999999999999999999999999999997542211 11


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ......||+.|+|||++.+..++..   +|+|++|  ++.+.+|
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlGvil~elltg  279 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATC  279 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcH---HHHHHHHHHHHHHHHC
Confidence            2234679999999999977666543   4556655  4444443

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=7.3e-27  Score=258.69  Aligned_cols=178  Identities=24%  Similarity=0.339  Sum_probs=146.5

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||+||+|+.. +++.||+|+++...   .........|..+++.. +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999864 47899999997542   23345566788888764 899999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++... ..+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTC  154 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Ccee
Confidence            9999998754 34788999999999999999999   9999999999999999999999999999988532211  1223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...||+.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~---~DvwslG  183 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTS---VDWWSFG  183 (316)
T ss_pred             eecCCccccCHHHHcCCCCCch---hhhhhHH
Confidence            4579999999999977665544   4555555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.3e-27  Score=255.45  Aligned_cols=196  Identities=22%  Similarity=0.292  Sum_probs=163.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--------chhhhhHHHHHHHhhhcC---CccceeEEeeec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSIR---HRNLIKVISSCS  846 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~  846 (982)
                      ..+|+..+.+|+|+||.|+.|.++ +..+|+||.+.++.        +.....+-.|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            456899999999999999999865 47789999986541        222334566999999997   999999999999


Q ss_pred             CCCeeEEEEEec-cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          847 TEEFKALILEYM-PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       847 ~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      ++++.|++||-. +|.+|.+++..+. .+++.+++.|++||+.|+++||   ++||||||||-+||.++.+|-+||+|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            999999999974 5669999997544 5899999999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee--eecccCCCC
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM--IFIGRGNYY  982 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~--~l~~~~~f~  982 (982)
                      .|....    ..+...++||..|+|||++.|..|-....++|+.|+.+  +.+-+.|||
T Consensus       716 saa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            988642    23345688999999999999988877766666655553  455677887

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-26  Score=258.86  Aligned_cols=187  Identities=24%  Similarity=0.280  Sum_probs=144.8

Q ss_pred             eeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc---CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI---RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      ||+|+||+||+|+.. +++.||+|++....   .........|..++...   +||+|+++++++..++..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999864 58999999986432   12233445567776655   699999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++... ..+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            9999888754 45889999999999999999999   9999999999999999999999999999987542221  2223


Q ss_pred             ccccccccccCceeeeee-eeeEEeeEeeeeeeeeec--ccCCC
Q 036229          941 QTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLMIFI--GRGNY  981 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~~l~--~~~~f  981 (982)
                      ...||+.|||||++.+.. ++.. .+.|++|+.++.+  |..||
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~-~DvwslGvil~elltG~~Pf  197 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKH-VDFWSLGVLVFEMCCGWSPF  197 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCc-cceeccccEEEEeccCCCCC
Confidence            567999999999986543 3333 2233333334444  34444

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=5.9e-27  Score=261.48  Aligned_cols=184  Identities=21%  Similarity=0.292  Sum_probs=156.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+.. ++..||+|+++... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999865 58899999987543 3345678999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++.... .+++..+..++.|++.|+.|||   ++ +|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999987644 4788899999999999999999   75 6999999999999999999999999999865322  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......|++.|+|||++.+..++.   .+|+|++|+
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~---~~DiwslG~  190 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSV---QSDIWSMGL  190 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCc---hHhHHHHHH
Confidence              123457899999999997765553   355666664

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.94  E-value=6.5e-27  Score=254.80  Aligned_cols=178  Identities=25%  Similarity=0.378  Sum_probs=148.1

Q ss_pred             eeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ||+|+||+||+|... +++.||+|++....   ....+.+..|+++++.++||+|+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            689999999999854 68899999986432   22345677899999999999999999999999999999999999999


Q ss_pred             HHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          864 EKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       864 ~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      .+++..   ....+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            887753   2345889999999999999999999   99999999999999999999999999999987643222  223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...||+.|+|||++.+..++..   .|+|++|+
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~---~DvwslG~  185 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFS---VDYFALGV  185 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCcc---ccHHHHHH
Confidence            4578999999999987766543   55666663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-28  Score=281.72  Aligned_cols=200  Identities=28%  Similarity=0.368  Sum_probs=165.7

Q ss_pred             HHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..+-+|+.+.+||.|.||.||-|. ..+|+..|+|.++..  ..+..+.+..|..++..++|||+|++||+-.+.+..++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            345678889999999999999998 567999999988654  34556788999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      .||||++|+|.+.+...+ ..++.....+..|++.|+.|||   +.|||||||||+||+++.+|.+|++|||.|..+.+.
T Consensus      1312 FMEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            999999999999986543 4667777789999999999999   999999999999999999999999999999988654


Q ss_pred             CCc--eeecccccccccccCceeeeee--eeeEEeeEeeeeeeeeecccCC
Q 036229          934 DQS--ITQTQTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFLMIFIGRGN  980 (982)
Q Consensus       934 ~~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~~~l~~~~~  980 (982)
                      .+.  .......||+.|||||++.+..  ....++++|+.||+++.|+||.
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence            221  2224678999999999995432  2223455667777777777764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.94  E-value=8.7e-27  Score=258.60  Aligned_cols=189  Identities=26%  Similarity=0.364  Sum_probs=154.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCe----EEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGM----EVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..+|+..+.||+|+||.||+|++. +++    .||+|+++... ....+++..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356999999999999999999853 333    48999986442 34456788999999999999999999999765 567


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +|+||+++|+|.+++.+....+++..+.+++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++.+..
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999999876666889999999999999999999   99999999999999999999999999999997644


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ...........++..|+|||++.+..++.   ..|+|++|++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~---~~Di~slGv~  200 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTH---QSDVWSYGVT  200 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCc---hhhhHHHHHH
Confidence            33322223334567899999997765553   3566777743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=6.5e-27  Score=279.02  Aligned_cols=188  Identities=27%  Similarity=0.306  Sum_probs=153.9

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.++||+|+||.||+|+.. +++.||+|+++...   ....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            58999999999999999999864 58999999986432   233567899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcC----------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          856 EYMPHGSLEKSLYSS----------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       856 E~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      ||++||+|.+++...          ....++..+.+++.|+++||+|||   ++||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988632          123456778899999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCc----------------eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          926 IAKLLIGEDQS----------------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       926 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +|+........                ......+||+.|||||++.+..++.   ..|+|++|+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~---kSDIWSLGV  219 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE---STDIYALGV  219 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc---HhHHHHHHH
Confidence            99875211100                0112356999999999997766553   355666663

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-28  Score=253.68  Aligned_cols=139  Identities=27%  Similarity=0.324  Sum_probs=83.8

Q ss_pred             cCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccC-CCCCCchhhhc
Q 036229          168 EIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGY-SGLQGEIPREF  246 (982)
Q Consensus       168 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~  246 (982)
                      ++|.++   -+.-+.++|..|+|+.+.|++|+.+++|+.||||+|+|+.+-|.+|.++.+|.+|-+.+ |+|+....+.|
T Consensus        60 eVP~~L---P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F  136 (498)
T KOG4237|consen   60 EVPANL---PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAF  136 (498)
T ss_pred             cCcccC---CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHh
Confidence            455444   23455566666666655556666666666666666666655666666666655544433 66665555566


Q ss_pred             CCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCcc
Q 036229          247 GNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNK  309 (982)
Q Consensus       247 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  309 (982)
                      ++|.+|+.|.+.-|++.-...+.|+.+++|..|.+.+|.+..+....|..+..++.+.+..|.
T Consensus       137 ~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np  199 (498)
T KOG4237|consen  137 GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNP  199 (498)
T ss_pred             hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCc
Confidence            666666666666666665555666666666666666666664444466666666666666665

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-27  Score=223.14  Aligned_cols=201  Identities=25%  Similarity=0.281  Sum_probs=158.2

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc-cchhhhhHHHHHHHhhh-cCCccceeEEeeecCCCee
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKS-IRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~  851 (982)
                      ++...+.....+.||+|+||.|-+-+ ..+|+..|+|.++.. ..+..++..+|+.+..+ ..+|++|++||....++..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            44455666778899999999998887 457999999999754 34556777888887544 5799999999999999999


Q ss_pred             EEEEEeccCCChHHHHh---cCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          852 ALILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      ++.||.|+. +|+.+.+   +.+..+++...-+|+..+++||.|||.  +..+||||+||+|||++.+|++|+||||++.
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999954 8877655   356678999999999999999999995  6789999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeee-eEEeeEeeeeee--eeecccCCC
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYIL-FVVNFLTSYSFL--MIFIGRGNY  981 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~d~~~~~--~~l~~~~~f  981 (982)
                      .+.+   +...+...|...|||||.+..+... ..+..+|+||+|  ++.++++.|
T Consensus       198 ~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~  250 (282)
T KOG0984|consen  198 YLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF  250 (282)
T ss_pred             eehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence            8733   2233335677889999999544211 344556666666  566666554

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.9e-27  Score=274.17  Aligned_cols=191  Identities=23%  Similarity=0.327  Sum_probs=156.5

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----  849 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----  849 (982)
                      ...++|++.+.||+|+||.||+|+. .+++.||||+++..  .......+.+|+.++..++|++|+++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            4567999999999999999999985 46899999998754  2344567888999999999999999988764332    


Q ss_pred             ----eeEEEEEeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE
Q 036229          850 ----FKALILEYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  922 (982)
Q Consensus       850 ----~~~lv~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  922 (982)
                          ..++||||+++|+|.+++...   ...+++..+..++.|++.||.|+|   ++||+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                367999999999999998643   345788999999999999999999   9999999999999999999999999


Q ss_pred             eecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          923 DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       923 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |||+++.+.............||+.|+|||++.+..++..   +|+|++|+
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k---~DVwSlGv  233 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK---ADMFSLGV  233 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcH---HHHHHHHH
Confidence            9999987643322223345679999999999987665533   55666663

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=6.8e-27  Score=268.35  Aligned_cols=184  Identities=19%  Similarity=0.217  Sum_probs=154.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+|.+.+.||+|+||.||+|+.. .++.||||...      ...+.+|++++++++|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447999999999999999999865 48889999643      23457899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +. ++|.+++......+++.++..++.|++.||.|||   ++|||||||||+||+++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6898888766567899999999999999999999   9999999999999999999999999999998764332222


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ......||+.|||||++.+..++.   .+|+|++|+++
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~---~sDvwSlGviL  352 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTP---SVDIWSAGLVI  352 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCc---hHHHHHHHHHH
Confidence            223457999999999997766553   35667777443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=7.5e-27  Score=255.53  Aligned_cols=186  Identities=23%  Similarity=0.296  Sum_probs=153.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999965 58899999987542  2335677889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++++.+..+. .....+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            99987665544 33456889999999999999999999   9999999999999999999999999999998763222 1


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......|++.|+|||++.+..++.   .+|+|++|+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslGv  189 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGK---AVDMWSVGC  189 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCC---chhHHhHHH
Confidence            2223457899999999997765553   355666663

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=1.1e-26  Score=249.67  Aligned_cols=187  Identities=22%  Similarity=0.370  Sum_probs=156.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      ++|++.+.||+|+||.||+|+++++..+|+|.+... ....+++.+|++++++++||||+++++++..++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            468888999999999999999888888999988643 2334678899999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +|+|.+++......+++..+..++.|++.|++|||   ++||+||||||+||++++++.+||+|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eecc
Confidence            99999999765556889999999999999999999   9999999999999999999999999999988653222 1122


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....++..|+|||++.+..++   ..+|+|++|++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~---~~~Di~s~G~~  190 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYS---SKSDVWSFGVL  190 (256)
T ss_pred             CCCCCchhhCChhhcccCccc---hhhhhHHHHHH
Confidence            233456789999999766544   34666777743

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.94  E-value=9.8e-27  Score=259.69  Aligned_cols=183  Identities=21%  Similarity=0.302  Sum_probs=154.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.++||+|+||.||+|+.. +++.||+|+++... ....+++.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999865 58889999987542 3345678999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++...+ .+++..+..++.|++.|+.|||   +. +|+||||||+||++++++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999997643 4788889999999999999999   64 7999999999999999999999999998765321  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        ......|+..|+|||++.+..++.   .+|+|++|
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG  189 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSV---QSDIWSMG  189 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCc---HHHHHHHH
Confidence              123456899999999997765543   35566666

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2e-26  Score=251.67  Aligned_cols=183  Identities=25%  Similarity=0.383  Sum_probs=152.6

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999854 68999999986432   2223456789999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++... ...+++..+..++.|++.|++|||   +.||+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999999888653 345899999999999999999999   9999999999999999999999999999998753221 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        ......|++.|+|||++.+..++..   .|+|++|
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~---~Diws~G  188 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFS---PDWWGLG  188 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCcc---ccchhHH
Confidence              1234578999999999977655543   4455555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.94  E-value=1.8e-26  Score=249.65  Aligned_cols=189  Identities=28%  Similarity=0.345  Sum_probs=157.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45799999999999999999985 46899999999765545556788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++... ..+++..+..++.|++.|++|||   +.||+|||+||+||++++++.+||+|||++..+....  .
T Consensus        88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            9999999988654 35789999999999999999999   9999999999999999999999999999998763221  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......|++.|+|||.+........+...|+|++|+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~  197 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI  197 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHH
Confidence            123456889999999985432222334456676663

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=7.7e-27  Score=263.04  Aligned_cols=184  Identities=25%  Similarity=0.368  Sum_probs=148.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999864 58999999986543 33456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++|+|.+..     ..++..+..++.||+.||+|||   ++||+||||||+||++++++.+||+|||+++.+....  .
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            9999986532     3466778889999999999999   9999999999999999999999999999998763221  1


Q ss_pred             eecccccccccccCceeeeeeee--eEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYIL--FVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~d~~~~~~  973 (982)
                      ......||..|+|||++......  +....+|+|++|+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGv  261 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV  261 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHH
Confidence            22345799999999998432111  1112356677664

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=1.5e-26  Score=252.20  Aligned_cols=190  Identities=27%  Similarity=0.438  Sum_probs=157.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|.+.+.||+|+||.||+|+..      +++.||+|+++..... ..+.+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356888999999999999999753      3578999998755433 457899999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCC-------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 036229          852 ALILEYMPHGSLEKSLYSSN-------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV  918 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  918 (982)
                      ++||||+++++|.+++...+             ..+++.++..++.|++.|++|+|   ++|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999997532             34678889999999999999999   999999999999999999999


Q ss_pred             EEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          919 AHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       919 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +||+|||.+................+++.|+|||++.+..++..   +|+|++|++
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  213 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE---SDVWSFGVV  213 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh---hhHHHHHHH
Confidence            99999999986533322222234456788999999977665544   566776643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=9.8e-27  Score=257.37  Aligned_cols=184  Identities=22%  Similarity=0.349  Sum_probs=152.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999864 58889999987543 22334677899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++ ++.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence            975 898888776666889999999999999999999   9999999999999999999999999999998643221  1


Q ss_pred             eecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      ......+++.|+|||++.+. .++   ..+|+|++|
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~---~~~DiwslG  192 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYS---TQIDMWGVG  192 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCC---cHHHHHHHH
Confidence            22345678999999998653 233   234556666

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=2.7e-26  Score=248.07  Aligned_cols=190  Identities=25%  Similarity=0.428  Sum_probs=158.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|++.    +...||+|+++... .....++.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357899999999999999999864    24679999987543 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++......+++..+.+++.|++.|++|||   +++|+||||||+||++++++.+||+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999977432


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ..........++..|+|||.+.+..++   ...|+|++|++
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~---~~~Dv~slG~~  197 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFT---SASDVWSFGIV  197 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCc---cccchHHHHHH
Confidence            222222333456789999999766544   34566777744

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=2e-27  Score=260.82  Aligned_cols=189  Identities=26%  Similarity=0.447  Sum_probs=154.2

Q ss_pred             CccceeeeeceEEEEEEEeC-CCeEEEEEEeecc----cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCe--eEEEE
Q 036229          783 SENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF--KALIL  855 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lv~  855 (982)
                      ...+.||+|+|-+||+|.+. +|.+||.-.++..    .....+++..|+.+|+.|+||||+++|++|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999864 4888886544322    34456889999999999999999999999977654  77899


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~  934 (982)
                      |.+..|+|..|.++.+. ++....+.|++||++||.||| .+..+|||||||.+||+|+ ..|.|||+|+|+|...... 
T Consensus       123 EL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLH-s~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLH-SQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhh-cCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            99999999999987654 788999999999999999999 5678999999999999997 5689999999999976322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccCCC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRGNY  981 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~~f  981 (982)
                         .....+|||.|||||++..+|.    ...|+|+||  ++.|+|+.|
T Consensus       200 ---~aksvIGTPEFMAPEmYEE~Yn----E~VDVYaFGMCmLEMvT~eY  241 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYEENYN----ELVDVYAFGMCMLEMVTSEY  241 (632)
T ss_pred             ---ccceeccCccccChHHHhhhcc----hhhhhhhhhHHHHHHHhccC
Confidence               2234789999999999985533    335667777  555666655

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=1.1e-26  Score=260.54  Aligned_cols=191  Identities=23%  Similarity=0.341  Sum_probs=151.2

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC-----CeeE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EFKA  852 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~  852 (982)
                      +|++.+.||+|+||.||+|+.. +++.||||+++..  ......++.+|+++++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999854 6899999998643  223345688999999999999999999987543     3579


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||++ ++|.+++.... .+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68998886543 4889999999999999999999   99999999999999999999999999999986532


Q ss_pred             CCC-ceeecccccccccccCceeee--eeeeeEEeeEeeeeee--eeecccC
Q 036229          933 EDQ-SITQTQTLATIGYMAPGLFHV--KYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       933 ~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ... ........||+.|+|||++.+  ..++   ..+|+|++|  ++.+.+|
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~~~DvwSlGvvl~el~tg  204 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYT---PAIDIWSIGCIFAEVLTG  204 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccC---chhHHHHHHHHHHHHHcC
Confidence            221 122244679999999999865  2333   345566666  3444444

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=1.3e-26  Score=250.69  Aligned_cols=190  Identities=27%  Similarity=0.351  Sum_probs=157.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++.........+.+|+.+++.++||||+++++++..++..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35788889999999999999985 45899999999866555566788899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++...+ .+++.++..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++......  ..
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA  161 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence            99999999886544 5889999999999999999999   999999999999999999999999999998865322  12


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......|+..|+|||++........+..+|+|++|++
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~i  198 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT  198 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHH
Confidence            2234578999999999742222223345667777743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=1.9e-26  Score=255.76  Aligned_cols=178  Identities=24%  Similarity=0.311  Sum_probs=148.1

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999865 48899999997542   23445677899998887 799999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            99998887543 5899999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...|++.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~---~DiwslG  183 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPA---VDWWALG  183 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcc---hhhhhHH
Confidence            4568999999999987766543   5556665

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=9e-27  Score=250.32  Aligned_cols=193  Identities=21%  Similarity=0.288  Sum_probs=163.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeec--ccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDL--QCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ....|++.++||+||.+.||++...+.+.||+|++..  .+.+....+.+|+..|.++ .|.+|+++++|-..++++|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            3456999999999999999999988888888887743  3556678899999999999 599999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||- ..+|.++++++....+...++.+..|++.|+.++|   ++||||.|+||.|+|+. .|.+||+|||+|..+..+.
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            9987 45999999987766665588899999999999999   99999999999999997 5699999999999987777


Q ss_pred             CceeecccccccccccCceeeeeee--------eeEEeeEeeeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYI--------LFVVNFLTSYSFLMIF  975 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~--------~~~~~~~d~~~~~~~l  975 (982)
                      ........+||+.|||||.+....+        ......+|+|++|+++
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCIL  562 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCIL  562 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHH
Confidence            7777778899999999999843322        2344567778777543

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.93  E-value=2.2e-26  Score=251.94  Aligned_cols=189  Identities=26%  Similarity=0.418  Sum_probs=157.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..+|.+.+.||+|+||.||++..      .++..||+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35788999999999999999974      235678999987655556678999999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCC------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 036229          853 LILEYMPHGSLEKSLYSSN------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  920 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  920 (982)
                      +||||+++++|.+++....            ..+++.++..++.|++.||+|||   ++|++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999987432            24789999999999999999999   99999999999999999999999


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |+|||+++...............++..|+|||++.+..++.   .+|+|++|+
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDiwslG~  210 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT---ESDVWSLGV  210 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCc---hhhHHHHHH
Confidence            99999998664333222233445678899999997665443   466677663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=5.7e-26  Score=256.90  Aligned_cols=203  Identities=25%  Similarity=0.316  Sum_probs=166.7

Q ss_pred             HHHHHHHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeec---
Q 036229          772 YLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCS---  846 (982)
Q Consensus       772 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~---  846 (982)
                      ++.....++.|++.+.||+|.+|.||+++ .++++.+|+|+..... ...++++.|..+++.. .|||++.+++++.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34444567889999999999999999998 4568999999987553 3446788899999887 6999999999884   


Q ss_pred             --CCCeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          847 --TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       847 --~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                        .++.+|+|||||.+|+..|+++.. +..+.|..+..|+++++.|+.+||   ...++|||||-.|||++.++.||++|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEee
Confidence              356899999999999999999853 446888899999999999999999   99999999999999999999999999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeee--eeeeeEEeeEeeeeeee--eecccCC
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV--KYILFVVNFLTSYSFLM--IFIGRGN  980 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~d~~~~~~--~l~~~~~  980 (982)
                      ||.+.....  ........+|||.|||||++..  .+....+..+|+||+|+  +.+|.|+
T Consensus       167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~  225 (953)
T KOG0587|consen  167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA  225 (953)
T ss_pred             eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence            999987732  2334456889999999999943  34445566778888885  5555553

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.93  E-value=1.6e-26  Score=251.60  Aligned_cols=191  Identities=20%  Similarity=0.361  Sum_probs=155.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      ..++|+..+.||+|+||.||+|...      .+..||+|++.... .....++.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            5678999999999999999998742      35779999986432 2345578899999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC---------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 036229          851 KALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  921 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  921 (982)
                      .++||||+++++|.+++.+..         ...++..+..++.|++.|++|||   +.|++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999987532         23567788899999999999999   999999999999999999999999


Q ss_pred             EeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          922 SDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       922 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +|||++................+++.|||||++.+..++.   ..|+|++|++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  210 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT---YSDVWSFGVV  210 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCc---hhHHHHHHHH
Confidence            9999988653332222222345678899999997665543   4567777754

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.93  E-value=5.8e-27  Score=230.60  Aligned_cols=194  Identities=24%  Similarity=0.274  Sum_probs=158.5

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEec
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .+....+|.|+.|.|++++.. +|...|||.+.... ....+++...++++..- .+|+||+.+|||..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344567999999999999864 58999999997653 34556777778776665 4899999999999999999999998


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      .. -.+++++.-..++++..+-++...+++||.||.+  .+||+|||+||+|||+|+.|.+|+||||++..+.+..   .
T Consensus       174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A  247 (391)
T KOG0983|consen  174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A  247 (391)
T ss_pred             HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence            43 6777777777778998888999999999999986  7899999999999999999999999999999875443   3


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccCCC
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRGNY  981 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~~f  981 (982)
                      .+...|.+.|||||.+.-......+..+|+|++|  ++.++||.|
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~y  292 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQY  292 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccC
Confidence            3456789999999999655444455666777776  667777766

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.93  E-value=7.8e-28  Score=235.98  Aligned_cols=193  Identities=27%  Similarity=0.287  Sum_probs=154.2

Q ss_pred             CCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc-chhhhhHHHHHHHhhh-cCCccceeEEeeecCCCeeEEEEEec
Q 036229          782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKS-IRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .+....||.|+||+|++-.. +.|+..|||+++... .+..+++..|.+...+ -+.||||++||.+..++..|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            34456799999999999874 469999999998654 3667888888887544 47999999999999999999999999


Q ss_pred             cCCChHHHHhc----CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          859 PHGSLEKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       859 ~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      + .+++.+.+.    .+..+++.-.-.|....+.||.||.+  +..|||||+||+|||++..|.+||||||++..+.   
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---  219 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---  219 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---
Confidence            4 488766542    23357777777888899999999986  7789999999999999999999999999988762   


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccCCC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRGNY  981 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~~f  981 (982)
                      .+...+.-.|...|||||.+..... ..+..+|+||+|  ++..+||.|
T Consensus       220 ~SiAkT~daGCrpYmAPERi~p~~~-gyDiRSDvWSLGITL~EvAtG~f  267 (361)
T KOG1006|consen  220 DSIAKTVDAGCRPYMAPERIDPSDK-GYDIRSDVWSLGITLYEVATGNF  267 (361)
T ss_pred             HHHHhhhccCCccccChhccCCccC-CcchhhhhhhhcceEeeeecCCC
Confidence            3344455678899999999954322 234556666666  778889887

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=2.7e-26  Score=246.49  Aligned_cols=187  Identities=22%  Similarity=0.367  Sum_probs=156.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      ++|++.+.||+|+||.||+|++.++..||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688889999999999999998777789999887432 334678999999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +|+|.+++......+++.++..++.|++.|++|||   +.|++|+||||+||++++++.+||+|||.++...... ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            99999999765556899999999999999999999   9999999999999999999999999999988653322 1122


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....++..|+|||++.+..++   ...|+|++|++
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~---~~~Di~slG~~  190 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFS---SKSDVWAFGVL  190 (256)
T ss_pred             CCCccChhhCCHHHHhcCccc---chhHHHHHHHH
Confidence            233456789999999765444   34667777744

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=1.8e-26  Score=248.20  Aligned_cols=185  Identities=34%  Similarity=0.524  Sum_probs=151.9

Q ss_pred             ccceeeeeceEEEEEEEeC-----CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          784 ENNLIGRGGFGSVYKARIG-----EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       784 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+.||.|+||.||+|.+.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999865     36889999996543 33478899999999999999999999999988889999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++|+|.+++... ...+++.++..|+.||++||.|||   +++++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999887 567899999999999999999999   999999999999999999999999999999876333333


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .......+...|+|||.+....++   ..+|+|+||++
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~---~ksDVysfG~~  194 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYT---KKSDVYSFGML  194 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEES---HHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccc---ccccccccccc
Confidence            333445677899999999776544   45667777744

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.93  E-value=4e-26  Score=250.19  Aligned_cols=184  Identities=26%  Similarity=0.354  Sum_probs=147.5

Q ss_pred             cCCCccceeeeeceEEEEEEEeC--CCeEEEEEEeeccc--chhhhhHHHHHHHhhhc---CCccceeEEeeec-----C
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSI---RHRNLIKVISSCS-----T  847 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~  847 (982)
                      ++|++.+.||+|+||.||+|+..  +++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999852  47889999987442  22234566788777765   6999999999874     3


Q ss_pred             CCeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          848 EEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      ....++||||++ ++|.+++... ...+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 5898888653 345789999999999999999999   99999999999999999999999999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++.....   .......||+.|+|||++.+..++.   .+|+|++|+
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~  197 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYAT---PVDLWSVGC  197 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCC---ccchHHHHH
Confidence            9875322   2233457899999999997665543   356677664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=2.1e-26  Score=262.85  Aligned_cols=182  Identities=22%  Similarity=0.239  Sum_probs=151.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC---CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG---EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..+|.+.+.||+|+||.||+|...   .++.||+|.+...     ....+|++++++++||||+++++++...+..++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999743   3678999987643     24567999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+. +++.+++.. ...+++.++..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||+|+.......
T Consensus       166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 688888843 446899999999999999999999   99999999999999999999999999999987644333


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ........||+.|+|||++.+..++..   +|+|++|+
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DvwslGv  275 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAK---TDIWSAGL  275 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCch---hhHHHHHH
Confidence            233345679999999999977665543   55566663

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=5.6e-26  Score=247.51  Aligned_cols=176  Identities=19%  Similarity=0.221  Sum_probs=146.3

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccch---hhhhHHHHHHHhhhcCCccceeEEeeecC----CCeeEEEEEe
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR---AFKSFDVECEMMKSIRHRNLIKVISSCST----EEFKALILEY  857 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~E~  857 (982)
                      ...||+|++|.||+|++ +|+.||||+++.....   ..+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 6899999998754322   24678899999999999999999999866    3478899999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++|+|.+++.+.+ .+++..+.+++.|++.|+.|+|   + .+++||||||+||++++++.+||+|||+++.....   
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---  176 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---  176 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence            99999999997643 5888999999999999999999   7 48999999999999999999999999999865322   


Q ss_pred             eeecccccccccccCceeee--eeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHV--KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~d~~~~~~  973 (982)
                        .....|+..|+|||++.+  ..++   ..+|+|++|+
T Consensus       177 --~~~~~~~~~y~aPE~~~~~~~~~~---~k~Di~SlGv  210 (283)
T PHA02988        177 --PFKNVNFMVYFSYKMLNDIFSEYT---IKDDIYSLGV  210 (283)
T ss_pred             --cccccCcccccCHHHhhhcccccc---chhhhhHHHH
Confidence              123568899999999865  3333   4456677764

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.93  E-value=3.6e-26  Score=249.55  Aligned_cols=189  Identities=23%  Similarity=0.396  Sum_probs=154.3

Q ss_pred             cCCCccceeeeeceEEEEEEEe-----CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ++|++.+.||+|+||.||+|+.     ..++.||+|.+.... ......+.+|++++++++||||+++++++..++..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688889999999999999974     246789999987433 3344678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcC----------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          854 ILEYMPHGSLEKSLYSS----------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~----------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      ||||+++++|.+++...                ...+++.++..++.|++.|++|||   ++||+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            99999999999998532                124678888999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .+||+|||+++...............++..|+|||++.+..++   ..+|+|++|++
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~i  215 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS---SDSDIWSFGVV  215 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCC---chhhhHHHHHH
Confidence            9999999999876433322233444567789999998766544   34566776643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.93  E-value=1.8e-26  Score=257.78  Aligned_cols=191  Identities=26%  Similarity=0.424  Sum_probs=153.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCC-
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE-  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-  848 (982)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|+++... ....+.+..|+++++++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            346899999999999999999963      235789999987442 23345678899999999 899999999988654 


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------------------------------------------------------
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------------------------------------------------------  871 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------  871 (982)
                      ...+++|||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56889999999999999886421                                                         


Q ss_pred             ---CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeeccccccccc
Q 036229          872 ---YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY  948 (982)
Q Consensus       872 ---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y  948 (982)
                         ..+++..+..++.||+.|++|||   ++||+||||||+||++++++.+||+|||++..+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               25788899999999999999999   999999999999999999999999999999876433333333345567789


Q ss_pred             ccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          949 MAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       949 ~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +|||++.+..++..   .|+|++|++
T Consensus       242 ~aPE~~~~~~~~~~---~Di~SlGv~  264 (337)
T cd05054         242 MAPESIFDKVYTTQ---SDVWSFGVL  264 (337)
T ss_pred             cCcHHhcCCCCCcc---ccHHHHHHH
Confidence            99999977665544   556666644

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=3.6e-26  Score=244.99  Aligned_cols=184  Identities=24%  Similarity=0.368  Sum_probs=150.3

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999864 68999999876432 33456789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccc
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL  943 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  943 (982)
                      .+++......+++.++..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999766656889999999999999999999   9999999999999999999999999999988643221111111122


Q ss_pred             cccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          944 ATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       944 gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ++..|+|||.+.+..++.   ..|+|++|+++
T Consensus       158 ~~~~y~aPE~~~~~~~~~---~~Dv~slG~il  186 (252)
T cd05084         158 IPVKWTAPEALNYGRYSS---ESDVWSFGILL  186 (252)
T ss_pred             CceeecCchhhcCCCCCh---HHHHHHHHHHH
Confidence            345799999987665443   35677777544

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.93  E-value=5.8e-26  Score=249.32  Aligned_cols=193  Identities=28%  Similarity=0.432  Sum_probs=156.3

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  848 (982)
                      ...++|+..+.||+|+||.||+|...      ....||+|.+... ......++.+|+++++++ +||||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567899999999999999999753      2478999998754 233446688999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcC---------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          849 EFKALILEYMPHGSLEKSLYSS---------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                      +..+++|||+++|+|.+++...               ...+++..+..++.|++.|++|||   +++|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            9999999999999999998642               245788999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ++++.+||+|||.++.+.............++..|+|||++.+..++   ..+|+|++|+++
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~il  224 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT---HQSDVWSFGVLL  224 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC---cccceeehhhHH
Confidence            99999999999999876433222222233456789999998766554   335667777543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=4.3e-26  Score=245.81  Aligned_cols=189  Identities=26%  Similarity=0.376  Sum_probs=156.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346789999999999999999998778899999987543 3356788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   ++||+||||||+||++++++.+||+|||++........ 
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence            99999999997543 45889999999999999999999   99999999999999999999999999999987642211 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ........+..|+|||++.+..++   ...|+|++|++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~~  193 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFS---IKSDVWSFGIL  193 (261)
T ss_pred             cccCCCcCceeccCccccccCCCC---chhhHHHHHHH
Confidence            111122234579999998765544   44677777744

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.93  E-value=4.6e-26  Score=248.05  Aligned_cols=188  Identities=24%  Similarity=0.370  Sum_probs=153.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCe----EEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGM----EVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ++|++.+.||+|+||+||+|++. +++    .||+|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            56888899999999999999863 343    47778775332 2334677888889999999999999998864 45788


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ++||+++|+|.+++......+++..+..++.|++.|++|+|   ++|++||||||+||++++++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876443


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ..........++..|+|||.+.+..++   ..+|+|++|++
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~---~~~Dv~slG~i  200 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYT---HQSDVWSYGVT  200 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcC---chhhHHHHHHH
Confidence            333333445577889999999766554   34667777744

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=2.4e-26  Score=259.00  Aligned_cols=182  Identities=19%  Similarity=0.235  Sum_probs=152.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999864 4788999975422      23569999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+. +++.+++......+++..+..++.|++.||.|||   ++|||||||||+||+++.++.+||+|||.++.....   
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            995 5898988776677899999999999999999999   999999999999999999999999999999753211   


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .......||+.|+|||++.+..++.   .+|+|++|+++
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlGvvl  246 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNS---KADIWSAGIVL  246 (357)
T ss_pred             cccccccccccccCCeecCCCCCCc---hhhHHHHHHHH
Confidence            1223456899999999997766553   35667776443

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=8.5e-26  Score=246.49  Aligned_cols=189  Identities=23%  Similarity=0.324  Sum_probs=156.0

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      |++.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            677889999999999999865 4888999998766555667888999999999999999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      +++..++......+++..+..++.|++.||.|||   +.||+||||||+||+++.++.+||+|||++......  .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence            9999988765567899999999999999999999   999999999999999999999999999998765322  12223


Q ss_pred             ccccccccccCceeeeee--eeeEEeeEeeeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~~~l  975 (982)
                      ...+++.|+|||++....  ....+..+|+|++|+++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil  198 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL  198 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHH
Confidence            456899999999984221  11122346667776433

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.93  E-value=2.4e-26  Score=265.25  Aligned_cols=181  Identities=29%  Similarity=0.411  Sum_probs=142.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCC--------
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--------  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------  848 (982)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            346799999999999999999986 458999999885432    2345799999999999999998876332        


Q ss_pred             CeeEEEEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEee
Q 036229          849 EFKALILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDF  924 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DF  924 (982)
                      ...++||||+++ ++.+++..   ....+++..+..++.|++.||+|||   ++||+||||||+||+++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 77776652   3456889999999999999999999   99999999999999998654 7999999


Q ss_pred             cCceeecCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          925 GIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       925 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      |+|+.+....   ......||+.|||||++.+. .++.   .+|+|++|
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwSlG  258 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTT---HIDLWSLG  258 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCc---HHHHHHHH
Confidence            9998763322   22345789999999998654 3433   34555555

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.93  E-value=9.2e-27  Score=271.37  Aligned_cols=197  Identities=26%  Similarity=0.416  Sum_probs=157.9

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecC-------
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCST-------  847 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------  847 (982)
                      +...+|++.+.||+||||.||+|+.+ +|+.||||++... .......+.+|++++++++|||||++|..|.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45677889999999999999999854 7999999999765 34456778999999999999999999832200       


Q ss_pred             --------------------------------------------------------------------------------
Q 036229          848 --------------------------------------------------------------------------------  847 (982)
Q Consensus       848 --------------------------------------------------------------------------------  847 (982)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHc
Q 036229          848 ------------------------E--------EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF  895 (982)
Q Consensus       848 ------------------------~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~  895 (982)
                                              +        ..+||-||||+..++.+++.+....-.....+++++||+.||.|+| 
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence                                    0        1357899999987777777654432246678899999999999999 


Q ss_pred             cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec----------------CCCCceeecccccccccccCceeeeeee
Q 036229          896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI----------------GEDQSITQTQTLATIGYMAPGLFHVKYI  959 (982)
Q Consensus       896 ~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~  959 (982)
                        ++|||||||||.||+++++..|||+|||+|....                ........+..+||.-|+|||++.+...
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence              9999999999999999999999999999998721                0112224467899999999999976653


Q ss_pred             eeEEeeEeeeeeeeeec
Q 036229          960 LFVVNFLTSYSFLMIFI  976 (982)
Q Consensus       960 ~~~~~~~d~~~~~~~l~  976 (982)
                      ...+.++|+|++|++++
T Consensus       793 ~~Yn~KiDmYSLGIVlF  809 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLF  809 (1351)
T ss_pred             ccccchhhhHHHHHHHH
Confidence            45567789999998775

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.93  E-value=7.2e-26  Score=246.15  Aligned_cols=176  Identities=26%  Similarity=0.399  Sum_probs=145.8

Q ss_pred             eeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ||+|+||.||+++.. +|+.||+|++....   ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999854 58999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             HHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeeccc
Q 036229          864 EKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT  942 (982)
Q Consensus       864 ~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  942 (982)
                      .+++... ...+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            8887643 335788889999999999999999   9999999999999999999999999999998763221   22345


Q ss_pred             ccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          943 LATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       943 ~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .|++.|+|||++.+..++..   +|+|++|
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~---~DvwslG  181 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYP---VDWFAMG  181 (277)
T ss_pred             CCCCCccCHHHHccCCCCCc---hhHHHHH
Confidence            68999999999977665533   4556666

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=4.2e-26  Score=250.62  Aligned_cols=191  Identities=24%  Similarity=0.379  Sum_probs=154.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC---------------CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE---------------GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVI  842 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~  842 (982)
                      .++|++.+.||+|+||.||+|+...               ...||+|.++.. .......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4589999999999999999987532               235899998754 233456789999999999999999999


Q ss_pred             eeecCCCeeEEEEEeccCCChHHHHhcCC-----------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCE
Q 036229          843 SSCSTEEFKALILEYMPHGSLEKSLYSSN-----------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNV  911 (982)
Q Consensus       843 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NI  911 (982)
                      +++...+..++||||+++++|.+++....           ..+++..+..++.|++.|++|||   ++|++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999986432           13578888999999999999999   99999999999999


Q ss_pred             EEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          912 LLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       912 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ++++++.+||+|||++................++..|+|||++.+..++   ..+|+|++|+++
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DvwSlG~~l  221 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT---TASDVWAFGVTL  221 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC---chhhHHHHHHHH
Confidence            9999999999999999865333222222334457789999998766544   446677777543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=4.2e-26  Score=245.06  Aligned_cols=187  Identities=25%  Similarity=0.389  Sum_probs=154.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      .+|++.+.||+|+||.||+|+++++..+|+|++.... ...+++.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4588899999999999999998777889999986432 234568889999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            99999999866556899999999999999999999   99999999999999999999999999999986532211 111


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....++..|+|||.+.+..++.   ..|+|++|++
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~---~~Di~slG~i  190 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSS---KSDVWSFGVL  190 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCc---hhhHHHHHHH
Confidence            2223445799999997765553   3566776643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.9e-26  Score=249.96  Aligned_cols=190  Identities=23%  Similarity=0.320  Sum_probs=160.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999864 5899999999866666667889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++.+.+..+++..+..++.|++.|+.|||   ++||+||||||+||+++.++.+||+|||.+.......  .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            9999999999876667899999999999999999999   9999999999999999999999999999987643221  1


Q ss_pred             eecccccccccccCceeeeeee--eeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYI--LFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~d~~~~~~  973 (982)
                      ......+++.|+|||++..+..  ...+..+|+|++|+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~  196 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGI  196 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHH
Confidence            2234568999999999854321  22334566677664

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=3.9e-26  Score=259.31  Aligned_cols=183  Identities=26%  Similarity=0.326  Sum_probs=149.5

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC-----eeE
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-----FKA  852 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~  852 (982)
                      +|+..+.||+|+||.||+|+. .+++.||+|++...  .....+++.+|+++++.++||||+++++++..++     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999985 46899999998643  2234567889999999999999999999998776     789


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+. +++.+.+... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus        81 lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 5888877543 35889999999999999999999   99999999999999999999999999999986532


Q ss_pred             CCCceeecccccccccccCceeeeee-eeeEEeeEeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL  972 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~  972 (982)
                      .. ........+++.|+|||++.+.. ++.   ..|+|++|
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~---~~DiwslG  192 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTS---AVDIWSVG  192 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCc---HHHHHhHH
Confidence            22 12223456899999999987643 332   34556655

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=240.19  Aligned_cols=201  Identities=29%  Similarity=0.428  Sum_probs=163.4

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecc-------cchhhhhHHHHHHHhhhcCCccceeEEeeecC-CC
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ-------CGRAFKSFDVECEMMKSIRHRNLIKVISSCST-EE  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~  849 (982)
                      .++|-....+|+|+|+.||+|. ....+.||||+-...       .....+...+|.+|-+.+.||.||++|+++.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4678888999999999999997 556899999986432       12234567789999999999999999999854 46


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecC
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGI  926 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGl  926 (982)
                      .+|-|+|||+|.+|+-+++..+ .+++.++..|+.||+.||.||. +-+.+|||-|+||.|||+.   ..|.+||.|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7889999999999998887654 5899999999999999999998 4467899999999999995   458999999999


Q ss_pred             ceeecCCCCc-----eeecccccccccccCcee-eeeeeeeEEeeEeeeeeeeee----cccCCC
Q 036229          927 AKLLIGEDQS-----ITQTQTLATIGYMAPGLF-HVKYILFVVNFLTSYSFLMIF----IGRGNY  981 (982)
Q Consensus       927 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~~d~~~~~~~l----~~~~~f  981 (982)
                      ++++.++...     .......||.+|.+||.+ -++.....+.+.|+|++|+++    +|.+||
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPF  684 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPF  684 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCC
Confidence            9998654322     223567899999999998 444455566778888888765    455555

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=1.1e-25  Score=245.74  Aligned_cols=189  Identities=24%  Similarity=0.426  Sum_probs=154.3

Q ss_pred             cCCCccceeeeeceEEEEEEEe-----CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCC--Cee
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFK  851 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~  851 (982)
                      .-|++.+.||+|+||.||+|+.     .+++.||+|.++... ......+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478899999999999999974     347889999987543 33456789999999999999999999998775  568


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++.+....+++.++..++.|++.||+|+|   ++||+||||||+||+++.++.+||+|||++..+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            8999999999999999766556899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCce-eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          932 GEDQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       932 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ...... ......++..|+|||++.+..++..   .|+|++|++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~---~Di~slG~i  201 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA---SDVWSFGVT  201 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCcc---ccchhhhhh
Confidence            332221 1223456778999999876655433   455666643

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=2.1e-26  Score=248.28  Aligned_cols=189  Identities=26%  Similarity=0.413  Sum_probs=160.0

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      +...+|+..+.||+|+||.||+|+..+++.||+|++.........++..|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567999999999999999999987799999999986655566788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++++|.+++... ...+++.++..++.|++.|++|||   ++||+||||||+||++++++.+||+|||.+....... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence            99999999999763 345789999999999999999999   9999999999999999999999999999998763321 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       .......++..|+|||++.+..++..   .|+|++|+
T Consensus       159 -~~~~~~~~~~~~~~PE~~~~~~~~~~---~DiwslG~  192 (261)
T cd05148         159 -YLSSDKKIPYKWTAPEAASHGTFSTK---SDVWSFGI  192 (261)
T ss_pred             -ccccCCCCceEecCHHHHccCCCCch---hhHHHHHH
Confidence             11223456778999999876655433   55666663

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=7.8e-28  Score=248.58  Aligned_cols=429  Identities=24%  Similarity=0.246  Sum_probs=263.0

Q ss_pred             EEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCcccccc-Cc
Q 036229           86 LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY-NA  164 (982)
Q Consensus        86 L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~  164 (982)
                      ++-++.+|+ .+|..+.  ..-+.++|..|+|+..-|.+|..+++|+.||||+|+|+..-|+.|..+.+|..|-+.+ |+
T Consensus        51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk  127 (498)
T KOG4237|consen   51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK  127 (498)
T ss_pred             EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence            445555665 5565443  2446788888888855555788888999999999998888888888888877766655 88


Q ss_pred             ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccccccccc-ccccccchhhhhccCCCCC----
Q 036229          165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPK-EIGNLTKLKELYLGYSGLQ----  239 (982)
Q Consensus       165 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~----  239 (982)
                      |+ .+|.+.|.+|..|+.|.+.-|++.-...++|..+++|..|.|.+|.+. .+++ .|..+..++.+.+..|.+.    
T Consensus       128 I~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCn  205 (498)
T KOG4237|consen  128 IT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCN  205 (498)
T ss_pred             hh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccc
Confidence            88 889988899999999999989888778888888999999999999887 4444 7888888999988888732    


Q ss_pred             --------CchhhhcCCCcccceEeccccccCCcCChhhhcc-CCCcEEEccCCccccCCC-ccccccCCCcEEEccCcc
Q 036229          240 --------GEIPREFGNLAELELMALQVSNLQGEIPQELANL-TGLEVLKLGKNFLTGEIP-PEIHNLHNLKLLDLSHNK  309 (982)
Q Consensus       240 --------~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~  309 (982)
                              ...|..++...-..-..+..+++..+-+..|... .++..=-.+....-++-| ..|..+++|++|+|++|+
T Consensus       206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~  285 (498)
T KOG4237|consen  206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK  285 (498)
T ss_pred             cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence                    2234444444444444555555544444433321 222111122222323334 357778888888888888


Q ss_pred             ccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCC
Q 036229          310 LVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN  389 (982)
Q Consensus       310 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~  389 (982)
                      |+++-+.+|.....++.|.|.+|+|. .+++..|..+..|++|+|.+|+|+...|.+|..+.+|.+|.|-.|.+.--   
T Consensus       286 i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn---  361 (498)
T KOG4237|consen  286 ITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN---  361 (498)
T ss_pred             cchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc---
Confidence            88777777877777777777777765 44555555666667777777777766677777777777777766655321   


Q ss_pred             ccccCCcccee--cccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCC
Q 036229          390 TFGNLRNLRLM--TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFP  467 (982)
Q Consensus       390 ~~~~l~~L~~L--~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p  467 (982)
                          + .|..|  .|..+.-...+       ..+.-..++.+.++++.+........        +.   .++.-++.-|
T Consensus       362 ----C-~l~wl~~Wlr~~~~~~~~-------~Cq~p~~~~~~~~~dv~~~~~~c~~~--------ee---~~~~~s~~cP  418 (498)
T KOG4237|consen  362 ----C-RLAWLGEWLRKKSVVGNP-------RCQSPGFVRQIPISDVAFGDFRCGGP--------EE---LGCLTSSPCP  418 (498)
T ss_pred             ----c-chHHHHHHHhhCCCCCCC-------CCCCCchhccccchhccccccccCCc--------cc---cCCCCCCCCC
Confidence                0 01000  01111100000       11222345566666665443211100        00   0011111112


Q ss_pred             cccccccccceE-EecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCC
Q 036229          468 KEIGNLTNLIGI-YLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLA  546 (982)
Q Consensus       468 ~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  546 (982)
                      .   .++-+.+. .-+++.++ .+|..+.  ..-.+|++.+|.++ .+|+.  .+..| .+|+++|+|+......|.+++
T Consensus       419 ~---~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~t  488 (498)
T KOG4237|consen  419 P---PCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMT  488 (498)
T ss_pred             C---CcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchh
Confidence            1   22333332 23333333 4444332  34567778888887 56655  45666 778888888766666777777


Q ss_pred             cccccccCCC
Q 036229          547 SLGTLSLGSN  556 (982)
Q Consensus       547 ~L~~L~L~~N  556 (982)
                      +|.+|.|++|
T Consensus       489 ql~tlilsyn  498 (498)
T KOG4237|consen  489 QLSTLILSYN  498 (498)
T ss_pred             hhheeEEecC
Confidence            7777777765

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=4.4e-26  Score=249.48  Aligned_cols=193  Identities=21%  Similarity=0.353  Sum_probs=154.6

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.++... ......+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999642      25689999886443 233456788999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCC---------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 036229          850 FKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  920 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  920 (982)
                      ..++||||+++|+|.+++....         ...++..+..++.|++.|+.|||   +++|+||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999997422         23456778899999999999999   99999999999999999999999


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      |+|||+++...............++..|+|||.+.+..++   ...|+|++|+++
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~---~~~DvwslG~~l  211 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT---TSSDMWSFGVVL  211 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCC---hHhHHHHHHHHH
Confidence            9999999865333222222233456789999998766554   345677777554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=8.2e-26  Score=246.89  Aligned_cols=189  Identities=27%  Similarity=0.414  Sum_probs=154.6

Q ss_pred             cCCCccceeeeeceEEEEEEEe-----CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC--CCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~  852 (982)
                      .+|++.+.||+|+||.||+|+.     .+++.||+|+++.......+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788899999999999999974     2478999999876655566788999999999999999999998743  34688


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++++|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999766666899999999999999999999   99999999999999999999999999999997643


Q ss_pred             CCCceee-cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          933 EDQSITQ-TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       933 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....... ....++..|+|||++.+..++.   ..|+|++|++
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  200 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSV---ASDVWSFGVV  200 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcCh---HHHHHHHHHH
Confidence            3322111 1223445699999997665543   3556666644

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.93  E-value=7.6e-26  Score=243.87  Aligned_cols=188  Identities=23%  Similarity=0.401  Sum_probs=156.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46789999999999999999998788889999886432 33568899999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++++|.+++... ....++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.+........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999998753 345788889999999999999999   99999999999999999999999999999987633221 1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......++..|+|||++.+..++.   ..|+|++|++
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  193 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTI---KSDVWSFGIL  193 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCCh---hhhhhhhHHH
Confidence            122334667899999987665543   3556666643

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.93  E-value=5.7e-26  Score=246.02  Aligned_cols=187  Identities=24%  Similarity=0.317  Sum_probs=146.0

Q ss_pred             ceeeeeceEEEEEEEeCC---CeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          786 NLIGRGGFGSVYKARIGE---GMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.||+|+||.||+|+..+   ...+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997432   4578888775432 233456788999999999999999999999999999999999999


Q ss_pred             ChHHHHhcCCC----cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          862 SLEKSLYSSNY----ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       862 sL~~~l~~~~~----~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +|.+++.....    ..++..+..++.|++.|++|||   ++||+||||||+||++++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999976432    2457778899999999999999   9999999999999999999999999999987543322222


Q ss_pred             eecccccccccccCceeeeeee----eeEEeeEeeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYI----LFVVNFLTSYSFLMIF  975 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~d~~~~~~~l  975 (982)
                      ......+++.|+|||++.....    ...+..+|+|++|+++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM  199 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence            2233456778999999753211    1223456777777443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.93  E-value=1e-25  Score=247.79  Aligned_cols=191  Identities=23%  Similarity=0.347  Sum_probs=157.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC-----------------CeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCcccee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE-----------------GMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIK  840 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~  840 (982)
                      .++|++.+.||+|+||.||+|+...                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4679999999999999999987532                 3568999987543 344678889999999999999999


Q ss_pred             EEeeecCCCeeEEEEEeccCCChHHHHhcCC----------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 036229          841 VISSCSTEEFKALILEYMPHGSLEKSLYSSN----------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSN  910 (982)
Q Consensus       841 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~N  910 (982)
                      +++++..++..++||||+++++|.+++....          ..+++..+..++.|++.||+|||   +.||+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987543          25789999999999999999999   9999999999999


Q ss_pred             EEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          911 VLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       911 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      |++++++.+||+|||+++...............+++.|||||++.+..++   ..+|+|++|+++
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~~l  222 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT---TKSDVWAFGVTL  222 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC---ccchhhhhHHHH
Confidence            99999999999999999865433322333345567899999998765544   446677777544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=1.1e-25  Score=245.67  Aligned_cols=183  Identities=23%  Similarity=0.371  Sum_probs=152.2

Q ss_pred             CCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      |+..+.||+|+||+||+|.. .+++.||+|.+....   ......+.+|++++++++|++|+++++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67778999999999999986 468999999986442   22334577899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++... ...+++..+..++.|++.||.|||   ++||+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999888653 335899999999999999999999   9999999999999999999999999999997653221  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ......|+..|+|||++.+..++..   .|+|++|+
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~---~Di~slG~  189 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLS---PDYWGLGC  189 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcc---cchHHHHH
Confidence             1234578999999999977655543   45566553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=4.7e-26  Score=258.54  Aligned_cols=195  Identities=23%  Similarity=0.387  Sum_probs=156.1

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcC-CccceeEEeeec
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCS  846 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~  846 (982)
                      +....++|.+.++||+|+||.||+|++.      .++.||+|+++... ....+.+.+|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3345567888999999999999999853      35789999997542 233457889999999997 999999999999


Q ss_pred             CCCeeEEEEEeccCCChHHHHhcCC-------------------------------------------------------
Q 036229          847 TEEFKALILEYMPHGSLEKSLYSSN-------------------------------------------------------  871 (982)
Q Consensus       847 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  871 (982)
                      ..+..++||||+++|+|.+++++.+                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999986432                                                       


Q ss_pred             ------------------------------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 036229          872 ------------------------------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPS  909 (982)
Q Consensus       872 ------------------------------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~  909 (982)
                                                                ..+++..+..++.|++.||+|||   +++|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence                                                      13566778889999999999999   999999999999


Q ss_pred             CEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          910 NVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       910 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ||++++++.+||+|||+++.+.............+++.|||||.+.+..++.   ..|+|++|+++
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslGvil  331 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT---LSDVWSFGILL  331 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc---HhHHHHHHHHH
Confidence            9999999999999999998753332222223345788999999997665543   35667777543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.93  E-value=7.9e-26  Score=247.88  Aligned_cols=188  Identities=27%  Similarity=0.420  Sum_probs=156.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .+|...+.||+|+||.||+|+..      ++..||+|.++.......+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888899999999999999742      356789999876555556788999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 036229          854 ILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV  918 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  918 (982)
                      ||||+++++|.+++....               ..+++..+..++.|++.|++|||   ++||+||||||+||++++++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999996432               24788999999999999999999   999999999999999999999


Q ss_pred             EEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          919 AHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       919 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +||+|||++................++..|+|||++.+..++.   .+|+|++|+
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  213 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT---ESDVWSFGV  213 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCc---hhhHHHHHH
Confidence            9999999998654333222234456788999999987765543   356677663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.93  E-value=7.1e-26  Score=249.94  Aligned_cols=191  Identities=28%  Similarity=0.434  Sum_probs=155.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe--------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI--------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      ..++|++.+.||+|+||.||+|+.        .++..||+|.++... .....++.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            456788999999999999999963        124579999986442 34456788999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                      .+..++||||+++|+|.+++....               ..+++.++..++.|++.|++|||   ++||+||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            999999999999999999987532               24678888999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       913 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +++++.+||+|||.++...............+++.|+|||++.+..++.   .+|+|++|++
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  228 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH---QSDVWSFGVL  228 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc---hhhHHHHHHH
Confidence            9999999999999998764333222223345677899999997765543   3566777754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.93  E-value=9.2e-26  Score=244.10  Aligned_cols=186  Identities=25%  Similarity=0.374  Sum_probs=154.4

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|+. .+++.||+|.++..   .......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999985 46899999987642   2334457888999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   ++|++||||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2345788899999999999999999   99999999999999999999999999999987632


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..  .......|++.|+|||.+.+...+.   ..|+|++|+
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~---~~Di~slG~  194 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNF---KSDIWSLGC  194 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCc---hhhHHHHHH
Confidence            22  1123456888999999987655443   356666663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.93  E-value=7.4e-26  Score=255.79  Aligned_cols=189  Identities=25%  Similarity=0.296  Sum_probs=151.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC-----
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-----  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----  849 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999854 5899999998643  2334567788999999999999999999886543     


Q ss_pred             -eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          850 -FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       850 -~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                       ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             57999999965 66666643   3678888999999999999999   9999999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .....   .......||+.|+|||++.+..++..   +|+|++|  ++.+.+|
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~---~DiwSlG~il~el~tg  218 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVGCIMGELVKG  218 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCchhccCCCCCcc---hhhHHHHHHHHHHHhC
Confidence            64221   22234578999999999987666544   4556666  4444443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=1.1e-25  Score=243.89  Aligned_cols=189  Identities=24%  Similarity=0.430  Sum_probs=153.9

Q ss_pred             cCCCccceeeeeceEEEEEEEeCC-C---eEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGE-G---MEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +.|++.+.||+|+||.||+|+... +   ..||+|+++.. ......++..|++++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457889999999999999998542 3   46999998754 334467899999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++......+++.++..++.|++.|++|||   ++|++||||||+||+++.++.+|++|||.+.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999988654322


Q ss_pred             Cceeecccc---cccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          935 QSITQTQTL---ATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       935 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .........   .+..|+|||++.+..++.   ..|+|++|++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~---~~DvwslG~~  200 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTS---ASDVWSYGIV  200 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccc---hhhhhhhHHH
Confidence            211111111   245799999997665543   4566666643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=249.28  Aligned_cols=196  Identities=24%  Similarity=0.395  Sum_probs=162.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC-----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE-----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .+..+..+.||+|-||.||+|.+.+     .-.||||..+.+ .....+.|..|+.+|+.++||||++++|.|.+. ..|
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            3445667899999999999997422     345899998764 345578899999999999999999999999765 579


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +|||.++.|.|..+++..+..++......++.||..||.|||   ++.+|||||..+|||+.....||++|||+++.+.+
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999999998888999999999999999999999   99999999999999999999999999999998755


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee-----eeecccCCCC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL-----MIFIGRGNYY  982 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~-----~~l~~~~~f~  982 (982)
                      +..+.. +...-...|||||.+.-..++.+   +|+|.||     ++.+|..||+
T Consensus       544 ~~yYka-S~~kLPIKWmaPESINfRrFTtA---SDVWMFgVCmWEIl~lGvkPfq  594 (974)
T KOG4257|consen  544 DAYYKA-SRGKLPIKWMAPESINFRRFTTA---SDVWMFGVCMWEILSLGVKPFQ  594 (974)
T ss_pred             cchhhc-cccccceeecCccccchhcccch---hhHHHHHHHHHHHHHhcCCccc
Confidence            443332 33344668999999977766655   4555555     3556777774

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.93  E-value=9.3e-26  Score=250.66  Aligned_cols=179  Identities=22%  Similarity=0.303  Sum_probs=140.3

Q ss_pred             cceeeeeceEEEEEEEeC---CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC--CCeeEEEEEecc
Q 036229          785 NNLIGRGGFGSVYKARIG---EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFKALILEYMP  859 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~E~~~  859 (982)
                      .++||+|+||+||+|+..   +++.||+|.++...  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46889999986432  23457789999999999999999998854  457889999995


Q ss_pred             CCChHHHHhcC--------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCc
Q 036229          860 HGSLEKSLYSS--------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA  927 (982)
Q Consensus       860 ~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla  927 (982)
                       +++.+++...        ...+++..++.++.|++.||+|||   ++||+||||||+||++    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5888877532        224788899999999999999999   9999999999999999    45679999999999


Q ss_pred             eeecCCCCc-eeecccccccccccCceeeeee-eeeEEeeEeeeeee
Q 036229          928 KLLIGEDQS-ITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL  972 (982)
Q Consensus       928 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~  972 (982)
                      +.+...... .......||+.|+|||++.+.. ++..   +|+|++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwslG  203 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA---IDIWAIG  203 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCch---hhHHHHH
Confidence            876432211 2224567899999999987643 3333   4455555

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.93  E-value=1.6e-25  Score=243.90  Aligned_cols=178  Identities=26%  Similarity=0.312  Sum_probs=150.2

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|+..+.||+|+||.||+|+. .+++.||+|++... .......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999985 46899999998754 233456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++++++..+.     .+++..+..++.|++.|++|||   +.||+|+||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999996542     3578888899999999999999   999999999999999999999999999999865322    


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ......|+..|+|||++.+..++.   ..|+|++|
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG  180 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGI---HSDVWSLG  180 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCC---cchHHHHH
Confidence            223457899999999997765543   35566666

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.4e-26  Score=249.09  Aligned_cols=198  Identities=20%  Similarity=0.343  Sum_probs=159.6

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..-|..++.||-|+||+|.+++ .++...+|+|.+++.+   ......++.|.+||.....+-||++|-.|++++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            3458889999999999999997 5567889999987653   23445678899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC--
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG--  932 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~--  932 (982)
                      |||++||++..++.+.+ .+++..+..++.++..|+++.|   ..|+|||||||+|||||.+|++||.|||++.-+..  
T Consensus       708 MdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             EeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecc
Confidence            99999999999887654 5888889999999999999999   99999999999999999999999999999864321  


Q ss_pred             ------CCCc--------------------------------eeecccccccccccCceeeeeeeeeEEeeEeeeeee--
Q 036229          933 ------EDQS--------------------------------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--  972 (982)
Q Consensus       933 ------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--  972 (982)
                            +..+                                ......+||+.|+|||++....+....||| ..|++  
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww-s~gvil~  862 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW-SVGVILY  862 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh-HhhHHHH
Confidence                  0000                                001134799999999999877777665554 33443  


Q ss_pred             eeecccCCC
Q 036229          973 MIFIGRGNY  981 (982)
Q Consensus       973 ~~l~~~~~f  981 (982)
                      .+++|.-||
T Consensus       863 em~~g~~pf  871 (1034)
T KOG0608|consen  863 EMLVGQPPF  871 (1034)
T ss_pred             HHhhCCCCc
Confidence            344555555

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.93  E-value=1.2e-25  Score=243.48  Aligned_cols=186  Identities=24%  Similarity=0.341  Sum_probs=147.4

Q ss_pred             ceeeeeceEEEEEEEeC---CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          786 NLIGRGGFGSVYKARIG---EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.||+|+||.||+|+..   ++..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46899999999999753   35679999886543 233457888999999999999999999999999999999999999


Q ss_pred             ChHHHHhcCC----CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          862 SLEKSLYSSN----YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       862 sL~~~l~~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +|.+++....    ...++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+||+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999987532    23567778889999999999999   9999999999999999999999999999997643322222


Q ss_pred             eecccccccccccCceeeeeee----eeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYI----LFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~d~~~~~~~  974 (982)
                      ......++..|+|||++.+...    ...+..+|+|++|++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~  198 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT  198 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHH
Confidence            2234567888999999864321    112345677777754

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.93  E-value=9.7e-26  Score=249.95  Aligned_cols=192  Identities=27%  Similarity=0.418  Sum_probs=153.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC--------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG--------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      ..++|.+.+.||+|+||.||+|+..        ....||+|.++.. .......+..|+++++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467889999999999999999741        2567999998743 233456788999999999 69999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                      ++..++||||+++|+|.+++....               ..+++.++.+++.|++.|++|||   ++||+||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence            999999999999999999997532               34788899999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       913 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      +++++.+||+|||.++...............++..|||||++.+..++.   ..|+|++|+++
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~~l  226 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH---QSDVWSFGILM  226 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc---cchhhHHHHHH
Confidence            9999999999999998653322211122223456799999987765553   35667777443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.93  E-value=1.8e-25  Score=245.19  Aligned_cols=191  Identities=24%  Similarity=0.324  Sum_probs=158.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .+.|++.++||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467999999999999999999864 4899999999866666677888999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++++++..++.+....+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+......  ..
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            9999999888766667899999999999999999999   999999999999999999999999999998764222  11


Q ss_pred             eecccccccccccCceeeeee--eeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~~~  974 (982)
                      ......+++.|+|||++.+..  ....+...|+|++|++
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i  204 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT  204 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHH
Confidence            223456888999999985322  1112334566666643

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.93  E-value=8.1e-26  Score=246.82  Aligned_cols=189  Identities=26%  Similarity=0.479  Sum_probs=155.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeCC------CeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGE------GMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ++|++.+.||+|+||.||+|....      ...||+|.++... .....++.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478889999999999999997532      2679999986443 334567899999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          853 LILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      ++|||+++++|.+++....               ..+++.++..++.|++.|+.|||   ++|++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999987532               34778889999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .+||+|||+++...............+++.|+|||.+.+..++   ..+|+|++|++
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~sDv~slG~i  215 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT---TESDIWSFGVV  215 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc---hhhhHHHHHHH
Confidence            9999999999865433322333445678899999998765554   34667777744

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=1.2e-25  Score=243.06  Aligned_cols=190  Identities=23%  Similarity=0.422  Sum_probs=155.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+..    .+..||+|.++... ....+.+..|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357888999999999999999753    24479999986542 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++......+++.++..++.|++.|+.|||   +++++||||||+||+++.++.+|++|||++..+...
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999876666899999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCce-eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .... ......++..|+|||.+.+..++   ...|+|++|++
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~---~~~Dv~slG~~  198 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFT---SASDVWSYGIV  198 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccC---chhhhHHHHHH
Confidence            2211 11222345689999999766544   34566766643

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.93  E-value=9.6e-26  Score=245.64  Aligned_cols=189  Identities=24%  Similarity=0.352  Sum_probs=153.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCe----EEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGM----EVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|+..+.||+|+||+||+|++ .+++    .||+|+++... ......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            45788999999999999999984 3343    58999986543 33456788999999999999999999998754 467


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ++|||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ...........+++.|+|||...+..++   ..+|+|++|++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~---~~~Di~slG~~  200 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFT---HQSDVWSYGVT  200 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCC---chhHHHHHHHH
Confidence            3222222233456789999998766544   34566777743

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=7.7e-26  Score=253.71  Aligned_cols=191  Identities=25%  Similarity=0.414  Sum_probs=151.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCC-
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE-  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-  848 (982)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|++++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346899999999999999999973      347889999997543 23345788899999999 689999999987654 


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------------------------------------------------------
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------------------------------------------------------  871 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------  871 (982)
                      ...++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            46789999999999999986421                                                         


Q ss_pred             ---------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeeccc
Q 036229          872 ---------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT  942 (982)
Q Consensus       872 ---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  942 (982)
                               ..+++..+..++.|++.|++|||   ++||+||||||+||++++++.+||+|||++...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     13577788899999999999999   999999999999999999999999999999875333222222234


Q ss_pred             ccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          943 LATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       943 ~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .++..|+|||++.+..++.   ..|+|++|++
T Consensus       242 ~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  270 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTI---QSDVWSFGVL  270 (343)
T ss_pred             CCCcceECcHHhcCCCCCc---hhhHHHHHHH
Confidence            4567899999987665543   3566777744

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.3e-25  Score=242.13  Aligned_cols=190  Identities=27%  Similarity=0.354  Sum_probs=160.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||.||+|+.. +++.+|+|++........+.+.+|++++++++||||+++++++...+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367999999999999999999864 5788999999866555678899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++......+++.++..++.|++.|++|||   +.+|+|+||||+||++++++.+||+|||.+.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999998776567899999999999999999999   9999999999999999999999999999988653221  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......++..|+|||++.+......+..+|+|++|+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~  192 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI  192 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHH
Confidence            223456888999999986652122234466677663

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.93  E-value=7e-26  Score=249.59  Aligned_cols=186  Identities=23%  Similarity=0.342  Sum_probs=152.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            357999999999999999999864 58899999987542 2334567789999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++ ++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||++.......  
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            996 5999988776667889999999999999999999   9999999999999999999999999999997642221  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .......+++.|+|||++.+....  +..+|+|++|
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~--~~~~Dv~slG  192 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDY--STQIDMWGVG  192 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCC--ccHHHHHHHH
Confidence            122334678899999998654221  2334566666

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.6e-25  Score=239.98  Aligned_cols=187  Identities=25%  Similarity=0.372  Sum_probs=154.9

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc-----chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ++|+..+.||+|++|.||+|.. .++++||+|.+....     ....+.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5789999999999999999985 458999999986432     1234568889999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |+||+++++|.+++.... .+++..+..++.|++.|+.|||   +.||+||||||+||++++++.+||+|||.++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999987543 4788889999999999999999   999999999999999999999999999999865322


Q ss_pred             CCcee-ecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSIT-QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..... .....++..|+|||++.+..++   ...|+|++|+
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~  195 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYG---RKADVWSVGC  195 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCC---chhhhHHHHH
Confidence            11111 1345678899999999776544   3456676663

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.93  E-value=1.7e-25  Score=242.22  Aligned_cols=192  Identities=26%  Similarity=0.344  Sum_probs=156.3

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +.+++.+.....||+|+||.||+|+.. ++..||+|.++.......+.+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            445666777789999999999999854 5788999998766555667889999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcC--CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceeec
Q 036229          855 LEYMPHGSLEKSLYSSNYIL--DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLI  931 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~--~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~  931 (982)
                      +||+++++|.+++.......  ++..+..++.|++.|++|||   ++||+||||||+||+++. ++.+||+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999997654444  78888899999999999999   999999999999999976 6799999999988653


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....  ......|++.|+|||++.+.... .+..+|+|++|+
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~-~~~~~Dv~slGv  199 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRG-YGAPADIWSLGC  199 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhcccccc-CCchhhhHHHHH
Confidence            2221  12234588999999998553211 123456677663

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.8e-26  Score=232.43  Aligned_cols=190  Identities=24%  Similarity=0.298  Sum_probs=163.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|....+||+|+|++|..++. ++.+.+|+|+++++   ++...+.++.|..+..+. +||++|.++.+|+++...+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            356789999999999999999984 56899999999865   445566778888888777 7999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +|.||++||+|.-++++.+ +++++.+..+..+|.-||.|||   ++|||.||+|.+|||+|.+|++|+.|+|+++.-. 
T Consensus       328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l-  402 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-  402 (593)
T ss_pred             EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC-
Confidence            9999999999988776554 5889999999999999999999   9999999999999999999999999999998632 


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                       ........++|||.|+|||++++..|.+..| ||+.|+.++
T Consensus       403 -~~gd~tstfcgtpnyiapeilrgeeygfsvd-wwalgvlmf  442 (593)
T KOG0695|consen  403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVD-WWALGVLMF  442 (593)
T ss_pred             -CCCcccccccCCCcccchhhhcccccCceeh-HHHHHHHHH
Confidence             2334556789999999999999999987755 455555544

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.93  E-value=1.6e-25  Score=246.03  Aligned_cols=190  Identities=23%  Similarity=0.361  Sum_probs=153.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-----------------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCcccee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-----------------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIK  840 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~  840 (982)
                      .++|++.+.||+|+||.||+|+..                 ++..||+|++... .....+++.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998532                 2456899998754 2334568899999999999999999


Q ss_pred             EEeeecCCCeeEEEEEeccCCChHHHHhcCC----------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 036229          841 VISSCSTEEFKALILEYMPHGSLEKSLYSSN----------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSN  910 (982)
Q Consensus       841 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~N  910 (982)
                      +++++..++..++||||+++++|.+++....          ..+++.++..++.|++.|++|||   +.||+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            9999999999999999999999999987532          23667789999999999999999   9999999999999


Q ss_pred             EEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          911 VLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       911 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |++++++.+||+|||+++.+.............+++.|+|||+..++.++.   ..|+|++|++
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~~DiwSlG~~  221 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT---ASDVWAFGVT  221 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc---hhhhhHHHHH
Confidence            999999999999999998653322222222334567899999876665543   3566776644

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.93  E-value=1.1e-25  Score=245.18  Aligned_cols=188  Identities=26%  Similarity=0.416  Sum_probs=155.8

Q ss_pred             cCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .+|...++||+|+||.||+|..      .++..||+|.++.......+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            5678899999999999999963      2367899999876666667789999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCC--------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          854 ILEYMPHGSLEKSLYSSN--------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                      ||||+++++|.+++....              ..+++..+..++.|++.|++|||   ++||+||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987542              24788899999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||+|||++................+++.|+|||.+.+..++..   +|+|++|+
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  212 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE---SDIWSFGV  212 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch---hhHHHHHH
Confidence            9999999986543222222233445788999999877655533   56677663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=2.1e-25  Score=243.53  Aligned_cols=183  Identities=24%  Similarity=0.378  Sum_probs=151.7

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .|+..+.||+|+||.||+|... +++.||+|.+....   ......+.+|+.++++++|++|+++++.+.+++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999854 58999999986432   2223456789999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++++|.+++... ...+++..+..++.|++.|+.|||   +.||+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            99999999988643 335888999999999999999999   9999999999999999999999999999987653222 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        ......|+..|+|||++.+..++..   .|+|++|
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~---~DiwslG  188 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFS---PDWWALG  188 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCc---cccHHHH
Confidence              1223578999999999977665544   4455555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.92  E-value=1.8e-25  Score=246.33  Aligned_cols=187  Identities=29%  Similarity=0.462  Sum_probs=149.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCe--EEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGM--EVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|++. ++.  .+|+|.++.. .......+.+|++++.++ +||||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            457889999999999999999864 343  4677776543 233456788899999999 89999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 036229          854 ILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV  918 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  918 (982)
                      ||||+++++|.+++....               ..+++.++..++.|++.|++|||   ++||+||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999987432               24788899999999999999999   999999999999999999999


Q ss_pred             EEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          919 AHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       919 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +||+|||++.....   ........++..|+|||++.+..++.   ..|+|++|++
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~i  212 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTT---NSDVWSYGVL  212 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcc---cccchhhhhH
Confidence            99999999864211   11111223466799999987665543   3566777643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=2.1e-25  Score=244.34  Aligned_cols=182  Identities=28%  Similarity=0.362  Sum_probs=155.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|++|.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47889999999999999999864 58999999986432   234567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   ++||+||||+|+||++++++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            999999999998765 45889999999999999999999   999999999999999999999999999999876332  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....+++.|+|||.+.+...+   ...|+|++|+
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~  186 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYG---KAVDWWALGI  186 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCC---ccccHHHHHH
Confidence               2345688999999998765444   3356666663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.92  E-value=9.2e-26  Score=249.37  Aligned_cols=190  Identities=28%  Similarity=0.416  Sum_probs=153.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC--------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCC
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG--------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE  848 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  848 (982)
                      .++|.+.+.||+|+||.||+|+..        +...||+|.++... .....++..|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999742        23569999987542 33456788899999999 799999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                      +..++||||+++|+|.+++...+               ..+++.++.+++.|++.||+|||   ++|++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997532               24788899999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ++++.+||+|||.+................+++.|+|||++.+..++.   .+|+|++|++
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~~  231 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH---QSDVWSFGVL  231 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc---HHHHHHHHHH
Confidence            999999999999988653222111122233457899999987665543   3566666643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=7.6e-26  Score=270.82  Aligned_cols=192  Identities=21%  Similarity=0.331  Sum_probs=151.6

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC--CCe
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEF  850 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~  850 (982)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++...  .......+..|+.++++++||||++++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345678999999999999999999864 5788999998743  23345678899999999999999999998844  457


Q ss_pred             eEEEEEeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCC-------CCeEEcCCCCCCEEEcC-----
Q 036229          851 KALILEYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYS-------APVIHCDLKPSNVLLDD-----  915 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~-------~~ivHrDlkp~NILl~~-----  915 (982)
                      .|+||||+++|+|.+++...   ...+++..++.|+.||+.||+|||   +       ++||||||||+|||++.     
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH---s~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH---NLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hcccccccCCceeccCcHHHeEeecCcccc
Confidence            89999999999999998742   345899999999999999999999   6       45999999999999964     


Q ss_pred             ------------CCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          916 ------------NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       916 ------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                                  .+.+||+|||++..+....   ......||+.|+|||++.+.... .+..+|+|+||++
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~-~s~KSDVWSLG~I  232 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKS-YDDKSDMWALGCI  232 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCC-CCchhHHHHHHHH
Confidence                        2358999999998653221   22345799999999998543211 2234566666643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=8.9e-26  Score=253.59  Aligned_cols=182  Identities=25%  Similarity=0.294  Sum_probs=148.3

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCC-----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  848 (982)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++....  ......+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3567899999999999999999985 468899999986432  22345677899999999999999999987543     


Q ss_pred             -CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          849 -EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       849 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                       ...|+++|++ +++|.+++..  ..+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence             3568999988 7799888754  34889999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      +.....     .....||+.|+|||++.+. .++.   .+|+|++|
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG  203 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQ---TVDIWSVG  203 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCc---hhhhHhHH
Confidence            865321     2345789999999998663 3332   34555555

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.92  E-value=2.2e-25  Score=239.46  Aligned_cols=184  Identities=25%  Similarity=0.305  Sum_probs=156.1

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|++|.||+|+.. +++.||+|.++..  .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999864 5899999998643  344567888999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++... ...+++..+..++.|++.|+.|||   +.||+||||||+||++++++.+||+|||+++.+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999764 456888999999999999999999   99999999999999999999999999999987643221 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                       ......|++.|+|||++.+..++.   .+|+|++|
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG  188 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNE---KSDVWALG  188 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCC---ccchHHHH
Confidence             223456889999999997765543   35566666

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.92  E-value=9e-26  Score=254.78  Aligned_cols=185  Identities=25%  Similarity=0.282  Sum_probs=150.2

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC-----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  848 (982)
                      ...++|+..+.||+|+||.||+|... .++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35678999999999999999999854 5899999998643  233446778899999999999999999987543     


Q ss_pred             -CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          849 -EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       849 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                       ...++||||+++ ++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357999999965 67666643   3788889999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +....   ........||+.|+|||++.+..++.   .+|+|++|++
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~---~~DiwslG~i  207 (355)
T cd07874         167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKE---NVDIWSVGCI  207 (355)
T ss_pred             ccCCC---ccccCCccccCCccCHHHHcCCCCCc---hhhHHHHHHH
Confidence            86422   12223467899999999997765553   3566666643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.92  E-value=4.5e-26  Score=245.38  Aligned_cols=183  Identities=31%  Similarity=0.480  Sum_probs=152.1

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhh--hhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAF--KSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      |+..+.||+|+||.||+|+.. +++.||+|++........  ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999965 478999999986643322  23456999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      ++++|.+++.. ...+++.++..++.|+++||+|||   +.||+||||||+||++++++.++|+|||.+...  ......
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN  154 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred             ccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence            99999999973 345799999999999999999999   999999999999999999999999999999864  122234


Q ss_pred             ecccccccccccCceee-eeeeeeEEeeEeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFH-VKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~-~~~~~~~~~~~d~~~~~~  973 (982)
                      .....++..|+|||++. +...+..   +|+|++|+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~---~Di~slG~  187 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRK---SDIWSLGI  187 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTH---HHHHHHHH
T ss_pred             ccccccccccccccccccccccccc---cccccccc
Confidence            45677899999999987 4444433   44556553

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.92  E-value=2.1e-25  Score=240.24  Aligned_cols=184  Identities=30%  Similarity=0.496  Sum_probs=156.0

Q ss_pred             ceeeeeceEEEEEEEeCC----CeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIGE----GMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|....    +..||+|+++..... ..+++.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998643    888999999765433 367889999999999999999999999999999999999999


Q ss_pred             CChHHHHhcC--------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          861 GSLEKSLYSS--------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       861 gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ++|.+++...        ...+++.++..++.|++.|++|||   ++|++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        466899999999999999999999   99999999999999999999999999999997754


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ...........++..|+|||.+....++   ...|+|++|+++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~il  197 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFT---SKSDVWSFGVLL  197 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcc---hhhccHHHHHHH
Confidence            3322333455678899999998765443   446777777544

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.92  E-value=1.4e-25  Score=246.97  Aligned_cols=192  Identities=24%  Similarity=0.395  Sum_probs=156.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  849 (982)
                      ..++|.+.+.||+|+||.||+|..      ..+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            346799999999999999999963      235689999987542 33456788999999999 7999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          850 FKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      ..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||   +++|+|+||||+||++++++.+|++|||+++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997543 34799999999999999999999   9999999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ...............++..|+|||++.+..++.   .+|+|++|+++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslGvil  233 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF---ESDVWSYGILL  233 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCc---HhHHHHHHHHH
Confidence            664332222223345678899999987665543   35667777543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=2.2e-25  Score=238.51  Aligned_cols=183  Identities=25%  Similarity=0.383  Sum_probs=151.1

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChH
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLE  864 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~  864 (982)
                      +.||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999987889999999865432 33456889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeeccccc
Q 036229          865 KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA  944 (982)
Q Consensus       865 ~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  944 (982)
                      +++......+++..+..++.|++.|+.|+|   ++|++||||||+||++++++.+|++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            998766666889999999999999999999   99999999999999999999999999999876432211 11122334


Q ss_pred             ccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          945 TIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       945 t~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      +..|+|||++.+..++   ...|+|++|+++
T Consensus       157 ~~~y~aPE~~~~~~~~---~~~Di~slG~ll  184 (250)
T cd05085         157 PIKWTAPEALNYGRYS---SESDVWSYGILL  184 (250)
T ss_pred             cccccCHHHhccCCCC---chhHHHHHHHHH
Confidence            6679999998765444   346777777543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.92  E-value=8.3e-26  Score=246.73  Aligned_cols=188  Identities=23%  Similarity=0.341  Sum_probs=152.4

Q ss_pred             cCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .+|.+.+.||+|+||.||+|+..      +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35777899999999999999753      257899999875432 23467889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcC---------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          853 LILEYMPHGSLEKSLYSS---------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      +++||+++++|.+++...               +..+++..+..++.|++.||+|+|   ++||+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998532               224678888999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .+||+|||+++...............+++.|+|||++.+..++.   .+|+|++|+
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~  214 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI---DSDIWSYGV  214 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCc---chhHHHHHH
Confidence            99999999988654333222223445678999999986655443   356666663

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.92  E-value=2.1e-25  Score=245.02  Aligned_cols=185  Identities=26%  Similarity=0.371  Sum_probs=156.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            45789999999999999999985 46899999999866555567788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++...  .+++.++..++.|++.|+.|||   +.||+||||||+||+++.++.+||+|||.+........  
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--  171 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence            9999999998643  4788899999999999999999   99999999999999999999999999999886532221  


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......|++.|+|||.+.+...+   ...|+|++|+
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~s~Gv  204 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYG---PKVDIWSLGI  204 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCC---ccchHHHHHH
Confidence            12345688999999998765544   3456667663

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=2.1e-25  Score=246.54  Aligned_cols=183  Identities=22%  Similarity=0.281  Sum_probs=154.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|++.+.||+|+||.||+|+.. ++..||+|.++... .....++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999854 58889999987542 23446688999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++... ..+++..+..++.|++.||.|||   + .+++||||||+||++++++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999765 45788899999999999999999   7 59999999999999999999999999998765322   


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ......|++.|+|||++.+..++.   ..|+|++|+
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~  186 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTV---QSDIWSLGL  186 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCc---cchHHHHHH
Confidence             123457889999999987665543   355666663

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.2e-25  Score=242.61  Aligned_cols=191  Identities=20%  Similarity=0.347  Sum_probs=155.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            467899999999999999999753      24789999986442 23456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCC---------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE
Q 036229          852 ALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  922 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  922 (982)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         23678889999999999999999   9999999999999999999999999


Q ss_pred             eecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          923 DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       923 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      |||+++.+.............++..|+|||.+.+..++.   .+|+|++|+++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~il  211 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT---KSDVWSFGVVL  211 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCc---ccchHHHHHHH
Confidence            999998654333222233445678999999987655443   35667777443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.92  E-value=2.1e-25  Score=244.15  Aligned_cols=183  Identities=27%  Similarity=0.386  Sum_probs=146.2

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhc---CCccceeEEeeecC-----CC
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSI---RHRNLIKVISSCST-----EE  849 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~  849 (982)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999864 589999999875422  2233556788777665   79999999998754     34


Q ss_pred             eeEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          850 FKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      ..++||||+++ ++.+++.... ..+++..+..++.|++.||+|+|   ++||+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            57899999975 8888886543 34789999999999999999999   9999999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....   .......||..|+|||++.+..++.   .+|+|++|+
T Consensus       157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~  195 (288)
T cd07863         157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYAT---PVDMWSVGC  195 (288)
T ss_pred             cccCc---ccCCCccccccccCchHhhCCCCCC---cchhhhHHH
Confidence            65322   1223456899999999997665543   356666664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=2.3e-25  Score=243.62  Aligned_cols=192  Identities=26%  Similarity=0.335  Sum_probs=158.1

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999864 58999999987543  33456789999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      + +++|.+++......+++.++..++.|++.||+|||   +.|++|+||||+||++++++.++|+|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999776667899999999999999999999   99999999999999999999999999999987643321 1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ......|+..|+|||++.+....  +...|+|++|  ++.+.+|
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~--~~~~Di~slG~~l~~l~tg  197 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKY--DPGVDLWAVGCIFAELLNG  197 (286)
T ss_pred             ccccccCcccccCceeeeccccC--CchhHHHHHHHHHHHHHcC
Confidence            22345689999999998654321  2234556655  4444333

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=6.4e-28  Score=234.42  Aligned_cols=199  Identities=22%  Similarity=0.333  Sum_probs=158.6

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC-----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----  848 (982)
                      ...+.|+...+||+|.||+||+|+. ++++.||+|++-.+  .........+|++++..++|+|++.+++.|...     
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            3456688889999999999999984 45888999876432  333456678899999999999999999887432     


Q ss_pred             ---CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          849 ---EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       849 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                         ..+|+||++|+. +|.-++......++..++++++.++..||.|+|   +..|+|||+||+|+||+.+|.+||+|||
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence               358999999987 999998877778999999999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCC--ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          926 IAKLLIGEDQ--SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       926 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      +|+.+...+.  ....+..+.|.+|.+||.+.+........+.|+.++++-.+.++
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtr  225 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTR  225 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHcc
Confidence            9987643332  22335667899999999997765444445555555555444443

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.92  E-value=1.9e-25  Score=240.77  Aligned_cols=186  Identities=24%  Similarity=0.390  Sum_probs=152.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.++||+|+||.||+|+..+...||+|+++... ...+++.+|++++++++||||+++++++.. +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            45799999999999999999987776779999987533 234678999999999999999999998754 5679999999


Q ss_pred             cCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++|+|.+++.+. ...+++..+..++.|++.||+|+|   +.+|+||||||+||++++++.+||+|||.+..+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            999999999753 345788999999999999999999   99999999999999999999999999999987643221 1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......++..|+|||+..+..++   ...|+|++|+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~---~~~DvwslG~  191 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFT---IKSDVWSFGI  191 (262)
T ss_pred             cccCCcccceecCHhHhccCCCC---chhhHHHHHH
Confidence            12234467789999998665544   3456666663

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=2.1e-25  Score=240.63  Aligned_cols=185  Identities=24%  Similarity=0.423  Sum_probs=153.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .+|++.+.||+|+||.||+|.+. .++.||+|+++.. ....+++.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45888899999999999999854 5889999998744 334567889999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++++|.+++... ...+++..+..++.|++.|++|||   ++|++||||||+||++++++.+||+|||.+........ .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            999999998754 345789999999999999999999   99999999999999999999999999999987533211 1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ......++..|+|||.+.+..++..   .|+|++|
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~---~Dv~slG  192 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIK---SDVWAFG  192 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCch---hHHHHHH
Confidence            1122334668999999877655533   5566666

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.92  E-value=3.3e-25  Score=238.17  Aligned_cols=181  Identities=24%  Similarity=0.388  Sum_probs=146.3

Q ss_pred             eeeeeceEEEEEEEeC---CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCC
Q 036229          787 LIGRGGFGSVYKARIG---EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGS  862 (982)
Q Consensus       787 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs  862 (982)
                      .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999753   36679999987553 2334678899999999999999999998864 46789999999999


Q ss_pred             hHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce-eecc
Q 036229          863 LEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI-TQTQ  941 (982)
Q Consensus       863 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~~  941 (982)
                      |.+++......+++..+.+++.|++.|++|||   ++|++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999766667899999999999999999999   9999999999999999999999999999998653322211 1122


Q ss_pred             cccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          942 TLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       942 ~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ..++..|+|||++.+..++.   ..|+|++|++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  187 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSS---RSDVWSYGIT  187 (257)
T ss_pred             CCCCcccCCHHHHccCCCCc---hhhHHHHHHH
Confidence            23457899999987665543   3566777743

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.92  E-value=1.8e-25  Score=244.87  Aligned_cols=188  Identities=24%  Similarity=0.377  Sum_probs=152.7

Q ss_pred             CCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      +|++.+.||+|+||.||+|+..      ....||+|.+.... .....++.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999742      23678999886543 2345678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCC-----------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 036229          854 ILEYMPHGSLEKSLYSSN-----------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSN  910 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~N  910 (982)
                      ||||+.+++|.+++....                       ..+++..+..++.|++.|++|||   +++|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999886421                       24678889999999999999999   9999999999999


Q ss_pred             EEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          911 VLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       911 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |++++++.+||+|||+++...............++..|+|||++.+..++   ..+|+|++|++
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~---~~~Di~slG~~  218 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT---TQSDVWSFGVL  218 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc---hHhHHHHHHHH
Confidence            99999999999999999865433322222334567789999998665544   44677777744

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.92  E-value=3.7e-25  Score=240.20  Aligned_cols=187  Identities=27%  Similarity=0.425  Sum_probs=149.7

Q ss_pred             CCccceeeeeceEEEEEEEeCC----CeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCe-----
Q 036229          782 FSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF-----  850 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----  850 (982)
                      |.+.+.||+|+||.||+|....    +..||+|+++.+.  ....+.+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998532    4789999987542  3345678999999999999999999998865543     


Q ss_pred             -eEEEEEeccCCChHHHHhcC-----CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 036229          851 -KALILEYMPHGSLEKSLYSS-----NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  924 (982)
Q Consensus       851 -~~lv~E~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  924 (982)
                       .++||||+++|+|.+++...     ...+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999888532     235788999999999999999999   999999999999999999999999999


Q ss_pred             cCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          925 GIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       925 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |.++.+.............++..|+|||.+.+..++..   +|+|++|++
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~---~Dv~SlG~i  204 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK---SDVWAFGVT  204 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcc---cchHHHHHH
Confidence            99987644332222223345678999999876655543   555666643

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=2.2e-25  Score=240.29  Aligned_cols=177  Identities=20%  Similarity=0.356  Sum_probs=145.1

Q ss_pred             ceeeeeceEEEEEEEeCC-------------CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          786 NLIGRGGFGSVYKARIGE-------------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      +.||+|+||.||+|+...             ...||+|+++.........+..|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997421             3358999887655555567888999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-------EEEEeec
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV-------AHLSDFG  925 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-------~kL~DFG  925 (982)
                      +||||+++|+|..++......+++..+..++.||+.|++|||   +++|+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999988766667899999999999999999999   999999999999999986653       8999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~~  974 (982)
                      .+.....      .....++..|+|||.+.. ..++   ..+|+|++|++
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~---~~~DiwslG~~  198 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLS---IAADKWSFGTT  198 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCC---chhHHHHHHHH
Confidence            9875421      123457889999999863 3333   33566776644

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.92  E-value=2e-25  Score=249.68  Aligned_cols=192  Identities=27%  Similarity=0.424  Sum_probs=153.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC--------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG--------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      ...+|++.+.||+|+||.||+|+..        .+..||+|.++... ....+++.+|+++++++ +||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            3457899999999999999999742        13468999887432 33456888999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                      ++..+++|||+++|+|.+++.+..               ..+++.++..++.|++.|++|||   ++||+||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence            999999999999999999987532               24678888999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       913 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      +++++.+||+|||+++...............++..|+|||++.+..++..   +|+|++|+++
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~il  226 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ---SDVWSFGVLL  226 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch---hhhHHHHHHH
Confidence            99999999999999987643222222223334568999999977655543   5667766443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.8e-25  Score=241.94  Aligned_cols=189  Identities=26%  Similarity=0.383  Sum_probs=154.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CC----eEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EG----MEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|++.+.||+|+||.||+|... ++    ..||+|..+... ......+.+|+.++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            357888999999999999999853 23    368999886553 2345678899999999999999999999987 7889


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|+|.+++......+++..+..++.|++.|++|||   ++||+||||||+||++++++.+||+|||.++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999876666899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ...........++..|+|||.+....++   ...|+|++|++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~---~~~Di~slG~~  200 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYT---HKSDVWSYGVT  200 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcC---chhhHHHHHHH
Confidence            3332222223346789999998655444   34666777744

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.92  E-value=2.4e-25  Score=243.47  Aligned_cols=198  Identities=21%  Similarity=0.285  Sum_probs=157.1

Q ss_pred             CCHHHHHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeec-
Q 036229          770 FSYLELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCS-  846 (982)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~-  846 (982)
                      +.++.+....++|++.+.||+|+||.||+|+.. +++.||+|+.+... ....++.+|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344566678899999999999999999999864 58899999876432 2345678899999999 6999999999873 


Q ss_pred             ----CCCeeEEEEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          847 ----TEEFKALILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       847 ----~~~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                          .++..++||||+++++|.+++..   ....+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                44578999999999999988753   2345788889999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeee--eeeEEeeEeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFLM  973 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~~  973 (982)
                      ||+|||++..+....  .......|++.|+|||++....  ....+..+|+|++|+
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv  217 (286)
T cd06638         164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI  217 (286)
T ss_pred             EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence            999999998763321  1223456899999999985321  111234456677663

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-26  Score=247.11  Aligned_cols=195  Identities=24%  Similarity=0.387  Sum_probs=163.1

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      ++|+-...+.....+||-|.||.||.|.|+. ...||||.++.+ ....++|.+|+.+|+.++|||+|+++|+|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444445567888999999999999999865 778999998754 44578999999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCC-cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          852 ALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      |||+|||..|+|.+|++++.+ .++....+.++.||..|++||.   .+++||||+..+|+|+.++..||++|||+++.+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999997654 4566667889999999999999   999999999999999999999999999999988


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .++. +.......-...|.|||-+..   .....++|+|+||+++
T Consensus       416 tgDT-YTAHAGAKFPIKWTAPEsLAy---NtFSiKSDVWAFGVLL  456 (1157)
T KOG4278|consen  416 TGDT-YTAHAGAKFPIKWTAPESLAY---NTFSIKSDVWAFGVLL  456 (1157)
T ss_pred             cCCc-eecccCccCcccccCcccccc---cccccchhhHHHHHHH
Confidence            5443 222233344678999999844   4455778888888655

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=2.1e-25  Score=245.09  Aligned_cols=186  Identities=26%  Similarity=0.362  Sum_probs=157.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ...+|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            346899999999999999999985 4689999999976655556778899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++++|.+++.+.  .+++.++..++.|++.|+.|||   +.||+||||||+||+++.++.+||+|||.+........ 
T Consensus        97 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            99999999998653  4788899999999999999999   99999999999999999999999999999986533221 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ......+++.|+|||.+.+...+.   ..|+|++|+
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slGv  203 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGP---KVDIWSLGI  203 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCc---HHHHHHHHH
Confidence             123456889999999997665543   355666663

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.92  E-value=7.8e-25  Score=235.09  Aligned_cols=184  Identities=20%  Similarity=0.307  Sum_probs=154.0

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      +|++.+.||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788999999999999999854 5899999998643 3344567888999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++.+++... ...+++..+..++.|++.|+.|||   ++||+|+||||+||++++++.++++|||.+.......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            999999988653 345788899999999999999999   9999999999999999999999999999998763322  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ......|++.|+|||++.+..++..   .|+|++|
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~---~Dv~slG  187 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNK---SDIWSLG  187 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCch---hhhhhhc
Confidence            2234568899999999977655443   4445555

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.92  E-value=2.6e-25  Score=243.88  Aligned_cols=186  Identities=23%  Similarity=0.346  Sum_probs=152.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|+..+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            367999999999999999999865 589999999875432 223456789999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++ +|.+++......+++..+..++.|++.||.|||   +++|+||||||+||++++++.+||+|||.++......  
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            9975 999988776667899999999999999999999   9999999999999999999999999999987542111  


Q ss_pred             eeecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      .......++..|+|||++.+. .++   ...|+|++|+
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~---~~~Dv~slG~  192 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYS---TSLDMWGVGC  192 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccC---cHHHHHHHHH
Confidence            112233568899999998653 233   2355666663

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.92  E-value=3e-25  Score=240.28  Aligned_cols=190  Identities=23%  Similarity=0.440  Sum_probs=155.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CC---eEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EG---MEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|+..+.||+|+||.||+|+.. ++   ..||+|.++.. .....+++..|++++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            357888999999999999999864 22   47999998754 23445678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++......+++.++..++.|++.|++|||   +.|++||||||+||++++++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876432


Q ss_pred             CCcee-ecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSIT-QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ..... ......+..|+|||++.+..++   ...|+|++|++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~---~~~Dv~slG~i  199 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFT---SASDVWSFGIV  199 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcC---hHhHHHHHHHH
Confidence            22111 1122234579999998765544   34566777744

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.92  E-value=1.7e-25  Score=242.70  Aligned_cols=190  Identities=26%  Similarity=0.306  Sum_probs=153.6

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCC------
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE------  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------  848 (982)
                      .+.+.|+..+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35678999999999999999999854 58899999987543 3346788899999998 799999999998642      


Q ss_pred             CeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          849 EFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      ...++||||+++++|.+++... ...+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            4689999999999999998764 345789999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeee--eeeEEeeEeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFL  972 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~  972 (982)
                      .......  .......|++.|+|||++.+..  ....+...|+|++|
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  203 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG  203 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence            8653221  2223456899999999985321  11223345666666

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.92  E-value=1.9e-25  Score=243.03  Aligned_cols=192  Identities=25%  Similarity=0.372  Sum_probs=154.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      .+++|.+.+.||+|++|.||+|.+.      .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567999999999999999999864      36789999886443 3334578899999999999999999999999889


Q ss_pred             eEEEEEeccCCChHHHHhcCC------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEE
Q 036229          851 KALILEYMPHGSLEKSLYSSN------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHL  921 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL  921 (982)
                      .++||||+++++|.+++...+      ..+++..+.+++.||+.|++|||   +++++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            999999999999999987543      24788999999999999999999   99999999999999998654   6999


Q ss_pred             EeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          922 SDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       922 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      +|||+++.+..............+..|+|||++.+..++   ..+|+|++|+++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DiwslG~il  211 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT---SKTDVWSFGVLL  211 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC---chhHHHHHHHHH
Confidence            999999876322221222233345689999999766555   346677777543

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.92  E-value=2.6e-25  Score=239.59  Aligned_cols=187  Identities=26%  Similarity=0.395  Sum_probs=153.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|++|+++++++.. +..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            457899999999999999999987888899999875432 34678999999999999999999998854 5678999999


Q ss_pred             cCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++++|.+++... ...+++.++..++.|++.|++|||   ++||+||||||+||++++++.+||+|||.+..+..... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence            999999998753 345789999999999999999999   99999999999999999999999999999987533221 1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......++..|+|||++.+..++   ...|+|++|++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~~  192 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFT---IKSDVWSFGIL  192 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCc---chhhhHHHHHH
Confidence            11223456789999998665544   34566777743

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.92  E-value=3.2e-25  Score=243.10  Aligned_cols=187  Identities=23%  Similarity=0.314  Sum_probs=151.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999985 4588999999865432 22346778999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+. +++.+++......+++..+..++.|++.||.|||   +.||+||||||+||+++.++.+||+|||+++...... 
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-  157 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence            9995 6887777655556788888999999999999999   9999999999999999999999999999988642221 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                       .......+++.|+|||++.+...  .+...|+|++|
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG  191 (291)
T cd07870         158 -QTYSSEVVTLWYRPPDVLLGATD--YSSALDIWGAG  191 (291)
T ss_pred             -CCCCCccccccccCCceeecCCC--CCcHHHHHHHH
Confidence             12233457899999999865321  12235666666

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.92  E-value=4e-25  Score=236.69  Aligned_cols=183  Identities=29%  Similarity=0.427  Sum_probs=151.0

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChH
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLE  864 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~  864 (982)
                      ++||+|+||.||+|...+++.||+|.++..... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            478999999999999766999999998755333 5568899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeeccccc
Q 036229          865 KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA  944 (982)
Q Consensus       865 ~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g  944 (982)
                      +++.......++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||.+................+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999766556788999999999999999999   99999999999999999999999999999986532221111122234


Q ss_pred             ccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          945 TIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       945 t~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +..|+|||++.+..++.   ..|+|++|++
T Consensus       158 ~~~y~~PE~~~~~~~~~---~~Di~slG~i  184 (251)
T cd05041         158 PIKWTAPEALNYGRYTS---ESDVWSYGIL  184 (251)
T ss_pred             eeccCChHhhccCCCCc---chhHHHHHHH
Confidence            56799999987665543   3556666643

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.92  E-value=2.1e-25  Score=252.65  Aligned_cols=183  Identities=25%  Similarity=0.274  Sum_probs=149.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC------
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE------  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------  848 (982)
                      ..++|+..+.||+|+||.||+|+.. .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999854 5889999998643  233456778899999999999999999987543      


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 77777743   3678889999999999999999   9999999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....   ........||+.|+|||++.+..++..   +|+|++|+
T Consensus       175 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~---~DiwSlG~  213 (364)
T cd07875         175 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVGC  213 (364)
T ss_pred             ccCC---CCcccCCcccCCcCCHHHHhCCCCCch---hhHHhHHH
Confidence            6422   122234578999999999977665543   55666663

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.92  E-value=4.5e-26  Score=227.32  Aligned_cols=193  Identities=23%  Similarity=0.303  Sum_probs=153.1

Q ss_pred             HhcCCCcc-ceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecC----CCe
Q 036229          778 ATNRFSEN-NLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCST----EEF  850 (982)
Q Consensus       778 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~  850 (982)
                      .+++|++. ++||-|-.|.|..|.. .+++.+|+|++..     ....++|++.--.. .|||||+++++|+.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45667654 7899999999999974 4699999998752     24456788875554 79999999998854    346


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecC
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGI  926 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGl  926 (982)
                      +.+|||.++||.|...+++++ ..+++.++..|++||..|+.|||   +.+|.||||||+|+|..   .+..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            779999999999999998654 46899999999999999999999   99999999999999996   455899999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccCCCC
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRGNYY  982 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~~f~  982 (982)
                      |+.-   .........+.||+|.|||++..+.|+...|.| ..+++  +++.|--|||
T Consensus       211 AK~t---~~~~~L~TPc~TPyYvaPevlg~eKydkscdmw-SlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  211 AKET---QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMW-SLGVIMYILLCGYPPFY  264 (400)
T ss_pred             cccc---CCCccccCCcccccccCHHHhCchhcCCCCCcc-chhHHHHHhhcCCCccc
Confidence            9964   223444567899999999999877777664432 33333  4455666887

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.92  E-value=4.9e-25  Score=238.38  Aligned_cols=186  Identities=25%  Similarity=0.381  Sum_probs=155.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||.||+|... +++.||+|.++..   .....+++.+|++++++++|++|+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            67999999999999999999865 7899999988632   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ||+++++|.+++..   ....+++.++..++.|++.|+.|||   +.||+||||||+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998863   2345788999999999999999999   99999999999999999999999999999886532


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...  ......+++.|+|||.+.+..++.   ..|+|++|+
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~---~~Di~slG~  194 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNF---KSDIWSLGC  194 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCc---hhcHHHHHH
Confidence            221  123356888999999987665443   356666664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.92  E-value=4.3e-25  Score=237.84  Aligned_cols=189  Identities=22%  Similarity=0.403  Sum_probs=154.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|++.++||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            346789999999999999999998888999999987543 33467889999999999999999999874 4568999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++... ...+++.++..++.|++.|++|||   +.|++||||||+||++++++.++|+|||.+....... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-Y  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-c
Confidence            9999999988653 346788999999999999999999   9999999999999999999999999999998764221 1


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .......++..|+|||++.+..++.   .+|+|++|+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~---~~Di~slG~~l  193 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTI---KSDVWSFGILL  193 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCc---ccchHHHHHHH
Confidence            1222344667899999987665543   35667777443

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.92  E-value=3e-25  Score=242.97  Aligned_cols=190  Identities=26%  Similarity=0.424  Sum_probs=154.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|+..+.||+|+||.||+|+..      ++..||+|+++... .....++.+|++++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999853      46889999987543 23456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCC---------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCC
Q 036229          852 ALILEYMPHGSLEKSLYSSN---------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSN  910 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~N  910 (982)
                      ++||||+++|+|.+++....                     ..+++..+..++.|++.||+|+|   +++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999987422                     23677888999999999999999   9999999999999


Q ss_pred             EEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          911 VLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       911 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |++++++.+||+|||.+..+..............+..|+|||.+.+..++   ..+|+|++|++
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~i  221 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT---TESDVWAYGVV  221 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC---chhHHHHHHHH
Confidence            99999999999999998865332222222233456789999998766554   34567777744

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.92  E-value=1.3e-25  Score=245.42  Aligned_cols=185  Identities=25%  Similarity=0.338  Sum_probs=151.4

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5888899999999999999864 58999999987542  22345678899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++ +++.+++......+++..+..++.||++||.|||   ++||+||||||+||+++.++.+||+|||+++......  .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence            96 5888888765566899999999999999999999   9999999999999999999999999999998653221  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......+++.|+|||++.+....  +...|+|++|+
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~--~~~~DiwslG~  188 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLY--STSIDMWSAGC  188 (284)
T ss_pred             CcCCCccccCCcChHHHhCCccc--CcHHHHHHHHH
Confidence            22345678899999998654321  22345566663

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=1.9e-25  Score=242.41  Aligned_cols=177  Identities=20%  Similarity=0.319  Sum_probs=143.3

Q ss_pred             eeeeeceEEEEEEEeCC-------------------------CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeE
Q 036229          787 LIGRGGFGSVYKARIGE-------------------------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV  841 (982)
Q Consensus       787 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l  841 (982)
                      .||+|+||.||+|+...                         ...||+|+++.........+..|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999986311                         24588998875544445678889999999999999999


Q ss_pred             EeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----
Q 036229          842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM----  917 (982)
Q Consensus       842 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----  917 (982)
                      ++++..+...++||||+++|+|..++......+++..+..++.|+++||+|||   ++||+||||||+||++++.+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999766667899999999999999999999   99999999999999997543    


Q ss_pred             ---cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          918 ---VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       918 ---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                         .+|++|||.+......      ....++..|+|||.+.+..  ..+...|+|++|++
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~--~~~~~~Dv~slG~~  210 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGN--SLSTAADKWSFGTT  210 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCC--CCCcHHHHHHHHHH
Confidence               4899999998653211      2245778899999986532  12344667777753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=6.1e-25  Score=236.04  Aligned_cols=186  Identities=21%  Similarity=0.320  Sum_probs=156.6

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||.++. .+++.||+|.+...  ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999999999984 45889999998654  234456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++... ...+++.++..++.|++.|+.|||   +.|++||||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 345789999999999999999999   99999999999999999999999999999987643321 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                       ......+++.|+|||++.+...+.   ..|+|++|++
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~---~~Dv~slG~i  190 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNF---KSDIWALGCV  190 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCC---cchhHHHHHH
Confidence             223456899999999987654443   3556776643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.4e-25  Score=239.97  Aligned_cols=189  Identities=28%  Similarity=0.439  Sum_probs=157.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|++.+.||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            457899999999999999999998778889999987543 3356789999999999999999999999988899999999


Q ss_pred             ccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++.... ..+++.++..++.|++.|+.|||   ++|++|+||||+||++++++.+|++|||.+....... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999999997643 46889999999999999999999   9999999999999999999999999999998763221 1


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .......++..|+|||.+.+...+.   .+|+|++|++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~---~~Di~slG~i  193 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTI---KSDVWSFGIL  193 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCc---hhHHHHHHHH
Confidence            1112233556899999997665443   3566776644

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.92  E-value=5.9e-25  Score=237.47  Aligned_cols=187  Identities=24%  Similarity=0.325  Sum_probs=151.9

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-----chhhhhHHHHHHHhhhcCCccceeEEeeecCC--Cee
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFK  851 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~  851 (982)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999864 58999999886331     22345788899999999999999999988664  467


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+|+||||+||+++.++.+||+|||.+....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987543 4788889999999999999999   9999999999999999999999999999988653


Q ss_pred             CCCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..... .......|+..|+|||++.+...+   ...|+|++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~  197 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYG---RKADIWSVGC  197 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCC---cchhHHHHHH
Confidence            21111 112335688999999998765444   4456677663

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.92  E-value=3.6e-25  Score=240.16  Aligned_cols=186  Identities=26%  Similarity=0.424  Sum_probs=146.7

Q ss_pred             CCccceeeeeceEEEEEEEeCC-C--eEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC------Ce
Q 036229          782 FSENNLIGRGGFGSVYKARIGE-G--MEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE------EF  850 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~  850 (982)
                      |.+.+.||+|+||.||+|++.. +  ..||+|.++..  .....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999998654 3  36899988654  234456788999999999999999999987432      24


Q ss_pred             eEEEEEeccCCChHHHHhc-----CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          851 KALILEYMPHGSLEKSLYS-----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      .+++|||+++|+|.+++..     ....+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988742     2234789999999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +++.+.............+++.|+|||...+..++..   .|+|++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~---~Di~slG~  202 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK---SDVWSFGV  202 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChH---HHHHHHHH
Confidence            9987643322222233346778999999976655533   45566664

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.92  E-value=4.5e-25  Score=237.26  Aligned_cols=183  Identities=24%  Similarity=0.342  Sum_probs=151.5

Q ss_pred             ceeeeeceEEEEEEEeCC----CeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIGE----GMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|++|.||+|.+.+    ...||+|.++.... ...+++.+|++++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643    34699999976654 566789999999999999999999999988 889999999999


Q ss_pred             CChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce-e
Q 036229          861 GSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI-T  938 (982)
Q Consensus       861 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~  938 (982)
                      ++|.+++.+.. ..+++..+..++.|++.||+|||   ++|++||||||+||+++.++.+||+|||+++.+....... .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997654 46889999999999999999999   9999999999999999999999999999998764432211 1


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .....++..|+|||++.+..++.   ..|+|++|+++
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~---~~Di~slG~~l  190 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSH---ASDVWMFGVTL  190 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCc---hhhhHHHHHHH
Confidence            22345778899999987665543   35667777443

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=5.2e-25  Score=236.63  Aligned_cols=184  Identities=29%  Similarity=0.454  Sum_probs=156.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457899999999999999999874 78899999975543 4678899999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||   ++||+||||||+||+++.++.+||+|||.++......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            9999999997554 25899999999999999999999   9999999999999999999999999999998752211   


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                        ....++..|+|||++....++   ...|+|++|+++
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~---~~~Di~slG~il  189 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFS---TKSDVWSFGILL  189 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCC---cHHHHHHHHHHH
Confidence              123345679999998665444   346778888553

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.92  E-value=2.8e-25  Score=243.86  Aligned_cols=185  Identities=26%  Similarity=0.385  Sum_probs=157.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            45699999999999999999985 56899999999766555567888999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++...  .+++.++..++.|++.|+.|||   +.|++||||||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            9999999988643  4789999999999999999999   99999999999999999999999999999886533221  


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......++..|+|||.+.+...+   ..+|+|++|+
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slGv  203 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYG---PKVDIWSLGI  203 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCC---chhhHHHHHH
Confidence            12335688899999998765544   3456666663

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=5.3e-25  Score=237.89  Aligned_cols=186  Identities=24%  Similarity=0.398  Sum_probs=154.4

Q ss_pred             CCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc------chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC------GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +|+..+.||+|+||.||+|...+++.+|+|.++...      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            588899999999999999998789999999986432      12345688899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|+|   +.+|+|+||||+||++++++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997543 4788899999999999999999   9999999999999999999999999999987642211


Q ss_pred             ----CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 ----QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                          .........|+..|+|||++.+..++   ...|+|++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~---~~~Dv~slG~  196 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYG---RKSDIWSIGC  196 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCc---chhhHHHHHH
Confidence                11112345688999999999766544   3356666663

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.92  E-value=6.6e-25  Score=239.61  Aligned_cols=185  Identities=29%  Similarity=0.471  Sum_probs=148.7

Q ss_pred             cCC-CccceeeeeceEEEEEEEe-----CCCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCC--Ce
Q 036229          780 NRF-SENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EF  850 (982)
Q Consensus       780 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~  850 (982)
                      ++| +..+.||+|+||+||++..     .+++.||+|.++.... .....+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            344 8889999999999988652     3578899999875432 3456788999999999999999999987653  46


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++||||+++++|.+++...  .+++.++..++.|++.|++|||   ++||+||||||+||++++++.+||+|||+++..
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            88999999999999998654  4899999999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCcee-ecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          931 IGEDQSIT-QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       931 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ........ .....++..|+|||++.+..++.   .+|+|++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~Di~slG  197 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSY---ASDVWSFG  197 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCc---ccccHHHH
Confidence            43222111 12234567799999987665543   35566666

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.92  E-value=5.1e-25  Score=238.71  Aligned_cols=188  Identities=24%  Similarity=0.372  Sum_probs=153.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC----CeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568889999999999999998533    3568999887554 3456688999999999999999999999875 45789


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999876656899999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .. .......++..|+|||.+....++   ...|+|++|++
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~i  197 (270)
T cd05056         161 SY-YKASKGKLPIKWMAPESINFRRFT---SASDVWMFGVC  197 (270)
T ss_pred             cc-eecCCCCccccccChhhhccCCCC---chhhhHHHHHH
Confidence            21 112233355689999998766554   34667777744

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.92  E-value=3.1e-25  Score=242.51  Aligned_cols=185  Identities=26%  Similarity=0.335  Sum_probs=151.0

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++...  ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999864 58999999986442  22346788899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCC--CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSN--YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ++ +++.+++....  ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58888886432  46889999999999999999999   9999999999999999999999999999998653221 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       .......+++.|+|||++.+...  .+..+|+|++|+
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~  190 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPR--YSTPVDIWSIGT  190 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCC--cCcHHHHHHHHH
Confidence             12233467889999999865421  123456666664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.92  E-value=5.3e-25  Score=244.67  Aligned_cols=186  Identities=22%  Similarity=0.305  Sum_probs=142.4

Q ss_pred             cceeeeeceEEEEEEEeC---CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeec--CCCeeEEEEEecc
Q 036229          785 NNLIGRGGFGSVYKARIG---EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS--TEEFKALILEYMP  859 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~E~~~  859 (982)
                      +.+||+|+||.||+|+..   ++..||+|.++...  ....+.+|++++++++||||+++++++.  .+...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999854   35789999886432  2346788999999999999999999884  3567899999996


Q ss_pred             CCChHHHHhcC--------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCc
Q 036229          860 HGSLEKSLYSS--------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA  927 (982)
Q Consensus       860 ~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla  927 (982)
                      + ++.+++...        ...+++..+..++.|++.||+|||   ++||+||||||+||++    +.++.+||+|||+|
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 787776421        224788889999999999999999   9999999999999999    45679999999999


Q ss_pred             eeecCCCCc-eeecccccccccccCceeeeee-eeeEEeeEeeeeee--eeecccC
Q 036229          928 KLLIGEDQS-ITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       928 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      +........ .......||+.|+|||++.+.. ++   ..+|+|++|  ++.+.+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~~DiwSlG~il~el~tg  212 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT---KAIDIWAIGCIFAELLTS  212 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccC---cHHHHHhHHHHHHHHHhC
Confidence            876433221 1223457899999999986542 33   234555555  4344443

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.92  E-value=3.9e-25  Score=241.05  Aligned_cols=191  Identities=20%  Similarity=0.320  Sum_probs=155.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC-----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecC-CCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE-----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCST-EEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~  850 (982)
                      ..++|++.+.||+|+||.||+|....     +..||+|++... .....+.+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45789999999999999999998654     788999988644 23445678899999999999999999998765 567


Q ss_pred             eEEEEEeccCCChHHHHhcCC-------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          851 KALILEYMPHGSLEKSLYSSN-------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                      .++++||+++++|.+++....       ..+++.++..++.|++.||+|||   +++++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999987532       35789999999999999999999   99999999999999999999999999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||+++.+.............++..|+|||++.+..++   ..+|+|++|++
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~---~~~Di~slG~~  208 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS---SASDVWSFGVL  208 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC---chhhHHHhHHH
Confidence            9999866433322222334467789999999765544   44667777754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.92  E-value=4.9e-25  Score=242.32  Aligned_cols=186  Identities=27%  Similarity=0.442  Sum_probs=149.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeCC-C--eEEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGE-G--MEVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ++|++.+.||+|+||.||+|...+ +  ..+|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999998643 3  34788887642 334456788999999999 799999999999999999999


Q ss_pred             EEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          855 LEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                      |||+++++|.+++....               ..+++..+..++.|++.|++|||   ++||+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               24778899999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||+|||++....   ..........+..|+|||++.+..++.   .+|+|++|++
T Consensus       159 kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwSlG~i  207 (297)
T cd05089         159 KIADFGLSRGEE---VYVKKTMGRLPVRWMAIESLNYSVYTT---KSDVWSFGVL  207 (297)
T ss_pred             EECCcCCCcccc---ceeccCCCCcCccccCchhhccCCCCc---hhhHHHHHHH
Confidence            999999987421   111111222355799999987665553   3566777643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=3.5e-25  Score=238.31  Aligned_cols=175  Identities=21%  Similarity=0.379  Sum_probs=144.3

Q ss_pred             ceeeeeceEEEEEEEeCC-C----------eEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          786 NLIGRGGFGSVYKARIGE-G----------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +.||+|+||.||+|.... +          ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            478999999999998643 3          35788877644333 6788899999999999999999999887 778999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-------cEEEEeecCc
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-------VAHLSDFGIA  927 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-------~~kL~DFGla  927 (982)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876656899999999999999999999   99999999999999999887       7999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeee--eeeeEEeeEeeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVK--YILFVVNFLTSYSFLMI  974 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~d~~~~~~~  974 (982)
                      .....      .....++..|+|||++.+.  .++   ...|+|++|++
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~---~~~Di~slG~~  195 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLT---IAADKWSFGTT  195 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcc---hhhHHHHHHHH
Confidence            86532      2234567789999998665  333   34566777743

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PTZ00284 protein kinase; Provisional

Probab=99.92  E-value=2.2e-25  Score=260.42  Aligned_cols=191  Identities=20%  Similarity=0.269  Sum_probs=148.2

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCC------ccceeEEeeecC
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH------RNLIKVISSCST  847 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~~  847 (982)
                      +....++|++.+.||+|+||+||+|+.. +++.||||+++... ........|+++++.++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999854 58899999996432 233456678888877754      458889888866


Q ss_pred             C-CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCC--------
Q 036229          848 E-EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNM--------  917 (982)
Q Consensus       848 ~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~--------  917 (982)
                      + ++.++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||   + .|||||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999998 77898888654 35889999999999999999999   7 5999999999999998665        


Q ss_pred             --------cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          918 --------VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       918 --------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                              .+||+|||.+....     ......+||+.|||||++.+..++..   +|+|++|  ++.+.+|
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~---~DiwSlGvil~elltG  341 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYS---TDMWSMGCIIYELYTG  341 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcH---HHHHHHHHHHHHHHhC
Confidence                    49999999886421     12245679999999999988766644   3445555  4444444

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.92  E-value=7.5e-25  Score=235.94  Aligned_cols=188  Identities=23%  Similarity=0.398  Sum_probs=154.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|++.+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|+||+++++++.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            45789999999999999999999777888999988643 2345678899999999999999999999887 778999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++... ....++.++..++.|++.|+.|||   +.|++||||||+||+++.++.+||+|||.+........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999999999753 345788889999999999999999   99999999999999999999999999999986533221 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .......++..|+|||++....++.   .+|+|++|++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~---~~Di~slG~~  192 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTI---KSDVWSFGIL  192 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCc---cccchHHHHH
Confidence            1122334567899999997655443   3566777744

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.92  E-value=5e-25  Score=238.40  Aligned_cols=186  Identities=19%  Similarity=0.290  Sum_probs=143.6

Q ss_pred             ceeeeeceEEEEEEEeCCC---eEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          786 NLIGRGGFGSVYKARIGEG---MEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.||+|+||.||+|+..++   ..+++|.++... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999975332   345677665432 344578899999999999999999999999999999999999999


Q ss_pred             ChHHHHhcCC---CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          862 SLEKSLYSSN---YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       862 sL~~~l~~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      +|.+++.+..   ...++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999987532   23566677889999999999999   99999999999999999999999999999864322221122


Q ss_pred             ecccccccccccCceeeeeee----eeEEeeEeeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYI----LFVVNFLTSYSFLMI  974 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~----~~~~~~~d~~~~~~~  974 (982)
                      .....++..|+|||++.....    ...+..+|+|++|++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~  197 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVT  197 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHH
Confidence            234568889999999853211    112234567777744

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.92  E-value=1.1e-24  Score=234.32  Aligned_cols=184  Identities=24%  Similarity=0.420  Sum_probs=152.3

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecC-CCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCST-EEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E  856 (982)
                      +|++.+.||+|++|.||+++.. +++.||+|+++...  ....+.+.+|++++++++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5889999999999999999854 47889999986542  3345678889999999999999999998764 446789999


Q ss_pred             eccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |++++++.+++... ...+++.++..++.|++.|++|+|   ++||+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999998764 345899999999999999999999   99999999999999999999999999999987633221


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        ......+++.|+|||++.+..++..   +|+|++|
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~---~Dv~slG  189 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYK---SDVWALG  189 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCch---hhhHHHH
Confidence              2234568899999999977655533   4566666

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.92  E-value=5e-25  Score=236.66  Aligned_cols=185  Identities=28%  Similarity=0.357  Sum_probs=158.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|+..+.||+|+||.||+|+... ++.||+|.++....  .+++.+|++++++++||||+++++++..+...|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3679999999999999999999754 88999999875432  67899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++......+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.+||+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            9999999999876677899999999999999999999   99999999999999999999999999999987643221  


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......++..|+|||++.+..++   ...|+|++|+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~---~~~Di~s~G~  187 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYN---NKADIWSLGI  187 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCC---chhhHHHHHH
Confidence            22345588899999998776444   3456677664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.92  E-value=4.8e-25  Score=242.63  Aligned_cols=185  Identities=28%  Similarity=0.384  Sum_probs=152.4

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccch-----hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGR-----AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +|+..+.||+|++|.||+|... +++.||+|.++.....     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999864 5899999999754322     334567899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+ +++|.+++......+++..+..++.|+++||.|||   ++||+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999765546899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .  ......+++.|+|||.+.+...  .+..+|+|++|+
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~  191 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARH--YGVGVDMWSVGC  191 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCC--CCcHHHHHHHHH
Confidence            1  2223456788999999854321  123456666664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=8.3e-25  Score=237.34  Aligned_cols=188  Identities=28%  Similarity=0.397  Sum_probs=153.1

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc----------hhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG----------RAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      +|...+.||+|+||.||+|.. .+++.||+|.++....          ...+.+..|+++++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            578889999999999999985 4589999998863211          12346788999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..++||||+++++|.+++... ..+++..+..++.|++.|+.|||   +++++||||||+||+++.++.+|++|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            999999999999999998765 35888899999999999999999   99999999999999999999999999999986


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..............|+..|+|||.+..... ..+...|+|++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~~Dv~slG~  200 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQ-GYSAKVDIWSLGC  200 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccC-CCCccchhHHHHH
Confidence            532222222234568899999999865431 1234456677663

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=7.5e-25  Score=238.08  Aligned_cols=189  Identities=22%  Similarity=0.365  Sum_probs=155.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ++|+..+.||+|+||.||+|+..      +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999853      2467999988654333 4577899999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCC--------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 036229          853 LILEYMPHGSLEKSLYSSN--------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  924 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  924 (982)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997543        14789999999999999999999   999999999999999999999999999


Q ss_pred             cCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          925 GIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       925 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      |++...... .........++..|+|||.+.+....   ...|+|++|+++
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~---~~~Di~slG~~l  208 (275)
T cd05046         162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS---TKSDVWSFGVLM  208 (275)
T ss_pred             ccccccCcc-cccccCCceeEEeecChhhhccCCCC---chhhHHHHHHHH
Confidence            998754222 11222344567889999998765444   335667777543

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.92  E-value=4e-25  Score=239.08  Aligned_cols=186  Identities=26%  Similarity=0.392  Sum_probs=154.9

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|++|.||+|+. .+++.||||.+...   ......++.+|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4788899999999999999985 57899999987643   2234567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ||+++++|.+++..   ....+++..+..++.|++.|+.|||   ++|++|+||||+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863   2345789999999999999999999   99999999999999999999999999999886532


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...  ......|+..|+|||++.+...+.   ..|+|++|+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~---~~Dv~slG~  194 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNF---KSDIWSLGC  194 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccc---hhhHHHHHH
Confidence            221  123456889999999997665443   356666663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=5.5e-25  Score=240.62  Aligned_cols=186  Identities=24%  Similarity=0.326  Sum_probs=153.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.. ......++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999865 6899999988754 233456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC--CCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          858 MPHGSLEKSLYSS--NYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       858 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||   + .+|+||||||+||+++.++.+||+|||.+..+... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999988754  235899999999999999999999   6 59999999999999999999999999999865322 


Q ss_pred             CceeecccccccccccCceeeeeee---eeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYI---LFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~d~~~~~  972 (982)
                         ......+++.|+|||.+.+...   ...+...|+|++|
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG  194 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG  194 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence               1223457889999999855422   1123345666666

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=7.7e-25  Score=240.13  Aligned_cols=198  Identities=24%  Similarity=0.302  Sum_probs=157.6

Q ss_pred             CHHHHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCC
Q 036229          771 SYLELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE  848 (982)
Q Consensus       771 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  848 (982)
                      ...++..+.++|++.+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3455566788999999999999999999986 468899999986432 2346678899999998 899999999988643


Q ss_pred             -----CeeEEEEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 036229          849 -----EFKALILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  920 (982)
Q Consensus       849 -----~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  920 (982)
                           +..++||||+++++|.++++.   ....+++..+..++.|++.|++|||   +.||+||||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEE
Confidence                 368999999999999998763   3446789999999999999999999   99999999999999999999999


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeeee--eeEEeeEeeeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYI--LFVVNFLTSYSFLMI  974 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~d~~~~~~~  974 (982)
                      |+|||.+........  ......|+..|+|||++.....  ...+..+|+|++|++
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi  222 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT  222 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence            999999886532221  1233568899999999854321  112345667777743

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=1.7e-25  Score=240.70  Aligned_cols=182  Identities=25%  Similarity=0.346  Sum_probs=147.4

Q ss_pred             ceeeeeceEEEEEEEeCC--------CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          786 NLIGRGGFGSVYKARIGE--------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +.||+|+||.||+|....        ..+||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997532        334888888755555567788899999999999999999999998899999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--------EEEEeecCcee
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLSDFGIAKL  929 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kL~DFGla~~  929 (982)
                      +++|+|.+++...+..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.        +|++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876667899999999999999999999   999999999999999987664        69999999875


Q ss_pred             ecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeee--eeecccC
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ...      .....+++.|+|||++.+.. ++   ...|+|++|  ++.+.+|
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~---~~~DiwslG~~l~~l~~g  201 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLS---LAADKWSFGTTLWEIFSG  201 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCC---chhhHHHHHHHHHHHHcC
Confidence            421      12346788999999996532 33   335566666  3334443

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.92  E-value=3.9e-25  Score=243.81  Aligned_cols=189  Identities=27%  Similarity=0.441  Sum_probs=152.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCe----EEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGM----EVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|+..+.||+|+||.||+|.+. +++    .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            456888899999999999999853 343    578888764432 3344688899999999999999999998754 467


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +++||+++|++.+++......+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999876666889999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ...........++..|+|||++.+..++   ..+|+|++|++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~---~~~DiwslG~~  200 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFT---HQSDVWSYGVT  200 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCC---hHHHHHHHHHH
Confidence            3322222334467789999998766544   33567777743

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=1.1e-24  Score=235.82  Aligned_cols=185  Identities=27%  Similarity=0.413  Sum_probs=151.9

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc---------hhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG---------RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      +|.+.+.||+|++|.||+|... +++.||+|.+.....         ...+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999854 588999998864321         123568889999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++||||+++++|.+++... ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            99999999999999999764 35788889999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCc----eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          931 IGEDQS----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       931 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ......    .......|+..|+|||.+.+..++..   .|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~---~Dv~slG  199 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK---ADIWSLG  199 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCch---hhhHHHH
Confidence            422111    11123458889999999976655433   4555555

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.92  E-value=1.2e-24  Score=233.98  Aligned_cols=187  Identities=29%  Similarity=0.486  Sum_probs=155.2

Q ss_pred             CCccceeeeeceEEEEEEEeCC-----CeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          782 FSENNLIGRGGFGSVYKARIGE-----GMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      +++.+.||+|+||.||+|+...     +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999998643     388999999755433 5678899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCc-CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||+++++|.+++...... +++.++..++.|++.|++|||   +.|++||||||+||++++++.+||+|||.+.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765444 899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .... ....+++.|+|||.+.+..++   ...|+|++|+++
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~---~~~Di~slG~i~  194 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFT---SKSDVWSFGVLL  194 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCC---cchhHHHHHHHH
Confidence            2211 123377899999998655444   446677777543

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=8.6e-25  Score=237.49  Aligned_cols=184  Identities=28%  Similarity=0.333  Sum_probs=156.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|+..+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+++++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999864 58999999987553 34456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   +++++||||+|+||++++++.++|+|||.++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998754  5789999999999999999999   9999999999999999999999999999998764322  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......+++.|+|||.+.+..++   ..+|+|++|+
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~---~~sDv~slG~  186 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYD---EKADIWSLGI  186 (274)
T ss_pred             ccccccCCccccChhhhccCCCC---chhhHHHHHH
Confidence            22345688899999999776544   3455666663

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.91  E-value=7.9e-25  Score=235.20  Aligned_cols=188  Identities=26%  Similarity=0.408  Sum_probs=156.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|+++... ....++.+|++++++++||+|+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4688899999999999999988778889999886432 234578899999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+....... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            99999999876666889999999999999999999   9999999999999999999999999999998653221 1112


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ....++..|+|||.+.+..++.   ..|+|++|+++
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~---~~Dv~slG~~l  191 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSS---KSDVWSFGVLM  191 (256)
T ss_pred             CCCccchhhcCHhHhccCCcCh---HHHHHHHHHHH
Confidence            2334567899999997665543   35667777433

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=9.4e-25  Score=238.79  Aligned_cols=184  Identities=26%  Similarity=0.344  Sum_probs=151.6

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47899999999999999999865 58999999986432  2234567889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++++.+..+.... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            99998887776543 35899999999999999999999   99999999999999999999999999999987643321 


Q ss_pred             eeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                       ......++..|+|||++.+. .++   ..+|+|++|
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~---~~~Di~slG  188 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYG---PPVDVWAIG  188 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcC---chhhhHHHH
Confidence             22345678899999998653 233   334556655

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=1.2e-24  Score=234.07  Aligned_cols=184  Identities=28%  Similarity=0.356  Sum_probs=154.7

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-----chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +|+..+.||+|++|+||+|... +++.||+|.+....     ....+.+.+|+++++.++||||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5788899999999999999865 68999999986532     23456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.||+|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999987643 4788899999999999999999   9999999999999999999999999999988753322


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         ......|+..|+|||.+....  ..+..+|+|++|+
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~--~~~~~~D~~slG~  190 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQG--GYGLAADIWSLGC  190 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCC--CCCchhhhHHHHH
Confidence               223456889999999986544  1234466677774

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.91  E-value=1.1e-24  Score=234.14  Aligned_cols=182  Identities=28%  Similarity=0.409  Sum_probs=150.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeee-cCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC-STEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||.||+|.. .+..||+|.++..  ...+.+.+|+.++++++|++++++++++ ..++..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            35788999999999999999986 4788999998643  2346788999999999999999999975 455678999999


Q ss_pred             ccCCChHHHHhcCCC-cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++.+... .+++..+..++.|++.|++|||   ++||+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999999876443 4788999999999999999999   9999999999999999999999999999988643221  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                         ....++..|+|||++.+..++   ...|+|++|++
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~i  188 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFS---TKSDVWSFGIL  188 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCC---chhhhHHHHHH
Confidence               223456689999998766554   34666777744

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=3.6e-25  Score=247.04  Aligned_cols=194  Identities=26%  Similarity=0.395  Sum_probs=163.3

Q ss_pred             CCccceeeeeceEEEEEEEe-CC----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          782 FSENNLIGRGGFGSVYKARI-GE----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ....++||+|+||+||+|.| ++    +.+||+|++... ..+..+++..|+-+|.+++|||+++++++|.... ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568999999999999974 33    456899988643 3455678999999999999999999999998776 77999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      +|++.|.|.++++..+..+.....+.|..|||+||+|||   ++++|||||.++||||..-..+||.|||+|+....++.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999998888999999999999999999999   99999999999999999999999999999998876665


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee-----eeecccCCCC
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL-----MIFIGRGNYY  982 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~-----~~l~~~~~f~  982 (982)
                      ..........+.|||=|.+....++..   +|||+||     ++-+|..||+
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thq---SDVWsfGVtiWElmTFGa~Py~  902 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQ---SDVWSFGVTIWELMTFGAKPYD  902 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCch---hhhhhhhhhHHHHHhcCCCccC
Confidence            555555556788999999988877755   4556666     3455666663

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.91  E-value=3.3e-25  Score=242.82  Aligned_cols=182  Identities=25%  Similarity=0.301  Sum_probs=152.4

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      .|.....||+|+||.||++... +++.||||.++.......+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444567999999999999854 588999999876555566778899999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +++|.+++...  .+++.++..++.|++.|++|||   ++||+||||||+||++++++.+||+|||++........  ..
T Consensus       103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  175 (292)
T cd06658         103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR  175 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence            99999988543  4788999999999999999999   99999999999999999999999999999876532221  22


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ....|+..|+|||++.+..++.   ..|+|++|
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG  205 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGT---EVDIWSLG  205 (292)
T ss_pred             ceeecCccccCHHHHccCCCCc---hhhHHHHH
Confidence            3456889999999987655543   45666666

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=1.6e-24  Score=239.28  Aligned_cols=187  Identities=22%  Similarity=0.334  Sum_probs=152.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|+..+.||+|+||.||+++.. +++.||+|.++...   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999864 48899999987543   233457788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC-
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED-  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~-  934 (982)
                      ||+++++|.+++...+ .+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+|++|||+++...... 
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997654 5788899999999999999999   9999999999999999999999999999987421000 


Q ss_pred             ------------CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 ------------QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                                  .........++..|+|||.+.+..++   ...|+|++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Di~slG~  204 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG---KPVDWWAMGI  204 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCC---chhhHHHHHH
Confidence                        00111234578899999998765544   3356666663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.91  E-value=1.5e-24  Score=236.70  Aligned_cols=193  Identities=28%  Similarity=0.330  Sum_probs=150.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHH-hhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEM-MKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++... .....++..|+.+ ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999864 59999999987542 2233455666665 566789999999999999999999999


Q ss_pred             eccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          857 YMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       857 ~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      |++ |+|.+++..   ....+++..+..++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||.+..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 588777753   2346899999999999999999999   87 999999999999999999999999999986532


Q ss_pred             CCCceeecccccccccccCceeeeeee-eeEEeeEeeeeee--eeecccC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYI-LFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .   .......++..|+|||++.+... ...+...|+|++|  ++.+.+|
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g  203 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG  203 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhC
Confidence            2   12233568889999999865221 1223345666666  3344444

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.91  E-value=8.2e-25  Score=240.15  Aligned_cols=187  Identities=22%  Similarity=0.283  Sum_probs=153.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCC--CeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.++....  .....+.+|++++++++||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            457999999999999999999965 588999999875432  2234567899999999999999999998777  88999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||++ ++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+......
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999997 4999988766666899999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .  .......+++.|+|||.+.+...  .+..+|+|++|+
T Consensus       160 ~--~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~  195 (293)
T cd07843         160 L--KPYTQLVVTLWYRAPELLLGAKE--YSTAIDMWSVGC  195 (293)
T ss_pred             c--cccccccccccccCchhhcCCcc--ccchhhHHHHHH
Confidence            2  12234557889999999865432  223456676664

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.91  E-value=1.6e-24  Score=234.77  Aligned_cols=180  Identities=29%  Similarity=0.489  Sum_probs=143.9

Q ss_pred             ceeeeeceEEEEEEEeCC-Ce--EEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIGE-GM--EVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|+..+ +.  .+|+|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998643 43  5788887643 234456788999999999 899999999999999999999999999


Q ss_pred             CChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          861 GSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       861 gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      |+|.+++....               ..+++.++..++.|++.|++|||   ++|++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               24678899999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ++....   ..........+..|+|||++....++   ..+|+|++|++
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~---~~~Di~slG~i  200 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYT---TNSDVWSYGVL  200 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCC---chhhHHHHHHH
Confidence            986321   11111122345679999998665544   34566777744

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=1.4e-24  Score=233.92  Aligned_cols=185  Identities=25%  Similarity=0.389  Sum_probs=150.6

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      ++|.+.+.||+|++|.||+|....+..||+|.+.... ...+.+.+|++++++++||+++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            5688999999999999999998777789999876432 334678899999999999999999998754 56789999999


Q ss_pred             CCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          860 HGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       860 ~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      +++|.+++... ...+++..+..++.|++.|+.|||   +.||+||||||+||++++++.+||+|||.+........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            99999999754 334788999999999999999999   99999999999999999999999999999986532211 11


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....++..|+|||...+...+   ...|+|++|+
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~---~~~Di~slG~  191 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFT---IKSDVWSFGI  191 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcC---hHHHHHHHHH
Confidence            1233466789999988665444   3456666663

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.91  E-value=1.5e-24  Score=233.24  Aligned_cols=179  Identities=24%  Similarity=0.337  Sum_probs=144.3

Q ss_pred             eeeeeceEEEEEEEe---CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCC
Q 036229          787 LIGRGGFGSVYKARI---GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       787 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      .||+|+||.||+|.+   ++++.||+|+++...  ....+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            689999999999964   357889999986442  2345678899999999999999999998864 4678999999999


Q ss_pred             ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce-eec
Q 036229          862 SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI-TQT  940 (982)
Q Consensus       862 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~  940 (982)
                      +|.+++.... .+++..+..++.|++.|++|+|   ++||+||||||+||++++++.+||+|||++.......... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999986543 5889999999999999999999   9999999999999999999999999999998764332221 112


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...++..|+|||.+....++.   .+|+|++|+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  186 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSS---KSDVWSFGV  186 (257)
T ss_pred             CCCCCccccCHhHhccCCcCc---hhHHHHHHH
Confidence            233467899999986654443   355666663

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.91  E-value=1.1e-24  Score=234.94  Aligned_cols=183  Identities=25%  Similarity=0.406  Sum_probs=145.6

Q ss_pred             ceeeeeceEEEEEEEeC----CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeec-CCCeeEEEEEecc
Q 036229          786 NLIGRGGFGSVYKARIG----EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCS-TEEFKALILEYMP  859 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~E~~~  859 (982)
                      +.||+|+||.||+|...    .+..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999742    2467999988543 2344567889999999999999999999765 4556889999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc--e
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS--I  937 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~--~  937 (982)
                      +|+|.+++.......++..+..++.|++.|+.|||   +.+++||||||+||++++++.+||+|||+++.+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999766555778888899999999999999   999999999999999999999999999999865332111  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......++..|+|||.+.+..++.   ..|+|++|++
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  191 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTT---KSDVWSFGVL  191 (262)
T ss_pred             ccccCcCCccccChhHhccCccch---HHHHHHHHHH
Confidence            112334677899999987655443   4566777744

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.91  E-value=6.5e-25  Score=241.10  Aligned_cols=182  Identities=26%  Similarity=0.318  Sum_probs=152.4

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      |+....||+|+||.||+|... +++.||+|+++.......+.+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334557999999999999854 6899999999765555567788999999999999999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      ++|.+++..  ..+++..+..++.|++.|+.|||   +.||+||||||+||+++.++.+||+|||++..+....  ....
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            999988754  34789999999999999999999   9999999999999999999999999999987653221  1223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...|+..|+|||++.+..++   ..+|+|++|+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~  205 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYG---TEVDIWSLGI  205 (297)
T ss_pred             ceecCccccCHHHHccCCCC---chhhHHHHHH
Confidence            45689999999999765544   3466677763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=2.4e-24  Score=235.35  Aligned_cols=193  Identities=25%  Similarity=0.393  Sum_probs=156.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-----CCeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecC--CCee
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCST--EEFK  851 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~  851 (982)
                      +.|+..+.||+|+||.||+|++.     +++.||+|+++..... ..+.+.+|+++++.++||||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999853     3788999999755443 46789999999999999999999999877  5578


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876656899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCcee-ecccccccccccCceeeeeeeeeEEeeEeeeeee--eeeccc
Q 036229          932 GEDQSIT-QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGR  978 (982)
Q Consensus       932 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~  978 (982)
                      ....... .....++..|+|||.+.+...+..   +|+|++|  ++.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~---~Di~slG~~l~el~t  207 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA---SDVWSFGVTLYELFT  207 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcc---cchHHHhhhhheeec
Confidence            3322211 122345567999999876655433   4555555  444443

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.91  E-value=2.3e-24  Score=233.02  Aligned_cols=186  Identities=23%  Similarity=0.352  Sum_probs=150.8

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc-----chhhhhHHHHHHHhhhcCCccceeEEeeecC--CCee
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFK  851 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~  851 (982)
                      .+|+..+.||+|+||.||+|.. .+++.||+|+++...     .+....+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3689999999999999999985 458999999886432     2234568889999999999999999998865  3578


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      +++|||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999987544 4788889999999999999999   9999999999999999999999999999988653


Q ss_pred             CCCC-ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          932 GEDQ-SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       932 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .... ........++..|+|||.+.+..++..   .|+|++|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Dv~slG  196 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRK---ADVWSLG  196 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCch---hhhHHHH
Confidence            2111 111123458889999999976654433   4556665

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.3e-24  Score=236.02  Aligned_cols=191  Identities=25%  Similarity=0.306  Sum_probs=155.4

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCC-----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE-----  849 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~-----  849 (982)
                      ..+++|++.+.||+|++|.||+|+.. +++.||+|+++.... ..+++.+|+++++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999999864 578999999875433 346789999999999 7999999999986544     


Q ss_pred             -eeEEEEEeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          850 -FKALILEYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       850 -~~~lv~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                       ..++||||+++++|.+++...   +..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             589999999999999988643   356889999999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeee--eeEEeeEeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYI--LFVVNFLTSYSFLM  973 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~d~~~~~~  973 (982)
                      .+.......  .......|+..|+|||++.....  ...+..+|+|++|+
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~  206 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI  206 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHH
Confidence            988653222  22234568899999999854321  12234467777774

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.91  E-value=2.3e-24  Score=238.12  Aligned_cols=186  Identities=27%  Similarity=0.320  Sum_probs=152.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..+|+..+.||+|+||.||+|+.. +++.||+|++....   ....+++.+|+++++.++||||+++++++..++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356889999999999999999864 58999999986432   23345788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||++ |++.+++......+++..+..++.|++.|+.|||   +.||+||||+|+||++++++.+||+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99996 5787777655556899999999999999999999   999999999999999999999999999998764221 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                           ....+++.|+|||++.+......+..+|+|++|++
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~i  203 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  203 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHH
Confidence                 23467889999999853222223345677777743

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.91  E-value=2.4e-24  Score=231.40  Aligned_cols=185  Identities=19%  Similarity=0.356  Sum_probs=154.6

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||+++. .+++.||+|.+...  .....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588899999999999999985 45899999998643  233456789999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++.... ..+++.++..++.|++.|+.|||   ++|++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999887543 35788999999999999999999   99999999999999999999999999999986533221 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ......|++.|+|||++.+...+   ...|+|++|+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~---~~~Dv~slG~  189 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYN---NKSDIWALGC  189 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCC---CccchhHHHH
Confidence             12234688899999998765544   3456666663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=5.5e-25  Score=257.80  Aligned_cols=195  Identities=18%  Similarity=0.192  Sum_probs=146.7

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeCC--CeEEEEEEe--------------e---cccchhhhhHHHHHHHhhhcCCcc
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIGE--GMEVAVKVF--------------D---LQCGRAFKSFDVECEMMKSIRHRN  837 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~n  837 (982)
                      ...++|++.+.||+|+||+||+|..+.  +..++.|.+              .   .........+.+|++++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            345789999999999999999986432  222222211              0   011223456789999999999999


Q ss_pred             ceeEEeeecCCCeeEEEEEeccCCChHHHHhcCC----CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN----YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       838 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                      |+++++++..++..|+|+|++. +++.+++....    ......++..++.|++.||+|||   ++|||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999995 57777765432    12335667789999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      +.++.+||+|||+|+.+..... .......||+.|+|||++.+..++..   .|+|++|  ++.+.++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlGvil~ell~~  364 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEI---TDIWSCGLILLDMLSH  364 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcH---HHHHHHHHHHHHHHHC
Confidence            9999999999999987643222 22234679999999999987665543   4556666  4444443

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.91  E-value=2e-24  Score=235.74  Aligned_cols=197  Identities=25%  Similarity=0.308  Sum_probs=156.7

Q ss_pred             CHHHHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecC-
Q 036229          771 SYLELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCST-  847 (982)
Q Consensus       771 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~-  847 (982)
                      +..+.....+.|++.+.||+|+||.||+|+. .+++.||+|++.... ....++..|+.+++++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455555678999999999999999999986 458899999986543 3346688899999998 79999999999853 


Q ss_pred             -----CCeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 036229          848 -----EEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  921 (982)
Q Consensus       848 -----~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  921 (982)
                           .+..+++|||+++|+|.+++... ...+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence                 45789999999999999988753 335788888999999999999999   999999999999999999999999


Q ss_pred             EeecCceeecCCCCceeecccccccccccCceeeeee--eeeEEeeEeeeeeee
Q 036229          922 SDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFLM  973 (982)
Q Consensus       922 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~~  973 (982)
                      +|||++.......  .......|++.|+|||++....  ....+..+|+|++|+
T Consensus       163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~  214 (282)
T cd06636         163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGI  214 (282)
T ss_pred             eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHH
Confidence            9999987653211  1223456899999999985321  122234466777774

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.9e-24  Score=240.04  Aligned_cols=187  Identities=27%  Similarity=0.349  Sum_probs=155.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc---hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....   ...+.+..|+++++.++||+|+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46889999999999999999865 489999999975432   24567888999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||+++++|.+++... ...+++..+..++.|++.||+|||   +.|++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998754 346889999999999999999999   9999999999999999999999999999987643211


Q ss_pred             Cc---------------------------eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QS---------------------------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ..                           .......|+..|+|||++.+..++.   .+|+|++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Di~slG  219 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS---AVDWWTLG  219 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc---hHHHHHHH
Confidence            10                           0112346889999999997665543   35666666

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.91  E-value=7e-25  Score=239.80  Aligned_cols=186  Identities=27%  Similarity=0.357  Sum_probs=152.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|+..+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999975 589999998764322  234567889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++++++.++.... ..+++.++..++.|++.|++|||   +.||+||||+|+||++++++.+||+|||++.......  
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            99998888776543 34899999999999999999999   9999999999999999999999999999998753322  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......++..|+|||++.+...  .+..+|+|++|+
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~  189 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTK--YGRAVDIWAVGC  189 (286)
T ss_pred             cccCcccceeeccCcHHhccccc--cCchHhHHHHHH
Confidence            22234568899999999865322  123356676663

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.91  E-value=1.5e-24  Score=241.82  Aligned_cols=184  Identities=18%  Similarity=0.240  Sum_probs=147.0

Q ss_pred             ccceeeee--ceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          784 ENNLIGRG--GFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       784 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      +.++||+|  +|++||+++. .+++.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7889999985 568999999997542  233456788999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++|++.+++... ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++++|||.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998653 335889999999999999999999   9999999999999999999999999998765432211110


Q ss_pred             -----eecccccccccccCceeeee--eeeeEEeeEeeeeeee
Q 036229          938 -----TQTQTLATIGYMAPGLFHVK--YILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~d~~~~~~  973 (982)
                           ......++..|+|||++.+.  .++   ..+|+|++|+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~~~DiwslG~  198 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYD---AKSDIYSVGI  198 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCC---chhhHHHHHH
Confidence                 11223567789999999653  233   3356666663

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.91  E-value=3.5e-24  Score=231.68  Aligned_cols=187  Identities=27%  Similarity=0.334  Sum_probs=155.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|++.+.||.|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999854 58899999986432 33567889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC--CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSS--NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      +++++|.+++...  ...+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999754  245789999999999999999999   99999999999999999999999999999987654332


Q ss_pred             ce--eecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          936 SI--TQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      ..  ......|+..|+|||++... ..+   ...|+|++|
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~---~~~Dv~slG  194 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYD---FKADIWSFG  194 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcC---cccchHhHh
Confidence            21  22345688999999998665 333   334556555

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.91  E-value=3.4e-24  Score=230.17  Aligned_cols=184  Identities=26%  Similarity=0.432  Sum_probs=153.4

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+...  .......+..|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588899999999999999985 46889999998754  234456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~  935 (982)
                      +++++|.+++.+. ...+++..+..++.|++.|++|||   ++|++||||||+||+++++ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            9999999999764 345789999999999999999999   9999999999999999854 568999999998763322 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......++..|+|||.+.+...+.   ..|+|++|+
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~  189 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQ---KSDIWALGC  189 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCc---ccchHHHHH
Confidence              122356888999999997655443   356666663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.91  E-value=1.6e-24  Score=236.61  Aligned_cols=191  Identities=26%  Similarity=0.354  Sum_probs=153.1

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999964 589999999875432 23456778999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCC--CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          859 PHGSLEKSLYSSN--YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       859 ~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      ++ ++.+++....  ..+++..+..++.|++.|++|||   ++|++||||||+||++++++.+|++|||.+.......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            75 8888876543  45899999999999999999999   9999999999999999999999999999997653221  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .......++..|+|||++.+....  +...|+|++|  ++.+.+|
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~--~~~~Dv~slG~~l~~l~~g  197 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTY--STSIDIWSVGCIMAEMITG  197 (284)
T ss_pred             cccccccccccccChHHhcCCCCC--CcHHHHHHHHHHHHHHHhC
Confidence            122334578899999998654321  2234555555  4444433

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.91  E-value=8.3e-25  Score=237.99  Aligned_cols=183  Identities=27%  Similarity=0.342  Sum_probs=153.3

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999854 58899999987442 344567889999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      ++++|.+++..  ..+++..+..++.|++.|+.|||   ++|++|+||+|+||++++++.+|++|||++..+....  ..
T Consensus        85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            99999998864  34788899999999999999999   9999999999999999999999999999998653221  12


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....|+..|+|||++.+..++   ..+|+|++|+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~  189 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYD---FKADIWSLGI  189 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCc---hhhhHHHHHH
Confidence            2334688899999999766544   3466777773

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.91  E-value=3.3e-24  Score=231.49  Aligned_cols=189  Identities=30%  Similarity=0.380  Sum_probs=157.4

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||+|... +++.||+|.++....  ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999854 689999999876543  3567889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++.... ..++..+..++.|++.|++|||   +.||+|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999987643 4788899999999999999999   9999999999999999999999999999998764332211


Q ss_pred             e--ecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 T--QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .  .....++..|+|||++.+......+...|+|++|+
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~  194 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGC  194 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHH
Confidence            1  12356788999999997654222334566777773

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.5e-24  Score=231.33  Aligned_cols=186  Identities=24%  Similarity=0.354  Sum_probs=151.4

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-----cchhhhhHHHHHHHhhhcCCccceeEEeeecCC--Cee
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-----CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFK  851 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~  851 (982)
                      .+|++.+.||+|+||.||+|+. .+++.||+|.+...     .......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4789999999999999999985 45899999987532     123446788999999999999999999998654  467


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++.... .+++..+.+++.|++.|+.|||   +.|++||||||+||+++.++.+||+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987543 4788899999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCC-ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          932 GEDQ-SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       932 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .... ........++..|+|||.+.+...+.   ..|+|++|
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG  196 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGR---KADVWSVA  196 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCc---cccHHHHH
Confidence            2111 11123456889999999997654443   35566666

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.91  E-value=1.1e-24  Score=235.34  Aligned_cols=184  Identities=25%  Similarity=0.289  Sum_probs=156.4

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.... ....+++.+|++++++++||||+++++++..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999865 58999999987553 34456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++......+++..+..++.|++.|++|+|   + .|++||||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999876567889999999999999999999   8 9999999999999999999999999999876532211 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         ....++..|+|||.+.+..++   ...|+|++|+
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~---~~~Dv~slG~  187 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYS---VKSDIWSLGL  187 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCC---chhhHHHHHH
Confidence               126688899999999776544   3356677663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.91  E-value=3.3e-24  Score=234.94  Aligned_cols=187  Identities=24%  Similarity=0.297  Sum_probs=152.2

Q ss_pred             CCCccceeeeeceEEEEEEEe----CCCeEEEEEEeeccc----chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCee
Q 036229          781 RFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQC----GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  851 (982)
                      +|++.+.||+|+||.||+|+.    .+|+.||+|+++...    ....+.+.+|+++++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999985    368999999987432    23346678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||   +.|++||||||+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987643 4788888999999999999999   9999999999999999999999999999998653


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ... ........|+..|+|||.+..... ..+...|+|++|+
T Consensus       157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Dv~slG~  196 (290)
T cd05613         157 EDE-VERAYSFCGTIEYMAPDIVRGGDG-GHDKAVDWWSMGV  196 (290)
T ss_pred             ccc-ccccccccCCcccCChhhccCCCC-CCCccccHHHHHH
Confidence            322 122234568899999999864321 1123456677663

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=1e-25  Score=246.95  Aligned_cols=190  Identities=27%  Similarity=0.363  Sum_probs=164.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|+...++|.|+||.|||+++ .+++.+|+|+++.+......-+++|+-+++..+||||+.+++.+...+..|+.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            456899999999999999999995 4689999999998887888888999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      ||.||+|++..+-. .++++.++..++++.++|++|+|   ++|-+|||||-.||++++.|.+|++|||.+..+..  ..
T Consensus        93 ycgggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             ecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            99999998876543 45888999999999999999999   99999999999999999999999999999887632  22


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....+.||++|||||+..-+.-......+|+|++|+
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gi  203 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGI  203 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhccccccccccccccc
Confidence            3345688999999999974443334446677888874

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.91  E-value=2.1e-24  Score=238.75  Aligned_cols=187  Identities=27%  Similarity=0.335  Sum_probs=151.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCC--CeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|++++++++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            4578999999999999999999864 589999999875422  2234567899999999999999999998654  5689


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++ +|.+++......+++.++..++.|++.|++|||   +.|++||||||+||++++++.+||+|||.+.....
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99999964 898888765567899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCceeecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      ...  ......+++.|+|||++.+. .++   ...|+|++|+
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~---~~~DvwslG~  197 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGCTTYT---TAIDMWAVGC  197 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCCCCcC---chHHHHHHHH
Confidence            221  22234567889999998653 233   3355666663

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=2.4e-24  Score=236.20  Aligned_cols=184  Identities=27%  Similarity=0.376  Sum_probs=155.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46899999999999999999985 46889999998765555567788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++.+.  .+++.++..++.|++.|+.|||   ++|++||||||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            9999999998653  3688899999999999999999   99999999999999999999999999999876533222  


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ......+++.|+|||.+.+..++   ...|+|++|
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~---~~~Dv~slG  202 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYG---PKVDIWSLG  202 (293)
T ss_pred             ccccccCChhhcCchhhccCCCC---chhhHHHHH
Confidence            22334688899999998665444   345566666

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PLN03210 Resistant to P

Probab=99.91  E-value=2.5e-23  Score=265.52  Aligned_cols=348  Identities=23%  Similarity=0.287  Sum_probs=169.6

Q ss_pred             CchhhhcCCCCCCeeeeccee------eecccCCCccCcC-cccEEEeeccccccccccccccccchhhhhccCCCCCCc
Q 036229          169 IPANICSNLPFLESISLSQNM------FHGRIPSALSNCK-YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGE  241 (982)
Q Consensus       169 ip~~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  241 (982)
                      +....|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.++.+. .+|..| ...+|++|++++|++. .
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence            334445566666666665442      2233455555443 4666666666654 455555 3455666666666655 3


Q ss_pred             hhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCC
Q 036229          242 IPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM  321 (982)
Q Consensus       242 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  321 (982)
                      ++..+..+++|+.++|++++....+|+ +..+++|++|+|++|.....+|..+.++++|+.|++++|...+.+|..+ ++
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            455555555566666655543334443 4555555555555554444555555555555555555543333444332 34


Q ss_pred             CCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceec
Q 036229          322 STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMT  401 (982)
Q Consensus       322 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  401 (982)
                                               ++|++|++++|.....+|..   ..+|+.|++++|.+... |..+ .+++|+.|.
T Consensus       704 -------------------------~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P~~~-~l~~L~~L~  753 (1153)
T PLN03210        704 -------------------------KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-PSNL-RLENLDELI  753 (1153)
T ss_pred             -------------------------CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccc-cccc-ccccccccc
Confidence                                     44455555555433333332   34566677777766533 3222 344444444


Q ss_pred             ccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEe
Q 036229          402 LHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYL  481 (982)
Q Consensus       402 L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L  481 (982)
                      +..+....+.                      +.+                          ....|..+...++|+.|+|
T Consensus       754 l~~~~~~~l~----------------------~~~--------------------------~~l~~~~~~~~~sL~~L~L  785 (1153)
T PLN03210        754 LCEMKSEKLW----------------------ERV--------------------------QPLTPLMTMLSPSLTRLFL  785 (1153)
T ss_pred             ccccchhhcc----------------------ccc--------------------------cccchhhhhccccchheeC
Confidence            3322111000                      000                          0000111112234444555


Q ss_pred             cCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccccc
Q 036229          482 GGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI  561 (982)
Q Consensus       482 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~i  561 (982)
                      ++|...+.+|.+++++++|+.|++++|..-+.+|..+ ++++|+.|++++|..-..+|..   .++|+.|+|++|.++++
T Consensus       786 s~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~i  861 (1153)
T PLN03210        786 SDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEEV  861 (1153)
T ss_pred             CCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCccC
Confidence            5554444455555555555555555543222344433 4555555555554432233332   24555566666666666


Q ss_pred             ccccccccCceEEecCCCcccCCCccccccccccceeecccc
Q 036229          562 PLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN  603 (982)
Q Consensus       562 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N  603 (982)
                      |.++..+++|++|++++|.--..+|..+..++.|+.+++++|
T Consensus       862 P~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        862 PWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             hHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence            655555666666666553322235555556666666666655

syringae 6; Provisional

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=4.9e-24  Score=229.17  Aligned_cols=181  Identities=27%  Similarity=0.348  Sum_probs=145.9

Q ss_pred             ceeeeeceEEEEEEEeCC----CeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIGE----GMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      ++||+|+||.||+|++..    +..||+|.++.... ...+++.+|+++++.+.||||+++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            479999999999997422    37899999875533 345678899999999999999999998764 467999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee-e
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT-Q  939 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~  939 (982)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||.++.......... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997654 5889999999999999999999   99999999999999999999999999999987643322211 1


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....++..|+|||.+.+..++.   .+|+|++|++
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~  187 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSS---KSDVWSYGVT  187 (257)
T ss_pred             cCccccccccCHHHhcCCCCCc---cchHHHHHHH
Confidence            1222456799999997665543   4666777744

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.91  E-value=2.6e-24  Score=234.09  Aligned_cols=190  Identities=27%  Similarity=0.384  Sum_probs=157.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..|+..+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999864 58999999987543 34457788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++...  .+++.++..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++.......  .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            9999999998643  4788899999999999999999   9999999999999999999999999999998764322  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ......++..|+|||++.+...+   ...|+|++|  ++.+.+|
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~---~~~Dv~slG~il~el~tg  197 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYD---SKADIWSLGITAIELAKG  197 (277)
T ss_pred             ccccccCcccccCHhHhccCCCc---cHHHHHHHHHHHHHHHHC
Confidence            22335688899999998765544   345566666  4444444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.91  E-value=2.7e-24  Score=232.71  Aligned_cols=185  Identities=25%  Similarity=0.374  Sum_probs=152.8

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc------chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC------GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      +|+..+.||+|++|.||+|+. .+++.||+|+++...      ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999985 568999999986432      1235678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceeecC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIG  932 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~  932 (982)
                      ||||+++++|.+++.+.+ .+++..+..++.|++.|+.|||   ++|++||||||+||+++.++ .+||+|||.+..+..
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999987543 5788999999999999999999   99999999999999998765 699999999987643


Q ss_pred             CCCc--eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          933 EDQS--ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       933 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ....  .......++..|+|||++.+..++..   .|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~---~Dv~slG  195 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRS---CDVWSVG  195 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcc---cchHHHH
Confidence            2111  11223468889999999876655433   5556665

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.91  E-value=5.3e-24  Score=232.54  Aligned_cols=183  Identities=25%  Similarity=0.301  Sum_probs=153.7

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      .|...+.||+|++|.||+|.. .+++.||+|+++.......+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            355567999999999999985 4688999999876555556678899999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +++|.+++..  ..+++..+..++.|++.|++|||   ++||+||||+|+||+++.++.+||+|||.+.......  ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            9999999876  34788899999999999999999   9999999999999999999999999999887653221  122


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....|++.|+|||.+.+..++   ...|+|++|+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slGv  203 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYG---TEVDIWSLGI  203 (285)
T ss_pred             ccccCCccccCHHHhcCCCCC---CcccHHHHHH
Confidence            335689999999998765544   3466777773

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.91  E-value=2.1e-24  Score=233.79  Aligned_cols=183  Identities=28%  Similarity=0.446  Sum_probs=148.2

Q ss_pred             ceeeeeceEEEEEEEeCC-------CeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          786 NLIGRGGFGSVYKARIGE-------GMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +.||+|+||.||+|+..+       ++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998532       3679999886442 23456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-----cEEEEeecC
Q 036229          858 MPHGSLEKSLYSS------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-----VAHLSDFGI  926 (982)
Q Consensus       858 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-----~~kL~DFGl  926 (982)
                      +++++|.+++...      ...+++.++..++.|++.|++|+|   +.+++|+||||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998742      234688899999999999999999   99999999999999999877     899999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +................++..|+|||++.+..++   ..+|+|++|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~i  202 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT---TQSDVWSFGVL  202 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcc---cchhHHHHHHH
Confidence            9865433222222334567889999999766554   44667777744

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.2e-24  Score=233.46  Aligned_cols=184  Identities=26%  Similarity=0.379  Sum_probs=153.1

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcC---CccceeEEeeecCCCeeEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIR---HRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .|+..+.||+|+||.||+|.. .+++.||+|.++.. .....+++.+|++++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            478889999999999999985 46899999998754 2344567889999999996   999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++++|.+++...  .+++..+..++.|++.|+.|||   +.||+||||+|+||++++++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999998653  5889999999999999999999   9999999999999999999999999999998764332 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       .......|+..|+|||.+.++..  .+...|+|++|+
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~  190 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKY--YDTKADIWSLGI  190 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCc--cccchhHHHHHH
Confidence             22234568899999999865322  123456666663

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.91  E-value=6.5e-24  Score=230.95  Aligned_cols=183  Identities=28%  Similarity=0.370  Sum_probs=152.6

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      -|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            367788999999999999985 458899999986432 334567889999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   +.|++|+||||+||+++.++.++|+|||++..+....  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            999999998643  4789999999999999999999   9999999999999999999999999999988653321  12


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....++..|+|||.+.+...+   ..+|+|++|+
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~---~~~Dv~slG~  189 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYD---SKADIWSLGI  189 (277)
T ss_pred             hccccCCccccChhhhccCCCC---chhhHHHHHH
Confidence            2335688899999998665443   3456676663

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.90  E-value=2.6e-24  Score=238.98  Aligned_cols=186  Identities=24%  Similarity=0.364  Sum_probs=149.5

Q ss_pred             CCCccceeeeeceEEEEEEEeC---CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCC--CeeE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG---EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFKA  852 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~  852 (982)
                      +|++.+.||+|++|.||+|...   +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            5788899999999999999864   47999999997632   33446778899999999999999999999888  7899


Q ss_pred             EEEEeccCCChHHHHhcC----CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC----CCcEEEEee
Q 036229          853 LILEYMPHGSLEKSLYSS----NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDF  924 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kL~DF  924 (982)
                      +||||+++ ++.+.+...    ...+++..+..++.|++.|++|||   +++|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 676666422    225788899999999999999999   999999999999999998    899999999


Q ss_pred             cCceeecCCCC-ceeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          925 GIAKLLIGEDQ-SITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       925 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      |++........ ........+++.|+|||++.+.. ++   ..+|+|++|+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~~Dv~slG~  204 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYT---KAIDIWAIGC  204 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCC---cHHHHHHHHH
Confidence            99987643222 12233456889999999886532 33   3356666663

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.90  E-value=7e-24  Score=226.93  Aligned_cols=185  Identities=31%  Similarity=0.428  Sum_probs=159.3

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      +|+..+.||+|++|.||+|... +++.||+|++........+.+.+|+++++.++||+++++++++..++..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999875 688999999976655566789999999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +++|.+++......+++..+..++.|++.|++|||   ++|++||||+|+||++++++.+||+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999876567899999999999999999999   99999999999999999999999999999987643321   2


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....++..|+|||.+.+...+   ..+|+|++|++
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~---~~~Dv~slG~i  186 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYD---YKADIWSLGIT  186 (253)
T ss_pred             cceecCCcccCHHHHcCCCCC---ccccHHHHHHH
Confidence            345688899999998765533   44667777743

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.90  E-value=6.8e-24  Score=235.45  Aligned_cols=184  Identities=26%  Similarity=0.300  Sum_probs=151.0

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .|+..+.||+|+||.||+|+.. +++.||+|++....   .....++..|++++++++|||++++++++..++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999854 58899999986432   2334578889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++ ++.+.+......+++.++..++.|++.|+.|||   ++||+||||+|+||+++.++.+||+|||++.....    
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            9964 888887665666899999999999999999999   99999999999999999999999999999875421    


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                        .....|++.|+|||++........+..+|+|++|++
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvi  213 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  213 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHH
Confidence              123468889999999743211223345677777744

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.90  E-value=5.1e-24  Score=233.00  Aligned_cols=188  Identities=29%  Similarity=0.365  Sum_probs=159.4

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++.|+..+.+|+|++|.||+|... +++.||+|+++.... ..+.+.+|+++++.++|+||+++++++..++..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            35677889999999999999999875 588999999976544 4577889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++++|.+++......+++..+..++.|++.|+.|||   +.||+|+||+|+||+++.++.+||+|||.+........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999999876546899999999999999999999   99999999999999999999999999999876532221


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......++..|+|||++.+..++   ...|+|++|+
T Consensus       172 --~~~~~~~~~~y~~PE~~~~~~~~---~~~Dv~slGv  204 (286)
T cd06614         172 --KRNSVVGTPYWMAPEVIKRKDYG---PKVDIWSLGI  204 (286)
T ss_pred             --hhccccCCcccCCHhHhcCCCCC---CccccHHHHH
Confidence              22334578899999998766544   4466677663

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=3.4e-24  Score=230.00  Aligned_cols=180  Identities=26%  Similarity=0.454  Sum_probs=149.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      ++|++.+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.++++++||||+++++++..++ .++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence            5689999999999999999975 67889999986432  3467889999999999999999999987654 789999999


Q ss_pred             CCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          860 HGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       860 ~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      +++|.+++.... ..+++..+..++.|++.|+.|+|   +.|++||||||+||+++.++.+||+|||.+......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999997543 35788999999999999999999   999999999999999999999999999998864221     


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......+..|+|||++.+..++   ...|+|++|++
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~---~~~Dv~slG~~  186 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFS---SKSDVWSYGVL  186 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcC---chhhHHHHHHH
Confidence            1123345689999998765544   34667777744

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.90  E-value=3.6e-24  Score=237.11  Aligned_cols=191  Identities=23%  Similarity=0.326  Sum_probs=151.4

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCC----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----  849 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----  849 (982)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++...+    
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            34568999999999999999999864 58999999986432  222345678999999999999999999886544    


Q ss_pred             ----eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          850 ----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       850 ----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                          ..++||||++ +++.+.+......+++.++..++.|++.|++|||   ++|++||||||+||+++.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence                4599999996 4888888766556899999999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCc--eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          926 IAKLLIGEDQS--ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       926 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .+.........  .......++..|+|||.+.+....  +..+|+|++|+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~Di~slG~  212 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY--GPPIDMWGAGC  212 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCccc--CchhhhHHHHH
Confidence            99876432211  112345678899999988654321  23356666663

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.4e-26  Score=241.09  Aligned_cols=193  Identities=23%  Similarity=0.298  Sum_probs=161.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCe-EEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGM-EVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..+++....+|-|+||.|-+++..... .+|+|++++.   +.+..+.+..|..+|...+.|+||++|..|.+..+.|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            455667788999999999999865433 4888888654   445567788899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||-|-||.+...+++++ .++...++.++..+++|++|||   ++|||.||+||+|.++|.+|.+||.|||+|+.+....
T Consensus       499 mEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999999999997655 4888899999999999999999   9999999999999999999999999999999985443


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                         ..-+++|||.|.|||++.++..+.+.|+ |+.|+.++.+.+|
T Consensus       575 ---KTwTFcGTpEYVAPEIILnKGHD~avDy-WaLGIli~ELL~G  615 (732)
T KOG0614|consen  575 ---KTWTFCGTPEYVAPEIILNKGHDRAVDY-WALGILIYELLTG  615 (732)
T ss_pred             ---ceeeecCCcccccchhhhccCcchhhHH-HHHHHHHHHHHcC
Confidence               3345899999999999988888877554 3444444444333

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=2.5e-24  Score=235.12  Aligned_cols=184  Identities=24%  Similarity=0.299  Sum_probs=154.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+++.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            357888999999999999999854 58899999886543 3445788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++++|.+++... ..+++..+..++.|++.|+.|||   + .+++||||||+||++++++.++|+|||++......  
T Consensus        84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            99999999988654 35789999999999999999999   5 68999999999999999999999999998754221  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......|+..|+|||++.+...+   ...|+|++|+
T Consensus       158 --~~~~~~~~~~~~aPE~~~~~~~~---~~~Di~slG~  190 (284)
T cd06620         158 --IADTFVGTSTYMSPERIQGGKYT---VKSDVWSLGI  190 (284)
T ss_pred             --ccCccccCcccCCHHHHccCCCC---ccchHHHHHH
Confidence              11245689999999998665444   3455666663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.90  E-value=2.9e-24  Score=234.63  Aligned_cols=185  Identities=27%  Similarity=0.356  Sum_probs=150.7

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|++|.||+|+.. +++.||||+++...  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999864 58999999986442  22345788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +. +++.+++... ...+++..+..++.|++.|++|||   +.+++||||+|+||++++++.+||+|||++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            96 5898888653 345789999999999999999999   9999999999999999999999999999988653221  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......+++.|+|||++.+...  .+..+|+|++|+
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~  189 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKY--YSTAVDIWSLGC  189 (284)
T ss_pred             cccccccccccccCCeEEecCCC--CCcHHHHHHHHH
Confidence            12233457889999999865432  123355666664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=6.5e-24  Score=229.13  Aligned_cols=185  Identities=25%  Similarity=0.345  Sum_probs=157.5

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|++.+++++|+||+++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999865 499999999876543 4567889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++++|.+++... ..+++..+..++.|+++|++|+|   + .+++||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999765 45899999999999999999999   9 99999999999999999999999999999876432221


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        .....++..|+|||.+.+..++   ..+|+|++|+
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~---~~~Dv~slG~  188 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYS---YAADIWSLGL  188 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCC---chhhHHHHHH
Confidence              1245678899999998776444   3456677664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.90  E-value=3.1e-24  Score=230.90  Aligned_cols=183  Identities=27%  Similarity=0.370  Sum_probs=155.7

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999865 58999999997542   2346788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++++|.+++... ..+++..+..++.|+++|+.|||   +++++|+||||+||++++++.+||+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998765 46889999999999999999999   9999999999999999999999999999988653322  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ......|+..|+|||++.+...+   ...|+|++|+
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~---~~~Di~slG~  187 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYS---VAVDWWSLGV  187 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCC---CcccchhhHH
Confidence             22345688899999999766544   3456666663

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.90  E-value=4.4e-24  Score=234.61  Aligned_cols=186  Identities=23%  Similarity=0.296  Sum_probs=147.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcC-CccceeEEeeecCCCe-----
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEF-----  850 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~-----  850 (982)
                      ++|+..+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|+++++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999864 58999999986542  223457788999999995 6999999999877665     


Q ss_pred             eEEEEEeccCCChHHHHhcC----CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeec
Q 036229          851 KALILEYMPHGSLEKSLYSS----NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFG  925 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFG  925 (982)
                      .|+||||+++ ++.+++...    ...+++..+..++.||+.||+|||   ++||+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 888887643    235789999999999999999999   999999999999999998 8899999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++..+....  .......+++.|+|||++.+...  .+..+|+|++|+
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~  200 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTH--YSTPVDIWSVGC  200 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCC--CCchHHHHHHHH
Confidence            998653221  11223457889999998854322  123455666663

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.3e-23  Score=230.38  Aligned_cols=166  Identities=20%  Similarity=0.220  Sum_probs=130.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC--CCeEEEEEEeecc-----cchhhhhHHHHHHHhhhcCCcccee-EEeeecCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQ-----CGRAFKSFDVECEMMKSIRHRNLIK-VISSCSTE  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~  848 (982)
                      ...++|+..+.||+|+||+||+|+..  +++.||||++...     .....+.+.+|++++++++|+++++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            35678999999999999999999864  5778899987532     1223567899999999999999985 5442    


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC-CCCCEEEcCCCcEEEEeecCc
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kL~DFGla  927 (982)
                      +..|+||||++|++|.. ... .   .   ...++.|+++||.|+|   ++||+|||| ||+||+++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~-~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP-H---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc-c---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            45799999999999963 211 1   1   1467899999999999   999999999 999999999999999999999


Q ss_pred             eeecCCCCcee------ecccccccccccCceeeee
Q 036229          928 KLLIGEDQSIT------QTQTLATIGYMAPGLFHVK  957 (982)
Q Consensus       928 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  957 (982)
                      +.+........      .+...+++.|+|||++..+
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            97754332111      1356688899999998544

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.90  E-value=3.7e-24  Score=234.30  Aligned_cols=187  Identities=26%  Similarity=0.332  Sum_probs=154.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|+..+.||+|++|.||+|... +++.||+|+++..  .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46899999999999999999865 5889999998643  23345778999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++++.+..+... ...+++.++..++.|++.|+.|||   +++++|||++|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            9988666655543 445889999999999999999999   99999999999999999999999999999987643322 


Q ss_pred             eeecccccccccccCceeeee-eeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~  974 (982)
                      .......++..|+|||++.+. .++   ...|+|++|++
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~---~~~Dv~slG~~  191 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYG---KPVDVWAIGCI  191 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcC---chhhHHHHHHH
Confidence            122345688999999999765 333   34566666643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.90  E-value=6.3e-24  Score=230.55  Aligned_cols=187  Identities=28%  Similarity=0.445  Sum_probs=148.2

Q ss_pred             CCccceeeeeceEEEEEEEeC----CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC------
Q 036229          782 FSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------  849 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  849 (982)
                      |.+.+.||+|+||.||+|.+.    +++.||+|++..+  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999743    3789999998654  2344567889999999999999999999875432      


Q ss_pred             eeEEEEEeccCCChHHHHhcC-----CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 036229          850 FKALILEYMPHGSLEKSLYSS-----NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  924 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  924 (982)
                      ..++++||+++|++.+++...     ...+++..+..++.|++.|++|||   ++||+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            347889999999998887532     224688889999999999999999   999999999999999999999999999


Q ss_pred             cCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          925 GIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       925 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |.++...............+++.|+|||.+....++.   .+|+|++|++
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~---~sDi~slG~i  204 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT---HSDVWAFGVT  204 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccch---hhhhHHHHHH
Confidence            9998754332222223345667899999987665543   3566777744

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.90  E-value=2.1e-23  Score=252.01  Aligned_cols=173  Identities=25%  Similarity=0.359  Sum_probs=149.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|.+.++||+|+||.||+|+.. +++.||||+++...   ......+..|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999865 58999999997432   23346788899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++...+ .+++..++.|+.||+.||+|||   +++||||||||+|||++.++.+||+|||+++..... 
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~-  157 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR-  157 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC-
Confidence            99999999999987543 4788889999999999999999   999999999999999999999999999999875322 


Q ss_pred             CceeecccccccccccCceeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVK  957 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~  957 (982)
                       ........+|+.|+|||.....
T Consensus       158 -~~~~~~~~~t~~~~~pe~~~~~  179 (669)
T cd05610         158 -ELNMMDILTTPSMAKPKNDYSR  179 (669)
T ss_pred             -cccccccccCccccCccccccC
Confidence             2233456799999999986444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN03210 Resistant to P

Probab=99.90  E-value=4.8e-23  Score=263.00  Aligned_cols=316  Identities=23%  Similarity=0.260  Sum_probs=191.5

Q ss_pred             hhhhcCCCc-ccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccC
Q 036229          242 IPREFGNLA-ELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN  320 (982)
Q Consensus       242 ~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  320 (982)
                      +|..|..++ +|+.|++.++.+. .+|..| ...+|++|+|++|++. .++..+..+++|+.|+|++|.....+|. +..
T Consensus       580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~  655 (1153)
T PLN03210        580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSM  655 (1153)
T ss_pred             cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-ccc
Confidence            444444442 4666666665554 344444 3566677777777666 3455566666777777766543334442 444


Q ss_pred             CCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCcccee
Q 036229          321 MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM  400 (982)
Q Consensus       321 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  400 (982)
                      +++|+.|+|++|.....++. ....+++|+.|++++|.....+|..+ ++++|+.|++++|......|..          
T Consensus       656 l~~Le~L~L~~c~~L~~lp~-si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~----------  723 (1153)
T PLN03210        656 ATNLETLKLSDCSSLVELPS-SIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI----------  723 (1153)
T ss_pred             CCcccEEEecCCCCccccch-hhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc----------
Confidence            44444444433322111111 01123333444444432222333322 3455555555555332222211          


Q ss_pred             cccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEE
Q 036229          401 TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY  480 (982)
Q Consensus       401 ~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~  480 (982)
                                            ..+|++|++++|.+..++..                           + .+++|+.|+
T Consensus       724 ----------------------~~nL~~L~L~~n~i~~lP~~---------------------------~-~l~~L~~L~  753 (1153)
T PLN03210        724 ----------------------STNISWLDLDETAIEEFPSN---------------------------L-RLENLDELI  753 (1153)
T ss_pred             ----------------------cCCcCeeecCCCcccccccc---------------------------c-ccccccccc
Confidence                                  23455566666554433221                           1 223333344


Q ss_pred             ecCCC-------CCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccccccc
Q 036229          481 LGGNK-------LNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL  553 (982)
Q Consensus       481 L~~N~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  553 (982)
                      +.++.       +....|..+...++|+.|+|++|...+.+|.++.++++|+.|++++|..-+.+|... ++++|+.|+|
T Consensus       754 l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~L  832 (1153)
T PLN03210        754 LCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDL  832 (1153)
T ss_pred             ccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEEC
Confidence            33321       122233334445789999999998888899999999999999999986545777766 7999999999


Q ss_pred             CCC-cccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc
Q 036229          554 GSN-KLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR  628 (982)
Q Consensus       554 ~~N-~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  628 (982)
                      ++| .+..+|..   ..++++|+|++|.++ .+|..+..+++|+.|++++|+--..+|..+..+++|+.|++++|.
T Consensus       833 s~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        833 SGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence            996 45567653   367999999999998 578899999999999999944334577788999999999999884

syringae 6; Provisional

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.90  E-value=9.7e-24  Score=227.59  Aligned_cols=177  Identities=27%  Similarity=0.381  Sum_probs=148.7

Q ss_pred             eeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ||+|++|.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999965 48999999987532   23456789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccc
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL  943 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  943 (982)
                      .+++.+.. .+++..+..++.|++.|++|+|   +++++|+||||+||+++.++.+||+|||.+.......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997643 4788899999999999999999   9999999999999999999999999999998764322   223356


Q ss_pred             cccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          944 ATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       944 gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +++.|+|||.+.+..++.   ..|+|++|++
T Consensus       154 ~~~~~~~PE~~~~~~~~~---~~Di~slG~i  181 (262)
T cd05572         154 GTPEYVAPEIILNKGYDF---SVDYWSLGIL  181 (262)
T ss_pred             CCcCccChhHhcCCCCCC---hhhhhhhHHH
Confidence            889999999987655443   3566666643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=5.5e-24  Score=231.53  Aligned_cols=175  Identities=26%  Similarity=0.329  Sum_probs=138.3

Q ss_pred             eeeeeceEEEEEEEeC-CCeEEEEEEeecccc---hhhhhHHHHHHHhh---hcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          787 LIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG---RAFKSFDVECEMMK---SIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       787 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      .||+|+||.||+|+.. +++.||+|.+.....   .....+..|..+++   ..+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 589999999864321   11223344444433   3479999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +++|.+++...+ .+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||++......    ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            999999887543 5899999999999999999999   999999999999999999999999999998765321    12


Q ss_pred             cccccccccccCceeee-eeeeeEEeeEeeeeee
Q 036229          940 TQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFL  972 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~  972 (982)
                      ....|+..|+|||++.. ..++   ...|+|++|
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~---~~~Di~slG  183 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYD---SSADWFSLG  183 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCC---chhhhHHHH
Confidence            23568999999999853 3333   335566666

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.4e-23  Score=247.72  Aligned_cols=262  Identities=26%  Similarity=0.286  Sum_probs=124.0

Q ss_pred             cEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEE
Q 036229          350 EELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI  429 (982)
Q Consensus       350 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L  429 (982)
                      ..|++++|.++ .+|..+.  ++|+.|++++|+++.+ |.   ..++|+.|++++|+|+.++..         .++|+.|
T Consensus       204 ~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~LtsLP~l---------p~sL~~L  267 (788)
T PRK15387        204 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTSLPVL---------PPGLLEL  267 (788)
T ss_pred             cEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccCcccCc---------cccccee
Confidence            44555555555 3444332  2455555555555542 22   134455555555555544311         2345555


Q ss_pred             EccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccC
Q 036229          430 GLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK  509 (982)
Q Consensus       430 ~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  509 (982)
                      ++++|++..++.      ....|+.|++++|+++.. |.   ..++|+.|+|++|+|+++ |...   .+|+.|++++|+
T Consensus       268 ~Ls~N~L~~Lp~------lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~  333 (788)
T PRK15387        268 SIFSNPLTHLPA------LPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQ  333 (788)
T ss_pred             eccCCchhhhhh------chhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCCc---ccccccccccCc
Confidence            555555543321      122344455555554432 22   124555556666655532 2211   235555666666


Q ss_pred             CCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCcccc
Q 036229          510 LEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI  589 (982)
Q Consensus       510 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~  589 (982)
                      |++ +|..   ..+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+.+|...   .+|+.|++++|++++ +|...
T Consensus       334 L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~-LP~l~  401 (788)
T PRK15387        334 LTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTS-LPVLP  401 (788)
T ss_pred             ccc-cccc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCcccc---cccceEEecCCcccC-CCCcc
Confidence            653 3321   1355666666666653 3332   234555566666666555422   345555555555553 22221


Q ss_pred             ccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccc
Q 036229          590 GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL  661 (982)
Q Consensus       590 ~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  661 (982)
                         ++|+.||+|+|+|++ +|..   ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|..+
T Consensus       402 ---s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        402 ---SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             ---cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence               234455555555543 3322   123445555555554 345555555555555555555555444443

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.90  E-value=5.8e-24  Score=231.31  Aligned_cols=177  Identities=25%  Similarity=0.367  Sum_probs=146.6

Q ss_pred             eeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ||+|+||+||+|... +++.||+|++....   ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 58999999986432   22345567899999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeeccc
Q 036229          864 EKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT  942 (982)
Q Consensus       864 ~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  942 (982)
                      .+++.... ..+++..+..++.|++.|+.|||   +.|++||||+|+||++++++.+||+|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99987644 35889999999999999999999   999999999999999999999999999998865321   122345


Q ss_pred             ccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          943 LATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       943 ~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .++..|+|||++.+..++.   ..|+|++|+
T Consensus       155 ~~~~~y~~PE~~~~~~~~~---~~Di~slG~  182 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDF---SVDWFALGC  182 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCc---hhhhHHHHH
Confidence            6788999999987665443   355666663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=5.7e-24  Score=233.58  Aligned_cols=185  Identities=26%  Similarity=0.358  Sum_probs=147.4

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999864 68899999986432  2334567889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceeecCCC
Q 036229          857 YMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~  934 (982)
                      |++ +++.+++.... ...++..+..++.||+.||+|||   +++++||||||+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 58888775433 23578888899999999999999   999999999999999985 5689999999997653221


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        .......+++.|+|||++.+...  .+...|+|++|
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Dv~slG  191 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRH--YSTPVDIWSVG  191 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCC--CCcHHHHHHHH
Confidence              11233467889999999865322  12335556666

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.90  E-value=8e-24  Score=228.47  Aligned_cols=188  Identities=23%  Similarity=0.337  Sum_probs=153.3

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC--CCeeEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFKALIL  855 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~  855 (982)
                      +|++.+.||.|+||.||+|.. .+++.||+|+++..  .....+++..|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            578889999999999999985 46889999998643  23445678889999999999999999997753  45689999


Q ss_pred             EeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccC--CCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          856 EYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGY--SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       856 E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~--~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ||+++++|.+++...   ...+++..+..++.|++.|+.|+|...  +.+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998753   456889999999999999999999443  678999999999999999999999999999876


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....  ......+++.|+|||++.+..++   ..+|+|++|+
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~---~~~Dv~slG~  198 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYD---EKSDIWSLGC  198 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCC---chhHHHHHHH
Confidence            43221  12345689999999999766544   3356677663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.90  E-value=8.4e-24  Score=230.07  Aligned_cols=175  Identities=26%  Similarity=0.309  Sum_probs=138.3

Q ss_pred             eeeeeceEEEEEEEe-CCCeEEEEEEeecccc---hhhhhHHHHHH---HhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          787 LIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG---RAFKSFDVECE---MMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       787 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      .||+|+||.||+|+. .+++.||+|++.....   .....+..|..   .++...||+|+++++++..++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 4588999999865421   11122333433   3444579999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      ||+|.+++... ..+++..+..++.|++.|+.|||   +++|+||||||+||+++.++.+||+|||++......    ..
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~  152 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence            99999988654 45899999999999999999999   999999999999999999999999999998865322    12


Q ss_pred             cccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      ....|+..|+|||++.++ .++..   .|+|++|
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~---~Di~s~G  183 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSS---ADWFSLG  183 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcc---cchHhHH
Confidence            235689999999998643 33433   4455555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.5e-23  Score=247.48  Aligned_cols=264  Identities=25%  Similarity=0.321  Sum_probs=214.0

Q ss_pred             CCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccc
Q 036229          371 SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSH  450 (982)
Q Consensus       371 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  450 (982)
                      ..-..|+++.|.++. +|..+.  ++|+.|++.+|+++.++.         .+++|++|+|++|+|+.++.      ...
T Consensus       201 ~~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt~LP~---------lp~~Lk~LdLs~N~LtsLP~------lp~  262 (788)
T PRK15387        201 NGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSLPA---------LPPELRTLEVSGNQLTSLPV------LPP  262 (788)
T ss_pred             CCCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCCCCCC---------CCCCCcEEEecCCccCcccC------ccc
Confidence            456789999999995 555554  479999999999998763         24789999999999998743      346


Q ss_pred             cccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEcc
Q 036229          451 SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLS  530 (982)
Q Consensus       451 ~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  530 (982)
                      +|+.|++++|.++. +|..   .++|+.|++++|+++. +|..   .++|+.|+|++|+|++ +|..   ..+|+.|+++
T Consensus       263 sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls  330 (788)
T PRK15387        263 GLLELSIFSNPLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAY  330 (788)
T ss_pred             ccceeeccCCchhh-hhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCC---cccccccccc
Confidence            89999999999985 3433   3578899999999995 4542   4789999999999995 4542   3468899999


Q ss_pred             CCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccccccccccc
Q 036229          531 GNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP  610 (982)
Q Consensus       531 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p  610 (982)
                      +|+|++ +|..   ..+|++|+|++|+|+.+|..   ..+|+.|++++|++++ +|...   .+|+.|++++|+|++ +|
T Consensus       331 ~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l~---~~L~~LdLs~N~Lt~-LP  398 (788)
T PRK15387        331 NNQLTS-LPTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS-LP  398 (788)
T ss_pred             cCcccc-cccc---ccccceEecCCCccCCCCCC---Ccccceehhhcccccc-Ccccc---cccceEEecCCcccC-CC
Confidence            999985 5542   25899999999999999964   3578889999999995 56543   568899999999986 45


Q ss_pred             ccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC
Q 036229          611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       611 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                      ..   .++|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..
T Consensus       399 ~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~  464 (788)
T PRK15387        399 VL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA  464 (788)
T ss_pred             Cc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHH
Confidence            43   3679999999999985 66543   46889999999998 68999999999999999999999987763

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.90  E-value=7.1e-24  Score=233.82  Aligned_cols=191  Identities=28%  Similarity=0.358  Sum_probs=152.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCC----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----  849 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----  849 (982)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999965 58899999987542  223356778999999999999999999887654    


Q ss_pred             ------eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          850 ------FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       850 ------~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.||+|||   +.||+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 777777665556899999999999999999999   99999999999999999999999999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||.+........ .......++..|+|||.+.+...  .+...|+|++|++
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~~  207 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEER--YGPAIDVWSCGCI  207 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCC--CCchhHHHHHHHH
Confidence            999987643221 12223456788999998854322  1234566666643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.90  E-value=6.8e-24  Score=237.69  Aligned_cols=188  Identities=27%  Similarity=0.362  Sum_probs=151.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhc-CCccceeEEeeecCC--Cee
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE--EFK  851 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~  851 (982)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999865 5889999988532  223345677899999999 999999999988654  368


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999997 5999888654  5788889999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCc---eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQS---ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....   .......|+..|+|||++.+..  ..+..+|+|++|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~  201 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGST--RYTKGVDMWSVGC  201 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccc--cccccchHHHHHH
Confidence            33221   1223456899999999885432  1223466677763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.9e-24  Score=237.36  Aligned_cols=189  Identities=23%  Similarity=0.355  Sum_probs=155.3

Q ss_pred             CCccceeeeeceEEEEEEEeCC--C--eEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          782 FSENNLIGRGGFGSVYKARIGE--G--MEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ....|+||+|.||+|++|.|..  |  ..||||+++.+... ..++|.+|+.+|.+++|||++++||...+ ....||||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            4456799999999999998753  3  45899999765433 67899999999999999999999999887 56789999


Q ss_pred             eccCCChHHHHhc-CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      .++.|+|.+.+++ .+..+-......++.|||.|+.||.   +++.||||+..+|+++.....|||+|||+.+.+...+.
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999987 4556778888999999999999999   99999999999999999888999999999998865554


Q ss_pred             ceee-cccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          936 SITQ-TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       936 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .... ....-...|.|||.++...++.++| .|+||+.++.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSD-vWmyGVTiWE  307 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASD-VWMYGVTIWE  307 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccch-hhhhhhhHHh
Confidence            4433 3334566899999998877765533 3455555433

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.7e-23  Score=224.45  Aligned_cols=184  Identities=31%  Similarity=0.404  Sum_probs=156.2

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|++|.||+|+.. +++.||+|.+.....  ...+.+.+|++++++++||+++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5788999999999999999864 588999999975543  4567889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++... ..+++..+..++.|++.|+.|||   +.||+||||||+||+++.++.+||+|||.+........  
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            9999999998765 45899999999999999999999   99999999999999999999999999999987643322  


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......++..|+|||...+...+   ...|+|++|+
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~---~~~Dv~~lG~  187 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGAS---TASDIWSLGC  187 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCC---cchhHHHHHH
Confidence            12345688899999998665433   4456677663

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.90  E-value=1.6e-23  Score=225.15  Aligned_cols=187  Identities=28%  Similarity=0.377  Sum_probs=158.4

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCC--CeeEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFKALIL  855 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  855 (982)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999865 689999999875542  4567889999999999999999999999888  8899999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++|+||+|+||++++++.+||+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999987655 6899999999999999999999   99999999999999999999999999999987644332


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ........++..|+|||.+.+...+   ..+|+|++|++
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~---~~~Dv~slG~i  192 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYG---RAADIWSLGCT  192 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCC---chhhHHHHHHH
Confidence            1123445688999999998766533   44667777743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.90  E-value=4.9e-24  Score=238.65  Aligned_cols=186  Identities=26%  Similarity=0.329  Sum_probs=148.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCC-----Cee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~  851 (982)
                      +++|++.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            57899999999999999999985 46899999998643 233456678899999999999999999876543     357


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++|+||++ +++.+++..  ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 488887754  34889999999999999999999   9999999999999999999999999999998753


Q ss_pred             CCCCc-eeecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          932 GEDQS-ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      ..... .......|++.|+|||.+.+. .++   ..+|+|++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~~DvwslGv  198 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYT---KAIDIWSVGC  198 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCC---cHHHHHHHHH
Confidence            32211 122345689999999987542 233   3355666663

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.90  E-value=9.8e-24  Score=230.81  Aligned_cols=186  Identities=27%  Similarity=0.369  Sum_probs=152.7

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCC--CeeEEEEE
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFKALILE  856 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~E  856 (982)
                      |++.+.||+|++|.||+|+.. +++.||+|++....  ......+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677899999999999999865 48999999997653  33445688899999999999999999999887  89999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++ ++.+++......+++..+..++.|++.|++|||   +.|++|+||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 898888766557899999999999999999999   99999999999999999999999999999987643321 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .......++..|+|||.+.+...  .+..+|+|++|++
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Dv~slG~~  191 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATR--YGPEVDMWSVGCI  191 (287)
T ss_pred             ccccccccccccCCceeeEcccc--CChHHHHHHHHHH
Confidence            12233457888999998765321  1234566776643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.90  E-value=1e-23  Score=230.28  Aligned_cols=184  Identities=28%  Similarity=0.359  Sum_probs=149.5

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      |++.+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|+++++.++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677899999999999999864 69999999987543  223456788999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      + ++|.+++.... ..+++..+..++.|+++||+|||   +++++||||+|+||++++++.+||+|||.+.......  .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence            5 68999887544 35899999999999999999999   9999999999999999999999999999997653221  1


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......++..|+|||++.+...  .+..+|+|++|+
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~  188 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQ--YSTPVDIWSIGC  188 (283)
T ss_pred             ccCccccccCCCCCceeecCcc--cCcHHHHHHHHH
Confidence            1223456889999998865422  123355566663

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.90  E-value=1.1e-23  Score=229.79  Aligned_cols=182  Identities=22%  Similarity=0.297  Sum_probs=145.9

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcC-CccceeEEeeecCC--CeeEEEEE
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSTE--EFKALILE  856 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~E  856 (982)
                      |++.+.||+|+||.||+|+.. +++.||+|+++... ........+|+.+++++. ||||+++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667889999999999999854 58999999986532 222234457888898885 99999999999887  88999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |++ +++.+.+......+++.++..++.|++.||+|||   +.|++||||||+||++++ +.+||+|||.+.......  
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--  153 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--  153 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence            996 5888888765567899999999999999999999   999999999999999999 999999999998763222  


Q ss_pred             eeecccccccccccCceeeee-eeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~  974 (982)
                       ......++..|+|||++... ..+   ..+|+|++|++
T Consensus       154 -~~~~~~~~~~y~aPE~~~~~~~~~---~~~Di~slGv~  188 (282)
T cd07831         154 -PYTEYISTRWYRAPECLLTDGYYG---PKMDIWAVGCV  188 (282)
T ss_pred             -CcCCCCCCcccCChhHhhcCCCCC---cchhHHHHHHH
Confidence             12235678999999987443 233   33556666643

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.90  E-value=2.2e-23  Score=225.25  Aligned_cols=183  Identities=22%  Similarity=0.239  Sum_probs=146.2

Q ss_pred             HHHHHHhcCCCcccee--eeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCC
Q 036229          773 LELCRATNRFSENNLI--GRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE  848 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  848 (982)
                      .+.....++|++.+.+  |+|+||.||+++. .+++.+|+|+++......   .  |+.....+ +||||+++++++..+
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecC
Confidence            4445556778877777  9999999999985 458889999987432211   1  22222222 799999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCc
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIA  927 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla  927 (982)
                      +..++||||+++++|.+++.... .+++.++..++.|+++|++|||   +.|++||||||+||+++.++ .++|+|||.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999997654 6899999999999999999999   99999999999999999888 9999999998


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......      ....++..|+|||++.+..++.   ..|+|++|+
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~  194 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDV---SFDWWAVGV  194 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCc---hhhHHHHHH
Confidence            865321      2346889999999997765553   355666663

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.90  E-value=9e-24  Score=228.06  Aligned_cols=179  Identities=27%  Similarity=0.380  Sum_probs=149.1

Q ss_pred             eeeeceEEEEEEEeCC-CeEEEEEEeecccc---hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ||+|+||.||+|+... ++.||+|+++....   ...+.+.+|++++++++||||+++++.+..+...|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            5899999999999764 89999999865432   4456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC------ce
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ------SI  937 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~------~~  937 (982)
                      .+++.+.. .+++..+..++.|++.||+|||   +.|++||||+|+||++++++.+||+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99987654 5899999999999999999999   99999999999999999999999999999886432211      11


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......++..|+|||.......+   ...|+|++|+
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~---~~~Dv~slG~  189 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHS---KTVDWWSLGC  189 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCC---cchhhHHHHH
Confidence            22345678899999998665543   3456677663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.90  E-value=2.4e-23  Score=230.48  Aligned_cols=183  Identities=26%  Similarity=0.305  Sum_probs=149.7

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      |...+.||+|+||.||+|+.. +++.||+|++....   ......+..|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999864 58899999987432   23345678899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +. |++.+++......+++.++..++.|++.|+.|||   ++|++||||||+||++++++.+||+|||++....      
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------  172 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------  172 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence            95 5888888766667899999999999999999999   9999999999999999999999999999986431      


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......|+..|+|||++........+..+|+|++|++
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvi  209 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  209 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHH
Confidence            1224568889999999853211223344667777743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.90  E-value=1.7e-23  Score=226.56  Aligned_cols=184  Identities=23%  Similarity=0.391  Sum_probs=150.8

Q ss_pred             CCCccceeeeeceEEEEEEEeCC--CeEEEEEEeecc----------cchhhhhHHHHHHHhhh-cCCccceeEEeeecC
Q 036229          781 RFSENNLIGRGGFGSVYKARIGE--GMEVAVKVFDLQ----------CGRAFKSFDVECEMMKS-IRHRNLIKVISSCST  847 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~  847 (982)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998654  788999987532          12234556778888765 799999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          848 EEFKALILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.|+.|||   + .+++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3446888999999999999999999   6 6899999999999999999999999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||.+.......   ......|+..|+|||++.+..++   ..+|+|++|+
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~---~~~Dv~slG~  201 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYG---EKADVWAFGC  201 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCc---hHHHHHHHHH
Confidence            99998753322   23456688999999999765443   4466777773

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.89  E-value=9.6e-24  Score=236.11  Aligned_cols=188  Identities=26%  Similarity=0.314  Sum_probs=151.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecC----CCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCST----EEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~  851 (982)
                      .++|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999854 59999999987542  2345667889999999999999999988753    3468


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+. +++.+++.... .+++..+..++.|++.||.|||   ++||+||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 58988886544 4899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCc--eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQS--ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....  .......|+..|+|||++.+...  .+..+|+|++|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~~Di~slG~  200 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPE--YTTAIDMWSVGC  200 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcc--cccccchHHHHH
Confidence            32211  11234578899999999855321  234466677664

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.9e-23  Score=239.03  Aligned_cols=175  Identities=19%  Similarity=0.261  Sum_probs=132.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-----------------CCCeEEEEEEeecccchhhh--------------hHHHH
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-----------------GEGMEVAVKVFDLQCGRAFK--------------SFDVE  826 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E  826 (982)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 23567999998654332222              23446


Q ss_pred             HHHhhhcCCccc-----eeEEeeecC--------CCeeEEEEEeccCCChHHHHhcCC----------------------
Q 036229          827 CEMMKSIRHRNL-----IKVISSCST--------EEFKALILEYMPHGSLEKSLYSSN----------------------  871 (982)
Q Consensus       827 ~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~----------------------  871 (982)
                      +.++.+++|.++     ++++++|..        ++..++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777643        356899999999999999886421                      


Q ss_pred             -CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeeccccccccccc
Q 036229          872 -YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA  950 (982)
Q Consensus       872 -~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a  950 (982)
                       ...++..+..++.|++.|+.|+|   +.+|+||||||+||+++.++.+||+|||++..+..... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence             12356678889999999999999   99999999999999999999999999999976532211 11122345789999


Q ss_pred             Cceeee
Q 036229          951 PGLFHV  956 (982)
Q Consensus       951 PE~~~~  956 (982)
                      ||.+..
T Consensus       379 PE~l~~  384 (507)
T PLN03224        379 PEELVM  384 (507)
T ss_pred             hhhhcC
Confidence            999854

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.89  E-value=1.5e-23  Score=236.47  Aligned_cols=182  Identities=25%  Similarity=0.282  Sum_probs=149.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC------
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE------  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------  848 (982)
                      ..++|+..+.||+|+||.||+|+.. +++.||+|++...  .....+++.+|+++++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999854 6899999998643  233445677899999999999999999988644      


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      ...|+||||+. +++.+.+...   +++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999995 4888877543   788889999999999999999   9999999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ......   ......+++.|+|||++.+..++..   .|+|++|
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~---~DvwslG  204 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVG  204 (353)
T ss_pred             eCCCCC---CCCCCcccccccCHHHHhCCCCCCc---hhhHhHH
Confidence            753221   1234568899999999977665544   4556655

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.89  E-value=1.3e-23  Score=230.15  Aligned_cols=186  Identities=26%  Similarity=0.268  Sum_probs=145.9

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5666789999999999999854 58999999986542 234567889999999996 99999999999999999999999


Q ss_pred             ccCCChHHHHh---c-CCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          858 MPHGSLEKSLY---S-SNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       858 ~~~gsL~~~l~---~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +.. ++.++..   . ....+++..+..++.|++.|++|||   + .+|+||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            854 6554432   2 2356889999999999999999999   6 5999999999999999999999999999976532


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..   ......|++.|+|||++.+......+...|+|++|+
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~  198 (288)
T cd06616         161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGI  198 (288)
T ss_pred             CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHH
Confidence            21   123346888999999986652112223456666663

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=2.1e-23  Score=228.18  Aligned_cols=190  Identities=27%  Similarity=0.300  Sum_probs=153.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecC--CCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~  855 (982)
                      ++|+..+.||.|++|.||+|... +++.||+|.+.... .....++.+|++++++++||||+++++++..  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999964 58999999987543 2345778999999999999999999998854  34789999


Q ss_pred             EeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||   +.|++|+||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999887653   3345788889999999999999999   99999999999999999999999999999876432


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ..    .....++..|+|||.+.+..++.   ..|+|++|  ++.+.+|
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~---~~Dv~slG~il~~l~~g  199 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSI---TSDVWSLGLTLLEVAQN  199 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCc---hhhHHHHHHHHHHHHhC
Confidence            21    12345788999999987665543   35666666  4444444

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.89  E-value=2.6e-23  Score=229.73  Aligned_cols=184  Identities=27%  Similarity=0.337  Sum_probs=150.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..|+..+.||+|+||.||+|+.. +++.||+|.+...   ......++.+|+++++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777889999999999999864 5888999998642   2234457788999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+. |++.+++......+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++.....   
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---  167 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence            9996 5888877655566889999999999999999999   99999999999999999999999999999886532   


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....+++.|+|||.+.+......+..+|+|++|+
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~  202 (308)
T cd06634         168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  202 (308)
T ss_pred             ---cccccCCccccCHHHHhhcccCCCCcccchHHHHH
Confidence               12346888999999974321122234466677663

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.89  E-value=1.3e-23  Score=225.83  Aligned_cols=186  Identities=24%  Similarity=0.381  Sum_probs=153.4

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||+|... ++..||+|.+....  ....+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788999999999999999864 58899999986542  23456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~  935 (982)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987543 35789999999999999999999   99999999999999998775 579999999987643221


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                        ......|++.|+|||++.+...+   ...|+|++|++
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~---~~~Dv~slG~i  191 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYN---NKTDIWSLGCV  191 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCC---chhhHHHHHHH
Confidence              12234688999999998665443   34667777743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1.4e-23  Score=235.31  Aligned_cols=184  Identities=23%  Similarity=0.313  Sum_probs=148.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC----
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----  849 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----  849 (982)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|++++++++||||+++++++..+.    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3567899999999999999999984 46899999998643  2233456889999999999999999999886653    


Q ss_pred             --eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          850 --FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       850 --~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                        ..++||||+ ++++.+++..  ..+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+|++|||++
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence              458999999 7799888864  34789999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......     .....+++.|+|||++.+...  .....|+|++|+
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~  204 (343)
T cd07880         166 RQTDSE-----MTGYVVTRWYRAPEVILNWMH--YTQTVDIWSVGC  204 (343)
T ss_pred             cccccC-----ccccccCCcccCHHHHhCCCC--CCcHHHHHHHHH
Confidence            865221     123467889999999865321  223355666663

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.89  E-value=1.9e-23  Score=234.52  Aligned_cols=188  Identities=24%  Similarity=0.298  Sum_probs=151.0

Q ss_pred             CHHHHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecC
Q 036229          771 SYLELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCST  847 (982)
Q Consensus       771 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  847 (982)
                      ...++....++|++.+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3455667789999999999999999999985 468999999986432  2234567889999999999999999998754


Q ss_pred             C------CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 036229          848 E------EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  921 (982)
Q Consensus       848 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  921 (982)
                      .      ...++++|++ +++|.+++...  .+++..+..++.|+++|++|||   +.||+||||||+||++++++.+||
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence            3      3467888887 77998887543  4789999999999999999999   999999999999999999999999


Q ss_pred             EeecCceeecCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          922 SDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       922 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      +|||++.....     ......++..|+|||.+.+. .++   ...|+|++|
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~---~~~DvwslG  205 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYN---QTVDIWSVG  205 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCC---chhhHHHHH
Confidence            99999886421     12345688899999998552 223   235556666

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.89  E-value=2.6e-23  Score=228.57  Aligned_cols=189  Identities=25%  Similarity=0.281  Sum_probs=150.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..++|++.+.||+|++|.||+|+..+ ++.||||.++... ......+..|++++.+. .||||+++++++.++...++|
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34678899999999999999999764 8999999997542 23345566677777666 499999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |||++ +++.++.......+++..+..++.|++.|++|||   + .||+||||+|+||++++++.+||+|||++..+...
T Consensus        93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99985 5787777665557899999999999999999999   7 59999999999999999999999999998865322


Q ss_pred             CCceeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      .   ......++..|+|||++.+.. ....+...|+|++|+
T Consensus       169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~  206 (296)
T cd06618         169 K---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGI  206 (296)
T ss_pred             C---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHH
Confidence            2   122345788999999986543 122334566777773

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.89  E-value=2.3e-23  Score=215.78  Aligned_cols=182  Identities=21%  Similarity=0.251  Sum_probs=150.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcC--Cc----cceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR--HR----NLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----nIv~l~~~~~~~~~  850 (982)
                      .+.+|.+...+|+|.||.|-++.+. .+..||+|+++.- .+..+...-|+++++++.  .|    -++++.+||...++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            4789999999999999999999854 4789999999743 456677888999999993  22    37888999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC--------------
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD--------------  915 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~--------------  915 (982)
                      .|+|+|.+ |-++.+++.+.+ .+++...+..+++|++++++|||   +.+++|-|+||+||++.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 669999998754 36888999999999999999999   999999999999999942              


Q ss_pred             ------CCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          916 ------NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       916 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                            +..+|++|||.|......     ....+.|..|+|||++.+-.++...   |+||+|
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pC---DvWSiG  296 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPC---DVWSIG  296 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCcc---Cceeee
Confidence                  235899999999964222     2457789999999999988777663   444444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.5e-25  Score=217.48  Aligned_cols=185  Identities=25%  Similarity=0.347  Sum_probs=148.3

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC-----eeEE
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-----FKAL  853 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~l  853 (982)
                      .+..+.||-|+||+||.+.++ +|+.||.|++..-  .-...+++.+|++++..++|.|+...++..+...     +.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345578999999999999864 5999999988632  2334578889999999999999999988776543     5678


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ++|.+ ..+|.+++-.. +.++...++-+.+||++||+|||   +.+|.||||||.|.+++.+..+||||||+|+.-. .
T Consensus       135 ~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee-~  208 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD-Q  208 (449)
T ss_pred             HHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc-h
Confidence            99988 45898887654 45777888889999999999999   9999999999999999999999999999999642 2


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ++....+..+.|.+|+|||++.+.......  .|+|++|++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~A--vDiWSVGCI  247 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGA--VDIWSVGCI  247 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCc--cceehhhHH
Confidence            334445677889999999999876544333  445666643

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.89  E-value=1.4e-23  Score=228.64  Aligned_cols=187  Identities=29%  Similarity=0.428  Sum_probs=155.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ++|...+.||+|+||.||+|+.. +++.||+|++...   .....+.+..|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999864 6899999998653   2233467888999999998 99999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++.+.. .+++..+..++.|++.|+.|||   +.|++|+||||+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999997654 5899999999999999999999   9999999999999999999999999999988764322


Q ss_pred             Cc------------------eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QS------------------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..                  .......++..|+|||+......+   ...|+|++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~---~~~Di~slG~  210 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG---KSSDLWALGC  210 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC---hhhhHHHHHH
Confidence            11                  122344678899999998665433   3456676663

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.89  E-value=1.8e-23  Score=228.89  Aligned_cols=178  Identities=25%  Similarity=0.294  Sum_probs=149.7

Q ss_pred             cceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          785 NNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ..+||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46899999999999986 46899999998755555567789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccc
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL  943 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  943 (982)
                      .+++...  .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.++|+|||++.......  .......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            9987543  4788899999999999999999   9999999999999999999999999999987653322  1223456


Q ss_pred             cccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          944 ATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       944 gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      |++.|+|||.+.+..++.   ..|+|++|
T Consensus       178 ~~~~y~~pE~~~~~~~~~---~~Dv~slG  203 (292)
T cd06657         178 GTPYWMAPELISRLPYGP---EVDIWSLG  203 (292)
T ss_pred             cCccccCHHHhcCCCCCc---hhhHHHHH
Confidence            889999999986654443   45566666

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.89  E-value=4.9e-23  Score=221.27  Aligned_cols=185  Identities=28%  Similarity=0.410  Sum_probs=157.0

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|+..+.||+|+||.||++... +++.||+|++.....  ...+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888899999999999999864 589999999975432  4566788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          858 MPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       858 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      +++++|.+++...   ...+++..+..++.|++.|+.|||   +.|++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999765   366899999999999999999999   9999999999999999999999999999998763332


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        .......|++.|+|||...+...+.   ..|+|++|+
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~---~~Dv~slG~  191 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNY---KSDIWSLGC  191 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCc---cccHHHHHH
Confidence              1223456889999999987665443   355666663

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.89  E-value=2.7e-23  Score=227.95  Aligned_cols=193  Identities=22%  Similarity=0.265  Sum_probs=137.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC----CeEEEEEEeecccchhh-----------hhHHHHHHHhhhcCCccceeEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQCGRAF-----------KSFDVECEMMKSIRHRNLIKVIS  843 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~nIv~l~~  843 (982)
                      .++|.+.+.||+|+||.||+|+..+    +..+|+|+.........           .....+...+..+.|++|+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999998643    45667776543321110           11122334456678999999999


Q ss_pred             eecCCC----eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          844 SCSTEE----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       844 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                      ++....    ..++++|++. .++.+.+... ...++..+..++.|++.|++|||   +++|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            765443    4578888874 3666666543 23567788899999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          920 HLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ||+|||+|+.+......     .......||+.|+|||++.+..++..   .|+|++|  ++.+.+|
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~---~DiwSlG~~l~el~~g  229 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR---GDLESLGYCMLKWAGI  229 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH---HHHHHHHHHHHHHHhC
Confidence            99999999876432211     11123469999999999987766544   4455555  3334444

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.89  E-value=2e-23  Score=231.38  Aligned_cols=190  Identities=24%  Similarity=0.330  Sum_probs=149.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCC-------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTE-------  848 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------  848 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.....  .....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999864 589999999864422  2234677899999999999999999877443       


Q ss_pred             -CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          849 -EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       849 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                       ...++||||+.+ ++.+.+......+++..+..++.|+++||+|||   ++||+||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             356999999965 787777665567899999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCc---------eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          928 KLLIGEDQS---------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       928 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .........         ...+...+++.|+|||.+.+...  .+...|+|++|++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG~i  216 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERR--YTTAVDIWGIGCV  216 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCc--cCchhHhHHHHHH
Confidence            865432211         11133467889999998854321  2233566676643

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.89  E-value=3.5e-23  Score=226.57  Aligned_cols=187  Identities=24%  Similarity=0.333  Sum_probs=151.4

Q ss_pred             CCCccceeeeeceEEEEEEEe----CCCeEEEEEEeeccc----chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCee
Q 036229          781 RFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQC----GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  851 (982)
                      +|++.+.||+|++|.||+|+.    .+++.||||+++...    ....+.+..|+++++++ +||+|+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478889999999999999874    347889999987432    22345678899999999 599999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++|+|.+++... ..+++..+..++.|+++||+|||   +.|++||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            9999999999999998654 35788899999999999999999   9999999999999999999999999999988654


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .... .......|+..|+|||.+.+... ..+...|+|++|+
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~Dv~slG~  196 (288)
T cd05583         157 AEEE-ERAYSFCGTIEYMAPEVIRGGSG-GHDKAVDWWSLGV  196 (288)
T ss_pred             cccc-cccccccCCccccCHHHhcCCCC-CCcchhhhHHHHH
Confidence            3322 12233568899999999865431 1224456676663

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.89  E-value=5.1e-23  Score=224.68  Aligned_cols=184  Identities=23%  Similarity=0.308  Sum_probs=150.4

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEEEec
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      |++.+.||+|++|.||+|+.. +++.||+|++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999975 488999999864422 22234457899999998 999999999999999999999999


Q ss_pred             cCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                       +|++.+++.... ..+++..+..++.|++.|+.|||   ++|++|+||+|+||++++++.+||+|||.+.......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             779988887654 46799999999999999999999   9999999999999999999999999999998653222   


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......++..|+|||++.....  .+...|+|++|++
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~s~G~~  188 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTS--YSSPVDIWALGCI  188 (283)
T ss_pred             CcCCCCCcccccCceeeecCcC--cCCccchhhHHHH
Confidence            2234568889999999854321  2345667777744

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.89  E-value=3.9e-23  Score=231.39  Aligned_cols=187  Identities=23%  Similarity=0.313  Sum_probs=147.7

Q ss_pred             hcCCC-ccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchh--------------hhhHHHHHHHhhhcCCccceeEE
Q 036229          779 TNRFS-ENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRA--------------FKSFDVECEMMKSIRHRNLIKVI  842 (982)
Q Consensus       779 ~~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~nIv~l~  842 (982)
                      .++|. +.+.||+|+||+||+|+.. +++.||+|+++......              ...+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            45665 4577999999999999854 58999999986432211              12477899999999999999999


Q ss_pred             eeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE
Q 036229          843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  922 (982)
Q Consensus       843 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  922 (982)
                      +++..++..++||||++ |++.+++... ..+++.....++.|++.|++|||   +.||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 5999888653 34788999999999999999999   9999999999999999999999999


Q ss_pred             eecCceeecCCC------------CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          923 DFGIAKLLIGED------------QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       923 DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      |||.+.......            .........+++.|+|||.+.+...  .+..+|+|++|
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Dv~slG  221 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK--YHFAVDMWSVG  221 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCC--CCcHHHHHHHH
Confidence            999998654110            0111123456889999999865432  12335566666

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.89  E-value=2.6e-23  Score=232.79  Aligned_cols=186  Identities=26%  Similarity=0.315  Sum_probs=150.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC-----Ce
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~  850 (982)
                      .++|.+.+.||+|+||.||+|+. .+++.||||.++..  ......++.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46799999999999999999985 46899999998643  233345677899999999999999999987544     35


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++||||+. ++|.+++... ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 6898888654 45899999999999999999999   999999999999999999999999999999865


Q ss_pred             cCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMI  974 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~  974 (982)
                      ....  .......++..|+|||.+... .++   ..+|+|++|++
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~---~~~DiwslG~i  198 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYT---TAIDVWSVGCI  198 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCC---CcccHHHHHHH
Confidence            3322  222345678899999998542 333   34666777643

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.88  E-value=3.4e-23  Score=226.02  Aligned_cols=184  Identities=27%  Similarity=0.325  Sum_probs=152.8

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      |++.+.||+|++|.||+|... +++.+|+|.++....  .....+.+|++++++++|++|+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            667889999999999999864 689999999875432  24567888999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      ++ ++.+++......+++.++..++.|++.|+.|||   +++|+|+||||+||++++++.+||+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 888888776567899999999999999999999   9999999999999999999999999999998764332  12


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....++..|+|||.+.+..  ..+..+|+|++|+
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~--~~~~~~Di~slG~  187 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDK--GYSTPVDIWSVGC  187 (283)
T ss_pred             ccCccCcccccCcHHHhcCC--CCCchhHHHHHHH
Confidence            23356788999999986541  1234456666664

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.88  E-value=3.4e-23  Score=231.50  Aligned_cols=186  Identities=27%  Similarity=0.325  Sum_probs=153.3

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCC-----eeE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-----FKA  852 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~  852 (982)
                      +|++.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999965 48999999987543  344567889999999999999999999987765     789


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||++ +++.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 58988886544 6899999999999999999999   99999999999999999999999999999997643


Q ss_pred             CCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .... .......+++.|+|||++.+..  ..+...|+|++|+
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~sDi~slG~  195 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSS--RYTKAIDIWSVGC  195 (330)
T ss_pred             cccccccccccccccCcCCceeeeccc--CCCcchhHHHHHH
Confidence            3210 1223456889999999997762  2234456666664

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=6.8e-23  Score=220.69  Aligned_cols=175  Identities=24%  Similarity=0.303  Sum_probs=141.9

Q ss_pred             ceeeeeceEEEEEEEeC-CCeEEEEEEeecccc---hhhhhHHHHHHHh-hhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG---RAFKSFDVECEMM-KSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|... +++.||+|+++....   .....+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57899999999999864 589999999864321   2223344555544 455899999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      ++|.+++.... .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++.....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999987543 5788999999999999999999   99999999999999999999999999999885422      22


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...+++.|+|||.+.+..++   ...|+|++|+
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~---~~~Dv~slG~  181 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDD---KMSDWWSLGC  181 (260)
T ss_pred             cCCCCcCccChhhhcCCCCc---chhhhHHHHH
Confidence            34688899999999776544   3456666663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.88  E-value=6.3e-23  Score=241.45  Aligned_cols=170  Identities=21%  Similarity=0.261  Sum_probs=121.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-C----CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEee------ec
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-E----GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISS------CS  846 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~~  846 (982)
                      ..++|+..+.||+|+||.||+|+.. +    +..||+|++.....  .+....|  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999864 4    68999998763221  1111111  1112222222222211      24


Q ss_pred             CCCeeEEEEEeccCCChHHHHhcCCCcC-------------------CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 036229          847 TEEFKALILEYMPHGSLEKSLYSSNYIL-------------------DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK  907 (982)
Q Consensus       847 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlk  907 (982)
                      .+...++||||+++++|.+++.......                   ....+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5667899999999999999887543211                   12345679999999999999   9999999999


Q ss_pred             CCCEEEcC-CCcEEEEeecCceeecCCCCceeecccccccccccCceee
Q 036229          908 PSNVLLDD-NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH  955 (982)
Q Consensus       908 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  955 (982)
                      |+|||+++ ++.+||+|||+|+.+..... .......+++.|||||.+.
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~  330 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYI  330 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhh
Confidence            99999985 57999999999986533222 2234567899999999763

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.88  E-value=4.4e-23  Score=225.08  Aligned_cols=183  Identities=29%  Similarity=0.367  Sum_probs=152.5

Q ss_pred             CCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          782 FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      |+..+.||+|++|.||+|+.. +++.||+|++....  ....+.+..|++++++++|+||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567789999999999999865 48999999997652  334567788999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      + ++|.+++.+....+++..+..++.|++.|++|||   ++||+||||+|+||++++++.+||+|||.+........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876556899999999999999999999   99999999999999999999999999999987533221  2


Q ss_pred             ecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      .....++..|+|||++.+. ..+   ...|+|++|+
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~---~~~Dv~slG~  187 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYS---TAVDIWSVGC  187 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCC---ccccHHHHHH
Confidence            2334567889999998655 333   3466677764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.88  E-value=5.8e-23  Score=230.40  Aligned_cols=180  Identities=25%  Similarity=0.320  Sum_probs=144.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  849 (982)
                      .++|...+.||+|+||.||+|+. .+++.||+|+++..  .......+.+|+++++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999985 46899999998643  2223456788999999999999999999886543      


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..++|+||+.. ++.++..   ..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776652   34788999999999999999999   99999999999999999999999999999886


Q ss_pred             ecCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      ...     ......+++.|+|||++.+. .++   ..+|+|++|+
T Consensus       167 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~---~~~Dv~slGv  203 (342)
T cd07879         167 ADA-----EMTGYVVTRWYRAPEVILNWMHYN---QTVDIWSVGC  203 (342)
T ss_pred             CCC-----CCCCceeeecccChhhhcCccccC---chHHHHHHHH
Confidence            422     12235678899999998653 233   3456666663

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.88  E-value=5.5e-23  Score=228.97  Aligned_cols=182  Identities=29%  Similarity=0.344  Sum_probs=148.1

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC-CCeeE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST-EEFKA  852 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~  852 (982)
                      ..+++|++.+.||+|+||.||+|+.. +++.||+|++...  .....+.+..|++++++++||||+++++++.. .+..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            46788999999999999999999854 6899999988543  22334677889999999999999999998865 56789


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+ +++|.+++...  .+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||.+.....
T Consensus        87 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            999999 56898888643  4678888899999999999999   99999999999999999999999999999885421


Q ss_pred             CCCceeecccccccccccCceeee-eeeeeEEeeEeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFL  972 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~  972 (982)
                           ......++..|+|||.+.+ ..++   ..+|+|++|
T Consensus       161 -----~~~~~~~~~~y~aPE~~~~~~~~~---~~~Dv~slG  193 (328)
T cd07856         161 -----QMTGYVSTRYYRAPEIMLTWQKYD---VEVDIWSAG  193 (328)
T ss_pred             -----CcCCCcccccccCceeeeccCCcC---cHHHHHHHH
Confidence                 1123467889999999855 3333   335556666

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=6.4e-23  Score=227.58  Aligned_cols=186  Identities=19%  Similarity=0.198  Sum_probs=145.3

Q ss_pred             CccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          783 SENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      .+.+.+|.|+++.||+++. +++.||+|++...  .....+.+.+|+++++.++||||+++++++..++..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3445555566666666554 6899999998754  344567899999999999999999999999999999999999999


Q ss_pred             CChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc---
Q 036229          861 GSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS---  936 (982)
Q Consensus       861 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~---  936 (982)
                      |++.+++... ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+.........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999998753 345788899999999999999999   999999999999999999999999999998765432211   


Q ss_pred             --eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 --ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        .......++..|+|||++...... .+...|+|++|+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~Diws~G~  198 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQG-YNEKSDIYSVGI  198 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCC-CCcchhHHHHHH
Confidence              111234577889999998653211 123356666663

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.88  E-value=6.7e-23  Score=229.09  Aligned_cols=186  Identities=24%  Similarity=0.264  Sum_probs=145.7

Q ss_pred             CCCccceeeeeceEEEEEEEeC-C--CeEEEEEEeecc--cchhhhhHHHHHHHhhhc-CCccceeEEeeecC----CCe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-E--GMEVAVKVFDLQ--CGRAFKSFDVECEMMKSI-RHRNLIKVISSCST----EEF  850 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~  850 (982)
                      +|++.+.||+|+||.||+|+.. +  +..||+|+++..  .....+++.+|+++++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5788899999999999999854 3  778999998643  222345678899999999 59999999987532    245


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++++||+. ++|.+++... ..+++..++.++.|++.||+|||   ++||+||||||+||++++++.+||+|||.++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999985 6898888654 45889999999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCc--eeecccccccccccCceeeee-eeeeEEeeEeeeeeeee
Q 036229          931 IGEDQS--ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMI  974 (982)
Q Consensus       931 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~  974 (982)
                      ......  .......|++.|+|||.+.+. .++   ...|+|++|++
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~~Di~slGv~  199 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYT---KAIDVWSVGCI  199 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCC---cHHHHHHHHHH
Confidence            432211  112345789999999987543 233   33556666643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.88  E-value=5.4e-23  Score=230.70  Aligned_cols=188  Identities=26%  Similarity=0.338  Sum_probs=148.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCC---------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE---------  848 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~---------  848 (982)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            46899999999999999999986 45899999999766555667788999999999999999999876543         


Q ss_pred             -----CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEE
Q 036229          849 -----EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLS  922 (982)
Q Consensus       849 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~  922 (982)
                           ...++||||++ ++|.+++...  .+++..+..++.|++.|++|||   +.||+||||||+||+++ +++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 5898887543  4788999999999999999999   99999999999999997 45689999


Q ss_pred             eecCceeecCCCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          923 DFGIAKLLIGEDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       923 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |||.+......... .......++..|+|||++.....  .+..+|+|++|++
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwSlGvi  208 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCI  208 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccc--cCchhhHHHHHHH
Confidence            99999865322111 11123457889999998744221  2234566776643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.88  E-value=1e-22  Score=227.14  Aligned_cols=183  Identities=24%  Similarity=0.290  Sum_probs=143.2

Q ss_pred             ceeeee--ceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRG--GFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|  +||+||+|+. .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999986 469999999987542  23456788999999999999999999999999999999999999


Q ss_pred             CChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee-
Q 036229          861 GSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT-  938 (982)
Q Consensus       861 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-  938 (982)
                      +++.+++... ...+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+|++|||.+........... 
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999988754 235788899999999999999999   99999999999999999999999999986543322111100 


Q ss_pred             ----ecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          939 ----QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       939 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                          .....++..|||||++.+.... .+..+|+|++|
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~DiwslG  197 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVG  197 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCC-CCchhhHHHHH
Confidence                0112345679999999664221 22345666666

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=9e-23  Score=219.12  Aligned_cols=182  Identities=25%  Similarity=0.405  Sum_probs=153.0

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +|++.+.||+|+||.||+++.. +++.+|+|.+....  .....++.+|++++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788999999999999999754 68899999987542  33456778899999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          858 MPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       858 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      +++++|.+++.+.   +..+++..+..++.|++.|++|||   +.|++||||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   345788899999999999999999   999999999999999999999999999999876433 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                         ......+++.|+|||.+.+..++..   .|+|++|
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~---~D~~slG  188 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYK---SDIWSLG  188 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCch---hhHHHHH
Confidence               2223568889999999977655433   4556655

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.87  E-value=1e-23  Score=202.54  Aligned_cols=189  Identities=20%  Similarity=0.388  Sum_probs=151.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCC--eeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEE--FKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~l  853 (982)
                      ..++|++.+++|+|.|++||.|. ..++++++||++++-   ..+.+.+|++|++.+. ||||+++++...++.  ...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            35789999999999999999997 567889999999743   4567899999999996 999999999987764  5679


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceeecC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~  932 (982)
                      |+||+.+.+...+..    .++...+..++.|+++||.|+|   ++||.|||+||.|++||. .-.++|+|+|+|..+.+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999887766542    3667788899999999999999   999999999999999995 45899999999998744


Q ss_pred             CCCceeecccccccccccCcee-eeeeeeeEEeeEeeeeeee----eecccCCCC
Q 036229          933 EDQSITQTQTLATIGYMAPGLF-HVKYILFVVNFLTSYSFLM----IFIGRGNYY  982 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~~d~~~~~~----~l~~~~~f~  982 (982)
                      ..+   ....+.+..|.-||.+ .-..|++.   .|+||+|+    +++-..|||
T Consensus       186 ~~e---YnVRVASRyfKGPELLVdy~~YDYS---LD~WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  186 GKE---YNVRVASRYFKGPELLVDYQMYDYS---LDMWSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             Cce---eeeeeehhhcCCchheeechhcccc---HHHHHHHHHHHHHHhccCccc
Confidence            333   3346678889999998 33445544   44566664    445566665

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=8e-22  Score=234.87  Aligned_cols=318  Identities=19%  Similarity=0.320  Sum_probs=225.9

Q ss_pred             hcCCCChhHHHHHHHHHHHhcCCCCc--cccCCCCCCCCCCceee----------------EEecCCCCcEEEEEeCCCC
Q 036229           31 ANTSSITTDQDALLALKAHITHDPTN--FLAKNWNTSTPVCNWTG----------------VTCDVHSHRVKVLNISHLN   92 (982)
Q Consensus        31 ~~~~~~~~~~~~ll~~k~~~~~~~~~--~~~~~w~~~~~~c~w~g----------------v~c~~~~~~v~~L~l~~~~   92 (982)
                      ...-..++|.+.++++.+.+... +.  +.-+.|++.+++|.-..                |.|.  .+.|+.+..-+..
T Consensus        56 ~~~~~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~  132 (754)
T PRK15370         56 PPETASPEEIKSKFECLRMLAFP-AYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESE  132 (754)
T ss_pred             CCCCCCHHHHHHHHHHHHHhcCC-chhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccc
Confidence            34456688999999999999773 21  12234999999996433                5665  3455555543311


Q ss_pred             cccc---------------------CC-------ccc-----cCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCC
Q 036229           93 LTGT---------------------IP-------SQL-----WNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGN  139 (982)
Q Consensus        93 l~g~---------------------~~-------~~l-----~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N  139 (982)
                      ....                     .+       ..+     +-..+.+.|++++++++ .+|..+.  +.|+.|+|++|
T Consensus       133 ~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N  209 (754)
T PRK15370        133 QASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNN  209 (754)
T ss_pred             ccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCC
Confidence            1100                     00       011     11235678888888887 6776653  57889999999


Q ss_pred             cccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccc
Q 036229          140 QLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIP  219 (982)
Q Consensus       140 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  219 (982)
                      +|+ .+|..+.  ++|++|++++|.++ .+|..+.   ++|+.|+|++|++. .+|..+.  ++|+.|+|++|+++ .+|
T Consensus       210 ~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP  278 (754)
T PRK15370        210 ELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLP  278 (754)
T ss_pred             CCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccc
Confidence            888 5676654  58899999999888 6887663   47888999999887 5666654  47889999999888 567


Q ss_pred             cccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCC
Q 036229          220 KEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHN  299 (982)
Q Consensus       220 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  299 (982)
                      ..+.  ++|+.|+|++|++++ +|..+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|.+++ +|..+.  ++
T Consensus       279 ~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~s  347 (754)
T PRK15370        279 ENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PE  347 (754)
T ss_pred             cccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--Cc
Confidence            6654  478889999998884 454443  468888899998885 454442  688999999999985 565554  68


Q ss_pred             CcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCccccccccc----ccCCCCCCE
Q 036229          300 LKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF----IFNASKLSV  375 (982)
Q Consensus       300 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~  375 (982)
                      |+.|+|++|+|+ .+|..+.  ++|+.|+|++|.++..++...    ..|+.|++++|+++ .+|..    ....+++..
T Consensus       348 L~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP~~l~----~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~  419 (754)
T PRK15370        348 LQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPENLP----AALQIMQASRNNLV-RLPESLPHFRGEGPQPTR  419 (754)
T ss_pred             ccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCCHhHH----HHHHHHhhccCCcc-cCchhHHHHhhcCCCccE
Confidence            999999999987 5666553  689999999999885544322    36899999999998 44543    444578899


Q ss_pred             EEeccccCc
Q 036229          376 LELGRNSFS  384 (982)
Q Consensus       376 L~L~~N~i~  384 (982)
                      |++.+|.++
T Consensus       420 L~L~~Npls  428 (754)
T PRK15370        420 IIVEYNPFS  428 (754)
T ss_pred             EEeeCCCcc
Confidence            999999987

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.87  E-value=3.4e-22  Score=218.67  Aligned_cols=182  Identities=26%  Similarity=0.361  Sum_probs=146.7

Q ss_pred             CCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccc--hhhhhHHHHHHHhhhc---CCccceeEEeeecCCCe-----
Q 036229          782 FSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCG--RAFKSFDVECEMMKSI---RHRNLIKVISSCSTEEF-----  850 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~-----  850 (982)
                      |++.+.||+|+||.||+|+... ++.||+|+++....  .....+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6778999999999999999754 89999999974322  2234566788877666   59999999999987776     


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      .+++|||+.+ ++.+++.... ..+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999964 8988886543 35899999999999999999999   99999999999999999999999999999987


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....   ......++..|+|||++.+..++.   ..|+|++|+
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~---~~Di~s~G~  194 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYAT---PVDMWSVGC  194 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCC---cchhhhHHH
Confidence            63322   112345788999999997765543   355666663

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.87  E-value=1.1e-22  Score=218.96  Aligned_cols=186  Identities=23%  Similarity=0.344  Sum_probs=147.6

Q ss_pred             CCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecc-----cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQ-----CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +|.+.+.||+|+||.||+++... +..+++|+.+..     ......++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999998643 445566655421     122334567899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          855 LEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      |||+++++|.+++..   ....+++..++.++.|++.|+.|||   +.|++|+||||+||++++ +.+||+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988863   3446899999999999999999999   999999999999999975 579999999998764


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ....  ......|++.|+|||.+.+..++   ...|+|++|+++
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~---~~~Dv~slG~~~  195 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYD---SKSDIWSLGCIL  195 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCC---chhhHHHHHHHH
Confidence            3222  22345678899999998665444   335667777443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.87  E-value=2.7e-22  Score=214.56  Aligned_cols=177  Identities=31%  Similarity=0.381  Sum_probs=148.7

Q ss_pred             eeeeceEEEEEEEeC-CCeEEEEEEeecccc---hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      ||+|+||.||++... +++.||+|+++....   ...+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 489999999875422   2456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccc
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL  943 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  943 (982)
                      .+++.... .+++..+..++.|++.|+.|+|   +.+++|+||+|+||+++.++.++|+|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99997654 4789999999999999999999   9999999999999999999999999999998753321  1223456


Q ss_pred             cccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          944 ATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       944 gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++..|+|||...+...+   ...|+|++|+
T Consensus       155 ~~~~~~~Pe~~~~~~~~---~~~D~~slG~  181 (250)
T cd05123         155 GTPEYLAPEVLLGKGYG---KAVDWWSLGV  181 (250)
T ss_pred             CCccccChHHhCCCCCC---chhhHHHHHH
Confidence            88899999998765433   3466677663

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-22  Score=239.10  Aligned_cols=194  Identities=26%  Similarity=0.405  Sum_probs=158.2

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEeC--------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEe
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARIG--------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVIS  843 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  843 (982)
                      .++...++..+.+.+|+|+||.|++|...        ....||||..+.. ...+.+.+..|+++|+.+ +||||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34444555667779999999999999632        1467999998744 335678899999999999 6999999999


Q ss_pred             eecCCCeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCC
Q 036229          844 SCSTEEFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKP  908 (982)
Q Consensus       844 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp  908 (982)
                      +|..++..++|+||++.|+|.++++..+               ..++..+...++.|||.|++||+   +.++||||+.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence            9999999999999999999999999776               34788899999999999999999   99999999999


Q ss_pred             CCEEEcCCCcEEEEeecCceeecCCCCceeecccc--cccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          909 SNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL--ATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       909 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +|||+.++..+||+|||+|+.....+.... ....  -...|||||.+....++..   +|+||||+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~k---SDVWSfGI~  510 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSK---SDVWSFGIL  510 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCccccc---chhhHHHHH
Confidence            999999999999999999997654443332 1222  2456999999987666544   567777753

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.87  E-value=2.4e-22  Score=212.98  Aligned_cols=166  Identities=16%  Similarity=0.084  Sum_probs=135.2

Q ss_pred             eceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChHHHHhc
Q 036229          791 GGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS  869 (982)
Q Consensus       791 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  869 (982)
                      |.+|.||+|+.. +++.||+|+++...     ....|...+....||||+++++++...+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999864 58999999987542     233455555566799999999999999999999999999999999875


Q ss_pred             CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccc
Q 036229          870 SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM  949 (982)
Q Consensus       870 ~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~  949 (982)
                      .. .+++..+..++.|++.|++|+|   ++||+||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            43 4889999999999999999999   999999999999999999999999999988755221     12344677899


Q ss_pred             cCceeeeeeeeeEEeeEeeeeeee
Q 036229          950 APGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       950 aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |||.+.+..++..   .|+|++|+
T Consensus       150 aPE~~~~~~~~~~---~DvwslG~  170 (237)
T cd05576         150 APEVGGISEETEA---CDWWSLGA  170 (237)
T ss_pred             CCcccCCCCCCch---hhHHHHHH
Confidence            9999876555543   45566663

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.87  E-value=1.1e-22  Score=228.41  Aligned_cols=183  Identities=25%  Similarity=0.313  Sum_probs=149.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCe----
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF----  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----  850 (982)
                      ..++|++.+.||+|++|.||+|+.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999864 5889999998643  22334567789999999999999999988766554    


Q ss_pred             --eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          851 --KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       851 --~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                        .++|+||+ +++|.+++..  ..+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999999 6699998865  34899999999999999999999   9999999999999999999999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....     .....++..|+|||.+.+...  .+..+|+|++|+
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslGv  204 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGC  204 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCC--CCchHhHHHHHH
Confidence            65321     234567889999999854321  223355666663

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.87  E-value=1.8e-22  Score=227.65  Aligned_cols=180  Identities=29%  Similarity=0.433  Sum_probs=143.3

Q ss_pred             CCccceeeeeceEE-EEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEecc
Q 036229          782 FSENNLIGRGGFGS-VYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       782 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      |...+.+|.|+.|+ ||+|.+ ++++||||++-.+   ..+-..+|+..++.- +||||+++|+.-+++.+.|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44557889998885 899998 6889999987633   345678899999888 69999999999999999999999996


Q ss_pred             CCChHHHHhcCCCcC---CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---C--CcEEEEeecCceeec
Q 036229          860 HGSLEKSLYSSNYIL---DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---N--MVAHLSDFGIAKLLI  931 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~---~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~--~~~kL~DFGla~~~~  931 (982)
                      . +|.++++......   .......+..|++.|+++||   +-+|||||+||.||||+.   +  .+++|+|||+++++.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5 9999998741111   11344678999999999999   999999999999999975   2  489999999999987


Q ss_pred             CCCCce-eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          932 GEDQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       932 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .+.... ......||-+|+|||++.......+   .|++++|
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~a---vDiFslG  701 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQA---VDIFSLG  701 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcc---cchhhcC
Confidence            655443 3356779999999999977655544   4445555

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=4e-22  Score=196.53  Aligned_cols=192  Identities=19%  Similarity=0.337  Sum_probs=147.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEe-eecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVIS-SCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~-~~~~~~~~~lv~  855 (982)
                      .+.|.+.+.+|+|.||.+-+|+++ ..+.+|+|.++.. .....+|.+|...--.+ .|.||+.-|+ .|+..+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            467899999999999999999864 5888999998754 33457788887765555 5899998777 467888888999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCceeecCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~  933 (982)
                      ||++.|+|.+-+...  .+.+...++++.|++.|+.|+|   ++++||||||.+||||-  +..++|+||||..+...  
T Consensus       102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--  174 (378)
T ss_pred             ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence            999999999888653  4788888999999999999999   99999999999999994  44599999999988642  


Q ss_pred             CCceeecccccccccccCceee----eeeeeeEEeeEeeeeeeeeecccCCC
Q 036229          934 DQSITQTQTLATIGYMAPGLFH----VKYILFVVNFLTSYSFLMIFIGRGNY  981 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~~~d~~~~~~~l~~~~~f  981 (982)
                         .+......+..|.|||...    ++...-+..++|.+|+.++.+.+|.|
T Consensus       175 ---~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~  223 (378)
T KOG1345|consen  175 ---TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF  223 (378)
T ss_pred             ---ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence               1222233456789999863    22333333455555665666666654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.2e-22  Score=222.53  Aligned_cols=186  Identities=22%  Similarity=0.282  Sum_probs=149.6

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++.|.....+|.|+|+.|-++. ..+++..++|++...    ..+..+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5678888889999999999997 456899999999755    23345577666555 79999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE-cCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl-~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ++.|+-+.+.+...+.  ...++..|+.+|+.|+.|||   ++|+||||+||+|||+ ++.++++|+|||.++.....  
T Consensus       397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988887765442  22677789999999999999   9999999999999999 58899999999999976333  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                         ....+-|..|.|||+.....++.+.| ||++|+.+|.|.+|
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD-~WSLGvlLy~ML~G  509 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACD-WWSLGVLLYEMLTG  509 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchh-hHHHHHHHHHHHhC
Confidence               23446788999999998777776644 34555555555554

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.85  E-value=1.1e-21  Score=209.14  Aligned_cols=195  Identities=22%  Similarity=0.278  Sum_probs=159.3

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccchhhhhHHHHHHHhhhcC------CccceeEEeeecCC
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIR------HRNLIKVISSCSTE  848 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~  848 (982)
                      +.--.+|.+....|+|-|+.|.+|.+.. |..||||++... ....+.=..|++||++++      --++++++..|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3455789999999999999999998644 889999999744 344566678999999995      34789999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeec
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFG  925 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFG  925 (982)
                      +++|+|+|-+ .-+|.+.+++.+.  .+....+..|+.|+..||..|.   ..||+|.||||+||||.+. ..+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence            9999999988 4599999986543  4677889999999999999999   9999999999999999854 589999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccCC
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGN  980 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~~  980 (982)
                      .|......    ..+.+..+..|.|||++.|.+|++..| .|+.||.+|.+.||.
T Consensus       583 SA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD-~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  583 SASFASEN----EITPYLVSRFYRAPEIILGLPYDYPID-TWSVGCTLYELYTGK  632 (752)
T ss_pred             cccccccc----cccHHHHHHhccCcceeecCcccCCcc-ceeeceeeEEeeccc
Confidence            99875322    234566788999999999999987744 345566666666664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.1e-21  Score=187.20  Aligned_cols=196  Identities=20%  Similarity=0.290  Sum_probs=159.2

Q ss_pred             HHhcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCC-ccceeEEeeecCCCeeEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH-RNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv  854 (982)
                      ...++|...++||.|+||.+|.|. ..+|++||||+-+..  ....++..|.++++.++| ..|+.+..+..++.+-.+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            346789999999999999999997 667999999986543  334677889999999964 6888888888999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceeec
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~  931 (982)
                      ||.. |.+|++++.-+.+.++..+++..+-|++.-++|+|   .+++|||||||+|+|+.   ....+.++|||+|+.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9998 88999999888888999999999999999999999   99999999999999996   34589999999999875


Q ss_pred             CCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          932 GEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       932 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      +....     .......||.+|++-....+...+..||.- +.|..++.+..|
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDme-SvgYvLmYfnrG  217 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDME-SVGYVLMYFNRG  217 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhh-hhcceeeeeecC
Confidence            44321     223456799999998888776666665543 344444444443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=3.2e-21  Score=229.68  Aligned_cols=99  Identities=27%  Similarity=0.346  Sum_probs=45.5

Q ss_pred             cccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccc
Q 036229          547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGY  626 (982)
Q Consensus       547 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~  626 (982)
                      +|+.|++++|.++.+|..+.  ++|+.|++++|+++. +|..+.  +.|+.|++++|+|++ +|..+.  .+|+.|++++
T Consensus       326 sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~  397 (754)
T PRK15370        326 GLKTLEAGENALTSLPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASR  397 (754)
T ss_pred             cceeccccCCccccCChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhcc
Confidence            44444444444444444332  344444555544442 333221  345555555555543 233222  2455555555


Q ss_pred             ccccCCccc----cccCCCCCCeeeCCCCcCC
Q 036229          627 NRLQGSISE----SFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       627 N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~  654 (982)
                      |+|+ .+|.    .+..++++..|+|.+|.++
T Consensus       398 N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        398 NNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            5555 2332    2233355566666666554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.84  E-value=6.7e-21  Score=200.04  Aligned_cols=185  Identities=29%  Similarity=0.373  Sum_probs=154.3

Q ss_pred             CCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          782 FSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      |...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999998754 899999999865444 56788999999999999999999999999899999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +++|.+++.......++..+..++.+++.++.|+|   +.+++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            99999999765433788999999999999999999   99999999999999999999999999999987643321 122


Q ss_pred             cccccccccccCceee-eeeeeeEEeeEeeeeeee
Q 036229          940 TQTLATIGYMAPGLFH-VKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~-~~~~~~~~~~~d~~~~~~  973 (982)
                      ....++..|++||++. ......   ..|+|++|+
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~---~~Dv~~lG~  188 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGE---AVDIWSLGV  188 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCc---hhhHHHHHH
Confidence            3456788899999983 333332   456677663

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=5.9e-21  Score=193.62  Aligned_cols=195  Identities=20%  Similarity=0.278  Sum_probs=162.0

Q ss_pred             hcCCCccceeeeeceEEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .-.|.++++||+|+||+++.|+ .-++++||||.-+.+.  ...++..|.+.++.+ ..++|+++|-+.+.+-+-.+|+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            4579999999999999999998 5579999999876443  346788899999988 57999999988888888999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-----CcEEEEeecCceeec
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIAKLLI  931 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kL~DFGla~~~~  931 (982)
                      .. |.+|+|++.-+++.++..++..+|.|++.-++|+|   ++..|.|||||+|+||...     ..+.++|||+|+.+.
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            98 88999999888888999999999999999999999   9999999999999999743     479999999999986


Q ss_pred             CCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccCC
Q 036229          932 GEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGN  980 (982)
Q Consensus       932 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~~  980 (982)
                      +....     .......||.+||+--...++..++.|| .-+.|-+.+.+.+|.
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDD-LEaLGHvFmYFLRGs  233 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDD-LEALGHVFMYFLRGS  233 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhh-HHHhhhhhhhhccCC
Confidence            55422     2234567999999999988888876654 445555555555553

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.83  E-value=1.4e-21  Score=197.76  Aligned_cols=181  Identities=26%  Similarity=0.295  Sum_probs=145.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  849 (982)
                      ..+|.-.+.+|.|+. .|..|.+ -.++.||+|+....  .....++..+|...+..++|+||++++.++....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357777888999988 5555543 24889999987533  3344567889999999999999999999985543      


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..|+|||||. .+|.+.+..   .++-.....+..|++.|++|+|   +.||+|||+||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            6799999995 599888863   3677888999999999999999   99999999999999999999999999999996


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      -   +.....+.++.|..|.|||++.+..+...   .|+|++|+
T Consensus       168 e---~~~~~mtpyVvtRyyrapevil~~~~ke~---vdiwSvGc  205 (369)
T KOG0665|consen  168 E---DTDFMMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVGC  205 (369)
T ss_pred             c---CcccccCchhheeeccCchheeccCCccc---chhhhhhh
Confidence            3   33356678899999999999977765433   34445443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.83  E-value=2e-21  Score=200.63  Aligned_cols=196  Identities=20%  Similarity=0.242  Sum_probs=159.2

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeee
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSC  845 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  845 (982)
                      .++.....+++....+.+|.||.||+|.|.      +.+.|-+|.++.. .+-....+..|...+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            445555677888888999999999999653      2455777877644 333456788899999999999999999987


Q ss_pred             cC-CCeeEEEEEeccCCChHHHHhcC-------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          846 ST-EEFKALILEYMPHGSLEKSLYSS-------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       846 ~~-~~~~~lv~E~~~~gsL~~~l~~~-------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      .+ .+..++++.++.-|+|..++...       .+.++..+...++.|++.|++|||   ++||||.||..+|++||+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            54 46778999999999999999832       234666778889999999999999   99999999999999999999


Q ss_pred             cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ++||+|=.+++.+.+.+...-......+..||+||.+..+.++.+   +|+|+||+.
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa---sDvWsfGVl  487 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA---SDVWSFGVL  487 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcch---hhhHHHHHH
Confidence            999999999998877766655555667789999999988888755   556777743

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.6e-20  Score=189.69  Aligned_cols=139  Identities=17%  Similarity=0.179  Sum_probs=108.7

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccch--h------------------------hhhHHHHHHHhhhcCCccc
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR--A------------------------FKSFDVECEMMKSIRHRNL  838 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~nI  838 (982)
                      .+.||+|++|.||+|...+|+.||||+++.....  .                        ......|++.++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999778999999999754211  0                        1122459999999988776


Q ss_pred             eeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHH-HccCCCCeEEcCCCCCCEEEcCCC
Q 036229          839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       839 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yL-H~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      .....+...  ..++||||++++++...... ...++...+..++.|++.+|.|+ |   +.||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            443332222  23899999998877654332 24578889999999999999999 7   89999999999999998 47


Q ss_pred             cEEEEeecCceee
Q 036229          918 VAHLSDFGIAKLL  930 (982)
Q Consensus       918 ~~kL~DFGla~~~  930 (982)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.83  E-value=3.6e-20  Score=191.98  Aligned_cols=181  Identities=34%  Similarity=0.531  Sum_probs=150.3

Q ss_pred             eeeeceEEEEEEEeCC-CeEEEEEEeecccch-hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChHH
Q 036229          788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEK  865 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~  865 (982)
                      ||+|++|.||+++... ++++++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999755332 35678999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceeecCCCCceeeccccc
Q 036229          866 SLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSITQTQTLA  944 (982)
Q Consensus       866 ~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~g  944 (982)
                      ++.......++..+..++.+++++++|+|   +.|++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99765445789999999999999999999   999999999999999998 89999999999987633221  1233557


Q ss_pred             ccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          945 TIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       945 t~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ...|++||.+...  ...+...|+|++|+++
T Consensus       156 ~~~~~~pe~~~~~--~~~~~~~D~~~lg~~~  184 (215)
T cd00180         156 TPAYMAPEVLLGK--GYYSEKSDIWSLGVIL  184 (215)
T ss_pred             CCCccChhHhccc--CCCCchhhhHHHHHHH
Confidence            8899999998664  1223445677777554

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.82  E-value=1.4e-20  Score=198.20  Aligned_cols=145  Identities=28%  Similarity=0.374  Sum_probs=126.9

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCC
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE  849 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  849 (982)
                      +....+.|...++||+|.|++||++...    ..+.||+|.+....  ...++.+|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3344567899999999999999999732    47889999987543  346789999999999 5899999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCce
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK  928 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~  928 (982)
                      ...+|+||+++.+..++...    ++..++..+++.+..||+++|   .+|||||||||.|++.+ ..+.-.|+|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            99999999999888888754    567889999999999999999   99999999999999998 55788999999998

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=1.6e-19  Score=183.41  Aligned_cols=140  Identities=21%  Similarity=0.249  Sum_probs=110.5

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccchh--------------------------hhhHHHHHHHhhhcCCccc
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRA--------------------------FKSFDVECEMMKSIRHRNL  838 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~nI  838 (982)
                      .+.||+|++|.||+|+..+|+.||||+++......                          ......|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            57899999999999997789999999987542110                          1223578999999999987


Q ss_pred             eeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCC
Q 036229          839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       839 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~  917 (982)
                      .....+....  .++||||++|+++...... ...++..++..++.|++.++.++|   + .||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~  154 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DG  154 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CC
Confidence            5544433322  4899999998765433222 234677888999999999999999   8 9999999999999998 78


Q ss_pred             cEEEEeecCceeec
Q 036229          918 VAHLSDFGIAKLLI  931 (982)
Q Consensus       918 ~~kL~DFGla~~~~  931 (982)
                      .++|+|||+|....
T Consensus       155 ~~~liDFG~a~~~~  168 (190)
T cd05145         155 KPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEcccceecC
Confidence            99999999998763

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.81  E-value=4e-20  Score=196.45  Aligned_cols=172  Identities=31%  Similarity=0.391  Sum_probs=145.7

Q ss_pred             ceEEEEEEEeC-CCeEEEEEEeecccchh-hhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChHHHHhc
Q 036229          792 GFGSVYKARIG-EGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS  869 (982)
Q Consensus       792 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  869 (982)
                      +||.||+|+.. +++.||+|++....... .+.+.+|++.+++++|++|+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 48999999997654433 67899999999999999999999999998999999999999999999876


Q ss_pred             CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccc
Q 036229          870 SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM  949 (982)
Q Consensus       870 ~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~  949 (982)
                      ... +++..+..++.+++.++.|||   +.+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            543 788999999999999999999   9999999999999999999999999999998764332   223456888999


Q ss_pred             cCceeeeeeeeeEEeeEeeeeeee
Q 036229          950 APGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       950 aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |||...+...+.   ..|+|++|+
T Consensus       154 ~pE~~~~~~~~~---~~Di~slG~  174 (244)
T smart00220      154 APEVLLGKGYGK---AVDVWSLGV  174 (244)
T ss_pred             CHHHHccCCCCc---hhhHHHHHH
Confidence            999987555443   456666663

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=5.6e-20  Score=195.62  Aligned_cols=131  Identities=27%  Similarity=0.358  Sum_probs=112.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-----C---ccceeEEeeecC--
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-----H---RNLIKVISSCST--  847 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~--  847 (982)
                      ..+|.+.++||-|.|++||+|.+ .+.+.||+|+++.. ....+....||++|++++     |   .+||++++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            47899999999999999999985 45789999999744 445577788999999983     3   479999999855  


Q ss_pred             --CCeeEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          848 --EEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       848 --~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                        +.+.|||+|+. |.+|..+|+... +.++...+++|++||+.||.|||.  +.||||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence              34899999999 668888887653 358999999999999999999996  7799999999999999

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=3.6e-19  Score=196.88  Aligned_cols=192  Identities=23%  Similarity=0.319  Sum_probs=152.3

Q ss_pred             CCCccceeeeeceEEEEEEEeCC--CeEEEEEEeecccchhhhhHHHHHHHhhhcCC----ccceeEEeee-cCCCeeEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH----RNLIKVISSC-STEEFKAL  853 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~l  853 (982)
                      +|.+.++||+|+||.||.|....  ...+|+|+...........+..|+.++..+..    +++.++++.+ ..+.+.++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999998654  35889998775533333378889999999863    6899999999 57888999


Q ss_pred             EEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-----CcEEEEeecCc
Q 036229          854 ILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIA  927 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-----~~~kL~DFGla  927 (982)
                      ||+.+ |.+|.++..... +.++..++.+++.|++.+|+++|   +.|++||||||+|+.+...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 789999886544 67899999999999999999999   9999999999999999854     46999999999


Q ss_pred             e--eecCCCCc-----ee-ecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecc
Q 036229          928 K--LLIGEDQS-----IT-QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIG  977 (982)
Q Consensus       928 ~--~~~~~~~~-----~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~  977 (982)
                      +  .+......     .. .....||..|+++++..+...++.+|. |+|...++.+.
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl-es~~Y~l~el~  231 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL-ESLFYMLLELL  231 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh-hhHHHHHHHHh
Confidence            9  43222211     11 134569999999999988888877554 44544444433

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=2.2e-18  Score=175.45  Aligned_cols=139  Identities=16%  Similarity=0.284  Sum_probs=108.9

Q ss_pred             CCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-----CCccceeEEeeecCCC---eeE-
Q 036229          782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-----RHRNLIKVISSCSTEE---FKA-  852 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~~~-  852 (982)
                      +...+.||+|+||.||. .-.++.. +||++........+.+.+|+++++.+     .||||++++++++++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            44568999999999996 3223444 69988765445567899999999999     5799999999998873   433 


Q ss_pred             EEEEe--ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHH-HHHHccCCCCeEEcCCCCCCEEEcC----CCcEEEEe-e
Q 036229          853 LILEY--MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL-EYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSD-F  924 (982)
Q Consensus       853 lv~E~--~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L-~yLH~~~~~~ivHrDlkp~NILl~~----~~~~kL~D-F  924 (982)
                      +|+||  +.+|+|.+++.+..  +++.  ..++.|++.++ +|||   +++||||||||+||+++.    ++.++|+| |
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  55799999996642  4544  35678888887 9999   999999999999999974    34899999 5


Q ss_pred             cCcee
Q 036229          925 GIAKL  929 (982)
Q Consensus       925 Gla~~  929 (982)
                      |.+..
T Consensus       155 G~~~~  159 (210)
T PRK10345        155 GESTF  159 (210)
T ss_pred             CCcce
Confidence            55444

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=3.2e-20  Score=170.81  Aligned_cols=165  Identities=31%  Similarity=0.576  Sum_probs=130.6

Q ss_pred             hhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcc
Q 036229          125 IFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYL  204 (982)
Q Consensus       125 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  204 (982)
                      ++++.+.+.|.||+|+++ .+|+.+..+.+|+.|++++|+++ ++|.++ +.+++|+.|+++-|++. ..|..|+.++.|
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~i-ssl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSI-SSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhh-hhchhhhheecchhhhh-cCccccCCCchh
Confidence            455666777777777777 66777778888888888888887 788888 78888888888888887 688889999999


Q ss_pred             cEEEeeccccc-cccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccC
Q 036229          205 EILSLSINNLL-GAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGK  283 (982)
Q Consensus       205 ~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  283 (982)
                      +.|||.+|++. ..+|..|..++.|+-|+|+.|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+++|++|.+.+
T Consensus       105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg  182 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG  182 (264)
T ss_pred             hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence            99999988886 357888888999999999999887 67777888888888888777776 5677777777777777777


Q ss_pred             CccccCCCccccc
Q 036229          284 NFLTGEIPPEIHN  296 (982)
Q Consensus       284 N~l~~~~p~~~~~  296 (982)
                      |+++ .+|+.+++
T Consensus       183 nrl~-vlppel~~  194 (264)
T KOG0617|consen  183 NRLT-VLPPELAN  194 (264)
T ss_pred             ceee-ecChhhhh
Confidence            7777 45555544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.77  E-value=1.1e-18  Score=177.53  Aligned_cols=139  Identities=13%  Similarity=0.138  Sum_probs=114.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhh---h------HHHHHHHhhhcCCccceeEEeeecCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFK---S------FDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      ..++|...+.+|.|+||.||.+.. ++..+|+|++.........   .      +.+|++.+.++.||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            367899999999999999999766 5778999999754322222   2      67899999999999999999886533


Q ss_pred             --------CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 036229          849 --------EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  920 (982)
Q Consensus       849 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  920 (982)
                              +..++||||++|.+|.++..     .+.    ....+++.++..+|   +.|++|||+||+||+++++| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999987631     222    34669999999999   99999999999999999988 99


Q ss_pred             EEeecCceee
Q 036229          921 LSDFGIAKLL  930 (982)
Q Consensus       921 L~DFGla~~~  930 (982)
                      ++|||.....
T Consensus       175 liDfg~~~~~  184 (232)
T PRK10359        175 IIDLSGKRCT  184 (232)
T ss_pred             EEECCCcccc
Confidence            9999988754

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=3.4e-20  Score=206.20  Aligned_cols=277  Identities=25%  Similarity=0.278  Sum_probs=137.5

Q ss_pred             EEeCCCCcc-ccCCccccCCCCCCEEEcCCCCcccc----CcchhhhccCCcEEEccCCcccC------ccCccccCcCC
Q 036229           86 LNISHLNLT-GTIPSQLWNLSSLQSLNLGFNRLSGS----IPSAIFTLYTLKYVNFRGNQLSG------AFPSFIFNKSS  154 (982)
Q Consensus        86 L~l~~~~l~-g~~~~~l~~l~~L~~L~L~~n~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~~  154 (982)
                      |+|..+.++ +.....+..+..|+.|+++++.++..    ++..+...++|++|+++++.+.+      .++..+..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            455555555 23334445555666666666665422    34444455556666666665542      12233444555


Q ss_pred             CCccccccCcccccCchhhhcCCCC---CCeeeecceeeec----ccCCCccCc-CcccEEEeecccccccccccccccc
Q 036229          155 LQHLDFSYNALSGEIPANICSNLPF---LESISLSQNMFHG----RIPSALSNC-KYLEILSLSINNLLGAIPKEIGNLT  226 (982)
Q Consensus       155 L~~L~Ls~N~l~~~ip~~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~  226 (982)
                      |++|++++|.+.+..+..+ ..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++..+.      
T Consensus        83 L~~L~l~~~~~~~~~~~~~-~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~------  155 (319)
T cd00116          83 LQELDLSDNALGPDGCGVL-ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE------  155 (319)
T ss_pred             eeEEEccCCCCChhHHHHH-HHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH------
Confidence            5555555555543222222 22222   5555555554441    111222333 4444444444444421110      


Q ss_pred             chhhhhccCCCCCCchhhhcCCCcccceEeccccccCCc----CChhhhccCCCcEEEccCCccccC----CCccccccC
Q 036229          227 KLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGE----IPQELANLTGLEVLKLGKNFLTGE----IPPEIHNLH  298 (982)
Q Consensus       227 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~  298 (982)
                                    .++..+..+++|+.|++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..++
T Consensus       156 --------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~  221 (319)
T cd00116         156 --------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK  221 (319)
T ss_pred             --------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence                          1222344444555555555555432    222344445666666666666532    223344556


Q ss_pred             CCcEEEccCccccccCccccc-----CCCCCceeecCCCcCCCCcC---ccccccCCCccEEEccCCccccc----cccc
Q 036229          299 NLKLLDLSHNKLVGAVPATIF-----NMSTLTGLGLQSNSLSGSLS---SIADVQLPNLEELRLWSNNFSGT----IPRF  366 (982)
Q Consensus       299 ~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~~~----~p~~  366 (982)
                      +|++|++++|.+++.....+.     ..+.|+.|++++|.++..-.   ......+++|+++++++|.++..    ....
T Consensus       222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~  301 (319)
T cd00116         222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES  301 (319)
T ss_pred             CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence            666666666666542222222     12566777777776642110   01122346778888888888744    3333


Q ss_pred             ccCC-CCCCEEEeccccC
Q 036229          367 IFNA-SKLSVLELGRNSF  383 (982)
Q Consensus       367 ~~~l-~~L~~L~L~~N~i  383 (982)
                      +... +.|+.+++.+|++
T Consensus       302 ~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         302 LLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HhhcCCchhhcccCCCCC
Confidence            3334 6788888888764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=3.9e-20  Score=205.70  Aligned_cols=279  Identities=23%  Similarity=0.289  Sum_probs=179.7

Q ss_pred             EEEcCCCCcc-ccCcchhhhccCCcEEEccCCcccCc----cCccccCcCCCCccccccCcccccCchhhhcCCCCCCee
Q 036229          109 SLNLGFNRLS-GSIPSAIFTLYTLKYVNFRGNQLSGA----FPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESI  183 (982)
Q Consensus       109 ~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L  183 (982)
                      .|+|+.+.++ +..+..+..+.+|++|+++++.++..    ++..+...++|++|+++++.+.+ .+..+          
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~----------   70 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL----------   70 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence            4677777776 44566667778888888888888532    45556666777777777776652 11111          


Q ss_pred             eecceeeecccCCCccCcCcccEEEeeccccccccccccccccc---hhhhhccCCCCCC----chhhhcCCC-cccceE
Q 036229          184 SLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTK---LKELYLGYSGLQG----EIPREFGNL-AELELM  255 (982)
Q Consensus       184 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L  255 (982)
                              ..++..+..+++|+.|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|
T Consensus        71 --------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L  142 (319)
T cd00116          71 --------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL  142 (319)
T ss_pred             --------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEE
Confidence                    112223333444444444444444333333333333   5555555555442    222334445 667777


Q ss_pred             eccccccCCc----CChhhhccCCCcEEEccCCccccC----CCccccccCCCcEEEccCcccccc----CcccccCCCC
Q 036229          256 ALQVSNLQGE----IPQELANLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKLVGA----VPATIFNMST  323 (982)
Q Consensus       256 ~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~  323 (982)
                      ++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+++|+.|+|++|.+++.    ++..+..+++
T Consensus       143 ~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~  222 (319)
T cd00116         143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS  222 (319)
T ss_pred             EcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCC
Confidence            7777776632    334577888999999999999852    334455667999999999998744    3445667889


Q ss_pred             CceeecCCCcCCCC-cCccc---cccCCCccEEEccCCcccc----cccccccCCCCCCEEEeccccCccc----cCCcc
Q 036229          324 LTGLGLQSNSLSGS-LSSIA---DVQLPNLEELRLWSNNFSG----TIPRFIFNASKLSVLELGRNSFSGF----IPNTF  391 (982)
Q Consensus       324 L~~L~L~~N~l~~~-~~~~~---~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~i~~~----~~~~~  391 (982)
                      |+.|++++|.+.+. +....   ....+.|++|++++|.++.    .+...+...++|+++++++|.++..    ....+
T Consensus       223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~  302 (319)
T cd00116         223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL  302 (319)
T ss_pred             CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence            99999999998752 11111   1134799999999999972    3345566678999999999999855    33344


Q ss_pred             ccC-Cccceecccccc
Q 036229          392 GNL-RNLRLMTLHYNY  406 (982)
Q Consensus       392 ~~l-~~L~~L~L~~N~  406 (982)
                      ... +.|+.+++.+|.
T Consensus       303 ~~~~~~~~~~~~~~~~  318 (319)
T cd00116         303 LEPGNELESLWVKDDS  318 (319)
T ss_pred             hhcCCchhhcccCCCC
Confidence            444 678888888774

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=3.3e-20  Score=170.71  Aligned_cols=161  Identities=29%  Similarity=0.467  Sum_probs=93.2

Q ss_pred             CccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeec
Q 036229          521 LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDF  600 (982)
Q Consensus       521 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldl  600 (982)
                      +.+++.|.||+|+++ .+|..+..+.+|+.|++++|+++++|..+..+++|+.|+++-|++. ..|..|+.++.|+.|||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            344444445555554 3444445555555555555555555555555555555555555554 44555555555555555


Q ss_pred             ccccccc-cccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccc
Q 036229          601 STNNFSD-VIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKG  679 (982)
Q Consensus       601 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  679 (982)
                      +.|+++. .+|..|-.++.|+.|+|+.|.+. .+|...+.+++|+.|.+..|.+- ..|..++.++.|++|.+.+|.++-
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v  187 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV  187 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence            5555542 45666666666666666666665 56666666666666666666665 466666666666666666666665


Q ss_pred             cCCCCC
Q 036229          680 EIPKGG  685 (982)
Q Consensus       680 ~~p~~~  685 (982)
                      ..|.-+
T Consensus       188 lppel~  193 (264)
T KOG0617|consen  188 LPPELA  193 (264)
T ss_pred             cChhhh
Confidence            445443

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2.4e-17  Score=172.34  Aligned_cols=143  Identities=18%  Similarity=0.177  Sum_probs=112.5

Q ss_pred             hcCCCccceeeeeceEEEEEEE--eCCCeEEEEEEeecccch------------------------hhhhHHHHHHHhhh
Q 036229          779 TNRFSENNLIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGR------------------------AFKSFDVECEMMKS  832 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  832 (982)
                      ..-|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|++.+++
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458889999999999999998  457999999998743210                        11235689999999


Q ss_pred             cCCc--cceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCC-eEEcCCCCC
Q 036229          833 IRHR--NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP-VIHCDLKPS  909 (982)
Q Consensus       833 l~h~--nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~-ivHrDlkp~  909 (982)
                      +.+.  .+++++++    ...++||||++|+++....... ......++..++.|++.+++++|   +.| |+||||||+
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~  178 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY  178 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence            9753  34555543    2348999999998886654322 23555667789999999999999   999 999999999


Q ss_pred             CEEEcCCCcEEEEeecCceee
Q 036229          910 NVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       910 NILl~~~~~~kL~DFGla~~~  930 (982)
                      ||+++ ++.++++|||.|...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=9.8e-17  Score=164.54  Aligned_cols=141  Identities=21%  Similarity=0.181  Sum_probs=111.4

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccch----------------------hhhhHHHHHHHhhhc
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR----------------------AFKSFDVECEMMKSI  833 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l  833 (982)
                      ......|...+.||+|+||.||+|...+|+.||||+++.....                      .......|+.++..+
T Consensus        11 ~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   90 (198)
T cd05144          11 VKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL   90 (198)
T ss_pred             HHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence            3333348888999999999999999878999999987643210                      112356788889988


Q ss_pred             CCc--cceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCE
Q 036229          834 RHR--NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNV  911 (982)
Q Consensus       834 ~h~--nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NI  911 (982)
                      .|+  .+++.++.    +..++||||++|+++.+....       .....++.+++.++.++|   +.||+||||||+||
T Consensus        91 ~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Ni  156 (198)
T cd05144          91 YEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNI  156 (198)
T ss_pred             HHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccE
Confidence            777  45555543    345899999999998765421       234678899999999999   99999999999999


Q ss_pred             EEcCCCcEEEEeecCceee
Q 036229          912 LLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       912 Ll~~~~~~kL~DFGla~~~  930 (982)
                      ++++++.++|+|||.|...
T Consensus       157 ll~~~~~~~liDfg~~~~~  175 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             EEcCCCcEEEEECCccccC
Confidence            9999999999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.1e-16  Score=158.90  Aligned_cols=132  Identities=17%  Similarity=0.147  Sum_probs=105.9

Q ss_pred             CccceeeeeceEEEEEEEeCCCeEEEEEEeecccc----hhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEEEe
Q 036229          783 SENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG----RAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .+...|++|+||+||.+.. .+.+++.+.++....    .....+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998766 677788776654322    11225789999999995 5889999886    346899999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC-CCCCEEEcCCCcEEEEeecCceee
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDl-kp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ++|.+|.+....        ....++.|++.+++++|   ++||+|||| ||+||+++.++.++|+|||+|...
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999998654321        12357889999999999   999999999 799999999999999999999864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1e-16  Score=166.52  Aligned_cols=135  Identities=24%  Similarity=0.307  Sum_probs=113.7

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccc--------hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG--------RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      +.||+|++|.||+|+. .+..|++|+......        ....++.+|++++..++|++++....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 677899998653221        1224678899999999999988777777677788999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ++|++|.+++....    . .+..++.+++.++.++|   +.|++|||++|+||+++ ++.++++|||.+...
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999886432    2 77889999999999999   99999999999999999 789999999998853

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1.6e-16  Score=187.93  Aligned_cols=140  Identities=21%  Similarity=0.255  Sum_probs=113.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEe-ecc-c------chhhhhHHHHHHHhhhcCCccceeEEeeecCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF-DLQ-C------GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      .....|...+.||+|+||.||+|.+.... +++|+. ... .      ....+++.+|+++++.++|++++....++..+
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            34455677899999999999999875443 444432 211 1      11235688999999999999999888777777


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      ...++||||+++++|.+++.         ....++.|++.++.|+|   +.|++|||+||+||++ +++.++|+|||+|+
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            77899999999999998874         35678999999999999   9999999999999999 57799999999998


Q ss_pred             ee
Q 036229          929 LL  930 (982)
Q Consensus       929 ~~  930 (982)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            64

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=2.6e-17  Score=195.73  Aligned_cols=189  Identities=23%  Similarity=0.316  Sum_probs=147.9

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcC---CccceeEEeeecCCCe
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR---HRNLIKVISSCSTEEF  850 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~  850 (982)
                      +.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+.......   .-=.+++.+++   -+.|..+..++...+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            34455678999999999999999999977799999999765543321   11122333343   3455666666677777


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-------CCCcEEEEe
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-------DNMVAHLSD  923 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-------~~~~~kL~D  923 (982)
                      -++|+||.+.|+|.+++. ..+.+++.-++.+..|+++.++.||   ..+|||+||||+|+++.       +..-++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            889999999999999997 4556899999999999999999999   99999999999999994       234799999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ||.|..+.--.+........+|-.+-.+|+..|+.+++..|.   ||++
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~Dy---fGlA  890 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDY---FGLA  890 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhh---HHHH
Confidence            999987653333345566778899999999999998887554   5544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=2.7e-16  Score=161.68  Aligned_cols=131  Identities=20%  Similarity=0.313  Sum_probs=106.2

Q ss_pred             eeeeeceEEEEEEEeCCCeEEEEEEeecccc--------hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCG--------RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       787 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .||+|++|.||+|.+ ++..|++|+......        ....++.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999986 578899998643211        11356778999999999887655554555566678999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      +|+++.+.+.....        .++.+++.++.++|   +.|++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999988754221        78999999999999   99999999999999999 789999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.66  E-value=3.2e-16  Score=186.97  Aligned_cols=154  Identities=27%  Similarity=0.480  Sum_probs=129.0

Q ss_pred             cCCCChhHHHHHHHHHHHhcCCCCccccCCCCCCCCCC----ceeeEEecCCC----CcEEEEEeCCCCccccCCccccC
Q 036229           32 NTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVC----NWTGVTCDVHS----HRVKVLNISHLNLTGTIPSQLWN  103 (982)
Q Consensus        32 ~~~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~c----~w~gv~c~~~~----~~v~~L~l~~~~l~g~~~~~l~~  103 (982)
                      ...+.++|.+||+++|+++... .   ..+|.+ ++||    .|.||.|+...    .+|+.|+|+++++.|.+|+.++.
T Consensus       366 ~~~t~~~~~~aL~~~k~~~~~~-~---~~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~  440 (623)
T PLN03150        366 ESKTLLEEVSALQTLKSSLGLP-L---RFGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISK  440 (623)
T ss_pred             ccccCchHHHHHHHHHHhcCCc-c---cCCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhC
Confidence            4567889999999999998652 2   147964 4453    79999996322    25899999999999999999999


Q ss_pred             CCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCee
Q 036229          104 LSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESI  183 (982)
Q Consensus       104 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L  183 (982)
                      +++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|++|||++|.++|.+|..+...+.++..+
T Consensus       441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l  520 (623)
T PLN03150        441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF  520 (623)
T ss_pred             CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence            99999999999999999999999999999999999999999999999999999999999999999998874434566677


Q ss_pred             eecceee
Q 036229          184 SLSQNMF  190 (982)
Q Consensus       184 ~Ls~N~l  190 (982)
                      ++++|..
T Consensus       521 ~~~~N~~  527 (623)
T PLN03150        521 NFTDNAG  527 (623)
T ss_pred             EecCCcc
Confidence            7777654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.65  E-value=6.2e-16  Score=172.79  Aligned_cols=170  Identities=35%  Similarity=0.511  Sum_probs=144.7

Q ss_pred             CCccceeeeeceEEEEEEEeCCCeEEEEEEeecccch---hhhhHHHHHHHhhhcCCc-cceeEEeeecCCCeeEEEEEe
Q 036229          782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR---AFKSFDVECEMMKSIRHR-NLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      |...+.+|.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999876  78899998755322   467889999999999988 799999999777778999999


Q ss_pred             ccCCChHHHHhcCC--CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceeecCCC
Q 036229          858 MPHGSLEKSLYSSN--YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGED  934 (982)
Q Consensus       858 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~  934 (982)
                      +.++++.+++....  ..+.......++.|++.+++|+|   +.+++|||+||+||+++..+ .+|++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997776544  25888899999999999999999   99999999999999999888 79999999998654333


Q ss_pred             Cce----eecccccccccccCceeee
Q 036229          935 QSI----TQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       935 ~~~----~~~~~~gt~~y~aPE~~~~  956 (982)
                      ...    ......|+..|+|||.+.+
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~  182 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLG  182 (384)
T ss_pred             ccccccccccccccccccCCHHHhcC
Confidence            221    3456789999999999976

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.1e-16  Score=187.83  Aligned_cols=194  Identities=21%  Similarity=0.245  Sum_probs=149.0

Q ss_pred             CccceeeeeceEEEEEEEe-CCCeEEEEEEee-----cccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          783 SENNLIGRGGFGSVYKARI-GEGMEVAVKVFD-----LQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~-----~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ...+.+|.|++|.|+.+.. ...+..+.|.+.     .... +....+..|..+-..++|||++.....+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999997777653 233334444332     1111 11222566777778889999988888777766666669


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||++ +|..++... ..+...++..+++|++.|++|+|   +.||.|||+|++|+++...|.+||+|||.+....-..+
T Consensus       401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 999988764 34777888899999999999999   99999999999999999999999999999887643333


Q ss_pred             c--eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccCCC
Q 036229          936 S--ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRGNY  981 (982)
Q Consensus       936 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~~f  981 (982)
                      .  ......+|+..|+|||++.+..|.+...++|..++.++.|.+|.|
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~  523 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF  523 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence            3  455678899999999999998888887777777766777666654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.64  E-value=5.6e-17  Score=201.53  Aligned_cols=136  Identities=14%  Similarity=0.164  Sum_probs=98.1

Q ss_pred             hcCC-ccceeEEeee-------cCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 036229          832 SIRH-RNLIKVISSC-------STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH  903 (982)
Q Consensus       832 ~l~h-~nIv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  903 (982)
                      .++| +||.++++++       ...+.++.++||+ +++|.+++......+++.+++.++.||++||+|||   ++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            3455 5788888877       2234567888988 56999999866666899999999999999999999   999999


Q ss_pred             cCCCCCCEEEcCC-------------------CcEEEEeecCceeecCCCC--------------ceeeccccccccccc
Q 036229          904 CDLKPSNVLLDDN-------------------MVAHLSDFGIAKLLIGEDQ--------------SITQTQTLATIGYMA  950 (982)
Q Consensus       904 rDlkp~NILl~~~-------------------~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~a  950 (982)
                      |||||+|||++..                   +.+|++|||+++.......              .......+||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999654                   4555666666653211000              000112468999999


Q ss_pred             CceeeeeeeeeEEeeEeeeeeeee
Q 036229          951 PGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       951 PE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||++.+..++.   .+|+|++|++
T Consensus       184 PE~~~~~~~~~---~sDVwSlGvi  204 (793)
T PLN00181        184 PEEDNGSSSNC---ASDVYRLGVL  204 (793)
T ss_pred             hhhhccCCCCc---hhhhhhHHHH
Confidence            99998776654   3556666644

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=2.7e-15  Score=146.78  Aligned_cols=135  Identities=20%  Similarity=0.257  Sum_probs=114.2

Q ss_pred             ccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCC--ccceeEEeeecCCCeeEEEEEeccCC
Q 036229          784 ENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH--RNLIKVISSCSTEEFKALILEYMPHG  861 (982)
Q Consensus       784 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~E~~~~g  861 (982)
                      +.+.||+|.++.||+++..+ ..+++|..+....  ...+..|+.+++.++|  ..+++++++...++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999754 7899999865433  4678899999999976  59999999988888899999999987


Q ss_pred             ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          862 SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       862 sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543        4556678899999999999943336899999999999999989999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=4.4e-15  Score=151.08  Aligned_cols=135  Identities=23%  Similarity=0.248  Sum_probs=98.1

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccch--hhhh----------------------HHHHHHHhhhcCCc--cc
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR--AFKS----------------------FDVECEMMKSIRHR--NL  838 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--nI  838 (982)
                      .+.||+|+||.||+|...+++.||||+++.....  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4689999999999999878999999998753211  1111                      13456666666443  24


Q ss_pred             eeEEeeecCCCeeEEEEEeccCCChHH-HHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCC
Q 036229          839 IKVISSCSTEEFKALILEYMPHGSLEK-SLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDN  916 (982)
Q Consensus       839 v~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~  916 (982)
                      .+.+++.    ..++||||++++++.. .+....  .. .++..++.+++.++.++|   . .||+||||||+||+++ +
T Consensus        82 ~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDLN----RHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEecC----CCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            4555432    3589999999854321 111111  11 556789999999999999   8 9999999999999999 8


Q ss_pred             CcEEEEeecCceee
Q 036229          917 MVAHLSDFGIAKLL  930 (982)
Q Consensus       917 ~~~kL~DFGla~~~  930 (982)
                      +.++++|||.|...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            89999999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PLN03150 hypothetical protein; Provisional

Probab=99.60  E-value=1.8e-15  Score=180.50  Aligned_cols=119  Identities=33%  Similarity=0.521  Sum_probs=100.7

Q ss_pred             ccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecC
Q 036229          594 VLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLS  673 (982)
Q Consensus       594 ~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls  673 (982)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|||+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            46778999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCCCC--CCCCCCcccccCcccCCCCCCCCCCCCc
Q 036229          674 FNKLKGEIPKGGS--FGNFSAKSFEGNELLCGSPNLQVPPCKT  714 (982)
Q Consensus       674 ~N~l~~~~p~~~~--~~~~~~~~~~gn~~lc~~~~~~~~~c~~  714 (982)
                      +|+++|.+|....  +.......+.+|+++||.|.  ..+|..
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~  539 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGP  539 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcc
Confidence            9999999996531  22334567899999999875  566753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.56  E-value=1.5e-16  Score=176.54  Aligned_cols=179  Identities=25%  Similarity=0.307  Sum_probs=143.6

Q ss_pred             eeeeceEEEEEEE----eCCCeEEEEEEeecccc--hhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEEEeccC
Q 036229          788 IGRGGFGSVYKAR----IGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       788 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +|+|+||.|+.++    .+.+..+|+|+.++...  ........|..++...+ ||.++++.-.++.+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999875    23477789998865422  11224566888888886 99999999999999999999999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |++...+.+.. .+++.....+...++-|++++|   +.+|+|||+|++||+++.+|++|+.|||.++......      
T Consensus        82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------  151 (612)
T KOG0603|consen   82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------  151 (612)
T ss_pred             chhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh------
Confidence            99988886554 3666777778899999999999   9999999999999999999999999999998753322      


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ..+||..|||||++.+.  . ...+||++++.++.+.+|
T Consensus       152 ~~cgt~eymApEI~~gh--~-~a~D~ws~gvl~felltg  187 (612)
T KOG0603|consen  152 IACGTYEYRAPEIINGH--L-SAADWWSFGVLAFELLTG  187 (612)
T ss_pred             hcccchhhhhhHhhhcc--C-CcccchhhhhhHHHHhhC
Confidence            22899999999999833  3 335566777776655554

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=3.4e-14  Score=149.06  Aligned_cols=136  Identities=19%  Similarity=0.247  Sum_probs=105.6

Q ss_pred             cceee-eeceEEEEEEEeCCCeEEEEEEeeccc-------------chhhhhHHHHHHHhhhcCCccc--eeEEeeecCC
Q 036229          785 NNLIG-RGGFGSVYKARIGEGMEVAVKVFDLQC-------------GRAFKSFDVECEMMKSIRHRNL--IKVISSCSTE  848 (982)
Q Consensus       785 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~  848 (982)
                      ...|| .|+.|+||+++.. +..+|+|.+....             .....++.+|+++++.++|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8889999999874 6788999885321             1223567889999999998875  6777764332


Q ss_pred             C----eeEEEEEeccC-CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          849 E----FKALILEYMPH-GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       849 ~----~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                      .    ..++||||++| .+|.+++...  .++..    .+.+++.++.++|   ++||+||||||+|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    23599999997 6898887543  23432    3678999999999   99999999999999999888999999


Q ss_pred             ecCceee
Q 036229          924 FGIAKLL  930 (982)
Q Consensus       924 FGla~~~  930 (982)
                      ||.+...
T Consensus       186 fg~~~~~  192 (239)
T PRK01723        186 FDRGELR  192 (239)
T ss_pred             CCCcccC
Confidence            9998864

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.55  E-value=2.9e-16  Score=170.55  Aligned_cols=192  Identities=31%  Similarity=0.449  Sum_probs=162.5

Q ss_pred             EEecCCCCCCCCCccc-cCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCc
Q 036229          479 IYLGGNKLNGSIPITL-GKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNK  557 (982)
Q Consensus       479 L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  557 (982)
                      |.|++-+++..+-..+ ..+..-...||+.|++. .+|..++.+..|+.+.|.+|.|. .+|.++.++..|..|||+.|+
T Consensus        55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq  132 (722)
T KOG0532|consen   55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ  132 (722)
T ss_pred             cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence            4445555542221111 44566678899999998 78888999999999999999998 788999999999999999999


Q ss_pred             ccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccc
Q 036229          558 LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESF  637 (982)
Q Consensus       558 l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  637 (982)
                      ++.+|..++.++ |+.|-+++|+++ .+|..++.+..|..||.|.|++. .+|..++++.+|+.|++..|++. ..|+.+
T Consensus       133 lS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El  208 (722)
T KOG0532|consen  133 LSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEEL  208 (722)
T ss_pred             hhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHH
Confidence            999999888764 888999999998 68888998899999999999996 47888999999999999999998 677777


Q ss_pred             cCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCccc
Q 036229          638 GDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK  678 (982)
Q Consensus       638 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~  678 (982)
                      ..| .|..||+|.|+++ .+|-.|.+|+.|++|.|.+|+|.
T Consensus       209 ~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  209 CSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             hCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence            776 5999999999998 79999999999999999999997

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=2.7e-13  Score=154.75  Aligned_cols=139  Identities=21%  Similarity=0.262  Sum_probs=100.2

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccchhh----------------------------------------hhHH
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAF----------------------------------------KSFD  824 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  824 (982)
                      .+.||.|++|+||+|+..+|+.||||+.+.......                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            478999999999999998999999999864311100                                        1244


Q ss_pred             HHHHHhhhc----C-Cccc--eeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHH-HHHHHHcc
Q 036229          825 VECEMMKSI----R-HRNL--IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT-TLEYLHFG  896 (982)
Q Consensus       825 ~E~~~l~~l----~-h~nI--v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~-~L~yLH~~  896 (982)
                      +|++.+.++    + ++++  ++++  ....+..++||||++|+++.+.........   ...+++.+++. .+..+|  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH--
Confidence            555555554    2 3332  2333  223345789999999999988765322222   23456666666 467888  


Q ss_pred             CCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       897 ~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                       ..|++|+|+||.||++++++.++++|||++..+.
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             9999999999999999999999999999998874

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.44  E-value=1.1e-14  Score=158.28  Aligned_cols=183  Identities=30%  Similarity=0.509  Sum_probs=124.6

Q ss_pred             CCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCe
Q 036229          103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLES  182 (982)
Q Consensus       103 ~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~  182 (982)
                      .+..-...||+.|++. ++|..+..+..|+.|.|.+|.+. .+|..++++..|++|||+.|+++ .+|..+|        
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC--------  141 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLC--------  141 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhh--------
Confidence            4555567777777776 77777777777777777777776 67777777777777777777776 5665553        


Q ss_pred             eeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEecccccc
Q 036229          183 ISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL  262 (982)
Q Consensus       183 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l  262 (982)
                                       .|+ |+.|-+++|+++ .+|..++.+.+|..||.+.|.+. .+|..++++.+|+.|.+..|++
T Consensus       142 -----------------~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l  201 (722)
T KOG0532|consen  142 -----------------DLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHL  201 (722)
T ss_pred             -----------------cCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhh
Confidence                             222 566666666665 56666666666777777777666 4555666666666666666666


Q ss_pred             CCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccC
Q 036229          263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN  320 (982)
Q Consensus       263 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  320 (982)
                      . .+|..+..| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.+. ..|..++-
T Consensus       202 ~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~  255 (722)
T KOG0532|consen  202 E-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE  255 (722)
T ss_pred             h-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence            5 455556644 4777888888887 56777888888888888888876 56666654

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=3.8e-13  Score=154.02  Aligned_cols=200  Identities=34%  Similarity=0.497  Sum_probs=152.5

Q ss_pred             EEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcC-CCCccccccCcccccCchhhhcCCCCCCeeeecc
Q 036229          109 SLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKS-SLQHLDFSYNALSGEIPANICSNLPFLESISLSQ  187 (982)
Q Consensus       109 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~  187 (982)
                      .++++.|.+. .-+..+..++.++.|++.+|.++ .+|.....++ +|++||+++|.+. .+|..+ ..+++|+.|++++
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~-~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL-RNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhh-hccccccccccCC
Confidence            5777777764 23345666688888888888888 6777777774 8888899888887 676566 7888888888888


Q ss_pred             eeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCC
Q 036229          188 NMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIP  267 (982)
Q Consensus       188 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p  267 (982)
                      |++. .+|...+.++.|+.|++++|++. .+|........|++|.+++|.+. ..+..+.++.++..+.+.+|++.. .+
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~  248 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LP  248 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-cc
Confidence            8888 45555557788888999999888 66766666777888999888644 456677788888888888887763 35


Q ss_pred             hhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccc
Q 036229          268 QELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATI  318 (982)
Q Consensus       268 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  318 (982)
                      ..+..++++++|++++|+++...+  +..+.+++.||+++|.+....|...
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~  297 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA  297 (394)
T ss_pred             chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence            677888888888888888885433  7788888888888888876665544

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.39  E-value=2.9e-14  Score=141.07  Aligned_cols=183  Identities=20%  Similarity=0.372  Sum_probs=137.9

Q ss_pred             CccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          783 SENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      ....+|.+...|+.|+|+++. ..+++|++...  ....-.+|..|.-.++-+.||||+.+++.|..+....++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            344578889999999999954 45566776533  233446788899999999999999999999999999999999999


Q ss_pred             CChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          861 GSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       861 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      |+|...+++.. -..+..++.+++.++++|++|||. .+.-|.---+.+..++||++.+++|.- +-++.      ....
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarism-ad~kf------sfqe  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQE  343 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheec-cccee------eeec
Confidence            99999998653 356788999999999999999993 233344556888999999998877651 11111      1122


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....-.|.||+||.++.++.+.--...|+|+|+++
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfail  378 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAIL  378 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHH
Confidence            23456789999999988766655555677777754

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.38  E-value=4.2e-13  Score=153.59  Aligned_cols=199  Identities=36%  Similarity=0.490  Sum_probs=130.7

Q ss_pred             eEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCc-cccEEEccCCcCCcCCCccccCCCcccccccCCC
Q 036229          478 GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLT-KLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN  556 (982)
Q Consensus       478 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  556 (982)
                      .+.++.|.+.. .+.....++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            45566665532 2233344466677777777776 4444455553 6777777777776 44455667777777777777


Q ss_pred             cccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCcccc
Q 036229          557 KLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES  636 (982)
Q Consensus       557 ~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  636 (982)
                      +++++|......+.|+.|++++|+++ .+|...+....|..+++++|.+. ..+..+..+.++..|.+++|++. .++..
T Consensus       174 ~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~  250 (394)
T COG4886         174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES  250 (394)
T ss_pred             hhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence            77777766656667777777777776 44444445555777777777532 34566777777777777777776 34667


Q ss_pred             ccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC
Q 036229          637 FGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       637 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                      ++.+++++.|++++|+++. ++. +..+.+++.|++++|.+...+|..
T Consensus       251 ~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         251 IGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             hccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchhh
Confidence            7777778888888888874 333 777777888888888887666554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.36  E-value=1.4e-12  Score=137.11  Aligned_cols=167  Identities=24%  Similarity=0.351  Sum_probs=104.8

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcC----------CccceeEEeeec
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIR----------HRNLIKVISSCS  846 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~nIv~l~~~~~  846 (982)
                      .+...+.||.|+++.||.+++. +++++|+|++....   ....+++++|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4566789999999999999975 49999999985432   234566666665544432          222222222221


Q ss_pred             ------------CCC-----eeEEEEEeccCCChHHHHh---cCCC---cCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 036229          847 ------------TEE-----FKALILEYMPHGSLEKSLY---SSNY---ILDIFQRLNIMVDVATTLEYLHFGYSAPVIH  903 (982)
Q Consensus       847 ------------~~~-----~~~lv~E~~~~gsL~~~l~---~~~~---~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  903 (982)
                                  ...     ..+++|+-+ .++|.+++.   ....   ......+..+..|+++.++++|   +.|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                        111     235678877 458887765   2221   1333445667799999999999   999999


Q ss_pred             cCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeee
Q 036229          904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       904 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                      +||||+|++++++|.++|+||+.....   +....  ....+..|.|||....
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~---g~~~~--~~~~~~~~~PPe~~~~  216 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRA---GTRYR--CSEFPVAFTPPELESC  216 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEET---TEEEE--GGGS-TTTS-HHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeec---Cceee--ccCCCcccCChhhhhh
Confidence            999999999999999999999987754   11111  1345578999998743

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.35  E-value=7.1e-14  Score=162.78  Aligned_cols=169  Identities=25%  Similarity=0.299  Sum_probs=129.2

Q ss_pred             CCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc-chhhhhHH---HHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC-GRAFKSFD---VECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~---~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      +|...+.+|.+.|=+|.+|+.++|. |+||++-+.+ .-....+.   .|++ ...++|||.+++..+-..+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777899999999999999988887 8899985543 22233333   3444 555699999999988888888899999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee-cCCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~-~~~~~  935 (982)
                      |..+ +|.|.+..+. .+...+.+-|+.|++.|+.-+|   ..||+|+|||.+||||+.=..+.|+||..-+.. -++++
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9966 9999886543 4677778889999999999999   999999999999999998889999999765432 12222


Q ss_pred             ceeec----ccccccccccCceeee
Q 036229          936 SITQT----QTLATIGYMAPGLFHV  956 (982)
Q Consensus       936 ~~~~~----~~~gt~~y~aPE~~~~  956 (982)
                      ....+    +...-..|+|||.+-.
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~  201 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVS  201 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhc
Confidence            22211    1223346999999843

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=3.4e-12  Score=146.81  Aligned_cols=148  Identities=17%  Similarity=0.139  Sum_probs=94.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccch----------------------------------hhh-
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGR----------------------------------AFK-  821 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-  821 (982)
                      ....|+. +.+|.|++|+||+|+.++ |+.||||+.++....                                  ..+ 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3455776 799999999999999877 999999998744110                                  011 


Q ss_pred             -----hHHHHHHHhhhc----CCccceeEEeee-cCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHH-H
Q 036229          822 -----SFDVECEMMKSI----RHRNLIKVISSC-STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT-L  890 (982)
Q Consensus       822 -----~~~~E~~~l~~l----~h~nIv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~-L  890 (982)
                           ++.+|+..+.++    .+...+.+-.++ ......++||||++|+.+.++-.-.....+.   ..++...+.. +
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~---~~la~~~v~~~~  273 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM---KLLAERGVEVFF  273 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH---HHHHHHHHHHHH
Confidence                 233344444333    233323322222 2234567999999999997743211111222   1222222222 2


Q ss_pred             HHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCceeecC
Q 036229          891 EYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLIG  932 (982)
Q Consensus       891 ~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGla~~~~~  932 (982)
                      ..++   ..|++|+|+||.||+++.++    .++++|||++..+..
T Consensus       274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3344   78999999999999999887    999999999988743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.28  E-value=5.7e-13  Score=155.47  Aligned_cols=162  Identities=24%  Similarity=0.379  Sum_probs=108.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+|..++.|..|+||.||.++++ +.+.+|+|+-+ +.     .+.+-  ++.....|++|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hhhhc--cccccCCccee------------------
Confidence            467899999999999999999865 37778885422 11     11110  33333344433                  


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC----
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE----  933 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~----  933 (982)
                         |+-...++..+. ++.        +++.+++|+|   +.||+|||+||+|.+|+.-|++|+.|||+++..-..    
T Consensus       136 ---gDc~tllk~~g~-lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP-LPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCCC-Ccc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               344444443221 221        2278999999   999999999999999999999999999998753110    


Q ss_pred             ---------CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee--eecccCCCC
Q 036229          934 ---------DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM--IFIGRGNYY  982 (982)
Q Consensus       934 ---------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~--~l~~~~~f~  982 (982)
                               .......+.+|||.|+|||++..+.|....|| |+.+.+.  ++.+.-+||
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdw-wamGiIlyeFLVgcvpff  259 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDW-WAMGIILYEFLVGCVPFF  259 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccH-HHHHHHHHHHheeeeecc
Confidence                     01112245689999999999988888877554 4555543  334444443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.28  E-value=2e-12  Score=130.03  Aligned_cols=93  Identities=22%  Similarity=0.152  Sum_probs=77.1

Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeec
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |+|.+++...+..+++.++..++.|++.||+|||   +++      ||+||+++.++.+|+  ||.++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999876667999999999999999999999   777      999999999999999  9999875321       


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ...||+.|||||++.+..++.   .+|+|++|++
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~---~~DiwSlG~i   93 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTE---KADIYSLGIT   93 (176)
T ss_pred             cCCCcccccChHHhcCCCCcc---hhhHHHHHHH
Confidence            226889999999998776654   3566776643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=1.8e-11  Score=122.31  Aligned_cols=128  Identities=23%  Similarity=0.265  Sum_probs=97.1

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccc-eeEEeeecCCCeeEEEEEeccCCCh
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+.+|+++++.+.+.++ ++++.+..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            357889999999999874 77899998764422 23456789999998865444 45555543  335799999999887


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~-----ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      .+.    .     .....++.++++++..||   +.+     ++|+|++|.||+++ ++.++++|||.|..
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            543    0     112346789999999999   666     59999999999999 66899999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=6.1e-12  Score=131.44  Aligned_cols=117  Identities=20%  Similarity=0.286  Sum_probs=87.9

Q ss_pred             CCccceeEEeeecC---------------------------CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHH
Q 036229          834 RHRNLIKVISSCST---------------------------EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV  886 (982)
Q Consensus       834 ~h~nIv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi  886 (982)
                      +|||||++.++|.+                           +...|+||..++. +|.+++....  .+...+.-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            69999999887633                           2257899998865 9999997544  4566777799999


Q ss_pred             HHHHHHHHccCCCCeEEcCCCCCCEEEc--CCC--cEEEEeecCceeecCCC----CceeecccccccccccCceeee
Q 036229          887 ATTLEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFGIAKLLIGED----QSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       887 ~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~--~~kL~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                      ++|+.|||   ++||.|||+|++|||+.  +|+  ...++|||++---....    .....-...|...-||||+...
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            99999999   99999999999999994  443  67899999876422110    0011123457778999999854

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.23  E-value=1.4e-12  Score=131.16  Aligned_cols=140  Identities=26%  Similarity=0.264  Sum_probs=101.4

Q ss_pred             CCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccccccccccc
Q 036229          488 GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWN  567 (982)
Q Consensus       488 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~  567 (982)
                      |..-.....++.|+++|||+|.|+ .+.++..-+++++.|++|+|.|..+  +.+..+++|+.||||+|.++++..+--.
T Consensus       274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~K  350 (490)
T KOG1259|consen  274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLK  350 (490)
T ss_pred             CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhh
Confidence            333344455678999999999998 5667778889999999999999743  3388889999999999999988766666


Q ss_pred             ccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCc-cccccCCCCCCee
Q 036229          568 LKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI-SESFGDLISLKSL  646 (982)
Q Consensus       568 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L  646 (982)
                      +.+++.|.|++|.+...  .                        .++.|-+|.+||+++|+|.... -..+++||-|+.|
T Consensus       351 LGNIKtL~La~N~iE~L--S------------------------GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l  404 (490)
T KOG1259|consen  351 LGNIKTLKLAQNKIETL--S------------------------GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETL  404 (490)
T ss_pred             hcCEeeeehhhhhHhhh--h------------------------hhHhhhhheeccccccchhhHHHhcccccccHHHHH
Confidence            77788888888876521  1                        2334445556666666655221 2467788888888


Q ss_pred             eCCCCcCCCC
Q 036229          647 NLSNNNLSRS  656 (982)
Q Consensus       647 ~Ls~N~l~~~  656 (982)
                      .|.+|.+.+.
T Consensus       405 ~L~~NPl~~~  414 (490)
T KOG1259|consen  405 RLTGNPLAGS  414 (490)
T ss_pred             hhcCCCcccc
Confidence            8888888753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=1.4e-12  Score=153.38  Aligned_cols=194  Identities=23%  Similarity=0.282  Sum_probs=152.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEe--CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI--GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l  853 (982)
                      ...|...+.||+|+|+.|-.+..  .....+|+|.+....  ....++...|..+-+.+. |+|++++++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            45677888899999999988764  335667777765432  333455566888877776 9999999999999999999


Q ss_pred             EEEeccCCChHHHH-hcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceeec
Q 036229          854 ILEYMPHGSLEKSL-YSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLI  931 (982)
Q Consensus       854 v~E~~~~gsL~~~l-~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~  931 (982)
                      ++||..|+++.+.+ .......+...+..++.|+..++.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999888 4443256667788899999999999995  78999999999999999999 99999999999886


Q ss_pred             C-CCCceeeccccc-ccccccCceeeeeeeeeEEeeEeeeeeeeeec
Q 036229          932 G-EDQSITQTQTLA-TIGYMAPGLFHVKYILFVVNFLTSYSFLMIFI  976 (982)
Q Consensus       932 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~  976 (982)
                      . .+........+| ++.|+|||...+..+....  .|+|+.|+.++
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~--~d~~S~g~~l~  221 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPS--VDVWSLGIVLS  221 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCC--ccccccccccc
Confidence            6 455555567788 9999999999775333232  34455554443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.21  E-value=2.2e-10  Score=114.48  Aligned_cols=136  Identities=20%  Similarity=0.206  Sum_probs=99.2

Q ss_pred             cceeeeeceEEEEEEEeCC-------CeEEEEEEeeccc------------c----------hhhhh----HHHHHHHhh
Q 036229          785 NNLIGRGGFGSVYKARIGE-------GMEVAVKVFDLQC------------G----------RAFKS----FDVECEMMK  831 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~E~~~l~  831 (982)
                      ...||.|.-+.||.|...+       +..+|||+.+...            +          ...+.    .++|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999997542       4789999874210            0          01122    237999999


Q ss_pred             hcC--CccceeEEeeecCCCeeEEEEEeccCCChH-HHHhcCCCcCCHHHHHHHHHHHHHHHHHH-HccCCCCeEEcCCC
Q 036229          832 SIR--HRNLIKVISSCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYL-HFGYSAPVIHCDLK  907 (982)
Q Consensus       832 ~l~--h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~-~~l~~~~~~~~~~~~~~i~~qi~~~L~yL-H~~~~~~ivHrDlk  907 (982)
                      ++.  .-++++++++    ...++||||+.++.+. ..++.  ...+..+...+..+++.++.++ |   +.||||+|++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            884  3567777765    4567999999764332 12222  1244456677889999999999 8   8999999999


Q ss_pred             CCCEEEcCCCcEEEEeecCceee
Q 036229          908 PSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       908 p~NILl~~~~~~kL~DFGla~~~  930 (982)
                      +.||+++ ++.++++|||.|...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999998865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.16  E-value=2.3e-11  Score=136.26  Aligned_cols=143  Identities=30%  Similarity=0.434  Sum_probs=116.0

Q ss_pred             hhhcCCccceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCe-EEcCCCC
Q 036229          830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV-IHCDLKP  908 (982)
Q Consensus       830 l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~i-vHrDlkp  908 (982)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+......+++.....+.++++.||+|+|   ...| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            46789999999999999999999999999999999999988888999999999999999999999   4444 9999999


Q ss_pred             CCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeee----EEeeEeeeeeeeee
Q 036229          909 SNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILF----VVNFLTSYSFLMIF  975 (982)
Q Consensus       909 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----~~~~~d~~~~~~~l  975 (982)
                      .|+++|....+|++|||+.................-..-|.|||.+.......    .....|+|++++++
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~  148 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM  148 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence            99999999999999999988653211111112223445799999997653322    35667889998643

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.16  E-value=8.7e-12  Score=132.39  Aligned_cols=211  Identities=22%  Similarity=0.215  Sum_probs=146.9

Q ss_pred             hhhccCCcEEEccCCcccCccC-ccccCcCCCCccccccCcccccCc-hhhhcCCCCCCeeeecceeeecccCCCc-cCc
Q 036229          125 IFTLYTLKYVNFRGNQLSGAFP-SFIFNKSSLQHLDFSYNALSGEIP-ANICSNLPFLESISLSQNMFHGRIPSAL-SNC  201 (982)
Q Consensus       125 ~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~ip-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l  201 (982)
                      -.++++|+...|.+.......- .....+++++.||||.|-+..--| ..+++.||+|+.|+|+.|++.-...... ..+
T Consensus       117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            3578899999999998863221 356789999999999998873222 3667899999999999999874433322 357


Q ss_pred             CcccEEEeecccccccccc-ccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcC-ChhhhccCCCcEE
Q 036229          202 KYLEILSLSINNLLGAIPK-EIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEI-PQELANLTGLEVL  279 (982)
Q Consensus       202 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L  279 (982)
                      ++|+.|.|+.|.++..--. ....+++|+.|+|..|.....-.....-+..|+.|||++|++.... -...+.++.|+.|
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence            8899999999999843322 3456789999999999644444455666788899999988886432 1347788888999


Q ss_pred             EccCCccccCCCcc------ccccCCCcEEEccCccccccC-cccccCCCCCceeecCCCcCC
Q 036229          280 KLGKNFLTGEIPPE------IHNLHNLKLLDLSHNKLVGAV-PATIFNMSTLTGLGLQSNSLS  335 (982)
Q Consensus       280 ~Ls~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~  335 (982)
                      +++.+.++.+--..      ...+++|++|+++.|+|.... -..+..+.+|+.|....|.++
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            99988888643222      255678888888888885211 122333444444454455443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.16  E-value=1.2e-11  Score=124.66  Aligned_cols=208  Identities=21%  Similarity=0.199  Sum_probs=144.3

Q ss_pred             CcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCC-cCCcCCCccccCC
Q 036229          467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGN-KLSGSIPACFSNL  545 (982)
Q Consensus       467 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l  545 (982)
                      |-.+.-+.+|+.+.++.+.-..+. +.-..-|.|+++...+..++. .| .+-..+.+....-+.- -..|..-..+..+
T Consensus       207 ~f~l~~f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~-~~-~l~pe~~~~D~~~~E~~t~~G~~~~~~dTW  283 (490)
T KOG1259|consen  207 SFNLNAFRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQD-VP-SLLPETILADPSGSEPSTSNGSALVSADTW  283 (490)
T ss_pred             ccchHHhhhhheeeeeccchhhee-ceeecCchhheeeeecccccc-cc-cccchhhhcCccCCCCCccCCceEEecchH
Confidence            333444556666666666443222 112233678888887766652 22 2222223332222221 1233333445566


Q ss_pred             CcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecc
Q 036229          546 ASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLG  625 (982)
Q Consensus       546 ~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls  625 (982)
                      +.|+++|||+|.|+.|..+..-.+.++.|++|+|.+...-  .+..+++|+.||||+|.++. +...=..|-+++.|+|+
T Consensus       284 q~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  284 QELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhhccccccchhhhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence            8899999999999999988888899999999999998433  37788999999999999975 34444567889999999


Q ss_pred             cccccCCccccccCCCCCCeeeCCCCcCCCCCC-cccccccccceeecCCCcccccCC
Q 036229          626 YNRLQGSISESFGDLISLKSLNLSNNNLSRSIP-ISLEKLSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       626 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~l~ls~N~l~~~~p  682 (982)
                      .|.|..  -..++.|-+|..||+++|+|...-. ..++++|-|+.+.|.+|++.+.+-
T Consensus       361 ~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  361 QNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            999863  2457778899999999999974322 467899999999999999996554

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.15  E-value=2.1e-12  Score=141.31  Aligned_cols=119  Identities=24%  Similarity=0.360  Sum_probs=99.0

Q ss_pred             CeeEEEEEeccCCChHHHHhcC--CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          849 EFKALILEYMPHGSLEKSLYSS--NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      .+.|+.|++|+..+|.+++..+  ....++...+.++.|++.|++|      ++.+|||+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            3688999999999999999643  3346778889999999999998      7899999999999999999999999999


Q ss_pred             ceeecCCC----CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeec
Q 036229          927 AKLLIGED----QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFI  976 (982)
Q Consensus       927 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~  976 (982)
                      ........    .....+..+||..||+||.+.+..|...   .|+|++|++++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k---vdIyaLGlil~  453 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK---VDIYALGLILA  453 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh---cchhhHHHHHH
Confidence            88764433    2334567789999999999998877744   67888887654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=3.5e-10  Score=108.21  Aligned_cols=132  Identities=21%  Similarity=0.300  Sum_probs=99.5

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecc--------cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--------CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+++|+-+.||.+.+. |.++++|.-.++        ..-..++-.+|++++.+++--.|...+=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999763 445666653222        111235667899999998765555555555667777899999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ++|..+.+.+...        ...++..+-.-+.-||   ..||||+|+.++||++..+. +.++|||++..-
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9998888888654        2456677777778899   99999999999999998664 999999999853

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.13  E-value=5.1e-10  Score=106.20  Aligned_cols=143  Identities=17%  Similarity=0.169  Sum_probs=106.3

Q ss_pred             ccceeeeeceEEEEEEEeCCCeEEEEEEeecc--------cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          784 ENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--------CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       784 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ....+-+|+-+.|+++.+ .|+.++||.-..+        ..-...+..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999988 5677777753211        1223457788999999886556555555565666677999


Q ss_pred             EeccC-CChHHHHhcCCCcCCHHHH-HHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecCceee
Q 036229          856 EYMPH-GSLEKSLYSSNYILDIFQR-LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLL  930 (982)
Q Consensus       856 E~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~  930 (982)
                      ||++| .++.+++...-..-..... ...+.+|-+.+.-||   ..+|||+|+..+||++.+++   .+.++|||++..-
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99976 4778887754332233333 678899999999999   99999999999999997554   4589999998753

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.13  E-value=5.4e-12  Score=130.56  Aligned_cols=219  Identities=19%  Similarity=0.230  Sum_probs=128.8

Q ss_pred             CcEEEEEeCCCCccc----cCCccccCCCCCCEEEcCC---CCccccCcchh-------hhccCCcEEEccCCcccCccC
Q 036229           81 HRVKVLNISHLNLTG----TIPSQLWNLSSLQSLNLGF---NRLSGSIPSAI-------FTLYTLKYVNFRGNQLSGAFP  146 (982)
Q Consensus        81 ~~v~~L~l~~~~l~g----~~~~~l~~l~~L~~L~L~~---n~~~~~~p~~~-------~~l~~L~~L~Ls~N~l~~~~p  146 (982)
                      ..++.|+|++|.+.-    .+.+.|.+.++|+..++|+   -+....+|+++       ...++|++||||.|.|.-.-+
T Consensus        30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~  109 (382)
T KOG1909|consen   30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI  109 (382)
T ss_pred             CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence            468999999998742    4556788888999999986   23334566643       356789999999999974433


Q ss_pred             cc----ccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccc----c
Q 036229          147 SF----IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGA----I  218 (982)
Q Consensus       147 ~~----~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~  218 (982)
                      ..    +.+++.|++|.|.+|.+. .......+  ..|..|.  .|..       .++-++|+++..++|++...    +
T Consensus       110 ~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~--~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga~~~  177 (382)
T KOG1909|consen  110 RGLEELLSSCTDLEELYLNNCGLG-PEAGGRLG--RALFELA--VNKK-------AASKPKLRVFICGRNRLENGGATAL  177 (382)
T ss_pred             HHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHH--HHHHHHH--HHhc-------cCCCcceEEEEeeccccccccHHHH
Confidence            33    567889999999999875 22221111  1122222  1211       22345678888888877532    2


Q ss_pred             ccccccccchhhhhccCCCCCC----chhhhcCCCcccceEeccccccCCcCC----hhhhccCCCcEEEccCCccccCC
Q 036229          219 PKEIGNLTKLKELYLGYSGLQG----EIPREFGNLAELELMALQVSNLQGEIP----QELANLTGLEVLKLGKNFLTGEI  290 (982)
Q Consensus       219 p~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~~  290 (982)
                      ...|...+.|+.+.+++|.|.-    .+...|..++.|++|||+.|-++....    +.+..+++|++|++++|.+...-
T Consensus       178 A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~G  257 (382)
T KOG1909|consen  178 AEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEG  257 (382)
T ss_pred             HHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccccc
Confidence            2345556677777777776652    123345555555555555555543222    23444555566666666555432


Q ss_pred             Cccc-----cccCCCcEEEccCcccc
Q 036229          291 PPEI-----HNLHNLKLLDLSHNKLV  311 (982)
Q Consensus       291 p~~~-----~~l~~L~~L~Ls~N~l~  311 (982)
                      ...|     ...++|+.|+|.+|.|+
T Consensus       258 a~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  258 AIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             HHHHHHHHhccCCCCceeccCcchhH
Confidence            2222     12345555555555554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=3.3e-11  Score=117.88  Aligned_cols=55  Identities=33%  Similarity=0.413  Sum_probs=17.7

Q ss_pred             ccCcceEecccccccCCc-cccccCCCCCCeeeCCCCcCCCCCCc----ccccccccceee
Q 036229          616 LTNLQYLFLGYNRLQGSI-SESFGDLISLKSLNLSNNNLSRSIPI----SLEKLSYLEDLD  671 (982)
Q Consensus       616 l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~l~  671 (982)
                      +++|++|+|++|+|...- -..+..+++|+.|+|.+|.++.. +.    .+..+|+|+.||
T Consensus        87 lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   87 LPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             -TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred             CCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence            344444444444443211 12334445555555555555422 21    234556666665

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.08  E-value=1.4e-11  Score=141.22  Aligned_cols=244  Identities=27%  Similarity=0.289  Sum_probs=104.8

Q ss_pred             hccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccE
Q 036229          127 TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEI  206 (982)
Q Consensus       127 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  206 (982)
                      .+..++.+++..|.+.. +-..+..+++|+.|++.+|.|. .+...+ ..+++|++|+|++|.|+...+  +..++.|+.
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l-~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~  144 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLL-SSLVNLQVLDLSFNKITKLEG--LSTLTLLKE  144 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccch-hhhhcchheeccccccccccc--hhhccchhh
Confidence            34444444455444442 2223444455555555555554 232212 344555555555555543222  233344555


Q ss_pred             EEeeccccccccccccccccchhhhhccCCCCCCchh-hhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCc
Q 036229          207 LSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIP-REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNF  285 (982)
Q Consensus       207 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~  285 (982)
                      |++++|.++..  ..+..++.|+.+++++|+++..-+ . ...+.+++.+++.+|.+...  ..+..+..+..+++..|.
T Consensus       145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~  219 (414)
T KOG0531|consen  145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK  219 (414)
T ss_pred             heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence            55555555421  233334555555555555543222 1 34444555555555554321  223333344444555555


Q ss_pred             cccCCCccccccC--CCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCccccc-
Q 036229          286 LTGEIPPEIHNLH--NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT-  362 (982)
Q Consensus       286 l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-  362 (982)
                      ++...+  +..+.  .|+.+++++|++. ..+..+..+..+..|++.+|.+...-.   ....+.+..+.+..|.+... 
T Consensus       220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  293 (414)
T KOG0531|consen  220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG---LERLPKLSELWLNDNKLALSE  293 (414)
T ss_pred             ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccc---ccccchHHHhccCcchhcchh
Confidence            553221  11112  2555566666554 222334444455555555555432111   11123334444444444311 


Q ss_pred             --cccc-ccCCCCCCEEEeccccCccc
Q 036229          363 --IPRF-IFNASKLSVLELGRNSFSGF  386 (982)
Q Consensus       363 --~p~~-~~~l~~L~~L~L~~N~i~~~  386 (982)
                        .... ......++...+..|.+...
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
T KOG0531|consen  294 AISQEYITSAAPTLVTLTLELNPIRKI  320 (414)
T ss_pred             hhhccccccccccccccccccCccccc
Confidence              1111 23344555555555555443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=9.3e-10  Score=115.24  Aligned_cols=142  Identities=19%  Similarity=0.216  Sum_probs=110.6

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCC--ccceeEEeeecCC---CeeEEEEEecc
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRH--RNLIKVISSCSTE---EFKALILEYMP  859 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~---~~~~lv~E~~~  859 (982)
                      +.++.|..+.||+++..+|+.+++|+...... ....++..|+++++.+++  ..+++++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999876678999999764322 235678999999999975  4467788777654   36689999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc-------------------------------------------
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG-------------------------------------------  896 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-------------------------------------------  896 (982)
                      |.++.+.+..  ...+..+...++.++++++.++|..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888765432  2356777778888888888888831                                           


Q ss_pred             ----------CCCCeEEcCCCCCCEEEcC--CCcEEEEeecCcee
Q 036229          897 ----------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKL  929 (982)
Q Consensus       897 ----------~~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~  929 (982)
                                ....++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1356899999999999998  67789999998874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.07  E-value=2.3e-11  Score=126.02  Aligned_cols=88  Identities=18%  Similarity=0.253  Sum_probs=52.2

Q ss_pred             CCcccceEeccccccCCcCC----hhhhccCCCcEEEccCCccccC----CCccccccCCCcEEEccCcccccc----Cc
Q 036229          248 NLAELELMALQVSNLQGEIP----QELANLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKLVGA----VP  315 (982)
Q Consensus       248 ~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p  315 (982)
                      +-+.|+++...+|++.....    ..|...+.|+.+.++.|.|...    ....|..+++|+.|||..|-++..    +.
T Consensus       155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La  234 (382)
T KOG1909|consen  155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA  234 (382)
T ss_pred             CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence            34567777777777764332    2356667777777777777521    223456677777777777777532    22


Q ss_pred             ccccCCCCCceeecCCCcCC
Q 036229          316 ATIFNMSTLTGLGLQSNSLS  335 (982)
Q Consensus       316 ~~~~~l~~L~~L~L~~N~l~  335 (982)
                      ..+..++.|+.|++++|.+.
T Consensus       235 kaL~s~~~L~El~l~dcll~  254 (382)
T KOG1909|consen  235 KALSSWPHLRELNLGDCLLE  254 (382)
T ss_pred             HHhcccchheeecccccccc
Confidence            33444455555555555553

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.07  E-value=7.1e-11  Score=115.59  Aligned_cols=85  Identities=34%  Similarity=0.384  Sum_probs=35.3

Q ss_pred             ccccceeecccccccccccccccCccCcceEecccccccCCccccc-cCCCCCCeeeCCCCcCCCCCC-cccccccccce
Q 036229          592 LKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESF-GDLISLKSLNLSNNNLSRSIP-ISLEKLSYLED  669 (982)
Q Consensus       592 l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~  669 (982)
                      +.+|+.||||+|.|+.+  +.+..+++|++|++++|+|+. +++.+ ..+++|+.|+|++|+|...-. ..+..+++|++
T Consensus        41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~  117 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV  117 (175)
T ss_dssp             -TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred             hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence            44555556666666543  245667888888888888884 43344 467888888888888875322 35667888888


Q ss_pred             eecCCCcccc
Q 036229          670 LDLSFNKLKG  679 (982)
Q Consensus       670 l~ls~N~l~~  679 (982)
                      |+|.+||++.
T Consensus       118 L~L~~NPv~~  127 (175)
T PF14580_consen  118 LSLEGNPVCE  127 (175)
T ss_dssp             EE-TT-GGGG
T ss_pred             eeccCCcccc
Confidence            8888888873

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.06  E-value=2.5e-11  Score=139.02  Aligned_cols=226  Identities=27%  Similarity=0.311  Sum_probs=112.2

Q ss_pred             ccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccc
Q 036229          367 IFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMG  446 (982)
Q Consensus       367 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  446 (982)
                      +..+.+|+.|++.+|+|..+.. .+..+++|+.|++++|.|+++.       .+..++.|+.|++++|+|+.+       
T Consensus        91 l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~-------~l~~l~~L~~L~l~~N~i~~~-------  155 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE-------GLSTLTLLKELNLSGNLISDI-------  155 (414)
T ss_pred             cccccceeeeeccccchhhccc-chhhhhcchheecccccccccc-------chhhccchhhheeccCcchhc-------
Confidence            3445556666666666654321 1444555555555555555432       233444455555555555433       


Q ss_pred             cccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCC-ccccCcCCCCeEEeeccCCCCCCCcccCCCcccc
Q 036229          447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP-ITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLY  525 (982)
Q Consensus       447 ~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  525 (982)
                                           ..+..+++|+.+++++|.+..+.+ . ...+.+++.+++.+|.+..  ...+..+..+.
T Consensus       156 ---------------------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~  211 (414)
T KOG0531|consen  156 ---------------------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLV  211 (414)
T ss_pred             ---------------------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHH
Confidence                                 112224555555555555554333 2 3455566666666666652  23344444555


Q ss_pred             EEEccCCcCCcCCCccccCCC--cccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccc
Q 036229          526 ELGLSGNKLSGSIPACFSNLA--SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN  603 (982)
Q Consensus       526 ~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N  603 (982)
                      .+++..|+++...+  +..+.  .|+.+++++|++..++..+..+..                        +..+|+++|
T Consensus       212 ~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~------------------------l~~l~~~~n  265 (414)
T KOG0531|consen  212 LLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKN------------------------LPVLDLSSN  265 (414)
T ss_pred             HhhcccccceeccC--cccchhHHHHHHhcccCcccccccccccccc------------------------ccccchhhc
Confidence            55666666653322  11222  256666666666655433333334                        444444444


Q ss_pred             cccccccccccCccCcceEecccccccCC---cccc-ccCCCCCCeeeCCCCcCCCCCCc
Q 036229          604 NFSDVIPTVIGGLTNLQYLFLGYNRLQGS---ISES-FGDLISLKSLNLSNNNLSRSIPI  659 (982)
Q Consensus       604 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~Ls~N~l~~~~p~  659 (982)
                      +++..  ..+.....+..+.+..|.+...   .... ....+.++...+..|.+....+.
T Consensus       266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
T KOG0531|consen  266 RISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL  323 (414)
T ss_pred             ccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence            44332  1233344555555666655421   1111 44456777777777777655543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.05  E-value=2.5e-11  Score=128.95  Aligned_cols=209  Identities=23%  Similarity=0.247  Sum_probs=155.8

Q ss_pred             cCCCCCCEEEcCCCCccccCc--chhhhccCCcEEEccCCcccCccC--ccccCcCCCCccccccCcccccCchhhhcCC
Q 036229          102 WNLSSLQSLNLGFNRLSGSIP--SAIFTLYTLKYVNFRGNQLSGAFP--SFIFNKSSLQHLDFSYNALSGEIPANICSNL  177 (982)
Q Consensus       102 ~~l~~L~~L~L~~n~~~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  177 (982)
                      .++.+|+...|.+.... ..+  .-.-.+++++.||||+|-|....|  .....|++|+.|+||.|++.--+....-..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            36778888888887764 222  356689999999999998874322  3356889999999999998755544444578


Q ss_pred             CCCCeeeecceeeecccCC-CccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCch-hhhcCCCcccceE
Q 036229          178 PFLESISLSQNMFHGRIPS-ALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEI-PREFGNLAELELM  255 (982)
Q Consensus       178 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L  255 (982)
                      ++|+.|.|+.|.++...-. ....+++|+.|+|..|.....-.....-+..|++|||++|.+.... -...+.++.|..|
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L  276 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL  276 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence            8999999999999843322 3457889999999999643344445566788999999999887332 1456788999999


Q ss_pred             eccccccCCc-CChh-----hhccCCCcEEEccCCccccCCC--ccccccCCCcEEEccCccccc
Q 036229          256 ALQVSNLQGE-IPQE-----LANLTGLEVLKLGKNFLTGEIP--PEIHNLHNLKLLDLSHNKLVG  312 (982)
Q Consensus       256 ~L~~n~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~  312 (982)
                      +++.+.+... .|+.     ...+++|++|+++.|+|.. ++  ..+..+++|+.|....|.++.
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchhhhhhcccccccc
Confidence            9999988753 2333     4677999999999999963 22  345667888888888998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=9.9e-09  Score=102.35  Aligned_cols=125  Identities=24%  Similarity=0.263  Sum_probs=83.6

Q ss_pred             EEEEEEeCCCeEEEEEEeeccc-------------c-------------hhhhhHHHHHHHhhhcCCc--cceeEEeeec
Q 036229          795 SVYKARIGEGMEVAVKVFDLQC-------------G-------------RAFKSFDVECEMMKSIRHR--NLIKVISSCS  846 (982)
Q Consensus       795 ~Vy~~~~~~~~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~  846 (982)
                      .||.|...+|..||+|+.+...             .             .......+|.+.|+++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998899999999975320             0             0123567899999999755  567777653 


Q ss_pred             CCCeeEEEEEecc--CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHH-HHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          847 TEEFKALILEYMP--HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY-LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       847 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~y-LH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                         ..++||||++  |..+..+... .  .+......++.+++..+.. +|   +.||||+|+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3469999998  5455433322 1  1123455677888885555 58   9999999999999999877 999999


Q ss_pred             ecCceee
Q 036229          924 FGIAKLL  930 (982)
Q Consensus       924 FGla~~~  930 (982)
                      ||.|...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.90  E-value=5.4e-10  Score=125.20  Aligned_cols=189  Identities=22%  Similarity=0.211  Sum_probs=145.7

Q ss_pred             cCCCccceeee--eceEEEEEEEe---CCCeEEEEEEeec--ccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCee
Q 036229          780 NRFSENNLIGR--GGFGSVYKARI---GEGMEVAVKVFDL--QCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       780 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  851 (982)
                      ..|.+.+.+|.  |.+|.||.++.   .++..+|+|.-+.  .......+-.+|+...+.+ .|++.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34667788999  99999999875   3578899998432  2223334445677766666 499999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHH----HHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecC
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT----TLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGI  926 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~----~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGl  926 (982)
                      ++-+|++. .++.++.......++....+.+..+...    |+.++|   ..+|+|-|+||+||+...+ ...+++|||.
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            99999994 6898888776666778888888999888    999999   9999999999999999988 8999999999


Q ss_pred             ceeecCCCCc---eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeec
Q 036229          927 AKLLIGEDQS---ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFI  976 (982)
Q Consensus       927 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~  976 (982)
                      ...+.+..-.   .......|...|++||..++-+.    ...|+++++++++
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~----~~~di~sl~ev~l  318 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT----FASDIFSLGEVIL  318 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccc----hHhhhcchhhhhH
Confidence            9887544311   11122357788999999877532    2345677775544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.84  E-value=7.4e-09  Score=117.01  Aligned_cols=123  Identities=17%  Similarity=0.233  Sum_probs=104.2

Q ss_pred             EeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHH
Q 036229          800 RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQR  879 (982)
Q Consensus       800 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~  879 (982)
                      +..++.+|.|.+.+.......+...+-++.++.++||+|+++++.++.++..|+|+|.+.  .|..++++..    ....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            345688999998886655445667788899999999999999999999999999999984  6777776533    4556


Q ss_pred             HHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       880 ~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .-.++||+.||.|||.  +.+++|++|.-.-|+|+..|+.||++|.++...
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            6688999999999984  889999999999999999999999999988754

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.84  E-value=1.7e-09  Score=87.08  Aligned_cols=58  Identities=36%  Similarity=0.556  Sum_probs=29.0

Q ss_pred             cceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCc
Q 036229          595 LIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNN  652 (982)
Q Consensus       595 L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  652 (982)
                      |+.|++++|+|+.+.+..|.++++|++|++++|+++...|.+|.++++|++|++++|+
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            4444445555544444455555555555555555554444455555555555555554

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.84  E-value=1.5e-09  Score=87.40  Aligned_cols=61  Identities=43%  Similarity=0.531  Sum_probs=57.5

Q ss_pred             cCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcc
Q 036229          617 TNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKL  677 (982)
Q Consensus       617 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l  677 (982)
                      ++|++|++++|+|+...+.+|.++++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999988888999999999999999999988888999999999999999986

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.83  E-value=4.9e-09  Score=128.07  Aligned_cols=294  Identities=22%  Similarity=0.249  Sum_probs=153.7

Q ss_pred             EEEEEeCCCCccccCCccccCCCCCCEEEcCCCC--ccccCcch-hhhccCCcEEEccCCcccCccCccccCcCCCCccc
Q 036229           83 VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNR--LSGSIPSA-IFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLD  159 (982)
Q Consensus        83 v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~--~~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  159 (982)
                      +....+-++.+. .++.+.. .+.|++|-+..|.  +. .++.. |-.++.|+.||||+|.=-+.+|+.++.|-+|++|+
T Consensus       525 ~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~  601 (889)
T KOG4658|consen  525 VRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD  601 (889)
T ss_pred             eeEEEEeccchh-hccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence            444444455443 2332222 2367778777775  43 45544 44688888888888776667888888888888888


Q ss_pred             cccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccc--ccccccccccccchhhhhccCCC
Q 036229          160 FSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNL--LGAIPKEIGNLTKLKELYLGYSG  237 (982)
Q Consensus       160 Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~~~~l~~L~~L~L~~N~  237 (982)
                      |++..+. .+|.++ .+|+.|.+|++..+.-...+|.....+.+|++|.+-.-..  +...-..+.++.+|+.+......
T Consensus       602 L~~t~I~-~LP~~l-~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s  679 (889)
T KOG4658|consen  602 LSDTGIS-HLPSGL-GNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISS  679 (889)
T ss_pred             ccCCCcc-ccchHH-HHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecch
Confidence            8888887 788887 7888888888888776656677777788888888775542  12222334444444444442222


Q ss_pred             CCCchhhhcCCCcccc----eEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCcccccc
Q 036229          238 LQGEIPREFGNLAELE----LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGA  313 (982)
Q Consensus       238 l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  313 (982)
                      .  .+-..+..+..|.    .+.+..+... ..+..+..+.+|+.|.+.++.++......+...   +.++         
T Consensus       680 ~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~---~~~~---------  744 (889)
T KOG4658|consen  680 V--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESL---IVLL---------  744 (889)
T ss_pred             h--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhccccccc---chhh---------
Confidence            1  1111122222222    1111111111 222334455555555555555543222111111   1110         


Q ss_pred             CcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccc-cCCccc
Q 036229          314 VPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGF-IPNTFG  392 (982)
Q Consensus       314 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~-~~~~~~  392 (982)
                         .   ++++..+...++.....+.  ...-.|+|+.|++........+.+....+..+..+-+..+.+.+. .-...+
T Consensus       745 ---~---f~~l~~~~~~~~~~~r~l~--~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~  816 (889)
T KOG4658|consen  745 ---C---FPNLSKVSILNCHMLRDLT--WLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLG  816 (889)
T ss_pred             ---h---HHHHHHHHhhccccccccc--hhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCC
Confidence               0   1111111111111100011  112346778888887766655555555566666666777766655 233444


Q ss_pred             cCCccceecccc
Q 036229          393 NLRNLRLMTLHY  404 (982)
Q Consensus       393 ~l~~L~~L~L~~  404 (982)
                      .++++..+.+.+
T Consensus       817 ~l~~i~~~~l~~  828 (889)
T KOG4658|consen  817 GLPQLYWLPLSF  828 (889)
T ss_pred             CCceeEecccCc
Confidence            555555444443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.83  E-value=4.3e-08  Score=103.93  Aligned_cols=140  Identities=16%  Similarity=0.081  Sum_probs=100.2

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccch-hh----------hhHHHHHHHhhhcCCcc--ceeEEeeecC-----
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AF----------KSFDVECEMMKSIRHRN--LIKVISSCST-----  847 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~n--Iv~l~~~~~~-----  847 (982)
                      +.+-+.....|+++.+ +|+.|.||........ ..          ..+.+|...+.++...+  .++++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4555444455777766 5788999976432211 01          14778999888884333  3344555432     


Q ss_pred             CCeeEEEEEeccCC-ChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-------CCc
Q 036229          848 EEFKALILEYMPHG-SLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-------NMV  918 (982)
Q Consensus       848 ~~~~~lv~E~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-------~~~  918 (982)
                      ....++|||++++. +|.+++... ....+...+..++.+++..+.-||   ..||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999876 798887532 223456677789999999999999   999999999999999975       468


Q ss_pred             EEEEeecCcee
Q 036229          919 AHLSDFGIAKL  929 (982)
Q Consensus       919 ~kL~DFGla~~  929 (982)
                      +.++||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998864

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=2.9e-09  Score=129.97  Aligned_cols=102  Identities=31%  Similarity=0.437  Sum_probs=44.8

Q ss_pred             CCCccccccCc--ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhh
Q 036229          154 SLQHLDFSYNA--LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKEL  231 (982)
Q Consensus       154 ~L~~L~Ls~N~--l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  231 (982)
                      +|++|-+..|.  +. .++..+|..+|.|+.|||++|.=-+.+|..++++-+|++|+|++..+. .+|..++++.+|.+|
T Consensus       546 ~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L  623 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL  623 (889)
T ss_pred             ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence            44444444443  22 344444444444444444444433344444444444444444444444 344444444444444


Q ss_pred             hccCCCCCCchhhhcCCCcccceEec
Q 036229          232 YLGYSGLQGEIPREFGNLAELELMAL  257 (982)
Q Consensus       232 ~L~~N~l~~~~~~~~~~l~~L~~L~L  257 (982)
                      ++.++.-...+|.....+++|++|.+
T Consensus       624 nl~~~~~l~~~~~i~~~L~~Lr~L~l  649 (889)
T KOG4658|consen  624 NLEVTGRLESIPGILLELQSLRVLRL  649 (889)
T ss_pred             ccccccccccccchhhhcccccEEEe
Confidence            44444333233333333444444433

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.75  E-value=4.9e-08  Score=99.34  Aligned_cols=136  Identities=22%  Similarity=0.206  Sum_probs=103.5

Q ss_pred             CCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc----------------------chhhhhHHHHHHHhhhcCCc--c
Q 036229          782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC----------------------GRAFKSFDVECEMMKSIRHR--N  837 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n  837 (982)
                      +.++..||.|.-+.||.|..+.|.++|||.=+...                      .......++|.++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999999999999743210                      11123567899999998654  6


Q ss_pred             ceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       838 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      +++.+++    +...+||||++|-.|...-      ++......++..|+.-+.-.-   ..||||+|+.+=||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            7777754    4567999999986664321      133445566777777776666   79999999999999999999


Q ss_pred             cEEEEeecCceee
Q 036229          918 VAHLSDFGIAKLL  930 (982)
Q Consensus       918 ~~kL~DFGla~~~  930 (982)
                      .+.++||--+...
T Consensus       240 ~~~vIDwPQ~v~~  252 (304)
T COG0478         240 DIVVIDWPQAVPI  252 (304)
T ss_pred             CEEEEeCcccccC
Confidence            9999999877654

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.74  E-value=7.3e-09  Score=76.12  Aligned_cols=40  Identities=43%  Similarity=0.897  Sum_probs=30.9

Q ss_pred             hhHHHHHHHHHHHhcCCCCccccCCCCCC--CCCCceeeEEec
Q 036229           37 TTDQDALLALKAHITHDPTNFLAKNWNTS--TPVCNWTGVTCD   77 (982)
Q Consensus        37 ~~~~~~ll~~k~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~   77 (982)
                      ++|++||++||+++..+ +...+.+|+.+  ++||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~-~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNND-PSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-S-C-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccc-cCcccccCCCcCCCCCeeeccEEeC
Confidence            67999999999999876 46789999987  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.68  E-value=1.6e-09  Score=97.24  Aligned_cols=136  Identities=22%  Similarity=0.213  Sum_probs=93.2

Q ss_pred             ccccccCCCccccccccccc---ccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEec
Q 036229          548 LGTLSLGSNKLTSIPLTIWN---LKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL  624 (982)
Q Consensus       548 L~~L~L~~N~l~~ip~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~L  624 (982)
                      +..++|++++|-.|+.....   ...|+..+|++|.+....+.--...+.++.++|++|.|++ +|.++..++.|+.|++
T Consensus        29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~lNl  107 (177)
T KOG4579|consen   29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSLNL  107 (177)
T ss_pred             hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhccc
Confidence            44566666666655554443   3344555666666664433333344567778888888865 5677888999999999


Q ss_pred             ccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCCCC
Q 036229          625 GYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGS  686 (982)
Q Consensus       625 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~  686 (982)
                      +.|.+. ..|+.+..|.+|-.||..+|.+. .+|..+---+..-..++.+++|.+..|.+.|
T Consensus       108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  108 RFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ  167 (177)
T ss_pred             ccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence            999987 67777777888999999999886 5665543334445566788888888887653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.67  E-value=5.3e-10  Score=125.38  Aligned_cols=131  Identities=32%  Similarity=0.233  Sum_probs=98.1

Q ss_pred             CcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecc
Q 036229          546 ASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLG  625 (982)
Q Consensus       546 ~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls  625 (982)
                      ..|...+.+.|.|+.+...+.-++.++.|||+.|+++...  .+..+..|++|||+.|.+..+.--...++. |+.|+|+
T Consensus       164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            3566777777777777776666777777888888777543  677788888888888888765444555555 9999999


Q ss_pred             cccccCCccccccCCCCCCeeeCCCCcCCCCCC-cccccccccceeecCCCcccccC
Q 036229          626 YNRLQGSISESFGDLISLKSLNLSNNNLSRSIP-ISLEKLSYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       626 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~l~ls~N~l~~~~  681 (982)
                      +|.++..  ..+.+|.+|+.||||+|-|++.-. .-+..|..|..|+|.+|++.+..
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            9998743  357788899999999998886432 22456788999999999998654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=2.1e-07  Score=106.77  Aligned_cols=140  Identities=19%  Similarity=0.170  Sum_probs=96.1

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccchh----------------------------------------hhhHHH
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRA----------------------------------------FKSFDV  825 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  825 (982)
                      +.|+.++-|+||+|++++|+.||||+.++.-...                                        .-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            7899999999999999999999999975431100                                        012334


Q ss_pred             HHHHhhhc-----CCccceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHH-HHHHHccCCC
Q 036229          826 ECEMMKSI-----RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT-LEYLHFGYSA  899 (982)
Q Consensus       826 E~~~l~~l-----~h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~-L~yLH~~~~~  899 (982)
                      |+.-+.++     ..+.+.-..=+++..+...++|||++|-.+.+....+....+.   +.++..++++ ++.+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHH---hc
Confidence            55544444     2344333333444456678999999999888875433333553   3344444443 22333   67


Q ss_pred             CeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       900 ~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      |+.|.|..|.||+++.+|++.+.|||+...+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            99999999999999999999999999988764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.58  E-value=2.7e-08  Score=111.80  Aligned_cols=149  Identities=25%  Similarity=0.235  Sum_probs=118.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe--CCCeEEEEEEeecccchh--hhhHHHHHHHhhhc-CCccceeEEeeecCCCee
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI--GEGMEVAVKVFDLQCGRA--FKSFDVECEMMKSI-RHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  851 (982)
                      ....+|.....||.|.|+.|+.+..  .++..|++|.........  ...-..|+.+...+ .|.++++++..|......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788999999999999999864  357889999875432221  12224466665555 599999999888888888


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCcee
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKL  929 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~  929 (982)
                      |+--|||++++...... ....+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.+..
T Consensus       342 ~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            89999999998876652 2334677888999999999999999   9999999999999999875 7889999999874

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.57  E-value=1.2e-09  Score=122.47  Aligned_cols=130  Identities=30%  Similarity=0.326  Sum_probs=101.9

Q ss_pred             cCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeC
Q 036229          569 KGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNL  648 (982)
Q Consensus       569 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  648 (982)
                      ..|...+.+.|++. .....+.-++.++.||||+|+++.+-  .+..++.|+.|||++|+++..+--...+.. |..|.|
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeee
Confidence            36778899999998 45567778899999999999998864  899999999999999999844333444554 999999


Q ss_pred             CCCcCCCCCCcccccccccceeecCCCcccccC--CCCCCCCCCCCcccccCcccCCC
Q 036229          649 SNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI--PKGGSFGNFSAKSFEGNELLCGS  704 (982)
Q Consensus       649 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~--p~~~~~~~~~~~~~~gn~~lc~~  704 (982)
                      ++|.++..  ..+.+|.+|+.||||+|-|++.-  -.-+.+..+...-.+|||..|.+
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            99999853  46789999999999999998532  12222334445667999998865

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.52  E-value=4.4e-09  Score=94.51  Aligned_cols=130  Identities=18%  Similarity=0.247  Sum_probs=85.1

Q ss_pred             cEEeccCCccccCCCc---ccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEc
Q 036229          453 EYFDMSYCNVSGGFPK---EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGL  529 (982)
Q Consensus       453 ~~Ldls~n~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  529 (982)
                      ..+||++|++.- +++   .+.....|+.++|++|.+...++..-...+.+++|+|++|+|+ .+|..+..++.|+.|++
T Consensus        30 h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl  107 (177)
T KOG4579|consen   30 HFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL  107 (177)
T ss_pred             hhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence            345555555442 222   2334456777788888887433333345567888888888888 56777888888888888


Q ss_pred             cCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCC
Q 036229          530 SGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPL  585 (982)
Q Consensus       530 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~  585 (982)
                      +.|.+. ..|..+..|.++..|+..+|.+.+||..++.-+..-..++.++.+.+.-
T Consensus       108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~  162 (177)
T KOG4579|consen  108 RFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDET  162 (177)
T ss_pred             ccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccC
Confidence            888887 5667777788888888888888888876554333333344444444433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.50  E-value=8.9e-07  Score=90.99  Aligned_cols=107  Identities=24%  Similarity=0.253  Sum_probs=84.0

Q ss_pred             hhhHHHHHHHhhhcCC--ccceeEEeeecCC----CeeEEEEEeccCC-ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHH
Q 036229          820 FKSFDVECEMMKSIRH--RNLIKVISSCSTE----EFKALILEYMPHG-SLEKSLYSSNYILDIFQRLNIMVDVATTLEY  892 (982)
Q Consensus       820 ~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~----~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~y  892 (982)
                      .....+|...+..+..  -..++.+++.+..    ...++|+|++++. +|.+++..... .+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            4567888888877743  3345566665442    2458999999874 79988875332 4566778899999999999


Q ss_pred             HHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecCceee
Q 036229          893 LHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLL  930 (982)
Q Consensus       893 LH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~  930 (982)
                      ||   +.||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99   99999999999999999776   8999999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.47  E-value=4.3e-08  Score=99.44  Aligned_cols=86  Identities=28%  Similarity=0.352  Sum_probs=45.2

Q ss_pred             cCCCcEEEccCCcccc--CCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCcc
Q 036229          273 LTGLEVLKLGKNFLTG--EIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLE  350 (982)
Q Consensus       273 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  350 (982)
                      .+.++.|||..|+|+.  .+...+.++|.|++|+||+|.+...+...-....+|+.|-|.+-.+.-.........+|.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            4566777777777763  22334456667777777777665333221133445555555555443333333333455555


Q ss_pred             EEEccCCc
Q 036229          351 ELRLWSNN  358 (982)
Q Consensus       351 ~L~Ls~N~  358 (982)
                      +|++|.|+
T Consensus       150 elHmS~N~  157 (418)
T KOG2982|consen  150 ELHMSDNS  157 (418)
T ss_pred             hhhhccch
Confidence            55555553

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.43  E-value=6.3e-08  Score=98.27  Aligned_cols=220  Identities=23%  Similarity=0.251  Sum_probs=114.0

Q ss_pred             cchhhhccCCcEEEccCCcccCc--cCccccCcCCCCccccccCcccc--cCchhhhcCCCCCCeeeecceeeecccCCC
Q 036229          122 PSAIFTLYTLKYVNFRGNQLSGA--FPSFIFNKSSLQHLDFSYNALSG--EIPANICSNLPFLESISLSQNMFHGRIPSA  197 (982)
Q Consensus       122 p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~--~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~  197 (982)
                      |-.++.+..++.|-+.++.|-..  .-..=...+.+++|||.+|.|+.  +|. .++.++|.|+.|+|+.|++...+-..
T Consensus        38 ~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~-~ile~lP~l~~LNls~N~L~s~I~~l  116 (418)
T KOG2982|consen   38 YLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIG-AILEQLPALTTLNLSCNSLSSDIKSL  116 (418)
T ss_pred             eeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHH-HHHhcCccceEeeccCCcCCCccccC
Confidence            33344444444555555444211  11111234667777777777752  222 34578888888888888887544322


Q ss_pred             ccCcCcccEEEeecccccccc-ccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCC
Q 036229          198 LSNCKYLEILSLSINNLLGAI-PKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGL  276 (982)
Q Consensus       198 ~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  276 (982)
                      =..+.+|++|-|.+..+...- ...+..++.+++|++|.|.+.              .+++..|.+...-|.       +
T Consensus       117 p~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~~s~~-------v  175 (418)
T KOG2982|consen  117 PLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCIEDWSTE-------V  175 (418)
T ss_pred             cccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh--------------hhccccccccccchh-------h
Confidence            245678899999888776433 234567788888888887554              223333333221111       1


Q ss_pred             cEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccC
Q 036229          277 EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWS  356 (982)
Q Consensus       277 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~  356 (982)
                      ++               +..++.+..+.++-|++...+       +++..+-+-.|++...-....+..+|.+.-|+|+.
T Consensus       176 ~t---------------lh~~~c~~~~w~~~~~l~r~F-------pnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~  233 (418)
T KOG2982|consen  176 LT---------------LHQLPCLEQLWLNKNKLSRIF-------PNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGA  233 (418)
T ss_pred             hh---------------hhcCCcHHHHHHHHHhHHhhc-------ccchheeeecCcccchhhcccCCCCCcchhhhhcc
Confidence            11               112222333333333333222       23334444444444333344444555555666666


Q ss_pred             Cccccc-ccccccCCCCCCEEEeccccCcc
Q 036229          357 NNFSGT-IPRFIFNASKLSVLELGRNSFSG  385 (982)
Q Consensus       357 N~l~~~-~p~~~~~l~~L~~L~L~~N~i~~  385 (982)
                      |+|..- --+.+..+++|..|.+++|.+..
T Consensus       234 ~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  234 NNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             cccccHHHHHHHcCCchhheeeccCCcccc
Confidence            666432 12345566666667777766653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.39  E-value=2.4e-06  Score=93.92  Aligned_cols=137  Identities=18%  Similarity=0.202  Sum_probs=108.0

Q ss_pred             EEEEEEE-eCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC----CCeeEEEEEeccC-CChHHHH
Q 036229          794 GSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST----EEFKALILEYMPH-GSLEKSL  867 (982)
Q Consensus       794 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~E~~~~-gsL~~~l  867 (982)
                      .+.|++. ..+|..|++|++.............-++.++++.|+|+|++.+++..    +...++|++|+++ ++|.++.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            4678987 45799999999954433333334456788999999999999998863    3468899999886 4776654


Q ss_pred             hc--------------CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          868 YS--------------SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       868 ~~--------------~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ..              .+...++...+.++.|+..||.++|   +.|..-+-+.|.+|+++.+.+++|...|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            42              1234678889999999999999999   999999999999999999999999988887765433

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.31  E-value=6e-06  Score=82.95  Aligned_cols=138  Identities=16%  Similarity=0.172  Sum_probs=89.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhh---------HHHHHHHhhhcC---CccceeEEeee
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKS---------FDVECEMMKSIR---HRNLIKVISSC  845 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~nIv~l~~~~  845 (982)
                      ...+|...+.+-......|.+... +|+.+++|..+.........         ..+++....+++   -.....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346777777777777666766665 57889999876543322222         222333333332   22223322222


Q ss_pred             -----cCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 036229          846 -----STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  920 (982)
Q Consensus       846 -----~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  920 (982)
                           ......+++|||++|..+.+...     +++    .++..+++++.-+|   +.|++|+|..|.|++++++ .++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEE
Confidence                 22235568999999988865431     222    35567778899999   9999999999999999865 599


Q ss_pred             EEeecCcee
Q 036229          921 LSDFGIAKL  929 (982)
Q Consensus       921 L~DFGla~~  929 (982)
                      ++||+..+.
T Consensus       175 iID~~~k~~  183 (229)
T PF06176_consen  175 IIDTQGKRM  183 (229)
T ss_pred             EEECccccc
Confidence            999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.30  E-value=9.3e-06  Score=81.42  Aligned_cols=138  Identities=16%  Similarity=0.086  Sum_probs=100.1

Q ss_pred             eeeeceEEEEEEEeCCCeEEEEEEeecc------cchhhhhHHHHHHHhhhcCCc--cceeEEeeecC----CCeeEEEE
Q 036229          788 IGRGGFGSVYKARIGEGMEVAVKVFDLQ------CGRAFKSFDVECEMMKSIRHR--NLIKVISSCST----EEFKALIL  855 (982)
Q Consensus       788 lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~----~~~~~lv~  855 (982)
                      -|+||.+-|++.... |+.+-+|.-...      .+.....|.+|...+.++...  .++++..+...    .-..++|+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            466888889988764 345777765311      133457899999999888432  24555422111    12467999


Q ss_pred             EeccC-CChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--EEEEeecCcee
Q 036229          856 EYMPH-GSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKL  929 (982)
Q Consensus       856 E~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~  929 (982)
                      |-+++ .+|.+++.+.. ...+......+..+++.++.-||   +.|+.|+|+-+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97753 58888886532 24567777889999999999999   999999999999999986666  99999987664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	982
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-40
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-35
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-18
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-10
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-40
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-36
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-18
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-26
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-24
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-21
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		9e-21
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-16
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		7e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-09
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-09
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-09
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-09
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		8e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-07
3soa_A	444	Full-Length Human Camkii Length = 444		6e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-06
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-06
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		3e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-06
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		4e-06
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		5e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-06
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		7e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-06
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		9e-06
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		9e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-05
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-05
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		1e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-05
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		2e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-05
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		4e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-05
3m18_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		5e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		7e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-05
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		8e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		9e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-04
3m19_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		4e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		8e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-04

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  164 bits (416), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 144/440 (32%), Positives = 199/440 (45%), Gaps = 61/440 (13%)
Query: 115 NRLSGSIP-SAIFTLYTLKYVNFRGNQLSGAFPSFIFN-KSSLQHLDFSYNALSGEIPAN 172
           N  SG +P   +  +  LK ++   N+ SG  P  + N  +SL  LD S N  SG I  N
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 173 ICSNLP-FLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEIGNLTKLKEL 231
           +C N    L+ + L  N F G+IP  LSNC  L           G IP  +G+L+KL++L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 232 YLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIP 291
            L  + L+GEIP+E   +  LE + L  ++L GEIP  L+N T L  + L  N LTGEIP
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 292 PEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLPNLEE 351
             I  L NL +L LS+N   G +PA                        + D +  +L  
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAE-----------------------LGDCR--SLIW 542
Query: 352 LRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG----FIPNT--------FGNLRNLRL 399
           L L +N F+GTIP  +F  S     ++  N  +G    +I N          GNL     
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNL----- 593
Query: 400 MTLHYNYLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSY 459
             L +  +                 S  Y G ++   D           + S+ + DMSY
Sbjct: 594 --LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN----------NGSMMFLDMSY 641
Query: 460 CNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDIC 519
             +SG  PKEIG++  L  + LG N ++GSIP             L  NKL+G IP  + 
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701
Query: 520 RLTKLYELGLSGNKLSGSIP 539
            LT L E+ LS N LSG IP
Sbjct: 702 ALTMLTEIDLSNNNLSGPIP 721

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  149 bits (375), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 180/636 (28%), Positives = 264/636 (41%), Gaps = 107/636 (16%)
Query: 115 NRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANI- 173
           N++SG +   +     L++++   N  S   P F+ + S+LQHLD S N LSG+    I 
Sbjct: 188 NKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 244
Query: 174 -CSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEI-GNLTKLKEL 231
            C+ L  L   ++S N F G IP      K L+          G IP  + G    L  L
Sbjct: 245 TCTELKLL---NISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
Query: 232 YLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEI 290
            L  +   G +P  FG+ + LE +AL  +N  GE+P + L  + GL+VL L  N  +GE+
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 291 PPEIHNLH-NLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLP-- 347
           P  + NL  +L  LDLS N   G +   +                          Q P  
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNL-------------------------CQNPKN 394
Query: 348 NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYL 407
            L+EL L +N F+G IP  + N S+L  L L  N  SG IP++ G+L  LR + L  N L
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454
Query: 408 TXXXXXXXXXXXX-------------------XXCKSLTYIGLSNNPLDGILPRMSMGNL 448
                                             C +L +I LSNN L G +P+  +G L
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-IGRL 513
Query: 449 SHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDN 508
             +L    +S  + SG  P E+G+  +LI + L  N  NG+IP            +    
Sbjct: 514 -ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 509 KLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW-- 566
           K    I +D  +     E   +GN L       F  + S     L +    +I   ++  
Sbjct: 573 KRYVYIKNDGMK----KECHGAGNLLE------FQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 567 -------NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
                  N   M++L+ S N  +G +P +IG++  L  ++   N+ S  IP  +G L  L
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 620 QYLFLGYNRLQGSISESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKG 679
             L L  N+L G I ++                           L+ L ++DLS N L G
Sbjct: 683 NILDLSSNKLDGRIPQAM------------------------SALTMLTEIDLSNNNLSG 718
Query: 680 EIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTS 715
            IP+ G F  F    F  N  LCG P   +P C  S
Sbjct: 719 PIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPS 751

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 125/467 (26%), Positives = 186/467 (39%), Gaps = 78/467 (16%)
Query: 232 YLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQ--ELANLTGLEVLKLGKNFLTGE 289
           +L  S + G +   F   A L  + L  ++L G +     L + +GL+ L +  N L  +
Sbjct: 83  FLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--D 139
Query: 290 IPPEIH---NLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQL 346
            P ++     L++L++LDLS N + GA    +                        DV +
Sbjct: 140 FPGKVSGGLKLNSLEVLDLSANSISGA---NVVGWVLSDGCGELKHLAISGNKISGDVDV 196
Query: 347 P---NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLH 403
               NLE L + SNNFS  IP F+ + S L  L++  N  SG                  
Sbjct: 197 SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAI------------ 243
Query: 404 YNYLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVS 463
                              C  L  + +S+N   G +P + +     SL+Y  ++    +
Sbjct: 244 -----------------STCTELKLLNISSNQFVGPIPPLPL----KSLQYLSLAENKFT 282
Query: 464 GGFPKEI-GNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIP-DDICRL 521
           G  P  + G    L G+ L GN   G++P             L  N   G +P D + ++
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 342
Query: 522 TKLYELGLSGNKLSGSIPACFSNL-ASLGTLSLGSNKLTS--IPLTIWNLKGMLY-LNFS 577
             L  L LS N+ SG +P   +NL ASL TL L SN  +   +P    N K  L  L   
Sbjct: 343 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 578 SNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESF 637
           +N FTG +P  + N   L+ +  S N  S  IP+ +G L+ L+ L L  N L+G I +  
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 638 GDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKG 684
                                     +  LE L L FN L GEIP G
Sbjct: 463 ------------------------MYVKTLETLILDFNDLTGEIPSG 485

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 118/278 (42%), Gaps = 42/278 (15%)
Query: 423 CKSLTYIGLSNNPLDGILPRMSMGNLS-HSLEYFDMSYCNVSGG------FPKEIGNLTN 475
           C  L ++ +S+N LD   P    G L  +SLE  D+S  ++SG            G L +
Sbjct: 125 CSGLKFLNVSSNTLD--FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 182
Query: 476 LIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS 535
           L    + GNK++G + ++           +  N     IP  +   + L  L +SGNKLS
Sbjct: 183 LA---ISGNKISGDVDVSRCVNLEFL--DVSSNNFSTGIPF-LGDCSALQHLDISGNKLS 236
Query: 536 GSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI-GNLKV 594
           G      S    L  L++ SN+    P+    LK + YL+ + N FTG +P  + G    
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVG-PIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 595 LIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDXXXXXXXXXXXXXXX 654
           L G+D S N+F   +P   G  + L+ L L  N   G +                     
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP-------------------- 335
Query: 655 XXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSA 692
                   K+  L+ LDLSFN+  GE+P+  S  N SA
Sbjct: 336 ---MDTLLKMRGLKVLDLSFNEFSGELPE--SLTNLSA 368

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  164 bits (416), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 143/434 (32%), Positives = 197/434 (45%), Gaps = 49/434 (11%)
Query: 115 NRLSGSIP-SAIFTLYTLKYVNFRGNQLSGAFPSFIFN-KSSLQHLDFSYNALSGEIPAN 172
           N  SG +P   +  +  LK ++   N+ SG  P  + N  +SL  LD S N  SG I  N
Sbjct: 325 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 384
Query: 173 ICSNLP-FLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEIGNLTKLKEL 231
           +C N    L+ + L  N F G+IP  LSNC  L           G IP  +G+L+KL++L
Sbjct: 385 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 444
Query: 232 YLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIP 291
            L  + L+GEIP+E   +  LE + L  ++L GEIP  L+N T L  + L  N LTGEIP
Sbjct: 445 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 504
Query: 292 PEIHNLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLPNLEE 351
             I  L NL +L LS+N   G +PA                        + D +  +L  
Sbjct: 505 KWIGRLENLAILKLSNNSFSGNIPAE-----------------------LGDCR--SLIW 539
Query: 352 LRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTXXX 411
           L L +N F+GTIP  +F               SG I   F  +   R + +  + +    
Sbjct: 540 LDLNTNLFNGTIPAAMFKQ-------------SGKIAANF--IAGKRYVYIKNDGMKKEC 584
Query: 412 XXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLS------HSLEYFDMSYCNVSGG 465
                       +S     LS      I  R+  G+ S       S+ + DMSY  +SG 
Sbjct: 585 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 644
Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICRLTKLY 525
            PKEIG++  L  + LG N ++GSIP             L  NKL+G IP  +  LT L 
Sbjct: 645 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 704
Query: 526 ELGLSGNKLSGSIP 539
           E+ LS N LSG IP
Sbjct: 705 EIDLSNNNLSGPIP 718

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  150 bits (378), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 182/645 (28%), Positives = 267/645 (41%), Gaps = 112/645 (17%)
Query: 115 NRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANI- 173
           N++SG +   +     L++++   N  S   P F+ + S+LQHLD S N LSG+    I 
Sbjct: 185 NKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAIS 241
Query: 174 -CSNLPFLESISLSQNMFHGRIPSALSNCKYLEXXXXXXXXXXGAIPKEI-GNLTKLKEL 231
            C+ L  L   ++S N F G IP      K L+          G IP  + G    L  L
Sbjct: 242 TCTELKLL---NISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 296
Query: 232 YLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEI 290
            L  +   G +P  FG+ + LE +AL  +N  GE+P + L  + GL+VL L  N  +GE+
Sbjct: 297 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 356
Query: 291 PPEIHNLH-NLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLPN- 348
           P  + NL  +L  LDLS N   G +   +                          Q P  
Sbjct: 357 PESLTNLSASLLTLDLSSNNFSGPILPNL-------------------------CQNPKN 391
Query: 349 -LEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYL 407
            L+EL L +N F+G IP  + N S+L  L L  N  SG IP++ G+L  LR + L  N L
Sbjct: 392 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 451
Query: 408 TXXXXXXXXXXXX-------------------XXCKSLTYIGLSNNPLDGILPRMSMGNL 448
                                             C +L +I LSNN L G +P+  +G L
Sbjct: 452 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-IGRL 510
Query: 449 SHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDN 508
             +L    +S  + SG  P E+G+  +LI + L  N  NG+IP            +    
Sbjct: 511 -ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 569
Query: 509 KLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW-- 566
           K    I +D  +     E   +GN L       F  + S     L +    +I   ++  
Sbjct: 570 KRYVYIKNDGMK----KECHGAGNLLE------FQGIRSEQLNRLSTRNPCNITSRVYGG 619
Query: 567 -------NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
                  N   M++L+ S N  +G +P +IG++  L  ++   N+ S  IP  +G L  L
Sbjct: 620 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 679
Query: 620 QYLFLGYNRLQGSISESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKG 679
             L L  N+L G I ++                           L+ L ++DLS N L G
Sbjct: 680 NILDLSSNKLDGRIPQAM------------------------SALTMLTEIDLSNNNLSG 715
Query: 680 EIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTS-----IHHK 719
            IP+ G F  F    F  N  LCG P   +P C  S      HH+
Sbjct: 716 PIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGYAHHQ 757

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 125/467 (26%), Positives = 186/467 (39%), Gaps = 78/467 (16%)
Query: 232 YLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQ--ELANLTGLEVLKLGKNFLTGE 289
           +L  S + G +   F   A L  + L  ++L G +     L + +GL+ L +  N L  +
Sbjct: 80  FLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--D 136
Query: 290 IPPEIH---NLHNLKLLDLSHNKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQL 346
            P ++     L++L++LDLS N + GA    +                        DV +
Sbjct: 137 FPGKVSGGLKLNSLEVLDLSANSISGA---NVVGWVLSDGCGELKHLAISGNKISGDVDV 193
Query: 347 P---NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLH 403
               NLE L + SNNFS  IP F+ + S L  L++  N  SG                  
Sbjct: 194 SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAI------------ 240
Query: 404 YNYLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVS 463
                              C  L  + +S+N   G +P + +     SL+Y  ++    +
Sbjct: 241 -----------------STCTELKLLNISSNQFVGPIPPLPL----KSLQYLSLAENKFT 279
Query: 464 GGFPKEI-GNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIP-DDICRL 521
           G  P  + G    L G+ L GN   G++P             L  N   G +P D + ++
Sbjct: 280 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM 339
Query: 522 TKLYELGLSGNKLSGSIPACFSNL-ASLGTLSLGSNKLTS--IPLTIWNLKGMLY-LNFS 577
             L  L LS N+ SG +P   +NL ASL TL L SN  +   +P    N K  L  L   
Sbjct: 340 RGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 399
Query: 578 SNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESF 637
           +N FTG +P  + N   L+ +  S N  S  IP+ +G L+ L+ L L  N L+G I +  
Sbjct: 400 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 459
Query: 638 GDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKG 684
                                     +  LE L L FN L GEIP G
Sbjct: 460 ------------------------MYVKTLETLILDFNDLTGEIPSG 482

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 118/278 (42%), Gaps = 42/278 (15%)
Query: 423 CKSLTYIGLSNNPLDGILPRMSMGNLS-HSLEYFDMSYCNVSGG------FPKEIGNLTN 475
           C  L ++ +S+N LD   P    G L  +SLE  D+S  ++SG            G L +
Sbjct: 122 CSGLKFLNVSSNTLD--FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH 179
Query: 476 LIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS 535
           L    + GNK++G + ++           +  N     IP  +   + L  L +SGNKLS
Sbjct: 180 LA---ISGNKISGDVDVSRCVNLEFL--DVSSNNFSTGIPF-LGDCSALQHLDISGNKLS 233
Query: 536 GSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI-GNLKV 594
           G      S    L  L++ SN+    P+    LK + YL+ + N FTG +P  + G    
Sbjct: 234 GDFSRAISTCTELKLLNISSNQFVG-PIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDT 292
Query: 595 LIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDXXXXXXXXXXXXXXX 654
           L G+D S N+F   +P   G  + L+ L L  N   G +                     
Sbjct: 293 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP-------------------- 332
Query: 655 XXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSA 692
                   K+  L+ LDLSFN+  GE+P+  S  N SA
Sbjct: 333 ---MDTLLKMRGLKVLDLSFNEFSGELPE--SLTNLSA 365

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  116 bits (290), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 71/192 (36%), Positives = 104/192 (54%), Gaps = 5/192 (2%)
Query: 764 IATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFK-S 822
           +   +RFS  EL  A++ FS  N++GRGGFG VYK R+ +G  VAVK    +  +  +  
Sbjct: 22  LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ 81
Query: 823 FDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY---SSNYILDIFQR 879
           F  E EM+    HRNL+++   C T   + L+  YM +GS+   L     S   LD  +R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
             I +  A  L YLH      +IH D+K +N+LLD+   A + DFG+AKL+  +D  +  
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 201
Query: 940 TQTLATIGYMAP 951
                TIG++AP
Sbjct: 202 A-VRGTIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Composition-based stats.
 Identities = 69/188 (36%), Positives = 101/188 (53%), Gaps = 5/188 (2%)
Query: 768 RRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFK-SFDVE 826
           +RFS  EL  A++ F   N++GRGGFG VYK R+ +G  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY---SSNYILDIFQRLNIM 883
            EM+    HRNL+++   C T   + L+  YM +GS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
           +  A  L YLH      +IH D+K +N+LLD+   A + DFG+AKL+  +D  +      
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VR 196
Query: 944 ATIGYMAP 951
             IG++AP
Sbjct: 197 GXIGHIAP 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/189 (35%), Positives = 100/189 (52%), Gaps = 6/189 (3%)
Query: 769 RFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECE 828
           R   ++L  ATN F    LIG G FG VYK  + +G +VA+K    +  +  + F+ E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN---YILDIFQRLNIMVD 885
            +   RH +L+ +I  C       LI +YM +G+L++ LY S+     +   QRL I + 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
            A  L YLH   +  +IH D+K  N+LLD+N V  ++DFGI+K     DQ+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 946 IGYMAPGLF 954
           +GY+ P  F
Sbjct: 205 LGYIDPEYF 213

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 93/287 (32%), Positives = 131/287 (45%), Gaps = 18/287 (6%)
Query: 39  DQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVTCDV--HSHRVKVLNISHLNLT 94
           D+ ALL +K  +  +PT     +W  +T  CN  W GV CD    ++RV  L++S LNL 
Sbjct: 7   DKQALLQIKKDL-GNPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 95  GTIPXXXXXXXXXXXX---XXGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFN 151
              P                 G N L G IP AI  L  L Y+      +SGA P F+  
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 152 KSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL-SNCKYLEXXXXX 210
             +L  LDFSYNALSG +P +I S+LP L  I+   N   G IP +  S  K        
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 211 XXXXXGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE- 269
                G IP    NL  L  + L  + L+G+    FG+    + + L  ++L  ++ +  
Sbjct: 183 RNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 270 -LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVP 315
              NL GL+   L  N + G +P  +  L  L  L++S N L G +P
Sbjct: 242 LSKNLNGLD---LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 114/254 (44%), Gaps = 31/254 (12%)
Query: 461 NVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPDDICR 520
           N+ G  P  I  LT L  +Y+    ++G+IP                N L G +P  I  
Sbjct: 88  NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 521 LTKLYELGLSGNKLSGSIPACFSNLASLGT-LSLGSNKLT-SIPLTIWNLKGMLYLNFSS 578
           L  L  +   GN++SG+IP  + + + L T +++  N+LT  IP T  NL  + +++ S 
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSR 206
Query: 579 NFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFG 638
           N   G   +  G+ K    I  + N+ +  +  V G   NL  L L  NR+ G++ +   
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGL- 264
Query: 639 DXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGN 698
                                   +L +L  L++SFN L GEIP+GG+   F   ++  N
Sbjct: 265 -----------------------TQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 699 ELLCGSPNLQVPPC 712
           + LCGSP   +P C
Sbjct: 302 KCLCGSP---LPAC 312

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/189 (34%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 769 RFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECE 828
           R   ++L  ATN F    LIG G FG VYK  + +G +VA+K    +  +  + F+ E E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN---YILDIFQRLNIMVD 885
            +   RH +L+ +I  C       LI +YM +G+L++ LY S+     +   QRL I + 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
            A  L YLH   +  +IH D+K  N+LLD+N V  ++DFGI+K      Q+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 946 IGYMAPGLF 954
           +GY+ P  F
Sbjct: 205 LGYIDPEYF 213

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 16/194 (8%)
Query: 770 FSYLELCRATNRFSEN------NLIGRGGFGSVYKARIGEGMEVAVK----VFDLQCGRA 819
           FS+ EL   TN F E       N +G GGFG VYK  +     VAVK    + D+     
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 73
Query: 820 FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--LDIF 877
            + FD E ++M   +H NL++++   S  +   L+  YMP+GSL   L   +    L   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
            R  I    A  + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      Q++
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 938 TQTQTLATIGYMAP 951
             ++ + T  YMAP
Sbjct: 191 MXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 770 FSYLELCRATNRFSEN------NLIGRGGFGSVYKARIGEGMEVAVK----VFDLQCGRA 819
           FS+ EL   TN F E       N +G GGFG VYK  +     VAVK    + D+     
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 73
Query: 820 FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--LDIF 877
            + FD E ++M   +H NL++++   S  +   L+  YMP+GSL   L   +    L   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
            R  I    A  + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      Q++
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 938 TQTQTLATIGYMAP 951
              + + T  YMAP
Sbjct: 191 MXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 94/194 (48%), Gaps = 16/194 (8%)
Query: 770 FSYLELCRATNRFSEN------NLIGRGGFGSVYKARIGEGMEVAVK----VFDLQCGRA 819
           FS+ EL   TN F E       N +G GGFG VYK  +     VAVK    + D+     
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 67
Query: 820 FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--LDIF 877
            + FD E ++M   +H NL++++   S  +   L+  YMP+GSL   L   +    L   
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
            R  I    A  + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      Q +
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 938 TQTQTLATIGYMAP 951
              + + T  YMAP
Sbjct: 185 MXXRIVGTTAYMAP 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/194 (31%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 770 FSYLELCRATNRFSEN------NLIGRGGFGSVYKARIGEGMEVAVK----VFDLQCGRA 819
           FS+ EL   TN F E       N  G GGFG VYK  +     VAVK    + D+     
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 64
Query: 820 FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--LDIF 877
            + FD E ++    +H NL++++   S  +   L+  Y P+GSL   L   +    L   
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
            R  I    A  + +LH  +    IH D+K +N+LLD+   A +SDFG+A+      Q +
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 938 TQTQTLATIGYMAP 951
             ++ + T  Y AP
Sbjct: 182 XXSRIVGTTAYXAP 195

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 50/147 (34%), Positives = 81/147 (55%), Gaps = 8/147 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG G FG+V++A    G +VAVK+    D    R    F  E  +MK +RH N++  + +
Sbjct: 45  IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHPNIVLFMGA 102
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            +     +++ EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + P++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKL 929
           H DLK  N+L+D      + DFG+++L
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 10/173 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG G FG+V++A    G +VAVK+    D    R    F  E  +MK +RH N++  + +
Sbjct: 45  IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHPNIVLFMGA 102
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSS--NYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            +     +++ EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + P++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
           H +LK  N+L+D      + DFG+++L       ++      T  +MAP +  
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLR 212

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 19/179 (10%)
Query: 785 NNLIGRGGFGSVYKARIGEGMEVAVKVF----DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
             +IG GGFG VY+A    G EVAVK      D    +  ++   E ++   ++H N+I 
Sbjct: 12  EEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +   C  E    L++E+   G L + L       DI   +N  V +A  + YLH     P
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVP 128
Query: 901 VIHCDLKPSNVLLDD--------NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +IH DLK SN+L+          N +  ++DFG+A+    E    T+        +MAP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAP 183

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 129 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 171

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 127 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 169

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 126 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 168

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 128 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 170

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 121 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 163

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 781 RFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVECEMM 830
           +F E +L     +G+G FGSV   R        G  VAVK          + F+ E E++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 831 KSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 781 RFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVECEMM 830
           +F E +L     +G+G FGSV   R        G  VAVK          + F+ E E++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 831 KSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+E++P+GSL + L      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 781 RFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVECEMM 830
           +F E +L     +G+G FGSV   R        G  VAVK          + F+ E E++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 831 KSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 781 RFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVECEMM 830
           +F E +L     +G+G FGSV   R        G  VAVK          + F+ E E++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 831 KSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 86/172 (50%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDL--QCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+  +       F++F  E  +++  RH N++  +   
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           + +   A++ ++    SL K L+       +FQ ++I    A  ++YLH   +  +IH D
Sbjct: 102 TKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRD 157
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           +K +N+ L + +   + DFG+A +      S    Q   ++ +MAP +  ++
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 781 RFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVECEMM 830
           +F E +L     +G+G FGSV   R        G  VAVK          + F+ E E++
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 831 KSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +EYL    +   IH DL   N+L+++     + DFG+ K+L
Sbjct: 124 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 162

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 777 RATNRFSENNL-----IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCGRAFKSFDVE 826
           R   +F E +L     +G+G FGSV   R        G  VAVK          + F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E++KS++H N++K    C +   +   LI+EY+P+GSL   L      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            +   +EYL    +   IH +L   N+L+++     + DFG+ K+L
Sbjct: 123 QICKGMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG+A++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 785 NNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSI-RHRNLI 839
            ++IG G FG V KARI   G  M+ A+K       +   + F  E E++  +  H N+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------------LDIFQRLNIMV 884
            ++ +C    +  L +EY PHG+L   L  S  +               L   Q L+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T    
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 945 TIGYMAPGLFHVKYILFVVNF-LTSYSFLMIFI 976
            + +MA  +  + Y ++  N  + SY  L+  I
Sbjct: 204 PVRWMA--IESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 5/167 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG G FG V+        +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    L+ E+M HG L   L +   +      L + +DV   + YL     A VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             N L+ +N V  +SDFG+ + ++ +DQ  + T T   + + +P +F
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF 176

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 26/186 (13%)
Query: 785 NNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSI-RHRNLI 839
            ++IG G FG V KARI   G  M+ A+K       +   + F  E E++  +  H N+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------------LDIFQRLNIMV 884
            ++ +C    +  L +EY PHG+L   L  S  +               L   Q L+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +T    
Sbjct: 140 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 945 TIGYMA 950
            + +MA
Sbjct: 194 PVRWMA 199

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 5/167 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG G FG V+        +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    L+ E+M HG L   L +   +      L + +DV   + YL     A VIH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             N L+ +N V  +SDFG+ + ++ +DQ  + T T   + + +P +F
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF 174

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 5/167 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG G FG V+        +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    L+ E+M HG L   L +   +      L + +DV   + YL     A VIH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             N L+ +N V  +SDFG+ + ++ +DQ  + T T   + + +P +F
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF 179

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 5/167 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG G FG V+        +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    L+ E+M HG L   L +   +      L + +DV   + YL     A VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             N L+ +N V  +SDFG+ + ++ +DQ  + T T   + + +P +F
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF 176

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF-------DLQCGRAFKSFDVECEM 829
           A N       IG+GGFG V+K R + +   VA+K         + +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           M ++ H N++K+           +++E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 890 LEYLHFGYSAPVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLIGEDQSI-TQTQTL 943
           +EY+    + P++H DL+  N+    LD+N  + A ++DFG+++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVSGLL 187
Query: 944 ATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF 975
               +MAP     +   +     T YSF MI 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADT-YSFAMIL 218

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 5/167 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG G FG V+        +VA+K    +   +   F  E E+M  + H  L+++   C  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    L+ E+M HG L   L +   +      L + +DV   + YL     A VIH DL 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 150
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             N L+ +N V  +SDFG+ + ++ +DQ  + T T   + + +P +F
Sbjct: 151 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF 196

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 11/179 (6%)
Query: 780 NRFSENNLIGRGGFGSVY--KARIGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIR 834
           +R     +IG G  G V   + R+    +V V +  L+ G   R  + F  E  +M    
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H N+I++    +      ++ EYM +GSL+  L + +    I Q + ++  V   + YL 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 895 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQTLATIGYMAP 951
             GY    +H DL   NVL+D N+V  +SDFG++++L  + D + T T     I + AP
Sbjct: 169 DLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 11/179 (6%)
Query: 780 NRFSENNLIGRGGFGSVY--KARIGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIR 834
           +R     +IG G  G V   + R+    +V V +  L+ G   R  + F  E  +M    
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H N+I++    +      ++ EYM +GSL+  L + +    I Q + ++  V   + YL 
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 895 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQTLATIGYMAP 951
             GY    +H DL   NVL+D N+V  +SDFG++++L  + D + T T     I + AP
Sbjct: 169 DLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 29  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 85
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 86  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 145
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++
Sbjct: 146 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 201
Query: 937 ITQTQ 941
              T+
Sbjct: 202 AYTTR 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 5/167 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG G FG V+        +VA+K    +   + + F  E E+M  + H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    L+ E+M HG L   L +   +      L + +DV   + YL     A VIH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             N L+ +N V  +SDFG+ + ++ +DQ  + T T   + + +P +F
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVF 177

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 89/170 (52%), Gaps = 11/170 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG---RAFKSFDVECEMMKS 832
           ATN  S + ++G G FG V   R+      E++V +  L+ G   +  + F  E  +M  
Sbjct: 32  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
             H N+I++    +  +   ++ EYM +GSL+  L   +    + Q + ++  +A+ ++Y
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 893 L-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 151 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 196

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 5/168 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VAVK+   +   +   F  E + M  + H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           E    ++ EY+ +G L   L S    L+  Q L +  DV   + +L    S   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
             N L+D ++   +SDFG+ + ++ +DQ ++   T   + + AP +FH
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFH 178

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 93/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG+ ++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 783 SENNLIGRGGFGSVYKARIGEG---MEVAVKVFDLQCGRAFKS---FDVECEMMKSIRHR 836
           +   +IG G FG VYK  +       EV V +  L+ G   K    F  E  +M    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL-HF 895
           N+I++    S  +   +I EYM +G+L+K L   +    + Q + ++  +A  ++YL + 
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
            Y    +H DL   N+L++ N+V  +SDFG++++L  + ++   T
Sbjct: 167 NY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 96/187 (51%), Gaps = 16/187 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 333 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVKYI 959
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP     G F +K  
Sbjct: 389 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 960 LFVVNFL 966
           ++    L
Sbjct: 447 VWSFGIL 453

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF-------DLQCGRAFKSFDVECEM 829
           A N       IG+GGFG V+K R + +   VA+K         + +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           M ++ H N++K+           +++E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 890 LEYLHFGYSAPVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLIGEDQSI-TQTQTL 943
           +EY+    + P++H DL+  N+    LD+N  + A ++DFG ++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVSGLL 187
Query: 944 ATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF 975
               +MAP     +   +     T YSF MI 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADT-YSFAMIL 218

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 89/170 (52%), Gaps = 11/170 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG---RAFKSFDVECEMMKS 832
           ATN  S + ++G G FG V   R+      E++V +  L+ G   +  + F  E  +M  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
             H N+I++    +  +   ++ EYM +GSL+  L   +    + Q + ++  +A+ ++Y
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 893 L-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 134 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 29/213 (13%)
Query: 785 NNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSI-RHRNLI 839
            ++IG G FG V KARI   G  M+ A+K       +   + F  E E++  +  H N+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------------LDIFQRLNIMV 884
            ++ +C    +  L +EY PHG+L   L  S  +               L   Q L+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           DVA  ++YL        IH +L   N+L+ +N VA ++DFG+++   G++  + +T    
Sbjct: 147 DVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 945 TIGYMAPGLFHVKYILFVVNF-LTSYSFLMIFI 976
            + +MA  +  + Y ++  N  + SY  L+  I
Sbjct: 201 PVRWMA--IESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKV----FDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
            ++G+G FG   K    E  EV V      FD +  R F     E ++M+ + H N++K 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPNVLKF 72
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
           I     ++    I EY+  G+L   + S +      QR++   D+A+ + YLH   S  +
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
           IH DL   N L+ +N    ++DFG+A+L++ E    TQ + L ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSL 171

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 16/178 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 250 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP     G F +K
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 95/189 (50%), Gaps = 14/189 (7%)
Query: 773 LELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFD-------V 825
           L++     R+ + + +G G F +VYKAR     ++ V +  ++ G   ++ D        
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI-VAIKKIKLGHRSEAKDGINRTALR 61
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E ++++ + H N+I ++ +   +   +L+ ++M    LE  +  ++ +L        M+ 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
               LEYLH  +   ++H DLKP+N+LLD+N V  L+DFG+AK     +++      + T
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVT 175
Query: 946 IGYMAPGLF 954
             Y AP L 
Sbjct: 176 RWYRAPELL 184

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 16/178 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 250 -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP     G F +K
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ EYM +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   G+    +H DL   N+L++ N+V  +SDFG++++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGF----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF-------DLQCGRAFKSFDVECEM 829
           A N       IG+GGFG V+K R + +   VA+K         + +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           M ++ H N++K+           +++E++P G L   L    + +    +L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 890 LEYLHFGYSAPVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLIGEDQSI-TQTQTL 943
           +EY+    + P++H DL+  N+    LD+N  + A ++DF +++      QS+ + +  L
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVSGLL 187
Query: 944 ATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF 975
               +MAP     +   +     T YSF MI 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADT-YSFAMIL 218

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 89/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 76
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L++S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 77  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L ++    + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 16/178 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 250 -EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q     I + AP     G F +K
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 47/149 (31%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 788 IGRGGFGSVY-----KARIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKV 841
           +G G FG V          G G  VAVK     CG   +S +  E ++++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 842 ISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C  +  K+L  ++EY+P GSL    Y   + + + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             IH +L   NVLLD++ +  + DFG+AK
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 13/188 (6%)
Query: 777 RATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVF-DLQCGRAFKSFDV-ECEMMKSI 833
           ++  ++    L+G G +G V K R  + G  VA+K F +    +  K   + E +++K +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEK-SLYSSNYILDIFQRLNIMVDVATTLEY 892
           RH NL+ ++  C  ++   L+ E++ H  L+   L+ +     + Q+    +     +  
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----ING 136
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPG 952
           + F +S  +IH D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP 
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPE 194
Query: 953 LF--HVKY 958
           L    VKY
Sbjct: 195 LLVGDVKY 202

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 24/185 (12%)
Query: 788 IGRGGFGSVYKAR------IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYS---------------SNYILDIFQRLNIMVDV 886
              C   +   ++ EYM HG L K L +               +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
           A+ + YL    S   +H DL   N L+  N++  + DFG+++ +   D       T+  I
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 947 GYMAP 951
            +M P
Sbjct: 200 RWMPP 204

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 115/238 (48%), Gaps = 35/238 (14%)
Query: 760 NMPPIATCRR---FSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQ 815
           +MPP+        F + E+ RA         IG+G FG V   +  +  ++ A+K  + Q
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 816 -CGRAFKSFDV--ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNY 872
            C    +  +V  E ++M+ + H  L+ +  S   EE   ++++ +  G L   L  + +
Sbjct: 52  KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH 111
Query: 873 ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 932
             +   +L I  ++   L+YL    +  +IH D+KP N+LLD++   H++DF IA +L  
Sbjct: 112 FKEETVKLFI-CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 933 EDQSITQTQTLA-TIGYMAPGLFHVKY---ILFVVNF----LTSYSFLMIFIGRGNYY 982
           E    TQ  T+A T  YMAP +F  +      F V++    +T+Y  L    GR  Y+
Sbjct: 168 E----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR---GRRPYH 218

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 74  -EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQ 163

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 787 LIGRGGFGSVYKA-RIGEG----MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIK 840
           ++G G FG+VYK   + EG    + VA+K+ +   G +A   F  E  +M S+ H +L++
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           ++  C +   + L+ + MPHG L + ++     +     LN  V +A  + YL       
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 160
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           ++H DL   NVL+       ++DFG+A+LL G+++          I +MA    H +
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   +++EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEXTARQ 173

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   +++EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 173

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 17/149 (11%)
Query: 792 GFGSVYKARIGE----GMEVAVKVFDLQCGRAFKSFDV------ECEMMKSIRHRNLIKV 841
           G G+  K +IGE    G +VAVK+ + Q     +S DV      E + +K  RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
               ST     +++EY+  G L   +     + ++  R  +   + + ++Y H      V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           +H DLKP NVLLD +M A ++DFG++ ++
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 93/185 (50%), Gaps = 13/185 (7%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ E M +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
           Q + ++  +A+ ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++
Sbjct: 148 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 937 ITQTQ 941
              T+
Sbjct: 204 AYTTR 208

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK IRH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 173

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY     +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    ++ EYMP+G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N V  ++DFG+++L+ G+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGD 183

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 179
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 180 EAINYGTFTIK 190

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 10  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 66
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 67  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 125
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 126 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 180
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 181 EAINYGTFTIK 191

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 786 NLIGRGGFGSVYKA-RIGEG----MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLI 839
            ++G G FG+VYK   + EG    + VA+K+ +   G +A   F  E  +M S+ H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           +++  C +   + L+ + MPHG L + ++     +     LN  V +A  + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYI 959
            ++H DL   NVL+       ++DFG+A+LL G+++          I +MA    H +  
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 960 LF---VVNFLTSYSFLMIFIGR 978
                V ++  +   LM F G+
Sbjct: 197 THQSDVWSYGVTIWELMTFGGK 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 11  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 67
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 68  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 126
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 127 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 181
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 182 EAINYGTFTIK 192

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 179
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 180 EAINYGTFTIK 190

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 18  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 74
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 75  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 133
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 134 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 188
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 189 EAINYGTFTIK 199

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 17  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 73
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 74  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 132
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 133 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 187
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 188 EAINYGTFTIK 198

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 71
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 72  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 131 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWTAP 185
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 186 EAINYGTFTIK 196

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 15  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 71
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 72  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 130
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 131 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 185
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 186 EAINYGTFTIK 196

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 19  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 75
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 76  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 134
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 135 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 189
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 190 EAINYGTFTIK 200

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 179
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 180 EAINYGTFTIK 190

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 4   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 60
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 61  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 119
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 120 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 174
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 175 EAINYGTFTIK 185

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 56/191 (29%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 14  EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 70
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 71  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 129
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 130 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 184
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 185 EAINYGTFTIK 195

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 77
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 15/180 (8%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           ++   +IG G FG V++A++ E  EVA+K   LQ  R FK  + E ++M+ ++H N++ +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FK--NRELQIMRIVKHPNVVDL 97
Query: 842 IS------SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
            +          E F  L+LEY+P      S + +  +      L I + +   L  L +
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAY 156
Query: 896 GYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
            +S  + H D+KP N+LLD  + V  L DFG AK+LI  + +++    + +  Y AP L 
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYYRAPELI 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 77  -EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 133 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 166

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 73/144 (50%), Gaps = 9/144 (6%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG+G F  V  AR I  G EVAVK+ D   L      K F  E  +MK + H N++K+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 73
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
              TE+   L++EY   G +   L +  ++ +   R      + + ++Y H  +   ++H
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVH 129
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIA 927
            DLK  N+LLD +M   ++DFG +
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFS 153

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 88/170 (51%), Gaps = 11/170 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG---RAFKSFDVECEMMKS 832
           ATN  S + ++G G FG V   R+      E++V +  L+ G   +  + F  E  +M  
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
             H N+I++    +  +   ++ E M +GSL+  L   +    + Q + ++  +A+ ++Y
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 893 L-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L   GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 134 LSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 179

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 251 -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +N+L+ +N+V  ++DFG+ +L+  ED   T  Q     I + AP     G F +K
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 788 IGRGGFGSVY-----KARIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKV 841
           +G G FG V          G G  VAVK     CG   +S +  E ++++++ H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 842 ISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C  +  K+L  ++EY+P GSL    Y   + + + Q L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             IH +L   NVLLD++ +  + DFG+AK
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ G+AFK  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQ-GKAFK--NRELQIMRKLDHCNIVR 77
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 951 PGL 953
           P L
Sbjct: 191 PEL 193

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 74
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 100
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ G+AFK  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQ-GKAFK--NRELQIMRKLDHCNIVR 77
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 951 PGL 953
           P L
Sbjct: 191 PEL 193

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 99
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 100 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 88/172 (51%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 88
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L++S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 89  STKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L ++    + DFG+A        S    Q   +I +MAP +  ++
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ G+AFK  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQ-GKAFK--NRELQIMRKLDHCNIVR 77
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 951 PGL 953
           P L
Sbjct: 191 PEL 193

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++  +   
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           +  +  A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 74  TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A +      S    Q   +I +MAP +  ++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 73  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 129 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 162

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 75  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 131 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 164

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 173

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 81  -EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 170

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 173

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + + VAVK        A K F  E E++ +++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSN------------YILDIFQRLNIMVDVATT 889
              C   +   ++ EYM HG L K L +                L   Q L+I   +A  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D       T+  I +M
Sbjct: 141 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 950 AP 951
            P
Sbjct: 198 PP 199

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 17/149 (11%)
Query: 792 GFGSVYKARIGE----GMEVAVKVFDLQCGRAFKSFDV------ECEMMKSIRHRNLIKV 841
           G G+  K +IGE    G +VAVK+ + Q     +S DV      E + +K  RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
               ST     +++EY+  G L   +     + ++  R  +   + + ++Y H      V
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH---RHMV 132
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           +H DLKP NVLLD +M A ++DFG++ ++
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMM 161

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 788 IGRGGFGSVY-----KARIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKV 841
           +G G FG V          G G  VAVK     CG   +S +  E E+++++ H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C  +  K+  L++EY+P GSL    Y   + + + Q L     +   + YLH   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             IH  L   NVLLD++ +  + DFG+AK
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 13/149 (8%)
Query: 788 IGRGGFGSVY-----KARIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKV 841
           +G G FG V          G G  VAVK     CG   +S +  E E+++++ H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C  +  K+  L++EY+P GSL    Y   + + + Q L     +   + YLH   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             IH  L   NVLLD++ +  + DFG+AK
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 91/184 (49%), Gaps = 11/184 (5%)
Query: 763 PIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG--- 817
           P  T   F+  +   ATN  S + ++G G FG V   R+      E++V +  L+ G   
Sbjct: 31  PTQTVHEFA--KELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF 877
           +  + F  E  +M    H N+I++    +  +   ++ E M +GSL+  L   +    + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI 147
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
           Q + ++  +A+ ++YL        +H DL   N+L++ N+V  +SDFG++++L  + ++ 
Sbjct: 148 QLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 938 TQTQ 941
             T+
Sbjct: 205 YTTR 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 87/172 (50%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           +  +  A++ ++    SL   L++S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L ++    + DFG+A        S    Q   +I +MAP +  ++
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 847 TEEFKALILEYMPHGSLEKSLY-SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L   +   L + Q +++   +A+ + Y+        +H D
Sbjct: 81  -EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI--EDNEWTARQ 170

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 152
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 956 VK 957
            K
Sbjct: 211 EK 212

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 956 VK 957
            K
Sbjct: 208 EK 209

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 956 VK 957
            K
Sbjct: 209 EK 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 46/156 (29%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   +++EYM  G L   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 173

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+ + +     K   V     E ++M  + H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 66
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 124
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 125 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 956 VK 957
            K
Sbjct: 183 EK 184

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I+E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+ + +     K   V     E ++M  + H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 67
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 125
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 956 VK 957
            K
Sbjct: 184 EK 185

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 956 VK 957
            K
Sbjct: 205 EK 206

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I+E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+ + +     K   V     E ++M  + H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 68
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 126
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 127 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 956 VK 957
            K
Sbjct: 185 EK 186

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 87/172 (50%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 72
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A        S    Q   +I +MAP +  ++
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 956 VK 957
            K
Sbjct: 208 EK 209

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+ + +     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 956 VK 957
            K
Sbjct: 206 EK 207

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 146
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 956 VK 957
            K
Sbjct: 205 EK 206

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 956 VK 957
            K
Sbjct: 206 EK 207

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 956 VK 957
            K
Sbjct: 208 EK 209

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 29/197 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 943 LATIGYMAP-GLFHVKY 958
              + +MAP  LF   Y
Sbjct: 220 RLPVKWMAPEALFDRVY 236

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+ + +     K   V     E ++M  + H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 69
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 127
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 128 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 956 VK 957
            K
Sbjct: 186 EK 187

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 12/181 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVA---VKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
           F     IGRG F  VY+A  + +G+ VA   V++FDL   +A      E +++K + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLE---KSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           +IK  +S   +    ++LE    G L    K       ++         V + + LE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
              S  V+H D+KP+NV +    V  L D G+ +      ++      + T  YM+P   
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERI 208
Query: 955 H 955
           H
Sbjct: 209 H 209

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 87/172 (50%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 92
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A        S    Q   +I +MAP +  ++
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 150
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 956 VK 957
            K
Sbjct: 209 EK 210

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 11/176 (6%)
Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL---QCGRAFKSFDVECEMMKSIRHR 836
           R+   + +G GG  +VY A      ++VA+K   +   +     K F+ E      + H+
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           N++ +I     ++   L++EY+   +L + +  S+  L +   +N    +   +++ H  
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH-- 128
Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT-QTLATIGYMAP 951
               ++H D+KP N+L+D N    + DFGIAK L   + S+TQT   L T+ Y +P
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSP 181

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 956 VK 957
            K
Sbjct: 206 EK 207

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 131
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 956 VK 957
            K
Sbjct: 190 EK 191

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 956 VK 957
            K
Sbjct: 208 EK 209

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 956 VK 957
            K
Sbjct: 208 EK 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 149
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 956 VK 957
            K
Sbjct: 208 EK 209

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 87/172 (50%), Gaps = 8/172 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N++ +    
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFMGY 100
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           ST+   A++ ++    SL   L+      ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 101 STKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           LK +N+ L +++   + DFG+A        S    Q   +I +MAP +  ++
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G FG V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 5   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 61
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 62  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 120
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH +L+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 121 IE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWTAP 175
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 176 EAINYGTFTIK 186

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG+G F  V  AR I  G EVAVK+ D   L      K F  E  +MK + H N++K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
              TE+   L++EY   G +   L +   + +   R      + + ++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIA 927
            DLK  N+LLD +M   ++DFG +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG+G F  V  AR I  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             TE+   L++EY   G +   L +   + +   R      + + ++Y H  +   ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 905 DLKPSNVLLDDNMVAHLSDFGIA 927
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG+G F  V  AR I  G EVAVK+ D   L      K F  E  +MK + H N++K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
              TE+   L++EY   G +   L +   + +   R      + + ++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIA 927
            DLK  N+LLD +M   ++DFG +
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS 160

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L  +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LAAANILVGENLVCKVADFGLARLI--EDNEYTARQ 173

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 4/149 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    +I EYM +G L   L    +     Q L +  DV   +EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
             N L++D  V  +SDFG+++ ++ ++++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEET 176

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 13/171 (7%)
Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           ++GRG FG V KA+     +VA+K  + +  R  K+F VE   +  + H N++K+  +C 
Sbjct: 16  VVGRGAFGVVCKAK-WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI--LDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
                 L++EY   GSL   L+ +  +        ++  +  +  + YLH      +IH 
Sbjct: 73  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 905 DLKPSNVLL-DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
           DLKP N+LL     V  + DFG A      D     T    +  +MAP +F
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 176

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 13/171 (7%)
Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           ++GRG FG V KA+     +VA+K  + +  R  K+F VE   +  + H N++K+  +C 
Sbjct: 15  VVGRGAFGVVCKAK-WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI--LDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
                 L++EY   GSL   L+ +  +        ++  +  +  + YLH      +IH 
Sbjct: 72  NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 905 DLKPSNVLL-DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
           DLKP N+LL     V  + DFG A      D     T    +  +MAP +F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVF 175

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 15/178 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+        +VAVK   L+ G  + ++F  E  +MK+++H  L+++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL-NIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   +I EYM  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +NVL+ ++++  ++DFG+A+++  ED   T  +     I + AP     G F +K
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG+G F  V  AR +  G EVAVK+ D       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             TE+   L++EY   G +   L +   + +   R      + + ++Y H  Y   ++H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 905 DLKPSNVLLDDNMVAHLSDFGIA 927
           DLK  N+LLD +M   ++DFG +
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFS 161

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    +I EYM +G L   L    +     Q L +  DV   +EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGED 934
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 55/174 (31%), Positives = 84/174 (48%), Gaps = 17/174 (9%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVF-DLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           IG G +G V+K R  + G  VA+K F + +     K   + E  M+K ++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQR--LNIMVDVAT--TLEYLHFGYSAP 900
              +    L+ EY  H  L +        LD +QR     +V   T  TL+ ++F +   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
            IH D+KP N+L+  + V  L DFG A+LL G   S      +AT  Y +P L 
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELL 174

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I+E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I+E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I+E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +V  AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+      +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 154
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 956 VK 957
            K
Sbjct: 213 EK 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 135
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
            IH DL   N L+ +N +  ++DFG+++L+ G+
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 8/176 (4%)
Query: 781 RFSENN---LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR 836
            + EN    ++G+G +G VY  R +   + +A+K    +  R  +    E  + K ++H+
Sbjct: 6   EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           N+++ + S S   F  + +E +P GSL   L S    L   ++  I       LE L + 
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYL 124
Query: 897 YSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +   ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ YMAP
Sbjct: 125 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 178

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 29/187 (15%)
Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYS--------------SNYILDIFQRLNIMVDVA 887
              C+      ++ EYM HG L + L S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 888 TTLEY---LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
             + Y   LHF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 945 TIGYMAP 951
            I +M P
Sbjct: 223 PIRWMPP 229

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG+G F  V  AR I  G EVAV++ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             TE+   L++EY   G +   L +   + +   R      + + ++Y H  +   ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 905 DLKPSNVLLDDNMVAHLSDFGIA 927
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 46/156 (29%), Positives = 83/156 (53%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG V+         VA+K   L+ G  + ++F  E ++MK +RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  G L   L       L + Q +++   +A+ + Y+        +H D
Sbjct: 84  -EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ +N+V  ++DFG+A+L+  ED   T  Q
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 173

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 780 NRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSI 833
            +F+   ++G+G FGSV +A++    G  ++VAVK+   D+      + F  E   MK  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 834 RHRNLIKVISSCSTEEFKA------LILEYMPHGSLEKSLYSSN-----YILDIFQRLNI 882
            H ++ K++        K       +IL +M HG L   L +S      + L +   +  
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           MVD+A  +EYL    S   IH DL   N +L ++M   ++DFG+++ +   D
Sbjct: 143 MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG+G F  V  AR I  G EVAV++ D       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             TE+   L++EY   G +   L +   + +   R      + + ++Y H  +   ++H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 905 DLKPSNVLLDDNMVAHLSDFGIA 927
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 29/191 (15%)
Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
            LIGRG +G+VYK  + E   VAVKVF     + F + +     +  + H N+ + I   
Sbjct: 19  ELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFI--V 74
Query: 846 STEEFKA-------LILEYMPHGSLEK--SLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
             E   A       L++EY P+GSL K  SL++S+++        +   V   L YLH  
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV----SSCRLAHSVTRGLAYLHTE 130
Query: 897 ------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE------DQSITQTQTLA 944
                 Y   + H DL   NVL+ ++    +SDFG++  L G       ++       + 
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 945 TIGYMAPGLFH 955
           TI YMAP +  
Sbjct: 191 TIRYMAPEVLE 201

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 29/197 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL-----------YSSNYILDIFQRLNIMV-- 884
           +I ++ +C+ +    +I+EY   G+L + L           Y  N + +       +V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 885 --DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 943 LATIGYMAP-GLFHVKY 958
              + +MAP  LF   Y
Sbjct: 220 RLPVKWMAPEALFDRVY 236

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 13/176 (7%)
Query: 785 NNLIGRGGFGSVYKARIGE--GMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLI 839
             +IG G FG V + R+      E  V +  L+ G   R  + F  E  +M    H N+I
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL-HFGYS 898
           ++    +      ++ E+M +G+L+  L  ++    + Q + ++  +A+ + YL    Y 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY- 139
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA---TIGYMAP 951
              +H DL   N+L++ N+V  +SDFG+++ L       T+T +L     I + AP
Sbjct: 140 ---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 756 PNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYK-ARIGEGMEVAVKVFDL 814
           P D  +P  A  + F          ++   ++IGRG    V +      G E AVK+ ++
Sbjct: 79  PED-ELPDWAAAKEF--------YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEV 129
Query: 815 QCGR--------AFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILEYMPHGSL-- 863
              R          ++   E  +++ +  H ++I +I S  +  F  L+ + M  G L  
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189
Query: 864 ---EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 920
              EK   S      I + L         LE + F ++  ++H DLKP N+LLDDNM   
Sbjct: 190 YLTEKVALSEKETRSIMRSL---------LEAVSFLHANNIVHRDLKPENILLDDNMQIR 240
Query: 921 LSDFGIA-KLLIGEDQSITQTQTLATIGYMAPGLF 954
           LSDFG +  L  GE       +   T GY+AP + 
Sbjct: 241 LSDFGFSCHLEPGE----KLRELCGTPGYLAPEIL 271

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 89/176 (50%), Gaps = 8/176 (4%)
Query: 781 RFSENN---LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR 836
            + EN    ++G+G +G VY  R +   + +A+K    +  R  +    E  + K ++H+
Sbjct: 20  EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           N+++ + S S   F  + +E +P GSL   L S    L   ++  I       LE L + 
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYL 138
Query: 897 YSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +   ++H D+K  NVL++  + V  +SDFG +K L G +   T+T T  T+ YMAP
Sbjct: 139 HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAP 192

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 12/182 (6%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRH 835
           F    ++G G F +   AR +    E A+K+  L+     K   V     E ++M  + H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              +K+  +   +E     L Y  +G L K +       +   R     ++ + LEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH- 147
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
                +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P L  
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 956 VK 957
            K
Sbjct: 206 EK 207

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    +I EYM +G L   L    +     Q L +  DV   +EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGED 934
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDE 165

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    +I EYM +G L   L    +     Q L +  DV   +EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGED 934
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDE 158

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    +I EYM +G L   L    +     Q L +  DV   +EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGED 934
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    +I EYM +G L   L    +     Q L +  DV   +EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGED 934
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 4/147 (2%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK 907
           +    +I EYM +G L   L    +     Q L +  DV   +EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 908 PSNVLLDDNMVAHLSDFGIAKLLIGED 934
             N L++D  V  +SDFG+++ ++ ++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 29/187 (15%)
Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYS--------------SNYILDIFQRLNIMVDVA 887
              C+      ++ EYM HG L + L S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 888 TTLEY---LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
             + Y   LHF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 945 TIGYMAP 951
            I +M P
Sbjct: 200 PIRWMPP 206

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 29/187 (15%)
Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYS--------------SNYILDIFQRLNIMVDVA 887
              C+      ++ EYM HG L + L S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 888 TTLEY---LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
             + Y   LHF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 945 TIGYMAP 951
            I +M P
Sbjct: 194 PIRWMPP 200

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 787 LIGRGGFGSVYKARIGE--GMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKV 841
           +IG G FG V + R+      E  V +  L+ G   R  + F  E  +M    H N+I+ 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR- 79
Query: 842 ISSCSTEEFKALIL-EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +    T     +IL E+M +G+L+  L  ++    + Q + ++  +A+ + YL       
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMS 136
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA---TIGYMAP 951
            +H DL   N+L++ N+V  +SDFG+++ L       T T +L     I + AP
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 16/191 (8%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           E+ R T +  E   +G G  G V+        +VAVK    Q   +  +F  E  +MK +
Sbjct: 9   EVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEY 892
           +H+ L++ + +  T+E   +I EYM +GSL   L + + I L I + L++   +A  + +
Sbjct: 66  QHQRLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +        IH DL+ +N+L+ D +   ++DFG+A+L+  ED   T  +     I + AP
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWTAP 179
Query: 952 -----GLFHVK 957
                G F +K
Sbjct: 180 EAINYGTFTIK 190

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 29/197 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 943 LATIGYMAP-GLFHVKY 958
              + +MAP  LF   Y
Sbjct: 266 RLPVKWMAPEALFDRVY 282

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 81/155 (52%), Gaps = 20/155 (12%)
Query: 786 NLIGRGGFGSVYKARIGE----GMEVAVKVFDLQCGRAFKSFDV------ECEMMKSIRH 835
           + +G G FG   K ++G+    G +VAVK+ + Q     +S DV      E + +K  RH
Sbjct: 22  DTLGVGTFG---KVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRH 75
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
            ++IK+    ST     +++EY+  G L   +   N  LD  +   +   + + ++Y H 
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH- 133
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                V+H DLKP NVLLD +M A ++DFG++ ++
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 15/178 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+        +VAVK   L+ G  + ++F  E  +MK+++H  L+++ +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKT--LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL-NIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   +I E+M  GSL   L S      +  +L +    +A  + Y+        IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP-----GLFHVK 957
           L+ +NVL+ ++++  ++DFG+A+++  ED   T  +     I + AP     G F +K
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGD 162

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD 164

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I E+M +G+L   L   N   +     L +   +++ +EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGE 933
           L   N L+ +N +  ++DFG+++L+ G+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGD 169

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 42/161 (26%), Positives = 82/161 (50%), Gaps = 10/161 (6%)
Query: 787 LIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKV 841
           +IG G FG V   R+      E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-FGYSAP 900
               +  +   ++ EYM +GSL+  L  ++    + Q + ++  ++  ++YL   GY   
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY--- 145
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
            +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 185

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 787 LIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR--AFKSFDVECEMMKSIRHRNLIKVISS 844
           LIG+G FG VY  R     EVA+++ D++       K+F  E    +  RH N++  + +
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
           C +    A+I       +L   +  +  +LD+ +   I  ++   + YLH   +  ++H 
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 905 DLKPSNVLLDDNMVAHLSDFGI 926
           DLK  NV  D+  V  ++DFG+
Sbjct: 155 DLKSKNVFYDNGKVV-ITDFGL 175

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 96
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 157 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 209
Query: 951 PGL 953
           P L
Sbjct: 210 PEL 212

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 85
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 146 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 198
Query: 951 PGL 953
           P L
Sbjct: 199 PEL 201

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 53/175 (30%), Positives = 90/175 (51%), Gaps = 17/175 (9%)
Query: 789 GRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISS---- 844
            RG FG V+KA++     VAVK+F +Q  +++++ + E   +  ++H N+++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF-------GY 897
            S +    LI  +   GSL   L ++  ++   +  +I   +A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLIGEDQSITQTQTLATIGYMAP 951
              + H D+K  NVLL +N+ A ++DFG+A K   G+    T  Q + T  YMAP
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAP 202

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG+G F  V  AR I  G EVA+K+ D       + +    E  +MK + H N++K+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             TE+   LI+EY   G +   L +   + +   R      + + ++Y H      ++H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 135
Query: 905 DLKPSNVLLDDNMVAHLSDFGIA 927
           DLK  N+LLD +M   ++DFG +
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS 158

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 44/185 (23%), Positives = 92/185 (49%), Gaps = 19/185 (10%)
Query: 771 SYLELCRATNRFSEN---------NLIGRGGFGSVYKARIG--EGMEVAVKVFDLQCG-- 817
           +Y +  RA ++F++           +IG G FG V   R+      +VAV +  L+ G  
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 818 -RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI 876
            +  + F  E  +M    H N++ +    +  +   +++E+M +G+L+  L   +    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 877 FQRLNIMVDVATTLEYL-HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
            Q + ++  +A  + YL   GY    +H DL   N+L++ N+V  +SDFG+++++  + +
Sbjct: 145 IQLVGMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 936 SITQT 940
           ++  T
Sbjct: 201 AVYTT 205

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 182

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 78
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 139 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 191
Query: 951 PGL 953
           P L
Sbjct: 192 PEL 194

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 89
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 951 PGL 953
           P L
Sbjct: 203 PEL 205

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 841 V------ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 224
Query: 951 PGL 953
           P L
Sbjct: 225 PEL 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 77
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 951 PGL 953
           P L
Sbjct: 191 PEL 193

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 77
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 951 PGL 953
           P L
Sbjct: 191 PEL 193

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 182

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 781 RFSENNL-----IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR 834
            F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 835 -------HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVA 887
                  H N++ ++ +C+      +I EY  +G L   L   + +L+      I    A
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 888 TTLEYLHFG----------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
           +T + LHF            S   IH D+   NVLL +  VA + DFG+A+ ++ +   I
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 938 TQTQTLATIGYMAP-GLFHVKYILFVVNFLTSYSFLMIFI 976
            +      + +MAP  +F   Y   V + + SY  L+  I
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYT--VQSDVWSYGILLWEI 259

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 89
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 951 PGL 953
           P L
Sbjct: 203 PEL 205

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 81
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 142 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 194
Query: 951 PGL 953
           P L
Sbjct: 195 PEL 197

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 175

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 30/187 (16%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----------NYILDIFQRLNIMVDVA 887
           +K++    TE    L+ E++ H  L+K + +S           +Y+  + Q L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS------ 117
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
                  F +S  V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 168
Query: 948 YMAPGLF 954
           Y AP + 
Sbjct: 169 YRAPEIL 175

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+LL  N    ++DFG +        S  +T    T+ Y+ P +
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 181

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/180 (32%), Positives = 86/180 (47%), Gaps = 25/180 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           +G+G +G V++    +G  VAVK+F     R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH---FGYS 898
            T    +    LI  Y   GSL   L  +   LD    L I++ +A+ L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 899 A-PVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-----LATIGYMAP 951
             P I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 788 IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V   R        G +VAVK    + G         E E+++++ H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C+ +      LI+E++P GSL++ L  +   +++ Q+L   V +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
             +H DL   NVL++      + DFG+ K +  + +  T
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 172

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 25/183 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           +G+G +G V++    +G  VAVK+F     R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 45  VGKGRYGEVWRGS-WQGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH---FGYS 898
            T    +    LI  Y   GSL   L  +   LD    L I++ +A+ L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 899 A--PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-----LATIGYMAP 951
               + H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 952 GLF 954
            + 
Sbjct: 216 EVL 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 788 IGRGGFGSVYKARIG-----EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V   R        G +VAVK    + G         E E+++++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C+ +      LI+E++P GSL++ L  +   +++ Q+L   V +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
             +H DL   NVL++      + DFG+ K +  + +  T
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT 184

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 96/183 (52%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 77
Query: 841 V----ISSCSTEE--FKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +     SS   ++  +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 951 PGL 953
           P L
Sbjct: 191 PEL 193

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG+G F  V  AR I  G EVA+K+ D       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             TE+   LI+EY   G +   L +   + +   R      + + ++Y H      ++H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVHR 138
Query: 905 DLKPSNVLLDDNMVAHLSDFGIA 927
           DLK  N+LLD +M   ++DFG +
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS 161

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D            E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 10/171 (5%)
Query: 786 NLIGRGGFGSVYKA-RIGEG----MEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLI 839
            ++G G FG+V+K   I EG    + V +KV + + GR +F++       + S+ H +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           +++  C     + L+ +Y+P GSL   +      L     LN  V +A  + YL      
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 152
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
            ++H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 90
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 151 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 203
Query: 951 PGL 953
           P L
Sbjct: 204 PEL 206

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 82
Query: 841 V------ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 143 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 195
Query: 951 PGL 953
           P L
Sbjct: 196 PEL 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 174

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 175

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 176

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 115
Query: 841 V------ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 228
Query: 951 PGL 953
           P L
Sbjct: 229 PEL 231

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 111
Query: 841 V------ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 224
Query: 951 PGL 953
           P L
Sbjct: 225 PEL 227

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 8/160 (5%)
Query: 787 LIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKV 841
           +IG G FG V   R  +    E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
               +  +   +I EYM +GSL+  L  ++    + Q + ++  + + ++YL        
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSA 152
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 153 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 192

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 105
Query: 841 V------ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 166 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 218
Query: 951 PGL 953
           P L
Sbjct: 219 PEL 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 113
Query: 841 V------ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 174 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 226
Query: 951 PGL 953
           P L
Sbjct: 227 PEL 229

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 77
Query: 841 VI------SSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 951 PGL 953
           P L
Sbjct: 191 PEL 193

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 27/197 (13%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAF-----KSFDVECEMMKSIRHRNLIKV 841
           +G GGFG V +      G +VA+K    QC +       + + +E ++MK + H N++  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 842 ------ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQR--LNIMVDVATTLEYL 893
                 +   +  +   L +EY   G L K L        + +     ++ D+++ L YL
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 894 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      +IH DLKP N++L      ++  + D G AK L   DQ    T+ + T+ Y+A
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 191
Query: 951 PGLFHVKYILFVVNFLT 967
           P L   K     V++ +
Sbjct: 192 PELLEQKKYTVTVDYWS 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 175

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 174

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 88
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 175

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 207 RLPVKWMAP 215

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 174

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 17/171 (9%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLHFGYSAP 900
            E    +I E+M +G+L   L   N      Q +N +V       +++ +EYL       
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KKN 377
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            IH +L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 427

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 25/183 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           +G+G +G V++    +G  VAVK+F     R  KS+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGS-WQGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH---FGYS 898
            T    +    LI  Y   GSL   L  +   LD    L I++ +A+ L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 899 A--PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-----LATIGYMAP 951
               + H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 952 GLF 954
            + 
Sbjct: 187 EVL 189

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 111
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 212 RLPVKWMAP 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 22/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +++  +IG G FG VY+A++ +  E VA+K   LQ  R FK  + E ++M+ + H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FK--NRELQIMRKLDHCNIVR 156
Query: 841 V------ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +            E +  L+L+Y+P     + +    +   L +      M  +  +L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 893 LH-FGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H FG    + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 269
Query: 951 PGL 953
           P L
Sbjct: 270 PEL 272

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 27/197 (13%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAF-----KSFDVECEMMKSIRHRNLIKV 841
           +G GGFG V +      G +VA+K    QC +       + + +E ++MK + H N++  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIK----QCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 842 ------ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQR--LNIMVDVATTLEYL 893
                 +   +  +   L +EY   G L K L        + +     ++ D+++ L YL
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 138
Query: 894 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      +IH DLKP N++L      ++  + D G AK L   DQ    T+ + T+ Y+A
Sbjct: 139 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLA 192
Query: 951 PGLFHVKYILFVVNFLT 967
           P L   K     V++ +
Sbjct: 193 PELLEQKKYTVTVDYWS 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/189 (29%), Positives = 87/189 (46%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 209 RLPVKWMAP 217

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 85
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 112
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC-GRAFKSFDV-ECEMMKSIRHRN 837
            ++ +   +G G +G VYKA+  +G  VA+K   L        S  + E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++ +I    +E    L+ E+M    L+K L  +   L   Q   I + +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
              ++H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP + 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVL 191

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 88/167 (52%), Gaps = 11/167 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+ A   +  +VAVK   ++ G  + ++F  E  +MK+++H  L+K + +  
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVK-LHAVV 252
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL-EYLHFGYSAPVIHCD 905
           T+E   +I E+M  GSL   L S        Q L  ++D +  + E + F      IH D
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           L+ +N+L+  ++V  ++DFG+A+++  ED   T  +     I + AP
Sbjct: 310 LRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAP 354

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 42/141 (29%), Positives = 73/141 (51%), Gaps = 4/141 (2%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E G   A KV + +     + + VE E++ +  H  ++K++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            +    +++E+ P G+++  +   +  L   Q   I V     LE L+F +S  +IH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 907 KPSNVLLDDNMVAHLSDFGIA 927
           K  NVL+       L+DFG++
Sbjct: 136 KAGNVLMTLEGDIRLADFGVS 156

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 42/141 (29%), Positives = 73/141 (51%), Gaps = 4/141 (2%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E G   A KV + +     + + VE E++ +  H  ++K++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            +    +++E+ P G+++  +   +  L   Q   I V     LE L+F +S  +IH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 907 KPSNVLLDDNMVAHLSDFGIA 927
           K  NVL+       L+DFG++
Sbjct: 144 KAGNVLMTLEGDIRLADFGVS 164

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 90
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 8/160 (5%)
Query: 787 LIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKV 841
           +IG G FG V   R  +    E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
               +  +   +I EYM +GSL+  L  ++    + Q + ++  + + ++YL        
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 131
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 171

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 8/160 (5%)
Query: 787 LIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKV 841
           +IG G FG V   R  +    E+ V +  L+ G   +  + F  E  +M    H N+I +
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
               +  +   +I EYM +GSL+  L  ++    + Q + ++  + + ++YL        
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 137
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           +H DL   N+L++ N+V  +SDFG++++L  + ++   T+
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR 177

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ ++ ++      +T A   + +MA
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC-GRAFKSFDV-ECEMMKSIRHRN 837
            ++ +   +G G +G VYKA+  +G  VA+K   L        S  + E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++ +I    +E    L+ E+M    L+K L  +   L   Q   I + +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
              ++H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP + 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVL 191

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           IG+G FG V++ +   G EVAVK+F     R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGK-WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF----GY 897
           + +        L+ +Y  HGSL    Y + Y + +   + + +  A+ L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 898 SAPVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAP 951
             P I H DLK  N+L+  N    ++D G+A   +  D +     I     + T  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 220

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 788 IGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG+G FG V    +G+  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 846 STEEFKALIL-EYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
             E+    I+ EYM  GSL   L S    +L     L   +DV   +EYL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 168

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 788 IGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG+G FG V    +G+  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 20  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 846 STEEFKALIL-EYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
             E+    I+ EYM  GSL   L S    +L     L   +DV   +EYL        +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 174

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC-------GRAFKSFDVECEMMKSI 833
           F   NL+G+G F  VY+A  I  G+EVA+K+ D +         R      + C++    
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL---- 68
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           +H +++++ +      +  L+LE   +G + + L +        +  + M  + T + YL
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           H   S  ++H DL  SN+LL  NM   ++DFG+A  L
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 788 IGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG+G FG V    +G+  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 29  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 846 STEEFKALIL-EYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
             E+    I+ EYM  GSL   L S    +L     L   +DV   +EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAP 183

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSC 845
           IGRG FG V+  R+  +   VAVK          K+ F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           + ++   +++E +  G     L +    L +   L ++ D A  +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 906 LKPSNVLLDDNMVAHLSDFGIAK 928
           L   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSC 845
           IGRG FG V+  R+  +   VAVK          K+ F  E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
           + ++   +++E +  G     L +    L +   L ++ D A  +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 906 LKPSNVLLDDNMVAHLSDFGIAK 928
           L   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 788 IGRGGFGSVY-----KARIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKV 841
           +G G FG V          G G  VAVK      G   +S +  E ++++++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 842 ISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C      +L  ++EY+P GSL    Y   + + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             IH DL   NVLLD++ +  + DFG+AK
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +G G FG V+ A   +  +VAVK        + ++F  E  +MK+++H  L+K + +  T
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK-LHAVVT 80
Query: 848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL-EYLHFGYSAPVIHCDL 906
           +E   +I E+M  GSL   L S        Q L  ++D +  + E + F      IH DL
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
           + +N+L+  ++V  ++DFG+A+++  ED   T
Sbjct: 138 RAANILVSASLVCKIADFGLARVI--EDNEYT 167

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 7/166 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +G VY+    +  + VAVK    +     + F  E  +MK I+H NL++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            E    +I E+M +G+L   L   N   +     L +   +++ +EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           L   N L+ +N +  ++DFG+++L+ G D           I + AP
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAP 388

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+        +VA+K   L+ G  + +SF  E ++MK ++H  L+++ +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 847 TEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            EE   ++ EYM  GSL   L       L +   +++   VA  + Y+        IH D
Sbjct: 75  -EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
           L+ +N+L+ + ++  ++DFG+A+L+  ED   T  Q
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI--EDNEXTARQ 164

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 19/165 (11%)
Query: 786 NLIGRGGFGSVY----KARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLI 839
            ++G G FGSV     K   G  ++VAVK   L     R  + F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 840 KVISSCSTEEFKAL-----ILEYMPHGSLEKSLYSSNYI-----LDIFQRLNIMVDVATT 889
           +++  C     + +     IL +M +G L   L  S        + +   L  MVD+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           +EYL    +   +H DL   N +L D+M   ++DFG++K +   D
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 787 LIGRGGFGSVYKAR-IGEG----MEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIK 840
           ++G G FG+V+K   I EG    + V +KV + + GR +F++       + S+ H ++++
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           ++  C     + L+ +Y+P GSL   +      L     LN  V +A  + YL       
Sbjct: 80  LLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHG 135
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           ++H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 4/141 (2%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E  +  A KV D +     + + VE +++ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            E    +++E+   G+++  +      L   Q   I V    TL+ L++ +   +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 907 KPSNVLLDDNMVAHLSDFGIA 927
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 4/141 (2%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E  +  A KV D +     + + VE +++ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            E    +++E+   G+++  +      L   Q   I V    TL+ L++ +   +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 907 KPSNVLLDDNMVAHLSDFGIA 927
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 4/141 (2%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG VYKA+  E  +  A KV D +     + + VE +++ S  H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            E    +++E+   G+++  +      L   Q   I V    TL+ L++ +   +IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQ---IQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 907 KPSNVLLDDNMVAHLSDFGIA 927
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/177 (32%), Positives = 85/177 (48%), Gaps = 15/177 (8%)
Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEM------MKSIRHRNL 838
            +IG+G FG V  AR   E +  AVKV  LQ     K  + +  M      +K+++H  L
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           + +  S  T +    +L+Y+  G L   L      L+   R     ++A+ L YLH   S
Sbjct: 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---S 157
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
             +++ DLKP N+LLD      L+DFG+ K  I E  S T T    T  Y+AP + H
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNSTTST-FCGTPEYLAPEVLH 212

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G + K L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 182

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 129
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 948 YMA 950
           +MA
Sbjct: 187 WMA 189

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 904 CDLKPSNVLLDDNMVAHLSDFG 925
            D+KP N+LL  N    ++DFG
Sbjct: 136 RDIKPENLLLGSNGELKIADFG 157

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       ++DFG +        S  +T+   T+ Y+ P +
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTELCGTLDYLPPEM 177

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 130
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 948 YMA 950
           +MA
Sbjct: 188 WMA 190

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 131
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 948 YMA 950
           +MA
Sbjct: 189 WMA 191

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLL------NWCVQIA 128
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 948 YMA 950
           +MA
Sbjct: 186 WMA 188

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 788 IGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG+G FG V    +G+  G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 201 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 846 STEEFKALIL-EYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
             E+    I+ EYM  GSL   L S    +L     L   +DV   +EYL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP     K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREK 361

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 128
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 129 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 948 YMA 950
           +MA
Sbjct: 186 WMA 188

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 8/173 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 176

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L K+   ++ +  I   L I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 120
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEIL 174

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 89/196 (45%), Gaps = 12/196 (6%)
Query: 778 ATNRF---SENNLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI 833
           A N F   S+  ++G G FG V+K      G+++A K+   +  +  +    E  +M  +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
            H NLI++  +  ++    L++EY+  G L   +   +Y L     +  M  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 894 HFGYSAPVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H  Y   ++H DLKP N+L    D     + DFG+A+     ++         T  ++AP
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAP 257
Query: 952 GLFHVKYILFVVNFLT 967
            + +  ++ F  +  +
Sbjct: 258 EVVNYDFVSFPTDMWS 273

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+ Y   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 14/174 (8%)
Query: 786 NLIGRGGFGSVYKARIGEG--------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++ +I +  T     LILEY+  G L   L      ++       + +++  L +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +I+ DLKP N++L+      L+DFG+ K  I  D ++T T    TI YMAP
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAP 190

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 98
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  +++L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 161
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 162 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 948 YMA 950
           +MA
Sbjct: 219 WMA 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 152
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  +++L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNL 838
           N +IGRG FG VY   +    G+ +  AVK  +     G     F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 839 IKVISSCSTEEFKALI-LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           + ++  C   E   L+ L YM HG L   + +  +   +   +   + VA  +++L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMA 950
           S   +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           IG+G FG V++ +   G EVAVK+F     R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGK-WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF----GY 897
           + +        L+ +Y  HGSL    Y + Y + +   + + +  A+ L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 898 SAPVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAP 951
             P I H DLK  N+L+  N    ++D G+A   +  D +     I     + T  YMAP
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 182

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           IG+G FG V++ +   G EVAVK+F     R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF----GY 897
           + +        L+ +Y  HGSL    Y + Y + +   + + +  A+ L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 898 SAPVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAP 951
             P I H DLK  N+L+  N    ++D G+A   +  D +     I     + T  YMAP
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 181

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           IG+G FG V++ +   G EVAVK+F     R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGK-WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF----GY 897
           + +        L+ +Y  HGSL    Y + Y + +   + + +  A+ L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 898 SAPVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAP 951
             P I H DLK  N+L+  N    ++D G+A   +  D +     I     + T  YMAP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 207

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           IG+G FG V++ +   G EVAVK+F     R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGK-WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF----GY 897
           + +        L+ +Y  HGSL    Y + Y + +   + + +  A+ L +LH       
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 898 SAPVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAP 951
             P I H DLK  N+L+  N    ++D G+A   +  D +     I     + T  YMAP
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 187

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 25/180 (13%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           IG+G FG V++ +   G EVAVK+F     R  +S+  E E+ +++  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGK-WRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF----GY 897
           + +        L+ +Y  HGSL    Y + Y + +   + + +  A+ L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 898 SAPVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAP 951
             P I H DLK  N+L+  N    ++D G+A   +  D +     I     + T  YMAP
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 184

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 8/179 (4%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
            +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +  + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   S
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---S 134
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
             VIH D+K  N+LL  +    L+DFG    +  E     +++ + T  +MAP +   K
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRK 191

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 179

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 69/142 (48%), Gaps = 8/142 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G + K L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 904 CDLKPSNVLLDDNMVAHLSDFG 925
            D+KP N+LL       ++DFG
Sbjct: 137 RDIKPENLLLGSAGELKIADFG 158

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +  E + VAVK+  D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----NYILDI---------FQRL-NI 882
           +I ++ +C+ +    +I+ Y   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 174

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 176

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 176

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 781 RFSENNL-----IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR 834
            F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 835 -------HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVA 887
                  H N++ ++ +C+      +I EY  +G L   L   + +L+      I     
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 888 TTLEYLHFG----------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
           +T + LHF            S   IH D+   NVLL +  VA + DFG+A+ ++ +   I
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 938 TQTQTLATIGYMAP-GLFHVKYILFVVNFLTSYSFLMIFI 976
            +      + +MAP  +F   Y   V + + SY  L+  I
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYT--VQSDVWSYGILLWEI 259

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 177

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 174

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 176

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 11/175 (6%)
Query: 785 NNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLI 839
             +IG G FG V     ++    E+ V +  L+ G   +  + F  E  +M    H N+I
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +    +      +I E+M +GSL+  L  ++    + Q + ++  +A  ++YL      
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 154
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA---TIGYMAP 951
             +H DL   N+L++ N+V  +SDFG+++ L  +    T T  L     I + AP
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEM 181

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 79/144 (54%), Gaps = 8/144 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V+ A   +  +VAVK   ++ G  + ++F  E  +MK+++H  L+K + +  
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVK-LHAVV 246
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL-EYLHFGYSAPVIHCD 905
           T+E   +I E+M  GSL   L S        Q L  ++D +  + E + F      IH D
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 303
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKL 929
           L+ +N+L+  ++V  ++DFG+A++
Sbjct: 304 LRAANILVSASLVCKIADFGLARV 327

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A  
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAKG 129
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +M
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 950 A 950
           A
Sbjct: 187 A 187

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 157
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP----GLFHVKYI 959
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P    G  H + +
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 213
Query: 960 LFVVNFLTSYSFLM 973
                 +  Y FL+
Sbjct: 214 DLWSLGVLCYEFLV 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 36/203 (17%)
Query: 788 IGRGGFGSVYKARIGEGM-------EVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLI 839
           IG G FG V++AR   G+        VAVK+   +     ++ F  E  +M    + N++
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNY-----------------------ILDI 876
           K++  C+  +   L+ EYM +G L + L S +                         L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
            ++L I   VA  + YL        +H DL   N L+ +NMV  ++DFG+++ +   D  
Sbjct: 174 AEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 937 ITQTQTLATIGYMAP-GLFHVKY 958
                    I +M P  +F+ +Y
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRY 253

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 178

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L K+   ++ +  I   L I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDL-KTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 177

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 129
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 948 YMA 950
           +MA
Sbjct: 187 WMA 189

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 152
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 153 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 948 YMA 950
           +MA
Sbjct: 210 WMA 212

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 182

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 134
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 948 YMA 950
           +MA
Sbjct: 192 WMA 194

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 130
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 948 YMA 950
           +MA
Sbjct: 188 WMA 190

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 130
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 948 YMA 950
           +MA
Sbjct: 188 WMA 190

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEM 177

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 130
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 131 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 948 YMA 950
           +MA
Sbjct: 188 WMA 190

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L+K + +S   L       I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP +
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEI 174

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 785 NNLIGRGGFGSVYKARIGE-GMEVAVKVFD-LQCGRAFKSFDVECEMMKSIRHRNLIKV- 841
           ++++G+G   +V++ R  + G   A+KVF+ +   R       E E++K + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 842 -ISSCSTEEFKALILEYMPHGSLEKSLY--SSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
            I   +T   K LI+E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 899 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             ++H ++KP N++     D   V  L+DFG A+ L  ++Q ++      T  Y+ P ++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMY 187

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIR 834
           ++R+    ++G GG   V+ AR + +  +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 835 HRNLIKVISSCSTEE----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           H  ++ V  +   E        +++EY+   +L   +++      +  +  I V +A   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT-QTLATIGYM 949
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 950 AP 951
           +P
Sbjct: 187 SP 188

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 26/181 (14%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSC 845
           +G G FG V+       G+E  +K  +    +   +  + E E++KS+ H N+IK+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 846 STEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTLEYLHFG 896
                  +++E    G L + + S+          Y+ ++ +++         L Y H  
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAYFH-- 141
Query: 897 YSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            S  V+H DLKP N+L  D   +    + DFG+A+L   ++ S   T    T  YMAP +
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEV 197
Query: 954 F 954
           F
Sbjct: 198 F 198

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIR 834
           ++R+    ++G GG   V+ AR + +  +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 835 HRNLIKVISSCSTEE----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           H  ++ V  +   E        +++EY+   +L   +++      +  +  I V +A   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT-QTLATIGYM 949
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 950 AP 951
           +P
Sbjct: 187 SP 188

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 133
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 134 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 948 YMA 950
           +MA
Sbjct: 191 WMA 193

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 785 NNLIGRGGFGSVYKA----RIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLI 839
           N ++G G FG VY+       GE + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K+I     EE   +I+E  P+G L   L  +   L +   +   + +   + YL    S 
Sbjct: 89  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 195

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 148
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 194

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 785 NNLIGRGGFGSVYKA----RIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLI 839
           N ++G G FG VY+       GE + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K+I     EE   +I+E  P+G L   L  +   L +   +   + +   + YL    S 
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 179

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 10/172 (5%)
Query: 785 NNLIGRGGFGSVYKA----RIGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLI 839
           N ++G G FG VY+       GE + VAVK     C    K  F  E  +MK++ H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K+I     EE   +I+E  P+G L   L  +   L +   +   + +   + YL    S 
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+P
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSP 183

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 137
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 138 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 948 YMA 950
           +MA
Sbjct: 195 WMA 197

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 132
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS----CHAPSSRRTTLSGTLDYLPPEM 178

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 87/187 (46%), Gaps = 17/187 (9%)
Query: 778 ATNRFSEN----NLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMM 830
           A+ +FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E  + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 831 KSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           + ++H N++++  S   E F  L+ + +  G L + + +  +    +   +    +   L
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQIL 138
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
           E + + +S  ++H +LKP N+LL          L+DFG+A   I  + S        T G
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 195
Query: 948 YMAPGLF 954
           Y++P + 
Sbjct: 196 YLSPEVL 202

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 789 GRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISS---- 844
            RG FG V+KA++     VAVK+F LQ  ++++S + E      ++H NL++ I++    
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF--------G 896
            + E    LI  +   GSL    Y    I+   +  ++   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTD--YLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLIGEDQSITQTQTLATIGYMAP 951
           +   + H D K  NVLL  ++ A L+DFG+A +   G+    T  Q + T  YMAP
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-VGTRRYMAP 194

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 182

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 8/179 (4%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
            +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +  + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   S
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---S 134
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
             VIH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP +   K
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRK 191

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 129
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG AKLL  E++          I 
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 948 YMA 950
           +MA
Sbjct: 187 WMA 189

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 129
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG AKLL  E++          I 
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 948 YMA 950
           +MA
Sbjct: 187 WMA 189

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 131
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG AKLL  E++          I 
Sbjct: 132 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 948 YMA 950
           +MA
Sbjct: 189 WMA 191

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 134
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P +
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTTLCGTLDYLPPEM 180

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 8/179 (4%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
            +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +  + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   S
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---S 134
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
             VIH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP +   K
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 191

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 8/179 (4%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
            +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +  + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   S
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---S 135
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
             VIH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP +   K
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPEVVTRK 192

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 131
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLPP 175

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 39/136 (28%), Positives = 74/136 (54%), Gaps = 11/136 (8%)
Query: 794 GSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EE 849
           G ++K R  +G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 850 FKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI--HCDL 906
              LI  +MP+GSL   L+  +N+++D  Q +   +D+A  + +LH     P+I  H  L
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA-L 139
Query: 907 KPSNVLLDDNMVAHLS 922
              +V++D++M A +S
Sbjct: 140 NSRSVMIDEDMTARIS 155

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 16/192 (8%)
Query: 773 LELCRATNRFSENNL-----IGRGGFGSVYKAR---IGE--GMEVAVKVFDLQCGRAFKS 822
           L  C+    F E +L     +G+G FGSV   R   +G+  G  VAVK          + 
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 823 FDVECEMMKSIRHRNLIKV--ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL 880
           F  E +++K++    ++K   +S     +   L++EY+P G L   L      LD  + L
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQ 939
                +   +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +
Sbjct: 131 LYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 940 TQTLATIGYMAP 951
               + I + AP
Sbjct: 188 EPGQSPIFWYAP 199

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 130
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 174

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 134
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 178

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 180

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 16/189 (8%)
Query: 776 CRATNRFSENNL-----IGRGGFGSVYKAR---IGE--GMEVAVKVFDLQCGRAFKSFDV 825
           C+    F E +L     +G+G FGSV   R   +G+  G  VAVK          + F  
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 826 ECEMMKSIRHRNLIKV--ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
           E +++K++    ++K   +S     +   L++EY+P G L   L      LD  + L   
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQT 942
             +   +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +   
Sbjct: 121 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 943 LATIGYMAP 951
            + I + AP
Sbjct: 178 QSPIFWYAP 186

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 20/194 (10%)
Query: 764 IATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQ--CGRAF 820
           +ATC RF        T+ +     +G+G F  V +  +     E A K+ + +    R  
Sbjct: 23  MATCTRF--------TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDH 74
Query: 821 KSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL 880
           +  + E  + + ++H N++++  S S E F  L+ + +  G L + + +  Y    +   
Sbjct: 75  QKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEA 130
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSI 937
           +    +   LE ++  +   ++H DLKP N+LL          L+DFG+A  + GE Q+ 
Sbjct: 131 DASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW 190
Query: 938 TQTQTLATIGYMAP 951
                  T GY++P
Sbjct: 191 --FGFAGTPGYLSP 202

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 16/180 (8%)
Query: 785 NNLIGRGGFGSVYKARIGE-GMEVAVKVFD-LQCGRAFKSFDVECEMMKSIRHRNLIKV- 841
           ++++G+G   +V++ R  + G   A+KVF+ +   R       E E++K + H+N++K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 842 -ISSCSTEEFKALILEYMPHGSLEKSLY--SSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
            I   +T   K LI+E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 899 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             ++H ++KP N++     D   V  L+DFG A+ L  ++Q +       T  Y+ P ++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX---LYGTEEYLHPDMY 187

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++ H  L K    ++ +  I   L I   +   L+ L F +S
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDL-KDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 121
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 175

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 14/174 (8%)
Query: 786 NLIGRGGFGSVYKARIGEG--------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
            ++G+GG+G V++ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++ +I +  T     LILEY+  G L   L      ++       + +++  L +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +I+ DLKP N++L+      L+DFG+ K  I  D ++T      TI YMAP
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAP 190

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLL------NWCVQIAKG 129
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +M
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 950 A 950
           A
Sbjct: 187 A 187

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAKG 129
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +M
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 950 A 950
           A
Sbjct: 187 A 187

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAKG 123
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +M
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 950 A 950
           A
Sbjct: 181 A 181

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAKG 129
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +M
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 950 A 950
           A
Sbjct: 187 A 187

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 74  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAEG 126
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +M
Sbjct: 127 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 950 A 950
           A
Sbjct: 184 A 184

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +    +A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 128
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 172

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 28/184 (15%)
Query: 788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G +G V  AR    G +VA+K       +   +FDV     +++R   ++K     +
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQR-LNIMVDVAT--TLEY----------- 892
               K ++   +P+G   KS+Y    +LD+ +  L+ ++  +   TLE+           
Sbjct: 116 IIAIKDILRPTVPYGEF-KSVY---VVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE--DQSITQTQTLATIGYMA 950
           L + +SA VIH DLKPSN+L+++N    + DFG+A+ L     +     T+ +AT  Y A
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 951 PGLF 954
           P L 
Sbjct: 232 PELM 235

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++  G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI++ MP G L       K    S Y+L      N  V +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 134
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 948 YMA 950
           +MA
Sbjct: 192 WMA 194

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 8/144 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 157
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIA 927
            D+KP N+LL       ++DFG +
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWS 181

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIR 834
           ++R+    ++G GG   V+ AR +    +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 835 HRNLIKVISSCSTEE----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           H  ++ V ++   E        +++EY+   +L   +++      +  +  I V +A   
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT-QTLATIGYM 949
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 950 AP 951
           +P
Sbjct: 187 SP 188

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG 154

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 133
Query: 904 CDLKPSNVLLDDNMVAHLSDFG 925
            D+KP N+LL       ++DFG
Sbjct: 134 RDIKPENLLLGSAGELKIADFG 155

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     IG G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EYMP G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 28/184 (15%)
Query: 788 IGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G +G V  AR    G +VA+K       +   +FDV     +++R   ++K     +
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQR-LNIMVDVAT--TLEY----------- 892
               K ++   +P+G   KS+Y    +LD+ +  L+ ++  +   TLE+           
Sbjct: 115 IIAIKDILRPTVPYGEF-KSVY---VVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE--DQSITQTQTLATIGYMA 950
           L + +SA VIH DLKPSN+L+++N    + DFG+A+ L     +     T+ +AT  Y A
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 951 PGLF 954
           P L 
Sbjct: 231 PELM 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     IG G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EYMP G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 13/182 (7%)
Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIR 834
           ++R+    ++G GG   V+ AR + +  +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 835 HRNLIKVISSCSTEE----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           H  ++ V  +   E        +++EY+   +L   +++      +  +  I V +A   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT-QTLATIGYM 949
           + L+F +   +IH D+KP+N+L+       + DFGIA+ +     S+ QT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 950 AP 951
           +P
Sbjct: 187 SP 188

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 131
Query: 904 CDLKPSNVLLDDNMVAHLSDFG 925
            D+KP N+LL       ++DFG
Sbjct: 132 RDIKPENLLLGSAGELKIADFG 153

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 131
Query: 904 CDLKPSNVLLDDNMVAHLSDFG 925
            D+KP N+LL       ++DFG
Sbjct: 132 RDIKPENLLLGSAGELKIADFG 153

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A     +  E E+   +RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 134
Query: 904 CDLKPSNVLLDDNMVAHLSDFG 925
            D+KP N+LL       ++DFG
Sbjct: 135 RDIKPENLLLGSAGELKIADFG 156

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMK 831
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM---VDVAT 888
            +  R ++ +  +  T+    L++  M  G +   +Y+ +     FQ    +     + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLIGEDQSITQTQTLA-TI 946
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 947 GYMAPGLFHVKYILFVVNFLT 967
           G+MAP L   +   F V++  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFA 374

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 134
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG AKLL  E++          I 
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 948 YMA 950
           +MA
Sbjct: 192 WMA 194

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMK 831
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM---VDVAT 888
            +  R ++ +  +  T+    L++  M  G +   +Y+ +     FQ    +     + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLIGEDQSITQTQTLA-TI 946
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 947 GYMAPGLFHVKYILFVVNFLT 967
           G+MAP L   +   F V++  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFA 374

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 129
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG AKLL  E++          I 
Sbjct: 130 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 948 YMA 950
           +MA
Sbjct: 187 WMA 189

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 29/186 (15%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           F++   IG+G FG V+K       +V           A K  D+E    +    +  I V
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVV----------AIKIIDLEEAEDEIEDIQQEITV 74
Query: 842 ISSCSTEEFKA------------LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           +S C +                 +I+EY+  GS    L +  +  D FQ   ++ ++   
Sbjct: 75  LSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKG 132
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  I +   + T  +M
Sbjct: 133 LDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 187
Query: 950 APGLFH 955
           AP +  
Sbjct: 188 APEVIQ 193

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMK 831
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM---VDVAT 888
            +  R ++ +  +  T+    L++  M  G +   +Y+ +     FQ    +     + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLIGEDQSITQTQTLA-TI 946
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 947 GYMAPGLFHVKYILFVVNFLT 967
           G+MAP L   +   F V++  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFA 374

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 788 IGRGGFGSVYKARIGEG-MEVAVKV-FDLQCGR--AFKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +    VA+KV F  Q  +         E E+   + H N++++ +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G L K L  S    D  +   IM ++A  L Y H      VIH
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALMYCH---GKKVIH 146
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
            D+KP N+LL       ++DFG +        S+ +     T+ Y+ P + 
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMI 193

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 8/165 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G +GSVYKA   E G  VA+K   ++     +    E  +M+     +++K   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
                 +++EY   GS+   +   N  L   +   I+      LEYLHF      IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           K  N+LL+    A L+DFG+A  L   D    +   + T  +MAP
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAP 194

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G+G F  V +  +I  G E A K+ + +    R  +  + E  + + ++H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            S E F  L+ + +  G L + + +  Y    +   +    +   LE ++  +   ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 905 DLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DLKP N+LL          L+DFG+A  + G+ Q+        T GY++P
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSP 175

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G+G F  V +  +I  G E A K+ + +    R  +  + E  + + ++H N++++  S
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            S E F  L+ + +  G L + + +  Y    +   +    +   LE ++  +   ++H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 905 DLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DLKP N+LL          L+DFG+A  + G+ Q+        T GY++P
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSP 175

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYK-ARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG+G F  V +  ++  G E A K+ + +    R  +  + E  + + ++H N++++  S
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            S E F  L+ + +  G L + + +  Y    +   +    +   LE +   +   V+H 
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 905 DLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DLKP N+LL          L+DFG+A  + G+ Q+        T GY++P
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSP 175

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 24/201 (11%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMK 831
           + F +  ++GRGGFG V+  +    M+   K++         L+  + ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM---VDVAT 888
            +  R ++ +  +  T+    L++  M  G +   +Y+ +     FQ    +     + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLIGEDQSITQTQTLA-TI 946
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A +L  G+    T+T+  A T 
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTP 353
Query: 947 GYMAPGLFHVKYILFVVNFLT 967
           G+MAP L   +   F V++  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFA 374

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R+++   IG G +G V  A        VA+K    F+ Q  C R  +    E +++   R
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLR----EIQILLRFR 99
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN-----IMVDVATT 889
           H N+I +         +A+   Y+    +E  LY    +L   Q  N      +  +   
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQLSNDHICYFLYQILRG 156
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQTLATIGY 948
           L+Y+H   SA V+H DLKPSN+L++      + DFG+A++   E D +   T+ +AT  Y
Sbjct: 157 LKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 949 MAPGLF 954
            AP + 
Sbjct: 214 RAPEIM 219

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRAFKSFDV--ECEMMKSI 833
           A   F     +G+G FG+VY AR      + A+KV F  Q  +A     +  E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
           H   S  VIH D+KP N+LL       ++DFG
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSI 833
           A   F     +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           RH N++++           LILEY P G++ + L   +   D  +    + ++A  L Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   S  VIH D+KP N+LL       +++FG +        S  +T    T+ Y+ P +
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEM 180

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 57/177 (32%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSC 845
           +G+G +G V++  +  G  VAVK+F     R  +S+  E E+  ++  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH---FGYS 898
            T    +    LI  Y  HGSL   L      L+    L + V  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 899 A-PVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQ-SITQTQTLATIGYMAP 951
             P I H D K  NVL+  N+   ++D G+A +   G D   I     + T  YMAP
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 13/182 (7%)
Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIR 834
           ++R+    ++G GG   V+ AR +    +VAVKV      R    +  F  E +   ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 835 HRNLIKVISSCSTEE----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           H  ++ V  +   E        +++EY+   +L   +++      +  +  I V +A   
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT-QTLATIGYM 949
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 950 AP 951
           +P
Sbjct: 204 SP 205

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 13/182 (7%)
Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIR 834
           ++R+    ++G GG   V+ AR +    +VAVKV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 835 HRNLIKVISSCSTEE----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           H  ++ V  +   E        +++EY+   +L   +++      +  +  I V +A   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT-QTLATIGYM 949
           + L+F +   +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 950 AP 951
           +P
Sbjct: 187 SP 188

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 43/183 (23%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 779 TNRFSEN----NLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMK 831
           + +FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE 891
            ++H N++++  S   E F  L+ + +  G L + + +  +    +   +    +   LE
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 116
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            + + +S  ++H +LKP N+LL          L+DFG+A   I  + S        T GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGY 173
Query: 949 MAP 951
           ++P
Sbjct: 174 LSP 176

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 43/183 (23%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 779 TNRFSEN----NLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMK 831
           + +FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE 891
            ++H N++++  S   E F  L+ + +  G L + + +  +    +   +    +   LE
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILE 116
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            + + +S  ++H +LKP N+LL          L+DFG+A   I  + S        T GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGY 173
Query: 949 MAP 951
           ++P
Sbjct: 174 LSP 176

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         YS N   +  ++L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 254 RLPVKWMAP 262

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V    + A  G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +     T   K ++ E  P GSL   L  +  +++L    R    V VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAP 951
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V    + A  G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +     T   K ++ E  P GSL   L  +  +++L    R    V VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAP 951
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 202

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+AP +
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEI 195

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 92/197 (46%), Gaps = 34/197 (17%)
Query: 778 ATNRFSEN----NLIGRGGFGSVYKARIGEGM--EVAVKVFDLQCGRAFKSFDV------ 825
           +T+ F EN     ++GRG   SV +  I +    E AVK+ D+  G +F + +V      
Sbjct: 11  STHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 826 ---ECEMMKSIR-HRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDI 876
              E ++++ +  H N+I++  +  T  F  L+ + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
            + L   ++V   L  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D  
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 177
Query: 937 ITQTQTLATIGYMAPGL 953
               +   T  Y+AP +
Sbjct: 178 EKLREVCGTPSYLAPEI 194

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 782 FSENNL-----IGRGGFGSVYKAR---IGE--GMEVAVKVFDLQCGRAFKSFDVECEMMK 831
           F E +L     +G+G FGSV   R   +G+  G  VAVK          + F  E +++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 832 SIRHRNLIKV--ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           ++    ++K   +S     +   L++EY+P G L   L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLATIGY 948
           +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 949 MAP 951
            AP
Sbjct: 185 YAP 187

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKV-FDLQCGRA--FKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV F  Q  +A        E E+   +RH N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                    LILEY P G++ + L   +   D  +    + ++A  L Y H   S  VIH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 133
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
            D+KP N+LL       +++FG +        S  +T    T+ Y+ P +
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWS----VHAPSSRRTTLCGTLDYLPPEM 179

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++   S++   +     L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++   S++   +     L       I   +   L+ L F +S
Sbjct: 66  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 176

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEI 210

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V    + A  G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +     T   K ++ E  P GSL   L  +  +++L    R    V VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 133
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLATIGYMAP 951
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++   S++   +     L       I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVA----VKVFDLQCGRAFKSFDVECEMMKSIRH 835
            ++ +   IG G +G+V+KA+  E  E+     V++ D   G    +    C ++K ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKH 60
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +N++++     +++   L+ E+     L+K   S N  LD     + +  +   L+ L F
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGF 116
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            +S  V+H DLKP N+L++ N    L+DFG+A+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
           R  + F E  ++G+G FG V KAR   +    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 836 -------------RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
                        RN +K +++   +    + +EY  +G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
              +   L Y+H   S  +IH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 43/181 (23%), Positives = 84/181 (46%), Gaps = 17/181 (9%)
Query: 781 RFSEN----NLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSI 833
           +FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E  + + +
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           +H N++++  S   E F  L+ + +  G L + + +  +    +   +    +   LE +
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESI 117
Query: 894 HFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
            + +S  ++H +LKP N+LL          L+DFG+A   I  + S        T GY++
Sbjct: 118 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLS 174
Query: 951 P 951
           P
Sbjct: 175 P 175

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V    + A  G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +     T   K ++ E  P GSL   L  +  +++L    R    V VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 133
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAP 951
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V    + A  G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +     T   K ++ E  P GSL   L  +  +++L    R    V VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAP 951
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V    + A  G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +     T   K ++ E  P GSL   L  +  +++L    R    V VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 139
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAP 951
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/174 (30%), Positives = 75/174 (43%), Gaps = 16/174 (9%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V    + A  G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +     T   K ++ E  P GSL   L  +  +++L    R    V VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLE---S 129
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAP 951
              IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 22/183 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI 833
             F +  ++  G FG+VYK      GE +++ V + +L+     +A K    E  +M S+
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVA 887
            + ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIA 134
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
             + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I 
Sbjct: 135 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 948 YMA 950
           +MA
Sbjct: 192 WMA 194

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 8/179 (4%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
            +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +  + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   S
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---S 135
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
             VIH ++K  N+LL  +    L+DFG    +  E     ++  + T  +MAP +   K
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRK 192

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 10/177 (5%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 839 IKVISSCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           +K++    TE    L+ E++   S++ K    ++ +  I   L I   +   L+ L F +
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCH 122
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
           S  V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 177

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 202

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 87/189 (46%), Gaps = 30/189 (15%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGM--EVAVKVFDLQCGRAFKSFDV---------ECEMM 830
           +    ++GRG   SV +  I +    E AVK+ D+  G +F + +V         E +++
Sbjct: 6   YEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 831 KSIR-HRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMV 884
           + +  H N+I++  +  T  F  L+ + M  G L     EK   S      I + L   +
Sbjct: 65  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL---L 121
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           +V   L  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D      +   
Sbjct: 122 EVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCG 172
Query: 945 TIGYMAPGL 953
           T  Y+AP +
Sbjct: 173 TPSYLAPEI 181

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 43/170 (25%), Positives = 80/170 (47%), Gaps = 12/170 (7%)
Query: 788 IGRGGFGSVYK-ARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G+G F  V +  ++  G E A K+ + +    R  +  + E  + + ++H N++++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            S E    LI + +  G L + + +  Y    +   +    +   LE +   +   V+H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 905 DLKPSNVLLDDNM---VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DLKP N+LL   +      L+DFG+A  + GE Q+        T GY++P
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSP 193

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 782 FSENNL-----IGRGGFGSVYKAR---IGE--GMEVAVKVFDLQCGRAFKSFDVECEMMK 831
           F E +L     +G+G FGSV   R   +G+  G  VAVK          + F  E +++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 832 SIRHRNLIKV--ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           ++    ++K   +S         L++EY+P G L   L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLATIGY 948
           +EYL    S   +H DL   N+L++      ++DFG+AKLL + +D  + +    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 949 MAP 951
            AP
Sbjct: 181 YAP 183

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 230

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAKG 129
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG AKLL  E++          I +M
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 950 A 950
           A
Sbjct: 187 A 187

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 785 NNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLI 839
             +IG G FG V     ++    E+ V +  L+ G   +  + F  E  +M    H N+I
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +    +      +I E+M +GSL+  L  ++    + Q + ++  +A  ++YL      
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 128
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA---TIGYMAPGLFHV 956
             +H  L   N+L++ N+V  +SDFG+++ L  +    T T  L     I + AP    +
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA--I 186
Query: 957 KYILFV-VNFLTSYSFLM 973
           +Y  F   + + SY  +M
Sbjct: 187 QYRKFTSASDVWSYGIVM 204

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 8/176 (4%)
Query: 782 FSENNLIGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           F +   IG G +G VYKAR    GE + +     D +      +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +K++    TE    L+ E++      K    ++ +  I   L I   +   L+ L F +S
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDL--KKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHS 124
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             V+H DLKP N+L++      L+DFG+A+      +  T    + T+ Y AP + 
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWYRAPEIL 178

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 34/197 (17%)
Query: 778 ATNRFSEN----NLIGRGGFGSVYKARIGEGM--EVAVKVFDLQCGRAFKSFDV------ 825
           +T+ F EN     ++GRG   SV +  I +    E AVK+ D+  G +F + +V      
Sbjct: 11  STHGFYENYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 826 ---ECEMMKSIR-HRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDI 876
              E ++++ +  H N+I++  +  T  F  L+ + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
            + L   ++V   L  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D  
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 177
Query: 937 ITQTQTLATIGYMAPGL 953
                   T  Y+AP +
Sbjct: 178 EKLRSVCGTPSYLAPEI 194

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     IG G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 9/182 (4%)
Query: 772 YLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSF-DVECEM 829
           Y +       F++   IG+G FG V+K       +V A+K+ DL+           E  +
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           +       + K   S   +    +I+EY+  GS    L      LD  Q   I+ ++   
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 136
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           L+YLH   S   IH D+K +NVLL ++    L+DFG+A  L   D  I +   + T  +M
Sbjct: 137 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 191
Query: 950 AP 951
           AP
Sbjct: 192 AP 193

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 9/144 (6%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG+G F  V  AR I  G EVAVK+ D   L      K F  E  + K + H N++K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFE 80
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
              TE+   L+ EY   G +   L +     +   R      + + ++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIA 927
            DLK  N+LLD +    ++DFG +
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFS 160

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV     L+          E E+   +RH N++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                +   L+LE+ P G L K L       D  +    M ++A  L Y H      VIH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVIH 137
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
            D+KP N+L+       ++DFG +        S+ +     T+ Y+ P +   K
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMIEGK 187

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 47/174 (27%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 788 IGRGGFGSVYKARIGEGMEV-AVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG+VY AR  +   + A+KV     L+          E E+   +RH N++++ +
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                +   L+LE+ P G L K L       D  +    M ++A  L Y H      VIH
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVIH 138
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
            D+KP N+L+       ++DFG +        S+ +     T+ Y+ P +   K
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMIEGK 188

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         YS N   +  ++L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 205 RLPVKWMAP 213

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         YS N   +  ++L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 202 RLPVKWMAP 210

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         YS N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/189 (28%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         YS N   +  ++L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 206 RLPVKWMAP 214

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++ + R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFR 81
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 82  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 132
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 190 VATRWYRAPEIM 201

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 130
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEY 187
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 188 VATRWYRAPEIM 199

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 9/172 (5%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSF-DVECEMMKSIRHRNLI 839
           F++   IG+G FG V+K       +V A+K+ DL+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K   S   +    +I+EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             IH D+K +NVLL ++    L+DFG+A  L   D  I +   + T  +MAP
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 173

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 782 FSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRH 835
           F +  ++  G FG+VYK      GE +++ V + +L+     +A K    E  +M S+ +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIFQRLNIMVDVATT 889
            ++ +++  C T   + LI + MP G L       K    S Y+L      N  V +A  
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLL------NWCVQIAKG 129
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           + YL       ++H DL   NVL+       ++DFG+AKLL  E++          I +M
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 950 A 950
           A
Sbjct: 187 A 187

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 9/172 (5%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSF-DVECEMMKSIRHRNLI 839
           F++   IG+G FG V+K       +V A+K+ DL+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K   S   +    +I+EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             IH D+K +NVLL ++    L+DFG+A  L   D  I +   + T  +MAP
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAP 173

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 761 MPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARI-----GEGME-VAVKVF-D 813
           MP I   ++    E+  +  RF E   +G   FG VYK  +     GE  + VA+K   D
Sbjct: 9   MPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD 66
Query: 814 LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI 873
              G   + F  E  +   ++H N++ ++   + ++  ++I  Y  HG L + L   +  
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 874 LDIFQR---------------LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV 918
            D+                  ++++  +A  +EYL    S  V+H DL   NVL+ D + 
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183
Query: 919 AHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +SD G+ + +   D       +L  I +MAP
Sbjct: 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++ + R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLAFR 81
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 82  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 132
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 190 VATRWYRAPEIM 201

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDL---QCGRAFKSFDVECEMMKSIRHRN 837
           FS+   IG G FG+VY AR     EV A+K       Q    ++    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT----TLEYL 893
            I+       E    L++EY         L S++ +L++ ++    V++A      L+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            + +S  +IH D+K  N+LL +  +  L DFG A ++
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 130
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 188 VATRWYRAPEIM 199

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 786 NLIGRGGFGSVYKA------RIGEGMEVAVKVFDLQCGRAFK-SFDVECEMMKSI-RHRN 837
            ++G G FG V  A      + G  ++VAVK+   +   + + +   E +MM  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 838 LIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYI-------LDIFQRLNIMV 884
           ++ ++ +C+      LI EY  +G L      ++  +S + I       L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 885 ---------DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
                     VA  +E+L F      +H DL   NVL+    V  + DFG+A+ ++ +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 936 SITQTQTLATIGYMAP-----GLFHVK 957
            + +      + +MAP     G++ +K
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIK 254

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 134
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 192 VATRWYRAPEIM 203

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 778 ATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRH 835
           ++++F +   +G G + +VYK      G+ VA+K   L       S  + E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNY----------ILDIFQRLNIMVD 885
            N++++     TE    L+ E+M    L+K + S             ++  FQ       
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ------- 114
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
               L+ L F +   ++H DLKP N+L++      L DFG+A+
Sbjct: 115 -WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 9/172 (5%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSF-DVECEMMKSIRHRNLI 839
           F++   IG+G FG V+K       +V A+K+ DL+           E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K   S   +    +I+EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 138
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             IH D+K +NVLL ++    L+DFG+A  L   D  I +   + T  +MAP
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAP 188

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 130
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 188 VATRWYRAPEIM 199

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 80/186 (43%), Gaps = 37/186 (19%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           F++ + IG+G FG VYK       EV           A K  D+E    +    +  I V
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVV----------AIKIIDLEEAEDEIEDIQQEITV 70
Query: 842 ISSCS----TEEFKA--------LILEYMPHGS----LEKSLYSSNYILDIFQRLNIMVD 885
           +S C     T  F +        +I+EY+  GS    L+       YI        I+ +
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA------TILRE 124
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           +   L+YLH   S   IH D+K +NVLL +     L+DFG+A  L   D  I +   + T
Sbjct: 125 ILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGT 179
Query: 946 IGYMAP 951
             +MAP
Sbjct: 180 PFWMAP 185

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + IG G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 136
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 137 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYV 188
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 189 ATRWYRAPEIM 199

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 84
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 85  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 135
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 192
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 193 VATRWYRAPEIM 204

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 85
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 86  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 136
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 137 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 193
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 194 VATRWYRAPEIM 205

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 76
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 77  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 127
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 128 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 184
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 185 VATRWYRAPEIM 196

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 134
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 192 VATRWYRAPEIM 203

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LI 131
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 132 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYV 183
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 184 ATRWYRAPEIM 194

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 130
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 188 VATRWYRAPEIM 199

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSV---YKARIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKSIRHRNL 838
           +G G +GSV   Y AR+ +  +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 839 IKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV-DVATTLEYL 893
           I ++     + S E+F  + L     G+   ++  S  + D  + +  +V  +   L+Y+
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD--EHVQFLVYQLLRGLKYI 147
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   SA +IH DLKPSNV ++++    + DFG+A+    E      T  +AT  Y AP +
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEI 199
Query: 954 F 954
Sbjct: 200 M 200

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 81
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 82  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 132
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 133 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 189
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 190 VATRWYRAPEIM 201

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 77
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 78  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 128
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 186 VATRWYRAPEIM 197

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  +  +  G+++AVK    +  R F+S         E  ++K 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVK----KLSRPFQSIIHAKRTYRELRLLKH 106
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 165
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 166 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 217
Query: 949 MAPGLF 954
            AP + 
Sbjct: 218 RAPEIM 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKCQHLSNDHIC------YFL 134
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 192 VATRWYRAPEIM 203

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 77
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 78  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 128
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 129 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 185
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 186 VATRWYRAPEIM 197

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 87
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 88  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 138
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 139 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 195
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 196 VATRWYRAPEIM 207

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 79
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 80  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 130
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 131 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 187
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 188 VATRWYRAPEIM 199

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 99
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 100 HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 150
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 151 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 208 VATRWYRAPEIM 219

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  + +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        ++LEY P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 84
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWY 195
Query: 949 MAPGLF 954
            AP + 
Sbjct: 196 RAPEIM 201

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 99
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGS----LEKSLYSSNYILDIFQRLNIMVDVA 887
           H N+I    +I + + E+ K + L     G+    L K+ + SN  +  F     +  + 
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF-----LYQIL 154
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQTLATI 946
             L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT 
Sbjct: 155 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 947 GYMAPGLF 954
            Y AP + 
Sbjct: 212 WYRAPEIM 219

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         +S N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVA----VKVFDLQCGRAFKSFDVECEMMKSIRH 835
            ++ +   IG G +G+V+KA+  E  E+     V++ D   G    +    C ++K ++H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKH 60
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +N++++     +++   L+ E+     L+K   S N  LD     + +  +   L+ L F
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGF 116
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            +S  V+H DLKP N+L++ N    L++FG+A+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 83
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 142
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 143 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYV 194
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 195 ATRWYRAPEIM 205

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 84
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWY 195
Query: 949 MAPGLF 954
            AP + 
Sbjct: 196 RAPEIM 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 8/169 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQC-GRAFKSFDV-ECEMMKSIRHRNLIKVISSC 845
           IG G +G VYKA+   G   A+K   L+       S  + E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            T++   L+ E++    L+K L      L+     + ++ +   + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP + 
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVL 172

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 84
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWY 195
Query: 949 MAPGLF 954
            AP + 
Sbjct: 196 RAPEIM 201

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 30/195 (15%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDVECEM--- 829
           LCRA  ++     IG G +G V+KAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 830 --MKSIRHRNLIKVISSCST-----EEFKALILEYMPHG------SLEKSLYSSNYILDI 876
             +++  H N++++   C+      E    L+ E++          + +    +  I D+
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
                 M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++       
Sbjct: 126 ------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 937 ITQTQTLATIGYMAP 951
           +  T  + T+ Y AP
Sbjct: 174 MALTSVVVTLWYRAP 188

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 30/195 (15%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDVECEM--- 829
           LCRA  ++     IG G +G V+KAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 830 --MKSIRHRNLIKVISSCST-----EEFKALILEYMPHG------SLEKSLYSSNYILDI 876
             +++  H N++++   C+      E    L+ E++          + +    +  I D+
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
                 M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++       
Sbjct: 126 ------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 937 ITQTQTLATIGYMAP 951
           +  T  + T+ Y AP
Sbjct: 174 MALTSVVVTLWYRAP 188

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 30/195 (15%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDVECEM--- 829
           LCRA  ++     IG G +G V+KAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 830 --MKSIRHRNLIKVISSCST-----EEFKALILEYMPHG------SLEKSLYSSNYILDI 876
             +++  H N++++   C+      E    L+ E++          + +    +  I D+
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
                 M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++       
Sbjct: 126 ------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 937 ITQTQTLATIGYMAP 951
           +  T  + T+ Y AP
Sbjct: 174 MALTSVVVTLWYRAP 188

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 27/197 (13%)
Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV----ECEMM 830
           C   +++ +   IG+G FG V+KAR  + G +VA+K   ++  +  + F +    E +++
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 831 KSIRHRNLIKVISSCSTE-----EFKA---LILEYMPH---GSLEKSLYSSNYILDIFQR 879
           + ++H N++ +I  C T+       KA   L+ ++  H   G L   L    + L   +R
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKR 129
Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LIGEDQSI 937
           +  M+     L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q  
Sbjct: 130 VMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 938 TQTQTLATIGYMAPGLF 954
                + T+ Y  P L 
Sbjct: 185 RYXNRVVTLWYRPPELL 201

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 77
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 78  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 136
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 137 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYV 188
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 189 ATRWYRAPEIM 199

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 75
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 134
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 135 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 186
Query: 949 MAPGLF 954
            AP + 
Sbjct: 187 RAPEIM 192

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 73
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 132
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 184
Query: 949 MAPGLF 954
            AP + 
Sbjct: 185 RAPEIM 190

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 74
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 133
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 185
Query: 949 MAPGLF 954
            AP + 
Sbjct: 186 RAPEIM 191

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 8/169 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQC-GRAFKSFDV-ECEMMKSIRHRNLIKVISSC 845
           IG G +G VYKA+   G   A+K   L+       S  + E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            T++   L+ E++    L+K L      L+     + ++ +   + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP + 
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVL 172

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQF-LI 131
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 132 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYV 183
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 184 ATRWYRAPEIM 194

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           N FS + +IGRGGFG VY  R  + G   A+K  D       K   ++     ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 839 IKVISS-------CSTEEFK-----ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
           + ++S+       C +  F      + IL+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLAT 945
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 353
Query: 946 IGYMAPGLFH 955
            GYMAP +  
Sbjct: 354 HGYMAPEVLQ 363

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 74
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 133
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 134 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 185
Query: 949 MAPGLF 954
            AP + 
Sbjct: 186 RAPEIM 191

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           N FS + +IGRGGFG VY  R  + G   A+K  D       K   ++     ++  R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 241
Query: 839 IKVISS-------CSTEEFK-----ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
           + ++S+       C +  F      + IL+ M  G L   L       +   R     ++
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 300
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLAT 945
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T
Sbjct: 301 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 352
Query: 946 IGYMAPGLFH 955
            GYMAP +  
Sbjct: 353 HGYMAPEVLQ 362

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 72
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++  S  + D   +  ++
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQF-LI 131
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+ +    E      T  +
Sbjct: 132 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYV 183
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 184 ATRWYRAPEIM 194

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 8/169 (4%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQC-GRAFKSFDV-ECEMMKSIRHRNLIKVISSC 845
           IG G +G VYKA+   G   A+K   L+       S  + E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            T++   L+ E++    L+K L      L+     + ++ +   + Y H      V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP + 
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVL 172

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDL---QCGRAFKSFDVECEMMKSIRHRN 837
           FS+   IG G FG+VY AR     EV A+K       Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 838 LIKVISSCSTEEFKA-LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT----LEY 892
            I+    C   E  A L++EY         L S++ +L++ ++    V++A      L+ 
Sbjct: 77  TIQY-RGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           L + +S  +IH D+K  N+LL +  +  L DFG A ++
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 96
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 155
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 156 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 207
Query: 949 MAPGLF 954
            AP + 
Sbjct: 208 RAPEIM 213

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 97
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 156
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 208
Query: 949 MAPGLF 954
            AP + 
Sbjct: 209 RAPEIM 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 20/192 (10%)
Query: 766 TCRRFSYLELCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQ--CGRAFKS 822
           TC RF        T  +     +G+G F  V +  ++  G E A  + + +    R  + 
Sbjct: 5   TCTRF--------TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK 56
Query: 823 FDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
            + E  + + ++H N++++  S S E    LI + +  G L + + +  Y    +   + 
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADA 112
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLIGEDQSITQ 939
              +   LE +   +   V+H +LKP N+LL   +      L+DFG+A  + GE Q+   
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--W 170
Query: 940 TQTLATIGYMAP 951
                T GY++P
Sbjct: 171 FGFAGTPGYLSP 182

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 78
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 137
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 138 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYV 189
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 190 ATRWYRAPEIM 200

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 100
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 159
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 160 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 211
Query: 949 MAPGLF 954
            AP + 
Sbjct: 212 RAPEIM 217

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 133
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 134 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYV 185
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 186 ATRWYRAPEIM 196

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA++    F+ Q  C R  +    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 134
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 192 VATRWYRAPEIM 203

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 82
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 141
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 193
Query: 949 MAPGLF 954
            AP + 
Sbjct: 194 RAPEIM 199

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 79
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 138
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 190
Query: 949 MAPGLF 954
            AP + 
Sbjct: 191 RAPEIM 196

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 84
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 195
Query: 949 MAPGLF 954
            AP + 
Sbjct: 196 RAPEIM 201

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 89
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 148
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 200
Query: 949 MAPGLF 954
            AP + 
Sbjct: 201 RAPEIM 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           N FS + +IGRGGFG VY  R  + G   A+K  D       K   ++     ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 839 IKVISS-------CSTEEFK-----ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
           + ++S+       C +  F      + IL+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLAT 945
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 353
Query: 946 IGYMAPGLFH 955
            GYMAP +  
Sbjct: 354 HGYMAPEVLQ 363

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 79
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 138
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 139 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 190
Query: 949 MAPGLF 954
            AP + 
Sbjct: 191 RAPEIM 196

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 74
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 133
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 134 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYV 185
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 186 ATRWYRAPEIM 196

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           N FS + +IGRGGFG VY  R  + G   A+K  D       K   ++     ++  R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIM 242
Query: 839 IKVISS-------CSTEEFK-----ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
           + ++S+       C +  F      + IL+ M  G L   L       +   R     ++
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEI 301
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLAT 945
              LE++H  +   V++ DLKP+N+LLD++    +SD G+A      D S  +   ++ T
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 353
Query: 946 IGYMAPGLFH 955
            GYMAP +  
Sbjct: 354 HGYMAPEVLQ 363

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 89
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 148
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 200
Query: 949 MAPGLF 954
            AP + 
Sbjct: 201 RAPEIM 206

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFD------VECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 82
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 141
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 142 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 193
Query: 949 MAPGLF 954
            AP + 
Sbjct: 194 RAPEIM 199

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 76
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 77  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 135
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 136 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 187
Query: 949 MAPGLF 954
            AP + 
Sbjct: 188 RAPEIM 193

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 83
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 142
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 194
Query: 949 MAPGLF 954
            AP + 
Sbjct: 195 RAPEIM 200

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFD------VECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFD------VECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 88
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 147
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 148 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 199
Query: 949 MAPGLF 954
            AP + 
Sbjct: 200 RAPEIM 205

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 15/179 (8%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G      +T  LA T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAPEI 209

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG+AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 83
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 142
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 194
Query: 949 MAPGLF 954
            AP + 
Sbjct: 195 RAPEIM 200

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFD------LQCGRAFKSFDVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK         +   R ++    E  ++K 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR----ELRLLKH 89
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 148
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 149 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 200
Query: 949 MAPGLF 954
            AP + 
Sbjct: 201 RAPEIM 206

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         Y  N   +  ++L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 28/189 (14%)
Query: 788 IGRGGFGSVY--------KARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRN 837
           +G G FG V         K +     +VAVK+       +       E EMMK I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSL---------YSSNYILDIFQRLN------I 882
           +I ++ +C+ +    +I+EY   G+L + L         Y  N   +  ++L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 943 LATIGYMAP 951
              + +MAP
Sbjct: 198 RLPVKWMAP 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
           R  + F E  ++G+G FG V KAR   +    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNH 61
Query: 836 -------------RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
                        RN +K +++   +    + +EY  + +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
              +   L Y+H   S  +IH DLKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D+     ++DFG AK + G    +       T  Y+AP +
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 196

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAI 209

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 16/180 (8%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEV----AVKVFD---LQCGRAFKSFDVECEMMKS 832
           ++F    ++G+G FG V+  +   G +     A+KV     L+     ++  +E +++  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI-MVDVATTLE 891
           + H  ++K+  +  TE    LIL+++  G L   L  S  ++   + +   + ++A  L+
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALALD 140
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +LH   S  +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAP 195

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV----ECEM 829
            C   +++ +   IG+G FG V+KAR  + G +VA+K   ++  +  + F +    E ++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 830 MKSIRHRNLIKVISSCSTEEFKA--------LILEYMPH---GSLEKSLYSSNYILDIFQ 878
           ++ ++H N++ +I  C T+            L+ ++  H   G L   L    + L   +
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIK 128
Query: 879 RLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LIGEDQS 936
           R+  M+     L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q 
Sbjct: 129 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 937 ITQTQTLATIGYMAPGLF 954
                 + T+ Y  P L 
Sbjct: 184 NRYXNRVVTLWYRPPELL 201

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 16/180 (8%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEV----AVKVFD---LQCGRAFKSFDVECEMMKS 832
           ++F    ++G+G FG V+  +   G +     A+KV     L+     ++  +E +++  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI-MVDVATTLE 891
           + H  ++K+  +  TE    LIL+++  G L   L  S  ++   + +   + ++A  L+
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALALD 140
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +LH   S  +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAP 195

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 16/173 (9%)
Query: 787 LIGRGGFGSVY----KARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLI 839
           ++G+G FG V+      R   G   A+KV     L+     ++  +E +++  + H  ++
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFVV 93
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI-MVDVATTLEYLHFGYS 898
           K+  +  TE    LIL+++  G L   L  S  ++   + +   + ++A  L++LH   S
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALGLDHLH---S 148
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEYMAP 199

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 16/180 (8%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEV----AVKVFD---LQCGRAFKSFDVECEMMKS 832
           ++F    ++G+G FG V+  +   G +     A+KV     L+     ++  +E +++  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 83
Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI-MVDVATTLE 891
           + H  ++K+  +  TE    LIL+++  G L   L  S  ++   + +   + ++A  L+
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLAELALALD 141
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +LH   S  +I+ DLKP N+LLD+     L+DFG++K  I  D          T+ YMAP
Sbjct: 142 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAP 196

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 15/179 (8%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G       T TL  T  Y+AP +
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAPEI 230

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 83
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 84  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 134
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +    + 
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 191
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 192 VATRWYRAPEIM 203

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 34/192 (17%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKV---FDLQ--CGRAFKSFDVECEMMKSIR 834
           R++  + IG G +G V  A      + VA+K    F+ Q  C R  +    E +++   R
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFR 84
Query: 835 HRNLI---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIM 883
           H N+I    +I + + E+ K +   Y+    +E  LY        S+++I         +
Sbjct: 85  HENIIGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFL 135
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQT 942
             +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +    + 
Sbjct: 136 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX 192
Query: 943 LATIGYMAPGLF 954
           +AT  Y AP + 
Sbjct: 193 VATRWYRAPEIM 204

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 204

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 230

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 16/165 (9%)
Query: 785 NNLIGRGGFGSVY--------KARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR 836
           + +IG+G FG VY        + RI   ++   ++ ++Q   AF     E  +M+ + H 
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR---EGLLMRGLNHP 82
Query: 837 NLIKVIS-SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           N++ +I      E    ++L YM HG L + + S      +   ++  + VA  +EYL  
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA- 141
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLIGEDQSITQ 939
                 +H DL   N +LD++    ++DFG+A+ +L  E  S+ Q
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 73
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 132
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 184
Query: 949 MAPGLF 954
            AP + 
Sbjct: 185 RAPEIM 190

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 27/197 (13%)
Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV----ECEMM 830
           C   +++ +   IG+G FG V+KAR  + G +VA+K   ++  +  + F +    E +++
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 70
Query: 831 KSIRHRNLIKVISSCSTEEFKA--------LILEYMPH---GSLEKSLYSSNYILDIFQR 879
           + ++H N++ +I  C T+            L+ ++  H   G L   L    + L   +R
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKR 128
Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LIGEDQSI 937
           +  M+     L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q  
Sbjct: 129 VMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 938 TQTQTLATIGYMAPGLF 954
                + T+ Y  P L 
Sbjct: 184 RYXNRVVTLWYRPPELL 200

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 786 NLIGRGGFGSVYKARIGEG--------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
            ++G G +G V+  R   G        M+V  K   +Q  +  +    E ++++ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 838 -LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV-DVATTLEYLHF 895
            L+ +  +  TE    LIL+Y+  G L   L       +    + I V ++   LE+LH 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALEHLH- 176
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
                +I+ D+K  N+LLD N    L+DFG++K  +  D++        TI YMAP +
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGTIEYMAPDI 231

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 27/200 (13%)
Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARI-----GEGME-VAVKVF-DLQCGRAFKSFDVE 826
           E+  +  RF E   +G   FG VYK  +     GE  + VA+K   D   G   + F  E
Sbjct: 5   EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQR------- 879
             +   ++H N++ ++   + ++  ++I  Y  HG L + L   +   D+          
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 880 --------LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 931
                   ++++  +A  +EYL    S  V+H DL   NVL+ D +   +SD G+ + + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 932 GEDQSITQTQTLATIGYMAP 951
             D       +L  I +MAP
Sbjct: 180 AADYYKLLGNSLLPIRWMAP 199

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPEI 209

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 778 ATNRFSENN-----LIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMK 831
           ++NR   +N     ++G+G FG V  AR+ E G   AVKV  L+     +  DVEC M +
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTE 73
Query: 832 ------SIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
                 +  H  L ++     T +    ++E++  G L   +  S    +   R     +
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAE 132
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           + + L +LH      +I+ DLK  NVLLD      L+DFG+ K  I     +T      T
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGT 187
Query: 946 IGYMAPGLFH 955
             Y+AP +  
Sbjct: 188 PDYIAPEILQ 197

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 94/197 (47%), Gaps = 27/197 (13%)
Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV----ECEMM 830
           C   +++ +   IG+G FG V+KAR  + G +VA+K   ++  +  + F +    E +++
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 831 KSIRHRNLIKVISSCSTEEFKA--------LILEYMPH---GSLEKSLYSSNYILDIFQR 879
           + ++H N++ +I  C T+            L+ ++  H   G L   L    + L   +R
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKR 129
Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LIGEDQSI 937
           +  M+     L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+   L    Q  
Sbjct: 130 VMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 938 TQTQTLATIGYMAPGLF 954
                + T+ Y  P L 
Sbjct: 185 RYXNRVVTLWYRPPELL 201

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 781 RFSENNL-----IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR 834
            F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 835 -------HRNLIKVISSCSTEEFKALILEYMPHGSL--------EKSLYSSN-YILDIFQ 878
                  H N++ ++ +C+      +I EY  +G L        E  L   +   L++  
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 879 RLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
            L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +   I 
Sbjct: 154 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 939 QTQTLATIGYMAP-GLFHVKYILFVVNFLTSYSFLMIFI 976
           +      + +MAP  +F   Y   V + + SY  L+  I
Sbjct: 211 KGNARLPVKWMAPESIFDCVYT--VQSDVWSYGILLWEI 247

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G  VAVK    +  R F+S         E 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 91
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 92  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 150
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +
Sbjct: 151 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYV 202
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 203 ATRWYRAPEIM 213

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRHRNLIKVIS 843
           +G G FG V+  R    G   A+KV   +     K  +    E  M+  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
           +    +   +I++Y+  G L   L  S    +   +     +V   LEYLH   S  +I+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLL 930
            DLKP N+LLD N    ++DFG AK +
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYV 156

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 769 RFSYLELCRAT-NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDV- 825
           ++ +LE    T N F +  ++G+GGFG V   ++   G   A K  + +  +  K   + 
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 826 --ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNI 882
             E ++++ +  R ++ +  +  T++   L+L  M  G L+  +Y          + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
             ++   LE LH      +++ DLKP N+LLDD+    +SD G+A + + E Q+I     
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGR 345
Query: 943 LATIGYMAPGLFHVKYILFVVNFLT 967
           + T+GYMAP +   +   F  ++  
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWA 370

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 97
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 156
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 157 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 208
Query: 949 MAPGLF 954
            AP + 
Sbjct: 209 RAPEIM 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + D+G+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSV---YKARIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKSIRHRNL 838
           +G G +GSV   Y AR+ +  +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 839 IKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV-DVATTLEYL 893
           I ++     + S E+F  + L     G+   ++     + D  + +  +V  +   L+Y+
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLVYQLLRGLKYI 139
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   SA +IH DLKPSNV ++++    + DFG+A+    E      T  +AT  Y AP +
Sbjct: 140 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRAPEI 191
Query: 954 F 954
Sbjct: 192 M 192

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 781 RFSENNL-----IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR 834
            F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 835 -------HRNLIKVISSCSTEEFKALILEYMPHGSL--------EKSLYSSN-YILDIFQ 878
                  H N++ ++ +C+      +I EY  +G L        E  L   +   L++  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 879 RLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
            L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +   I 
Sbjct: 162 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 939 QTQTLATIGYMAP-GLFHVKYILFVVNFLTSYSFLMIFI 976
           +      + +MAP  +F   Y   V + + SY  L+  I
Sbjct: 219 KGNARLPVKWMAPESIFDCVYT--VQSDVWSYGILLWEI 255

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSV---YKARIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKSIRHRNL 838
           +G G +GSV   Y AR+ +  +VAVK    +  R F+S         E  ++K ++H N+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 839 IKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV-DVATTLEYL 893
           I ++     + S E+F  + L     G+   ++     + D  + +  +V  +   L+Y+
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSD--EHVQFLVYQLLRGLKYI 147
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H   SA +IH DLKPSNV ++++    + DFG+A+    E      T  +AT  Y AP +
Sbjct: 148 H---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEI 199
Query: 954 F 954
Sbjct: 200 M 200

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/180 (23%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMK-SIRHRNLIK 840
           F   +++G G  G++    + +  +VAVK    +C   F   D E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
              +    +F+ + +E +   +L++ +   ++     + + ++    + L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 901 VIHCDLKPSNVLLD-----DNMVAHLSDFGIA-KLLIGEDQSITQTQTLATIGYMAPGLF 954
           ++H DLKP N+L+        + A +SDFG+  KL +G      ++    T G++AP + 
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 83
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 142
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 143 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 194
Query: 949 MAPGLF 954
            AP + 
Sbjct: 195 RAPEIM 200

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 769 RFSYLELCRAT-NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDV- 825
           ++ +LE    T N F +  ++G+GGFG V   ++   G   A K  + +  +  K   + 
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 826 --ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNI 882
             E ++++ +  R ++ +  +  T++   L+L  M  G L+  +Y          + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
             ++   LE LH      +++ DLKP N+LLDD+    +SD G+A + + E Q+I     
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGR 345
Query: 943 LATIGYMAPGLFHVKYILFVVNFLT 967
           + T+GYMAP +   +   F  ++  
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWA 370

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 19/152 (12%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQC-GRAFKSFDVECEM--MKSIRHRNLIKVIS 843
           +G G FG V  A       +VA+K    Q   ++     VE E+  +K +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 844 SCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
             +T     +++EY   G L     EK   + +     FQ+      +   +EY H    
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQ------IICAIEYCH---R 126
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
             ++H DLKP N+LLDDN+   ++DFG++ ++
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 93/194 (47%), Gaps = 32/194 (16%)
Query: 777 RATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGR---AFK--SFDVECEMMK 831
           R T  F E  ++G G F  V+  +      +  K+F L+C +   AF+  S + E  ++K
Sbjct: 8   RKTFIFME--VLGSGAFSEVFLVK----QRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGS-----LEKSLYSSNYILDIFQRLNIMVDV 886
            I+H N++ +     +     L+++ +  G      LE+ +Y+      + Q+      V
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ------V 115
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
            + ++YLH      ++H DLKP N+L    ++N    ++DFG++K+    +Q+   +   
Sbjct: 116 LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTAC 168
Query: 944 ATIGYMAPGLFHVK 957
            T GY+AP +   K
Sbjct: 169 GTPGYVAPEVLAQK 182

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L K+  S        +++EY P G +   L       +   R      +  T EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 210

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 95
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 154
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         +
Sbjct: 155 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYV 206
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 207 ATRWYRAPEIM 217

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)
Query: 779 TNRFSENNLIGRGGFGSVY--KARIGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSI 833
           ++R+    ++G+G FG V   K +I  G E AVKV     ++     +S   E +++K +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
            H N++K+      + +  L+ E    G L   + S     ++     I+  V + + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 894 HFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      ++H DLKP N+LL+    +    + DFG++      + S      + T  Y+A
Sbjct: 149 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 202
Query: 951 PGLFHVKY 958
           P + H  Y
Sbjct: 203 PEVLHGTY 210

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 73
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF-LIYQILR 132
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 184
Query: 949 MAPGLF 954
            AP + 
Sbjct: 185 RAPEIM 190

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+     +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 87
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 88  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 146
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 147 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 198
Query: 949 MAPGLF 954
            AP + 
Sbjct: 199 RAPEIM 204

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 98/386 (25%), Positives = 157/386 (40%), Gaps = 69/386 (17%)
Query: 249 LAELELMALQVSNLQGEIPQ-ELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
           LAE     L  +N+   + Q +L  +T L+  +LG   + G     +  L+NL  ++ S+
Sbjct: 18  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 72
Query: 308 NKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLPNLEELRLWSNNFSGTIPRFI 367
           N+L    P                              L  L ++ + +N  +   P  +
Sbjct: 73  NQLTDITPLK---------------------------NLTKLVDILMNNNQIADITP--L 103
Query: 368 FNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTXXXXXXXXXXXXXXCKSLT 427
            N + L+ L L  N  +   P    NL NL  + L  N ++                SL 
Sbjct: 104 ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG-------LTSLQ 154
Query: 428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
            +  S+N +  + P   + NL+ +LE  D+S   VS      +  LTNL  +    N+++
Sbjct: 155 QLSFSSNQVTDLKP---LANLT-TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS 208
Query: 488 GSIPITXXXXXXXXXXHLEDNKLEGPIPDDI---CRLTKLYELGLSGNKLSGSIPACFSN 544
              P+           +L++  L G    DI     LT L +L L+ N++S   P   S 
Sbjct: 209 DITPL-------GILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSG 259
Query: 545 LASLGTLSLGSNKLTSI-PLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN 603
           L  L  L LG+N++++I PL    L  +  L  + N      P  I NLK L  +    N
Sbjct: 260 LTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 315
Query: 604 NFSDVIPTVIGGLTNLQYLFLGYNRL 629
           N SD+ P  +  LT LQ LF   N++
Sbjct: 316 NISDISP--VSSLTKLQRLFFSNNKV 339

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIKVI 842
           +G G FGSV    Y+ R  + ++VA+KV      +A  +    E ++M  + +  ++++I
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
             C  E    L++E    G L K L      + +     ++  V+  ++YL        +
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
           H DL   NVLL +   A +SDFG++K L  +D   T
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+++D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
             S  +I+ DLKP N+L+D      ++DFG AK + G    +       T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEI 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMK------SIR 834
           F  + ++G+G FG V+ A   +  +  A+K   L+        DVEC M++      +  
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H  L  +  +  T+E    ++EY+  G L   + S  +  D+ +      ++   L++LH
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 136
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LIGEDQSITQTQTLATIGYMAPGL 953
              S  +++ DLK  N+LLD +    ++DFG+ K  ++G+ ++    +   T  Y+AP +
Sbjct: 137 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NEFCGTPDYIAPEI 190

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV---ECEMMKSIRH 835
           ++F     +G G FG V   +  E G   A+K+ D Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L       +   R      +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 932
             S  +I+ DLKP N+L+D      ++DFG AK + G
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 40/205 (19%)
Query: 782 FSENNLI-----GRGGFGSVYKA-------RIGEGMEVAVKVFDLQCGRA-FKSFDVECE 828
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY-TTVAVKMLKENASPSELRDLLSEFN 78
Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--------------- 873
           ++K + H ++IK+  +CS +    LI+EY  +GSL   L  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 874 --------LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFG 195
Query: 926 IAKLLIGEDQSITQTQTLATIGYMA 950
           +++ +  ED  + ++Q    + +MA
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 50/189 (26%), Positives = 85/189 (44%), Gaps = 30/189 (15%)
Query: 782 FSENNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           F E  LIG GGFG V+KA  RI +G    +K       +A    + E + +  + H N++
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 840 KV------------ISSCSTEEFKA----LILEYMPHGSLEKSLYSSN-YILDIFQRLNI 882
                          SS ++   K     + +E+   G+LE+ +       LD    L +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L  + +   + ++
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRS 181
Query: 943 LATIGYMAP 951
             T+ YM+P
Sbjct: 182 KGTLRYMSP 190

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)
Query: 779 TNRFSENNLIGRGGFGSVY--KARIGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSI 833
           ++R+    ++G+G FG V   K +I  G E AVKV     ++     +S   E +++K +
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
            H N++K+      + +  L+ E    G L   + S     ++     I+  V + + Y+
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 166
Query: 894 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      ++H DLKP N+LL+    +    + DFG++      + S      + T  Y+A
Sbjct: 167 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 220
Query: 951 PGLFHVKY 958
           P + H  Y
Sbjct: 221 PEVLHGTY 228

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 40/205 (19%)
Query: 782 FSENNLI-----GRGGFGSVYKA-------RIGEGMEVAVKVFDLQCGRA-FKSFDVECE 828
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY-TTVAVKMLKENASPSELRDLLSEFN 78
Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--------------- 873
           ++K + H ++IK+  +CS +    LI+EY  +GSL   L  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 874 --------LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 926 IAKLLIGEDQSITQTQTLATIGYMA 950
           +++ +  ED  + ++Q    + +MA
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 89/188 (47%), Gaps = 26/188 (13%)
Query: 781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRNL 838
           R++  + IG G +G V  A      + VA+K       + +    + E +++   RH N+
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 839 I---KVISSCSTEEFKALILEYMPHGSLEKSLY--------SSNYILDIFQRLNIMVDVA 887
           I    +I + + E+ K +   Y+    +E  LY        S+++I         +  + 
Sbjct: 88  IGINDIIRAPTIEQMKDV---YIVQDLMETDLYKLLKTQHLSNDHIC------YFLYQIL 138
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQTLATI 946
             L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT 
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 947 GYMAPGLF 954
            Y AP + 
Sbjct: 196 WYRAPEIM 203

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)
Query: 779 TNRFSENNLIGRGGFGSVY--KARIGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSI 833
           ++R+    ++G+G FG V   K +I  G E AVKV     ++     +S   E +++K +
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
            H N++K+      + +  L+ E    G L   + S     ++     I+  V + + Y+
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 165
Query: 894 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      ++H DLKP N+LL+    +    + DFG++      + S      + T  Y+A
Sbjct: 166 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 219
Query: 951 PGLFHVKY 958
           P + H  Y
Sbjct: 220 PEVLHGTY 227

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 14/147 (9%)
Query: 788 IGRGGFGSVYK--ARIGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISS 844
           +G G + +VYK  +++ + + VA+K   L+         + E  ++K ++H N++ +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILD---IFQRLNIMVDVATTLEYLHFGYSAPV 901
             TE+   L+ EY     L+K L    Y+ D   I    N+ + +   L  L + +   V
Sbjct: 69  IHTEKSLTLVFEY-----LDKDL--KQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           +H DLKP N+L+++     L+DFG+A+
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     M VA+K   +       + F  E   M+   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 788 IGRGGFGSVYK-ARIGEGMEVAVKVFDL-QCGRAFKSFDV-ECEMMKSIRHRNLIK---- 840
           IG G +G   K  R  +G  +  K  D      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 841 VISSCSTEEFKALILEYMPHGSLE----KSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           +I   +T  +  +++EY   G L     K      Y+ + F  L +M  +   L+  H  
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 897 YSA--PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                 V+H DLKP+NV LD      L DFG+A++L   D S  +T  + T  YM+P
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT-FVGTPYYMSP 185

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 71/174 (40%), Gaps = 6/174 (3%)
Query: 514 IPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWN-LKGML 572
           IP +I   TK  +L L  NKLS      F  L  L  L L  NKL ++P  I+  LK + 
Sbjct: 31  IPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 573 YLNFSSNFFTGPLPLDI-GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG 631
            L  + N     LP+ +   L  L  +    N    + P V   LT L YL LGYN LQ 
Sbjct: 89  TLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS 147
Query: 632 SISESFGDXXXXXXXXXXXXXXXXXXXXXXEKLSYLEDLDLSFNKLKGEIPKGG 685
                F                        +KL+ L+ L L  N+LK  +P+G 
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 346 LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYN 405
           L NL ++   +N  +   P  + N +KL  + +  N  +   P    NL NL  +TL  N
Sbjct: 66  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 121
Query: 406 YLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGI--------LPRMSMGN-------LSH 450
            +T                +L  + LS+N +  I        L ++S GN       L++
Sbjct: 122 QITDIDPLKN-------LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLAN 174
Query: 451 --SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDN 508
             +LE  D+S   VS      +  LTNL  +    N+++   P+           +L++ 
Sbjct: 175 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL-------GILTNLDEL 225
Query: 509 KLEGPIPDDI---CRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI-PLT 564
            L G    DI     LT L +L L+ N++S   P   S L  L  L LG+N++++I PL 
Sbjct: 226 SLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 283
Query: 565 IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL 624
              L  +  L  + N      P  I NLK L  +    NN SD+ P  +  LT LQ LF 
Sbjct: 284 --GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 337
Query: 625 GYNRL 629
             N++
Sbjct: 338 ANNKV 342

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 16/188 (8%)
Query: 779 TNRFSENNLIGRGGFGSVY--KARIGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSI 833
           ++R+    ++G+G FG V   K +I  G E AVKV     ++     +S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
            H N++K+      + +  L+ E    G L   + S     ++     I+  V + + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 894 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      ++H DLKP N+LL+    +    + DFG++      + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIA 196
Query: 951 PGLFHVKY 958
           P + H  Y
Sbjct: 197 PEVLHGTY 204

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 24/191 (12%)
Query: 775 LCRATNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVEC 827
           +     R+   + +G G +GSV  A     G  VAVK    +  R F+S         E 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYREL 92
Query: 828 EMMKSIRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++K ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 151
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         +
Sbjct: 152 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXV 203
Query: 944 ATIGYMAPGLF 954
           AT  Y AP + 
Sbjct: 204 ATRWYRAPEIM 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 40/205 (19%)
Query: 782 FSENNLI-----GRGGFGSVYKA-------RIGEGMEVAVKVFDLQCGRA-FKSFDVECE 828
           F   NL+     G G FG V KA       R G    VAVK+       +  +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGY-TTVAVKMLKENASPSELRDLLSEFN 78
Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--------------- 873
           ++K + H ++IK+  +CS +    LI+EY  +GSL   L  S  +               
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 874 --------LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
                   L +   ++    ++  ++YL       ++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 926 IAKLLIGEDQSITQTQTLATIGYMA 950
           +++ +  ED  + ++Q    + +MA
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMA 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 73
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 132
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         +AT  Y
Sbjct: 133 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWY 184
Query: 949 MAPGLF 954
            AP + 
Sbjct: 185 RAPEIM 190

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 98/386 (25%), Positives = 157/386 (40%), Gaps = 69/386 (17%)
Query: 249 LAELELMALQVSNLQGEIPQ-ELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
           LAE     L  +N+   + Q +L  +T L+  +LG   + G     +  L+NL  ++ S+
Sbjct: 18  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 72
Query: 308 NKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLPNLEELRLWSNNFSGTIPRFI 367
           N+L    P                              L  L ++ + +N  +   P  +
Sbjct: 73  NQLTDITPLK---------------------------NLTKLVDILMNNNQIADITP--L 103
Query: 368 FNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTXXXXXXXXXXXXXXCKSLT 427
            N + L+ L L  N  +   P    NL NL  + L  N ++                SL 
Sbjct: 104 ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG-------LTSLQ 154
Query: 428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
            +  S+N +  + P   + NL+ +LE  D+S   VS      +  LTNL  +    N+++
Sbjct: 155 QLSFSSNQVTDLKP---LANLT-TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS 208
Query: 488 GSIPITXXXXXXXXXXHLEDNKLEGPIPDDI---CRLTKLYELGLSGNKLSGSIPACFSN 544
              P+           +L++  L G    DI     LT L +L L+ N++S   P   S 
Sbjct: 209 DITPL-------GILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSG 259
Query: 545 LASLGTLSLGSNKLTSI-PLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN 603
           L  L  L LG+N++++I PL    L  +  L  + N      P  I NLK L  +    N
Sbjct: 260 LTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 315
Query: 604 NFSDVIPTVIGGLTNLQYLFLGYNRL 629
           N SD+ P  +  LT LQ LF   N++
Sbjct: 316 NISDISP--VSSLTKLQRLFFYNNKV 339

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 27/156 (17%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMKSIRHRNL 838
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH ++
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 76
Query: 839 IKVISSCSTEEFKALILEYMPHG----SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           IK+     +++   +++EY  +      +++   S       FQ+      + + +EY H
Sbjct: 77  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 130
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                 ++H DLKP N+LLD+++   ++DFG++ ++
Sbjct: 131 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 163

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + D G+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 781 RFSENNL-----IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR 834
            F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 835 -------HRNLIKVISSCSTEEFKALILEYMPHGSL------------EKSLYSSNYILD 875
                  H N++ ++ +C+      +I EY  +G L            E S   S+   +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 876 IFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
                +++   +   + + F  S   IH D+   NVLL +  VA + DFG+A+ ++ +  
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 936 SITQTQTLATIGYMAP-GLFHVKYILFVVNFLTSYSFLMIFI 976
            I +      + +MAP  +F   Y   V + + SY  L+  I
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYT--VQSDVWSYGILLWEI 261

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    +  FG+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 27/156 (17%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMKSIRHRNL 838
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH ++
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 75
Query: 839 IKVISSCSTEEFKALILEYMPHG----SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           IK+     +++   +++EY  +      +++   S       FQ+      + + +EY H
Sbjct: 76  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 129
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                 ++H DLKP N+LLD+++   ++DFG++ ++
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     M VA+K   +       + F  E   M+   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    + LD+   +     ++T L YL 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAP 181

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 27/156 (17%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMKSIRHRNL 838
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH ++
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 70
Query: 839 IKVISSCSTEEFKALILEYMPHG----SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           IK+     +++   +++EY  +      +++   S       FQ+      + + +EY H
Sbjct: 71  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 124
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                 ++H DLKP N+LLD+++   ++DFG++ ++
Sbjct: 125 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 157

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 27/156 (17%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVF--------DLQCGRAFKSFDVECEMMKSIRHRNL 838
           +G G FG V  A     G +VA+K+         D+Q GR     + E   ++ +RH ++
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQ-GR----IEREISYLRLLRHPHI 66
Query: 839 IKVISSCSTEEFKALILEYMPHG----SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           IK+     +++   +++EY  +      +++   S       FQ+      + + +EY H
Sbjct: 67  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 120
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
                 ++H DLKP N+LLD+++   ++DFG++ ++
Sbjct: 121 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 153

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + D G+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 29/191 (15%)
Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEM-----MK 831
           AT+R+     IG G +G+VYKAR    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 832 SIRHRNLIKVISSCST----EEFK-ALILEYMPHG---SLEKSL---YSSNYILDIFQRL 880
           +  H N+++++  C+T     E K  L+ E++       L+K+      +  I D+ ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
                    L  L F ++  ++H DLKP N+L+       L+DFG+A++       +   
Sbjct: 122 ---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALA 169
Query: 941 QTLATIGYMAP 951
             + T+ Y AP
Sbjct: 170 PVVVTLWYRAP 180

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 43/202 (21%)
Query: 782 FSENNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           F E  LIG GGFG V+KA  RI +G    ++       +A    + E + +  + H N++
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRI-DGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIV 68
Query: 840 KV---------------------------ISSCSTEEFKALI--LEYMPHGSLEKSLYSS 870
                                          + S  + K L   +E+   G+LE+ +   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 871 N-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
               LD    L +   +   ++Y+H   S  +IH DLKPSN+ L D     + DFG+   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 930 LIGEDQSITQTQTLATIGYMAP 951
           L  + +   +T++  T+ YM+P
Sbjct: 186 LKNDGK---RTRSKGTLRYMSP 204

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 10/170 (5%)
Query: 786 NLIGRGGFGSVYKARIGEGMEV-AVKV---FDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
            +IGRG FG V   R     +V A+K+   F++        F  E ++M       ++++
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
             +   +++  +++EYMP G L   +  SNY +          +V   L+ +H   S  +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGL 195
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           IH D+KP N+LLD +    L+DFG   + + E   +     + T  Y++P
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAVGTPDYISP 244

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E         +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     + VA+K   +       + F  E   M+   
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 98  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 157 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 209

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 346 LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYN 405
           L NL ++   +N  +   P  + N +KL  + +  N  +   P    NL NL  +TL  N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 406 YLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGI--------LPRMSMGN-------LSH 450
            +T                +L  + LS+N +  I        L +++ GN       L++
Sbjct: 118 QITDIDPLKN-------LTNLNRLELSSNTISDISALSGLTSLQQLNFGNQVTDLKPLAN 170
Query: 451 --SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDN 508
             +LE  D+S   VS      +  LTNL  +    N+++   P+           +L++ 
Sbjct: 171 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL-------GILTNLDEL 221
Query: 509 KLEGPIPDDI---CRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI-PLT 564
            L G    DI     LT L +L L+ N++S   P   S L  L  L LG+N++++I PL 
Sbjct: 222 SLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 279
Query: 565 IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL 624
              L  +  L  + N      P  I NLK L  +    NN SD+ P  +  LT LQ LF 
Sbjct: 280 --GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 333
Query: 625 GYNRL 629
             N++
Sbjct: 334 SNNKV 338

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 98/386 (25%), Positives = 157/386 (40%), Gaps = 69/386 (17%)
Query: 249 LAELELMALQVSNLQGEIPQ-ELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
           LAE     L  +N+   + Q +L  +T L+  +LG   + G     +  L+NL  ++ S+
Sbjct: 18  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 72
Query: 308 NKLVGAVPATIFNMXXXXXXXXXXXXXXXXXXXIADVQLPNLEELRLWSNNFSGTIPRFI 367
           N+L    P                              L  L ++ + +N  +   P  +
Sbjct: 73  NQLTDITPLK---------------------------NLTKLVDILMNNNQIADITP--L 103
Query: 368 FNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTXXXXXXXXXXXXXXCKSLT 427
            N + L+ L L  N  +   P    NL NL  + L  N ++                SL 
Sbjct: 104 ANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG-------LTSLQ 154
Query: 428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
            +  S+N +  + P   + NL+ +LE  D+S   VS      +  LTNL  +    N+++
Sbjct: 155 QLNFSSNQVTDLKP---LANLT-TLERLDISSNKVSD--ISVLAKLTNLESLIATNNQIS 208
Query: 488 GSIPITXXXXXXXXXXHLEDNKLEGPIPDDI---CRLTKLYELGLSGNKLSGSIPACFSN 544
              P+           +L++  L G    DI     LT L +L L+ N++S   P   S 
Sbjct: 209 DITPL-------GILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSG 259
Query: 545 LASLGTLSLGSNKLTSI-PLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN 603
           L  L  L LG+N++++I PL    L  +  L  + N      P  I NLK L  +    N
Sbjct: 260 LTKLTELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN 315
Query: 604 NFSDVIPTVIGGLTNLQYLFLGYNRL 629
           N SD+ P  +  LT LQ LF   N++
Sbjct: 316 NISDISP--VSSLTKLQRLFFYNNKV 339

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 41/197 (20%)
Query: 788 IGRGGFGSVYKA---RIGEGMEVAVKVFD-----LQCGRAFKSFDVECEMMKSIRHRNLI 839
           +G+G +G V+K+   R GE + V  K+FD         R F+   +  E+       NL+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-KIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYS--SNYILDIFQRLNIMVDVATTLEYLHFGY 897
            V+ + +  +   L+ +YM     E  L++     IL+   +  ++  +   ++YLH G 
Sbjct: 76  NVLRADNDRDV-YLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG- 128
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI--------------------GEDQSI 937
              ++H D+KPSN+LL+      ++DFG+++  +                     +DQ I
Sbjct: 129 --GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 938 TQTQTLATIGYMAPGLF 954
             T  +AT  Y AP + 
Sbjct: 187 L-TDYVATRWYRAPEIL 202

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 17/161 (10%)
Query: 780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVK----VFD--LQCGRAFKSFDVECEMMKS 832
           +R+   +LIG G +G V +A    E   VA+K    VF+  + C R  +    E  ++  
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR----EIAILNR 108
Query: 833 IRHRNLIKVISSC---STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           + H +++KV+        E+F  L +      S  K L+ +   L       ++ ++   
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           ++Y+H   SA ++H DLKP+N L++ +    + DFG+A+ +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 954 F 954
Sbjct: 179 L 179

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     + VA+K   +       + F  E   M+   
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 75  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 134 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 186

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G+ VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + D G+A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     + VA+K   +       + F  E   M+   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/136 (25%), Positives = 65/136 (47%), Gaps = 10/136 (7%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  ++KS+ H N+IK+      +++  L+ E+   G L + + +  +  D     NIM  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQ 154
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSITQTQT 942
           + + + YLH      ++H D+KP N+LL++    +   + DFG++       +       
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDR 208
Query: 943 LATIGYMAPGLFHVKY 958
           L T  Y+AP +   KY
Sbjct: 209 LGTAYYIAPEVLKKKY 224

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 29/191 (15%)
Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEM-----MK 831
           AT+R+     IG G +G+VYKAR    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 832 SIRHRNLIKVISSCST----EEFK-ALILEYMPHG---SLEKSL---YSSNYILDIFQRL 880
           +  H N+++++  C+T     E K  L+ E++       L+K+      +  I D+ ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
                    L  L F ++  ++H DLKP N+L+       L+DFG+A++       +   
Sbjct: 122 ---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALD 169
Query: 941 QTLATIGYMAP 951
             + T+ Y AP
Sbjct: 170 PVVVTLWYRAP 180

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 794 GSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EE 849
           G ++K R  +G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 850 FKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI--HCDL 906
              LI  + P+GSL   L+  +N+++D  Q +   +D A    +LH     P+I  H  L
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-L 139
Query: 907 KPSNVLLDDNMVAHLS 922
              +V +D++  A +S
Sbjct: 140 NSRSVXIDEDXTARIS 155

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 77  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 130
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 131 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 788 IGRGGFGSVYK-ARIGEGMEVAVKVFDL-QCGRAFKSFDV-ECEMMKSIRHRNLIK---- 840
           IG G +G   K  R  +G  +  K  D      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 841 VISSCSTEEFKALILEYMPHGSLE----KSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           +I   +T  +  +++EY   G L     K      Y+ + F  L +M  +   L+  H  
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 897 YSA--PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                 V+H DLKP+NV LD      L DFG+A++L   D+   + + + T  YM+P
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAK-EFVGTPYYMSP 185

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     + VA+K   +       + F  E   M+   
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 73  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 132 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 184

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 17/175 (9%)
Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISS 844
           L+G G +G VYK R +  G   A+KV D+  G   +    E  M+K    HRN+     +
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 845 C------STEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGY 897
                    ++   L++E+   GS+   + ++    L       I  ++   L +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
              VIH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAP 198

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     + VA+K   +       + F  E   M+   
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 72  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 131 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 183

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     + VA+K   +       + F  E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 178

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++  + H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 952 GLF 954
             F
Sbjct: 216 EAF 218

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 346 LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYN 405
           L NL ++   +N  +   P  + N +KL  + +  N  +   P    NL NL  +TL  N
Sbjct: 67  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122
Query: 406 YLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGI--------LPRMSMGN-------LSH 450
            +T                +L  + LS+N +  I        L ++S GN       L++
Sbjct: 123 QITDIDPLKN-------LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLAN 175
Query: 451 --SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDN 508
             +LE  D+S   VS      +  LTNL  +    N+++   P+           +L++ 
Sbjct: 176 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL-------GILTNLDEL 226
Query: 509 KLEGPIPDDI---CRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI-PLT 564
            L G    DI     LT L +L L+ N++S   P   S L  L  L LG+N++++I PL 
Sbjct: 227 SLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 284
Query: 565 IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL 624
              L  +  L  + N      P  I NLK L  +    NN SD+ P  +  LT LQ LF 
Sbjct: 285 --GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338
Query: 625 GYNRL 629
             N++
Sbjct: 339 YNNKV 343

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 85/177 (48%), Gaps = 17/177 (9%)
Query: 785 NNLIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMMK------SIRHRN 837
           + ++G+G FG V+ A   +  +  A+K   L+        DVEC M++      +  H  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           L  +  +  T+E    ++EY+  G L   + S  +  D+ +      ++   L++LH   
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH--- 135
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LIGEDQSITQTQTLATIGYMAPGL 953
           S  +++ DLK  N+LLD +    ++DFG+ K  ++G+ ++        T  Y+AP +
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NXFCGTPDYIAPEI 189

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 18/166 (10%)
Query: 777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
           R  + F E  ++G+G FG V KAR   +    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNH 61
Query: 836 -------------RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
                        RN +K  ++   +    +  EY  + +L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
              +   L Y+H   S  +IH +LKP N+ +D++    + DFG+AK
Sbjct: 122 FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++  + H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 952 GLF 954
             F
Sbjct: 230 EAF 232

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 29/191 (15%)
Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEM-----MK 831
           AT+R+     IG G +G+VYKAR    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 832 SIRHRNLIKVISSCST----EEFK-ALILEYMPHG---SLEKSL---YSSNYILDIFQRL 880
           +  H N+++++  C+T     E K  L+ E++       L+K+      +  I D+ ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
                    L  L F ++  ++H DLKP N+L+       L+DFG+A++       +   
Sbjct: 122 ---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALF 169
Query: 941 QTLATIGYMAP 951
             + T+ Y AP
Sbjct: 170 PVVVTLWYRAP 180

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 18/177 (10%)
Query: 788 IGRGGFGSVYK-ARIGEGMEVAVKVFDL-QCGRAFKSFDV-ECEMMKSIRHRNLIK---- 840
           IG G +G   K  R  +G  +  K  D      A K   V E  +++ ++H N+++    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 841 VISSCSTEEFKALILEYMPHGSLE----KSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           +I   +T  +  +++EY   G L     K      Y+ + F  L +M  +   L+  H  
Sbjct: 74  IIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 897 YSA--PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                 V+H DLKP+NV LD      L DFG+A++L   D S  +   + T  YM+P
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKA-FVGTPYYMSP 185

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 16/188 (8%)
Query: 779 TNRFSENNLIGRGGFGSVY--KARIGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSI 833
           ++R+    ++G+G FG V   K +I  G E AVKV     ++     +S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
            H N+ K+      + +  L+ E    G L   + S     ++     I+  V + + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 894 HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      ++H DLKP N+LL+    +    + DFG++      + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYIA 196
Query: 951 PGLFHVKY 958
           P + H  Y
Sbjct: 197 PEVLHGTY 204

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 177
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 14/171 (8%)
Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKV---FDL--QCGRAFKSFDVECEMMKSIRHRNLIK 840
           +IGRG FG V   R     +V A+K+   F++  +   AF  F  E ++M       +++
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 138
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  +   + +  +++EYMP G L  +L S+  + + + R     +V   L+ +H   S  
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 193
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            IH D+KP N+LLD +    L+DFG   + + ++  +     + T  Y++P
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 243

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 14/171 (8%)
Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKV---FDL--QCGRAFKSFDVECEMMKSIRHRNLIK 840
           +IGRG FG V   R     +V A+K+   F++  +   AF  F  E ++M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 133
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  +   + +  +++EYMP G L  +L S+  + + + R     +V   L+ +H   S  
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 188
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            IH D+KP N+LLD +    L+DFG   + + ++  +     + T  Y++P
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 238

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     M VA+K   +       + F  E   M+   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    + LD+   +     ++T L YL 
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 509 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 561

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 952 GLF 954
             F
Sbjct: 207 EAF 209

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSF------DVECEMMKS 832
            R+   + +G G +GSV  A     G  VAVK    +  R F+S         E  ++K 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK----KLSRPFQSIIHAKRTYRELRLLKH 77
Query: 833 IRHRNLIKVIS----SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++H N+I ++     + S EEF  + L     G+   ++     + D   +  ++  +  
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILR 136
Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
            L+Y+H   SA +IH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y
Sbjct: 137 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWY 188
Query: 949 MAPGLF 954
            AP + 
Sbjct: 189 RAPEIM 194

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 788 IGRGGFGSV----YKARIGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLIKVI 842
           +G G FGSV    Y+ R  + ++VA+KV      +A  +    E ++M  + +  ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
             C  E    L++E    G L K L      + +     ++  V+  ++YL        +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
           H +L   NVLL +   A +SDFG++K L  +D   T
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 782 FSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           ++  N IGRG +G V  A + G  +  A K            F  E E+MKS+ H N+I+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 841 VISSCSTEEFKALILEYMPHGSL-EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           +  +        L++E    G L E+ ++   +      R  IM DV + + Y H     
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---KL 125
Query: 900 PVIHCDLKPSNVL-LDDNMVAHLS--DFGIA 927
            V H DLKP N L L D+  + L   DFG+A
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/169 (23%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 177
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 37/198 (18%)
Query: 779 TNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVK--------VFDLQCGRAFKSFDVECEM 829
           ++ F   +L+G G +G V  A     G  VA+K        +F L+  R       E ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDV 886
           +K  +H N+I + +    + F+     Y+    ++  L+   S+  + D     +I   +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD----HIQYFI 118
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ------- 939
             TL  +   + + VIH DLKPSN+L++ N    + DFG+A+++   D+S          
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII---DESAADNSEPTGQ 175
Query: 940 ----TQTLATIGYMAPGL 953
               T+ +AT  Y AP +
Sbjct: 176 QSGMTEXVATRWYRAPEV 193

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 952 GLF 954
             F
Sbjct: 215 EAF 217

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 782 FSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           ++  N IGRG +G V  A + G  +  A K            F  E E+MKS+ H N+I+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 841 VISSCSTEEFKALILEYMPHGSL-EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           +  +        L++E    G L E+ ++   +      R  IM DV + + Y H     
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---KL 142
Query: 900 PVIHCDLKPSNVL-LDDNMVAHLS--DFGIA 927
            V H DLKP N L L D+  + L   DFG+A
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 20/176 (11%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI-FQRL--NIMVDVATTLEYLHFGYS 898
                    + L LEY   G L   +     + +   QR    +M  V     YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 952 GLF 954
             F
Sbjct: 222 EAF 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 954 F 954
Sbjct: 179 L 179

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 954 F 954
Sbjct: 179 L 179

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 13  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 68
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 119
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 954 F 954
Sbjct: 177 L 177

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 954 F 954
Sbjct: 179 L 179

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 130/305 (42%), Gaps = 49/305 (16%)
Query: 346 LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYN 405
           L NL ++   +N  +   P  + N +KL  + +  N  +   P    NL NL  +TL  N
Sbjct: 62  LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 117
Query: 406 YLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGI--------LPRMSMGN-------LSH 450
            +T                +L  + LS+N +  I        L +++ GN       L++
Sbjct: 118 QITDIDPLKN-------LTNLNRLELSSNTISDISALSGLTSLQQLNFGNQVTDLKPLAN 170
Query: 451 --SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDN 508
             +LE  D+S   VS      +  LTNL  +    N+++   P+           +L++ 
Sbjct: 171 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPL-------GILTNLDEL 221
Query: 509 KLEGPIPDDI---CRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI-PLT 564
            L G    DI     LT L +L L+ N++S   P   S L  L  L LG+N++++I PL 
Sbjct: 222 SLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA 279
Query: 565 IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL 624
              L  +  L  + N      P  I NLK L  +    NN SD+ P  +  LT LQ LF 
Sbjct: 280 --GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 333
Query: 625 GYNRL 629
             N++
Sbjct: 334 YNNKV 338

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 954 F 954
Sbjct: 179 L 179

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 954 F 954
Sbjct: 179 L 179

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 20/176 (11%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI-FQRL--NIMVDVATTLEYLHFGYS 898
                    + L LEY   G L   +     + +   QR    +M  V     YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 122
Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 952 GLF 954
             F
Sbjct: 216 EAF 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 14/171 (8%)
Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKV---FDL--QCGRAFKSFDVECEMMKSIRHRNLIK 840
           +IGRG FG V   R     +V A+K+   F++  +   AF  F  E ++M       +++
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQ 138
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  +   + +  +++EYMP G L  +L S+  + + + R     +V   L+ +H   S  
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARF-YTAEVVLALDAIH---SMG 193
Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            IH D+KP N+LLD +    L+DFG   + + ++  +     + T  Y++P
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISP 243

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 952 GLF 954
             F
Sbjct: 232 EAF 234

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 952 GLF 954
             F
Sbjct: 233 EAF 235

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 952 GLF 954
             F
Sbjct: 242 EAF 244

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 40/169 (23%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 76  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 129
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 130 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 177

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAK 928
             +    IH D+   N LL       VA + DFG+A+
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 952 GLF 954
             F
Sbjct: 216 EAF 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 761 MPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRA 819
           MP      R+   E  R    F   +++G G F  V  A      + VA+K    +    
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG 58
Query: 820 FK-SFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYI 873
            + S + E  ++  I+H N++ +     +     LI++ +  G L     EK  Y+    
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER-- 116
Query: 874 LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLL 930
                   ++  V   ++YLH      ++H DLKP N+L   LD++    +SDFG++K+ 
Sbjct: 117 ----DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM- 168
Query: 931 IGEDQSITQTQTLATIGYMAPGLFHVK 957
             ED     +    T GY+AP +   K
Sbjct: 169 --EDPGSVLSTACGTPGYVAPEVLAQK 193

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 40/169 (23%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 96  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 149
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 6/139 (4%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  AR    G +VAVK+ DL+  +  +    E  +M+  +H N++++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             E   +++E++  G+L   +  S   L+  Q   +   V   L YLH   +  VIH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 907 KPSNVLLDDNMVAHLSDFG 925
           K  ++LL  +    LSDFG
Sbjct: 168 KSDSILLTLDGRVKLSDFG 186

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 784 ENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKV 841
           + +++G G    V     +    E AVK+ + Q G        E EM+   + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
           I     E+   L+ E M  GS+   ++   +  ++   + ++ DVA+ L++LH   +  +
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGI 132
Query: 902 IHCDLKPSNVLLDD-NMVA--HLSDFGIAK--LLIGEDQSITQTQTLATIG---YMAP 951
            H DLKP N+L +  N V+   + DFG+     L G+   I+  + L   G   YMAP
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 37/198 (18%)
Query: 779 TNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVK--------VFDLQCGRAFKSFDVECEM 829
           ++ F   +L+G G +G V  A     G  VA+K        +F L+  R       E ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDV 886
           +K  +H N+I + +    + F+     Y+    ++  L+   S+  + D     +I   +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD----HIQYFI 118
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ------- 939
             TL  +   + + VIH DLKPSN+L++ N    + DFG+A+++   D+S          
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII---DESAADNSEPTGQ 175
Query: 940 ----TQTLATIGYMAPGL 953
               T+ +AT  Y AP +
Sbjct: 176 QSGMTEYVATRWYRAPEV 193

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 40/169 (23%), Positives = 83/169 (49%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 80  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 133
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 134 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 181

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + +++E M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 952 GLF 954
             F
Sbjct: 230 EAF 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK     C    +  F +E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLH 894
            I        + +++E M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 895 FGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +    IH D+   N LL       VA + DFG+A+ +            +  + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 952 GLF 954
             F
Sbjct: 215 EAF 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 41/232 (17%)
Query: 781 RFSENNL-----IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR 834
            F  NNL     +G G FG V +A   G G E AV    ++  ++    D +  +M  ++
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 835 -------HRNLIKVISSCSTEEFKALILEYMPHGSL----------------------EK 865
                  H N++ ++ +C+      +I EY  +G L                      E 
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 866 SLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 925
                   L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 926 IAKLLIGEDQSITQTQTLATIGYMAP-GLFHVKYILFVVNFLTSYSFLMIFI 976
           +A+ ++ +   I +      + +MAP  +F   Y   V + + SY  L+  I
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT--VQSDVWSYGILLWEI 253

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 777 RATNRFSENNLIGRGGFGSVY-KARIGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIR 834
           R  NR+     IG G FG +Y    I  G EVA+K   L+C +       +E ++ K ++
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQ 62
Query: 835 HRNLIKVISSCSTE-EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
               I  I  C  E ++  +++E +   SLE      +    +   L +   + + +EY+
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 894 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 928
           H   S   IH D+KP N L+       + ++ DFG+AK
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 777 RATNRFSENNLIGRGGFGSVY-KARIGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIR 834
           R  NR+     IG G FG +Y    I  G EVA+K   L+C +       +E ++ K ++
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLHIESKIYKMMQ 60
Query: 835 HRNLIKVISSCSTE-EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
               I  I  C  E ++  +++E +   SLE      +    +   L +   + + +EY+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 894 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 928
           H   S   IH D+KP N L+       + ++ DFG+AK
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 23/186 (12%)
Query: 777 RATNRFSENNLIGRGGFGSVY-KARIGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIR 834
           R  N++     IG G FG +Y  A I  G EVA+K   L+C +       +E +  K ++
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIK---LECVKTKHPQLHIESKFYKMMQ 62
Query: 835 HRNLIKVISSCSTE-EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
               I  I  C  E ++  +++E +   SLE      +    +   L +   + + +EY+
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 894 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK----------LLIGEDQSITQT 940
           H   S   IH D+KP N L+       + ++ DFG+AK          +   E++++T T
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 941 QTLATI 946
              A+I
Sbjct: 179 ARYASI 184

>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 39/112 (34%), Positives = 53/112 (47%), Gaps = 3/112 (2%)
Query: 521 LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWN-LKGMLYLNFSSN 579
           LTKL  L L  N+L       F +L  LGTL L +N+L S+PL +++ L  +  L    N
Sbjct: 58  LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN 117
Query: 580 FFTGPLPLDI-GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ 630
                LP  +   L  L  +  +TN    +       LTNLQ L L  N+LQ
Sbjct: 118 QLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC------GRAFKSFDVECEMMKSIRHRNLIK 840
           +G G F  V K R  G G E A K    +       G + +  + E  +++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +      +    LILE +  G L     EK   + +      +++         L+ +H+
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI---------LDGVHY 123
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIA 927
            +S  + H DLKP N++L D  V +    L DFGIA
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 23/183 (12%)
Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           F   + +GRG    VY+ +  G     A+KV      +  K    E  ++  + H N+IK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +     T    +L+LE +  G L     EK  YS     D  +++         LE + +
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI---------LEAVAY 163
Query: 896 GYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPG 952
            +   ++H DLKP N+L      +    ++DFG++K++  E Q + +T    T GY AP 
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAPE 220
Query: 953 LFH 955
           +  
Sbjct: 221 ILR 223

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC------GRAFKSFDVECEMMKSIRHRNLIK 840
           +G G F  V K R  G G E A K    +       G + +  + E  +++ IRH N+I 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +      +    LILE +  G L     EK   + +      +++         L+ +H+
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI---------LDGVHY 144
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIA 927
            +S  + H DLKP N++L D  V +    L DFGIA
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 180

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 43/137 (31%), Positives = 70/137 (51%), Gaps = 23/137 (16%)
Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIF 877
           + E E++K + H  +IK+ +    E++  ++LE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGED 934
           Q L         ++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE- 169
Query: 935 QSITQTQTLATIGYMAP 951
            S+ +T    T  Y+AP
Sbjct: 170 TSLMRT-LCGTPTYLAP 185

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 22/176 (12%)
Query: 786 NLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIKVIS 843
           +++G G F  V  A      + VA+K    +     + S + E  ++  I+H N++ +  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 844 SCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
              +     LI++ +  G L     EK  Y+            ++  V   ++YLH    
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH---D 134
Query: 899 APVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+AP
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 187

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 22/176 (12%)
Query: 786 NLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIKVIS 843
           +++G G F  V  A      + VA+K    +     + S + E  ++  I+H N++ +  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 844 SCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
              +     LI++ +  G L     EK  Y+            ++  V   ++YLH    
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH---D 134
Query: 899 APVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+AP
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 187

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 22/176 (12%)
Query: 786 NLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFK-SFDVECEMMKSIRHRNLIKVIS 843
           +++G G F  V  A      + VA+K    +     + S + E  ++  I+H N++ +  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 844 SCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
              +     LI++ +  G L     EK  Y+            ++  V   ++YLH    
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH---D 134
Query: 899 APVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             ++H DLKP N+L   LD++    +SDFG++K+   ED     +    T GY+AP
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 187

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC------GRAFKSFDVECEMMKSIRHRNLIK 840
           +G G F  V K R  G G E A K    +       G + +  + E  +++ IRH N+I 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +      +    LILE +  G L     EK   + +      +++         L+ +H+
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI---------LDGVHY 130
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIA 927
            +S  + H DLKP N++L D  V +    L DFGIA
Sbjct: 131 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 166

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 31/195 (15%)
Query: 779 TNRFSENNLIGRGGFGSVYKA-RIGEGMEVAVK--------VFDLQCGRAFKSFDVECEM 829
           ++ F   +L+G G +G V  A     G  VA+K        +F L+  R       E ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDV 886
           +K  +H N+I + +    + F+     Y+    ++  L+   S+  + D     +I   +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD----HIQYFI 118
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL---IGEDQSITQTQT- 942
             TL  +   + + VIH DLKPSN+L++ N    + DFG+A+++     ++   T  Q+ 
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 943 ----LATIGYMAPGL 953
               +AT  Y AP +
Sbjct: 179 MVEFVATRWYRAPEV 193

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 81/175 (46%), Gaps = 11/175 (6%)
Query: 786 NLIGRGGFGSVYKARIGE-GMEVAVKVFDL-----QCGRAFKSFDVECEMMKSIRHRNLI 839
            +IG+G F  V +    E G + AVK+ D+       G + +    E  +   ++H +++
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           +++ + S++    ++ E+M    L   +        ++        +   LE L + +  
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 900 PVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +IH D+KP NVLL   +++    L DFG+A + +GE   +     + T  +MAP
Sbjct: 150 NIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGE-SGLVAGGRVGTPHFMAP 202

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 10/171 (5%)
Query: 786 NLIGRGGFGSVYKA-RIGEG----MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLI 839
            ++G G FG+VYK   I +G    + VA+KV       +A K    E  +M  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           +++  C T   + L+ + MP+G L   +  +   L     LN  + +A  + YL      
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
            ++H DL   NVL+       ++DFG+A+LL  ++           I +MA
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 777 RATNRFSENNLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR- 834
           R T  F E   IG G FGSV+K  +  +G   A+K       R+ K      +   ++R 
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-------RSKKPLAGSVDEQNALRE 60
Query: 835 ---------HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL---NI 882
                    H ++++  S+ + ++   +  EY   GSL  ++  +  I+  F+     ++
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLL 913
           ++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 121 LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 777 RATNRFSENNLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR- 834
           R T  F E   IG G FGSV+K  +  +G   A+K       R+ K      +   ++R 
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-------RSKKPLAGSVDEQNALRE 56
Query: 835 ---------HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL---NI 882
                    H ++++  S+ + ++   +  EY   GSL  ++  +  I+  F+     ++
Sbjct: 57  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 116
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLL 913
           ++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 117 LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 777 RATNRFSENNLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR- 834
           R T  F E   IG G FGSV+K  +  +G   A+K       R+ K      +   ++R 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-------RSKKPLAGSVDEQNALRE 58
Query: 835 ---------HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL---NI 882
                    H ++++  S+ + ++   +  EY   GSL  ++  +  I+  F+     ++
Sbjct: 59  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 118
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLL 913
           ++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 119 LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 24/151 (15%)
Query: 777 RATNRFSENNLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR- 834
           R T  F E   IG G FGSV+K  +  +G   A+K       R+ K      +   ++R 
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-------RSKKPLAGSVDEQNALRE 58
Query: 835 ---------HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL---NI 882
                    H ++++  S+ + ++   +  EY   GSL  ++  +  I+  F+     ++
Sbjct: 59  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 118
Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLL 913
           ++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 119 LLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 82/169 (48%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 124 YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 177
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   +  + YM P
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     M VA+K   +       + F  E   M+   
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    + LD+   +     ++T L YL 
Sbjct: 70  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 129 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 181

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 62/128 (48%), Gaps = 6/128 (4%)
Query: 825 VECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTL 943
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 944 ATIGYMAP 951
             + + AP
Sbjct: 534 WPVKWYAP 541

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG G FG     +  E G +  +K  ++     +  +    E  ++ +++H N+++   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQR---LNIMVDVATTLEYLHFGYSAPV 901
                   ++++Y   G L K + +   +L  FQ    L+  V +   L+++H      +
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVH---DRKI 146
Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           +H D+K  N+ L  +    L DFGIA++L
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVL 175

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/184 (22%), Positives = 80/184 (43%), Gaps = 11/184 (5%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVISSC 845
           +G G FG V++        V V  F +        + V  E  +M  + H  LI +  + 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
             +    LILE++  G L   + + +Y +   + +N M      L+++H      ++H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 906 LKPSNVLLDDNMVAHLS--DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVV 963
           +KP N++ +    + +   DFG+A  L  ++  I +  T AT  + AP +   + + F  
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKV-TTATAEFAAPEIVDREPVGFYT 231
Query: 964 NFLT 967
           +   
Sbjct: 232 DMWA 235

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 29/293 (9%)
Query: 341 IADVQ----LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRN 396
           +A +Q    L NLE L L  N  +   P  + N  KL+ L +G N  +    +   NL N
Sbjct: 56  VASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN 111
Query: 397 LRLMTLHYNYLTXXXXXXXXXXXXXXCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFD 456
           LR + L+ + ++               K  +    +N+ L  + P   + N +  L Y  
Sbjct: 112 LRELYLNEDNISDISPLANL------TKXYSLNLGANHNLSDLSP---LSNXT-GLNYLT 161
Query: 457 MSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITXXXXXXXXXXHLEDNKLEGPIPD 516
           ++   V    P  I NLT+L  + L  N++    P+           ++  N++    P 
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYV--NQITDITP- 216
Query: 517 DICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNF 576
            +   T+L  L +  NK++   P   +NL+ L  L +G+N+++ I   + +L  +  LN 
Sbjct: 217 -VANXTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDIN-AVKDLTKLKXLNV 272
Query: 577 SSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRL 629
            SN  +    L+  NL  L  +  + N   +    VIGGLTNL  LFL  N +
Sbjct: 273 GSNQISDISVLN--NLSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHI 323

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 62/128 (48%), Gaps = 6/128 (4%)
Query: 825 VECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
            E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTL 943
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT   
Sbjct: 478 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 944 ATIGYMAP 951
             + + AP
Sbjct: 535 WPVKWYAP 542

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 14/162 (8%)
Query: 779 TNRFSENNLIGRGGFGSVYKARIGEG--MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR 836
           T+ +     IG G + SV K  I +   ME AVK+ D       +  ++   +++  +H 
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHP 76
Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           N+I +       ++  ++ E M  G L   +    +  +  +   ++  +  T+EYLH  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH-- 133
Query: 897 YSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKLLIGED 934
            +  V+H DLKPSN+L  D         + DFG AK L  E+
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 5/107 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
           E ++++ +RH+N+I+++     EE + +  ++EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
             +   LEYLH   S  ++H D+KP N+LL       +S  G+A+ L
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 784 ENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKV 841
           + +++G G    V     +    E AVK+ + Q G        E EM+   + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
           I     E+   L+ E M  GS+   ++   +  ++   + ++ DVA+ L++LH   +  +
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGI 132
Query: 902 IHCDLKPSNVLLDD-NMVAHLS----DFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
            H DLKP N+L +  N V+ +     D G    L G+   I+  + L   G   YMAP
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 70/160 (43%), Gaps = 16/160 (10%)
Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSIRHR 836
           R     ++  GGF  VY+A+ +G G E A+K     + +  RA       C M K   H 
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHP 86
Query: 837 NLIKVISSCS-------TEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVA 887
           N+++  S+ S       T + + L+L  +  G L + L    S   L     L I     
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
             ++++H     P+IH DLK  N+LL +     L DFG A
Sbjct: 147 RAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 32/194 (16%)
Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFK-----SFDVECEMMK 831
           AT+R+     IG G +G+VYKAR    G  VA+K   +  G         S   E  +++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 832 ---SIRHRNLIKVISSCST----EEFK-ALILEYMPHG---SLEKSL---YSSNYILDIF 877
              +  H N+++++  C+T     E K  L+ E++       L+K+      +  I D+ 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
           ++          L  L F ++  ++H DLKP N+L+       L+DFG+A++       +
Sbjct: 127 RQF---------LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQM 174
Query: 938 TQTQTLATIGYMAP 951
             T  + T+ Y AP
Sbjct: 175 ALTPVVVTLWYRAP 188

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 39/169 (23%), Positives = 82/169 (48%), Gaps = 12/169 (7%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRN--LIKVIS 843
           IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +  +I++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 844 SCSTEEFKALILEYMPHGSLE-KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
              T+++  +++E    G+++  S       +D ++R +   ++   LE +H  +   ++
Sbjct: 96  YEITDQYIYMVMEC---GNIDLNSWLKKKKSIDPWERKSYWKNM---LEAVHTIHQHGIV 149
Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DLKP+N L+ D M+  L DFGIA  +  +   + +   + T+ YM P
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPP 197

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 23/182 (12%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISS- 844
           IG+G +G V+  +   G +VAVKVF         S+  E E+ +++  RH N++  I++ 
Sbjct: 45  IGKGRYGEVWMGK-WRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 845 -----CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF---- 895
                  T+ +  LI +Y  +GSL   L S+   LD    L +     + L +LH     
Sbjct: 101 IKGTGSWTQLY--LITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 896 GYSAPVI-HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE--DQSITQTQTLATIGYMAPG 952
               P I H DLK  N+L+  N    ++D G+A   I +  +  I     + T  YM P 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 953 LF 954
           + 
Sbjct: 217 VL 218

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 76/181 (41%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G  G V  A  R+ E   VAVK+ D++    C    K    E  + K + H N++K 
Sbjct: 14  LGEGAAGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKF 69
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 120
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 954 F 954
Sbjct: 178 L 178

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 30/181 (16%)
Query: 788 IGRGGFGSVYKA--RIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G +G V  A  R+ E   VAVK+ D++    C    K    E  +   + H N++K 
Sbjct: 15  LGEGAYGEVQLAVNRVTE-EAVAVKIVDMKRAVDCPENIKK---EICINAMLNHENVVKF 70
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI------FQRL--NIMVDVATTLEYL 893
                    + L LEY   G L   +       DI       QR    +M  V     YL
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVV----YL 121
Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGL 953
           H      + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP L
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 954 F 954
Sbjct: 179 L 179

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 24/176 (13%)
Query: 788 IGRGGFGSVYKAR-IGEGMEVAVK-----VFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +GRG +G V K R +  G  +AVK     V   +  R     D+    M+++     +  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL------NIMVDVATTLEYLHF 895
             +   E    + +E M   SL+K  Y    ++D  Q +       I V +   LE+LH 
Sbjct: 116 YGALFREGDVWICMELM-DTSLDK-FYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  VIH D+KPSNVL++      + DFGI+  L+    S+ +T       YMAP
Sbjct: 172 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAP 222

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 10/176 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRH 835
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L  +  +  T +    ++EY   G L   L       +   R     ++ + LEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  V++ D+K  N++LD +    ++DFG+ K  I +    T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAP 174

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 72/172 (41%), Gaps = 27/172 (15%)
Query: 781 RFSENNLIGRGGFGSVYKARIGEG--------------MEVAVKVFDLQCGRAFKSFDVE 826
           R S  NL+   G+  V K  IG G              ME AVKV D       +  ++ 
Sbjct: 17  RGSHMNLVFSDGY--VVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI- 73
Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
             +++  +H N+I +       +   L+ E M  G L   +    +  +      ++  +
Sbjct: 74  --LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTI 130
Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKLLIGED 934
             T+EYLH   S  V+H DLKPSN+L  D         + DFG AK L  E+
Sbjct: 131 GKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 17/178 (9%)
Query: 787 LIGRGGFGSVYKARIGEGME-VAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +IG G    V  A      E VA+K  +L+ C  +      E + M    H N++   +S
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 845 CSTEEFKALILEYMPHGSL--------EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
              ++   L+++ +  GS+         K  + S  +LD      I+ +V   LEYLH  
Sbjct: 77  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVLEGLEYLH-- 133
Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQT--LATIGYMAP 951
                IH D+K  N+LL ++    ++DFG++  L  G D +  + +   + T  +MAP
Sbjct: 134 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 190

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 17/178 (9%)
Query: 787 LIGRGGFGSVYKARIGEGME-VAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +IG G    V  A      E VA+K  +L+ C  +      E + M    H N++   +S
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 845 CSTEEFKALILEYMPHGSL--------EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
              ++   L+++ +  GS+         K  + S  +LD      I+ +V   LEYLH  
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVLEGLEYLH-- 138
Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQT--LATIGYMAP 951
                IH D+K  N+LL ++    ++DFG++  L  G D +  + +   + T  +MAP
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 79/195 (40%), Gaps = 22/195 (11%)
Query: 761 MPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA 819
           M P  T   F YL             L+G+G FG V   R    G   A+K+   +   A
Sbjct: 3   MDPKVTMNDFDYL------------KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA 50
Query: 820 FKSFD---VECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI 876
                    E  ++++ RH  L  +  +  T +    ++EY   G L   L       + 
Sbjct: 51  KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE 110
Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
             R     ++ + LEYLH   S  V++ D+K  N++LD +    ++DFG+ K  I +   
Sbjct: 111 RARF-YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--G 164
Query: 937 ITQTQTLATIGYMAP 951
            T      T  Y+AP
Sbjct: 165 ATMKXFCGTPEYLAP 179

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 10/176 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRH 835
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L  +  +  T +    ++EY   G L   L       +   R     ++ + LEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  V++ D+K  N++LD +    ++DFG+ K  I +    T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAP 174

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 19/174 (10%)
Query: 788 IGRGGFGSVYK-ARIGEGMEVAVK-----VFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           IGRG +GSV K      G  +AVK     V + +  +     DV   +M+S     +++ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 842 ISSCSTEEFKALILEYMPHG--SLEKSLYSSNYILD--IFQRLNIMVDVATTLEYLHFGY 897
             +   E    + +E M        K +YS   +LD  I + +   + +AT     H   
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYS---VLDDVIPEEILGKITLATVKALNHLKE 143
Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +  +IH D+KPSN+LLD +    L DFGI+  L+    SI +T+      YMAP
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAP 194

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 10/176 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRH 835
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L  +  +  T +    ++EY   G L   L       +   R     ++ + LEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  V++ D+K  N++LD +    ++DFG+ K  I +    T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAP 174

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 12/178 (6%)
Query: 780 NRFSENNLIGRGGFGSV----YKARIGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIR 834
            R      IG G FG V    Y +     M VA+K   +       + F  E   M+   
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    + LD+   +     ++T L YL 
Sbjct: 450 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ-TQTLATIGYMAP 951
              S   +H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAP
Sbjct: 509 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAP 561

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 17/132 (12%)
Query: 826 ECEMMKSIRHRNLIKVISSCST--EEFKALILEYMPHGSLEK----SLYSSNYILDIFQR 879
           E  ++K + H N++K++       E+   ++ E +  G + +       S +     FQ 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ- 144
Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
                D+   +EYLH+     +IH D+KPSN+L+ ++    ++DFG++    G D  +  
Sbjct: 145 -----DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL-- 194
Query: 940 TQTLATIGYMAP 951
           + T+ T  +MAP
Sbjct: 195 SNTVGTPAFMAP 206

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 10/176 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRH 835
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L  +  +  T +    ++EY   G L   L       +   R     ++ + LEYLH 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 125
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  V++ D+K  N++LD +    ++DFG+ K  I +    T      T  Y+AP
Sbjct: 126 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAP 177

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQ------CGRAFKSFDVECEMM 830
           + +R+     +G G +G VYKA      E VA+K   L+       G A +    E  ++
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLL 87
Query: 831 KSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           K ++HRN+I++ S         LI EY     L+K +  +    D+  R+ I   +   +
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNP---DVSMRV-IKSFLYQLI 142
Query: 891 EYLHFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFGIAK 928
             ++F +S   +H DLKP N+LL      +  V  + DFG+A+
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 6/139 (4%)
Query: 788 IGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  A     G +VAVK  DL+  +  +    E  +M+   H N++ + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++E++  G+L   +  +   ++  Q   + + V   L YLH   +  VIH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 907 KPSNVLLDDNMVAHLSDFG 925
           K  ++LL  +    LSDFG
Sbjct: 168 KSDSILLTSDGRIKLSDFG 186

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 10/176 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRH 835
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L  +  +  T +    ++EY   G L   L       +   R     ++ + LEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  V++ D+K  N++LD +    ++DFG+ K  I +    T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAP 174

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 10/176 (5%)
Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFD---VECEMMKSIRH 835
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L  +  +  T +    ++EY   G L   L       +   R     ++ + LEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH- 122
Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  V++ D+K  N++LD +    ++DFG+ K   G     T      T  Y+AP
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAP 174

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 25/186 (13%)
Query: 788 IGRGGFGSVYKARIG------EGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK   ++   +    F +E  ++    H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYL- 893
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 894 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 173 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 949 MAPGLF 954
           M P  F
Sbjct: 227 MPPEAF 232

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 68/155 (43%), Gaps = 18/155 (11%)
Query: 788 IGRGGFGS----VYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG G +      V+KA     ME AVKV D       +  ++   +++  +H N+I +  
Sbjct: 35  IGVGSYSECKRCVHKAT---NMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPNIITLKD 88
Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
                +   L+ E M  G L   +    +  +      ++  +  T+EYLH   S  V+H
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH---SQGVVH 144
Query: 904 CDLKPSNVLLDDN----MVAHLSDFGIAKLLIGED 934
            DLKPSN+L  D         + DFG AK L  E+
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAEN 179

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 785 NNLIGRGGFGSVYKA---RIGE-----GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR 836
           N  +G+G F  ++K     +G+       EV +KV D       +SF     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           +L+     C   +   L+ E++  GSL+  L  +   ++I  +L +   +A     +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 897 YSAPVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLIGED 934
               +IH ++   N+LL   +D    +     LSD GI+  ++ +D
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 21/148 (14%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKA----LILEYMPHGSL----EKSLYSSNYILDIF 877
           E +M +   H N++++++ C  E        L+L +   G+L    E+     N++ +  
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED- 134
Query: 878 QRLNIMVDVATTLEYLHF-GYSAPVIHCDLKPSNVLLDDNMVAHLSDFG-IAKLLI---G 932
           Q L +++ +   LE +H  GY+    H DLKP+N+LL D     L D G + +  I   G
Sbjct: 135 QILWLLLGICRGLEAIHAKGYA----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 933 EDQSITQTQTLA---TIGYMAPGLFHVK 957
             Q++T     A   TI Y AP LF V+
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQ 218

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 84/167 (50%), Gaps = 22/167 (13%)
Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           +R+ +   +G GG G V+ A   +    VA+K   L   ++ K    E ++++ + H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 839 IKVIS------SCSTEEFKAL--------ILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
           +KV        S  T++  +L        + EYM       ++     +L+   RL  M 
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDL--ANVLEQGPLLEEHARL-FMY 127
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLL 930
            +   L+Y+H   SA V+H DLKP+N+ ++ +++V  + DFG+A+++
Sbjct: 128 QLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 33/196 (16%)
Query: 779 TNRFSENNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIR 834
             R++   ++G+G FG V K   RI +  E AVKV +    +   +  +  E E++K + 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-IFQR--------LNIMVD 885
           H N++K+            ILE      +   LY+   + D I +R          I+  
Sbjct: 80  HPNIMKLFE----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
           V + + Y+H      ++H DLKP N+LL   + +    + DFG++       Q+      
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDR 183
Query: 943 LATIGYMAPGLFHVKY 958
           + T  Y+AP +    Y
Sbjct: 184 IGTAYYIAPEVLRGTY 199

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 33/188 (17%)
Query: 787 LIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVI 842
           ++G+G FG V K   RI +  E AVKV +    +   +  +  E E++K + H N++K+ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-IFQR--------LNIMVDVATTLEYL 893
                      ILE      +   LY+   + D I +R          I+  V + + Y+
Sbjct: 88  E----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 894 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      ++H DLKP N+LL   + +    + DFG++       Q+      + T  Y+A
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIA 191
Query: 951 PGLFHVKY 958
           P +    Y
Sbjct: 192 PEVLRGTY 199

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 31/189 (16%)
Query: 779 TNRFSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMM--KSIRH 835
           ++R+     IG G FG     R     E VAVK   ++ G A    +V+ E++  +S+RH
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDE-NVQREIINHRSLRH 75
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSL-----YSSNYILDIFQRLNIMVDVATTL 890
            N+++      T    A+I+EY   G L + +     +S +     FQ+L         L
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL---------L 126
Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLIGEDQSITQTQTLATIG- 947
             + + +S  + H DLK  N LLD +    L   DFG +K       S+  +Q  +T+G 
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGT 180
Query: 948 --YMAPGLF 954
             Y+AP + 
Sbjct: 181 PAYIAPEVL 189

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 33/196 (16%)
Query: 779 TNRFSENNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIR 834
             R++   ++G+G FG V K   RI +  E AVKV +    +   +  +  E E++K + 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-IFQR--------LNIMVD 885
           H N++K+            ILE      +   LY+   + D I +R          I+  
Sbjct: 80  HPNIMKLFE----------ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ 129
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
           V + + Y+H      ++H DLKP N+LL   + +    + DFG++       Q+      
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDR 183
Query: 943 LATIGYMAPGLFHVKY 958
           + T  Y+AP +    Y
Sbjct: 184 IGTAYYIAPEVLRGTY 199

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFK----SFDVECEMMKSIRH 835
           F     +G G F  V  A      +   K+F ++C   +A K    S + E  +++ I+H
Sbjct: 24  FEFKETLGTGAFSEVVLAE----EKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTL 890
            N++ +     +     L+++ +  G L     EK  Y+      + +++         L
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQV---------L 130
Query: 891 EYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
           + +++ +   ++H DLKP N+L    D+     +SDFG++K+   E +    +    T G
Sbjct: 131 DAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPG 187
Query: 948 YMAPGLFHVK 957
           Y+AP +   K
Sbjct: 188 YVAPEVLAQK 197

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 23/154 (14%)
Query: 788 IGRGGFGSVYKARIGE-GMEVAVKVF------DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G +G+V  A  G  G +VA+K        +L   RA++    E  ++K +RH N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIG 88
Query: 841 VISSCSTEEFKA------LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           ++   + +E         L++ +M    L K +       D  Q L     V   L+ L 
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL-----VYQMLKGLR 142
Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           + ++A +IH DLKP N+ ++++    + DFG+A+
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 70/131 (53%), Gaps = 11/131 (8%)
Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
           + E E++K + H  +IK+ +    E++  ++LE M  G L   +  +  + +   +L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 259
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQT 940
             +   ++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE  S+ +T
Sbjct: 260 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE-TSLMRT 314
Query: 941 QTLATIGYMAP 951
               T  Y+AP
Sbjct: 315 -LCGTPTYLAP 324

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 70/131 (53%), Gaps = 11/131 (8%)
Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
           + E E++K + H  +IK+ +    E++  ++LE M  G L   +  +  + +   +L   
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 245
Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQT 940
             +   ++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE  S+ +T
Sbjct: 246 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE-TSLMRT 300
Query: 941 QTLATIGYMAP 951
               T  Y+AP
Sbjct: 301 -LCGTPTYLAP 310

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 39/198 (19%)
Query: 752 VKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK 810
           +++PP    +  +A C           + ++S  + +G G FG V+ A   E   EV VK
Sbjct: 3   LEEPPKAVELEGLAACE-------GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK 55
Query: 811 ------------VFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM 858
                       + D + G+      +E  ++  + H N+IKV+     + F  L++E  
Sbjct: 56  FIKKEKVLEDCWIEDPKLGKV----TLEIAILSRVEHANIIKVLDIFENQGFFQLVME-- 109
Query: 859 PHGSLEKSLYSSNYILDIFQRLN------IMVDVATTLEYLHFGYSAPVIHCDLKPSNVL 912
            HGS    L++    +D   RL+      I   + + + YL       +IH D+K  N++
Sbjct: 110 KHGS-GLDLFA---FIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIV 162
Query: 913 LDDNMVAHLSDFGIAKLL 930
           + ++    L DFG A  L
Sbjct: 163 IAEDFTIKLIDFGSAAYL 180

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 177 PVKWYAP 183

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 40/180 (22%), Positives = 77/180 (42%), Gaps = 19/180 (10%)
Query: 788 IGRGGFGSVYKARI-----GEG-MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG VY+        GE    VAVK  +     R    F  E  +MK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD---------IFQRLNIMVDVATTLE 891
           ++   S  +   +++E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 40/180 (22%), Positives = 77/180 (42%), Gaps = 19/180 (10%)
Query: 788 IGRGGFGSVYKARI-----GEG-MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG VY+        GE    VAVK  +     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD---------IFQRLNIMVDVATTLE 891
           ++   S  +   +++E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 40/180 (22%), Positives = 77/180 (42%), Gaps = 19/180 (10%)
Query: 788 IGRGGFGSVYKARI-----GEG-MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG VY+        GE    VAVK  +     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD---------IFQRLNIMVDVATTLE 891
           ++   S  +   +++E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 31/195 (15%)
Query: 773 LELCRATNRFSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMM- 830
           L +   ++R+     IG G FG     R  +  E VAVK   ++ G    + +V+ E++ 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIAA-NVKREIIN 68
Query: 831 -KSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSL-----YSSNYILDIFQRLNIMV 884
            +S+RH N+++      T    A+++EY   G L + +     +S +     FQ+L    
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 124
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLIGEDQSITQTQT 942
              + + Y H   +  V H DLK  N LLD +    L   DFG +K       S+  +Q 
Sbjct: 125 --ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQP 173
Query: 943 LATIG---YMAPGLF 954
            +T+G   Y+AP + 
Sbjct: 174 KSTVGTPAYIAPEVL 188

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 785 NNLIGRGGFGSVYKA---RIGE-----GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR 836
           N  +G+G F  ++K     +G+       EV +KV D       +SF     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           +L+     C   +   L+ E++  GSL+  L  +   ++I  +L +   +A     +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 897 YSAPVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLIGED 934
               +IH ++   N+LL   +D    +     LSD GI+  ++ +D
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 87/175 (49%), Gaps = 11/175 (6%)
Query: 780 NRFSENNLIGRGGFGSVYK-ARIGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRN 837
           + F + + +G G  G V+K +    G+ +A K+  L+   A ++  + E +++       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-IFQRLNIMVDVATTLEYLHFG 896
           ++    +  ++   ++ +E+M  GSL++ L  +  I + I  +++I V     L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGLTYLREK 126
Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +   ++H D+KPSN+L++      L DFG++  LI E       + + T  YM+P
Sbjct: 127 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSP 175

>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 53/112 (47%), Gaps = 3/112 (2%)
Query: 521 LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWN-LKGMLYLNFSSN 579
           LTKL  L L  N+L       F +L  LGTL L +N+L S+PL +++ L  +  L    N
Sbjct: 58  LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN 117
Query: 580 FFTGPLPLDI-GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ 630
                LP  +   L  L  +  +TN    +       LTNLQ L L  N+LQ
Sbjct: 118 QLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 91/223 (40%), Gaps = 43/223 (19%)
Query: 760 NMPPIATCRRFSY----LELCRATNRFSENNLIGRGGFGSVYKA------RIGEGMEVAV 809
            +P    C R  Y     E  R  +R +    +GRG FG V +A      +      VAV
Sbjct: 5   ELPLDEHCERLPYDASKWEFPR--DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAV 62
Query: 810 KVFDLQCGRA-FKSFDVECEMMKSIRHR-NLIKVISSCSTEEFKALIL------------ 855
           K+       +  ++   E +++  I H  N++ ++ +C+      +++            
Sbjct: 63  KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 856 ------EYMPHGSLEKSLYSSNYILDI-FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKP 908
                 E++P+  L K   +  +++   FQ       VA  +E+L    S   IH DL  
Sbjct: 123 LRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ-------VAKGMEFLA---SRKXIHRDLAA 172
Query: 909 SNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            N+LL +  V  + DFG+A+ +  +   + +      + +MAP
Sbjct: 173 RNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAP 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 8/168 (4%)
Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  A +   G  VAVK  DL+  +  +    E  +M+  +H N++++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++E++  G+L   +  +   ++  Q   + + V   L  LH   +  VIH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
           K  ++LL  +    LSDFG    +  E     +   + T  +MAP L 
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELI 242

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 113
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 171 PVKWYAP 177

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 125
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 126 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 183 PVKWYAP 189

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 193 PVKWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 193 PVKWYAP 199

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 115
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 173 PVKWYAP 179

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 177 PVKWYAP 183

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 6/127 (4%)
Query: 826 ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           E  +M+ + +  ++++I  C  E +  L++E    G L K L  + ++ D    + ++  
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 133
Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLA 944
           V+  ++YL     +  +H DL   NVLL     A +SDFG++K L   E+    QT    
Sbjct: 134 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 945 TIGYMAP 951
            + + AP
Sbjct: 191 PVKWYAP 197

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 27/215 (12%)
Query: 761 MPPIATCRRFSY----LELCRATNRFSENNLIGRGGFGSVYKA------RIGEGMEVAVK 810
           +P    C R  Y     E  R  +R      +GRG FG V +A      +      VAVK
Sbjct: 8   LPLDEHCERLPYDASKWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 65
Query: 811 VFDLQCGRA-FKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKAL-ILEYMPHGSLEKSL 867
           +       +  ++   E +++  I  H N++ ++ +C+      + I+E+   G+L   L
Sbjct: 66  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
Query: 868 YSSNYILDIFQRLNIMVDVATTLEYL-----------HFGYSAPVIHCDLKPSNVLLDDN 916
            S       ++  ++  D   TLE+L            F  S   IH DL   N+LL + 
Sbjct: 126 RSKRNEFVPYKPEDLYKDF-LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEK 184
Query: 917 MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            V  + DFG+A+ +  +   + +      + +MAP
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAP 219

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 88/195 (45%), Gaps = 31/195 (15%)
Query: 773 LELCRATNRFSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMM- 830
           L +   ++R+     IG G FG     R  +  E VAVK   ++ G      +V+ E++ 
Sbjct: 11  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKY--IERGEKIDE-NVKREIIN 67
Query: 831 -KSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSL-----YSSNYILDIFQRLNIMV 884
            +S+RH N+++      T    A+++EY   G L + +     +S +     FQ+L    
Sbjct: 68  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 123
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLIGEDQSITQTQT 942
              + + Y H   +  V H DLK  N LLD +    L   DFG +K       S+  +Q 
Sbjct: 124 --ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQP 172
Query: 943 LATIG---YMAPGLF 954
            +T+G   Y+AP + 
Sbjct: 173 KSTVGTPAYIAPEVL 187

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 23/140 (16%)
Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIF 877
           + E E++K + H  +IK+ +    E++  ++LE M  G L       K L  +   L  +
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGED 934
           Q L         ++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 128 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE- 175
Query: 935 QSITQTQTLATIGYMAPGLF 954
            S+ +T    T  Y+AP + 
Sbjct: 176 TSLMRT-LCGTPTYLAPEVL 194

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 41/191 (21%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGM-------EVAVK-VFDLQCGRAFKSFDVECEM 829
           A  + + +  +G+G FG VY+  + +G+        VA+K V +    R    F  E  +
Sbjct: 8   AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS------SNYIL---DIFQRL 880
           MK     ++++++   S  +   +I+E M  G L+  L S      +N +L    + + +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
            +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      
Sbjct: 127 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 941 QTLATIGYMAP 951
           + L  + +M+P
Sbjct: 184 KGLLPVRWMSP 194

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 23/140 (16%)
Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIF 877
           + E E++K + H  +IK+ +    E++  ++LE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGED 934
           Q L         ++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE- 169
Query: 935 QSITQTQTLATIGYMAPGLF 954
            S+ +T    T  Y+AP + 
Sbjct: 170 TSLMRT-LCGTPTYLAPEVL 188

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 41/191 (21%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGM-------EVAVK-VFDLQCGRAFKSFDVECEM 829
           A  + + +  +G+G FG VY+  + +G+        VA+K V +    R    F  E  +
Sbjct: 17  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS------SNYIL---DIFQRL 880
           MK     ++++++   S  +   +I+E M  G L+  L S      +N +L    + + +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
            +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      
Sbjct: 136 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 941 QTLATIGYMAP 951
           + L  + +M+P
Sbjct: 193 KGLLPVRWMSP 203

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 23/140 (16%)
Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIF 877
           + E E++K + H  +IK+ +    E++  ++LE M  G L       K L  +   L  +
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGED 934
           Q L         ++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 121 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE- 168
Query: 935 QSITQTQTLATIGYMAPGLF 954
            S+ +T    T  Y+AP + 
Sbjct: 169 TSLMRT-LCGTPTYLAPEVL 187

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 33/132 (25%), Positives = 64/132 (48%), Gaps = 6/132 (4%)
Query: 785 NNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVI 842
           + L+G G +  V  A  +  G E AVK+ + Q G +      E E +   + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
                +    L+ E +  GS+   +    +  +  +   ++ DVA  L++LH   +  + 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 903 HCDLKPSNVLLD 914
           H DLKP N+L +
Sbjct: 134 HRDLKPENILCE 145

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 71/140 (50%), Gaps = 23/140 (16%)
Query: 824 DVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL------EKSLYSSNYILDIF 877
           + E E++K + H  +IK+ +    E++  ++LE M  G L       K L  +   L  +
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGED 934
           Q L         ++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L GE 
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GE- 169
Query: 935 QSITQTQTLATIGYMAPGLF 954
            S+ +T    T  Y+AP + 
Sbjct: 170 TSLMRT-LCGTPTYLAPEVL 188

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 761 MPPIATCRRFSY----LELCRATNRFSENNLIGRGGFGSVYKA------RIGEGMEVAVK 810
           +P    C R  Y     E  R  +R +    +GRG FG V +A      +      VAVK
Sbjct: 7   LPLDEHCERLPYDASKWEFPR--DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 64
Query: 811 VFDLQCGRA-FKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKAL-ILEYMPHGSLEKSL 867
           +       +  ++   E +++  I  H N++ ++ +C+      + I+E+   G+L   L
Sbjct: 65  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
Query: 868 YSSNYILDIFQRLNIMVDVATTLEYL-----------HFGYSAPVIHCDLKPSNVLLDDN 916
            S       ++    +     TLE+L            F  S   IH DL   N+LL + 
Sbjct: 125 RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 917 MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            V  + DFG+A+ +  +   + +      + +MAP
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAP 219

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 10/169 (5%)
Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G  G V  A +   G  VAVK  DL+  +  +    E  +M+  +H N++++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
             +   +++E++  G+L   +  +   ++  Q   + + V   L  LH   +  VIH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY-MAPGLF 954
           K  ++LL  +    LSDFG    +  E   + + + L    Y MAP L 
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKXLVGTPYWMAPELI 319

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 40/180 (22%), Positives = 77/180 (42%), Gaps = 19/180 (10%)
Query: 788 IGRGGFGSVYKARI-----GEG-MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG VY+        GE    VAVK  +     R    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD---------IFQRLNIMVDVATTLE 891
           ++   S  +   +++E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 40/180 (22%), Positives = 77/180 (42%), Gaps = 19/180 (10%)
Query: 788 IGRGGFGSVYKARI-----GEG-MEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG VY+        GE    VAVK  +     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD---------IFQRLNIMVDVATTLE 891
           ++   S  +   +++E M HG L+  L S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YL+   +   +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 31/192 (16%)
Query: 773 LELCRATNRFSENNLIGRGGFGSVYKARIGEGME-VAVKVFDLQCGRAFKSFDVECEMM- 830
           L +   ++R+     IG G FG     R  +  E VAVK   ++ G      +V+ E++ 
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKY--IERGEKIDE-NVKREIIN 68
Query: 831 -KSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSL-----YSSNYILDIFQRLNIMV 884
            +S+RH N+++      T    A+++EY   G L + +     +S +     FQ+L    
Sbjct: 69  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL---- 124
Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSITQTQT 942
                +  + + ++  V H DLK  N LLD +    L  +DFG +K       S+  +Q 
Sbjct: 125 -----ISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK------ASVLHSQP 173
Query: 943 LATIG---YMAP 951
            + +G   Y+AP
Sbjct: 174 KSAVGTPAYIAP 185

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 32/188 (17%)
Query: 788 IGRGGFGSVYKARIGEGMEVAVKVF--DLQCGRAFKS----FDVECEMMKSIRHRNLIKV 841
           IGRG F +VYK   G   E  V+V   +LQ  +  KS    F  E E +K ++H N+++ 
Sbjct: 34  IGRGSFKTVYK---GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 842 ISSC-STEEFK---ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLE 891
             S  ST + K    L+ E    G+L+  L         F+   I V       +   L+
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKR-------FKVXKIKVLRSWCRQILKGLQ 143
Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +LH   + P+IH DLK  N+ +        + D G+A L     ++      + T  + A
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXA 198
Query: 951 PGLFHVKY 958
           P  +  KY
Sbjct: 199 PEXYEEKY 206

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/191 (21%), Positives = 87/191 (45%), Gaps = 21/191 (10%)
Query: 778 ATNRFSENNLIGRGGFGSVYKARIGEGM-------EVAVK-VFDLQCGRAFKSFDVECEM 829
           A  + + +  +G+G FG VY+  + +G+        VA+K V +    R    F  E  +
Sbjct: 45  AREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 830 MKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYS------SNYIL---DIFQRL 880
           MK     ++++++   S  +   +I+E M  G L+  L S      +N +L    + + +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
            +  ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      
Sbjct: 164 QMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 941 QTLATIGYMAP 951
           + L  + +M+P
Sbjct: 221 KGLLPVRWMSP 231

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	982
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	0.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-169
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-112
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-95
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-112
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-87
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-71
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-34
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-93
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-69
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-68
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-32
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-30
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-91
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-47
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-46
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-26
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-87
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-68
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-82
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-82
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-73
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-31
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-80
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-52
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-70
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-25
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-59
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-58
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-59
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-59
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-29
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-27
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-58
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-55
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-52
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-23
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-53
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-52
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-39
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-30
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-52
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-40
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-28
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-51
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-45
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-09
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-36
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-41
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-40
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-37
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-37
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-40
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-35
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-34
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-39
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-36
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-29
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-39
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-34
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-18
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-27
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-30
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-27
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-37
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-37
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-35
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-15
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-35
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-35
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-09
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-33
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-28
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-22
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-10
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-10
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-26
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-21
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-17
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-06
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-27
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-26
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-25
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-24
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-24
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-12
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-14
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-22
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-22
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-21
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-21
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-22
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-21
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-12
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-20
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-20
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-10
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-19
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-13
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-17
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-06
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-07
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-08
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-14
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-13
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-12
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-12
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-11
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	5e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	9e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	9e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-08
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	7e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  554 bits (1430), Expect = 0.0
 Identities = 199/648 (30%), Positives = 294/648 (45%), Gaps = 31/648 (4%)

Query: 84  KVLNISHLNLTGTIP-SQLWNLSSLQSLNLGFNRLSGSIPSAIFT---LYTLKYVNFRGN 139
           K LN+S   L      S    L+SL+ L+L  N +SG+             LK++   GN
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188

Query: 140 QLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALS 199
           ++SG     +    +L+ LD S N  S  IP     +   L+ + +S N   G    A+S
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAIS 244

Query: 200 NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQ 258
            C  L++L++S N  +G IP     L  L+ L L  +   GEIP    G    L  + L 
Sbjct: 245 TCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302

Query: 259 VSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-IHNLHNLKLLDLSHNKLVGAVPAT 317
            ++  G +P    + + LE L L  N  +GE+P + +  +  LK+LDLS N+  G +P +
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362

Query: 318 IFNMST-LTGLGLQSNSLSGSL-SSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSV 375
           + N+S  L  L L SN+ SG +  ++       L+EL L +N F+G IP  + N S+L  
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
           L L  N  SG IP++ G+L  LR + L  N      LE          K+L  + L  N 
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLN-----MLEGEIPQELMYVKTLETLILDFND 477

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLG 495
           L G +P   + N + +L +  +S   ++G  PK IG L NL  + L  N  +G+IP  LG
Sbjct: 478 LTGEIPS-GLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535

Query: 496 KLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS 555
             + L  L L  N   G IP  + + +      ++ N ++G       N           
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAG 591

Query: 556 NKLT---SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTV 612
           N L         +  L      N +S  + G       N   ++ +D S N  S  IP  
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKE 651

Query: 613 IGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDL 672
           IG +  L  L LG+N + GSI +  GDL  L  L+LS+N L   IP ++  L+ L ++DL
Sbjct: 652 IGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711

Query: 673 SFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSIHHKS 720
           S N L G IP+ G F  F    F  N  LCG P   +P C  S     
Sbjct: 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRCDPSNADGY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  511 bits (1319), Expect = e-169
 Identities = 170/670 (25%), Positives = 289/670 (43%), Gaps = 57/670 (8%)

Query: 27  AAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVL 86
           +   + + S+  +   L++ K  +     N L  +W+++   C + GVTC     +V  +
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVL--PDKNLLP-DWSSNKNPCTFDGVTCR--DDKVTSI 55

Query: 87  NISHLNLT---GTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
           ++S   L      + S L +L+ L+SL L  + ++GS+        +L  ++   N LSG
Sbjct: 56  DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSG 114

Query: 144 AFPSF--IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL--- 198
              +   + + S L+ L+ S N L      +    L  LE + LS N   G         
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174

Query: 199 SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQ 258
             C  L+ L++S N + G +   +     L+ L +  +     IP               
Sbjct: 175 DGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP--------------- 217

Query: 259 VSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATI 318
                      L + + L+ L +  N L+G+    I     LKLL++S N+ VG +P   
Sbjct: 218 ----------FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-- 265

Query: 319 FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLEL 378
             + +L  L L  N  +G +          L  L L  N+F G +P F  + S L  L L
Sbjct: 266 LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLAL 325

Query: 379 GRNSFSGFIP-NTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCK-SLTYIGLSNNPL 436
             N+FSG +P +T   +R L+++ L +N             S +N   SL  + LS+N  
Sbjct: 326 SSNNFSGELPMDTLLKMRGLKVLDLSFN-----EFSGELPESLTNLSASLLTLDLSSNNF 380

Query: 437 DGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGK 496
            G +      N  ++L+   +     +G  P  + N + L+ ++L  N L+G+IP +LG 
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS 440

Query: 497 LQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN 556
           L KL+ L L  N LEG IP ++  +  L  L L  N L+G IP+  SN  +L  +SL +N
Sbjct: 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNN 500

Query: 557 KLT-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGG 615
           +LT  IP  I  L+ +  L  S+N F+G +P ++G+ + LI +D +TN F+  IP  +  
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

Query: 616 LTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN--NLSRSIPISLEKLSYLEDLDLS 673
            +      +  N + G       +    K  + + N           L +LS     +++
Sbjct: 561 QSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNIT 616

Query: 674 FNKLKGEIPK 683
                G    
Sbjct: 617 SRVYGGHTSP 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  360 bits (927), Expect = e-112
 Identities = 138/658 (20%), Positives = 240/658 (36%), Gaps = 46/658 (6%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
           +V + SHL LT  +P  L   +++  LNL  N+L     +       L  ++   N +S 
Sbjct: 7   EVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
             P        L+ L+  +N LS  +     +    L  + L  N       +     K 
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN-- 261
           L  L LS N L          L  L+EL L  + +Q     E    A   L  L++S+  
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182

Query: 262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI---HNLHNLKLLDLSHNKLVGAVPATI 318
           ++   P     +  L  L L    L   +  ++       +++ L LS+++L      T 
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242

Query: 319 FNM--STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVL 376
             +  + LT L L  N+L+  + + +   LP LE   L  NN        +     +  L
Sbjct: 243 LGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301

Query: 377 ELGRN---------SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLT 427
            L R+         S       +F  L+ L  + +  N +          + F+   +L 
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK-----SNMFTGLINLK 356

Query: 428 YIGLSNNPL--DGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNK 485
           Y+ LSN+      +     +      L   +++   +S         L +L  + LG N+
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416

Query: 486 LNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSG--SIPACF 542
           +   +       L+ +  ++L  NK      +    +  L  L L    L    S P+ F
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476

Query: 543 SNLASLGTLSLGSNKLTSIP-LTIWNLKGMLYLNFSSN--------FFTGPLPLDIGNLK 593
             L +L  L L +N + +I    +  L+ +  L+   N           G     +  L 
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536

Query: 594 VLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNL 653
            L  ++  +N F ++   V   L  L+ + LG N L    +  F + +SLKSLNL  N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596

Query: 654 SRSIPISLEK-LSYLEDLDLSFNKLKGEIPKGGSFGNFSAKS-----FEGNELLCGSP 705
           +             L +LD+ FN           F N+  ++        +  LC +P
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  316 bits (811), Expect = 1e-95
 Identities = 118/568 (20%), Positives = 198/568 (34%), Gaps = 42/568 (7%)

Query: 154 SLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINN 213
           S +  D S+  L+ ++P ++ +N+     ++L+ N       +  +    L  L +  N 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTNI---TVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 214 LLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANL 273
           +    P+    L  LK L L ++ L     + F     L  + L  +++Q          
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 274 TGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATI--FNMSTLTGLGLQS 331
             L  L L  N L+         L NL+ L LS+NK+       +  F  S+L  L L S
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 332 NSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF---NASKLSVLELGRNSFSGFIP 388
           N +    S      +  L  L L +     ++   +      + +  L L  +  S    
Sbjct: 181 NQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 389 NTFGNLRNLRLMTLH--YNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGI------- 439
            TF  L+   L  L   YN L           SF+    L Y  L  N +  +       
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVG-----NDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294

Query: 440 LPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQK 499
           L  +   NL  S     +S  ++          L  L  + +  N + G        L  
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN 354

Query: 500 LQGLHLEDNKLE-GPIPDDICR---LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS 555
           L+ L L ++      + ++       + L+ L L+ NK+S      FS L  L  L LG 
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414

Query: 556 NKLTSI--PLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDV--IPT 611
           N++           L+ +  +  S N +          +  L  +        +V   P+
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474

Query: 612 VIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR--------SIPISLEK 663
               L NL  L L  N +     +    L  L+ L+L +NNL+R             L+ 
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534

Query: 664 LSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
           LS+L  L+L  N           F +  
Sbjct: 535 LSHLHILNLESNGFDEIPV--EVFKDLF 560

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  179 bits (455), Expect = 4e-47
 Identities = 82/400 (20%), Positives = 131/400 (32%), Gaps = 42/400 (10%)

Query: 80  SHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGN 139
                  +IS  +L          L  L+ LN+  N + G   +    L  LKY++   +
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363

Query: 140 QLS-GAFPSFIF---NKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP 195
             S     +  F     S L  L+ + N +S  I ++  S L  LE + L  N     + 
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWLGHLEVLDLGLNEIGQELT 422

Query: 196 -SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELEL 254
                  + +  + LS N  L         +  L+ L L    L+               
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN-------------- 468

Query: 255 MALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL---- 310
                       P     L  L +L L  N +       +  L  L++LDL HN L    
Sbjct: 469 --------VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520

Query: 311 ----VGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
                G     +  +S L  L L+SN     +       L  L+ + L  NN +      
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNLNTLPASV 579

Query: 367 IFNASKLSVLELGRNSFSGFIPNTFG-NLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
             N   L  L L +N  +      FG   RNL  + + +N    +   +++  ++ N   
Sbjct: 580 FNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETH 639

Query: 426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG 465
                LS++ L    P          +  FD S C  S  
Sbjct: 640 TNIPELSSHYLCNTPPHYH----GFPVRLFDTSSCKDSAH 675

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.5 bits (124), Expect = 1e-06
 Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 23/96 (23%)

Query: 617 TNLQYLFLGY---------------------NRLQGSISESFGDLISLKSLNLSNNNLSR 655
            + +     +                     N+L+   + +F     L SL++  N +S+
Sbjct: 4   VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63

Query: 656 SIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
             P   +KL  L+ L+L  N+L        +F   +
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSD--KTFAFCT 97

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  358 bits (921), Expect = e-112
 Identities = 97/671 (14%), Positives = 195/671 (29%), Gaps = 98/671 (14%)

Query: 33  TSSITTDQDALLALKAHI------THDPTNFLAKNWNTSTPVCNWT---GVTCDVHSHRV 83
           T+    D  AL  +   +                NWN +  +  W    GV+ + +  RV
Sbjct: 25  TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNG-RV 83

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
             L++     +G +P  +  L+ L+ L LG +    +                       
Sbjct: 84  TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG------------------ 125

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICS-NLPFLESISLSQNMFHGRIPSALSNCK 202
             P  I    S +                    +   L    ++ +     I  +     
Sbjct: 126 --PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183

Query: 203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
               +    +N +  + K +  LTKL++ Y+G S    E   E       E      +  
Sbjct: 184 KDTQIGQL-SNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQ 237

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGA--------V 314
                 +  NL  L  +++       ++P  +  L  ++L++++ N+ +           
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297

Query: 315 PATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLS 374
            A       +  + +  N+L       +  ++  L  L    N   G +P F  +  KL+
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLA 356

Query: 375 VLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNN 434
            L L  N  +    N  G    +  ++  +N L      +  +    +   ++ I  S N
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY----IPNIFDAKSVSVMSAIDFSYN 412

Query: 435 PLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITL 494
            +  +                                   N+  I L  N+++       
Sbjct: 413 EIGSVDG-------------------KNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453

Query: 495 GKLQKLQGLHLEDNKLEG-------PIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLA 546
                L  ++L  N L            ++      L  + L  NKL+        + L 
Sbjct: 454 STGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513

Query: 547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
            L  + L  N  +  P    N   +      +                    D   N   
Sbjct: 514 YLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTL 555

Query: 607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY 666
              P  I    +L  L +G N ++  ++E      ++  L++ +N         +     
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIE 612

Query: 667 LEDLDLSFNKL 677
                L ++K 
Sbjct: 613 AGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  293 bits (752), Expect = 1e-87
 Identities = 77/503 (15%), Positives = 148/503 (29%), Gaps = 39/503 (7%)

Query: 86  LNISHLNLTGTIPSQL--WNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
                ++   T        + S L    +  +    SI  +         +    N ++ 
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
                +   + L+      +    E            E+ +      +        N K 
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENI------CEAWENENSEYAQQYKTEDLKWDNLKD 250

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGY--------SGLQGEIPREFGNLAELELM 255
           L  + +     L  +P  +  L +++ + +               +   +     +++++
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310

Query: 256 ALQVSNLQ-GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAV 314
            +  +NL+   +   L  +  L +L+   N L G   P   +   L  L+L++N++    
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIP 369

Query: 315 PATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG-------TIPRFI 367
                    +  L    N L    +      +  +  +    N            +    
Sbjct: 370 ANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429

Query: 368 FNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS--SNLELSFLSSFSNCKS 425
           F    +S + L  N  S F    F     L  + L  N LT    N       +F N   
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489

Query: 426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLG--- 482
           LT I L  N L  +        L   L   D+SY + S  FP +  N + L G  +    
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLP-YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547

Query: 483 ---GNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP 539
              GN+     P  +     L  L +  N +   + + I     +  L +  N       
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDL 604

Query: 540 ACFSNLASLGTLSLGSNKLTSIP 562
           +        G   L  +K   I 
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQDIR 627

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  247 bits (632), Expect = 6e-71
 Identities = 76/427 (17%), Positives = 142/427 (33%), Gaps = 47/427 (11%)

Query: 269 ELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG----AVPATIFNMSTL 324
            L +   +  L L     +G +P  I  L  L++L L  +          P  I    + 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 325 TGLGLQSNSLSGS-LSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
                       + +         +L +  + S+    +I +      K + +    N+ 
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 384 SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
           +  +      L  LR   +  +   + N+          C++                  
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENI----------CEAWENENSEYAQQYKTEDL- 243

Query: 444 SMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKL--------NGSIPITLG 495
              NL   L   ++  C      P  +  L  +  I +  N+         +        
Sbjct: 244 KWDNLK-DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302

Query: 496 KLQKLQGLHLEDNKL-EGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLG 554
             +K+Q +++  N L   P+   + ++ KL  L    N+L G +PA F +   L +L+L 
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLA 361

Query: 555 SNKLTSIPLTIW-NLKGMLYLNFSSNFFTG-PLPLDIGNLKVLIGIDFSTNNFSDVIPTV 612
            N++T IP       + +  L+F+ N     P   D  ++ V+  IDFS N    V    
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421

Query: 613 IGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDL 672
                               +  +    I++ S+NLSNN +S+         S L  ++L
Sbjct: 422 FDP-----------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464

Query: 673 SFNKLKG 679
             N L  
Sbjct: 465 MGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  138 bits (349), Expect = 5e-34
 Identities = 32/244 (13%), Positives = 72/244 (29%), Gaps = 13/244 (5%)

Query: 455 FDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGP- 513
           F+             + +   + G+ L G   +G +P  +G+L +L+ L L  +  +   
Sbjct: 62  FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121

Query: 514 ---IPDDICRLTKLYELGLSGNKLSGSIPACFSNLA--SLGTLSLGSNKLT-SIPLTIWN 567
               P  I       +          +            L    + S+    SI  +   
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181

Query: 568 LKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYN 627
                 +   SN  T  +   +  L  L       + F            N +Y      
Sbjct: 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----A 235

Query: 628 RLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSF 687
           +   +    + +L  L  + + N      +P  L+ L  ++ ++++ N+          +
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295

Query: 688 GNFS 691
              +
Sbjct: 296 QALA 299

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  314 bits (807), Expect = 2e-93
 Identities = 96/671 (14%), Positives = 191/671 (28%), Gaps = 89/671 (13%)

Query: 29  ATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNI 88
               T+    D  AL A+   +      + +   N +    NW               N 
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-------------FNK 306

Query: 89  SHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSF 148
                       L N   +  L+L      G +P AI  L  LK ++F  +  + +   F
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 149 IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR---IPSALSNCKYLE 205
              + +    +   + +              L    L Q+  +      P    +   L+
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426

Query: 206 ILSLS-INNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQG 264
              +  + N +  I K I  LTKL+ +Y   S    +           E      +    
Sbjct: 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYE 481

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG---------AVP 315
                 +NL  L  ++L       ++P  +++L  L+ L+++ N+ +           + 
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 316 ATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSV 375
                   +    +  N+L    +S +  ++  L  L    N              KL+ 
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTD 599

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
           L+L  N       +       +  +   +N L      +  + +  +   +  +  S N 
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY----IPNIFNAKSVYVMGSVDFSYNK 655

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLG 495
           +                          +     +     N   + L  N++         
Sbjct: 656 IGSEGR---------------------NISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694

Query: 496 KLQKLQGLHLEDNKLE-------GPIPDDICRLTKLYELGLSGNKLSGSIPA--CFSNLA 546
               +  + L +N +         P   +      L  + L  NKL+ S+      + L 
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753

Query: 547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
            L  + +  N  +S P    N   +                           D   N   
Sbjct: 754 YLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRIL 795

Query: 607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY 666
              PT I    +L  L +G N ++  + E       L  L++++N        S+     
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852

Query: 667 LEDLDLSFNKL 677
                L ++K 
Sbjct: 853 AGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  247 bits (632), Expect = 3e-69
 Identities = 78/463 (16%), Positives = 145/463 (31%), Gaps = 45/463 (9%)

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPAT 317
           ++     +   +L N   +  L L      G +P  I  L  LK+L    +    +    
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366

Query: 318 IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS-----GTIPRFIFNASK 372
                T      + + +      +       L    L  +  +       I +    + K
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426

Query: 373 LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLS 432
            + +    N  +  I      L  L+++    +  T  N+ + +  +             
Sbjct: 427 DTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN----------SD 475

Query: 433 NNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG---- 488
                      S  NL   L   ++  C      P  + +L  L  + +  N+       
Sbjct: 476 YAKQYENEEL-SWSNLK-DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533

Query: 489 -----SIPITLGKLQKLQGLHLEDNKLEG-PIPDDICRLTKLYELGLSGNKLSGSIPACF 542
                 +        K+Q  ++  N LE  P    + ++ KL  L    NK+   + A F
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-F 591

Query: 543 SNLASLGTLSLGSNKLTSIPLTIWNLKGML-YLNFSSNFFTG-PLPLDIGNLKVLIGIDF 600
                L  L L  N++  IP         +  L FS N     P   +  ++ V+  +DF
Sbjct: 592 GTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDF 651

Query: 601 STNNFSDVIPTVIGGL-----TNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS- 654
           S N        +   +      N   + L YN +Q   +E F     + ++ LSNN ++ 
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711

Query: 655 ------RSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
                 +    + +    L  +DL FNKL   +          
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLP 753

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  244 bits (624), Expect = 4e-68
 Identities = 78/521 (14%), Positives = 158/521 (30%), Gaps = 70/521 (13%)

Query: 182 SISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGE 241
           + +   +M+  +    L N   +  LSL+     G +P  IG LT+LK L  G       
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 242 IPREFGNLAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPPEIHNLHNL 300
                      ++   +   ++    +  L     L +  L ++ +     PE+  +   
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKD 420

Query: 301 KLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS 360
             + L   ++                 G  +N ++    +I   +L  L+ +   ++ F+
Sbjct: 421 SRISLKDTQI-----------------GNLTNRITFISKAIQ--RLTKLQIIYFANSPFT 461

Query: 361 GTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSF 420
                    A                   ++ NL++L  + L+                 
Sbjct: 462 YDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC-----PNMTQLPDFL 511

Query: 421 SNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY 480
            +   L  + ++ N         +                        +      +   Y
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWT-----------------RLADDEDTGPKIQIFY 554

Query: 481 LGGNKLNG-SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP 539
           +G N L       +L K+ KL  L    NK+     +      KL +L L  N++     
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEEIPE 612

Query: 540 ACFSNLASLGTLSLGSNKLTSIP--LTIWNLKGMLYLNFSSNFFTG-----PLPLDIGNL 592
              +    +  L    NKL  IP      ++  M  ++FS N            +D    
Sbjct: 613 DFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672

Query: 593 KVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ-------GSISESFGDLISLKS 645
                +  S N        +    + +  + L  N +             ++ +   L +
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT 732

Query: 646 LNLSNNNLSRSIP--ISLEKLSYLEDLDLSFNKLKGEIPKG 684
           ++L  N L+ S+        L YL ++D+S+N      P  
Sbjct: 733 IDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQ 771

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  135 bits (341), Expect = 1e-32
 Identities = 41/275 (14%), Positives = 94/275 (34%), Gaps = 31/275 (11%)

Query: 84  KVLNISHLNLTGTIPSQLW-NLSSLQSLNLGFNRLSGSIPSAIF--TLYTLKYVNFRGNQ 140
             L + +  +   IP         ++ L    N+L   IP+     ++Y +  V+F  N+
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655

Query: 141 LSGAFPSF-----IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMF----- 190
           +     +       +   +   +  SYN +    P  + +    + +I LS N+      
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIPE 714

Query: 191 --HGRIPSALSNCKYLEILSLSINNLLGAIPKEI--GNLTKLKELYLGYSGLQGEIPREF 246
                      N   L  + L   N L ++  +     L  L  + + Y+      P + 
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLR-FNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQP 772

Query: 247 GNLAELELMALQVS------NLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNL 300
            N ++L+   ++         +  + P  +     L  L++G N +  ++  ++     L
Sbjct: 773 LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQL 829

Query: 301 KLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLS 335
            +LD++ N  +     ++          L  +   
Sbjct: 830 YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  127 bits (320), Expect = 5e-30
 Identities = 39/254 (15%), Positives = 80/254 (31%), Gaps = 15/254 (5%)

Query: 455 FDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPI 514
           F+            ++ N   + G+ L G    G +P  +G+L +L+ L    +      
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 515 PDDICRLTKLYELGLSGNKLSGSIPACF-SNLASLGTLSLGSNKLTSIP-------LTIW 566
                            +++       F      L    L  + +   P        +  
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423

Query: 567 NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGY 626
           +LK    +   +N  T  +   I  L  L  I F+ + F+     V     + +     Y
Sbjct: 424 SLK-DTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDY 476

Query: 627 NRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGS 686
            +   +   S+ +L  L  + L N      +P  L  L  L+ L+++ N+          
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536

Query: 687 FGNFSAKSFEGNEL 700
           +   +     G ++
Sbjct: 537 WTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.0 bits (153), Expect = 4e-10
 Identities = 26/223 (11%), Positives = 62/223 (27%), Gaps = 29/223 (13%)

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
           S  +   KL K   + ++  +    I D          L     +          +  + 
Sbjct: 243 SFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW 302

Query: 549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDV 608
                         + + N   +  L+ +     G +P  IG L  L  + F T++ +  
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGD-LISLKSLNLSNNNLSR------------ 655
                             +R++    + F D    L   +L  + ++R            
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 656 ----------------SIPISLEKLSYLEDLDLSFNKLKGEIP 682
                            I  ++++L+ L+ +  + +    +  
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI 465

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  303 bits (777), Expect = 1e-91
 Identities = 117/632 (18%), Positives = 213/632 (33%), Gaps = 64/632 (10%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
                  LN    IP  L    S ++L+L FN L      + F+   L+ ++    ++  
Sbjct: 10  ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
                  + S L  L  + N +         S L  L+ +   +          + + K 
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAF-SGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 204 LEILSLSINNLLGA-IPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVS-- 260
           L+ L+++ N +    +P+   NLT L+ L L  + +Q     +   L ++ L+ L +   
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185

Query: 261 --NLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-IHNLHNLKLLDLSHNKLVGAV--- 314
              +    P     +  L  L L  NF +  +    I  L  L++  L   +        
Sbjct: 186 LNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 315 ---PATIFNMSTLTGLGLQSNSLSGSLSSIADV--QLPNLEELRLWSNNFSGTIPRFIFN 369
               + +  +  LT    +   L   L  I D+   L N+    L S      +  F +N
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYN 303

Query: 370 ASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI 429
                 LEL    F  F      +L+ L            ++ +     S  +  SL ++
Sbjct: 304 -FGWQHLELVNCKFGQFPTLKLKSLKRLTF----------TSNKGGNAFSEVDLPSLEFL 352

Query: 430 GLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGS 489
            LS N L                        +  G   +     T+L  + L  N +   
Sbjct: 353 DLSRNGL------------------------SFKGCCSQSDFGTTSLKYLDLSFNGVIT- 387

Query: 490 IPITLGKLQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKLSGSIPACFSNLASL 548
           +      L++L+ L  + + L+      +   L  L  L +S      +    F+ L+SL
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 549 GTLSLGSNKLTS--IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
             L +  N      +P     L+ + +L+ S        P    +L  L  ++ S NNF 
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507

Query: 607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLI-SLKSLNLSNNNLSRSIPIS--LEK 663
            +       L +LQ L    N +  S  +       SL  LNL+ N+ + +      L+ 
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQW 567

Query: 664 LSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSF 695
           +     L +   +++   P           S 
Sbjct: 568 IKDQRQLLVEVERMECATP--SDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  178 bits (453), Expect = 3e-47
 Identities = 70/406 (17%), Positives = 123/406 (30%), Gaps = 28/406 (6%)

Query: 82  RVKVLNISHLNLTGTIPSQ-LWNLSSLQSLNL------GFNRLSGSIPSAIFTLYTLKYV 134
           R+  L + +   +  +    +  L+ L+   L          L     SA+  L  L   
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 135 NFRGNQLS---GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
            FR   L              +++         +         S     + + L    F 
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF---SYNFGWQHLELVNCKFG 317

Query: 192 GRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQ--GEIPREFGNL 249
                 L + K L   S    N          +L  L+ L L  +GL   G   +     
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 250 AELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHN 308
             L+ + L  + +   +      L  LE L    + L       +  +L NL  LD+SH 
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 309 KLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
               A       +S+L  L +  NS   +       +L NL  L L         P    
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNC-KSLT 427
           + S L VL +  N+F       +  L +L+++    N++ +S           +   SL 
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK-----KQELQHFPSSLA 546

Query: 428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNL 473
           ++ L+ N         S            +    +    P +   +
Sbjct: 547 FLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  174 bits (442), Expect = 6e-46
 Identities = 74/378 (19%), Positives = 126/378 (33%), Gaps = 31/378 (8%)

Query: 328 GLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFI 387
            +    +  +   I D    + + L L  N          F+  +L VL+L R       
Sbjct: 9   NITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68

Query: 388 PNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGN 447
              + +L +L  + L  N + S  L      +FS   SL  +      L  +     +G+
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALG-----AFSGLSSLQKLVAVETNLASLENF-PIGH 122

Query: 448 LSHSLEYFDMSYCNVSGG-FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ----G 502
           L  +L+  ++++  +     P+   NLTNL  + L  NK+       L  L ++      
Sbjct: 123 LK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181

Query: 503 LHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLTSI 561
           L L  N +   I     +  +L++L L  N  S ++   C   LA L    L   +  + 
Sbjct: 182 LDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 562 P----LTIWNLKGMLYLNFSSN------FFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPT 611
                     L+G+  L           ++   +      L  +      +     V   
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD- 299

Query: 612 VIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLD 671
                   Q+L L   +     +       SLK L  ++N        S   L  LE LD
Sbjct: 300 -FSYNFGWQHLELVNCKFGQFPTLKLK---SLKRLTFTSNKG--GNAFSEVDLPSLEFLD 353

Query: 672 LSFNKLKGEIPKGGSFGN 689
           LS N L  +     S   
Sbjct: 354 LSRNGLSFKGCCSQSDFG 371

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  162 bits (413), Expect = 4e-42
 Identities = 61/329 (18%), Positives = 115/329 (34%), Gaps = 18/329 (5%)

Query: 81  HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQ 140
             V   ++  + +              Q L L   +        + +L  L + + +G  
Sbjct: 282 TNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339

Query: 141 LSGAFPSFIFNKSSLQHLDFSYNALS--GEIPANICSNLPFLESISLSQNMFHGRIPSAL 198
                     +  SL+ LD S N LS  G    +       L+ + LS N     + S  
Sbjct: 340 AFS-----EVDLPSLEFLDLSRNGLSFKGCCSQSDF-GTTSLKYLDLSFNGVIT-MSSNF 392

Query: 199 SNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMAL 257
              + LE L    +NL       +  +L  L  L + ++  +      F  L+ LE++ +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452

Query: 258 QVSNLQGEI-PQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPA 316
             ++ Q    P     L  L  L L +  L    P   ++L +L++L++SHN        
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512

Query: 317 TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIP--RFIFNASKLS 374
               +++L  L    N +  S          +L  L L  N+F+ T     F+       
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572

Query: 375 VLELGRNSFSGFIPNTFGNLRNLRLMTLH 403
            L +         P    + + + +++L+
Sbjct: 573 QLLVEVERMECATP---SDKQGMPVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  112 bits (283), Expect = 7e-26
 Identities = 35/200 (17%), Positives = 79/200 (39%), Gaps = 6/200 (3%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQLW-NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFR 137
              +++ L+  H NL       ++ +L +L  L++       +       L +L+ +   
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453

Query: 138 GNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS 196
           GN     F   IF +  +L  LD S   L    P    ++L  L+ +++S N F      
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF-NSLSSLQVLNMSHNNFFSLDTF 512

Query: 197 ALSNCKYLEILSLSINNLLGAIPKEIGNL-TKLKELYLGYSGLQGEIPRE--FGNLAELE 253
                  L++L  S+N+++ +  +E+ +  + L  L L  +        +     + +  
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQR 572

Query: 254 LMALQVSNLQGEIPQELANL 273
            + ++V  ++   P +   +
Sbjct: 573 QLLVEVERMECATPSDKQGM 592

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  280 bits (720), Expect = 4e-87
 Identities = 90/308 (29%), Positives = 142/308 (46%), Gaps = 16/308 (5%)

Query: 414 LSFLSSFSNCKSL----TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGF--P 467
           L       N  +L          N    G+L   +       +   D+S  N+   +  P
Sbjct: 12  LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCD-TDTQTYR-VNNLDLSGLNLPKPYPIP 69

Query: 468 KEIGNLTNLIGIYLGG-NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE 526
             + NL  L  +Y+GG N L G IP  + KL +L  L++    + G IPD + ++  L  
Sbjct: 70  SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129

Query: 527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGML-YLNFSSNFFTGP 584
           L  S N LSG++P   S+L +L  ++   N+++ +IP +  +   +   +  S N  TG 
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189

Query: 585 LPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLK 644
           +P    NL  L  +D S N        + G   N Q + L  N L   +    G   +L 
Sbjct: 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLN 247

Query: 645 SLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGS 704
            L+L NN +  ++P  L +L +L  L++SFN L GEIP+GG+   F   ++  N+ LCGS
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307

Query: 705 PNLQVPPC 712
           P   +P C
Sbjct: 308 P---LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  229 bits (587), Expect = 3e-68
 Identities = 91/333 (27%), Positives = 139/333 (41%), Gaps = 64/333 (19%)

Query: 38  TDQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVTCDV--HSHRVKVLNISHLNL 93
            D+ ALL +K  +  +PT     +W  +T  CN  W GV CD    ++RV  L++S LNL
Sbjct: 6   QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 94  ---------------------------TGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIF 126
                                       G IP  +  L+ L  L +    +SG+IP  + 
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122

Query: 127 TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
            +                         +L  LDFSYNALSG +P +I S+LP L  I+  
Sbjct: 123 QI------------------------KTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFD 157

Query: 187 QNMFHGRIPSALSNCKYL-EILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE 245
            N   G IP +  +   L   +++S N L G IP    NL  L  + L  + L+G+    
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL 216

Query: 246 FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDL 305
           FG+    + + L  ++L  ++  ++     L  L L  N + G +P  +  L  L  L++
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275

Query: 306 SHNKLVGAVPATIFNMSTLTGLGLQSNS-LSGS 337
           S N L G +P    N+         +N  L GS
Sbjct: 276 SFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  210 bits (538), Expect = 2e-61
 Identities = 90/358 (25%), Positives = 137/358 (38%), Gaps = 69/358 (19%)

Query: 194 IPSALSNCKYL----EILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGE--IPREFG 247
           I   L N   L              LG +        ++  L L    L     IP    
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 248 NLAELELMALQVSN-LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLS 306
           NL  L  + +   N L G IP  +A LT L  L +    ++G IP  +  +  L  LD S
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
           +N L G +P +I +                         LPNL  +    N  SG IP  
Sbjct: 134 YNALSGTLPPSISS-------------------------LPNLVGITFDGNRISGAIPDS 168

Query: 367 IFNASKLS-VLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
             + SKL   + + RN  +G IP TF NL                              +
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANL------------------------------N 198

Query: 426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNK 485
           L ++ LS N L+G    +  G+   + +   ++  +++     ++G   NL G+ L  N+
Sbjct: 199 LAFVDLSRNMLEGDAS-VLFGSDK-NTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255

Query: 486 LNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNK-LSGS-IPAC 541
           + G++P  L +L+ L  L++  N L G IP     L +      + NK L GS +PAC
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPLPAC 312

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  277 bits (711), Expect = 3e-82
 Identities = 108/570 (18%), Positives = 198/570 (34%), Gaps = 47/570 (8%)

Query: 132 KYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
           K  N     L+   P  +   +S + L+FS+N L   I     S L  L  + L++   +
Sbjct: 15  KTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIY 70

Query: 192 GRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAE 251
                   +   L+ L L+ N L+      +     LK L+   +G+         N   
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 252 LELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKL--LDLSHNK 309
           LE + L  +++      +      L+VL    N +      ++ +L       L+L+ N 
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 310 LVGAVPATIFNMSTLTGLGLQSNSLSG-SLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
           +   +    F+ +    L              + +  + +L        +     P    
Sbjct: 191 I-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249

Query: 369 NASKLSV--LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL 426
              ++SV  + L ++ F     NTF     L+ + L   +L+         S      +L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE------LPSGLVGLSTL 303

Query: 427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE-IGNLTNLIGIYLGGNK 485
             + LS N  + +  ++S  N   SL +  +             + NL NL  + L  + 
Sbjct: 304 KKLVLSANKFENL-CQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361

Query: 486 LNGS--IPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP-ACF 542
           +  S    + L  L  LQ L+L  N+      +      +L  L L+  +L      + F
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421

Query: 543 SNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFS 601
            NL  L  L+L  + L      ++  L  + +LN   N F         +L+        
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ-------- 473

Query: 602 TNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL 661
                         L  L+ L L +  L      +F  L  +  ++LS+N L+ S   +L
Sbjct: 474 -------------TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520

Query: 662 EKLSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
             L  +  L+L+ N +   +P        S
Sbjct: 521 SHLKGIY-LNLASNHISIILP--SLLPILS 547

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  277 bits (710), Expect = 5e-82
 Identities = 114/582 (19%), Positives = 204/582 (35%), Gaps = 22/582 (3%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
            + L  S   L     +    L +L  L+L   ++         + + L  +    N L 
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCK 202
               + +    +L+HL F    +S  I      N   LES+ L  N             +
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153

Query: 203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQ-GEIPREFGNLAELELMALQVSN 261
            L++L    N +     +++ +L +   L L  +G     I     + A  + +    + 
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213

Query: 262 LQGEIPQELAN--LTGLEVLKLGKNFLTGEIPPEIHNLHNLKL--LDLSHNKLVGAVPAT 317
               I + L N  +  L +            P     L  + +  ++L  +        T
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273

Query: 318 IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLE 377
               S L  L L +  LS   S +    L  L++L L +N F         N   L+ L 
Sbjct: 274 FHCFSGLQELDLTATHLSELPSGLVG--LSTLKKLVLSANKFENLCQISASNFPSLTHLS 331

Query: 378 LGRNSFSGFI-PNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPL 436
           +  N+    +      NL NLR + L ++ + +S+          N   L  + LS N  
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC---NLQLRNLSHLQSLNLSYNEP 388

Query: 437 DGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEI-GNLTNLIGIYLGGNKLNGSIPITLG 495
             +    +       LE  D+++  +     +    NL  L  + L  + L+ S      
Sbjct: 389 LSL-KTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 496 KLQKLQGLHLEDNKLEGPI---PDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS 552
            L  LQ L+L+ N          + +  L +L  L LS   LS      F++L  +  + 
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506

Query: 553 LGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTV 612
           L  N+LTS  +   +    +YLN +SN  +  LP  +  L     I+   N         
Sbjct: 507 LSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLD----CT 562

Query: 613 IGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS 654
              +  L++      +L+ +      +   L+ + LS+  LS
Sbjct: 563 CSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  251 bits (644), Expect = 8e-73
 Identities = 106/498 (21%), Positives = 179/498 (35%), Gaps = 19/498 (3%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRG 138
             HR+  L ++   L     + L    +L+ L      +S      +    TL+ +    
Sbjct: 79  SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138

Query: 139 NQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNM-FHGRIPSA 197
           N +S       F    L+ LDF  NA+   +     S+L    ++SL+ N      I   
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197

Query: 198 LSNCKYLEILSLSINNLLGAIPKEIGN--LTKLKELYLGYSGLQGEIPREFGNLAELELM 255
             +    + L+      L  I K + N  +  L          +   P  F  L E+ + 
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVE 257

Query: 256 ALQVSN--LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGA 313
           ++ +                +GL+ L L    L+ E+P  +  L  LK L LS NK    
Sbjct: 258 SINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENL 316

Query: 314 VPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN--FSGTIPRFIFNAS 371
              +  N  +LT L ++ N+    L +     L NL EL L  ++   S      + N S
Sbjct: 317 CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376

Query: 372 KLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGL 431
            L  L L  N         F     L L+ L +  L          S F N   L  + L
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV----KDAQSPFQNLHLLKVLNL 432

Query: 432 SNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIG---NLTNLIGIYLGGNKLNG 488
           S++ LD          L  +L++ ++   +   G  ++      L  L  + L    L+ 
Sbjct: 433 SHSLLDIS-SEQLFDGLP-ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
                   L+ +  + L  N+L     + +  L  +Y L L+ N +S  +P+    L+  
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQ 549

Query: 549 GTLSLGSNKLTSIPLTIW 566
            T++L  N L      I+
Sbjct: 550 RTINLRQNPLDCTCSNIY 567

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  130 bits (328), Expect = 2e-31
 Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 12/286 (4%)

Query: 81  HRVKVLNISHLNLTGTIPSQ-LWNLSSLQSLNLGFNRL--SGSIPSAIFTLYTLKYVNFR 137
             +  L+I        + +  L NL +L+ L+L  + +  S      +  L  L+ +N  
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384

Query: 138 GNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSA 197
            N+              L+ LD ++  L  +   +   NL  L+ ++LS ++        
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444

Query: 198 LSNCKYLEILSLSINNLLGAIPKEIG---NLTKLKELYLGYSGLQGEIPREFGNLAELEL 254
                 L+ L+L  N+      ++      L +L+ L L +  L       F +L  +  
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504

Query: 255 MALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAV 314
           + L  + L     + L++L G+  L L  N ++  +P  +  L   + ++L  N L    
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC-- 561

Query: 315 PATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS 360
                +         ++               P L  +RL     S
Sbjct: 562 ---TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  271 bits (694), Expect = 6e-80
 Identities = 117/577 (20%), Positives = 191/577 (33%), Gaps = 39/577 (6%)

Query: 119 GSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLP 178
           GS+   I  +           +LS   P  I   SS +++D S+N L   + +   SN  
Sbjct: 2   GSLNPCIEVV-PNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLK-ILKSYSFSNFS 56

Query: 179 FLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGL 238
            L+ + LS+         A     +L  L L+ N +    P     LT L+ L    + L
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 239 QGEIPREFGNLAELELMALQVSNLQG-EIPQELANLTGLEVLKLGKNFLTGEIPPEIHNL 297
                   G L  L+ + +  + +   ++P   +NLT L  + L  N++      ++  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 298 HNLKL----LDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELR 353
                    LD+S N +   +    F    L  L L+ N  S ++       L  L   R
Sbjct: 177 RENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235

Query: 354 LWSNNFSGTIPRFIFNASKLSVLE--------LGRNSFSGFIPNTFGNLRNLRLMTLHYN 405
           L    F       IF  S +  L         L   +        F  L N+  M+L   
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295

Query: 406 YLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG 465
            +         L           + +    L          +L   L+   ++    S  
Sbjct: 296 SIKY-------LEDVPKHFKWQSLSIIRCQLKQF----PTLDLPF-LKSLTLTMNKGSIS 343

Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPITL--GKLQKLQGLHLEDNKLEGPIPDDICRLTK 523
           F      L +L  + L  N L+ S   +        L+ L L  N     +  +   L +
Sbjct: 344 FK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEE 400

Query: 524 LYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFF 581
           L  L    + L        F +L  L  L +           I+  L  +  L  + N F
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460

Query: 582 TGPLPLDI-GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDL 640
                 ++  N   L  +D S      +   V   L  LQ L + +N L    S  +  L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520

Query: 641 ISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKL 677
            SL +L+ S N +  S  I       L   +L+ N +
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  191 bits (488), Expect = 8e-52
 Identities = 94/491 (19%), Positives = 162/491 (32%), Gaps = 60/491 (12%)

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST 323
           G +   +  +  +         L+ ++P +I +  + K +DLS N L      +  N S 
Sbjct: 2   GSLNPCIEVVPNITYQ-CMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
           L  L L    +  ++   A   L +L  L L  N      P      + L  L       
Sbjct: 58  LQWLDLSRCEIE-TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 384 SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
           +       G L  L+ + + +N++ S  L     + FSN  +L ++ LS N +  I    
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLP----AYFSNLTNLVHVDLSYNYIQTITVND 172

Query: 444 --SMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP-ITLGKLQKL 500
              +          DMS   +      +      L  + L GN  + +I    L  L  L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231

Query: 501 QGLHL------EDNKLEGPIPDDICRLTKLY--ELGLSGNKLSGSIPACFSNLASLGTLS 552
               L      ++  LE   P  +  L  +   E  L+           F  LA++  +S
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291

Query: 553 LGSNKLTSIP--------------------LTIWNLKGMLYLNFSSNFFTGPLPLDIGNL 592
           L    +  +                         +L  +  L  + N  +         L
Sbjct: 292 LAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKK--VAL 349

Query: 593 KVLIGIDFSTNNFSDVIPTV--IGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSN 650
             L  +D S N  S          G  +L++L L +N     +S +F  L  L+ L+  +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408

Query: 651 NNLSRSIPIS-LEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSA-----------KSFEGN 698
           + L R    S    L  L  LD+S+   K +    G F   ++           K    +
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD--GIFLGLTSLNTLKMAGNSFKDNTLS 466

Query: 699 ELLCGSPNLQV 709
            +   + NL  
Sbjct: 467 NVFANTTNLTF 477

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  160 bits (408), Expect = 1e-41
 Identities = 58/365 (15%), Positives = 109/365 (29%), Gaps = 24/365 (6%)

Query: 84  KVLNISHLNLTGTIPS-QLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLK--------YV 134
             L +     +  I    L NL+ L    L            IF    ++          
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266

Query: 135 NFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI 194
                             +++  +  +  ++   +           +S+S+ +       
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDV--PKHFKWQSLSIIRCQLKQFP 323

Query: 195 PSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELEL 254
              L     L+ L+L++N     I  +   L  L  L L  + L       + +L    L
Sbjct: 324 TLDLPF---LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSL 378

Query: 255 MALQVS-NLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-IHNLHNLKLLDLSHNKLVG 312
             L +S N    +      L  L+ L    + L          +L  L  LD+S+     
Sbjct: 379 RHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438

Query: 313 AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK 372
                   +++L  L +  NS   +  S       NL  L L                 +
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498

Query: 373 LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLS 432
           L +L +  N+      + +  L +L  +   +N + +S             KSL +  L+
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK-----GILQHFPKSLAFFNLT 553

Query: 433 NNPLD 437
           NN + 
Sbjct: 554 NNSVA 558

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  243 bits (622), Expect = 3e-70
 Identities = 111/554 (20%), Positives = 198/554 (35%), Gaps = 45/554 (8%)

Query: 134 VNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR 193
                       P  +    S ++LD S+N L   + +    + P L+ + LS+      
Sbjct: 12  YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTI 67

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELE 253
              A  +  +L  L L+ N +          L+ L++L    + L        G+L  L+
Sbjct: 68  EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 254 LMALQVSNLQ-GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKL----LDLSHN 308
            + +  + +Q  ++P+  +NLT LE L L  N +      ++  LH + L    LDLS N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 309 KLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
            +   +    F    L  L L++N  S ++       L  LE  RL    F         
Sbjct: 188 PM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE------ 240

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY 428
                        +   F  +    L NL +      YL     ++     F+   +++ 
Sbjct: 241 ------------GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDII--DLFNCLTNVSS 286

Query: 429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
             L +  ++ +            LE  +  +             L +L  +    NK   
Sbjct: 287 FSLVSVTIERVKDFSYNFGW-QHLELVNCKFGQFPTL------KLKSLKRLTFTSNKGGN 339

Query: 489 SIPITLGKLQKLQGLHLEDNKLE--GPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLA 546
           +   +   L  L+ L L  N L   G         T L  L LS N +  ++ + F  L 
Sbjct: 340 AF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 396

Query: 547 SLGTLSLGSNKLTSIPLTI--WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN 604
            L  L    + L  +       +L+ ++YL+ S              L  L  +  + N+
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456

Query: 605 FSDVIPT-VIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEK 663
           F +     +   L NL +L L   +L+     +F  L SL+ LN+++N L        ++
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516

Query: 664 LSYLEDLDLSFNKL 677
           L+ L+ + L  N  
Sbjct: 517 LTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  122 bits (309), Expect = 4e-29
 Identities = 74/384 (19%), Positives = 122/384 (31%), Gaps = 66/384 (17%)

Query: 86  LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIF------TLYTLKYVNFRGN 139
           L++S   +    P     +  L  L L  N  S ++            ++ L    FR  
Sbjct: 182 LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 140 QLSGAFPSFIFN---KSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP- 195
                F           +++    +Y     +   ++ + L  + S SL           
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300

Query: 196 SALSNCKYLEILSLSIN-----------------NLLGAIPKEIGNLTKLKELYLGYSGL 238
           S     ++LE+++                     N  G    E+ +L  L+ L L  +GL
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGL 359

Query: 239 Q--GEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-- 294
              G   +       L+ + L   N    +      L  LE L    + L  ++      
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLS-FNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 417

Query: 295 HNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRL 354
            +L NL  LD+SH          IFN                         L +LE L++
Sbjct: 418 LSLRNLIYLDISHTHTRV-AFNGIFN------------------------GLSSLEVLKM 452

Query: 355 WSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLE 413
             N+F       IF     L+ L+L +       P  F +L +L+++ +  N L S    
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP-- 510

Query: 414 LSFLSSFSNCKSLTYIGLSNNPLD 437
                 F    SL  I L  NP D
Sbjct: 511 ---DGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  112 bits (283), Expect = 6e-26
 Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 21/291 (7%)

Query: 83  VKVLNISHLNLTGT-IPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT--LYTLKYVNFRGN 139
           ++   +++L+     I      L+++ S +L    +   +    +      L+ VN +  
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFG 317

Query: 140 QLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH--GRIPSA 197
           Q             SL+ L F+ N       + +  +LP LE + LS+N     G    +
Sbjct: 318 QFPTLKLK------SLKRLTFTSNKGG-NAFSEV--DLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 198 LSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMA 256
                 L+ L LS  N +  +      L +L+ L   +S L+       F +L  L  + 
Sbjct: 369 DFGTTSLKYLDLS-FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427

Query: 257 LQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVP 315
           +  ++ +         L+ LEVLK+  N       P+I   L NL  LDLS  +L   + 
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLS 486

Query: 316 ATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPR 365
            T F ++S+L  L + SN L  S+      +L +L+++ L +N +  + PR
Sbjct: 487 PTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  112 bits (281), Expect = 1e-25
 Identities = 48/245 (19%), Positives = 84/245 (34%), Gaps = 14/245 (5%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
           NL  S +  D+S+  +         +   L  + L   ++          L  L  L L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL--T 564
            N ++         L+ L +L      L+        +L +L  L++  N + S  L   
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 565 IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVL----IGIDFSTNNFSDVIPTVIGGLTNLQ 620
             NL  + +L+ SSN        D+  L  +    + +D S N  + + P     +  L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH 203

Query: 621 YLFLGYNRLQGSISE-SFGDLISLKSLNL------SNNNLSRSIPISLEKLSYLEDLDLS 673
            L L  N    ++ +     L  L+   L      +  NL +    +LE L  L   +  
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 674 FNKLK 678
              L 
Sbjct: 264 LAYLD 268

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 92.1 bits (229), Expect = 3e-19
 Identities = 30/152 (19%), Positives = 55/152 (36%), Gaps = 6/152 (3%)

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTI-WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGID 599
           C   + ++ T          IP  + ++ K    L+ S N           +   L  +D
Sbjct: 3   CVEVVPNI-TYQCMELNFYKIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLD 58

Query: 600 FSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI 659
            S      +       L++L  L L  N +Q     +F  L SL+ L     NL+     
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118

Query: 660 SLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
            +  L  L++L+++ N ++        F N +
Sbjct: 119 PIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  210 bits (537), Expect = 1e-59
 Identities = 103/475 (21%), Positives = 190/475 (40%), Gaps = 43/475 (9%)

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
           L   +++ +  +  I      L +  +  LG + +   +     +L ++    LQ   L 
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVT--TLQADRLG 57

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST 323
            +    +  L  L  +    N LT   P  + NL  L  + +++N++    P  + N++ 
Sbjct: 58  IKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTN 113

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
           LTGL L +N ++  +  +    L NL  L L SN  S      +   + L  L  G N  
Sbjct: 114 LTGLTLFNNQIT-DIDPLK--NLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQV 167

Query: 384 SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
           +   P    NL  L  + +  N ++        +S  +   +L  +  +NN +  I P  
Sbjct: 168 TDLKP--LANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQISDITP-- 216

Query: 444 SMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGL 503
            +G L+ +L+   ++   +       + +LTNL  + L  N+++   P  L  L KL  L
Sbjct: 217 -LGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270

Query: 504 HLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL 563
            L  N++    P  +  LT L  L L+ N+L    P   SNL +L  L+L  N ++ I  
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS- 325

Query: 564 TIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLF 623
            + +L  +  L F +N  +    L   NL  +  +    N  SD+ P  +  LT +  L 
Sbjct: 326 PVSSLTKLQRLFFYNNKVSDVSSL--ANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381

Query: 624 LGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK 678
           L       +      ++    ++      L    P ++       + D+++N   
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  207 bits (529), Expect = 2e-58
 Identities = 110/505 (21%), Positives = 191/505 (37%), Gaps = 45/505 (8%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL 141
            +    I+       I      L+      LG   ++ ++      L  +  +      +
Sbjct: 2   PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNC 201
                  +   ++L  ++FS N L+   P     NL  L  I ++ N       + L+N 
Sbjct: 59  KS--IDGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIAD--ITPLANL 111

Query: 202 KYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN 261
             L  L+L  N +    P  + NLT L  L L  + +          L  L+   L   N
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQ--LSFGN 165

Query: 262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM 321
              ++   LANLT LE L +  N ++      +  L NL+ L  ++N++    P  +  +
Sbjct: 166 QVTDLK-PLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGIL 220

Query: 322 STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRN 381
           + L  L L  N L   + ++A   L NL +L L +N  S   P  +   +KL+ L+LG N
Sbjct: 221 TNLDELSLNGNQLK-DIGTLA--SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275

Query: 382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
             S   P     L  L  + L+ N L         +S  SN K+LTY+ L  N +  I P
Sbjct: 276 QISNISP--LAGLTALTNLELNENQLED-------ISPISNLKNLTYLTLYFNNISDISP 326

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ 501
              + +L+  L+        VS      + NLTN+  +  G N+++   P+    L ++ 
Sbjct: 327 ---VSSLT-KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRIT 378

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI 561
            L L D        +    ++    +      L    PA  S+  S     +  N  +  
Sbjct: 379 QLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSYT 436

Query: 562 PLTIWNLKGMLYLNFSSNFFTGPLP 586
               +     + +   +  F+G + 
Sbjct: 437 NEVSYTFSQPVTIGKGTTTFSGTVT 461

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  205 bits (524), Expect = 2e-59
 Identities = 67/188 (35%), Positives = 99/188 (52%), Gaps = 6/188 (3%)

Query: 767 CRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVE 826
             R   ++L  ATN F    LIG G FG VYK  + +G +VA+K    +  +  + F+ E
Sbjct: 26  SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85

Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN---YILDIFQRLNIM 883
            E +   RH +L+ +I  C       LI +YM +G+L++ LY S+     +   QRL I 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
           +  A  L YLH      +IH D+K  N+LLD+N V  ++DFGI+K     DQ+   T   
Sbjct: 146 IGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202

Query: 944 ATIGYMAP 951
            T+GY+ P
Sbjct: 203 GTLGYIDP 210

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  216 bits (552), Expect = 7e-59
 Identities = 128/640 (20%), Positives = 218/640 (34%), Gaps = 98/640 (15%)

Query: 80  SHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGN 139
           S   ++      NLT  +P     L++ + L L FN +  ++ ++ F             
Sbjct: 3   SFDGRIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLE--------- 48

Query: 140 QLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALS 199
                          LQ L+         I      NLP L  + L  +  +   P A  
Sbjct: 49  --------------QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94

Query: 200 NCKYLEILSLSINNLLGAI--PKEIGNLTKLKELYLGYSGLQG-EIPREFGNLAELELMA 256
              +L  L L    L  A+       NL  L  L L  + ++   +   FG L  L+ + 
Sbjct: 95  GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154

Query: 257 LQVSNLQGEIPQELANLTG--LEVLKLGKNFLTGEIPPEIHNLHN------LKLLDLSHN 308
              + +      EL  L G  L    L  N L   +  +     N      L++LD+S N
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214

Query: 309 KLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
                         T+   G  SN++S    + + +   ++       +N      +  F
Sbjct: 215 GW------------TVDITGNFSNAISK-SQAFSLILAHHIMGAGFGFHNIK-DPDQNTF 260

Query: 369 ---NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
                S +  L+L            F  L++L+++ L YN +           +F    +
Sbjct: 261 AGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD-----EAFYGLDN 315

Query: 426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNK 485
           L  + LS N L  +      G     + Y D+   +++    +    L  L  + L  N 
Sbjct: 316 LQVLNLSYNLLGELYSSNFYGL--PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373

Query: 486 LNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSG-SIPACFSN 544
           L      T+  +  +  + L  NKL   +P        ++   LS N+L    I      
Sbjct: 374 LT-----TIHFIPSIPDIFLSGNKLVT-LPKINLTANLIH---LSENRLENLDILYFLLR 424

Query: 545 LASLGTLSLGSNKLTSIPL--TIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFST 602
           +  L  L L  N+ +S     T      +  L    N                       
Sbjct: 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML-------------------QL 465

Query: 603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLE 662
              +++   V  GL++LQ L+L +N L       F  L +L+ L+L++N L+      L 
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL- 524

Query: 663 KLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLC 702
             + LE LD+S N+L    P    F + S      N+ +C
Sbjct: 525 -PANLEILDISRNQLL--APNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  204 bits (520), Expect = 1e-54
 Identities = 119/588 (20%), Positives = 198/588 (33%), Gaps = 81/588 (13%)

Query: 153 SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSIN 212
              +   + +  L+ ++P      L   E + LS N       S+    + L++L L   
Sbjct: 4   FDGRIAFYRFCNLT-QVP----QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ 58

Query: 213 NLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELA 271
                I KE   NL  L+ L LG S +   +                        P    
Sbjct: 59  YTPLTIDKEAFRNLPNLRILDLGSSKIY-FLH-----------------------PDAFQ 94

Query: 272 NLTGLEVLKLGKNFLTGEIPPE--IHNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLG 328
            L  L  L+L    L+  +  +    NL  L  LDLS N++        F  +++L  + 
Sbjct: 95  GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154

Query: 329 LQSNSLSG-SLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK------LSVLELGRN 381
             SN +       +  +Q   L    L +N+    +               L +L++  N
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214

Query: 382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
            ++  I   F N                  +  S   S      +   G   + +     
Sbjct: 215 GWTVDITGNFSN-----------------AISKSQAFSLILAHHIMGAGFGFHNIKDPDQ 257

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ 501
               G    S+ + D+S+  V     +    L +L  + L  NK+N         L  LQ
Sbjct: 258 NTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI 561
            L+L  N L      +   L K+  + L  N ++      F  L  L TL L  N LT+I
Sbjct: 318 VLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377

Query: 562 P---------LTIWNLKGMLYLNFSSN--------FFTGPLPLDIGNLKVLIGIDFSTNN 604
                     L+   L  +  +N ++N             +   +  +  L  +  + N 
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNR 437

Query: 605 FSDVIPTVI-GGLTNLQYLFLGYNRLQGSI-----SESFGDLISLKSLNLSNNNLSRSIP 658
           FS            +L+ LFLG N LQ +       + F  L  L+ L L++N L+   P
Sbjct: 438 FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPP 497

Query: 659 ISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPN 706
                L+ L  L L+ N+L   +       N        N+LL  +P+
Sbjct: 498 GVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPD 544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  123 bits (310), Expect = 7e-29
 Identities = 76/404 (18%), Positives = 141/404 (34%), Gaps = 52/404 (12%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
           V+ L++SH  +          L  L+ LNL +N+++     A + L  L+ +N   N L 
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCK 202
             + S  +    + ++D   N ++  I       L  L+++ L  N              
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT----------- 375

Query: 203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
                              I  +  + +++L  + L   +P+       + L   ++ NL
Sbjct: 376 ------------------TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENL 416

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPE--IHNLHNLKLLDLSHNKLVGAVPATI-- 318
              I   L  +  L++L L +N  +     +       +L+ L L  N L  A    +  
Sbjct: 417 D--ILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473

Query: 319 ---FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSV 375
                +S L  L L  N L+ SL       L  L  L L SN  +  +       + L +
Sbjct: 474 DVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL-PANLEI 530

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
           L++ RN      P+ F    +L ++ + +N       ELS   ++ N  ++T  G   + 
Sbjct: 531 LDISRNQLLAPNPDVF---VSLSVLDITHNKF-ICECELSTFINWLNHTNVTIAGPPADI 586

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGI 479
                   S      SL       C+          +L  +  +
Sbjct: 587 YCVYPDSFSG----VSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  118 bits (297), Expect = 3e-27
 Identities = 68/330 (20%), Positives = 116/330 (35%), Gaps = 23/330 (6%)

Query: 81  HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQ 140
             +KVLN+++  +        + L +LQ LNL +N L     S  + L  + Y++ + N 
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 141 LSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSN 200
           ++            LQ LD   NAL+          +P +  I LS N     +P     
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALTT------IHFIPSIPDIFLSGNKLV-TLPKINLT 402

Query: 201 CKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG-EIPREFGNLAELELMALQV 259
              + +    + NL   I   +  +  L+ L L  +        +       LE + L  
Sbjct: 403 ANLIHLSENRLENL--DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGE 460

Query: 260 SNLQGEIPQEL-----ANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGA 313
           + LQ     EL       L+ L+VL L  N+L   +PP +  +L  L+ L L+ N+L   
Sbjct: 461 NMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-V 518

Query: 314 VPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKL 373
           +       + L  L +  N     L +       +L  L +  N F        F     
Sbjct: 519 LSHNDL-PANLEILDISRN----QLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLN 573

Query: 374 SVLELGRNSFSGFIPNTFGNLRNLRLMTLH 403
                     +        +   + L +L 
Sbjct: 574 HTNVTIAGPPADIYCVYPDSFSGVSLFSLS 603

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  201 bits (513), Expect = 7e-58
 Identities = 73/188 (38%), Positives = 105/188 (55%), Gaps = 5/188 (2%)

Query: 768 RRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKS-FDVE 826
           +RFS  EL  A++ FS  N++GRGGFG VYK R+ +G  VAVK    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY---SSNYILDIFQRLNIM 883
            EM+    HRNL+++   C T   + L+  YM +GS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
           +  A  L YLH      +IH D+K +N+LLD+   A + DFG+AKL+  +D  +T T   
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVR 196

Query: 944 ATIGYMAP 951
            TIG++AP
Sbjct: 197 GTIGHIAP 204

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  199 bits (507), Expect = 9e-55
 Identities = 91/558 (16%), Positives = 184/558 (32%), Gaps = 58/558 (10%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
           +  +    +      + SIPS +     +K ++   N+++      +   ++LQ L    
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLG-AIPKE 221
           + ++  I  +   +L  LE + LS N       S       L+ L+L  N      +   
Sbjct: 60  SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 222 IGNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQELANLTGLEVLK 280
             NLT L+ L +G      EI R  F  L  L  + ++  +L+    Q L ++  +  L 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 281 LGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSS 340
           L  +     +      L +++ L+L    L      +   +  ++    +       L+ 
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 341 IADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM 400
            +  +L  L    L  +           + +   + +   +       +    L  +  +
Sbjct: 238 ESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSES-----DVVSELGKVETV 286

Query: 401 TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYC 460
           T+   ++    L     + +S  + +  I + N+ +  +    S                
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQ--------------- 331

Query: 461 NVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPIT---LGKLQKLQGLHLEDNKLE--GPIP 515
                      +L +L  + L  N +           G    LQ L L  N L       
Sbjct: 332 -----------HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380

Query: 516 DDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLN 575
           + +  L  L  L +S N     +P        +  L+L S  +  +   I   + +  L+
Sbjct: 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI--PQTLEVLD 437

Query: 576 FSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISE 635
            S+N       L +  L+ L     S N    +    +     L  + +  N+L+     
Sbjct: 438 VSNNNLDS-FSLFLPRLQEL---YISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDG 491

Query: 636 SFGDLISLKSLNLSNNNL 653
            F  L SL+ + L  N  
Sbjct: 492 IFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  190 bits (485), Expect = 6e-52
 Identities = 93/499 (18%), Positives = 185/499 (37%), Gaps = 21/499 (4%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
           +K L++S   +T      L   ++LQ L L  +R++     A ++L +L++++   N LS
Sbjct: 28  MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP-SALSNC 201
               S+    SSL++L+   N        ++  NL  L+++ +        I     +  
Sbjct: 88  SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147

Query: 202 KYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN 261
             L  L +   +L     + + ++  +  L L  S     +      L+ +  + L+ +N
Sbjct: 148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207

Query: 262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM 321
           L       L        +K      +       + L  L    L  +++        F+ 
Sbjct: 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-------FDD 260

Query: 322 STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRN 381
            TL GLG  + S S  +S +  V+   +  L +        +        K+  + +  +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320

Query: 382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
                  +   +L++L  + L  N +    L+ S  +      SL  + LS N L  +  
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS--ACKGAWPSLQTLVLSQNHLRSMQK 378

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ 501
              +     +L   D+S        P        +  + L    +     +     Q L+
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLE 434

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI 561
            L + +N L+      + RL +LY   +S NKL  ++P   S    L  + +  N+L S+
Sbjct: 435 VLDVSNNNLDS-FSLFLPRLQELY---ISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSV 488

Query: 562 PLTIW-NLKGMLYLNFSSN 579
           P  I+  L  +  +   +N
Sbjct: 489 PDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  184 bits (470), Expect = 7e-50
 Identities = 107/567 (18%), Positives = 192/567 (33%), Gaps = 88/567 (15%)

Query: 134 VNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR 193
            + R    + + PS +   ++++ LD S+N ++  I          L+ + L  +  +  
Sbjct: 10  CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTI 65

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKE-IGNLTKLKELYLGYSGLQGEIPREFGNLAEL 252
              A  +   LE L LS +N L ++     G L+ LK L L  +  Q  +          
Sbjct: 66  EGDAFYSLGSLEHLDLS-DNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLG--------- 114

Query: 253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-IHNLHNLKLLDLSHNKLV 311
                        +     NLT L+ L++G      EI       L +L  L++    L 
Sbjct: 115 -------------VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161

Query: 312 GAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNAS 371
                ++ ++  +  L L  +  +  L  I    L ++  L L   N +      +    
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220

Query: 372 KLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGL 431
             S ++      S     +F  L  L    L  + +   +  L+ L  F+  +S     L
Sbjct: 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL 280

Query: 432 SNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP 491
                                                       +  +++    L   + 
Sbjct: 281 GKV-------------------------------------ETVTIRRLHIPQFYLFYDLS 303

Query: 492 ITLGKLQKLQGLHLEDNKLEGPIPDDICR-LTKLYELGLSGNKLSGSI---PACFSNLAS 547
                L+K++ + +E++K+   +P    + L  L  L LS N +        AC     S
Sbjct: 304 TVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362

Query: 548 LGTLSLGSNKLTSIPLTIWNLKGM---LYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN 604
           L TL L  N L S+  T   L  +     L+ S N F  P+P      + +  ++ S+  
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421

Query: 605 FSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKL 664
              V          L+ L +  N L          L  L+ L +S N L  ++P      
Sbjct: 422 IRVVKT---CIPQTLEVLDVSNNNL----DSFSLFLPRLQELYISRNKLK-TLP-DASLF 472

Query: 665 SYLEDLDLSFNKLKGEIPKGGSFGNFS 691
             L  + +S N+LK  +P  G F   +
Sbjct: 473 PVLLVMKISRNQLK-SVPD-GIFDRLT 497

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  122 bits (308), Expect = 4e-29
 Identities = 66/376 (17%), Positives = 114/376 (30%), Gaps = 38/376 (10%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
             L I  L+L       L ++  +  L L  +  +  +      L +++Y+  R   L+ 
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

Query: 144 AFPSFIFNKSSLQHL-----------DFSYNALSG------EIPANICSNLPFLESISLS 186
              S +        +           D S+N L        E+      +         +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270

Query: 187 QNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREF 246
            +               +  L +    L   +      L K+K + +  S +        
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330

Query: 247 GNLAELELMAL---QVSNLQGEIPQELANLTGLEVLKLGKNFLT--GEIPPEIHNLHNLK 301
            +L  LE + L    +     +          L+ L L +N L    +    +  L NL 
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390

Query: 302 LLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG 361
            LD+S N     +P +      +  L L S  +      +       LE L + +NN   
Sbjct: 391 SLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR----VVKTCIPQTLEVLDVSNNNLD- 444

Query: 362 TIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFS 421
           +   F+     L  L + RN        +      L +M +  N L S          F 
Sbjct: 445 SFSLFLPR---LQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPD-----GIFD 494

Query: 422 NCKSLTYIGLSNNPLD 437
              SL  I L  NP D
Sbjct: 495 RLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  103 bits (258), Expect = 5e-23
 Identities = 44/278 (15%), Positives = 96/278 (34%), Gaps = 8/278 (2%)

Query: 422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYL 481
           +C +       +     I        L+ +++  D+S+  ++     ++    NL  + L
Sbjct: 3   SCDASGVCDGRSRSFTSIPS-----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57

Query: 482 GGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSG-SIPA 540
             +++N         L  L+ L L DN L          L+ L  L L GN      + +
Sbjct: 58  KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 541 CFSNLASLGTLSLGS-NKLTSIP-LTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGI 598
            F NL +L TL +G+    + I  +    L  +  L   +          + +++ +  +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 599 DFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP 658
               +  + ++      L++++YL L    L                +       S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 659 ISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFE 696
            S  +L  L    L  ++++ +       G+F+    +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  101 bits (253), Expect = 3e-22
 Identities = 59/339 (17%), Positives = 120/339 (35%), Gaps = 22/339 (6%)

Query: 13  FLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWT 72
              L  +  + L          S     +    +K  +    +    +++N    +  + 
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK-KLAFRGSVLTDESFNELLKLLRYI 250

Query: 73  GVTCDVHSHRVKVLNISHLNLTGTIPSQ---LWNLSSLQSLNLGFNRLSGSIPSAIFTLY 129
               +V      +  +   N + +            +++ L++    L   + +    L 
Sbjct: 251 LELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLE 310

Query: 130 TLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPAN--ICSNLPFLESISLSQ 187
            +K +    +++     SF  +  SL+ LD S N +  E   N       P L+++ LSQ
Sbjct: 311 KVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370

Query: 188 NMFH--GRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE 245
           N      +    L   K L  L +S  N    +P       K++ L L  +G++  +   
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDIS-RNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTC 428

Query: 246 -FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLD 304
               L  L++    + +           L  L+ L + +N L   +P        L ++ 
Sbjct: 429 IPQTLEVLDVSNNNLDSFS-------LFLPRLQELYISRNKLK-TLPDAS-LFPVLLVMK 479

Query: 305 LSHNKLVGAVPATIF-NMSTLTGLGLQSNSLSGSLSSIA 342
           +S N+L  +VP  IF  +++L  + L +N    S   I 
Sbjct: 480 ISRNQL-KSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 517

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  188 bits (480), Expect = 4e-53
 Identities = 81/379 (21%), Positives = 159/379 (41%), Gaps = 34/379 (8%)

Query: 300 LKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNF 359
              L      +    P    +++      LQ  S++  + +  +  L ++ +L +     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD-VVTQEE--LESITKLVVAGEKV 56

Query: 360 SGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS 419
           + +I   I   + L  L L  N  +   P    NL  L  + +  N +T        +S+
Sbjct: 57  A-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISA 105

Query: 420 FSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGI 479
             N  +L  + L+ + +  I P   + NL+  +   ++   +        + N+T L  +
Sbjct: 106 LQNLTNLRELYLNEDNISDISP---LANLT-KMYSLNLGANHNLS-DLSPLSNMTGLNYL 160

Query: 480 YLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP 539
            +  +K+    PI    L  L  L L  N++E   P  +  LT L+      N+++   P
Sbjct: 161 TVTESKVKDVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216

Query: 540 ACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGID 599
              +N+  L +L +G+NK+T +   + NL  + +L   +N  +    +   +L  L  ++
Sbjct: 217 --VANMTRLNSLKIGNNKITDLS-PLANLSQLTWLEIGTNQISDINAV--KDLTKLKMLN 271

Query: 600 FSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI 659
             +N  SD+    +  L+ L  LFL  N+L     E  G L +L +L LS N+++   P+
Sbjct: 272 VGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPL 329

Query: 660 SLEKLSYLEDLDLSFNKLK 678
           +   LS ++  D +   +K
Sbjct: 330 A--SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  185 bits (471), Expect = 6e-52
 Identities = 90/407 (22%), Positives = 158/407 (38%), Gaps = 61/407 (14%)

Query: 249 LAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHN 308
            A L  +   ++ +        A+L       L K  +T  +      L ++  L ++  
Sbjct: 2   AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54

Query: 309 KLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
           K+           +++ G+                  L NLE L L  N  +   P  + 
Sbjct: 55  KV-----------ASIQGIE----------------YLTNLEYLNLNGNQITDISP--LS 85

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY 428
           N  KL+ L +G N  +        NL NLR + L+ + ++        +S  +N   +  
Sbjct: 86  NLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISD-------ISPLANLTKMYS 136

Query: 429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
           + L  N     L    + N++  L Y  ++   V       I NLT+L  + L  N++  
Sbjct: 137 LNLGANHNLSDLS--PLSNMT-GLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED 191

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
             P  L  L  L       N++    P  +  +T+L  L +  NK++   P   +NL+ L
Sbjct: 192 ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQL 245

Query: 549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDV 608
             L +G+N+++ I   + +L  +  LN  SN  +      + NL  L  +  + N   + 
Sbjct: 246 TWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNE 302

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR 655
              VIGGLTNL  LFL  N +          L  + S + +N  + +
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQVIKK 347

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  176 bits (450), Expect = 4e-49
 Identities = 76/364 (20%), Positives = 144/364 (39%), Gaps = 33/364 (9%)

Query: 196 SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELM 255
              ++        L   ++   +      L  + +L +    +   I      L  LE +
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYL 71

Query: 256 ALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVP 315
            L  + +    P  L+NL  L  L +G N +T      + NL NL+ L L+ + +    P
Sbjct: 72  NLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP 127

Query: 316 ATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSV 375
             + N++ +  L L +N     LS ++   +  L  L +  +      P  I N + L  
Sbjct: 128 --LANLTKMYSLNLGANHNLSDLSPLS--NMTGLNYLTVTESKVKDVTP--IANLTDLYS 181

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
           L L  N      P    +L +L   T + N +T        ++  +N   L  + + NN 
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-------ITPVANMTRLNSLKIGNNK 232

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLG 495
           +  + P   + NLS  L + ++    +S      + +LT L  + +G N+++    +   
Sbjct: 233 ITDLSP---LANLS-QLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVL--N 284

Query: 496 KLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS 555
            L +L  L L +N+L     + I  LT L  L LS N ++   P   ++L+ + +    +
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342

Query: 556 NKLT 559
             + 
Sbjct: 343 QVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  163 bits (416), Expect = 2e-44
 Identities = 75/335 (22%), Positives = 134/335 (40%), Gaps = 31/335 (9%)

Query: 349 LEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLT 408
              L       +   P    + ++     L + S +  +      L ++  + +    + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 409 SSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPK 468
           S       +       +L Y+ L+ N +  I P   + NL   L    +    ++     
Sbjct: 58  S-------IQGIEYLTNLEYLNLNGNQITDISP---LSNLV-KLTNLYIGTNKITD--IS 104

Query: 469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELG 528
            + NLTNL  +YL  + ++   P  L  L K+  L+L  N         +  +T L  L 
Sbjct: 105 ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLT 161

Query: 529 LSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLD 588
           ++ +K+    P   +NL  L +LSL  N++  I   + +L  + Y     N  T   P+ 
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITPV- 217

Query: 589 IGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNL 648
             N+  L  +    N  +D+ P  +  L+ L +L +G N++      +  DL  LK LN+
Sbjct: 218 -ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNV 272

Query: 649 SNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPK 683
            +N +S  I   L  LS L  L L+ N+L  E  +
Sbjct: 273 GSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDME 305

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  163 bits (415), Expect = 2e-44
 Identities = 80/426 (18%), Positives = 155/426 (36%), Gaps = 84/426 (19%)

Query: 86  LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAF 145
           L      +    P    +L+      L    ++  +      L ++  +   G +++   
Sbjct: 5   LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58

Query: 146 PSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLE 205
              I   ++L++L+ + N ++   P    SNL  L ++ +  N       SAL N   L 
Sbjct: 59  IQGIEYLTNLEYLNLNGNQITDISPL---SNLVKLTNLYIGTNKI--TDISALQNLTNLR 113

Query: 206 ILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGE 265
            L L+ +N+    P  + NLTK+  L LG                          N    
Sbjct: 114 ELYLNEDNISDISP--LANLTKMYSLNLGA-------------------------NHNLS 146

Query: 266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLT 325
               L+N+TGL  L + ++ +       I NL +L  L L++N++             ++
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQI-----------EDIS 193

Query: 326 GLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG 385
            L                  L +L     + N  +   P  + N ++L+ L++G N  + 
Sbjct: 194 PLA----------------SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSM 445
             P    NL  L  + +  N ++        +++  +   L  + + +N +  I     +
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISD-------INAVKDLTKLKMLNVGSNQISDISV---L 283

Query: 446 GNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHL 505
            NLS  L    ++   +     + IG LTNL  ++L  N +    P  L  L K+     
Sbjct: 284 NNLS-QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340

Query: 506 EDNKLE 511
            +  ++
Sbjct: 341 ANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  149 bits (378), Expect = 2e-39
 Identities = 79/354 (22%), Positives = 144/354 (40%), Gaps = 54/354 (15%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
           +  L ++   +       +  L++L+ LNL  N+++   P  +  L  L  +    N+++
Sbjct: 46  ITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT 101

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCK 202
               S + N ++L+ L  + + +S   P    +NL  + S++L  N       S LSN  
Sbjct: 102 D--ISALQNLTNLRELYLNEDNISDISPL---ANLTKMYSLNLGANHNLS-DLSPLSNMT 155

Query: 203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
            L  L+++ + +    P  I NLT L  L L Y+ ++   P                   
Sbjct: 156 GLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP------------------- 194

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS 322
                  LA+LT L       N +T   P  + N+  L  L + +NK+    P  + N+S
Sbjct: 195 -------LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLS 243

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
            LT L + +N +S  ++++    L  L+ L + SN  S      + N S+L+ L L  N 
Sbjct: 244 QLTWLEIGTNQIS-DINAVK--DLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQ 298

Query: 383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPL 436
                    G L NL  + L  N++T        +   ++   +     +N  +
Sbjct: 299 LGNEDMEVIGGLTNLTTLFLSQNHITD-------IRPLASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  121 bits (306), Expect = 4e-30
 Identities = 64/277 (23%), Positives = 118/277 (42%), Gaps = 21/277 (7%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
             L I    +T    S L NL++L+ L L  + +S   P  +  L  +  +N   N    
Sbjct: 91  TNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
              S + N + L +L  + + +    P    +NL  L S+SL+ N       S L++   
Sbjct: 147 -DLSPLSNMTGLNYLTVTESKVKDVTPI---ANLTDLYSLSLNYNQIED--ISPLASLTS 200

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
           L   +  +N +    P  + N+T+L  L +G + +    P    NL++L    L++   Q
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTW--LEIGTNQ 254

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST 323
                 + +LT L++L +G N ++      ++NL  L  L L++N+L       I  ++ 
Sbjct: 255 ISDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS 360
           LT L L  N ++  +  +A   L  ++     +    
Sbjct: 313 LTTLFLSQNHIT-DIRPLA--SLSKMDSADFANQVIK 346

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  189 bits (482), Expect = 3e-52
 Identities = 102/508 (20%), Positives = 172/508 (33%), Gaps = 85/508 (16%)

Query: 195 PSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELEL 254
           P  +SN  +L+      +NL   +P E  N+    E Y  +S  +   P   G   E+ +
Sbjct: 5   PRNVSNT-FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 255 MALQVSNLQG------------EIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKL 302
             L+    +              +P+   +L   E L    N LT E+P    +L +L +
Sbjct: 63  SRLRDCLDRQAHELELNNLGLSSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLV 118

Query: 303 LDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT 362
            + +   L             L  LG+ +N L   L  +       L+ + + +N+    
Sbjct: 119 DNNNLKALSD-------LPPLLEYLGVSNNQLE-KLPELQ--NSSFLKIIDVDNNSLK-K 167

Query: 363 IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS------------- 409
           +P    +   L  +  G N     +P    NL  L  +    N L               
Sbjct: 168 LPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKLPDLPLSLESIVA 222

Query: 410 SNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE 469
            N  L  L    N   LT I   NN L  +           SLE  ++    ++   P+ 
Sbjct: 223 GNNILEELPELQNLPFLTTIYADNNLLKTLPDLPP------SLEALNVRDNYLTD-LPEL 275

Query: 470 IGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGL 529
             +LT L       + L+   P        L  L+   N++   + D    L +L    +
Sbjct: 276 PQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-LCDLPPSLEELN---V 324

Query: 530 SGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI 589
           S NKL   +PA    L  L       N L  +P    NLK    L+   N      P   
Sbjct: 325 SNNKLI-ELPALPPRLERL---IASFNHLAEVPELPQNLK---QLHVEYNPLRE-FPDIP 376

Query: 590 GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLS 649
            +++ L       N+    +P +     NL+ L +  N L+    +      S++ L ++
Sbjct: 377 ESVEDL-----RMNSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIPE---SVEDLRMN 424

Query: 650 NNNLSRSIPISLEKLSYLEDLDLSFNKL 677
           +  +      + E    LED     +  
Sbjct: 425 SERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  179 bits (457), Expect = 5e-49
 Identities = 101/534 (18%), Positives = 179/534 (33%), Gaps = 83/534 (15%)

Query: 121 IPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFL 180
           I     +   L+      + L+   P    N  S      +++      P          
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQR--- 58

Query: 181 ESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG 240
                   M   R+   L   +    L L+ N  L ++P+   +L     L    + L  
Sbjct: 59  -------EMAVSRLRDCL--DRQAHELELN-NLGLSSLPELPPHLE---SLVASCNSLT- 104

Query: 241 EIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNL 300
           E+P    +L  L +    +  L    P        LE L +  N L  ++P E+ N   L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFL 155

Query: 301 KLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS 360
           K++D+ +N L   +P    +   L  +   +N L   L  +    LP L  +   +N+  
Sbjct: 156 KIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPELQ--NLPFLTAIYADNNSLK 208

Query: 361 GTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSF 420
             +P    +   L  +  G N           NL  L  +    N L +           
Sbjct: 209 -KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPP----- 257

Query: 421 SNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY 480
               SL  + + +N L  +        L  SL + D+S    SG   +   NL  L    
Sbjct: 258 ----SLEALNVRDNYLTDLP------ELPQSLTFLDVSENIFSG-LSELPPNLYYL---N 303

Query: 481 LGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA 540
              N++  S+      L++L   ++ +NKL   +P    RL +L     S N L+  +P 
Sbjct: 304 ASSNEIR-SLCDLPPSLEEL---NVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPE 354

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDF 600
              NL  L    +  N L   P    +++ +   +  +      +P    NLK L     
Sbjct: 355 LPQNLKQL---HVEYNPLREFPDIPESVEDLRMNSHLAE-----VPELPQNLKQL---HV 403

Query: 601 STNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS 654
            TN      P +     +++ L +   R+      +      L+     +++  
Sbjct: 404 ETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  167 bits (426), Expect = 7e-45
 Identities = 95/518 (18%), Positives = 175/518 (33%), Gaps = 83/518 (16%)

Query: 87  NISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFP 146
            + H +    +P +  N+ S       ++    + P        +     R         
Sbjct: 16  PLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD----- 70

Query: 147 SFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEI 206
                      L+ +   LS  +P       P LES+  S N     +P    + K L +
Sbjct: 71  ------RQAHELELNNLGLS-SLPELP----PHLESLVASCNSLT-ELPELPQSLKSLLV 118

Query: 207 LSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEI 266
            + ++  L    P        L+ L +  + L+ ++P E  N + L+++ +  ++L+ ++
Sbjct: 119 DNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KL 168

Query: 267 PQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTG 326
           P    +L     +  G N L     PE+ NL  L  +   +N L   +P    +   L  
Sbjct: 169 PDLPPSLE---FIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPLS---LES 219

Query: 327 LGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGF 386
           +   +N L   L  +    LP L  +   +N    T+P        L  L +  N  +  
Sbjct: 220 IVAGNNILE-ELPELQ--NLPFLTTIYADNNLLK-TLPDLP---PSLEALNVRDNYLTD- 271

Query: 387 IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMG 446
           +P    +L  L +    ++ L+                +L Y+  S+N +  +       
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSEL------------PPNLYYLNASSNEIRSLCDLPP-- 317

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
               SLE  ++S   +    P     L  L       N L   +P     L++   LH+E
Sbjct: 318 ----SLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQNLKQ---LHVE 365

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW 566
            N L    PD    +  L       + L+  +P    NL     L + +N L   P    
Sbjct: 366 YNPLRE-FPDIPESVEDLR----MNSHLA-EVPELPQNLK---QLHVETNPLREFPDIPE 416

Query: 567 NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN 604
           +++    L  +S     P          L   D   ++
Sbjct: 417 SVE---DLRMNSERVVDPYEFAHETTDKL-EDDVFEHH 450

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  163 bits (415), Expect = 2e-43
 Identities = 89/423 (21%), Positives = 154/423 (36%), Gaps = 65/423 (15%)

Query: 266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLT 325
           I     + T L+      + LT E+P E  N+ +      + ++     P        + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 326 GLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG 385
                       +S + D       EL L +   S ++P    +   L  L    NS + 
Sbjct: 62  ------------VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT- 104

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTS----------SNLELSFLSSFSNCKSLTYIGLSNNP 435
            +P    +L++L +   +   L+           SN +L  L    N   L  I + NN 
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLG 495
           L  +           SLE+       +      E+ NL  L  IY   N L   +P    
Sbjct: 165 LKKLPDLPP------SLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KLPDLPL 215

Query: 496 KLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS 555
            L+ +      +N LE     ++  L  L  +    N L  ++P    +L +L   ++  
Sbjct: 216 SLESI---VAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRD 266

Query: 556 NKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGG 615
           N LT +P    +L    +L+ S N F+G L     NL  L   + S+N     I ++   
Sbjct: 267 NYLTDLPELPQSLT---FLDVSENIFSG-LSELPPNLYYL---NASSNE----IRSLCDL 315

Query: 616 LTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
             +L+ L +  N+L   +         L+ L  S N+L+  +P   + L     L + +N
Sbjct: 316 PPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQ---LHVEYN 367

Query: 676 KLK 678
            L+
Sbjct: 368 PLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  154 bits (392), Expect = 2e-40
 Identities = 90/454 (19%), Positives = 154/454 (33%), Gaps = 72/454 (15%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL 141
           +   L +++L L+ ++P    +L   +SL    N L+  +P    +L +L   N     L
Sbjct: 72  QAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 126

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNC 201
           S   P        L++L  S N L  ++P     N  FL+ I +  N    ++P    + 
Sbjct: 127 SDLPPL-------LEYLGVSNNQLE-KLPEL--QNSSFLKIIDVDNNSLK-KLPDLPPS- 174

Query: 202 KYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN 261
             LE ++   NN L  +P E+ NL  L  +Y   + L+ ++P    +L  +        N
Sbjct: 175 --LEFIAAG-NNQLEELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVA-----GN 224

Query: 262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM 321
              E   EL NL  L  +    N L   +P    +L  L + D     L    P    ++
Sbjct: 225 NILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL----PELPQSL 279

Query: 322 STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRN 381
           + L       + LS           PNL  L   SN    ++         L  L +  N
Sbjct: 280 TFLDVSENIFSGLSELP--------PNLYYLNASSNEIR-SLCDLP---PSLEELNVSNN 327

Query: 382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
                +P     L  L      +N+L                 +L  + +  NPL     
Sbjct: 328 KLI-ELPALPPRLERL---IASFNHLAEVPELPQ---------NLKQLHVEYNPLREFPD 374

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ 501
                ++       D+   +     P+   NL  L   ++  N L    P     ++ L 
Sbjct: 375 --IPESVE------DLRMNSHLAEVPELPQNLKQL---HVETNPLR-EFPDIPESVEDL- 421

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS 535
              +   ++  P         KL +     +   
Sbjct: 422 --RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  118 bits (299), Expect = 2e-28
 Identities = 59/309 (19%), Positives = 103/309 (33%), Gaps = 43/309 (13%)

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSM 445
           FI     +   L+    H + LT   +E        N KS T    + +  +   P  + 
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLTEMPVEA------ENVKSKTEYYNAWSEWERNAPPGNG 55

Query: 446 -----------GNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITL 494
                        L       +++   +S   P+   +L +L       N L   +P   
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELP 110

Query: 495 GKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLG 554
             L+ L   +     L    P        L  LG+S N+L   +P    N + L  + + 
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD 161

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
           +N L  +P    +L+   ++   +N     LP ++ NL  L  I    N+    +  +  
Sbjct: 162 NNSLKKLPDLPPSLE---FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNS----LKKLPD 212

Query: 615 GLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF 674
              +L+ +  G N L         +L  L ++   NN L  ++P     L  L   D   
Sbjct: 213 LPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYL 269

Query: 675 NKLKGEIPK 683
             L      
Sbjct: 270 TDLPELPQS 278

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  181 bits (462), Expect = 3e-51
 Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 16/196 (8%)

Query: 768 RRFSYLELCRATNRFSE------NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRA-- 819
             FS+ EL   TN F E       N +G GGFG VYK  +     VAVK           
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 820 --FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNY--ILD 875
              + FD E ++M   +H NL++++   S  +   L+  YMP+GSL   L   +    L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 876 IFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
              R  I    A  + +LH       IH D+K +N+LLD+   A +SDFG+A+      Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 936 SITQTQTLATIGYMAP 951
           ++  ++ + T  YMAP
Sbjct: 189 TVMTSRIVGTTAYMAP 204

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  170 bits (432), Expect = 2e-45
 Identities = 66/421 (15%), Positives = 116/421 (27%), Gaps = 49/421 (11%)

Query: 266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLT 325
           I +   N    ++ K+  + L   +     +  N+K LDLS N L     A +   + L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 326 GLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG 385
            L L SN L      +    L  L  L L +N         +     +  L    N+ S 
Sbjct: 62  LLNLSSNVLY-ETLDLE--SLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR 113

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSM 445
              +     +N+    L  N +T                 + Y+ L  N +D +      
Sbjct: 114 VSCSRGQGKKNIY---LANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTV------ 159

Query: 446 GNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHL 505
                               F +   +   L  + L  N +   +   +    KL+ L L
Sbjct: 160 -------------------NFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDL 198

Query: 506 EDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTI 565
             NKL   +  +      +  + L  NKL   I        +L    L  N      L  
Sbjct: 199 SSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 566 WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLG 625
           +  K       +          +     V     +      D+       L  L+     
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHA 316

Query: 626 YNRLQGS----ISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI 681
               QGS    +     +    + ++         I     +      L+     L  ++
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376

Query: 682 P 682
            
Sbjct: 377 S 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  167 bits (425), Expect = 1e-44
 Identities = 64/437 (14%), Positives = 138/437 (31%), Gaps = 43/437 (9%)

Query: 242 IPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLK 301
           I     N    ++  +  S+L+  +     +   ++ L L  N L+     ++     L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 302 LLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG 361
           LL+LS N L       + ++STL  L L +N +   L        P++E L   +NN S 
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS- 112

Query: 362 TIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFS 421
            +            + L  N  +       G    ++ + L  N + +    ++F    +
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT----VNFAELAA 166

Query: 422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYL 481
           +  +L ++ L  N +  +  ++        L+  D+S   ++     E  +   +  I L
Sbjct: 167 SSDTLEHLNLQYNFIYDVKGQVVF----AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

Query: 482 GGNKLNGSIPITLGKLQKLQGLHLEDNKLE-GPIPDDICRLTKLYELGLSGNKLSGSIPA 540
             NKL   I   L   Q L+   L  N    G + D   +  ++    ++   +      
Sbjct: 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQ 278

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDF 600
                        G+     +P               + F    + L      +L G   
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLP---------------APFADRLIALKRKEHALLSG--- 320

Query: 601 STNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS 660
              + ++ +          + +     + +  I +      +  +L      L   +   
Sbjct: 321 -QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379

Query: 661 LEKLSYLEDLDLSFNKL 677
               + L+         
Sbjct: 380 RRAHAELDGTLQQAVGQ 396

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  157 bits (399), Expect = 3e-41
 Identities = 64/423 (15%), Positives = 129/423 (30%), Gaps = 51/423 (12%)

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
           A      N +  +    + ++L  +  A++  +   ++ + LS N       + L+    
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
           LE+L+LS +N+L     ++ +L+ L+ L L  + +                         
Sbjct: 60  LELLNLS-SNVLYETL-DLESLSTLRTLDLNNNYV------------------------- 92

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST 323
               QEL     +E L    N ++  +          K + L++NK+           S 
Sbjct: 93  ----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSR 145

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
           +  L L+ N +     +        LE L L  N     +   +   +KL  L+L  N  
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL 203

Query: 384 SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
           + F+   F +   +  ++L  N L           +    ++L +  L  N       R 
Sbjct: 204 A-FMGPEFQSAAGVTWISLRNNKLV------LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 444 SMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGL 503
                         +   ++G   +E    T     + G             +L  L+  
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG---HYGAYCCEDLPAPFADRLIALKRK 313

Query: 504 HLEDNKLEG----PIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT 559
                  +G     +  +     +  E+     +    I        +  TL      L 
Sbjct: 314 EHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373

Query: 560 SIP 562
              
Sbjct: 374 EQV 376

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  154 bits (391), Expect = 4e-40
 Identities = 64/493 (12%), Positives = 145/493 (29%), Gaps = 47/493 (9%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRG 138
           + +R K+  ++  +L   + S   +  +++ L+L  N LS    + +     L+ +N   
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 139 NQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL 198
           N L       + + S+L+ LD + N +  E+        P +E++  + N       S  
Sbjct: 68  NVLYETLD--LESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSCSRG 119

Query: 199 SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG-EIPREFGNLAELELMAL 257
                 + + L+ N +      + G  ++++ L L  + +          +   LE + L
Sbjct: 120 QG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPAT 317
           Q + +  ++         L+ L L  N L   + PE  +   +  + L +NKLV  +   
Sbjct: 177 QYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 318 IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLE 377
           +     L    L+ N            +   ++ +            +     +  ++  
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGH 290

Query: 378 LGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
            G              L  L+           S  E        N      I        
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYR 349

Query: 438 GILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKL 497
            ++ +++                                I +      L+  +       
Sbjct: 350 TVIDQVT--------------------------LRKQAKITLEQKKKALDEQVSNGRRAH 383

Query: 498 QKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS-GSIPACFSNLASLGTLSLGSN 556
            +L G   +       +       + L  L     +     +        ++    +  +
Sbjct: 384 AELDGTLQQAVGQIE-LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH 442

Query: 557 KLTSIPLTIWNLK 569
           K T +      LK
Sbjct: 443 KETQLAEENARLK 455

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  109 bits (273), Expect = 4e-25
 Identities = 36/197 (18%), Positives = 73/197 (37%), Gaps = 11/197 (5%)

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
           +I        + +   + D+ L+  +         + EL LSGN LS    A  +    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDV 608
             L+L SN L      + +L  +  L+ ++N+       ++     +  +  + NN S V
Sbjct: 61  ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR-SIPISLEKLSYL 667
                      + ++L  N++        G    ++ L+L  N +   +          L
Sbjct: 115 SC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 668 EDLDLSFNKLKGEIPKG 684
           E L+L +N +  ++   
Sbjct: 172 EHLNLQYNFIY-DVKGQ 187

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 6/102 (5%)

Query: 585 LPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLK 644
           +  +    K+      + ++    + ++     N++ L L  N L    +        L+
Sbjct: 5   IKQNGNRYKIE---KVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 645 SLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGS 686
            LNLS+N L  ++ +    LS L  LDL+ N ++ E+  G S
Sbjct: 62  LLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-ELLVGPS 100

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 10/58 (17%), Positives = 24/58 (41%), Gaps = 2/58 (3%)

Query: 632 SISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGN 689
           +I E   +    K   +++++L +++    +    +++LDLS N L            
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAP 56

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  165 bits (419), Expect = 3e-45
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 15/193 (7%)

Query: 770 FSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEM 829
                L   +       +  RG FG V+KA++     VAVK+F +Q  ++++  + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 830 MKSIRHRNLIKVISSCSTEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
           +  ++H N+++ I +            LI  +   GSL   L     ++   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAET 129

Query: 886 VATTLEYLH-------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
           +A  L YLH        G+   + H D+K  NVLL +N+ A ++DFG+A        +  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 939 QTQTLATIGYMAP 951
               + T  YMAP
Sbjct: 190 THGQVGTRRYMAP 202

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  161 bits (409), Expect = 7e-44
 Identities = 64/338 (18%), Positives = 103/338 (30%), Gaps = 32/338 (9%)

Query: 267 PQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTG 326
                + +G E L    +         +         D +             N +    
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQI 60

Query: 327 LGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGF 386
                 +L  +   + D   P    L L S       P   F  S L  + +        
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME- 118

Query: 387 IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMG 446
           +P+T      L  +TL  N L       +  +S ++   L  + +   P    LP   + 
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR------ALPASIASLNRLRELSIRACPELTELPE-PLA 171

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
           +                     E   L NL  + L    +  S+P ++  LQ L+ L + 
Sbjct: 172 STD----------------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIR 214

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL-GSNKLTSIPLTI 565
           ++ L   +   I  L KL EL L G     + P  F   A L  L L   + L ++PL I
Sbjct: 215 NSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273

Query: 566 WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN 603
             L  +  L+         LP  I  L     I    +
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  160 bits (407), Expect = 1e-43
 Identities = 64/365 (17%), Positives = 119/365 (32%), Gaps = 59/365 (16%)

Query: 200 NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQV 259
           +    E L    +  L      +    +                    N    ++     
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTG 65

Query: 260 SNLQGEIPQELANLT--GLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPAT 317
             L+      L + T  G   L+L    L  + P +   L +L+ + +    L+  +P T
Sbjct: 66  RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122

Query: 318 IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLE 377
           +   + L  L L  N L    +SIA   L  L EL + +      +P  + +        
Sbjct: 123 MQQFAGLETLTLARNPLRALPASIA--SLNRLRELSIRACPELTELPEPLASTD------ 174

Query: 378 LGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
                           L NL+ + L +  + S        +S +N ++L  + + N+PL 
Sbjct: 175 ---------ASGEHQGLVNLQSLRLEWTGIRS------LPASIANLQNLKSLKIRNSPLS 219

Query: 438 GILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKL 497
            + P  ++ +L   LE  D+  C     +P   G    L  + L                
Sbjct: 220 ALGP--AIHHL-PKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC------------- 263

Query: 498 QKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNK 557
                     + L   +P DI RLT+L +L L G      +P+  + L +   + +  + 
Sbjct: 264 ----------SNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL 312

Query: 558 LTSIP 562
              + 
Sbjct: 313 QAQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  157 bits (399), Expect = 1e-42
 Identities = 55/344 (15%), Positives = 109/344 (31%), Gaps = 49/344 (14%)

Query: 345 QLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHY 404
                E L    +         +    +    +  R   +    N      N ++ T   
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTG 65

Query: 405 NYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSG 464
             L ++   L   +          + L + PL           LSH L++  +    +  
Sbjct: 66  RALKATADLLEDATQ----PGRVALELRSVPLPQFPD--QAFRLSH-LQHMTIDAAGLME 118

Query: 465 GFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICR---- 520
             P  +     L  + L  N L  ++P ++  L +L+ L +        +P+ +      
Sbjct: 119 -LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 521 -----LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLN 575
                L  L  L L    +  S+PA  +NL +L +L + ++ L+++   I +L       
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLP------ 229

Query: 576 FSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL-GYNRLQGSIS 634
                           L+ L   D          P + GG   L+ L L   + L  ++ 
Sbjct: 230 ---------------KLEEL---DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLP 270

Query: 635 ESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK 678
                L  L+ L+L        +P  + +L     + +  +   
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  153 bits (390), Expect = 2e-41
 Identities = 59/345 (17%), Positives = 114/345 (33%), Gaps = 33/345 (9%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRG 138
           HS   + L              L       + +      +    +        +     G
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTG 65

Query: 139 NQLSGAFPSFIFNKSS--LQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS 196
             L  A    + + +      L+     L  + P      L  L+ +++        +P 
Sbjct: 66  RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDAAGLM-ELPD 121

Query: 197 ALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMA 256
            +     LE L+L+  N L A+P  I +L +L+EL +       E+P    +        
Sbjct: 122 TMQQFAGLETLTLA-RNPLRALPASIASLNRLRELSIRACPELTELPEPLAST------- 173

Query: 257 LQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPA 316
                   +   E   L  L+ L+L    +   +P  I NL NLK L + ++ L  A+  
Sbjct: 174 --------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223

Query: 317 TIFNMSTLTGLGLQSNSLSGSL-SSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSV 375
            I ++  L  L L+  +   +            L+ L L   +   T+P  I   ++L  
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFG--GRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSF 420
           L+L        +P+    L    ++ +  +    + L+     + 
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ--AQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  149 bits (379), Expect = 8e-40
 Identities = 52/329 (15%), Positives = 98/329 (29%), Gaps = 31/329 (9%)

Query: 361 GTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSF 420
           G+      ++S    L    ++      +     +       +                 
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW---------HSAWRQ 52

Query: 421 SNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY 480
           +N  +      +   L      +            ++    +   FP +   L++L  + 
Sbjct: 53  ANSNNPQIETRTGRALKATADLLEDATQP-GRVALELRSVPLPQ-FPDQAFRLSHLQHMT 110

Query: 481 LGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA 540
           +    L   +P T+ +   L+ L L  N L   +P  I  L +L EL +        +P 
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPE 168

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDF 600
             ++                       L  +  L          LP  I NL+ L  +  
Sbjct: 169 PLAST--------------DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKI 213

Query: 601 STNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS 660
             +  S  +   I  L  L+ L L       +    FG    LK L L + +   ++P+ 
Sbjct: 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272

Query: 661 LEKLSYLEDLDLSFNKLKGEIPKGGSFGN 689
           + +L+ LE LDL        +P       
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPS--LIAQ 299

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.0 bits (141), Expect = 6e-09
 Identities = 22/153 (14%), Positives = 46/153 (30%), Gaps = 26/153 (16%)

Query: 558 LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVI-------- 609
           + S      +  G   L F  +    P    +   +     D +  + +           
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60

Query: 610 -----------PTVIGGLT--NLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRS 656
                        ++   T      L L    L     +    L  L+ + +    L   
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-ME 118

Query: 657 IPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGN 689
           +P ++++ + LE L L+ N L+  +P   S  +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPA--SIAS 148

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  157 bits (399), Expect = 9e-43
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 8/168 (4%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           IG G FG+V++A    G +VAVK+   Q         F  E  +MK +RH N++  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 846 STEEFKALILEYMPHGSLEKSLYSSN--YILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
           +     +++ EY+  GSL + L+ S     LD  +RL++  DVA  + YLH   + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +LK  N+L+D      + DFG+++L       ++      T  +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAP 208

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  155 bits (395), Expect = 2e-41
 Identities = 75/416 (18%), Positives = 148/416 (35%), Gaps = 58/416 (13%)

Query: 266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIF-NMSTL 324
           I   L        + +           E   L+N K++   ++ +   +PA +  +   +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 325 TGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSF 383
             L L    +   + + A      +++L +  N     +P  +F N   L+VL L RN  
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129

Query: 384 SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
           S      F N   L  +++  N L     +      F    SL  + LS+N L  +    
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV---- 180

Query: 444 SMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGL 503
            +  +  SL + ++SY  +S      +     +  +    N +N    +      +L  L
Sbjct: 181 DLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPVNVELTIL 231

Query: 504 HLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL 563
            L+ N L       +     L E+ LS N+L   +   F  +  L  L + +N+L ++ L
Sbjct: 232 KLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNL 289

Query: 564 TIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLF 623
               +  +  L+ S N                             +         L+ L+
Sbjct: 290 YGQPIPTLKVLDLSHNHLL-------------------------HVERNQPQFDRLENLY 324

Query: 624 LGYNRLQGSISESFGDLISLKSLNLSNNNLS----RSIPISLEKLSYLEDLDLSFN 675
           L +N +    +       +LK+L LS+N+      R++  ++ + + ++D D    
Sbjct: 325 LDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPA-VDDADQHCK 376

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  145 bits (368), Expect = 7e-38
 Identities = 72/379 (18%), Positives = 133/379 (35%), Gaps = 31/379 (8%)

Query: 86  LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLSGA 144
           ++I           +   L++ + +    + +   +P+A+      ++ +N    Q+   
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 83

Query: 145 FPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
             ++ F    ++Q L   +NA+   +P ++  N+P L  + L +N           N   
Sbjct: 84  IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 142

Query: 204 LEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
           L  LS+S NN L  I  +     T L+ L L  + L         +L           N+
Sbjct: 143 LTTLSMS-NNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHA--------NV 193

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS 322
              +   LA    +E L    N +   +   +     L +L L HN L     A + N  
Sbjct: 194 SYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYP 248

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
            L  + L  N L   +     V++  LE L + +N     +  +      L VL+L  N 
Sbjct: 249 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306

Query: 383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPR 442
               +         L  + L +N + +           S   +L  + LS+N  D    R
Sbjct: 307 LL-HVERNQPQFDRLENLYLDHNSIVT--------LKLSTHHTLKNLTLSHNDWDCNSLR 357

Query: 443 MSMGNLSHSLEYFDMSYCN 461
               N++         +C 
Sbjct: 358 ALFRNVARPAVDDADQHCK 376

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  145 bits (367), Expect = 9e-38
 Identities = 69/368 (18%), Positives = 137/368 (37%), Gaps = 31/368 (8%)

Query: 215 LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLT 274
              I   +       ++++           E   L   +++  + S ++      L +  
Sbjct: 10  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69

Query: 275 GLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSN 332
            +E+L L    +  EI        H ++ L +  N +   +P  +F N+  LT L L+ N
Sbjct: 70  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 127

Query: 333 SLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTF 391
            LS SL        P L  L + +NN    I    F   + L  L+L  N  +    +  
Sbjct: 128 DLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLI 185

Query: 392 GNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHS 451
            +L +     + YN L+          + +   ++  +  S+N ++ +        ++  
Sbjct: 186 PSLFHAN---VSYNLLS----------TLAIPIAVEELDASHNSINVVRG-----PVNVE 227

Query: 452 LEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLE 511
           L    + + N++      + N   L+ + L  N+L   +     K+Q+L+ L++ +N+L 
Sbjct: 228 LTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

Query: 512 GPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGM 571
             +      +  L  L LS N L   +         L  L L  N + ++ L+      +
Sbjct: 286 A-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLS--THHTL 341

Query: 572 LYLNFSSN 579
             L  S N
Sbjct: 342 KNLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  141 bits (357), Expect = 2e-36
 Identities = 77/349 (22%), Positives = 132/349 (37%), Gaps = 26/349 (7%)

Query: 77  DVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVN 135
           D+  +  K++   +  +     + L +   ++ LNL   ++   I +  F   +T++ + 
Sbjct: 41  DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLY 99

Query: 136 FRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI 194
              N +    P  +F     L  L    N LS  +P  I  N P L ++S+S N      
Sbjct: 100 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIE 157

Query: 195 PSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELEL 254
                    L+ L LS +N L  +   +  +  L    + Y+ L             +E 
Sbjct: 158 DDTFQATTSLQNLQLS-SNRLTHVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEE 209

Query: 255 MALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAV 314
           +     N    +   +     L +LKL  N LT      + N   L  +DLS+N+L   +
Sbjct: 210 LDAS-HNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KI 263

Query: 315 PATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKL 373
               F  M  L  L + +N L  +L+      +P L+ L L  N+    + R      +L
Sbjct: 264 MYHPFVKMQRLERLYISNNRLV-ALNLYGQ-PIPTLKVLDLSHNHLL-HVERNQPQFDRL 320

Query: 374 SVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN 422
             L L  NS      +T   L+NL   TL +N    ++L   F +    
Sbjct: 321 ENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWDCNSLRALFRNVARP 366

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  139 bits (351), Expect = 1e-35
 Identities = 70/419 (16%), Positives = 133/419 (31%), Gaps = 81/419 (19%)

Query: 96  TIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNK-SS 154
            I S L        +++              TL   K V F+ + +    P+ + +    
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 155 LQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNL 214
           ++ L+ +   +  EI     +    ++ + +  N      P    N   L +L L   N 
Sbjct: 71  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE-RND 128

Query: 215 LGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE-LAN 272
           L ++P+ I  N  KL  L +                           N    I  +    
Sbjct: 129 LSSLPRGIFHNTPKLTTLSMSN-------------------------NNLERIEDDTFQA 163

Query: 273 LTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSN 332
            T L+ L+L  N LT  +      + +L   ++S+N L     +T+     +  L    N
Sbjct: 164 TTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHN 215

Query: 333 SLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFG 392
               S++ +       L  L+L  NN +      + N   L  ++L  N     + + F 
Sbjct: 216 ----SINVVRGPVNVELTILKLQHNNLT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFV 269

Query: 393 NLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSL 452
            ++ L  + +  N L + N             +L  + LS+N L  +             
Sbjct: 270 KMQRLERLYISNNRLVALN------LYGQPIPTLKVLDLSHNHLLHV------------- 310

Query: 453 EYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLE 511
                          +       L  +YL  N +  ++ +       L+ L L  N  +
Sbjct: 311 --------------ERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  132 bits (335), Expect = 1e-33
 Identities = 62/324 (19%), Positives = 121/324 (37%), Gaps = 23/324 (7%)

Query: 362 TIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFS 421
            I   +        + +   +   +       L N +++T   + +      L       
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL-----LD 66

Query: 422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYL 481
           + + +  + L++  ++ I    +     H+++   M +  +    P    N+  L  + L
Sbjct: 67  SFRQVELLNLNDLQIEEI-DTYAFAYA-HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124

Query: 482 GGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICR-LTKLYELGLSGNKLSGSIPA 540
             N L+           KL  L + +N LE  I DD  +  T L  L LS N+L+  +  
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVD- 181

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDF 600
             S + SL   ++  N L+++         +  L+ S N       +       L  +  
Sbjct: 182 -LSLIPSLFHANVSYNLLSTLA----IPIAVEELDASHNSINV---VRGPVNVELTILKL 233

Query: 601 STNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS 660
             NN +D     +     L  + L YN L+  +   F  +  L+ L +SNN L  ++ + 
Sbjct: 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 290

Query: 661 LEKLSYLEDLDLSFNKLKGEIPKG 684
            + +  L+ LDLS N L   + + 
Sbjct: 291 GQPIPTLKVLDLSHNHLL-HVERN 313

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  151 bits (384), Expect = 4e-41
 Identities = 39/169 (23%), Positives = 79/169 (46%), Gaps = 14/169 (8%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           +     G ++K R  +G ++ VKV  ++    R  + F+ EC  ++   H N++ V+ +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 846 STEEFK--ALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            +       LI  +MP+GSL   L+  +N+++D  Q +   +D+A  + +LH      + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              L   +V++D++M A +S   +         S      +    ++AP
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAP 177

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  156 bits (396), Expect = 1e-40
 Identities = 85/483 (17%), Positives = 166/483 (34%), Gaps = 38/483 (7%)

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
             IL++S N +      +I +L+KL+ L + ++ +Q      F    ELE + L  + L 
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82

Query: 264 GEIPQELANLTGLEVLKLGKNFLTG-EIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS 322
            +I         L+ L L  N      I  E  N+  LK L LS   L  +    I +++
Sbjct: 83  -KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139

Query: 323 TLTGLGLQSNSL--SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGR 380
               L +   +         + D    +L  +   +  F   +   +   + L +  +  
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

Query: 381 NSFSGFIPNTFGNL----RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPL 436
                        L     N +L  L  N + ++      +       ++ Y  +SN  L
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259

Query: 437 DGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGK 496
            G L          SL+   +                       +  +            
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQ---------------------VVSDVFGFPQSYIYEI 298

Query: 497 LQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN 556
              +   +   +           +++    L  S N L+ ++     +L  L TL L  N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 557 KLTSIPLTI---WNLKGMLYLNFSSNFFTGPLPLDI-GNLKVLIGIDFSTNNFSDVIPTV 612
           +L  +         +K +  L+ S N  +           K L+ ++ S+N  +D I   
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 613 IGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDL 672
           +     ++ L L  N+++ SI +    L +L+ LN+++N L        ++L+ L+ + L
Sbjct: 419 L--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWL 475

Query: 673 SFN 675
             N
Sbjct: 476 HTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  152 bits (386), Expect = 3e-39
 Identities = 98/539 (18%), Positives = 174/539 (32%), Gaps = 82/539 (15%)

Query: 134 VNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR 193
           V+   N L    P  +        L+ S N +S E+  +   +L  L  + +S N     
Sbjct: 5   VDRSKNGLI-HVPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYL 60

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPR--EFGNLAE 251
             S     + LE L LS +N L  I         LK L L ++     +P   EFGN+++
Sbjct: 61  DISVFKFNQELEYLDLS-HNKLVKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116

Query: 252 LELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLV 311
           L+ + L  ++L+      +A+L   +VL +       +  PE   L +     L      
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPT 174

Query: 312 GAVPATIFNMSTLTGLGLQSNSLSGSLSSIA----------DVQLPNLEELRLWSNNFSG 361
                 I ++S  T   L+ +++   L                  P L  L L +   + 
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234

Query: 362 TIPRFIFN---ASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLS 418
                I      + +    +      G +     +     L  L  + + S         
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294

Query: 419 SFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG 478
            +    ++     + +    ++  +    +S    + D S   ++    +  G+LT L  
Sbjct: 295 IYEIFSNMNIKNFTVSGT-RMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELET 352

Query: 479 IYLGGNKLNGSIPITLG---KLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGNKL 534
           + L  N+L   +        +++ LQ L +  N +        C     L  L +S N L
Sbjct: 353 LILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411

Query: 535 SGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKV 594
           + +I  C      +  L L SNK+ SIP  +  L                          
Sbjct: 412 TDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKL-------------------------- 443

Query: 595 LIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNL 653
                                   LQ L +  N+L+      F  L SL+ + L  N  
Sbjct: 444 ----------------------EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  147 bits (373), Expect = 2e-37
 Identities = 88/483 (18%), Positives = 180/483 (37%), Gaps = 36/483 (7%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQL 141
             +LNIS   ++    S + +LS L+ L +  NR+   +  ++F     L+Y++   N+L
Sbjct: 23  TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL 81

Query: 142 SGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSN 200
                    +   +L+HLD S+NA           N+  L+ + LS           +++
Sbjct: 82  V----KISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137

Query: 201 CKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVS 260
               ++L +          ++   L       L       +      +++   +  L++S
Sbjct: 138 LNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195

Query: 261 NLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN 320
           N++  +     +     + KL  N     +      L+N++    S  +++      +  
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNL-----TLNNIETTWNSFIRIL-----QLVW 245

Query: 321 MSTLTGLGLQSNSLSG----SLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSV 375
            +T+    + +  L G         +   L  L   ++ S+ F      +I+   S +++
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNI 304

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
                +            +     +    N LT      +   +  +   L  + L  N 
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD-----TVFENCGHLTELETLILQMNQ 359

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEI-GNLTNLIGIYLGGNKLNGSIPITL 494
           L  +     M     SL+  D+S  +VS    K       +L+ + +  N L  +I   L
Sbjct: 360 LKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419

Query: 495 GKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPAC-FSNLASLGTLSL 553
               +++ L L  NK++  IP  + +L  L EL ++ N+L  S+P   F  L SL  + L
Sbjct: 420 --PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWL 475

Query: 554 GSN 556
            +N
Sbjct: 476 HTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  145 bits (367), Expect = 8e-37
 Identities = 93/527 (17%), Positives = 176/527 (33%), Gaps = 56/527 (10%)

Query: 85  VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGA 144
           +++ S   L   +P  L        LN+  N +S  + ++     +              
Sbjct: 4   LVDRSKNGLI-HVPKDL--SQKTTILNISQNYIS-ELWTSDILSLS-------------- 45

Query: 145 FPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYL 204
                     L+ L  S+N +   +  ++      LE + LS N           N   L
Sbjct: 46  ---------KLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKISCHPTVN---L 92

Query: 205 EILSLSINNLLGAIP--KEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
           + L LS  N   A+P  KE GN+++LK L L  + L+        +L   +++ +     
Sbjct: 93  KHLDLS-FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS 322
             +   +   L       L   F T +    I ++    + +L  +           N+ 
Sbjct: 152 GEKE--DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS-----------NIK 198

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
            +      S  LS       + +L NL    + +   S      +   + +    +    
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258

Query: 383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPR 442
             G +     +     L  L  + + S          +    ++     + +    ++  
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-RMVHM 317

Query: 443 MSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLG---KLQK 499
           +    +S    + D S   ++    +  G+LT L  + L  N+L   +        +++ 
Sbjct: 318 LCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375

Query: 500 LQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKL 558
           LQ L +  N +        C     L  L +S N L+ +I  C      +  L L SNK+
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI 433

Query: 559 TSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNF 605
            SIP  +  L+ +  LN +SN            L  L  I   TN +
Sbjct: 434 KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  116 bits (293), Expect = 2e-27
 Identities = 69/383 (18%), Positives = 131/383 (34%), Gaps = 31/383 (8%)

Query: 302 LLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG 361
           L+D S N L+  VP  +      T L +  N +S  L +   + L  L  L +  N    
Sbjct: 4   LVDRSKNGLI-HVPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQ- 58

Query: 362 TIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSF 420
            +   +F    +L  L+L  N        +     NL+ + L +N   +    L     F
Sbjct: 59  YLDISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDA----LPICKEF 111

Query: 421 SNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY 480
            N   L ++GLS   L+      S+  ++H      +     + G  ++   L +     
Sbjct: 112 GNMSQLKFLGLSTTHLEKS----SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167

Query: 481 LGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA 540
           L            +  +      +LE + ++  + D+ C            + L+     
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL--------SILAKLQTN 219

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIG-----NLKVL 595
              +  +L  +    N    I   +W+   + Y + S+    G L          +LK L
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTT-VWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278

Query: 596 IGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR 655
                 ++ F      +    +N+       +  +         +     L+ SNN L+ 
Sbjct: 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338

Query: 656 SIPISLEKLSYLEDLDLSFNKLK 678
           ++  +   L+ LE L L  N+LK
Sbjct: 339 TVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  106 bits (265), Expect = 5e-24
 Identities = 69/397 (17%), Positives = 116/397 (29%), Gaps = 51/397 (12%)

Query: 84  KVLNISHLNLTG-TIPSQLWNLSSLQSLNLGFNRLSGSIPSAIF---------------- 126
           K L++S        I  +  N+S L+ L L    L  S    I                 
Sbjct: 93  KHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152

Query: 127 ------TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANIC------ 174
                  L      +      +     FI + S     +   + +   +  N C      
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212

Query: 175 ----------SNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNL--LGAIPKEI 222
                     SNL      +   +          +   Y  I ++ +             
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
            +L  L    +            +   + + +    VS  +       + ++    L   
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKL--VGAVPATIFNMSTLTGLGLQSNSLSGSLSS 340
            N LT  +     +L  L+ L L  N+L  +  +      M +L  L +  NS+S     
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392

Query: 341 IADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM 400
                  +L  L + SN  + TI R +    ++ VL+L  N     IP     L  L+ +
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449

Query: 401 TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
            +  N L S          F    SL  I L  NP D
Sbjct: 450 NVASNQLKSVPD-----GIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 48/289 (16%), Positives = 87/289 (30%), Gaps = 50/289 (17%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
           +LS      ++S   +S  +  +I +L+ L  + +  N++           Q+L+ L L 
Sbjct: 18  DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPAC--FSNLASLGTLSLGSNKLTSIPLT 564
            NKL   I         L  L LS N    ++P C  F N++ L  L L +  L    + 
Sbjct: 78  HNKLVK-ISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133

Query: 565 IWNLKGMLYLNFSSN----FFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQ 620
                 +  +             P  L   N + L  +  +   F  ++   +  + NL+
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLE 193

Query: 621 YLFLGYNRLQGSISESFGDL---------------------------------ISLKSLN 647
              +         S     L                                  ++   +
Sbjct: 194 LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253

Query: 648 LSNNNL-----SRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
           +SN  L      R    S   L  L    +  +      P+   +  FS
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG--FPQSYIYEIFS 300

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 71.4 bits (175), Expect = 7e-13
 Identities = 39/278 (14%), Positives = 90/278 (32%), Gaps = 30/278 (10%)

Query: 34  SSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHS-HRVKVLNISHLN 92
           ++I T  ++ + +   + H    + + +        ++        S   + +  +    
Sbjct: 228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287

Query: 93  LTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNK 152
                       S++   N   +            +    +++F  N L+        + 
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347

Query: 153 SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSIN 212
           + L+ L    N L                 +S    M        + +   L+ L +S N
Sbjct: 348 TELETLILQMNQLK---------------ELSKIAEMTTQ-----MKS---LQQLDISQN 384

Query: 213 NLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELA 271
           ++     K        L  L +  + L   I R       ++++ L  + ++  IP+++ 
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV 441

Query: 272 NLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHN 308
            L  L+ L +  N L   +P  I   L +L+ + L  N
Sbjct: 442 KLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.7 bits (173), Expect = 1e-12
 Identities = 35/216 (16%), Positives = 75/216 (34%), Gaps = 32/216 (14%)

Query: 514 IPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL-TIWNLKGML 572
           +P D+    K   L +S N +S    +   +L+ L  L +  N++  + +      + + 
Sbjct: 15  VPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72

Query: 573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG- 631
           YL+ S N     +                                NL++L L +N     
Sbjct: 73  YLDLSHNKLVK-ISCH--------------------------PTVNLKHLDLSFNAFDAL 105

Query: 632 SISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
            I + FG++  LK L LS  +L +S  + +  L+  + L +       +        +F+
Sbjct: 106 PICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED-PEGLQDFN 164

Query: 692 AKSFEGNELLCGSPNLQVPPCKTSIHHKSRKNVLLL 727
            +S           +  +     ++ +    N+  +
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  151 bits (384), Expect = 2e-40
 Identities = 57/201 (28%), Positives = 82/201 (40%), Gaps = 25/201 (12%)

Query: 770 FSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEM 829
            +  E     +      LIGRG +G+VYK  +     VAVKVF        ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFA---NRQNFINEKNI 58

Query: 830 MK--SIRHRNLIKVISSC-----STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
            +   + H N+ + I               L++EY P+GSL K  Y S +  D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRL 116

Query: 883 MVDVATTLEYLH------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 936
              V   L YLH        Y   + H DL   NVL+ ++    +SDFG++  L G    
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 937 ITQTQTLA------TIGYMAP 951
               +  A      TI YMAP
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP 197

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  148 bits (377), Expect = 5e-40
 Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 10/167 (5%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISS 844
           IG G FG+VYK +  G+   VAVK+ ++     +  ++F  E  +++  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            +  +  A++ ++    SL   L++S    ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DLK +N+ L ++    + DFG+A        S    Q   +I +MAP
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (373), Expect = 1e-39
 Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 21/177 (11%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-------FKSFDVECEMMKSIRHRNLI 839
           IG+GGFG V+K R + +   VA+K   L            F+ F  E  +M ++ H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           K+           +++E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLM-HNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 900 PVIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           P++H DL+  N+ L        + A ++DFG+++         + +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  155 bits (392), Expect = 1e-39
 Identities = 72/412 (17%), Positives = 145/412 (35%), Gaps = 31/412 (7%)

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIF-NMST 323
            I   L        + +           E   L+N K++   ++ +   +PA +  +   
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNS 382
           +  L L    +   + + A      +++L +  N     +P  +F N   L+VL L RN 
Sbjct: 77  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134

Query: 383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPR 442
            S      F N   L  +++  N L     +      F    SL  + LS+N L  +   
Sbjct: 135 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT-----FQATTSLQNLQLSSNRLTHV--- 186

Query: 443 MSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQG 502
             +  +  SL + ++SY  +S      +     +  +    N +N    +      +L  
Sbjct: 187 -DLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRGPVNVELTI 236

Query: 503 LHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIP 562
           L L+ N L       +     L E+ LS N+L   +   F  +  L  L + +N+L ++ 
Sbjct: 237 LKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALN 294

Query: 563 LTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYL 622
           L    +  +  L+ S N     +  +      L  +    N+   +    +     L+ L
Sbjct: 295 LYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNL 350

Query: 623 FLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF 674
            L +N    +   +     ++    + + +    I   LE     ++ D  +
Sbjct: 351 TLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  145 bits (366), Expect = 3e-36
 Identities = 103/598 (17%), Positives = 191/598 (31%), Gaps = 57/598 (9%)

Query: 86  LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLSGA 144
           ++I           +   L++ + +    + +   +P+A+      ++ +N    Q+   
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89

Query: 145 FPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
             ++ F    ++Q L   +NA+   +P ++  N+P L  + L +N           N   
Sbjct: 90  IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPK 148

Query: 204 LEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
           L  LS+S NN L  I  +     T L+ L L  + L         +L    +    +S  
Sbjct: 149 LTTLSMS-NNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-- 205

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS 322
                  LA    +E L    N +   +   +     L +L L HN L     A + N  
Sbjct: 206 ------TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYP 254

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
            L  + L  N L   +     V++  LE L + +N     +  +      L VL+L  N 
Sbjct: 255 GLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312

Query: 383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPR 442
               +         L  + L +N + +           S   +L  + LS+N  D    R
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIVT--------LKLSTHHTLKNLTLSHNDWDCNSLR 363

Query: 443 MSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQG 502
               N++         +C     +  E G              L      ++ +  +   
Sbjct: 364 ALFRNVARPAVDDADQHC--KIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQ 421

Query: 503 LHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIP 562
                      +      +T+   + L GN+            A +  L     +LT+  
Sbjct: 422 GRCSATDTINSVQSLSHYITQQGGVPLQGNEQL---------EAEVNELRAEVQQLTNEQ 472

Query: 563 LTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYL 622
           +    L   L+    +N     LP D                 SD +  V   L   Q  
Sbjct: 473 IQQEQLLQGLHAEIDTNLRRYRLPKD------------GLARSSDNLNKVFTHLKERQAF 520

Query: 623 FLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSI-PISLEKLSYLEDLDLSFNKLKG 679
            L     Q   +E+       + L   N  L + +     ++    ++  L   K+K 
Sbjct: 521 KLRET--QARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  143 bits (361), Expect = 1e-35
 Identities = 84/501 (16%), Positives = 167/501 (33%), Gaps = 65/501 (12%)

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELE 253
           I S L        + + +         E   L   K +    S ++ ++P          
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL------- 70

Query: 254 LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVG 312
                           L +   +E+L L    +  EI        H ++ L +  N +  
Sbjct: 71  ----------------LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR- 112

Query: 313 AVPATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NA 370
            +P  +F N+  LT L L+ N LS SL        P L  L + +NN    I    F   
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170

Query: 371 SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIG 430
           + L  L+L  N  +    +   +L +     + YN L+          + +   ++  + 
Sbjct: 171 TSLQNLQLSSNRLTHVDLSLIPSLFHAN---VSYNLLS----------TLAIPIAVEELD 217

Query: 431 LSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSI 490
            S+N ++ +        ++  L    + + N++      + N   L+ + L  N+L   +
Sbjct: 218 ASHNSINVVRG-----PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIM 270

Query: 491 PITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGT 550
                K+Q+L+ L++ +N+L   +      +  L  L LS N L   +         L  
Sbjct: 271 YHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328

Query: 551 LSLGSNKLTSIPLTIWNLKGMLYLNFSSN---------FFTGPLPLDIGNLKVLIGIDFS 601
           L L  N + ++ L+      +  L  S N          F       + +      ID+ 
Sbjct: 329 LYLDHNSIVTLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQ 386

Query: 602 TNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL 661
             +             +    ++    +   +  + G   +  ++N   +          
Sbjct: 387 LEH-GLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGG 445

Query: 662 EKLSYLEDLDLSFNKLKGEIP 682
             L   E L+   N+L+ E+ 
Sbjct: 446 VPLQGNEQLEAEVNELRAEVQ 466

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  139 bits (352), Expect = 2e-34
 Identities = 78/343 (22%), Positives = 136/343 (39%), Gaps = 26/343 (7%)

Query: 77  DVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVN 135
           D+  +  K++   +  +     + L +   ++ LNL   ++   I +  F   +T++ + 
Sbjct: 47  DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLY 105

Query: 136 FRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI 194
              N +    P  +F     L  L    N LS  +P  I  N P L ++S+S N      
Sbjct: 106 MGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIE 163

Query: 195 PSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELEL 254
                    L+ L LS +N L  +   +  +  L    + Y+ L   +      + EL+ 
Sbjct: 164 DDTFQATTSLQNLQLS-SNRLTHVD--LSLIPSLFHANVSYNLLS-TLAIPI-AVEELDA 218

Query: 255 MALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAV 314
               ++ ++G +         L +LKL  N LT      + N   L  +DLS+N+L   +
Sbjct: 219 SHNSINVVRGPV------NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KI 269

Query: 315 PATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKL 373
               F  M  L  L + +N L  +L+      +P L+ L L  N+    + R      +L
Sbjct: 270 MYHPFVKMQRLERLYISNNRLV-ALNLYGQ-PIPTLKVLDLSHNHLL-HVERNQPQFDRL 326

Query: 374 SVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSF 416
             L L  NS      +T   L+NL   TL +N    ++L   F
Sbjct: 327 ENLYLDHNSIVTLKLSTHHTLKNL---TLSHNDWDCNSLRALF 366

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  138 bits (348), Expect = 5e-34
 Identities = 71/418 (16%), Positives = 134/418 (32%), Gaps = 79/418 (18%)

Query: 96  TIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNK-SS 154
            I S L        +++              TL   K V F+ + +    P+ + +    
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 155 LQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNL 214
           ++ L+ +   +  EI     +    ++ + +  N      P    N   L +L L   N 
Sbjct: 77  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE-RND 134

Query: 215 LGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANL 273
           L ++P+ I  N  KL  L +  + L+  I  +                            
Sbjct: 135 LSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT-----------------------FQAT 170

Query: 274 TGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNS 333
           T L+ L+L  N LT  +      + +L   ++S+N L     +T+     +  L    N 
Sbjct: 171 TSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHN- 221

Query: 334 LSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGN 393
              S++ +       L  L+L  NN +      + N   L  ++L  N     + + F  
Sbjct: 222 ---SINVVRGPVNVELTILKLQHNNLT-DTAWLL-NYPGLVEVDLSYNELEKIMYHPFVK 276

Query: 394 LRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLE 453
           ++ L  + +  N L + N             +L  + LS+N L  +              
Sbjct: 277 MQRLERLYISNNRLVALN------LYGQPIPTLKVLDLSHNHLLHV-------------- 316

Query: 454 YFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLE 511
                         +       L  +YL  N +     + L     L+ L L  N  +
Sbjct: 317 -------------ERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  128 bits (324), Expect = 5e-31
 Identities = 90/436 (20%), Positives = 154/436 (35%), Gaps = 31/436 (7%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQ 140
           +V++LN++ L +            ++Q L +GFN +   +P  +F  +  L  +    N 
Sbjct: 76  QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134

Query: 141 LSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALS 199
           LS + P  IF+    L  L  S N L   I  +       L+++ LS N       S + 
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP 192

Query: 200 NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQV 259
           +   L   ++S N L       +     ++EL   ++ +          L  L+L    +
Sbjct: 193 S---LFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNL 244

Query: 260 SNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATI 318
           ++        L N  GL  + L  N L  +I       +  L+ L +S+N+LV A+    
Sbjct: 245 TDTAW-----LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297

Query: 319 FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLEL 378
             + TL  L L  N L     +    Q   LE L L  N+   T+         L  L L
Sbjct: 298 QPIPTLKVLDLSHNHLLHVERNQP--QFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTL 352

Query: 379 GRNSFSGF-IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN----CKSLTYIGLSN 433
             N +    +   F N+    +     +      LE       S+     + L YI L++
Sbjct: 353 SHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTS 412

Query: 434 NPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPIT 493
                   +              +S+     G     GN      +     ++       
Sbjct: 413 VVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQ 472

Query: 494 LGKLQKLQGLHLEDNK 509
           + + Q LQGLH E + 
Sbjct: 473 IQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  123 bits (309), Expect = 3e-29
 Identities = 56/290 (19%), Positives = 103/290 (35%), Gaps = 16/290 (5%)

Query: 390 TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLS 449
              +         +  ++     ++ F        +   +   N+ +  + P   + +  
Sbjct: 17  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL-PAALLDSFR 75

Query: 450 HSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK 509
             +E  +++   +             +  +Y+G N +    P     +  L  L LE N 
Sbjct: 76  -QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134

Query: 510 LEGPIPDDI-CRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNL 568
           L   +P  I     KL  L +S N L       F    SL  L L SN+LT + L+   +
Sbjct: 135 LSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLS--LI 191

Query: 569 KGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR 628
             + + N S N  +      +     +  +D S N+ + V          L  L L +N 
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRG---PVNVELTILKLQHNN 243

Query: 629 LQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK 678
           L    +    +   L  ++LS N L + +     K+  LE L +S N+L 
Sbjct: 244 LT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 66.9 bits (163), Expect = 2e-11
 Identities = 17/110 (15%), Positives = 44/110 (40%), Gaps = 4/110 (3%)

Query: 575 NFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSIS 634
             + + + G   + + N K++    F  +    +   ++     ++ L L   +++   +
Sbjct: 36  MQTQDVYFGFEDITLNNQKIV---TFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDT 92

Query: 635 ESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG 684
            +F    +++ L +  N +    P   + +  L  L L  N L   +P+G
Sbjct: 93  YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRG 141

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  151 bits (382), Expect = 5e-39
 Identities = 84/367 (22%), Positives = 140/367 (38%), Gaps = 47/367 (12%)

Query: 75  TCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYV 134
            C      V             +P  +   +  + L+LG NR+  ++    F  +     
Sbjct: 8   ECSAQDRAV---LCHRKRFV-AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFP---- 56

Query: 135 NFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI 194
                               L+ L+ + N +S  +     +NL  L ++ L  N      
Sbjct: 57  -------------------HLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIP 96

Query: 195 PSALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPRE-FGNLAEL 252
               +    L  L +S  N +  +   +  +L  LK L +G + L   I    F  L  L
Sbjct: 97  LGVFTGLSNLTKLDIS-ENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSL 154

Query: 253 ELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKL 310
           E + L+  NL   IP E L++L GL VL+L    +   I       L+ LK+L++SH   
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPY 212

Query: 311 VGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-N 369
           +  +         LT L +   +L+ ++  +A   L  L  L L  N  S TI   +   
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHE 270

Query: 370 ASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI 429
             +L  ++L     +   P  F  L  LR++ +  N LT+    L   S F +  +L  +
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT----LEE-SVFHSVGNLETL 325

Query: 430 GLSNNPL 436
            L +NPL
Sbjct: 326 ILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  144 bits (365), Expect = 8e-37
 Identities = 66/309 (21%), Positives = 122/309 (39%), Gaps = 14/309 (4%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQ 140
             ++L++    +      +  +   L+ L L  N +S ++    F  L+ L+ +  R N+
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91

Query: 141 LSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALS 199
           L    P  +F   S+L  LD S N +   +   +  +L  L+S+ +  N        A S
Sbjct: 92  LK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS 149

Query: 200 NCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQ 258
               LE L+L     L +IP E   +L  L  L L +  +       F  L  L+++ + 
Sbjct: 150 GLNSLEQLTLE-KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208

Query: 259 VSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-IHNLHNLKLLDLSHNKLVGAVPAT 317
                  +         L  L +    LT  +P   + +L  L+ L+LS+N +   +  +
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266

Query: 318 IF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSV 375
           +   +  L  + L    L+  +   A   L  L  L +  N  + T+   +F++   L  
Sbjct: 267 MLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324

Query: 376 LELGRNSFS 384
           L L  N  +
Sbjct: 325 LILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  142 bits (360), Expect = 3e-36
 Identities = 75/345 (21%), Positives = 133/345 (38%), Gaps = 39/345 (11%)

Query: 362 TIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFS 421
            +P  I   ++  +L+LG+N       + F +  +L  + L+ N +++  +E     +F+
Sbjct: 25  AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA--VEPG---AFN 77

Query: 422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYL 481
           N  +L  +GL +N L  I   +           F                 L+NL  + +
Sbjct: 78  NLFNLRTLGLRSNRLKLIPLGV-----------FT---------------GLSNLTKLDI 111

Query: 482 GGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA- 540
             NK+   +      L  L+ L + DN L          L  L +L L    L+ SIP  
Sbjct: 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTE 170

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGID 599
             S+L  L  L L    + +I    +  L  +  L  S   +   +  +      L  + 
Sbjct: 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLS 230

Query: 600 FSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI 659
            +  N + V    +  L  L++L L YN +         +L+ L+ + L    L+   P 
Sbjct: 231 ITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY 290

Query: 660 SLEKLSYLEDLDLSFNKLKGEIPKG--GSFGNFSAKSFEGNELLC 702
           +   L+YL  L++S N+L   + +    S GN      + N L C
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  139 bits (352), Expect = 4e-35
 Identities = 66/354 (18%), Positives = 130/354 (36%), Gaps = 42/354 (11%)

Query: 137 RGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS 196
              +   A P  I   +  + LD   N +   +  +  ++ P LE + L++N+     P 
Sbjct: 19  HRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPG 74

Query: 197 ALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELM 255
           A +N   L  L L  +N L  IP  +   L+ L +L +  + +   +             
Sbjct: 75  AFNNLFNLRTLGLR-SNRLKLIPLGVFTGLSNLTKLDISENKIV-ILL------------ 120

Query: 256 ALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAV 314
                           +L  L+ L++G N L   I       L++L+ L L    L  ++
Sbjct: 121 -----------DYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SI 167

Query: 315 PATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKL 373
           P     ++  L  L L+  +++ ++   +  +L  L+ L +    +  T+         L
Sbjct: 168 PTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226

Query: 374 SVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSN 433
           + L +   + +        +L  LR + L YN +++  +E    S       L  I L  
Sbjct: 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST--IE---GSMLHELLRLQEIQLVG 281

Query: 434 NPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
             L  +    +   L+  L   ++S   ++        ++ NL  + L  N L 
Sbjct: 282 GQLAVV-EPYAFRGLN-YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  121 bits (306), Expect = 3e-29
 Identities = 58/284 (20%), Positives = 99/284 (34%), Gaps = 34/284 (11%)

Query: 81  HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGN 139
             ++ L +    L          LS+L  L++  N++   +   +F  LY LK +    N
Sbjct: 80  FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDN 138

Query: 140 QLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL 198
            L        F+  +SL+ L      L+  IP    S+L  L  + L     +     + 
Sbjct: 139 DLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 199 SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQ 258
                L++L +S    L  +         L  L + +  L   +P               
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVP--------------- 240

Query: 259 VSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPAT 317
                      + +L  L  L L  N ++  I   + H L  L+ + L   +L   V   
Sbjct: 241 --------YLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQL-AVVEPY 290

Query: 318 IF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS 360
            F  ++ L  L +  N L+ +L       + NLE L L SN  +
Sbjct: 291 AFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 63.2 bits (154), Expect = 2e-10
 Identities = 29/115 (25%), Positives = 56/115 (48%), Gaps = 5/115 (4%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFR 137
           +   +  L+I+H NLT      + +L  L+ LNL +N +S +I  ++   L  L+ +   
Sbjct: 222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLV 280

Query: 138 GNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
           G QL+     + F   + L+ L+ S N L+  +  ++  ++  LE++ L  N   
Sbjct: 281 GGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  150 bits (380), Expect = 7e-39
 Identities = 84/447 (18%), Positives = 152/447 (34%), Gaps = 77/447 (17%)

Query: 241 EIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHN 299
           ++P    ++  ++L    ++ L        + L  L+ LK+ +      I       L +
Sbjct: 24  QVPELPAHVNYVDLSLNSIAELN---ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 300 LKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSL-SGSLSSIADVQLPNLEELRLWSN 357
           L +L L +N+ +  +    F  ++ L  L L   +L    LS      L +LE L L  N
Sbjct: 81  LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139

Query: 358 NFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSF 416
           N     P   F N  +  VL+L  N           N +      L  + +T  ++   +
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199

Query: 417 LSS-----FSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIG 471
           L            S+T + LS N     + +     ++ +     +   + + G      
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259

Query: 472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICR-LTKLYELGLS 530
           N  +       G + +            ++   L  +K+   +   +    T L +L L+
Sbjct: 260 NFKDPDNFTFKGLEAS-----------GVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLA 307

Query: 531 GNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI 589
            N+++  I    F  L  L  L+L  N L SI                            
Sbjct: 308 QNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSID--------------------------- 339

Query: 590 GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLS 649
                                 +   L  L+ L L YN ++    +SF  L +LK L L 
Sbjct: 340 --------------------SRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379

Query: 650 NNNLSRSIPIS-LEKLSYLEDLDLSFN 675
            N L +S+P    ++L+ L+ + L  N
Sbjct: 380 TNQL-KSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  140 bits (354), Expect = 1e-35
 Identities = 80/374 (21%), Positives = 133/374 (35%), Gaps = 49/374 (13%)

Query: 322 STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGR 380
           + +  + L  NS++  L+  +  +L +L+ L++        I    F   S L +L+L  
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 381 NSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGIL 440
           N F       F  L NL ++TL    L  + L  +    F    SL  + L +N +  I 
Sbjct: 89  NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGN---FFKPLTSLEMLVLRDNNIKKIQ 145

Query: 441 PRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQK- 499
           P            +F                N+     + L  NK+       L   Q  
Sbjct: 146 PA----------SFFL---------------NMRRFHVLDLTFNKVKSICEEDLLNFQGK 180

Query: 500 -LQGLHLEDNKLEGPIPDDIC--------RLTKLYELGLSGNKLSGSIPACFSNLASLGT 550
               L L    L+      +         + T +  L LSGN    S+   F +   +  
Sbjct: 181 HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA--IAG 238

Query: 551 LSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP 610
             + S  L++      +     + +  +  F G   L+   +K     D S +    ++ 
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG---LEASGVKTC---DLSKSKIFALLK 292

Query: 611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDL 670
           +V    T+L+ L L  N +      +F  L  L  LNLS N L        E L  LE L
Sbjct: 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVL 352

Query: 671 DLSFNKLKGEIPKG 684
           DLS+N ++  +   
Sbjct: 353 DLSYNHIR-ALGDQ 365

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  136 bits (344), Expect = 3e-34
 Identities = 85/432 (19%), Positives = 150/432 (34%), Gaps = 72/432 (16%)

Query: 120 SIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPF 179
            +P+       + YV+   N ++    +       LQ L          I  N    L  
Sbjct: 27  ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 180 LESISLSQNMFHGRIPSALSNCKYLEILSLSINNL-LGAIPKEI-GNLTKLKELYLGYSG 237
           L  + L  N F      A +    LE+L+L+  NL    +       LT L+ L L  + 
Sbjct: 81  LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140

Query: 238 LQGEIPRE-FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHN 296
           ++   P   F N+    ++ L  + ++    ++L N  G     L               
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------R 186

Query: 297 LHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWS 356
           L ++ L D++   L        F  +++T L L  N    S++      +   +   L  
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246

Query: 357 NNFSGTIPRFIFN--------------ASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL 402
           +N       F                 AS +   +L ++     + + F +  +L  +TL
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306

Query: 403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNV 462
             N +    ++    ++F     L  + LS N L  I  RM           F+      
Sbjct: 307 AQNEINK--ID---DNAFWGLTHLLKLNLSQNFLGSIDSRM-----------FE------ 344

Query: 463 SGGFPKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDI-CR 520
                    NL  L  + L  N +  ++   +   L  L+ L L+ N+L+  +PD I  R
Sbjct: 345 ---------NLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDR 393

Query: 521 LTKLYELGLSGN 532
           LT L ++ L  N
Sbjct: 394 LTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  132 bits (335), Expect = 5e-33
 Identities = 81/387 (20%), Positives = 138/387 (35%), Gaps = 42/387 (10%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQL 141
           V  +++S  ++     +    L  LQ L +        I +  F  L +L  +    NQ 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 142 SGAFPSFIFNK-SSLQHLDFSYNAL-SGEIPANICSNLPFLESISLSQNMFHGRIPSAL- 198
                +  FN  ++L+ L  +   L    +  N    L  LE + L  N      P++  
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 199 SNCKYLEILSLSINNLLGAIPKEI---GNLTKLKELYLGY-----------SGLQGEIPR 244
            N +   +L L+  N + +I +E            L L                +   P 
Sbjct: 151 LNMRRFHVLDLT-FNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209

Query: 245 EFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPP--EIHNLHN--- 299
           +  ++  L+L          +   +    T ++ L L  ++  G         +  N   
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269

Query: 300 -------LKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEE 351
                  +K  DLS +K+  A+  ++F + + L  L L  N ++  +   A   L +L +
Sbjct: 270 KGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327

Query: 352 LRLWSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSS 410
           L L  N    +I   +F    KL VL+L  N        +F  L NL+ + L  N L S 
Sbjct: 328 LNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386

Query: 411 NLELSFLSSFSNCKSLTYIGLSNNPLD 437
              +     F    SL  I L  NP D
Sbjct: 387 PDGI-----FDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 88.6 bits (220), Expect = 2e-18
 Identities = 47/260 (18%), Positives = 86/260 (33%), Gaps = 24/260 (9%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHL 505
            L   + Y D+S  +++         L +L  + +        I   T   L  L  L L
Sbjct: 27  ELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86

Query: 506 EDNKLEGPIPDDI-CRLTKLYELGLSGNKL-SGSIPA-CFSNLASLGTLSLGSNKLTSIP 562
           + N+    +       L  L  L L+   L    +    F  L SL  L L  N +  I 
Sbjct: 87  DYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145

Query: 563 LTIW--NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQ 620
              +  N++    L+ + N     +  +   L    G  F+              L+++ 
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVKS-ICEED--LLNFQGKHFTLLR-----------LSSIT 191

Query: 621 YLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP---ISLEKLSYLEDLDLSFNKL 677
              +    L      +     S+ +L+LS N    S+          + ++ L LS +  
Sbjct: 192 LQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYN 251

Query: 678 KGEIPKGGSFGNFSAKSFEG 697
            G      +F +    +F+G
Sbjct: 252 MGSSFGHTNFKDPDNFTFKG 271

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  145 bits (368), Expect = 1e-38
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 13/167 (7%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           +GRG FG V KA+     +VA+K  + +     K+F VE   +  + H N++K+  +C  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC-L 71

Query: 848 EEFKALILEYMPHGSLEKSLYSSN--YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
                L++EY   GSL   L+ +           ++  +  +  + YLH      +IH D
Sbjct: 72  NPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 906 LKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           LKP N+LL     V  + DFG A      D     T    +  +MAP
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  145 bits (367), Expect = 2e-38
 Identities = 58/349 (16%), Positives = 99/349 (28%), Gaps = 46/349 (13%)

Query: 266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLT 325
           I +   N    ++ K+  + L   +     +  N+K LDLS N L     A +   + L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 326 GLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG 385
            L L SN L      +    L  L  L L +N         +     +  L    N+ S 
Sbjct: 62  LLNLSSNVLY-ETLDLE--SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSM 445
              +     +N+    L  N +T                 + Y+ L  N +D +      
Sbjct: 114 VSCSRGQGKKNIY---LANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTV------ 159

Query: 446 GNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHL 505
                               F +   +   L  + L  N +   +   +    KL+ L L
Sbjct: 160 -------------------NFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDL 198

Query: 506 EDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTI 565
             NKL   +  +      +  + L  NKL   I        +L    L  N      L  
Sbjct: 199 SSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 566 WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
           +  K       +       L         +  +        + +P    
Sbjct: 257 FFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (352), Expect = 2e-36
 Identities = 58/346 (16%), Positives = 114/346 (32%), Gaps = 48/346 (13%)

Query: 242 IPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLK 301
           I     N    ++  +  S+L+  +     +   ++ L L  N L+     ++     L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 302 LLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG 361
           LL+LS N L       + ++STL  L L +N +   L        P++E L   +NN S 
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNIS- 112

Query: 362 TIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFS 421
            +            + L  N  +       G    ++ + L  N + +    ++F    +
Sbjct: 113 RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT----VNFAELAA 166

Query: 422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYL 481
           +  +L ++ L  N +  +                             ++     L  + L
Sbjct: 167 SSDTLEHLNLQYNFIYDV---------------------------KGQV-VFAKLKTLDL 198

Query: 482 GGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS-GSIPA 540
             NKL   +         +  + L +NKL   I   +     L    L GN    G++  
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP 586
            FS    + T++     +  +         +  L     +    LP
Sbjct: 257 FFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  136 bits (345), Expect = 2e-35
 Identities = 46/342 (13%), Positives = 100/342 (29%), Gaps = 95/342 (27%)

Query: 340 SIADV--QLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNL 397
           +I ++       +  ++  ++    +     +A  +  L+L  N  S            L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 398 RLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDM 457
            L+ L  N L              +  +L  + L+NN +                     
Sbjct: 61  ELLNLSSNVLYE-------TLDLESLSTLRTLDLNNNYV--------------------- 92

Query: 458 SYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDD 517
                     +E+    ++  ++   N ++    ++  + Q  + ++L +NK+      D
Sbjct: 93  ----------QELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLD 139

Query: 518 ICRLTKLYELGLSGNKLSG-SIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNF 576
               +++  L L  N++   +     ++  +L  L+L  N +  +   +           
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV----------- 188

Query: 577 SSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES 636
                                                     L+ L L  N+L   +   
Sbjct: 189 --------------------------------------VFAKLKTLDLSSNKLA-FMGPE 209

Query: 637 FGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK 678
           F     +  ++L NN L   I  +L     LE  DL  N   
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  135 bits (343), Expect = 3e-35
 Identities = 56/314 (17%), Positives = 116/314 (36%), Gaps = 24/314 (7%)

Query: 217 AIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGL 276
           AI +   N  + K   +  S L+  +     +   ++ + L  + L      +LA  T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 277 EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSG 336
           E+L L  N L      ++ +L  L+ LDL++N +       +    ++  L   +N    
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANN---- 109

Query: 337 SLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGF-IPNTFGNLR 395
           ++S ++  +    + + L +N  +          S++  L+L  N            +  
Sbjct: 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 396 NLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYF 455
            L  + L YN++         +        L  + LS+N L  + P     + +  + + 
Sbjct: 170 TLEHLNLQYNFIYD-------VKGQVVFAKLKTLDLSSNKLAFMGP--EFQSAA-GVTWI 219

Query: 456 DMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN-GSIPITLGKLQKLQGLHLEDNKLEGPI 514
            +    +     K +    NL    L GN  + G++     K Q++Q +  +  K     
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278

Query: 515 PDDICRLTKLYELG 528
            ++ C +  L   G
Sbjct: 279 NEEECTVPTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  135 bits (342), Expect = 4e-35
 Identities = 52/321 (16%), Positives = 112/321 (34%), Gaps = 18/321 (5%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRG 138
           + +R K+  ++  +L   + S   +  +++ L+L  N LS    + +     L+ +N   
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 139 NQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL 198
           N L       + + S+L+ LD + N +  E+        P +E++  + N       S  
Sbjct: 68  NVLYETLD--LESLSTLRTLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSCSRG 119

Query: 199 SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG-EIPREFGNLAELELMAL 257
                 + + L+ N +      + G  ++++ L L  + +          +   LE + L
Sbjct: 120 QG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPAT 317
           Q + +  ++         L+ L L  N L   + PE  +   +  + L +NKLV  +   
Sbjct: 177 QYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 318 IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLE 377
           +     L    L+ N       ++ D    N     +          +     +  ++  
Sbjct: 233 LRFSQNLEHFDLRGNGF--HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 378 LGRNSFSGFIPNTFGNLRNLR 398
            G              L  L 
Sbjct: 291 YGAYCCEDLPAPFADRLIALG 311

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  133 bits (338), Expect = 1e-34
 Identities = 53/276 (19%), Positives = 102/276 (36%), Gaps = 17/276 (6%)

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
           A      N +  +    + ++L  +  A++  +   ++ + LS N       + L+    
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
           LE+L+LS +N+L     ++ +L+ L+ L L  + +Q     E      +E +    +N  
Sbjct: 60  LELLNLS-SNVLYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA-NNNI 111

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG-AVPATIFNMS 322
             +        G + + L  N +T     +      ++ LDL  N++          +  
Sbjct: 112 SRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
           TL  L LQ N +   +     V    L+ L L SN  +  +     +A+ ++ + L  N 
Sbjct: 170 TLEHLNLQYNFIY-DVK--GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLS 418
               I       +NL    L  N      L   F  
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  112 bits (281), Expect = 4e-27
 Identities = 45/220 (20%), Positives = 81/220 (36%), Gaps = 23/220 (10%)

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
           +I        + +   + D+ L+  +         + EL LSGN LS    A  +    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFT--GPLP--------------LDIGNL 592
             L+L SN L      + +L  +  L+ ++N+       P              +     
Sbjct: 61  ELLNLSSNVLYETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRG 119

Query: 593 KVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG-SISESFGDLISLKSLNLSNN 651
           +    I  + N  + +     G  + +QYL L  N +   + +E      +L+ LNL  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 652 NLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFS 691
            +   +       + L+ LDLS NKL   +     F + +
Sbjct: 180 FIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGP--EFQSAA 214

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  142 bits (361), Expect = 4e-38
 Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 19/176 (10%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVF----DLQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           IG GGFG VY+A    G EVAVK      D    +  ++   E ++   ++H N+I +  
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
            C  E    L++E+   G L + L      +     +N  V +A  + YLH     P+IH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 904 CDLKPSNVLLD--------DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DLK SN+L+          N +  ++DFG+A+         T+        +MAP
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAAGAYAWMAP 183

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  143 bits (363), Expect = 7e-38
 Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 13/172 (7%)

Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVI 842
            LIG+G FG VY  R  GE   VA+++ D++       K+F  E    +  RH N++  +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
            +C +    A+I       +L   +  +  +LD+ +   I  ++   + YLH   +  ++
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA---TIGYMAP 951
           H DLK  NV  D+  V  ++DFG+  +         + +       + ++AP
Sbjct: 153 HKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  150 bits (379), Expect = 8e-38
 Identities = 73/347 (21%), Positives = 122/347 (35%), Gaps = 50/347 (14%)

Query: 330 QSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN 389
           +S   +  +  +          L +   +   T+P  +     ++ L +  N+ +  +P 
Sbjct: 23  ESRGRAAVVQKMRACLNNGNAVLNV-GESGLTTLPDCLPA--HITTLVIPDNNLT-SLPA 78

Query: 390 TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLS 449
               LR L    +  N LTS                L+        L  +          
Sbjct: 79  LPPELRTL---EVSGNQLTS------LPVLPPGLLELSIFSNPLTHLPALPS-------- 121

Query: 450 HSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK 509
             L    +    ++   P     L  L    +  N+L  S+P    +L KL      +N+
Sbjct: 122 -GLCKLWIFGNQLTS-LPVLPPGLQEL---SVSDNQLA-SLPALPSELCKL---WAYNNQ 172

Query: 510 LEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLK 569
           L   +P     L +L    +S N+L+ S+P   S L  L      +N+LTS+P     LK
Sbjct: 173 LTS-LPMLPSGLQELS---VSDNQLA-SLPTLPSELYKL---WAYNNRLTSLPALPSGLK 224

Query: 570 GMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRL 629
               L  S N  T  LP+    LK L     S N  +  +P +      L  L +  N+L
Sbjct: 225 ---ELIVSGNRLTS-LPVLPSELKEL---MVSGNRLTS-LPMLPS---GLLSLSVYRNQL 273

Query: 630 QGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNK 676
              + ES   L S  ++NL  N LS     +L +++          +
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  141 bits (358), Expect = 3e-35
 Identities = 76/418 (18%), Positives = 137/418 (32%), Gaps = 82/418 (19%)

Query: 100 QLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLD 159
           +    +    LN+G + L+ ++P  +                             +  L 
Sbjct: 35  RACLNNGNAVLNVGESGLT-TLPDCLPA--------------------------HITTLV 67

Query: 160 FSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIP 219
              N L+  +PA        L ++ +S N     +P        L I S  + +L    P
Sbjct: 68  IPDNNLT-SLPALPPE----LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----P 117

Query: 220 KEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVL 279
                L    +L++  + L   +P     L EL +   Q++     +P   + L     L
Sbjct: 118 ALPSGLC---KLWIFGNQLT-SLPVLPPGLQELSVSDNQLA----SLPALPSELC---KL 166

Query: 280 KLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLS 339
               N LT  +P     L     L +S N+L  ++P     +  L     +  SL    S
Sbjct: 167 WAYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPS 221

Query: 340 SIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRL 399
                    L+EL + S N   ++P      S+L  L +  N  +  +P     L +L  
Sbjct: 222 --------GLKELIV-SGNRLTSLPVLP---SELKELMVSGNRLTS-LPMLPSGLLSL-- 266

Query: 400 MTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYF--DM 457
            +++ N LT          S  +  S T + L  NPL       ++  ++ +  Y    +
Sbjct: 267 -SVYRNQLT------RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPII 318

Query: 458 SYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPIT----LGKLQKLQGLHLEDNKLE 511
            +       P+E   L      +L   +     P       G+        L  ++L 
Sbjct: 319 RFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  137 bits (347), Expect = 8e-34
 Identities = 68/403 (16%), Positives = 127/403 (31%), Gaps = 79/403 (19%)

Query: 193 RIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAEL 252
           ++ + L+N     +L++   + L  +P  +     +  L +  + L   +P     L  L
Sbjct: 33  KMRACLNNG--NAVLNVG-ESGLTTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL 86

Query: 253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG 312
           E+   Q+++L    P     L  L +       L             L  L +  N+L  
Sbjct: 87  EVSGNQLTSL----PVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-T 134

Query: 313 AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK 372
           ++P     +  L+    Q  SL    S         L +L  ++N  + ++P      S 
Sbjct: 135 SLPVLPPGLQELSVSDNQLASLPALPS--------ELCKLWAYNNQLT-SLPMLP---SG 182

Query: 373 LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLS 432
           L  L +  N  +  +P     L  L             N  L+ L +      L  + +S
Sbjct: 183 LQELSVSDNQLA-SLPTLPSELYKLWA----------YNNRLTSLPA--LPSGLKELIVS 229

Query: 433 NNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI 492
            N L  +                           P     L  L    + GN+L  S+P+
Sbjct: 230 GNRLTSL---------------------------PVLPSELKEL---MVSGNRLT-SLPM 258

Query: 493 TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS 552
               L  L    +  N+L   +P+ +  L+    + L GN LS         + S    S
Sbjct: 259 LPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYS 314

Query: 553 LGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVL 595
               +      +       L+L  ++++       +       
Sbjct: 315 GPIIRFDMAGASAPRETRALHLA-AADWLVPAREGEPAPADRW 356

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  126 bits (317), Expect = 5e-30
 Identities = 69/317 (21%), Positives = 114/317 (35%), Gaps = 43/317 (13%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
           +  L I   NLT ++P+       L++L +  N+L+ S+P     L  L   +     L 
Sbjct: 63  ITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCK 202
            A P      S L  L    N L+  +P         L+ +S+S N     +P+  S   
Sbjct: 118 -ALP------SGLCKLWIFGNQLT-SLPVLPPG----LQELSVSDNQL-ASLPALPSELC 164

Query: 203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
            L       NN L ++P     L    EL +  + L   +P     L +L     ++++L
Sbjct: 165 KLWAY----NNQLTSLPMLPSGLQ---ELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL 216

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS 322
                      +GL+ L +  N LT  +P     L     L +S N+L  ++P      S
Sbjct: 217 PALP-------SGLKELIVSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLP---S 261

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
            L  L +  N L+    S+    L +   + L  N  S    + +   +           
Sbjct: 262 GLLSLSVYRNQLTRLPESLI--HLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIR 319

Query: 383 FSGFIPNTFGNLRNLRL 399
           F     +     R L L
Sbjct: 320 FDMAGASAPRETRALHL 336

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  118 bits (296), Expect = 1e-27
 Identities = 57/289 (19%), Positives = 93/289 (32%), Gaps = 48/289 (16%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
           + L +S   LT ++P     L  L   +     L             L  +   GNQL+ 
Sbjct: 84  RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT- 134

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
           + P        LQ L  S N L+  +PA        L  +    N     +P   S    
Sbjct: 135 SLPVLPPG---LQELSVSDNQLA-SLPALPSE----LCKLWAYNNQLT-SLPMLPSG--- 182

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
           L+ LS+S +N L ++P     L KL       +     +P     L EL +      N  
Sbjct: 183 LQELSVS-DNQLASLPTLPSELYKLWAYNNRLT----SLPALPSGLKELIVS----GNRL 233

Query: 264 GEIPQELANLT-----------------GLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLS 306
             +P   + L                  GL  L + +N LT  +P  + +L +   ++L 
Sbjct: 234 TSLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLW 355
            N L       +  +++  G          + +S              W
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  104 bits (262), Expect = 3e-23
 Identities = 48/211 (22%), Positives = 78/211 (36%), Gaps = 27/211 (12%)

Query: 473 LTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGN 532
                 + +G + L  ++P  L     +  L + DN L   +P     L  L    +SGN
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPALPPELRTLE---VSGN 91

Query: 533 KLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNL 592
           +L+ S+P     L  L   S     L ++P       G+  L    N  T  LP+    L
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALP------SGLCKLWIFGNQLTS-LPVLPPGL 143

Query: 593 KVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNN 652
           + L     S N  +  +P +   L  L       N+L  S+         L+ L++S+N 
Sbjct: 144 QEL---SVSDNQLAS-LPALPSELCKLW---AYNNQLT-SLPMLPS---GLQELSVSDNQ 192

Query: 653 LSRSIPISLEKLSYLEDLDLSFNKLKGEIPK 683
           L+ S+P    +L  L   +     L      
Sbjct: 193 LA-SLPTLPSELYKLWAYNNRLTSLPALPSG 222

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  142 bits (361), Expect = 8e-38
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 15/177 (8%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
             +G+G +G V++     G  VAVK+F  +  +++   + E      +RH N++  I+S 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71

Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-----FG 896
            T    +    LI  Y   GSL   L      LD    L I++ +A+ L +LH       
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA--TIGYMAP 951
               + H DLK  N+L+  N    ++D G+A +       +         T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  142 bits (359), Expect = 3e-37
 Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 15/177 (8%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
             IG+G +G V+  +   G +VAVKVF      ++   + E      +RH N++  I++ 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAAD 100

Query: 846 STEEFK----ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-----FG 896
                      LI +Y  +GSL   L   +  LD    L +     + L +LH       
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA--TIGYMAP 951
               + H DLK  N+L+  N    ++D G+A   I +   +         T  YM P
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  143 bits (362), Expect = 6e-36
 Identities = 93/490 (18%), Positives = 164/490 (33%), Gaps = 42/490 (8%)

Query: 212 NNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQEL- 270
           N  L  +PK++    + K L L  + +      +   L+EL ++ L  + ++  +   + 
Sbjct: 40  NRNLTHVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVF 96

Query: 271 ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGL 329
                LE L +  N L   I      + +L+ LDLS N          F N++ LT LGL
Sbjct: 97  LFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153

Query: 330 QSNSL-SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF--NASKLSVLELGRNSFSGF 386
            +       L  +A + L  +  L L S +  G     +   N + L ++    + FS  
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCIL-LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212

Query: 387 IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMG 446
           +  +   L +L+L  +  N      L             L               ++   
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGN-----LTNLIGIYLGGNKLNGSIPITLGKLQKLQ 501
                +EY ++    ++    +E        L +L+  ++       S         ++ 
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI 561
              L  +             +    L  + N  + S+    S L  L TL L  N L + 
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392

Query: 562 PLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQY 621
                  K M  L          L                    S           ++  
Sbjct: 393 FKVALMTKNMSSLETLDVSLNS-LN-------------------SHAYDRTCAWAESILV 432

Query: 622 LFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI 681
           L L  N L GS+         +K L+L NN +  SIP  +  L  L++L+++ N+LK  +
Sbjct: 433 LNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488

Query: 682 PKGGSFGNFS 691
           P  G F   +
Sbjct: 489 PD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  141 bits (357), Expect = 2e-35
 Identities = 89/467 (19%), Positives = 162/467 (34%), Gaps = 30/467 (6%)

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNL 262
            + LSLS N++      +I  L++L+ L L ++ ++  +    F    +LE + +  + L
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPP--EIHNLHNLKLLDLSHNKLVGAVPATIFN 320
           Q  I      +  L  L L  N     +P   E  NL  L  L LS  K    +      
Sbjct: 113 Q-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF-RQLDLLPVA 167

Query: 321 MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSN-NFSGTIPRFIFNAS----KLSV 375
              L+ + L   S          +Q+PN   L L  + N   ++   +   +    +LS 
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
           ++L   +    +       R   L+ +   ++ ++      L  F   + + Y+ + N  
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIG---NLTNLIGIYLGGNKLNGSIPI 492
           +   + R        +L+   + +         +         +    L  +       +
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347

Query: 493 TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS 552
                     L+   N     +      L +L  L L  N L  +         ++ +L 
Sbjct: 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLE 406

Query: 553 LGSNKLTSIP------LTIWNLKGMLYLNFSSNFFTGPLPLDI-GNLKVLIGIDFSTNNF 605
                L S+          W  + +L LN SSN  TG +   +   +KVL   D   N  
Sbjct: 407 TLDVSLNSLNSHAYDRTCAW-AESILVLNLSSNMLTGSVFRCLPPKVKVL---DLHNNRI 462

Query: 606 SDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNN 652
              IP  +  L  LQ L +  N+L+      F  L SL+ + L +N 
Sbjct: 463 MS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  104 bits (260), Expect = 4e-23
 Identities = 74/386 (19%), Positives = 122/386 (31%), Gaps = 33/386 (8%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
              ++D S+  L   VP  +        L L  NS+S  L       L  L  LRL  N 
Sbjct: 32  LESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNR 87

Query: 359 FSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFL 417
              ++   +F     L  L++  N     I      + +LR + L +N        L   
Sbjct: 88  IR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFDV----LPVC 139

Query: 418 SSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLI 477
             F N   LT++GLS       L  + + +L  S    D+   ++ GG  + +    N  
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQ-LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTT 197

Query: 478 GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGS 537
            ++L  +  +         +  L  L L + KL     ++  RL         G  L   
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN---DENCQRLMTFLSELTRGPTLLNV 254

Query: 538 IPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGN-----L 592
                    +L  +         +    W  + + YLN  +   T  +  +        L
Sbjct: 255 ---------TLQHIETTWKCSVKLFQFFWP-RPVEYLNIYNLTITERIDREEFTYSETAL 304

Query: 593 KVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNN 652
           K L+        F      +      +    L  +              S   LN + N 
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364

Query: 653 LSRSIPISLEKLSYLEDLDLSFNKLK 678
            + S+      L  L+ L L  N LK
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  104 bits (260), Expect = 4e-23
 Identities = 67/377 (17%), Positives = 119/377 (31%), Gaps = 52/377 (13%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYV--NFRGNQLS-GAFPSFIFNKSSLQHLD 159
           NL+ L  L L   +    +         L  +  +     +  G   S     +++ HL 
Sbjct: 144 NLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202

Query: 160 FSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNC------------------ 201
           F  N+L         + L  L+  ++  N  + +      +                   
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262

Query: 202 -------------KYLEILSLSINNLLGAIPKEIGN-----LTKLKELYLGYSGLQGEIP 243
                        + +E L++    +   I +E        L  L   ++          
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322

Query: 244 REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLL 303
             +   AE+ +  L +S+          + +    L   +N  T  +      L  L+ L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382

Query: 304 DLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADV---QLPNLEELRLWSNNFS 360
            L  N L             ++ L     SL+   S   D       ++  L L SN  +
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441

Query: 361 GTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSF 420
           G++ R +    K+ VL+L  N     IP    +L+ L+ + +  N L S          F
Sbjct: 442 GSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVP-----DGVF 493

Query: 421 SNCKSLTYIGLSNNPLD 437
               SL YI L +NP D
Sbjct: 494 DRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 78.4 bits (193), Expect = 5e-15
 Identities = 55/315 (17%), Positives = 115/315 (36%), Gaps = 17/315 (5%)

Query: 6   SLSMMSRFLFLHCLILISLLTAAATANTSSITTDQDALLALKAHITHDPTNFLAKNWNTS 65
            L ++     L  + +   + A      S+I  + +    L   ++         N    
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ 257

Query: 66  TPVCNWTGVTCDVHS---HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSG--- 119
                W              V+ LNI +L +T  I  + +  S     +L    +     
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF 317

Query: 120 -SIPSAIFTLYT-LKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNL 177
                A+++++  +       +           + SS   L+F+ N  + +     CS L
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTL 376

Query: 178 PFLESISLSQNMFH--GRIPSALSNCKYLEILSLSINNLL-GAIPKEIGNLTKLKELYLG 234
             L+++ L +N      ++     N   LE L +S+N+L   A  +       +  L L 
Sbjct: 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436

Query: 235 YSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI 294
            + L G + R      +++++ L  + +   IP+++ +L  L+ L +  N L   +P  +
Sbjct: 437 SNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGV 492

Query: 295 -HNLHNLKLLDLSHN 308
              L +L+ + L  N
Sbjct: 493 FDRLTSLQYIWLHDN 507

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  137 bits (347), Expect = 1e-35
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 15/177 (8%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
             IG+G FG V++ +   G EVAVK+F  +  R++   + E      +RH N++  I++ 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 105

Query: 846 STEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-----FG 896
           + +        L+ +Y  HGSL   L  + Y + +   + + +  A+ L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA--TIGYMAP 951
               + H DLK  N+L+  N    ++D G+A        +I         T  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  135 bits (342), Expect = 4e-35
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 16/177 (9%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G+G FG   K      G  + +K          ++F  E ++M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL 906
            ++    I EY+  G+L   + S +      QR++   D+A+ + YLH   S  +IH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA------------TIGYMAP 951
              N L+ +N    ++DFG+A+L++ E       ++L                +MAP
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  139 bits (351), Expect = 4e-35
 Identities = 75/430 (17%), Positives = 131/430 (30%), Gaps = 75/430 (17%)

Query: 248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
           N A     A ++             L  L  L    + +T      I  L  L  L  + 
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTS 73

Query: 308 NKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFI 367
           N +       +   + LT L   SN L+    ++    L  L  L   +N  +  +   +
Sbjct: 74  NNITTL---DLSQNTNLTYLACDSNKLT----NLDVTPLTKLTYLNCDTNKLT-KLD--V 123

Query: 368 FNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLT 427
                L+ L   RN+ +        +   L  +  H N   +           +    LT
Sbjct: 124 SQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKIT-------KLDVTPQTQLT 173

Query: 428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
            +  S N +  +                             ++     L  +    N + 
Sbjct: 174 TLDCSFNKITEL-----------------------------DVSQNKLLNRLNCDTNNIT 204

Query: 488 GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLAS 547
               + L +  +L  L    NKL      D+  LT+L     S N L+  +    S L+ 
Sbjct: 205 K---LDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELD--VSTLSK 255

Query: 548 LGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSD 607
           L TL      L  I LT  +   ++Y           L  D+ +   L  +D      ++
Sbjct: 256 LTTLHCIQTDLLEIDLT--HNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITE 311

Query: 608 VIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYL 667
           +    +     L YL+L    L             LKSL+  N ++      S+ K+  L
Sbjct: 312 L---DLSQNPKLVYLYLNNTELT---ELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPAL 363

Query: 668 EDLDLSFNKL 677
            +   +  + 
Sbjct: 364 NNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  125 bits (316), Expect = 1e-30
 Identities = 63/380 (16%), Positives = 121/380 (31%), Gaps = 67/380 (17%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
           N      +  ++      +   ++TLT L   ++S++  ++ I   +L  L +L   SNN
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIE--KLTGLTKLICTSNN 75

Query: 359 FSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLS 418
            + T+   +   + L+ L    N  +         L  L  +    N LT  +       
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLD------- 122

Query: 419 SFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG 478
             S    LTY+  + N L  I     + + +  L   D            ++   T L  
Sbjct: 123 -VSQNPLLTYLNCARNTLTEI----DVSHNT-QLTELDCHLNKKIT--KLDVTPQTQLTT 174

Query: 479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSI 538
           +    NK+     + + + + L  L+ + N +      D+ +  +L  L  S NKL+  I
Sbjct: 175 LDCSFNKITE---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EI 227

Query: 539 PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGI 598
               + L  L       N LT +   +  L  +  L+           +D+ +   LI  
Sbjct: 228 D--VTPLTQLTYFDCSVNPLTELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYF 280

Query: 599 DFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP 658
                     +                                 L  L+     ++    
Sbjct: 281 QAEGCRKIKELD--------------------------VTHNTQLYLLDCQAAGITE--- 311

Query: 659 ISLEKLSYLEDLDLSFNKLK 678
           + L +   L  L L+  +L 
Sbjct: 312 LDLSQNPKLVYLYLNNTELT 331

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  115 bits (291), Expect = 2e-27
 Identities = 71/500 (14%), Positives = 150/500 (30%), Gaps = 76/500 (15%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
                +   +  T       L++L SL+   + ++  +   I  L  L  +    N ++ 
Sbjct: 21  ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT- 77

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
                +   ++L +L    N L+  +     + L  L  ++   N         +S    
Sbjct: 78  TLD--LSQNTNLTYLACDSNKLT-NLDV---TPLTKLTYLNCDTNKL---TKLDVSQNPL 128

Query: 204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
           L  L+ +  N L  I   + + T+L EL    +    ++        +L  +    + + 
Sbjct: 129 LTYLNCA-RNTLTEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST 323
                +++    L  L    N +T     +++    L  LD S NKL       +  ++ 
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTE---IDVTPLTQ 234

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
           LT      N     L+ +    L  L  L     +    I   + + ++L   +      
Sbjct: 235 LTYFDCSVN----PLTELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK 287

Query: 384 SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
              +     +   L L+      +T  +         S    L Y+ L+N  L  +    
Sbjct: 288 IKELD--VTHNTQLYLLDCQAAGITELD--------LSQNPKLVYLYLNNTELTEL---- 333

Query: 444 SMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGL 503
                                    ++ + T L  +      +      ++GK+  L   
Sbjct: 334 -------------------------DVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNN 366

Query: 504 HLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL 563
              + +    +P +      L  + +S + L              G     +N +T   L
Sbjct: 367 FEAEGQTIT-MPKETLTNNSLT-IAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENL 424

Query: 564 TIWNLKGMLYLNFSSNFFTG 583
           +  N          +    G
Sbjct: 425 STDNPAVTYTFTSENGAIVG 444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  109 bits (275), Expect = 2e-25
 Identities = 59/332 (17%), Positives = 107/332 (32%), Gaps = 55/332 (16%)

Query: 367 IFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL 426
            F     +               +   L  L  +  H + +T        ++       L
Sbjct: 14  WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-------MTGIEKLTGL 66

Query: 427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKL 486
           T +  ++N +  +     +   + +L Y       ++     ++  LT L  +    NKL
Sbjct: 67  TKLICTSNNITTL----DLSQNT-NLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKL 118

Query: 487 NGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLA 546
                + + +   L  L+   N L      D+   T+L EL    NK    +    +   
Sbjct: 119 T---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQT 170

Query: 547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
            L TL    NK+T + ++    K +  LN  +N  T    LD+     L  +D S+N  +
Sbjct: 171 QLTTLDCSFNKITELDVS--QNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT 225

Query: 607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS------ 660
           + I   +  LT L Y     N L          L  L +L+    +L   I ++      
Sbjct: 226 E-ID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL-EIDLTHNTQLI 278

Query: 661 --------------LEKLSYLEDLDLSFNKLK 678
                         +   + L  LD     + 
Sbjct: 279 YFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  134 bits (339), Expect = 1e-34
 Identities = 77/356 (21%), Positives = 123/356 (34%), Gaps = 61/356 (17%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
           +L+++  S   L   VP  +        L LQ+N ++  +       L NL  L L +N 
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87

Query: 359 FSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFL 417
            S  I    F    KL  L L +N            L+ LR+   H N +T         
Sbjct: 88  IS-KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRV---HENEITKVRK----- 138

Query: 418 SSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLI 477
           S F+    +  + L  NPL            S  +E         +G F      +  L 
Sbjct: 139 SVFNGLNQMIVVELGTNPLK-----------SSGIE---------NGAF----QGMKKLS 174

Query: 478 GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGS 537
            I +    +  +IP  L     L  LHL+ NK+       +  L  L +LGLS N +S  
Sbjct: 175 YIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 231

Query: 538 IPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIG 597
                +N   L  L L +NKL  +P  + + K +  +   +N  +               
Sbjct: 232 DNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS--------------- 276

Query: 598 IDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI--SESFGDLISLKSLNLSNN 651
               +N+F    P       +   + L  N +Q       +F  +    ++ L N 
Sbjct: 277 -AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  128 bits (324), Expect = 1e-32
 Identities = 67/305 (21%), Positives = 123/305 (40%), Gaps = 31/305 (10%)

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMST 323
           ++P++L       +L L  N +T EI      NL NL  L L +NK+    P     +  
Sbjct: 45  KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNS 382
           L  L L  N L      + +     L+ELR+  N  +  + + +F   +++ V+ELG N 
Sbjct: 102 LERLYLSKNQLK----ELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNP 156

Query: 383 F--SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGIL 440
              SG     F  ++ L  + +    +T+  +      S      LT + L  N +  + 
Sbjct: 157 LKSSGIENGAFQGMKKLSYIRIADTNITT--IPQGLPPS------LTELHLDGNKITKV- 207

Query: 441 PRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKL 500
              S+  L ++L    +S+ ++S      + N  +L  ++L  NKL   +P  L   + +
Sbjct: 208 DAASLKGL-NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 501 QGLHLEDNKLEG------PIPDDICRLTKLYELGLSGNKLSGSI--PACFSNLASLGTLS 552
           Q ++L +N +          P    +      + L  N +      P+ F  +     + 
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325

Query: 553 LGSNK 557
           LG+ K
Sbjct: 326 LGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  121 bits (305), Expect = 4e-30
 Identities = 56/271 (20%), Positives = 99/271 (36%), Gaps = 19/271 (7%)

Query: 424 KSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGG 483
                + L NN +  I       NL + L    +    +S   P     L  L  +YL  
Sbjct: 52  PDTALLDLQNNKITEI-KDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 109

Query: 484 NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKLSGSI--PA 540
           N+L   +P  +   + LQ L + +N++   +   +   L ++  + L  N L  S     
Sbjct: 110 NQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDF 600
            F  +  L  + +    +T+IP  +     +  L+   N  T      +  L  L  +  
Sbjct: 166 AFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 223

Query: 601 STNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR----- 655
           S N+ S V    +    +L+ L L  N+L   +     D   ++ + L NNN+S      
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 282

Query: 656 -SIPISLEKLSYLEDLDLSFNKLK-GEIPKG 684
              P    K +    + L  N ++  EI   
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  119 bits (301), Expect = 1e-29
 Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 47/311 (15%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQL 141
             +L++ +  +T        NL +L +L L  N++S  I    F  L  L+ +    NQL
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH-GRIPS-ALS 199
               P  +    +LQ L    N ++ ++  ++ + L  +  + L  N      I + A  
Sbjct: 113 K-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 200 NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQV 259
             K L  + ++ +  +  IP+  G    L EL+L                          
Sbjct: 169 GMKKLSYIRIA-DTNITTIPQ--GLPPSLTELHLDG------------------------ 201

Query: 260 SNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPAT 317
            N   ++    L  L  L  L L  N ++  +      N  +L+ L L++NKLV  VP  
Sbjct: 202 -NKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGG 258

Query: 318 IFNMSTLTGLGLQSNSLS-----GSLSSIADVQLPNLEELRLWSNNFSGT-IPRFIF-NA 370
           + +   +  + L +N++S            + +  +   + L+SN      I    F   
Sbjct: 259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318

Query: 371 SKLSVLELGRN 381
              + ++LG  
Sbjct: 319 YVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  118 bits (299), Expect = 2e-29
 Identities = 56/266 (21%), Positives = 103/266 (38%), Gaps = 20/266 (7%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
           +L       D+    ++     +  NL NL  + L  NK++   P     L KL+ L+L 
Sbjct: 49  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL--- 563
            N+L+  +P+ +     L EL +  N+++    + F+ L  +  + LG+N L S  +   
Sbjct: 109 KNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 564 TIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLF 623
               +K + Y+  +    T    +  G    L  +    N  + V    + GL NL  L 
Sbjct: 166 AFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222

Query: 624 LGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPK 683
           L +N +    + S  +   L+ L+L+NN L   +P  L    Y++ + L  N +      
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS----- 276

Query: 684 GGSFGNFSAKSFEGNELLCGSPNLQV 709
                   +  F          +   
Sbjct: 277 -----AIGSNDFCPPGYNTKKASYSG 297

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  118 bits (297), Expect = 5e-29
 Identities = 64/333 (19%), Positives = 118/333 (35%), Gaps = 39/333 (11%)

Query: 106 SLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNAL 165
            L+ +      L   +P  +        ++ + N+++        N  +L  L    N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 166 SGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI-GN 224
           S +I     + L  LE + LS+N               L+ L +   N +  + K +   
Sbjct: 89  S-KISPGAFAPLVKLERLYLSKNQLKELPEKMPKT---LQELRVH-ENEITKVRKSVFNG 143

Query: 225 LTKLKELYLGYSGLQ-GEIPRE-FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
           L ++  + LG + L+   I    F  + +L  + +  +N+   IPQ L     L  L L 
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200

Query: 283 KNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSI 341
            N +T ++       L+NL  L LS N +      ++ N   L  L L +N L   +   
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG- 257

Query: 342 ADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMT 401
                  ++ + L +NN S                 +G N F    P       +   ++
Sbjct: 258 GLADHKYIQVVYLHNNNIS----------------AIGSNDFCP--PGYNTKKASYSGVS 299

Query: 402 LHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNN 434
           L  N +    ++    S+F        + L N 
Sbjct: 300 LFSNPVQYWEIQ---PSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  102 bits (255), Expect = 1e-23
 Identities = 43/264 (16%), Positives = 90/264 (34%), Gaps = 22/264 (8%)

Query: 81  HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQ 140
             +  L + +  ++   P     L  L+ L L  N+L   +P  +    TL+ +    N+
Sbjct: 76  KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENE 132

Query: 141 LSGAFPSFIFNK-SSLQHLDFSYNAL-SGEIPANICSNLPFLESISLSQNMFHGRIPSAL 198
           ++      +FN  + +  ++   N L S  I       +  L  I ++            
Sbjct: 133 IT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP 191

Query: 199 SNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMAL 257
            +   L  L L   N +  +       L  L +L L ++ +         N   L  + L
Sbjct: 192 PS---LTELHLD-GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-------IHNLHNLKLLDLSHNKL 310
             + L  ++P  LA+   ++V+ L  N ++  I               +   + L  N +
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 305

Query: 311 -VGAVPATIF-NMSTLTGLGLQSN 332
               +  + F  +     + L + 
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 27/138 (19%), Positives = 47/138 (34%), Gaps = 30/138 (21%)

Query: 547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
            L  +      L  +P  +                    P D   L      D   N  +
Sbjct: 32  HLRVVQCSDLGLEKVPKDL--------------------PPDTALL------DLQNNKIT 65

Query: 607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY 666
           ++       L NL  L L  N++      +F  L+ L+ L LS N L   +P  +     
Sbjct: 66  EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKT 122

Query: 667 LEDLDLSFNKLKGEIPKG 684
           L++L +  N++  ++ K 
Sbjct: 123 LQELRVHENEIT-KVRKS 139

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  131 bits (331), Expect = 2e-33
 Identities = 83/356 (23%), Positives = 132/356 (37%), Gaps = 62/356 (17%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
           +L+++  S   L  AVP  I      T L LQ+N +S  L       L +L  L L +N 
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89

Query: 359 FSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFL 417
            S  I    F    KL  L + +N      PN   +L  LR+   H N +      +   
Sbjct: 90  IS-KIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRI---HDNRIRK----VP-K 140

Query: 418 SSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLI 477
             FS  +++  I +  NPL+                         + GF     +   L 
Sbjct: 141 GVFSGLRNMNCIEMGGNPLE-------------------------NSGFEPGAFDGLKLN 175

Query: 478 GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGS 537
            + +   KL   IP  L   + L  LHL+ NK++    +D+ R +KLY LGL  N++   
Sbjct: 176 YLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232

Query: 538 IPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIG 597
                S L +L  L L +NKL+ +P  + +LK +  +   +N  T               
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT--------------- 277

Query: 598 IDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ-GSISES-FGDLISLKSLNLSNN 651
                N+F  V   V         + L  N +    +  + F  +    ++   N 
Sbjct: 278 -KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  123 bits (312), Expect = 5e-31
 Identities = 68/341 (19%), Positives = 120/341 (35%), Gaps = 55/341 (16%)

Query: 228 LKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFL 286
           L+ +     GL+  +P+E   +   L+L    +S L+     +   L  L  L L  N +
Sbjct: 35  LRVVQCSDLGLK-AVPKEISPDTTLLDLQNNDISELR---KDDFKGLQHLYALVLVNNKI 90

Query: 287 TGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQ 345
           + +I  +    L  L+ L +S N LV  +P  +   S+L  L +  N +   +       
Sbjct: 91  S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSG 145

Query: 346 LPNLEELRLWSNNF-SGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHY 404
           L N+  + +  N   +       F+  KL+ L +     +G   +    L  L L    +
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHL---DH 202

Query: 405 NYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSG 464
           N + +  LE            L  +GL +N +  I                         
Sbjct: 203 NKIQAIELE-----DLLRYSKLYRLGLGHNQIRMIENGS-----------LS-------- 238

Query: 465 GFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC----- 519
                   L  L  ++L  NKL+  +P  L  L+ LQ ++L  N +     +D C     
Sbjct: 239 -------FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFG 290

Query: 520 -RLTKLYELGLSGNKLSGSI--PACFSNLASLGTLSLGSNK 557
            +      + L  N +      PA F  +     +  G+ K
Sbjct: 291 VKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  120 bits (302), Expect = 9e-30
 Identities = 57/264 (21%), Positives = 96/264 (36%), Gaps = 19/264 (7%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
            +S      D+   ++S     +   L +L  + L  NK++         L+KLQ L++ 
Sbjct: 51  EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW 566
            N L   IP ++   + L EL +  N++       FS L ++  + +G N L +      
Sbjct: 111 KNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 567 NLKGM--LYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL 624
              G+   YL  S    TG        L  L       N    +    +   + L  L L
Sbjct: 168 AFDGLKLNYLRISEAKLTGIPKDLPETLNEL---HLDHNKIQAIELEDLLRYSKLYRLGL 224

Query: 625 GYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG 684
           G+N+++   + S   L +L+ L+L NN LS  +P  L  L  L+ + L  N +       
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT------ 277

Query: 685 GSFGNFSAKSFEGNELLCGSPNLQ 708
                     F             
Sbjct: 278 ----KVGVNDFCPVGFGVKRAYYN 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  115 bits (290), Expect = 4e-28
 Identities = 66/311 (21%), Positives = 112/311 (36%), Gaps = 48/311 (15%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQL 141
             +L++ + +++         L  L +L L  N++S  I    F+ L  L+ +    N L
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI--PSALS 199
               P  +   SSL  L    N +  ++P  + S L  +  I +  N        P A  
Sbjct: 115 V-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 200 NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQV 259
             K L  L +S    L  IPK       L EL+L ++ +Q                    
Sbjct: 171 GLK-LNYLRIS-EAKLTGIPK--DLPETLNELHLDHNKIQ-------------------- 206

Query: 260 SNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPAT 317
                 I  E L   + L  L LG N +   I       L  L+ L L +NKL   VPA 
Sbjct: 207 -----AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAG 259

Query: 318 IFNMSTLTGLGLQSNSLS----GSLSSI-ADVQLPNLEELRLWSNNFS-GTIPRFIF-NA 370
           + ++  L  + L +N+++         +   V+      + L++N      +    F   
Sbjct: 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319

Query: 371 SKLSVLELGRN 381
           +    ++ G  
Sbjct: 320 TDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  114 bits (288), Expect = 8e-28
 Identities = 64/288 (22%), Positives = 107/288 (37%), Gaps = 20/288 (6%)

Query: 154 SLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINN 213
            L+ +  S   L   +P  I    P    + L  N             ++L  L L  NN
Sbjct: 34  HLRVVQCSDLGLK-AVPKEI---SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLV-NN 88

Query: 214 LLGAIPKEI-GNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQELA 271
            +  I ++    L KL++LY+  + L  EIP     +L EL +   ++  +   +    +
Sbjct: 89  KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGV---FS 144

Query: 272 NLTGLEVLKLGKNFLT-GEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQ 330
            L  +  +++G N L      P   +   L  L +S  KL   +P  +    TL  L L 
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLP--ETLNELHLD 201

Query: 331 SNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPN 389
            N +  ++     ++   L  L L  N     I          L  L L  N  S  +P 
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPA 258

Query: 390 TFGNLRNLRLMTLHYNYLTS-SNLELSFLSSFSNCKSLTYIGLSNNPL 436
              +L+ L+++ LH N +T     +   +           I L NNP+
Sbjct: 259 GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV 306

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  112 bits (283), Expect = 3e-27
 Identities = 59/346 (17%), Positives = 114/346 (32%), Gaps = 74/346 (21%)

Query: 348 NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYL 407
           +L  ++         +P+ I      ++L+L  N  S    + F  L++L  + L  N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 408 TSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFP 467
           +  + +     +FS  + L  + +S N L  I P +                        
Sbjct: 91  SKIHEK-----AFSPLRKLQKLYISKNHLVEIPPNL------------------------ 121

Query: 468 KEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKL-EGPIPDDICRLTKLYE 526
                 ++L+ + +  N++          L+ +  + +  N L             KL  
Sbjct: 122 -----PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNY 176

Query: 527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP 586
           L +S  KL+  IP       +L  L L  NK+ +I                         
Sbjct: 177 LRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIE-----------------------L 210

Query: 587 LDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSL 646
            D+     L  +    N    +    +  L  L+ L L  N+L   +     DL  L+ +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269

Query: 647 NLSNNNLSRSIPIS-------LEKLSYLEDLDLSFNKLK-GEIPKG 684
            L  NN++  + ++         K +Y   + L  N +   E+   
Sbjct: 270 YLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 96.6 bits (241), Expect = 8e-22
 Identities = 53/242 (21%), Positives = 92/242 (38%), Gaps = 25/242 (10%)

Query: 81  HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGN 139
            +++ L IS  +L   IP  L   SSL  L +  NR+   +P  +F+ L  +  +   GN
Sbjct: 102 RKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGN 157

Query: 140 QL-SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS-A 197
            L +  F    F+   L +L  S   L+  IP ++   L     + L  N     I    
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETL---NELHLDHNKIQ-AIELED 212

Query: 198 LSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMA 256
           L     L  L L  +N +  I       L  L+EL+L  + L   +P    +L  L+++ 
Sbjct: 213 LLRYSKLYRLGLG-HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270

Query: 257 LQVSNLQGEIPQE-------LANLTGLEVLKLGKNFLT-GEIPPEI-HNLHNLKLLDLSH 307
           L  +N+  ++                   + L  N +   E+ P     + +   +   +
Sbjct: 271 LHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329

Query: 308 NK 309
            K
Sbjct: 330 YK 331

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  117 bits (294), Expect = 7e-29
 Identities = 61/290 (21%), Positives = 97/290 (33%), Gaps = 42/290 (14%)

Query: 154 SLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINN 213
           S   +  +   L+  +P  I         + L  N               L  LSLS N 
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 214 L--LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELA 271
           L   G   +     T LK L L ++G+                           +     
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVI-------------------------TMSSNFL 98

Query: 272 NLTGLEVLKLGKNFLTGEIPPE--IHNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLG 328
            L  LE L    + L  ++       +L NL  LD+SH          IF  +S+L  L 
Sbjct: 99  GLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLK 156

Query: 329 LQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFI 387
           +  NS   +       +L NL  L L        +    FN+ S L VL +  N+F    
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLD 215

Query: 388 PNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
              +  L +L+++    N++ +   +   L  F    SL ++ L+ N   
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIMT--SKKQELQHFP--SSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  115 bits (289), Expect = 3e-28
 Identities = 52/241 (21%), Positives = 85/241 (35%), Gaps = 15/241 (6%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN--GSIPITLGKLQKLQGLH 504
            +  S    ++    +          LT L  + L  N L+  G    +      L+ L 
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 505 LEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPAC--FSNLASLGTLSLGSNKLTSIP 562
           L  N +   +  +   L +L  L    + L   +     F +L +L  L +         
Sbjct: 85  LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAF 142

Query: 563 LTI-WNLKGMLYLNFSSNFFTGPLPLDI----GNLKVLIGIDFSTNNFSDVIPTVIGGLT 617
             I   L  +  L  + N F      DI     NL  L   D S      + PT    L+
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL---DLSQCQLEQLSPTAFNSLS 199

Query: 618 NLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKL-SYLEDLDLSFNK 676
           +LQ L + +N      +  +  L SL+ L+ S N++  S    L+   S L  L+L+ N 
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 259

Query: 677 L 677
            
Sbjct: 260 F 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  113 bits (286), Expect = 8e-28
 Identities = 52/260 (20%), Positives = 97/260 (37%), Gaps = 11/260 (4%)

Query: 106 SLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNAL 165
           S   +      L+ S+P+ I +  +   +    N+L           + L  L  S N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 166 S-GEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI-G 223
           S     +        L+ + LS N     + S     + LE L    +NL       +  
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 224 NLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQE-LANLTGLEVLKL 281
           +L  L  L + ++  +       F  L+ LE++ +  ++ Q     +    L  L  L L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 282 GKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSS 340
            +  L  ++ P   ++L +L++L++SHN            +++L  L    N +  S   
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241

Query: 341 IADVQLPNLEELRLWSNNFS 360
                  +L  L L  N+F+
Sbjct: 242 ELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  102 bits (255), Expect = 1e-23
 Identities = 48/234 (20%), Positives = 85/234 (36%), Gaps = 9/234 (3%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLS-GSIPSAIFT-LYTLKYVNFRGNQ 140
              L +    L          L+ L  L+L  N LS     S       +LKY++   N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 141 LSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSN 200
           +     S       L+HLDF ++ L      ++  +L  L  + +S            + 
Sbjct: 90  VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148

Query: 201 CKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQ 258
              LE+L ++ N+       +I   L  L  L L    L+ ++    F +L+ L+++ + 
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207

Query: 259 VSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI--HNLHNLKLLDLSHNKL 310
            +N           L  L+VL    N +      +   H   +L  L+L+ N  
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  101 bits (253), Expect = 2e-23
 Identities = 51/251 (20%), Positives = 90/251 (35%), Gaps = 14/251 (5%)

Query: 289 EIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLS-GSLSSIADVQLP 347
            +P  I    +   L+L  NKL          ++ LT L L SN LS     S +D    
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 348 NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIP-NTFGNLRNLRLMTLHYNY 406
           +L+ L L  N    T+        +L  L+   ++       + F +LRNL  + + + +
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGF 466
              +   +     F+   SL  + ++ N             L + L + D+S C +    
Sbjct: 138 TRVAFNGI-----FNGLSSLEVLKMAGNSFQENFLPDIFTELRN-LTFLDLSQCQLEQLS 191

Query: 467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICR--LTKL 524
           P    +L++L  + +  N            L  LQ L    N +         +   + L
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSL 250

Query: 525 YELGLSGNKLS 535
             L L+ N  +
Sbjct: 251 AFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 34/161 (21%), Positives = 62/161 (38%), Gaps = 10/161 (6%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQ--LWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVN 135
              +++ L+  H NL   +       +L +L  L++          + IF  L +L+ + 
Sbjct: 99  GLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLK 156

Query: 136 FRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI 194
             GN     F   IF +  +L  LD S   L  ++     ++L  L+ +++S N F    
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLD 215

Query: 195 PSALSNCKYLEILSLSINNLLGAIPKEI--GNLTKLKELYL 233
                    L++L  S  N +    K+      + L  L L
Sbjct: 216 TFPYKCLNSLQVLDYS-LNHIMTSKKQELQHFPSSLAFLNL 255

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 9/88 (10%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLS 142
             L++S   L    P+   +LSSLQ LN+  N    S+ +  +  L +L+ +++  N + 
Sbjct: 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236

Query: 143 ----GAFPSFIFNKSSLQHLDFSYNALS 166
                    F    SSL  L+ + N  +
Sbjct: 237 TSKKQELQHFP---SSLAFLNLTQNDFA 261

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  116 bits (293), Expect = 2e-28
 Identities = 61/355 (17%), Positives = 120/355 (33%), Gaps = 83/355 (23%)

Query: 304 DLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTI 363
             S   L  ++P+ +     +  L L +N ++  +S+    +  NL+ L L SN      
Sbjct: 37  KGSSGSL-NSIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN------ 86

Query: 364 PRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS--FS 421
                    ++ +E           ++F +L +L  + L YNYL++       LSS  F 
Sbjct: 87  --------GINTIE----------EDSFSSLGSLEHLDLSYNYLSN-------LSSSWFK 121

Query: 422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYL 481
              SLT++ L  NP   +                       +  F     +LT L  + +
Sbjct: 122 PLSSLTFLNLLGNPYKTLGE---------------------TSLF----SHLTKLQILRV 156

Query: 482 GGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA 540
           G       I       L  L+ L ++ + L+   P  +  +  +  L L   +    +  
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215

Query: 541 -CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGID 599
                 +S+  L L    L +   +            S+      +            + 
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFS----------ELSTGETNSLI-----KKFTFRNVK 260

Query: 600 FSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES-FGDLISLKSLNLSNNNL 653
            +  +    +  ++  ++ L  L    N+L+ S+ +  F  L SL+ + L  N  
Sbjct: 261 ITDESLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  110 bits (278), Expect = 2e-26
 Identities = 66/320 (20%), Positives = 115/320 (35%), Gaps = 51/320 (15%)

Query: 266 IPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMST 323
           IP  L     ++ L L  N +T  I         NL+ L L+ N +   +    F ++ +
Sbjct: 46  IPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSVLELGRNS 382
           L  L L  N LS +LSS     L +L  L L  N +       +F+  +KL +L +G   
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD 160

Query: 383 FSGFIP-NTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
               I    F  L  L  + +  + L S   +     S  + ++++++ L       +L 
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPK-----SLKSIQNVSHLILHMKQHILLLE 215

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG----SIPI----T 493
                         D                 +++  + L    L+      +      +
Sbjct: 216 IF-----------VD---------------VTSSVECLELRDTDLDTFHFSELSTGETNS 249

Query: 494 LGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLS 552
           L K    + + + D  L   +   + +++ L EL  S N+L  S+P   F  L SL  + 
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIW 307

Query: 553 LGSNKLTSIPLTIWNLKGML 572
           L +N        I  L   L
Sbjct: 308 LHTNPWDCSCPRIDYLSRWL 327

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  106 bits (266), Expect = 7e-25
 Identities = 62/288 (21%), Positives = 120/288 (41%), Gaps = 22/288 (7%)

Query: 85  VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYT-LKYVNFRGNQLSG 143
           +   S  +L  +IPS L    +++SL+L  NR++  I ++       L+ +    N ++ 
Sbjct: 35  ICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN- 89

Query: 144 AFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP--SALSN 200
                 F+   SL+HLD SYN LS  + ++    L  L  ++L  N +   +   S  S+
Sbjct: 90  TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSH 147

Query: 201 CKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQV 259
              L+IL +   +    I ++    LT L+EL +  S LQ   P+   ++  +  + L +
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207

Query: 260 SNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIH--------NLHNLKLLDLSHNKLV 311
                 +   +   + +E L+L    L      E+              + + ++   L 
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267

Query: 312 GAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNF 359
             V   +  +S L  L    N L  S+      +L +L+++ L +N +
Sbjct: 268 -QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (262), Expect = 2e-24
 Identities = 53/305 (17%), Positives = 101/305 (33%), Gaps = 46/305 (15%)

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
           + PS +    +++ LD S N ++  I  +       L+++ L+ N  +     + S+   
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS 101

Query: 204 LEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
           LE L LS  N L  +       L+ L  L L  +  +                       
Sbjct: 102 LEHLDLS-YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSL---------------- 144

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-N 320
                   ++LT L++L++G      +I  +    L  L+ L++  + L  +       +
Sbjct: 145 -------FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKS 196

Query: 321 MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT----IPRFIFNA----SK 372
           +  ++ L L        L  I      ++E L L   +        +     N+      
Sbjct: 197 IQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255

Query: 373 LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLS 432
              +++   S    +      +  L  +    N L S  +       F    SL  I L 
Sbjct: 256 FRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS--VP---DGIFDRLTSLQKIWLH 309

Query: 433 NNPLD 437
            NP D
Sbjct: 310 TNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (257), Expect = 1e-23
 Identities = 55/265 (20%), Positives = 105/265 (39%), Gaps = 18/265 (6%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQL 141
           VK L++S+  +T    S L    +LQ+L L  N ++ +I    F+ L +L++++   N L
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112

Query: 142 SGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS-ALS 199
           S    S  F   SSL  L+   N        ++ S+L  L+ + +       +I     +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171

Query: 200 NCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELE----- 253
              +LE L +  ++ L +   +   ++  +  L L        +       + +E     
Sbjct: 172 GLTFLEELEIDASD-LQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230

Query: 254 ---LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL 310
              L     S L       L        +K+    L  ++   ++ +  L  L+ S N+L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289

Query: 311 VGAVPATIF-NMSTLTGLGLQSNSL 334
              VP  IF  +++L  + L +N  
Sbjct: 290 KS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 99.4 bits (248), Expect = 1e-22
 Identities = 47/252 (18%), Positives = 102/252 (40%), Gaps = 19/252 (7%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHL 505
            L+ +++  D+S   ++     ++    NL  + L  N +N +I   +   L  L+ L L
Sbjct: 49  GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDL 107

Query: 506 EDNKLEGPIPDDICR-LTKLYELGLSGNKLSGSIP--ACFSNLASLGTLSLGSN-KLTSI 561
             N L   +     + L+ L  L L GN    ++   + FS+L  L  L +G+    T I
Sbjct: 108 SYNYLSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKI 165

Query: 562 PL-TIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQ 620
                  L  +  L   ++      P  + +++ +  +         ++   +   ++++
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225

Query: 621 YLFLGYNRLQGS--------ISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDL 672
            L L    L            + S     + +++ +++ +L   +   L ++S L +L+ 
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEF 284

Query: 673 SFNKLKGEIPKG 684
           S N+LK  +P G
Sbjct: 285 SRNQLKS-VPDG 295

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 38/154 (24%), Positives = 61/154 (39%), Gaps = 5/154 (3%)

Query: 534 LSGSIPACFSNLA--SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGN 591
           LS    +  ++L+    G     S  L SIP  +   + +  L+ S+N  T     D+  
Sbjct: 17  LSKEESSNQASLSCDRNGICKGSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQR 74

Query: 592 LKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
              L  +  ++N  + +       L +L++L L YN L    S  F  L SL  LNL  N
Sbjct: 75  CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGN 134

Query: 652 NLSRSIPISL-EKLSYLEDLDLSFNKLKGEIPKG 684
                   SL   L+ L+ L +       +I + 
Sbjct: 135 PYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  114 bits (288), Expect = 5e-28
 Identities = 48/192 (25%), Positives = 77/192 (40%), Gaps = 18/192 (9%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
            +     +G GGF  V     + +G   A+K       +  +    E +M +   H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 840 KVISSCSTEEFKA----LILEYMPHGSLE---KSLYSSNYILDIFQRLNIMVDVATTLEY 892
           ++++ C  E        L+L +   G+L    + L      L   Q L +++ +   LE 
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-------T 945
           +H   +    H DLKP+N+LL D     L D G         +   Q  TL        T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 946 IGYMAPGLFHVK 957
           I Y AP LF V+
Sbjct: 207 ISYRAPELFSVQ 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (294), Expect = 6e-28
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 14/178 (7%)

Query: 781 RFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMK-SIRHRNLI 839
            F   +++G G  G++    + +  +VAVK    +C   F   D E ++++ S  H N+I
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           +   +    +F+ + +E     +L++ +   ++     + + ++    + L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137

Query: 900 PVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
            ++H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G++AP
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  117 bits (294), Expect = 8e-28
 Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 14/257 (5%)

Query: 131 LKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMF 190
              V      LS   P  I   S+ ++L+   N +   I A+   +L  LE + L +N  
Sbjct: 56  FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI 111

Query: 191 HGRIPSALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPRE-FGN 248
                 A +    L  L L  +N L  IP      L+KL+EL+L  + ++  IP   F  
Sbjct: 112 RQIEVGAFNGLASLNTLELF-DNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169

Query: 249 LAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
           +  L  + L        I +     L  L+ L LG   +     P +  L  L+ L++S 
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSG 227

Query: 308 NKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFI 367
           N      P +   +S+L  L + ++ +S  +   A   L +L EL L  NN S ++P  +
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDL 285

Query: 368 FNA-SKLSVLELGRNSF 383
           F     L  L L  N +
Sbjct: 286 FTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  113 bits (285), Expect = 1e-26
 Identities = 63/289 (21%), Positives = 101/289 (34%), Gaps = 43/289 (14%)

Query: 153 SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSIN 212
           +    +  +   LS E+P  I         ++L +N           +  +LE+L L   
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGI---PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG-R 108

Query: 213 NLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELA 271
           N +  I       L  L  L L  + L   IP                            
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLT-VIP-----------------------SGAFE 144

Query: 272 NLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGL 329
            L+ L  L L  N +   IP    + + +L  LDL   K +  +    F  +  L  L L
Sbjct: 145 YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203

Query: 330 QSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIP 388
              ++   + ++    L  LEEL +  N+F   I    F   S L  L +  +  S    
Sbjct: 204 GMCNIK-DMPNLTP--LVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIER 259

Query: 389 NTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           N F  L +L  + L +N L+S    L     F+  + L  + L +NP +
Sbjct: 260 NAFDGLASLVELNLAHNNLSS----LPH-DLFTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (279), Expect = 6e-26
 Identities = 68/332 (20%), Positives = 110/332 (33%), Gaps = 88/332 (26%)

Query: 347 PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNY 406
               ++       S  +P+ I   S    L L  N+      +TF +L +L ++ L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGF 466
           +    +E+    +F+   SL  + L +N L  I               F+          
Sbjct: 111 IRQ--IEVG---AFNGLASLNTLELFDNWLTVIPSGA-----------FE---------- 144

Query: 467 PKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLED-NKLEGPIPDDI-CRLTK 523
                 L+ L  ++L  N +  SIP     ++  L  L L +  KLE  I +     L  
Sbjct: 145 -----YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEY-ISEGAFEGLFN 197

Query: 524 LYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTG 583
           L  L L    +   +P   + L  L  L +  N    I                      
Sbjct: 198 LKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIR--------------------- 234

Query: 584 PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISL 643
                                     P    GL++L+ L++  +++      +F  L SL
Sbjct: 235 --------------------------PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 644 KSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
             LNL++NNLS         L YL +L L  N
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (279), Expect = 7e-26
 Identities = 67/283 (23%), Positives = 97/283 (34%), Gaps = 57/283 (20%)

Query: 80  SHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGN 139
               + LN+   N+         +L  L+ L LG N +   I    F             
Sbjct: 74  PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFN------------ 120

Query: 140 QLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS-AL 198
                        +SL  L+   N L+  IP+     L  L  + L  N     IPS A 
Sbjct: 121 -----------GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 199 SNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMAL 257
           +    L  L L     L  I +     L  LK L LG   ++ ++P              
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-------------- 212

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-IHNLHNLKLLDLSHNKLVGAVPA 316
                       L  L GLE L++  N    EI P   H L +LK L + ++++      
Sbjct: 213 -----------NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERN 260

Query: 317 TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNF 359
               +++L  L L  N+LS SL       L  L EL L  N +
Sbjct: 261 AFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (270), Expect = 9e-25
 Identities = 54/234 (23%), Positives = 86/234 (36%), Gaps = 9/234 (3%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNK 533
           +N   + L  N +      T   L  L+ L L  N +          L  L  L L  N 
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134

Query: 534 LSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFFTGPLPLDI-G 590
           L+  IP+  F  L+ L  L L +N + SIP   +  +  ++ L+         +      
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFE 193

Query: 591 NLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSN 650
            L  L  ++    N  D +P  +  L  L+ L +  N        SF  L SLK L + N
Sbjct: 194 GLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251

Query: 651 NNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG--GSFGNFSAKSFEGNELLC 702
           + +S     + + L+ L +L+L+ N L   +P                 N   C
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 7/110 (6%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLS 142
           K LN+   N+   +P+ L  L  L+ L +  N     I    F  L +LK +    +Q+S
Sbjct: 199 KYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS 255

Query: 143 GAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
                  F+  +SL  L+ ++N LS  +P ++ + L +L  + L  N ++
Sbjct: 256 -LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  112 bits (282), Expect = 2e-27
 Identities = 56/229 (24%), Positives = 87/229 (37%), Gaps = 13/229 (5%)

Query: 212 NNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELA 271
              L A+P  I      + ++L  + +       F     L ++ L  + L         
Sbjct: 20  QQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 272 NLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGL 329
            L  LE L L  N     + P   H L  L  L L    L   +   +F  ++ L  L L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 330 QSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIP 388
           Q N+L  +L       L NL  L L  N  S ++P   F     L  L L +N  +   P
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 389 NTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           + F +L  L  + L  N L++   E       +  ++L Y+ L++NP  
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEA-----LAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  108 bits (271), Expect = 5e-26
 Identities = 57/231 (24%), Positives = 81/231 (35%), Gaps = 26/231 (11%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
            +  + +   +    +S           NL  ++L  N L          L  L+ L L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 507 DNKLEGPIPDDI-CRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIPLT 564
           DN     +       L +L+ L L    L   +    F  LA+L  L L  N L ++P  
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 565 IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFL 624
            +                     D+GNL  L       N  S V      GL +L  L L
Sbjct: 148 TFR--------------------DLGNLTHL---FLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 625 GYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
             NR+      +F DL  L +L L  NNLS     +L  L  L+ L L+ N
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  102 bits (256), Expect = 5e-24
 Identities = 52/212 (24%), Positives = 70/212 (33%), Gaps = 25/212 (11%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNK 533
                I+L GN+++     +    + L  L L  N L          L  L +L LS N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 534 LSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNL 592
              S+    F  L  L TL L    L  +                   F G L      L
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELG---------------PGLFRG-LA----AL 131

Query: 593 KVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNN 652
           + L       N    +       L NL +LFL  NR+      +F  L SL  L L  N 
Sbjct: 132 QYL---YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188

Query: 653 LSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG 684
           ++   P +   L  L  L L  N L   +P  
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 54/242 (22%), Positives = 92/242 (38%), Gaps = 21/242 (8%)

Query: 76  CDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYT-LKYV 134
           C  ++      +     L   +P  +   ++ Q + L  NR+S  +P+A F     L  +
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTIL 61

Query: 135 NFRGNQLS----GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMF 190
               N L+     AF       + L+ LD S NA    +       L  L ++ L +   
Sbjct: 62  WLHSNVLARIDAAAF----TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117

Query: 191 HGRIPS-ALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGN 248
              +          L+ L L  +N L A+P +   +L  L  L+L  + +     R F  
Sbjct: 118 Q-ELGPGLFRGLAALQYLYLQ-DNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175

Query: 249 LAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLS 306
           L  L+ + L  + +   +      +L  L  L L  N L+  +P E    L  L+ L L+
Sbjct: 176 LHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLN 233

Query: 307 HN 308
            N
Sbjct: 234 DN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 57/248 (22%), Positives = 91/248 (36%), Gaps = 41/248 (16%)

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMS 322
            +P  +      + + L  N ++  +P        NL +L L  N L   + A  F  ++
Sbjct: 25  AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLA 80

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRN 381
            L  L L  N+   S+       L  L  L L        +   +F   + L  L L  N
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139

Query: 382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
           +      +TF +L NL  + LH N ++S  +      +F    SL  + L  N +  + P
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISS--VP---ERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKL 500
                        F                +L  L+ +YL  N L+ ++P   L  L+ L
Sbjct: 195 HA-----------FR---------------DLGRLMTLYLFANNLS-ALPTEALAPLRAL 227

Query: 501 QGLHLEDN 508
           Q L L DN
Sbjct: 228 QYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 28/137 (20%), Positives = 48/137 (35%), Gaps = 6/137 (4%)

Query: 550 TLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVI 609
           T S     L ++P+ I        +    N  +          + L  +   +N  + + 
Sbjct: 15  TTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 610 PTVIGGLTNLQYLFLGYNRLQGSIS-ESFGDLISLKSLNLSNNNLSRSIPI-SLEKLSYL 667
                GL  L+ L L  N    S+   +F  L  L +L+L    L   +       L+ L
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL 131

Query: 668 EDLDLSFNKLKGEIPKG 684
           + L L  N L+  +P  
Sbjct: 132 QYLYLQDNALQ-ALPDD 147

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  117 bits (294), Expect = 2e-27
 Identities = 48/274 (17%), Positives = 96/274 (35%), Gaps = 24/274 (8%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL 141
           +  +   +       +   L  ++    L L    LS S+P  +     +  +    N L
Sbjct: 38  KQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNAL 92

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNC 201
             + P      +SL++LD   N LS  +P    S    L+ + +  N     +P   +  
Sbjct: 93  I-SLPELP---ASLEYLDACDNRLS-TLPELPAS----LKHLDVDNNQLT-MLPELPAL- 141

Query: 202 KYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN 261
             LE ++   NN L  +P+   +L   + L +  + L   +P    +L  L++    + +
Sbjct: 142 --LEYINAD-NNQLTMLPELPTSL---EVLSVRNNQLT-FLPELPESLEALDVSTNLLES 194

Query: 262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM 321
           L     +   +       +  +N +T  IP  I +L     + L  N L   +  ++   
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253

Query: 322 STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLW 355
           +            S S      +  P  + +  W
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW 287

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (293), Expect = 3e-27
 Identities = 57/290 (19%), Positives = 107/290 (36%), Gaps = 35/290 (12%)

Query: 392 GNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHS 451
            N  +L   +  YN ++ +  +      FS         L     +  +  +    ++  
Sbjct: 8   NNNFSLSQNSF-YNTISGTYADY-----FSAWDKWEKQALPGENRNEAVSLLKECLINQ- 60

Query: 452 LEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLE 511
                ++  N+S   P  +     +  + +  N L  S+P     L+ L      DN+L 
Sbjct: 61  FSELQLNRLNLSS-LPDNLP--PQITVLEITQNAL-ISLPELPASLEYL---DACDNRLS 113

Query: 512 GPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGM 571
             +P+    L  L    +  N+L+  +P   + L     ++  +N+LT +P    +L+  
Sbjct: 114 T-LPELPASLKHLD---VDNNQLT-MLPELPALLE---YINADNNQLTMLPELPTSLE-- 163

Query: 572 LYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQ----YLFLGYN 627
             L+  +N  T  LP    +L+ L   D STN     +P V     + +    +     N
Sbjct: 164 -VLSVRNNQLTF-LPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCREN 217

Query: 628 RLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKL 677
           R+   I E+   L    ++ L +N LS  I  SL + +   D        
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  113 bits (283), Expect = 5e-26
 Identities = 54/287 (18%), Positives = 102/287 (35%), Gaps = 41/287 (14%)

Query: 177 LPFLESISLSQNMFHGRIP-------SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLK 229
           LP   + SLSQN F+  I        SA    +   +   + N  +  + +    + +  
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFS 62

Query: 230 ELYLGYSGLQGEIPREFG-NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTG 288
           EL L    L   +P      +  LE+      N    +P+  A+L     L    N L+ 
Sbjct: 63  ELQLNRLNLS-SLPDNLPPQITVLEIT----QNALISLPELPASLE---YLDACDNRLS- 113

Query: 289 EIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPN 348
            +P    +L +   LD+ +N+L   +P      + L  +   +N L+  L         +
Sbjct: 114 TLPELPASLKH---LDVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPE----LPTS 161

Query: 349 LEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLT 408
           LE L + +N  +  +P    +   L  L++  N     +P       +     +      
Sbjct: 162 LEVLSVRNNQLT-FLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIF---FR 213

Query: 409 SSNLELSFL-SSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEY 454
                ++ +  +  +      I L +NPL     R S+   +   +Y
Sbjct: 214 CRENRITHIPENILSLDPTCTIILEDNPLSS-RIRESLSQQTAQPDY 259

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  112 bits (281), Expect = 8e-26
 Identities = 55/322 (17%), Positives = 105/322 (32%), Gaps = 62/322 (19%)

Query: 294 IHNLHNLKLLDLSHNKLVGAVPATIFNM-STLTGLGLQSNSLSGSLSSIADVQLPNLEEL 352
           I+N  +L   +  +N +     A  F+         L   + + ++S + +  +    EL
Sbjct: 7   INNNFSLSQ-NSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSEL 64

Query: 353 RLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNL 412
           +L   N S ++P  +    +++VLE+ +N+    +P    +L  L       N L++   
Sbjct: 65  QLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLDA---CDNRLST--- 114

Query: 413 ELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGN 472
                   ++ K L    + NN L  +                           P+    
Sbjct: 115 ---LPELPASLKHLD---VDNNQLTML---------------------------PELPAL 141

Query: 473 LTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGN 532
           L  +       N+L   +P     L+ L    + +N+L   +P+    L  L    +S N
Sbjct: 142 LEYI---NADNNQLT-MLPELPTSLEVL---SVRNNQLTF-LPELPESLEALD---VSTN 190

Query: 533 KLSGSIPACFSNLASLGT----LSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLD 588
            L  S+PA                   N++T IP  I +L     +    N  +  +   
Sbjct: 191 LLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRES 249

Query: 589 IGNLKVLIGIDFSTNNFSDVIP 610
           +               FS    
Sbjct: 250 LSQQTAQPDYHGPRIYFSMSDG 271

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  111 bits (279), Expect = 1e-25
 Identities = 52/276 (18%), Positives = 97/276 (35%), Gaps = 37/276 (13%)

Query: 387 IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMG 446
             + +       L   + N   S  L+   +         + + L+   L   LP     
Sbjct: 29  YFSAWDKWEKQALPGENRNEAVSL-LKECLI------NQFSELQLNRLNLS-SLPD---- 76

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE 506
           NL   +   +++   +    P+   +L  L       N+L+ ++P     L+ L    ++
Sbjct: 77  NLPPQITVLEITQNALIS-LPELPASLEYL---DACDNRLS-TLPELPASLKHL---DVD 128

Query: 507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW 566
           +N+L   +P+    L  +       N+L+  +P   ++L  L   S+ +N+LT +P    
Sbjct: 129 NNQLTM-LPELPALLEYIN---ADNNQLT-MLPELPTSLEVL---SVRNNQLTFLPELPE 180

Query: 567 NLKGMLYLNFSSNFFTGPLPLDIGNL----KVLIGIDFSTNNFSDVIPTVIGGLTNLQYL 622
           +L+    L+ S+N     LP          +  I      N  +  IP  I  L     +
Sbjct: 181 SLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTI 235

Query: 623 FLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP 658
            L  N L   I ES     +    +      S S  
Sbjct: 236 ILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 98.5 bits (245), Expect = 2e-21
 Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 27/217 (12%)

Query: 470 IGNLTNLIG--IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYEL 527
           I N  +L     Y   +           K +K        N+    + +  C + +  EL
Sbjct: 7   INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSEL 64

Query: 528 GLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPL 587
            L+   LS S+P        +  L +  N L S+P    +L+   YL+   N  +  LP 
Sbjct: 65  QLNRLNLS-SLPDNL--PPQITVLEITQNALISLPELPASLE---YLDACDNRLST-LPE 117

Query: 588 DIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLN 647
              +LK L   D   N  + ++P +      L+Y+    N+L   + E      SL+ L+
Sbjct: 118 LPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPT---SLEVLS 166

Query: 648 LSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG 684
           + NN L   +P   E    LE LD+S N L+  +P  
Sbjct: 167 VRNNQL-TFLP---ELPESLEALDVSTNLLE-SLPAV 198

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 85.0 bits (210), Expect = 3e-17
 Identities = 42/194 (21%), Positives = 71/194 (36%), Gaps = 26/194 (13%)

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICR----LTKLYELGLSGNKLSGSIPACFSN 544
           SI + +     L       N + G    D         K    G + N+    +  C   
Sbjct: 2   SIMLPINNNFSLSQN-SFYNTISG-TYADYFSAWDKWEKQALPGENRNEAVSLLKECL-- 57

Query: 545 LASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN 604
           +     L L    L+S+P  +     +  L  + N     LP    +L+ L   D   N 
Sbjct: 58  INQFSELQLNRLNLSSLPDNL--PPQITVLEITQNALI-SLPELPASLEYL---DACDNR 111

Query: 605 FSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKL 664
            S  +P +     +L++L +  N+L   + E       L+ +N  NN L+  +P   E  
Sbjct: 112 LST-LPELPA---SLKHLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLP---ELP 159

Query: 665 SYLEDLDLSFNKLK 678
           + LE L +  N+L 
Sbjct: 160 TSLEVLSVRNNQLT 173

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  115 bits (289), Expect = 3e-27
 Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 18/268 (6%)

Query: 174 CSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYL 233
           CS       +   +      +P  +S      +L+L  N +         +L  L+ L L
Sbjct: 39  CSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95

Query: 234 GYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPP 292
             + ++      F  LA L  + L  + L   IP      L+ L+ L L  N +   IP 
Sbjct: 96  SRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153

Query: 293 EI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLE 350
              + + +L+ LDL   K +  +    F  +S L  L L   +L   + ++    L  L+
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP--LIKLD 210

Query: 351 ELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS 409
           EL L  N+ S  I    F     L  L + ++       N F NL++L  + L +N LT 
Sbjct: 211 ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269

Query: 410 SNLELSFLSSFSNCKSLTYIGLSNNPLD 437
               L     F+    L  I L +NP +
Sbjct: 270 ----LPH-DLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (275), Expect = 2e-25
 Identities = 63/271 (23%), Positives = 99/271 (36%), Gaps = 41/271 (15%)

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMST 323
           E+P  +   T   +L L +N +   I      +L +L++L LS N +          ++ 
Sbjct: 57  EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSVLELGR-N 381
           L  L L  N L+ ++ + A V L  L+EL L +N    +IP + FN    L  L+LG   
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171

Query: 382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
             S      F  L NLR + L    L         + + +    L  + LS N L  I  
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLRE-------IPNLTPLIKLDELDLSGNHLSAI-- 222

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ 501
                                 G F      L +L  +++  +++          LQ L 
Sbjct: 223 --------------------RPGSFQ----GLMHLQKLWMIQSQIQVIERNAFDNLQSLV 258

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGN 532
            ++L  N L     D    L  L  + L  N
Sbjct: 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  108 bits (272), Expect = 4e-25
 Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 9/234 (3%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNK 533
           TN   + L  N++      +   L+ L+ L L  N +          L  L  L L  N+
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

Query: 534 LSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFFTGPLPLDI-G 590
           L+ +IP   F  L+ L  L L +N + SIP   +  +  +  L+         +      
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 591 NLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSN 650
            L  L  ++ +  N  + IP  +  L  L  L L  N L      SF  L+ L+ L +  
Sbjct: 183 GLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 651 NNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG--GSFGNFSAKSFEGNELLC 702
           + +      + + L  L +++L+ N L   +P        +        N   C
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  108 bits (271), Expect = 5e-25
 Identities = 68/332 (20%), Positives = 117/332 (35%), Gaps = 88/332 (26%)

Query: 347 PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNY 406
               ++     N    +P  I   +   +L L  N       N+F +LR+L ++ L  N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGF 466
           + +  +E+    +F+   +L  + L +N L  I               F           
Sbjct: 100 IRT--IEIG---AFNGLANLNTLELFDNRLTTIPNGA-----------FV---------- 133

Query: 467 PKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLED-NKLEGPIPDDI-CRLTK 523
                 L+ L  ++L  N +  SIP     ++  L+ L L +  +L   I +     L+ 
Sbjct: 134 -----YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSY-ISEGAFEGLSN 186

Query: 524 LYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTG 583
           L  L L+   L   IP   + L  L  L L  N L++I                      
Sbjct: 187 LRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIR--------------------- 223

Query: 584 PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISL 643
                                     P    GL +LQ L++  +++Q     +F +L SL
Sbjct: 224 --------------------------PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257

Query: 644 KSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
             +NL++NNL+         L +LE + L  N
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (269), Expect = 1e-24
 Identities = 59/283 (20%), Positives = 94/283 (33%), Gaps = 57/283 (20%)

Query: 80  SHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGN 139
           S   ++LN+    +     +   +L  L+ L L  N +  +I    F             
Sbjct: 63  STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFN------------ 109

Query: 140 QLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS-AL 198
                        ++L  L+   N L+  IP      L  L+ + L  N     IPS A 
Sbjct: 110 -----------GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156

Query: 199 SNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMAL 257
           +    L  L L     L  I +     L+ L+ L L                        
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM---------------------- 194

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPA 316
                  EIP  L  L  L+ L L  N L+  I P     L +L+ L +  +++      
Sbjct: 195 ---CNLREIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERN 249

Query: 317 TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNF 359
              N+ +L  + L  N+L+  L       L +LE + L  N +
Sbjct: 250 AFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 73.6 bits (181), Expect = 1e-13
 Identities = 36/147 (24%), Positives = 52/147 (35%), Gaps = 4/147 (2%)

Query: 539 PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGI 598
           P+  S       +      L  +P  I        LN   N           +L+ L  +
Sbjct: 36  PSVCSCSNQFSKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEIL 93

Query: 599 DFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP 658
             S N+   +      GL NL  L L  NRL    + +F  L  LK L L NN +     
Sbjct: 94  QLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPS 153

Query: 659 ISLEKLSYLEDLDLS-FNKLKGEIPKG 684
            +  ++  L  LDL    +L   I +G
Sbjct: 154 YAFNRIPSLRRLDLGELKRLS-YISEG 179

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 22/110 (20%), Positives = 43/110 (39%), Gaps = 25/110 (22%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL 141
           ++  L++S  +L+   P     L  LQ L +  +++   I    F               
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD-------------- 252

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
                    N  SL  ++ ++N L+  +P ++ + L  LE I L  N ++
Sbjct: 253 ---------NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  112 bits (282), Expect = 4e-27
 Identities = 46/207 (22%), Positives = 77/207 (37%), Gaps = 14/207 (6%)

Query: 750 KRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVA 808
           +R+     D     +    +    E     +  +    +GRG FG V++ +    G + A
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87

Query: 809 VKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLY 868
           VK   L+  R       E      +    ++ +  +     +  + +E +  GSL   L 
Sbjct: 88  VKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLI 141

Query: 869 SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIA 927
                L   + L  +      LEYLH   +  ++H D+K  NVLL  +   A L DFG A
Sbjct: 142 KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198

Query: 928 KLLIGEDQSITQTQTLATIG---YMAP 951
             L  +    +        G   +MAP
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAP 225

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  112 bits (281), Expect = 4e-27
 Identities = 39/176 (22%), Positives = 80/176 (45%), Gaps = 10/176 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRN 837
             +S    IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 838 L--IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              I++     T+++  +++E   +  L   L      +D ++R +   ++   +  +H 
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH- 144

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                ++H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 145 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (278), Expect = 6e-27
 Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 11/178 (6%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
            +   +  ++G+G +G VY  R +   + +A+K    +  R  +    E  + K ++H+N
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL--NIMVDVATTLEYLHF 895
           +++ + S S   F  + +E +P GSL   L S    L   ++        +   L+YLH 
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH- 139

Query: 896 GYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
                ++H D+K  NVL++  + V  +SDFG +K L G +     T+T   T+ YMAP
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAP 192

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  110 bits (278), Expect = 1e-26
 Identities = 43/173 (24%), Positives = 80/173 (46%), Gaps = 16/173 (9%)

Query: 788 IGRGGFGSVYKAR-----IGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG+V+K           + V +KV + + G ++F++       + S+ H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYS 898
           +  C     + L+ +Y+P GSL   +      L     LN  V +A  + YL        
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +H +L   NVLL       ++DFG+A LL  +D+ +  ++    I +MA 
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  110 bits (278), Expect = 1e-26
 Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 20/175 (11%)

Query: 788 IGRGGFGSVYKAR-----IGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLI 839
           +G G FG+VYK           + VA+K   L+     +A K    E  +M S+ + ++ 
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKE--LREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFG 896
           +++  C T   + LI + MP G L   +      +     LN  V +A  + YL      
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL- 138

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                +H DL   NVL+       ++DFG+AKLL  E++          I +MA 
Sbjct: 139 -----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (278), Expect = 2e-26
 Identities = 39/176 (22%), Positives = 80/176 (45%), Gaps = 10/176 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRN 837
             +S    IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 838 L--IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              I++     T+++  +++E   +  L   L      +D ++R +   ++   +  +H 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH- 125

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                ++H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   + T+ YM P
Sbjct: 126 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  111 bits (279), Expect = 2e-26
 Identities = 38/176 (21%), Positives = 79/176 (44%), Gaps = 10/176 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRN 837
             +S    IG GG   V++    +    A+K  +L+    +   S+  E   +  ++  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 838 L--IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              I++     T+++  +++E   +  L   L      +D ++R +   ++   +  +H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH- 172

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                ++H DLKP+N L+ D M+  L DFGIA  +  +  S+ +   +  + YM P
Sbjct: 173 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (273), Expect = 4e-26
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 14/181 (7%)

Query: 788 IGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
           +G+G FGSV   R        G  VAVK          + F+ E E++KS++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 843 SSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
             C +   +   LI+EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMAP-GLFHVK 957
            IH DL   N+L+++     + DFG+ K ++ +D+   + +      I + AP  L   K
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 958 Y 958
           +
Sbjct: 194 F 194

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  108 bits (273), Expect = 4e-26
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 15/182 (8%)

Query: 788 IGRGGFGSVYKAR-----IGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V   R        G +VAVK    + G         E E+++++ H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C+ +      LI+E++P GSL++ L  +   +++ Q+L   V +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMAP-GLFHV 956
             +H DL   NVL++      + DFG+ K  I  D+     +      + + AP  L   
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPECLMQS 204

Query: 957 KY 958
           K+
Sbjct: 205 KF 206

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 4e-26
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 14/181 (7%)

Query: 788 IGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
           +G+G FGSV   R        G  VAVK          + F+ E E++KS++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 843 SSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
             C +   +   LI+EY+P+GSL   L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMAP-GLFHVK 957
            IH DL   N+L+++     + DFG+ K ++ +D+   + +      I + AP  L   K
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 958 Y 958
           +
Sbjct: 225 F 225

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  107 bits (270), Expect = 8e-26
 Identities = 45/177 (25%), Positives = 77/177 (43%), Gaps = 17/177 (9%)

Query: 786 NLIGRGGFGSVYKARI----GEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
            +IGRG FG VY   +    G+ +  AVK    +        F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 841 VISSCSTEEFKAL-ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFG 896
           ++  C   E   L +L YM HG L   + +  +   +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED--QSITQTQTLATIGYMAP 951
                +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA 
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  107 bits (269), Expect = 9e-26
 Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 20/185 (10%)

Query: 785 NNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL--QCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +  IGRG F +VYK       +EVA              + F  E EM+K ++H N+++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 842 ISSCSTEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
             S  +         L+ E M  G+L K+      ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTL-KTYLKRFKVMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 898 SAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAPGL 953
           + P+IH DLK  N+ +        + D G+A L          +   A IG   +MAP +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-------RASFAKAVIGTPEFMAPEM 201

Query: 954 FHVKY 958
           +  KY
Sbjct: 202 YEEKY 206

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  106 bits (266), Expect = 1e-25
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 13/168 (7%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IG G FG V+        +VA+K   ++ G  + + F  E E+M  + H  L+++   C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYSAPVIH 903
            +    L+ E+M HG L   L +   +      L + +DV   + YL           IH
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IH 127

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DL   N L+ +N V  +SDFG+ +  + +DQ  + T T   + + +P
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASP 174

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  106 bits (268), Expect = 2e-25
 Identities = 47/164 (28%), Positives = 64/164 (39%), Gaps = 17/164 (10%)

Query: 788 IGRGGFGSVYKAR----IGEGMEVAVKVF---DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V +       G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGY 897
           +     T   K ++ E  P GSL   L        +       V VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
               IH DL   N+LL    +  + DFG+ + L   D      +
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  108 bits (273), Expect = 2e-25
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 9/168 (5%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIKVIS 843
           IGRG FG V+  R+  +   VAVK    +          F  E  ++K   H N++++I 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS--CRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
            C+ ++   +++E +  G     L +    L +   L ++ D A  +EYL    S   IH
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DL   N L+ +  V  +SDFG+++       + +       + + AP
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  106 bits (267), Expect = 2e-25
 Identities = 47/193 (24%), Positives = 81/193 (41%), Gaps = 28/193 (14%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
           R    F E  LIG GGFG V+KA+   +G    +K       +A +    E + +  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 836 RNLIKVISSCSTEEFKA----------------LILEYMPHGSLEKSL-YSSNYILDIFQ 878
            N++         ++                  + +E+   G+LE+ +       LD   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 879 RLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
            L +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L        
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGK 177

Query: 939 QTQTLATIGYMAP 951
           +T++  T+ YM+P
Sbjct: 178 RTRSKGTLRYMSP 190

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (267), Expect = 2e-25
 Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 17/189 (8%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVF-DLQCGRAFKSFDVECE 828
            +         + +IG+G FG VY           ++ A+K    +   +  ++F  E  
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74

Query: 829 MMKSIRHRNLIKVISSCSTEE-FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVA 887
           +M+ + H N++ +I      E    ++L YM HG L + + S      +   ++  + VA
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134

Query: 888 TTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
             +EYL    F      +H DL   N +LD++    ++DFG+A+ ++  +    Q    A
Sbjct: 135 RGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 945 T--IGYMAP 951
              + + A 
Sbjct: 189 RLPVKWTAL 197

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (270), Expect = 3e-25
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 17/177 (9%)

Query: 786 NLIGRGGFGSVYKARI----GEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
            +IGRG FG VY   +    G+ +  AVK    +        F  E  +MK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 841 VISSCSTEEFKAL-ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFG 896
           ++  C   E   L +L YM HG L   + +  +   +   +   + VA  +++L    F 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMAP 951
                +H DL   N +LD+     ++DFG+A+ +  ++      +T A   + +MA 
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  106 bits (267), Expect = 4e-25
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 16/173 (9%)

Query: 788 IGRGGFGSVYKAR-IGEG----MEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG+VYK   I EG    + VA+K   +    +A K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYS 898
           +  C T   + LI + MP G L   +      +     LN  V +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +H DL   NVL+       ++DFG+AKLL  E++          I +MA 
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  105 bits (263), Expect = 4e-25
 Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 12/175 (6%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVIS 843
            IG G +G   K R   +G  +  K  D         +    E  +++ ++H N+++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 844 SCSTEEFKAL--ILEYMPHGSLE---KSLYSSNYILDIFQRLNIMVDVATTLEYLH--FG 896
                    L  ++EY   G L             LD    L +M  +   L+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               V+H DLKP+NV LD      L DFG+A++L   D S  +T  + T  YM+P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTF-VGTPYYMSP 185

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (264), Expect = 4e-25
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 18/163 (11%)

Query: 788 IGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKS---FDVECEMMKSIRHRNLIKV 841
           +G G FGSV +       + ++VA+KV  L+ G           E ++M  + +  ++++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYS 898
           I  C  E    L++E    G L K L      + +     ++  V+  ++YL   +F   
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
              +H DL   NVLL +   A +SDFG++K L  +D   T   
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  105 bits (265), Expect = 5e-25
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 25/183 (13%)

Query: 788 IGRGGFGSVYKARI----GEGMEVAVKV--FDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FGSV +  +    G  ++VAVK    D    R  + F  E   MK   H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 842 ISSCSTEEFKA-----LILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLE 891
           +  C     +      +IL +M +G L        L +    + +   L  MVD+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 892 YL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
           YL   +F      +H DL   N +L D+M   ++DFG++K +   D           + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 949 MAP 951
           +A 
Sbjct: 216 IAI 218

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  110 bits (276), Expect = 6e-25
 Identities = 36/174 (20%), Positives = 71/174 (40%), Gaps = 23/174 (13%)

Query: 787 LIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIRHRNLIKVIS 843
            I  GG G +Y A      G  V +K          ++    E + +  + H +++++ +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 844 SCSTEEFKA-----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
                +        +++EY+   SL++S       L + + +  ++++   L YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---S 200

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
             +++ DLKP N++L +  +  L D G           I        T G+ AP
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAP 246

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  108 bits (272), Expect = 6e-25
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 19/219 (8%)

Query: 744 LIVRYRK-------RVKQP-PNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGS 795
           L+  +          +  P P             +   E+ R     +  + +G G +G 
Sbjct: 178 LVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGE 235

Query: 796 VYKARI-GEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL 853
           VY+       + VAVK   L+      + F  E  +MK I+H NL++++  C+ E    +
Sbjct: 236 VYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293

Query: 854 ILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL 912
           I E+M +G+L   L   N   +     L +   +++ +EYL        IH +L   N L
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCL 350

Query: 913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           + +N +  ++DFG+++ L+  D           I + AP
Sbjct: 351 VGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  105 bits (263), Expect = 6e-25
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 12/176 (6%)

Query: 788 IGRGGFGSVYKARI-GEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G G +G VY+       + VAVK    D      F     E  +MK I+H NL++++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
           C+ E    +I E+M +G+L   L   N   +     L +   +++ +EYL        IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-GLFHVKY 958
            DL   N L+ +N +  ++DFG+++ L+  D           I + AP  L + K+
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  105 bits (265), Expect = 7e-25
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 10/154 (6%)

Query: 788 IGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
           +G+G FGSV   R        G  VAVK          + F  E +++K++    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 843 SSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
                   ++  L++EY+P G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
            +H DL   N+L++      ++DFG+AKLL  + 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (262), Expect = 7e-25
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V   +     +VA+K+  ++ G  +   F  E ++M ++ H  L+++   C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYSAPVIH 903
            +    +I EYM +G L   L    +     Q L +  DV   +EYL    F      +H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LH 143

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  P
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPP 190

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  105 bits (263), Expect = 9e-25
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 18/208 (8%)

Query: 752 VKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK 810
           ++ PP     P  A      Y  L      F     IGRG F  VY+A  + +G+ VA+K
Sbjct: 8   MQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALK 63

Query: 811 ---VFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLE--- 864
              +FDL   +A      E +++K + H N+IK  +S   +    ++LE    G L    
Sbjct: 64  KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI 123

Query: 865 KSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 924
           K       ++         V + + LE++H   S  V+H D+KP+NV +    V  L D 
Sbjct: 124 KHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 180

Query: 925 GIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           G+ +         T   +L  T  YM+P
Sbjct: 181 GLGRFF---SSKTTAAHSLVGTPYYMSP 205

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  107 bits (270), Expect = 1e-24
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 16/211 (7%)

Query: 751 RVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVK 810
           R+ +P               S   L            IG+G FG V       G +VAVK
Sbjct: 166 RLIKPKVMEGTVAAQDEFYRSGWALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVK 222

Query: 811 VFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA-LILEYMPHGSLEKSLYS 869
              ++     ++F  E  +M  +RH NL++++     E+    ++ EYM  GSL   L S
Sbjct: 223 C--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

Query: 870 SN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
               +L     L   +DV   +EYL        +H DL   NVL+ ++ VA +SDFG+ K
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337

Query: 929 LLIGEDQSITQTQTLATIGYMAP-GLFHVKY 958
                + S TQ      + + AP  L   K+
Sbjct: 338 -----EASSTQDTGKLPVKWTAPEALREKKF 363

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  103 bits (260), Expect = 1e-24
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 15/169 (8%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           +G G FG V   +     +VAVK+          F     E + M  + H  L+K    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYSAPVI 902
           S E    ++ EY+ +G L   L S    L+  Q L +  DV   + +L    F      I
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           H DL   N L+D ++   +SDFG+ +  + +DQ ++   T   + + AP
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAP 174

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  104 bits (261), Expect = 1e-24
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 23/176 (13%)

Query: 788 IGRGGFGSVYKARI---GEGMEVAVKVFDLQCG----RAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG+V K           VAVK+  L+              E  +M+ + +  +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGY 897
           +I  C  E +  L++E    G L K L  + + +     + ++  V+  ++YL   +F  
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMAP 951
               +H DL   NVLL     A +SDFG++K  +  D++  + QT     + + AP
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAP 189

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  104 bits (262), Expect = 1e-24
 Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 11/170 (6%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKV--FDLQCGRAFKS-FDVECEMMKSIRHRNLIKVI 842
           L+GRGG G VY+A        VA+K+    L     F++    E      ++  +++ + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
                +    + +  +    L  ++      L   + + I+  + + L+  H   +A   
Sbjct: 101 DFGEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
           H D+KP N+L+  +  A+L DFGIA      D+ +TQ    + T+ YMAP
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP 204

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  105 bits (263), Expect = 2e-24
 Identities = 37/183 (20%), Positives = 78/183 (42%), Gaps = 23/183 (12%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHR 836
            ++     IG G FG     +   +G +  +K  ++     +  +    E  ++ +++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLE-------KSLYSSNYILDIFQRLNIMVDVATT 889
           N+++   S        ++++Y   G L          L+  + ILD F      V +   
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF------VQICLA 137

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGY 948
           L+++H      ++H D+K  N+ L  +    L DFGIA++L   + ++   +    T  Y
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYY 191

Query: 949 MAP 951
           ++P
Sbjct: 192 LSP 194

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  103 bits (260), Expect = 3e-24
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 26/184 (14%)

Query: 788 IGRGGFGSVYKARI----GEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G+G FGSV +A++    G  ++VAVK+   D+      + F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 842 ISSCSTEEFKA------LILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTL 890
           +        K       +IL +M HG L        +  + + L +   +  MVD+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 891 EYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
           EYL   +F      IH DL   N +L ++M   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 948 YMAP 951
           ++A 
Sbjct: 205 WLAL 208

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (258), Expect = 3e-24
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 11/177 (6%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKV--FDLQCGRAFKS-FDVECEMMKSIRH 835
            R+   + +G GG  +VY A      ++VA+K      +        F+ E      + H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +N++ +I     ++   L++EY+   +L      S+  L +   +N    +   +++ H 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH- 128

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMAP 951
                ++H D+KP N+L+D N    + DFGIAK L   + S+TQT   L T+ Y +P
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSP 181

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  107 bits (268), Expect = 4e-24
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 18/163 (11%)

Query: 788 IGRGGFGSVYKAR---IGEGMEVAVKVFDLQCGRAFKS---FDVECEMMKSIRHRNLIKV 841
           +G G FGSV +       + ++VA+KV  L+ G           E ++M  + +  ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYS 898
           I  C  E    L++E    G L K L      + +     ++  V+  ++YL   +F   
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 457

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
              +H +L   NVLL +   A +SDFG++K L  +D   T   
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  102 bits (256), Expect = 4e-24
 Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 16/209 (7%)

Query: 472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG 531
            + + + +      L  ++P      +    LHL +N L       +   T+L +L L  
Sbjct: 8   KVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 532 NKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI-- 589
            +L+  +      L  LGTL L  N+L S+PL    L  +  L+ S N  T  LPL    
Sbjct: 65  AELT-KLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPLGALR 121

Query: 590 --GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES-FGDLISLKSL 646
             G L+ L       N    + P ++     L+ L L  N L   +       L +L +L
Sbjct: 122 GLGELQEL---YLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 647 NLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
            L  N+L  +IP        L    L  N
Sbjct: 178 LLQENSL-YTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 52/237 (21%), Positives = 86/237 (36%), Gaps = 43/237 (18%)

Query: 346 LPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYN 405
           + +  E+     N +  +P  +      ++L L  N    F   T      L  + L   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 406 YLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG 465
            LT        L        L  + LS+N L  +                          
Sbjct: 66  ELTK-------LQVDGTLPVLGTLDLSHNQLQSL-------------------------- 92

Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTK 523
            P     L  L  + +  N+L  S+P+  L  L +LQ L+L+ N+L+  +P  +     K
Sbjct: 93  -PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPK 149

Query: 524 LYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSN 579
           L +L L+ N L+  +PA   + L +L TL L  N L +IP   +    + +     N
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 54/216 (25%), Positives = 76/216 (35%), Gaps = 17/216 (7%)

Query: 224 NLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
            +    E+      L   +P +   +   L L    +          L   T L  L L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFS---LATLMPYTRLTQLNLD 63

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIA 342
           +  LT         L  L  LDLSHN+L  ++P     +  LT L +  N L+ SL   A
Sbjct: 64  RAELT--KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA 119

Query: 343 DVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMT 401
              L  L+EL L  N    T+P  +     KL  L L  N+ +         L NL  + 
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 402 LHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           L  N L +          F +   L +  L  NP  
Sbjct: 179 LQENSLYTIPKGF-----FGS-HLLPFAFLHGNPWL 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 53/234 (22%), Positives = 81/234 (34%), Gaps = 34/234 (14%)

Query: 419 SFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG 478
             S   S   +      L  + P     +L        +S   +       +   T L  
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PP----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSI 538
           + L   +L   +    G L  L  L L  N+L+  +P     L  L  L +S N+L+ S+
Sbjct: 60  LNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SL 115

Query: 539 PA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIG 597
           P      L  L  L L  N+L ++P                   T P P     L+ L  
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLP---------------PGLLT-PTP----KLEKL-- 153

Query: 598 IDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
              + NN +++   ++ GL NL  L L  N L  +I + F     L    L  N
Sbjct: 154 -SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 38/233 (16%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
            ++S   +N     L+ ++P  +        ++   N L     + +   + L  L+   
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
             L+ ++  +    LP L ++ LS                         +N L ++P   
Sbjct: 65  AELT-KLQVD--GTLPVLGTLDLS-------------------------HNQLQSLPLLG 96

Query: 223 GNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQEL-ANLTGLEVLK 280
             L  L  L + ++ L   +P      L EL+ + L+ + L+  +P  L      LE L 
Sbjct: 97  QTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLS 154

Query: 281 LGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSN 332
           L  N LT E+P  + + L NL  L L  N L   +P   F    L    L  N
Sbjct: 155 LANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 9/148 (6%)

Query: 539 PAC-FSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIG 597
           P C  S +AS   ++     LT++P  +   K    L+ S N         +     L  
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 598 IDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSI 657
           ++      +  +  V G L  L  L L +N+LQ S+      L +L  L++S N L+ S+
Sbjct: 60  LNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115

Query: 658 PISL-EKLSYLEDLDLSFNKLKGEIPKG 684
           P+     L  L++L L  N+LK  +P G
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPG 142

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 49/203 (24%), Positives = 74/203 (36%), Gaps = 33/203 (16%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
            +L++S   L     + L   + L  LNL    L+  +     TL  L  ++   NQL  
Sbjct: 34  TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ- 90

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
           + P       +L  LD S+N L+                 SL      G     L     
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLT-----------------SLPLGALRG-----LGE--- 125

Query: 204 LEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSN 261
           L+ L L   N L  +P  +     KL++L L  + L  E+P      L  L+ + LQ ++
Sbjct: 126 LQELYLK-GNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENS 183

Query: 262 LQGEIPQELANLTGLEVLKLGKN 284
           L   IP+       L    L  N
Sbjct: 184 LYT-IPKGFFGSHLLPFAFLHGN 205

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  105 bits (263), Expect = 4e-24
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 29/194 (14%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECE-MMKSIRHRNL 838
           N      ++G G  G+V      +G  VAVK   +          +E + + +S  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 839 IKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNY-ILDIFQRLNIMVDVATTLEY 892
           I+   S +T+ F  + LE     +L      K++   N  +   +  ++++  +A+ + +
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 893 LHFGYSAPVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLIGEDQSITQ 939
           LH   S  +IH DLKP N+L+              +N+   +SDFG+ K L     S   
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 940 TQTLA--TIGYMAP 951
                  T G+ AP
Sbjct: 188 NLNNPSGTSGWRAP 201

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  101 bits (254), Expect = 7e-24
 Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 14/176 (7%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
             IG+G FG V       G +VAVK   ++     ++F  E  +M  +RH NL++++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 846 STEEFKALI-LEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIH 903
             E+    I  EYM  GSL   L S    +L     L   +DV   +EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-GLFHVKY 958
            DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP  L   K+
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKF 191

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (256), Expect = 8e-24
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 17/182 (9%)

Query: 788 IGRGGFGSVYKARI-----GEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V          G G  VAVK      G +    +  E ++++++ H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 842 ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              C      +  L++EY+P GSL   L   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT--IGYMAP-GLFHV 956
             IH DL   NVLLD++ +  + DFG+AK  + E     + +      + + AP  L   
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 957 KY 958
           K+
Sbjct: 213 KF 214

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  102 bits (256), Expect = 8e-24
 Identities = 51/286 (17%), Positives = 110/286 (38%), Gaps = 26/286 (9%)

Query: 393 NLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSL 452
            L N   +    + +T          + ++   +T +      +  I     +  L++ L
Sbjct: 17  ALANAIKIAAGKSNVTD-------TVTQADLDGITTLSAFGTGVTTIEG---VQYLNN-L 65

Query: 453 EYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEG 512
              ++    ++      + NLT +  + L GN L  ++   +  LQ ++ L L   ++  
Sbjct: 66  IGLELKDNQITD--LAPLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD 121

Query: 513 PIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGML 572
             P  +  L+ L  L L  N+++ +I    + L +L  LS+G+ +++ +   + NL  + 
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLT-PLANLSKLT 176

Query: 573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS 632
            L    N  +   PL   +L  LI +    N  SDV P  +   +NL  + L    +   
Sbjct: 177 TLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232

Query: 633 ISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK 678
                 +L+      +   + +   P ++         +L++N   
Sbjct: 233 PVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 41/185 (22%), Positives = 75/185 (40%), Gaps = 13/185 (7%)

Query: 494 LGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL 553
              L     +    + +   +      L  +  L   G  ++ +I      L +L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 554 GSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVI 613
             N++T +   + NL  +  L  S N       +    L+ +  +D ++   +DV P  +
Sbjct: 71  KDNQITDLA-PLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTP--L 125

Query: 614 GGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLS 673
            GL+NLQ L+L  N++  +       L +L+ L++ N  +S  +   L  LS L  L   
Sbjct: 126 AGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKAD 181

Query: 674 FNKLK 678
            NK+ 
Sbjct: 182 DNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 24/262 (9%)

Query: 253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG 312
             + +             A+L G+  L      +T  I   +  L+NL  L+L  N++  
Sbjct: 20  NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD 77

Query: 313 AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK 372
             P  + N++ +T L L  N L  ++S+IA   L +++ L L S   +   P  +   S 
Sbjct: 78  LAP--LKNLTKITELELSGNPLK-NVSAIA--GLQSIKTLDLTSTQITDVTP--LAGLSN 130

Query: 373 LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLS 432
           L VL L  N  +   P     L NL+ +++    ++        L+  +N   LT +   
Sbjct: 131 LQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-------LTPLANLSKLTTLKAD 181

Query: 433 NNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI 492
           +N +  I P  S+ N    L    +    +S      + N +NL  + L    +      
Sbjct: 182 DNKISDISPLASLPN----LIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVF 235

Query: 493 TLGKLQKLQGLHLEDNKLEGPI 514
               L     +         P 
Sbjct: 236 YNNNLVVPNVVKGPSGAPIAPA 257

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.4 bits (217), Expect = 8e-19
 Identities = 53/263 (20%), Positives = 109/263 (41%), Gaps = 25/263 (9%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
            L++   +  G + ++ ++  A      +  ++  G  ++      +   ++L  L+   
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLD--GITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
           N ++ ++      NL  +  + LS N    +  SA++  + ++ L L+   +    P  +
Sbjct: 73  NQIT-DLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--L 125

Query: 223 GNLTKLKELYLGYSGLQGEIP-REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKL 281
             L+ L+ LYL  + +    P     NL  L +   QVS+L       LANL+ L  LK 
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-----LANLSKLTTLKA 180

Query: 282 GKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSI 341
             N ++ +I P + +L NL  + L +N++    P  + N S L  + L +     ++++ 
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQ----TITNQ 232

Query: 342 ADVQLPNLEELRLWSNNFSGTIP 364
                 NL    +        I 
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAPIA 255

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 56/257 (21%), Positives = 100/257 (38%), Gaps = 25/257 (9%)

Query: 82  RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL 141
            +  L+     +T TI   +  L++L  L L  N+++    + +  L  +  +   GN L
Sbjct: 42  GITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPL 97

Query: 142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP--SALS 199
                  I    S++ LD +   ++   P    + L  L+ + L  N    +I   S L+
Sbjct: 98  KNVSA--IAGLQSIKTLDLTSTQITDVTP---LAGLSNLQVLYLDLN----QITNISPLA 148

Query: 200 NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG-EIPREFGNLAELELMALQ 258
               L+ LS+    +    P  + NL+KL  L    + +          NL E+ L   Q
Sbjct: 149 GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQ 206

Query: 259 VSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATI 318
           +S++       LAN + L ++ L    +T +     +NL    ++       +   PATI
Sbjct: 207 ISDVSP-----LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATI 259

Query: 319 FNMSTLTGLGLQSNSLS 335
            +  T     L  N  S
Sbjct: 260 SDNGTYASPNLTWNLTS 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  102 bits (255), Expect = 9e-24
 Identities = 39/201 (19%), Positives = 80/201 (39%), Gaps = 29/201 (14%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIR 834
           R    F     +GRGGFG V++A+   +    A+K   L     A +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 835 HRNLIKVISSCSTEEFKA------------LILEYMPHGSLEKSL--YSSNYILDIFQRL 880
           H  +++  ++   +                + ++     +L+  +    +    +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
           +I + +A  +E+LH   S  ++H DLKPSN+    + V  + DFG+   +  +++  T  
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 941 QTLATIG----------YMAP 951
             +              YM+P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSP 199

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  101 bits (255), Expect = 1e-23
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 19/175 (10%)

Query: 788 IGRGGFGSVYKARI----GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIK 840
           IG G  G V   R+       + VA+K   L+ G   R  + F  E  +M    H N+I+
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGY 897
           +    +      ++ EYM +GSL+  L + +    I Q + ++  V   + YL    +  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY-- 172

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG-EDQSITQTQTLATIGYMAP 951
               +H DL   NVL+D N+V  +SDFG++++L    D + T T     I + AP
Sbjct: 173 ----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  104 bits (260), Expect = 2e-23
 Identities = 43/175 (24%), Positives = 86/175 (49%), Gaps = 8/175 (4%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
             +G G FG V+ A   +  +VAVK        + ++F  E  +MK+++H  L+K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            T+E   +I E+M  GSL   L S       + + ++    +A  + ++        IH 
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-GLFHVKY 958
           DL+ +N+L+  ++V  ++DFG+A+ +I +++   +      I + AP  +    +
Sbjct: 309 DLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 362

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  100 bits (251), Expect = 2e-23
 Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 25/166 (15%)

Query: 788 IGRGGFGSVYKAR--------IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           +G+G F  ++K               EV +KV D       +SF     MM  + H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFG 896
                C   +   L+ E++  GSL+  L  +   ++I  +L +   +A  + +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 897 YSAPVIHCDLKPSNVLLD--------DNMVAHLSDFGIAKLLIGED 934
                IH ++   N+LL         +     LSD GI+  ++ +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  100 bits (251), Expect = 2e-23
 Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 20/174 (11%)

Query: 788 IGRGGFGSVYKAR----IGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG VY+       GE + VAVK    +        + F  E  +MK++ H +++K
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKT--CKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGY 897
           +I     E    +I+E  P+G L   L  +   L +   +   + +   + YL   +   
Sbjct: 78  LIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC-- 134

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               +H D+   N+L+       L DFG+++  I ++     + T   I +M+P
Sbjct: 135 ----VHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSP 183

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (250), Expect = 3e-23
 Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 20/174 (11%)

Query: 788 IGRGGFGSVYKAR----IGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIK 840
           IG G FG V++          + VA+K    +        + F  E   M+   H +++K
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGY 897
           +I   +      +I+E    G L   L    Y LD+   +     ++T L YL    F  
Sbjct: 81  LIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF-- 137

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               +H D+   NVL+  N    L DFG+++  + +      ++    I +MAP
Sbjct: 138 ----VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 186

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  100 bits (251), Expect = 3e-23
 Identities = 44/201 (21%), Positives = 82/201 (40%), Gaps = 30/201 (14%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
           R  + F E  ++G+G FG V KAR   +    A+K           +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61

Query: 836 RNLIKVISSCSTEEFKA-------------LILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
           + +++  ++                     + +EY  +G+L   ++S N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--------IGED 934
              +   L Y+H   S  +IH DLKP N+ +D++    + DFG+AK +        +   
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 935 QSITQTQTLAT-IG---YMAP 951
                +  L + IG   Y+A 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVAT 199

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (253), Expect = 3e-23
 Identities = 33/194 (17%), Positives = 65/194 (33%), Gaps = 24/194 (12%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR------IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKS 832
           +     ++L+G G F  VY+A            +  +KV        F       E +K 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSL----EKSLYSSNYILDIFQRLNIMVDVAT 888
                 +K  S+   +    L+ E   +G+L         +   ++     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH-----------LSDFGIAKLLIGEDQSI 937
            +E +H      +IH D+KP N +L +  +             L D G +  +    +  
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 938 TQTQTLATIGYMAP 951
             T    T G+   
Sbjct: 241 IFTAKCETSGFQCV 254

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  102 bits (257), Expect = 3e-23
 Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 7/167 (4%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
             +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 846 STEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            +EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H 
Sbjct: 249 -SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DL+ +N+L+ +N+V  ++DFG+A+ LI +++   +      I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 350

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 11/167 (6%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           +G G FG V+        +VAVK          AF +   E  +MK ++H+ L+++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77

Query: 846 STEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
           + E    +I EYM +GSL   L + +   L I + L++   +A  + ++        IH 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DL+ +N+L+ D +   ++DFG+A+ LI +++   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  100 bits (250), Expect = 5e-23
 Identities = 44/181 (24%), Positives = 86/181 (47%), Gaps = 13/181 (7%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKV--FDLQCGRAFKS-FDVECEMMKSIRH 835
           +R+    ++G GG   V+ AR + +  +VAVKV   DL    +F   F  E +   ++ H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 836 RNLIKVISSCSTEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE 891
             ++ V  +   E        +++EY+   +L + +  +   +   + + ++ D    L 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT-LATIGYMA 950
           + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT   + T  Y++
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 951 P 951
           P
Sbjct: 188 P 188

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  101 bits (253), Expect = 5e-23
 Identities = 43/175 (24%), Positives = 84/175 (48%), Gaps = 19/175 (10%)

Query: 788 IGRGGFGSVYKARI----GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V   R+     + + VA+K   L+ G   +  + F  E  +M    H N+I+
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGY 897
           +    +  +   ++ EYM +GSL+  L   +    + Q + ++  +A+ ++YL    +  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSITQTQTLATIGYMAP 951
               +H DL   N+L++ N+V  +SDFG+ ++L    + + T       I + +P
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  103 bits (257), Expect = 7e-23
 Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 7/167 (4%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
             +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 846 STEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
            +EE   ++ EYM  GSL   L       L + Q +++   +A+ + Y+        +H 
Sbjct: 332 -SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DL+ +N+L+ +N+V  ++DFG+A+ LI +++   +      I + AP
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 99.8 bits (249), Expect = 7e-23
 Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 26/180 (14%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD-LQCGRAFKSFDVECEMMKSIRHRNLIK---V 841
           ++G+G   +V++ R    G   A+KVF+ +   R       E E++K + H+N++K   +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYS--SNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
               +T   K LI+E+ P GSL   L    + Y L   + L ++ DV   + +L      
Sbjct: 76  EEE-TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 900 PVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI----GYMAP 951
            ++H ++KP N++     D   V  L+DFG A+ L          +   ++     Y+ P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-------EDDEQFVSLYGTEEYLHP 184

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 26/177 (14%)

Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKV 841
             +G+G FG+VY AR       +A+KV     L+          E E+   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------IMVDVATTLEYLHF 895
                      LILEY P G++ + L           + +       + ++A  L Y H 
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH- 126

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
             S  VIH D+KP N+LL       ++DFG +           +   L  T+ Y+ P
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPP 176

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 35/188 (18%), Positives = 74/188 (39%), Gaps = 20/188 (10%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G+G FG VY+              VA+K   +    R    F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 841 VISSCSTEEFKALILEYMPHGSL---------EKSLYSSNYILDIFQRLNIMVDVATTLE 891
           ++   S  +   +I+E M  G L           +         + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 952 -GLFHVKY 958
             L    +
Sbjct: 210 ESLKDGVF 217

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 54/214 (25%), Positives = 82/214 (38%), Gaps = 19/214 (8%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGN 532
            +   + L  N L      +     +LQ L L   +++  I D     L+ L  L L+GN
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGN 86

Query: 533 KLSGSIPA-CFSNLASLGTLSLGSNKLTSIP-LTIWNLKGMLYLNFSSNFFTGPLPLD-- 588
            +  S+    FS L+SL  L      L S+    I +LK +  LN + N       L   
Sbjct: 87  PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPEY 144

Query: 589 ---IGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQY----LFLGYNRLQGSISESFGDLI 641
              + NL+ L   D S+N    +  T +  L  +      L L  N +   I       I
Sbjct: 145 FSNLTNLEHL---DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200

Query: 642 SLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
            LK L L  N L        ++L+ L+ + L  N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 61/253 (24%), Positives = 90/253 (35%), Gaps = 48/253 (18%)

Query: 313 AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NAS 371
            +P  +    +   L L  N L   L S +    P L+ L L       TI    + + S
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76

Query: 372 KLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS--FSNCKSLTYI 429
            LS L L  N         F  L +L+ +      L S       L +    + K+L  +
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-------LENFPIGHLKTLKEL 129

Query: 430 GLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGS 489
            +++N +                EYF                NLTNL  + L  NK+  S
Sbjct: 130 NVAHNLIQSF----------KLPEYFS---------------NLTNLEHLDLSSNKIQ-S 163

Query: 490 IPI-TLGKLQKLQG----LHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFS 543
           I    L  L ++      L L  N +   I     +  +L EL L  N+L  S+P   F 
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFD 221

Query: 544 NLASLGTLSLGSN 556
            L SL  + L +N
Sbjct: 222 RLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 52/232 (22%), Positives = 84/232 (36%), Gaps = 22/232 (9%)

Query: 215 LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLT 274
              IP  +      K L L ++ L+      F +  EL+++ L    +Q        +L+
Sbjct: 19  FYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS 76

Query: 275 GLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSN 332
            L  L L  N +   +       L +L+ L      L  ++      ++ TL  L +  N
Sbjct: 77  HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134

Query: 333 SLSGSLSSIADV--QLPNLEELRLWSNNFSGTIPRFIF-NASKLSV----LELGRNSFSG 385
            +  S     +    L NLE L L SN    +I         ++ +    L+L  N  + 
Sbjct: 135 LIQ-SFKL-PEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
             P  F  +  L+ + L  N L S    +     F    SL  I L  NP D
Sbjct: 192 IQPGAFKEI-RLKELALDTNQLKSVPDGI-----FDRLTSLQKIWLHTNPWD 237

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 60/297 (20%), Positives = 99/297 (33%), Gaps = 73/297 (24%)

Query: 68  VCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT 127
           V     +T                     IP  L    S ++L+L FN L   + S  F 
Sbjct: 4   VEVVPNITYQCMELN----------FY-KIPDNL--PFSTKNLDLSFNPLR-HLGSYSFF 49

Query: 128 LYT-LKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISL 185
            +  L+ ++    ++        +   S L  L  + N +   +     S L  L+ +  
Sbjct: 50  SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107

Query: 186 SQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE 245
            +                  + SL            IG+L  LKEL + ++ +Q      
Sbjct: 108 VET----------------NLASLE--------NFPIGHLKTLKELNVAHNLIQ-SFK-- 140

Query: 246 FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKL-- 302
                               +P+  +NLT LE L L  N +   I       LH + L  
Sbjct: 141 --------------------LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179

Query: 303 --LDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSN 357
             LDLS N +   +    F    L  L L +N L  S+      +L +L+++ L +N
Sbjct: 180 LSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 60/234 (25%), Positives = 93/234 (39%), Gaps = 35/234 (14%)

Query: 425 SLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVS----GGFPKEIGNLTNLIGIY 480
           S   + LS NPL   L   S  +    L+  D+S C +     G +     +L++L  + 
Sbjct: 29  STKNLDLSFNPL-RHLGSYSFFSFPE-LQVLDLSRCEIQTIEDGAY----QSLSHLSTLI 82

Query: 481 LGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKL-SGS 537
           L GN +  S+ +     L  LQ L   +  L   + +     L  L EL ++ N + S  
Sbjct: 83  LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 538 IPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIG 597
           +P  FSNL +L  L L SNK+ SI                         + + NL     
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIY---------------CTDLRVLHQMPLLNLS---- 181

Query: 598 IDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
           +D S N  + + P     +  L+ L L  N+L+      F  L SL+ + L  N
Sbjct: 182 LDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 32/176 (18%), Positives = 52/176 (29%), Gaps = 50/176 (28%)

Query: 514 IPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLY 573
           IPD++        L LS N L       F +   L  L L   ++ +I            
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE----------- 68

Query: 574 LNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI 633
                                                     L++L  L L  N +Q   
Sbjct: 69  ------------------------------------DGAYQSLSHLSTLILTGNPIQSLA 92

Query: 634 SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGN 689
             +F  L SL+ L     NL+      +  L  L++L+++ N ++        F N
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 27/115 (23%), Positives = 47/115 (40%), Gaps = 11/115 (9%)

Query: 84  KVLNISHLNLTGTIPSQ--LWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFR--- 137
           K LN++H  +  +        NL++L+ L+L  N++  SI       L+ +  +N     
Sbjct: 127 KELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184

Query: 138 -GNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
             N ++       F +  L+ L    N L   +P  I   L  L+ I L  N + 
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 237

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 20/176 (11%)

Query: 788 IGRGGFGSVYKAR-----IGEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSIRHRNLI 839
           IG G FG VYK         + + VA+K   L+ G   +    F  E  +M    H N+I
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFG 896
           ++    S  +   +I EYM +G+L+K L   +    + Q + ++  +A  ++YL   ++ 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY- 168

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ-TLATIGYMAP 951
                +H DL   N+L++ N+V  +SDFG++++L  + ++   T      I + AP
Sbjct: 169 -----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 66/188 (35%), Positives = 86/188 (45%), Gaps = 30/188 (15%)

Query: 500 LQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKL 558
            + L L+ NKL         RLTKL  L L+ NKL  ++PA  F  L +L TL +  NKL
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97

Query: 559 TSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTN 618
            ++P                  F         NL  L       N    + P V   LT 
Sbjct: 98  QALP---------------IGVFDQL-----VNLAEL---RLDRNQLKSLPPRVFDSLTK 134

Query: 619 LQYLFLGYNRLQGSISE-SFGDLISLKSLNLSNNNLSRSIPISL-EKLSYLEDLDLSFNK 676
           L YL LGYN LQ S+ +  F  L SLK L L NN L + +P    +KL+ L+ L L  N+
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQ 192

Query: 677 LKGEIPKG 684
           LK  +P+G
Sbjct: 193 LK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 59/206 (28%), Positives = 85/206 (41%), Gaps = 30/206 (14%)

Query: 472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLS 530
           +   L    L  NKL+        +L KL+ L+L DNKL+  +P  I   L  L  L ++
Sbjct: 38  DTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVT 93

Query: 531 GNKLSGSIPAC-FSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI 589
            NKL  ++P   F  L +L  L L  N+L S+P  +               F       +
Sbjct: 94  DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRV---------------FDS-----L 132

Query: 590 GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLS 649
             L  L       N    +   V   LT+L+ L L  N+L+     +F  L  LK+L L 
Sbjct: 133 TKLTYL---SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLD 189

Query: 650 NNNLSRSIPISLEKLSYLEDLDLSFN 675
           NN L R    + + L  L+ L L  N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 53/193 (27%), Positives = 80/193 (41%), Gaps = 15/193 (7%)

Query: 248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLS 306
           +  +L+L + ++S+L     +    LT L +L L  N L   +P  I   L NL+ L ++
Sbjct: 38  DTKKLDLQSNKLSSLP---SKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVT 93

Query: 307 HNKLVGAVPATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPR 365
            NKL  A+P  +F  +  L  L L  N L  SL       L  L  L L  N    ++P+
Sbjct: 94  DNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150

Query: 366 FIFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCK 424
            +F+  + L  L L  N         F  L  L+ + L  N L            F + +
Sbjct: 151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA-----FDSLE 205

Query: 425 SLTYIGLSNNPLD 437
            L  + L  NP D
Sbjct: 206 KLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 62/238 (26%), Positives = 95/238 (39%), Gaps = 45/238 (18%)

Query: 348 NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYL 407
           N   +   S   +  IP  I   +    L+L  N  S      F  L  LRL+ L+ N L
Sbjct: 17  NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73

Query: 408 TSSNLELSFLSS--FSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG 465
            +       L +  F   K+L  + +++N L  +   +           FD         
Sbjct: 74  QT-------LPAGIFKELKNLETLWVTDNKLQALPIGV-----------FD--------- 106

Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPITL-GKLQKLQGLHLEDNKLEGPIPDDIC-RLTK 523
                  L NL  + L  N+L  S+P  +   L KL  L L  N+L+  +P  +  +LT 
Sbjct: 107 ------QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTS 158

Query: 524 LYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSN 579
           L EL L  N+L   +P   F  L  L TL L +N+L  +P   + +L+ +  L    N
Sbjct: 159 LKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 7/183 (3%)

Query: 105 SSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSY 162
           +  + L+L  N+LS S+PS  F  L  L+ +    N+L    P+ IF +  +L+ L  + 
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
           N L   +P  +   L  L  + L +N      P    +   L  LSL   N L ++PK +
Sbjct: 95  NKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG-YNELQSLPKGV 152

Query: 223 -GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKL 281
              LT LKEL L  + L+      F  L EL+ + L  + L+        +L  L++L+L
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212

Query: 282 GKN 284
            +N
Sbjct: 213 QEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 54/160 (33%), Positives = 78/160 (48%), Gaps = 13/160 (8%)

Query: 530 SGNKLSGSIPACFSNL-ASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFFTGPLPL 587
           S  KL+ +IP   SN+ A    L L SNKL+S+P   +  L  +  L  + N     LP 
Sbjct: 24  SSKKLT-AIP---SNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78

Query: 588 DI-GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES-FGDLISLKS 645
            I   LK L  +  + N    +   V   L NL  L L  N+L+ S+    F  L  L  
Sbjct: 79  GIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTY 137

Query: 646 LNLSNNNLSRSIPISL-EKLSYLEDLDLSFNKLKGEIPKG 684
           L+L  N L  S+P  + +KL+ L++L L  N+LK  +P+G
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEG 175

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 9/138 (6%)

Query: 550 TLSLGSNKLTSIPLTI-WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDV 608
           ++   S KLT+IP  I  + K    L+  SN  +         L  L  +  + N    +
Sbjct: 20  SVDCSSKKLTAIPSNIPADTK---KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL 76

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISES-FGDLISLKSLNLSNNNLSRSIPISL-EKLSY 666
              +   L NL+ L++  N+LQ ++    F  L++L  L L  N L  S+P  + + L+ 
Sbjct: 77  PAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK 134

Query: 667 LEDLDLSFNKLKGEIPKG 684
           L  L L +N+L+  +PKG
Sbjct: 135 LTYLSLGYNELQ-SLPKG 151

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 41/187 (21%), Positives = 68/187 (36%), Gaps = 13/187 (6%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKV--FDLQCGRAFKSFDVECEMMKSI 833
                F   + +G G +G V+K R   +G   AVK      +  +       E    + +
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 834 -RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
            +H   +++  +        L  E     SL++   +    L   Q    + D    L +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           LH   S  ++H D+KP+N+ L       L DFG+   L     +    +       YMAP
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMAP 225

Query: 952 GLFHVKY 958
            L    Y
Sbjct: 226 ELLQGSY 232

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.8 bits (246), Expect = 4e-22
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 18/176 (10%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD-LQCGRAFKSFDVECEMMKSIRHRNLIK---V 841
           ++G+G   +V++ R    G   A+KVF+ +   R       E E++K + H+N++K   +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYS--SNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
               +T   K LI+E+ P GSL   L    + Y L   + L ++ DV   + +L      
Sbjct: 76  EEE-TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 900 PVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            ++H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHP 184

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.9 bits (242), Expect = 5e-22
 Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 40/207 (19%)

Query: 769 RFSYLELCRATNRFSEN----NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSF 823
           R + L    +T+ F EN     ++GRG    V +        E AVK+ D+  G +F + 
Sbjct: 2   RDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE 61

Query: 824 DV---------ECEMMKSI-RHRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLY 868
           +V         E ++++ +  H N+I++  +  T  F  L+ + M  G L     EK   
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121

Query: 869 S----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 924
           S       +  + +           +  LH      ++H DLKP N+LLDD+M   L+DF
Sbjct: 122 SEKETRKIMRALLE----------VICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 168

Query: 925 GIAKLLIGEDQSITQTQTLATIGYMAP 951
           G +   +   + +   +   T  Y+AP
Sbjct: 169 GFSC-QLDPGEKL--REVCGTPSYLAP 192

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 96.6 bits (241), Expect = 6e-22
 Identities = 43/177 (24%), Positives = 82/177 (46%), Gaps = 12/177 (6%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
              +     +G G FG VYKA+    G   A KV + +     + + VE E++ +  H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++K++ +   +    +++E+ P G+++  +   +  L   Q   +   +   L +LH   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
           S  +IH DLK  NVL+       L+DFG++       +++ +  +   IG   +MAP
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSF--IGTPYWMAP 186

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.1 bits (242), Expect = 7e-22
 Identities = 49/197 (24%), Positives = 77/197 (39%), Gaps = 22/197 (11%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNL 838
           R     ++  GGF  VY+A+ +G G E A+K          ++   E   MK +  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 839 IKVISSCS-------TEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATT 889
           ++  S+ S       T + + L+L  +  G L + L    S   L     L I       
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA----- 944
           ++++H     P+IH DLK  N+LL +     L DFG A  +          Q  A     
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 945 -----TIGYMAPGLFHV 956
                T  Y  P +  +
Sbjct: 208 ITRNTTPMYRTPEIIDL 224

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 95.7 bits (239), Expect = 8e-22
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 7/153 (4%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
           L+G+G F  VY+A  I  G+EVA+K+ D   +      +    E ++   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
           +      +  L+LE   +G + + L +        +  + M  + T + YLH   S  ++
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
           H DL  SN+LL  NM   ++DFG+A  L    +
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  100 bits (250), Expect = 8e-22
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 16/172 (9%)

Query: 788 IGRGGFGSVYKAR----IGEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
           IG G FG V++          M VA+K   +       + F  E   M+   H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYSA 899
              +      +I+E    G L   L    + LD+   +     ++T L YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +H D+   NVL+  N    L DFG+++  + +      ++    I +MAP
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 561

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 40/205 (19%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V KA             VAVK + +       +    E  ++K + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 841 VISSCSTEEFKALILEYMPHGSL-----------------------EKSLYSSNYILDIF 877
           +  +CS +    LI+EY  +GSL                           +     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 878 QRLNIMVDVATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
             ++    ++  ++YL           +H DL   N+L+ +     +SDFG+++ +  ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 935 QSITQTQTLATIGYMAP-GLFHVKY 958
             + ++Q    + +MA   LF   Y
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIY 229

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 96.6 bits (241), Expect = 1e-21
 Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 37/241 (15%)

Query: 747 RYRKRVKQPPN-DANMPPIATCRRFSYL---ELCRATNRFSENNLIGRGGFGSVYKARI- 801
           +Y+ R K   + + N        +  Y    E  R  N       +G G FG V +A   
Sbjct: 11  KYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPR--NNLQFGKTLGAGAFGKVVEATAF 68

Query: 802 -----GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALI 854
                   ++VAVK +         ++   E ++M  + +H N++ ++ +C+      +I
Sbjct: 69  GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128

Query: 855 LEYMPHGSL-------------EKSLYSSNYILDIFQRLNIMVDVATTLEYL---HFGYS 898
            EY  +G L             + +   +N        L+    VA  + +L   +    
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC--- 185

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-GLFHVK 957
              IH D+   NVLL +  VA + DFG+A+ ++ +   I +      + +MAP  +F   
Sbjct: 186 ---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 242

Query: 958 Y 958
           Y
Sbjct: 243 Y 243

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 52/200 (26%), Positives = 81/200 (40%), Gaps = 35/200 (17%)

Query: 788 IGRGGFGSVYKARI--------GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V  A           E + VAVK + D    +       E EMMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 838 LIKVISSCSTEEFKALILEYMPHGSL---------------EKSLYSSNYILDIFQRLNI 882
           +I ++ +C+ +    +I+EY   G+L                         +     ++ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 883 MVDVATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
              +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D     
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 940 TQTLATIGYMAP-GLFHVKY 958
           T     + +MAP  LF   Y
Sbjct: 217 TNGRLPVKWMAPEALFDRVY 236

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK   ++   +    F +E  ++    H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSS------NYILDIFQRLNIMVDVATTLEYL- 893
            I        + +++E M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 894 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 949 MAP 951
           M P
Sbjct: 212 MPP 214

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 41/188 (21%), Positives = 75/188 (39%), Gaps = 27/188 (14%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRNLI 839
           +GRG FG V +A             VAVK + +       ++   E +++  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 840 KVISSCSTEEFKA-LILEYMPHGSL---------------EKSLYSSNYILDIFQRLNIM 883
            ++ +C+       +I+E+   G+L                         L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
             VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +   + +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 944 ATIGYMAP 951
             + +MAP
Sbjct: 212 LPLKWMAP 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.8 bits (244), Expect = 2e-21
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 32/180 (17%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVISS 844
           +G+G F  V +   +  G E A  + + +   A     +  E  + + ++H N++++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 845 CSTEEFKALILEYMPHGSL-----EKSLYS----SNYILDIFQRLNIMVDVATTLEYLHF 895
            S E    LI + +  G L      +  YS    S+ I  I +           + + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----------AVLHCH- 127

Query: 896 GYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
                V+H +LKP N+LL          L+DFG+A  + GE Q+       A T GY++P
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSP 182

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 37/199 (18%)

Query: 786 NLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI-RHRNL 838
           ++IG G FG V KARI   G  M+ A+K   ++        + F  E E++  +  H N+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 839 IKVISSCSTEEFKALILEYMPHGSL---------------EKSLYSSNYILDIFQRLNIM 883
           I ++ +C    +  L +EY PHG+L                    S+   L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 884 VDVATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQT 940
            DVA  ++YL    F      IH DL   N+L+ +N VA ++DFG+++   G++  + +T
Sbjct: 149 ADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 199

Query: 941 QTLATIGYMAP-GLFHVKY 958
                + +MA   L +  Y
Sbjct: 200 MGRLPVRWMAIESLNYSVY 218

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 96.3 bits (240), Expect = 2e-21
 Identities = 52/200 (26%), Positives = 81/200 (40%), Gaps = 35/200 (17%)

Query: 788 IGRGGFGSVYKARI--------GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V  A           E + VAVK + D    +       E EMMK I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 838 LIKVISSCSTEEFKALILEYMPHGSL---------------EKSLYSSNYILDIFQRLNI 882
           +I ++ +C+ +    +I+EY   G+L                         +     ++ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 883 MVDVATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
              +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D     
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 940 TQTLATIGYMAP-GLFHVKY 958
           T     + +MAP  LF   Y
Sbjct: 263 TNGRLPVKWMAPEALFDRVY 282

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 14/177 (7%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
             +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++  + S    +   +++EY+  GSL   +  +   +D  Q   +  +    LE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH--- 133

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
           S  VIH D+K  N+LL  +    L+DFG    +       ++  T+  +G   +MAP
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTM--VGTPYWMAP 185

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 98.6 bits (245), Expect = 2e-21
 Identities = 55/271 (20%), Positives = 93/271 (34%), Gaps = 41/271 (15%)

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGF 466
             + +  +  +             L    +   +       L+  ++    +  ++    
Sbjct: 4   TITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVT---QNELNS-IDQIIANNSDIKSVQ 59

Query: 467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE 526
              I  L N+  ++L GNKL   I   L  L+ L  L L++NK++      +  L KL  
Sbjct: 60  G--IQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKS 113

Query: 527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP 586
           L L  N +S  I     +L  L +L LG+NK+T I                         
Sbjct: 114 LSLEHNGIS-DING-LVHLPQLESLYLGNNKITDIT------------------------ 147

Query: 587 LDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSL 646
             +  L  L  +    N  SD++P  + GLT LQ L+L  N +   +      L +L  L
Sbjct: 148 -VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVL 202

Query: 647 NLSNNNLSRSIPISLEKLSYLEDLDLSFNKL 677
            L +             L     +  +   L
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.5 bits (229), Expect = 2e-19
 Identities = 44/185 (23%), Positives = 78/185 (42%), Gaps = 13/185 (7%)

Query: 494 LGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL 553
                +    +L+   +   +      L  + ++  + + +  S+      L ++  L L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 72

Query: 554 GSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVI 613
             NKLT I   + NLK + +L    N       L   +LK L  +    N  SD+    +
Sbjct: 73  NGNKLTDIK-PLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGISDING--L 127

Query: 614 GGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLS 673
             L  L+ L+LG N++   I+     L  L +L+L +N +S  I   L  L+ L++L LS
Sbjct: 128 VHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLS 183

Query: 674 FNKLK 678
            N + 
Sbjct: 184 KNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.5 bits (229), Expect = 2e-19
 Identities = 46/267 (17%), Positives = 88/267 (32%), Gaps = 29/267 (10%)

Query: 249 LAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHN 308
           + E   ++  +  +                  L K  +T  +    + L+++  +  +++
Sbjct: 1   MGETITVSTPIKQIFP-----DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS 53

Query: 309 KLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF 368
            +       I  +  +T L L  N L+  +  +    L NL  L L  N         + 
Sbjct: 54  DIKSVQG--IQYLPNVTKLFLNGNKLT-DIKPLT--NLKNLGWLFLDENKIKDLSS--LK 106

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY 428
           +  KL  L L  N  S  I     +L  L  + L  N +T        ++  S    L  
Sbjct: 107 DLKKLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKITD-------ITVLSRLTKLDT 157

Query: 429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
           + L +N +  I+P   +  L    +   +S  ++S    + +  L NL  + L   +   
Sbjct: 158 LSLEDNQISDIVPLAGLTKL----QNLYLSKNHISD--LRALAGLKNLDVLELFSQECLN 211

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIP 515
                   L     +   D  L  P  
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLVTPEI 238

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.6 bits (224), Expect = 8e-19
 Identities = 54/308 (17%), Positives = 108/308 (35%), Gaps = 22/308 (7%)

Query: 371 SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIG 430
           ++     L + S +  +      L ++  +  + + + S       +       ++T + 
Sbjct: 21  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 71

Query: 431 LSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSI 490
           L+ N L  I P   + NL + L +  +    +       + +L  L  + L  N ++  I
Sbjct: 72  LNGNKLTDIKP---LTNLKN-LGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DI 124

Query: 491 PITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGT 550
              L  L +L+ L+L +NK+       + RLTKL  L L  N++S  I    + L  L  
Sbjct: 125 N-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQN 179

Query: 551 LSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP 610
           L L  N ++ +   +  LK +  L   S            NL V   +  +  +      
Sbjct: 180 LYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238

Query: 611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDL 670
               G      +          +S  F   +++       +         +  +SY  D 
Sbjct: 239 ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDG 298

Query: 671 DLSFNKLK 678
            +   K++
Sbjct: 299 TVIKTKVE 306

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.3 bits (213), Expect = 2e-17
 Identities = 40/179 (22%), Positives = 72/179 (40%), Gaps = 13/179 (7%)

Query: 500 LQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT 559
           +         ++   PDD     +  +  L    ++ ++    + L S+  +   ++ + 
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
           S+   I  L  +  L  + N  T   PL   NLK L  +    N   D+    +  L  L
Sbjct: 57  SVQ-GIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSS--LKDLKKL 111

Query: 620 QYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK 678
           + L L +N +   I      L  L+SL L NN ++  I   L +L+ L+ L L  N++ 
Sbjct: 112 KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.0 bits (207), Expect = 9e-17
 Identities = 52/253 (20%), Positives = 94/253 (37%), Gaps = 25/253 (9%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
               N+   ++T  +      L+S+  +    + +  S+   I  L  +  +   GN+L+
Sbjct: 23  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 78

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP--SALSN 200
              P  + N  +L  L    N +  ++ +    +L  L+S+SL  N     I   + L +
Sbjct: 79  DIKP--LTNLKNLGWLFLDENKIK-DLSS--LKDLKKLKSLSLEHN----GISDINGLVH 129

Query: 201 CKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIP-REFGNLAELELMALQV 259
              LE L L  N +       +  LTKL  L L  + +   +P      L  L L    +
Sbjct: 130 LPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 187

Query: 260 SNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIF 319
           S+L+      LA L  L+VL+L       +      NL     +  +   L    P  I 
Sbjct: 188 SDLRA-----LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIIS 240

Query: 320 NMSTLTGLGLQSN 332
           +        ++ +
Sbjct: 241 DDGDYEKPNVKWH 253

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 48/177 (27%), Positives = 82/177 (46%), Gaps = 14/177 (7%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
                    IG G  G V  AR    G +VAVK+ DL+  +  +    E  +M+  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++++  S    E   +++E++  G+L   +  S   L+  Q   +   V   L YLH   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH--- 158

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
           +  VIH D+K  ++LL  +    LSDFG    +    + + + ++L  +G   +MAP
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAP 210

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 96.7 bits (240), Expect = 3e-21
 Identities = 30/201 (14%), Positives = 58/201 (28%), Gaps = 40/201 (19%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCG---------------------------- 817
           ++G+    +  +A     G    V V                                  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 818 RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM-PHGSLE------KSLYSS 870
           +    F    +++K  + + +I+V          +    Y     +L+       S  S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 871 NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           +  L    RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 931 IGEDQSITQTQTLATIGYMAP 951
            G        +  A     A 
Sbjct: 262 -GASAVSPIGRGFAPPETTAE 281

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 98.6 bits (245), Expect = 3e-21
 Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 19/177 (10%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVI--- 842
           +G GGFG V +      G +VA+K    +   +  + + +E ++MK + H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 843 ---SSCSTEEFKALILEYMPHGSLEKSL--YSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
                 +  +   L +EY   G L K L  + +   L       ++ D+++ L YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 898 SAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +IH DLKP N++L      ++  + D G AK L  +   +     + T+ Y+AP
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAP 192

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 94.2 bits (235), Expect = 3e-21
 Identities = 31/153 (20%), Positives = 64/153 (41%), Gaps = 8/153 (5%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
            +G+GGF   ++          A K+     L      +   +E  + +S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
                 +F  ++LE     SL +       + +   R   +  +    +YLH      VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
           H DLK  N+ L++++   + DFG+A  +  + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 14/177 (7%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
              F     +G G +GSVYKA     G  VA+K   ++     +    E  +M+     +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++K   S        +++EY   GS+   +   N  L   +   I+      LEYLH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
               IH D+K  N+LL+    A L+DFG+A  L     ++ +  T+  IG   +MAP
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAP 194

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 94.7 bits (236), Expect = 4e-21
 Identities = 31/148 (20%), Positives = 62/148 (41%), Gaps = 8/148 (5%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
            +G+GGF   ++          A K+     L      +   +E  + +S+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
                 +F  ++LE     SL +       + +   R   +  +    +YLH      VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIAKLL 930
           H DLK  N+ L++++   + DFG+A  +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKV 191

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.5 bits (238), Expect = 5e-21
 Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 35/200 (17%)

Query: 788 IGRGGFGSVYKA--------RIGEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRN 837
           +G G FG V  A        +     +VAVK +      +       E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 838 LIKVISSCSTEEFKALILEYMPHGSL---------------EKSLYSSNYILDIFQRLNI 882
           +I ++ +C+ +    +I+EY   G+L                   ++    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 883 MVDVATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
              VA  +EYL           IH DL   NVL+ ++ V  ++DFG+A+ +   D     
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 940 TQTLATIGYMAP-GLFHVKY 958
           T     + +MAP  LF   Y
Sbjct: 251 TNGRLPVKWMAPEALFDRIY 270

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 30/188 (15%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A K F  E E++ +++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 842 ISSCSTEEFKALILEYMPHGSL---------------EKSLYSSNYILDIFQRLNIMVDV 886
              C   +   ++ EYM HG L               +     +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 887 ATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
           A+ + YL   HF      +H DL   N L+  N++  + DFG+++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 944 ATIGYMAP 951
             I +M P
Sbjct: 197 LPIRWMPP 204

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 90.4 bits (225), Expect = 8e-21
 Identities = 33/190 (17%), Positives = 61/190 (32%), Gaps = 11/190 (5%)

Query: 492 ITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTL 551
           I     +      L  +            +  L  + L+   ++           ++  L
Sbjct: 17  IPDSTFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDLTG--IEYAHNIKDL 71

Query: 552 SLGSNKLTSI-PLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP 610
           ++ +   T+  P++   L  +  L       T     ++  L  L  +D S +   D I 
Sbjct: 72  TINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDL 670
           T I  L  +  + L YN     I      L  LKSLN+  + +       +E    L  L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186

Query: 671 DLSFNKLKGE 680
                 + G+
Sbjct: 187 YAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 33/188 (17%), Positives = 67/188 (35%), Gaps = 13/188 (6%)

Query: 199 SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIP-REFGNLAELELMAL 257
           S  K      L  ++           +  L  + L    +          N+ +L +  +
Sbjct: 20  STFKAYLNGLLGQSST---ANITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNI 76

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPAT 317
             +N        ++ L+ LE L++    +T +  P +  L +L LLD+SH+    ++   
Sbjct: 77  HATNYNP-----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 318 IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLE 377
           I  +  +  + L  N     +  +    LP L+ L +  +         I +  KL+ L 
Sbjct: 132 INTLPKVNSIDLSYNGAITDIMPLKT--LPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187

Query: 378 LGRNSFSG 385
               +  G
Sbjct: 188 AFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 29/188 (15%), Positives = 62/188 (32%), Gaps = 11/188 (5%)

Query: 421 SNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY 480
           S  K+     L  +    I    +   ++ SL Y  ++  NV+      I    N+  + 
Sbjct: 20  STFKAYLNGLLGQSSTANI----TEAQMN-SLTYITLANINVTD--LTGIEYAHNIKDLT 72

Query: 481 LGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA 540
           +         P  +  L  L+ L +    +      ++  LT L  L +S +    SI  
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 541 CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDF 600
             + L  + ++ L  N   +  + +  L  +  LN   +       ++  +   L  +  
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYA 188

Query: 601 STNNFSDV 608
            +      
Sbjct: 189 FSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 31/217 (14%), Positives = 64/217 (29%), Gaps = 42/217 (19%)

Query: 224 NLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGK 283
                    LG S        +  +L  + L  + V++L G     +     ++ L +  
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75

Query: 284 NFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGS-LSSIA 342
              T    P I  L NL+ L +    +       +  +++LT L +  ++   S L+ I 
Sbjct: 76  IHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 343 DVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL 402
              LP +  + L  N     I                              L  L+ + +
Sbjct: 134 --TLPKVNSIDLSYNGAITDI-------------------------MPLKTLPELKSLNI 166

Query: 403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGI 439
            ++ +              +   L  +   +  + G 
Sbjct: 167 QFDGVHD-------YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 30/208 (14%), Positives = 61/208 (29%), Gaps = 35/208 (16%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
              +  +  LG +  +    +    + +L Y+      ++    + I    +++ L  + 
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
              +   P    S L  LE + +            LS    L +L +S +    +I  +I
Sbjct: 76  IHATNYNP---ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
             L K+  + L Y                         N        L  L  L+ L + 
Sbjct: 133 NTLPKVNSIDLSY-------------------------NGAITDIMPLKTLPELKSLNIQ 167

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKL 310
            + +       I +   L  L      +
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 32/236 (13%), Positives = 72/236 (30%), Gaps = 44/236 (18%)

Query: 253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG 312
           E   L+ S     IP   +         LG++  T  I      +++L  + L++  +  
Sbjct: 4   EQTGLKASQDNVNIP--DSTFKAYLNGLLGQS-STANITEA--QMNSLTYITLANINVTD 58

Query: 313 AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK 372
                I     +  L + +   + + + I+   L NLE LR+   + +      +   + 
Sbjct: 59  LTG--IEYAHNIKDLTINNIHAT-NYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTS 113

Query: 373 LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLS 432
           L++L++  ++    I      L  +  + L YN   +       +        L  + + 
Sbjct: 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD------IMPLKTLPELKSLNIQ 167

Query: 433 NNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
            + +                                 I +   L  +Y     + G
Sbjct: 168 FDGVHDYRG----------------------------IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 31/153 (20%), Positives = 62/153 (40%), Gaps = 8/153 (5%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
           +  + ++++N+T      +    +++ L +     +    + I  L  L+ +   G  ++
Sbjct: 46  LTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVT 101

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCK 202
                 +   +SL  LD S++A    I   I + LP + SI LS N     I   L    
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKI-NTLPKVNSIDLSYNGAITDI-MPLKTLP 159

Query: 203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGY 235
            L+ L++  + +       I +  KL +LY   
Sbjct: 160 ELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 22/130 (16%), Positives = 44/130 (33%), Gaps = 9/130 (6%)

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
           S    +IP +    K  L      +       +    +  L  I  +  N +D+    I 
Sbjct: 11  SQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IE 63

Query: 615 GLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF 674
              N++ L +       +       L +L+ L +   +++     +L  L+ L  LD+S 
Sbjct: 64  YAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 675 NKLKGEIPKG 684
           +     I   
Sbjct: 122 SAHDDSILTK 131

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 24/131 (18%), Positives = 52/131 (39%), Gaps = 6/131 (4%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
           K L I++++ T   P  +  LS+L+ L +    ++      +  L +L  ++   +    
Sbjct: 69  KDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY 203
           +  + I     +  +D SYN    +I       LP L+S+++  +  H      + +   
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMPL--KTLPELKSLNIQFDGVHD--YRGIEDFPK 182

Query: 204 LEILSLSINNL 214
           L  L      +
Sbjct: 183 LNQLYAFSQTI 193

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.4 bits (235), Expect = 9e-21
 Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 41/227 (18%)

Query: 749 RKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSEN----NLIGRGGFGSVYKAR-IGE 803
           +K     P         +      L    A   F +     ++IGRG    V +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 804 GMEVAVKVFDL--------QCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALI 854
           G E AVK+ ++        Q     ++   E  +++ +  H ++I +I S  +  F  L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 855 LEYMPHGSL-----EKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD 905
            + M  G L     EK   S     + +  + +           + +LH   +  ++H D
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLE----------AVSFLH---ANNIVHRD 225

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           LKP N+LLDDNM   LSDFG +   +   + +     L  T GY+AP
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAP 268

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 94.4 bits (235), Expect = 9e-21
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG VY+ ++         ++VAVK   ++   +    F +E  ++    H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSS------NYILDIFQRLNIMVDVATTLEYL- 893
            I        + ++LE M  G L+  L  +         L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 894 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGY 948
             HF      IH D+   N LL       VA + DFG+A+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 949 MAP 951
           M P
Sbjct: 253 MPP 255

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 43/197 (21%), Positives = 78/197 (39%), Gaps = 29/197 (14%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRNLI 839
           +G G FG V +A           M VAVK +         ++   E +++  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 840 KVISSCSTEEFKALILEYMPHGSL-----------------EKSLYSSNYILDIFQRLNI 882
            ++ +C+      +I EY  +G L                    +      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 943 LATIGYMAP-GLFHVKY 958
              + +MAP  +F+  Y
Sbjct: 208 RLPVKWMAPESIFNCVY 224

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 57/296 (19%), Positives = 98/296 (33%), Gaps = 30/296 (10%)

Query: 295 HNLHNLKLLDLSHN-KLVGAVPATIFNMSTLTGLGLQSNSLSGSL--SSIADVQLPNLEE 351
               +L+ L    + +        I    +L  L +++  +   +   ++  + +  L+E
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 352 LRLWSNNFSGTIPRFIFNAS--KLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS 409
           L L +   +GT P  +  A+   L++L L   S++         L+      L    +  
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQ 158

Query: 410 SNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE 469
           ++             +L+ + LS+NP  G         L  +L              P +
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERG------LISAL-------------CPLK 199

Query: 470 IGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICR-LTKLYELG 528
              L  L     G    +G          +LQGL L  N L        C   ++L  L 
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 529 LSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGP 584
           LS   L   +P      A L  L L  N+L   P     L  +  L+   N F   
Sbjct: 260 LSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 54/340 (15%), Positives = 91/340 (26%), Gaps = 63/340 (18%)

Query: 358 NFSGTIPRF--IFNASKLSVLELGRNSFSGF--------IPNTFGNLRNLRLMTLHYNYL 407
           NFS   P +   FN    + +EL     S            +       ++ ++L    +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75

Query: 408 TS---SNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSG 464
            +    +  L           L  + L N  + G  P   +      L   ++   + + 
Sbjct: 76  RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA- 134

Query: 465 GFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKL 524
                +  L   +                      L+ L +          + +     L
Sbjct: 135 TRDAWLAELQQWL-------------------KPGLKVLSIAQAHSLNFSCEQVRVFPAL 175

Query: 525 YELGLSGNKLSGSIP----ACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNF 580
             L LS N   G        C     +L  L+L +  + +       L            
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL------------ 223

Query: 581 FTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVI-GGLTNLQYLFLGYNRLQGSISESFGD 639
                         L G+D S N+  D          + L  L L +  L+       G 
Sbjct: 224 --------AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK---QVPKGL 272

Query: 640 LISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKG 679
              L  L+LS N L    P   E L  + +L L  N    
Sbjct: 273 PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 85.7 bits (212), Expect = 3e-18
 Identities = 41/178 (23%), Positives = 60/178 (33%), Gaps = 12/178 (6%)

Query: 63  NTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSI- 121
            +      W           +KVL+I+  +       Q+    +L +L+L  N   G   
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

Query: 122 ------PSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICS 175
                 P    TL  L   N      SG   +    +  LQ LD S+N+L     A  C 
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

Query: 176 NLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYL 233
               L S++LS            +    L +L LS  N L   P     L ++  L L
Sbjct: 251 WPSQLNSLNLSFTGLKQVPKGLPAK---LSVLDLS-YNRLDRNPS-PDELPQVGNLSL 303

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.6 bits (209), Expect = 8e-18
 Identities = 55/292 (18%), Positives = 82/292 (28%), Gaps = 58/292 (19%)

Query: 80  SHRVKVLNISHLNLTGTIPSQ---LWNLSSLQSLNLGFNRLSGSIPSAIFTLY--TLKYV 134
           S  +K L +    +   I      +  +S LQ L L    ++G+ P  +       L  +
Sbjct: 67  SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 135 NFRGNQLSGAFPS----FIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMF 190
           N R    +           + K  L+ L  +                P L ++ LS N  
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPE 185

Query: 191 HGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLA 250
            G      + C                                         P +F  L 
Sbjct: 186 LGERGLISALC-----------------------------------------PLKFPTLQ 204

Query: 251 ELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNK 309
            L L    +    G      A    L+ L L  N L              L  L+LS   
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 310 LVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG 361
           L   VP  +   + L+ L L  N L  + S     +LP +  L L  N F  
Sbjct: 265 LK-QVPKGLP--AKLSVLDLSYNRLDRNPSPD---ELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 81.5 bits (201), Expect = 9e-17
 Identities = 63/353 (17%), Positives = 103/353 (29%), Gaps = 65/353 (18%)

Query: 68  VCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLW--NLSSLQSLNLGFNRLSGSIPSAI 125
            CN++    D  S           N  G    +L+    S    L            + I
Sbjct: 14  SCNFSDPKPDWSSA---------FNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI 64

Query: 126 FTLYTLKYVNFRGNQLSGAFPS---FIFNKSSLQHLDFSYNALSGEIPANICSN-LPFLE 181
               +LK +  R  ++          +   S LQ L      ++G  P  +     P L 
Sbjct: 65  IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLN 124

Query: 182 SISLSQNMFHGR--IPSALSNC--KYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSG 237
            ++L    +  R    + L       L++LS++  + L    +++     L  L L  + 
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184

Query: 238 LQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNL 297
             GE                    +    P +   L  L +   G    +G         
Sbjct: 185 ELGERG-----------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227

Query: 298 HNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSN 357
             L+ LDLSHN L  A  A   +                            L  L L   
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDW------------------------PSQLNSLNLSFT 263

Query: 358 NFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSS 410
                +P+ +   +KLSVL+L  N            L  +  ++L  N    S
Sbjct: 264 GLK-QVPKGLP--AKLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.5 bits (162), Expect = 9e-12
 Identities = 38/225 (16%), Positives = 65/225 (28%), Gaps = 27/225 (12%)

Query: 471 GNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRL---TKLYEL 527
           G  +    +     + +      + K   L+ L +   ++   I     R+   + L EL
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 528 GLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPL 587
            L   +++G+ P     L       L         L + N+       + +       P 
Sbjct: 101 TLENLEVTGTAP---PPLLEATGPDLNI-------LNLRNVSWATRDAWLAELQQWLKP- 149

Query: 588 DIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES----FGDLISL 643
               LKVL     +  +  +     +     L  L L  N   G              +L
Sbjct: 150 ---GLKVL---SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203

Query: 644 KSLNLSNNN---LSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGG 685
           + L L N      S            L+ LDLS N L+       
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 94.3 bits (234), Expect = 1e-20
 Identities = 22/226 (9%), Positives = 49/226 (21%), Gaps = 45/226 (19%)

Query: 761 MPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQC 816
            P  A     S   L +   +      +  G    V+  R +    + A+KVF       
Sbjct: 45  WPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102

Query: 817 GRAFKSFDVECEMMKSIRHRNLIKVISSCS-TEEFKALILEYMPHGSLEKSLYSSNYILD 875
               +           +   +  +            A+ ++  P  +          + +
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 876 IF------------------------------QRLNIMVDVATTLEYLHFGYSAPVIHCD 905
                                               +   +      L    S  ++H  
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219

Query: 906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             P N+ +  +    L D       +G     +       + Y   
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW-KVGTRGPASSV----PVTYAPR 260

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 31/189 (16%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G   FG VYK  +       +   VA+K   D   G   + F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 841 VISSCSTEEFKALILEYMPHGSL---------------EKSLYSSNYILDIFQRLNIMVD 885
           ++   + ++  ++I  Y  HG L                    +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 886 VATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
           +A  +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 943 LATIGYMAP 951
           L  I +MAP
Sbjct: 191 LLPIRWMAP 199

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 26/176 (14%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVI 842
            +G+G FG+VY AR       +A+KV     L+          E E+   +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------IMVDVATTLEYLHFG 896
           +     +   L+LE+ P G L K L           R +       M ++A  L Y H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
               VIH D+KP N+L+       ++DFG +           + +T+  T+ Y+ P
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPP 181

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 42/193 (21%), Positives = 81/193 (41%), Gaps = 36/193 (18%)

Query: 777 RATNRFSEN----NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMK 831
             T    +      ++G G F  V+  +    G   A+K           S + E  ++K
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61

Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYS----SNYILDIFQRLNI 882
            I+H N++ +     +     L+++ +  G L     E+ +Y+    S  I  +      
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS---- 117

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQ 939
                  ++YLH      ++H DLKP N+L    ++N    ++DFG++K  + ++  ++ 
Sbjct: 118 ------AVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS- 165

Query: 940 TQTLA-TIGYMAP 951
             T   T GY+AP
Sbjct: 166 --TACGTPGYVAP 176

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 30/195 (15%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
           +G G FG V+ A         + M VAVK        A + F  E E++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 842 ISSCSTEEFKALILEYMPHGSL--------------EKSLYSSNYILDIFQRLNIMVDVA 887
              C+      ++ EYM HG L                    +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 888 TTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
             + YL   HF      +H DL   N L+   +V  + DFG+++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 945 TIGYMAP-GLFHVKY 958
            I +M P  + + K+
Sbjct: 223 PIRWMPPESILYRKF 237

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.8 bits (231), Expect = 3e-20
 Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 36/215 (16%)

Query: 756 PNDANMPPIATCRRFSYLELCRATNRFSEN----NLIGRGGFGSVYKAR-IGEGMEVAVK 810
           P+ A+M       R S   +  A+ +FS+N      +G+G F  V +      G+E A K
Sbjct: 2   PHMASMTGGQQMGRGSEF-MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 811 VFD--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL----- 863
           + +      R F+  + E  + + ++H N++++  S   E F  L+ + +  G L     
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 864 EKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDN 916
            +  YS    S+ I  I +          ++ Y H   S  ++H +LKP N+LL      
Sbjct: 121 AREFYSEADASHCIQQILE----------SIAYCH---SNGIVHRNLKPENLLLASKAKG 167

Query: 917 MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               L+DFG+A   + + ++        T GY++P
Sbjct: 168 AAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSP 199

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 35/192 (18%)

Query: 779 TNRFSEN----NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMK 831
           + +FS+N      +G+G F  V +      G+E A K+ + +    R F+  + E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYS----SNYILDIFQRLNI 882
            ++H N++++  S   E F  L+ + +  G L      +  YS    S+ I  I +    
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---- 116

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQ 939
                 ++ Y H   S  ++H +LKP N+LL          L+DFG+A   + + ++   
Sbjct: 117 ------SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW-- 164

Query: 940 TQTLATIGYMAP 951
                T GY++P
Sbjct: 165 HGFAGTPGYLSP 176

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 92.5 bits (230), Expect = 3e-20
 Identities = 54/215 (25%), Positives = 82/215 (38%), Gaps = 29/215 (13%)

Query: 753 KQPPNDANMPPIATCRRFSYL------ELCRATN---RFSENNLIGRGGFGSVYKAR-IG 802
           +       M P+    R   L      EL    +    FS+   IG G FG+VY AR + 
Sbjct: 18  ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77

Query: 803 EGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP 859
               VA+K       ++   ++    E   ++ +RH N I+       E    L++EY  
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137

Query: 860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 919
            GS    L      L   +   +       L YLH   S  +IH D+K  N+LL +  + 
Sbjct: 138 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLV 193

Query: 920 HLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
            L DFG A         +    +   +G   +MAP
Sbjct: 194 KLGDFGSA-------SIMAPANSF--VGTPYWMAP 219

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 15/184 (8%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIRHRN 837
           + +    +IG G    V  A    +  +VA+K  +L +C  +      E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 838 LIKVISSCSTEEFKALILEYMPHGSL-------EKSLYSSNYILDIFQRLNIMVDVATTL 890
           ++   +S   ++   L+++ +  GS+              + +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG--- 947
           EYLH       IH D+K  N+LL ++    ++DFG++  L               +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 948 YMAP 951
           +MAP
Sbjct: 192 WMAP 195

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 48/214 (22%), Positives = 79/214 (36%), Gaps = 42/214 (19%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRNLI 839
           +G G FG V  A        G  ++VAVK + +       ++   E +MM  +  H N++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 840 KVISSCSTEEFKALILEYMPHGSL----------------------EKSLYSSNYILDIF 877
            ++ +C+      LI EY  +G L                               +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI 937
             L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ ++ +   +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 938 TQTQTLATIGYMAP-GLFHVKYILFVVNFLTSYS 970
            +      + +MAP  LF   Y        T  S
Sbjct: 230 VRGNARLPVKWMAPESLFEGIY--------TIKS 255

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.0 bits (229), Expect = 4e-20
 Identities = 47/197 (23%), Positives = 75/197 (38%), Gaps = 39/197 (19%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVKVF-DLQCGRAFKSFDVECEMMKSIRHRNLIK 840
           IG G FG V++AR            VAVK+  +         F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 841 VISSCSTEEFKALILEYMPHGSL-----------------------EKSLYSSNYILDIF 877
           ++  C+  +   L+ EYM +G L                        +        L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 878 QRLNIMVDVATTLEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           ++L I   VA  + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 935 QSITQTQTLATIGYMAP 951
                      I +M P
Sbjct: 229 YYKADGNDAIPIRWMPP 245

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 23/182 (12%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD--LQCGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G+G FG V K +      E AVKV +      +   +   E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 845 CSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
                   ++ E    G L     ++  +S +    I +       V + + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH---KH 140

Query: 900 PVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV 956
            ++H DLKP N+LL   + +    + DFG++     ++  +     + T  Y+AP +   
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRG 197

Query: 957 KY 958
            Y
Sbjct: 198 TY 199

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 90.5 bits (225), Expect = 9e-20
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 17/173 (9%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-FKSFDVECE-MMKSIRHRNLIKVISS 844
           IGRG +GSV K      G  +AVK           K   ++ + +M+S     +++   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------IMVDVATTLEYLHFGYS 898
              E    + +E M   S +K          +   +       I +     L +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             +IH D+KPSN+LLD +    L DFGI+  L+    SI +T+      YMAP
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAP 194

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.8 bits (226), Expect = 1e-19
 Identities = 42/186 (22%), Positives = 75/186 (40%), Gaps = 37/186 (19%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEM--MKSIRHRNLIKV 841
           IG+G F  V +      G + AVK+ D           + D++ E      ++H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 842 ISSCSTEEFKALILEYMPHGSL---------EKSLYS----SNYILDIFQRLNIMVDVAT 888
           + + S++    ++ E+M    L            +YS    S+Y+  I +          
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---------- 141

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
            L Y H      +IH D+KP  VLL   +++    L  FG+A  L            + T
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

Query: 946 IGYMAP 951
             +MAP
Sbjct: 197 PHFMAP 202

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 91.2 bits (226), Expect = 1e-19
 Identities = 33/214 (15%), Positives = 64/214 (29%), Gaps = 45/214 (21%)

Query: 774 ELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL----------------QC 816
           EL           ++G+    +  +A     G    V V                     
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 817 GRAFK------------SFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM-PHGSL 863
            R  +             F    +++K  + + +I+V          +    Y     +L
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 864 EK------SLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM 917
           +       S  S++  L    RL + + V   L  LH      ++H  L+P +++LD   
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRG 243

Query: 918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              L+ F         D +   +    + G+  P
Sbjct: 244 GVFLTGFEHLV----RDGARVVSSV--SRGFEPP 271

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 90.4 bits (225), Expect = 1e-19
 Identities = 46/203 (22%), Positives = 79/203 (38%), Gaps = 50/203 (24%)

Query: 774 ELCRATNRFSEN----NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECE 828
           +L R + +F++       IG G +    +       ME AVK+ D          D   E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEE 65

Query: 829 ---MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL----- 880
              +++  +H N+I +       ++  ++ E M  G L               ++     
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKF 112

Query: 881 -------NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKL 929
                   ++  +  T+EYLH   +  V+H DLKPSN+L      +     + DFG AK 
Sbjct: 113 FSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 930 LIGEDQSITQTQTLA-TIGYMAP 951
           L  E+  +    T   T  ++AP
Sbjct: 170 LRAENGLLM---TPCYTANFVAP 189

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 47/180 (26%), Positives = 77/180 (42%), Gaps = 24/180 (13%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISS 844
           ++G G    V     +    E AVK+ + Q G        E EM+   + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 845 CSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
              E+   L+ E M  GS+     ++  ++      + Q      DVA+ L++LH   + 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ------DVASALDFLH---NK 130

Query: 900 PVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLL-IGEDQSITQTQTLATI----GYMAP 951
            + H DLKP N+L    +      + DF +   + +  D S   T  L T      YMAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 92.1 bits (229), Expect = 1e-19
 Identities = 43/183 (23%), Positives = 78/183 (42%), Gaps = 24/183 (13%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKVIS 843
           +G+G FG V   +    G E AVKV     ++     +S   E +++K + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 844 SCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
               + +  L+ E    G L      +  +S      I ++      V + + Y+H    
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---K 144

Query: 899 APVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
             ++H DLKP N+LL     +    + DFG++       + +     + T  Y+AP + H
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAPEVLH 201

Query: 956 VKY 958
             Y
Sbjct: 202 GTY 204

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.1 bits (229), Expect = 2e-19
 Identities = 43/221 (19%), Positives = 84/221 (38%), Gaps = 27/221 (12%)

Query: 753 KQPPNDANMPPIATCRRFSYLELCRATNRFSEN----NLIGRGGFGSVYKAR-IGEGMEV 807
                  N+      +    + +       SE       +G G +G V   R     +E 
Sbjct: 6   HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65

Query: 808 AVKVFDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSL-- 863
           A+K+          +  +  E  ++K + H N++K+      +    L++E    G L  
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125

Query: 864 ---EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNM 917
               +  ++      I +       V + + YLH      ++H DLKP N+LL   + + 
Sbjct: 126 EIIHRMKFNEVDAAVIIK------QVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDA 176

Query: 918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY 958
           +  + DFG++  +    + +   + L T  Y+AP +   KY
Sbjct: 177 LIKIVDFGLSA-VFENQKKM--KERLGTAYYIAPEVLRKKY 214

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 15/176 (8%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIRHRNL 838
            F++   IG+G FG V+K         VA+K+ DL +     +    E  ++       +
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
            K   S   +    +I+EY+  GS    L      LD  Q   I+ ++   L+YLH   S
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPG-PLDETQIATILREILKGLDYLH---S 137

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
              IH D+K +NVLL ++    L+DFG+A  L     +  +  T   +G   +MAP
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAP 188

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 46/180 (25%), Positives = 70/180 (38%), Gaps = 21/180 (11%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           IGRG +G V  A   G  +  A K            F  E E+MKS+ H N+I++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 847 TEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
                 L++E    G L      K ++  +    I +      DV + + Y H      V
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127

Query: 902 IHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY 958
            H DLKP N L      +    L DFG+A       + +     + T  Y++P +    Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSPQVLEGLY 184

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 30/181 (16%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDV-----ECEMMKSIRHRNL 838
           +G G  G V  A       +VA+K+        G A ++        E E++K + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 839 IKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           IK+ +    E++  ++LE M  G L                  F        +   ++YL
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 894 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      +IH DLKP NVLL   +++ +  ++DFG +K+L   + S+ +T    T  Y+A
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT-LCGTPTYLA 184

Query: 951 P 951
           P
Sbjct: 185 P 185

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 89.5 bits (222), Expect = 3e-19
 Identities = 39/172 (22%), Positives = 78/172 (45%), Gaps = 9/172 (5%)

Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKSIRHRNLI 839
           F + + +G G  G V+K      G+ +A K+  L+   A       E +++       ++
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
               +  ++   ++ +E+M  GSL++ +      +       + + V   L YL   +  
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 152

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            ++H D+KPSN+L++      L DFG++  LI    S+  +  + T  YM+P
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSP 199

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 18/173 (10%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-FKSFDVECEM-MKSIRHRNLIKVISS 844
           +GRG +G V K R +  G  +AVK           K   ++ ++ M+++     +    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------IMVDVATTLEYLHFGYS 898
              E    + +E M   SL+K       ++D  Q +       I V +   LE+LH   S
Sbjct: 75  LFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             VIH D+KPSNVL++      + DFGI+  L+     + +        YMAP
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAP 178

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.1 bits (221), Expect = 5e-19
 Identities = 54/285 (18%), Positives = 90/285 (31%), Gaps = 62/285 (21%)

Query: 395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEY 454
           RN   +      L           +FS    L  I +S N +  ++            + 
Sbjct: 30  RNAIELRFVLTKLRVIQK-----GAFSGFGDLEKIEISQNDVLEVIEA----------DV 74

Query: 455 FDMSYCNVSGGFPKEIGNLTNLIGIYL-GGNKLNGSIPITLGKLQKLQGLHLEDNKLEGP 513
           F                NL  L  I +   N L    P     L  LQ L + +  ++  
Sbjct: 75  FS---------------NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH- 118

Query: 514 IPDDI-CRLTKLYELGLSGNKLSGSIPA-CFSNLAS-LGTLSLGSNKLTSIPLTIWNLKG 570
           +PD       +   L +  N    +I    F  L+     L L  N +  I  + +N   
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQ 178

Query: 571 MLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ 630
           +  LN S N                       NN  ++   V  G +    L +   R+ 
Sbjct: 179 LDELNLSDN-----------------------NNLEELPNDVFHGASGPVILDISRTRIH 215

Query: 631 GSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
              S    +L  L++ +  N    + +P +LEKL  L +  L++ 
Sbjct: 216 SLPSYGLENLKKLRARSTYNL---KKLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 60/265 (22%), Positives = 103/265 (38%), Gaps = 28/265 (10%)

Query: 106 SLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS----GAFPSFIFNKSSLQHLDFS 161
           S +      ++++  IPS +        + F   +L     GAF  F      L+ ++ S
Sbjct: 10  SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGF----GDLEKIEIS 62

Query: 162 YNALSGEIPANICSNLPFLESISLSQ-NMFHGRIPSALSNCKYLEILSLSINNLLGAIPK 220
            N +   I A++ SNLP L  I + + N      P A  N   L+ L +S N  +  +P 
Sbjct: 63  QNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS-NTGIKHLPD 121

Query: 221 EI-GNLTKLKELYLGYSGLQGEIPRE-FGNL-AELELMALQVSNLQGEIPQELANLTGL- 276
               +  +   L +  +     I R  F  L  E  ++ L  + +Q EI     N T L 
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLD 180

Query: 277 EVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSL 334
           E+     N L  E+P ++ H      +LD+S  ++  ++P+    N+  L      +   
Sbjct: 181 ELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK 238

Query: 335 SGSLSSIADVQLPNLEELRLWSNNF 359
             +L       L  L E  L +   
Sbjct: 239 LPTLEK-----LVALMEASL-TYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.4 bits (214), Expect = 3e-18
 Identities = 51/333 (15%), Positives = 94/333 (28%), Gaps = 88/333 (26%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
           + ++     +K+   +P+ +        L      L   +   A     +LE++ +  N+
Sbjct: 10  SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65

Query: 359 FSGTIPRFIF-NASKLSVLELGR-NSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSF 416
               I   +F N  KL  + + + N+     P  F NL NL+ + +    +      L  
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH----LPD 121

Query: 417 LSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNL 476
           +    +      + + +N     + R S   LS                           
Sbjct: 122 VH-KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI---------------------- 158

Query: 477 IGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSG 536
                                     L L  N ++  I +     T+L EL LS N    
Sbjct: 159 --------------------------LWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE 191

Query: 537 SIPA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVL 595
            +P   F   +    L +   ++ S+P               S          +  L+  
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIHSLP---------------SYGLEN-----LKKLRAR 231

Query: 596 IGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR 628
                ST N   +    +  L  L    L Y  
Sbjct: 232 -----STYNLKKLPT--LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 85.3 bits (211), Expect = 7e-18
 Identities = 46/243 (18%), Positives = 83/243 (34%), Gaps = 24/243 (9%)

Query: 212 NNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE-L 270
            + +  IP ++       EL    + L+      F    +LE + +  +++   I  +  
Sbjct: 18  ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75

Query: 271 ANLTGLEVLKLGK-NFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLG 328
           +NL  L  +++ K N L   I PE   NL NL+ L +S+  +         +      L 
Sbjct: 76  SNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134

Query: 329 LQSNSLSGSLSSIADVQLP-NLEELRLWSNNFSGTIPRFIFNASKLSVLEL-GRNSFSGF 386
           +Q N    ++   + V L      L L  N     I    FN ++L  L L   N+    
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEEL 193

Query: 387 IPNTFGNLRNLRLMTLHYNYLTS---------------SNLELSFLSSFSNCKSLTYIGL 431
             + F       ++ +    + S               S   L  L +     +L    L
Sbjct: 194 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASL 253

Query: 432 SNN 434
           +  
Sbjct: 254 TYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.5 bits (209), Expect = 1e-17
 Identities = 36/209 (17%), Positives = 69/209 (33%), Gaps = 7/209 (3%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLS-G 531
            N I +     KL             L+ + +  N +   I  D+   L KL+E+ +   
Sbjct: 30  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89

Query: 532 NKLSGSIPA-CFSNLASLGTLSLGSNKLTSIP-LTIWNLKGMLYLNFSSNFFTGPLPLDI 589
           N L   I    F NL +L  L + +  +  +P +   +    + L+   N     +  + 
Sbjct: 90  NNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 590 --GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLN 647
             G     + +  + N   ++  +   G    +      N L+   ++ F        L+
Sbjct: 149 FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208

Query: 648 LSNNNLSRSIPISLEKLSYLEDLDLSFNK 676
           +S   +       LE L  L        K
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 43/260 (16%), Positives = 84/260 (32%), Gaps = 26/260 (10%)

Query: 67  PVCNWTGVTCDVHSHRV-----------KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFN 115
            +C+ +         +V             L      L             L+ + +  N
Sbjct: 5   RICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 64

Query: 116 RLSGSIPSAIFT-LYTLKYVNF-RGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPAN 172
            +   I + +F+ L  L  +   + N L        F    +LQ+L  S   +   +P  
Sbjct: 65  DVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDV 122

Query: 173 ICSNLPFLESISLSQNMFHGRIPS-ALSNCKY-LEILSLSINNLLGAIPKEIGNLTKLKE 230
              +      + +  N+    I   +     +   IL L+  N +  I     N T+L E
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN-KNGIQEIHNSAFNGTQLDE 181

Query: 231 LYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTG 288
           L L  +    E+P + F   +   ++ +  + +   +P   L NL  L            
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK--- 237

Query: 289 EIPPEIHNLHNLKLLDLSHN 308
           ++P  +  L  L    L++ 
Sbjct: 238 KLPT-LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 33/150 (22%), Positives = 53/150 (35%), Gaps = 5/150 (3%)

Query: 547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
           S        +K+T IP  +   +  + L F                  L  I+ S N+  
Sbjct: 10  SNRVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67

Query: 607 DVIPT-VIGGLTNLQYLFL-GYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKL 664
           +VI   V   L  L  + +   N L     E+F +L +L+ L +SN  +     +     
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127

Query: 665 SYLEDLDLSFNKLKGEIPKGGSFGNFSAKS 694
                LD+  N     I +  SF   S +S
Sbjct: 128 LQKVLLDIQDNINIHTIER-NSFVGLSFES 156

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 38/190 (20%), Positives = 73/190 (38%), Gaps = 35/190 (18%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFD---LQCGRAFKSFDV--------------ECEMM 830
           + +G F  +      +    A+K ++   L+  R F   +               E +++
Sbjct: 39  LNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 831 KSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT- 889
             I++   +      +  +   +I EYM + S+ K      ++LD      I + V    
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVIKCI 156

Query: 890 -------LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
                    Y+H      + H D+KPSN+L+D N    LSDFG ++ ++ +       + 
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKG 209

Query: 943 LA-TIGYMAP 951
              T  +M P
Sbjct: 210 SRGTYEFMPP 219

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 41/202 (20%), Positives = 78/202 (38%), Gaps = 37/202 (18%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSI 833
           R T  F E   IG G FGSV+K     +G   A+K            ++   E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 834 -RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF---QRLNIMVDVATT 889
            +H ++++  S+ + ++   +  EY   GSL  ++  +  I+  F   +  ++++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDN-------------------MVAHLSDFGIAKLL 930
           L Y+H   S  ++H D+KPSN+ +                      ++  + D G     
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-- 182

Query: 931 IGEDQSITQTQTLA-TIGYMAP 951
                 I+  Q       ++A 
Sbjct: 183 -----RISSPQVEEGDSRFLAN 199

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.8 bits (223), Expect = 6e-19
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 30/181 (16%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDV-----ECEMMKSIRHRNL 838
           +G G  G V  A       +VA+++        G A ++        E E++K + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 839 IKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
           IK+ +    E++  ++LE M  G L                  F        +   ++YL
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 255

Query: 894 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      +IH DLKP NVLL   +++ +  ++DFG +K+L   + S+ +T    T  Y+A
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT-LCGTPTYLA 309

Query: 951 P 951
           P
Sbjct: 310 P 310

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 44/217 (20%)

Query: 760 NMPPIATCRRFSYLELCRATN---RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ 815
           +M   +  R    ++L    +    F    L+G G +G VYK R +  G   A+KV D+ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 816 CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKA------LILEYMPHGSLEKSLY 868
            G   +    E  M+K    HRN+     +   +          L++E+   GS+     
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 869 SSNYILDIFQRLN-----------IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM 917
                 D+ +              I  ++   L +LH      VIH D+K  NVLL +N 
Sbjct: 115 -----TDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166

Query: 918 VAHLSDFGIAKLLIGEDQSITQTQTLATIG---YMAP 951
              L DFG++  L   D+++ +  T   IG   +MAP
Sbjct: 167 EVKLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAP 198

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.1 bits (224), Expect = 7e-19
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 23/182 (12%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISS 844
           +G+G FG V K +      E AVKV +      +   +   E E++K + H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 845 CSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
                   ++ E    G L     ++  +S +    I +       V + + Y+H     
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH---KH 140

Query: 900 PVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV 956
            ++H DLKP N+LL   + +    + DFG++     ++  +     + T  Y+AP +   
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRG 197

Query: 957 KY 958
            Y
Sbjct: 198 TY 199

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 88.0 bits (218), Expect = 1e-18
 Identities = 34/176 (19%), Positives = 72/176 (40%), Gaps = 16/176 (9%)

Query: 788 IGRG--GFGSVYKAR-IGEGMEVAVKVFDL--QCGRAFKSFDVECEMMKSIRHRNLIKVI 842
           IG+G     +V  AR    G  V V+  +L             E  + K   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYI--LDIFQRLNIMVDVATTLEYLHFGYSAP 900
           ++   +    ++  +M +GS  K L  ++++  ++      I+  V   L+Y+H      
Sbjct: 93  ATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMG 148

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI--GEDQSITQTQTLATIG---YMAP 951
            +H  +K S++L+  +   +LS       +I  G+ Q +       ++    +++P
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 9/167 (5%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA-FKSFDVECE-MMKSIRHRNLIKVISS 844
           +G G  G V+K R    G  +AVK       +   K   ++ + ++KS     +++   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
             T     + +E M     EK        +       + V +   L YL   +   VIH 
Sbjct: 93  FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           D+KPSN+LLD+     L DFGI+  L+       + ++     YMAP
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAP 193

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 47/222 (21%)

Query: 753 KQPPNDANMPPIATCRRFSYLELCRATNRFSEN----NLIGRGGFGSVYKAR-IGEGMEV 807
                 A+  P        Y       +  S+     + +GRG    VY+ +  G     
Sbjct: 22  SMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPY 81

Query: 808 AVKVFDLQCGRAFKSFDV-----ECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGS 862
           A+KV         K+ D      E  ++  + H N+IK+     T    +L+LE +  G 
Sbjct: 82  ALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134

Query: 863 L-----EKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL 913
           L     EK  YS    ++ +  I +           + YLH      ++H DLKP N+L 
Sbjct: 135 LFDRIVEKGYYSERDAADAVKQILE----------AVAYLH---ENGIVHRDLKPENLLY 181

Query: 914 ---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
                +    ++DFG++K ++     +    T+  T GY AP
Sbjct: 182 ATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCGTPGYCAP 219

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 39/177 (22%), Positives = 69/177 (38%), Gaps = 29/177 (16%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS 846
           +G G FG V++      G     K  +        +   E  +M  + H  LI +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 847 TEEFKALILEYMPHGSL------EKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFG 896
            +    LILE++  G L      E    S     NY+    +           L+++H  
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE----------GLKHMH-- 166

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
               ++H D+KP N++ +    + +   DFG+A   +  D+ +    T AT  + AP
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAP 219

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 59/290 (20%), Positives = 109/290 (37%), Gaps = 34/290 (11%)

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGF 466
             +    +  + S           L    +   + +  +    +S++    +  ++    
Sbjct: 7   TITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIKS-- 60

Query: 467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE 526
            + I  L N+  ++L GNKL    P  L  L+ L  L L++NK++      +  L KL  
Sbjct: 61  VQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK--DLSSLKDLKKLKS 116

Query: 527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP 586
           L L  N +S  I     +L  L +L LG+NK+T I   +  L  +  L+   N  +  +P
Sbjct: 117 LSLEHNGIS-DING-LVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVP 173

Query: 587 LDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSL 646
           L    L  L  +  S N+ SD+    + GL NL  L L              +L+   ++
Sbjct: 174 LA--GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229

Query: 647 -----------------NLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKG 679
                            +    N+   +P    ++S++    ++  K K 
Sbjct: 230 KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 279

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 45/244 (18%), Positives = 82/244 (33%), Gaps = 24/244 (9%)

Query: 270 LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGL 329
                      L K  +T  +    + L+++  +  +++ +       I  +  +T L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFL 75

Query: 330 QSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN 389
             N L+  +  +A   L NL  L L  N         + +  KL  L L  N  S     
Sbjct: 76  NGNKLT-DIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDING- 129

Query: 390 TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLS 449
              +L  L  + L  N +T        ++  S    L  + L +N +  I+P   +  L 
Sbjct: 130 -LVHLPQLESLYLGNNKITD-------ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKL- 180

Query: 450 HSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK 509
              +   +S  ++S    + +  L NL  + L   +           L     +   D  
Sbjct: 181 ---QNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 510 LEGP 513
           L  P
Sbjct: 236 LVTP 239

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 60/290 (20%), Positives = 106/290 (36%), Gaps = 49/290 (16%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
               N+   ++T  +      L+S+  +    + +  S+   I  L  +  +   GN+L+
Sbjct: 26  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT 81

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANIC--SNLPFLESISLSQNMFHGRIPSALSN 200
              P  + N  +L  L    N +      ++    +L  L+S+SL  N       + L +
Sbjct: 82  DIKP--LANLKNLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGI--SDINGLVH 132

Query: 201 CKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVS 260
              LE L L  N +       +  LTKL  L L              N         Q+S
Sbjct: 133 LPQLESLYLGNNKITDITV--LSRLTKLDTLSLE------------DN---------QIS 169

Query: 261 NLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN 320
           ++       LA LT L+ L L KN ++ ++   +  L NL +L+L   + +        N
Sbjct: 170 DIVP-----LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSN 222

Query: 321 MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRL-WSNNFSGTIPRFIFN 369
           +     +     SL  +   I+D    + E+  + W          FIF 
Sbjct: 223 LVVPNTVKNTDGSLV-TPEIISD--DGDYEKPNVKWHLPEFTNEVSFIFY 269

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 42/181 (23%), Positives = 70/181 (38%), Gaps = 38/181 (20%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSC 845
           +G G F    K          AVK+      R   +   E   +K    H N++K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL------------NIMVDVATTLEYL 893
             +    L++E +  G L             F+R+             IM  + + + ++
Sbjct: 76  HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 894 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           H      V+H DLKP N+L    +DN+   + DFG A+L   ++Q +       T+ Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177

Query: 951 P 951
           P
Sbjct: 178 P 178

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 45/281 (16%), Positives = 89/281 (31%), Gaps = 60/281 (21%)

Query: 129 YTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN 188
           +  +        +    PS      S Q L      L   IP++  SNLP +  I +S +
Sbjct: 11  HQEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSID 65

Query: 189 MFHGRIPS-ALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREF 246
           +   ++ S +  N   +  + +     L  I  +    L  LK L +  +GL+       
Sbjct: 66  VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK------- 118

Query: 247 GNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLS 306
                               P                          +++     +L+++
Sbjct: 119 ------------------MFPDLTK----------------------VYSTDIFFILEIT 138

Query: 307 HNKLVGAVPATIFN--MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIP 364
            N  + ++P   F    +    L L +N  + S+   A      L+ + L  N +   I 
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYA-FNGTKLDAVYLNKNKYLTVID 196

Query: 365 RFIFN--ASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLH 403
           +  F    S  S+L++ + S +        +L+ L      
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 28/210 (13%), Positives = 71/210 (33%), Gaps = 18/210 (8%)

Query: 248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLS 306
           +   L+L+   +  +        +NL  +  + +  +    ++     +NL  +  +++ 
Sbjct: 32  STQTLKLIETHLRTIP---SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 307 HNKLVGAVPATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPR 365
           + + +  +       +  L  LG+ +  L                 L +  N +  +IP 
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 366 FIFN--ASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLS--SFS 421
             F    ++   L+L  N F+      F   +   +         + N  L+ +   +F 
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAV-------YLNKNKYLTVIDKDAFG 201

Query: 422 NCKS-LTYIGLSNNPLDGILPRMSMGNLSH 450
              S  + + +S   +   LP   + +L  
Sbjct: 202 GVYSGPSLLDVSQTSVTA-LPSKGLEHLKE 230

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 33/220 (15%), Positives = 64/220 (29%), Gaps = 32/220 (14%)

Query: 473 LTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLS 530
             +   + L    L  +IP      L  +  +++  +     +       L+K+  + + 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 531 GNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI 589
             +    I       L  L  L + +  L   P                           
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP--------------DLTKVYS------ 128

Query: 590 GNLKVLIGIDFSTNNFSDVIPT-VIGGLTN-LQYLFLGYNRLQGSISESFGDLISLKSLN 647
               +   ++ + N +   IP     GL N    L L  N    S+     +   L ++ 
Sbjct: 129 --TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185

Query: 648 LSNNNLSRSIPI-SLEKL-SYLEDLDLSFNKLKGEIPKGG 685
           L+ N     I   +   + S    LD+S   +   +P  G
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 47/279 (16%), Positives = 89/279 (31%), Gaps = 61/279 (21%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
           +   ++  ++   IPS      S Q+L L    L  +IPS                    
Sbjct: 14  EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPS-------------------H 49

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS-ALSNCK 202
           AF +      ++  +  S +    ++ ++   NL  +  I +        I   AL    
Sbjct: 50  AFSNL----PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105

Query: 203 YLEILSLSINNLLGAIPKE--IGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVS 260
            L+ L +  N  L   P    + +      L +  +                      ++
Sbjct: 106 LLKFLGIF-NTGLKMFPDLTKVYSTDIFFILEITDN--------------------PYMT 144

Query: 261 NLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN 320
           ++     Q L N      LKL  N  T  +     N   L  + L+ NK +  +    F 
Sbjct: 145 SIPVNAFQGLCNE--TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201

Query: 321 --MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSN 357
              S  + L +       S++++    L +L+EL   + 
Sbjct: 202 GVYSGPSLLDVSQT----SVTALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 29/225 (12%)

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMS 322
            IP    +      LKL +  L   IP     NL N+  + +S +  +  + +  F N+S
Sbjct: 25  RIPSLPPSTQ---TLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80

Query: 323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIP--RFIFNASKLSVLELGR 380
            +T + +++      +   A  +LP L+ L +++       P    +++     +LE+  
Sbjct: 81  KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139

Query: 381 NSFSGFIP-NTFGNLRN-LRLMTLHYNYLTSSNLELSFLSS--FSNCKSLTYIGLSNNPL 436
           N +   IP N F  L N    + L+ N  TS       +    F+  K L  + L+ N  
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-------VQGYAFNGTK-LDAVYLNKNKY 191

Query: 437 DGILPRMSMGNLSHSLEYFDMSYCNVS----GGFPKEIGNLTNLI 477
             ++ + + G +       D+S  +V+     G      +L  LI
Sbjct: 192 LTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGL----EHLKELI 232

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 45/249 (18%), Positives = 80/249 (32%), Gaps = 37/249 (14%)

Query: 410 SNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE 469
           +  ++  + S     S   + L    L   +P  +  NL + +    +S           
Sbjct: 19  TCKDIQRIPSLP--PSTQTLKLIETHLR-TIPSHAFSNLPN-ISRIYVSIDVTLQQLESH 74

Query: 470 I-GNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDD--ICRLTKLY 525
              NL+ +  I +   +    I    L +L  L+ L + +  L+   PD   +      +
Sbjct: 75  SFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFF 133

Query: 526 ELGLSGNKLSGSIPA-CFSNLAS-LGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTG 583
            L ++ N    SIP   F  L +   TL L +N  TS+                   F G
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQ---------------GYAFNG 178

Query: 584 PLPLDIGNLKVLIGIDFSTNNFSDVIPT-VIGGL-TNLQYLFLGYNRLQGSISESFGDLI 641
                   L  +     + N +  VI     GG+ +    L +    +    S+    L 
Sbjct: 179 T------KLDAV---YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLK 229

Query: 642 SLKSLNLSN 650
            L + N   
Sbjct: 230 ELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 40/233 (17%), Positives = 76/233 (32%), Gaps = 35/233 (15%)

Query: 83  VKVLNISHLNLTGTIPSQ-LWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQ 140
            + L +   +L  TIPS    NL ++  + +  +     + S  F  L  + ++  R  +
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 141 LSGAFPSFIFNK-SSLQHLDFSYNALSGEIPA-NICSNLPFLESISLSQNMFHGRIPS-A 197
                      +   L+ L      L    P      +      + ++ N +   IP  A
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 198 LSN-CKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE-FGNLAELELM 255
               C     L L  NN   ++     N TKL  +YL  +     I ++ FG +      
Sbjct: 151 FQGLCNETLTLKLY-NNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV------ 203

Query: 256 ALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSH 307
                             +G  +L + +  +T  +P +   +L  L   +   
Sbjct: 204 -----------------YSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 32/175 (18%), Positives = 57/175 (32%), Gaps = 13/175 (7%)

Query: 517 DICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIP-LTIWNLKGMLYLN 575
             C   +  +  ++   +   IP   S   S  TL L    L +IP     NL  +  + 
Sbjct: 6   PPCECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61

Query: 576 FSSNFFTGPLPLDI-GNLKVLIGIDFSTNNFSDVIPT-VIGGLTNLQYLFLGYNRLQGSI 633
            S +     L      NL  +  I+         I    +  L  L++L +    L+   
Sbjct: 62  VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120

Query: 634 SE--SFGDLISLKSLNLSNNNLSRSIPI-SLEKL-SYLEDLDLSFNKLKGEIPKG 684
            +            L +++N    SIP+ + + L +    L L  N     +   
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 40/193 (20%), Positives = 68/193 (35%), Gaps = 31/193 (16%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVK-------------VFD--LQCGRAFKSF 823
            + ++    I  G +G+V      EG+ VA+K             +      C R  +  
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-- 78

Query: 824 DVECEMMKSIRHRNLIK---VISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQ 878
             E  ++    H N++    +             L+ E M    L + ++    ++    
Sbjct: 79  --EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQH 135

Query: 879 RLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
               M  +   L  LH    A V+H DL P N+LL DN    + DF +A+    +     
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-- 190

Query: 939 QTQTLATIGYMAP 951
            T  +    Y AP
Sbjct: 191 -THYVTHRWYRAP 202

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 86.0 bits (213), Expect = 1e-17
 Identities = 47/233 (20%), Positives = 106/233 (45%), Gaps = 26/233 (11%)

Query: 749 RKRVKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEV 807
           ++  ++  + ++ P  +  R  S  ++    +R+   +LIG G +G V +A    E   V
Sbjct: 25  QEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81

Query: 808 AVK----VFD--LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSTEEFKA--LILE 856
           A+K    VF+  + C R  +    E  ++  + H +++K   ++     E+F    ++LE
Sbjct: 82  AIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137

Query: 857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN 916
                  +K   +  Y+ ++  +  ++ ++   ++Y+H   SA ++H DLKP+N L++ +
Sbjct: 138 IADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQD 192

Query: 917 MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSY 969
               + DFG+A+ +  +      +Q   +       L    +   +   LT +
Sbjct: 193 CSVKVCDFGLARTV--DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 45/213 (21%), Positives = 72/213 (33%), Gaps = 52/213 (24%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRHRNLIKV 841
           IG+G +G V  A         A+K+ +    R     DV     E  +MK + H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 842 ISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRL---------------- 880
                 E++  L++E    G L          S+        +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 881 ------------------NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL- 921
                             NIM  + + L YLH   +  + H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 922 -SDFGIAKLLIGEDQSITQT-QTLA-TIGYMAP 951
             DFG++K     +        T A T  ++AP
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 86.0 bits (213), Expect = 2e-17
 Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 29/186 (15%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
            + +  +  +G G FG V++      G   A K          ++   E + M  +RH  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 838 LIKVISSCSTEEFKALILEYMPHGSL------EKSLYS----SNYILDIFQRLNIMVDVA 887
           L+ +  +   +    +I E+M  G L      E +  S      Y+  + +         
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK--------- 266

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSITQTQTLAT 945
             L ++H       +H DLKP N++        L   DFG+    +   QS+    T  T
Sbjct: 267 -GLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSV--KVTTGT 319

Query: 946 IGYMAP 951
             + AP
Sbjct: 320 AEFAAP 325

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 85.5 bits (212), Expect = 2e-17
 Identities = 41/195 (21%), Positives = 79/195 (40%), Gaps = 34/195 (17%)

Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKV-------------FDLQCGRAFKSFDVECEMMK 831
             +G G +G V   +      E A+KV              +    +  +    E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 832 SIRHRNLIKVISSCSTEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDV 886
           S+ H N+IK+      +++  L+ E+   G L      +  +      +I ++      +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ------I 155

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
            + + YLH      ++H D+KP N+LL   +  +   + DFG++     +D  +     L
Sbjct: 156 LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRL 209

Query: 944 ATIGYMAPGLFHVKY 958
            T  Y+AP +   KY
Sbjct: 210 GTAYYIAPEVLKKKY 224

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 39/183 (21%), Positives = 76/183 (41%), Gaps = 29/183 (15%)

Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
            S+  ++G G FG V+K      G+++A K+   +  +  +    E  +M  + H NLI+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 841 VISSCSTEEFKALILEYMPHGSL------EKSLYS----SNYILDIFQRLNIMVDVATTL 890
           +  +  ++    L++EY+  G L      E    +      ++  I +           +
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE----------GI 200

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSITQTQTLATIGY 948
            ++H  Y   ++H DLKP N+L  +     +   DFG+A+                T  +
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEF 254

Query: 949 MAP 951
           +AP
Sbjct: 255 LAP 257

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 84.6 bits (210), Expect = 4e-17
 Identities = 80/458 (17%), Positives = 139/458 (30%), Gaps = 71/458 (15%)

Query: 153 SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR----IPSALSNCKYLEILS 208
             +Q LD     LS    A +   L   + + L            I SAL     L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 209 LSINNLLGAIPKEIGNL-----TKLKELYLGYSGLQGE----IPREFGNLAELELMALQV 259
           L  N L       +         K+++L L    L G     +      L  L+ + L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 260 SNLQGEIPQELA-----NLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKL 310
           + L     Q L          LE L+L    L+      +   +    + K L +S+N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 311 --VGA---VPATIFNMSTLTGLGLQSNSLSG-SLSSIADV--QLPNLEELRLWSNNFSGT 362
              G          +   L  L L+S  ++  +   +  +     +L EL L SN     
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 363 IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN 422
                   ++L    L  +               LR + +    +T+             
Sbjct: 243 ------GMAELCPGLLHPS-------------SRLRTLWIWECGITAKGCG-DLCRVLRA 282

Query: 423 CKSLTYIGLSNNPL--DGILP-RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNL----TN 475
            +SL  + L+ N L  +G      ++      LE   +  C+ +        ++      
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342

Query: 476 LIGIYLGGNKLNGSIPITLGKL-----QKLQGLHLEDNKL--EG--PIPDDICRLTKLYE 526
           L+ + +  N+L  +    L +        L+ L L D  +       +   +     L E
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 402

Query: 527 LGLSGNKLSGSIPACFS-----NLASLGTLSLGSNKLT 559
           L LS N L  +               L  L L     +
Sbjct: 403 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 81.5 bits (202), Expect = 3e-16
 Identities = 82/412 (19%), Positives = 141/412 (34%), Gaps = 56/412 (13%)

Query: 82  RVKVLNISHLNLTGT----IPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTL-----YTLK 132
           + +V+ +    LT      I S L    +L  LNL  N L       +          ++
Sbjct: 29  QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 88

Query: 133 YVNFRGNQLS----GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNL----PFLESIS 184
            ++ +   L+    G   S +    +LQ L  S N L       +C  L      LE + 
Sbjct: 89  KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ 148

Query: 185 LSQNMFHGR----IPSALSNCKYLEILSLSINNLLGAIPKEIG-----NLTKLKELYLGY 235
           L            + S L      + L++S N++  A  + +      +  +L+ L L  
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLES 208

Query: 236 SGLQGEIPREFG-------NLAELELMA--LQVSNLQGEIPQELANLTGLEVLKLGKNFL 286
            G+  +  R+         +L EL L +  L    +    P  L   + L  L + +  +
Sbjct: 209 CGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268

Query: 287 TGE----IPPEIHNLHNLKLLDLSHNKL--VGA---VPATIFNMSTLTGLGLQSNSLS-G 336
           T +    +   +    +LK L L+ N+L   GA       +     L  L ++S S +  
Sbjct: 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328

Query: 337 SLSSIADV--QLPNLEELRLWSNNFSGTIPRFIFNA-----SKLSVLELGRNSFS----G 385
             S  + V  Q   L EL++ +N       R +        S L VL L     S     
Sbjct: 329 CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS 388

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
            +  T     +LR + L  N L  + +     S       L  + L +    
Sbjct: 389 SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 76.9 bits (190), Expect = 9e-15
 Identities = 85/452 (18%), Positives = 140/452 (30%), Gaps = 84/452 (18%)

Query: 104 LSSLQSLNLGFNRLS----GSIPSAIFTLYTLKYVNFRGNQLSGA-----FPSFIFNKSS 154
           L   Q + L    L+      I SA+     L  +N R N+L                  
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 155 LQHLDFSYNALSGEIPANICSNL---PFLESISLSQNMFHGR-----IPSALSNCKYLEI 206
           +Q L      L+G     + S L   P L+ + LS N+             L     LE 
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 207 LSLSINNL----LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
           L L   +L       +   +      KEL +  + +             +    L+ S  
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG-------VRVLCQGLKDSPC 199

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKL--VGAV-- 314
           Q            LE LKL    +T +    +   + +  +L+ L L  NKL  VG    
Sbjct: 200 Q------------LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAEL 247

Query: 315 -PATIFNMSTLTGLGLQSNSLSG-SLSSIADV--QLPNLEELRLWSNNFSGTIPRFIFNA 370
            P  +   S L  L +    ++      +  V     +L+EL L  N             
Sbjct: 248 CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE-------- 299

Query: 371 SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIG 430
                   G       +      L +L +        T++     F S  +  + L  + 
Sbjct: 300 --------GARLLCETLLEPGCQLESLWVK---SCSFTAACCS-HFSSVLAQNRFLLELQ 347

Query: 431 LSNNPL-DGILPRMSMG--NLSHSLEYFDMSYCNVSGGFPKEIG----NLTNLIGIYLGG 483
           +SNN L D  +  +  G       L    ++ C+VS      +        +L  + L  
Sbjct: 348 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 407

Query: 484 NKLNGSIPITLGKLQK-----LQGLHLEDNKL 510
           N L  +  + L +  +     L+ L L D   
Sbjct: 408 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 64.2 bits (157), Expect = 9e-11
 Identities = 57/347 (16%), Positives = 112/347 (32%), Gaps = 58/347 (16%)

Query: 371 SKLSVLELGRNSFS-GFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI 429
             +  L++     S          L+  +++ L    LT +  +    S+     +L  +
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAEL 61

Query: 430 GLSNNPLDG----ILPRMSMGNLSHSLEYFDMSYCNVS----GGFPKEIGNLTNLIGIYL 481
            L +N L       + +  +   S  ++   +  C ++    G     +  L  L  ++L
Sbjct: 62  NLRSNELGDVGVHCVLQG-LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 482 GGNKLN--GSIPITLGKLQ---KLQGLHLEDNKLEGPIPDDICRL----TKLYELGLSGN 532
             N L   G   +  G L    +L+ L LE   L     + +  +        EL +S N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 533 KLSGS-----IPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPL 587
            ++ +           +   L  L L S  +TS             L             
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTS--------DNCRDLCGI---------- 222

Query: 588 DIGNLKVLIGIDFSTNNFSD-----VIPTVIGGLTNLQYLFLGYNRLQ----GSISESFG 638
            + +   L  +   +N   D     + P ++   + L+ L++    +     G +     
Sbjct: 223 -VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 639 DLISLKSLNLSNNNLS----RSIPISLEKLSY-LEDLDLSFNKLKGE 680
              SLK L+L+ N L     R +  +L +    LE L +        
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 56.1 bits (136), Expect = 4e-08
 Identities = 43/260 (16%), Positives = 83/260 (31%), Gaps = 45/260 (17%)

Query: 448 LSHSLEYFDMSYCNVS-GGFPKEIGNLTNLIGIYLGGNKLN----GSIPITLGKLQKLQG 502
           +S  ++  D+    +S   + + +  L     + L    L       I   L     L  
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 503 LHLEDNKLEGPIPDDICRL-----TKLYELGLSGNKLS----GSIPACFSNLASLGTLSL 553
           L+L  N+L       + +       K+ +L L    L+    G + +    L +L  L L
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 554 GSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDV----I 609
             N L           G+  L         P       L+ L        + S      +
Sbjct: 121 SDNLLGD--------AGLQLL---CEGLLDPQC----RLEKL---QLEYCSLSAASCEPL 162

Query: 610 PTVIGGLTNLQYLFLGYNRLQGSISESFGDLI-----SLKSLNLSNNNLS----RSIPIS 660
            +V+    + + L +  N +  +        +      L++L L +  ++    R +   
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222

Query: 661 LEKLSYLEDLDLSFNKLKGE 680
           +   + L +L L  NKL   
Sbjct: 223 VASKASLRELALGSNKLGDV 242

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 80.5 bits (199), Expect = 6e-17
 Identities = 46/163 (28%), Positives = 66/163 (40%), Gaps = 10/163 (6%)

Query: 277 EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN-MSTLTGLGLQSNSLS 335
           E L L    L          L  L  L+L +N+L   + A +F+ ++ L  LGL +N L+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 336 GSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNL 394
            SL       L  L++L L  N    ++P  +F   +KL  L L  N         F  L
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154

Query: 395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
            NL+ ++L  N L S         +F     L  I L  N  D
Sbjct: 155 TNLQTLSLSTNQLQSVPH-----GAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 74.3 bits (183), Expect = 9e-15
 Identities = 54/187 (28%), Positives = 75/187 (40%), Gaps = 54/187 (28%)

Query: 501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLT 559
           + L L+   L          LTKL  L L  N+L  ++ A  F +L  LGTL L +N+L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
           S+P                                                 V   LT L
Sbjct: 97  SLP-----------------------------------------------LGVFDHLTQL 109

Query: 620 QYLFLGYNRLQGSISES-FGDLISLKSLNLSNNNLSRSIPISL-EKLSYLEDLDLSFNKL 677
             L+LG N+L+ S+    F  L  LK L L+ N L +SIP    +KL+ L+ L LS N+L
Sbjct: 110 DKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQL 167

Query: 678 KGEIPKG 684
           +  +P G
Sbjct: 168 QS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 37/132 (28%), Positives = 53/132 (40%), Gaps = 7/132 (5%)

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
              L S+P  I      L L   S             L  L  ++   N    +   V  
Sbjct: 23  GKSLDSVPSGIPADTEKLDLQ--STGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD 80

Query: 615 GLTNLQYLFLGYNRLQGSISES-FGDLISLKSLNLSNNNLSRSIPISL-EKLSYLEDLDL 672
            LT L  L L  N+L  S+    F  L  L  L L  N L  S+P  + ++L+ L++L L
Sbjct: 81  DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRL 138

Query: 673 SFNKLKGEIPKG 684
           + N+L+  IP G
Sbjct: 139 NTNQLQ-SIPAG 149

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 15/157 (9%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLS 142
           + L++    L     +    L+ L  LNL +N+L  ++ + +F  L  L  +    NQL+
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 143 GAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS----A 197
            + P  +F+  + L  L    N L   +P+ +   L  L+ + L+ N     IP+     
Sbjct: 97  -SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153

Query: 198 LSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYL 233
           L+N   L+ LSLS  N L ++P      L KL+ + L
Sbjct: 154 LTN---LQTLSLS-TNQLQSVPHGAFDRLGKLQTITL 186

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 49/211 (23%), Positives = 68/211 (32%), Gaps = 63/211 (29%)

Query: 350 EELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTS 409
           E+L L S   +          +KL+ L L  N         F +L  L  + L  N L S
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 410 SNLELSFLSS--FSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFP 467
                  L    F +   L  + L  N L  +   +           FD           
Sbjct: 98  -------LPLGVFDHLTQLDKLYLGGNQLKSLPSGV-----------FD----------- 128

Query: 468 KEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYE 526
                                       +L KL+ L L  N+L+  IP     +LT L  
Sbjct: 129 ----------------------------RLTKLKELRLNTNQLQS-IPAGAFDKLTNLQT 159

Query: 527 LGLSGNKLSGSIPA-CFSNLASLGTLSLGSN 556
           L LS N+L  S+P   F  L  L T++L  N
Sbjct: 160 LSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 44/191 (23%), Positives = 74/191 (38%), Gaps = 31/191 (16%)

Query: 120 SIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPF 179
           S+PS I      + ++ +   L+    +     + L  L+  YN L   + A +  +L  
Sbjct: 28  SVPSGIPA--DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTE 84

Query: 180 LESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGL 238
           L ++ L+ N                          L ++P  +  +LT+L +LYLG + L
Sbjct: 85  LGTLGLANNQ-------------------------LASLPLGVFDHLTQLDKLYLGGNQL 119

Query: 239 QGEIPREFGNLAELELMALQVSNLQGEIPQEL-ANLTGLEVLKLGKNFLTGEIPPEIHNL 297
           +      F  L +L+ + L  + LQ  IP      LT L+ L L  N L          L
Sbjct: 120 KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRL 178

Query: 298 HNLKLLDLSHN 308
             L+ + L  N
Sbjct: 179 GKLQTITLFGN 189

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 82.6 bits (204), Expect = 6e-17
 Identities = 55/200 (27%), Positives = 75/200 (37%), Gaps = 40/200 (20%)

Query: 514 IPDDICRLTKLYELGLSGNKLSGSIPA--CFSNLASLGTLSLGSNKLTSIPLTIWNLKGM 571
           +P  +   T    L LS N LS  + A    + L +L +L L  N L  I          
Sbjct: 33  VPQSLPSYTA--LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFIS--------- 80

Query: 572 LYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG 631
                 S  F   +P    NL+ L   D S+N+   +   +   L  L+ L L  N +  
Sbjct: 81  ------SEAFVP-VP----NLRYL---DLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV 126

Query: 632 SISESFGDLISLKSLNLSNNNLSRSIP----ISLEKLSYLEDLDLSFNKLKGEIPKGGSF 687
               +F D+  L+ L LS N +S   P        KL  L  LDLS NKLK ++P     
Sbjct: 127 VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL-TDL 183

Query: 688 GNFSAK-----SFEGNELLC 702
               A          N L C
Sbjct: 184 QKLPAWVKNGLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 46/181 (25%), Positives = 66/181 (36%), Gaps = 29/181 (16%)

Query: 500 LQGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKLSGSIPAC-FSNLASLGTLSLGSNK 557
              L L  N L     +    RLT L+ L LS N L+  I +  F  + +L  L L SN 
Sbjct: 41  TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99

Query: 558 LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLT 617
           L ++                   F+  L      L+VL       N+   V       + 
Sbjct: 100 LHTLD---------------EFLFSD-LQ----ALEVL---LLYNNHIVVVDRNAFEDMA 136

Query: 618 NLQYLFLGYNRLQGSISESFGD---LISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF 674
            LQ L+L  N++     E   D   L  L  L+LS+N L +     L+KL       L  
Sbjct: 137 QLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196

Query: 675 N 675
           +
Sbjct: 197 H 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 17/174 (9%)

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKEI--GNLTKLKELYLGYSGLQGEIPRE-FGNLA 250
           +P +L +  Y  +L LS NNL   +  E     LT L  L L ++ L   I  E F  + 
Sbjct: 33  VPQSLPS--YTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 251 ELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHN 308
            L  + L  ++L   + +   ++L  LEVL L  N +   +      ++  L+ L LS N
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146

Query: 309 KLVGAVPATIF----NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
           ++    P  +      +  L  L L SN L   L      +LP   +  L+ +N
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 43/213 (20%), Positives = 64/213 (30%), Gaps = 53/213 (24%)

Query: 447 NLSHSLEYFDMSYCNVSGGFPKEI-GNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLH 504
           +L       D+S+ N+S    +     LTNL  + L  N LN  I       +  L+ L 
Sbjct: 36  SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94

Query: 505 LEDNKLEGPIPDDICR-LTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIP 562
           L  N L   + + +   L  L  L L  N +   +    F ++A L  L L  N+++  P
Sbjct: 95  LSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFP 152

Query: 563 LTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYL 622
                                                                L  L  L
Sbjct: 153 ---------------VELIKD-----------------------------GNKLPKLMLL 168

Query: 623 FLGYNRLQGSISESFGDLISLK--SLNLSNNNL 653
            L  N+L+         L +     L L NN L
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.0 bits (179), Expect = 9e-14
 Identities = 56/262 (21%), Positives = 91/262 (34%), Gaps = 44/262 (16%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
              +L  S  +L   VP ++   S    L L  N+LS   +     +L NL  L L  N+
Sbjct: 19  ASNILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75

Query: 359 FSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFL 417
            +  I    F     L  L+L  N         F +L+ L ++ L+ N++    ++    
Sbjct: 76  LN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV--VD---R 129

Query: 418 SSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLI 477
           ++F +   L  + LS N +    P   + + +                       L  L+
Sbjct: 130 NAFEDMAQLQKLYLSQNQISRF-PVELIKDGNK----------------------LPKLM 166

Query: 478 GIYLGGNKLNGSIPITLGKLQKL--QGLHLEDNKLEGPIPDDICRL----TKLYELGLSG 531
            + L  NKL       L KL      GL+L +N    P+  D C+L    +      LS 
Sbjct: 167 LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN----PLECD-CKLYQLFSHWQYRQLSS 221

Query: 532 NKLSGSIPACFSNLASLGTLSL 553
                    C  +       SL
Sbjct: 222 VMDFQEDLYCMHSKKLHNIFSL 243

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 46/180 (25%), Positives = 66/180 (36%), Gaps = 14/180 (7%)

Query: 89  SHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLSGAFPS 147
           S   L   +P  L   S    L+L  N LS        T L  L  +    N L+    S
Sbjct: 26  SKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81

Query: 148 FIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS-ALSNCKYLE 205
             F    +L++LD S N L   +   + S+L  LE + L  N     +   A  +   L+
Sbjct: 82  EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQ 139

Query: 206 ILSLSINNLLGAIPKEI----GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN 261
            L LS  N +   P E+      L KL  L L  + L+     +   L       L + N
Sbjct: 140 KLYLS-QNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.4 bits (175), Expect = 3e-13
 Identities = 43/208 (20%), Positives = 82/208 (39%), Gaps = 32/208 (15%)

Query: 106 SLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSYNA 164
           +   L+    +L  ++P ++ +      ++   N LS     +   + ++L  L  S+N 
Sbjct: 19  ASNILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH 75

Query: 165 LSGEIPANICSNLPFLESISLSQNMFHGRIPS-ALSNCKYLEILSLSINNLLGAIPKEI- 222
           L+  I +     +P L  + LS N  H  +     S+ + LE+L L  NN +  + +   
Sbjct: 76  LN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY-NNHIVVVDRNAF 132

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
            ++ +L++LYL              N         Q+S    E+ ++   L  L +L L 
Sbjct: 133 EDMAQLQKLYLSQ------------N---------QISRFPVELIKDGNKLPKLMLLDLS 171

Query: 283 KNFLTGEIPPEIHNLHNLKL--LDLSHN 308
            N L      ++  L       L L +N
Sbjct: 172 SNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 13/159 (8%)

Query: 83  VKVLNISHLNLTGTIPSQ--LWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGN 139
             +L++SH NL+  + ++     L++L SL L  N L+  I S  F  +  L+Y++   N
Sbjct: 41  TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 140 QLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP--- 195
            L      F+F+   +L+ L    N +   +  N   ++  L+ + LSQN    R P   
Sbjct: 99  HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155

Query: 196 -SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYL 233
               +    L +L LS N L      ++  L    +  L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 70.3 bits (172), Expect = 8e-13
 Identities = 33/144 (22%), Positives = 58/144 (40%), Gaps = 5/144 (3%)

Query: 550 TLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP-LDIGNLKVLIGIDFSTNNFSDV 608
            LS    +L ++P ++        L+ S N  +          L  L  +  S N+ + +
Sbjct: 22  ILSCSKQQLPNVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI 79

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLE 668
                  + NL+YL L  N L       F DL +L+ L L NN++      + E ++ L+
Sbjct: 80  SSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139

Query: 669 DLDLSFNKLKGEIPKGGSFGNFSA 692
            L LS N++    P      + + 
Sbjct: 140 KLYLSQNQIS-RFPV-ELIKDGNK 161

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 10/109 (9%)

Query: 84  KVLNISHLNLTGTIPSQ-LWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQL 141
           + L++S  +L  T+      +L +L+ L L  N +   +    F  +  L+ +    NQ+
Sbjct: 91  RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI 148

Query: 142 S----GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
           S                L  LD S N L  ++P      LP      L 
Sbjct: 149 SRFPVELIKDG-NKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLY 195

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 81.5 bits (202), Expect = 7e-17
 Identities = 40/187 (21%), Positives = 74/187 (39%), Gaps = 40/187 (21%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD----LQCGRAFKSFDVECEMMKSIRHRNLIK- 840
           L+G G +G V +          AVK+       +      +   E ++++ +RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 841 --VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD----------IFQRLNIMVDVAT 888
             V+ +   ++   +++EY   G  E  +   + + +           F +L        
Sbjct: 72  VDVLYN-EEKQKMYMVMEYCVCGMQE--ML--DSVPEKRFPVCQAHGYFCQL------ID 120

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI-- 946
            LEYLH   S  ++H D+KP N+LL       +S  G+A+ L           T  T   
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQG 173

Query: 947 --GYMAP 951
              +  P
Sbjct: 174 SPAFQPP 180

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 45/183 (24%), Positives = 77/183 (42%), Gaps = 36/183 (19%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSF-----DVEC-----EMMKSIRH 835
           ++G G F +V  AR +    E A+K+ +       K        V       ++M  + H
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILE-------KRHIIKENKVPYVTRERDVMSRLDH 89

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATT 889
              +K+  +   +E     L Y  +G L K +             +         ++ + 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSA 142

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGY 948
           LEYLH      +IH DLKP N+LL+++M   ++DFG AK+L  E +      +   T  Y
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQY 198

Query: 949 MAP 951
           ++P
Sbjct: 199 VSP 201

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 83.3 bits (206), Expect = 1e-16
 Identities = 50/181 (27%), Positives = 83/181 (45%), Gaps = 20/181 (11%)

Query: 782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEM-----MKSIRH 835
           F +  ++GRGGFG V+  ++   G   A K   L   R  K    +  M     +  +  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV----DVATTLE 891
           R ++ +  +  T+    L++  M  G +   +Y+ +     F +    +     + + LE
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAIFYTAQIVSGLE 303

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMA 950
           +LH      +I+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MA
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMA 357

Query: 951 P 951
           P
Sbjct: 358 P 358

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 44/184 (23%), Positives = 68/184 (36%), Gaps = 36/184 (19%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDV-----ECEMMKSIRHRNLIK 840
           +G G F  V K R    G+E A K     Q   + +         E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYS----SNYILDIFQRLNIMVDVATTLE 891
           +           LILE +  G L     +K   S    +++I  I             + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD----------GVN 129

Query: 892 YLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
           YLH   +  + H DLKP N++L           L DFG+A   I +           T  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPE 183

Query: 948 YMAP 951
           ++AP
Sbjct: 184 FVAP 187

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 56/207 (27%), Positives = 81/207 (39%), Gaps = 32/207 (15%)

Query: 479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSI 538
             L    +      T  +L  +  +   ++ ++         L  +  L L GNKL   I
Sbjct: 24  ANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH-DI 78

Query: 539 PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGI 598
            A    L +L  L L  N+L S+P  +               F     L    L      
Sbjct: 79  SA-LKELTNLTYLILTGNQLQSLPNGV---------------FDKLTNLKELVL------ 116

Query: 599 DFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP 658
               N    +   V   LTNL YL L +N+LQ      F  L +L  L+LS N L  S+P
Sbjct: 117 --VENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLP 173

Query: 659 ISL-EKLSYLEDLDLSFNKLKGEIPKG 684
             + +KL+ L+DL L  N+LK  +P G
Sbjct: 174 EGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 18/225 (8%)

Query: 215 LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLT 274
               P +     +  +  L    +   +      L  ++ +    S+++      +  L 
Sbjct: 10  KQIFPDDA--FAETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLP 63

Query: 275 GLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN-MSTLTGLGLQSNS 333
            +  L LG N L       +  L NL  L L+ N+L  ++P  +F+ ++ L  L L  N 
Sbjct: 64  NVRYLALGGNKLHD--ISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120

Query: 334 LSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFG 392
           L  SL      +L NL  L L  N    ++P+ +F+  + L+ L+L  N         F 
Sbjct: 121 LQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFD 178

Query: 393 NLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
            L  L+ + L+ N L S          F    SL YI L +NP D
Sbjct: 179 KLTQLKDLRLYQNQLKSVPDG-----VFDRLTSLQYIWLHDNPWD 218

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 45/190 (23%), Positives = 76/190 (40%), Gaps = 43/190 (22%)

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
             L + S +  +      L ++  +  + + + S       +       ++ Y+ L  N 
Sbjct: 24  ANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVRYLALGGNK 74

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITL- 494
           L               +                    LTNL  + L GN+L  S+P  + 
Sbjct: 75  LH-------------DISALK---------------ELTNLTYLILTGNQLQ-SLPNGVF 105

Query: 495 GKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLS 552
            KL  L+ L L +N+L+  +PD +  +LT L  L L+ N+L  S+P   F  L +L  L 
Sbjct: 106 DKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELD 163

Query: 553 LGSNKLTSIP 562
           L  N+L S+P
Sbjct: 164 LSYNQLQSLP 173

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 56/234 (23%), Positives = 88/234 (37%), Gaps = 46/234 (19%)

Query: 303 LDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT 362
            +L    +          ++++  +   ++ +  S+  I    LPN+  L L  N     
Sbjct: 24  ANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIK-SVQGIQ--YLPNVRYLALGGNKLH-D 77

Query: 363 IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS--F 420
           I       + L+ L L  N         F  L NL+ + L  N L S       L    F
Sbjct: 78  ISAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-------LPDGVF 129

Query: 421 SNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY 480
               +LTY+ L++N L  +   +           FD                LTNL  + 
Sbjct: 130 DKLTNLTYLNLAHNQLQSLPKGV-----------FD---------------KLTNLTELD 163

Query: 481 LGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGN 532
           L  N+L  S+P     KL +L+ L L  N+L+  +PD +  RLT L  + L  N
Sbjct: 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 15/138 (10%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIF-TLYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDF 160
            L++L  L L  N+L  S+P+ +F  L  LK +    NQL  + P  +F+K ++L +L+ 
Sbjct: 83  ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140

Query: 161 SYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSA----LSNCKYLEILSLSINNLLG 216
           ++N L   +P  +   L  L  + LS N     +P      L+    L+ L L   N L 
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ---LKDLRLY-QNQLK 194

Query: 217 AIPKEI-GNLTKLKELYL 233
           ++P  +   LT L+ ++L
Sbjct: 195 SVPDGVFDRLTSLQYIWL 212

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 52/240 (21%), Positives = 80/240 (33%), Gaps = 39/240 (16%)

Query: 96  TIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSL 155
             P      +     NL    ++ ++             N    +             ++
Sbjct: 12  IFPDDA--FAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYL----PNV 65

Query: 156 QHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLL 215
           ++L    N L                   +S           L+N   L  L L+  N L
Sbjct: 66  RYLALGGNKLH-----------------DIS--ALKE-----LTN---LTYLILT-GNQL 97

Query: 216 GAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLT 274
            ++P  +   LT LKEL L  + LQ      F  L  L  + L  + LQ         LT
Sbjct: 98  QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLT 157

Query: 275 GLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSN 332
            L  L L  N L   +P  +   L  LK L L  N+L  +VP  +F  +++L  + L  N
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 37/144 (25%), Positives = 61/144 (42%), Gaps = 11/144 (7%)

Query: 537 SIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI-GNLKVL 595
             P      A     +L    +T    T   L  +  +  +++       +    N++ L
Sbjct: 12  IFPDDAF--AETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQGIQYLPNVRYL 68

Query: 596 IGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR 655
                  N   D+  + +  LTNL YL L  N+LQ   +  F  L +LK L L  N L  
Sbjct: 69  ---ALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122

Query: 656 SIPISL-EKLSYLEDLDLSFNKLK 678
           S+P  + +KL+ L  L+L+ N+L+
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQ 146

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 52/184 (28%), Positives = 72/184 (39%), Gaps = 36/184 (19%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDV---ECEMMKSIRHRNLIK 840
           +G G F  V K R  G G E A K      L   R   S +    E  +++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYS----SNYILDIFQRLNIMVDVATTLE 891
           +      +    LILE +  G L     EK   +    + ++  I             + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD----------GVH 122

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLIGEDQSITQTQTLATIG 947
           YLH   S  + H DLKP N++L D  V +    L DFGIA   I             T  
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFGTPE 176

Query: 948 YMAP 951
           ++AP
Sbjct: 177 FVAP 180

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 36/172 (20%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVK-VFDLQC--GRAFKSFDVECEMMKSIRH 835
              ++   +IG G FG V++A++ E  EVA+K V   +    R       E ++M+ ++H
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKH 91

Query: 836 RNLIK----VISSCSTEEFKA--LILEYMP--------HGSLEKSLYSSNYI-LDIFQRL 880
            N++       S+   ++     L+LEY+P        H +  K       I L ++Q L
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLI 931
                   +L Y+H   S  + H D+KP N+LLD  + V  L DFG AK+LI
Sbjct: 152 R-------SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 44/184 (23%), Positives = 69/184 (37%), Gaps = 36/184 (19%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD------LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G F  V K R    G+E A K          + G   +  + E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYS----SNYILDIFQRLNIMVDVATTLE 891
           +           LILE +  G L     +K   S    +++I  I             + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD----------GVN 129

Query: 892 YLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
           YLH   +  + H DLKP N++L           L DFG+A   I +           T  
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPE 183

Query: 948 YMAP 951
           ++AP
Sbjct: 184 FVAP 187

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 44/200 (22%), Positives = 74/200 (37%), Gaps = 48/200 (24%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD--------------------LQCGRAFKSFDV 825
            IG+G +G V  A    +    A+KV                         G   +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 826 ------ECEMMKSIRHRNLIK---VISSCSTEEFKALILEYMPHGSL----EKSLYSSNY 872
                 E  ++K + H N++K   V+     E+   ++ E +  G +         S + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDD-PNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138

Query: 873 ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 932
               FQ      D+   +EYLH      +IH D+KPSN+L+ ++    ++DFG++    G
Sbjct: 139 ARFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 933 EDQSITQTQTLA-TIGYMAP 951
            D           T  +MAP
Sbjct: 190 SD---ALLSNTVGTPAFMAP 206

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 42/191 (21%), Positives = 72/191 (37%), Gaps = 54/191 (28%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECE---MMKSIRHRNLIKVI 842
           ++G G  G V +      G + A+K+          S     E     ++    +++ ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 843 ----SSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-IFQRLN----------IMVDVA 887
               +    +    +I+E M  G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLA 944
           T +++LH   S  + H D+KP N+L    + + V  L+DFG AK         T    L 
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--------ETTQNALQ 187

Query: 945 TI----GYMAP 951
           T      Y+AP
Sbjct: 188 TPCYTPYYVAP 198

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.5 bits (199), Expect = 4e-16
 Identities = 51/189 (26%), Positives = 80/189 (42%), Gaps = 33/189 (17%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK----VFDLQ--CGRAFKSFDVECEMMK 831
             R+     IG G  G V  A        VA+K     F  Q    RA++    E  +MK
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMK 79

Query: 832 SIRHRNLIKV----ISSCSTEEFKA--LILEYMP---HGSLEKSLYSSNYILDIFQRLNI 882
            + H+N+I +        S EEF+   +++E M       ++  L        ++Q L  
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC- 138

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
                  +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S   T  
Sbjct: 139 ------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 186

Query: 943 LATIGYMAP 951
           + T  Y AP
Sbjct: 187 VVTRYYRAP 195

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 45/181 (24%), Positives = 71/181 (39%), Gaps = 18/181 (9%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD-LQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           +G G FG V+       G+E  +K  +  +     +  + E E++KS+ H N+IK+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 846 STEEFKALILEYMPHGSL-----EKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
                  +++E    G L                       +M  +   L Y H   S  
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG--YVAELMKQMMNALAYFH---SQH 144

Query: 901 VIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK 957
           V+H DLKP N+L      +    + DFG+A+ L   D+    T    T  YMAP +F   
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDE--HSTNAAGTALYMAPEVFKRD 201

Query: 958 Y 958
            
Sbjct: 202 V 202

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 42/203 (20%), Positives = 87/203 (42%), Gaps = 28/203 (13%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK----VFD--LQCGRAFKSFDVECEMMK 831
            + +   +LIGRG +G VY A        VA+K    +F+  + C R  +    E  ++ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR----EITILN 80

Query: 832 SIRHRNLIK---VISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
            ++   +I+   +I      +F    ++LE      L+K   +  ++ +   +  I+ ++
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKT-ILYNL 138

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
                ++H    + +IH DLKP+N LL+ +    + DFG+A       ++I   +    +
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA-------RTINSEKDTNIV 188

Query: 947 GYMAPGLFHVKYILFVVNFLTSY 969
             +        +   +   LTS+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSH 211

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 31/179 (17%), Positives = 63/179 (35%), Gaps = 34/179 (18%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV--ECEMMKSIRHRNLIKVISS 844
           +GRG FG V++            K       +      V  E  ++   RHRN++ +  S
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 845 CSTEEFKALILEYMPHGSL------EKSLYS----SNYILDIFQRLNIMVDVATTLEYLH 894
             + E   +I E++    +           +     +Y+  + +           L++LH
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE----------ALQFLH 119

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                 + H D++P N++      + +   +FG A+  +    +           Y AP
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAPEYYAP 172

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 78.8 bits (195), Expect = 9e-16
 Identities = 43/184 (23%), Positives = 68/184 (36%), Gaps = 36/184 (19%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFD-LQCGRAFKSFDV-----ECEMMKSIRHRNLIK 840
           +G G F  V K R    G++ A K     +   + +         E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 841 VISSCSTEEFKALILEYMPHGSL-----EKSLYS----SNYILDIFQRLNIMVDVATTLE 891
           +      +    LILE +  G L     EK   +    + ++  I             + 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN----------GVY 128

Query: 892 YLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIG 947
           YLH   S  + H DLKP N++L           + DFG+A   I             T  
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPE 182

Query: 948 YMAP 951
           ++AP
Sbjct: 183 FVAP 186

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.2 bits (196), Expect = 9e-16
 Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 28/188 (14%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK---VFD--LQCGRAFKSFDVECEMMKS 832
             R++  + IG G +G V  A      + VA+K    F+    C R  +    E +++  
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLR 81

Query: 833 IRHRNLIK---VISSCSTEEFKA--LILEYMPHGSLEKSLY---SSNYILDIFQRLNIMV 884
            RH N+I    +I + + E+ K   ++ + M     E  LY    + ++ +       + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY-FLY 135

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSITQTQTL 943
            +   L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 944 ATIGYMAP 951
           AT  Y AP
Sbjct: 193 ATRWYRAP 200

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 23/145 (15%), Positives = 44/145 (30%), Gaps = 10/145 (6%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA--FKS-FDVECEMMKSIRHRNLIKVI 842
             G       ++A       +VA+   D Q                 +  I    + +V+
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVI 902
               T     ++ E++  GSL++   +S         +  M  +A   +  H    A V 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVA 151

Query: 903 HCDLKPSNVLLDDNMVAHLSDFGIA 927
                PS V +  +    L+     
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATM 176

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 44/235 (18%), Positives = 81/235 (34%), Gaps = 59/235 (25%)

Query: 749 RKRVKQPPNDANMPPIATCRRFSYLE-LCRATNRFSEN-----NLIGRGGFGSVYKAR-I 801
              +  PP     PP     +F     L    N   ++      ++G G  G V +    
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84

Query: 802 GEGMEVAVKVFDLQCGRAFKSFDVECE---MMKSIRHRNLIKVI----SSCSTEEFKALI 854
               + A+K+                E     ++ +  ++++++    +  +  +   ++
Sbjct: 85  RTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137

Query: 855 LEYMPHGSLEKSLYSSNYILD-IFQRLN----------IMVDVATTLEYLHFGYSAPVIH 903
           +E +  G L             I  R +          IM  +   ++YLH   S  + H
Sbjct: 138 MECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAH 184

Query: 904 CDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI----GYMAP 951
            D+KP N+L      N +  L+DFG AK         T   +L T      Y+AP
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKE-------TTSHNSLTTPCYTPYYVAP 232

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 79.4 bits (196), Expect = 1e-15
 Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 23/172 (13%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK-VFDLQ--CGRAFKSFDVECEMMKSIR 834
              +++  +IG G FG VY+A++ + G  VA+K V   +    R       E ++M+ + 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLD 105

Query: 835 HRNLIK----VISSCSTEEFKAL--ILEYMPH--GSLEKSLYSSNYILDIFQRLNIMVDV 886
           H N+++      SS   ++   L  +L+Y+P     + +    +   L +      M  +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSI 937
             +L Y+H   S  + H D+KP N+LLD D  V  L DFG AK L+  + ++
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 214

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 35/189 (18%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK----VFD--LQCGRAFKSFDVECEMMK 831
              +     +G G +GSV  A     G +VA+K     F   +   RA++    E  ++K
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----ELLLLK 78

Query: 832 SIRHRNLIK----VISSCSTEEFKA--LILEYMP---HGSLEKSLYSSNYILDIFQRLNI 882
            ++H N+I        + S   F    L++ +M       +            ++Q L  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK- 137

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
                  L+Y+H   SA V+H DLKP N+ ++++    + DFG+A+           T  
Sbjct: 138 ------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGY 183

Query: 943 LATIGYMAP 951
           + T  Y AP
Sbjct: 184 VVTRWYRAP 192

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 44/220 (20%)

Query: 752 VKQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK 810
           +++PP    +  +A C           + ++S  + +G G FG V+ A    +  EV VK
Sbjct: 3   LEEPPKAVELEGLAACEG-------EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK 55

Query: 811 VFD--------LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGS 862
                                 +E  ++  + H N+IKV+     + F  L++E    G 
Sbjct: 56  FIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSG- 114

Query: 863 LEKSLYSSNYILD-----------IFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNV 911
           L+  L+   +I             IF++L       + + YL       +IH D+K  N+
Sbjct: 115 LD--LF--AFIDRHPRLDEPLASYIFRQL------VSAVGYLR---LKDIIHRDIKDENI 161

Query: 912 LLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           ++ ++    L DFG A  L  E   +  T    TI Y AP
Sbjct: 162 VIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAP 198

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 39/174 (22%), Positives = 72/174 (41%), Gaps = 21/174 (12%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK-VFD--LQCGRAFKSFDVECEMMKSIR 834
            +RF    + G+G FG+V   +    GM VA+K V        R  +      + +  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ----IMQDLAVLH 77

Query: 835 HRNLIK---VISSCSTEEFK----ALILEYMP---HGSLEKSLYSSNYILDIFQRLNIMV 884
           H N+++      +    + +     +++EY+P   H               I  ++  + 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLF 136

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSI 937
            +  ++  LH   S  V H D+KP NVL++  +    L DFG AK L   + ++
Sbjct: 137 QLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.9 bits (197), Expect = 2e-15
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 21/180 (11%)

Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVEC--------EMMKS 832
           FS + +IGRGGFG VY  R    G   A+K   L   R                  ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
                ++ +  +  T +  + IL+ M  G L   L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA-AEIILGLEH 307

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +H   +  V++ DLKP+N+LLD++    +SD G+A     +     +      T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 47/298 (15%), Positives = 99/298 (33%), Gaps = 54/298 (18%)

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGF 466
                  ++ +       +     L    +  ++       LS  ++ F+    N+    
Sbjct: 2   SIQRPTPINQVFPDPGLANAVKQNLGKQSVTDLVS---QKELSG-VQNFNGDNSNIQS-- 55

Query: 467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE 526
              +   TNL  ++L  N+++  +   L  L KL+ L +  N+L+         L++L+ 
Sbjct: 56  LAGMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF- 112

Query: 527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP 586
             L  N+L  +      +L +L  LS+ +NKL SI                         
Sbjct: 113 --LDNNELRDTDS--LIHLKNLEILSIRNNKLKSIV------------------------ 144

Query: 587 LDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSL 646
             +G L  L  +D   N  ++     +  L  + ++ L   +      +   +L    ++
Sbjct: 145 -MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201

Query: 647 -----------NLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAK 693
                       +SN        +  E   Y +++   F++    I  G +   F   
Sbjct: 202 KDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVSYKFSEY---INVGETEAIFDGT 256

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 47/221 (21%), Positives = 76/221 (34%), Gaps = 23/221 (10%)

Query: 294 IHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELR 353
              L N    +L    +   V      +S +      ++++  SL+ +      NL+EL 
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQ--FFTNLKELH 69

Query: 354 LWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLE 413
           L  N  S   P  + + +KL  L + RN            L  L L           N E
Sbjct: 70  LSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFL----------DNNE 117

Query: 414 LSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNL 473
           L    S  + K+L  + + NN L  I+    +G LS  LE  D+    ++      +  L
Sbjct: 118 LRDTDSLIHLKNLEILSIRNNKLKSIVM---LGFLS-KLEVLDLHGNEITN--TGGLTRL 171

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPI 514
             +  I L G K          +L     +   D +   P 
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 36/218 (16%), Positives = 82/218 (37%), Gaps = 25/218 (11%)

Query: 137 RGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS 196
           R   ++  FP      ++    +    +++  +       L  +++ +   +    +  +
Sbjct: 5   RPTPINQVFP--DPGLANAVKQNLGKQSVTDLVSQ---KELSGVQNFNGDNSNI--QSLA 57

Query: 197 ALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMA 256
            +     L+ L LS +N +  +   + +LTKL+EL +  + L+         L+ L L  
Sbjct: 58  GMQFFTNLKELHLS-HNQISDL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDN 115

Query: 257 LQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPA 316
            ++ +        L +L  LE+L +  N L   I   +  L  L++LDL  N++      
Sbjct: 116 NELRDTDS-----LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG- 167

Query: 317 TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRL 354
            +  +  +  + L             +  +    EL +
Sbjct: 168 -LTRLKKVNWIDLTGQ-------KCVNEPVKYQPELYI 197

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 39/215 (18%), Positives = 81/215 (37%), Gaps = 44/215 (20%)

Query: 99  SQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHL 158
                L++    NLG   ++     +   L  ++  N   + +       +   ++L+ L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68

Query: 159 DFSYNALSGEIPANICSNLPFLESISLSQNMFHGRI--PSALSNCKYLEILSLSINNLLG 216
             S+N +S ++   +  +L  LE +S+++N    R+   + + +   L  L L  N L  
Sbjct: 69  HLSHNQIS-DLS-PL-KDLTKLEELSVNRN----RLKNLNGIPSAC-LSRLFLDNNEL-- 118

Query: 217 AIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGL 276
                + +L  L+ L +  +                     ++ ++       L  L+ L
Sbjct: 119 RDTDSLIHLKNLEILSIRNN---------------------KLKSIVM-----LGFLSKL 152

Query: 277 EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLV 311
           EVL L  N +T      +  L  +  +DL+  K V
Sbjct: 153 EVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 50/253 (19%), Positives = 89/253 (35%), Gaps = 42/253 (16%)

Query: 83  VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLS 142
               N+   ++T  +      LS +Q+ N   + +  S+ + +     LK ++   NQ+S
Sbjct: 21  AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS 76

Query: 143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCK 202
               S + + + L+ L  + N L   +          L  + L  N    R   +L + K
Sbjct: 77  D--LSPLKDLTKLEELSVNRNRLK-NLNG---IPSACLSRLFLDNNEL--RDTDSLIHLK 128

Query: 203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL 262
            LEILS+  NN L +I   +G L+KL+ L L             GN         +++N 
Sbjct: 129 NLEILSIR-NNKLKSIV-MLGFLSKLEVLDLH------------GN---------EITNT 165

Query: 263 QGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS 322
            G     L  L  +  + L       E       L+    +     + +   P  I N  
Sbjct: 166 GG-----LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI--SPYYISNGG 218

Query: 323 TLTGLGLQSNSLS 335
           +     +      
Sbjct: 219 SYVDGCVLWELPV 231

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 42/170 (24%), Positives = 66/170 (38%), Gaps = 44/170 (25%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV------ECEMMKSIRHRNLI 839
            +G G +G V  A        VAVK+ D++     ++ D       E  + K + H N++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 840 K---VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-----------IFQRLNIMVD 885
           K           ++  L LEY   G L       + I              F +L   V 
Sbjct: 69  KFYGHRRE-GNIQY--LFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
                 YLH      + H D+KP N+LLD+     +SDFG+A +    ++
Sbjct: 120 ------YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.7 bits (192), Expect = 3e-15
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 41/184 (22%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVEC-----EMMKSIRHRNLIK 840
            IG+G FG V   +        A+K   +   +  +  +V       ++M+ + H  L+ 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKY--MNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------------DVAT 888
           +  S   EE   ++++ +  G             D+   L   V            ++  
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGG-------------DLRYHLQQNVHFKEETVKLFICELVM 126

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIG 947
            L+YL    +  +IH D+KP N+LLD++   H++DF IA +L  E    TQ  T+A T  
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKP 179

Query: 948 YMAP 951
           YMAP
Sbjct: 180 YMAP 183

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 47/201 (23%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK---VFD--LQCGRAFKSFDVECEMMKS 832
           ++ F   +L+G G +G V  A     G  VA+K    FD  L   R  +    E +++K 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKH 65

Query: 833 IRHRNLIK---VISSCSTEEFKA--LILEYMPHGSLEKSLY---SSNYILD------IFQ 878
            +H N+I    +    S E F    +I E M     +  L+   S+  + D      I+Q
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQ 120

Query: 879 RLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
            L         ++ LH    + VIH DLKPSN+L++ N    + DFG+A+++       +
Sbjct: 121 TLR-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 939 Q--------TQTLATIGYMAP 951
           +         + +AT  Y AP
Sbjct: 171 EPTGQQSGMVEFVATRWYRAP 191

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.0 bits (192), Expect = 5e-15
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 37/204 (18%)

Query: 768 RRFSYLELCRAT----NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK----VFD--LQC 816
            +F  +E+  +T     R+     IG G  G V  A        VA+K     F      
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 105

Query: 817 GRAFKSFDVECEMMKSIRHRNLIKVI----SSCSTEEFKA--LILEYMP---HGSLEKSL 867
            RA++    E  +MK + H+N+I ++       + EEF+   L++E M       ++  L
Sbjct: 106 KRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161

Query: 868 YSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
                   ++Q L         +++LH   SA +IH DLKPSN+++  +    + DFG+A
Sbjct: 162 DHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211

Query: 928 KLLIGEDQSITQTQTLATIGYMAP 951
           +       S   T  + T  Y AP
Sbjct: 212 R---TAGTSFMMTPYVVTRYYRAP 232

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 75.7 bits (187), Expect = 5e-15
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 36/159 (22%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK-- 840
            +G G FG V        G +VAVK+ +   ++          E + +K  RH ++IK  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 841 -VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-----------IFQRLNIMVDVAT 888
            VIS+  T+ F  +++EY+  G L       +YI             +FQ++       +
Sbjct: 78  QVIST-PTDFF--MVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQI------LS 122

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
            ++Y H      V+H DLKP NVLLD +M A ++DFG++
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLS 158

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 41/185 (22%), Positives = 64/185 (34%), Gaps = 40/185 (21%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRHR-NLIK 840
           +GRG F  V +      G E A K       R            E  +++  +    +I 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 841 VISSCSTEEFKALILEYMPHGSL-------EKSLYS----SNYILDIFQRLNIMVDVATT 889
           +           LILEY   G +          + S       I  I +           
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE----------G 143

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH---LSDFGIAKLLIGEDQSITQTQTLATI 946
           + YLH      ++H DLKP N+LL          + DFG+++  IG    +   + + T 
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTP 197

Query: 947 GYMAP 951
            Y+AP
Sbjct: 198 EYLAP 202

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.6 bits (189), Expect = 7e-15
 Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK----VFD--LQCGRAFKSFDVECEMMK 831
             R+   + +G G +GSV  A   + G+ VAVK     F   +   R ++    E  ++K
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR----ELRLLK 83

Query: 832 SIRHRNLIKV----ISSCSTEEFKA--LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVD 885
            ++H N+I +      + S EEF    L+   M    L   +       D  Q   ++  
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQ 140

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVAT 192

Query: 946 IGYMAP 951
             Y AP
Sbjct: 193 RWYRAP 198

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.8 bits (187), Expect = 8e-15
 Identities = 42/164 (25%), Positives = 64/164 (39%), Gaps = 44/164 (26%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV------ECEMMKSIRHRNLI 839
            +G G +G V  A        VAVK+ D++     ++ D       E  + K + H N++
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVV 68

Query: 840 K---VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-----------IFQRLNIMVD 885
           K           ++  L LEY   G L       + I              F +L   V 
Sbjct: 69  KFYGHRRE-GNIQY--LFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
                 YLH      + H D+KP N+LLD+     +SDFG+A +
Sbjct: 120 ------YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATV 154

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 12/151 (7%)

Query: 289 EIPPEIHNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLP 347
           EIP  +     +  + L  N +   +P   F     L  + L +N +S  L+  A   L 
Sbjct: 25  EIPTNLPE--TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80

Query: 348 NLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNY 406
           +L  L L+ N  +  +P+ +F     L +L L  N  +    + F +L NL L++L+ N 
Sbjct: 81  SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           L +         +FS  +++  + L+ NP  
Sbjct: 140 LQTIAKG-----TFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 38/176 (21%), Positives = 63/176 (35%), Gaps = 49/176 (27%)

Query: 501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLT 559
             + LE N ++   P       KL  + LS N++S  +    F  L SL +L L  NK+T
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
            +P                                                ++  GL +L
Sbjct: 94  ELP-----------------------------------------------KSLFEGLFSL 106

Query: 620 QYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN 675
           Q L L  N++     ++F DL +L  L+L +N L      +   L  ++ + L+ N
Sbjct: 107 QLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 41/157 (26%), Positives = 55/157 (35%), Gaps = 35/157 (22%)

Query: 402 LHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCN 461
           L  N +      +    +FS  K L  I LSNN +  + P             F      
Sbjct: 39  LEQNTIKV----IPP-GAFSPYKKLRRIDLSNNQISELAPDA-----------FQ----- 77

Query: 462 VSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDI-C 519
                      L +L  + L GNK+   +P      L  LQ L L  NK+   +  D   
Sbjct: 78  ----------GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQ 125

Query: 520 RLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN 556
            L  L  L L  NKL       FS L ++ T+ L  N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 40/169 (23%), Positives = 68/169 (40%), Gaps = 24/169 (14%)

Query: 69  CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTL 128
           C+   V C                LT  IP+ L    ++  + L  N +   IP   F+ 
Sbjct: 11  CSNNIVDC------------RGKGLT-EIPTNL--PETITEIRLEQNTIK-VIPPGAFSP 54

Query: 129 YT-LKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
           Y  L+ ++   NQ+S       F    SL  L    N ++ E+P ++   L  L+ + L+
Sbjct: 55  YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112

Query: 187 QNMFHGRIPS-ALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYL 233
            N  +  +   A  +   L +LSL  +N L  I K     L  ++ ++L
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLY-DNKLQTIAKGTFSPLRAIQTMHL 159

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 40/156 (25%), Positives = 60/156 (38%), Gaps = 29/156 (18%)

Query: 530 SGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI 589
            G  L+  IP       ++  + L  N +  IP                  F+       
Sbjct: 19  RGKGLT-EIPTNLP--ETITEIRLEQNTIKVIP---------------PGAFSP------ 54

Query: 590 GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLS 649
              K L  ID S N  S++ P    GL +L  L L  N++       F  L SL+ L L+
Sbjct: 55  --YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112

Query: 650 NNNLSRSIPI-SLEKLSYLEDLDLSFNKLKGEIPKG 684
            N ++  + + + + L  L  L L  NKL+  I KG
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 32/130 (24%), Positives = 52/130 (40%), Gaps = 4/130 (3%)

Query: 205 EILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQG 264
             + L  N +    P       KL+ + L  + +    P  F  L  L  + L  + +  
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 265 EIPQEL-ANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIFNMS 322
           E+P+ L   L  L++L L  N +   +  +   +LHNL LL L  NKL      T   + 
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 323 TLTGLGLQSN 332
            +  + L  N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 40/163 (24%), Positives = 59/163 (36%), Gaps = 33/163 (20%)

Query: 347 PNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYN 405
             + E+RL  N     IP   F    KL  ++L  N  S   P+ F  LR+L  + L+ N
Sbjct: 32  ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90

Query: 406 YLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG 465
            +T     L     F    SL  + L+ N ++ +               F          
Sbjct: 91  KITELPKSL-----FEGLFSLQLLLLNANKINCLRVDA-----------FQ--------- 125

Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDN 508
                 +L NL  + L  NKL      T   L+ +Q +HL  N
Sbjct: 126 ------DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 75.3 bits (186), Expect = 1e-14
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 7/155 (4%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDL-QCGRAFKSFDV-ECEMMKS 832
            ++  ++    L+G G +G V K R  + G  VA+K F      +  K   + E +++K 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           +RH NL+ ++  C  ++   L+ E++ H ++   L      LD       +  +   + +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
            H   S  +IH D+KP N+L+  + V  L DFG A
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 24/164 (14%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECE------- 828
                ++ +   +G G +G VYKA+  +G  VA+K   L         D E E       
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---------DAEDEGIPSTAI 67

Query: 829 ----MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV 884
               ++K + H N++ +I    +E    L+ E+M    L+K L  +   L   Q    + 
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY 126

Query: 885 DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            +   + + H      ++H DLKP N+L++ +    L+DFG+A+
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 45/243 (18%), Positives = 84/243 (34%), Gaps = 72/243 (29%)

Query: 788 IGRGGFGSVYKARI------GEGMEVAVK-VFDLQCGRAFKSFDVECEMMKSI-RHRNLI 839
           +GRG FG V +A             VAVK + +       ++   E +++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 840 KVISSCSTEEFKA-LILEYMPHGSLEKSL----------------------YSSNYILDI 876
            ++ +C+       +I+E+   G+L   L                      Y     +D+
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 877 FQRLNIMV------------------------------DVATTLEYLHFGY--------- 897
            +RL+ +                               D  T    + + +         
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 898 -SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP-GLFH 955
            S   IH DL   N+LL +  V  + DFG+A+ +  +   + +      + +MAP  +F 
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 956 VKY 958
             Y
Sbjct: 270 RVY 272

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 33/171 (19%), Positives = 63/171 (36%), Gaps = 48/171 (28%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECE---MMKSIRHRNLIKVI- 842
           +G G  G V +        + A+K+                E     ++ +  ++++++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 843 ---SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL--------------NIMVD 885
              +  +  +   +++E +  G L             F R+               IM  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGE 933
           +   ++YLH   S  + H D+KP N+L      N +  L+DFG AK   GE
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 76.4 bits (188), Expect = 2e-14
 Identities = 50/164 (30%), Positives = 81/164 (49%), Gaps = 42/164 (25%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV------ECEMMKSIRHRNLI 839
            +G G FG V   +    G +VAVK+ + Q     +S DV      E + +K  RH ++I
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHII 79

Query: 840 K---VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-----------IFQRLNIMVD 885
           K   VIS+  ++ F  +++EY+  G L       +YI             +FQ++     
Sbjct: 80  KLYQVIST-PSDIF--MVMEYVSGGEL------FDYICKNGRLDEKESRRLFQQI----- 125

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
             + ++Y H      V+H DLKP NVLLD +M A ++DFG++ +
Sbjct: 126 -LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 35/157 (22%)

Query: 788 IGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-----ECEMMKSIRHRNLIKV 841
           IG+G F  V  AR I  G EVA+K+ D           +     E  +MK + H N++K+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-----------IFQRLNIMVDVATTL 890
                TE+   LI+EY   G +       +Y++             F+++       + +
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV------FDYLVAHGRMKEKEARSKFRQI------VSAV 127

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
           +Y H      ++H DLK  N+LLD +M   ++DFG +
Sbjct: 128 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)

Query: 773 LELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFK-SFDV----E 826
           L++     R+ + + +G G F +VYKAR       VA+K   L      K   +     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDV 886
            ++++ + H N+I ++ +   +   +L+ ++M    LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
              LEYLH      ++H DLKP+N+LLD+N V  L+DFG+AK
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 26/153 (16%)

Query: 501 QGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKL 558
             L L +N+        I  +L +L ++  S NK++  I    F   + +  + L SN+L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 559 TSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTN 618
            ++                   F G     + +LK L      +N  + V      GL++
Sbjct: 94  ENVQ---------------HKMFKG-----LESLKTL---MLRSNRITCVGNDSFIGLSS 130

Query: 619 LQYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
           ++ L L  N++      +F  L SL +LNL  N
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 33/151 (21%), Positives = 61/151 (40%), Gaps = 11/151 (7%)

Query: 289 EIPPEIHNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSLSGSLSSIADVQLP 347
           +IP  I        L L++N+        IF  +  L  +   +N ++  +   A     
Sbjct: 25  KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 348 NLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNY 406
            + E+ L SN     +   +F     L  L L  N  +    ++F  L ++RL++L+ N 
Sbjct: 82  GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ 140

Query: 407 LTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           +T+         +F    SL+ + L  NP +
Sbjct: 141 ITTVAPG-----AFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 39/132 (29%), Positives = 57/132 (43%), Gaps = 6/132 (4%)

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI-GNLKVLIGIDFSTNNFSDVIPTVI 613
           + KL  IP  I      L LN   N FT      I   L  L  I+FS N  +D+     
Sbjct: 20  NQKLNKIPEHIPQYTAELRLNN--NEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF 77

Query: 614 GGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI-SLEKLSYLEDLDL 672
            G + +  + L  NRL+    + F  L SLK+L L +N ++  +   S   LS +  L L
Sbjct: 78  EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136

Query: 673 SFNKLKGEIPKG 684
             N++   +  G
Sbjct: 137 YDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 34/168 (20%), Positives = 57/168 (33%), Gaps = 21/168 (12%)

Query: 69  CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT- 127
           C  T V C            S+  L   IP  +        L L  N  +    + IF  
Sbjct: 11  CEGTTVDC------------SNQKLN-KIPEHI--PQYTAELRLNNNEFTVLEATGIFKK 55

Query: 128 LYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
           L  L+ +NF  N+++       F   S +  +  + N L   +   +   L  L+++ L 
Sbjct: 56  LPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113

Query: 187 QNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYL 233
            N        +      + +LSL  +N +  +       L  L  L L
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLY-DNQITTVAPGAFDTLHSLSTLNL 160

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 32/161 (19%), Positives = 54/161 (33%), Gaps = 36/161 (22%)

Query: 375 VLELGRNSFSGFIPN-TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSN 433
            L L  N F+       F  L  LR +    N +T   +E     +F     +  I L++
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD--IEEG---AFEGASGVNEILLTS 90

Query: 434 NPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI- 492
           N L+ +  +M           F                 L +L  + L  N++   +   
Sbjct: 91  NRLENVQHKM-----------FK---------------GLESLKTLMLRSNRIT-CVGND 123

Query: 493 TLGKLQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGN 532
           +   L  ++ L L DN++   +       L  L  L L  N
Sbjct: 124 SFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 29/142 (20%), Positives = 57/142 (40%), Gaps = 7/142 (4%)

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPREFGNLAEL 252
           IP  +   +Y   L L+ N         I   L +L+++    + +       F   + +
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83

Query: 253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLV 311
             + L  + L+    +    L  L+ L L  N +T  +  +    L +++LL L  N++ 
Sbjct: 84  NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142

Query: 312 GAVPATIF-NMSTLTGLGLQSN 332
             V    F  + +L+ L L +N
Sbjct: 143 -TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 32/155 (20%), Positives = 55/155 (35%), Gaps = 7/155 (4%)

Query: 132 KYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
             V+    +L+   P  I        L  + N  +      I   LP L  I+ S N   
Sbjct: 14  TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70

Query: 192 GRIPSALSNCKYLEILSLSINNLLGAIPKEI-GNLTKLKELYLGYSGLQGEIPRE-FGNL 249
                A      +  + L+ +N L  +  ++   L  LK L L  + +   +  + F  L
Sbjct: 71  DIEEGAFEGASGVNEILLT-SNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGL 128

Query: 250 AELELMALQVSNLQGEIPQELANLTGLEVLKLGKN 284
           + + L++L  + +    P     L  L  L L  N
Sbjct: 129 SSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 37/197 (18%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK--VFD--LQCGRAFKSFDVECEMMKSI 833
            +R+ +   +G GG G V+ A   +    VA+K  V         A +    E ++++ +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRL 65

Query: 834 RHRNLIKVI------------SSCSTEEFKA--LILEYMPHGSLEKSLY---SSNYILDI 876
            H N++KV                S  E  +  ++ EYM     E  L        +L+ 
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEE 120

Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQ 935
             RL  M  +   L+Y+H   SA V+H DLKP+N+ ++ +++V  + DFG+A+++     
Sbjct: 121 HARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 936 SITQ-TQTLATIGYMAP 951
                ++ L T  Y +P
Sbjct: 177 HKGHLSEGLVTKWYRSP 193

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 49/185 (26%), Positives = 67/185 (36%), Gaps = 45/185 (24%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV------ECEMMKSIRHRNLI 839
            IG G FG     R       VAVK  +       +   +      E    +S+RH N++
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD-----------IFQRLNIMVDVAT 888
           +      T    A+I+EY   G L         I +            FQ+L   V    
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGEL------YERICNAGRFSEDEARFFFQQLLSGVS--- 130

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSITQTQTLATI 946
              Y H   S  + H DLK  N LLD +    L   DFG +K  +   Q  +   T A  
Sbjct: 131 ---YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-- 182

Query: 947 GYMAP 951
            Y+AP
Sbjct: 183 -YIAP 186

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 7/162 (4%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDL-QCGRAFKSFDV-ECEMMKSIRHR 836
            ++ +   IG G +G V+K R  + G  VA+K F   +     K   + E  M+K ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           NL+ ++     +    L+ EY  H ++   L      +      +I       + + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT 938
                IH D+KP N+L+  + V  L DFG A+LL G      
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.8 bits (184), Expect = 7e-14
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 23/181 (12%)

Query: 782 FSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEM-----MKSIRH 835
           F +  ++G+GGFG V   ++   G   A K   L+  R  K       +     ++ +  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV----DVATTLE 891
           R ++ +  +  T++   L+L  M  G L+  +Y  +     F      V    ++   LE
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGF-PEARAVFYAAEICCGLE 300

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMA 950
            LH      +++ DLKP N+LLDD+    +SD G+A  +          +    T+GYMA
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMA 353

Query: 951 P 951
           P
Sbjct: 354 P 354

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.0 bits (181), Expect = 9e-14
 Identities = 31/195 (15%), Positives = 67/195 (34%), Gaps = 8/195 (4%)

Query: 484 NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFS 543
                         ++L    L   K    +  ++    +L EL         +I     
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMR 393

Query: 544 NLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN 603
            L  L          ++  L   +     YL+   + F     +       +  +  +  
Sbjct: 394 ALDPLLYEKETLQYFST--LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451

Query: 604 NFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEK 663
           + + +    +  L  + +L L +NRL+ ++  +   L  L+ L  S+N L  ++   +  
Sbjct: 452 DLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVAN 506

Query: 664 LSYLEDLDLSFNKLK 678
           L  L++L L  N+L+
Sbjct: 507 LPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 73.3 bits (179), Expect = 2e-13
 Identities = 45/273 (16%), Positives = 78/273 (28%), Gaps = 35/273 (12%)

Query: 401 TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYC 460
                 +   +    +    +  + L    LS      +   +        LE  +    
Sbjct: 326 DSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCL 385

Query: 461 NVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICR 520
                  + +  L          + L    P+    L  L+   L +N +          
Sbjct: 386 LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL------KME 439

Query: 521 LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNF 580
              +  L L+   L+  +      L  +  L L  N+L ++P  +  L+           
Sbjct: 440 YADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALR----------- 486

Query: 581 FTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG-SISESFGD 639
                      L+VL     S N   +V    +  L  LQ L L  NRLQ  +  +    
Sbjct: 487 ----------CLEVL---QASDNALENVDG--VANLPRLQELLLCNNRLQQSAAIQPLVS 531

Query: 640 LISLKSLNLSNNNLSRSIPISLEKLSYLEDLDL 672
              L  LNL  N+L +   I       L  +  
Sbjct: 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 3e-13
 Identities = 43/219 (19%), Positives = 74/219 (33%), Gaps = 21/219 (9%)

Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLY 525
           + ++      L    L   K    +   L   ++LQ L  E+      +   I  +  L 
Sbjct: 341 WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENK---WCLLTIILLMRALD 396

Query: 526 ELGLSGNKLSGSIPACFSNLASLGTLSLG------SNKLTSIPLTIWNLKGMLYLNFSSN 579
            L      L       FS L ++  +         S  L    +       +  L+ +  
Sbjct: 397 PLLYEKETLQY-----FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451

Query: 580 FFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGD 639
             T    L+   L ++  +D S N     +P  +  L  L+ L    N L+ ++     +
Sbjct: 452 DLTVLCHLE--QLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VAN 506

Query: 640 LISLKSLNLSNNNLSR-SIPISLEKLSYLEDLDLSFNKL 677
           L  L+ L L NN L + +    L     L  L+L  N L
Sbjct: 507 LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.1 bits (163), Expect = 1e-11
 Identities = 44/224 (19%), Positives = 74/224 (33%), Gaps = 14/224 (6%)

Query: 139 NQLSGAFPSFIFNKSSLQHLDFSYNALS-GEIPANICSNLPFLESISLSQNMFHGRIPSA 197
                 +         L   + S    +  +     C  L  LE  +    +    +  A
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA 394

Query: 198 LSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMAL 257
           L    Y +      + L    P     L  L+  +L  + +      E+ ++  L L   
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL---KMEYADVRVLHLAHK 451

Query: 258 QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPAT 317
            ++ L       L  L  +  L L  N L   +PP +  L  L++L  S N L       
Sbjct: 452 DLTVLCH-----LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG-- 503

Query: 318 IFNMSTLTGLGLQSNSLSGSLSSIADV-QLPNLEELRLWSNNFS 360
           + N+  L  L L +N L    ++I  +   P L  L L  N+  
Sbjct: 504 VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.8 bits (144), Expect = 3e-09
 Identities = 51/364 (14%), Positives = 98/364 (26%), Gaps = 101/364 (27%)

Query: 131 LKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMF 190
           L  V+     +    P      S +   D    +L+ ++P +    +           + 
Sbjct: 275 LLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334

Query: 191 HGRI---PSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFG 247
             R        +  + L    LS+      +  E+ +  +L+EL          I     
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI----- 388

Query: 248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLG-----KNFLTGEIPPEIHNLHNLKL 302
               L + AL     + E  Q  + L  ++ ++       ++    E         ++++
Sbjct: 389 ---ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445

Query: 303 LDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT 362
           L L+H  L           + L  L                 QL  +  L L  N     
Sbjct: 446 LHLAHKDL-----------TVLCHLE----------------QLLLVTHLDLSHNRLRA- 477

Query: 363 IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN 422
                                   +P     LR L ++    N L +       +   +N
Sbjct: 478 ------------------------LPPALAALRCLEVLQASDNALEN-------VDGVAN 506

Query: 423 CKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLG 482
              L  + L NN L            +                  + + +   L+ + L 
Sbjct: 507 LPRLQELLLCNNRLQ---------QSAA----------------IQPLVSCPRLVLLNLQ 541

Query: 483 GNKL 486
           GN L
Sbjct: 542 GNSL 545

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 24/160 (15%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECE----------- 828
            ++     IG G +G VYKA+   G   A+K   L         + E E           
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL---------EKEDEGIPSTTIREIS 52

Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           ++K ++H N++K+     T++   L+ E++    L+K L      L+     + ++ +  
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
            + Y H      V+H DLKP N+L++      ++DFG+A+
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 34/181 (18%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVEC-----EMMKSIRHRNLIK 840
           +IGRG FG V   R     +V A+K+  L      K  D        ++M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVA--------TTLEY 892
           +  +   + +  +++EYMP G L          +++    ++    A          L+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H   S   IH D+KP N+LLD +   H  L+DFG    +  E      T  + T  Y++
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYIS 237

Query: 951 P 951
           P
Sbjct: 238 P 238

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 28/142 (19%), Positives = 60/142 (42%), Gaps = 15/142 (10%)

Query: 822 SFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI--LDIFQR 879
           +  V+   M     +N +  +   S + +  + ++     +L+  +     +   +    
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
           L+I + +A  +E+LH   S  ++H DLKPSN+    + V  + DFG+   +  +++  T 
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 940 TQTLA----------TIGYMAP 951
              +           T  YM+P
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 18/96 (18%), Positives = 36/96 (37%), Gaps = 2/96 (2%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIR 834
           R    F     +GRGGFG V++A+   +    A+K   L     A +    E + +  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSS 870
           H  +++  ++      +    E       ++S    
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 44/189 (23%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVK----VFD--LQCGRAFKSFDVECEMMK 831
              + +   +G G +G+V  A  G  G +VA+K     F   L   RA++    E  ++K
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLK 79

Query: 832 SIRHRNLIKVI----SSCSTEEFKA--LILEYMPHGSLEKSLY---SSNYILDIFQRLNI 882
            +RH N+I ++       + ++F    L++ +M        L        + +   +  +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQF-L 133

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
           +  +   L Y+H   +A +IH DLKP N+ ++++    + DFG+A+           T  
Sbjct: 134 VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADSEMTGY 185

Query: 943 LATIGYMAP 951
           + T  Y AP
Sbjct: 186 VVTRWYRAP 194

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 27/162 (16%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD----LQCGRAFKSFDV--ECEMMKSIR----H 835
           L+G+GGFG+V+    + + ++VA+KV      L       S     E  ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRL------NIMVDVATT 889
             +I+++    T+E   L+LE        + L+  +YI +    L           V   
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA---QDLF--DYITE-KGPLGEGPSRCFFGQVVAA 151

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLL 930
           +++ H   S  V+H D+K  N+L+D     A L DFG   LL
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 72.1 bits (177), Expect = 3e-13
 Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 16/173 (9%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVEC-----EMMKSIRHRNLIK 840
           +IGRG FG V   ++    +V A+K+  L      K  +  C     +++ +   + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  +   +    L+++Y   G L   L      L        + ++   ++ +H      
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLH 195

Query: 901 VIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +H D+KP N+L+D N   H  L+DFG    L+ +    +    + T  Y++P
Sbjct: 196 YVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISP 245

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 40/165 (24%), Positives = 81/165 (49%), Gaps = 19/165 (11%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV----ECEMM 830
           C   +++ +   IG+G FG V+KAR    G +VA+K   ++     + F +    E +++
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKIL 70

Query: 831 KSIRHRN---LIKVISSCSTEEFKA-----LILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
           + ++H N   LI++  + ++   +      L+ ++  H  L   L +      + +   +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
           M  +   L Y+H      ++H D+K +NVL+  + V  L+DFG+A
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 33/159 (20%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK-- 840
            +G G FG V  A       +VA+K      L+        + E   +K +RH ++IK  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 841 -VISSCSTEEFKALILEY---------MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
            VI++  T+    +++EY         +    + +      +    FQ++         +
Sbjct: 76  DVITT-PTDIV--MVIEYAGGELFDYIVEKKRMTEDE-GRRF----FQQI------ICAI 121

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
           EY H      ++H DLKP N+LLDDN+   ++DFG++ +
Sbjct: 122 EYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 25/160 (15%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFD----LQCGRAFKSFDV--ECEMMKSIRHR--N 837
           L+G GGFGSVY    + + + VA+K  +       G       V  E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLN------IMVDVATTLE 891
           +I+++      +   LILE  P    +  L+  ++I +    L           V   + 
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LF--DFITE-RGALQEELARSFFWQVLEAVR 163

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL 930
           + H   +  V+H D+K  N+L+D N     L DFG   LL
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 69.9 bits (172), Expect = 5e-13
 Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 25/161 (15%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECE---------- 828
            ++ +   IG G +G+V+KA+       VA+K   L         D + E          
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---------DDDDEGVPSSALREI 52

Query: 829 -MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVA 887
            ++K ++H+N++++     +++   L+ E+     L+K   S N  LD     + +  + 
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             L + H   S  V+H DLKP N+L++ N    L++FG+A+
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 6/151 (3%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRHRN 837
             + + + +G G + +VYK +       VA+K   L+         + E  ++K ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++ +     TE+   L+ EY+    L++ L     I+++      +  +   L Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
              V+H DLKP N+L+++     L+DFG+A+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 40/208 (19%), Positives = 81/208 (38%), Gaps = 42/208 (20%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVK----VFD--LQCGRAFKSFDVECEMMK 831
             ++     +G+G +G V+K+     G  VAVK     F       R F+    E  ++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIMILT 63

Query: 832 SIR-HRNLIKVISSCSTEEFKA--LILEYMPHGSLEKSLYSSN-------YILDIFQRLN 881
            +  H N++ +++    +  +   L+ +YM    L   + ++        Y+  ++Q + 
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLIK 120

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQ 941
                   ++YLH   S  ++H D+KPSN+LL+      ++DFG+++  +   +      
Sbjct: 121 -------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 942 TLATIGYMAPGLFHVKYILFVVNFLTSY 969
                                   LT Y
Sbjct: 171 LSINENTENFDD--------DQPILTDY 190

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 16/173 (9%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEM-----MKSIRHRNLIK 840
           +IGRG F  V   ++ +  +V A+K+  +      K  +V C       + +   R + +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +  +   E +  L++EY   G L   L      +        + ++   ++ +H      
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLG 182

Query: 901 VIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            +H D+KP N+LLD     H  L+DFG    L  +    +    + T  Y++P
Sbjct: 183 YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSP 232

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 67/357 (18%), Positives = 114/357 (31%), Gaps = 70/357 (19%)

Query: 106 SLQSLNLGFNRLSG----SIPSAIFTLYTLKYVNFRGNQLSG----AFPSFIFNKSSLQH 157
           S++  +L  + ++     S+ + +    ++K +   GN +           I +K  L+ 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 158 LDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNL--- 214
            +FS     G +   I   L  L                AL  C  L  + LS N     
Sbjct: 65  AEFSDIFT-GRVKDEIPEALRLL--------------LQALLKCPKLHTVRLSDNAFGPT 109

Query: 215 -LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANL 273
               +   +   T L+ LYL  +GL    P+    +A     ALQ    +  + ++  N 
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIAR----ALQ----ELAVNKKAKNA 158

Query: 274 TGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKL--VGAVPA---TIFNMSTL 324
             L  +  G+N L             +   L  + +  N +   G        +     L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218

Query: 325 TGLGLQSNSLSGS-LSSIADV--QLPNLEELRLWSNNFSGTIPRFIFNASKLS-VLELGR 380
             L LQ N+ +    S++A      PNL EL L     S         A+ +        
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR------GAAAVVDAFSKLE 272

Query: 381 NSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           N            L+ LR   L YN +    +             L ++ L+ N   
Sbjct: 273 NI----------GLQTLR---LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 53/308 (17%), Positives = 91/308 (29%), Gaps = 67/308 (21%)

Query: 101 LWNLSSLQSLNLGFNRLSG----SIPSAIFTLYTLKYVNFRGNQLS----------GAFP 146
           L    S++ + L  N +       +   I +   L+   F                    
Sbjct: 28  LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87

Query: 147 SFIFNKSSLQHLDFSYNALSGEIPANICSNL---PFLESISLSQNMF------------- 190
             +     L  +  S NA        +   L     LE + L  N               
Sbjct: 88  QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147

Query: 191 HGRIPSALSNCKYLEILSLSINNL----LGAIPKEIGNLTKLKELYLGYSGLQGEIPREF 246
              +     N   L  +    N L    +    K   +   L  + +  +G++ E     
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE----- 202

Query: 247 GNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKL 302
                          ++  + + LA    L+VL L  N  T      +   + +  NL+ 
Sbjct: 203 --------------GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 248

Query: 303 LDLSHNKL--VGAVP----ATIFNMSTLTGLGLQSNSLSG----SLSSIADVQLPNLEEL 352
           L L+   L   GA       +      L  L LQ N +      +L ++ D ++P+L  L
Sbjct: 249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 308

Query: 353 RLWSNNFS 360
            L  N FS
Sbjct: 309 ELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 65/363 (17%), Positives = 116/363 (31%), Gaps = 83/363 (22%)

Query: 204 LEILSLSINNL----LGAIPKEIGNLTKLKELYLGYSGLQ-------GEIPREFGNLAEL 252
           +E  SL ++ +      ++   +     +KE+ L  + +         E      +L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL-- 310
           E   +    ++ EIP+ L  L  L+ L                    L  + LS N    
Sbjct: 66  EFSDIFTGRVKDEIPEALRLL--LQALL---------------KCPKLHTVRLSDNAFGP 108

Query: 311 VGAVP--ATIFNMSTLTGLGLQSNSLS-GSLSSIADVQLPNLEELRLWSNNFSGTIPRFI 367
               P    +   + L  L L +N L   + + IA   L  L   +   N          
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQELAVNKKAKNA--------- 158

Query: 368 FNASKLSVLELGRNSFSG----FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNC 423
                L  +  GRN            TF + R L  + +  N +    +E   L   + C
Sbjct: 159 ---PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215

Query: 424 KSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGG 483
           + L  + L +N        +    L+ +L+                  +  NL  + L  
Sbjct: 216 QELKVLDLQDNTFT----HLGSSALAIALK------------------SWPNLRELGLND 253

Query: 484 NKL--NGSIPI----TLGKLQKLQGLHLEDNKLEGPIPDDICR-----LTKLYELGLSGN 532
             L   G+  +    +  +   LQ L L+ N++E      +       +  L  L L+GN
Sbjct: 254 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN 313

Query: 533 KLS 535
           + S
Sbjct: 314 RFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 51/312 (16%), Positives = 98/312 (31%), Gaps = 58/312 (18%)

Query: 424 KSLTYIGLSNNPL--DGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIG----NLTNLI 477
            S+    L  + +  +      ++     S++   +S   +     + +     +  +L 
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 478 GIYLGGNKLNGSIPIT----------LGKLQKLQGLHLEDNKL--EG--PIPDDICRLTK 523
                                     L K  KL  + L DN        P+ D + + T 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 524 LYELGLSGNKLS-------------GSIPACFSNLASLGTLSLGSNKLTS-----IPLTI 565
           L  L L  N L               ++     N   L ++  G N+L +        T 
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183

Query: 566 WNLKGMLYLNFSSNFFT-----GPLPLDIGNLKVLIGIDFSTNNFSD----VIPTVIGGL 616
            + + +  +    N          L   +   + L  +D   N F+      +   +   
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243

Query: 617 TNLQYLFLGYNRLQG----SISESFGDL--ISLKSLNLSNNNLSRSIPISL-----EKLS 665
            NL+ L L    L      ++ ++F  L  I L++L L  N +      +L     EK+ 
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303

Query: 666 YLEDLDLSFNKL 677
            L  L+L+ N+ 
Sbjct: 304 DLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 55.1 bits (133), Expect = 6e-08
 Identities = 46/358 (12%), Positives = 101/358 (28%), Gaps = 72/358 (20%)

Query: 323 TLTGLGLQSNSLSGS-LSSIADV--QLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELG 379
           ++ G  L+ ++++     S+  V  +  +++E+ L  N       R++          + 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN-------IA 57

Query: 380 RNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLE--LSFLSSFSNCKSLTYIGLSNNPL- 436
                        +L       +    +     E     L +   C  L  + LS+N   
Sbjct: 58  SKK----------DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107

Query: 437 -DGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLG 495
                P +   +    LE+  +    +               G  +       ++     
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLG-----PQA------GAKIARALQELAVNKKAK 156

Query: 496 KLQKLQGLHLEDNKLEGP----IPDDICRLTKLYELGLSGNKL-----SGSIPACFSNLA 546
               L+ +    N+LE                L+ + +  N +        +    +   
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216

Query: 547 SLGTLSLGSNKLT-----SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFS 601
            L  L L  N  T     ++ + + +   +  L  +    +       G   V+      
Sbjct: 217 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS-----ARGAAAVVDAFSKL 271

Query: 602 TNNFSDVIPTVIGGLTNLQYLFLGYNRLQG----SISESFGD-LISLKSLNLSNNNLS 654
            N               LQ L L YN ++     ++     + +  L  L L+ N  S
Sbjct: 272 EN-------------IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 37/264 (14%), Positives = 71/264 (26%), Gaps = 67/264 (25%)

Query: 445 MGNLSHSLEYFDMSYCNVSG----GFPKEIGNLTNLIGIYLGGNKLN--GSIPI--TLGK 496
           M   S  +E   +    ++          +    ++  I L GN +    +  +   +  
Sbjct: 1   MARFS--IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58

Query: 497 LQKLQGLHLEDNKL-----EGP-----IPDDICRLTKLYELGLSGNKLSG----SIPACF 542
            + L+     D        E P     +   + +  KL+ + LS N         +    
Sbjct: 59  KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118

Query: 543 SNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFST 602
           S    L  L L +N L                                      G   + 
Sbjct: 119 SKHTPLEHLYLHNNGLG----------------------------PQA------GAKIAR 144

Query: 603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQG----SISESFGDLISLKSLNLSNNNL----- 653
                 +         L+ +  G NRL+       +++F     L ++ +  N +     
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204

Query: 654 SRSIPISLEKLSYLEDLDLSFNKL 677
              +   L     L+ LDL  N  
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 35/214 (16%), Positives = 67/214 (31%), Gaps = 35/214 (16%)

Query: 105 SSLQSLNLGFNRLS-------------GSIPSAIFTLYTLKYVNFRGNQLSG----AFPS 147
           + L+ L L  N L               ++         L+ +    N+L       +  
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181

Query: 148 FIFNKSSLQHLDFSYNALSGE-IPANICSNL---PFLESISLSQNMFHGR----IPSALS 199
              +   L  +    N +  E I   +   L     L+ + L  N F       +  AL 
Sbjct: 182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241

Query: 200 NCKYLEILSLSINNL-------LGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAEL 252
           +   L  L L+   L       +     ++ N   L+ L L Y+ ++ +  R    + + 
Sbjct: 242 SWPNLRELGLNDCLLSARGAAAVVDAFSKLEN-IGLQTLRLQYNEIELDAVRTLKTVIDE 300

Query: 253 ELMALQVSNLQG-EIPQELANLTGL-EVLKLGKN 284
           ++  L    L G    +E   +  + EV      
Sbjct: 301 KMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGR 334

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 42/172 (24%), Positives = 60/172 (34%), Gaps = 55/172 (31%)

Query: 501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLT 559
           Q L+L DN++    P     L  L EL L  N+L  ++P   F +L  L  L LG+N+LT
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
            +P                                                 V   L +L
Sbjct: 102 VLP-----------------------------------------------SAVFDRLVHL 114

Query: 620 QYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI----SLEKLSYL 667
           + LF+  N+L   +      L  L  L L  N L +SIP      L  L++ 
Sbjct: 115 KELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPHGAFDRLSSLTHA 164

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 41/162 (25%), Positives = 61/162 (37%), Gaps = 33/162 (20%)

Query: 277 EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSG 336
           ++L L  N +T   P    +L NLK L L  N+L  A+P  +F+                
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD---------------- 85

Query: 337 SLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGNLR 395
                    L  L  L L +N  +  +P  +F+    L  L +  N  +  +P     L 
Sbjct: 86  --------SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLT 135

Query: 396 NLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           +L  + L  N L S         +F    SLT+  L  NP D
Sbjct: 136 HLTHLALDQNQLKSIPHG-----AFDRLSSLTHAYLFGNPWD 172

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 42/130 (32%), Positives = 59/130 (45%), Gaps = 4/130 (3%)

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
           S +  S+P  I     +LYL+   N  T   P    +L  L  +   +N    +   V  
Sbjct: 28  SKRHASVPAGIPTNAQILYLH--DNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85

Query: 615 GLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF 674
            LT L  L LG N+L    S  F  L+ LK L +  N L   +P  +E+L++L  L L  
Sbjct: 86  SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQ 144

Query: 675 NKLKGEIPKG 684
           N+LK  IP G
Sbjct: 145 NQLKS-IPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 44/177 (24%), Positives = 63/177 (35%), Gaps = 58/177 (32%)

Query: 480 YLGGNKLNGSIPITLGKLQKLQGLHLEDNKL----EGPIPDDICRLTKLYELGLSGNKLS 535
           YL  N++    P     L  L+ L+L  N+L     G + D    LT+L  L L  N+L+
Sbjct: 46  YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG-VFD---SLTQLTVLDLGTNQLT 101

Query: 536 GSIPA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKV 594
             +P+  F  L  L  L +  NKLT +P                                
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTELP-------------------------------- 128

Query: 595 LIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
             GI+                LT+L +L L  N+L+     +F  L SL    L  N
Sbjct: 129 -RGIE---------------RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 40/161 (24%), Positives = 61/161 (37%), Gaps = 38/161 (23%)

Query: 375 VLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS--FSNCKSLTYIGLS 432
           +L L  N  +   P  F +L NL+ + L  N L +       L    F +   LT + L 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-------LPVGVFDSLTQLTVLDLG 96

Query: 433 NNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI 492
            N L  +   +           FD                L +L  +++  NKL   +P 
Sbjct: 97  TNQLTVLPSAV-----------FD---------------RLVHLKELFMCCNKLT-ELPR 129

Query: 493 TLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGN 532
            + +L  L  L L+ N+L+  IP     RL+ L    L GN
Sbjct: 130 GIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 38/152 (25%), Positives = 56/152 (36%), Gaps = 28/152 (18%)

Query: 108 QSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSYNALS 166
           Q L L  N+++   P    +L  LK +    NQL  A P  +F+  + L  LD   N L+
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 167 GEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLT 226
                             L   +F       L +   L+ L +   N L  +P+ I  LT
Sbjct: 102 -----------------VLPSAVFD-----RLVH---LKELFMC-CNKLTELPRGIERLT 135

Query: 227 KLKELYLGYSGLQGEIPREFGNLAELELMALQ 258
            L  L L  + L+      F  L+ L    L 
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 40/141 (28%), Positives = 59/141 (41%), Gaps = 6/141 (4%)

Query: 169 IPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI-GNLTK 227
           +PA I +N   L    L  N      P    +   L+ L L  +N LGA+P  +  +LT+
Sbjct: 34  VPAGIPTNAQILY---LHDNQITKLEPGVFDSLINLKELYLG-SNQLGALPVGVFDSLTQ 89

Query: 228 LKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLT 287
           L  L LG + L       F  L  L+ + +  + L  E+P+ +  LT L  L L +N L 
Sbjct: 90  LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148

Query: 288 GEIPPEIHNLHNLKLLDLSHN 308
                    L +L    L  N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 55/180 (30%), Positives = 78/180 (43%), Gaps = 35/180 (19%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVEC-----EMMKSIRHRNLIK 840
            +G G FG V+  R    G   A+KV  L+     +   VE       M+  + H  +I+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLH 894
           +  +    +   +I++Y+  G L   L  S       QR    V      +V   LEYLH
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLH 123

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
              S  +I+ DLKP N+LLD N   H  ++DFG AK           T TL  T  Y+AP
Sbjct: 124 ---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVTYTLCGTPDYIAP 172

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 45/178 (25%), Positives = 74/178 (41%), Gaps = 31/178 (17%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVEC-----EMMKSIRHRNLIK 840
            +G G FG V   +    G   A+K+  L   +  K   +E       +++++    L+K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------DVATTLEYLH 894
           +  S        +++EY+  G +          L    R +          +  T EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEM-------FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
              S  +I+ DLKP N+L+D      ++DFG AK + G      +T TL  T   +AP
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAP 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 43/193 (22%), Positives = 73/193 (37%), Gaps = 40/193 (20%)

Query: 753 KQPPNDANMPPIATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKV 811
            Q P   ++    +              R+     +G G +G VYKA        VA+K 
Sbjct: 16  TQGPGSMSVSAAPSATSID---------RYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66

Query: 812 FDLQCGRAFKSFDVECE-----------MMKSIRHRNLIKVISSCSTEEFKALILEYMPH 860
             L         + E E           ++K ++HRN+I++ S         LI EY  +
Sbjct: 67  IRL---------EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 920
             L K     N  + +    + +  +   + + H   S   +H DLKP N+LL  +  + 
Sbjct: 118 -DL-KKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASE 172

Query: 921 -----LSDFGIAK 928
                + DFG+A+
Sbjct: 173 TPVLKIGDFGLAR 185

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 68.8 bits (168), Expect = 5e-12
 Identities = 69/456 (15%), Positives = 151/456 (33%), Gaps = 64/456 (14%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQL-WNLSSLQSLNL-GFNRLSGSIPSAIFT-LYTLKYVN 135
               ++ + +  + +T      +  +  + + L L      S    +AI      LK ++
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162

Query: 136 FRGNQLSG----AFPSFIFNKSSLQHLDFS--YNALSGEIPANICSNLPFLESISLSQNM 189
            R + +          F    +SL  L+ S   + +S      + +  P L+S+ L++ +
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222

Query: 190 FHGRIPSALSNCKYLEILSLS------INNLLGAIPKEIGNLTKLKEL----YLGYSGLQ 239
              ++ + L     LE L           ++   +   +    +L+ L        + L 
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282

Query: 240 GEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHN 299
             +      L  L L    V +      + L     L+ L +        +        +
Sbjct: 283 -AVYSVCSRLTTLNLSYATVQSYDLV--KLLCQCPKLQRLWVLDYIEDAGLEVLASTCKD 339

Query: 300 LKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNF 359
           L+ L +  ++     P  +     LT  GL S S+            P LE +  +    
Sbjct: 340 LRELRVFPSE-----PFVMEPNVALTEQGLVSVSMG----------CPKLESVLYFCRQM 384

Query: 360 SGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM---TLHYNYLTSSNLELSF 416
                      +  +++ + RN           N+   RL        +YLT   L++ F
Sbjct: 385 -----------TNAALITIARN---------RPNMTRFRLCIIEPKAPDYLTLEPLDIGF 424

Query: 417 LSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSG-GFPKEIGNLTN 475
            +   +CK L  + LS    D +     +G  +  +E   +++   S  G    +    +
Sbjct: 425 GAIVEHCKDLRRLSLSGLLTDKVF--EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDS 482

Query: 476 LIGIYLGG-NKLNGSIPITLGKLQKLQGLHLEDNKL 510
           L  + +      + ++     KL+ ++ L +    +
Sbjct: 483 LRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 63.4 bits (154), Expect = 2e-10
 Identities = 84/544 (15%), Positives = 163/544 (29%), Gaps = 93/544 (17%)

Query: 153 SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSIN 212
                            PA +    P + S+ L                         + 
Sbjct: 41  ERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGW------GGYVY 94

Query: 213 NLLGAIPKEIGNLTKL--KELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQEL 270
             + A+      L ++  K + +    L+  I + F N   L L                
Sbjct: 95  PWIEAMSSSYTWLEEIRLKRMVVTDDCLE-LIAKSFKNFKVLVL-------------SSC 140

Query: 271 ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQ 330
              +   +  +                 NLK LDL  + +       + +        L 
Sbjct: 141 EGFSTDGLAAIAA------------TCRNLKELDLRESDVDDVSGHWLSHFPDTYT-SLV 187

Query: 331 SNSLSGSLSSIADVQL-------PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
           S ++S   S ++   L       PNL+ L+L        +   +  A +L  L  G    
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG---- 243

Query: 384 SGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
                               Y      ++      + S CK L  +    + +   LP  
Sbjct: 244 -------------------GYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP-- 282

Query: 444 SMGNLSHSLEYFDMSYCNVSG-GFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQG 502
           ++ ++   L   ++SY  V      K +     L  +++     +  + +     + L+ 
Sbjct: 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRE 342

Query: 503 LHLEDNKLEGPIPDDICRLTK--LYELGLSGNKLSGSIPACFSNL--ASLGTLSLGSNKL 558
           L +     E  + +    LT+  L  + +   KL  S+      +  A+L T++     +
Sbjct: 343 LRVFP--SEPFVMEPNVALTEQGLVSVSMGCPKLE-SVLYFCRQMTNAALITIARNRPNM 399

Query: 559 TSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIG------NLKVLIGIDFSTNNFSDVIPTV 612
           T   L I   K   YL           PLDIG      + K L  +  S    +D +   
Sbjct: 400 TRFRLCIIEPKAPDYLT--------LEPLDIGFGAIVEHCKDLRRLSLS-GLLTDKVFEY 450

Query: 613 IG-GLTNLQYLFLGYNRL-QGSISESFGDLISLKSLNLSNNNLS-RSIPISLEKLSYLED 669
           IG     ++ L + +       +        SL+ L + +     +++  +  KL  +  
Sbjct: 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRS 510

Query: 670 LDLS 673
           L +S
Sbjct: 511 LWMS 514

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 42/201 (20%), Positives = 77/201 (38%), Gaps = 33/201 (16%)

Query: 774 ELCRATNRFS-ENNLIGRGGFGSVYKAR---IGEGMEVAVK-----VFDLQCGRAFKSFD 824
           E  R  + F  E   +GRG +G VYKA+     +  + A+K        +   R      
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------ 67

Query: 825 VECEMMKSIRHRNLIKVISSCSTEEFKA--LILEYMPH-------GSLEKSLYSSNYILD 875
            E  +++ ++H N+I +     +   +   L+ +Y  H                    L 
Sbjct: 68  -EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126

Query: 876 IFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLI 931
                +++  +   + YLH   +  V+H DLKP+N+L+           ++D G A+L  
Sbjct: 127 RGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183

Query: 932 GEDQSITQ-TQTLATIGYMAP 951
              + +      + T  Y AP
Sbjct: 184 SPLKPLADLDPVVVTFWYRAP 204

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.5 bits (167), Expect = 6e-12
 Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 35/182 (19%)

Query: 787 LIGRGGFGSVYKARIGEGMEV-AVKVFDLQCGRAFKSFDVECEMM------KSIRHRNLI 839
           ++G+G FG V  +      E+ AVK+  L+     +  DVEC M+         +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTL 890
           ++ S   T +    ++EY+  G L   +             Y  +I          A  L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 455

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYM 949
            +L    S  +I+ DLK  NV+LD      ++DFG+ K  I +      T+T   T  Y+
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 509

Query: 950 AP 951
           AP
Sbjct: 510 AP 511

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.4 bits (165), Expect = 9e-12
 Identities = 42/184 (22%), Positives = 77/184 (41%), Gaps = 39/184 (21%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEM-----MKSIRHRNLIK 840
           L+G+G FG V   +    G   A+K+  L+        +V   +     +++ RH  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNI------------MVDVAT 888
           +  S  T +    ++EY   G             ++F  L+               ++ +
Sbjct: 213 LKYSFQTHDRLCFVMEYANGG-------------ELFFHLSRERVFSEDRARFYGAEIVS 259

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIG 947
            L+YLH   +  V++ DLK  N++LD +    ++DFG+ K  I +  +    +T   T  
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPE 314

Query: 948 YMAP 951
           Y+AP
Sbjct: 315 YLAP 318

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 48/216 (22%), Positives = 80/216 (37%), Gaps = 54/216 (25%)

Query: 779 TNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
           + ++S    +G G FG V +    E G   A+K          +    E ++MK + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 838 LIK---VISSCSTEEFKA-----------------------------------LILEYMP 859
           +IK      +   EE K                                    +I+EY+P
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 860 ---HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-D 915
              H  L+  + S   I      +  +  +   + ++H   S  + H D+KP N+L++  
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSK 177

Query: 916 NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           +    L DFG AK LI  + S      + +  Y AP
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAP 210

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 26/162 (16%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECE---------- 828
             F +   IG G +G VYKAR    G  VA+K   L         D E E          
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---------DTETEGVPSTAIREI 53

Query: 829 -MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDV 886
            ++K + H N++K++    TE    L+ E++    L+K + +S    + +    + +  +
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL 112

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
              L + H   S  V+H DLKP N+L++      L+DFG+A+
Sbjct: 113 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 37/177 (20%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECE------ 828
             AT+R+     IG G +G+VYKAR    G  VA+K   +                    
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---------PNGGGGGGGLP 55

Query: 829 -----------MMKSIRHRNLIKVISSCSTEEFKA-----LILEYMPHGSLEKSLYSSNY 872
                       +++  H N+++++  C+T          L+ E++    L   L  +  
Sbjct: 56  ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP 114

Query: 873 I-LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             L      ++M      L++LH   +  ++H DLKP N+L+       L+DFG+A+
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 34/181 (18%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMM-----KSIRHRNLIK 840
           L+G+G FG V   R    G   A+K+  L+        +V   +      ++ RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTLE 891
           +  +  T +    ++EY   G L   L             Y  +I           + LE
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----------VSALE 119

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMA 950
           YLH   S  V++ D+K  N++LD +    ++DFG+ K  I +  +    +T   T  Y+A
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173

Query: 951 P 951
           P
Sbjct: 174 P 174

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 54/187 (28%), Positives = 82/187 (43%), Gaps = 45/187 (24%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMM------KSIRHRNLI 839
           +IG+G FG V  AR   E +  AVKV  LQ     K  + +  M       K+++H  L+
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------------DVA 887
            +  S  T +    +L+Y+  G             ++F  L                ++A
Sbjct: 103 GLHFSFQTADKLYFVLDYINGG-------------ELFYHLQRERCFLEPRARFYAAEIA 149

Query: 888 TTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQTQTL-A 944
           + L YLH   S  +++ DLKP N+LLD     H  L+DFG+ K  I  + +   T T   
Sbjct: 150 SALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFCG 201

Query: 945 TIGYMAP 951
           T  Y+AP
Sbjct: 202 TPEYLAP 208

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 64.9 bits (159), Expect = 3e-11
 Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 35/175 (20%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGE--GMEVAVKVFDLQCGRAFKSFDVECE----- 828
           CRA  ++     IG G +G V+KAR  +  G  VA+K   +             E     
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------QTGEEGMPLS 57

Query: 829 ---------MMKSIRHRNLIKVISSCSTEEFKA-----LILEYMPHGSLEKSLYSSNYI- 873
                     +++  H N++++   C+           L+ E++    L   L       
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116

Query: 874 LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
           +      ++M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A+
Sbjct: 117 VPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 35/132 (26%), Positives = 54/132 (40%), Gaps = 9/132 (6%)

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
             + +  +P  I      T L L  N L    S     +LP+L +L L  N  +  I   
Sbjct: 16  TGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPN 72

Query: 367 IF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
            F  AS +  L+LG N         F  L  L+ + L+ N ++          SF +  S
Sbjct: 73  AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM-----PGSFEHLNS 127

Query: 426 LTYIGLSNNPLD 437
           LT + L++NP +
Sbjct: 128 LTSLNLASNPFN 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 7/88 (7%)

Query: 479 IYLGGNKLNGSIPIT--LGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGNKLS 535
           + L  N+L   I      G+L  L  L L+ N+L G I  +     + + EL L  NK+ 
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKIK 91

Query: 536 GSIPA-CFSNLASLGTLSLGSNKLTSIP 562
             I    F  L  L TL+L  N+++ + 
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQISCVM 118

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 37/154 (24%), Positives = 52/154 (33%), Gaps = 52/154 (33%)

Query: 501 QGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKL 558
             L L DN+L     D +  RL  L +L L  N+L+  I    F   + +  L LG NK+
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 559 TSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTN 618
             I                                                  +  GL  
Sbjct: 91  KEIS-----------------------------------------------NKMFLGLHQ 103

Query: 619 LQYLFLGYNRLQGSISE-SFGDLISLKSLNLSNN 651
           L+ L L  N++   +   SF  L SL SLNL++N
Sbjct: 104 LKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 6/88 (6%)

Query: 472 NLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGL 529
            L +L+ + L  N+L   I          +Q L L +NK++  I + +   L +L  L L
Sbjct: 52  RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNL 109

Query: 530 SGNKLSGSIP-ACFSNLASLGTLSLGSN 556
             N++S  +    F +L SL +L+L SN
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 30/118 (25%), Positives = 49/118 (41%), Gaps = 8/118 (6%)

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI-GNLKVLIGIDFSTNNFSDVIPTVI 613
              L  IP  I      L LN   N         + G L  L+ ++   N  + + P   
Sbjct: 17  GRGLKEIPRDIPLHTTELLLN--DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74

Query: 614 GGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI----SLEKLSYL 667
            G +++Q L LG N+++   ++ F  L  LK+LNL +N +   +       L  L+ L
Sbjct: 75  EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSL 131

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 23/70 (32%), Positives = 31/70 (44%), Gaps = 4/70 (5%)

Query: 617 TNLQYLFLGYNRLQG-SISESFGDLISLKSLNLSNNNLSRSIPISL-EKLSYLEDLDLSF 674
            +   L L  N L   S    FG L  L  L L  N L+  I  +  E  S++++L L  
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGE 87

Query: 675 NKLKGEIPKG 684
           NK+K EI   
Sbjct: 88  NKIK-EISNK 96

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 34/153 (22%), Positives = 54/153 (35%), Gaps = 52/153 (33%)

Query: 501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLT 559
             L+L+ N+    +P ++     L  + LS N++S ++    FSN+  L TL L  N+L 
Sbjct: 34  TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91

Query: 560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
            IP                                               P    GL +L
Sbjct: 92  CIP-----------------------------------------------PRTFDGLKSL 104

Query: 620 QYLFLGYNRLQGSISE-SFGDLISLKSLNLSNN 651
           + L L  N +   + E +F DL +L  L +  N
Sbjct: 105 RLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 5/85 (5%)

Query: 480 YLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGNKLSGSI 538
           YL GN+    +P  L   + L  + L +N++   + +     +T+L  L LS N+L   I
Sbjct: 37  YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLR-CI 93

Query: 539 PA-CFSNLASLGTLSLGSNKLTSIP 562
           P   F  L SL  LSL  N ++ +P
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDISVVP 118

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 11/132 (8%)

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
            NK +  +P  I     +T L L  N  +  L         +L  + L +N  S T+   
Sbjct: 18  SNKGLKVLPKGIP--RDVTELYLDGNQFT--LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72

Query: 367 IF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
            F N ++L  L L  N      P TF  L++LRL++LH N ++          +F++  +
Sbjct: 73  SFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPE-----GAFNDLSA 127

Query: 426 LTYIGLSNNPLD 437
           L+++ +  NPL 
Sbjct: 128 LSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 35/107 (32%), Positives = 50/107 (46%), Gaps = 6/107 (5%)

Query: 277 EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSLS 335
             L L  N  T  +P E+ N  +L L+DLS+N++   +    F NM+ L  L L  N L 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91

Query: 336 GSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRN 381
             +       L +L  L L  N+ S  +P   F + S LS L +G N
Sbjct: 92  -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLY 525
           PKE+ N  +L  I L  N+++     +   + +L  L L  N+L   IP      L  L 
Sbjct: 47  PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLR 105

Query: 526 ELGLSGNKLSGSIP-ACFSNLASLGTLSLGSN 556
            L L GN +S  +P   F++L++L  L++G+N
Sbjct: 106 LLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 39/117 (33%), Positives = 55/117 (47%), Gaps = 8/117 (6%)

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
           +  L  +P  I      LYL+   N FT  +P ++ N K L  ID S N  S +      
Sbjct: 19  NKGLKVLPKGIPRDVTELYLD--GNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFS 75

Query: 615 GLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP----ISLEKLSYL 667
            +T L  L L YNRL+     +F  L SL+ L+L  N++S  +P      L  LS+L
Sbjct: 76  NMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 23/77 (29%), Positives = 37/77 (48%), Gaps = 3/77 (3%)

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL-EKLSYL 667
           +P  +    +L  + L  NR+    ++SF ++  L +L LS N L R IP    + L  L
Sbjct: 46  VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSL 104

Query: 668 EDLDLSFNKLKGEIPKG 684
             L L  N +   +P+G
Sbjct: 105 RLLSLHGNDIS-VVPEG 120

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 30/131 (22%), Positives = 52/131 (39%), Gaps = 15/131 (11%)

Query: 69  CNWTGVTCDVHSHR---------VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSG 119
           C  T V C     +         V  L +   N    +P +L N   L  ++L  NR+S 
Sbjct: 10  CLDTVVRCSNKGLKVLPKGIPRDVTELYL-DGNQFTLVPKELSNYKHLTLIDLSNNRIS- 67

Query: 120 SIPSAIF-TLYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNL 177
           ++ +  F  +  L  +    N+L    P   F+   SL+ L    N +S  +P    ++L
Sbjct: 68  TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDL 125

Query: 178 PFLESISLSQN 188
             L  +++  N
Sbjct: 126 SALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 8/119 (6%)

Query: 168 EIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI-GNLT 226
            +P  I  ++  L    L  N F   +P  LSN K+L ++ LS NN +  +  +   N+T
Sbjct: 24  VLPKGIPRDVTELY---LDGNQFT-LVPKELSNYKHLTLIDLS-NNRISTLSNQSFSNMT 78

Query: 227 KLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQEL-ANLTGLEVLKLGKN 284
           +L  L L Y+ L+   PR F  L  L L++L  +++   +P+    +L+ L  L +G N
Sbjct: 79  QLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 18/68 (26%), Positives = 33/68 (48%), Gaps = 2/68 (2%)

Query: 617 TNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNK 676
            ++  L+L  N+    + +   +   L  ++LSNN +S     S   ++ L  L LS+N+
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89

Query: 677 LKGEIPKG 684
           L+  IP  
Sbjct: 90  LR-CIPPR 96

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.2 bits (157), Expect = 6e-11
 Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 35/182 (19%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMM------KSIRHRNLI 839
           ++G+G FG V  +   G     AVK+  L+     +  DVEC M+         +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTL 890
           ++ S   T +    ++EY+  G L   +             Y  +I          A  L
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 134

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYM 949
            +L    S  +I+ DLK  NV+LD      ++DFG+ K  I +      T+T   T  Y+
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 188

Query: 950 AP 951
           AP
Sbjct: 189 AP 190

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.8 bits (156), Expect = 7e-11
 Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 17/173 (9%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMM------KSIRHRNLI 839
           ++G+G FG V  AR    G   AVKV  L+     +  DVEC M        +  H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           ++     T +    ++E++  G L   +  S    +   R     ++ + L +LH     
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---DK 143

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYMAP 951
            +I+ DLK  NVLLD      L+DFG+ K  I    +   T T   T  Y+AP
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAP 193

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 63.4 bits (155), Expect = 8e-11
 Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 11/157 (7%)

Query: 778 ATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV-ECEMMKSIRH 835
           ++++F +   +G G + +VYK      G+ VA+K   L       S  + E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-----LDIFQRLNIMVDVATTL 890
            N++++     TE    L+ E+M +  L+K + S         L++         +   L
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 927
            + H      ++H DLKP N+L++      L DFG+A
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 63.8 bits (156), Expect = 8e-11
 Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 39/184 (21%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMM------KSIRHRNLI 839
           ++G+G FG V+ A         A+K   L+        DVEC M+       +  H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTL 890
            +  +  T+E    ++EY+  G L   + S +         Y  +I             L
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI----------ILGL 131

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQTQTL-ATIG 947
           ++LH   S  +++ DLK  N+LLD +   H  ++DFG+ K  +  D     T T   T  
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPD 183

Query: 948 YMAP 951
           Y+AP
Sbjct: 184 YIAP 187

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.9 bits (154), Expect = 1e-10
 Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 54/193 (27%)

Query: 787 LIGRGGFGSVYKARIGEGMEV----AVKVFD----LQCGRAFKSFDVECEMM-----KSI 833
           ++G+GG+G V++ R   G       A+KV      ++      + D           + +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEV 78

Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV--------- 884
           +H  ++ +I +  T     LILEY+  G             ++F +L             
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGG-------------ELFMQLEREGIFMEDTACF 125

Query: 885 ---DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQ 939
              +++  L +LH      +I+ DLKP N++L+     H  L+DFG+ K  I +      
Sbjct: 126 YLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV--- 177

Query: 940 TQTLA-TIGYMAP 951
           T T   TI YMAP
Sbjct: 178 THTFCGTIEYMAP 190

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 48/172 (27%), Positives = 61/172 (35%), Gaps = 54/172 (31%)

Query: 501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLT 559
             L LE N L+         LT L +L L GNKL  S+P   F+ L SL  L+L +N+L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
           S+P                                                 V   LT L
Sbjct: 90  SLP-----------------------------------------------NGVFDKLTQL 102

Query: 620 QYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI----SLEKLSYL 667
           + L L  N+LQ      F  L  LK L L  N L +S+P      L  L Y+
Sbjct: 103 KELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYI 153

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 42/149 (28%), Positives = 60/149 (40%), Gaps = 10/149 (6%)

Query: 290 IPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNL 349
           +P  I        LDL  N L          +++LT L L  N L  SL +    +L +L
Sbjct: 22  VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 350 EELRLWSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLT 408
             L L +N    ++P  +F+  ++L  L L  N         F  L  L+ + L+ N L 
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137

Query: 409 SSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           S          F    SL YI L +NP D
Sbjct: 138 SVPDG-----VFDRLTSLQYIWLHDNPWD 161

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 42/131 (32%), Positives = 56/131 (42%), Gaps = 5/131 (3%)

Query: 555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIG 614
           S   TS+P  I      L L    N            L  L  +    N    +   V  
Sbjct: 16  SQGRTSVPTGIPAQTTYLDLET--NSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73

Query: 615 GLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL-EKLSYLEDLDLS 673
            LT+L YL L  N+LQ   +  F  L  LK L L+ N L  S+P  + +KL+ L+DL L 
Sbjct: 74  KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132

Query: 674 FNKLKGEIPKG 684
            N+LK  +P G
Sbjct: 133 QNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 29/84 (34%), Positives = 39/84 (46%), Gaps = 2/84 (2%)

Query: 480 YLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP 539
            L  N L         +L  L  L+L  NKL+        +LT L  L LS N+L  S+P
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLP 92

Query: 540 A-CFSNLASLGTLSLGSNKLTSIP 562
              F  L  L  L+L +N+L S+P
Sbjct: 93  NGVFDKLTQLKELALNTNQLQSLP 116

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 46/162 (28%), Positives = 64/162 (39%), Gaps = 39/162 (24%)

Query: 375 VLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS--FSNCKSLTYIGLS 432
            L+L  NS        F  L +L  + L  N L S       L +  F+   SLTY+ LS
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-------LPNGVFNKLTSLTYLNLS 84

Query: 433 NNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI 492
            N L  +   +           FD                LT L  + L  N+L  S+P 
Sbjct: 85  TNQLQSLPNGV-----------FD---------------KLTQLKELALNTNQLQ-SLPD 117

Query: 493 -TLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGN 532
               KL +L+ L L  N+L+  +PD +  RLT L  + L  N
Sbjct: 118 GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 14/131 (10%)

Query: 69  CNWTGVTCDVHSH---------RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSG 119
           C+ T V C              +   L++   +L          L+SL  L LG N+L  
Sbjct: 7   CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ- 65

Query: 120 SIPSAIF-TLYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSYNALSGEIPANICSNL 177
           S+P+ +F  L +L Y+N   NQL  + P+ +F+K + L+ L  + N L   +P  +   L
Sbjct: 66  SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKL 123

Query: 178 PFLESISLSQN 188
             L+ + L QN
Sbjct: 124 TQLKDLRLYQN 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 41/167 (24%), Positives = 59/167 (35%), Gaps = 33/167 (19%)

Query: 169 IPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGN-LTK 227
           +P  I +   +L+   L  N               L  L L   N L ++P  + N LT 
Sbjct: 22  VPTGIPAQTTYLD---LETNSLKSLPNGVFDELTSLTQLYLG-GNKLQSLPNGVFNKLTS 77

Query: 228 LKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLT 287
           L  L L  + LQ      F                          LT L+ L L  N L 
Sbjct: 78  LTYLNLSTNQLQSLPNGVFD------------------------KLTQLKELALNTNQLQ 113

Query: 288 GEIPPEI-HNLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSN 332
             +P  +   L  LK L L  N+L  +VP  +F  +++L  + L  N
Sbjct: 114 -SLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 41/175 (23%), Positives = 57/175 (32%), Gaps = 33/175 (18%)

Query: 335 SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNL 394
           S   +S+          L L +N+            + L+ L LG N         F  L
Sbjct: 16  SQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKL 75

Query: 395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEY 454
            +L  + L  N L S  L        +    L  + L+ N L   LP             
Sbjct: 76  TSLTYLNLSTNQLQS--LPNGVFDKLTQ---LKELALNTNQLQS-LP------------- 116

Query: 455 FDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDN 508
                    G F K    LT L  + L  N+L  S+P     +L  LQ + L DN
Sbjct: 117 --------DGVFDK----LTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 37/158 (23%), Positives = 68/158 (43%), Gaps = 17/158 (10%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
             F     IG G FG +   + +     VA+K+  ++         +E    K +   + 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 839 I-KVISSCSTEEFKALILEYMPHG-SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           I +V       ++ A++LE +  G SLE      +    +   L I + + + +EY+H  
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH-- 122

Query: 897 YSAPVIHCDLKPSNVLL------DDNMVAHLSDFGIAK 928
            S  +I+ D+KP N L+         ++ H+ DF +AK
Sbjct: 123 -SKNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 46/188 (24%)

Query: 787 LIGRGGFGSVYKARIGEGMEV----AVKVFDLQCGRAFKSFDVECEM----MKSIRHRNL 838
           ++G+G FG V+  +   G +     A+KV  L+         V  +M    +  + H  +
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV------------DV 886
           +K+  +  TE    LIL+++  G L             F RL+  V            ++
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDL-------------FTRLSKEVMFTEEDVKFYLAEL 135

Query: 887 ATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSITQTQTL- 943
           A  L++LH   S  +I+ DLKP N+LLD+    H  L+DFG++K  I  ++      +  
Sbjct: 136 ALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFC 187

Query: 944 ATIGYMAP 951
            T+ YMAP
Sbjct: 188 GTVEYMAP 195

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.5 bits (150), Expect = 5e-10
 Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 35/182 (19%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMM------KSIRHRNLI 839
           +IGRG +  V   R        A+KV  ++        D++          ++  H  L+
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTL 890
            + S   TE     ++EY+  G L   +             Y  +I          +  L
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 123

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYM 949
            YLH      +I+ DLK  NVLLD      L+D+G+ K  +        T T   T  Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 177

Query: 950 AP 951
           AP
Sbjct: 178 AP 179

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.2 bits (149), Expect = 6e-10
 Identities = 43/182 (23%), Positives = 68/182 (37%), Gaps = 35/182 (19%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMM------KSIRHRNLI 839
           +IGRG +  V   R        A++V  ++        D++          ++  H  L+
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTL 890
            + S   TE     ++EY+  G L   +             Y  +I          +  L
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 166

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL-ATIGYM 949
            YLH      +I+ DLK  NVLLD      L+D+G+ K  +        T T   T  Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 220

Query: 950 AP 951
           AP
Sbjct: 221 AP 222

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 29/157 (18%), Positives = 57/157 (36%), Gaps = 15/157 (9%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
             +     IG G FG +++   +    +VA+K    +          E    K +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67

Query: 839 I-KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           I  V           L+++ +   SLE  L        +         +   ++ +H   
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--- 123

Query: 898 SAPVIHCDLKPSNVLL------DDNMVAHLSDFGIAK 928
              +++ D+KP N L+      + NM+ ++ DFG+ K
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 40/132 (30%), Positives = 57/132 (43%), Gaps = 10/132 (7%)

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
           ++K + +VP  I   S+ T L L+SN L  SL      +L  L +L L  N    ++P  
Sbjct: 15  NSKGLTSVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDG 70

Query: 367 IFNA-SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
           +F+  +KL++L L  N         F  L  L+ + L  N L S          F    S
Sbjct: 71  VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPD-----GIFDRLTS 125

Query: 426 LTYIGLSNNPLD 437
           L  I L  NP D
Sbjct: 126 LQKIWLHTNPWD 137

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.9 bits (138), Expect = 2e-09
 Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 4/85 (4%)

Query: 480 YLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGNKLSGSI 538
            L  NKL         KL +L  L L  N+++  +PD +  +LTKL  L L  NKL  S+
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ-SL 91

Query: 539 PA-CFSNLASLGTLSLGSNKLTSIP 562
           P   F  L  L  L+L +N+L S+P
Sbjct: 92  PNGVFDKLTQLKELALDTNQLKSVP 116

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 28/87 (32%), Positives = 41/87 (47%), Gaps = 3/87 (3%)

Query: 599 DFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP 658
           +  +N    +   V   LT L  L L  N++Q      F  L  L  L L  N L  S+P
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLP 92

Query: 659 ISL-EKLSYLEDLDLSFNKLKGEIPKG 684
             + +KL+ L++L L  N+LK  +P G
Sbjct: 93  NGVFDKLTQLKELALDTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 6/87 (6%)

Query: 473 LTNLIGIYLGGNKLNGSIPITL-GKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLS 530
           LT L  + L  N++  S+P  +  KL KL  L+L +NKL+  +P+ +  +LT+L EL L 
Sbjct: 51  LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALD 108

Query: 531 GNKLSGSIP-ACFSNLASLGTLSLGSN 556
            N+L  S+P   F  L SL  + L +N
Sbjct: 109 TNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 40/152 (26%), Positives = 52/152 (34%), Gaps = 49/152 (32%)

Query: 501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLT 559
             L LE NKL+        +LT+L +L LS N++  S+P   F  L  L  L L  NKL 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89

Query: 560 SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL 619
           S                        LP                         V   LT L
Sbjct: 90  S------------------------LP-----------------------NGVFDKLTQL 102

Query: 620 QYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
           + L L  N+L+      F  L SL+ + L  N
Sbjct: 103 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 24/69 (34%), Positives = 35/69 (50%), Gaps = 3/69 (4%)

Query: 617 TNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL-EKLSYLEDLDLSFN 675
           ++   L L  N+LQ      F  L  L  L+LS N +  S+P  + +KL+ L  L L  N
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86

Query: 676 KLKGEIPKG 684
           KL+  +P G
Sbjct: 87  KLQ-SLPNG 94

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 5/87 (5%)

Query: 104 LSSLQSLNLGFNRLSGSIPSAIF-TLYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFS 161
           L+ L  L+L  N++  S+P  +F  L  L  +    N+L  + P+ +F+K + L+ L   
Sbjct: 51  LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108

Query: 162 YNALSGEIPANICSNLPFLESISLSQN 188
            N L   +P  I   L  L+ I L  N
Sbjct: 109 TNQLKS-VPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 28/110 (25%), Positives = 45/110 (40%), Gaps = 5/110 (4%)

Query: 105 SSLQSLNLGFNRLSGSIPSAIF-TLYTLKYVNFRGNQLSGAFPSFIFNK-SSLQHLDFSY 162
           SS   L L  N+L  S+P  +F  L  L  ++   NQ+  + P  +F+K + L  L    
Sbjct: 28  SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHE 85

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSIN 212
           N L   +P  +   L  L+ ++L  N               L+ + L  N
Sbjct: 86  NKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 7/93 (7%)

Query: 346 LPNLEELRLWSNNFSGTIPRFIF-NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHY 404
             NL EL + +      +         +L  L + ++      P+ F     L  + L +
Sbjct: 30  AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89

Query: 405 NYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
           N L S  L    +       SL  + LS NPL 
Sbjct: 90  NALES--LSWKTVQGL----SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.6 bits (141), Expect = 4e-09
 Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 5/97 (5%)

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSI-SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYL 667
               + G  NL  L++   +    +       L  L++L +  + L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 668 EDLDLSFNKLKGEIPKGGSFGNFSAKS--FEGNELLC 702
             L+LSFN L+  +    +    S +     GN L C
Sbjct: 83  SRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 19/101 (18%), Positives = 33/101 (32%), Gaps = 3/101 (2%)

Query: 484 NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPD-DICRLTKLYELGLSGNKLSGSIPA-C 541
                     L   + L  L++E+ +    +   D+  L +L  L +  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 542 FSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFT 582
           F     L  L+L  N L S+         +  L  S N   
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 18/120 (15%), Positives = 28/120 (23%), Gaps = 27/120 (22%)

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPE-IHNLHNLKLLDLSHNKLVGAVPATIFNMST 323
           +    L     L  L +        +    +  L  L+ L +  + L   V    F+   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFH--- 77

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
                                  P L  L L  N    ++         L  L L  N  
Sbjct: 78  ---------------------FTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 22/141 (15%), Positives = 35/141 (24%), Gaps = 49/141 (34%)

Query: 514 IPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLGSNKLTSIPLTIWNLKGML 572
               +     L EL +   +    +       L  L  L++  + L  +           
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA---------- 72

Query: 573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS 632
                                                P        L  L L +N L+ S
Sbjct: 73  -------------------------------------PDAFHFTPRLSRLNLSFNALE-S 94

Query: 633 ISESFGDLISLKSLNLSNNNL 653
           +S      +SL+ L LS N L
Sbjct: 95  LSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 6e-06
 Identities = 19/86 (22%), Positives = 30/86 (34%), Gaps = 4/86 (4%)

Query: 82  RVKVLNISHLNLTGTIPSQ-LWNLSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGN 139
            +  L I +      +  + L  L  L++L +  + L   +    F     L  +N   N
Sbjct: 32  NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFN 90

Query: 140 QLSGAFPSFIFNKSSLQHLDFSYNAL 165
            L  +         SLQ L  S N L
Sbjct: 91  ALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 23/143 (16%), Positives = 36/143 (25%), Gaps = 50/143 (34%)

Query: 193 RIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAEL 252
                L   + L  L +     L  +                                  
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLE--------------------------------- 48

Query: 253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-HNLHNLKLLDLSHNKLV 311
                          ++L  L  L  L + K+ L   + P+  H    L  L+LS N L 
Sbjct: 49  --------------LRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE 93

Query: 312 GAVPATIFNMSTLTGLGLQSNSL 334
            ++        +L  L L  N L
Sbjct: 94  -SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 20/103 (19%), Positives = 33/103 (32%), Gaps = 4/103 (3%)

Query: 211 INNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE-FGNLAELELMALQVSNLQGEIPQE 269
             +        +     L ELY+        +       L EL  + +  S L+  +  +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 270 -LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLV 311
                  L  L L  N L   +  +     +L+ L LS N L 
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 3e-05
 Identities = 19/108 (17%), Positives = 33/108 (30%), Gaps = 6/108 (5%)

Query: 86  LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYT-LKYVNFRGNQLSGA 144
           L  +           L    +L  L +   +    +          L+ +    + L   
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-F 70

Query: 145 FPSFIFNK-SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
                F+    L  L+ S+NAL   +       L  L+ + LS N  H
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 1/81 (1%)

Query: 153 SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSIN 212
            +L  L          +       L  L ++++ ++      P A      L  L+LS  
Sbjct: 31  ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS-F 89

Query: 213 NLLGAIPKEIGNLTKLKELYL 233
           N L ++  +      L+EL L
Sbjct: 90  NALESLSWKTVQGLSLQELVL 110

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 25/122 (20%), Positives = 38/122 (31%), Gaps = 28/122 (22%)

Query: 414 LSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNL 473
           L  L      ++LT + + N                  LE  D+               L
Sbjct: 21  LDSLHHLPGAENLTELYIENQ------------QHLQHLELRDLR-------------GL 55

Query: 474 TNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGN 532
             L  + +  + L   +         +L  L+L  N LE  +     +   L EL LSGN
Sbjct: 56  GELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113

Query: 533 KL 534
            L
Sbjct: 114 PL 115

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.9 bits (144), Expect = 1e-09
 Identities = 28/200 (14%), Positives = 55/200 (27%), Gaps = 52/200 (26%)

Query: 776 CRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKV--------FDLQCGRAFKSFDVEC 827
           C  T +      IG G FG V++    +   VA+K+         +    + F+    E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 828 EMMKSIRHRNLIKVISSCSTEEFKA----------------------------------- 852
            + K +   +      +       +                                   
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 853 ----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKP 908
               ++LE+   G   + + +   +  +    +I+  +  +L            H DL  
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHW 190

Query: 909 SNVLLDDNMVAHLSDFGIAK 928
            NVLL    +  L      K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 49/193 (25%), Positives = 77/193 (39%), Gaps = 52/193 (26%)

Query: 787 LIGRGGFGSVYKARIGEGMEV----AVKVFD----LQCGRAFKSFDVECEMM-----KSI 833
           ++G G +G V+  R   G +     A+KV      +Q     K+   E         + I
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHI 115

Query: 834 RHRN-LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMV-------- 884
           R    L+ +  +  TE    LIL+Y+  G L             F  L+           
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGEL-------------FTHLSQRERFTEHEVQ 162

Query: 885 ----DVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSIT 938
               ++   LE+LH      +I+ D+K  N+LLD N   H  L+DFG++K  + ++    
Sbjct: 163 IYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERA 217

Query: 939 QTQTLATIGYMAP 951
                 TI YMAP
Sbjct: 218 YD-FCGTIEYMAP 229

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 11/154 (7%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           NR+     IG G FG +Y    I  G EVA+K+  ++         +E ++ K ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66

Query: 839 I-KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           I  +    +  ++  +++E +   SLE      +    +   L +   + + +EY+H   
Sbjct: 67  IPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--- 122

Query: 898 SAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 928
           S   IH D+KP N L+       + ++ DFG+AK
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 59.2 bits (143), Expect = 5e-09
 Identities = 70/498 (14%), Positives = 150/498 (30%), Gaps = 80/498 (16%)

Query: 76  CDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVN 135
             + S   + + ++      T         +L+SL L               ++ L   N
Sbjct: 45  FKIDSETREHVTMALCYTA-TPDRLSRRFPNLRSLKLKGKP--------RAAMFNLIPEN 95

Query: 136 FRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANIC-SNLPFLESISLS--QNMFHG 192
           + G            N   L+ + F    +S      +  +    LE++ L         
Sbjct: 96  WGGYVTPW-VTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTD 154

Query: 193 RIPSALSNCKYLEILSLSINNL-------LGAIPKEIGNLTKLKELYLGYSGLQG----- 240
            + S +++C+ ++ L +  ++        L  + +   + T L+ L    +         
Sbjct: 155 GLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ---HNTSLEVLNFYMTEFAKISPKD 211

Query: 241 --EIPREFGNLAEL---------------------ELMALQVSNLQGEIPQELANLTGLE 277
              I R   +L  +                     E     ++   G   + +  +   +
Sbjct: 212 LETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRK 271

Query: 278 VLKLGKNFLTGEIPPEIH-NLHNLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSLS 335
           + +LG +++     P +      ++ LDL +  L      T+      L  L  ++    
Sbjct: 272 LCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD 331

Query: 336 GSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF------------NASKLSVLELGRNSF 383
             L  +A      L+ LR+        +                    +L  + +  +  
Sbjct: 332 RGLEVLAQ-YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI 390

Query: 384 SGF----IPNTFGNLRNLRLMTLHY-NYLTSSNLELSFLSSFSNCKSLTYIGLSNNPL-- 436
           +      I     NL + RL+ L     +T   L+    S    CK L            
Sbjct: 391 TNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL 450

Query: 437 --DGILPRMSMGNLSHSLEYFDMSYCNVS-GGFPKEIGNLTNLIGIYLGGNKL-NGSIPI 492
              G+     +G  S ++ +  + Y   S  G  +      NL  + + G      +I  
Sbjct: 451 TDLGLS---YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAA 507

Query: 493 TLGKLQKLQGLHLEDNKL 510
            + KL  L+ L ++  + 
Sbjct: 508 AVTKLPSLRYLWVQGYRA 525

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 56.5 bits (136), Expect = 3e-08
 Identities = 48/389 (12%), Positives = 106/389 (27%), Gaps = 63/389 (16%)

Query: 79  HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRG 138
           +   +  + +    +   +       ++L+    G       +P     L   + +   G
Sbjct: 218 NCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276

Query: 139 NQLSG--AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS 196
               G    P      + ++ LD  Y  L  E    +    P LE +     +    +  
Sbjct: 277 LSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336

Query: 197 ALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMA 256
               CK L+ L +        +  E G +++         GL   + +    L  + +  
Sbjct: 337 LAQYCKQLKRLRIERGADEQGMEDEEGLVSQ--------RGLI-ALAQGCQELEYMAVYV 387

Query: 257 LQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPA 316
             ++N              LE   +G             NL + +L+ L   + +  +P 
Sbjct: 388 SDITN------------ESLE--SIGTYL---------KNLCDFRLVLLDREERITDLP- 423

Query: 317 TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF---NASKL 373
                            L   + S+       L     +      T     +    +  +
Sbjct: 424 -----------------LDNGVRSLLI-GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNV 465

Query: 374 SVLELGRNSFSGF-IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLS 432
             + LG    S   +        NL+ + +     +      +  ++ +   SL Y+ + 
Sbjct: 466 RWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSER----AIAAAVTKLPSLRYLWVQ 521

Query: 433 NNPL-DGILPRMSMGNLSHSLEYFDMSYC 460
                      M M     ++E       
Sbjct: 522 GYRASMTGQDLMQMARPYWNIELIPSRRV 550

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 58/380 (15%), Positives = 114/380 (30%), Gaps = 67/380 (17%)

Query: 320 NMSTLTGLGLQSNSLS-GSLSSIADVQLPNLEELRLWS-NNFSGT-IPRFIFNASKLSVL 376
           N+  L  +  +   +S   L  +A  +  +LE L+L   + F+   +   + +  K+  L
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169

Query: 377 ELGRNSFS-------GFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI 429
            +  +SFS         +     +L  L      +  ++  +LE    +   NC+SL  +
Sbjct: 170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLE----TIARNCRSLVSV 225

Query: 430 GLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKL--N 487
            + +  +  ++        + +LE F     N   G P++  NL     +   G      
Sbjct: 226 KVGDFEILELV---GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP 282

Query: 488 GSIPITLGKLQKLQGLHLEDNKLEGP-IPDDICRLTKLYELGLSGNKLSGSIPACFSNLA 546
             +PI      +++ L L    LE       I +   L  L                +  
Sbjct: 283 NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN---------VIGD-R 332

Query: 547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
            L  L+    +L                            L I       G++      S
Sbjct: 333 GLEVLAQYCKQLKR--------------------------LRIERGADEQGMEDEEGLVS 366

Query: 607 DV-IPTVIGGLTNLQYLFLGYNRLQ----GSISESFGDLISLKSLNLSNNN------LSR 655
              +  +  G   L+Y+ +  + +      SI     +L   + + L          L  
Sbjct: 367 QRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDN 426

Query: 656 SIPISLEKLSYLEDLDLSFN 675
            +   L     L        
Sbjct: 427 GVRSLLIGCKKLRRFAFYLR 446

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 7e-09
 Identities = 81/518 (15%), Positives = 146/518 (28%), Gaps = 140/518 (27%)

Query: 40  QDALLALKAHITHDPTNFLA--------KNWNTSTPVCNWTGVTCDVHSHRVKVLNISHL 91
           + ALL L+      P   +         K W     VC    V C     ++  LN+ + 
Sbjct: 141 RQALLELR------PAKNVLIDGVLGSGKTWVALD-VCLSYKVQC-KMDFKIFWLNLKNC 192

Query: 92  NLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFN 151
           N   T+   L  L           ++  +  S       +K    R + +       + +
Sbjct: 193 NSPETVLEMLQKL---------LYQIDPNWTSRSDHSSNIKL---RIHSIQAELRRLLKS 240

Query: 152 KS---SLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILS 208
           K     L  L             N+ +     ++     N F+         CK   IL 
Sbjct: 241 KPYENCLLVLL------------NVQNA----KAW----NAFNLS-------CK---ILL 270

Query: 209 LS-----INNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ 263
            +      + L  A    I     L    +  +      P E        L+   +    
Sbjct: 271 TTRFKQVTDFLSAATTTHI----SLDHHSMTLT------PDE-----VKSLLLKYLDCRP 315

Query: 264 GEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNL--KLLDLSHNKLVGAVPATIFNM 321
            ++P+E    T    L +        I   I +          ++ +KL      TI   
Sbjct: 316 QDLPRE-VLTTNPRRLSI--------IAESIRDGLATWDNWKHVNCDKL-----TTIIES 361

Query: 322 STLTGLGLQSNSLSGSLSSIA----DVQLPN--LEELRLWSNNFSGTIPRFIFNASKLSV 375
           S      L+          ++       +P   L    +W +     +   +    K S+
Sbjct: 362 SLNV---LEPAEYRKMFDRLSVFPPSAHIPTILLS--LIWFDVIKSDVMVVVNKLHKYSL 416

Query: 376 LELGRNSFSGFIPNTFGNLR--NLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSN 433
           +E      +  IP+ +  L+        LH + +   N+  +F S            L  
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD----------DLIP 466

Query: 434 NPLDG-----ILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
             LD      I   +        +  F M + +    F   +                +G
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR--F---LEQKIRHDSTAWNA---SG 518

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE 526
           SI  TL +L+  +  ++ DN    P  +   RL     
Sbjct: 519 SILNTLQQLKFYKP-YICDND---PKYE---RLVNAIL 549

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 1e-05
 Identities = 38/201 (18%), Positives = 67/201 (33%), Gaps = 47/201 (23%)

Query: 50  ITHDPTNFLAKNWNTSTPVCNWTGVTCDVHS---------------HRVKVLNISHLNLT 94
           I  D    + K    S         T  + S               HR  +++  H N+ 
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-SIVD--HYNIP 456

Query: 95  GTIPSQLWNLSSLQSLN-----LGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFI 149
            T  S   +L            +G + L         TL+ + +++FR          F+
Sbjct: 457 KTFDS--DDLIPPYLDQYFYSHIGHH-LKNIEHPERMTLFRMVFLDFR----------FL 503

Query: 150 FNKSSLQHLDFSYNALSGEIP---------ANICSNLPFLESISLSQNMFHGRIPSALSN 200
             K  ++H   ++NA    +            IC N P  E +  +   F  +I   L  
Sbjct: 504 EQK--IRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLIC 561

Query: 201 CKYLEILSLSINNLLGAIPKE 221
            KY ++L +++     AI +E
Sbjct: 562 SKYTDLLRIALMAEDEAIFEE 582

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 1e-04
 Identities = 73/542 (13%), Positives = 139/542 (25%), Gaps = 186/542 (34%)

Query: 467 PKEIGNLTNLI-------GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC 519
            +    L   +        + + G  + GS     GK   +        K++  +   I 
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDG--VLGS-----GK-TWVALDVCLSYKVQCKMDFKI- 184

Query: 520 RLTKLYELGLSGNKLSGSIPACFSNLASL--GTLSLGSNKLTSIPLTIWNLKGMLYLNFS 577
                + L L       ++      L        +  S+  ++I L I +++  L     
Sbjct: 185 -----FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL----- 234

Query: 578 SNFFTGP------LPLD-IGNLKVLIGIDFS-----TNNFSDVIPTVIG----------- 614
                        L L  + N K     + S     T  F  V   +             
Sbjct: 235 RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294

Query: 615 --GLTN-------LQYLFLGYNRL-----QGS------ISESFGDLISL--KSLNLSNNN 652
              LT        L+YL      L       +      I+ES  D ++      +++ + 
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354

Query: 653 LSRSIPISLEKLS------YLEDLDLSFNK-----------LKGEIPKGGSFGNFSAKSF 695
           L+  I  SL  L         + L + F             +  ++ K            
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSV-FPPSAHIPTILLSLIWFDVIKSDVM--VVVNKL 411

Query: 696 EGNELLCGSPNLQVPPCKTSIHHKSRKNVLLLGIVLPLSTIFIIVVIL---LIVRYRKRV 752
               L+      Q      SI        + L + + L   +     L   ++  Y    
Sbjct: 412 HKYSLV----EKQPKESTISIPS------IYLELKVKLENEYA----LHRSIVDHYNIPK 457

Query: 753 KQPPNDANMPPIATCRRFSY--------LELCRATNRFSENNLIGRGGFGSVYKARIGEG 804
               +D   P +       Y        L+      R +         F  V+       
Sbjct: 458 TFDSDDLIPPYL-----DQYFYSHIGHHLKNIEHPERMTL--------FRMVF------- 497

Query: 805 MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLE 864
                   D         F     + + IRH +     +  ++      + +      L+
Sbjct: 498 -------LDF-------RF-----LEQKIRHDST----AWNASGSILNTLQQ------LK 528

Query: 865 KSLYSSNYILDIFQRLNIMVDVATTLEYLHF--GYSAPVI---HCDL------KPSNVLL 913
              Y   YI D   +   +V+       L F       +I   + DL           + 
Sbjct: 529 F--Y-KPYICDNDPKYERLVN-----AILDFLPKIEENLICSKYTDLLRIALMAEDEAIF 580

Query: 914 DD 915
           ++
Sbjct: 581 EE 582

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 2e-04
 Identities = 69/432 (15%), Positives = 128/432 (29%), Gaps = 119/432 (27%)

Query: 600 FSTNNFSDVI--PTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSI 657
            S      +I     + G   L +  L     Q  + + F +    + L ++   L   I
Sbjct: 46  LSKEEIDHIIMSKDAVSGTLRLFWTLLSK---QEEMVQKFVE----EVLRINYKFLMSPI 98

Query: 658 ------PISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVP- 710
                 P S+    Y+E  D  +N                      N++        V  
Sbjct: 99  KTEQRQP-SMMTRMYIEQRDRLYN---------------------DNQVF---AKYNVSR 133

Query: 711 -PCKTSIHH-----KSRKNVLLLGI------VLPLSTIFIIVVILLIVRYRKRVKQPPND 758
                 +       +  KNVL+ G+       + L                K   +    
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV----------CLSYKVQCKMDFK 183

Query: 759 A---NMPPIATCRRF-SYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVF-- 812
               N+     C    + LE+ +      + N   R    S  K RI        ++   
Sbjct: 184 IFWLNL---KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 813 -----------DLQCGRAFKSFDVECEMM-----KSI---------RHRNLIKVISSCST 847
                      ++Q  +A+ +F++ C+++     K +          H +L     + + 
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300

Query: 848 EEFKALILEY--MPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLE-YLHFGYSA--PV 901
           +E K+L+L+Y       L + + ++N   L I      + D   T + + H        +
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES--IRDGLATWDNWKHVNCDKLTTI 358

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI-GYMAPGLFHVKYIL 960
           I   L   NVL             +          I  T  L+ I   +         ++
Sbjct: 359 IESSL---NVLEPAEYRKMFDRLSV----FPPSAHIP-TILLSLIWFDVIK-----SDVM 405

Query: 961 FVVNFLTSYSFL 972
            VVN L  YS +
Sbjct: 406 VVVNKLHKYSLV 417

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 30/174 (17%), Positives = 64/174 (36%), Gaps = 31/174 (17%)

Query: 780 NRFSENNLIGRGGFGSVYKAR---------IGEGMEVAVKV---------FDLQCGRAFK 821
            ++   +   R   G +Y+A            +  + ++K+               RA K
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 822 SFDVECEM-MKSIRHRNLIKVISSCSTE-EFKALILEYMPHG-SLEKSL-YSSNYILDIF 877
              V     + S     +   +     + +++ L+L  +  G SL+ +L  S  ++L   
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER 159

Query: 878 QRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 928
             L +   +   LE+LH       +H ++   N+ +   D + V  L+ +G A 
Sbjct: 160 SVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 53/377 (14%), Positives = 103/377 (27%), Gaps = 81/377 (21%)

Query: 101 LWNLSSLQSLNLGFNRLSGSIPSAIF-----TLYTLKYVNFRGNQLSGA-----FPSFIF 150
                 + SL+L  N L       +      T  ++  +N  GN L              
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 151 NKSSLQHLDFSYNALSGEIPANICSNLPF----LESISLSQNMFHGR----IPSALSNC- 201
             +++  L+ S N LS +    +   L      +  + L  N F  +       A SN  
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 202 KYLEILSLSINNL--LGAIPKEIGNL-----TKLKELYLGYSGLQGEIPREFGNLAELEL 254
             +  L+L  N+L    +   E+  +       +  L L  + L  +   E   LA+   
Sbjct: 138 ASITSLNLRGNDLGIKSS--DELIQILAAIPANVNSLNLRGNNLASKNCAE---LAK--- 189

Query: 255 MALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI-----HNLHNLKLLDLSHNK 309
             L                  +  L L  N L  +   E+        +++  L+L  N 
Sbjct: 190 -FLASIP------------ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236

Query: 310 L----VGAVPATIFNMSTLTGLGLQSNSLSG----SLSSIADV--QLPNLEELRLWSNNF 359
           L    +  +     ++  L  + L  + +         ++      +  +  +       
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

Query: 360 SGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS 419
             +                     S  I    G      L+     +       +  L  
Sbjct: 297 HPS----------------HSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDL-- 338

Query: 420 FSNCKSLTYIGLSNNPL 436
            +    L     +  PL
Sbjct: 339 -NIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 50/316 (15%), Positives = 97/316 (30%), Gaps = 60/316 (18%)

Query: 402 LHYNYLTSSNLELSFLSSF-SNCKSLTYIGLSNNPL--DGILPRMSM-GNLSHSLEYFDM 457
           ++Y            +  F S    +T + LS N L     +  +    N   S+   ++
Sbjct: 1   MNYKLTLHPGSNP--VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNL 58

Query: 458 SYCNVSGGFPKEIG-----NLTNLIGIYLGGNKLNGSIPITLGKL-----QKLQGLHLED 507
           S  ++      E+         N+  + L GN L+      L K        +  L L  
Sbjct: 59  SGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118

Query: 508 NKLEGPIPDDICRL-----TKLYELGLSGNKLSGS-----IPACFSNLASLGTLSLGSNK 557
           N        +  +        +  L L GN L        I    +  A++ +L+L  N 
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 558 LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGL- 616
           L S        K    L          L     ++  L   D S N         +  + 
Sbjct: 179 LAS--------KNCAEL-------AKFLASIPASVTSL---DLSANLLGLKSYAELAYIF 220

Query: 617 ----TNLQYLFLGYNRLQGS----ISESFGDLISLKSLNLSNNNLS-------RSIPISL 661
                ++  L L  N L G     +      L  L+++ L  + +        +++  + 
Sbjct: 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAF 280

Query: 662 EKLSYLEDLDLSFNKL 677
             +  +  +D +  ++
Sbjct: 281 PNIQKIILVDKNGKEI 296

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 57.2 bits (138), Expect = 9e-09
 Identities = 56/267 (20%), Positives = 91/267 (34%), Gaps = 28/267 (10%)

Query: 99  SQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSF-IFNKSSLQH 157
             LW    L   NL         P     L +   + FR  +     P    F+   +QH
Sbjct: 46  ESLWQTLDLTGKNL--------HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQH 97

Query: 158 LDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSI-----N 212
           +D S + +       I S    L+++SL        I + L+    L  L+LS       
Sbjct: 98  MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE 157

Query: 213 NLLGAIPKEIGNLTKLKELYLGY------SGLQGEIPREFGNLAELELMALQVSNLQGEI 266
             L  +     + ++L EL L +        +Q  +      + +L L      NLQ   
Sbjct: 158 FALQTLLS---SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY-RKNLQKSD 213

Query: 267 PQELA-NLTGLEVLKLGK-NFLTGEIPPEIHNLHNLKLLDLSHNKLVG-AVPATIFNMST 323
              L      L  L L     L  +   E   L+ L+ L LS    +       +  + T
Sbjct: 214 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 273

Query: 324 LTGLGLQSNSLSGSLSSIADVQLPNLE 350
           L  L +      G+L  + +  LP+L+
Sbjct: 274 LKTLQVFGIVPDGTLQLLKE-ALPHLQ 299

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 30/129 (23%), Positives = 49/129 (37%), Gaps = 31/129 (24%)

Query: 551 LSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP 610
           L      +  +  T+  LK   +L  S+N         I +L                  
Sbjct: 30  LHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KISSL------------------ 66

Query: 611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS-LEKLSYLED 669
               G+ NL+ L LG N ++  I        +L+ L +S N ++    +S +EKL  L  
Sbjct: 67  ---SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRV 119

Query: 670 LDLSFNKLK 678
           L +S NK+ 
Sbjct: 120 LYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 36/196 (18%), Positives = 63/196 (32%), Gaps = 36/196 (18%)

Query: 485 KLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSN 544
           +    +     K++    LH     +E  +   +  L     L LS N +   I +  S 
Sbjct: 16  ERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSG 68

Query: 545 LASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN 604
           + +L  LSLG N +  I         +  L  S N         +  ++           
Sbjct: 69  MENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-----SLSGIE----------- 112

Query: 605 FSDVIPTVIGGLTNLQYLFLGYNRLQGSISE--SFGDLISLKSLNLSNNNLSRSIPISLE 662
                      L NL+ L++  N++  +  E      L  L+ L L+ N L      +  
Sbjct: 113 ----------KLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNA 161

Query: 663 KLSYLEDLDLSFNKLK 678
              Y  ++      LK
Sbjct: 162 TSEYRIEVVKRLPNLK 177

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 33/123 (26%), Positives = 56/123 (45%), Gaps = 12/123 (9%)

Query: 193 RIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQ--GEIPREFGNLA 250
           ++ + LS  K  + L+LS  N +  I   +  +  L+ L LG + ++    +      L 
Sbjct: 39  KMDATLSTLKACKHLALS-TNNIEKI-SSLSGMENLRILSLGRNLIKKIENLDAVADTLE 96

Query: 251 ELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLT--GEIPPEIHNLHNLKLLDLSHN 308
           EL +   Q+++L G     +  L  L VL +  N +T  GEI   +  L  L+ L L+ N
Sbjct: 97  ELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150

Query: 309 KLV 311
            L 
Sbjct: 151 PLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 34/145 (23%), Positives = 59/145 (40%), Gaps = 16/145 (11%)

Query: 369 NASKLSVLELGRNSFSGF--IPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL 426
            A++   +EL          +  T   L+  + + L  N +         +SS S  ++L
Sbjct: 21  VATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIEK-------ISSLSGMENL 72

Query: 427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKL 486
             + L  N +  I    ++  ++ +LE   +SY  ++      I  L NL  +Y+  NK+
Sbjct: 73  RILSLGRNLIKKI---ENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKI 127

Query: 487 NGSIPI-TLGKLQKLQGLHLEDNKL 510
                I  L  L KL+ L L  N L
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 29/150 (19%), Positives = 56/150 (37%), Gaps = 34/150 (22%)

Query: 86  LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAF 145
           L+     +   + + L  L + + L L  N +       I +L  ++             
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGME------------- 70

Query: 146 PSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLE 205
                   +L+ L    N +  +I  N+ +    LE + +S N     + S +     L 
Sbjct: 71  --------NLRILSLGRNLIK-KIE-NLDAVADTLEELWISYNQIA-SL-SGIEKLVNLR 118

Query: 206 ILSLSINNL--LGAIPKEIGNLTKLKELYL 233
           +L +S N +   G I  ++  L KL++L L
Sbjct: 119 VLYMSNNKITNWGEI-DKLAALDKLEDLLL 147

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 11/154 (7%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           N+F     IG G FG +Y    I    EVA+K+ +++          E ++ + ++    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64

Query: 839 I-KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           I  V       ++  L+++ +   SLE      +  L +   L +   +   +E++H   
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--- 120

Query: 898 SAPVIHCDLKPSNVLLDDNMVAH---LSDFGIAK 928
           S   +H D+KP N L+     A+   + DFG+AK
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 37/170 (21%)

Query: 787 LIGRGGFGSVYKAR------IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK 840
            IG+GGFG +Y A       +G      VKV     G  F     E +  +       I+
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQ 97

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYIL---------DIFQR----------LN 881
                   ++   + +Y   G  +K+  S  +++          I++           L 
Sbjct: 98  KWIRTRKLKYLG-VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQ 156

Query: 882 IMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 928
           + + +   LEY+H       +H D+K SN+LL   + + V +L D+G+A 
Sbjct: 157 LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 34/171 (19%), Positives = 68/171 (39%), Gaps = 28/171 (16%)

Query: 780 NRFSENNLIGRGGFGSVYKA-RIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           N++     IG GGFG +Y A    +  + A  V  ++          E +  + +  ++ 
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDC 95

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYIL---------DIFQR---------L 880
           IK        ++   I  +   G  E    S  +++          I  +         L
Sbjct: 96  IKKWIERKQLDYLG-IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154

Query: 881 NIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 928
            + + +   LEY+H       +H D+K +N+LL   + + V +L+D+G++ 
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 54.6 bits (132), Expect = 6e-08
 Identities = 37/160 (23%), Positives = 74/160 (46%), Gaps = 27/160 (16%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIR-H 835
            + +     +GRG +  V++A  I    +V VK+    +  +  +    E ++++++R  
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGG 90

Query: 836 RNLIK---VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDI----FQRLNIMVDVAT 888
            N+I    ++         AL+ E++ +    K LY +    DI    ++ L        
Sbjct: 91  PNIITLADIVKD-PVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEILK------- 141

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIA 927
            L+Y H   S  ++H D+KP NV++D ++    L D+G+A
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 25/74 (33%), Positives = 32/74 (43%), Gaps = 8/74 (10%)

Query: 490 IPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASL 548
           IP         Q L L +N++    P     L  L +L  + NKL+ +IP   F  L  L
Sbjct: 31  IPTDK------QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 549 GTLSLGSNKLTSIP 562
             L L  N L SIP
Sbjct: 84  TQLDLNDNHLKSIP 97

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 27/77 (35%), Positives = 44/77 (57%), Gaps = 5/77 (6%)

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL-EKLSYL 667
           +P  I   T+ Q L+L  N++       F  L++L+ L  ++N L+ +IP  + +KL+ L
Sbjct: 27  VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 668 EDLDLSFNKLKGEIPKG 684
             LDL+ N LK  IP+G
Sbjct: 84  TQLDLNDNHLKS-IPRG 99

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 30/85 (35%), Positives = 43/85 (50%), Gaps = 4/85 (4%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGN 532
           T+   ++L  N++    P     L  LQ L+   NKL   IP  +  +LT+L +L L+ N
Sbjct: 33  TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDN 91

Query: 533 KLSGSIP-ACFSNLASLGTLSLGSN 556
            L  SIP   F NL SL  + L +N
Sbjct: 92  HLK-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 37/131 (28%), Positives = 52/131 (39%), Gaps = 32/131 (24%)

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
            N  + +VPA I   +    L L +N ++  L       L NL++L   SN         
Sbjct: 20  QNIRLASVPAGIP--TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSN--------- 67

Query: 367 IFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL 426
                KL+ +  G           F  L  L  + L+ N+L S         +F N KSL
Sbjct: 68  -----KLTAIPTG----------VFDKLTQLTQLDLNDNHLKSIPR-----GAFDNLKSL 107

Query: 427 TYIGLSNNPLD 437
           T+I L NNP D
Sbjct: 108 THIYLYNNPWD 118

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.5 bits (119), Expect = 7e-07
 Identities = 30/74 (40%), Positives = 38/74 (51%), Gaps = 8/74 (10%)

Query: 490 IPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASL 548
           IP T       Q L+L DN++    P    RLT+L  L L  N+L+  +PA  F  L  L
Sbjct: 28  IPTTT------QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 549 GTLSLGSNKLTSIP 562
             LSL  N+L SIP
Sbjct: 81  TQLSLNDNQLKSIP 94

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 5/77 (6%)

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL-EKLSYL 667
           +PT I   T  Q L+L  N++       F  L  L  L+L NN L+  +P  + +KL+ L
Sbjct: 24  VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 668 EDLDLSFNKLKGEIPKG 684
             L L+ N+LK  IP+G
Sbjct: 81  TQLSLNDNQLKS-IPRG 96

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.2 bits (113), Expect = 3e-06
 Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 4/85 (4%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGN 532
           T    +YL  N++    P    +L +L  L L++N+L   +P  +  +LT+L +L L+ N
Sbjct: 30  TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDN 88

Query: 533 KLSGSIP-ACFSNLASLGTLSLGSN 556
           +L  SIP   F NL SL  + L +N
Sbjct: 89  QLK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 29/122 (23%), Positives = 44/122 (36%), Gaps = 31/122 (25%)

Query: 550 TLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVI 609
           T+      L S+P  I                    P     L          N  + + 
Sbjct: 13  TVDCSGKSLASVPTGI--------------------PTTTQVL------YLYDNQITKLE 46

Query: 610 PTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI----SLEKLS 665
           P V   LT L  L L  N+L    +  F  L  L  L+L++N L +SIP     +L+ L+
Sbjct: 47  PGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL-KSIPRGAFDNLKSLT 105

Query: 666 YL 667
           ++
Sbjct: 106 HI 107

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 37/131 (28%), Positives = 51/131 (38%), Gaps = 32/131 (24%)

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
             K + +VP  I   +T   L L  N ++  L      +L  L  L L +N         
Sbjct: 17  SGKSLASVPTGIP--TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNN--------- 64

Query: 367 IFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL 426
                +L+VL  G           F  L  L  ++L+ N L S         +F N KSL
Sbjct: 65  -----QLTVLPAG----------VFDKLTQLTQLSLNDNQLKSIPRG-----AFDNLKSL 104

Query: 427 TYIGLSNNPLD 437
           T+I L NNP D
Sbjct: 105 THIWLLNNPWD 115

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.9 bits (117), Expect = 9e-07
 Identities = 22/137 (16%), Positives = 40/137 (29%), Gaps = 29/137 (21%)

Query: 521 LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNF 580
             +  EL L G K+   I    + L     +    N++  +                   
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD------------------ 58

Query: 581 FTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISE--SFG 638
                      L+ L  +  + N    +   +   L +L  L L  N L   + +     
Sbjct: 59  -------GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLA 110

Query: 639 DLISLKSLNLSNNNLSR 655
            L SL  L +  N ++ 
Sbjct: 111 SLKSLTYLCILRNPVTN 127

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 21/103 (20%), Positives = 37/103 (35%), Gaps = 4/103 (3%)

Query: 472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG 531
           N      + L G K+   I      L +   +   DN++   + D    L +L  L ++ 
Sbjct: 17  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73

Query: 532 NKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL 574
           N++          L  L  L L +N L  +   +  L  +  L
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVEL-GDLDPLASLKSL 115

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 28/145 (19%), Positives = 45/145 (31%), Gaps = 32/145 (22%)

Query: 292 PEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEE 351
            +  N    + LDL   K+             +  LG                 L   + 
Sbjct: 13  AQYTNAVRDRELDLRGYKI-----------PVIENLG---------------ATLDQFDA 46

Query: 352 LRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSN 411
           +   S+N    +        +L  L +  N            L +L  + L  N L    
Sbjct: 47  IDF-SDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV--- 101

Query: 412 LELSFLSSFSNCKSLTYIGLSNNPL 436
            EL  L   ++ KSLTY+ +  NP+
Sbjct: 102 -ELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 2/76 (2%)

Query: 603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLE 662
                VI  +   L     +    N ++  + + F  L  LK+L ++NN + R      +
Sbjct: 28  GYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQ 85

Query: 663 KLSYLEDLDLSFNKLK 678
            L  L +L L+ N L 
Sbjct: 86  ALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 22/148 (14%), Positives = 42/148 (28%), Gaps = 32/148 (21%)

Query: 212 NNLLGAIPKEIGNLTKLKELYLGYSGLQ--GEIPREFGNLAELELMALQVSNLQGEIPQE 269
             L+     +  N  + +EL L    +     +         ++    ++  L G     
Sbjct: 6   AELIEQAA-QYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG----- 59

Query: 270 LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGL 329
              L  L+ L +  N +          L +L  L L++N         +  +  L  L  
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLDPLA- 110

Query: 330 QSNSLSGSLSSIADVQLPNLEELRLWSN 357
                           L +L  L +  N
Sbjct: 111 ---------------SLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 30/161 (18%), Positives = 55/161 (34%), Gaps = 38/161 (23%)

Query: 151 NKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS--ALSNCKYLEILS 208
           N    + LD     +   +  N+ + L   ++I  S N     I         + L+ L 
Sbjct: 17  NAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLL 70

Query: 209 LSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQ 268
           ++ N +          L  L EL L  + L          L +L+               
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLV--------ELGDLD--------------- 107

Query: 269 ELANLTGLEVLKLGKNFLTGEIPPE-----IHNLHNLKLLD 304
            LA+L  L  L + +N +T +         I+ +  +++LD
Sbjct: 108 PLASLKSLTYLCILRNPVTNK--KHYRLYVIYKVPQVRVLD 146

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 49/174 (28%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSF----DVECEMMKSI 833
             R+    +IG+G FG V KA        VA+K+      R  K F      E  +++ +
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHL 150

Query: 834 RHR------NLIKVISS-------CSTEEFKALILEYMPHGSLEKSLY----SSNYI--- 873
           R +      N+I ++ +       C T E             L  +LY     + +    
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFE------------LLSMNLYELIKKNKFQGFS 198

Query: 874 LDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFG 925
           L + ++      +   L+ LH      +IHCDLKP N+LL     +   + DFG
Sbjct: 199 LPLVRK--FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 25/70 (35%), Positives = 34/70 (48%), Gaps = 2/70 (2%)

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLE 668
           I  +     NL++L L    L  S+  +   L  LK L LS N +   + +  EKL  L 
Sbjct: 41  IEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98

Query: 669 DLDLSFNKLK 678
            L+LS NKLK
Sbjct: 99  HLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 29/97 (29%), Positives = 44/97 (45%), Gaps = 4/97 (4%)

Query: 479 IYLGGNKLN-GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGS 537
           + L   K N G I     +   L+ L L +  L      ++ +L KL +L LS N++ G 
Sbjct: 29  LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGG 86

Query: 538 IPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL 574
           +      L +L  L+L  NKL  I  T+  LK +  L
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKLKDIS-TLEPLKKLECL 122

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 6/117 (5%)

Query: 320 NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELG 379
             + +  L L +   +         +  NLE L L +     ++        KL  LEL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKL-PKLKKLELS 79

Query: 380 RNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPL 436
            N   G +      L NL  + L  N L      +S L      + L  + L N  +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD----ISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 32/134 (23%), Positives = 48/134 (35%), Gaps = 27/134 (20%)

Query: 520 RLTKLYELGLSGNKLS-GSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSS 578
               + EL L   K + G I    +   +L  LSL +  L S+                 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVS---------------- 65

Query: 579 NFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG-SISESF 637
                    ++  L  L  ++ S N     +  +   L NL +L L  N+L+  S  E  
Sbjct: 66  ---------NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116

Query: 638 GDLISLKSLNLSNN 651
             L  LKSL+L N 
Sbjct: 117 KKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 34/142 (23%), Positives = 54/142 (38%), Gaps = 16/142 (11%)

Query: 370 ASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI 429
           +S  S +++ R         T   +R L L     N      L        +   +L ++
Sbjct: 2   SSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGL-------TAEFVNLEFL 54

Query: 430 GLSNNPLDGI--LPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
            L N  L  +  LP++        L+  ++S   + GG       L NL  + L GNKL 
Sbjct: 55  SLINVGLISVSNLPKLP------KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

Query: 488 G-SIPITLGKLQKLQGLHLEDN 508
             S    L KL+ L+ L L + 
Sbjct: 109 DISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 26/104 (25%), Positives = 39/104 (37%), Gaps = 3/104 (2%)

Query: 85  VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGA 144
           VL+    N  G I        +L+ L+L    L  S+ S +  L  LK +    N++ G 
Sbjct: 30  VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86

Query: 145 FPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN 188
                    +L HL+ S N L           L  L+S+ L   
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 32/138 (23%), Positives = 53/138 (38%), Gaps = 33/138 (23%)

Query: 224 NLTKLKELYLGYSGLQ----GEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVL 279
               ++EL L            +  EF NL  L L+ + + ++       L  L  L+ L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN-----LPKLPKLKKL 76

Query: 280 KLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLS 339
           +L +N + G +      L NL  L+LS NK        + ++STL  L            
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEPLK----------- 117

Query: 340 SIADVQLPNLEELRLWSN 357
                +L  L+ L L++ 
Sbjct: 118 -----KLECLKSLDLFNC 130

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 22/70 (31%), Positives = 33/70 (47%), Gaps = 2/70 (2%)

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLE 668
           +  +      L++L      L  SI  +   L  LK L LS+N +S  + +  EK   L 
Sbjct: 34  LEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91

Query: 669 DLDLSFNKLK 678
            L+LS NK+K
Sbjct: 92  HLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 25/104 (24%), Positives = 49/104 (47%), Gaps = 4/104 (3%)

Query: 472 NLTNLIGIYLGGNKLN-GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLS 530
             +++  + L  ++ N G +     + ++L+ L   +  L      ++ +L KL +L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72

Query: 531 GNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL 574
            N++SG +        +L  L+L  NK+  +  TI  LK +  L
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLS-TIEPLKKLENL 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 30/134 (22%), Positives = 49/134 (36%), Gaps = 27/134 (20%)

Query: 520 RLTKLYELGLSGNKLS-GSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSS 578
             + + EL L  ++ + G +         L  LS  +  LTSI                 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIA---------------- 58

Query: 579 NFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG-SISESF 637
                    ++  L  L  ++ S N  S  +  +     NL +L L  N+++  S  E  
Sbjct: 59  ---------NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109

Query: 638 GDLISLKSLNLSNN 651
             L +LKSL+L N 
Sbjct: 110 KKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 21/99 (21%), Positives = 36/99 (36%), Gaps = 2/99 (2%)

Query: 90  HLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFI 149
             +  G +         L+ L+     L+ SI + +  L  LK +    N++SG      
Sbjct: 27  SRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84

Query: 150 FNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN 188
               +L HL+ S N +           L  L+S+ L   
Sbjct: 85  EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 28/170 (16%), Positives = 59/170 (34%), Gaps = 39/170 (22%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR--------HRN 837
            +G G F +V+ A+ +     VA+K+         ++ + E ++++ +            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 838 LIKVISSCSTEEFKALILEY--MPHGSLEKSLYSSNYILDIFQRLN------------IM 883
              ++        K     +  M    L ++L +         +              I 
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA-------LIKKYEHRGIPLIYVKQIS 137

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH------LSDFGIA 927
             +   L+Y+H      +IH D+KP NVL++            ++D G A
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 1e-05
 Identities = 25/183 (13%), Positives = 65/183 (35%), Gaps = 36/183 (19%)

Query: 239 QGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI--HN 296
           Q ++      +  L  + ++ +N      +   NL   + L++    L   +  +I   +
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSD 217

Query: 297 LHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADV----QLPNLEEL 352
           L NL+ L L                     +G++     G ++    +    + PNL+ L
Sbjct: 218 LPNLEKLVLY--------------------VGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257

Query: 353 RLWSNNFSGTIPRFIFNA---SKLSVLELGRNSFSGF----IPNTFGNLRNLRLMTLHYN 405
            +        +      +    +L  +++     +      + +    +++L+ + + YN
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317

Query: 406 YLT 408
           YL+
Sbjct: 318 YLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 3e-05
 Identities = 31/162 (19%), Positives = 48/162 (29%), Gaps = 17/162 (10%)

Query: 288 GEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGS-LSSIADVQL 346
            ++ P +  +  L  L +     +            L  L + S  L  S +  I    L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 347 PNLEELRLW--SNNFSG-----TIPRFIFNAS--KLSVLELGRNSFSGFIPNTFGN---L 394
           PNLE+L L+    ++                    L  L +        +   F     L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPL 436
             L  M +    LT     L  L      K L +I +  N L
Sbjct: 279 PQLETMDISAGVLTDEGARL-LLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 6e-05
 Identities = 24/137 (17%), Positives = 53/137 (38%), Gaps = 18/137 (13%)

Query: 559 TSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIG-----NLKVLIGIDFSTNNFSDVIPTVI 613
            ++ +       +  L   S      +  DI      NL+ L+      +   D    V 
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242

Query: 614 ------GGLTNLQYLFLGYNRLQGSISESFGD---LISLKSLNLSNNNLS----RSIPIS 660
                     NL++L +     Q  + E F +   L  L+++++S   L+    R +   
Sbjct: 243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDH 302

Query: 661 LEKLSYLEDLDLSFNKL 677
           ++K+ +L+ +++ +N L
Sbjct: 303 VDKIKHLKFINMKYNYL 319

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 41/160 (25%), Positives = 58/160 (36%), Gaps = 42/160 (26%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSF----DVECEMMKSI 833
            N F     +G G FG V   + I      AVKV      R  K +     +E +++K I
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKI 88

Query: 834 RHR-----NLIKVISS-------CSTEEFKALILEYMPHGSLEKSLY----SSNYI-LDI 876
           ++      N++K           C   E             L  SLY     +NY    I
Sbjct: 89  QNDDINNNNIVKYHGKFMYYDHMCLIFE------------PLGPSLYEIITRNNYNGFHI 136

Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN 916
                  +++   L YL       + H DLKP N+LLDD 
Sbjct: 137 EDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDP 173

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 41/173 (23%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSF----DVECEMMKSI 833
            +R+  ++LIG+G FG V KA    E   VA+K+      +  K+F     +E  +++ +
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-----KNKKAFLNQAQIEVRLLELM 107

Query: 834 RHR------NLIKVISSCSTEEFKALILEYMPHGSLEKSLY-----------SSNYILDI 876
                     ++ +           L+ E      L  +LY           S N     
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKF 162

Query: 877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIA 927
            Q++       T L +L       +IHCDLKP N+LL +   +   + DFG +
Sbjct: 163 AQQM------CTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 28/162 (17%), Positives = 55/162 (33%), Gaps = 44/162 (27%)

Query: 779 TNRFSENNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKSF----DVECEMMKS 832
             R+     +G G FG V +         +VA+K+      R    +     +E  ++K 
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKK 72

Query: 833 IRHR------NLIKVISS-------CSTEEFKALILEYMPHGSLEKSLY----SSNYI-L 874
           I+ +        + +          C   E             L K+ +     +N+   
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFE------------LLGKNTFEFLKENNFQPY 120

Query: 875 DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN 916
            +    ++   +   L +LH      + H DLKP N+L  ++
Sbjct: 121 PLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 27/162 (16%), Positives = 56/162 (34%), Gaps = 44/162 (27%)

Query: 779 TNRFSENNLIGRGGFGSVYKA--RIGEGMEVAVKVFDLQCGRAFKSF----DVECEMMKS 832
           + R+   + +G G FG V +       G  VAVK+      +    +      E ++++ 
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-----KNVDRYCEAARSEIQVLEH 67

Query: 833 IRHR------NLIKVISS-------CSTEEFKALILEYMPHGSLEKSLY----SSNYI-L 874
           +           ++++         C   E             L  S Y     + ++  
Sbjct: 68  LNTTDPNSTFRCVQMLEWFEHHGHICIVFE------------LLGLSTYDFIKENGFLPF 115

Query: 875 DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN 916
            +     +   +  ++ +LH   S  + H DLKP N+L   +
Sbjct: 116 RLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	982
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.97
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.96
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.96
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.96
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.94
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.94
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.94
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.94
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.94
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.94
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.94
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.94
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.94
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.94
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.94
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.94
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.94
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.94
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.94
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.94
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.94
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.93
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.93
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.93
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.93
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.93
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.93
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.93
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.93
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.93
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.92
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.92
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.91
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3uqc_A	286	Probable conserved transmembrane protein; structur	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.79
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.73
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.64
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.63
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.59
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.59
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.58
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.57
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.55
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.52
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.51
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.49
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.48
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.38
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.35
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.31
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.29
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.02
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.98
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.93
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.93
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.88
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.48
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.46
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.33
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.31
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.2
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.18
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.86
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.81
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.57
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.56
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.51
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.42
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.33
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.31
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.26
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.14
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.96
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.92
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.91
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.85
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.75
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.69
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.61
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.57
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.55
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.41
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.02
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.42

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.9e-92  Score=876.87  Aligned_cols=666  Identities=33%  Similarity=0.477  Sum_probs=475.8

Q ss_pred             hcCCCChhHHHHHHHHHHHhcCCCCccccCCCCCCCCCCceeeEEecCCCCcEEEEEeCCCCcccc---CCcc-------
Q 036229           31 ANTSSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGT---IPSQ-------  100 (982)
Q Consensus        31 ~~~~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~---~~~~-------  100 (982)
                      +...+.++|++||++||+++. ||.  .+++|+.++|||+|.||+|+  .++|+.|+|+++++.|.   +|++       
T Consensus         5 ~~~~~~~~~~~all~~k~~~~-~~~--~l~~W~~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L   79 (768)
T 3rgz_A            5 SPSQSLYREIHQLISFKDVLP-DKN--LLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL   79 (768)
T ss_dssp             ---CCHHHHHHHHHHHHTTCS-CTT--SSTTCCTTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred             ccccCCHHHHHHHHHHHhhCC-Ccc--cccCCCCCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence            344557899999999999997 433  78999988999999999999  68999999999999987   6654       


Q ss_pred             ----------------ccCCCCCCEEEcCCCCccccCcc--hhhhccCCcEEEccCCcccCccCccc-cCcCCCCccccc
Q 036229          101 ----------------LWNLSSLQSLNLGFNRLSGSIPS--AIFTLYTLKYVNFRGNQLSGAFPSFI-FNKSSLQHLDFS  161 (982)
Q Consensus       101 ----------------l~~l~~L~~L~L~~n~~~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls  161 (982)
                                      ++.+++|++|||++|.++|.+|.  .++++++|++|+|++|.+++.+|..+ .++++|++|||+
T Consensus        80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls  159 (768)
T 3rgz_A           80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS  159 (768)
T ss_dssp             CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred             cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence                            45555666666666666655555  56666666666666666665555544 556666666666


Q ss_pred             cCcccccCchhh--hcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCC
Q 036229          162 YNALSGEIPANI--CSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQ  239 (982)
Q Consensus       162 ~N~l~~~ip~~~--~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  239 (982)
                      +|.+++..|..+  +.++++|++|+|++|++++..|.  ..+++|++|+|++|++++.+|. ++++++|++|+|++|+++
T Consensus       160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~  236 (768)
T 3rgz_A          160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLS  236 (768)
T ss_dssp             SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCC
T ss_pred             CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCC
Confidence            666665544431  35566666666666666554432  5566666666666666655555 666666666666666666


Q ss_pred             CchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCcccccc-CCCcEEEccCccccccCcccc
Q 036229          240 GEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNL-HNLKLLDLSHNKLVGAVPATI  318 (982)
Q Consensus       240 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~  318 (982)
                      +.+|..++++++|+.|++++|++.+.+|..  .+++|++|++++|++++.+|..+... ++|++|+|++|++++.+|..+
T Consensus       237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~  314 (768)
T 3rgz_A          237 GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF  314 (768)
T ss_dssp             SCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred             CcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence            666666666666666666666666655554  56666666666666666666666554 666666666666666666666


Q ss_pred             cCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCC-CCCEEEeccccCccccCCcccc--CC
Q 036229          319 FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNAS-KLSVLELGRNSFSGFIPNTFGN--LR  395 (982)
Q Consensus       319 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~--l~  395 (982)
                      .++++|+.|++++|.+.+.++...+..+++|++|++++|++++.+|..+..++ +|++|++++|++++..|..+..  ++
T Consensus       315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~  394 (768)
T 3rgz_A          315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN  394 (768)
T ss_dssp             GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC
T ss_pred             hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC
Confidence            66666666666666666555555455666666666666666666666666665 6666666666666666666555  56


Q ss_pred             ccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccc
Q 036229          396 NLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTN  475 (982)
Q Consensus       396 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~  475 (982)
                      +|+.|++++|.++...     +..|.++++|++|+|++|++++..|... .. ..+|++|++++|++++.+|..+..+++
T Consensus       395 ~L~~L~L~~n~l~~~~-----p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~-l~~L~~L~L~~n~l~~~~p~~~~~l~~  467 (768)
T 3rgz_A          395 TLQELYLQNNGFTGKI-----PPTLSNCSELVSLHLSFNYLSGTIPSSL-GS-LSKLRDLKLWLNMLEGEIPQELMYVKT  467 (768)
T ss_dssp             CCCEEECCSSEEEEEC-----CGGGGGCTTCCEEECCSSEEESCCCGGG-GG-CTTCCEEECCSSCCCSCCCGGGGGCTT
T ss_pred             CccEEECCCCcccccc-----CHHHhcCCCCCEEECcCCcccCcccHHH-hc-CCCCCEEECCCCcccCcCCHHHcCCCC
Confidence            6666666666665321     2235666677777777776665544332 11 245667777777777666766777777


Q ss_pred             cceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCC
Q 036229          476 LIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS  555 (982)
Q Consensus       476 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  555 (982)
                      |+.|++++|++++.+|.+|.++++|++|+|++|++++.+|.++..+++|++|+|++|++++.+|..+.++++|+.|+|++
T Consensus       468 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~  547 (768)
T 3rgz_A          468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT  547 (768)
T ss_dssp             CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCS
T ss_pred             ceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCC
Confidence            77777777777766677777777777777777777766777777777777777777777766777777777777777777


Q ss_pred             Cccc-ccccccccccCce----------------------------------------------EEecCCCcccCCCccc
Q 036229          556 NKLT-SIPLTIWNLKGML----------------------------------------------YLNFSSNFFTGPLPLD  588 (982)
Q Consensus       556 N~l~-~ip~~~~~l~~L~----------------------------------------------~L~Ls~N~l~~~~~~~  588 (982)
                      |+++ .+|..++....+.                                              .++++.|.++|.+|..
T Consensus       548 N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~  627 (768)
T 3rgz_A          548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT  627 (768)
T ss_dssp             SEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCS
T ss_pred             CccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchh
Confidence            7766 6666554432222                                              2334446666666777


Q ss_pred             cccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccc
Q 036229          589 IGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLE  668 (982)
Q Consensus       589 ~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~  668 (982)
                      ++.+++|+.||||+|+++|.+|.+|+.+++|+.|+|++|+++|.+|..|+++++|++||||+|+++|.+|..+..+++|+
T Consensus       628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~  707 (768)
T 3rgz_A          628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT  707 (768)
T ss_dssp             CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred             hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence            77889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCcccccCCCCCCCCCCCCcccccCcccCCCCCCCCCCCCccc
Q 036229          669 DLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPCKTSI  716 (982)
Q Consensus       669 ~l~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~lc~~~~~~~~~c~~~~  716 (982)
                      +||||+|+++|.||.+++|.++.+.+|.|||++||.|.   ++|....
T Consensus       708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l---~~C~~~~  752 (768)
T 3rgz_A          708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL---PRCDPSN  752 (768)
T ss_dssp             EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS---CCCCSCC
T ss_pred             EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC---cCCCCCc
Confidence            99999999999999999999999999999999999984   4787543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=9.4e-73  Score=700.41  Aligned_cols=586  Identities=31%  Similarity=0.434  Sum_probs=534.3

Q ss_pred             CcEEEEEeCCCCccccCCc--cccCCCCCCEEEcCCCCccccCcchh-hhccCCcEEEccCCcccCccCcc---ccCcCC
Q 036229           81 HRVKVLNISHLNLTGTIPS--QLWNLSSLQSLNLGFNRLSGSIPSAI-FTLYTLKYVNFRGNQLSGAFPSF---IFNKSS  154 (982)
Q Consensus        81 ~~v~~L~l~~~~l~g~~~~--~l~~l~~L~~L~L~~n~~~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~  154 (982)
                      .+++.|+|++|.++|.+|.  .++++++|++|||++|.+++.+|..+ ..+++|++|+|++|++++..|..   +.++++
T Consensus       100 ~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~  179 (768)
T 3rgz_A          100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE  179 (768)
T ss_dssp             TTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTT
T ss_pred             CCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCC
Confidence            4688999999999999998  99999999999999999999999877 79999999999999999988887   889999


Q ss_pred             CCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhcc
Q 036229          155 LQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLG  234 (982)
Q Consensus       155 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  234 (982)
                      |++|++++|.+++.+|.   ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++.+|..++.+++|++|+|+
T Consensus       180 L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls  255 (768)
T 3rgz_A          180 LKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS  255 (768)
T ss_dssp             CCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECC
T ss_pred             CCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECC
Confidence            99999999999987764   6899999999999999998887 9999999999999999999999999999999999999


Q ss_pred             CCCCCCchhhhcCCCcccceEeccccccCCcCChhhhcc-CCCcEEEccCCccccCCCccccccCCCcEEEccCcccccc
Q 036229          235 YSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANL-TGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGA  313 (982)
Q Consensus       235 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  313 (982)
                      +|++++.+|..  .+++|+.|++++|++++.+|..+.+. ++|++|+|++|++++.+|..|.++++|++|+|++|++++.
T Consensus       256 ~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~  333 (768)
T 3rgz_A          256 SNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE  333 (768)
T ss_dssp             SSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred             CCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCc
Confidence            99999888875  89999999999999999999988775 9999999999999999999999999999999999999988


Q ss_pred             Cccc-ccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccC--CCCCCEEEeccccCccccCCc
Q 036229          314 VPAT-IFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFN--ASKLSVLELGRNSFSGFIPNT  390 (982)
Q Consensus       314 ~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~L~~N~i~~~~~~~  390 (982)
                      +|.. +..+++|+.|++++|.+.+.++.......++|++|++++|++++.+|..+..  +++|++|++++|++++.+|..
T Consensus       334 ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~  413 (768)
T 3rgz_A          334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT  413 (768)
T ss_dssp             CCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGG
T ss_pred             CCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHH
Confidence            8876 8999999999999999987666554433349999999999999999988877  889999999999999999999


Q ss_pred             cccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCccc
Q 036229          391 FGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEI  470 (982)
Q Consensus       391 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~  470 (982)
                      |..+++|+.|++++|.++....     ..|..+++|++|++++|++.+..|....  ...+|++|++++|++++.+|..+
T Consensus       414 l~~l~~L~~L~Ls~N~l~~~~p-----~~l~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~l  486 (768)
T 3rgz_A          414 LSNCSELVSLHLSFNYLSGTIP-----SSLGSLSKLRDLKLWLNMLEGEIPQELM--YVKTLETLILDFNDLTGEIPSGL  486 (768)
T ss_dssp             GGGCTTCCEEECCSSEEESCCC-----GGGGGCTTCCEEECCSSCCCSCCCGGGG--GCTTCCEEECCSSCCCSCCCGGG
T ss_pred             HhcCCCCCEEECcCCcccCccc-----HHHhcCCCCCEEECCCCcccCcCCHHHc--CCCCceEEEecCCcccCcCCHHH
Confidence            9999999999999999985432     3588899999999999999987665432  23689999999999999999999


Q ss_pred             ccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccc
Q 036229          471 GNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGT  550 (982)
Q Consensus       471 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  550 (982)
                      .++++|+.|++++|++++.+|.+|+.+++|++|+|++|++++.+|..+..+++|+.|++++|+++|.+|..+.....+..
T Consensus       487 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~  566 (768)
T 3rgz_A          487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA  566 (768)
T ss_dssp             GGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBC
T ss_pred             hcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999988766544433


Q ss_pred             ----------------------------------------------cccCCCccc-ccccccccccCceEEecCCCcccC
Q 036229          551 ----------------------------------------------LSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTG  583 (982)
Q Consensus       551 ----------------------------------------------L~L~~N~l~-~ip~~~~~l~~L~~L~Ls~N~l~~  583 (982)
                                                                    ++++.|.++ .+|..+..+++|++||+++|+++|
T Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g  646 (768)
T 3rgz_A          567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG  646 (768)
T ss_dssp             CSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBS
T ss_pred             hhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccc
Confidence                                                          344456666 577778889999999999999999


Q ss_pred             CCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccccc
Q 036229          584 PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEK  663 (982)
Q Consensus       584 ~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  663 (982)
                      .+|..+++++.|+.|||++|+++|.+|..|+++++|++|||++|+++|.+|..|+++++|++||||+|+++|.+|.. ..
T Consensus       647 ~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~  725 (768)
T 3rgz_A          647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQ  725 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SS
T ss_pred             cCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999965 44


Q ss_pred             ccccceeecCCCc-cccc
Q 036229          664 LSYLEDLDLSFNK-LKGE  680 (982)
Q Consensus       664 l~~L~~l~ls~N~-l~~~  680 (982)
                      +..+....+.+|+ |+|.
T Consensus       726 ~~~~~~~~~~gN~~Lcg~  743 (768)
T 3rgz_A          726 FETFPPAKFLNNPGLCGY  743 (768)
T ss_dssp             GGGSCGGGGCSCTEEEST
T ss_pred             hccCCHHHhcCCchhcCC
Confidence            5566667788886 6653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=7.1e-66  Score=633.13  Aligned_cols=594  Identities=22%  Similarity=0.225  Sum_probs=483.1

Q ss_pred             EEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcc
Q 036229           86 LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNAL  165 (982)
Q Consensus        86 L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  165 (982)
                      +++++++++ .+|..+.  +++++|||++|.+++..|.+|.++++|++|+|++|++++..|..++++++|++|+|++|.+
T Consensus         9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l   85 (680)
T 1ziw_A            9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL   85 (680)
T ss_dssp             EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCC
T ss_pred             eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCcc
Confidence            555666666 5666554  6788888888888876666788888888888888888887788888888888888888888


Q ss_pred             cccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhh
Q 036229          166 SGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE  245 (982)
Q Consensus       166 ~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  245 (982)
                      + .+|+..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++++++|++|++++|++++..+..
T Consensus        86 ~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  164 (680)
T 1ziw_A           86 S-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE  164 (680)
T ss_dssp             C-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred             C-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHH
Confidence            7 677766688888888888888888777778888888888888888888777778888888888888888888777766


Q ss_pred             cC--CCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCcccc---ccCCCcEEEccCccccccCcccccC
Q 036229          246 FG--NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIH---NLHNLKLLDLSHNKLVGAVPATIFN  320 (982)
Q Consensus       246 ~~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~~~  320 (982)
                      +.  .+++|+.|++++|++++..|..+..+++|+.|++++|.+.......+.   ..++|+.|++++|.+++..|..+.+
T Consensus       165 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~  244 (680)
T 1ziw_A          165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG  244 (680)
T ss_dssp             HGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGG
T ss_pred             hhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhc
Confidence            54  457888888888888888888888888888888888877643222211   2367888888888888877877777


Q ss_pred             CCC--CceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCcc---------ccCC
Q 036229          321 MST--LTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG---------FIPN  389 (982)
Q Consensus       321 l~~--L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~---------~~~~  389 (982)
                      ++.  |+.|++++|.+.+..+. .+..+++|++|++++|++++..|..+.++++|++|++++|...+         +...
T Consensus       245 l~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~  323 (680)
T 1ziw_A          245 LKWTNLTMLDLSYNNLNVVGND-SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF  323 (680)
T ss_dssp             GGGSCCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred             cCcCCCCEEECCCCCcCccCcc-cccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence            654  88888888888754433 34567888888888888888888888888889999888775442         2223


Q ss_pred             ccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCC--CCCccccccccccccEEeccCCccccCCC
Q 036229          390 TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDG--ILPRMSMGNLSHSLEYFDMSYCNVSGGFP  467 (982)
Q Consensus       390 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~~~~L~~Ldls~n~l~~~~p  467 (982)
                      .|..+++|+.|++++|.++.+...     .|.++++|++|++++|.+..  +....+.......++.|++++|++++..|
T Consensus       324 ~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~  398 (680)
T 1ziw_A          324 SFQWLKCLEHLNMEDNDIPGIKSN-----MFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES  398 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBCCCCTT-----TTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECT
T ss_pred             hcccCCCCCEEECCCCccCCCChh-----HhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeECh
Confidence            678888899999999988876543     47888899999999887542  22221111122578999999999999999


Q ss_pred             cccccccccceEEecCCCCCCCCC-ccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCC--cCCCccccC
Q 036229          468 KEIGNLTNLIGIYLGGNKLNGSIP-ITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS--GSIPACFSN  544 (982)
Q Consensus       468 ~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~  544 (982)
                      ..|..+++|+.|++++|++++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++  +..|..|.+
T Consensus       399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~  478 (680)
T 1ziw_A          399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP  478 (680)
T ss_dssp             TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTT
T ss_pred             hhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccccc
Confidence            999999999999999999987665 78999999999999999999889999999999999999999987  568899999


Q ss_pred             CCcccccccCCCcccccccc-cccccCceEEecCCCcccCCCc--------cccccccccceeecccccccccccccccC
Q 036229          545 LASLGTLSLGSNKLTSIPLT-IWNLKGMLYLNFSSNFFTGPLP--------LDIGNLKVLIGIDFSTNNFSDVIPTVIGG  615 (982)
Q Consensus       545 l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~Ldls~N~l~~~~p~~~~~  615 (982)
                      +++|++|+|++|+++.+|.. +..+++|++|++++|++++..+        ..++++++|+.|||++|+++.+.+..|++
T Consensus       479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~  558 (680)
T 1ziw_A          479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD  558 (680)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccc
Confidence            99999999999999988865 5679999999999999986422        24789999999999999999776678999


Q ss_pred             ccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccc-cccccceeecCCCcccccCCCCCCCCC
Q 036229          616 LTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLE-KLSYLEDLDLSFNKLKGEIPKGGSFGN  689 (982)
Q Consensus       616 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~l~ls~N~l~~~~p~~~~~~~  689 (982)
                      +++|++|+|++|++++.++..|.++++|+.|+|++|+|++..|..+. .+++|+.+++++|++.|.++...+|..
T Consensus       559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~  633 (680)
T 1ziw_A          559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN  633 (680)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEEC
T ss_pred             ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHH
Confidence            99999999999999988888899999999999999999988887787 799999999999999999886333433

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=9.5e-63  Score=605.33  Aligned_cols=571  Identities=23%  Similarity=0.247  Sum_probs=503.2

Q ss_pred             CcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCcccc
Q 036229           81 HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDF  160 (982)
Q Consensus        81 ~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  160 (982)
                      .+++.|+|++|.+++..+..+.++++|++|||++|.+++..|.++.++++|++|+|++|++++..+..|+++++|++|+|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            47999999999999877788999999999999999999989999999999999999999999655557999999999999


Q ss_pred             ccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccc--cccchhhhhccCCCC
Q 036229          161 SYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIG--NLTKLKELYLGYSGL  238 (982)
Q Consensus       161 s~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l  238 (982)
                      ++|.++ .+|+..|.++++|++|+|++|.+++..|..|+++++|++|++++|++++..+..+.  .+++|++|++++|++
T Consensus       105 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          105 MSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             CSSCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred             CCCccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence            999998 56665569999999999999999999999999999999999999999988777665  458999999999999


Q ss_pred             CCchhhhcCCCcccceEeccccccCCcCChhhh---ccCCCcEEEccCCccccCCCccccccCC--CcEEEccCcccccc
Q 036229          239 QGEIPREFGNLAELELMALQVSNLQGEIPQELA---NLTGLEVLKLGKNFLTGEIPPEIHNLHN--LKLLDLSHNKLVGA  313 (982)
Q Consensus       239 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~  313 (982)
                      ++..|..|..+.+|+.++++++.+.+.....+.   ..++|++|++++|.+++..|..|.+++.  |++|+|++|++++.
T Consensus       184 ~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~  263 (680)
T 1ziw_A          184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV  263 (680)
T ss_dssp             CCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEE
T ss_pred             cccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCcc
Confidence            999999999999999999999987643333221   3489999999999999999999998865  99999999999998


Q ss_pred             CcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccc-----cccc----cccCCCCCCEEEeccccCc
Q 036229          314 VPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG-----TIPR----FIFNASKLSVLELGRNSFS  384 (982)
Q Consensus       314 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-----~~p~----~~~~l~~L~~L~L~~N~i~  384 (982)
                      .|..+..+++|+.|++++|.+.+..+ ..+..+++|++|++++|...+     .+|.    .+..+++|++|++++|+++
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~  342 (680)
T 1ziw_A          264 GNDSFAWLPQLEYFFLEYNNIQHLFS-HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP  342 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBSEECT-TTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBC
T ss_pred             CcccccCcccccEeeCCCCccCccCh-hhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccC
Confidence            89999999999999999999986544 344578999999999886553     2332    6788999999999999999


Q ss_pred             cccCCccccCCccceecccccccccCcccccccccCCC--CccccEEEccCCCCCCCCCccccccccccccEEeccCCcc
Q 036229          385 GFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN--CKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNV  462 (982)
Q Consensus       385 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l  462 (982)
                      +..+..|.++++|+.|++++|.+.......   ..|..  .++|+.|++++|++.++.+... . ...+|++|++++|++
T Consensus       343 ~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~---~~f~~~~~~~L~~L~L~~n~l~~~~~~~~-~-~l~~L~~L~L~~N~l  417 (680)
T 1ziw_A          343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTN---ETFVSLAHSPLHILNLTKNKISKIESDAF-S-WLGHLEVLDLGLNEI  417 (680)
T ss_dssp             CCCTTTTTTCTTCCEEECTTCBSCCCEECT---TTTGGGTTSCCCEEECTTSCCCEECTTTT-T-TCTTCCEEECCSSCC
T ss_pred             CCChhHhccccCCcEEECCCCchhhhhcch---hhhcccccCcCceEECCCCCCCeEChhhh-h-CCCCCCEEeCCCCcC
Confidence            999999999999999999999854322211   12333  3589999999999998766432 2 246899999999999


Q ss_pred             ccCCC-cccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCC--CCCCcccCCCccccEEEccCCcCCcCCC
Q 036229          463 SGGFP-KEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLE--GPIPDDICRLTKLYELGLSGNKLSGSIP  539 (982)
Q Consensus       463 ~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  539 (982)
                      ++.+| ..|.++++|+.|++++|++++..+..|..+++|+.|++++|.++  +.+|..|..+++|+.|+|++|+|+++.|
T Consensus       418 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~  497 (680)
T 1ziw_A          418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND  497 (680)
T ss_dssp             EEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             ccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCCh
Confidence            98665 78999999999999999999999999999999999999999997  5789999999999999999999999888


Q ss_pred             ccccCCCcccccccCCCcccccccc---------cccccCceEEecCCCcccCCCccccccccccceeeccccccccccc
Q 036229          540 ACFSNLASLGTLSLGSNKLTSIPLT---------IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP  610 (982)
Q Consensus       540 ~~~~~l~~L~~L~L~~N~l~~ip~~---------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p  610 (982)
                      ..|.++++|++|+|++|+++.++..         +..+++|++|++++|+++...+..|.++++|+.|||++|+++++.+
T Consensus       498 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~  577 (680)
T 1ziw_A          498 DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA  577 (680)
T ss_dssp             TTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             hhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCH
Confidence            9999999999999999999987432         5678999999999999997666789999999999999999999888


Q ss_pred             ccccCccCcceEecccccccCCcccccc-CCCCCCeeeCCCCcCCCCCC
Q 036229          611 TVIGGLTNLQYLFLGYNRLQGSISESFG-DLISLKSLNLSNNNLSRSIP  658 (982)
Q Consensus       611 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p  658 (982)
                      ..|..+++|+.|+|++|+|++.+|..|. .+++|+.|+|++|.+...-+
T Consensus       578 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             TTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             hHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            8899999999999999999999888888 79999999999999987544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-59  Score=582.94  Aligned_cols=534  Identities=21%  Similarity=0.199  Sum_probs=365.7

Q ss_pred             EEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCcc-CccccCcCCCCccccccC
Q 036229           85 VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAF-PSFIFNKSSLQHLDFSYN  163 (982)
Q Consensus        85 ~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N  163 (982)
                      ..+.++++++ .+|.   ..++|+.|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|
T Consensus         8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N   83 (844)
T 3j0a_A            8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS   83 (844)
T ss_dssp             EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred             EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence            3456677777 5555   3467778888888877777777777777777777777665555 556777777777777777


Q ss_pred             cccccCchhhhcCCCCCCeeeecceeeecccCCC--ccCcCcccEEEeeccccccccc-cccccccchhhhhccCCCCCC
Q 036229          164 ALSGEIPANICSNLPFLESISLSQNMFHGRIPSA--LSNCKYLEILSLSINNLLGAIP-KEIGNLTKLKELYLGYSGLQG  240 (982)
Q Consensus       164 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~  240 (982)
                      .+++..|..+ .++++|++|+|++|.+++.+|..  |+++++|++|+|++|++++..+ ..|+++++|++|+|++|.+++
T Consensus        84 ~l~~~~p~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A           84 KIYFLHPDAF-QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             CCCEECTTSS-CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             cCcccCHhHc-cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            7764434443 66777777777777776655443  6677777777777777765543 356666666666666666666


Q ss_pred             chhhhcCCC--cccceEeccccccCCcCChhhhccCC------CcEEEccCCccccCCCcccccc---CCCcEEEccCcc
Q 036229          241 EIPREFGNL--AELELMALQVSNLQGEIPQELANLTG------LEVLKLGKNFLTGEIPPEIHNL---HNLKLLDLSHNK  309 (982)
Q Consensus       241 ~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~  309 (982)
                      ..+..+..+  ++|+.|+++.|.+.+..|..+..+++      |++|++++|.+++..+..+...   .+++.|+++++.
T Consensus       163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            656555555  55666666666665555554444433      5555555555555544444332   344444444332


Q ss_pred             ccccCcccccCCCCCceeecCCCcCCCCcCcccc--ccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCcccc
Q 036229          310 LVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIAD--VQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFI  387 (982)
Q Consensus       310 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~  387 (982)
                      +...               ...|.+.+.. ...+  ...++|++|++++|.+.+..|..+..+++|+.|+|++|++++..
T Consensus       243 ~~~~---------------~~~~~l~~~~-~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  306 (844)
T 3j0a_A          243 MGAG---------------FGFHNIKDPD-QNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA  306 (844)
T ss_dssp             CBCS---------------SSCSSSTTGG-GTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC
T ss_pred             cccc---------------ccccccCCCC-hhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC
Confidence            2110               0111111110 1111  12356777777777777666777777777777777777777777


Q ss_pred             CCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCC
Q 036229          388 PNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFP  467 (982)
Q Consensus       388 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p  467 (982)
                      |..|..+++|+.|++++|.++.+...     .|.++++|++|++++|+                          +.+..+
T Consensus       307 ~~~~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~~L~~L~L~~N~--------------------------i~~~~~  355 (844)
T 3j0a_A          307 DEAFYGLDNLQVLNLSYNLLGELYSS-----NFYGLPKVAYIDLQKNH--------------------------IAIIQD  355 (844)
T ss_dssp             TTTTTTCSSCCEEEEESCCCSCCCSC-----SCSSCTTCCEEECCSCC--------------------------CCCCCS
T ss_pred             hHHhcCCCCCCEEECCCCCCCccCHH-----HhcCCCCCCEEECCCCC--------------------------CCccCh
Confidence            77777777777666666666544322     35566666666666654                          444455


Q ss_pred             cccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCC-ccccCCC
Q 036229          468 KEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP-ACFSNLA  546 (982)
Q Consensus       468 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~  546 (982)
                      ..|..+++|+.|+|++|.+++..     .+++|+.|++++|+++ .+|..   ..+++.|++++|++++... ..+.+++
T Consensus       356 ~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~  426 (844)
T 3j0a_A          356 QTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVP  426 (844)
T ss_dssp             SCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCT
T ss_pred             hhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCC
Confidence            66777888888888888887432     2678888888888888 44543   4568888888888876432 2355788


Q ss_pred             cccccccCCCcccccccc--cccccCceEEecCCCccc-----CCCccccccccccceeecccccccccccccccCccCc
Q 036229          547 SLGTLSLGSNKLTSIPLT--IWNLKGMLYLNFSSNFFT-----GPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL  619 (982)
Q Consensus       547 ~L~~L~L~~N~l~~ip~~--~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L  619 (982)
                      +|++|+|++|+++.++..  +..+++|++|++++|.++     +..+..+.++++|+.|||++|++++.+|..|+++++|
T Consensus       427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  506 (844)
T 3j0a_A          427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL  506 (844)
T ss_dssp             TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred             ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence            888888888888866543  445778888888888886     4455678999999999999999999999999999999


Q ss_pred             ceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC
Q 036229          620 QYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       620 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                      ++|+|++|+|++.+|..+.  ++|+.|||++|+|++.+|..+.   +|+.+++++|++.|.++..
T Consensus       507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~~~  566 (844)
T 3j0a_A          507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECELS  566 (844)
T ss_dssp             SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSSCC
T ss_pred             heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccccH
Confidence            9999999999988887776  8999999999999999987764   6889999999999988754

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5.6e-59  Score=564.05  Aligned_cols=536  Identities=22%  Similarity=0.192  Sum_probs=364.1

Q ss_pred             EEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCc
Q 036229           85 VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA  164 (982)
Q Consensus        85 ~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  164 (982)
                      .++.++.+++ .+|..+..  .+++|||++|.+++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus        16 ~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           16 TYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             EEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             eEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            3555666776 67766653  67888888888887777788888888888888888887777778778888888888777


Q ss_pred             ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhh
Q 036229          165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPR  244 (982)
Q Consensus       165 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  244 (982)
                      +++..|..+ +++++|++|+|++|++++..|..|+++++|++|+|++|++++..+..+..+++|++|++++|++++..|.
T Consensus        93 l~~~~~~~~-~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  171 (606)
T 3t6q_A           93 LIFMAETAL-SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE  171 (606)
T ss_dssp             CSEECTTTT-SSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred             ccccChhhh-cccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence            774444443 6777777777777777766566677777777777777776653333333356666666666665554455


Q ss_pred             hcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCC
Q 036229          245 EFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTL  324 (982)
Q Consensus       245 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  324 (982)
                      .|+.+++|+.+                      .|++++|.+++..|..|.. .+|+.|++++|.   ..+..+..+..+
T Consensus       172 ~~~~l~~L~~l----------------------~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~  225 (606)
T 3t6q_A          172 DMSSLQQATNL----------------------SLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNS  225 (606)
T ss_dssp             HHHTTTTCCSE----------------------EEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTC
T ss_pred             hhhhhccccee----------------------EEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhcccc
Confidence            55555444400                      4444555554444433332 345555555543   122222223222


Q ss_pred             ceeecCCCcCCC----CcCccccccC--CCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccc
Q 036229          325 TGLGLQSNSLSG----SLSSIADVQL--PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLR  398 (982)
Q Consensus       325 ~~L~L~~N~l~~----~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  398 (982)
                      +...+.-+.+..    .+....+..+  .+|++|++++|++++..+..|..+++|++|++++|+++ .+|..+..+++|+
T Consensus       226 ~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~  304 (606)
T 3t6q_A          226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK  304 (606)
T ss_dssp             EEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCC
T ss_pred             chhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCC
Confidence            222221111110    1111111111  15667777777777666666667777777777777776 3455566666666


Q ss_pred             eecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCC-cccccccccc
Q 036229          399 LMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFP-KEIGNLTNLI  477 (982)
Q Consensus       399 ~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p-~~~~~l~~L~  477 (982)
                      .|++++|.++....     ..+..+++|++|++++|.+                          .+.+| ..+..+++|+
T Consensus       305 ~L~l~~n~l~~~~~-----~~~~~l~~L~~L~l~~n~~--------------------------~~~~~~~~~~~l~~L~  353 (606)
T 3t6q_A          305 KLVLSANKFENLCQ-----ISASNFPSLTHLSIKGNTK--------------------------RLELGTGCLENLENLR  353 (606)
T ss_dssp             EEECTTCCCSBGGG-----GCGGGCTTCSEEECCSCSS--------------------------CCBCCSSTTTTCTTCC
T ss_pred             EEECccCCcCcCch-----hhhhccCcCCEEECCCCCc--------------------------ccccchhhhhccCcCC
Confidence            66666666654432     1345556666666666544                          33233 3466777777


Q ss_pred             eEEecCCCCCCCC--CccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCc-cccCCCcccccccC
Q 036229          478 GIYLGGNKLNGSI--PITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPA-CFSNLASLGTLSLG  554 (982)
Q Consensus       478 ~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~  554 (982)
                      .|++++|++++..  |..+..+++|++|++++|++++..|..|..+++|+.|++++|++++..|. .|.++++|++|+++
T Consensus       354 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~  433 (606)
T 3t6q_A          354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS  433 (606)
T ss_dssp             EEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECT
T ss_pred             EEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECC
Confidence            7777777777655  66777777777777777777777777777777777777777777766544 37777777777777


Q ss_pred             CCccccc-ccccccccCceEEecCCCcccC---CCccccccccccceeecccccccccccccccCccCcceEeccccccc
Q 036229          555 SNKLTSI-PLTIWNLKGMLYLNFSSNFFTG---PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ  630 (982)
Q Consensus       555 ~N~l~~i-p~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  630 (982)
                      +|+++.+ |..+..+++|++|++++|++++   ..+..+..+++|+.|++++|++++..|..|+.+++|++|+|++|+++
T Consensus       434 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  513 (606)
T 3t6q_A          434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT  513 (606)
T ss_dssp             TCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccC
Confidence            7777754 4455667778888888887775   23356888999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCC
Q 036229          631 GSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       631 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  683 (982)
                      +.+|.+|.++++| .|+|++|++++.+|..+..+++|++|++++|++.|.++.
T Consensus       514 ~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          514 SSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             GGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             cCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            9999999999999 999999999998888899999999999999999998874

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=7.8e-60  Score=571.22  Aligned_cols=504  Identities=19%  Similarity=0.259  Sum_probs=325.5

Q ss_pred             CCChhHHHHHHHHHHHhcCCCCc------cccCCCCCCCCCCce---eeEEecCCCCcEEEEEeCCCCccccCCccccCC
Q 036229           34 SSITTDQDALLALKAHITHDPTN------FLAKNWNTSTPVCNW---TGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNL  104 (982)
Q Consensus        34 ~~~~~~~~~ll~~k~~~~~~~~~------~~~~~w~~~~~~c~w---~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l  104 (982)
                      .....|+.||.+||+++..++..      ...++|+.+++||.|   .||+|+ ..+||+.|+|++++++|.+|++++++
T Consensus        26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~-~~~~V~~L~L~~~~l~g~lp~~l~~L  104 (636)
T 4eco_A           26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQL  104 (636)
T ss_dssp             CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEEC-TTCCEEEEECTTSCCEEEECGGGGGC
T ss_pred             hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEc-CCCCEEEEEecCcccCCcCChHHhcC
Confidence            34457999999999998653211      123589999999999   999998 45899999999999999999999999


Q ss_pred             CCCCEEEcCCCCc------cc------cCcchhhhccCCcEEEccCCcccCccCccccC-cCCCCccccccCcccccCch
Q 036229          105 SSLQSLNLGFNRL------SG------SIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFN-KSSLQHLDFSYNALSGEIPA  171 (982)
Q Consensus       105 ~~L~~L~L~~n~~------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~ip~  171 (982)
                      ++|++|||++|.+      .|      .+|...  +..|+ +++++|.+.+.+|..+.. +..+..+++....+..    
T Consensus       105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~----  177 (636)
T 4eco_A          105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK----  177 (636)
T ss_dssp             TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC----
T ss_pred             ccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc----
Confidence            9999999999976      33      556554  66777 899999999888887763 3455666666544431    


Q ss_pred             hhhcCCCCCCeeeec--ceeeecccCCCccCcCcccEEEeeccccccc-----------------cccccc--cccchhh
Q 036229          172 NICSNLPFLESISLS--QNMFHGRIPSALSNCKYLEILSLSINNLLGA-----------------IPKEIG--NLTKLKE  230 (982)
Q Consensus       172 ~~~~~l~~L~~L~Ls--~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~  230 (982)
                         .....++.+.+.  +|++++ +|.+|+++++|++|+|++|++++.                 +|..++  ++++|++
T Consensus       178 ---~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~  253 (636)
T 4eco_A          178 ---SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTD  253 (636)
T ss_dssp             ---CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred             ---ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCE
Confidence               122334444443  578888 888888888888888888888875                 777777  7777777


Q ss_pred             hhccCCCCCCchhhhcCCCcccceEeccccc-cCC-cCChhhhcc------CCCcEEEccCCccccCCCc--cccccCCC
Q 036229          231 LYLGYSGLQGEIPREFGNLAELELMALQVSN-LQG-EIPQELANL------TGLEVLKLGKNFLTGEIPP--EIHNLHNL  300 (982)
Q Consensus       231 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L  300 (982)
                      |+|++|++.+.+|..|+++++|+.|++++|+ +++ .+|..++.+      ++|++|++++|+++ .+|.  .|.++++|
T Consensus       254 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L  332 (636)
T 4eco_A          254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL  332 (636)
T ss_dssp             EEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC
T ss_pred             EEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC
Confidence            7777777777777777777777777777776 776 677776665      77777777777777 5666  67777777


Q ss_pred             cEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCC-CCEEEec
Q 036229          301 KLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK-LSVLELG  379 (982)
Q Consensus       301 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~  379 (982)
                      ++|+|++|+++|.+| .+..+++|                         ++|++++|+++ .+|..+..+++ |++|+++
T Consensus       333 ~~L~L~~N~l~g~ip-~~~~l~~L-------------------------~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls  385 (636)
T 4eco_A          333 GMLECLYNQLEGKLP-AFGSEIKL-------------------------ASLNLAYNQIT-EIPANFCGFTEQVENLSFA  385 (636)
T ss_dssp             CEEECCSCCCEEECC-CCEEEEEE-------------------------SEEECCSSEEE-ECCTTSEEECTTCCEEECC
T ss_pred             CEEeCcCCcCccchh-hhCCCCCC-------------------------CEEECCCCccc-cccHhhhhhcccCcEEEcc
Confidence            777777777776666 55444444                         66666666665 55666666666 7777777


Q ss_pred             cccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccC
Q 036229          380 RNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSY  459 (982)
Q Consensus       380 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~  459 (982)
                      +|+++ .+|..+..++                           +++|++|++++|++.                      
T Consensus       386 ~N~l~-~lp~~~~~~~---------------------------l~~L~~L~Ls~N~l~----------------------  415 (636)
T 4eco_A          386 HNKLK-YIPNIFDAKS---------------------------VSVMSAIDFSYNEIG----------------------  415 (636)
T ss_dssp             SSCCS-SCCSCCCTTC---------------------------SSCEEEEECCSSCTT----------------------
T ss_pred             CCcCc-ccchhhhhcc---------------------------cCccCEEECcCCcCC----------------------
Confidence            77766 3344333221                           123334444444333                      


Q ss_pred             CccccCCCcccc-------cccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcc-cCCC-------ccc
Q 036229          460 CNVSGGFPKEIG-------NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDD-ICRL-------TKL  524 (982)
Q Consensus       460 n~l~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-------~~L  524 (982)
                          +..|..+.       .+++|+.|+|++|+++...+..+..+++|++|+|++|+|+ .+|.. +...       ++|
T Consensus       416 ----~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L  490 (636)
T 4eco_A          416 ----SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLL  490 (636)
T ss_dssp             ----TTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGC
T ss_pred             ----CcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCc
Confidence                33333333       4556677777777776544445556677777777777776 33332 2222       255


Q ss_pred             cEEEccCCcCCcCCCcccc--CCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccc
Q 036229          525 YELGLSGNKLSGSIPACFS--NLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFST  602 (982)
Q Consensus       525 ~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~  602 (982)
                      +.|+|++|+|+ .+|..+.  .+++|++|+|++|+++.+|..++.+++|++|++++|+                  ++++
T Consensus       491 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~------------------~ls~  551 (636)
T 4eco_A          491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR------------------DAQG  551 (636)
T ss_dssp             CEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCB------------------CTTC
T ss_pred             cEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCc------------------cccc
Confidence            55555555555 3444443  5555555555555555555555555555555554443                  2344


Q ss_pred             ccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCC
Q 036229          603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       603 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  654 (982)
                      |++.+.+|..++.+++|++|+|++|++ +.+|..+.  ++|+.|||++|++.
T Consensus       552 N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          552 NRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             CBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred             CcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence            555555555555555555555555555 34444433  34555555555443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.5e-58  Score=558.34  Aligned_cols=535  Identities=19%  Similarity=0.183  Sum_probs=384.3

Q ss_pred             EEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCc
Q 036229           85 VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA  164 (982)
Q Consensus        85 ~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  164 (982)
                      .++.++++++ .+|..+.  ++|++|||++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus        15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~   91 (606)
T 3vq2_A           15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP   91 (606)
T ss_dssp             EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence            4667777787 6776654  788888888888887777788888888888888888887777778888888888888888


Q ss_pred             ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccccc-ccccccccccchhhhhccCCCCCCchh
Q 036229          165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLG-AIPKEIGNLTKLKELYLGYSGLQGEIP  243 (982)
Q Consensus       165 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~  243 (982)
                      +++..|..+ .++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++++..|
T Consensus        92 l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~  170 (606)
T 3vq2_A           92 IQSFSPGSF-SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV  170 (606)
T ss_dssp             CCCCCTTSS-TTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred             ccccChhhc-CCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence            874444444 777777777777777777666777777777777777777765 456677777777777777777766555


Q ss_pred             hhcCCCcccc----eEeccccccCCcCChhhhccCCCcEEEccCCccc-cCCCccccccCCCcEEEccCccccccCcccc
Q 036229          244 REFGNLAELE----LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLT-GEIPPEIHNLHNLKLLDLSHNKLVGAVPATI  318 (982)
Q Consensus       244 ~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  318 (982)
                      ..|+.+++|+    .+++++|.+++..+..+... +|++|++++|.++ +..|..+.++++|+.+++..+.+.+...   
T Consensus       171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~---  246 (606)
T 3vq2_A          171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN---  246 (606)
T ss_dssp             TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCC---
T ss_pred             hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCc---
Confidence            5555554443    45555555543333333322 4555555555443 2333444444444444444333321100   


Q ss_pred             cCCCCCceeecCCCcCCCCcCccccc--cCCCccEEEc-cCCcccccccccccCCCCCCEEEeccccCccccCCccccCC
Q 036229          319 FNMSTLTGLGLQSNSLSGSLSSIADV--QLPNLEELRL-WSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLR  395 (982)
Q Consensus       319 ~~l~~L~~L~L~~N~l~~~~~~~~~~--~l~~L~~L~L-s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  395 (982)
                           +.           .+....+.  .--.++.+++ ..|.+.+.+|. +..+++|+.|++++|.+... | .+..++
T Consensus       247 -----l~-----------~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~  307 (606)
T 3vq2_A          247 -----LE-----------IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHF  307 (606)
T ss_dssp             -----CS-----------CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTC
T ss_pred             -----cc-----------ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhh-h-hccccc
Confidence                 00           00000000  0113455666 56666666665 66677777777777777643 3 566666


Q ss_pred             ccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccc
Q 036229          396 NLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTN  475 (982)
Q Consensus       396 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~  475 (982)
                      +|+.|++++|.++.++       .+ .+++|++|++++|                          +..+..  .+..+++
T Consensus       308 ~L~~L~l~~n~l~~lp-------~~-~l~~L~~L~l~~n--------------------------~~~~~~--~~~~l~~  351 (606)
T 3vq2_A          308 KWQSLSIIRCQLKQFP-------TL-DLPFLKSLTLTMN--------------------------KGSISF--KKVALPS  351 (606)
T ss_dssp             CCSEEEEESCCCSSCC-------CC-CCSSCCEEEEESC--------------------------SSCEEC--CCCCCTT
T ss_pred             cCCEEEcccccCcccc-------cC-CCCccceeeccCC--------------------------cCccch--hhccCCC
Confidence            6666666666664433       12 4555555555555                          322222  4567788


Q ss_pred             cceEEecCCCCCCC--CCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCC-ccccCCCcccccc
Q 036229          476 LIGIYLGGNKLNGS--IPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP-ACFSNLASLGTLS  552 (982)
Q Consensus       476 L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~  552 (982)
                      |+.|++++|++++.  .|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++++..| ..|.++++|++|+
T Consensus       352 L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  430 (606)
T 3vq2_A          352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD  430 (606)
T ss_dssp             CCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEE
T ss_pred             CCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEE
Confidence            88888888888866  37888888899999999998885 56788888999999999999988777 6788899999999


Q ss_pred             cCCCcccc-cccccccccCceEEecCCCcccC-CCccccccccccceeecccccccccccccccCccCcceEeccccccc
Q 036229          553 LGSNKLTS-IPLTIWNLKGMLYLNFSSNFFTG-PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ  630 (982)
Q Consensus       553 L~~N~l~~-ip~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  630 (982)
                      +++|+++. +|..+..+++|++|++++|++++ .+|..++.+++|+.||+++|++++.+|..|+.+++|++|+|++|+++
T Consensus       431 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  510 (606)
T 3vq2_A          431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL  510 (606)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCC
Confidence            99999885 56667788899999999999987 47888999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCeeeCCCCcCCCCCCccccccc-ccceeecCCCcccccCCCC
Q 036229          631 GSISESFGDLISLKSLNLSNNNLSRSIPISLEKLS-YLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       631 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~l~ls~N~l~~~~p~~  684 (982)
                      +.+|..|+++++|++|||++|+|+ .+|..+..++ +|++|++++|++.|.+|..
T Consensus       511 ~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          511 FLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             CEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             CcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            999999999999999999999998 6787899987 5999999999999988864

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.9e-58  Score=557.84  Aligned_cols=516  Identities=19%  Similarity=0.182  Sum_probs=408.9

Q ss_pred             cEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccc
Q 036229           82 RVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFS  161 (982)
Q Consensus        82 ~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  161 (982)
                      .++.|+|++|.+++..|..++++++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+++
T Consensus        34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  113 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI  113 (606)
T ss_dssp             TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred             cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence            68999999999998889999999999999999999998889999999999999999999999899999999999999999


Q ss_pred             cCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchh--hhhccCCCCC
Q 036229          162 YNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLK--ELYLGYSGLQ  239 (982)
Q Consensus       162 ~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~--~L~L~~N~l~  239 (982)
                      +|.++ .+++..+.++++|++|+|++|++++..+..+.++++|++|++++|++++..|..|+.+++|+  +|++++|+++
T Consensus       114 ~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~  192 (606)
T 3t6q_A          114 QTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA  192 (606)
T ss_dssp             TSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred             ccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence            99999 45444459999999999999999986655666699999999999999988899999999999  8999999999


Q ss_pred             CchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCcccc-----CCCccccccC--CCcEEEccCccccc
Q 036229          240 GEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTG-----EIPPEIHNLH--NLKLLDLSHNKLVG  312 (982)
Q Consensus       240 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~--~L~~L~Ls~N~l~~  312 (982)
                      +..|..|.. .+|+.|++++|.   ..+..+.++.++....+..+.+..     ..+..|..+.  +|+.|++++|++++
T Consensus       193 ~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~  268 (606)
T 3t6q_A          193 GIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN  268 (606)
T ss_dssp             EECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSS
T ss_pred             ccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCc
Confidence            888877765 689999999987   456677777777666655444332     2233344443  57777777777776


Q ss_pred             cCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccc
Q 036229          313 AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFG  392 (982)
Q Consensus       313 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~  392 (982)
                      ..+..+..+++|+.|++++|.++                          .+|..+..+++|++|++++|++++..|..+.
T Consensus       269 ~~~~~~~~l~~L~~L~l~~n~l~--------------------------~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~  322 (606)
T 3t6q_A          269 ISSNTFHCFSGLQELDLTATHLS--------------------------ELPSGLVGLSTLKKLVLSANKFENLCQISAS  322 (606)
T ss_dssp             CCTTTTTTCTTCSEEECTTSCCS--------------------------CCCSSCCSCTTCCEEECTTCCCSBGGGGCGG
T ss_pred             cCHHHhccccCCCEEeccCCccC--------------------------CCChhhcccccCCEEECccCCcCcCchhhhh
Confidence            66666666666655555555554                          3444444555555555555555555455555


Q ss_pred             cCCccceecccccccc-cCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccc
Q 036229          393 NLRNLRLMTLHYNYLT-SSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIG  471 (982)
Q Consensus       393 ~l~~L~~L~L~~N~l~-~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~  471 (982)
                      .+++|+.|++++|.+. .++.     ..|..+++|++|++++|++.++.                        ..|..+.
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~-----~~~~~l~~L~~L~l~~n~l~~~~------------------------~~~~~~~  373 (606)
T 3t6q_A          323 NFPSLTHLSIKGNTKRLELGT-----GCLENLENLRELDLSHDDIETSD------------------------CCNLQLR  373 (606)
T ss_dssp             GCTTCSEEECCSCSSCCBCCS-----STTTTCTTCCEEECCSSCCCEEE------------------------ESTTTTT
T ss_pred             ccCcCCEEECCCCCcccccch-----hhhhccCcCCEEECCCCcccccc------------------------Ccchhcc
Confidence            5555555555555443 1111     12555666667777776554321                        1245677


Q ss_pred             cccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcc-cCCCccccEEEccCCcCCcCCCccccCCCcccc
Q 036229          472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDD-ICRLTKLYELGLSGNKLSGSIPACFSNLASLGT  550 (982)
Q Consensus       472 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  550 (982)
                      .+++|+.|++++|++++..|..|..+++|++|++++|++++..|.. +..+++|+.|++++|++++..|..|.++++|++
T Consensus       374 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  453 (606)
T 3t6q_A          374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH  453 (606)
T ss_dssp             TCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCE
T ss_pred             cCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCE
Confidence            7788888888888888888888888888888888888888766544 788888888888888888888888888888888


Q ss_pred             cccCCCcccc--cc--cccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccc
Q 036229          551 LSLGSNKLTS--IP--LTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGY  626 (982)
Q Consensus       551 L~L~~N~l~~--ip--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~  626 (982)
                      |+|++|+++.  +|  ..+..+++|++|++++|++++..|..++++++|+.||+++|++++..|..+..+++| +|+|++
T Consensus       454 L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~  532 (606)
T 3t6q_A          454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLAS  532 (606)
T ss_dssp             EECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCS
T ss_pred             EECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcC
Confidence            8888888874  23  456778899999999999998889999999999999999999999999999999999 999999


Q ss_pred             ccccCCccccccCCCCCCeeeCCCCcCCCCCC
Q 036229          627 NRLQGSISESFGDLISLKSLNLSNNNLSRSIP  658 (982)
Q Consensus       627 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  658 (982)
                      |++++.+|..|..+++|+.|++++|.+++..+
T Consensus       533 N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          533 NHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             SCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             CcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            99999999999999999999999999987655

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.3e-58  Score=568.19  Aligned_cols=517  Identities=21%  Similarity=0.246  Sum_probs=331.0

Q ss_pred             cCCCChhHHHHHHHHHHHhcCCCCccccCCCCCCC-----CC--Cce------------eeEEecCCCCcEEEEEeCCCC
Q 036229           32 NTSSITTDQDALLALKAHITHDPTNFLAKNWNTST-----PV--CNW------------TGVTCDVHSHRVKVLNISHLN   92 (982)
Q Consensus        32 ~~~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~-----~~--c~w------------~gv~c~~~~~~v~~L~l~~~~   92 (982)
                      .+.+..+|++||++||+++.+  +     +|+.+.     +|  |+|            .||+|+ ..+||+.|+|++++
T Consensus       263 ~~~~~~~d~~ALl~~k~~l~~--~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~-~~~~V~~L~Ls~~~  334 (876)
T 4ecn_A          263 ETAEYIKDYKALKAIWEALDG--K-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD-NNGRVTGLSLAGFG  334 (876)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTG--G-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEEC-TTSCEEEEECTTTC
T ss_pred             ccccchHHHHHHHHHHHHcCC--C-----CCCcCCCcccccCCccccccccccccccCcCceEec-CCCCEEEEECccCC
Confidence            345567899999999999954  2     787554     55  999            999999 46899999999999


Q ss_pred             ccccCCccccCCCCCCEEEc-CCCCccccCcchhhhc---------cCCcEEE-------ccCCcccCcc----------
Q 036229           93 LTGTIPSQLWNLSSLQSLNL-GFNRLSGSIPSAIFTL---------YTLKYVN-------FRGNQLSGAF----------  145 (982)
Q Consensus        93 l~g~~~~~l~~l~~L~~L~L-~~n~~~~~~p~~~~~l---------~~L~~L~-------Ls~N~l~~~~----------  145 (982)
                      +.|.+|+++++|++|+.||| ++|.++|..|......         ..++...       .....+++.+          
T Consensus       335 L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~  414 (876)
T 4ecn_A          335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM  414 (876)
T ss_dssp             CEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTS
T ss_pred             CCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccc
Confidence            99999999999999999999 8899988755331111         0000000       0001111111          


Q ss_pred             -CccccCcCCCCcccccc--CcccccCchhhhcCCCCCCeeeecceeeec-----------------ccCCCcc--CcCc
Q 036229          146 -PSFIFNKSSLQHLDFSY--NALSGEIPANICSNLPFLESISLSQNMFHG-----------------RIPSALS--NCKY  203 (982)
Q Consensus       146 -p~~~~~l~~L~~L~Ls~--N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~  203 (982)
                       +....+...++.+.++.  |.+++ ||..+ +++++|++|+|++|++++                 .+|..++  ++++
T Consensus       415 ~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l-~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~  492 (876)
T 4ecn_A          415 KPIKKDSRISLKDTQIGNLTNRITF-ISKAI-QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKD  492 (876)
T ss_dssp             CCCCCCCCCCCCTTTTTCCSCEEEE-ECGGG-GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred             cccccccccchhhceeccccCcccc-hhHHH-hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCC
Confidence             11122334555565654  88887 88876 789999999999999987                 2555554  5555


Q ss_pred             ccEEEeeccccccccccccccccchhhhhccCCC-CCC-chhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEc
Q 036229          204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSG-LQG-EIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKL  281 (982)
Q Consensus       204 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  281 (982)
                      |++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++                 ..+..+++|++|+|
T Consensus       493 L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~-----------------~~~~~l~~L~~L~L  555 (876)
T 4ecn_A          493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA-----------------DDEDTGPKIQIFYM  555 (876)
T ss_dssp             CCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHH-----------------HCTTTTTTCCEEEC
T ss_pred             CCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhh-----------------hcccccCCccEEEe
Confidence            6666666555555555555555555555555555 554 4554443332                 01122336777777


Q ss_pred             cCCccccCCCc--cccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcc
Q 036229          282 GKNFLTGEIPP--EIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNF  359 (982)
Q Consensus       282 s~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l  359 (982)
                      ++|+++ .+|.  .|.++++|++|+|++|+++ .+| .+..+++|                         ++|+|++|++
T Consensus       556 s~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L-------------------------~~L~Ls~N~l  607 (876)
T 4ecn_A          556 GYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKL-------------------------TDLKLDYNQI  607 (876)
T ss_dssp             CSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEE-------------------------SEEECCSSCC
T ss_pred             eCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcc-------------------------eEEECcCCcc
Confidence            777776 5565  6777777777777777776 555 44444444                         4444444444


Q ss_pred             cccccccccCCCC-CCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCC
Q 036229          360 SGTIPRFIFNASK-LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDG  438 (982)
Q Consensus       360 ~~~~p~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  438 (982)
                      + .+|..+..+++ |++|+|++|+++ .+|..+..++.                           ++|+.|+|++|++.+
T Consensus       608 ~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~---------------------------~~L~~L~Ls~N~l~g  658 (876)
T 4ecn_A          608 E-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV---------------------------YVMGSVDFSYNKIGS  658 (876)
T ss_dssp             S-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS---------------------------SCEEEEECCSSCTTT
T ss_pred             c-cchHHHhhccccCCEEECcCCCCC-cCchhhhcccc---------------------------CCCCEEECcCCcCCC
Confidence            4 45555555665 666666666665 33443332211                           123344444444433


Q ss_pred             CCCccccccccccccEEeccCCccccCCCcccc--cccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCc
Q 036229          439 ILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIG--NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPD  516 (982)
Q Consensus       439 ~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  516 (982)
                      ..|..                       |..+.  .+++|+.|+|++|+++.+++..+..+++|+.|+|++|+|+ .+|.
T Consensus       659 ~ip~l-----------------------~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~  714 (876)
T 4ecn_A          659 EGRNI-----------------------SCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPE  714 (876)
T ss_dssp             TSSSC-----------------------SSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCT
T ss_pred             ccccc-----------------------hhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccCh
Confidence            22211                       01111  2235666666666666333333446677777777777776 3443


Q ss_pred             ccC--------CCccccEEEccCCcCCcCCCcccc--CCCcccccccCCCcccccccccccccCceEEecCCCcccCCCc
Q 036229          517 DIC--------RLTKLYELGLSGNKLSGSIPACFS--NLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP  586 (982)
Q Consensus       517 ~~~--------~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~  586 (982)
                      .+.        ++++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+++.+|..++.+++|+.|+|++|+      
T Consensus       715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~------  787 (876)
T 4ecn_A          715 NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQR------  787 (876)
T ss_dssp             TSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCB------
T ss_pred             HHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCC------
Confidence            322        2237777777777777 5666665  7777777777777777777777777777777777775      


Q ss_pred             cccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccc
Q 036229          587 LDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY  666 (982)
Q Consensus       587 ~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  666 (982)
                                  ++++|++.+.+|..|+.+++|++|+|++|+| +.+|..+.  ++|+.|||++|++....+..+.....
T Consensus       788 ------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~  852 (876)
T 4ecn_A          788 ------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIE  852 (876)
T ss_dssp             ------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHH
T ss_pred             ------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHcccccc
Confidence                        5677888888888888888888888888888 57777765  58888888888887666666666666


Q ss_pred             cceeecCCCccc
Q 036229          667 LEDLDLSFNKLK  678 (982)
Q Consensus       667 L~~l~ls~N~l~  678 (982)
                      +..+.|++|++.
T Consensus       853 ~~~~~L~~n~~~  864 (876)
T 4ecn_A          853 AGMYVLLYDKTQ  864 (876)
T ss_dssp             TTCCEEECCTTS
T ss_pred             chheeecCCCcc
Confidence            777777777665

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.8e-56  Score=542.12  Aligned_cols=512  Identities=21%  Similarity=0.196  Sum_probs=413.5

Q ss_pred             CcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCcccc
Q 036229           81 HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDF  160 (982)
Q Consensus        81 ~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  160 (982)
                      .+++.|+|++|.+++..+..+.++++|++|||++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            46899999999999888889999999999999999999888889999999999999999999888999999999999999


Q ss_pred             ccCcccccCchhhhcCCCCCCeeeecceeeec-ccCCCccCcCcccEEEeeccccccccccccccccchh----hhhccC
Q 036229          161 SYNALSGEIPANICSNLPFLESISLSQNMFHG-RIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLK----ELYLGY  235 (982)
Q Consensus       161 s~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~  235 (982)
                      ++|.++ .+|+..++++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..++.+++|+    +|++++
T Consensus       112 ~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~  190 (606)
T 3vq2_A          112 VETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL  190 (606)
T ss_dssp             TTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred             cCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence            999998 4554445999999999999999986 5799999999999999999999998888999988876    799999


Q ss_pred             CCCCCchhhhcCCCcccceEeccccccC-CcCChhhhccCCCcEEEccCCccccC------CCccccccC--CCcEEEc-
Q 036229          236 SGLQGEIPREFGNLAELELMALQVSNLQ-GEIPQELANLTGLEVLKLGKNFLTGE------IPPEIHNLH--NLKLLDL-  305 (982)
Q Consensus       236 N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~------~p~~~~~l~--~L~~L~L-  305 (982)
                      |.+++..+..+... +|+.|++++|.+. +..|..+.++++|+.+++..+.+.+.      .+..+.++.  .++.+++ 
T Consensus       191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~  269 (606)
T 3vq2_A          191 NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT  269 (606)
T ss_dssp             CCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred             CCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence            99997777766665 9999999999987 45678899999999999976665432      111122221  2344444 


Q ss_pred             cCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCcc
Q 036229          306 SHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG  385 (982)
Q Consensus       306 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~  385 (982)
                      ..|.+.+..|. +.                         .+++|+.|++++|.+.. +| .+..+++|++|++++|++ +
T Consensus       270 ~~~~~~~~~~~-~~-------------------------~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~  320 (606)
T 3vq2_A          270 YTNDFSDDIVK-FH-------------------------CLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-K  320 (606)
T ss_dssp             CCTTCCGGGGS-CG-------------------------GGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-S
T ss_pred             ccccccccccc-cc-------------------------cCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-c
Confidence            44444444443 44                         44555666666666653 34 566666777777777777 3


Q ss_pred             ccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccC
Q 036229          386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG  465 (982)
Q Consensus       386 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~  465 (982)
                      .+| .+ .+++|+.|++++|.....       ..+..+++|++|++++|++++.                        +.
T Consensus       321 ~lp-~~-~l~~L~~L~l~~n~~~~~-------~~~~~l~~L~~L~ls~n~l~~~------------------------~~  367 (606)
T 3vq2_A          321 QFP-TL-DLPFLKSLTLTMNKGSIS-------FKKVALPSLSYLDLSRNALSFS------------------------GC  367 (606)
T ss_dssp             SCC-CC-CCSSCCEEEEESCSSCEE-------CCCCCCTTCCEEECCSSCEEEE------------------------EE
T ss_pred             ccc-cC-CCCccceeeccCCcCccc-------hhhccCCCCCEEECcCCccCCC------------------------cc
Confidence            445 33 677777777777733210       1355666777777777644321                        01


Q ss_pred             CCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCC-cccCCCccccEEEccCCcCCcCCCccccC
Q 036229          466 FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIP-DDICRLTKLYELGLSGNKLSGSIPACFSN  544 (982)
Q Consensus       466 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  544 (982)
                      .|..+..+++|+.|++++|.+++ +|..|..+++|+.|++++|++++..| ..+..+++|++|++++|++++..|..|.+
T Consensus       368 ~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  446 (606)
T 3vq2_A          368 CSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG  446 (606)
T ss_dssp             CCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred             hhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcC
Confidence            35667778888888888888875 55788888899999999999888777 67888899999999999998888888999


Q ss_pred             CCcccccccCCCcccc--cccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceE
Q 036229          545 LASLGTLSLGSNKLTS--IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYL  622 (982)
Q Consensus       545 l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L  622 (982)
                      +++|++|++++|+++.  +|..+..+++|++|++++|++++..|..++++++|+.|++++|++++.+|..|+.+++|++|
T Consensus       447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  526 (606)
T 3vq2_A          447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL  526 (606)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred             CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence            9999999999999885  67778888999999999999998888999999999999999999999999999999999999


Q ss_pred             ecccccccCCccccccCCC-CCCeeeCCCCcCCCCCC
Q 036229          623 FLGYNRLQGSISESFGDLI-SLKSLNLSNNNLSRSIP  658 (982)
Q Consensus       623 ~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p  658 (982)
                      +|++|+|+ .+|..+..++ +|+.|++++|.+....+
T Consensus       527 ~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          527 DCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             ECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             ECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            99999999 6777799997 69999999999987555

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-55  Score=550.29  Aligned_cols=534  Identities=23%  Similarity=0.252  Sum_probs=451.1

Q ss_pred             CEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecc
Q 036229          108 QSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQ  187 (982)
Q Consensus       108 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~  187 (982)
                      +..|.++++++ .+|.   -.++|++|+|++|.+++..|..|.++++|++|||++|...+.+++..|.++++|++|+|++
T Consensus         7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~   82 (844)
T 3j0a_A            7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS   82 (844)
T ss_dssp             EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred             eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence            36788888887 7786   5689999999999999988999999999999999999887788777779999999999999


Q ss_pred             eeeecccCCCccCcCcccEEEeeccccccccccc--cccccchhhhhccCCCCCCchh-hhcCCCcccceEeccccccCC
Q 036229          188 NMFHGRIPSALSNCKYLEILSLSINNLLGAIPKE--IGNLTKLKELYLGYSGLQGEIP-REFGNLAELELMALQVSNLQG  264 (982)
Q Consensus       188 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~  264 (982)
                      |.+.+..|++|+++++|++|+|++|++++.+|..  |+++++|++|+|++|.+++..+ ..|+++++|+.|++++|.+++
T Consensus        83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A           83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            9999999999999999999999999999877665  9999999999999999988765 679999999999999999999


Q ss_pred             cCChhhhcc--CCCcEEEccCCccccCCCccccccCC------CcEEEccCccccccCcccccCC---CCCceeecCCCc
Q 036229          265 EIPQELANL--TGLEVLKLGKNFLTGEIPPEIHNLHN------LKLLDLSHNKLVGAVPATIFNM---STLTGLGLQSNS  333 (982)
Q Consensus       265 ~~p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~  333 (982)
                      ..|..+..+  ++|+.|+++.|.+++..|..+..+++      |+.|++++|.+++..|..+...   ..++.+.++.+.
T Consensus       163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            999998888  89999999999999888887777665      9999999999988877776543   456666666444


Q ss_pred             CCCCcCccccccCCCccEEEccCCcccccccccccCC--CCCCEEEeccccCccccCCccccCCccceecccccccccCc
Q 036229          334 LSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA--SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSN  411 (982)
Q Consensus       334 l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  411 (982)
                      +..                .++.|++.+..+..|.++  ++|+.|++++|.+.+..+..|..+++|+.|++++|.++.+.
T Consensus       243 ~~~----------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  306 (844)
T 3j0a_A          243 MGA----------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA  306 (844)
T ss_dssp             CBC----------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC
T ss_pred             ccc----------------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC
Confidence            321                123455555555555554  68999999999998888888888888888888888877654


Q ss_pred             ccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCC
Q 036229          412 LELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP  491 (982)
Q Consensus       412 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  491 (982)
                      ..     .|.++++|++|+|++|                          ++++..|..|..+++|+.|++++|++++..+
T Consensus       307 ~~-----~~~~l~~L~~L~Ls~N--------------------------~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  355 (844)
T 3j0a_A          307 DE-----AFYGLDNLQVLNLSYN--------------------------LLGELYSSNFYGLPKVAYIDLQKNHIAIIQD  355 (844)
T ss_dssp             TT-----TTTTCSSCCEEEEESC--------------------------CCSCCCSCSCSSCTTCCEEECCSCCCCCCCS
T ss_pred             hH-----HhcCCCCCCEEECCCC--------------------------CCCccCHHHhcCCCCCCEEECCCCCCCccCh
Confidence            32     3666777777777666                          4445567788899999999999999999999


Q ss_pred             ccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccc--ccccc
Q 036229          492 ITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLT--IWNLK  569 (982)
Q Consensus       492 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~--~~~l~  569 (982)
                      ..|..+++|++|+|++|.+++.     ..+++|+.|++++|+++ .+|..   ..+++.|++++|+++.++..  +..++
T Consensus       356 ~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~  426 (844)
T 3j0a_A          356 QTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVP  426 (844)
T ss_dssp             SCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCT
T ss_pred             hhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCC
Confidence            9999999999999999999853     23889999999999998 45543   46789999999999987653  45899


Q ss_pred             CceEEecCCCcccCCCcc-ccccccccceeeccccccc-----ccccccccCccCcceEecccccccCCccccccCCCCC
Q 036229          570 GMLYLNFSSNFFTGPLPL-DIGNLKVLIGIDFSTNNFS-----DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISL  643 (982)
Q Consensus       570 ~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~Ldls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  643 (982)
                      +|++|++++|++++..+. .+..+++|+.|++++|.++     +..|..|.++++|++|+|++|+|++.+|..|.++++|
T Consensus       427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  506 (844)
T 3j0a_A          427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL  506 (844)
T ss_dssp             TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred             ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence            999999999999976554 4667899999999999997     4556779999999999999999999999999999999


Q ss_pred             CeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCCCCCCCCCCcccccCcccCCCC
Q 036229          644 KSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       644 ~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~lc~~~  705 (982)
                      +.|+|++|+|++..|..+.  ++|+.|||++|++++.+|..  +..+....+.|||+.|+.+
T Consensus       507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred             heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence            9999999999987777666  88999999999999998864  5566777889999999654

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.1e-53  Score=511.41  Aligned_cols=502  Identities=20%  Similarity=0.237  Sum_probs=348.2

Q ss_pred             CCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCc
Q 036229           68 VCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPS  147 (982)
Q Consensus        68 ~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  147 (982)
                      .|.|.|+ |+.          ++++++ .+|+.+.  ++|++|||++|++++..|.++.++++|++|+|++|++++..|.
T Consensus         3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            4999998 973          456666 7777665  7999999999999988889999999999999999999988889


Q ss_pred             cccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeec-ccCCCccCcCcccEEEeeccccccccc-cccccc
Q 036229          148 FIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHG-RIPSALSNCKYLEILSLSINNLLGAIP-KEIGNL  225 (982)
Q Consensus       148 ~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l  225 (982)
                      .|+++++|++|||++|.+++ +|+..|+++++|++|+|++|++++ ..|..|+++++|++|++++|++.+.+| ..|.++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l  147 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL  147 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCS-CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred             hccccccCCEEECCCCccCc-cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcc
Confidence            99999999999999999994 555555899999999999999987 357789999999999999998555555 578899


Q ss_pred             cchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChh-hhccCCCcEEEccCCccccCC--C-ccccccCCCc
Q 036229          226 TKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE-LANLTGLEVLKLGKNFLTGEI--P-PEIHNLHNLK  301 (982)
Q Consensus       226 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~  301 (982)
                      ++|++|++++|++++..|..++.+++|+.|+++.|.+.. +|.. +..+++|++|++++|++++..  | .....+++|+
T Consensus       148 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~  226 (549)
T 2z81_A          148 TSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK  226 (549)
T ss_dssp             CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCC
T ss_pred             cccCeeeccCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhccc
Confidence            999999999999988888888888888888888888764 3443 456788888888888887642  1 2233456666


Q ss_pred             EEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccc
Q 036229          302 LLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRN  381 (982)
Q Consensus       302 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  381 (982)
                      .|++++|.+++..+..+..                                             .+..+++|+.+++++|
T Consensus       227 ~L~l~~n~l~~~~~~~l~~---------------------------------------------~~~~~~~L~~l~l~~~  261 (549)
T 2z81_A          227 KLAFRGSVLTDESFNELLK---------------------------------------------LLRYILELSEVEFDDC  261 (549)
T ss_dssp             EEEEESCEEEHHHHHHHHG---------------------------------------------GGGGCTTCCEEEEESC
T ss_pred             ceeccccccchhHHHHHHH---------------------------------------------Hhhhhccccccccccc
Confidence            6777666665543332211                                             1122233334444443


Q ss_pred             cCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCc
Q 036229          382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCN  461 (982)
Q Consensus       382 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~  461 (982)
                      .+.+...-     +...                  ...+..+.+|+.|+++++.+.....   +                
T Consensus       262 ~~~~~~~~-----~~~~------------------~~~~~~l~~L~~L~l~~~~i~~~~~---~----------------  299 (549)
T 2z81_A          262 TLNGLGDF-----NPSE------------------SDVVSELGKVETVTIRRLHIPQFYL---F----------------  299 (549)
T ss_dssp             EEECCSCC-----CCCT------------------TTCCCCCTTCCEEEEESCBCSCGGG---S----------------
T ss_pred             cccccccc-----cccc------------------hhhhhhhcccccccccccccchhhh---c----------------
Confidence            33321100     0000                  0012223344444444443322100   0                


Q ss_pred             cccCCCcccccccccceEEecCCCCCCCCCccc-cCcCCCCeEEeeccCCCCCCC---cccCCCccccEEEccCCcCCcC
Q 036229          462 VSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITL-GKLQKLQGLHLEDNKLEGPIP---DDICRLTKLYELGLSGNKLSGS  537 (982)
Q Consensus       462 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~  537 (982)
                        ...+..+...++|+.|++++|+++ .+|..+ ..+++|++|+|++|++++.+|   ..+..+++|++|+|++|+|++.
T Consensus       300 --~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~  376 (549)
T 2z81_A          300 --YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM  376 (549)
T ss_dssp             --CCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCH
T ss_pred             --ccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccccc
Confidence              001112223345566666666665 334333 456666666666666665443   2355566666666666666644


Q ss_pred             CC--ccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccC
Q 036229          538 IP--ACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGG  615 (982)
Q Consensus       538 ~p--~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~  615 (982)
                      .+  ..+..+++|++|+|++|+++.+|..+..+++|++|++++|++++. |..+  .++|+.||+++|++++.+    +.
T Consensus       377 ~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~  449 (549)
T 2z81_A          377 QKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS----LF  449 (549)
T ss_dssp             HHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC----CC
T ss_pred             ccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccc-cchh--cCCceEEECCCCChhhhc----cc
Confidence            32  346666677777777777776666666666777777777776632 2222  146788888888887753    56


Q ss_pred             ccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC
Q 036229          616 LTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       616 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                      +++|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|..+..+++|++|++++|++.|.+|..
T Consensus       450 l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  516 (549)
T 2z81_A          450 LPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  516 (549)
T ss_dssp             CTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred             CChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence            889999999999998 5665 467899999999999999988888999999999999999999998853

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-53  Score=506.85  Aligned_cols=537  Identities=22%  Similarity=0.234  Sum_probs=399.8

Q ss_pred             CCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeec
Q 036229          107 LQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS  186 (982)
Q Consensus       107 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls  186 (982)
                      ...++-++.+++ .+|..+.  +++++|+|++|++++..+..|.++++|++|||++|.++ .+++..|.++++|++|+|+
T Consensus         9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~   84 (570)
T 2z63_A            9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT   84 (570)
T ss_dssp             TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCC-EECTTTTTTCTTCCEEECT
T ss_pred             CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCC-ccCcccccCchhCCEEeCc
Confidence            356777777776 6777553  57999999999999877888999999999999999988 5666666899999999999


Q ss_pred             ceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCC-chhhhcCCCcccceEeccccccCCc
Q 036229          187 QNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG-EIPREFGNLAELELMALQVSNLQGE  265 (982)
Q Consensus       187 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~  265 (982)
                      +|++++..|.+|+++++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+++++|+.|++++|++++.
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~  164 (570)
T 2z63_A           85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI  164 (570)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEE
T ss_pred             CCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcccee
Confidence            999998888899999999999999999987666678899999999999999887 4688899999999999999998888


Q ss_pred             CChhhhccCCC----cEEEccCCccccCCCccccccCCCcEEEccCccccc-cCcccccCCCCCceeecCCCcCCCCcCc
Q 036229          266 IPQELANLTGL----EVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG-AVPATIFNMSTLTGLGLQSNSLSGSLSS  340 (982)
Q Consensus       266 ~p~~l~~l~~L----~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~  340 (982)
                      .|..++.+++|    +.|++++|.+++..|..|... +|+.|++++|.... ..+..+..++.++.+.+..+.+...   
T Consensus       165 ~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~---  240 (570)
T 2z63_A          165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE---  240 (570)
T ss_dssp             CGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC---
T ss_pred             cHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc---
Confidence            78888888888    889999999988888777766 78999998885432 3455566666666555543332210   


Q ss_pred             cccccCCCccEEEccCCcccccccccccCCCCCCEEEeccc-cCccccCCccccCCccceecccccccccCccccccccc
Q 036229          341 IADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRN-SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSS  419 (982)
Q Consensus       341 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  419 (982)
                            .+++  .+....+.+     +..+ +++.+++++| .+.+..|..|..+++|+.|++++|.++.++.      .
T Consensus       241 ------~~l~--~~~~~~~~~-----l~~l-~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~------~  300 (570)
T 2z63_A          241 ------GNLE--KFDKSALEG-----LCNL-TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD------F  300 (570)
T ss_dssp             ------SSCE--ECCTTTTGG-----GGGS-EEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCB------C
T ss_pred             ------hhhh--hcchhhhcc-----cccc-chhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhh------h
Confidence                  0011  111111111     1111 2445555555 5555556666666666666666665554332      2


Q ss_pred             CCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCC
Q 036229          420 FSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQK  499 (982)
Q Consensus       420 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  499 (982)
                      +..+ +|++|++++|.+..+                           |.  ..+++|+.|++++|.+.+..+.  ..+++
T Consensus       301 ~~~~-~L~~L~l~~n~~~~l---------------------------~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~  348 (570)
T 2z63_A          301 SYNF-GWQHLELVNCKFGQF---------------------------PT--LKLKSLKRLTFTSNKGGNAFSE--VDLPS  348 (570)
T ss_dssp             CSCC-CCSEEEEESCBCSSC---------------------------CB--CBCSSCCEEEEESCBSCCBCCC--CBCTT
T ss_pred             hccC-CccEEeeccCccccc---------------------------Cc--ccccccCEEeCcCCcccccccc--ccCCC
Confidence            3334 555666666544322                           22  2456677777777777655554  56777


Q ss_pred             CCeEEeeccCCCCCC--CcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccccccc--ccccccCceEEe
Q 036229          500 LQGLHLEDNKLEGPI--PDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL--TIWNLKGMLYLN  575 (982)
Q Consensus       500 L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~--~~~~l~~L~~L~  575 (982)
                      |++|++++|++++..  |..+..+++|++|++++|++++..+. +.++++|++|++++|+++.++.  .+..+++|++|+
T Consensus       349 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  427 (570)
T 2z63_A          349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD  427 (570)
T ss_dssp             CCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEE
T ss_pred             CCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEe
Confidence            777788777777543  56677778888888888888755444 7788888888888888876543  456788888888


Q ss_pred             cCCCcccCCCccccccccccceeeccccccc-ccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCC
Q 036229          576 FSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS-DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       576 Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  654 (982)
                      +++|.+++..|..+.++++|+.|++++|.++ +.+|..++.+++|++|+|++|++++..|.+|.++++|++|+|++|+++
T Consensus       428 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  507 (570)
T 2z63_A          428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK  507 (570)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCC
Confidence            8888888888888999999999999999998 578999999999999999999999988999999999999999999999


Q ss_pred             CCCCcccccccccceeecCCCcccccCCCCCCCCCC---CCcccccCcccCCCC
Q 036229          655 RSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNF---SAKSFEGNELLCGSP  705 (982)
Q Consensus       655 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~---~~~~~~gn~~lc~~~  705 (982)
                      +..|..+..+++|++|++++|+++|.+|....+..+   ....+.+.+ .|..|
T Consensus       508 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~  560 (570)
T 2z63_A          508 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGS  560 (570)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTT
T ss_pred             CCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCC
Confidence            988888999999999999999999999975422111   123344554 77665

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.7e-52  Score=498.40  Aligned_cols=513  Identities=20%  Similarity=0.196  Sum_probs=386.9

Q ss_pred             EEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcc
Q 036229           86 LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNAL  165 (982)
Q Consensus        86 L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  165 (982)
                      ++.++.+++ .+|..+.  ++++.|||++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|.+
T Consensus        12 ~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l   88 (570)
T 2z63_A           12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI   88 (570)
T ss_dssp             EECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             EEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC
Confidence            444555666 5666553  5788999999999877777888999999999999999877777888999999999999998


Q ss_pred             cccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccccc-ccccccccccchhhhhccCCCCCCchhh
Q 036229          166 SGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLG-AIPKEIGNLTKLKELYLGYSGLQGEIPR  244 (982)
Q Consensus       166 ~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~  244 (982)
                      + .+|+..|.++++|++|++++|++++..+..|+++++|++|++++|++++ .+|..|+++++|++|++++|++++..|.
T Consensus        89 ~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~  167 (570)
T 2z63_A           89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (570)
T ss_dssp             C-EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred             C-ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence            8 4555556889999999999999987766678899999999999999886 4688899999999999999999888888


Q ss_pred             hcCCCccc----ceEeccccccCCcCChhhhccCCCcEEEccCCcccc-CCCccccccCCCcEEEccCccccccCccccc
Q 036229          245 EFGNLAEL----ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTG-EIPPEIHNLHNLKLLDLSHNKLVGAVPATIF  319 (982)
Q Consensus       245 ~~~~l~~L----~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  319 (982)
                      .++.+++|    +.+++++|.+.+..|..+..+ +|++|++++|.... ..+..+.++++++.+++..+.+...      
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~------  240 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE------  240 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC------
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc------
Confidence            88888888    889999999988888777766 79999999886542 3455677778888777665443311      


Q ss_pred             CCCCCceeecCCCcCCCCcCccccccCCCccEEEccCC-cccccccccccCCCCCCEEEeccccCccccCCccccCCccc
Q 036229          320 NMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSN-NFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLR  398 (982)
Q Consensus       320 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  398 (982)
                        ..++.  +....+.+.       .--.++.+++++| .+.+..|..+..+++|++|++++|.+++ +|..+..+ +|+
T Consensus       241 --~~l~~--~~~~~~~~l-------~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~  307 (570)
T 2z63_A          241 --GNLEK--FDKSALEGL-------CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQ  307 (570)
T ss_dssp             --SSCEE--CCTTTTGGG-------GGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCS
T ss_pred             --hhhhh--cchhhhccc-------cccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-Ccc
Confidence              11111  111111100       0113577888888 7788888888889999999999999884 67778888 999


Q ss_pred             eecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccce
Q 036229          399 LMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG  478 (982)
Q Consensus       399 ~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~  478 (982)
                      .|++++|.++.++.        ..+++|++|++++|.+.+..+                          .  ..+++|+.
T Consensus       308 ~L~l~~n~~~~l~~--------~~l~~L~~L~l~~n~~~~~~~--------------------------~--~~~~~L~~  351 (570)
T 2z63_A          308 HLELVNCKFGQFPT--------LKLKSLKRLTFTSNKGGNAFS--------------------------E--VDLPSLEF  351 (570)
T ss_dssp             EEEEESCBCSSCCB--------CBCSSCCEEEEESCBSCCBCC--------------------------C--CBCTTCCE
T ss_pred             EEeeccCcccccCc--------ccccccCEEeCcCCccccccc--------------------------c--ccCCCCCE
Confidence            99999999885542        356788888888886654322                          1  34556666


Q ss_pred             EEecCCCCCCCC--CccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCC-ccccCCCcccccccCC
Q 036229          479 IYLGGNKLNGSI--PITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP-ACFSNLASLGTLSLGS  555 (982)
Q Consensus       479 L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~  555 (982)
                      |++++|++++..  |..+.++++|++|++++|++++..+ .+..+++|+.|++++|++++..| ..|.++++|++|++++
T Consensus       352 L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~  430 (570)
T 2z63_A          352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH  430 (570)
T ss_dssp             EECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTT
T ss_pred             EeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcC
Confidence            666666665443  5556666666666666666664333 36666677777777776665544 4566667777777777


Q ss_pred             Ccccc-cccccccccCceEEecCCCccc-CCCccccccccccceeecccccccccccccccCccCcceEecccccccCCc
Q 036229          556 NKLTS-IPLTIWNLKGMLYLNFSSNFFT-GPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI  633 (982)
Q Consensus       556 N~l~~-ip~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  633 (982)
                      |+++. +|..+..+++|++|++++|.++ +.+|..+..+++|+.||+++|++++..|..|+.+++|++|+|++|++++.+
T Consensus       431 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  510 (570)
T 2z63_A          431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP  510 (570)
T ss_dssp             SCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCC
Confidence            77664 3445556677777777777776 567778888889999999999999888999999999999999999999988


Q ss_pred             cccccCCCCCCeeeCCCCcCCCCCCc
Q 036229          634 SESFGDLISLKSLNLSNNNLSRSIPI  659 (982)
Q Consensus       634 ~~~~~~l~~L~~L~Ls~N~l~~~~p~  659 (982)
                      |..|.++++|+.|++++|++++..|.
T Consensus       511 ~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          511 DGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             HHHhhcccCCcEEEecCCcccCCCcc
Confidence            88999999999999999999988774

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.2e-52  Score=505.96  Aligned_cols=508  Identities=21%  Similarity=0.240  Sum_probs=316.0

Q ss_pred             CChhHHHHHHHHHHHhcCCCCccccCCCCCCCC----CCceee-EEecCCC---CcEEEEEeCCCCccccCCccccCCCC
Q 036229           35 SITTDQDALLALKAHITHDPTNFLAKNWNTSTP----VCNWTG-VTCDVHS---HRVKVLNISHLNLTGTIPSQLWNLSS  106 (982)
Q Consensus        35 ~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~----~c~w~g-v~c~~~~---~~v~~L~l~~~~l~g~~~~~l~~l~~  106 (982)
                      -.+++.+.-.++++-...-    .-..|+...+    .|+|.. ..|. ..   ..|+.   ..             -.+
T Consensus        24 ~~~~~~~d~~aL~~~~~~~----~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C---~~-------------~~~   82 (636)
T 4eco_A           24 RTAEYIKDYLALKEIWDAL----NGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSL---NS-------------NGR   82 (636)
T ss_dssp             CCCHHHHHHHHHHHHHHHT----TGGGCCCCC------CCCCCSSCGG-GTTCCTTEEE---CT-------------TCC
T ss_pred             hhhhHHHHHHHHHHHHHHc----CCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEE---cC-------------CCC
Confidence            3455667777888777553    2357874432    247853 2232 34   34542   11             046


Q ss_pred             CCEEEcCCCCccccCcchhhhccCCcEEEccCCcc------cC------ccCccccCcCCCCccccccCcccccCchhhh
Q 036229          107 LQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL------SG------AFPSFIFNKSSLQHLDFSYNALSGEIPANIC  174 (982)
Q Consensus       107 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l------~~------~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~  174 (982)
                      ++.|+|++|.++|.+|++++++++|++|+|++|.+      .|      .+|...  +..|+ +++++|.+.+.+|..+.
T Consensus        83 V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~  159 (636)
T 4eco_A           83 VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFS  159 (636)
T ss_dssp             EEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSC
T ss_pred             EEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHH
Confidence            78999999999999999999999999999999987      22      333333  44555 66666666665555442


Q ss_pred             cCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhcc--CCCCCCchhhhcCCCccc
Q 036229          175 SNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLG--YSGLQGEIPREFGNLAEL  252 (982)
Q Consensus       175 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~~~~~~~l~~L  252 (982)
                      ..+..+..+++....+..                              .....++.+.++  .|++++ +|..|+++++|
T Consensus       160 ~~~~~l~~~~l~~~~~~~------------------------------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L  208 (636)
T 4eco_A          160 DLIKDCINSDPQQKSIKK------------------------------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKL  208 (636)
T ss_dssp             HHHHHHHHHCTTSCCCCC------------------------------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTC
T ss_pred             HHHHHHhhcCcccccccc------------------------------ccccchhhhhhccccCCCcc-CCHHHhcccCC
Confidence            222233333333222210                              111122223222  355555 55555555555


Q ss_pred             ceEeccccccCCc-----------------CChhhh--ccCCCcEEEccCCccccCCCccccccCCCcEEEccCcc-ccc
Q 036229          253 ELMALQVSNLQGE-----------------IPQELA--NLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNK-LVG  312 (982)
Q Consensus       253 ~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~  312 (982)
                      +.|+|++|++++.                 +|+.++  ++++|++|+|++|++++.+|..|.++++|++|+|++|+ +++
T Consensus       209 ~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~  288 (636)
T 4eco_A          209 RQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG  288 (636)
T ss_dssp             CEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCH
T ss_pred             CEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcc
Confidence            5555555555553                 777777  88888888888888888888888888888888888888 887


Q ss_pred             -cCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccc--cccCCCCCCEEEeccccCccccCC
Q 036229          313 -AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPR--FIFNASKLSVLELGRNSFSGFIPN  389 (982)
Q Consensus       313 -~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~i~~~~~~  389 (982)
                       .+|..++.+..+                   ..+++|++|++++|+++ .+|.  .+.++++|++|++++|++++.+| 
T Consensus       289 ~~lp~~~~~L~~~-------------------~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-  347 (636)
T 4eco_A          289 EQLKDDWQALADA-------------------PVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-  347 (636)
T ss_dssp             HHHHHHHHHHHHS-------------------GGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-
T ss_pred             ccchHHHHhhhcc-------------------ccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-
Confidence             778777654110                   12244577777777777 6666  77888888888888888887667 


Q ss_pred             ccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcc
Q 036229          390 TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE  469 (982)
Q Consensus       390 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~  469 (982)
                      .|..+++|+.|++++|.++.+                                                        |..
T Consensus       348 ~~~~l~~L~~L~L~~N~l~~l--------------------------------------------------------p~~  371 (636)
T 4eco_A          348 AFGSEIKLASLNLAYNQITEI--------------------------------------------------------PAN  371 (636)
T ss_dssp             CCEEEEEESEEECCSSEEEEC--------------------------------------------------------CTT
T ss_pred             hhCCCCCCCEEECCCCccccc--------------------------------------------------------cHh
Confidence            666666666555555554422                                                        223


Q ss_pred             cccccc-cceEEecCCCCCCCCCccccCcC--CCCeEEeeccCCCCCCCcccC-------CCccccEEEccCCcCCcCCC
Q 036229          470 IGNLTN-LIGIYLGGNKLNGSIPITLGKLQ--KLQGLHLEDNKLEGPIPDDIC-------RLTKLYELGLSGNKLSGSIP  539 (982)
Q Consensus       470 ~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p  539 (982)
                      +..+++ |+.|++++|+++ .+|..+..++  +|++|++++|++++.+|..|.       .+++|++|+|++|+|+++.+
T Consensus       372 l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~  450 (636)
T 4eco_A          372 FCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK  450 (636)
T ss_dssp             SEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCT
T ss_pred             hhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCH
Confidence            333333 444444444444 3333333322  444455555555444444444       44455555555555553333


Q ss_pred             ccccCCCcccccccCCCccccccccccccc--------CceEEecCCCcccCCCccccc--cccccceeecccccccccc
Q 036229          540 ACFSNLASLGTLSLGSNKLTSIPLTIWNLK--------GMLYLNFSSNFFTGPLPLDIG--NLKVLIGIDFSTNNFSDVI  609 (982)
Q Consensus       540 ~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~--------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~Ldls~N~l~~~~  609 (982)
                      ..+..+++|++|+|++|+++.+|...+...        +|++|++++|+++ .+|..+.  .+++|+.|||++|++++ +
T Consensus       451 ~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-i  528 (636)
T 4eco_A          451 ELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-F  528 (636)
T ss_dssp             HHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-C
T ss_pred             HHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-c
Confidence            334445555555555555555554443321        5556666666655 4455554  56666666666666665 5


Q ss_pred             cccccCccCcceEec------ccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCccccc
Q 036229          610 PTVIGGLTNLQYLFL------GYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGE  680 (982)
Q Consensus       610 p~~~~~l~~L~~L~L------s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~  680 (982)
                      |..++.+++|++|+|      ++|++.+.+|.+|+++++|++|+|++|++ +.+|..+.  ++|++||+++|++...
T Consensus       529 p~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~  602 (636)
T 4eco_A          529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISI  602 (636)
T ss_dssp             CCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEE
T ss_pred             ChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccc
Confidence            666666666666666      67889999999999999999999999999 68898876  7999999999998743

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.3e-49  Score=482.75  Aligned_cols=559  Identities=19%  Similarity=0.160  Sum_probs=365.4

Q ss_pred             ccCCCCCCCCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEcc
Q 036229           58 LAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFR  137 (982)
Q Consensus        58 ~~~~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls  137 (982)
                      .+++|+.+.+ ..|....|....   +..+.++.+++ .+|+.+.  +++++|||++|+|++..|.+|.++++|++|+|+
T Consensus        12 ~~~~~~~~~p-~~~~~c~~~~~~---~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls   84 (635)
T 4g8a_A           12 KLAAANSSIP-ESWEPCVEVVPN---ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS   84 (635)
T ss_dssp             --------------CCSEEEETT---TEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred             hhhcccCCCC-CCCCCccccCCC---CEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECC
Confidence            4566655432 445554444222   12456677787 7777653  478999999999986666789999999999999


Q ss_pred             CCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccc
Q 036229          138 GNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGA  217 (982)
Q Consensus       138 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  217 (982)
                      +|+|++..|..|.++++|++|+|++|+|+ .+|+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++.
T Consensus        85 ~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~  163 (635)
T 4g8a_A           85 RCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF  163 (635)
T ss_dssp             TCCCCEECTTTTTTCTTCCEEECTTCCCC-EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC
T ss_pred             CCcCCCcChhHhcCCCCCCEEEccCCcCC-CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccC
Confidence            99999777778999999999999999998 67877778999999999999999887777889999999999999988753


Q ss_pred             -cccccccccchhhhhccCCCCCCchhhhcCCCcccc----eEeccccccCCcCChhhhccCCCcEEEccCCcccc-CCC
Q 036229          218 -IPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELE----LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTG-EIP  291 (982)
Q Consensus       218 -~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p  291 (982)
                       .|..++.+++|++|+|++|++++..+..|..+.+++    .++++.|.+....+..+ ....++.+++++|..+. ..+
T Consensus       164 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~  242 (635)
T 4g8a_A          164 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMK  242 (635)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHH
T ss_pred             CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccc
Confidence             567778888888888888888877676665554433    34444444443322222 22234444444443332 112


Q ss_pred             ccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccc---ccccccc
Q 036229          292 PEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG---TIPRFIF  368 (982)
Q Consensus       292 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~  368 (982)
                      ..+..+..++...+..+.......                  +. ............+...++..+....   ..+..+.
T Consensus       243 ~~~~~l~~l~~~~l~~~~~~~~~~------------------l~-~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~  303 (635)
T 4g8a_A          243 TCIQGLAGLEVHRLVLGEFRNEGN------------------LE-KFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFN  303 (635)
T ss_dssp             HHHHTTTTCEEEEEEEECCTTSCC------------------CS-CCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTG
T ss_pred             hhhcCCcccccccccccccccccc------------------cc-cccccccccccchhhhhhhhhhhcccccchhhhhh
Confidence            233334444433333222111000                  00 0000011112222333332222111   1222233


Q ss_pred             CCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccc
Q 036229          369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNL  448 (982)
Q Consensus       369 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  448 (982)
                      ...+++.+++.+|.+....  .+.....|+.|++.+|.+..+..        ..++.                       
T Consensus       304 ~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~--------~~l~~-----------------------  350 (635)
T 4g8a_A          304 CLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT--------LKLKS-----------------------  350 (635)
T ss_dssp             GGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC--------CBCTT-----------------------
T ss_pred             hhccccccccccccccccc--ccccchhhhhhhcccccccCcCc--------ccchh-----------------------
Confidence            3444555555555444321  22333344444444443332221        12233                       


Q ss_pred             cccccEEeccCCccccCCCcccccccccceEEecCCCCCC--CCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccE
Q 036229          449 SHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG--SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE  526 (982)
Q Consensus       449 ~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  526 (982)
                         ++.++++.|.+...  .....+++|+.+++++|.+..  ..+..+..+.+|+.|+++.|.+.. .+..+..+++|+.
T Consensus       351 ---L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~  424 (635)
T 4g8a_A          351 ---LKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEH  424 (635)
T ss_dssp             ---CCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCE
T ss_pred             ---hhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccc
Confidence               34444444443322  223456777777777777743  345566677788888888887763 4556777888888


Q ss_pred             EEccCCcCCcCCC-ccccCCCcccccccCCCccccccc-ccccccCceEEecCCCcc-cCCCccccccccccceeecccc
Q 036229          527 LGLSGNKLSGSIP-ACFSNLASLGTLSLGSNKLTSIPL-TIWNLKGMLYLNFSSNFF-TGPLPLDIGNLKVLIGIDFSTN  603 (982)
Q Consensus       527 L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ip~-~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~Ldls~N  603 (982)
                      ++++.|......+ ..|.++++++.++++.|+++.++. .+..++.+++|++++|.+ .+..|..+..+++|+.|||++|
T Consensus       425 l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N  504 (635)
T 4g8a_A          425 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC  504 (635)
T ss_dssp             EECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTS
T ss_pred             hhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCC
Confidence            8888777655443 457788888888888888885544 445677888888888874 4457788999999999999999


Q ss_pred             cccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccc-cccceeecCCCcccccCC
Q 036229          604 NFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKL-SYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       604 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~l~ls~N~l~~~~p  682 (982)
                      +|++++|..|+++++|++|+|++|+|++.+|..|.++++|++|||++|+|++..|..+..+ ++|++|+|++|+|.|.+.
T Consensus       505 ~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          505 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             ccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            9999999999999999999999999999999999999999999999999999999999988 689999999999999876


Q ss_pred             C
Q 036229          683 K  683 (982)
Q Consensus       683 ~  683 (982)
                      -
T Consensus       585 ~  585 (635)
T 4g8a_A          585 H  585 (635)
T ss_dssp             G
T ss_pred             c
Confidence            3

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-50  Score=477.28  Aligned_cols=458  Identities=20%  Similarity=0.210  Sum_probs=315.2

Q ss_pred             cEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeec
Q 036229          132 KYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSI  211 (982)
Q Consensus       132 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  211 (982)
                      ++|++++|+++ .+|..+.  ++|++|||++|.+++ +++..|.++++|++|+|++|++++..|.+|+++++|++|||++
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~   78 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH   78 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCC-CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccc-cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence            46777777777 4666555  677777777777763 4433346777777777777777766667777777777777777


Q ss_pred             cccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCC
Q 036229          212 NNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIP  291 (982)
Q Consensus       212 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p  291 (982)
                      |+++ .+|..  .+++|++|+|++|++++.                       .+|..|+++++|++|++++|++++   
T Consensus        79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~-----------------------~~p~~~~~l~~L~~L~L~~n~l~~---  129 (520)
T 2z7x_B           79 NKLV-KISCH--PTVNLKHLDLSFNAFDAL-----------------------PICKEFGNMSQLKFLGLSTTHLEK---  129 (520)
T ss_dssp             SCCC-EEECC--CCCCCSEEECCSSCCSSC-----------------------CCCGGGGGCTTCCEEEEEESSCCG---
T ss_pred             Ccee-ecCcc--ccCCccEEeccCCccccc-----------------------cchhhhccCCcceEEEecCcccch---
Confidence            7776 44444  555666666666665542                       234444444555555555555443   


Q ss_pred             ccccccCCC--cEEEccCccc--cccCcccccCCC-CCceeecCCCcCCCCcCccccccCCCccEEEccCCc-------c
Q 036229          292 PEIHNLHNL--KLLDLSHNKL--VGAVPATIFNMS-TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN-------F  359 (982)
Q Consensus       292 ~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~-------l  359 (982)
                      ..+..+++|  ++|++++|++  .+..|..+..+. +...+++++|.+.+.+....+..+++|+.|++++|.       +
T Consensus       130 ~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~  209 (520)
T 2z7x_B          130 SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF  209 (520)
T ss_dssp             GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHH
T ss_pred             hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccccccccccccee
Confidence            234444444  5555555555  444444444433 122344445554444444444455556666666665       4


Q ss_pred             cccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCC
Q 036229          360 SGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGI  439 (982)
Q Consensus       360 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~  439 (982)
                      .+.+| .+..+++|+.|++++|.+++..+..+..                          ...++               
T Consensus       210 ~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~--------------------------~~~~~---------------  247 (520)
T 2z7x_B          210 LSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQ--------------------------LVWHT---------------  247 (520)
T ss_dssp             HHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHH--------------------------HHHTS---------------
T ss_pred             ecchh-hhccccchhhccccccccCHHHHHHHHH--------------------------HhhhC---------------
Confidence            44444 4555666666666665554321110000                          00012               


Q ss_pred             CCccccccccccccEEeccCCccccCCCccc-----ccccccceEEecCCCCCCCCC-ccccCc---CCCCeEEeeccCC
Q 036229          440 LPRMSMGNLSHSLEYFDMSYCNVSGGFPKEI-----GNLTNLIGIYLGGNKLNGSIP-ITLGKL---QKLQGLHLEDNKL  510 (982)
Q Consensus       440 ~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l  510 (982)
                                 +|++|++++|++++.+|..+     ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+
T Consensus       248 -----------~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l  314 (520)
T 2z7x_B          248 -----------TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRM  314 (520)
T ss_dssp             -----------SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCC
T ss_pred             -----------cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcc
Confidence                       34444445556666666666     7888999999999998  344 566555   6799999999998


Q ss_pred             CCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccccc---ccccccccCceEEecCCCcccCCCcc
Q 036229          511 EGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI---PLTIWNLKGMLYLNFSSNFFTGPLPL  587 (982)
Q Consensus       511 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~i---p~~~~~l~~L~~L~Ls~N~l~~~~~~  587 (982)
                      .+..  .+..+++|++|++++|++++..|..+.++++|++|+|++|+++.+   |..+..+++|++|++++|++++.+|.
T Consensus       315 ~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~  392 (520)
T 2z7x_B          315 VHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK  392 (520)
T ss_dssp             CCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG
T ss_pred             cccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc
Confidence            7432  126788999999999999988899999999999999999999954   45677899999999999999986665


Q ss_pred             -ccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcc-ccccc
Q 036229          588 -DIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS-LEKLS  665 (982)
Q Consensus       588 -~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~  665 (982)
                       .+..+++|+.|++++|++++..|..+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|.. +..++
T Consensus       393 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~  468 (520)
T 2z7x_B          393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLT  468 (520)
T ss_dssp             CSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCT
T ss_pred             chhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCC
Confidence             488899999999999999988887765  79999999999999 788888899999999999999995 6655 89999


Q ss_pred             ccceeecCCCcccccCCC
Q 036229          666 YLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       666 ~L~~l~ls~N~l~~~~p~  683 (982)
                      +|++|++++|+++|.++.
T Consensus       469 ~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          469 SLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             TCCEEECCSSCBCCCHHH
T ss_pred             cccEEECcCCCCcccCCc
Confidence            999999999999998874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=3.8e-49  Score=471.97  Aligned_cols=486  Identities=21%  Similarity=0.218  Sum_probs=323.2

Q ss_pred             ccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCC
Q 036229          159 DFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGL  238 (982)
Q Consensus       159 ~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  238 (982)
                      |.++|.++ .+|..++   ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus        11 ~~~~~~l~-~ip~~~~---~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           11 DGRSRSFT-SIPSGLT---AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             ECTTSCCS-SCCSCCC---TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             ECCCCccc-cccccCC---CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            44444444 4554442   4555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCchhhhcCCCcccceEeccccccCC-cCChhhhccCCCcEEEccCCc-cccCCCccccccCCCcEEEccCccccccCcc
Q 036229          239 QGEIPREFGNLAELELMALQVSNLQG-EIPQELANLTGLEVLKLGKNF-LTGEIPPEIHNLHNLKLLDLSHNKLVGAVPA  316 (982)
Q Consensus       239 ~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  316 (982)
                      ++..|..|+++++|+.|++++|++++ ..|..++++++|++|++++|+ ++...+..|.++++|++|++++|++++..|.
T Consensus        87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  166 (549)
T 2z81_A           87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ  166 (549)
T ss_dssp             CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred             CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence            55555555555556666666555554 234556666666666666665 3333334566666666666666666666666


Q ss_pred             cccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccc--c-ccccCCCCCCEEEeccccCccccCCcccc
Q 036229          317 TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTI--P-RFIFNASKLSVLELGRNSFSGFIPNTFGN  393 (982)
Q Consensus       317 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~  393 (982)
                      .+..+++|+.|++++|.+.. ++......+++|++|++++|++++..  | .....+++|+.|++++|.+++..+..+. 
T Consensus       167 ~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~-  244 (549)
T 2z81_A          167 SLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-  244 (549)
T ss_dssp             TTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHH-
T ss_pred             hhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHH-
Confidence            66655555555555554431 11222223455566666666665431  1 1223345666666666665543322211 


Q ss_pred             CCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccc
Q 036229          394 LRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNL  473 (982)
Q Consensus       394 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l  473 (982)
                                              ..+..+++|+.+++++|.+.++...                    .......+..+
T Consensus       245 ------------------------~~~~~~~~L~~l~l~~~~~~~~~~~--------------------~~~~~~~~~~l  280 (549)
T 2z81_A          245 ------------------------KLLRYILELSEVEFDDCTLNGLGDF--------------------NPSESDVVSEL  280 (549)
T ss_dssp             ------------------------GGGGGCTTCCEEEEESCEEECCSCC--------------------CCCTTTCCCCC
T ss_pred             ------------------------HHhhhhccccccccccccccccccc--------------------cccchhhhhhh
Confidence                                    1234456667777777765543111                    00112335567


Q ss_pred             cccceEEecCCCCCCC-----CCccccCcCCCCeEEeeccCCCCCCCccc-CCCccccEEEccCCcCCcCCC---ccccC
Q 036229          474 TNLIGIYLGGNKLNGS-----IPITLGKLQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKLSGSIP---ACFSN  544 (982)
Q Consensus       474 ~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~  544 (982)
                      ++|+.|++.++.+...     .+..+...++|+.|++++|+++ .+|..+ ..+++|++|+|++|++++.+|   ..+..
T Consensus       281 ~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~  359 (549)
T 2z81_A          281 GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA  359 (549)
T ss_dssp             TTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTS
T ss_pred             cccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhc
Confidence            7888888888877532     2233445678999999999998 667665 579999999999999998764   45789


Q ss_pred             CCcccccccCCCccccccc---ccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcce
Q 036229          545 LASLGTLSLGSNKLTSIPL---TIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQY  621 (982)
Q Consensus       545 l~~L~~L~L~~N~l~~ip~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~  621 (982)
                      +++|++|+|++|+++.+|.   .+..+++|++|++++|+++ .+|..+..+++|+.|++++|++++. |..+  .++|++
T Consensus       360 l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~  435 (549)
T 2z81_A          360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEV  435 (549)
T ss_dssp             STTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSE
T ss_pred             cccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceE
Confidence            9999999999999998874   4778999999999999999 5788899999999999999999754 4433  268999


Q ss_pred             EecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC-CCCCCCCCcccccCcc
Q 036229          622 LFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG-GSFGNFSAKSFEGNEL  700 (982)
Q Consensus       622 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~gn~~  700 (982)
                      |+|++|+|++.+    .++++|++|+|++|+|+ .+|. ...+++|++|||++|++++.+|.. ..+.........+|++
T Consensus       436 L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~  509 (549)
T 2z81_A          436 LDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW  509 (549)
T ss_dssp             EECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCB
T ss_pred             EECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCc
Confidence            999999999753    57899999999999998 6776 568999999999999999877753 3455666777899999


Q ss_pred             cCCCC
Q 036229          701 LCGSP  705 (982)
Q Consensus       701 lc~~~  705 (982)
                      .|..|
T Consensus       510 ~~~~~  514 (549)
T 2z81_A          510 DCSCP  514 (549)
T ss_dssp             CCCHH
T ss_pred             cCCCc
Confidence            88754

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=469.56  Aligned_cols=462  Identities=20%  Similarity=0.215  Sum_probs=264.5

Q ss_pred             EEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccC
Q 036229           84 KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYN  163 (982)
Q Consensus        84 ~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  163 (982)
                      +.||+++++++ .+|..+.  ++|++|||++|++++..|.++..+++|++|+|++|++++..|..|+++++|++|||++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            36788888888 6777666  78888888888888777778888888888888888888777888888888888888888


Q ss_pred             cccccCchhhhcCCCCCCeeeecceeeec-ccCCCccCcCcccEEEeeccccccccccccccccch--hhhhccCCCC--
Q 036229          164 ALSGEIPANICSNLPFLESISLSQNMFHG-RIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKL--KELYLGYSGL--  238 (982)
Q Consensus       164 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--  238 (982)
                      .++ .+|..   .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++   ..+..+++|  ++|++++|++  
T Consensus        80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~  152 (520)
T 2z7x_B           80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG  152 (520)
T ss_dssp             CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred             cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence            887 67765   67888888888888876 467788888888888888888775   345566666  7777777777  


Q ss_pred             CCchhhhcCCCc-ccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCcc-------c
Q 036229          239 QGEIPREFGNLA-ELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNK-------L  310 (982)
Q Consensus       239 ~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------l  310 (982)
                      ++..|..+..+. +...+++++|++.+.+++                       ..+.++++|+.|++++|.       +
T Consensus       153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~-----------------------~~~~~l~~L~~L~l~~n~~~~~~~~~  209 (520)
T 2z7x_B          153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILD-----------------------VSVKTVANLELSNIKCVLEDNKCSYF  209 (520)
T ss_dssp             SSCCTTTTTTCCEEEEEEECCSSSCCCCCCC-----------------------CCCTTCSEEEECCEEECCSTTTTHHH
T ss_pred             cccccccccccccceEEEEeccCcchhhhhh-----------------------hhhhcccceeecccccccccccccee
Confidence            555666555544 222334444444433322                       234445555555555554       4


Q ss_pred             cccCcccccCCCCCceeecCCCcCCCCcCcc--ccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccC
Q 036229          311 VGAVPATIFNMSTLTGLGLQSNSLSGSLSSI--ADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIP  388 (982)
Q Consensus       311 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~  388 (982)
                      .+.+| .+..+++|+.|++++|.+.+.....  .....++|++|++++|++++.+|..++..                  
T Consensus       210 ~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~------------------  270 (520)
T 2z7x_B          210 LSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDY------------------  270 (520)
T ss_dssp             HHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCC------------------
T ss_pred             ecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhc------------------
Confidence            43333 3444444444443333332100000  00012234555555555544444444000                  


Q ss_pred             CccccCCccceecccccccccCcccccccccCCCC---ccccEEEccCCCCCCCCCccccccccccccEEeccCCccccC
Q 036229          389 NTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNC---KSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG  465 (982)
Q Consensus       389 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~  465 (982)
                       ....+++|+.+++++|.+ .++..     .+..+   .+|+.|++++|++..+..    ......|++|++++|++++.
T Consensus       271 -~~~~l~~L~~l~l~~n~~-~~p~~-----~~~~~~~~~~L~~L~l~~n~l~~~~~----~~~l~~L~~L~Ls~n~l~~~  339 (520)
T 2z7x_B          271 -SGTSLKALSIHQVVSDVF-GFPQS-----YIYEIFSNMNIKNFTVSGTRMVHMLC----PSKISPFLHLDFSNNLLTDT  339 (520)
T ss_dssp             -CSCCCCEEEEEEEEECCC-CSCTH-----HHHHHHHTCCCSEEEEESSCCCCCCC----CSSCCCCCEEECCSSCCCTT
T ss_pred             -ccccCceeEeccccccce-ecchh-----hhhcccccCceeEEEcCCCccccccc----hhhCCcccEEEeECCccChh
Confidence             004444444444444444 22210     01111   345566666665543210    01122344444444445544


Q ss_pred             CCcccccccccceEEecCCCCCC--CCCccccCcCCCCeEEeeccCCCCCCCc-ccCCCccccEEEccCCcCCcCCCccc
Q 036229          466 FPKEIGNLTNLIGIYLGGNKLNG--SIPITLGKLQKLQGLHLEDNKLEGPIPD-DICRLTKLYELGLSGNKLSGSIPACF  542 (982)
Q Consensus       466 ~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~  542 (982)
                      .|..++.+++|+.|++++|++++  .+|..++.+++|++|+|++|++++.+|. .+..+++|++|++++|++++..|..+
T Consensus       340 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l  419 (520)
T 2z7x_B          340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL  419 (520)
T ss_dssp             TTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSC
T ss_pred             hhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhh
Confidence            55555555566666666666554  3334555555555555555555553333 34555555555555555554444433


Q ss_pred             cCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceE
Q 036229          543 SNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYL  622 (982)
Q Consensus       543 ~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L  622 (982)
                      .  ++|++|+|++|+++++|..                        +..+++|+.||+++|+++++.+..|..+++|++|
T Consensus       420 ~--~~L~~L~Ls~N~l~~ip~~------------------------~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L  473 (520)
T 2z7x_B          420 P--PRIKVLDLHSNKIKSIPKQ------------------------VVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI  473 (520)
T ss_dssp             C--TTCCEEECCSSCCCCCCGG------------------------GGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             c--ccCCEEECCCCcccccchh------------------------hhcCCCCCEEECCCCcCCccCHHHhccCCcccEE
Confidence            2  4455555555555544444                        4455555566666666654333347777778888


Q ss_pred             ecccccccCCcc
Q 036229          623 FLGYNRLQGSIS  634 (982)
Q Consensus       623 ~Ls~N~l~~~~~  634 (982)
                      +|++|++++..+
T Consensus       474 ~l~~N~~~c~c~  485 (520)
T 2z7x_B          474 WLHTNPWDCSCP  485 (520)
T ss_dssp             ECCSSCBCCCHH
T ss_pred             ECcCCCCcccCC
Confidence            888888776544

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.2e-48  Score=476.15  Aligned_cols=460  Identities=20%  Similarity=0.183  Sum_probs=326.8

Q ss_pred             CCCCEEEcCCCCccccCcchhhhccCCcEEEc-cCCcccCccCccccCc----CCCC--ccc---------c-ccCcccc
Q 036229          105 SSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNF-RGNQLSGAFPSFIFNK----SSLQ--HLD---------F-SYNALSG  167 (982)
Q Consensus       105 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L-s~N~l~~~~p~~~~~l----~~L~--~L~---------L-s~N~l~~  167 (982)
                      .+++.|+|++|.+.|.+|+++++|++|++|+| ++|.++|..|-.....    +..+  .+.         . ....+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            56889999999999999999999999999999 9999998755332111    0000  000         0 0001110


Q ss_pred             cCchhh----------hcCCCCCCeeeecc--eeeecccCCCccCcCcccEEEeecccccc-ccccccccccchhhhhcc
Q 036229          168 EIPANI----------CSNLPFLESISLSQ--NMFHGRIPSALSNCKYLEILSLSINNLLG-AIPKEIGNLTKLKELYLG  234 (982)
Q Consensus       168 ~ip~~~----------~~~l~~L~~L~Ls~--N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~  234 (982)
                      .++..+          ......++.+.+..  |++++ +|..|+++++|++|+|++|++++ .+|..+.        ..+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~--------~~s  473 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE--------DAN  473 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS--------CTT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccc--------ccc
Confidence            110000          02334555565655  99998 89999999999999999999997 2332221        123


Q ss_pred             CCCCCCchhhhcC--CCcccceEeccccccCCcCChhhhccCCCcEEEccCCc-ccc-CCCccccccC-------CCcEE
Q 036229          235 YSGLQGEIPREFG--NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNF-LTG-EIPPEIHNLH-------NLKLL  303 (982)
Q Consensus       235 ~N~l~~~~~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L  303 (982)
                      .|.++|.+|..++  ++++|+.|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+.+++       +|++|
T Consensus       474 ~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L  553 (876)
T 4ecn_A          474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF  553 (876)
T ss_dssp             SHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEE
T ss_pred             cccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEE
Confidence            3566677888877  88999999999999888999889999999999999998 887 7787776665       99999


Q ss_pred             EccCccccccCcc--cccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccc
Q 036229          304 DLSHNKLVGAVPA--TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRN  381 (982)
Q Consensus       304 ~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  381 (982)
                      +|++|+++ .+|.  .+.++++|                         ++|+|++|+++ .+| .+..+++|+.|+|++|
T Consensus       554 ~Ls~N~L~-~ip~~~~l~~L~~L-------------------------~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N  605 (876)
T 4ecn_A          554 YMGYNNLE-EFPASASLQKMVKL-------------------------GLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYN  605 (876)
T ss_dssp             ECCSSCCC-BCCCHHHHTTCTTC-------------------------CEEECTTSCCC-BCC-CCCTTSEESEEECCSS
T ss_pred             EeeCCcCC-ccCChhhhhcCCCC-------------------------CEEECCCCCcc-cch-hhcCCCcceEEECcCC
Confidence            99999999 7777  77777666                         66667777776 666 7888999999999999


Q ss_pred             cCccccCCccccCCc-cceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCC
Q 036229          382 SFSGFIPNTFGNLRN-LRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYC  460 (982)
Q Consensus       382 ~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n  460 (982)
                      +++ .+|..+..+++ |+                             +|+|++|+++.+                     
T Consensus       606 ~l~-~lp~~l~~l~~~L~-----------------------------~L~Ls~N~L~~l---------------------  634 (876)
T 4ecn_A          606 QIE-EIPEDFCAFTDQVE-----------------------------GLGFSHNKLKYI---------------------  634 (876)
T ss_dssp             CCS-CCCTTSCEECTTCC-----------------------------EEECCSSCCCSC---------------------
T ss_pred             ccc-cchHHHhhccccCC-----------------------------EEECcCCCCCcC---------------------
Confidence            999 66666666655 55                             555665544322                     


Q ss_pred             ccccCCCcccccc--cccceEEecCCCCCCCCCccc---c--CcCCCCeEEeeccCCCCCCCcc-cCCCccccEEEccCC
Q 036229          461 NVSGGFPKEIGNL--TNLIGIYLGGNKLNGSIPITL---G--KLQKLQGLHLEDNKLEGPIPDD-ICRLTKLYELGLSGN  532 (982)
Q Consensus       461 ~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N  532 (982)
                            |..+..+  ++|+.|+|++|++++.+|...   .  .+++|+.|+|++|+|+. +|.. +..+++|+.|+|++|
T Consensus       635 ------p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~-lp~~~~~~l~~L~~L~Ls~N  707 (876)
T 4ecn_A          635 ------PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNN  707 (876)
T ss_dssp             ------CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCS-CCHHHHHTTCCCSEEECCSC
T ss_pred             ------chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCc-cCHHHHccCCCCCEEECCCC
Confidence                  2333333  237777777777776555322   2  23467788888888873 4443 346777778888887


Q ss_pred             cCCcCCCccccC-------CCcccccccCCCcccccccccc--cccCceEEecCCCcccCCCccccccccccceeecccc
Q 036229          533 KLSGSIPACFSN-------LASLGTLSLGSNKLTSIPLTIW--NLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN  603 (982)
Q Consensus       533 ~l~~~~p~~~~~-------l~~L~~L~L~~N~l~~ip~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N  603 (982)
                      +|+.+.+..+..       +++|++|+|++|+|+.+|..++  .+++|+.|+|++|++++ +|..+.++++|+.|+|++|
T Consensus       708 ~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N  786 (876)
T 4ecn_A          708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ  786 (876)
T ss_dssp             CCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCC
T ss_pred             cCCccChHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCC
Confidence            777333333322       2267777777777777766665  56666666666666665 4555556666666666665


Q ss_pred             cccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccC
Q 036229          604 NFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       604 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~  681 (982)
                      +                  ++++|++.+.+|.+|.++++|+.|+|++|+| +.+|..+.  ++|+.|||++|++...-
T Consensus       787 ~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~  843 (876)
T 4ecn_A          787 R------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISID  843 (876)
T ss_dssp             B------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEE
T ss_pred             C------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccC
Confidence            5                  4566999999999999999999999999999 68998876  69999999999997433

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=7e-47  Score=460.85  Aligned_cols=537  Identities=22%  Similarity=0.251  Sum_probs=344.2

Q ss_pred             EEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecce
Q 036229          109 SLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN  188 (982)
Q Consensus       109 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N  188 (982)
                      +.|-++.+++ .+|..+-  +++++|||++|+|++..|..|.++++|++|||++|.|+ .+|+..|.++++|++|+|++|
T Consensus        35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N  110 (635)
T 4g8a_A           35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN  110 (635)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTC
T ss_pred             EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCC
Confidence            3455555555 5665441  35677777777776555556666666666666666666 455555566666666666666


Q ss_pred             eeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCC-chhhhcCCCcccceEeccccccCCcCC
Q 036229          189 MFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG-EIPREFGNLAELELMALQVSNLQGEIP  267 (982)
Q Consensus       189 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p  267 (982)
                      +|++..+++|.++++|++|+|++|++++..+..|+++++|++|+|++|++++ ..|..++.+++|+.|++++|++++..|
T Consensus       111 ~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  190 (635)
T 4g8a_A          111 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  190 (635)
T ss_dssp             CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence            6665555556666666666666666665444455666666666666665543 234444455555555555555554444


Q ss_pred             hhhhccCCCc----EEEccCCccccCCCccccccCCCcEEEccCcccccc-CcccccCCCCCceeecCCCcCCCCcCccc
Q 036229          268 QELANLTGLE----VLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGA-VPATIFNMSTLTGLGLQSNSLSGSLSSIA  342 (982)
Q Consensus       268 ~~l~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  342 (982)
                      ..|..+.+++    .++++.|.++.+.+..+.. ..++.+++++|..... .+..+..+..+                  
T Consensus       191 ~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~~~~~~~~~~~~l~~l------------------  251 (635)
T 4g8a_A          191 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGL------------------  251 (635)
T ss_dssp             GGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSSHHHHHHHHHTTTTC------------------
T ss_pred             ccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhcccccccccchhhcCCccc------------------
Confidence            4444433322    3444444444333322222 2334444444433211 11222222222                  


Q ss_pred             cccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCC
Q 036229          343 DVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN  422 (982)
Q Consensus       343 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~  422 (982)
                             +...+..+....                  ...+.......+..+..+....+..+........  ....+..
T Consensus       252 -------~~~~l~~~~~~~------------------~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~--~~~~~~~  304 (635)
T 4g8a_A          252 -------EVHRLVLGEFRN------------------EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDG--IIDLFNC  304 (635)
T ss_dssp             -------EEEEEEEECCTT------------------SCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEE--CTTTTGG
T ss_pred             -------cccccccccccc------------------ccccccccccccccccchhhhhhhhhhhcccccc--hhhhhhh
Confidence                   222221111100                  0011111222233333333333333222211110  1122444


Q ss_pred             CccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCe
Q 036229          423 CKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQG  502 (982)
Q Consensus       423 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  502 (982)
                      +.+++.+++.+|.+..+.+.    .....++.|++++|.+.+..+.   .+..|+.+++.+|.+....  .+..+++|+.
T Consensus       305 ~~~l~~l~~~~~~~~~~~~~----~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~~--~~~~l~~L~~  375 (635)
T 4g8a_A          305 LTNVSSFSLVSVTIERVKDF----SYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNAF--SEVDLPSLEF  375 (635)
T ss_dssp             GTTCSEEEEESCEEEECGGG----GSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCBC--CCCBCTTCCE
T ss_pred             hccccccccccccccccccc----ccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCCc--cccccccccc
Confidence            55556666666655443221    1123566777777777654443   4567889999999987543  3567899999


Q ss_pred             EEeeccCCCC--CCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccc-c-ccccccCceEEecCC
Q 036229          503 LHLEDNKLEG--PIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIP-L-TIWNLKGMLYLNFSS  578 (982)
Q Consensus       503 L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip-~-~~~~l~~L~~L~Ls~  578 (982)
                      |++++|.+..  ..+..+..+.+|+.|+++.|.+.. .+..+..+++|+.++++.|+...++ . .+..+.++++++++.
T Consensus       376 L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~  454 (635)
T 4g8a_A          376 LDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH  454 (635)
T ss_dssp             EECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTT
T ss_pred             chhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccc
Confidence            9999999963  456677788999999999999984 5667889999999999999888543 2 455789999999999


Q ss_pred             CcccCCCccccccccccceeeccccccc-ccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCC
Q 036229          579 NFFTGPLPLDIGNLKVLIGIDFSTNNFS-DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSI  657 (982)
Q Consensus       579 N~l~~~~~~~~~~l~~L~~Ldls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  657 (982)
                      |.+.+..+..+..++.++.|++++|++. +.+|..|+.+++|++|+|++|+|++.+|.+|.++++|++|+|++|+|++..
T Consensus       455 n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~  534 (635)
T 4g8a_A          455 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD  534 (635)
T ss_dssp             SCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred             cccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCC
Confidence            9999999999999999999999999854 567889999999999999999999999999999999999999999999988


Q ss_pred             CcccccccccceeecCCCcccccCCCCCC-C-CCCCCcccccCcccCCCC
Q 036229          658 PISLEKLSYLEDLDLSFNKLKGEIPKGGS-F-GNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       658 p~~l~~l~~L~~l~ls~N~l~~~~p~~~~-~-~~~~~~~~~gn~~lc~~~  705 (982)
                      |..|..+++|++|||++|++++.+|..-. + .........|||+.|+..
T Consensus       535 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          535 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             hhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            99999999999999999999988886532 2 345556789999999854

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=5.8e-47  Score=453.59  Aligned_cols=461  Identities=19%  Similarity=0.170  Sum_probs=307.6

Q ss_pred             CCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEe
Q 036229          130 TLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSL  209 (982)
Q Consensus       130 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  209 (982)
                      ..+++++++|++++ +|..+.  ++|++|||++|.++ .+|+..|.++++|++|+|++|++++..|++|.++++|++|||
T Consensus        32 ~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  107 (562)
T 3a79_B           32 LESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV  107 (562)
T ss_dssp             -CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence            34777777777773 666553  67777777777776 344444467777777777777777666667777777777777


Q ss_pred             eccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccC
Q 036229          210 SINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGE  289 (982)
Q Consensus       210 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  289 (982)
                      ++|+++ .+|..  .+++|++|+|++|++++.                       .+|..|+++++|++|++++|++++.
T Consensus       108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l-----------------------~~p~~~~~l~~L~~L~L~~n~l~~~  161 (562)
T 3a79_B          108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVL-----------------------PVCKEFGNLTKLTFLGLSAAKFRQL  161 (562)
T ss_dssp             TTSCCC-EECSC--CCTTCSEEECCSSCCSBC-----------------------CCCGGGGGCTTCCEEEEECSBCCTT
T ss_pred             CCCcCC-ccCcc--ccccCCEEECCCCCcccc-----------------------CchHhhcccCcccEEecCCCccccC
Confidence            777766 44444  555566666666555532                       2234555555555555555555532


Q ss_pred             CCccccccCCC--cEEEccCccc--cccCcccccCCC-CCceeecCCCcCCCCcCccccccCCCccEEEccCCcc-----
Q 036229          290 IPPEIHNLHNL--KLLDLSHNKL--VGAVPATIFNMS-TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNF-----  359 (982)
Q Consensus       290 ~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l-----  359 (982)
                         .+..+++|  ++|++++|++  ++..|..+..+. ..-.+++++|.+.+.+.......+++|+.|++++|+.     
T Consensus       162 ---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l  238 (562)
T 3a79_B          162 ---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRL  238 (562)
T ss_dssp             ---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHH
T ss_pred             ---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchH
Confidence               23333344  6666666666  555555554433 1113345555555444444444555566666666641     


Q ss_pred             cccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCC
Q 036229          360 SGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGI  439 (982)
Q Consensus       360 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~  439 (982)
                      .+ ....+..+++|+.|+++++.+.+.                   .+....       .....+               
T Consensus       239 ~~-~~~~l~~l~~L~~L~L~~~~l~~~-------------------~~~~~~-------~~~~~~---------------  276 (562)
T 3a79_B          239 MT-FLSELTRGPTLLNVTLQHIETTWK-------------------CSVKLF-------QFFWPR---------------  276 (562)
T ss_dssp             HH-HHHHHHSCSSCEEEEEEEEEECHH-------------------HHHHHH-------HHHTTS---------------
T ss_pred             HH-HHHHHhccCcceEEEecCCcCcHH-------------------HHHHHH-------Hhhhcc---------------
Confidence            11 112233444444444444433221                   000000       000111               


Q ss_pred             CCccccccccccccEEeccCCccccCCCccc-----ccccccceEEecCCCCCCCCC-ccccCc---CCCCeEEeeccCC
Q 036229          440 LPRMSMGNLSHSLEYFDMSYCNVSGGFPKEI-----GNLTNLIGIYLGGNKLNGSIP-ITLGKL---QKLQGLHLEDNKL  510 (982)
Q Consensus       440 ~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~Ls~N~l  510 (982)
                                 +|++|++++|++++.+|..+     ..++.|+.++++.|.+  .+| .++..+   .+|+.|++++|.+
T Consensus       277 -----------~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~  343 (562)
T 3a79_B          277 -----------PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPF  343 (562)
T ss_dssp             -----------SEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred             -----------cccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCc
Confidence                       34455555556665566655     6777788888888887  344 333333   6799999999998


Q ss_pred             CCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccc---cccccccCceEEecCCCcccCCCcc
Q 036229          511 EGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIP---LTIWNLKGMLYLNFSSNFFTGPLPL  587 (982)
Q Consensus       511 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip---~~~~~l~~L~~L~Ls~N~l~~~~~~  587 (982)
                      ....  ....+++|++|++++|++++..|..|.++++|++|+|++|+++.+|   ..+..+++|++|++++|++++.+|.
T Consensus       344 ~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  421 (562)
T 3a79_B          344 IHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD  421 (562)
T ss_dssp             CCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSS
T ss_pred             cccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccCh
Confidence            6432  1267889999999999999888999999999999999999999765   4577889999999999999985554


Q ss_pred             -ccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcc-ccccc
Q 036229          588 -DIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS-LEKLS  665 (982)
Q Consensus       588 -~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~  665 (982)
                       .+..+++|+.|++++|++++.+|..+.  ++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++ +|.. +..++
T Consensus       422 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~  497 (562)
T 3a79_B          422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLT  497 (562)
T ss_dssp             CCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCT
T ss_pred             hhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCC
Confidence             588999999999999999988777665  78999999999998 677777799999999999999995 6665 89999


Q ss_pred             ccceeecCCCcccccCCCC
Q 036229          666 YLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       666 ~L~~l~ls~N~l~~~~p~~  684 (982)
                      +|++|++++|++.|.+|..
T Consensus       498 ~L~~L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          498 SLQYIWLHDNPWDCTCPGI  516 (562)
T ss_dssp             TCCCEECCSCCBCCCHHHH
T ss_pred             CCCEEEecCCCcCCCcchH
Confidence            9999999999999988754

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.1e-46  Score=447.32  Aligned_cols=464  Identities=20%  Similarity=0.237  Sum_probs=264.6

Q ss_pred             EEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccC
Q 036229           84 KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYN  163 (982)
Q Consensus        84 ~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  163 (982)
                      +.+++++++++ .+|..+.  ++|++|||++|.+++..|.+|..+++|++|+|++|++++..|..|.++++|++|||++|
T Consensus        34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            77899999999 4887665  89999999999999777789999999999999999999888889999999999999999


Q ss_pred             cccccCchhhhcCCCCCCeeeecceeeecc-cCCCccCcCcccEEEeeccccccccccccccccch--hhhhccCCCC--
Q 036229          164 ALSGEIPANICSNLPFLESISLSQNMFHGR-IPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKL--KELYLGYSGL--  238 (982)
Q Consensus       164 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--  238 (982)
                      .++ .+|..   .+++|++|+|++|++++. +|..|+++++|++|+|++|++++.   .+..+++|  ++|++++|++  
T Consensus       111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~  183 (562)
T 3a79_B          111 RLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI  183 (562)
T ss_dssp             CCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred             cCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence            998 78876   689999999999999873 467889999999999999988753   44455555  7888888877  


Q ss_pred             CCchhhhcCCCc--ccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCcc-----cc
Q 036229          239 QGEIPREFGNLA--ELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNK-----LV  311 (982)
Q Consensus       239 ~~~~~~~~~~l~--~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-----l~  311 (982)
                      ++..|..+..+.  .+ .++++.|.+.+.+++.                       .+..+++|+.|++++|+     +.
T Consensus       184 ~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~-----------------------~~~~l~~L~~L~l~~n~~~~~~l~  239 (562)
T 3a79_B          184 KGGETESLQIPNTTVL-HLVFHPNSLFSVQVNM-----------------------SVNALGHLQLSNIKLNDENCQRLM  239 (562)
T ss_dssp             CSSSCCEEEECCEEEE-EEEECSSSCCCCCCEE-----------------------EESSEEEEEEEEEECCSTTHHHHH
T ss_pred             cccCcccccccCcceE-EEEecCccchhhhhhh-----------------------cccccceEEEecccccccccchHH
Confidence            666666665543  22 3344555544433321                       23344455555555543     11


Q ss_pred             ccCcccccCCCCCceeecCCCcCCCCcCc--cccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCC
Q 036229          312 GAVPATIFNMSTLTGLGLQSNSLSGSLSS--IADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN  389 (982)
Q Consensus       312 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~  389 (982)
                      +. ...+..++.|+.|+++++.+.+....  ......++|++|++++|++++.+|..++...                  
T Consensus       240 ~~-~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~------------------  300 (562)
T 3a79_B          240 TF-LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYS------------------  300 (562)
T ss_dssp             HH-HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCC------------------
T ss_pred             HH-HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcc------------------
Confidence            11 12233344443333333222110000  0000112344444444444444444331100                  


Q ss_pred             ccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcc
Q 036229          390 TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE  469 (982)
Q Consensus       390 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~  469 (982)
                       ...++.|+.++++.|.+ .++.+.  ...+-...+|++|++++|.+.....    .....+|++|++++|++++..|..
T Consensus       301 -~~~L~~L~~~~~~~~~~-~~p~~~--~~~~~~~~~L~~L~l~~n~~~~~~~----~~~l~~L~~L~l~~n~l~~~~~~~  372 (562)
T 3a79_B          301 -ETALKSLMIEHVKNQVF-LFSKEA--LYSVFAEMNIKMLSISDTPFIHMVC----PPSPSSFTFLNFTQNVFTDSVFQG  372 (562)
T ss_dssp             -SCSCCEEEEEEEEECCC-SSCHHH--HHHHHHTCCCSEEEEESSCCCCCCC----CSSCCCCCEEECCSSCCCTTTTTT
T ss_pred             -cccchheehhhccccee-ecChhh--hhhhhccCcceEEEccCCCcccccC----ccCCCCceEEECCCCccccchhhh
Confidence             03344444444444433 111110  0001011346677777776543210    011223444444444444444444


Q ss_pred             cccccccceEEecCCCCCCCC--CccccCcCCCCeEEeeccCCCCCCCc-ccCCCccccEEEccCCcCCcCCCccccCCC
Q 036229          470 IGNLTNLIGIYLGGNKLNGSI--PITLGKLQKLQGLHLEDNKLEGPIPD-DICRLTKLYELGLSGNKLSGSIPACFSNLA  546 (982)
Q Consensus       470 ~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  546 (982)
                      +.++++|+.|++++|++++..  |..|.++++|++|+|++|++++.+|. .+..+++|++|++++|+|++..|..+.   
T Consensus       373 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~---  449 (562)
T 3a79_B          373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP---  449 (562)
T ss_dssp             CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC---
T ss_pred             hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc---
Confidence            445555555555555554321  23344445555555555555442222 344444455555555544443333322   


Q ss_pred             cccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccc
Q 036229          547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGY  626 (982)
Q Consensus       547 ~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~  626 (982)
                                            ++|++|++++|+++ .+|..+..+++|+.|||++|+++++.+..|..+++|++|+|++
T Consensus       450 ----------------------~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~  506 (562)
T 3a79_B          450 ----------------------PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHD  506 (562)
T ss_dssp             ----------------------TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCS
T ss_pred             ----------------------CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecC
Confidence                                  34555555555554 3444444566666666666666644333477788888888888


Q ss_pred             ccccCCcc
Q 036229          627 NRLQGSIS  634 (982)
Q Consensus       627 N~l~~~~~  634 (982)
                      |++++..+
T Consensus       507 N~~~c~c~  514 (562)
T 3a79_B          507 NPWDCTCP  514 (562)
T ss_dssp             CCBCCCHH
T ss_pred             CCcCCCcc
Confidence            88876554

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.9e-44  Score=397.53  Aligned_cols=293  Identities=34%  Similarity=0.529  Sum_probs=273.7

Q ss_pred             CCChhHHHHHHHHHHHhcCCCCccccCCCCCCCCCCc--eeeEEecCCC--CcEEEEEeCCCCccc--cCCccccCCCCC
Q 036229           34 SSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVTCDVHS--HRVKVLNISHLNLTG--TIPSQLWNLSSL  107 (982)
Q Consensus        34 ~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~L~l~~~~l~g--~~~~~l~~l~~L  107 (982)
                      .|.++|++||++||+++.+  +. .+++|+.+++||.  |.||+|+...  ++|+.|+|++++++|  .+|+.++++++|
T Consensus         2 ~c~~~~~~aL~~~k~~~~~--~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGN--PT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTC--CG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHhcCC--cc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            5999999999999999964  33 6899998889999  9999998544  799999999999999  999999999999


Q ss_pred             CEEEcCC-CCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeec
Q 036229          108 QSLNLGF-NRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS  186 (982)
Q Consensus       108 ~~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls  186 (982)
                      ++|+|++ |.+.+.+|.+++++++|++|+|++|++++.+|..+.++++|++|||++|.+++.+|..+ ..+++|++|+|+
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~  157 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFD  157 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG-GGCTTCCEEECC
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHH-hcCCCCCeEECc
Confidence            9999995 99999999999999999999999999999999999999999999999999998888887 889999999999


Q ss_pred             ceeeecccCCCccCcC-cccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCc
Q 036229          187 QNMFHGRIPSALSNCK-YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGE  265 (982)
Q Consensus       187 ~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  265 (982)
                      +|++++.+|..+..++ +|++|+|++|++++.+|..+..++ |++|++++|++++..|..|..+++|+.|++++|++++.
T Consensus       158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  236 (313)
T 1ogq_A          158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD  236 (313)
T ss_dssp             SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred             CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeee
Confidence            9999999999999998 999999999999999999999997 99999999999999999999999999999999999977


Q ss_pred             CChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCc
Q 036229          266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNS  333 (982)
Q Consensus       266 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  333 (982)
                      +|. +..+++|++|+|++|+|++.+|..|..+++|++|+|++|++++.+|.. ..+++|+.+++++|+
T Consensus       237 ~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          237 LGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             GGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             cCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence            766 888999999999999999999999999999999999999999988876 778888888888887

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=3.1e-43  Score=407.10  Aligned_cols=404  Identities=26%  Similarity=0.263  Sum_probs=227.5

Q ss_pred             CCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEe
Q 036229          177 LPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMA  256 (982)
Q Consensus       177 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  256 (982)
                      .++|++|++++|.+ +.+|.+++++++|++|++++|+++|.+|.+++++++|+.+++..|..           .+++.|+
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~   77 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE   77 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence            45566666666666 45666666666666666666666666666666666666665554421           2344555


Q ss_pred             ccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCC
Q 036229          257 LQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSG  336 (982)
Q Consensus       257 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  336 (982)
                      +++|.+++. |..   .++|++|++++|++++ +|..   .++|++|++++|+++                        +
T Consensus        78 l~~~~l~~l-p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~------------------------~  125 (454)
T 1jl5_A           78 LNNLGLSSL-PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK------------------------A  125 (454)
T ss_dssp             CTTSCCSCC-CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS------------------------C
T ss_pred             ecCCccccC-CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC------------------------c
Confidence            555555431 221   2345555555555543 2322   134444555544444                        3


Q ss_pred             CcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccc
Q 036229          337 SLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSF  416 (982)
Q Consensus       337 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  416 (982)
                      ...     ..++|++|++++|++++ +| .+.++++|++|++++|++++ +|..+   ++|+.|++++|+++.++     
T Consensus       126 l~~-----~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-----  189 (454)
T 1jl5_A          126 LSD-----LPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-----  189 (454)
T ss_dssp             CCS-----CCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-----
T ss_pred             ccC-----CCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc-----
Confidence            211     01456667777776665 44 46667777777777777765 33332   36777777777776542     


Q ss_pred             cccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccC
Q 036229          417 LSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGK  496 (982)
Q Consensus       417 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  496 (982)
                        .|.++++|++|++++|++++++.      ...+|++|++++|+++ .+| .++.+++|+.|++++|++++ +|..   
T Consensus       190 --~~~~l~~L~~L~l~~N~l~~l~~------~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---  255 (454)
T 1jl5_A          190 --ELQNLPFLTAIYADNNSLKKLPD------LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---  255 (454)
T ss_dssp             --CCTTCTTCCEEECCSSCCSSCCC------CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---
T ss_pred             --cccCCCCCCEEECCCCcCCcCCC------CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---
Confidence              26677777788888887776432      1247888888888887 455 48888999999999999986 4432   


Q ss_pred             cCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEec
Q 036229          497 LQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNF  576 (982)
Q Consensus       497 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L  576 (982)
                      +++|+.|++++|++++ +|..   +++|+.|++++|++++. |..   .++|++|++++|+++.+|..   .++|++|++
T Consensus       256 ~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~~~---~~~L~~L~L  324 (454)
T 1jl5_A          256 PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLCDL---PPSLEELNV  324 (454)
T ss_dssp             CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEECCC---CTTCCEEEC
T ss_pred             ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcccCC---cCcCCEEEC
Confidence            3789999999999986 5543   37889999999998863 221   26788999999998876632   247888899


Q ss_pred             CCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccC--CccccccCCCCCCeeeCCCCcCC
Q 036229          577 SSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG--SISESFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       577 s~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~  654 (982)
                      ++|++++ +|..   +++|+.||+++|++++ +|.   .+++|++|+|++|++++  .+|.+++++        +.|++.
T Consensus       325 s~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~  388 (454)
T 1jl5_A          325 SNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHL  388 (454)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC--
T ss_pred             CCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccc
Confidence            9998886 4543   4778888888888875 454   46888889999988887  566665533        346666


Q ss_pred             CCCCcccccccccceeecCCCcccc--cCCCC
Q 036229          655 RSIPISLEKLSYLEDLDLSFNKLKG--EIPKG  684 (982)
Q Consensus       655 ~~~p~~l~~l~~L~~l~ls~N~l~~--~~p~~  684 (982)
                      |.+|..   +++|++||+++|+++|  .+|..
T Consensus       389 ~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s  417 (454)
T 1jl5_A          389 AEVPEL---PQNLKQLHVETNPLREFPDIPES  417 (454)
T ss_dssp             --------------------------------
T ss_pred             cccccc---cCcCCEEECCCCcCCccccchhh
Confidence            777753   4678888899998887  77754

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.7e-43  Score=409.45  Aligned_cols=423  Identities=21%  Similarity=0.228  Sum_probs=171.0

Q ss_pred             cCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCC
Q 036229          102 WNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLE  181 (982)
Q Consensus       102 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~  181 (982)
                      ...++|++|++++|.+ |.+|++++++++|++|++++|+++|.+|..++++++|+.++++.|..            .+++
T Consensus         8 ~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~------------~~l~   74 (454)
T 1jl5_A            8 VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD------------RQAH   74 (454)
T ss_dssp             ---------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH------------HTCS
T ss_pred             cccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc------------cCCC
Confidence            3457888888888888 78888888888888888888888888888888888887777776642            3567


Q ss_pred             eeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccc
Q 036229          182 SISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN  261 (982)
Q Consensus       182 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~  261 (982)
                      +|++++|++++ +|..   .++|++|++++|++++ +|..+   ++|++|++++|++++. |..   .++|+.|++++|+
T Consensus        75 ~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~  142 (454)
T 1jl5_A           75 ELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQ  142 (454)
T ss_dssp             EEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSC
T ss_pred             EEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCcc-cCC---CCCCCEEECcCCC
Confidence            77777777775 3332   2567777777777775 55432   5666677777766642 111   1345555555555


Q ss_pred             cCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCcc
Q 036229          262 LQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSI  341 (982)
Q Consensus       262 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  341 (982)
                      +++ +| .|+++++|++|++++|++++ +|..+   ++|++|++++|++++ +| .+.++++|                 
T Consensus       143 l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L-----------------  197 (454)
T 1jl5_A          143 LEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFL-----------------  197 (454)
T ss_dssp             CSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTC-----------------
T ss_pred             CCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCC-----------------
Confidence            543 33 35555555555555555543 23221   245555555555543 23 23444444                 


Q ss_pred             ccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCC
Q 036229          342 ADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFS  421 (982)
Q Consensus       342 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  421 (982)
                              ++|++++|++++ +|..   .++|++|++++|+++. +| .++.+++|+.|++++|+++.++.         
T Consensus       198 --------~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l~~---------  254 (454)
T 1jl5_A          198 --------TAIYADNNSLKK-LPDL---PLSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKTLPD---------  254 (454)
T ss_dssp             --------CEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCS---------
T ss_pred             --------CEEECCCCcCCc-CCCC---cCcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCcccc---------
Confidence                    333333333332 1211   1244444444444442 22 13333333333333333322110         


Q ss_pred             CCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCC
Q 036229          422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ  501 (982)
Q Consensus       422 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  501 (982)
                      .+++|++|++++|+++++                           |..   .++|+.|++++|++++.. ..   .++|+
T Consensus       255 ~~~~L~~L~l~~N~l~~l---------------------------~~~---~~~L~~L~ls~N~l~~l~-~~---~~~L~  300 (454)
T 1jl5_A          255 LPPSLEALNVRDNYLTDL---------------------------PEL---PQSLTFLDVSENIFSGLS-EL---PPNLY  300 (454)
T ss_dssp             CCTTCCEEECCSSCCSCC---------------------------CCC---CTTCCEEECCSSCCSEES-CC---CTTCC
T ss_pred             cccccCEEECCCCccccc---------------------------Ccc---cCcCCEEECcCCccCccc-Cc---CCcCC
Confidence            012333444444433322                           111   134445555555554311 10   13455


Q ss_pred             eEEeeccCCCCCCCcccCCC-ccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCc
Q 036229          502 GLHLEDNKLEGPIPDDICRL-TKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNF  580 (982)
Q Consensus       502 ~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~  580 (982)
                      .|++++|++++ ++    .+ ++|++|++++|++++ +|..   +++|++|++++|+++++|.                 
T Consensus       301 ~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~-----------------  354 (454)
T 1jl5_A          301 YLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE-----------------  354 (454)
T ss_dssp             EEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC-----------------
T ss_pred             EEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccccc-----------------
Confidence            55555555553 11    11 345555555555553 3332   3455555555555555544                 


Q ss_pred             ccCCCccccccccccceeecccccccc--cccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCC--C
Q 036229          581 FTGPLPLDIGNLKVLIGIDFSTNNFSD--VIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR--S  656 (982)
Q Consensus       581 l~~~~~~~~~~l~~L~~Ldls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~  656 (982)
                                .+++|+.||+++|++++  .+|..++.        |+.|.+.+.+|..   +++|+.||+++|++++  .
T Consensus       355 ----------~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~  413 (454)
T 1jl5_A          355 ----------LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPD  413 (454)
T ss_dssp             ----------CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC------------------------------
T ss_pred             ----------hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCcccc
Confidence                      13344445555555544  34444332        2345555666653   4567778888888776  5


Q ss_pred             CCcccccccccceeecCCCcccccCCCC
Q 036229          657 IPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       657 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                      +|.+      ++.|.+++|.+.+.+|..
T Consensus       414 iP~s------l~~L~~~~~~~~~~~~~~  435 (454)
T 1jl5_A          414 IPES------VEDLRMNSERVVDPYEFA  435 (454)
T ss_dssp             ----------------------------
T ss_pred             chhh------HhheeCcCcccCCccccC
Confidence            5543      555667778877766643

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3e-42  Score=402.11  Aligned_cols=215  Identities=20%  Similarity=0.257  Sum_probs=118.2

Q ss_pred             CCCceee--EEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCc
Q 036229           67 PVCNWTG--VTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGA  144 (982)
Q Consensus        67 ~~c~w~g--v~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~  144 (982)
                      ..|.|.+  |.|+            +++++ .+|. +  .++|++|||++|.+++..|..+.++++|++|+|++|.+.+.
T Consensus         6 ~~c~~~~~~~~c~------------~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~   69 (455)
T 3v47_A            6 SECSVIGYNAICI------------NRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV   69 (455)
T ss_dssp             -CCEEETTEEECC------------SSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE
T ss_pred             ceeEEEccccCcC------------CCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce
Confidence            3577766  5555            33444 4554 2  25677777777777766676777777777777777776654


Q ss_pred             c-CccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCC--CccCcCcccEEEeeccccccccccc
Q 036229          145 F-PSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPS--ALSNCKYLEILSLSINNLLGAIPKE  221 (982)
Q Consensus       145 ~-p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~  221 (982)
                      + |..|.++++|++|||++|.+++..|..+ .++++|++|+|++|++++..|.  .|+++++|++|+|++|++++..|..
T Consensus        70 i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  148 (455)
T 3v47_A           70 IRNNTFRGLSSLIILKLDYNQFLQLETGAF-NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS  148 (455)
T ss_dssp             ECTTTTTTCTTCCEEECTTCTTCEECTTTT-TTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG
T ss_pred             ECcccccccccCCEEeCCCCccCccChhhc-cCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc
Confidence            4 3346666666666666666653333333 5555566666655555543332  2555555555555555555444443


Q ss_pred             -cccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCcc-------
Q 036229          222 -IGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE-------  293 (982)
Q Consensus       222 -~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-------  293 (982)
                       +.++++|++|++++|++++..|..+..+.                      ..+|+.|++++|.+++..+..       
T Consensus       149 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~----------------------~~~L~~L~l~~n~l~~~~~~~~~~~~~~  206 (455)
T 3v47_A          149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQ----------------------GKHFTLLRLSSITLQDMNEYWLGWEKCG  206 (455)
T ss_dssp             GGGGCTTCCEEECTTCCBSCCCTTTSGGGT----------------------TCEEEEEECTTCBCTTCSTTCTTHHHHC
T ss_pred             ccCCCCcccEEeCCCCcccccChhhhhccc----------------------cccccccccccCcccccchhhccccccc
Confidence             44555555555555555444444333320                      044555555555555433322       


Q ss_pred             -ccccCCCcEEEccCccccccCcccccC
Q 036229          294 -IHNLHNLKLLDLSHNKLVGAVPATIFN  320 (982)
Q Consensus       294 -~~~l~~L~~L~Ls~N~l~~~~p~~~~~  320 (982)
                       +..+++|++||+++|++++..|..+..
T Consensus       207 ~~~~~~~L~~L~Ls~n~l~~~~~~~~~~  234 (455)
T 3v47_A          207 NPFKNTSITTLDLSGNGFKESMAKRFFD  234 (455)
T ss_dssp             CTTTTCEEEEEECTTSCCCHHHHHHHHH
T ss_pred             cccccceeeeEecCCCcccccchhhhhc
Confidence             224456666666666666555555443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=7e-42  Score=398.95  Aligned_cols=396  Identities=19%  Similarity=0.166  Sum_probs=262.5

Q ss_pred             CCCCCCCCCCceeeEEecC-CCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCc-chhhhccCCcEEEcc
Q 036229           60 KNWNTSTPVCNWTGVTCDV-HSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIP-SAIFTLYTLKYVNFR  137 (982)
Q Consensus        60 ~~w~~~~~~c~w~gv~c~~-~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p-~~~~~l~~L~~L~Ls  137 (982)
                      +.|....-.|.+.|++.-. -..+++.|+|++|.+++..|..++++++|++|+|++|.+.+.+| .+|..+++|++|+|+
T Consensus         8 c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A            8 CSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             CEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             eEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            4454433347776654421 23579999999999998889999999999999999999987774 578999999999999


Q ss_pred             CCcccCccCccccCcCCCCccccccCcccccCch-hhhcCCCCCCeeeecceeeecccCCC-ccCcCcccEEEeeccccc
Q 036229          138 GNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPA-NICSNLPFLESISLSQNMFHGRIPSA-LSNCKYLEILSLSINNLL  215 (982)
Q Consensus       138 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~-~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~  215 (982)
                      +|++++..|..|+++++|++|+|++|.+++.+|. ..|..+++|++|+|++|++++..|.. |.++++|++|++++|+++
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence            9999988899999999999999999999976554 34589999999999999999988876 899999999999999999


Q ss_pred             cccccccccc--cchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCcc
Q 036229          216 GAIPKEIGNL--TKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE  293 (982)
Q Consensus       216 ~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  293 (982)
                      +..|..+..+  .+|+.|++++|.+++..+..++.                .....+..+++|++|++++|++++..|..
T Consensus       168 ~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~----------------~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~  231 (455)
T 3v47_A          168 SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW----------------EKCGNPFKNTSITTLDLSGNGFKESMAKR  231 (455)
T ss_dssp             CCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTH----------------HHHCCTTTTCEEEEEECTTSCCCHHHHHH
T ss_pred             ccChhhhhccccccccccccccCcccccchhhccc----------------cccccccccceeeeEecCCCcccccchhh
Confidence            9999988877  78999999999998654433220                01112334455666666666666555555


Q ss_pred             cccc---CCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCC
Q 036229          294 IHNL---HNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA  370 (982)
Q Consensus       294 ~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  370 (982)
                      +...   ++|+.|++++|.+.+.... ...+..+.            .........++|++|++++|++.+..|..+..+
T Consensus       232 ~~~~~~~~~L~~L~l~~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l  298 (455)
T 3v47_A          232 FFDAIAGTKIQSLILSNSYNMGSSFG-HTNFKDPD------------NFTFKGLEASGVKTCDLSKSKIFALLKSVFSHF  298 (455)
T ss_dssp             HHHHTTTCCEEEEECTTCTTTSCCTT-CCSSCCCC------------TTTTGGGTTSCCCEEECCSSCCCEECTTTTTTC
T ss_pred             hhccccccceeeEeeccccccccccc-hhhhccCc------------ccccccccccCceEEEecCccccccchhhcccC
Confidence            5443   5666666666665432110 00011000            000011122455666666666665555555555


Q ss_pred             CCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccc
Q 036229          371 SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSH  450 (982)
Q Consensus       371 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  450 (982)
                      ++|++|++++|++++..|..|..+++|+                             +|+|++|++              
T Consensus       299 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-----------------------------~L~Ls~N~l--------------  335 (455)
T 3v47_A          299 TDLEQLTLAQNEINKIDDNAFWGLTHLL-----------------------------KLNLSQNFL--------------  335 (455)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCC-----------------------------EEECCSSCC--------------
T ss_pred             CCCCEEECCCCcccccChhHhcCcccCC-----------------------------EEECCCCcc--------------
Confidence            5666666666655555444444433333                             444444422              


Q ss_pred             cccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEcc
Q 036229          451 SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLS  530 (982)
Q Consensus       451 ~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  530 (982)
                                  ++..|..|..+++|+.|+|++|++++..|.+|.++++|++|+|++|+|++..+..|..+++|++|+++
T Consensus       336 ------------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  403 (455)
T 3v47_A          336 ------------GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH  403 (455)
T ss_dssp             ------------CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             ------------CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEcc
Confidence                        22233444555555556666666655555556666666666666666665544555556666666666


Q ss_pred             CCcCCcCCC
Q 036229          531 GNKLSGSIP  539 (982)
Q Consensus       531 ~N~l~~~~p  539 (982)
                      +|++++..|
T Consensus       404 ~N~l~~~~~  412 (455)
T 3v47_A          404 TNPWDCSCP  412 (455)
T ss_dssp             SSCBCCCTT
T ss_pred             CCCcccCCC
Confidence            666654443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.4e-39  Score=376.96  Aligned_cols=357  Identities=15%  Similarity=0.125  Sum_probs=170.7

Q ss_pred             hhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCc
Q 036229          124 AIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKY  203 (982)
Q Consensus       124 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  203 (982)
                      .++++++|++|+|++|++++. | .++.+++|++|+|++|.+++ +|   ++.+++|++|+|++|++++. |  ++++++
T Consensus        37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~---~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~  107 (457)
T 3bz5_A           37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD---LSQNTNLTYLACDSNKLTNL-D--VTPLTK  107 (457)
T ss_dssp             EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSCCSCC-C--CTTCTT
T ss_pred             ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec---cccCCCCCEEECcCCCCcee-e--cCCCCc
Confidence            344444444444444444432 2 34444444444444444442 22   23444444444444444432 1  444455


Q ss_pred             ccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccC
Q 036229          204 LEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGK  283 (982)
Q Consensus       204 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  283 (982)
                      |++|++++|++++ +|  ++.+++|++|++++|++++.   .++.+++|+.|++++|+..+.+  .+..+++|++|++++
T Consensus       108 L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~  179 (457)
T 3bz5_A          108 LTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSF  179 (457)
T ss_dssp             CCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCC
Confidence            5555555555543 22  44444555555555554432   1344444444444444333333  244455555555555


Q ss_pred             CccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccc
Q 036229          284 NFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTI  363 (982)
Q Consensus       284 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  363 (982)
                      |++++. |  +..+++|+.|++++|++++.   .+..                         +++|++|++++|++++ +
T Consensus       180 n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~-------------------------l~~L~~L~Ls~N~l~~-i  227 (457)
T 3bz5_A          180 NKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQ-------------------------NIQLTFLDCSSNKLTE-I  227 (457)
T ss_dssp             SCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTT-------------------------CTTCSEEECCSSCCSC-C
T ss_pred             Ccccee-c--cccCCCCCEEECcCCcCCee---cccc-------------------------CCCCCEEECcCCcccc-c
Confidence            555542 2  44555555555555555432   1222                         3444555555555554 3


Q ss_pred             cccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCcc
Q 036229          364 PRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM  443 (982)
Q Consensus       364 p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  443 (982)
                      |  +..+++|++|++++|++++..   +..+++|+                             .|++++|+        
T Consensus       228 p--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~-----------------------------~L~l~~n~--------  265 (457)
T 3bz5_A          228 D--VTPLTQLTYFDCSVNPLTELD---VSTLSKLT-----------------------------TLHCIQTD--------  265 (457)
T ss_dssp             C--CTTCTTCSEEECCSSCCSCCC---CTTCTTCC-----------------------------EEECTTCC--------
T ss_pred             C--ccccCCCCEEEeeCCcCCCcC---HHHCCCCC-----------------------------EEeccCCC--------
Confidence            3  445556666666666665542   22233333                             33333331        


Q ss_pred             ccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCcc
Q 036229          444 SMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTK  523 (982)
Q Consensus       444 ~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  523 (982)
                              ++.+++++|.+.+.+|  ++.+++|+.|++++|...+.+|.   ..++|+.|++++|             ++
T Consensus       266 --------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~  319 (457)
T 3bz5_A          266 --------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PK  319 (457)
T ss_dssp             --------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TT
T ss_pred             --------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------cc
Confidence                    2333444444444443  34556666666666665555443   2234444443333             45


Q ss_pred             ccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccc
Q 036229          524 LYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN  603 (982)
Q Consensus       524 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N  603 (982)
                      |++|++++|+|++. +  +.++++|+.|++++|+++.+|       .|..|++++|.++|.     +.+..|..+|+++|
T Consensus       320 L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~l~-------~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N  384 (457)
T 3bz5_A          320 LVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQDFS-------SVGKIPALNNNFEAE-----GQTITMPKETLTNN  384 (457)
T ss_dssp             CCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCBCT-------TGGGSSGGGTSEEEE-----EEEEECCCBCCBTT
T ss_pred             CCEEECCCCccccc-c--cccCCcCcEEECCCCCCCCcc-------ccccccccCCcEEec-----ceeeecCccccccC
Confidence            66666666666653 2  556666666666666665532       334445555555543     23444555566666


Q ss_pred             ccccccccc
Q 036229          604 NFSDVIPTV  612 (982)
Q Consensus       604 ~l~~~~p~~  612 (982)
                      +++|.+|..
T Consensus       385 ~l~g~ip~~  393 (457)
T 3bz5_A          385 SLTIAVSPD  393 (457)
T ss_dssp             BEEEECCTT
T ss_pred             cEEEEcChh
Confidence            666655554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-40  Score=356.06  Aligned_cols=195  Identities=26%  Similarity=0.377  Sum_probs=166.3

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||+||+|+. .+++.||||++++.   .....+.+.+|++++++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999985 46999999999754   2344567899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||+||+|.+++.+.+ .+++.++..++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999997654 5899999999999999999999   99999999999999999999999999999998755444


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      .......+||+.|||||++.++.|+... |+|+.|+.++.+.+|
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~-DiWSlGvilyeml~G  230 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAG  230 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHH-HHHHHHHHHHHHHHS
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHH-HHHHHHHHHHHHHhC
Confidence            4445667899999999999888777553 233444444444443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.8e-39  Score=374.95  Aligned_cols=328  Identities=23%  Similarity=0.202  Sum_probs=273.1

Q ss_pred             CCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccc
Q 036229          347 PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL  426 (982)
Q Consensus       347 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L  426 (982)
                      ++++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|+.|++++|.++.++..     .|.++++|
T Consensus        32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L  106 (477)
T 2id5_A           32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG-----VFTGLSNL  106 (477)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT-----SSTTCTTC
T ss_pred             CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc-----cccCCCCC
Confidence            3557777777777777777788888888888888888877777788877777777777777765543     25666666


Q ss_pred             cEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEee
Q 036229          427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE  506 (982)
Q Consensus       427 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  506 (982)
                      ++|+|++|+                          +.+..|..|..+++|+.|++++|++++..|..|.++++|++|+|+
T Consensus       107 ~~L~Ls~n~--------------------------i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  160 (477)
T 2id5_A          107 TKLDISENK--------------------------IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLE  160 (477)
T ss_dssp             CEEECTTSC--------------------------CCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEE
T ss_pred             CEEECCCCc--------------------------cccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECC
Confidence            666666664                          444566778888899999999999998888899999999999999


Q ss_pred             ccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccc-ccccccccccCceEEecCCCcccCCC
Q 036229          507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGMLYLNFSSNFFTGPL  585 (982)
Q Consensus       507 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~Ls~N~l~~~~  585 (982)
                      +|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|++++|.+. .+|...+...+|++|++++|++++..
T Consensus       161 ~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  240 (477)
T 2id5_A          161 KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP  240 (477)
T ss_dssp             SCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCC
T ss_pred             CCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccC
Confidence            99999777778889999999999999999888888999999999999997655 78887777779999999999999766


Q ss_pred             ccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccccccc
Q 036229          586 PLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLS  665 (982)
Q Consensus       586 ~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  665 (982)
                      +..+..+++|+.|||++|.+++..+..|..+++|++|+|++|++++..|.+|.++++|+.|+|++|+|++..+..|..++
T Consensus       241 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  320 (477)
T 2id5_A          241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVG  320 (477)
T ss_dssp             HHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGG
T ss_pred             HHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCc
Confidence            67889999999999999999998888999999999999999999999999999999999999999999987777889999


Q ss_pred             ccceeecCCCcccccCCCCCCCCCCCCcccccCcccCCCC
Q 036229          666 YLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       666 ~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~lc~~~  705 (982)
                      +|++|+|++|++.|.++..+.+.......+.++...|+.|
T Consensus       321 ~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          321 NLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             GCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             ccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            9999999999999887654323333345677888888766

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=8.7e-38  Score=364.83  Aligned_cols=346  Identities=28%  Similarity=0.442  Sum_probs=226.5

Q ss_pred             CcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceee
Q 036229          249 LAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLG  328 (982)
Q Consensus       249 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  328 (982)
                      +++++.|+++++.+.. +| .+..+++|++|+|++|.+++..|  +.++++|++|++++|++++..+  +.++++|    
T Consensus        45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L----  114 (466)
T 1o6v_A           45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNL----  114 (466)
T ss_dssp             HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTC----
T ss_pred             hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCC----
Confidence            4556666666666653 33 25566666666666666664433  6666666666666666654333  5555555    


Q ss_pred             cCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccc
Q 036229          329 LQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLT  408 (982)
Q Consensus       329 L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  408 (982)
                                           ++|++++|++++..+  +..+++|++|++++|++++..  .+..+++|+.|+++ |.+.
T Consensus       115 ---------------------~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~  168 (466)
T 1o6v_A          115 ---------------------TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVT  168 (466)
T ss_dssp             ---------------------CEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCC
T ss_pred             ---------------------CEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-Cccc
Confidence                                 555555555443322  555556666666666555431  35555555555554 2222


Q ss_pred             cCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCC
Q 036229          409 SSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG  488 (982)
Q Consensus       409 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~  488 (982)
                      ..       ..+.++++|++|++++|++.++                            ..+..+++|+.|++++|++++
T Consensus       169 ~~-------~~~~~l~~L~~L~l~~n~l~~~----------------------------~~l~~l~~L~~L~l~~n~l~~  213 (466)
T 1o6v_A          169 DL-------KPLANLTTLERLDISSNKVSDI----------------------------SVLAKLTNLESLIATNNQISD  213 (466)
T ss_dssp             CC-------GGGTTCTTCCEEECCSSCCCCC----------------------------GGGGGCTTCSEEECCSSCCCC
T ss_pred             Cc-------hhhccCCCCCEEECcCCcCCCC----------------------------hhhccCCCCCEEEecCCcccc
Confidence            21       1255566666666666655432                            124556666667777776665


Q ss_pred             CCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccc
Q 036229          489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNL  568 (982)
Q Consensus       489 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l  568 (982)
                      ..|  ++.+++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|++|++++|+++.+|. +..+
T Consensus       214 ~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l  286 (466)
T 1o6v_A          214 ITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGL  286 (466)
T ss_dssp             CGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTC
T ss_pred             ccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCC
Confidence            544  55667777777777777643  356667777777777777765544  6677777777777777776665 5667


Q ss_pred             cCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeC
Q 036229          569 KGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNL  648 (982)
Q Consensus       569 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  648 (982)
                      ++|++|++++|++++..+  ++.+++|+.|++++|++++..|  ++.+++|++|++++|++++.  ..+.++++|+.|++
T Consensus       287 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l  360 (466)
T 1o6v_A          287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSA  360 (466)
T ss_dssp             TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEEC
T ss_pred             CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeC
Confidence            777777777777776544  6778888888888888887765  67888899999999988865  46888899999999


Q ss_pred             CCCcCCCCCCcccccccccceeecCCCccccc
Q 036229          649 SNNNLSRSIPISLEKLSYLEDLDLSFNKLKGE  680 (982)
Q Consensus       649 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~  680 (982)
                      ++|++++..|  +..+++|+.|++++|++++.
T Consensus       361 ~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          361 GHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             CSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             CCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            9999987766  78888999999999999863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.4e-38  Score=366.48  Aligned_cols=362  Identities=20%  Similarity=0.197  Sum_probs=213.4

Q ss_pred             CCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccc
Q 036229          239 QGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATI  318 (982)
Q Consensus       239 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  318 (982)
                      .+..+..++++++|+.|++++|.+++. | .+..+++|++|+|++|++++. |  +..+++|++|++++|++++. |  +
T Consensus        31 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~  102 (457)
T 3bz5_A           31 QATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--V  102 (457)
T ss_dssp             CTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--C
T ss_pred             CcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--c
Confidence            333344444455555555555555432 2 345555555555555555543 2  44555555555555555432 2  4


Q ss_pred             cCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccc
Q 036229          319 FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLR  398 (982)
Q Consensus       319 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  398 (982)
                      .++++|+.|++++|.+++.    ....+++|++|++++|++++. +  +..+++|++|++++|+..+.+  .+..+++|+
T Consensus       103 ~~l~~L~~L~L~~N~l~~l----~~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~  173 (457)
T 3bz5_A          103 TPLTKLTYLNCDTNKLTKL----DVSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLT  173 (457)
T ss_dssp             TTCTTCCEEECCSSCCSCC----CCTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred             CCCCcCCEEECCCCcCCee----cCCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCC
Confidence            4455555555555544432    133445555555555555542 1  445555555555555333222  244555555


Q ss_pred             eecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccce
Q 036229          399 LMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG  478 (982)
Q Consensus       399 ~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~  478 (982)
                      .|++++|.++.++        +..+++|+.|++++|+++++.    +.. .++|++|++++|++++ +|  ++.+++|+.
T Consensus       174 ~L~ls~n~l~~l~--------l~~l~~L~~L~l~~N~l~~~~----l~~-l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~  237 (457)
T 3bz5_A          174 TLDCSFNKITELD--------VSQNKLLNRLNCDTNNITKLD----LNQ-NIQLTFLDCSSNKLTE-ID--VTPLTQLTY  237 (457)
T ss_dssp             EEECCSSCCCCCC--------CTTCTTCCEEECCSSCCSCCC----CTT-CTTCSEEECCSSCCSC-CC--CTTCTTCSE
T ss_pred             EEECCCCccceec--------cccCCCCCEEECcCCcCCeec----ccc-CCCCCEEECcCCcccc-cC--ccccCCCCE
Confidence            5555555554432        344555555555555554431    111 1334444444445544 23  555566666


Q ss_pred             EEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcc
Q 036229          479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKL  558 (982)
Q Consensus       479 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  558 (982)
                      |++++|++++..   ++.+++|+.|++++|              +|+.|++++|++.+.+|  +.++++|+.|++++|..
T Consensus       238 L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~  298 (457)
T 3bz5_A          238 FDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQ  298 (457)
T ss_dssp             EECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTT
T ss_pred             EEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcc
Confidence            666666666543   234455556655554              34556777777766665  46778888888888865


Q ss_pred             c-ccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccc
Q 036229          559 T-SIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESF  637 (982)
Q Consensus       559 ~-~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  637 (982)
                      . .+|.   ...+|+.|++++|             ++|+.|++++|++++. +  ++.+++|+.|++++|+|++      
T Consensus       299 l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~------  353 (457)
T 3bz5_A          299 LYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD------  353 (457)
T ss_dssp             CCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB------
T ss_pred             cceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC------
Confidence            4 5663   3345555555554             6788999999999985 3  8899999999999999986      


Q ss_pred             cCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC
Q 036229          638 GDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       638 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                        ++.|..|++++|+++|.     ..+..|+.+++++|+|+|.||..
T Consensus       354 --l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          354 --FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             --CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             --ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence              35677889999999875     35677889999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.8e-40  Score=357.45  Aligned_cols=192  Identities=24%  Similarity=0.282  Sum_probs=164.6

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      +.|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++++++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999864 69999999998766666778999999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      +||+|.+++.+.  .+++.++..|+.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CC
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--Cc
Confidence            999999999764  4899999999999999999999   9999999999999999999999999999999864332  23


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ....+||+.|||||++.+..|+.. .|+|++|+.++.+.+|
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G  266 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDG  266 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHS
T ss_pred             ccccccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHC
Confidence            346789999999999988777654 2233444444444443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.7e-37  Score=362.48  Aligned_cols=351  Identities=29%  Similarity=0.442  Sum_probs=250.8

Q ss_pred             ccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcE
Q 036229          223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKL  302 (982)
Q Consensus       223 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  302 (982)
                      ..+++++.|++++|.++. +| .+..+++|+.|++++|.+++..|  +.++++|++|++++|++++..+  +.++++|++
T Consensus        43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            457889999999999985 45 48889999999999999997654  9999999999999999997655  999999999


Q ss_pred             EEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEecccc
Q 036229          303 LDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS  382 (982)
Q Consensus       303 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  382 (982)
                      |++++|++++..+  +..+++|+.|++++|.+.+.                          + .+..+++|++|+++ |.
T Consensus       117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--------------------------~-~~~~l~~L~~L~l~-~~  166 (466)
T 1o6v_A          117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--------------------------S-ALSGLTSLQQLSFG-NQ  166 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC--------------------------G-GGTTCTTCSEEEEE-ES
T ss_pred             EECCCCCCCCChH--HcCCCCCCEEECCCCccCCC--------------------------h-hhccCCcccEeecC-Cc
Confidence            9999999986543  67777776666666655432                          1 24444555555553 33


Q ss_pred             CccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCcc
Q 036229          383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNV  462 (982)
Q Consensus       383 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l  462 (982)
                      +.+..+  +..+++|+.|++++|.++.++       .+..+++|++|++++|++.++.+                     
T Consensus       167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L~~L~l~~n~l~~~~~---------------------  216 (466)
T 1o6v_A          167 VTDLKP--LANLTTLERLDISSNKVSDIS-------VLAKLTNLESLIATNNQISDITP---------------------  216 (466)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCCCG-------GGGGCTTCSEEECCSSCCCCCGG---------------------
T ss_pred             ccCchh--hccCCCCCEEECcCCcCCCCh-------hhccCCCCCEEEecCCccccccc---------------------
Confidence            333221  555555555555555554432       24556667777777776554321                     


Q ss_pred             ccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccc
Q 036229          463 SGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACF  542 (982)
Q Consensus       463 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  542 (982)
                             ++.+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++..+  +
T Consensus       217 -------~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~  283 (466)
T 1o6v_A          217 -------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--L  283 (466)
T ss_dssp             -------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--G
T ss_pred             -------ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--c
Confidence                   34455666666666666643  346666777777777777765443  6667777777777777765443  6


Q ss_pred             cCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceE
Q 036229          543 SNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYL  622 (982)
Q Consensus       543 ~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L  622 (982)
                      ..+++|++|+|++|+++.++. +..+++|++|++++|++++..|  +..+++|+.|++++|++++.  ..++.+++|++|
T Consensus       284 ~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  358 (466)
T 1o6v_A          284 AGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL  358 (466)
T ss_dssp             TTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred             cCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence            677777777777777776665 5667777777777777777655  67788888888888888775  468888999999


Q ss_pred             ecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcc
Q 036229          623 FLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS  660 (982)
Q Consensus       623 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  660 (982)
                      ++++|++++.+|  +..+++|+.|++++|++++ +|..
T Consensus       359 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~~  393 (466)
T 1o6v_A          359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVN  393 (466)
T ss_dssp             ECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCBC
T ss_pred             eCCCCccCccch--hhcCCCCCEEeccCCcccC-Cchh
Confidence            999999988776  8888999999999999886 4543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.4e-40  Score=353.98  Aligned_cols=189  Identities=26%  Similarity=0.420  Sum_probs=162.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++++|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888999999999999999853      478899999987666677889999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcC------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEE
Q 036229          854 ILEYMPHGSLEKSLYSS------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL  921 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL  921 (982)
                      |||||++|+|.++++..            ...+++.++..|+.||+.||+|||   +++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            99999999999999753            246899999999999999999999   999999999999999999999999


Q ss_pred             EeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          922 SDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       922 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +|||+|+.....+.........||+.|||||++.++.++..   +|+||+|++
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k---~DVwS~Gvv  219 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE---SDVWSLGVV  219 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch---hhHHHHHHH
Confidence            99999987644443334445679999999999988777644   566676643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=354.09  Aligned_cols=189  Identities=25%  Similarity=0.415  Sum_probs=154.6

Q ss_pred             cCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ++|...++||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++++|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46778899999999999999863      478999999987666677889999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCC--------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          854 ILEYMPHGSLEKSLYSSN--------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                      |||||++|+|.++++...              ..+++.++..|+.||+.||+|||   +++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997532              35899999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||+|||+|+.....+.........||+.|||||++.+..++..   +|+||||++
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~---sDvwS~Gvv  249 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE---SDVWSFGVV  249 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHH---HHHHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc---ccccchHHH
Confidence            9999999997654444444456789999999999988777644   566677643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-39  Score=357.27  Aligned_cols=193  Identities=19%  Similarity=0.323  Sum_probs=157.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++..  .....+++.+|++++++++|||||++++++++++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999986 46999999999754  3345678999999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+||+|.+++...+ ..+++.+++.|+.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+..  
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--  177 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--  177 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--
Confidence            9999999999997543 45789999999999999999999   99999999999999999999999999999997622  


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ........+||+.|||||++.++.|+..   +|+||+|  ++.+.+|
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~---~DiwSlGvilyemltG  221 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNK---SDIWALGCVLYELCTL  221 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHH---HHHHHHHHHHHHHHHS
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcH---HHHHHHHHHHHHHHHC
Confidence            1122345689999999999988877654   4445555  4444443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=348.89  Aligned_cols=190  Identities=25%  Similarity=0.420  Sum_probs=154.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++++..++||+|+||+||+|++++  .||||+++..  .....++|.+|++++++++|||||++++++.. +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            45678899999999999999998743  5999998743  33456789999999999999999999998865 5689999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||++|+|.+++...+..+++.++..|+.||+.||+|||   +++||||||||+|||+++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999877777999999999999999999999   99999999999999999999999999999987644333


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......+||+.|||||++.+......+..+|+||+|+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv  225 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI  225 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence            33445678999999999996543333334566777774

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.8e-39  Score=359.46  Aligned_cols=193  Identities=25%  Similarity=0.289  Sum_probs=165.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .+.|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999864 5999999999877666678899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      |+||+|.+++...  .+++.++..|+.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+....  .
T Consensus       230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~  302 (423)
T 4fie_A          230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  302 (423)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred             CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence            9999999999754  4899999999999999999999   9999999999999999999999999999999874332  2


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      .....+||+.|||||++.+..|+... |+|++|+.++.+.+|
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~-DiWSlGvilyeml~G  343 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEV-DIWSLGIMVIEMVDG  343 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHH-HHHHHHHHHHHHHHS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHH-HHHHHHHHHHHHHHC
Confidence            33467899999999999888776542 233444444444444

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.6e-39  Score=340.12  Aligned_cols=193  Identities=20%  Similarity=0.331  Sum_probs=147.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||+||+|+. .+++.||||+++..   .....+++.+|++++++++||||+++++++++++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            36899999999999999999985 46999999999754   233456789999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+ +|+|.+++.+.+ .+++.++..++.||+.||+|||   ++||+||||||+|||+++++.+||+|||+|+..... 
T Consensus        92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  165 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-  165 (275)
T ss_dssp             EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence            9999 679999997654 5899999999999999999999   999999999999999999999999999999875322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                        ......+||+.|||||++.+..+.....|+|++|+.++.+.+|
T Consensus       166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg  208 (275)
T 3hyh_A          166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR  208 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence              2234578999999999998876543223333444444444444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-38  Score=345.93  Aligned_cols=190  Identities=23%  Similarity=0.368  Sum_probs=160.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ++++..++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34667789999999999999852      47899999997543 344578999999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC
Q 036229          853 LILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~  917 (982)
                      +|||||++|+|.+++....               ..+++.++.+|+.||++||+|||   +++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996432               35889999999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .+||+|||+|+.....+.........||+.|||||++.++.++..   +|+||||+++
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k---sDVwSfGvvl  237 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID---SDIWSYGVVL  237 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH---HHHHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc---chhhhHHHHH
Confidence            999999999997654444444456789999999999987776644   5667777443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.7e-39  Score=345.70  Aligned_cols=191  Identities=26%  Similarity=0.351  Sum_probs=154.2

Q ss_pred             cCCCccceeeeeceEEEEEEEe----CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ++|++.+.||+|+||+||+|+.    .+++.||||+++...  .....++.+|++++++++|||||++++++++++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999985    247899999997542  2334578899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |||||+||+|.+++.+.+ .+++.++..++.|++.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999997654 5899999999999999999999   999999999999999999999999999999865332


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .  ......+||+.|||||++.++.++..   +|+||+|  ++.+.+|
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~---~DiwSlGvilyemltG  222 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTG  222 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTH---HHHHHHHHHHHHHHHS
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCC---CcccchHHHHHHHHhC
Confidence            2  23345789999999999988877754   4445555  4444433

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.5e-37  Score=358.07  Aligned_cols=319  Identities=21%  Similarity=0.185  Sum_probs=169.9

Q ss_pred             ccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCC
Q 036229          157 HLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYS  236 (982)
Q Consensus       157 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  236 (982)
                      .++.+++.++ .+|..+   .++++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus        15 ~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             EEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            4455555555 555544   245666666666666655666666666666666666666555666666666666666666


Q ss_pred             CCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcc
Q 036229          237 GLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPA  316 (982)
Q Consensus       237 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  316 (982)
                      ++++..+..|.++++|+.|++++|++.+..|..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+.
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  170 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE  170 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence            66544444455555555555555555555555555566666666666666555555555556666666666655544444


Q ss_pred             cccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCc
Q 036229          317 TIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRN  396 (982)
Q Consensus       317 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  396 (982)
                      .+.++++|                         +.|++++|++.+..+..+..+++|++|++++|.+.+.+|....... 
T Consensus       171 ~l~~l~~L-------------------------~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~-  224 (477)
T 2id5_A          171 ALSHLHGL-------------------------IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL-  224 (477)
T ss_dssp             HHTTCTTC-------------------------CEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTC-
T ss_pred             HhcccCCC-------------------------cEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCc-
Confidence            44443333                         4444444444443444444445555555555444333222211111 


Q ss_pred             cceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCccccccccc
Q 036229          397 LRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNL  476 (982)
Q Consensus       397 L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L  476 (982)
                                                  +|++|+|++|+                          +++..+..+..+++|
T Consensus       225 ----------------------------~L~~L~l~~n~--------------------------l~~~~~~~~~~l~~L  250 (477)
T 2id5_A          225 ----------------------------NLTSLSITHCN--------------------------LTAVPYLAVRHLVYL  250 (477)
T ss_dssp             ----------------------------CCSEEEEESSC--------------------------CCSCCHHHHTTCTTC
T ss_pred             ----------------------------cccEEECcCCc--------------------------ccccCHHHhcCcccc
Confidence                                        22233333332                          222222334445555


Q ss_pred             ceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCC
Q 036229          477 IGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN  556 (982)
Q Consensus       477 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  556 (982)
                      +.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus       251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  330 (477)
T 2id5_A          251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN  330 (477)
T ss_dssp             CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred             CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence            55555555555555555555555666666666665555555555666666666666665555555555556666666666


Q ss_pred             ccc
Q 036229          557 KLT  559 (982)
Q Consensus       557 ~l~  559 (982)
                      .++
T Consensus       331 ~l~  333 (477)
T 2id5_A          331 PLA  333 (477)
T ss_dssp             CEE
T ss_pred             Ccc
Confidence            555

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.1e-38  Score=343.63  Aligned_cols=189  Identities=24%  Similarity=0.296  Sum_probs=155.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .+.|+..++||+|+||+||+|+.. +|+.||||+++.+..     ..+|++++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356888899999999999999964 599999999975422     24699999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~  936 (982)
                      |+||+|.+++++.+ .+++.++..|+.||+.||+|||   ++|||||||||+|||++.+| ++||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999997654 5899999999999999999999   99999999999999999887 6999999999987433221


Q ss_pred             ---eeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          937 ---ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       937 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                         ......+||+.|||||++.++.++..   +|+|++|  ++.+.+|
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~---~DiwSlGvilyemltG  252 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAK---VDIWSSCCMMLHMLNG  252 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTH---HHHHHHHHHHHHHHHS
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcH---HHHHHHHHHHHHHHHC
Confidence               12234679999999999988877654   4445555  4444443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-37  Score=337.66  Aligned_cols=189  Identities=22%  Similarity=0.378  Sum_probs=147.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCC--------
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE--------  849 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--------  849 (982)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++... ....+++.+|++++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999864 69999999997543 334578899999999999999999999986543        


Q ss_pred             ----eeEEEEEeccCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          850 ----FKALILEYMPHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       850 ----~~~lv~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                          +.|+|||||++|+|.+++.....  ..++..+..|+.||+.||+|||   ++|||||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                47999999999999999976543  3456678899999999999999   99999999999999999999999999


Q ss_pred             ecCceeecCCCCc----------eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          924 FGIAKLLIGEDQS----------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       924 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||+|+.+......          ...+..+||+.|||||++.++.++..   +|+||+|++
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~---~DiwSlGvi  219 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK---VDIFSLGLI  219 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTH---HHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH---HHHHHHHHH
Confidence            9999976433221          12234679999999999988777654   455666643

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.1e-36  Score=333.27  Aligned_cols=258  Identities=33%  Similarity=0.559  Sum_probs=244.1

Q ss_pred             ccccEEeccCCcccc--CCCcccccccccceEEecC-CCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccE
Q 036229          450 HSLEYFDMSYCNVSG--GFPKEIGNLTNLIGIYLGG-NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE  526 (982)
Q Consensus       450 ~~L~~Ldls~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  526 (982)
                      .+++.|++++|++++  .+|..+.++++|++|++++ |++.+.+|..|+++++|++|+|++|++++.+|..|..+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            357788888888888  8899999999999999995 9999999999999999999999999999999999999999999


Q ss_pred             EEccCCcCCcCCCccccCCCcccccccCCCccc-cccccccccc-CceEEecCCCcccCCCccccccccccceeeccccc
Q 036229          527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLK-GMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN  604 (982)
Q Consensus       527 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~  604 (982)
                      |+|++|+|++.+|..|.++++|++|+|++|+++ .+|..++.++ +|++|++++|++++.+|..+..++ |+.|++++|+
T Consensus       130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~  208 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred             EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence            999999999999999999999999999999999 8999999988 999999999999999999999998 9999999999


Q ss_pred             ccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCC
Q 036229          605 FSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       605 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  684 (982)
                      +++.+|..|+.+++|++|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|+++|.+|..
T Consensus       209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            9999999999999999999999999977776 889999999999999999999999999999999999999999999998


Q ss_pred             CCCCCCCCcccccCcccCCCCCCCCCCC
Q 036229          685 GSFGNFSAKSFEGNELLCGSPNLQVPPC  712 (982)
Q Consensus       685 ~~~~~~~~~~~~gn~~lc~~~~~~~~~c  712 (982)
                      ..+..+....+.||+++||.|.   ++|
T Consensus       288 ~~l~~L~~l~l~~N~~lc~~p~---~~C  312 (313)
T 1ogq_A          288 GNLQRFDVSAYANNKCLCGSPL---PAC  312 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEESTTS---SCC
T ss_pred             ccccccChHHhcCCCCccCCCC---CCC
Confidence            8888888899999999999884   456

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-37  Score=332.28  Aligned_cols=185  Identities=25%  Similarity=0.374  Sum_probs=152.3

Q ss_pred             CccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC----CCeeEEEE
Q 036229          783 SENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST----EEFKALIL  855 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~  855 (982)
                      +..++||+|+||+||+|++. +++.||+|++...  .....+++.+|++++++++|||||+++++|++    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56778999999999999864 5899999999754  23445789999999999999999999999864    35689999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEc-CCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~  932 (982)
                      |||+||+|.+++.+.+ .+++..+..|+.||+.||+|||   +++  ||||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997643 5899999999999999999999   888  99999999999998 479999999999985422


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                          ......+||+.|||||++.++ ++.   .+|+||+|  ++.+.+|
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~~-y~~---~~DiwSlGvilyelltg  225 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEEK-YDE---SVDVYAFGMCMLEMATS  225 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGTC-CCT---HHHHHHHHHHHHHHHHS
T ss_pred             ----CccCCcccCccccCHHHcCCC-CCc---HHHHHHHHHHHHHHHHC
Confidence                123457899999999999764 443   34556666  4444443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=2.2e-36  Score=335.09  Aligned_cols=272  Identities=22%  Similarity=0.298  Sum_probs=185.2

Q ss_pred             CCCChhHHHHHHHHHHHhcCCCCccccCCC----CCCCCCCceeeEEecC--------CCCcEEEEEeCCCCccccCCcc
Q 036229           33 TSSITTDQDALLALKAHITHDPTNFLAKNW----NTSTPVCNWTGVTCDV--------HSHRVKVLNISHLNLTGTIPSQ  100 (982)
Q Consensus        33 ~~~~~~~~~~ll~~k~~~~~~~~~~~~~~w----~~~~~~c~w~gv~c~~--------~~~~v~~L~l~~~~l~g~~~~~  100 (982)
                      ..+..+|++||++||+++..| +.++..+|    +...++|.|.|+.|+.        ..++|+.|+|++++++ .+|+.
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~-~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~   99 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNAD-RNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ   99 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHC-CTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred             cccCchHHHHHHHHHHhccCC-chhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence            457789999999999999776 45577889    5667899999999952        3467889999999888 78888


Q ss_pred             ccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhh------
Q 036229          101 LWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANIC------  174 (982)
Q Consensus       101 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~------  174 (982)
                      ++++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+|++|.+.+.+|..+.      
T Consensus       100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~  177 (328)
T 4fcg_A          100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG  177 (328)
T ss_dssp             GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred             hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence            888999999999999888 88888888999999999999888 7788888888888888888888878887652      


Q ss_pred             --cCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCccc
Q 036229          175 --SNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAEL  252 (982)
Q Consensus       175 --~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  252 (982)
                        .++++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..++.+++|++|+|++|.+.+.+|..|+.+++|
T Consensus       178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L  255 (328)
T 4fcg_A          178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL  255 (328)
T ss_dssp             CEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCC
T ss_pred             hhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCC
Confidence              23555555555555555 455555555555555555555552 34445555555555555555555555555555555


Q ss_pred             ceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccc
Q 036229          253 ELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL  310 (982)
Q Consensus       253 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  310 (982)
                      +.|++++|++.+.+|..+.++++|++|+|++|++.+.+|..+.++++|+.++++.|.+
T Consensus       256 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             CEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             CEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            5555555555555555555555555555555555545555555555555555444433

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.7e-37  Score=340.64  Aligned_cols=199  Identities=23%  Similarity=0.370  Sum_probs=167.6

Q ss_pred             CCHHHHHHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCC-ccceeE
Q 036229          770 FSYLELCRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRH-RNLIKV  841 (982)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~nIv~l  841 (982)
                      ++..+++...++|++.+.||+|+||+||+|++.      .++.||||+++... ....+++.+|++++++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            455677777889999999999999999999853      24789999997543 3345679999999999965 899999


Q ss_pred             EeeecCC-CeeEEEEEeccCCChHHHHhcC---------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcC
Q 036229          842 ISSCSTE-EFKALILEYMPHGSLEKSLYSS---------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD  905 (982)
Q Consensus       842 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrD  905 (982)
                      +++|..+ +..++|||||++|+|.++++..               +..+++.++..++.||++||+|||   +++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence            9998664 5789999999999999999753               234789999999999999999999   99999999


Q ss_pred             CCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       906 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |||+|||+++++.+||+|||+|+.+.............||+.|||||++.++.++..   +|+||||++
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k---sDVwS~Gv~  276 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ---SDVWSFGVL  276 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc---ccEeehHHH
Confidence            999999999999999999999997755555555566789999999999988777644   566777743

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.6e-35  Score=337.53  Aligned_cols=346  Identities=21%  Similarity=0.227  Sum_probs=239.6

Q ss_pred             cCCCCCCCCCCc----eeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcch-hhhccCCcE
Q 036229           59 AKNWNTSTPVCN----WTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSA-IFTLYTLKY  133 (982)
Q Consensus        59 ~~~w~~~~~~c~----w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~-~~~l~~L~~  133 (982)
                      +++|....+||.    |.++.|+.   +     +............-..+.+++.|++++|.++ .+|.. +..+++|++
T Consensus         3 ~~~~~~~~~C~~~~~~~~c~~~~~---~-----i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~   73 (390)
T 3o6n_A            3 VKPRQPEYKCIDSNLQYDCVFYDV---H-----IDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL   73 (390)
T ss_dssp             ----CCEECBCC------EEEESC---E-----ECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSE
T ss_pred             cCCCCCccceehhhhhhccceeee---e-----eecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcE
Confidence            578988888886    55554441   1     1111111111112234677788888887776 45544 567788888


Q ss_pred             EEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccc
Q 036229          134 VNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINN  213 (982)
Q Consensus       134 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  213 (982)
                      |+|++|++++..|..|..+++|++|+|++|.++ .+|+..|.++++|++|+|++|+++...+..|+++++|++|++++|+
T Consensus        74 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~  152 (390)
T 3o6n_A           74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN  152 (390)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCc
Confidence            888888887666667778888888888888877 4555555778888888888888876555556778888888888888


Q ss_pred             cccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCcc
Q 036229          214 LLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE  293 (982)
Q Consensus       214 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  293 (982)
                      +++..|..+..+++|++|++++|++++.   .+..+++|+.+++++|.+++     +...++|++|++++|.++.... .
T Consensus       153 l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~~~-~  223 (390)
T 3o6n_A          153 LERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRG-P  223 (390)
T ss_dssp             CCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEEEC-C
T ss_pred             cCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeeccc-c
Confidence            8776677777788888888888887754   24556777788888877764     2334578888888888875432 2


Q ss_pred             ccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCC
Q 036229          294 IHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKL  373 (982)
Q Consensus       294 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  373 (982)
                        ..++|+.|++++|++++.  ..+..+++|+.|++++|.+.+..+ ..+..+++|++|++++|++++ +|..+..+++|
T Consensus       224 --~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L  297 (390)
T 3o6n_A          224 --VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMY-HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL  297 (390)
T ss_dssp             --CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEES-GGGTTCSSCCEEECCSSCCCE-EECSSSCCTTC
T ss_pred             --ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcCh-hHccccccCCEEECCCCcCcc-cCcccCCCCCC
Confidence              236788888888888753  467777888888888888775433 334467788888888888875 45566778888


Q ss_pred             CEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCC
Q 036229          374 SVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDG  438 (982)
Q Consensus       374 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  438 (982)
                      ++|++++|++++ +|..+..+++|+.|++++|.++.++        +..+++|++|++++|+++.
T Consensus       298 ~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~--------~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          298 KVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK--------LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             CEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC--------CCTTCCCSEEECCSSCEEH
T ss_pred             CEEECCCCccee-cCccccccCcCCEEECCCCccceeC--------chhhccCCEEEcCCCCccc
Confidence            888888888885 4556778888888888888887653        5667888899999998764

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.9e-35  Score=335.50  Aligned_cols=194  Identities=20%  Similarity=0.194  Sum_probs=134.6

Q ss_pred             cCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEec
Q 036229          497 LQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNF  576 (982)
Q Consensus       497 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L  576 (982)
                      +++|+.|++++|.+++     +...++|+.|++++|+++.. |..  ..++|+.|++++|+++.++ .+..+++|++|++
T Consensus       185 l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~L  255 (390)
T 3o6n_A          185 IPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDTA-WLLNYPGLVEVDL  255 (390)
T ss_dssp             CTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCCG-GGGGCTTCSEEEC
T ss_pred             ccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCcccH-HHcCCCCccEEEC
Confidence            3444444444444442     12223455555555555533 221  1245666666666666543 4555666777777


Q ss_pred             CCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCC
Q 036229          577 SSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRS  656 (982)
Q Consensus       577 s~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  656 (982)
                      ++|.+++..|..+..+++|+.|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|++++.
T Consensus       256 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~  333 (390)
T 3o6n_A          256 SYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL  333 (390)
T ss_dssp             CSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred             CCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee
Confidence            7777776667777788888888888888876 4666788999999999999998 5677788999999999999999854


Q ss_pred             CCcccccccccceeecCCCcccccCCCCCCCCCCCCcccccCcccCCCC
Q 036229          657 IPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       657 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~lc~~~  705 (982)
                       |  +..+++|++|++++|++.+..... .+..+....+.+++..|..+
T Consensus       334 -~--~~~~~~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          334 -K--LSTHHTLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             -C--CCTTCCCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCSCCCTT
T ss_pred             -C--chhhccCCEEEcCCCCccchhHHH-HHHHHHhhcccccCceeccc
Confidence             3  678899999999999999865432 34555566678888888765

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.8e-35  Score=354.16  Aligned_cols=194  Identities=20%  Similarity=0.195  Sum_probs=138.6

Q ss_pred             cCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEec
Q 036229          497 LQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNF  576 (982)
Q Consensus       497 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L  576 (982)
                      +++|+.|++++|.+++     +...++|+.|++++|.++...+..   .++|+.|+|++|.++.+ ..+..+++|++|++
T Consensus       191 l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~L  261 (597)
T 3oja_B          191 IPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTDT-AWLLNYPGLVEVDL  261 (597)
T ss_dssp             CTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCCC-GGGGGCTTCSEEEC
T ss_pred             hhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCCC-hhhccCCCCCEEEC
Confidence            3444444444444442     122334555555555554322221   14556666666666653 34556667777777


Q ss_pred             CCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCC
Q 036229          577 SSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRS  656 (982)
Q Consensus       577 s~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  656 (982)
                      ++|.+++..|..++.+++|+.|+|++|.+++ +|..++.+++|++|+|++|+++ .+|..+..+++|+.|+|++|++++.
T Consensus       262 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~  339 (597)
T 3oja_B          262 SYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL  339 (597)
T ss_dssp             CSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC
T ss_pred             CCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc
Confidence            7777777777778888888888888888877 5677788999999999999998 6788889999999999999999864


Q ss_pred             CCcccccccccceeecCCCcccccCCCCCCCCCCCCcccccCcccCCCC
Q 036229          657 IPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       657 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~lc~~~  705 (982)
                       |  +..+++|+.|++++|++.|..+.. .+..+....+.+++..|+.+
T Consensus       340 -~--~~~~~~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          340 -K--LSTHHTLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             -C--CCTTCCCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCCCCCTT
T ss_pred             -C--hhhcCCCCEEEeeCCCCCChhHHH-HHHHHhhhccccccccCCcc
Confidence             3  677889999999999999876543 36666777788999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-36  Score=330.42  Aligned_cols=188  Identities=25%  Similarity=0.365  Sum_probs=147.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC----eeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----FKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~  855 (982)
                      ++|...++||+|+||+||+|++ +|+.||||+++..... ....+.|+..+.+++|||||++++++.+++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4678889999999999999998 6899999999754322 223345666677899999999999997653    579999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC--------CeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA--------PVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~--------~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      |||++|+|.++++..  .+++..+.+++.|++.||+|||   ++        +||||||||+|||++.++.+||+|||+|
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999764  4899999999999999999999   55        9999999999999999999999999999


Q ss_pred             eeecCCCCce--eecccccccccccCceeeeeee---eeEEeeEeeeeeeee
Q 036229          928 KLLIGEDQSI--TQTQTLATIGYMAPGLFHVKYI---LFVVNFLTSYSFLMI  974 (982)
Q Consensus       928 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~d~~~~~~~  974 (982)
                      +.........  .....+||+.|||||++.+...   ...+..+|+||||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv  207 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  207 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence            9875443322  2234679999999999965421   112234566777643

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=7.9e-35  Score=350.25  Aligned_cols=349  Identities=18%  Similarity=0.193  Sum_probs=214.4

Q ss_pred             cccCCCCCCCCCCc----eeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCc
Q 036229           57 FLAKNWNTSTPVCN----WTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLK  132 (982)
Q Consensus        57 ~~~~~w~~~~~~c~----w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~  132 (982)
                      ..+++|.++.+||.    |.++.|+..      ++.......  .+..-..+.+++.|++++|.+.+..+..+..+++|+
T Consensus         7 ~~l~~~~~~~~C~~~~~~~~c~~~~~~------i~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~   78 (597)
T 3oja_B            7 YNVKPRQPEYKCIDSNLQYDCVFYDVH------IDMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE   78 (597)
T ss_dssp             ----CCCSEECCCCC--CCSEEECSCE------ECSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCS
T ss_pred             ccccCCCCCCcCcccCcCceeEecCce------ecccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCc
Confidence            35688998888885    777766621      111111111  111122467888889988888744444467788899


Q ss_pred             EEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecc
Q 036229          133 YVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSIN  212 (982)
Q Consensus       133 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  212 (982)
                      +|+|++|.+++..|..|+.+++|++|+|++|.+++ +|+..|+++++|++|+|++|.+++..+..|+++++|++|+|++|
T Consensus        79 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N  157 (597)
T 3oja_B           79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN  157 (597)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCC-CCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence            99998888887777788888888888888888884 55555688888888888888888666666788888888888888


Q ss_pred             ccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCc
Q 036229          213 NLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPP  292 (982)
Q Consensus       213 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~  292 (982)
                      ++++..|..|+.+++|++|+|++|.+++..   ++.+++|+.|++++|.+++     +...++|++|++++|.++...+.
T Consensus       158 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~  229 (597)
T 3oja_B          158 NLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP  229 (597)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS
T ss_pred             cCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc
Confidence            888777777888888888888888777542   3445566666666666553     22334566666666666543322


Q ss_pred             cccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCC
Q 036229          293 EIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK  372 (982)
Q Consensus       293 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  372 (982)
                      .   .++|+.|+|++|.+++  +..+..+++|                         ++|+|++|.+++..|..+..+++
T Consensus       230 ~---~~~L~~L~L~~n~l~~--~~~l~~l~~L-------------------------~~L~Ls~N~l~~~~~~~~~~l~~  279 (597)
T 3oja_B          230 V---NVELTILKLQHNNLTD--TAWLLNYPGL-------------------------VEVDLSYNELEKIMYHPFVKMQR  279 (597)
T ss_dssp             C---CSCCCEEECCSSCCCC--CGGGGGCTTC-------------------------SEEECCSSCCCEEESGGGTTCSS
T ss_pred             c---CCCCCEEECCCCCCCC--ChhhccCCCC-------------------------CEEECCCCccCCCCHHHhcCccC
Confidence            2   1456666666666653  2344444444                         55555555555555555555555


Q ss_pred             CCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccc
Q 036229          373 LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSL  452 (982)
Q Consensus       373 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L  452 (982)
                      |++|+|++|+++++ |..+..+++|+.|++++|.++.++..      +..+++|++|+|++|++.++..    . ..+.|
T Consensus       280 L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~~i~~~------~~~l~~L~~L~L~~N~l~~~~~----~-~~~~L  347 (597)
T 3oja_B          280 LERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLLHVERN------QPQFDRLENLYLDHNSIVTLKL----S-THHTL  347 (597)
T ss_dssp             CCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCCCCGGG------HHHHTTCSEEECCSSCCCCCCC----C-TTCCC
T ss_pred             CCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCCccCcc------cccCCCCCEEECCCCCCCCcCh----h-hcCCC
Confidence            55555555555543 33344455555555555555543322      3344555566666665554421    1 12356


Q ss_pred             cEEeccCCcccc
Q 036229          453 EYFDMSYCNVSG  464 (982)
Q Consensus       453 ~~Ldls~n~l~~  464 (982)
                      ++|++++|.+.+
T Consensus       348 ~~L~l~~N~~~~  359 (597)
T 3oja_B          348 KNLTLSHNDWDC  359 (597)
T ss_dssp             SEEECCSSCEEH
T ss_pred             CEEEeeCCCCCC
Confidence            666666666653

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=7.4e-34  Score=318.52  Aligned_cols=306  Identities=25%  Similarity=0.384  Sum_probs=224.2

Q ss_pred             cCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccc
Q 036229          319 FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLR  398 (982)
Q Consensus       319 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  398 (982)
                      ..+++|+.|++++|.+.... .  ...+++|++|++++|++++..+  +..+++|++|++++|.++..  ..|..+++|+
T Consensus        41 ~~l~~L~~L~l~~~~i~~~~-~--~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~  113 (347)
T 4fmz_A           41 EELESITKLVVAGEKVASIQ-G--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR  113 (347)
T ss_dssp             HHHTTCSEEECCSSCCCCCT-T--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred             hhcccccEEEEeCCccccch-h--hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence            34556666666666665321 1  3345556666666666554332  55555666666666655543  2355555555


Q ss_pred             eecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccce
Q 036229          399 LMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG  478 (982)
Q Consensus       399 ~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~  478 (982)
                      .|++++|.++.++.       +..+++|++|                          ++++|.....++ .+..+++|+.
T Consensus       114 ~L~l~~n~i~~~~~-------~~~l~~L~~L--------------------------~l~~n~~~~~~~-~~~~l~~L~~  159 (347)
T 4fmz_A          114 ELYLNEDNISDISP-------LANLTKMYSL--------------------------NLGANHNLSDLS-PLSNMTGLNY  159 (347)
T ss_dssp             EEECTTSCCCCCGG-------GTTCTTCCEE--------------------------ECTTCTTCCCCG-GGTTCTTCCE
T ss_pred             EEECcCCcccCchh-------hccCCceeEE--------------------------ECCCCCCccccc-chhhCCCCcE
Confidence            55555555543321       3444444444                          444443333333 3778888999


Q ss_pred             EEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcc
Q 036229          479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKL  558 (982)
Q Consensus       479 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  558 (982)
                      |++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|++++|++
T Consensus       160 L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l  233 (347)
T 4fmz_A          160 LTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI  233 (347)
T ss_dssp             EECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             EEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence            9999999886554  8888999999999999985433  7888999999999999986554  88889999999999999


Q ss_pred             cccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCcccccc
Q 036229          559 TSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFG  638 (982)
Q Consensus       559 ~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  638 (982)
                      +.+|. +..+++|++|++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|++|+|++|++++..|..|+
T Consensus       234 ~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~  308 (347)
T 4fmz_A          234 TDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG  308 (347)
T ss_dssp             CCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred             CCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence            98887 77888999999999998864  4688899999999999999875  4688999999999999999999999999


Q ss_pred             CCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCccc
Q 036229          639 DLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK  678 (982)
Q Consensus       639 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~  678 (982)
                      ++++|+.|+|++|++++..|  +..+++|++||+++|+++
T Consensus       309 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            99999999999999997666  888999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-35  Score=330.18  Aligned_cols=196  Identities=21%  Similarity=0.278  Sum_probs=157.3

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCee
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  851 (982)
                      ...++|++.++||+|+||+||+|+.+    +++.||+|++....  ...++.+|+++++.+ +||||+++++++.++++.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            35678999999999999999999742    47899999986543  345688999999998 699999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCceee
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL  930 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~~~  930 (982)
                      |+||||+++|+|.+++.    .+++.+++.++.|++.||+|||   ++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999984    3789999999999999999999   9999999999999999876 89999999999865


Q ss_pred             cCCCCc--------------------------eeecccccccccccCceeeeee-eeeEEeeEeeeeeeeeecccC--CC
Q 036229          931 IGEDQS--------------------------ITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLMIFIGRG--NY  981 (982)
Q Consensus       931 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~~l~~~~--~f  981 (982)
                      .+....                          ...+..+||+.|||||++.+.. ++.. .|+|+.|+.++.+.+|  ||
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~-~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA-IDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTH-HHHHHHHHHHHHHHHTCSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCc-cchhhhHHHHHHHHHCCCCC
Confidence            332110                          1123457999999999997653 4433 3334444445555554  66


Q ss_pred             C
Q 036229          982 Y  982 (982)
Q Consensus       982 ~  982 (982)
                      |
T Consensus       248 ~  248 (361)
T 4f9c_A          248 Y  248 (361)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.9e-35  Score=343.17  Aligned_cols=194  Identities=25%  Similarity=0.327  Sum_probs=158.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHH---HHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDV---ECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++++..   ......+.+   ++++++.++|||||++++++++++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999864 59999999997532   122223333   45667788999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      |+|||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||   ++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999997654 5899999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeeeeeec--ccCCC
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLMIFI--GRGNY  981 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~~l~--~~~~f  981 (982)
                      ..    .....+||+.|||||++.+ ..|+.. .|||++|+.+|.|  |..||
T Consensus       344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~-vDiWSLGvilYEmLtG~~PF  391 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPF  391 (689)
T ss_dssp             SC----CCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCTT
T ss_pred             CC----CCCCccCCcCccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCC
Confidence            32    2345789999999999964 456654 3344555554444  44455

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=331.15  Aligned_cols=195  Identities=27%  Similarity=0.299  Sum_probs=155.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecC------CC
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCST------EE  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~  849 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++...  ....+++.+|+++|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999986 469999999996542  2345678899999999999999999998753      36


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..|+|||||+ |+|.+++.+. ..+++.++..+++||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999996 6899998764 46899999999999999999999   99999999999999999999999999999987


Q ss_pred             ecCCC--CceeecccccccccccCceeeeee-eeeEEeeEeeeeeeeeecccC
Q 036229          930 LIGED--QSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       930 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      +....  ........+||+.|||||++.+.. ++.. .|+|++|+.++.+.+|
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~-~DiWSlG~il~ell~G  259 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQA-IDLWSVGCIFGEMLAR  259 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTH-HHHHHHHHHHHHHHHT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCCh-hheehhHHHHHHHHHC
Confidence            64322  122335678999999999987653 3433 3333444444444443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=6.5e-33  Score=310.83  Aligned_cols=306  Identities=28%  Similarity=0.420  Sum_probs=171.0

Q ss_pred             hccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCcc
Q 036229          271 ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLE  350 (982)
Q Consensus       271 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~  350 (982)
                      ..+++|++|++++|.++.. | .+..+++|++|++++|++++..+  +..+++|+.|++++|.+... +  .+..+++|+
T Consensus        41 ~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~-~--~~~~l~~L~  113 (347)
T 4fmz_A           41 EELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI-S--ALQNLTNLR  113 (347)
T ss_dssp             HHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G--GGTTCTTCS
T ss_pred             hhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc-h--HHcCCCcCC
Confidence            3445555555555555432 2 24455555555555555543222  44444444444444443321 0  122344445


Q ss_pred             EEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEE
Q 036229          351 ELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIG  430 (982)
Q Consensus       351 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~  430 (982)
                      +|++++|++++..+  +..+++|++|++++|......+ .+                             ..+++|++|+
T Consensus       114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~-----------------------------~~l~~L~~L~  161 (347)
T 4fmz_A          114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PL-----------------------------SNMTGLNYLT  161 (347)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GG-----------------------------TTCTTCCEEE
T ss_pred             EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-ch-----------------------------hhCCCCcEEE
Confidence            55555555553322  4555555555555554332221 13                             3344444555


Q ss_pred             ccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCC
Q 036229          431 LSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKL  510 (982)
Q Consensus       431 Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  510 (982)
                      +++|.+.++.                          +  +..+++|+.|++++|++++..+  +..+++|+.|++++|++
T Consensus       162 l~~~~~~~~~--------------------------~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l  211 (347)
T 4fmz_A          162 VTESKVKDVT--------------------------P--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQI  211 (347)
T ss_dssp             CCSSCCCCCG--------------------------G--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             ecCCCcCCch--------------------------h--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCC
Confidence            5555433221                          1  3344455555555555543322  45555555555555555


Q ss_pred             CCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccc
Q 036229          511 EGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIG  590 (982)
Q Consensus       511 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  590 (982)
                      ++..+  +..+++|++|++++|++++..+  +..+++|++|++++|+++.++ .+..+++|++|++++|++++.  ..+.
T Consensus       212 ~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~  284 (347)
T 4fmz_A          212 TDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI--SVLN  284 (347)
T ss_dssp             CCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGG
T ss_pred             CCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC--hhhc
Confidence            54322  5555556666666665554332  555666666666666666553 345566666666666666654  3467


Q ss_pred             cccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCC
Q 036229          591 NLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       591 ~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  654 (982)
                      .+++|+.|++++|++++..|..++.+++|++|+|++|++++..|  +..+++|++|++++|+|+
T Consensus       285 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            77888888888888888888888899999999999999987666  888899999999999885

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-34  Score=338.25  Aligned_cols=185  Identities=21%  Similarity=0.299  Sum_probs=162.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|++........+.+.+|+++|+.++||||+++++++++++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999864 6999999999876666677899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC--CcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN--MVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~~  935 (982)
                      |+||+|.+++......+++.++..++.||+.||+|||   ++||+||||||+|||++.+  +.+||+|||+|+.+...  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            9999999999876667999999999999999999999   9999999999999999854  89999999999987432  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                       ......+||+.|||||++.+..|+..   +|+||+|
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~~~---~DiWSlG  343 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVG  343 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBCHH---HHHHHHH
T ss_pred             -CceeeeEECccccCHHHhCCCCCCcH---HHHHHHH
Confidence             23345689999999999988877655   3445555

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=6.4e-36  Score=349.20  Aligned_cols=262  Identities=20%  Similarity=0.195  Sum_probs=148.0

Q ss_pred             CCCCEEEcCCCCccccCcc-hhhhccCCcEEEccCCcccC----ccCccccCcCCCCccccccCcccccCchhhhcCCC-
Q 036229          105 SSLQSLNLGFNRLSGSIPS-AIFTLYTLKYVNFRGNQLSG----AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLP-  178 (982)
Q Consensus       105 ~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~-  178 (982)
                      ++|++|||++|+++..... .+..+++|++|+|++|++++    .++..+..+++|++|||++|.+++..+..++..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            3567777777777643333 36677888888888888764    35666777788888888888877555555656666 


Q ss_pred             ---CCCeeeecceeeec----ccCCCccCcCcccEEEeecccccccccccccc-----ccchhhhhccCCCCCCch----
Q 036229          179 ---FLESISLSQNMFHG----RIPSALSNCKYLEILSLSINNLLGAIPKEIGN-----LTKLKELYLGYSGLQGEI----  242 (982)
Q Consensus       179 ---~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~----  242 (982)
                         +|++|+|++|+++.    .++..|..+++|++|+|++|++++..+..+..     .++|++|+|++|++++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               68888888888773    45777778888888888888876544443332     345666666666666432    


Q ss_pred             hhhcCCCcccceEeccccccCCcCChhhhc-----cCCCcEEEccCCccccC----CCccccccCCCcEEEccCcccccc
Q 036229          243 PREFGNLAELELMALQVSNLQGEIPQELAN-----LTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKLVGA  313 (982)
Q Consensus       243 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  313 (982)
                      +..+..+++|+.|++++|.+.+..+..+..     .++|++|++++|.+++.    ++..+..+++|++|+|++|++++.
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            333344444455555544444332222221     33444444444444432    233333444444444444444321


Q ss_pred             CcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCccccc----ccccccCCCCCCEEEeccccCccc
Q 036229          314 VPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT----IPRFIFNASKLSVLELGRNSFSGF  386 (982)
Q Consensus       314 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~i~~~  386 (982)
                      ....+.                    ......+++|++|++++|++++.    ++..+..+++|++|++++|.+++.
T Consensus       243 ~~~~l~--------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~  299 (461)
T 1z7x_W          243 GMAELC--------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE  299 (461)
T ss_dssp             HHHHHH--------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred             HHHHHH--------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence            110000                    01111244556666666666543    344555566666666666666543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.2e-32  Score=303.01  Aligned_cols=242  Identities=25%  Similarity=0.293  Sum_probs=203.9

Q ss_pred             EEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccC
Q 036229           84 KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYN  163 (982)
Q Consensus        84 ~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  163 (982)
                      +.+++++++++ .+|..+.  ++|+.|+|++|.+++..|.++.++++|++|+|++|++++..|..++++++|++|+|++|
T Consensus        36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  112 (332)
T 2ft3_A           36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN  112 (332)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred             CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence            34566677776 6777664  68999999999999777788999999999999999999888999999999999999999


Q ss_pred             cccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccc--cccccccccccchhhhhccCCCCCCc
Q 036229          164 ALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLL--GAIPKEIGNLTKLKELYLGYSGLQGE  241 (982)
Q Consensus       164 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~  241 (982)
                      .++ .+|..++   ++|++|++++|++++..+..|.++++|++|++++|+++  +..|..+..+ +|++|++++|++++ 
T Consensus       113 ~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-  186 (332)
T 2ft3_A          113 HLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-  186 (332)
T ss_dssp             CCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred             cCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence            998 8888774   89999999999999877778999999999999999996  3667788888 99999999999986 


Q ss_pred             hhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCC
Q 036229          242 IPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNM  321 (982)
Q Consensus       242 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  321 (982)
                      +|..+.  ++|+.|++++|.+++..+..+.++++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+
T Consensus       187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l  263 (332)
T 2ft3_A          187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL  263 (332)
T ss_dssp             CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred             cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence            555443  68888888888888887788888888888888888888877778888888888888888887 667777777


Q ss_pred             CCCceeecCCCcCCCC
Q 036229          322 STLTGLGLQSNSLSGS  337 (982)
Q Consensus       322 ~~L~~L~L~~N~l~~~  337 (982)
                      ++|+.|++++|++++.
T Consensus       264 ~~L~~L~l~~N~l~~~  279 (332)
T 2ft3_A          264 KLLQVVYLHTNNITKV  279 (332)
T ss_dssp             TTCCEEECCSSCCCBC
T ss_pred             ccCCEEECCCCCCCcc
Confidence            7777777776666543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=3.1e-32  Score=302.86  Aligned_cols=240  Identities=22%  Similarity=0.266  Sum_probs=180.9

Q ss_pred             EEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCc
Q 036229           85 VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA  164 (982)
Q Consensus        85 ~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  164 (982)
                      .+++++++++ .+|..+.  +.|+.|+|++|++++..+..+.++++|++|+|++|++++..|..++++++|++|++++|.
T Consensus        35 ~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  111 (330)
T 1xku_A           35 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ  111 (330)
T ss_dssp             EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence            3455566666 5666554  688999999999987777789999999999999999998889999999999999999999


Q ss_pred             ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccccc--ccccccccccchhhhhccCCCCCCch
Q 036229          165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLG--AIPKEIGNLTKLKELYLGYSGLQGEI  242 (982)
Q Consensus       165 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~  242 (982)
                      ++ .+|..++   ++|++|++++|++++..+..|.++++|++|++++|++..  ..+..+..+++|++|++++|+++. +
T Consensus       112 l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l  186 (330)
T 1xku_A          112 LK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-I  186 (330)
T ss_dssp             CS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-C
T ss_pred             CC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-C
Confidence            98 7887763   789999999999988777788889999999999998853  567778888888888888888874 4


Q ss_pred             hhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCC
Q 036229          243 PREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS  322 (982)
Q Consensus       243 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  322 (982)
                      |..+.  ++|+.|++++|++++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..++
T Consensus       187 ~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~  263 (330)
T 1xku_A          187 PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK  263 (330)
T ss_dssp             CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred             Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC
Confidence            44332  56777777777776666666777777777777777776666666666677777777777666 4555555555


Q ss_pred             CCceeecCCCcCC
Q 036229          323 TLTGLGLQSNSLS  335 (982)
Q Consensus       323 ~L~~L~L~~N~l~  335 (982)
                      +|+.|++++|+++
T Consensus       264 ~L~~L~l~~N~i~  276 (330)
T 1xku_A          264 YIQVVYLHNNNIS  276 (330)
T ss_dssp             SCCEEECCSSCCC
T ss_pred             CcCEEECCCCcCC
Confidence            5544444444443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.98  E-value=1.5e-31  Score=297.58  Aligned_cols=268  Identities=24%  Similarity=0.279  Sum_probs=144.5

Q ss_pred             CCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccc
Q 036229          347 PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL  426 (982)
Q Consensus       347 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L  426 (982)
                      ++|++|++++|++++..|..+.++++|++|++++|++++..|..|..+++|+.|++++|.++.++..             
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~-------------  120 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPN-------------  120 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSS-------------
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcc-------------
Confidence            3456666666666655566666666677777777766666666666555555554444444433221             


Q ss_pred             cEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCC--CCCCccccCcCCCCeEE
Q 036229          427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN--GSIPITLGKLQKLQGLH  504 (982)
Q Consensus       427 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~  504 (982)
                                      ..     .+|++|++++|++++..+..|..+++|+.|++++|.++  +..|..|..+ +|+.|+
T Consensus       121 ----------------~~-----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~  178 (332)
T 2ft3_A          121 ----------------LP-----SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR  178 (332)
T ss_dssp             ----------------CC-----TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCB
T ss_pred             ----------------cc-----ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEE
Confidence                            10     23333444444444444444555666666666666664  2445555555 566666


Q ss_pred             eeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCC
Q 036229          505 LEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGP  584 (982)
Q Consensus       505 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~  584 (982)
                      +++|++++ +|..+.  ++|++|++++|++++..|..|.++++|++|+|++|+++.++                      
T Consensus       179 l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~----------------------  233 (332)
T 2ft3_A          179 ISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE----------------------  233 (332)
T ss_dssp             CCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCC----------------------
T ss_pred             CcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCC----------------------
Confidence            66666553 333332  45555555555555555555555555555555555555443                      


Q ss_pred             CccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCC------CCCCeeeCCCCcCC--CC
Q 036229          585 LPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDL------ISLKSLNLSNNNLS--RS  656 (982)
Q Consensus       585 ~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~--~~  656 (982)
                       +..+..+++|+.|++++|+++ .+|..++.+++|++|+|++|+|++..+..|...      .+|+.|++++|.+.  +.
T Consensus       234 -~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~  311 (332)
T 2ft3_A          234 -NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV  311 (332)
T ss_dssp             -TTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGS
T ss_pred             -hhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccccc
Confidence             334444455555555555554 344455555566666666666655555555442      45666666666665  45


Q ss_pred             CCcccccccccceeecCCCc
Q 036229          657 IPISLEKLSYLEDLDLSFNK  676 (982)
Q Consensus       657 ~p~~l~~l~~L~~l~ls~N~  676 (982)
                      .|..|..+++|+.+++++|.
T Consensus       312 ~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          312 QPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CGGGGTTBCCSTTEEC----
T ss_pred             Ccccccccchhhhhhccccc
Confidence            55566666666666666653

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=3.2e-31  Score=294.75  Aligned_cols=269  Identities=22%  Similarity=0.256  Sum_probs=161.6

Q ss_pred             CCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccc
Q 036229          347 PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL  426 (982)
Q Consensus       347 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L  426 (982)
                      +++++|++++|++++..+..|.++++|++|++++|++++..|..|..+++|+.|++++|.++.++...        .++ 
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~--------~~~-  122 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM--------PKT-  122 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSC--------CTT-
T ss_pred             CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhh--------ccc-
Confidence            34577777777777666667777777788888777777776777777776666666666555433221        023 


Q ss_pred             cEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCC--CCCccccCcCCCCeEE
Q 036229          427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG--SIPITLGKLQKLQGLH  504 (982)
Q Consensus       427 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~  504 (982)
                                               |++|++++|++++..+..|.++++|+.|++++|.++.  ..+..|.++++|++|+
T Consensus       123 -------------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~  177 (330)
T 1xku_A          123 -------------------------LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR  177 (330)
T ss_dssp             -------------------------CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEE
T ss_pred             -------------------------ccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEE
Confidence                                     4444444445554455556667777777777777743  5566667777777777


Q ss_pred             eeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCC
Q 036229          505 LEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGP  584 (982)
Q Consensus       505 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~  584 (982)
                      +++|+++. +|..+.  ++|++|++++|++++..|..|.++++|++|+|++|+++.++.                     
T Consensus       178 l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---------------------  233 (330)
T 1xku_A          178 IADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN---------------------  233 (330)
T ss_dssp             CCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT---------------------
T ss_pred             CCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeCh---------------------
Confidence            77777763 444332  566777777777766666666666666666666666665443                     


Q ss_pred             CccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCC------CCCCeeeCCCCcCCC--C
Q 036229          585 LPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDL------ISLKSLNLSNNNLSR--S  656 (982)
Q Consensus       585 ~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~~--~  656 (982)
                        ..+..+++|+.|++++|+++ .+|..+..+++|++|+|++|+|++..+..|...      ++|+.|++++|.+..  .
T Consensus       234 --~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i  310 (330)
T 1xku_A          234 --GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI  310 (330)
T ss_dssp             --TTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred             --hhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccccc
Confidence              23334444444555555554 344455555566666666666655555555432      566677777776642  4


Q ss_pred             CCcccccccccceeecCCCc
Q 036229          657 IPISLEKLSYLEDLDLSFNK  676 (982)
Q Consensus       657 ~p~~l~~l~~L~~l~ls~N~  676 (982)
                      .|..|..++.++.++|++|+
T Consensus       311 ~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          311 QPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CGGGGTTCCCGGGEEC----
T ss_pred             CccccccccceeEEEecccC
Confidence            45666667777777777764

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.5e-34  Score=337.55  Aligned_cols=110  Identities=20%  Similarity=0.190  Sum_probs=54.3

Q ss_pred             CCCCeeeecceeeecccCCC-ccCcCcccEEEeecccccc----ccccccccccchhhhhccCCCCCCchhhhc-CCCc-
Q 036229          178 PFLESISLSQNMFHGRIPSA-LSNCKYLEILSLSINNLLG----AIPKEIGNLTKLKELYLGYSGLQGEIPREF-GNLA-  250 (982)
Q Consensus       178 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~-  250 (982)
                      ++|++|+|++|+++...... +..+++|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+ ..++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            45666666666665433322 4556666666666666553    234444555555666666555554333222 1222 


Q ss_pred             ---ccceEeccccccCC----cCChhhhccCCCcEEEccCCccc
Q 036229          251 ---ELELMALQVSNLQG----EIPQELANLTGLEVLKLGKNFLT  287 (982)
Q Consensus       251 ---~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~  287 (982)
                         +|+.|++++|+++.    .+|..+..+++|++|+|++|.++
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  126 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  126 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCc
Confidence               34444554444442    22444444444444444444444

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=5.8e-33  Score=318.02  Aligned_cols=180  Identities=19%  Similarity=0.306  Sum_probs=156.6

Q ss_pred             HHHHHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecC
Q 036229          772 YLELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCST  847 (982)
Q Consensus       772 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  847 (982)
                      +.++....++|++.+.||+|+||+||+|+.. +++.||+|+++..   .......+.+|+.+++.++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3444556789999999999999999999965 4899999999753   22334558899999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      ++..|+||||+++|+|.+++.+....+++..+..++.|++.||+|||   ++|||||||||+|||++.++.+||+|||+|
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            99999999999999999999876667999999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFH  955 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~  955 (982)
                      +...... .......+||+.|||||++.
T Consensus       223 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~  249 (437)
T 4aw2_A          223 LKLMEDG-TVQSSVAVGTPDYISPEILQ  249 (437)
T ss_dssp             EECCTTS-CEECCSCCSCGGGCCHHHHH
T ss_pred             hhcccCC-CcccccccCCcCeeChHHHh
Confidence            8764332 22334568999999999986

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=299.87  Aligned_cols=285  Identities=22%  Similarity=0.237  Sum_probs=222.3

Q ss_pred             CCCCCCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcc
Q 036229           62 WNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL  141 (982)
Q Consensus        62 w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l  141 (982)
                      |.....+|.|.|+ |+.          ++++++ .+|..+.  ++|++|++++|++++..+..+..+++|++|+|++|++
T Consensus        23 ~~~~~~~C~~~~~-c~~----------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l   88 (353)
T 2z80_A           23 SNQASLSCDRNGI-CKG----------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI   88 (353)
T ss_dssp             ----CCEECTTSE-EEC----------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             CCccCCCCCCCeE-eeC----------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCcc
Confidence            4444557999988 873          456666 6777665  5899999999999966666899999999999999999


Q ss_pred             cCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccC-CCccCcCcccEEEeecc-ccccccc
Q 036229          142 SGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP-SALSNCKYLEILSLSIN-NLLGAIP  219 (982)
Q Consensus       142 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p  219 (982)
                      ++..|..|.++++|++|||++|.++ .+|...|.++++|++|+|++|++++..+ ..|.++++|++|++++| .++...+
T Consensus        89 ~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~  167 (353)
T 2z80_A           89 NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR  167 (353)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECT
T ss_pred             CccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCH
Confidence            9888888999999999999999998 6888877999999999999999996544 48999999999999999 4776667


Q ss_pred             cccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCcccc---c
Q 036229          220 KEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIH---N  296 (982)
Q Consensus       220 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~  296 (982)
                      ..|.++++|++|++++|++++..|..+..+++|+.|++++|++....+..+..+++|++|++++|++++..+..+.   .
T Consensus       168 ~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~  247 (353)
T 2z80_A          168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET  247 (353)
T ss_dssp             TTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------C
T ss_pred             HHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccc
Confidence            8899999999999999999988899999999999999999998754444566789999999999999976655443   3


Q ss_pred             cCCCcEEEccCccccc----cCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCC
Q 036229          297 LHNLKLLDLSHNKLVG----AVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK  372 (982)
Q Consensus       297 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  372 (982)
                      .+.++.++|++|.+++    .+|..+..+++|                         ++|++++|+++...+..|..+++
T Consensus       248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L-------------------------~~L~Ls~N~l~~i~~~~~~~l~~  302 (353)
T 2z80_A          248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGL-------------------------LELEFSRNQLKSVPDGIFDRLTS  302 (353)
T ss_dssp             CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTC-------------------------CEEECCSSCCCCCCTTTTTTCTT
T ss_pred             cchhhccccccccccCcchhhhHHHHhcccCC-------------------------CEEECCCCCCCccCHHHHhcCCC
Confidence            4567777777777764    245555555555                         55555666555332233456666


Q ss_pred             CCEEEeccccCccc
Q 036229          373 LSVLELGRNSFSGF  386 (982)
Q Consensus       373 L~~L~L~~N~i~~~  386 (982)
                      |++|++++|++.+.
T Consensus       303 L~~L~L~~N~~~~~  316 (353)
T 2z80_A          303 LQKIWLHTNPWDCS  316 (353)
T ss_dssp             CCEEECCSSCBCCC
T ss_pred             CCEEEeeCCCccCc
Confidence            77777777766643

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=3.2e-31  Score=291.42  Aligned_cols=250  Identities=24%  Similarity=0.333  Sum_probs=194.0

Q ss_pred             CceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcc-hhhhccCCcEEEccCCcccC--cc
Q 036229           69 CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPS-AIFTLYTLKYVNFRGNQLSG--AF  145 (982)
Q Consensus        69 c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~--~~  145 (982)
                      |.|.+|.|+            +++++ .+|..+.  ++|++|+|++|+++ .+|. .+..+++|++|+|++|+++.  ..
T Consensus         7 C~~~~l~c~------------~~~l~-~ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~   70 (306)
T 2z66_A            7 CSGTEIRCN------------SKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCC   70 (306)
T ss_dssp             EETTEEECC------------SSCCS-SCCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred             eCCCEEEcC------------CCCcc-cCCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCc
Confidence            788888887            23344 4555443  57888888888887 4554 46788888888888888873  34


Q ss_pred             CccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccC-CCccCcCcccEEEeecccccccccccccc
Q 036229          146 PSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP-SALSNCKYLEILSLSINNLLGAIPKEIGN  224 (982)
Q Consensus       146 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  224 (982)
                      |..+..+++|++|+|++|.++ .+|..+ ..+++|++|++++|++++..+ ..+..+++|++|++++|++++..|..+..
T Consensus        71 ~~~~~~~~~L~~L~Ls~n~i~-~l~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  148 (306)
T 2z66_A           71 SQSDFGTTSLKYLDLSFNGVI-TMSSNF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG  148 (306)
T ss_dssp             EHHHHSCSCCCEEECCSCSEE-EEEEEE-ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT
T ss_pred             ccccccccccCEEECCCCccc-cChhhc-CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc
Confidence            667777888888888888887 577665 778888888888888887655 57888888888888888888777778888


Q ss_pred             ccchhhhhccCCCCCC-chhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEE
Q 036229          225 LTKLKELYLGYSGLQG-EIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLL  303 (982)
Q Consensus       225 l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  303 (982)
                      +++|++|++++|++++ ..|..+..+++|+.|++++|++++..|..+..+++|++|+|++|++++..+..|..+++|++|
T Consensus       149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  228 (306)
T 2z66_A          149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL  228 (306)
T ss_dssp             CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred             CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence            8888888888888876 567778888888888888888887777788888888888888888887777778888888888


Q ss_pred             EccCccccccCcccccCCC-CCceeecCCCcCCC
Q 036229          304 DLSHNKLVGAVPATIFNMS-TLTGLGLQSNSLSG  336 (982)
Q Consensus       304 ~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~  336 (982)
                      ||++|++++..|..+..++ +|+.|+|++|++.+
T Consensus       229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             ECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            8888888877777777663 66666666666554

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=2.3e-33  Score=338.57  Aligned_cols=256  Identities=18%  Similarity=0.130  Sum_probs=156.5

Q ss_pred             CCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCc---cccCcchhh------------hccCCc
Q 036229           68 VCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRL---SGSIPSAIF------------TLYTLK  132 (982)
Q Consensus        68 ~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~---~~~~p~~~~------------~l~~L~  132 (982)
                      |++|.++.+.  ..+  .+.+.. .....++..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        41 ck~W~~~~~~--~~~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSE--TRE--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHH--HCC--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhc--ccc--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            5589888544  122  222322 23333444566788899999987532   133443222            778888


Q ss_pred             EEEccCCcccCccCccccCc--CCCCccccccCc-ccccCchhhhcCCCCCCeeeecceeeecc----cCCCccCcCccc
Q 036229          133 YVNFRGNQLSGAFPSFIFNK--SSLQHLDFSYNA-LSGEIPANICSNLPFLESISLSQNMFHGR----IPSALSNCKYLE  205 (982)
Q Consensus       133 ~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~-l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~  205 (982)
                      +|+|++|.+++..+..+...  ++|++|+|++|. ++...-..+..++++|++|+|++|.+++.    ++..+..+++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            88888888877766666663  348888888876 22111123335778888888888887655    223345677788


Q ss_pred             EEEeeccccc----cccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccC---CcCChhhhccCCCcE
Q 036229          206 ILSLSINNLL----GAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQ---GEIPQELANLTGLEV  278 (982)
Q Consensus       206 ~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~p~~l~~l~~L~~  278 (982)
                      +|++++|+++    +.++..+.++++|++|++++|.+.+ +|..+.++++|+.|+++.....   +..+..+..+++|+.
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~  274 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR  274 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence            8888888776    2344455666777777777777764 5566777777777777643322   223344566666777


Q ss_pred             EEccCCccccCCCccccccCCCcEEEccCccccccCc-ccccCCCCCceeecC
Q 036229          279 LKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVP-ATIFNMSTLTGLGLQ  330 (982)
Q Consensus       279 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~  330 (982)
                      |+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++
T Consensus       275 L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~  326 (592)
T 3ogk_B          275 LGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR  326 (592)
T ss_dssp             EEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred             cCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence            776665332 455566666677777777766543332 224555666665555

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=5.8e-31  Score=287.76  Aligned_cols=186  Identities=26%  Similarity=0.367  Sum_probs=161.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            356899999999999999999985 5689999999987666666788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++|+|.+++...  .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|........ 
T Consensus        98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            99999999999765  4889999999999999999999   99999999999999999999999999999987643322 


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  204 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPK---VDIWSLGI  204 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTH---HHHHHHHH
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcH---HHHHHHHH
Confidence             3345679999999999987766543   45566663

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.97  E-value=4.3e-31  Score=293.12  Aligned_cols=185  Identities=24%  Similarity=0.319  Sum_probs=158.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++..   .......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467999999999999999999865 5999999999754   233456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+..... 
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence            99999999999987643 5889999999999999999999   999999999999999999999999999999864222 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                       .......+||+.|+|||++.+..++..   +|+|++|
T Consensus       159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  192 (337)
T 1o6l_A          159 -GATMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLG  192 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTT---HHHHHHH
T ss_pred             -CCcccccccChhhCChhhhcCCCCCch---hhcccch
Confidence             223345789999999999987766644   3445555

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.97  E-value=2.1e-31  Score=294.86  Aligned_cols=186  Identities=26%  Similarity=0.346  Sum_probs=159.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++...  .....+++.+|+++++.++||||+++++++..++..|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            357899999999999999999986 57999999999754  234456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++...+ .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            99999999999997654 4899999999999999999999   999999999999999999999999999999865322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        ......+||+.|+|||++.+..+...  .+|+|++|
T Consensus       168 --~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG  201 (328)
T 3fe3_A          168 --GKLDAFCGAPPYAAPELFQGKKYDGP--EVDVWSLG  201 (328)
T ss_dssp             --CGGGTTSSSGGGCCHHHHHTCCCCSH--HHHHHHHH
T ss_pred             --CccccccCCcceeCcccccCCCcCCc--hhhhhhhH
Confidence              22345789999999999977655422  24455555

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.9e-31  Score=301.77  Aligned_cols=180  Identities=21%  Similarity=0.326  Sum_probs=156.6

Q ss_pred             HHHHHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecC
Q 036229          772 YLELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCST  847 (982)
Q Consensus       772 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  847 (982)
                      +.+.....++|++.+.||+|+||+||+|+.. +++.||+|+++..   .....+.+.+|+++++.++||||+++++++++
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444455788999999999999999999964 6999999999753   22344668899999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      ++..|+||||+++|+|.+++.+.+..+++..+..++.||+.||+|||   ++|||||||||+||+++.++.+||+|||+|
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhh
Confidence            99999999999999999999876667899999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFH  955 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~  955 (982)
                      +...... .......+||+.|+|||++.
T Consensus       210 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~  236 (412)
T 2vd5_A          210 LKLRADG-TVRSLVAVGTPDYLSPEILQ  236 (412)
T ss_dssp             EECCTTS-CEECSSCCSCGGGCCHHHHH
T ss_pred             eeccCCC-ccccceeccccCcCCHHHHh
Confidence            8764332 22234568999999999996

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=2.7e-31  Score=301.79  Aligned_cols=179  Identities=23%  Similarity=0.320  Sum_probs=154.3

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      ++....++|++.+.||+|+||.||+|+.. +++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+++
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445688999999999999999999865 5899999999753   2233456889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..|+||||++||+|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            999999999999999999754  4789999999999999999999   99999999999999999999999999999987


Q ss_pred             ecCCCCceeecccccccccccCceeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKY  958 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  958 (982)
                      ..... .......+||+.|+|||++.+..
T Consensus       218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~  245 (410)
T 3v8s_A          218 MNKEG-MVRCDTAVGTPDYISPEVLKSQG  245 (410)
T ss_dssp             CCTTS-EEECCSCCSCGGGCCHHHHHTTT
T ss_pred             eccCC-cccccCCcCCccccCHHHhhccC
Confidence            64322 22334678999999999996543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=6.8e-31  Score=289.37  Aligned_cols=190  Identities=24%  Similarity=0.390  Sum_probs=162.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|...+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            467899999999999999999864 5899999998766666778899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++|+|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999887777999999999999999999999   9999999999999999999999999999998764322111


Q ss_pred             ------------eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 ------------TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                                  ......||+.|+|||++.+..++..   +|+|++|++
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~~  211 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK---VDVFSFGIV  211 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTH---HHHHHHHHH
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcH---HHHHHHHHH
Confidence                        1124579999999999987666543   556666643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=1.8e-31  Score=295.47  Aligned_cols=198  Identities=35%  Similarity=0.565  Sum_probs=168.4

Q ss_pred             CCHHHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          770 FSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      +++.++...+++|+..+.||+|+||.||+|+..+++.||+|++........+.+.+|+++++.++||||+++++++..++
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            33444556788999999999999999999998889999999988766666788999999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCC---CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          850 FKALILEYMPHGSLEKSLYSSN---YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      ..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999987543   35889999999999999999999   99999999999999999999999999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++...............||+.|+|||++.+..++..   +|+|++|+
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  229 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEK---SDVYSFGV  229 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTH---HHHHHHHH
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcc---cchHhHHH
Confidence            987543333333345668999999999977665543   55666664

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=4.1e-31  Score=295.30  Aligned_cols=194  Identities=24%  Similarity=0.288  Sum_probs=155.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++..   .....+.+.+|.++++.+ +||||+++++++.+++..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            4578999999999999999999864 5899999999754   233456678899999988 7999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999997654 4899999999999999999999   99999999999999999999999999999985422


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeeccc
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGR  978 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~  978 (982)
                        ........+||+.|+|||++.+..++.. .++|++|+.++.+.+
T Consensus       177 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~  219 (353)
T 3txo_A          177 --NGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLC  219 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHH
T ss_pred             --CCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHh
Confidence              2223445789999999999987766654 223344444444433

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=2e-30  Score=286.69  Aligned_cols=196  Identities=24%  Similarity=0.290  Sum_probs=166.8

Q ss_pred             ccCCHHHHHHHhcC----------CCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCc
Q 036229          768 RRFSYLELCRATNR----------FSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR  836 (982)
Q Consensus       768 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  836 (982)
                      ..++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677887777654          677789999999999999975 6999999999876666677889999999999999


Q ss_pred             cceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC
Q 036229          837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN  916 (982)
Q Consensus       837 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~  916 (982)
                      ||+++++++...+..++||||+++++|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998643  4899999999999999999999   9999999999999999999


Q ss_pred             CcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          917 MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       917 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +.+||+|||++.......  .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       178 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~---~Dv~slG~  229 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATE---VDIWSLGI  229 (321)
T ss_dssp             CCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTH---HHHHHHHH
T ss_pred             CcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCch---hhHHHHHH
Confidence            999999999998764322  22345679999999999977655543   55666663

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=6.6e-31  Score=296.92  Aligned_cols=193  Identities=24%  Similarity=0.283  Sum_probs=159.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||+||+|+.. +++.||+|+++..   .....+.+.+|..+++++ +||||+++++++.+++..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999865 5899999999754   233445688899999887 89999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999987644 5899999999999999999999   999999999999999999999999999999863222


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeeccc
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGR  978 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~  978 (982)
                        .......+||+.|+|||++.+..++... ++|++|+.++.+.+
T Consensus       207 --~~~~~~~~gt~~Y~aPE~l~~~~~~~~~-DiwslGvllyell~  248 (396)
T 4dc2_A          207 --GDTTSTFCGTPNYIAPEILRGEDYGFSV-DWWALGVLMFEMMA  248 (396)
T ss_dssp             --TCCBCCCCBCGGGCCHHHHTTCCBCTHH-HHHHHHHHHHHHHH
T ss_pred             --CCccccccCCcccCCchhhcCCCCChHH-HHHHHHHHHHHHHh
Confidence              2234567899999999999887776542 33344444443333

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=1e-30  Score=294.46  Aligned_cols=171  Identities=27%  Similarity=0.400  Sum_probs=151.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999864 58999999997542   33456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.+... 
T Consensus        94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            9999999999999764 45899999999999999999999   999999999999999999999999999999976332 


Q ss_pred             CceeecccccccccccCceeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                        ......+||+.|+|||++.+
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~  188 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSS  188 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCC
T ss_pred             --CceeccCCCccccCCeeecc
Confidence              23345789999999999964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=8.7e-31  Score=290.78  Aligned_cols=202  Identities=35%  Similarity=0.523  Sum_probs=171.1

Q ss_pred             cccccCCHHHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEe
Q 036229          765 ATCRRFSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVIS  843 (982)
Q Consensus       765 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~  843 (982)
                      .....+++.++....++|+..+.||+|+||.||+|+..+++.||||++..... .....+.+|+++++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34567899999999999999999999999999999987899999999875432 23347899999999999999999999


Q ss_pred             eecCCCeeEEEEEeccCCChHHHHhcCC---CcCCHHHHHHHHHHHHHHHHHHHccCCC---CeEEcCCCCCCEEEcCCC
Q 036229          844 SCSTEEFKALILEYMPHGSLEKSLYSSN---YILDIFQRLNIMVDVATTLEYLHFGYSA---PVIHCDLKPSNVLLDDNM  917 (982)
Q Consensus       844 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~L~yLH~~~~~---~ivHrDlkp~NILl~~~~  917 (982)
                      ++..++..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   ++   ||+||||||+||+++.++
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTC
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCC
Confidence            9999999999999999999999998643   34899999999999999999999   77   999999999999999999


Q ss_pred             cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          918 VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .+||+|||+|+...... ........||+.|+|||++.+..++.   .+|+|++|+
T Consensus       172 ~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~slG~  223 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSE---KTDVFGYGV  223 (326)
T ss_dssp             CEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECH---HHHHHHHHH
T ss_pred             CEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCc---cccchhHHH
Confidence            99999999998764332 22334566999999999997766553   355666664

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=2.3e-30  Score=290.01  Aligned_cols=185  Identities=23%  Similarity=0.335  Sum_probs=158.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccch------hhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGR------AFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|+++.....      ..+.+.+|++++++++||||+++++++.+++.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3568999999999999999999865 5899999999754321      34678999999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecC
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGI  926 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGl  926 (982)
                      .++||||+++|+|.+++... ..+++..+..++.||+.||+|||   ++||+||||||+||++++++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            99999999999999999654 45899999999999999999999   99999999999999998776    799999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ++.+....   ......||+.|+|||++.+..++..   +|+|++|
T Consensus       166 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  205 (361)
T 2yab_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIG  205 (361)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTH---HHHHHHH
T ss_pred             ceEcCCCC---ccccCCCCccEECchHHcCCCCCcc---ccHHHHH
Confidence            99764322   2345679999999999977666544   4455555

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=1.1e-30  Score=290.70  Aligned_cols=188  Identities=23%  Similarity=0.332  Sum_probs=157.6

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCe
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEF  850 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~  850 (982)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.++++.+ +||||+++++++.+++.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345689999999999999999999965 58999999997542   23456678899999877 99999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999997643 4899999999999999999999   999999999999999999999999999999864


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ....  ......+||+.|+|||++.+..++..   +|+|++|
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  205 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHS---VDWWSFG  205 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTH---HHHHHHH
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCCh---hhhHHHH
Confidence            2221  22345789999999999987766644   3445555

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=3e-30  Score=283.65  Aligned_cols=273  Identities=20%  Similarity=0.180  Sum_probs=225.6

Q ss_pred             cEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCC--CCccccCcCCCCeEE
Q 036229          427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGS--IPITLGKLQKLQGLH  504 (982)
Q Consensus       427 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~  504 (982)
                      +.++.+++.++.++...     ...+++|++++|++++..+..|.++++|+.|+|++|+++..  .|..+..+++|++|+
T Consensus        10 ~~l~c~~~~l~~ip~~~-----~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~   84 (306)
T 2z66_A           10 TEIRCNSKGLTSVPTGI-----PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD   84 (306)
T ss_dssp             TEEECCSSCCSSCCSCC-----CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred             CEEEcCCCCcccCCCCC-----CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence            36677777776665432     35678888888888876666788999999999999999843  367777899999999


Q ss_pred             eeccCCCCCCCcccCCCccccEEEccCCcCCcCCC-ccccCCCcccccccCCCcccccc-cccccccCceEEecCCCccc
Q 036229          505 LEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP-ACFSNLASLGTLSLGSNKLTSIP-LTIWNLKGMLYLNFSSNFFT  582 (982)
Q Consensus       505 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~Ls~N~l~  582 (982)
                      |++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|+++.++ ..+..+++|++|++++|.++
T Consensus        85 Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  163 (306)
T 2z66_A           85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ  163 (306)
T ss_dssp             CCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred             CCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence            9999998 467778999999999999999987665 67899999999999999999554 45667899999999999998


Q ss_pred             C-CCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccc
Q 036229          583 G-PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISL  661 (982)
Q Consensus       583 ~-~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  661 (982)
                      + ..|..+..+++|+.||+++|++++..|..|+.+++|++|+|++|++++..+..|..+++|+.|||++|++++..|..+
T Consensus       164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  243 (306)
T 2z66_A          164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL  243 (306)
T ss_dssp             GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSC
T ss_pred             cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHH
Confidence            7 678889999999999999999999889999999999999999999998888899999999999999999999999999


Q ss_pred             cccc-ccceeecCCCcccccCCCCC---CCCCCCCcccccCcccCCCC
Q 036229          662 EKLS-YLEDLDLSFNKLKGEIPKGG---SFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       662 ~~l~-~L~~l~ls~N~l~~~~p~~~---~~~~~~~~~~~gn~~lc~~~  705 (982)
                      ..++ +|++|+|++|+++|.++...   ++..........+...|..|
T Consensus       244 ~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p  291 (306)
T 2z66_A          244 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP  291 (306)
T ss_dssp             CCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred             HhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence            9884 89999999999998765321   11122222334566677665

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=9.9e-31  Score=294.92  Aligned_cols=189  Identities=28%  Similarity=0.433  Sum_probs=159.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe--------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCC
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI--------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE  848 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  848 (982)
                      .++|++.+.||+|+||.||+|+.        .++..||||+++... ....+++.+|+++++++ +||||+++++++..+
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46899999999999999999975        235789999997543 34457889999999999 899999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                      +..|+||||+++|+|.+++....               ..+++.++..++.||+.||+|||   ++||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998643               24788999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +.++.+||+|||+|+...............+|+.|+|||++.+..++..   +|+|++|+
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~DvwslG~  293 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ---SDVWSFGV  293 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH---HHHHHHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH---HHHHHHHH
Confidence            9999999999999997654433333345567889999999977666544   45566664

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.8e-29  Score=291.67  Aligned_cols=250  Identities=25%  Similarity=0.286  Sum_probs=227.1

Q ss_pred             ccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEe
Q 036229          426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHL  505 (982)
Q Consensus       426 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  505 (982)
                      .+.++.+++.++.++..     ++..+++|++++|++++..|..|.++++|+.|+|++|+|+++.|..|.++++|++|+|
T Consensus        56 ~~~v~c~~~~l~~iP~~-----~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L  130 (452)
T 3zyi_A           56 FSKVVCTRRGLSEVPQG-----IPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLEL  130 (452)
T ss_dssp             SCEEECCSSCCSSCCSC-----CCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CcEEEECCCCcCccCCC-----CCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEEC
Confidence            34677777777766543     2357889999999999989999999999999999999999999999999999999999


Q ss_pred             eccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCC-Ccccccccc-cccccCceEEecCCCcccC
Q 036229          506 EDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS-NKLTSIPLT-IWNLKGMLYLNFSSNFFTG  583 (982)
Q Consensus       506 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~  583 (982)
                      ++|+|++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++ |.++.+|.. +..+++|++|++++|++++
T Consensus       131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  210 (452)
T 3zyi_A          131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD  210 (452)
T ss_dssp             CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred             CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence            99999988888899999999999999999988888999999999999999 678888875 5679999999999999996


Q ss_pred             CCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccccc
Q 036229          584 PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEK  663 (982)
Q Consensus       584 ~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  663 (982)
                      . | .+..+++|+.|||++|++++..|..|.++++|++|+|++|++++..|.+|.++++|+.|+|++|+|++..+..+..
T Consensus       211 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  288 (452)
T 3zyi_A          211 M-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTP  288 (452)
T ss_dssp             C-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTT
T ss_pred             c-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhcc
Confidence            5 3 5889999999999999999999999999999999999999999999999999999999999999999888888899


Q ss_pred             ccccceeecCCCcccccCC
Q 036229          664 LSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       664 l~~L~~l~ls~N~l~~~~p  682 (982)
                      +++|+.|+|++|++.+.+.
T Consensus       289 l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          289 LRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             CTTCCEEECCSSCEECSTT
T ss_pred             ccCCCEEEccCCCcCCCCC
Confidence            9999999999999988765

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.6e-30  Score=285.59  Aligned_cols=185  Identities=20%  Similarity=0.321  Sum_probs=160.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.. ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999865 5899999998754 33456788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC--CCcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~~~~~~  935 (982)
                      +++|+|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.  ++.+||+|||++..+.... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999876667899999999999999999999   999999999999999986  7899999999999764322 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  191 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTA---TDMWSLGT  191 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHH---HHHHHHHH
T ss_pred             --ccccccCChhhcCcHHhcCCCCCch---hhHHHHHH
Confidence              2345679999999999977665543   45566663

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=8.5e-31  Score=289.91  Aligned_cols=188  Identities=23%  Similarity=0.319  Sum_probs=156.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999865 68999999997543 2334678899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++|+|.+++... ..+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999998654 35899999999999999999999   999999999999999999999999999999876443333


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .......||+.|+|||++.+..+...  .+|+|++|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG  195 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAE--PVDVWSCG  195 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHH--HHHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCC--cccHHHHH
Confidence            33456789999999999976644222  24455555

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=2.1e-30  Score=287.05  Aligned_cols=190  Identities=26%  Similarity=0.437  Sum_probs=158.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|++.    .+..||||+++.. .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467889999999999999999863    3567999999754 33455788999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877677999999999999999999999   999999999999999999999999999999976433


Q ss_pred             CC-ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQ-SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .. ........+|+.|+|||++.+..++.   .+|+|++|++
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~---~~Di~slG~i  243 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSS---ASDVWSFGVV  243 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECH---HHHHHHHHHH
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCc---HHHHHHHHHH
Confidence            22 22233445688999999997766554   3556666643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=2e-30  Score=285.66  Aligned_cols=182  Identities=27%  Similarity=0.340  Sum_probs=157.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999864 69999999997542   23456778899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.+|.+||+|||+|+..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999997644 5899999999999999999999   999999999999999999999999999999875321 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                          ....+||+.|+|||++.+..++..   +|+|++|
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  190 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFG  190 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTT---HHHHHHH
T ss_pred             ----cccccCCccccCHhHhcCCCCCcc---cchhhhH
Confidence                234679999999999987766644   3445555

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=1.7e-29  Score=292.35  Aligned_cols=244  Identities=21%  Similarity=0.217  Sum_probs=207.2

Q ss_pred             EEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcc
Q 036229           86 LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNAL  165 (982)
Q Consensus        86 L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  165 (982)
                      ++.++.+++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+
T Consensus        48 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l  124 (440)
T 3zyj_A           48 VICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL  124 (440)
T ss_dssp             EECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred             EEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence            444556666 6777665  6899999999999988888999999999999999999988888899999999999999999


Q ss_pred             cccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccccccc-ccccccccchhhhhccCCCCCCchhh
Q 036229          166 SGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAI-PKEIGNLTKLKELYLGYSGLQGEIPR  244 (982)
Q Consensus       166 ~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~  244 (982)
                      + .+|...|..+++|++|+|++|+++...+..|.++++|++|+|++|+..+.+ +..|.++++|++|+|++|+++. +| 
T Consensus       125 ~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-  201 (440)
T 3zyj_A          125 T-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-  201 (440)
T ss_dssp             S-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-
T ss_pred             C-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-
Confidence            8 788777799999999999999999888889999999999999985544444 4478899999999999999984 44 


Q ss_pred             hcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCC
Q 036229          245 EFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTL  324 (982)
Q Consensus       245 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  324 (982)
                      .+..+++|+.|++++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|||++|++++..+..+..+++|
T Consensus       202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  281 (440)
T 3zyj_A          202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL  281 (440)
T ss_dssp             CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred             ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence            47888888889998888888888888888888999998888888888888888888888888888887777777777778


Q ss_pred             ceeecCCCcCC
Q 036229          325 TGLGLQSNSLS  335 (982)
Q Consensus       325 ~~L~L~~N~l~  335 (982)
                      +.|+|++|++.
T Consensus       282 ~~L~L~~Np~~  292 (440)
T 3zyj_A          282 ERIHLHHNPWN  292 (440)
T ss_dssp             CEEECCSSCEE
T ss_pred             CEEEcCCCCcc
Confidence            77777777764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=2.2e-29  Score=278.75  Aligned_cols=224  Identities=21%  Similarity=0.260  Sum_probs=194.9

Q ss_pred             cccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEcc
Q 036229          451 SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLS  530 (982)
Q Consensus       451 ~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  530 (982)
                      .++.|++++|+++ .+|..+..+++|++|+|++|+++ .+|..++.+++|++|+|++|+++ .+|..+..+++|++|+|+
T Consensus        82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~  158 (328)
T 4fcg_A           82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR  158 (328)
T ss_dssp             TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred             ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence            3455555555555 45666777888888888888888 77888888888888888888888 678888888888888888


Q ss_pred             CCcCCcCCCccccC---------CCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecc
Q 036229          531 GNKLSGSIPACFSN---------LASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFS  601 (982)
Q Consensus       531 ~N~l~~~~p~~~~~---------l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls  601 (982)
                      +|++.+.+|..+..         +++|++|+|++|+++.+|..+..+++|++|++++|++++ +|..++.+++|+.|+++
T Consensus       159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls  237 (328)
T 4fcg_A          159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR  237 (328)
T ss_dssp             EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECT
T ss_pred             CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECc
Confidence            88777788877654         999999999999999999999999999999999999996 56679999999999999


Q ss_pred             cccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCccc
Q 036229          602 TNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK  678 (982)
Q Consensus       602 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~  678 (982)
                      +|++.+.+|..++.+++|++|+|++|++.+.+|.+|+++++|+.|+|++|++.+.+|..+..+++|+.++++.|.+.
T Consensus       238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988775

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=2.1e-30  Score=289.34  Aligned_cols=186  Identities=22%  Similarity=0.255  Sum_probs=157.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|+... ++.||+|+++..   .....+.+..|.++++.+ +||+|+++++++++.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            45789999999999999999999754 889999999754   223456778899999988 8999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||++||+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999997644 4899999999999999999999   99999999999999999999999999999986422


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .  .......+||+.|+|||++.+..++..   +|+|++|
T Consensus       174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  208 (353)
T 2i0e_A          174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFG  208 (353)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBSTH---HHHHHHH
T ss_pred             C--CcccccccCCccccChhhhcCCCcCCc---ccccchH
Confidence            2  223345789999999999987766644   3344444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.1e-30  Score=287.73  Aligned_cols=247  Identities=21%  Similarity=0.234  Sum_probs=118.3

Q ss_pred             CCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcc-cCccCcccc-------CcCCCCccccccCcccccCchhhh-
Q 036229          104 LSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQL-SGAFPSFIF-------NKSSLQHLDFSYNALSGEIPANIC-  174 (982)
Q Consensus       104 l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~ip~~~~-  174 (982)
                      .++|+.|++++|.+  .+|..+...  |++|+|++|++ .+.+|..+.       ++++|++|+|++|.+++.+|..+| 
T Consensus        42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  117 (312)
T 1wwl_A           42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE  117 (312)
T ss_dssp             EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSS
T ss_pred             CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHH
Confidence            34444555555554  444444433  45555555555 233444333       444455555555555444444432 


Q ss_pred             cCCCCCCeeeecceeeecccCCCccCc-----CcccEEEeeccccccccccccccccchhhhhccCCCCCCc--hhhhc-
Q 036229          175 SNLPFLESISLSQNMFHGRIPSALSNC-----KYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGE--IPREF-  246 (982)
Q Consensus       175 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~-  246 (982)
                      ..+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|+.+++|++|+|++|++.+.  .|..+ 
T Consensus       118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  196 (312)
T 1wwl_A          118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC  196 (312)
T ss_dssp             CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred             hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence            4444455555555554443 4444444     4455555555555444444455555555555555544433  12222 


Q ss_pred             -CCCcccceEeccccccCC--cCC-hhhhccCCCcEEEccCCccccCCC-ccccccCCCcEEEccCccccccCcccccCC
Q 036229          247 -GNLAELELMALQVSNLQG--EIP-QELANLTGLEVLKLGKNFLTGEIP-PEIHNLHNLKLLDLSHNKLVGAVPATIFNM  321 (982)
Q Consensus       247 -~~l~~L~~L~L~~n~l~~--~~p-~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  321 (982)
                       ..+++|+.|++++|++++  .++ ..+.++++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+.  
T Consensus       197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--  273 (312)
T 1wwl_A          197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--  273 (312)
T ss_dssp             TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--
T ss_pred             hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--
Confidence             444455555555554442  111 223344555555555555554442 23344455555555555554 3333322  


Q ss_pred             CCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCcc
Q 036229          322 STLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSG  385 (982)
Q Consensus       322 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~  385 (982)
                                               ++|++|+|++|++++. |. +..+++|++|++++|++++
T Consensus       274 -------------------------~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          274 -------------------------AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             -------------------------SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             -------------------------CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence                                     4456666666666644 43 5566666666666666654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.96  E-value=1.3e-30  Score=294.22  Aligned_cols=193  Identities=18%  Similarity=0.241  Sum_probs=160.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEE------eCCCeEEEEEEeecccchhhhhHHHHHHHhhhcC---CccceeEEeeecCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKAR------IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR---HRNLIKVISSCSTE  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~  848 (982)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|+++...   ..++..|+++++.++   |+||+++++++..+
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            45789999999999999999994      4468899999987543   456777888888876   99999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhc----CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---------
Q 036229          849 EFKALILEYMPHGSLEKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---------  915 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---------  915 (982)
                      +..++||||+++|+|.+++..    ....+++..+..++.|++.||+|||   ++|||||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999974    3456899999999999999999999   999999999999999988         


Q ss_pred             --CCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          916 --NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       916 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                        ++.+||+|||+|+.+............+||+.|||||++.+..++..   +|+|++|  ++.+.+|
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~il~elltg  281 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ---IDYFGVAATVYCMLFG  281 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH---HHHHHHHHHHHHHHHS
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc---ccHHHHHHHHHHHHhC
Confidence              89999999999987643334445566789999999999988766644   4455555  4444444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=4.8e-29  Score=288.57  Aligned_cols=250  Identities=24%  Similarity=0.263  Sum_probs=225.0

Q ss_pred             ccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEe
Q 036229          426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHL  505 (982)
Q Consensus       426 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  505 (982)
                      .+.++.+++.++.++...     ...++.|++++|++++..+..|.++++|+.|+|++|+|+++.+..|.++++|++|+|
T Consensus        45 ~~~v~c~~~~l~~iP~~~-----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           45 FSKVICVRKNLREVPDGI-----STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             SCEEECCSCCCSSCCSCC-----CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCEEEeCCCCcCcCCCCC-----CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            346777777777665433     356888888888999888899999999999999999999888899999999999999


Q ss_pred             eccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCC-Ccccccccc-cccccCceEEecCCCcccC
Q 036229          506 EDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS-NKLTSIPLT-IWNLKGMLYLNFSSNFFTG  583 (982)
Q Consensus       506 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~  583 (982)
                      ++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++ |.++.+|.. +.++++|++|++++|.++.
T Consensus       120 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  199 (440)
T 3zyj_A          120 FDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE  199 (440)
T ss_dssp             CSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred             CCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence            99999988778899999999999999999988888999999999999999 667788874 5679999999999999985


Q ss_pred             CCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccccc
Q 036229          584 PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEK  663 (982)
Q Consensus       584 ~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  663 (982)
                      . | .+..+++|+.|||++|++++..|..|.++++|++|+|++|++++..+.+|.++++|+.|+|++|+|++..+..+..
T Consensus       200 ~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  277 (440)
T 3zyj_A          200 I-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTP  277 (440)
T ss_dssp             C-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSS
T ss_pred             c-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcc
Confidence            4 4 5889999999999999999999999999999999999999999999999999999999999999999888888899


Q ss_pred             ccccceeecCCCcccccCC
Q 036229          664 LSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       664 l~~L~~l~ls~N~l~~~~p  682 (982)
                      +++|+.|+|++|++.+.+.
T Consensus       278 l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          278 LHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             CTTCCEEECCSSCEECSST
T ss_pred             ccCCCEEEcCCCCccCCCC
Confidence            9999999999999988764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.5e-31  Score=292.69  Aligned_cols=266  Identities=20%  Similarity=0.215  Sum_probs=224.4

Q ss_pred             cCCCCCCCCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCc-cccCcchhh-------hccC
Q 036229           59 AKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRL-SGSIPSAIF-------TLYT  130 (982)
Q Consensus        59 ~~~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~-~~~~p~~~~-------~l~~  130 (982)
                      ..+|.....|+.|..+.......+++.|++++|.+  .+|+.+...  |+.|+|++|++ .+.+|..+.       ++++
T Consensus        21 ~~~~~~~~~c~~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~   96 (312)
T 1wwl_A           21 KPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISG   96 (312)
T ss_dssp             SCCGGGGGGSSSCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSC
T ss_pred             ccchHHHhhhhccccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCC
Confidence            45687667777777665442345788888999999  888877766  99999999999 567888776       7999


Q ss_pred             CcEEEccCCcccCccCccc--cCcCCCCccccccCcccccCchhhhcCC-----CCCCeeeecceeeecccCCCccCcCc
Q 036229          131 LKYVNFRGNQLSGAFPSFI--FNKSSLQHLDFSYNALSGEIPANICSNL-----PFLESISLSQNMFHGRIPSALSNCKY  203 (982)
Q Consensus       131 L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~ip~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~  203 (982)
                      |++|+|++|++++.+|..+  +.+++|++|+|++|.+++. |+.+ ..+     ++|++|+|++|++++..|..|+++++
T Consensus        97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~-~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWL-AELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHH-HHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHH-HHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            9999999999999999986  8999999999999999965 7554 666     99999999999999988899999999


Q ss_pred             ccEEEeeccccccc--ccccc--ccccchhhhhccCCCCCCc--hh-hhcCCCcccceEeccccccCCcCC-hhhhccCC
Q 036229          204 LEILSLSINNLLGA--IPKEI--GNLTKLKELYLGYSGLQGE--IP-REFGNLAELELMALQVSNLQGEIP-QELANLTG  275 (982)
Q Consensus       204 L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~~--~~-~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~  275 (982)
                      |++|+|++|++.+.  .|..+  +.+++|++|+|++|++++.  ++ ..+.++++|+.|++++|++++..| ..+..+++
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~  254 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ  254 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTT
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCC
Confidence            99999999998865  34444  8999999999999999942  23 456788999999999999998875 55778899


Q ss_pred             CcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCC
Q 036229          276 LEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLS  335 (982)
Q Consensus       276 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  335 (982)
                      |++|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+++|+.|+|++|+++
T Consensus       255 L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          255 LNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             CCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             CCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            999999999999 6677766  8999999999999976 65 777788877777777665

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=1.9e-30  Score=285.73  Aligned_cols=186  Identities=24%  Similarity=0.347  Sum_probs=155.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||.||+|+..+++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357899999999999999999998889999999986442  233467889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++ ++.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....  
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence            99975 888888877777999999999999999999999   999999999999999999999999999999876322  


Q ss_pred             ceeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      ........||+.|+|||++.+. .++..   +|+|++|
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwslG  207 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTS---VDIWSIG  207 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTH---HHHHHHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCch---HHhHHHH
Confidence            2223456789999999998653 34433   4555555

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2e-29  Score=292.87  Aligned_cols=245  Identities=21%  Similarity=0.196  Sum_probs=206.1

Q ss_pred             EEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCc
Q 036229           85 VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA  164 (982)
Q Consensus        85 ~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  164 (982)
                      .++.++.+++ .+|..+.  ++++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.
T Consensus        58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            3455566666 6776554  689999999999998888899999999999999999998888899999999999999999


Q ss_pred             ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccccccc-ccccccccchhhhhccCCCCCCchh
Q 036229          165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAI-PKEIGNLTKLKELYLGYSGLQGEIP  243 (982)
Q Consensus       165 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~  243 (982)
                      ++ .+|...|..+++|++|+|++|++++..+..|.++++|++|+|++|+..+.+ +..|.++++|++|+|++|++++. |
T Consensus       135 l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~  212 (452)
T 3zyi_A          135 LT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P  212 (452)
T ss_dssp             CS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C
T ss_pred             CC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c
Confidence            98 677777789999999999999999877888999999999999985443344 44688899999999999999854 3


Q ss_pred             hhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCC
Q 036229          244 REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST  323 (982)
Q Consensus       244 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  323 (982)
                       .+..+++|+.|++++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|||++|++++..+..+..+++
T Consensus       213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  291 (452)
T 3zyi_A          213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY  291 (452)
T ss_dssp             -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred             -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence             5778888889999999888888888888888999999999888888888888888889999888888777777777777


Q ss_pred             CceeecCCCcCC
Q 036229          324 LTGLGLQSNSLS  335 (982)
Q Consensus       324 L~~L~L~~N~l~  335 (982)
                      |+.|+|++|++.
T Consensus       292 L~~L~L~~Np~~  303 (452)
T 3zyi_A          292 LVELHLHHNPWN  303 (452)
T ss_dssp             CCEEECCSSCEE
T ss_pred             CCEEEccCCCcC
Confidence            777777777665

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=2.2e-30  Score=288.88  Aligned_cols=185  Identities=24%  Similarity=0.301  Sum_probs=157.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.+++++ +||||+++++++.+++..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367999999999999999999965 58999999997542   23456688899999988 89999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999997643 5899999999999999999999   999999999999999999999999999999864222


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        .......+||+.|+|||++.+..++..   +|+|++|
T Consensus       164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  197 (345)
T 3a8x_A          164 --GDTTSTFCGTPNYIAPEILRGEDYGFS---VDWWALG  197 (345)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTH---HHHHHHH
T ss_pred             --CCcccccCCCccccCccccCCCCCChH---HhHHHHH
Confidence              123345689999999999987766544   3445554

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=5.9e-30  Score=289.26  Aligned_cols=185  Identities=21%  Similarity=0.337  Sum_probs=160.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+++++.++||||+++++++.+++..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999864 5899999999866555567889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~~  935 (982)
                      +++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++  .++.+||+|||+|+...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999876667899999999999999999999   99999999999999997  45789999999999764322 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        ......||+.|+|||++.+..++..   +|+|++|
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlG  237 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFY---TDMWAIG  237 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHH---HHHHHHH
T ss_pred             --ceeeeccCCCccCchhccCCCCCCc---ccEeeHh
Confidence              2234579999999999987666544   4556666

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=1.8e-30  Score=293.79  Aligned_cols=192  Identities=23%  Similarity=0.348  Sum_probs=160.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||.||+|++. +++.||||+++... ....+++.+|++++++++||||+++++++..++..++||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            4568899999999999999999975 68999999987542 334567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999999876667899999999999999999999   99999999999999999999999999999986532211


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ........+++.|+|||++.+..++.   .+|+|++|+++
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~il  305 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSS---ESDVWSFGILL  305 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEH---HHHHHHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCc---hhhHHHHHHHH
Confidence            11112234677899999997665553   45667777543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=283.26  Aligned_cols=278  Identities=18%  Similarity=0.179  Sum_probs=186.4

Q ss_pred             cEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEE
Q 036229          350 EELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI  429 (982)
Q Consensus       350 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L  429 (982)
                      ...+.++|+++ .+|..+.  ++|++|++++|++++..+..|.++++|+.|++++|.++.+...     .|.++++|++|
T Consensus        34 ~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L  105 (353)
T 2z80_A           34 GICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED-----SFSSLGSLEHL  105 (353)
T ss_dssp             SEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEE
T ss_pred             eEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh-----hcCCCCCCCEE
Confidence            34555555555 3344332  3566666666666655555566666666555555555543221     25555555566


Q ss_pred             EccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCC-ccccCcCCCCeEEeecc
Q 036229          430 GLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP-ITLGKLQKLQGLHLEDN  508 (982)
Q Consensus       430 ~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N  508 (982)
                      +|++|++++                          ..+..|+++++|++|++++|++++..+ ..|..+++|++|++++|
T Consensus       106 ~Ls~n~l~~--------------------------~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n  159 (353)
T 2z80_A          106 DLSYNYLSN--------------------------LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM  159 (353)
T ss_dssp             ECCSSCCSS--------------------------CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEES
T ss_pred             ECCCCcCCc--------------------------CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCC
Confidence            666664432                          233346677788888888888875554 57888888888888888


Q ss_pred             -CCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccc-cccCceEEecCCCcccCCCc
Q 036229          509 -KLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFFTGPLP  586 (982)
Q Consensus       509 -~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~Ls~N~l~~~~~  586 (982)
                       .+++..+..|.++++|++|++++|++++..|..|.++++|++|++++|+++.+|..+. .+++|++|++++|.+++..+
T Consensus       160 ~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~  239 (353)
T 2z80_A          160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF  239 (353)
T ss_dssp             SSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCC
T ss_pred             ccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccc
Confidence             4776667788888888888888888888888888888888888888888888877654 46778888888887776544


Q ss_pred             cccccccccceeecccccccccccccccCccCcceEecccccccC----CccccccCCCCCCeeeCCCCcCCCCCCcc-c
Q 036229          587 LDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG----SISESFGDLISLKSLNLSNNNLSRSIPIS-L  661 (982)
Q Consensus       587 ~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-l  661 (982)
                      ..+..                     ......++.++|++|.+++    .+|+++.++++|+.|+|++|+++. +|.. |
T Consensus       240 ~~l~~---------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~  297 (353)
T 2z80_A          240 SELST---------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIF  297 (353)
T ss_dssp             C---------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTT
T ss_pred             ccccc---------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cCHHHH
Confidence            33221                     1123345555555555544    467778888888888888888874 5554 5


Q ss_pred             ccccccceeecCCCcccccCCC
Q 036229          662 EKLSYLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       662 ~~l~~L~~l~ls~N~l~~~~p~  683 (982)
                      ..+++|++|++++|++.|.+|.
T Consensus       298 ~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          298 DRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             TTCTTCCEEECCSSCBCCCHHH
T ss_pred             hcCCCCCEEEeeCCCccCcCCC
Confidence            7888888888888888887774

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=3.7e-30  Score=287.37  Aligned_cols=182  Identities=24%  Similarity=0.308  Sum_probs=157.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999965 58999999997542   23456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999997654 4899999999999999999999   999999999999999999999999999999976322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                          ....+||+.|+|||++.+..++..   +|+|++|
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  225 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKA---VDWWALG  225 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTH---HHHHHHH
T ss_pred             ----cccccCCccccCHHHhcCCCCCCc---CCEeccc
Confidence                234679999999999987766544   4445555

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=5.9e-30  Score=280.16  Aligned_cols=188  Identities=24%  Similarity=0.366  Sum_probs=152.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--------------------------hhhhhHHHHHHHhh
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--------------------------RAFKSFDVECEMMK  831 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  831 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.....                          ...+++.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999864 589999999864421                          12367889999999


Q ss_pred             hcCCccceeEEeeecC--CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 036229          832 SIRHRNLIKVISSCST--EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPS  909 (982)
Q Consensus       832 ~l~h~nIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~  909 (982)
                      +++||||+++++++.+  .+..++||||+++++|.++..  ...+++.++..++.|++.||+|||   ++||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999976  568899999999999988654  345899999999999999999999   999999999999


Q ss_pred             CEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          910 NVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       910 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||+++.++.+||+|||+++......  .......||+.|+|||++.+......+..+|+|++|+
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~  228 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV  228 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHH
T ss_pred             HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHH
Confidence            9999999999999999998764332  2234567999999999997654322333456677664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=8.5e-30  Score=274.32  Aligned_cols=189  Identities=25%  Similarity=0.380  Sum_probs=162.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|++.+.||+|+||.||+|+..++..||+|+++... ...+++.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            356899999999999999999999888999999997543 2346789999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+....... ..
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  160 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YV  160 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EE
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hh
Confidence            9999999999877667899999999999999999999   9999999999999999999999999999998764332 22


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......+|+.|+|||++.+..++..   +|+|++|++
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  194 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSK---SDVWAFGIL  194 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETT---HHHHHHHHH
T ss_pred             cccCCCcCcccCCHHHHhccCCchh---hhhHHHHHH
Confidence            3344567788999999977665543   556666643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=2.7e-30  Score=286.42  Aligned_cols=185  Identities=23%  Similarity=0.366  Sum_probs=156.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|.+.+.||+|+||.||+|+. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999996 568999999997432   22345788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+ +|++.+++...+ .+++.++..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+|.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 679999887654 4899999999999999999999   9999999999999999999999999999998653322


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....+||+.|+|||++.+..+...  .+|+|++|+
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~  196 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGP--EVDVWSCGI  196 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCH--HHHHHHHHH
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCC--ccchhHHHH
Confidence               2245679999999999987655322  345566553

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=4.8e-30  Score=280.07  Aligned_cols=187  Identities=24%  Similarity=0.388  Sum_probs=153.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999864 5899999998543   234456789999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999997654 5899999999999999999999   9999999999999999999999999999998653221


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ........||+.|+|||++.+..++..   +|+|++|+
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  200 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDEC---TDIYSIGI  200 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTT---HHHHHHHH
T ss_pred             -ccccCccccCccccCHhHhcCCCCCch---HhHHHHHH
Confidence             122344679999999999977665533   45566663

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=4.2e-31  Score=318.70  Aligned_cols=407  Identities=14%  Similarity=0.089  Sum_probs=204.4

Q ss_pred             cCcchhhhccCCcEEEccCCcc---cCccCcccc------------CcCCCCccccccCcccccCchhhhcCCCC-CCee
Q 036229          120 SIPSAIFTLYTLKYVNFRGNQL---SGAFPSFIF------------NKSSLQHLDFSYNALSGEIPANICSNLPF-LESI  183 (982)
Q Consensus       120 ~~p~~~~~l~~L~~L~Ls~N~l---~~~~p~~~~------------~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~-L~~L  183 (982)
                      ..+..+..+++|++|+|+++..   .+.+|..++            ++++|++|+|++|.+++..+..+...+++ |++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            3444566889999999988643   133443332            56677777777776665444444222333 7777


Q ss_pred             eeccee-eec-ccCCCccCcCcccEEEeeccccccc----cccccccccchhhhhccCCCCC----CchhhhcCCCcccc
Q 036229          184 SLSQNM-FHG-RIPSALSNCKYLEILSLSINNLLGA----IPKEIGNLTKLKELYLGYSGLQ----GEIPREFGNLAELE  253 (982)
Q Consensus       184 ~Ls~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~  253 (982)
                      +|++|. ++. .++.....+++|++|+|++|.+++.    ++..+..+++|++|++++|.++    +.++..+.++++|+
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV  223 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence            777665 221 1122223566677777777766544    2333445566666666666665    23334444556666


Q ss_pred             eEeccccccCCcCChhhhccCCCcEEEccCCccc---cCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecC
Q 036229          254 LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLT---GEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQ  330 (982)
Q Consensus       254 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  330 (982)
                      .|++++|.+.+ +|..+.++++|++|+++.....   ...+..+..+++|+.|+++++.. +.+|..+..+++|      
T Consensus       224 ~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L------  295 (592)
T 3ogk_B          224 SVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQI------  295 (592)
T ss_dssp             EEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGC------
T ss_pred             EEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCC------
Confidence            66666665554 4455666666666666542221   12223444555555555555432 2344444445555      


Q ss_pred             CCcCCCCcCccccccCCCccEEEccCCccccccc-ccccCCCCCCEEEeccccCccccCCccccCCccceeccc------
Q 036229          331 SNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIP-RFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLH------  403 (982)
Q Consensus       331 ~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~------  403 (982)
                                         ++|+|++|.+++... ..+..+++|++|+++++.....++..+..+++|+.|+++      
T Consensus       296 -------------------~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~  356 (592)
T 3ogk_B          296 -------------------RKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQ  356 (592)
T ss_dssp             -------------------CEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSS
T ss_pred             -------------------cEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCcccc
Confidence                               455555444433222 223445555555555221111122222344555555554      


Q ss_pred             -----ccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCccccc-ccccc
Q 036229          404 -----YNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGN-LTNLI  477 (982)
Q Consensus       404 -----~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~-l~~L~  477 (982)
                           .|.++.....    ..+..+++|++|+++.|.+                          ++..+..+.. +++|+
T Consensus       357 ~~~~~~~~~~~~~~~----~l~~~~~~L~~L~l~~~~l--------------------------~~~~~~~l~~~~~~L~  406 (592)
T 3ogk_B          357 GMEDEEGLVSQRGLI----ALAQGCQELEYMAVYVSDI--------------------------TNESLESIGTYLKNLC  406 (592)
T ss_dssp             TTSSTTCCCCHHHHH----HHHHHCTTCSEEEEEESCC--------------------------CHHHHHHHHHHCCSCC
T ss_pred             ccccccCccCHHHHH----HHHhhCccCeEEEeecCCc--------------------------cHHHHHHHHhhCCCCc
Confidence                 1233221110    0122344555555544433                          2222223332 55566


Q ss_pred             eEEec----CCCCCCC-----CCccccCcCCCCeEEeecc--CCCCCCCcccC-CCccccEEEccCCcCCcC-CCccccC
Q 036229          478 GIYLG----GNKLNGS-----IPITLGKLQKLQGLHLEDN--KLEGPIPDDIC-RLTKLYELGLSGNKLSGS-IPACFSN  544 (982)
Q Consensus       478 ~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~-~p~~~~~  544 (982)
                      .|+++    .|++++.     ++..+.++++|+.|+|+++  .+++..+..+. .+++|++|++++|++++. ++..+.+
T Consensus       407 ~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~  486 (592)
T 3ogk_B          407 DFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG  486 (592)
T ss_dssp             EEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTC
T ss_pred             EEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhc
Confidence            66664    4555543     2223455666666666532  24433333332 256666666666666542 3334455


Q ss_pred             CCcccccccCCCcccc--cccccccccCceEEecCCCcccC
Q 036229          545 LASLGTLSLGSNKLTS--IPLTIWNLKGMLYLNFSSNFFTG  583 (982)
Q Consensus       545 l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~Ls~N~l~~  583 (982)
                      +++|++|+|++|.++.  ++..+..+++|++|++++|+++.
T Consensus       487 ~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence            6666666666666652  33333445566666666666553

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=3.9e-30  Score=288.14  Aligned_cols=186  Identities=20%  Similarity=0.345  Sum_probs=155.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-----chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++...     ....+.+.+|+++++.++||||+++++++.+++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457999999999999999999864 58999999986432     123567899999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeecC
Q 036229          853 LILEYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGI  926 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGl  926 (982)
                      +||||+++++|.+.+...   ...+++..+..++.|++.||+|||   ++||+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887643   335799999999999999999999   999999999999999986554   99999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      +.......  .......||+.|+|||++.+..++..   +|+|++|
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  220 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKP---VDVWGCG  220 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTH---HHHHHHH
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCch---HhhHHHH
Confidence            98764322  22345679999999999977666543   4556666

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=4.7e-30  Score=282.02  Aligned_cols=191  Identities=28%  Similarity=0.435  Sum_probs=151.5

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      ++....++|++.+.||+|+||.||+|+. +++.||||++....  ....+++.+|++++++++||||+++++++...+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3334567899999999999999999987 68899999986543  33456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      ++||||+++|+|.+++.....  .+++..+..++.|++.||+|||   ++|  |+||||||+||+++.++.+||+|||++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            999999999999999976532  3889999999999999999999   999  999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +.....  ........||+.|+|||++.+..++..   +|+|++|+
T Consensus       187 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  227 (309)
T 3p86_A          187 RLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEK---SDVYSFGV  227 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTT---HHHHHHHH
T ss_pred             cccccc--ccccccCCCCccccChhhhcCCCCCch---hhHHHHHH
Confidence            864222  222345679999999999977765543   45666663

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=2.2e-30  Score=291.68  Aligned_cols=200  Identities=23%  Similarity=0.372  Sum_probs=165.5

Q ss_pred             ccCCHHHHHHHhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccce
Q 036229          768 RRFSYLELCRATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLI  839 (982)
Q Consensus       768 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv  839 (982)
                      ..++..+++...++|++.+.||+|+||.||+|++      .+++.||||+++... ....+.+.+|+++++++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3455667777889999999999999999999973      246899999997543 33456789999999999 799999


Q ss_pred             eEEeeecCCC-eeEEEEEeccCCChHHHHhcCCC----------------------------------------------
Q 036229          840 KVISSCSTEE-FKALILEYMPHGSLEKSLYSSNY----------------------------------------------  872 (982)
Q Consensus       840 ~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------  872 (982)
                      ++++++.+++ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999987755 48999999999999999976432                                              


Q ss_pred             -------------------cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          873 -------------------ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       873 -------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                                         .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                               1889999999999999999999   999999999999999999999999999999876544


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..........||+.|+|||++.+..++..   +|+|++|+
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  283 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQ---SDVWSFGV  283 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCch---hhhhhHHH
Confidence            44444556778999999999977665533   55666664

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=6.5e-30  Score=293.93  Aligned_cols=188  Identities=21%  Similarity=0.330  Sum_probs=158.1

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3467899999999999999999985 469999999997543  2345678999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceee
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLL  930 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~  930 (982)
                      ||||+++|+|.+.+.... .+++..+..++.|++.||+|||   ++||+||||||+||+++   +++.+||+|||+|...
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999987654 5899999999999999999999   99999999999999998   4678999999999876


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....  .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       164 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~---~DIwSlGv  201 (444)
T 3soa_A          164 EGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKP---VDLWACGV  201 (444)
T ss_dssp             CTTC--CBCCCSCSCGGGCCHHHHTTCCBCTH---HHHHHHHH
T ss_pred             cCCC--ceeecccCCcccCCHHHhcCCCCCCc---cccHHHHH
Confidence            4332  22345689999999999987666544   55666663

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=4.7e-30  Score=284.56  Aligned_cols=186  Identities=25%  Similarity=0.369  Sum_probs=148.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEe----CCCeEEEEEEeeccc----chhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|+++++.++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999986    468999999997542    2334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||+++++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999997643 4788999999999999999999   999999999999999999999999999999864


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....  .......||+.|+|||++.+..++..   .|+|++|+
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  209 (327)
T 3a62_A          172 IHDG--TVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGA  209 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTH---HHHHHHHH
T ss_pred             ccCC--ccccccCCCcCccCHhhCcCCCCCCc---ccchhHHH
Confidence            3221  22345679999999999977665543   45555553

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=6.9e-30  Score=286.96  Aligned_cols=185  Identities=21%  Similarity=0.404  Sum_probs=157.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999999999864 58999999997542  33456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecCceeec
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLI  931 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~~  931 (982)
                      |||+++|+|.+++... ..+++..+..++.||+.||+|||   ++||+||||||+||+++.+   +.+||+|||+|....
T Consensus       107 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            9999999999998754 45899999999999999999999   9999999999999999864   469999999998764


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...   ......||+.|+|||++.+..++..   +|+|++|
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  217 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKP---VDIWACG  217 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTH---HHHHHHH
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCch---hhHHHHH
Confidence            222   2235679999999999977666544   4556665

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=7e-30  Score=278.69  Aligned_cols=185  Identities=24%  Similarity=0.319  Sum_probs=156.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999864 58999999997543  3334678899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++ ++.+.+......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....  .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--C
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--c
Confidence            9975 777777666667999999999999999999999   999999999999999999999999999999876322  2


Q ss_pred             eeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      .......||+.|+|||++.+.. ++.   .+|+|++|+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG~  190 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYST---SIDMWSAGC  190 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCT---HHHHHHHHH
T ss_pred             ccccCCccccCCcChHHHcCCCCcCc---hHHHHHHHH
Confidence            2334567899999999986654 343   345566664

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=2.6e-30  Score=281.45  Aligned_cols=185  Identities=24%  Similarity=0.340  Sum_probs=153.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|++.+.||+|+||.||+|+..+++.||+|+++...  ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5799999999999999999998789999999996543  22346788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++ +|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....  ..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence            975 999999877677899999999999999999999   999999999999999999999999999999865322  12


Q ss_pred             eecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      ......||+.|+|||++.+. .++.   .+|+|++|+
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG~  189 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYST---TIDIWSVGC  189 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCT---HHHHHHHHH
T ss_pred             ccccccccccccCchheeCCCCCCc---HHHHHHHHH
Confidence            23345789999999998653 2333   345566653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=7.6e-30  Score=283.89  Aligned_cols=191  Identities=23%  Similarity=0.364  Sum_probs=154.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCC------
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  849 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3467999999999999999999975 69999999997543 345678899999999999999999999885432      


Q ss_pred             ---------------------------------------------------eeEEEEEeccCCChHHHHhcCCC--cCCH
Q 036229          850 ---------------------------------------------------FKALILEYMPHGSLEKSLYSSNY--ILDI  876 (982)
Q Consensus       850 ---------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~--~~~~  876 (982)
                                                                         ..++||||+++|+|.+++.....  ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999986532  3466


Q ss_pred             HHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc----------eeeccccccc
Q 036229          877 FQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS----------ITQTQTLATI  946 (982)
Q Consensus       877 ~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~  946 (982)
                      ..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            678899999999999999   999999999999999999999999999999986543211          1224457999


Q ss_pred             ccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          947 GYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       947 ~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .|+|||++.+..++..   +|+|++|++
T Consensus       241 ~y~aPE~~~~~~~~~~---~Di~slG~i  265 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHK---VDIFSLGLI  265 (332)
T ss_dssp             GGSCHHHHHCCCCCTH---HHHHHHHHH
T ss_pred             CccChHHhcCCCCcch---hhHHHHHHH
Confidence            9999999987665543   556666643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=6.8e-30  Score=299.20  Aligned_cols=193  Identities=24%  Similarity=0.349  Sum_probs=160.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+.+|+++++.++||||+++++++.+++..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999864 6999999999754   223346678999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          855 LEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |||++||+|.+++.... ..+++..+..++.||+.||+|||   ++|||||||||+||+++.+|.+||+|||+|+.+...
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999987643 34899999999999999999999   999999999999999999999999999999876432


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeeccc
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGR  978 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~  978 (982)
                      .   .....+||+.|+|||++.+..++... ++|++|+.++.+.+
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~-DiwSLGvilyeLlt  380 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSP-DWWALGCLLYEMIA  380 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHH-HHHHHHHHHHHHHH
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccc-hHHHHHHHHHHHHh
Confidence            2   23346899999999999877666442 23344444443433

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=7.8e-29  Score=269.30  Aligned_cols=251  Identities=21%  Similarity=0.210  Sum_probs=169.9

Q ss_pred             cEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEee
Q 036229          427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE  506 (982)
Q Consensus       427 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls  506 (982)
                      +.++.+++.++.++..     ....+++|++++|++++..+..|..+++|+.|++++|++++..|..|.++++|++|+|+
T Consensus        14 ~~~~c~~~~l~~ip~~-----~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   88 (285)
T 1ozn_A           14 VTTSCPQQGLQAVPVG-----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS   88 (285)
T ss_dssp             CEEECCSSCCSSCCTT-----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             eEEEcCcCCcccCCcC-----CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCC
Confidence            3667777766665432     23467777777777777777777778888888888888877777778888888888888


Q ss_pred             ccC-CCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccc-cccccCceEEecCCCcccCC
Q 036229          507 DNK-LEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLT-IWNLKGMLYLNFSSNFFTGP  584 (982)
Q Consensus       507 ~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~  584 (982)
                      +|+ +++..|..|..+++|++|++++|++++..|..|.++++|++|++++|+++.+|.. +..+++|++|++++|++++.
T Consensus        89 ~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  168 (285)
T 1ozn_A           89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (285)
T ss_dssp             SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence            886 7766677777788888888888888777777777777787777777777776654 44566666666666666655


Q ss_pred             CccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccc
Q 036229          585 LPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKL  664 (982)
Q Consensus       585 ~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  664 (982)
                      .+..+..+++|+.|++++|++++..|..|+.+++|++|+|++|++++.++..|..+++|+.|+|++|++....+.. .-+
T Consensus       169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~  247 (285)
T 1ozn_A          169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLW  247 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHH
T ss_pred             CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHH
Confidence            5555666666666666666666666666666666666666666666655555666666666666666665433321 122


Q ss_pred             cccceeecCCCcccccCCC
Q 036229          665 SYLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       665 ~~L~~l~ls~N~l~~~~p~  683 (982)
                      ..++.+..+.|.+.|..|.
T Consensus       248 ~~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          248 AWLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             HHHHHCCSEECCCBEEESG
T ss_pred             HHHHhcccccCccccCCch
Confidence            3355555566666666654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=4.1e-30  Score=289.84  Aligned_cols=181  Identities=23%  Similarity=0.428  Sum_probs=151.1

Q ss_pred             ccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccCCC
Q 036229          784 ENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGS  862 (982)
Q Consensus       784 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~gs  862 (982)
                      ..+.||+|+||.||+|+. .+++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            367899999999999986 4589999999987655667789999999999999999999999999999999999999999


Q ss_pred             hHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE--cCCCcEEEEeecCceeecCCCCceeec
Q 036229          863 LEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLIGEDQSITQT  940 (982)
Q Consensus       863 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~  940 (982)
                      |.+++......+++..+..++.|++.||+|||   ++||+||||||+||++  +.++.+||+|||+++.+....   ...
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence            99999876667899999999999999999999   9999999999999999  567899999999999764322   223


Q ss_pred             ccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          941 QTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...||+.|+|||++.+..++..   +|+|++|+
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  276 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFP---TDMWSVGV  276 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHH---HHHHHHHH
T ss_pred             cccCCCcEeChhhccCCCCCcH---HhHHHHHH
Confidence            4579999999999977655543   45566663

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=4.4e-30  Score=276.74  Aligned_cols=188  Identities=26%  Similarity=0.395  Sum_probs=161.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            46789999999999999999998889999999997543 23467899999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      ++++|.+++......+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++..... ....
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-cccc
Confidence            999999999877777899999999999999999999   999999999999999999999999999999865322 1222


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .....+|+.|+|||++.+..++..   +|+|++|++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~~  196 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSK---SDVWSFGVL  196 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCCch---hhhHHHHHH
Confidence            334567888999999976665543   556666643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=3.2e-30  Score=289.89  Aligned_cols=196  Identities=28%  Similarity=0.342  Sum_probs=151.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHH-hhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEM-MKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...   ......+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999965 58899999997543   2234556677776 577899999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||++||+|.+++.+.+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.+|.+||+|||+|+.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999997643 4788999999999999999999   999999999999999999999999999999864222


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeec--ccCCC
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFI--GRGNY  981 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~--~~~~f  981 (982)
                        .......+||+.|+|||++.+..++... ++|++|+.++.+  |..||
T Consensus       193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~-DiwslG~il~ell~G~~Pf  239 (373)
T 2r5t_A          193 --NSTTSTFCGTPEYLAPEVLHKQPYDRTV-DWWCLGAVLYEMLYGLPPF  239 (373)
T ss_dssp             --CCCCCSBSCCCCCCCHHHHTTCCCCTHH-HHHHHHHHHHHHHHSSCTT
T ss_pred             --CCccccccCCccccCHHHhCCCCCCchh-hhHHHHHHHHHHHcCCCCC
Confidence              2233457899999999999877666442 233444444433  34444

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.4e-29  Score=280.67  Aligned_cols=185  Identities=23%  Similarity=0.327  Sum_probs=157.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc------hhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG------RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++....      ...+.+.+|++++++++||||+++++++.+++..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457999999999999999999865 589999999975432      1356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGla  927 (982)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||   ++||+||||||+||+++.++    .+||+|||+|
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            9999999999999999754 45899999999999999999999   99999999999999998877    8999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +......   ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  205 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGV  205 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTH---HHHHHHHH
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcH---HHHHHHHH
Confidence            8764322   2234679999999999977665543   45566663

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=3.8e-30  Score=281.23  Aligned_cols=189  Identities=27%  Similarity=0.430  Sum_probs=155.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-----CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCC--Cee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~  851 (982)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46899999999999999999984     35899999999876666678899999999999999999999998543  568


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++|+|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999877667899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..... .......+++.|+|||++.+..++..   +|+|++|+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  205 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVA---SDVWSFGV  205 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChH---HHHHHHHH
Confidence            33221 22234557888999999977665543   55666664

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=1.2e-29  Score=296.67  Aligned_cols=195  Identities=25%  Similarity=0.359  Sum_probs=161.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|...+.||+|+||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367889999999999999999974 59999999997542   23346788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          855 LEYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      |||++||+|.+++...   ...+++..+..++.||+.||+|||   ++||+||||||+||+++.+|.+||+|||+|+.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999998754   345899999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ...  ......+||+.|+|||++.+..++... ++|++|+.++.+.+|
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~-DiwSlGvilyelltG  385 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSV-DYFALGVTLYEMIAA  385 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHH-HHHHHHHHHHHHHHS
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHH-hcCcchHHHHHHHhC
Confidence            322  122345899999999999887666442 233444444444333

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=5e-30  Score=289.33  Aligned_cols=190  Identities=23%  Similarity=0.434  Sum_probs=149.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+..    ++..||||+++.. .....+++.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            467999999999999999999864    4778999999754 33445789999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999877767999999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ... .......+++.|+|||++.+..++.   .+|+|++|++
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~SlG~i  239 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTS---ASDVWSYGIV  239 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCH---HHHHHHHHHH
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCc---hhcHHHHHHH
Confidence            221 1222334577899999997766554   3566777643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=3.2e-29  Score=275.65  Aligned_cols=199  Identities=34%  Similarity=0.507  Sum_probs=169.5

Q ss_pred             cccCCHHHHHHHhcCCCcc------ceeeeeceEEEEEEEeCCCeEEEEEEeecc----cchhhhhHHHHHHHhhhcCCc
Q 036229          767 CRRFSYLELCRATNRFSEN------NLIGRGGFGSVYKARIGEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRHR  836 (982)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~  836 (982)
                      ...|++.++..++++|...      +.||+|+||.||+|+. +++.||+|++...    .....+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            4678999999999999877      9999999999999987 6889999998643    233457789999999999999


Q ss_pred             cceeEEeeecCCCeeEEEEEeccCCChHHHHhcC--CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc
Q 036229          837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSS--NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD  914 (982)
Q Consensus       837 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~  914 (982)
                      ||+++++++.+.+..++||||+++++|.+++...  ...+++..+..++.|++.||+|||   ++||+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998743  345899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          915 DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       915 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +++.+||+|||++................||+.|+|||++.+. ++   ..+|+|++|+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~---~~~Dv~slG~  222 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-IT---PKSDIYSFGV  222 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-EC---THHHHHHHHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-CC---ccchhHHHHH
Confidence            9999999999999876544333334456799999999998764 22   3456666664

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=7.4e-30  Score=282.51  Aligned_cols=195  Identities=25%  Similarity=0.314  Sum_probs=157.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC----eeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----FKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|++. ++.||||+++... .......+|+.++++++||||+++++++....    ..++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3568999999999999999999874 7999999997543 33445667999999999999999999987644    4699


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC----------CeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA----------PVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~----------~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                      ||||+++|+|.+++....  +++..+..++.|++.||+|||   +.          ||+||||||+||+++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            999999999999997643  899999999999999999999   88          999999999999999999999999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeeeeee--eeEEeeEeeeeee--eeecccC
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYI--LFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ||+|+.+.............||+.|+|||++.+...  ...+..+|+|++|  ++.+.+|
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg  234 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR  234 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence            999988755444444455689999999999865311  1111234556665  4444443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=287.40  Aligned_cols=191  Identities=28%  Similarity=0.423  Sum_probs=161.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe--------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI--------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      ..++|.+.+.||+|+||.||+|+.        ..+..||||+++... .....++.+|+++++++ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            356899999999999999999985        224689999997543 34457789999999999 99999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                      ++..++||||+++|+|.+++....               ..+++.++..++.|++.||+|||   ++||+||||||+||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            999999999999999999998653               35899999999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       913 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +++++.+||+|||+|+...............+|+.|+|||++.+..++..   +|+|++|++
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~DiwslG~i  282 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ---SDVWSFGVL  282 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH---HHHHHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch---hHHHHHHHH
Confidence            99999999999999987644433334455668899999999977665543   556666643

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=4.5e-29  Score=271.21  Aligned_cols=250  Identities=25%  Similarity=0.231  Sum_probs=219.6

Q ss_pred             cEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCC
Q 036229          453 EYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGN  532 (982)
Q Consensus       453 ~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  532 (982)
                      +.++.+++.++.. |..+  .++|+.|++++|++++..+..|..+++|++|+|++|++++..|..|..+++|++|++++|
T Consensus        14 ~~~~c~~~~l~~i-p~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQAV-PVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCSSC-CTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcccC-CcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            6788888888854 4433  468999999999999988899999999999999999999888999999999999999999


Q ss_pred             c-CCcCCCccccCCCcccccccCCCcccccc-cccccccCceEEecCCCcccCCCccccccccccceeeccccccccccc
Q 036229          533 K-LSGSIPACFSNLASLGTLSLGSNKLTSIP-LTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP  610 (982)
Q Consensus       533 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~ip-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p  610 (982)
                      + ++...|..|.++++|++|++++|+++.++ ..+..+++|++|++++|++++..+..++.+++|+.|++++|++++..+
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  170 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence            8 88777999999999999999999999875 456789999999999999998888889999999999999999998888


Q ss_pred             ccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCCCCCCCC
Q 036229          611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNF  690 (982)
Q Consensus       611 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~  690 (982)
                      ..|..+++|++|+|++|++++..|.+|.++++|+.|+|++|++++..|..+..+++|++|++++|++.+.++....+..+
T Consensus       171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l  250 (285)
T 1ozn_A          171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL  250 (285)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred             HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHH
Confidence            88999999999999999999998999999999999999999999877777999999999999999999887754211112


Q ss_pred             CCcccccCcccCCCC
Q 036229          691 SAKSFEGNELLCGSP  705 (982)
Q Consensus       691 ~~~~~~gn~~lc~~~  705 (982)
                      .......+...|..|
T Consensus       251 ~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          251 QKFRGSSSEVPCSLP  265 (285)
T ss_dssp             HHCCSEECCCBEEES
T ss_pred             HhcccccCccccCCc
Confidence            222344566667665

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=4e-29  Score=297.45  Aligned_cols=293  Identities=24%  Similarity=0.290  Sum_probs=222.3

Q ss_pred             cccCCCCCCCCCCceeeEEec------CCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccC
Q 036229           57 FLAKNWNTSTPVCNWTGVTCD------VHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYT  130 (982)
Q Consensus        57 ~~~~~w~~~~~~c~w~gv~c~------~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~  130 (982)
                      ...++|....+||.|.|..|.      +....++.|++++++++ .+|..+.  ++|+.|+|++|.++ .+|.   .+++
T Consensus        10 ~~w~~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~   82 (622)
T 3g06_A           10 AVWSAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE   82 (622)
T ss_dssp             CHHHHHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred             HHHHHHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence            345678877889999775432      11235889999999998 8888776  79999999999998 6776   5789


Q ss_pred             CcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEee
Q 036229          131 LKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLS  210 (982)
Q Consensus       131 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  210 (982)
                      |++|+|++|+++ .+|.   .+++|++|+|++|.++ .+|.    .+++|+.|++++|++++ +|..   +++|++|+|+
T Consensus        83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls  149 (622)
T 3g06_A           83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVS  149 (622)
T ss_dssp             CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred             CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECc
Confidence            999999999998 4666   6789999999999998 5665    46889999999999886 5543   4789999999


Q ss_pred             ccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCC
Q 036229          211 INNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEI  290 (982)
Q Consensus       211 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  290 (982)
                      +|++++ +|..   +++|+.|++++|++++ +|   ..+++|+.|++++|++++ +|.   .+++|+.|++++|.++. +
T Consensus       150 ~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l  216 (622)
T 3g06_A          150 DNQLAS-LPAL---PSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLTS-L  216 (622)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSS-C
T ss_pred             CCcCCC-cCCc---cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCcccc-c
Confidence            999884 4543   4678888999999885 44   456788888888888875 343   24788888888888884 4


Q ss_pred             CccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCC
Q 036229          291 PPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA  370 (982)
Q Consensus       291 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  370 (982)
                      |..   +++|++|+|++|+|++ +|   ..+++|+.|+|++|.|+....     .+++|++|+|++|+|+ .+|..+.++
T Consensus       217 ~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~-----~~~~L~~L~Ls~N~L~-~lp~~l~~l  283 (622)
T 3g06_A          217 PAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM-----LPSGLLSLSVYRNQLT-RLPESLIHL  283 (622)
T ss_dssp             CCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC-----CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred             CCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc-----ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence            432   4678888888888875 44   345778888888888774332     4567788888888887 567777777


Q ss_pred             CCCCEEEeccccCccccCCccccCC
Q 036229          371 SKLSVLELGRNSFSGFIPNTFGNLR  395 (982)
Q Consensus       371 ~~L~~L~L~~N~i~~~~~~~~~~l~  395 (982)
                      ++|+.|+|++|++++..|..+..++
T Consensus       284 ~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          284 SSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cccCEEEecCCCCCCcCHHHHHhcc
Confidence            8888888888888777666655544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=1.1e-29  Score=280.34  Aligned_cols=186  Identities=24%  Similarity=0.344  Sum_probs=140.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3568999999999999999999864 58999999997543 233467889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCC-----CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          856 EYMPHGSLEKSLYSSN-----YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ||++ |+|.+++....     ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 59999887432     35889999999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      ....  .......||+.|+|||++.+. .++.   .+|+|++|
T Consensus       159 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG  196 (317)
T 2pmi_A          159 GIPV--NTFSSEVVTLWYRAPDVLMGSRTYST---SIDIWSCG  196 (317)
T ss_dssp             TSCC--CCCCCCCSCCTTCCHHHHTTCCCCCT---HHHHHHHH
T ss_pred             CCCc--ccCCCCcccccccCchHhhCCCCCCc---HHHHHHHH
Confidence            3222  223356789999999998653 3343   34556555

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.96  E-value=1.2e-29  Score=293.44  Aligned_cols=185  Identities=25%  Similarity=0.365  Sum_probs=157.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||+++...   ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999865 69999999997542   23356788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++.+. ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|.......
T Consensus        95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999999754 45899999999999999999999   9999999999999999999999999999999764322


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                         .....+||+.|+|||++.+..+...  .+|+|++|
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwSlG  203 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGP--EVDIWSSG  203 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSH--HHHHHHHH
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCC--cceehhhH
Confidence               2345679999999999977654322  24455555

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.96  E-value=9.2e-30  Score=284.70  Aligned_cols=193  Identities=26%  Similarity=0.395  Sum_probs=160.6

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecC
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCST  847 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  847 (982)
                      +....++|++.+.||+|+||.||+|+..      +++.||+|+++... ....+.+.+|++++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3345688999999999999999999863      35899999997543 3345788999999999999999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCC-----------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSN-----------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC  904 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHr  904 (982)
                      ++..++||||+++|+|.+++....                       ..+++.++..++.|++.||+|||   ++||+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            999999999999999999997632                       46889999999999999999999   9999999


Q ss_pred             CCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       905 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++..   +|+|++|+
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  264 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE---SDVWAYGV  264 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc---cccHHHHH
Confidence            9999999999999999999999987643332233345678999999999977665543   55666664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2e-29  Score=282.12  Aligned_cols=192  Identities=24%  Similarity=0.391  Sum_probs=159.9

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      +...++|++.+.||+|+||.||+|+.      .+++.||+|+++.. .....+.+.+|+++++++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34567899999999999999999985      24678999999754 234457889999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCCC----------------------cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcC
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSNY----------------------ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCD  905 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrD  905 (982)
                      .+..++||||+++|+|.+++.....                      .+++..+..++.|++.||+|||   ++||+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence            9999999999999999999986543                      3688999999999999999999   99999999


Q ss_pred             CCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          906 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       906 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |||+||+++.++.+||+|||++................||+.|+|||++.+..++..   +|+|++|+
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  262 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK---SDVWSYGI  262 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh---HhHHHHHH
Confidence            999999999999999999999987654444444455678899999999977665543   45566663

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.96  E-value=2e-29  Score=278.13  Aligned_cols=190  Identities=24%  Similarity=0.371  Sum_probs=160.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      ..++|.+.+.||+|+||.||+|+.      .+++.||+|+++... ....+++.+|++++++++||||+++++++.+++.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            357899999999999999999975      235889999997543 3445778999999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC-----------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 036229          851 KALILEYMPHGSLEKSLYSSN-----------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK  907 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlk  907 (982)
                      .++||||+++++|.+++....                       ..+++.++..++.|++.||+|||   ++||+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            999999999999999998643                       24789999999999999999999   9999999999


Q ss_pred             CCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       908 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |+||+++.++.+||+|||+++...............+|+.|+|||++.+..++..   +|+|++|+
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  240 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ---SDVWSFGV  240 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH---HHHHHHHH
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch---hhHHHHHH
Confidence            9999999999999999999997754444334445667899999999977665543   55666664

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=3.8e-30  Score=279.44  Aligned_cols=189  Identities=22%  Similarity=0.367  Sum_probs=158.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|++.+.||+|+||.||+|++.++..||+|+++.... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4578999999999999999999998899999999975432 346789999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +++++|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc-ccc
Confidence            9999999999876667999999999999999999999   999999999999999999999999999999865322 112


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ......+|+.|+|||++.+..++..   +|+|++|++
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~---~Dv~slG~~  210 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSK---SDIWAFGVL  210 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHH---HHHHHHHHH
T ss_pred             cccCCccCcccCCHHHhccCCCCch---hhHHHHHHH
Confidence            2234557788999999976665543   556666643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=8e-30  Score=295.40  Aligned_cols=186  Identities=24%  Similarity=0.314  Sum_probs=148.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++..   .......+.+|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999985 45899999999753   233446678899999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||   + +||+||||||+||+++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999987644 5899999999999999999999   8 99999999999999999999999999999854222


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        .......+||+.|+|||++.+..++..   +|+|++|+
T Consensus       303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  337 (446)
T 4ejn_A          303 --GATMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGV  337 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTH---HHHHHHHH
T ss_pred             --CcccccccCCccccCHhhcCCCCCCCc---cchhhhHH
Confidence              223345789999999999977766544   45566553

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=3.3e-29  Score=277.06  Aligned_cols=171  Identities=26%  Similarity=0.433  Sum_probs=147.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCC--eeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE--FKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999965 48999999997543 234567789999999999999999999987655  78999


Q ss_pred             EEeccCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCce
Q 036229          855 LEYMPHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAK  928 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~  928 (982)
                      |||+++++|.+++.....  .+++.++..++.|++.||+|||   ++||+||||||+||++    +.++.+||+|||+|+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999986432  3899999999999999999999   9999999999999999    788899999999999


Q ss_pred             eecCCCCceeecccccccccccCceee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFH  955 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~  955 (982)
                      ......   ......||+.|+|||++.
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhh
Confidence            764332   223467999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=4.7e-29  Score=270.08  Aligned_cols=188  Identities=24%  Similarity=0.379  Sum_probs=142.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            346799999999999999999986 468999999997442   2234678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999877677899999999999999999999   999999999999999999999999999999876322


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .  .......||+.|+|||++.+..++.   .+|+|++|+
T Consensus       166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  200 (278)
T 3cok_A          166 H--EKHYTLCGTPNYISPEIATRSAHGL---ESDVWSLGC  200 (278)
T ss_dssp             -------------------------------CTHHHHHHH
T ss_pred             C--CcceeccCCCCcCCcchhcCCCCCc---hhhHHHHHH
Confidence            2  1223457899999999997765543   355666663

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=4.6e-30  Score=289.25  Aligned_cols=190  Identities=23%  Similarity=0.365  Sum_probs=157.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++.. ......++.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999842      4778999998644 334456788999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCC------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEE
Q 036229          852 ALILEYMPHGSLEKSLYSSN------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLS  922 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~  922 (982)
                      ++||||+++|+|.+++...+      ..+++.++..++.|++.||+|||   ++||+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999998543      35889999999999999999999   99999999999999999555   59999


Q ss_pred             eecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          923 DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       923 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |||+|+.+.............||+.|+|||++.+..++..   +|+|++|++
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~DvwslG~i  275 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK---TDTWSFGVL  275 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcH---HHHHHHHHH
Confidence            9999986533333233345678999999999977666544   556666643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=9.2e-30  Score=285.99  Aligned_cols=192  Identities=23%  Similarity=0.280  Sum_probs=150.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3578999999999999999999965 68999999997543 334678899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--EEEEeecCceeecCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKLLIGED  934 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~  934 (982)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.  +||+|||+|+....  
T Consensus        97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            999999999987644 4899999999999999999999   999999999999999987665  99999999985322  


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                       ........||+.|+|||++.+..+....  +|+|++|  ++.+.+|
T Consensus       171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~--~DiwslG~il~ell~g  214 (361)
T 3uc3_A          171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKI--ADVWSCGVTLYVMLVG  214 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHH--HHHHHHHHHHHHHHHS
T ss_pred             -cCCCCCCcCCCCcCChhhhcCCCCCCCe--eeeehhHHHHHHHHhC
Confidence             1223446799999999999766554332  3445555  4444443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=1.8e-29  Score=280.64  Aligned_cols=185  Identities=22%  Similarity=0.256  Sum_probs=157.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ..+++.+|+++++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46899999999999999999985 569999999987543  245788999999999 99999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-----EEEEeecCceeec
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLI  931 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kL~DFGla~~~~  931 (982)
                      |+ +++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.     +||+|||+|+.+.
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 89999999876667999999999999999999999   999999999999999998887     9999999999764


Q ss_pred             CCCCce-----eecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          932 GEDQSI-----TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       932 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ......     ......||+.|+|||++.+..++..   +|+|++|
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG  204 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR---DDLEALG  204 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH---HHHHHHH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCch---hHHHHHH
Confidence            432211     1245679999999999987766544   3445555

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=9.9e-30  Score=280.01  Aligned_cols=184  Identities=22%  Similarity=0.229  Sum_probs=151.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.++||+|+||+||+|+.. +++.||||++....  .....+...|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999975 69999999986432  23334455566665555 999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+ +++|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|...... 
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence            9999 67999998877777999999999999999999999   999999999999999999999999999999876322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        .......||+.|+|||++.+. ++   ..+|+|++|+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~-~~---~~~DiwslG~  243 (311)
T 3p1a_A          211 --GAGEVQEGDPRYMAPELLQGS-YG---TAADVFSLGL  243 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGTC-CS---THHHHHHHHH
T ss_pred             --CCCcccCCCccccCHhHhcCC-CC---chhhHHHHHH
Confidence              223445699999999998763 33   3456666664

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=8e-30  Score=280.88  Aligned_cols=188  Identities=21%  Similarity=0.370  Sum_probs=149.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCe----
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF----  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----  850 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++...   ......+.+|++++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999996 569999999997542   2334678899999999999999999999876543    


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||+++++|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999997654 5899999999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...... .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  207 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR---SDVYSLGC  207 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHH---HHHHHHHH
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCch---HhHHHHHH
Confidence            433222 22234579999999999977665543   55666663

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=1.8e-29  Score=293.86  Aligned_cols=191  Identities=23%  Similarity=0.304  Sum_probs=142.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC-----CCe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST-----EEF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~  850 (982)
                      .++|++.+.||+|+||+||+|+.. +++.||||++...  .....+++.+|+++++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999854 6899999998643  33445778899999999999999999999843     357


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||+ +++|.+++... ..+++..+..++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 56999988754 45899999999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCc-------------------------eeecccccccccccCcee-eeeeeeeEEeeEeeeeee--eeecc
Q 036229          931 IGEDQS-------------------------ITQTQTLATIGYMAPGLF-HVKYILFVVNFLTSYSFL--MIFIG  977 (982)
Q Consensus       931 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~~d~~~~~--~~l~~  977 (982)
                      ......                         ...+..+||++|+|||++ .+..++..   +|+|++|  ++.+.
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~---~DiwSlG~il~ell  278 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA---IDVWSIGCIFAELL  278 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH---HHHHHHHHHHHHHH
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH---hHHHHHHHHHHHHH
Confidence            422111                         123456789999999986 44445543   3445555  44444

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=4.8e-29  Score=276.12  Aligned_cols=177  Identities=22%  Similarity=0.288  Sum_probs=133.7

Q ss_pred             cceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEEEeccCCC
Q 036229          785 NNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILEYMPHGS  862 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E~~~~gs  862 (982)
                      .+.||+|+||.||+|+.. +++.||||++...   ....+.+|+++++.+. ||||+++++++.+++..|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            488999999999999864 5899999999743   3467788999999997 9999999999999999999999999999


Q ss_pred             hHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEEEEeecCceeecCCCCceee
Q 036229          863 LEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       863 L~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      |.+++... ..+++.++..++.|++.||+|||   ++||+||||||+||+++.++   .+||+|||+++.....  ....
T Consensus        93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~  166 (325)
T 3kn6_A           93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL  166 (325)
T ss_dssp             HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence            99999765 45899999999999999999999   99999999999999998665   8999999999865332  2223


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....||+.|+|||++.+..++..   +|+|++|+
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~---~DiwslG~  197 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDES---CDLWSLGV  197 (325)
T ss_dssp             -----------------CCCCHH---HHHHHHHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCc---cchHHHHH
Confidence            45678999999999987766544   45566663

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=4.7e-29  Score=277.70  Aligned_cols=191  Identities=27%  Similarity=0.434  Sum_probs=159.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC--------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG--------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      ..++|++.+.||+|+||.||+|+..        +++.||+|+++... ....+++.+|+++++++ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3578999999999999999999852        46789999997543 34457789999999999 89999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                      ++..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   ++||+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence            999999999999999999997643               23789999999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       913 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++..   +|+|++|++
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  248 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ---SDVWSFGVL  248 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH---HHHHHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH---HHHHHHHHH
Confidence            99999999999999997654433333445567889999999977655533   556666643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=3.8e-29  Score=288.15  Aligned_cols=187  Identities=23%  Similarity=0.318  Sum_probs=151.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC-----Ce
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~  850 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++..  .....+++.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            578999999999999999999864 5899999999753  334457889999999999999999999999766     57


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||++ ++|.+++... ..+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 5999998754 45899999999999999999999   999999999999999999999999999999976


Q ss_pred             cCCCCc--------------------eeecccccccccccCcee-eeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQS--------------------ITQTQTLATIGYMAPGLF-HVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~~~~d~~~~~~  973 (982)
                      ......                    ...+..+||++|+|||++ ....++..   +|+|++|+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~---~DiwSlG~  240 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS---IDIWSTGC  240 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTH---HHHHHHHH
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc---cccchHHH
Confidence            433211                    123567899999999986 44445433   44555553

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=4.6e-29  Score=273.68  Aligned_cols=189  Identities=24%  Similarity=0.432  Sum_probs=157.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-----CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCC--Ce
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~  850 (982)
                      .++|++.+.||+|+||.||+|++     .+++.||+|+++... ....+.+.+|++++++++||||+++++++..+  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35689999999999999999983     358999999997442 33457789999999999999999999999776  66


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++||||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++...
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            89999999999999999776667999999999999999999999   999999999999999999999999999999977


Q ss_pred             cCCCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...... .......||..|+|||++.+..++..   +|+|++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  217 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA---SDVWSFGV  217 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH---HHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcc---hhHHHHHH
Confidence            543322 22345668889999999977665543   45566663

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=5.6e-29  Score=283.29  Aligned_cols=190  Identities=17%  Similarity=0.224  Sum_probs=158.8

Q ss_pred             HhcCCCccceeeee--ceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRG--GFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|++.+.||+|  +||.||+|+.. +++.||||+++...  ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35689999999999  99999999965 69999999997543  344567888999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          853 LILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      +||||+++|+|.+++... ...+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999764 345899999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCc-----eeecccccccccccCceeee--eeeeeEEeeEeeeeeee
Q 036229          932 GEDQS-----ITQTQTLATIGYMAPGLFHV--KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~d~~~~~~  973 (982)
                      .....     .......||+.|+|||++.+  ..++.   .+|+|++|+
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~---~~DiwslG~  225 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA---KSDIYSVGI  225 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCT---HHHHHHHHH
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCc---HhHHHHHHH
Confidence            22211     11233578999999999976  34443   345566663

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=3.1e-29  Score=276.48  Aligned_cols=190  Identities=25%  Similarity=0.391  Sum_probs=161.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeecccc-hhhhhHHHHHHHhhhc-CCccceeEEeeecCCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  849 (982)
                      ..++|++.+.||+|+||.||+|+.      .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++..++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            457899999999999999999974      3478999999975432 3457889999999999 9999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCC-----------------cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          850 FKALILEYMPHGSLEKSLYSSNY-----------------ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                      ..++||||+++|+|.+++.....                 .+++..+..++.|++.||+|||   ++||+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999986542                 3889999999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       913 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++.++.+||+|||++................+|+.|+|||++.+..++..   +|+|++|+
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  235 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE---SDVWSYGI  235 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH---HHHHHHHH
Confidence            99999999999999987654444334445668889999999977655533   55666664

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=3e-29  Score=280.57  Aligned_cols=184  Identities=22%  Similarity=0.325  Sum_probs=141.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999975 58899999997543  34678889999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCceeecCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~  933 (982)
                      |+++|+|.+++... ..+++.++..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            99999999998764 35899999999999999999999   999999999999999975   889999999999865322


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  238 (349)
T 2w4o_A          205 ---VLMKTVCGTPGYCAPEILRGCAYGPE---VDMWSVGI  238 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTH---HHHHHHHH
T ss_pred             ---cccccccCCCCccCHHHhcCCCCCcc---cchHHHHH
Confidence               22235679999999999977655543   55666663

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=5.1e-29  Score=276.57  Aligned_cols=189  Identities=25%  Similarity=0.360  Sum_probs=160.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-----CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeec--CCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS--TEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  ..+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46799999999999999999984     358999999998766666778999999999999999999999875  45678


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999876667899999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..... .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  218 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ---SDVWSFGV  218 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH---HHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChH---HhHHHHHH
Confidence            33322 22344568889999999977665543   55566663

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=2e-29  Score=279.72  Aligned_cols=188  Identities=27%  Similarity=0.376  Sum_probs=150.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCe----EEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGM----EVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|+..+.||+|+||.||+|++. +++    +||+|.++.. .....+++.+|++++++++||||+++++++...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            467999999999999999999853 344    4688877543 2345578899999999999999999999998765 77


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   99999999999999999999999999999987754


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...........+|+.|+|||++.+..++..   +|+|++|+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  207 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQ---SDVWSYGV  207 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCch---hhhhhhHH
Confidence            444344445567889999999987766544   55666664

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=2.3e-29  Score=278.88  Aligned_cols=191  Identities=26%  Similarity=0.436  Sum_probs=142.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC-C---eEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE-G---MEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      ..++|++.+.||+|+||.||+|+... +   ..||||+++..  .....+++.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999998643 3   27999998754  344567899999999999999999999999877655


Q ss_pred             ------EEEEEeccCCChHHHHhcCC-----CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 036229          852 ------ALILEYMPHGSLEKSLYSSN-----YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  920 (982)
Q Consensus       852 ------~lv~E~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  920 (982)
                            ++||||+++|+|.+++....     ..+++.++..++.|++.||+|||   ++||+||||||+||++++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432     25889999999999999999999   99999999999999999999999


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |+|||+|+...............+++.|+|||++.+..++..   +|+|++|++
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  228 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH---SDVWAFGVT  228 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCc---cchhhHHHH
Confidence            999999987644433333345567889999999977765544   556666643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=3.3e-29  Score=279.81  Aligned_cols=182  Identities=27%  Similarity=0.357  Sum_probs=154.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|+..+.||+|+||.||+|+. .+++.||||++....   ....+++.+|++++++++||||+++++++..++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34588999999999999999985 569999999997542   23346788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||++ |++.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++.....  
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99997 5888888766667899999999999999999999   99999999999999999999999999999986522  


Q ss_pred             CceeecccccccccccCceee---eeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFH---VKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~~~d~~~~~~  973 (982)
                          .....||+.|+|||++.   ...++   ..+|+|++|+
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~---~~~DiwslG~  241 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYD---GKVDVWSLGI  241 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBC---THHHHHHHHH
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCC---cHHHHHHHHH
Confidence                23457999999999984   33333   3456666664

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=2.6e-29  Score=277.51  Aligned_cols=199  Identities=23%  Similarity=0.372  Sum_probs=165.1

Q ss_pred             cCCHHHHHHHhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeecccc-hhhhhHHHHHHHhhhc-CCcccee
Q 036229          769 RFSYLELCRATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRNLIK  840 (982)
Q Consensus       769 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~  840 (982)
                      .+...++....++|++.+.||+|+||.||+|++      .+++.||||+++.... ...+.+.+|+++++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345566666788999999999999999999974      3478999999975432 3456789999999999 7999999


Q ss_pred             EEeeecCCC-eeEEEEEeccCCChHHHHhcCCCc---------------CCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 036229          841 VISSCSTEE-FKALILEYMPHGSLEKSLYSSNYI---------------LDIFQRLNIMVDVATTLEYLHFGYSAPVIHC  904 (982)
Q Consensus       841 l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHr  904 (982)
                      +++++..++ ..++||||+++|+|.+++......               +++..+..++.|++.||.|||   ++||+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999987654 589999999999999999865432               789999999999999999999   9999999


Q ss_pred             CCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       905 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++..   +|+|++|+
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  238 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ---SDVWSFGV  238 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccch---hHHHHHHH
Confidence            9999999999999999999999987654444444456678999999999977665543   55666664

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=2.3e-27  Score=282.37  Aligned_cols=208  Identities=26%  Similarity=0.286  Sum_probs=119.7

Q ss_pred             ccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeE
Q 036229          424 KSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGL  503 (982)
Q Consensus       424 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  503 (982)
                      ++|++|+|++|++++++.      ...+|++|++++|++++ +|..   +++|+.|++++|++++. |.   .+++|+.|
T Consensus       101 ~~L~~L~Ls~N~l~~l~~------~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L  166 (622)
T 3g06_A          101 PGLLELSIFSNPLTHLPA------LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKL  166 (622)
T ss_dssp             TTCCEEEECSCCCCCCCC------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEE
T ss_pred             CCCCEEECcCCcCCCCCC------CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEE
Confidence            445555555555544332      12344555555555544 2222   25666666666666643 32   23566667


Q ss_pred             EeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccC
Q 036229          504 HLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTG  583 (982)
Q Consensus       504 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~  583 (982)
                      ++++|+|++ +|   ..+++|+.|++++|+|++ +|..   +++|+.|++++|.++.+|..   +++|++|++++|.+++
T Consensus       167 ~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~  235 (622)
T 3g06_A          167 WAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS  235 (622)
T ss_dssp             ECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC
T ss_pred             ECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc
Confidence            777777764 34   335666777777777664 3332   35666677777777766643   3556666666666664


Q ss_pred             CCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccccc
Q 036229          584 PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEK  663 (982)
Q Consensus       584 ~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  663 (982)
                       +|   ..+++|+.|++++|+|++ +|.   .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++.+|..+..
T Consensus       236 -lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~  306 (622)
T 3g06_A          236 -LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  306 (622)
T ss_dssp             -CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHH
T ss_pred             -CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHh
Confidence             33   334556666666666654 333   4566666667666666 55666666666667777777666666665554


Q ss_pred             cc
Q 036229          664 LS  665 (982)
Q Consensus       664 l~  665 (982)
                      ++
T Consensus       307 L~  308 (622)
T 3g06_A          307 IT  308 (622)
T ss_dssp             HH
T ss_pred             cc
Confidence            43

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.95  E-value=1.9e-29  Score=279.77  Aligned_cols=188  Identities=24%  Similarity=0.380  Sum_probs=153.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCe----EEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGM----EVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|++.+.||+|+||.||+|++. +++    +||+|++... .......+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357899999999999999999853 344    3788877533 2334567788999999999999999999986 45688


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|+|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.+..
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999998755


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...........||+.|+|||++.+..++..   +|+|++|+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  205 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQ---SDVWSYGV  205 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             ccccccccCCCCcccccChHHhccCCCChh---hHhHHhHH
Confidence            444444455678889999999977666544   45566664

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=1.4e-29  Score=280.43  Aligned_cols=196  Identities=20%  Similarity=0.333  Sum_probs=161.9

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeee
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSC  845 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  845 (982)
                      .++....++|++.+.||+|+||.||+|+..      +++.||+|++.... .....++.+|+++++.++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            344456788999999999999999999753      37889999997543 23456788999999999999999999999


Q ss_pred             cCCCeeEEEEEeccCCChHHHHhcCC---------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC
Q 036229          846 STEEFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN  916 (982)
Q Consensus       846 ~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~  916 (982)
                      .+.+..++||||+++|+|.+++...+         ..+++..+..++.|++.||+|||   ++||+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCC
Confidence            99999999999999999999987532         34688999999999999999999   9999999999999999999


Q ss_pred             CcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          917 MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       917 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +.+||+|||+++...............+|+.|+|||++.+..++..   +|+|++|++
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  229 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY---SDVWSFGVV  229 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCch---hhHHHHHHH
Confidence            9999999999987643333333344567899999999977665543   556666643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.95  E-value=2.2e-29  Score=279.98  Aligned_cols=187  Identities=24%  Similarity=0.318  Sum_probs=156.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--------chhhhhHHHHHHHhhhcCCccceeEEeeecCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||||+++...        ....+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999985 468999999997542        12345678899999999999999999999999


Q ss_pred             CeeEEEEEeccCC-ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          849 EFKALILEYMPHG-SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       849 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999887644 5899999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +......   ......||+.|+|||++.+..+...  .+|+|++|+
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~  218 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGP--ELEMWSLGV  218 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSH--HHHHHHHHH
T ss_pred             eECCCCC---ceeccCCCccccChhhhcCCCCCCC--cccchhHHH
Confidence            8764332   2234679999999999976654222  244555553

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=2.6e-29  Score=273.69  Aligned_cols=188  Identities=24%  Similarity=0.368  Sum_probs=158.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC-C-------eEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE-G-------MEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      .++|++.+.||+|+||.||+|+... +       +.||+|+++.......+.+.+|++++++++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4679999999999999999998532 3       5799999987666667889999999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--------EEEE
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLS  922 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--------~kL~  922 (982)
                      .++||||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999877666899999999999999999999   999999999999999988876        9999


Q ss_pred             eecCceeecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeee--eeeccc
Q 036229          923 DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFL--MIFIGR  978 (982)
Q Consensus       923 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~--~~l~~~  978 (982)
                      |||.+....      ......||+.|+|||++.+ ..++.   .+|+|++|  ++.+.+
T Consensus       164 Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~---~~DiwslG~il~el~~  213 (289)
T 4fvq_A          164 DPGISITVL------PKDILQERIPWVPPECIENPKNLNL---ATDKWSFGTTLWEICS  213 (289)
T ss_dssp             CCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCH---HHHHHHHHHHHHHHHT
T ss_pred             cCccccccc------CccccCCcCcccCHHHhCCCCCCCc---hhHHHHHHHHHHHHHc
Confidence            999987541      1123568899999999976 44443   34556665  444444

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.95  E-value=3.4e-29  Score=272.76  Aligned_cols=190  Identities=25%  Similarity=0.391  Sum_probs=143.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||.||+|+..  ..||+|+++..  .....+.+.+|++++++++||||+++++++ ..+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            4678999999999999999999864  35999998654  234457789999999999999999999966 455689999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++++|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999999877777999999999999999999999   99999999999999999999999999999986543333


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ........||+.|+|||++........+..+|+|++|+
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~  213 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI  213 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHH
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHH
Confidence            33334567999999999986332222223456666664

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=1.6e-28  Score=266.71  Aligned_cols=185  Identities=21%  Similarity=0.405  Sum_probs=157.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999864 58999999997542  334567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~~  932 (982)
                      ||+++++|.+.+.... .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999988887653 5899999999999999999999   999999999999999986654   99999999987633


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .   .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  195 (284)
T 3kk8_A          161 S---EAWHGFAGTPGYLSPEVLKKDPYSKP---VDIWACGV  195 (284)
T ss_dssp             S---CBCCCSCSCGGGCCHHHHTTCCBCTH---HHHHHHHH
T ss_pred             C---ccccCCCCCcCCcCchhhcCCCCCcc---cchHHHHH
Confidence            2   22234679999999999977665543   55666663

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=8.9e-29  Score=267.73  Aligned_cols=185  Identities=25%  Similarity=0.317  Sum_probs=159.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3567999999999999999999865 478999999987655667889999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceeecCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~  933 (982)
                      |+++++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999999999887644 4899999999999999999999   9999999999999999   78889999999999876432


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .   ......||+.|+|||++.+. ++   ..+|+|++|+
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~~-~~---~~~Di~slG~  195 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEGL-YG---PECDEWSAGV  195 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTTC-BC---TTHHHHHHHH
T ss_pred             c---chhccCCCCCccChHHhccc-CC---chhhehhHHH
Confidence            2   23346799999999998664 33   3456666663

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=4.4e-29  Score=268.51  Aligned_cols=187  Identities=26%  Similarity=0.380  Sum_probs=160.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.+.||+|+||.||+|+..+++.||+|+++.... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            467899999999999999999988899999999975432 3467899999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      ++++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+...... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            999999999877677899999999999999999999   999999999999999999999999999999865321 1122


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....+++.|+|||++.+..++.   .+|+|++|+
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  193 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSS---KSDVWSFGV  193 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCH---HHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCccc---hhchhhhHH
Confidence            23456788999999997665553   355666664

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=5.6e-29  Score=301.09  Aligned_cols=195  Identities=22%  Similarity=0.246  Sum_probs=161.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++..   .....+.+..|.+++..+ +||+|+++++++++.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999864 5889999999754   233456778899999987 7999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|+|.+++...+ .+++..+..|+.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998654 4899999999999999999999   99999999999999999999999999999986432


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ..  ......+||+.|||||++.+..++... ++|++|+.++.+.+|
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~-DvwSlGvilyelltG  538 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSV-DWWAFGVLLYEMLAG  538 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTCCCBSTHH-HHHHHHHHHHHHHHS
T ss_pred             CC--cccccccCCCcccCHhhhcCCCCCccc-eEechHHHHHHHHcC
Confidence            22  234567899999999999877776543 333444444444443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=4.8e-29  Score=277.61  Aligned_cols=182  Identities=25%  Similarity=0.360  Sum_probs=151.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...    ....+|++++.++ +||||+++++++.+++..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4567999999999999999999865 58999999997543    2345688888888 7999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC----CcEEEEeecCceeec
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKLLI  931 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~~~  931 (982)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||++.++    +.+||+|||+|+...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999987644 5899999999999999999999   9999999999999998533    359999999999764


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ....  .....+||+.|+|||++.+..++..   +|+|++|
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  207 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAA---CDIWSLG  207 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHH---HHHHHHH
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCc---cCeeeHh
Confidence            3322  2345679999999999977655543   4455555

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=1.2e-28  Score=272.83  Aligned_cols=185  Identities=23%  Similarity=0.339  Sum_probs=157.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccch------hhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGR------AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.....      ..+.+.+|++++++++||||+++++++.+++..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999865 5899999999754221      356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGla  927 (982)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            9999999999999999754 45889999999999999999999   99999999999999999887    7999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......   ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  206 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGV  206 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTH---HHHHHHHH
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCc---cccHHHHH
Confidence            8764322   2234679999999999977655533   45566663

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.7e-29  Score=278.24  Aligned_cols=185  Identities=23%  Similarity=0.350  Sum_probs=148.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999965 689999999875432 2223556799999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++ |+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....  ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence            97 5999999887777999999999999999999999   999999999999999999999999999999865322  22


Q ss_pred             eecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      ......||+.|+|||++.+. .++..   +|+|++|+
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwslG~  189 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQ---IDMWGVGC  189 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTH---HHHHHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcH---HHHHHHHH
Confidence            23445789999999998653 33433   45566653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=3.9e-29  Score=279.35  Aligned_cols=172  Identities=22%  Similarity=0.381  Sum_probs=144.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCC--ccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRH--RNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++++++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999888999999999754  23445778999999999976  9999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||| .+++|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++ ++.+||+|||+|+......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5789999998654 5889999999999999999999   99999999999999997 5789999999998765443


Q ss_pred             CceeecccccccccccCceeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                      .........||+.|+|||++.+
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~  183 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKD  183 (343)
T ss_dssp             --------CCCCSSCCHHHHHH
T ss_pred             ccccCCCCcCCcCcCCHHHHhh
Confidence            3333446689999999999854

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=1.9e-28  Score=268.15  Aligned_cols=186  Identities=16%  Similarity=0.151  Sum_probs=158.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++...  ...+.+.+|+++++.+ +|++++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999985 56999999998643  2346788999999999 89999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-----EEEEeecCceeec
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLI  931 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-----~kL~DFGla~~~~  931 (982)
                      |+ +++|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.     +||+|||+|+...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999877667999999999999999999999   999999999999999987765     9999999999765


Q ss_pred             CCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....     .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  206 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR---DDLEALGH  206 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH---HHHHHHHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChH---HHHHHHHH
Confidence            43221     12345679999999999977665543   55666663

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.4e-29  Score=279.30  Aligned_cols=189  Identities=27%  Similarity=0.382  Sum_probs=150.6

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-----hhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-----RAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      ....++|++.+.||+|+||.||+|+.. +++.||||+++....     .....+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            345678999999999999999999964 589999999864321     22356889999999999999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..++||||+++ ++.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999976 899998877667888999999999999999999   99999999999999999999999999999987


Q ss_pred             ecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      .....  .......||+.|+|||++.+.. ++.   .+|+|++|+
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG~  201 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGV---GVDMWAVGC  201 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCH---HHHHHHHHH
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCc---hhhhHhHHH
Confidence            53222  2234567899999999986542 332   345566663

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=4.5e-29  Score=270.62  Aligned_cols=188  Identities=24%  Similarity=0.351  Sum_probs=146.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|+..    .+..||+|+++.. .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            4578999999999999999999863    2567999998653 2344567899999999999999999999985 45689


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++++|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999877767899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .. ........+|+.|+|||++.+..++..   +|+|++|+
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  205 (281)
T 1mp8_A          169 ST-YYKASKGKLPIKWMAPESINFRRFTSA---SDVWMFGV  205 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHH---HHHHHHHH
T ss_pred             cc-ccccccCCCcccccChhhcccCCCCCc---cCchHHHH
Confidence            22 122234457889999999976655543   55666664

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.95  E-value=4.4e-29  Score=277.95  Aligned_cols=194  Identities=24%  Similarity=0.351  Sum_probs=161.2

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEeCC------CeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeec
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARIGE------GMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCS  846 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  846 (982)
                      ++...++|++.+.||+|+||.||+|+...      .+.||+|+++... ....+.+.+|+++++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34456789999999999999999998532      3579999997543 33457789999999999 8999999999999


Q ss_pred             CCCeeEEEEEeccCCChHHHHhcC-------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          847 TEEFKALILEYMPHGSLEKSLYSS-------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       847 ~~~~~~lv~E~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                      .++..++||||+++|+|.+++...             ...+++..+..++.|++.||+|||   ++||+||||||+||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence            999999999999999999998753             234789999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +.++.+||+|||++................+|+.|+|||++.+..++..   +|+|++|++
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  255 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ---SDVWSYGIL  255 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH---HHHHHHHHH
Confidence            9999999999999987654444344445668889999999977655533   556666643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=6.8e-29  Score=282.38  Aligned_cols=187  Identities=22%  Similarity=0.358  Sum_probs=143.5

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcC-CccceeEEeeecCCC--e
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEE--F  850 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~  850 (982)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++...  ......++.+|+.+++.+. ||||+++++++..++  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3567899999999999999999986 46899999998543  3344567889999999997 999999999986544  7


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||++ ++|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.+
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 5999988763  4889999999999999999999   999999999999999999999999999999875


Q ss_pred             cCCC-------------------CceeecccccccccccCceeee-eeeeeEEeeEeeeeee
Q 036229          931 IGED-------------------QSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFL  972 (982)
Q Consensus       931 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~  972 (982)
                      ....                   .....+..+||+.|+|||++.+ ..++..   +|+|++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~---~DiwSlG  218 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG---IDMWSLG  218 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTH---HHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCCh---hhHHHHH
Confidence            3211                   1122345689999999999965 344433   4445555

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=3.9e-29  Score=290.00  Aligned_cols=189  Identities=23%  Similarity=0.391  Sum_probs=157.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ...++|++.+.||+|+||.||+|++.++..||||+++... ...+++.+|++++++++||||+++++++. .+..++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3457889999999999999999999889999999997543 34678999999999999999999999986 567899999


Q ss_pred             eccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+..... .
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-E  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-H
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-c
Confidence            999999999997542 35788899999999999999999   999999999999999999999999999999875321 1


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ........+++.|+|||++....++.   .+|+|++|++
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~~  374 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTI---KSDVWSFGIL  374 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCH---HHHHHHHHHH
T ss_pred             eeccCCCcccccccCHHHhccCCCCc---HHHHHhHHHH
Confidence            11123345678999999997665553   3566777643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=8.3e-29  Score=267.75  Aligned_cols=190  Identities=23%  Similarity=0.321  Sum_probs=159.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3467999999999999999999865 68999999997543 344578899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            999999999988653 45899999999999999999999   99999999999999999999999999999987643332


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ........||+.|+|||++.+..+..  ..+|+|++|+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~Di~slG~  196 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHA--EPVDVWSCGI  196 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCH--HHHHHHHHHH
T ss_pred             hhcccCCccccCccChHHHhcCCCCC--CcchHHHHHH
Confidence            23334567999999999997654322  2245566653

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.4e-29  Score=277.52  Aligned_cols=267  Identities=16%  Similarity=0.132  Sum_probs=149.7

Q ss_pred             cEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEE
Q 036229          350 EELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYI  429 (982)
Q Consensus       350 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L  429 (982)
                      +..+++.+.+....+..+..+++|++|++++|++++..|..|..+++|+.|++++|.++...       .|..+++|++|
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~~L   85 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTL   85 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCCEE
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCCEE
Confidence            44455555554444444444455556666666555555555555555555555555554321       14455555566


Q ss_pred             EccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccC
Q 036229          430 GLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK  509 (982)
Q Consensus       430 ~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~  509 (982)
                      ++++|+++++.                               ..++|+.|++++|++++..+..   +++|++|++++|+
T Consensus        86 ~Ls~n~l~~l~-------------------------------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~  131 (317)
T 3o53_A           86 DLNNNYVQELL-------------------------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNK  131 (317)
T ss_dssp             ECCSSEEEEEE-------------------------------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSC
T ss_pred             ECcCCcccccc-------------------------------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCC
Confidence            66665443221                               1134444444444444333322   3445555555555


Q ss_pred             CCCCCCcccCCCccccEEEccCCcCCcCCCccc-cCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccc
Q 036229          510 LEGPIPDDICRLTKLYELGLSGNKLSGSIPACF-SNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLD  588 (982)
Q Consensus       510 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~  588 (982)
                      +++..+..+..+++|++|+|++|+|++..|..+ ..+++|++|+|++|+++.+|... .+++|++|++++|++++. |..
T Consensus       132 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L~Ls~N~l~~l-~~~  209 (317)
T 3o53_A          132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTLDLSSNKLAFM-GPE  209 (317)
T ss_dssp             CCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC-CCTTCCEEECCSSCCCEE-CGG
T ss_pred             CCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccccc-ccccCCEEECCCCcCCcc-hhh
Confidence            555444455555555555555555555444444 24555666666666665554332 255566666666666543 333


Q ss_pred             cccccccceeecccccccccccccccCccCcceEeccccccc-CCccccccCCCCCCeeeCC-CCcCCCCCCcc
Q 036229          589 IGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ-GSISESFGDLISLKSLNLS-NNNLSRSIPIS  660 (982)
Q Consensus       589 ~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls-~N~l~~~~p~~  660 (982)
                      +..+++|+.||+++|++++ +|..+..+++|+.|+|++|+++ +.+|.++..+++|+.|+++ .+.++|..|..
T Consensus       210 ~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             hcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            6666667777777777764 5666777777777777777777 6677777777777777777 44566655543

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.95  E-value=6.2e-31  Score=317.42  Aligned_cols=256  Identities=15%  Similarity=0.121  Sum_probs=163.1

Q ss_pred             CCceeeEEecCCCCcEEEEEeCCCCccccCC-ccccCCCCCCEEEcCCCCcccc---Cc------------chhhhccCC
Q 036229           68 VCNWTGVTCDVHSHRVKVLNISHLNLTGTIP-SQLWNLSSLQSLNLGFNRLSGS---IP------------SAIFTLYTL  131 (982)
Q Consensus        68 ~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~-~~l~~l~~L~~L~L~~n~~~~~---~p------------~~~~~l~~L  131 (982)
                      |++|.++..    .....++++.+..  ..| ..+..+++|+.|+++++.....   .|            .....+++|
T Consensus        34 ck~W~~~~~----~~~~~l~~~~~~~--~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L  107 (594)
T 2p1m_B           34 CKSWYEIER----WCRRKVFIGNCYA--VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWL  107 (594)
T ss_dssp             CHHHHHHHH----HHCCEEEESSTTS--SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred             HHHHHHhhh----hhceEEeeccccc--cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCC
Confidence            557887721    1233455554332  223 3466788999999998753211   11            123467889


Q ss_pred             cEEEccCCcccCccCcccc-CcCCCCccccccC-cccccCchhhhcCCCCCCeeeecceeeecccCCCcc----CcCccc
Q 036229          132 KYVNFRGNQLSGAFPSFIF-NKSSLQHLDFSYN-ALSGEIPANICSNLPFLESISLSQNMFHGRIPSALS----NCKYLE  205 (982)
Q Consensus       132 ~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~  205 (982)
                      ++|+|++|.+++..+..+. .+++|++|+|++| .++......++.++++|++|+|++|.+++..+.++.    .+++|+
T Consensus       108 ~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~  187 (594)
T 2p1m_B          108 EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV  187 (594)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCC
T ss_pred             CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCc
Confidence            9999999998877777765 6889999999988 555333344546789999999999988865554443    566899


Q ss_pred             EEEeeccc--cccc-cccccccccchhhhhccCC-CCCCchhhhcCCCcccceEecccc-------ccCCcCChhhhccC
Q 036229          206 ILSLSINN--LLGA-IPKEIGNLTKLKELYLGYS-GLQGEIPREFGNLAELELMALQVS-------NLQGEIPQELANLT  274 (982)
Q Consensus       206 ~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~n-------~l~~~~p~~l~~l~  274 (982)
                      +|++++|.  ++.. ++..+..+++|++|++++| .+++ +|..+..+++|+.|+++.+       .+.+ ++..+.+++
T Consensus       188 ~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~  265 (594)
T 2p1m_B          188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCK  265 (594)
T ss_dssp             EEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCT
T ss_pred             EEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCC
Confidence            99998886  2211 1222345688888888887 4443 7777777888888875433       3333 334677777


Q ss_pred             CCcEE-EccCCccccCCCccccccCCCcEEEccCccccccCcc-cccCCCCCceeecCCC
Q 036229          275 GLEVL-KLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPA-TIFNMSTLTGLGLQSN  332 (982)
Q Consensus       275 ~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N  332 (982)
                      +|+.| .+.+... +.++..+..+++|++|+|++|.+++.... .+..+++|+.|++++|
T Consensus       266 ~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~  324 (594)
T 2p1m_B          266 ELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY  324 (594)
T ss_dssp             TCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG
T ss_pred             CcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc
Confidence            77777 4443332 23444445667777777777776543222 2345666666666655

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=1.5e-28  Score=279.85  Aligned_cols=181  Identities=20%  Similarity=0.280  Sum_probs=142.7

Q ss_pred             hcCCCcc-ceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhh-hcCCccceeEEeeecC----CCee
Q 036229          779 TNRFSEN-NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMK-SIRHRNLIKVISSCST----EEFK  851 (982)
Q Consensus       779 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~----~~~~  851 (982)
                      .++|.+. +.||+|+||+||+|+.. +++.||||+++..     ..+.+|++++. ..+||||+++++++..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567665 78999999999999864 5899999998632     45677888874 4589999999998865    5678


Q ss_pred             EEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla  927 (982)
                      |+||||+++|+|.+++.... ..+++.++..++.||+.||+|||   ++||+||||||+||+++.   ++.+||+|||+|
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998653 35899999999999999999999   999999999999999987   789999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +.....   ......+||+.|+|||++.+..++..   +|+|++|+
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  251 (400)
T 1nxk_A          212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKS---CDMWSLGV  251 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSH---HHHHHHHH
T ss_pred             cccCCC---CccccCCCCCCccCHhhcCCCCCCCc---ccHHHHHH
Confidence            875322   22345679999999999977766644   44555553

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=9.8e-29  Score=267.70  Aligned_cols=185  Identities=26%  Similarity=0.385  Sum_probs=154.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3578999999999999999999864 47899999986432   2234678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++.... .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999999987653 4889999999999999999999   999999999999999999999999999998754221


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                          ......||+.|+|||++.+..++.   .+|+|++|+
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  195 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDE---KVDLWSLGV  195 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCT---THHHHHHHH
T ss_pred             ----cccccCCCCCccCHhHhccCCCCc---cchhHhHHH
Confidence                223467899999999997765553   355666664

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.95  E-value=1.7e-28  Score=268.96  Aligned_cols=195  Identities=27%  Similarity=0.393  Sum_probs=152.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhh--cCCccceeEEeeecC----CCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKS--IRHRNLIKVISSCST----EEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~~  852 (982)
                      .++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            56899999999999999999988 6899999998743   33455667777666  799999999998643    35689


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      +||||+++|+|.++++..  .+++..+..++.|++.||+|||..     +++||+||||||+||+++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999543  589999999999999999999932     2679999999999999999999999999999


Q ss_pred             eeecCCCCce--eecccccccccccCceeeeeeee---eEEeeEeeeeee--eeecccC
Q 036229          928 KLLIGEDQSI--TQTQTLATIGYMAPGLFHVKYIL---FVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       928 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~d~~~~~--~~l~~~~  979 (982)
                      +.........  ......||+.|+|||++.+....   ..+..+|+|++|  ++.+.+|
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence            8765443322  12345799999999999765211   111234556666  4444443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=2.1e-28  Score=267.23  Aligned_cols=186  Identities=20%  Similarity=0.310  Sum_probs=158.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999965 48899999987542   33456788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+.......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999887543 5899999999999999999999   9999999999999999999999999999998764222


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        .......||+.|+|||++.+..++.   .+|+|++|+
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  203 (294)
T 2rku_A          170 --ERKKVLCGTPNYIAPEVLSKKGHSF---EVDVWSIGC  203 (294)
T ss_dssp             --CCBCCCCSCCSSCCHHHHTTSCBCT---HHHHHHHHH
T ss_pred             --cccccccCCCCcCCcchhccCCCCc---hhhHHHHHH
Confidence              2233467999999999997765543   355666663

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=1.8e-28  Score=273.03  Aligned_cols=187  Identities=20%  Similarity=0.312  Sum_probs=158.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3468999999999999999999865 4889999998754   23445778899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus       119 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            999999999999887643 5899999999999999999999   999999999999999999999999999999876422


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .  .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  229 (335)
T 2owb_A          195 G--ERKKVLCGTPNYIAPEVLSKKGHSFE---VDVWSIGC  229 (335)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHHTSCBCTH---HHHHHHHH
T ss_pred             c--ccccccCCCccccCHHHhccCCCCch---hhHHHHHH
Confidence            2  22345679999999999977655533   45566663

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=9.8e-29  Score=273.06  Aligned_cols=193  Identities=23%  Similarity=0.288  Sum_probs=157.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeec----CCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS----TEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+++++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            356899999999999999999986 569999999997666666788999999999999999999999986    345789


Q ss_pred             EEEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          853 LILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      +||||+++|+|.+++..   ....+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999875   3456899999999999999999999   99999999999999999999999999999886


Q ss_pred             ecCCCCc-------eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQS-------ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......       .......||+.|+|||++.+......+..+|+|++|+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~  234 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGC  234 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHH
Confidence            4211100       0112345799999999997654433445567777774

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.7e-28  Score=272.16  Aligned_cols=189  Identities=27%  Similarity=0.428  Sum_probs=159.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-----CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC--ee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE--FK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~  851 (982)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46789999999999999999984     358999999998766666788999999999999999999999987654  78


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++...+..+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887777899999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCce-eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...... ......++..|+|||++.+..++.   .+|+|++|+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  236 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSV---ASDVWSFGV  236 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEH---HHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCc---hhhHHHHHH
Confidence            433221 123445778899999997765543   355666664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=2.1e-29  Score=280.81  Aligned_cols=178  Identities=19%  Similarity=0.250  Sum_probs=144.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--------chhhhhHHHHHHHhhhcC---------CccceeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSIR---------HRNLIKV  841 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~nIv~l  841 (982)
                      .++|++.+.||+|+||+||+|+. +++.||||+++...        ....+.+.+|++++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999998 78999999997542        223467889999998886         5555555


Q ss_pred             E-----------------eeecC-------------CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHH
Q 036229          842 I-----------------SSCST-------------EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE  891 (982)
Q Consensus       842 ~-----------------~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~  891 (982)
                      .                 +++.+             ++..|+||||+++|++.+.+.+  ..+++..++.++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            4                 44443             6789999999999977666643  45799999999999999999


Q ss_pred             HHHccCCCCeEEcCCCCCCEEEcCCC--------------------cEEEEeecCceeecCCCCceeecccccccccccC
Q 036229          892 YLHFGYSAPVIHCDLKPSNVLLDDNM--------------------VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP  951 (982)
Q Consensus       892 yLH~~~~~~ivHrDlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  951 (982)
                      |||.  ++||+||||||+|||++.++                    .+||+|||+|+....       ...+||+.||||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9993  48999999999999999876                    999999999997632       234799999999


Q ss_pred             ceeeeeeeeeEEeeEeeeeee
Q 036229          952 GLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       952 E~~~~~~~~~~~~~~d~~~~~  972 (982)
                      |++.+.. +   ..+|+|+++
T Consensus       247 E~~~g~~-~---~~~Diwsl~  263 (336)
T 2vuw_A          247 DLFTGDG-D---YQFDIYRLM  263 (336)
T ss_dssp             GGGCCCS-S---HHHHHHHHH
T ss_pred             hhhcCCC-c---cceehhhhh
Confidence            9998765 3   346677764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=8.1e-29  Score=267.01  Aligned_cols=184  Identities=22%  Similarity=0.373  Sum_probs=156.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCC--CeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE--EFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+++ ++.||+|+++...  ....+.+.+|++++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            468999999999999999999984 8999999997542  34456789999999999999999999999877  788999


Q ss_pred             EEeccCCChHHHHhcCCC-cCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          855 LEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      |||+++|+|.+++..... .+++..+..++.|++.||+|||   ++|  |+||||||+||+++.++.+|++|||++... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-  163 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-  163 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee-
Confidence            999999999999986543 5899999999999999999999   899  999999999999999999999999987642 


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                            ......||+.|+|||++.+..+...+..+|+|++|+
T Consensus       164 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~  199 (271)
T 3kmu_A          164 ------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV  199 (271)
T ss_dssp             ------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHH
T ss_pred             ------cccCccCCccccChhhhccCCCCCCCchhhHHHHHH
Confidence                  122456899999999997765544323456666663

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=7e-29  Score=284.57  Aligned_cols=189  Identities=23%  Similarity=0.294  Sum_probs=144.2

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--------chhhhhHHHHHHHhhhcCCccceeEEeeecC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSIRHRNLIKVISSCST  847 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  847 (982)
                      ...++|.+.+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            35678999999999999999999864 58999999997532        1223468899999999999999999999865


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEee
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDF  924 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DF  924 (982)
                       +..++||||+++|+|.+++... ..+++.++..++.|++.||+|||   ++||+||||||+||+++.+   +.+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             4578999999999999988654 45899999999999999999999   9999999999999999754   45999999


Q ss_pred             cCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          925 GIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       925 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |+|+....   ........||+.|+|||++.+......+..+|+|++|+
T Consensus       287 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~  332 (419)
T 3i6u_A          287 GHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV  332 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHH
T ss_pred             ccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHH
Confidence            99987532   22234567999999999985422222223455666663

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=271.86  Aligned_cols=186  Identities=25%  Similarity=0.315  Sum_probs=149.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            368999999999999999999975 48999999986442  233567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||++++++.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.|....... 
T Consensus        82 e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             ECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence            999999998887654 45899999999999999999999   9999999999999999999999999999998764322 


Q ss_pred             ceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                       .......||+.|+|||++.+ ..++.   .+|+|++|+
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~---~~Di~slG~  191 (311)
T 4agu_A          157 -DYYDDEVATRWYRSPELLVGDTQYGP---PVDVWAIGC  191 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCT---HHHHHHHHH
T ss_pred             -cccCCCcCCccccChHHHhcCCCCCc---chhhHHHHH
Confidence             22235678999999999865 33333   345566663

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=1.6e-28  Score=284.43  Aligned_cols=182  Identities=29%  Similarity=0.409  Sum_probs=153.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC-eeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE-FKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|++. ++.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            4567889999999999999999984 7899999997543  4578999999999999999999999976654 7899999


Q ss_pred             eccCCChHHHHhcCCC-cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++...+. .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999986543 3689999999999999999999   999999999999999999999999999999864211  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....+++.|+|||++.+..++..   +|+|++|+
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~---sDvwslG~  374 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTK---SDVWSFGI  374 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHH---HHHHHHHH
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcH---HHHHHHHH
Confidence               122357889999999977665543   55666664

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=7.4e-29  Score=290.41  Aligned_cols=189  Identities=23%  Similarity=0.419  Sum_probs=160.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|++.. ++.||||+++... ...+++.+|++++++++||||+++++++..++..++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34678899999999999999999764 8999999997543 346789999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..... .
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-T  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-C
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC-c
Confidence            99999999999864 345899999999999999999999   999999999999999999999999999999976432 2


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ........+++.|+|||++.+..++.   .+|+|++|++
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDvwSlG~~  408 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSI---KSDVWAFGVL  408 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECH---HHHHHHHHHH
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCc---HHhHHhHHHH
Confidence            22233455678999999997765553   3566777643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=7e-29  Score=279.50  Aligned_cols=194  Identities=26%  Similarity=0.292  Sum_probs=162.4

Q ss_pred             cccCCHHHHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-----Ccccee
Q 036229          767 CRRFSYLELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-----HRNLIK  840 (982)
Q Consensus       767 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~  840 (982)
                      ...+++.+.....++|++.++||+|+||.||+|+. .+++.||||+++.. ......+..|+++++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44556666666778999999999999999999986 46899999999743 334566788999999986     999999


Q ss_pred             EEeeecCCCeeEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC----
Q 036229          841 VISSCSTEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD----  915 (982)
Q Consensus       841 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~----  915 (982)
                      +++++...+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 889999998654 35899999999999999999999   999999999999999975    


Q ss_pred             ---------------------CCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          916 ---------------------NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       916 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                                           ++.+||+|||+|+.....     .....||+.|+|||++.+..++..   +|+|++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  247 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVS---SDMWSFGC  247 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTT---HHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCc---cchHHHHH
Confidence                                 789999999999864221     234679999999999987766544   45566663

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.95  E-value=9.1e-29  Score=267.93  Aligned_cols=189  Identities=24%  Similarity=0.402  Sum_probs=157.6

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ...++|++.+.||+|+||.||+|+..+++.||+|+++... ...+.+.+|++++++++||||+++++++.. +..++|||
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence            3457899999999999999999998888899999997543 345788999999999999999999999864 45899999


Q ss_pred             eccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||.+....... 
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  163 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence            999999999997532 25889999999999999999999   9999999999999999999999999999998764322 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ........+++.|+|||++.+..++.   .+|+|++|++
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~i  199 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTI---KSDVWSFGIL  199 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECH---HHHHHHHHHH
T ss_pred             cccccCCCCccCccChhhhccCCCCc---hhhhHHHHHH
Confidence            22233455788999999997665553   3556666643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.9e-29  Score=279.64  Aligned_cols=189  Identities=24%  Similarity=0.328  Sum_probs=155.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEe----CCCeEEEEEEeeccc----chhhhhHHHHHHHhhhc-CCccceeEEeeecCCC
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQC----GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  849 (982)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+.+|+++++.+ +||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999986    368999999986432    23446677899999999 6999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999997654 5889999999999999999999   99999999999999999999999999999987


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +.... ........||+.|+|||++.+.... .+..+|+|++|+
T Consensus       209 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~DvwslG~  250 (355)
T 1vzo_A          209 FVADE-TERAYDFCGTIEYMAPDIVRGGDSG-HDKAVDWWSLGV  250 (355)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHHH
T ss_pred             cccCC-CCcccCcccCcCccChhhhcCCCCC-CCchhhHHHHHH
Confidence            53222 1223346799999999999753211 223355666663

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=2.6e-28  Score=274.78  Aligned_cols=194  Identities=25%  Similarity=0.386  Sum_probs=159.8

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc--------hhhhhHHHHHHHhhhc-CCccceeEE
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG--------RAFKSFDVECEMMKSI-RHRNLIKVI  842 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~nIv~l~  842 (982)
                      .......++|++.+.||+|+||.||+|+.. +|+.||||+++....        ...+.+.+|+++++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344555678999999999999999999975 699999999875431        1245678899999999 899999999


Q ss_pred             eeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE
Q 036229          843 SSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  922 (982)
Q Consensus       843 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  922 (982)
                      +++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||   +.||+||||||+||+++.++.+||+
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999999999754 35899999999999999999999   9999999999999999999999999


Q ss_pred             eecCceeecCCCCceeecccccccccccCceeeeee---eeeEEeeEeeeeeee
Q 036229          923 DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY---ILFVVNFLTSYSFLM  973 (982)
Q Consensus       923 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~d~~~~~~  973 (982)
                      |||++..+....   ......||+.|+|||++.+..   ....+..+|+|++|+
T Consensus       243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~  293 (365)
T 2y7j_A          243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV  293 (365)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHH
T ss_pred             ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHH
Confidence            999998764322   234567999999999986431   111223456666663

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=273.29  Aligned_cols=188  Identities=27%  Similarity=0.376  Sum_probs=148.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCe----EEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGM----EVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|++.+.||+|+||.||+|++. +++    +||+|.+... .....+.+.+|++++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            468999999999999999999853 344    3577776533 3345678899999999999999999999998765 78


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...........+|+.|+|||++.+..++..   +|+|++|+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  207 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQ---SDVWSYGV  207 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChH---HHHHHHHH
Confidence            433333445567889999999987766644   45566664

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=1.9e-28  Score=266.70  Aligned_cols=185  Identities=20%  Similarity=0.332  Sum_probs=153.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++..  ......++.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4567999999999999999999975 6999999999754  234456788899999999 99999999999999999999


Q ss_pred             EEEeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC--------------
Q 036229          854 ILEYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN--------------  916 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--------------  916 (982)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||   ++||+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999754   245899999999999999999999   9999999999999999844              


Q ss_pred             -----CcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          917 -----MVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       917 -----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                           ..+||+|||.+......      ....||+.|+|||++.+.....  ..+|+|++|+
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~--~~~Di~slG~  219 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHL--PKADIFALAL  219 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTH--HHHHHHHHHH
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCC--chhhHHHHHH
Confidence                 47999999999875322      2345899999999997652221  2345566553

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=1.4e-28  Score=279.17  Aligned_cols=172  Identities=21%  Similarity=0.374  Sum_probs=145.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcC--CccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIR--HRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++++++  ||||+++++++..++..|+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3469999999999999999999878999999999754  2345578899999999996  59999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      || +.+++|.+++.... .+++.++..++.||+.||.|||   ++||+||||||+||+++ ++.+||+|||+|+.+....
T Consensus       135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 55889999998654 5788899999999999999999   99999999999999995 5899999999998764433


Q ss_pred             CceeecccccccccccCceeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                      ........+||+.|+|||++.+
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~  230 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKD  230 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHC
T ss_pred             ccccCCCCCcCCCccChHHhhh
Confidence            3333345679999999999865

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3e-28  Score=265.01  Aligned_cols=188  Identities=22%  Similarity=0.359  Sum_probs=155.9

Q ss_pred             hcCCCccc-eeeeeceEEEEEEEeC---CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENN-LIGRGGFGSVYKARIG---EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|.+.+ .||+|+||.||+|.+.   +++.||+|+++... ....+++.+|++++++++||||+++++++. .+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEE
Confidence            34566665 9999999999999753   58889999997643 345678899999999999999999999994 556899


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++......+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999877677999999999999999999999   999999999999999999999999999999976433


Q ss_pred             CCce-eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .... ......+|+.|+|||++.+..++..   +|+|++|+
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  201 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSR---SDVWSYGV  201 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHH---HHHHHHHH
T ss_pred             cceeeccccccccccccCHHHhccCCCCch---hhHHHHHH
Confidence            3221 2233457899999999976655543   55666664

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=1.5e-28  Score=276.90  Aligned_cols=194  Identities=23%  Similarity=0.264  Sum_probs=153.2

Q ss_pred             CCHHHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccc-----------hhhhhHHHHHHHhhhcCCccc
Q 036229          770 FSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG-----------RAFKSFDVECEMMKSIRHRNL  838 (982)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nI  838 (982)
                      ....++....++|++.+.||+|+||.||+|+..+++.||||++.....           ...+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345677888999999999999999999999988899999999854321           123678999999999999999


Q ss_pred             eeEEeeec-----CCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE
Q 036229          839 IKVISSCS-----TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL  913 (982)
Q Consensus       839 v~l~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl  913 (982)
                      +++++++.     .....++||||++ |++.+++...+..+++..+..++.|++.||.|||   ++||+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            99999983     3447899999997 6898988877777999999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      +.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.   .+|+|++|+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG~  222 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTK---LVDMWSAGC  222 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCT---HHHHHHHHH
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCc---HhHHHhHHH
Confidence            99999999999999854322   22345678999999999865 33333   345566663

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=3.4e-28  Score=264.20  Aligned_cols=184  Identities=25%  Similarity=0.357  Sum_probs=157.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999865 58899999986432   22346788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999997654 4889999999999999999999   999999999999999999999999999999865321 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         ......|++.|+|||++.+..++.   .+|+|++|+
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  200 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDE---KVDLWCAGV  200 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCT---THHHHHHHH
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCc---ccchhhHHH
Confidence               223467999999999997765553   355666663

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=2e-28  Score=270.45  Aligned_cols=188  Identities=22%  Similarity=0.305  Sum_probs=150.4

Q ss_pred             hcCCCcc-ceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSEN-NLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|++. +.||+|+||.||+|+. .+++.||||+++.......+.+.+|+++++++ +||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4578874 7899999999999985 46899999999866555667899999999985 7999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFGla~~~~~  932 (982)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999997653 5889999999999999999999   999999999999999987765   99999999986532


Q ss_pred             CCC-----ceeecccccccccccCceeee-----eeeeeEEeeEeeeeeee
Q 036229          933 EDQ-----SITQTQTLATIGYMAPGLFHV-----KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~~d~~~~~~  973 (982)
                      ...     ........||+.|+|||++.+     ..++.   .+|+|++|+
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~---~~DiwslG~  214 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGV  214 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTT---THHHHHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCc---ccccHhHHH
Confidence            211     111234569999999999864     33333   345566663

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=1.4e-28  Score=275.38  Aligned_cols=193  Identities=23%  Similarity=0.337  Sum_probs=153.6

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-----cchhhhhHHHHHHHhhhcCCccceeEEeeecCC
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-----CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      +....++|++.+.||+|+||.||+|+. .+++.||+|+++..     .....+.+.+|++++++++||||+++++++.++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345667899999999999999999986 45889999998643     234557889999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcC---------------------------------------CCcCCHHHHHHHHHHHHHH
Q 036229          849 EFKALILEYMPHGSLEKSLYSS---------------------------------------NYILDIFQRLNIMVDVATT  889 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~  889 (982)
                      +..++||||+++|+|.+++...                                       ...+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999988521                                       1123567788899999999


Q ss_pred             HHHHHccCCCCeEEcCCCCCCEEEcCCC--cEEEEeecCceeecCCCC--ceeecccccccccccCceeee--eeeeeEE
Q 036229          890 LEYLHFGYSAPVIHCDLKPSNVLLDDNM--VAHLSDFGIAKLLIGEDQ--SITQTQTLATIGYMAPGLFHV--KYILFVV  963 (982)
Q Consensus       890 L~yLH~~~~~~ivHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~  963 (982)
                      |+|||   ++||+||||||+||+++.++  .+||+|||+|+.+.....  ........||+.|+|||++.+  ..++.  
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--  255 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP--  255 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT--
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc--
Confidence            99999   99999999999999998766  899999999987643221  122345679999999999864  33333  


Q ss_pred             eeEeeeeeee
Q 036229          964 NFLTSYSFLM  973 (982)
Q Consensus       964 ~~~d~~~~~~  973 (982)
                       .+|+|++|+
T Consensus       256 -~~DiwslG~  264 (345)
T 3hko_A          256 -KCDAWSAGV  264 (345)
T ss_dssp             -HHHHHHHHH
T ss_pred             -HHHHHHHHH
Confidence             355666664

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=1.2e-28  Score=267.86  Aligned_cols=185  Identities=26%  Similarity=0.384  Sum_probs=151.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467999999999999999999864 58999999997553 3345788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceee
Q 036229          857 YMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       857 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~  930 (982)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||   ++||+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988642   356899999999999999999999   9999999999999999   45678999999999865


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...   .......||+.|+|||++.+. ++   ..+|+|++|+
T Consensus       178 ~~~---~~~~~~~~t~~y~aPE~~~~~-~~---~~~Di~slG~  213 (285)
T 3is5_A          178 KSD---EHSTNAAGTALYMAPEVFKRD-VT---FKCDIWSAGV  213 (285)
T ss_dssp             ------------CTTGGGCCHHHHTTC-CC---HHHHHHHHHH
T ss_pred             CCc---ccCcCcccccCcCChHHhccC-CC---cccCeehHHH
Confidence            332   223456799999999998653 33   3355666664

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=4e-28  Score=264.09  Aligned_cols=182  Identities=27%  Similarity=0.485  Sum_probs=151.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccch-------hhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGR-------AFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            47899999999999999999986 46899999998643221       1267889999999999999999999997765 


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCc-----EEEEe
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLDDNMV-----AHLSD  923 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~-----~kL~D  923 (982)
                       ++||||+++|+|.+++......+++..+..++.|++.|++|||   ++|  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999999877778999999999999999999999   999  999999999999987776     99999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeee--eeeeeEEeeEeeeeeee
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV--KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~d~~~~~~  973 (982)
                      ||+|+....     ......||+.|+|||++..  ..++   ..+|+|++|+
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~---~~~Di~slG~  216 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYT---EKADTYSFAM  216 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEEC---HHHHHHHHHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcC---chhhHHHHHH
Confidence            999985422     2345679999999999843  2333   3355566663

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=1.6e-28  Score=270.91  Aligned_cols=257  Identities=21%  Similarity=0.222  Sum_probs=153.8

Q ss_pred             CEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecc
Q 036229          108 QSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQ  187 (982)
Q Consensus       108 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~  187 (982)
                      +.++++.+.+....+..+..+++|++|+|++|++++..|..+.++++|++|+|++|.+++..|   +..+++|++|+|++
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEEECCS
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEEECcC
Confidence            344555555543333334455566666666666666555666666666666666666664333   36666777777777


Q ss_pred             eeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCC
Q 036229          188 NMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIP  267 (982)
Q Consensus       188 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p  267 (982)
                      |++++..     ..++|++|++++|++++..+..   +++|++|++++|++++..+..+..+++|+.|++++|.+++..+
T Consensus        90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  161 (317)
T 3o53_A           90 NYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF  161 (317)
T ss_dssp             SEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred             Ccccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence            7666432     2356777777777766544333   3456666666666666555566666666666666666665555


Q ss_pred             hhh-hccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccC
Q 036229          268 QEL-ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQL  346 (982)
Q Consensus       268 ~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l  346 (982)
                      ..+ ..+++|++|+|++|+|++..  ....+++|++|+|++|++++..+ .+..+++|                      
T Consensus       162 ~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L----------------------  216 (317)
T 3o53_A          162 AELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGV----------------------  216 (317)
T ss_dssp             GGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTC----------------------
T ss_pred             HHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchh-hhcccCcc----------------------
Confidence            554 35666677777777666542  22236666666666666664332 34444444                      


Q ss_pred             CCccEEEccCCcccccccccccCCCCCCEEEeccccCc-cccCCccccCCccceecccc
Q 036229          347 PNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFS-GFIPNTFGNLRNLRLMTLHY  404 (982)
Q Consensus       347 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~  404 (982)
                         ++|+|++|+++ .+|..+..+++|+.|++++|++. +..+..+..+++|+.+++++
T Consensus       217 ---~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~  271 (317)
T 3o53_A          217 ---TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT  271 (317)
T ss_dssp             ---SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHH
T ss_pred             ---cEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCC
Confidence               55555555555 34555666667777777777776 55666666677777666663

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.95  E-value=5.3e-28  Score=267.17  Aligned_cols=189  Identities=25%  Similarity=0.401  Sum_probs=154.8

Q ss_pred             CCccceeeeeceEEEEEEEe-----CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecC--CCeeEE
Q 036229          782 FSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFKAL  853 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l  853 (982)
                      |++.+.||+|+||.||+|.+     .+++.||||+++... ....+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48999999999999999864     258999999997553 3446778999999999999999999999976  467899


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|+|.+++....  +++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999997654  899999999999999999999   999999999999999999999999999999987543


Q ss_pred             CCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeeccc
Q 036229          934 DQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGR  978 (982)
Q Consensus       934 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~  978 (982)
                      ... .......+|+.|+|||++.+..++..   +|+|++|  ++.+.+
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~il~~ll~  232 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYA---SDVWSFGVTLYELLT  232 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHH---HHHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcH---HHHHHHHHHHHHHHh
Confidence            322 22344568889999999977665533   4555555  444443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.4e-28  Score=270.33  Aligned_cols=197  Identities=26%  Similarity=0.361  Sum_probs=153.0

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhc--CCccceeEEeeecCC---
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSCSTE---  848 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~---  848 (982)
                      ......++|++.+.||+|+||.||+|+.. ++.||||++....   ......|.+++...  +||||+++++++...   
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            33445678999999999999999999984 8999999986432   23445566665554  999999999998776   


Q ss_pred             -CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC--------CeEEcCCCCCCEEEcCCCcE
Q 036229          849 -EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA--------PVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       849 -~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~--------~ivHrDlkp~NILl~~~~~~  919 (982)
                       ...++||||+++|+|.++++..  .+++..+..++.|++.||+|||   ++        ||+||||||+||+++.++.+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCE
Confidence             6889999999999999999764  4899999999999999999999   77        99999999999999999999


Q ss_pred             EEEeecCceeecCCCCce--eecccccccccccCceeeeeeeeeEE---eeEeeeeee--eeecccC
Q 036229          920 HLSDFGIAKLLIGEDQSI--TQTQTLATIGYMAPGLFHVKYILFVV---NFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~---~~~d~~~~~--~~l~~~~  979 (982)
                      ||+|||+|+.+.......  ......||+.|+|||++.+.......   ..+|+|++|  ++.+.+|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            999999998764332211  12345799999999999765443220   013555555  4445544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.95  E-value=2.1e-28  Score=263.85  Aligned_cols=182  Identities=27%  Similarity=0.438  Sum_probs=143.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc----chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|+..+.||+|+||.||+|++ .++.||||+++...    ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46899999999999999999997 48999999986442    23346788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCC---eEEcCCCCCCEEEcC--------CCcEEEEe
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP---VIHCDLKPSNVLLDD--------NMVAHLSD  923 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~---ivHrDlkp~NILl~~--------~~~~kL~D  923 (982)
                      |||+++++|.+++..  ..+++..+..++.|++.|++|||   ++|   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999854  35899999999999999999999   888   999999999999985        67899999


Q ss_pred             ecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          924 FGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       924 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||.+......    ......||+.|+|||++.+..++..   .|+|++|+
T Consensus       160 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  202 (271)
T 3dtc_A          160 FGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKG---SDVWSYGV  202 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHH---HHHHHHHH
T ss_pred             CCcccccccc----cccCCCCccceeCHHHhccCCCCch---hhHHHHHH
Confidence            9999865322    1224579999999999977665543   45566663

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=7.1e-29  Score=275.51  Aligned_cols=189  Identities=24%  Similarity=0.331  Sum_probs=146.2

Q ss_pred             HHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          775 LCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       775 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .....++|++.+.||+|+||.||+|+. .+++.||||+++...  ....+.+.+|++++++++||||+++++++.+++..
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            344567899999999999999999985 469999999997543  22345678899999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-----CCCcEEEEeecC
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-----DNMVAHLSDFGI  926 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-----~~~~~kL~DFGl  926 (982)
                      ++||||+++ +|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++     ..+.+||+|||+
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999999974 9999987654 4899999999999999999999   99999999999999994     455699999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      |+.....  ........||+.|+|||++.+.. ++.   .+|+|++|+
T Consensus       184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG~  226 (329)
T 3gbz_A          184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYST---SVDIWSIAC  226 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCT---HHHHHHHHH
T ss_pred             ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCc---HHHHHHHHH
Confidence            9875322  22234567899999999996643 343   345566663

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.3e-28  Score=280.59  Aligned_cols=172  Identities=26%  Similarity=0.416  Sum_probs=147.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCC--eeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE--FKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999965 48999999997543 234567789999999999999999999987655  77999


Q ss_pred             EEeccCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEEEeecCce
Q 036229          855 LEYMPHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAK  928 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL~DFGla~  928 (982)
                      |||+++|+|.+++.....  .+++..+..++.|++.||+|||   ++||+||||||+||++    +.++.+||+|||+|+
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999975432  3899999999999999999999   9999999999999999    778889999999998


Q ss_pred             eecCCCCceeecccccccccccCceeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                      .....   .......||+.|+|||++.+
T Consensus       165 ~~~~~---~~~~~~~gt~~y~aPE~~~~  189 (396)
T 4eut_A          165 ELEDD---EQFVSLYGTEEYLHPDMYER  189 (396)
T ss_dssp             ECCCG---GGSSCSSSCCTTCCHHHHHH
T ss_pred             EccCC---CccccccCCccccCHHHhhc
Confidence            76332   22234679999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=1.7e-28  Score=287.48  Aligned_cols=185  Identities=22%  Similarity=0.354  Sum_probs=155.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...  .......+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4568999999999999999999865 6899999999643  233457789999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceeec
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~  931 (982)
                      |||+++|+|.+.+.... .+++..+..++.|++.||.|||   ++||+||||||+||+++   .++.+||+|||+|+...
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999887654 5899999999999999999999   99999999999999995   45689999999998653


Q ss_pred             CCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..   .......||+.|+|||++.+. ++   ..+|+|++|+
T Consensus       176 ~~---~~~~~~~gt~~y~aPE~~~~~-~~---~~~DiwslG~  210 (486)
T 3mwu_A          176 QN---TKMKDRIGTAYYIAPEVLRGT-YD---EKCDVWSAGV  210 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGSC-CC---HHHHHHHHHH
T ss_pred             CC---CccCCCcCCCCCCCHHHhCCC-CC---chhhHHHHHH
Confidence            22   223456799999999999764 33   2355666663

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=9.1e-29  Score=278.78  Aligned_cols=189  Identities=20%  Similarity=0.197  Sum_probs=150.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC------CeEEEEEEeecccchh-----------hhhHHHHHHHhhhcCCcccee
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE------GMEVAVKVFDLQCGRA-----------FKSFDVECEMMKSIRHRNLIK  840 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~nIv~  840 (982)
                      ..++|++.+.||+|+||.||+|++..      ++.||||++.......           ......|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998654      4789999987543211           122344566677788999999


Q ss_pred             EEeeecCC----CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--
Q 036229          841 VISSCSTE----EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD--  914 (982)
Q Consensus       841 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~--  914 (982)
                      +++++...    ...++||||+ +++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            99998664    4689999999 99999999887677999999999999999999999   99999999999999999  


Q ss_pred             CCCcEEEEeecCceeecCCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          915 DNMVAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       915 ~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .++.+||+|||+|+.+......     .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  249 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR---GDLEILGY  249 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH---HHHHHHHH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch---hhHHHHHH
Confidence            8899999999999876432211     11134559999999999987765543   45566663

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=1.2e-28  Score=285.43  Aligned_cols=187  Identities=24%  Similarity=0.395  Sum_probs=152.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|+..+.||+|+||.||+|++..+..||||+++... ...+++.+|++++++++||||+++++++.. +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            456789999999999999999999888899999997543 335689999999999999999999999876 678999999


Q ss_pred             ccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++|+|.+++... ...+++.++..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            9999999999753 345889999999999999999999   9999999999999999999999999999998764322 1


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......+++.|+|||++.+..++.   .+|+|++|+
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~---~sDvwslG~  369 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTI---KSDVWSFGI  369 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCH---HHHHHHHHH
T ss_pred             ecccCCcccccccCHhHHhcCCCCc---cccHHhHHH
Confidence            2223445788999999997665553   356666664

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=1.5e-28  Score=285.01  Aligned_cols=182  Identities=25%  Similarity=0.281  Sum_probs=147.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC------C
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE------E  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~  849 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+++.+|+++++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999854 5899999999754  334467788999999999999999999998654      3


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            57999999976 57666643   3789999999999999999999   99999999999999999999999999999987


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...   .......+||+.|+|||++.+..++..   +|+|++|+
T Consensus       214 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlG~  251 (464)
T 3ttj_A          214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVGC  251 (464)
T ss_dssp             ------CCCC----CCCTTCCHHHHTTCCCCTT---HHHHHHHH
T ss_pred             cCC---CcccCCCcccccccCHHHHcCCCCCHH---HHHHHHHH
Confidence            532   223345789999999999987766644   45566663

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=3e-28  Score=271.54  Aligned_cols=188  Identities=29%  Similarity=0.446  Sum_probs=145.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHH--hhhcCCccceeEEeee-----cCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEM--MKSIRHRNLIKVISSC-----STEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~-----~~~~~  850 (982)
                      ..++|++.+.||+|+||.||+|+. +++.||||+++...   ...+..|.++  ++.++||||+++++++     .....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            357899999999999999999987 68999999997543   2334444444  5568999999999744     33446


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC---------CeEEcCCCCCCEEEcCCCcEEE
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA---------PVIHCDLKPSNVLLDDNMVAHL  921 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~---------~ivHrDlkp~NILl~~~~~~kL  921 (982)
                      .++||||+++|+|.+++....  .++..+..++.|++.||+|||   +.         ||+||||||+||+++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            789999999999999997654  488899999999999999999   88         9999999999999999999999


Q ss_pred             EeecCceeecCCCC------ceeecccccccccccCceeeeeee----eeEEeeEeeeeeeee
Q 036229          922 SDFGIAKLLIGEDQ------SITQTQTLATIGYMAPGLFHVKYI----LFVVNFLTSYSFLMI  974 (982)
Q Consensus       922 ~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~d~~~~~~~  974 (982)
                      +|||+|+.+.....      ........||+.|+|||++.+...    ...+..+|+|++|++
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i  224 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI  224 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence            99999987643221      122234579999999999976211    111123556666643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.3e-28  Score=271.86  Aligned_cols=189  Identities=25%  Similarity=0.427  Sum_probs=150.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC-----CeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE-----GMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .++|+..+.||+|+||.||+|+...     +..||+|+++... ......+.+|++++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567888999999999999998532     3469999997543 334567889999999999999999999999999999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|+|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999877677999999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCC-ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQ-SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ... ........+|+.|+|||++.+..++.   .+|+|++|+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  238 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTS---ASDVWSFGI  238 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCH---HHHHHHHHH
T ss_pred             ccccccccCCCCccccccCchhcccCCCCc---hhhhHHHHH
Confidence            321 11223345678999999997665554   355666664

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=4.3e-28  Score=266.69  Aligned_cols=188  Identities=22%  Similarity=0.290  Sum_probs=148.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            4578999999999999999999964 68999999987542   2334778899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++......
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999997643 5899999999999999999999   999999999999999999999999999999865332


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      . ........|++.|+|||++.+..++.   .+|+|++|+
T Consensus       188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  223 (309)
T 2h34_A          188 K-LTQLGNTVGTLYYMAPERFSESHATY---RADIYALTC  223 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----C---CCHHHHHHH
T ss_pred             c-cccccccCCCcCccCHHHHcCCCCCc---hHhHHHHHH
Confidence            2 12223567999999999997765554   355666663

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=1.7e-28  Score=275.26  Aligned_cols=188  Identities=24%  Similarity=0.345  Sum_probs=154.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecC--------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCST--------  847 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------  847 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....  ......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999996 468999999986442  2234577899999999999999999999876        


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      .+..++||||+++ ++.+.+......+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            4468999999975 888888776667999999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCC--CceeecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          928 KLLIGED--QSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      +.+....  .........||+.|+|||++.+. .++.   .+|+|++|+
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~~DiwslG~  217 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP---PIDLWGAGC  217 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCT---HHHHHHHHH
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCc---HhHHHHHHH
Confidence            8764322  12223456789999999998653 3343   345566663

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=5.8e-28  Score=264.99  Aligned_cols=185  Identities=28%  Similarity=0.359  Sum_probs=158.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .+.|+..+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467999999999999999999864 58999999997553 3446788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++++|.+++..  ..+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||.+.......  
T Consensus       101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            9999999999864  35899999999999999999999   9999999999999999999999999999998764322  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  207 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSK---ADIWSLGI  207 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTH---HHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCCch---hhhHHHHH
Confidence            22345679999999999977655543   45666663

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=2.1e-27  Score=255.69  Aligned_cols=218  Identities=27%  Similarity=0.346  Sum_probs=133.0

Q ss_pred             CCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCcc
Q 036229           66 TPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAF  145 (982)
Q Consensus        66 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  145 (982)
                      .++|.|.|+.|+ ....++.+++++++++ .+|..+.  ++|+.|+|++|++++..+.++..+++|++|+|++|+++...
T Consensus         2 ~~~C~~~~~~C~-c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~   77 (270)
T 2o6q_A            2 EALCKKDGGVCS-CNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP   77 (270)
T ss_dssp             CCCBGGGTCSBE-EETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred             CccCCCCCCCCE-eCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence            468999999998 3344567788888877 4665443  45666666666666444445666666666666666665333


Q ss_pred             CccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccc
Q 036229          146 PSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNL  225 (982)
Q Consensus       146 p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  225 (982)
                      +..|.++++|++|+|++|.++ .+|...|..+++|++|+|++|++++..+                        ..|..+
T Consensus        78 ~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~------------------------~~~~~l  132 (270)
T 2o6q_A           78 AGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPP------------------------RVFDSL  132 (270)
T ss_dssp             TTTTSSCTTCCEEECCSSCCC-CCCTTTTTTCSSCCEEECCSSCCCCCCT------------------------TTTTTC
T ss_pred             hhhhcCCCCCCEEECCCCcCC-cCCHhHcccccCCCEEECCCCccCeeCH------------------------HHhCcC
Confidence            333445555555555555554 3444444444555555555554444444                        444455


Q ss_pred             cchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEc
Q 036229          226 TKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDL  305 (982)
Q Consensus       226 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  305 (982)
                      ++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus       133 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  212 (270)
T 2o6q_A          133 TKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL  212 (270)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence            55555555555555444444555566666666666666555556777777777777777777666666777788888888


Q ss_pred             cCccccc
Q 036229          306 SHNKLVG  312 (982)
Q Consensus       306 s~N~l~~  312 (982)
                      ++|.+..
T Consensus       213 ~~N~~~c  219 (270)
T 2o6q_A          213 QENPWDC  219 (270)
T ss_dssp             CSSCBCC
T ss_pred             cCCCeeC
Confidence            8887754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.94  E-value=2.3e-28  Score=265.06  Aligned_cols=188  Identities=24%  Similarity=0.383  Sum_probs=153.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|++..    +..||+|+++.. .....+++.+|++++++++||||+++++++.++ ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            35789999999999999999998532    456999998755 234567889999999999999999999998754 568


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++++|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999877667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .. ........+|+.|+|||++.+..++..   +|+|++|+
T Consensus       166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  202 (281)
T 3cc6_A          166 ED-YYKASVTRLPIKWMSPESINFRRFTTA---SDVWMFAV  202 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             cc-ccccccCCCCcceeCchhhccCCCCch---hccHHHHH
Confidence            22 122234567889999999976655543   55666664

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=3.1e-28  Score=285.81  Aligned_cols=184  Identities=22%  Similarity=0.355  Sum_probs=151.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...  ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999965 68999999997542  334567899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~  932 (982)
                      ||+++|+|.+.+.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+|||+|.....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999887653 4889999999999999999999   999999999999999975   45699999999987643


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..   ......||+.|+|||++.+. ++.   .+|+|++|+
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~~~-~~~---~~DiwslG~  225 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLRKK-YDE---KCDVWSIGV  225 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHTTC-BCT---HHHHHHHHH
T ss_pred             Cc---cccccCCCcCeeCHHHHccc-CCC---chhHHHHHH
Confidence            22   23456799999999998653 333   355666663

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=4.5e-28  Score=285.19  Aligned_cols=185  Identities=23%  Similarity=0.376  Sum_probs=153.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-------------hhhhhHHHHHHHhhhcCCccceeEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-------------RAFKSFDVECEMMKSIRHRNLIKVIS  843 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l~~  843 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999864 588999999875421             23567889999999999999999999


Q ss_pred             eecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC---cEE
Q 036229          844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAH  920 (982)
Q Consensus       844 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~---~~k  920 (982)
                      ++.+++..++||||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999887643 4899999999999999999999   99999999999999998765   699


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |+|||+|..+...   .......||+.|+|||++.+. ++.   .+|+|++|+
T Consensus       190 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~---~~DiwslG~  235 (504)
T 3q5i_A          190 IVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLKKK-YNE---KCDVWSCGV  235 (504)
T ss_dssp             ECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTTC-BCT---HHHHHHHHH
T ss_pred             EEECCCCEEcCCC---CccccccCCcCCCCHHHhccC-CCc---hHHHHHHHH
Confidence            9999999876432   223456799999999998754 333   345566663

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=5.4e-29  Score=271.11  Aligned_cols=190  Identities=24%  Similarity=0.420  Sum_probs=161.2

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeCC-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ...++|++.+.||+|+||.||+|++.. ++.||+|+++.. ....+++.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            356789999999999999999999754 899999999754 344678899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||+++++|.+++... ...+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999999764 345899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                       ........+|+.|+|||++.+..++..   +|+|++|++
T Consensus       166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  201 (288)
T 3kfa_A          166 -YTAHAGAKFPIKWTAPESLAYNKFSIK---SDVWAFGVL  201 (288)
T ss_dssp             -SEEETTEEECGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             -cccccCCccccCcCChhhhccCCCCch---hhHHHHHHH
Confidence             233345567889999999977665543   456666643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=2.9e-28  Score=263.47  Aligned_cols=185  Identities=24%  Similarity=0.365  Sum_probs=149.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999975 68999999997542   23356788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+...... 
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            99999999999997654 4789999999999999999999   999999999999999999999999999999875322 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        .......|++.|+|||++.+..+..  ..+|+|++|
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~--~~~Di~slG  198 (276)
T 2h6d_A          165 --EFLRTSCGSPNYAAPEVISGRLYAG--PEVDIWSCG  198 (276)
T ss_dssp             --------------CCTGGGTTSCCCH--HHHHHHHHH
T ss_pred             --cceecccCCccccCHHHHcCCCCCC--ccchHHHHH
Confidence              1223457899999999997654321  234556665

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=4.7e-28  Score=267.18  Aligned_cols=187  Identities=26%  Similarity=0.333  Sum_probs=154.5

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++....  ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34678999999999999999999865 48999999997543  3467889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++++|.+++......+++..+..++.|++.||.|||   +.||+||||||+||+++.++.+||+|||.+....... 
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            999999999999766667899999999999999999999   9999999999999999999999999999998764322 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       180 -~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  213 (314)
T 3com_A          180 -AKRNTVIGTPFWMAPEVIQEIGYNCV---ADIWSLGI  213 (314)
T ss_dssp             -SCBCCCCSCGGGCCHHHHSSSCBCTT---HHHHHHHH
T ss_pred             -cccCccCCCCCccChhhcCCCCCCcc---ccHHHHHH
Confidence             22334678999999999977655533   45666663

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=2.3e-28  Score=268.00  Aligned_cols=190  Identities=24%  Similarity=0.363  Sum_probs=151.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC---------
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST---------  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------  847 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++.. ....+.+.+|++++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3567999999999999999999964 6899999999643 3445778999999999999999999998754         


Q ss_pred             ----CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          848 ----EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       848 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                          .+..++||||+++|+|.+++.......++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence                45789999999999999999877767888999999999999999999   99999999999999999999999999


Q ss_pred             ecCceeecCCCC------------ceeecccccccccccCceeeee-eeeeEEeeEeeeeeeee
Q 036229          924 FGIAKLLIGEDQ------------SITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLMI  974 (982)
Q Consensus       924 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~~  974 (982)
                      ||.+........            ........||+.|+|||++.+. .++   ..+|+|++|++
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~~Di~slG~i  220 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN---EKIDMYSLGII  220 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCC---THHHHHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCc---chhhHHHHHHH
Confidence            999986532110            1122345789999999998654 333   33556666643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.94  E-value=2.6e-28  Score=265.03  Aligned_cols=184  Identities=26%  Similarity=0.428  Sum_probs=155.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC---------
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST---------  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~---------  847 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999975 69999999997543    456789999999999999999998754         


Q ss_pred             -------CCeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          848 -------EEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       848 -------~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                             ....++||||+++++|.+++... ...+++..+..++.|++.||.|||   ++||+||||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   44589999999999999999754 346899999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||+|||++.......   ......||+.|+|||++.+..++.   .+|+|++|++
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~i  210 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGK---EVDLYALGLI  210 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCT---HHHHHHHHHH
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcc---hhhhHHHHHH
Confidence            999999998764332   223457999999999997765553   3556666643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=3.1e-28  Score=267.83  Aligned_cols=185  Identities=27%  Similarity=0.399  Sum_probs=150.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc-----chhhhhHHHHHHHhhhcC---CccceeEEeeecCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC-----GRAFKSFDVECEMMKSIR---HRNLIKVISSCSTE  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~  848 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|+++...     ......+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467999999999999999999995 468999999987432     122346778888877764   99999999998765


Q ss_pred             C-----eeEEEEEeccCCChHHHHhcCCC-cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEE
Q 036229          849 E-----FKALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS  922 (982)
Q Consensus       849 ~-----~~~lv~E~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~  922 (982)
                      .     ..++||||++ ++|.+++..... .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5789999996 599999876543 4899999999999999999999   9999999999999999999999999


Q ss_pred             eecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          923 DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       923 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      |||+|+.....   .......||+.|+|||++.+..++..   +|+|++|
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG  206 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATP---VDMWSVG  206 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCST---HHHHHHH
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCch---HHHHHHH
Confidence            99999865322   22345679999999999977666544   4556666

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.94  E-value=9.1e-29  Score=280.09  Aligned_cols=169  Identities=18%  Similarity=0.195  Sum_probs=138.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHH---HhhhcCCccceeEE-------ee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECE---MMKSIRHRNLIKVI-------SS  844 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~nIv~l~-------~~  844 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++..   .....+.+.+|++   ++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788999999999999999995 56999999999743   3345678899994   55566899999998       55


Q ss_pred             ecCCC-----------------eeEEEEEeccCCChHHHHhcCCC------cCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 036229          845 CSTEE-----------------FKALILEYMPHGSLEKSLYSSNY------ILDIFQRLNIMVDVATTLEYLHFGYSAPV  901 (982)
Q Consensus       845 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~------~~~~~~~~~i~~qi~~~L~yLH~~~~~~i  901 (982)
                      +..++                 ..|+||||+ +|+|.+++...+.      .+++..+..++.|++.||+|||   ++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 6799999975422      2335788889999999999999   9999


Q ss_pred             EEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeee
Q 036229          902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK  957 (982)
Q Consensus       902 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  957 (982)
                      +||||||+||+++.++.+||+|||+|+...     .......| +.|+|||++.+.
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~  277 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARR  277 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhccc
Confidence            999999999999999999999999998631     12345567 999999999766

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.94  E-value=2.8e-28  Score=268.92  Aligned_cols=192  Identities=26%  Similarity=0.401  Sum_probs=146.2

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE  849 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  849 (982)
                      ....++|.+.+.||+|+||.||+|+..    +++.||+|+++..  .....+.+.+|++++++++||||+++++++...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            345678999999999999999999753    3568999998754  2344567899999999999999999999987655


Q ss_pred             -----eeEEEEEeccCCChHHHHhc-----CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          850 -----FKALILEYMPHGSLEKSLYS-----SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       850 -----~~~lv~E~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                           ..++||||+++|+|.+++..     ....+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence                 35999999999999999853     3346899999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||+|||+++...............+++.|+|||++.+..++..   +|+|++|+
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  237 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK---SDVWAFGV  237 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHH---HHHHHHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccch---hhhHHHHH
Confidence            9999999987644333333345567889999999977665543   55666664

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.94  E-value=4.5e-28  Score=266.24  Aligned_cols=182  Identities=26%  Similarity=0.403  Sum_probs=144.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.+.||+|+||.||+|++ .++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            35789999999999999999988 4788999998643  345788999999999999999999999874  478999999


Q ss_pred             cCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc-EEEEeecCceeecCCCC
Q 036229          859 PHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       859 ~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~~~  935 (982)
                      ++|+|.+++.....  .+++..+..++.|+++||+|||..+.+||+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999986543  4688899999999999999999222289999999999999998876 799999999865221  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....||+.|+|||++.+..++..   +|+|++|+
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  191 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEK---CDVFSWGI  191 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTH---HHHHHHHH
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcH---HHHHHHHH
Confidence               223469999999999977655543   55666663

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=3e-28  Score=268.26  Aligned_cols=188  Identities=26%  Similarity=0.388  Sum_probs=147.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|+++..   .....+++.+|++++++++||||+++++++..++..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            456799999999999999999986 46899999999743   23455778899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          854 ILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ||||+++++|.+++..   ....+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999998864   3456899999999999999999999   999999999999999999999999999999865


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....  .......|++.|+|||++.+..++..   +|+|++|+
T Consensus       187 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~---~Dv~slG~  224 (310)
T 2wqm_A          187 SSKT--TAAHSLVGTPYYMSPERIHENGYNFK---SDIWSLGC  224 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHH---HHHHHHHH
T ss_pred             cCCC--ccccccCCCeeEeChHHhCCCCCCch---hhHHHHHH
Confidence            3222  22234578999999999977655533   55666663

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=3.3e-28  Score=266.28  Aligned_cols=189  Identities=24%  Similarity=0.388  Sum_probs=154.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeee-cCCCeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSC-STEEFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~  852 (982)
                      ..+|++.+.||+|+||.||+|+..+    ...||+|.++.. .....+++.+|++++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4568889999999999999998532    346899998753 334457789999999999999999999985 5566889


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+|+....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999877777899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCC--ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQ--SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...  ........+|+.|+|||++.+..++..   .|+|++|+
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  220 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTK---SDVWSFGV  220 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChH---HHHHHHHH
Confidence            221  122345567889999999977665543   45666664

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=2.2e-28  Score=286.73  Aligned_cols=185  Identities=24%  Similarity=0.381  Sum_probs=156.9

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467999999999999999999865 68999999996542   3346778999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceee
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~  930 (982)
                      ||||+.+|+|.+++.... .+++..+..++.|++.||.|||   ++||+||||||+||++   +.++.+||+|||+|+.+
T Consensus       104 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            999999999999887644 5899999999999999999999   9999999999999999   46789999999999876


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....   ......||+.|+|||++.+. ++.   .+|+|++|+
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~---~~DiwslG~  215 (484)
T 3nyv_A          180 EASK---KMKDKIGTAYYIAPEVLHGT-YDE---KCDVWSTGV  215 (484)
T ss_dssp             CCCC---SHHHHTTGGGTCCHHHHHTC-CCT---HHHHHHHHH
T ss_pred             cccc---ccccCCCCccccCceeecCC-CCC---cceeHHHHH
Confidence            3322   23456799999999999764 332   355666663

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=5.3e-28  Score=274.46  Aligned_cols=183  Identities=26%  Similarity=0.368  Sum_probs=146.2

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC-------
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST-------  847 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------  847 (982)
                      +...++|++.+.||+|+||.||+|+. .+++.||||++....    ....+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            44568899999999999999999985 569999999986442    223479999999999999999999833       


Q ss_pred             -------------------------------CCeeEEEEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHH
Q 036229          848 -------------------------------EEFKALILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYL  893 (982)
Q Consensus       848 -------------------------------~~~~~lv~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yL  893 (982)
                                                     ....++||||++ |+|.+.+..   ....+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           345889999997 487777653   345689999999999999999999


Q ss_pred             HccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeee
Q 036229          894 HFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSF  971 (982)
Q Consensus       894 H~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~  971 (982)
                      |   ++||+||||||+||+++ .++.+||+|||+|+......   ......||+.|+|||++.+.. ++..   +|+|++
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~---~Diwsl  228 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPS---IDLWSI  228 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTH---HHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcc---hhhhhH
Confidence            9   99999999999999998 68899999999999764332   233567899999999986543 4433   445555


Q ss_pred             e
Q 036229          972 L  972 (982)
Q Consensus       972 ~  972 (982)
                      |
T Consensus       229 G  229 (383)
T 3eb0_A          229 G  229 (383)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=2.2e-28  Score=275.35  Aligned_cols=184  Identities=21%  Similarity=0.305  Sum_probs=155.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999865 5899999999765 33445778999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++++|.+++.... .+++..+..++.|++.||+|||   ++ ||+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999997654 4889999999999999999999   75 9999999999999999999999999999765221  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  218 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQ---SDIWSMGL  218 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHH---HHHHHHHH
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCch---hhHHHHHH
Confidence              2234679999999999977665543   45566653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=5.2e-28  Score=268.44  Aligned_cols=187  Identities=29%  Similarity=0.463  Sum_probs=151.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeE--EEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGME--VAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+.. ++..  ||+|.++.. .....+++.+|+++++++ +||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999853 5664  499988743 334557789999999999 99999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc
Q 036229          854 ILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV  918 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~  918 (982)
                      ||||+++|+|.+++...+               ..+++.++..++.|++.||+|||   ++||+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999997653               36899999999999999999999   999999999999999999999


Q ss_pred             EEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          919 AHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       919 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      +||+|||+++...   .........+++.|+|||++.+..++..   +|+|++|++
T Consensus       181 ~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~i  230 (327)
T 1fvr_A          181 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTN---SDVWSYGVL  230 (327)
T ss_dssp             EEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHH---HHHHHHHHH
T ss_pred             EEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCch---hcchHHHHH
Confidence            9999999998431   1122234457889999999977655543   556666643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.5e-28  Score=274.88  Aligned_cols=180  Identities=24%  Similarity=0.315  Sum_probs=145.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  849 (982)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++...  .....+++.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46899999999999999999986 46999999998543  2334567889999999999999999999987653      


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..|+||||+ +++|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 78999998763  4889999999999999999999   99999999999999999999999999999997


Q ss_pred             ecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFL  972 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~  972 (982)
                      ...     ......||+.|+|||++.+ ..++..   +|+|++|
T Consensus       178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwslG  213 (367)
T 1cm8_A          178 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQT---VDIWSVG  213 (367)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTT---HHHHHHH
T ss_pred             ccc-----ccCcCcCCCCcCCHHHHhCCCCCChh---hhHHHHH
Confidence            532     1245678999999999866 344433   4455555

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=2.2e-28  Score=271.43  Aligned_cols=190  Identities=23%  Similarity=0.361  Sum_probs=153.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      ..++|++.+.||+|+||.||+|++      .+++.||||++... ......++.+|+.++++++||||+++++++..++.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            357899999999999999999983      24778999999644 33445678899999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEE
Q 036229          851 KALILEYMPHGSLEKSLYSSN------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHL  921 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL  921 (982)
                      .++||||+++++|.+++....      ..+++..+..++.|++.||.|||   ++||+||||||+||+++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999998653      34889999999999999999999   999999999999999984   446999


Q ss_pred             EeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          922 SDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       922 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +|||++................||+.|+|||++.+..++..   +|+|++|+
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  233 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK---TDTWSFGV  233 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCch---hhHHHHHH
Confidence            99999986543333333345668999999999977655543   55666664

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=3.5e-28  Score=272.41  Aligned_cols=184  Identities=21%  Similarity=0.324  Sum_probs=156.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchh-----------------hhhHHHHHHHhhhcCCccceeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRA-----------------FKSFDVECEMMKSIRHRNLIKV  841 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~nIv~l  841 (982)
                      .++|++.+.||+|+||.||+|+. +++.||+|++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 89999999997442111                 1788999999999999999999


Q ss_pred             EeeecCCCeeEEEEEeccCCChHHH------HhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEE
Q 036229          842 ISSCSTEEFKALILEYMPHGSLEKS------LYSS-NYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLL  913 (982)
Q Consensus       842 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl  913 (982)
                      ++++.+++..++||||+++|+|.++      +... ...+++..+..++.|++.||.|||   + +||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      5442 456899999999999999999999   8 999999999999999


Q ss_pred             cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          914 DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       914 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      +.++.+||+|||.+......    ......||+.|+|||++.+. .+...  .+|+|++|
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~--~~Di~slG  239 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGA--KVDIWSLG  239 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHH--HHHHHHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcc--hhhHHHHH
Confidence            99999999999999876332    33456799999999999765 33321  34556655

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=1e-27  Score=262.33  Aligned_cols=189  Identities=24%  Similarity=0.331  Sum_probs=156.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---------chhhhhHHHHHHHhhhcC-CccceeEEeeec
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---------GRAFKSFDVECEMMKSIR-HRNLIKVISSCS  846 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~  846 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++...         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999864 58999999997542         123457789999999995 999999999999


Q ss_pred             CCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          847 TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       847 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      .++..++||||+++++|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            999999999999999999999764 35899999999999999999999   99999999999999999999999999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeee---eeeEEeeEeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKY---ILFVVNFLTSYSFLM  973 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~d~~~~~~  973 (982)
                      +.......   ......|++.|+|||++.+..   ....+..+|+|++|+
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~  217 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV  217 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHH
Confidence            98764322   223467899999999985321   111223456666663

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=8.3e-28  Score=267.22  Aligned_cols=179  Identities=21%  Similarity=0.351  Sum_probs=150.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecC--CCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCST--EEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++..   ..+.+.+|++++++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            46799999999999999999985 56899999998743   3467889999999997 9999999999987  5678999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceeecCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGE  933 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~  933 (982)
                      |||+++++|.+++..    +++.++..++.|++.||+|||   ++||+||||||+||+++.++ .+||+|||+|+.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998853    788999999999999999999   99999999999999999776 8999999999876432


Q ss_pred             CCceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      .   ......||+.|+|||++.+ ..++..   +|+|++|+
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~---~DiwslG~  219 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYS---LDMWSLGC  219 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTH---HHHHHHHH
T ss_pred             C---ccccccccccccChhhhcCCCcCCch---hhHHHHHH
Confidence            2   2344678999999999865 334433   45566653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=8.7e-28  Score=260.80  Aligned_cols=185  Identities=25%  Similarity=0.349  Sum_probs=154.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc------hhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG------RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++....      ...+.+.+|++++++++||||+++++++..++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999975 589999999875421      1356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGla  927 (982)
                      ++||||+++++|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++.++    .+||+|||.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999997543 5899999999999999999999   99999999999999998877    8999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .......   ......||+.|+|||++.+..++.   .+|+|++|+
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  199 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGL---EADMWSIGV  199 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCT---HHHHHHHHH
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCc---chhhhhHHH
Confidence            8763322   223456999999999997665543   355666663

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=3.7e-28  Score=268.99  Aligned_cols=185  Identities=24%  Similarity=0.318  Sum_probs=148.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--------chhhhhHHHHHHHhhhcCCccceeEEeeecCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....        ......+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999864 58999999986432        12235688999999999999999999998766


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEeec
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDFG  925 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DFG  925 (982)
                      + .++||||+++++|.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 79999999999999988654 45899999999999999999999   999999999999999986654   9999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeee---eeeeeEEeeEeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHV---KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~~d~~~~~~  973 (982)
                      +++.....   .......||+.|+|||++.+   ..++   ..+|+|++|+
T Consensus       163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~---~~~Di~slG~  207 (322)
T 2ycf_A          163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYN---RAVDCWSLGV  207 (322)
T ss_dssp             TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCT---THHHHHHHHH
T ss_pred             cceecccc---cccccccCCcCccCchhhccCCCCCCC---chhhHHHHHH
Confidence            99876322   12234578999999999742   2233   3355666664

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=4.1e-28  Score=290.82  Aligned_cols=186  Identities=22%  Similarity=0.356  Sum_probs=149.2

Q ss_pred             CCCccc-eeeeeceEEEEEEEeC---CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          781 RFSENN-LIGRGGFGSVYKARIG---EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       781 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999753   46789999997543 3456789999999999999999999999976 5689999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+++|+|.+++......+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+.+.....
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999877777999999999999999999999   99999999999999999999999999999987643222


Q ss_pred             c-eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 S-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      . .......+++.|+|||++.+..++..   +|+|++|+
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~---sDvwSlGv  527 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSR---SDVWSYGV  527 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcH---HHHHHHHH
Confidence            1 11223346789999999977666543   55666664

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.94  E-value=1.2e-27  Score=261.29  Aligned_cols=188  Identities=25%  Similarity=0.350  Sum_probs=152.2

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      ++|.....||+|+||.||+|+. .+++.||+|+++.......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            4456667999999999999986 458899999998766666778999999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCceeecCCCC
Q 036229          859 PHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       859 ~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~  935 (982)
                      ++++|.+++.....  ..++..+..++.|++.||+|||   ++||+||||||+||+++. ++.+||+|||.+....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999986532  4568888999999999999999   999999999999999987 8999999999998763321 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       .......||+.|+|||++.+.... .+..+|+|++|+
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~Di~slG~  213 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGC  213 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGG-CSHHHHHHHHHH
T ss_pred             -CcccccCCCccccChhhhcCCCCC-CCcHHHHHHHHH
Confidence             122346799999999998654211 122345566663

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=5.4e-28  Score=263.60  Aligned_cols=188  Identities=23%  Similarity=0.336  Sum_probs=152.3

Q ss_pred             HhcCCCccc-eeeeeceEEEEEEEe---CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          778 ATNRFSENN-LIGRGGFGSVYKARI---GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       778 ~~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      ..++|.+.+ .||+|+||.||+|.+   .+++.||||+++...  ....+++.+|+++++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788887 999999999999964   347889999997542  33467889999999999999999999999 55678


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999997643 4899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCce-eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...... ......+++.|+|||++.+..++.   .+|+|++|+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  208 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSS---KSDVWSFGV  208 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEH---HHHHHHHHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCCh---hhhHHHHHH
Confidence            433222 223345678999999997665543   356666664

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.94  E-value=2.5e-28  Score=273.00  Aligned_cols=187  Identities=20%  Similarity=0.193  Sum_probs=147.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecccch-----------hhhhHHHHHHHhhhcCCccceeEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQCGR-----------AFKSFDVECEMMKSIRHRNLIKVIS  843 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nIv~l~~  843 (982)
                      .++|++.+.||+|+||.||+|+..    ++..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            468999999999999999999864    5788999998754321           1234667888899999999999999


Q ss_pred             eecC----CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC--
Q 036229          844 SCST----EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM--  917 (982)
Q Consensus       844 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~--  917 (982)
                      ++..    ....++||||+ +++|.+++...+ .+++.++..++.|++.||+|||   ++||+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9877    77899999999 999999997654 6899999999999999999999   99999999999999999877  


Q ss_pred             cEEEEeecCceeecCCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          918 VAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       918 ~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .+||+|||+|+.+......     .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  248 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR---SDVEILGY  248 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH---HHHHHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch---hhHHHHHH
Confidence            9999999999876432211     11245579999999999987655543   55566663

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.94  E-value=2.8e-28  Score=270.51  Aligned_cols=198  Identities=25%  Similarity=0.310  Sum_probs=152.6

Q ss_pred             CCHHHHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          770 FSYLELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      ++..++....++|++.+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|+++++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            33334445678999999999999999999996 468999999997543 3457788999999999 89999999999866


Q ss_pred             ------CCeeEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEE
Q 036229          848 ------EEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH  920 (982)
Q Consensus       848 ------~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~k  920 (982)
                            .+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence                  468899999999999999997643 46889999999999999999999   99999999999999999999999


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeee--eeeEEeeEeeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY--ILFVVNFLTSYSFLM  973 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~d~~~~~~  973 (982)
                      |+|||++......  ........||+.|+|||++....  ....+...|+|++|+
T Consensus       170 l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~  222 (326)
T 2x7f_A          170 LVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI  222 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHH
T ss_pred             EeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHH
Confidence            9999999875322  11223457999999999986321  111223456666663

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=2.5e-28  Score=288.60  Aligned_cols=188  Identities=24%  Similarity=0.387  Sum_probs=156.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ...++|++.+.||+|+||.||+|++..+..||||+++... ...+++.+|++++++++||||+++++++.+ +..++|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            3456789999999999999999999888899999997543 335689999999999999999999999876 67899999


Q ss_pred             eccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++... ...+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++..... .
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-E  417 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-H
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-c
Confidence            99999999999753 345889999999999999999999   999999999999999999999999999999865321 1


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ........++..|+|||++.+..++.   .+|+|++|+
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~---~sDvwSlGv  452 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTI---KSDVWSFGI  452 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCH---HHHHHHHHH
T ss_pred             eecccCCcCcccccCHHHhccCCCCc---hhhHHHHHH
Confidence            11123345678999999997665553   355666664

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=6.3e-28  Score=264.84  Aligned_cols=185  Identities=22%  Similarity=0.360  Sum_probs=154.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467999999999999999999864 689999999986554455678899999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceeecCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~  933 (982)
                      |+++++|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||++   ++++.+||+|||++..... 
T Consensus        87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            999999999987644 4889999999999999999999   9999999999999999   7788999999999975421 


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .......||+.|+|||++.+..++..   .|+|++|+
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  195 (304)
T 2jam_A          162 ---GIMSTACGTPGYVAPEVLAQKPYSKA---VDCWSIGV  195 (304)
T ss_dssp             ---BTTHHHHSCCCBCCTTTBSSCSCCHH---HHHHHHHH
T ss_pred             ---CccccccCCCCccChHHhccCCCCch---hhHHHHHH
Confidence               12234568999999999977665543   55566663

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=2.9e-28  Score=270.91  Aligned_cols=186  Identities=26%  Similarity=0.364  Sum_probs=150.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999999965 48999999986442  233456789999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||++++++.++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++....... 
T Consensus       104 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             ECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence            999998888876543 45899999999999999999999   9999999999999999999999999999998653322 


Q ss_pred             ceeecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                       .......||+.|+|||++.+. .++.   .+|+|++|+
T Consensus       179 -~~~~~~~~t~~y~aPE~~~~~~~~~~---~~Di~slG~  213 (331)
T 4aaa_A          179 -EVYDDEVATRWYRAPELLVGDVKYGK---AVDVWAIGC  213 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCT---HHHHHHHHH
T ss_pred             -cccCCCcCCccccCcccccCCCCcch---HHHHHHHHH
Confidence             223456799999999998664 3332   345566653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.94  E-value=1.4e-27  Score=261.03  Aligned_cols=187  Identities=22%  Similarity=0.305  Sum_probs=151.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeee-cCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC-STEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++....  ..+++.+|+++++.++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999985 569999999876442  335688999999999988877666655 6677889999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~  932 (982)
                      ||+ +++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||++   ++++.+||+|||+|+....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 89999999876667999999999999999999999   9999999999999999   7889999999999997654


Q ss_pred             CCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....     .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  203 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR---DDLESLGY  203 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH---HHHHHHHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCch---hHHHHHHH
Confidence            3221     12235679999999999987665543   45666663

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.8e-28  Score=274.71  Aligned_cols=187  Identities=24%  Similarity=0.388  Sum_probs=144.3

Q ss_pred             CCCccceeeeeceEEEEEEEeC--C--CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeec-CCCeeEEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG--E--GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCS-TEEFKALI  854 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv  854 (982)
                      .|+..+.||+|+||.||+|++.  +  +..||+|.++.. .....+++.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999852  2  346899998643 3345678999999999999999999999865 45688999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++......+++.++..++.|++.||+|||   ++||+||||||+||++++++.+||+|||+|+.+....
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877777899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             Cc--eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 QS--ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..  .......+|+.|+|||++.+..++..   +|+|++|+
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~DvwSlG~  284 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTK---SDVWSFGV  284 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcH---HHHHHHHH
Confidence            11  12234567889999999977666543   45566663

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.94  E-value=1.6e-27  Score=261.76  Aligned_cols=191  Identities=20%  Similarity=0.310  Sum_probs=153.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc----chhhhhHHHHHHHhhhcCCccceeEEeee--cCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSC--STEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~  850 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...    ....+.+.+|++++++++||||+++++++  .+.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999964 58999999997542    23457789999999999999999999998  44568


Q ss_pred             eEEEEEeccCCChHHHHhc-CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          851 KALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      .++||||++++ +.+++.. ....+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999876 7676654 3446899999999999999999999   99999999999999999999999999999987


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..............||+.|+|||++.+.... .+..+|+|++|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~Di~slG~  201 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTF-SGFKVDIWSAGV  201 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCE-ESHHHHHHHHHH
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccC-CcchhhHHHHHH
Confidence            6443333344556799999999998653221 123456666664

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.94  E-value=1.6e-28  Score=269.28  Aligned_cols=188  Identities=23%  Similarity=0.329  Sum_probs=153.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++........+++.+|+++++.++||||+++++++..++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4578999999999999999999975 589999999976665667889999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+++++|.+++......+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999998876667899999999999999999999   999999999999999999999999999997643211  1


Q ss_pred             eeecccccccccccCceee-----eeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFH-----VKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~~~d~~~~~~  973 (982)
                      .......||+.|+|||++.     +..++   ..+|+|++|+
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~---~~~Di~slG~  210 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYD---YKADIWSLGI  210 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTT---THHHHHHHHH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCc---hhhhHHHHHH
Confidence            1223457899999999984     22333   3355666664

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.94  E-value=1.2e-27  Score=269.48  Aligned_cols=187  Identities=25%  Similarity=0.285  Sum_probs=152.8

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCC-----Ce
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~  850 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3568999999999999999999864 68999999997433 33457788999999999999999999998654     36


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++||||++ |+|.+++...  .+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            899999997 5999988754  4899999999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCc-eeecccccccccccCceeeee-eeeeEEeeEeeeeeee
Q 036229          931 IGEDQS-ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~~  973 (982)
                      ...... .......||+.|+|||++.+. .++.   .+|+|++|+
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~~DiwslG~  220 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK---SIDIWSVGC  220 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCST---HHHHHHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCc---chhHHHHHH
Confidence            432211 112446899999999987543 3443   345566653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.94  E-value=4.3e-27  Score=262.83  Aligned_cols=203  Identities=25%  Similarity=0.372  Sum_probs=160.5

Q ss_pred             CHHHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhh--cCCccceeEEeeecCC
Q 036229          771 SYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKS--IRHRNLIKVISSCSTE  848 (982)
Q Consensus       771 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~  848 (982)
                      .........++|++.+.||+|+||.||+|+. +++.||||++...   ....+.+|+++++.  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3334445667899999999999999999998 5899999998643   34567788998887  7999999999999877


Q ss_pred             C----eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCCEEEcCCCcE
Q 036229          849 E----FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       849 ~----~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                      +    ..++||||+++|+|.+++.+.  .+++.++..++.|++.||+|||..     +++||+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            5    789999999999999999764  489999999999999999999921     15799999999999999999999


Q ss_pred             EEEeecCceeecCCCCce--eecccccccccccCceeeeeeee---eEEeeEeeeeee--eeecccC
Q 036229          920 HLSDFGIAKLLIGEDQSI--TQTQTLATIGYMAPGLFHVKYIL---FVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ||+|||++..........  ......||+.|+|||++.+....   .....+|+|++|  ++.+.+|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999998775443221  23456799999999998664211   111234555555  4555544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.94  E-value=1.1e-27  Score=267.14  Aligned_cols=192  Identities=22%  Similarity=0.251  Sum_probs=140.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeee--------cC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSC--------ST  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~--------~~  847 (982)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++++. ||||+++++++        ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3458999999999999999999964 68999999987666666778899999999996 99999999998        34


Q ss_pred             CCeeEEEEEeccCCChHHHHhc--CCCcCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEcCCCcEEEEe
Q 036229          848 EEFKALILEYMPHGSLEKSLYS--SNYILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                      ....++||||++ |+|.+++..  ....+++.++..++.|++.||+|||   ++|  |+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence            456899999995 699988864  3446899999999999999999999   999  99999999999999999999999


Q ss_pred             ecCceeecCCCCce----------eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          924 FGIAKLLIGEDQSI----------TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       924 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||+++.........          ......||+.|+|||++........+..+|+|++|+
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~  241 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC  241 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHH
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHH
Confidence            99998764322111          112456899999999984221111223455666663

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.94  E-value=2.3e-27  Score=259.22  Aligned_cols=186  Identities=23%  Similarity=0.307  Sum_probs=154.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeee-cCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC-STEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++....  ..+++.+|+++++.++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999996 569999999987543  335788999999999988866655554 66778899999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceeecCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~  933 (982)
                      |+ +++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||++   ++++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999866667999999999999999999999   9999999999999999   47889999999999976543


Q ss_pred             CCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...     .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  203 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRR---DDLESLGY  203 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH---HHHHHHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcc---hhhHHHHH
Confidence            321     12245679999999999987665543   45566663

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=8.5e-28  Score=262.98  Aligned_cols=187  Identities=22%  Similarity=0.350  Sum_probs=154.2

Q ss_pred             CCCccceeeeeceEEEEEEEeC-C---CeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCee-EEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-E---GMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK-ALI  854 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv  854 (982)
                      .|...+.||+|+||.||+|++. +   +..||+|+++... ....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4666799999999999999842 2   3479999987543 34457889999999999999999999999776655 999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+.+|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999887777899999999999999999999   9999999999999999999999999999998653322


Q ss_pred             --CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          935 --QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        .........+|+.|+|||.+.+..++..   +|+|++|+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  216 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTK---SDVWSFGV  216 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHH---HHHHHHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChh---hchhhHHH
Confidence              1122334568899999999977665543   45666663

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=3.4e-28  Score=263.39  Aligned_cols=187  Identities=24%  Similarity=0.341  Sum_probs=153.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeee--cCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSC--STEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~l  853 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++  ...+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999865 68999999997542  34456789999999999999999999987  44678999


Q ss_pred             EEEeccCCChHHHHhcC---CCcCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          854 ILEYMPHGSLEKSLYSS---NYILDIFQRLNIMVDVATTLEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~-----ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||   ++|     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   334899999999999999999999   888     9999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .+.......  .......||+.|+|||++.+..++..   +|+|++|+
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  204 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEK---SDIWSLGC  204 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHH---HHHHHHHH
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCch---hhHHHHHH
Confidence            998653221  12234578999999999977655533   55666664

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.94  E-value=1e-27  Score=272.73  Aligned_cols=180  Identities=27%  Similarity=0.412  Sum_probs=143.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCC------CeeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE------EFKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~  852 (982)
                      ..+|++.+.||+|+||.||+|+...+..||+|++....    ....+|+++++.++||||+++++++...      ...+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            45799999999999999999998777779999886432    2224699999999999999999998443      3478


Q ss_pred             EEEEeccCCChHHHHh---cCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeecCce
Q 036229          853 LILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK  928 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFGla~  928 (982)
                      +||||++++ +.+.+.   .....+++..+..++.|++.||+|||   ++||+||||||+||+++ .++.+||+|||+|+
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            999999774 433332   23456899999999999999999999   99999999999999999 79999999999998


Q ss_pred             eecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL  972 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~  972 (982)
                      ......   ......||+.|+|||++.+.. ++..   +|+|++|
T Consensus       191 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwSlG  229 (394)
T 4e7w_A          191 ILIAGE---PNVSYICSRYYRAPELIFGATNYTTN---IDIWSTG  229 (394)
T ss_dssp             ECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTH---HHHHHHH
T ss_pred             cccCCC---CCcccccCcCccCHHHHcCCCCCCcH---HHHHHHH
Confidence            763322   233567899999999986543 4433   4455555

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.94  E-value=7.6e-28  Score=262.38  Aligned_cols=188  Identities=26%  Similarity=0.361  Sum_probs=147.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC--CC--eEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG--EG--MEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|++.  ++  ..||+|+++..   .....+++.+|++++++++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999852  23  36899998654   2345678899999999999999999999998765 8


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||   ++||+||||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876667899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCce-eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          932 GEDQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...... ......+|+.|+|||++.+..++.   ..|+|++|+
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~  212 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSH---ASDTWMFGV  212 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEH---HHHHHHHHH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCc---hhhHHHHHH
Confidence            433222 223456788999999997765543   355666664

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=1.6e-27  Score=278.31  Aligned_cols=234  Identities=17%  Similarity=0.163  Sum_probs=137.8

Q ss_pred             CCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCcccccccccc
Q 036229          372 KLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHS  451 (982)
Q Consensus       372 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~  451 (982)
                      +|++|+|++|.+++..|..|..+++|+.|++++|.++...       .|..+++|++|+|++|.++++            
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------~l~~l~~L~~L~Ls~N~l~~l------------   95 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTLDLNNNYVQEL------------   95 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEE-------ECTTCTTCCEEECCSSEEEEE------------
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCc-------ccccCCCCCEEEecCCcCCCC------------
Confidence            5666666666666655555555555555555555443211       134444444555555432211            


Q ss_pred             ccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccC
Q 036229          452 LEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG  531 (982)
Q Consensus       452 L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  531 (982)
                                    .     ..++|+.|++++|.+++..+..   +++|+.|+|++|.|++..|..|..+++|+.|+|++
T Consensus        96 --------------~-----~~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (487)
T 3oja_A           96 --------------L-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (487)
T ss_dssp             --------------E-----ECTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTT
T ss_pred             --------------C-----CCCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCC
Confidence                          1     1145556666666665544332   34555555555555555555555555555555555


Q ss_pred             CcCCcCCCcccc-CCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccccccccccc
Q 036229          532 NKLSGSIPACFS-NLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP  610 (982)
Q Consensus       532 N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p  610 (982)
                      |+|++..|..|. .+++|++|+|++|.++.+|.                         ...+++|+.|||++|.|++.+|
T Consensus       154 N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-------------------------~~~l~~L~~L~Ls~N~l~~~~~  208 (487)
T 3oja_A          154 NEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-------------------------QVVFAKLKTLDLSSNKLAFMGP  208 (487)
T ss_dssp             SCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-------------------------CCCCTTCCEEECCSSCCCEECG
T ss_pred             CCCCCcChHHHhhhCCcccEEecCCCccccccc-------------------------cccCCCCCEEECCCCCCCCCCH
Confidence            555554444443 44555555555555444332                         2235667777777777766444


Q ss_pred             ccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCC-CCCCcccccccccceeecC
Q 036229          611 TVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS-RSIPISLEKLSYLEDLDLS  673 (982)
Q Consensus       611 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~l~ls  673 (982)
                       .++.+++|+.|+|++|+|++ +|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       209 -~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          209 -EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             -GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             -hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence             47778888888888888874 6777888888888888888887 5667777788888888776

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=2e-27  Score=258.98  Aligned_cols=183  Identities=26%  Similarity=0.378  Sum_probs=151.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC----CCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST----EEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~  851 (982)
                      ...|.+.+.||+|+||.||+|... ++..||+|++...  .....+.+.+|++++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345788899999999999999864 5889999998754  23446778999999999999999999998754    4568


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEc-CCCcEEEEeecCce
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAK  928 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kL~DFGla~  928 (982)
                      ++||||+++++|.+++... ..+++..+..++.|++.||.|||   +++  |+||||||+||+++ +++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            9999999999999999764 34889999999999999999999   888  99999999999997 78999999999997


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .....    ......||+.|+|||++.+. ++   ...|+|++|+
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~~~-~~---~~~Di~slG~  217 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYEEK-YD---ESVDVYAFGM  217 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGTC-CC---THHHHHHHHH
T ss_pred             ccccc----ccccccCCcCcCCHHHHhcc-CC---CcchHHHHHH
Confidence            54222    22345799999999998754 33   3355666663

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.94  E-value=8.1e-28  Score=271.76  Aligned_cols=183  Identities=10%  Similarity=0.112  Sum_probs=133.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccc---hhhhhHHHHHHHhhhc--CCccceeEEe-------ee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG---RAFKSFDVECEMMKSI--RHRNLIKVIS-------SC  845 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~nIv~l~~-------~~  845 (982)
                      ..+|+..+.||+|+||.||+|++. +++.||||++.....   ...+.+.+|+++++.+  +||||++++.       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345889999999999999999964 699999999986432   3455677885554444  6999888653       33


Q ss_pred             cCC-----------------CeeEEEEEeccCCChHHHHhcCCCcCCHHHH------HHHHHHHHHHHHHHHccCCCCeE
Q 036229          846 STE-----------------EFKALILEYMPHGSLEKSLYSSNYILDIFQR------LNIMVDVATTLEYLHFGYSAPVI  902 (982)
Q Consensus       846 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~------~~i~~qi~~~L~yLH~~~~~~iv  902 (982)
                      ..+                 ...|+||||++ |+|.+++...+...++..+      ..++.|++.||+|||   ++||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            222                 34799999998 8999999865444455555      677899999999999   99999


Q ss_pred             EcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeee--eeeeeEEeeEeeeeeee
Q 036229          903 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV--KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       903 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~d~~~~~~  973 (982)
                      ||||||+|||++.++.+||+|||+|+....     ......+|+.|+|||++.+  ..++   ..+|+|++|+
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~---~~~DiwSlG~  281 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFT---HALNAWQLGL  281 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECC---HHHHHHHHHH
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcC---ccccHHHHHH
Confidence            999999999999999999999999996521     1124567799999999976  4444   3355666663

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.94  E-value=4.2e-28  Score=272.07  Aligned_cols=183  Identities=14%  Similarity=0.168  Sum_probs=150.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC---------CeEEEEEEeecccchhhhhHHHHHHHhhhcCCcccee---------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE---------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIK---------  840 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~---------  840 (982)
                      .++|++.+.||+|+||.||+|+...         ++.||+|+++..     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999998653         789999998743     56889999999999999988         


Q ss_pred             ------EEeeecC-CCeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          841 ------VISSCST-EEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       841 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                            +++++.. ++..++||||+ +++|.+++... ...+++.++..++.|++.||+|||   ++||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  5666654 67889999999 99999999865 356899999999999999999999   999999999999999


Q ss_pred             EcCCC--cEEEEeecCceeecCCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          913 LDDNM--VAHLSDFGIAKLLIGEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       913 l~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++.++  .+||+|||+|+.+......     .......||+.|+|||++.+..++.   .+|+|++|+
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~slG~  256 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR---RSDLQSLGY  256 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH---HHHHHHHHH
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc---hhhHHHHHH
Confidence            99988  9999999999876432211     1123457999999999997765554   355666664

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.94  E-value=1.4e-27  Score=273.93  Aligned_cols=179  Identities=27%  Similarity=0.426  Sum_probs=142.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC------CCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST------EEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~  852 (982)
                      .+|+..+.||+|+||.||+|++. +++.||||++....    ....+|+++++.++||||+++++++..      ..+.+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46889999999999999999975 59999999986432    223479999999999999999998743      22467


Q ss_pred             EEEEeccCCChHHHHh---cCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-CcEEEEeecCce
Q 036229          853 LILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAK  928 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-~~~kL~DFGla~  928 (982)
                      +||||+++ ++.+.+.   .....+++..+..++.||+.||+|||   ++||+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 6666554   34556899999999999999999999   9999999999999999955 678999999999


Q ss_pred             eecCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL  972 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~  972 (982)
                      .+....   ......||+.|+|||++.+. .++..   +|+|++|
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwSlG  244 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSS---IDVWSAG  244 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTH---HHHHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCch---hhhHHHH
Confidence            764322   22356789999999998654 34433   4455555

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=2.2e-28  Score=268.24  Aligned_cols=192  Identities=23%  Similarity=0.332  Sum_probs=139.1

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ....++|++.+.||+|+||.||+|+. .+++.||||++.... ....+++.+|++++++++||||+++++++..++..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34568899999999999999999985 468999999986442 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhc-------CCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecC
Q 036229          854 ILEYMPHGSLEKSLYS-------SNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI  926 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGl  926 (982)
                      ||||+++++|.+++..       ....+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999874       2445899999999999999999999   99999999999999999999999999999


Q ss_pred             ceeecCCCC---ceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          927 AKLLIGEDQ---SITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       927 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      +........   ........||+.|+|||++.+ ..++.   .+|+|++|+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~~Di~slG~  215 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF---KADIWSFGI  215 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCT---HHHHHHHHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCc---hhhHHHHHH
Confidence            986533211   112234579999999999865 33332   345666663

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.8e-26  Score=249.29  Aligned_cols=210  Identities=25%  Similarity=0.247  Sum_probs=143.9

Q ss_pred             ccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccC
Q 036229          475 NLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLG  554 (982)
Q Consensus       475 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  554 (982)
                      +|+.|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            45555555555555555555555666666666666655555555566666666666666665555556666666666666


Q ss_pred             CCccccccc-ccccccCceEEecCCCcccCC-CccccccccccceeecccccccccccccccCccCcc----eEeccccc
Q 036229          555 SNKLTSIPL-TIWNLKGMLYLNFSSNFFTGP-LPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQ----YLFLGYNR  628 (982)
Q Consensus       555 ~N~l~~ip~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~  628 (982)
                      +|+++.++. .+..+++|++|++++|.+++. +|..++++++|+.|++++|++++..+..+..+++|+    +|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            666665544 344566666666666666653 466777777777888888888777777777777777    88899999


Q ss_pred             ccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCCC
Q 036229          629 LQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGG  685 (982)
Q Consensus       629 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~  685 (982)
                      +++..+..+.. .+|+.|+|++|++++..+..+..+++|++|++++|++.|.+|.-.
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~  244 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  244 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence            98666655554 489999999999987766677889999999999999998887643

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=3.8e-27  Score=275.10  Aligned_cols=233  Identities=22%  Similarity=0.239  Sum_probs=144.3

Q ss_pred             CCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEe
Q 036229          130 TLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSL  209 (982)
Q Consensus       130 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  209 (982)
                      +|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|   +..+++|++|+|++|.+++..+     .++|++|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence            67777777777776666677777777777777777765444   4667777777777777765432     266777777


Q ss_pred             eccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhh-ccCCCcEEEccCCcccc
Q 036229          210 SINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELA-NLTGLEVLKLGKNFLTG  288 (982)
Q Consensus       210 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~  288 (982)
                      ++|++++..+..   +++|++|+|++|++++..|..|+++++|+.|++++|.+++..|..+. .+++|++|+|++|.|++
T Consensus       107 ~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          107 ANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             CSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             cCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            777777554432   35566666666666666666666666666666666666665555554 56666666666666665


Q ss_pred             CCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCccccccccccc
Q 036229          289 EIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF  368 (982)
Q Consensus       289 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  368 (982)
                      ..+  +..+++|++|+|++|++++..| .+..++                         +|+.|+|++|++++ +|..+.
T Consensus       184 ~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~-------------------------~L~~L~Ls~N~l~~-lp~~l~  234 (487)
T 3oja_A          184 VKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAA-------------------------GVTWISLRNNKLVL-IEKALR  234 (487)
T ss_dssp             EEC--CCCCTTCCEEECCSSCCCEECG-GGGGGT-------------------------TCSEEECTTSCCCE-ECTTCC
T ss_pred             ccc--cccCCCCCEEECCCCCCCCCCH-hHcCCC-------------------------CccEEEecCCcCcc-cchhhc
Confidence            422  2245666666666666654333 243333                         34556666666653 455566


Q ss_pred             CCCCCCEEEeccccCc-cccCCccccCCccceecc
Q 036229          369 NASKLSVLELGRNSFS-GFIPNTFGNLRNLRLMTL  402 (982)
Q Consensus       369 ~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L  402 (982)
                      .+++|+.|++++|.+. +.+|..+..++.|+.+++
T Consensus       235 ~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~  269 (487)
T 3oja_A          235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK  269 (487)
T ss_dssp             CCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHH
T ss_pred             cCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEec
Confidence            6677777777777776 444555555555554443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=1.5e-27  Score=264.66  Aligned_cols=193  Identities=19%  Similarity=0.271  Sum_probs=156.4

Q ss_pred             HHHHHHHhcCCCcc-ceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhc-CCccceeEEeeec
Q 036229          772 YLELCRATNRFSEN-NLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSI-RHRNLIKVISSCS  846 (982)
Q Consensus       772 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  846 (982)
                      +...+...++|.+. +.||+|+||.||+|+.. +++.||+|+++...  ......+.+|+.+++.+ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33445566778877 89999999999999865 58999999997542  23356788999999999 5699999999999


Q ss_pred             CCCeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEE
Q 036229          847 TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLS  922 (982)
Q Consensus       847 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~  922 (982)
                      ..+..++||||+++|+|.+++... ...+++.++..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence            999999999999999999998643 356899999999999999999999   999999999999999987   7899999


Q ss_pred             eecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          923 DFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       923 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |||+++......   ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  221 (327)
T 3lm5_A          177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTA---TDMWNIGI  221 (327)
T ss_dssp             CGGGCEEC------------CCCGGGCCHHHHTTCCCCTH---HHHHHHHH
T ss_pred             eCccccccCCcc---ccccccCCcCccCCeeecCCCCCch---hhHHHHHH
Confidence            999999763222   2234679999999999977665543   45566663

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.94  E-value=7.2e-28  Score=260.70  Aligned_cols=182  Identities=29%  Similarity=0.408  Sum_probs=146.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCC-CeeEEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-EFKALILE  856 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~E  856 (982)
                      ..++|++.+.||+|+||.||+|+. +++.||+|+++...  ..+.+.+|++++++++||||+++++++... +..++|||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            357899999999999999999987 48999999987442  456789999999999999999999987554 57899999


Q ss_pred             eccCCChHHHHhcCCC-cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++++|.+++..... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||++......  
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999999975432 3788899999999999999999   999999999999999999999999999999865322  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....+++.|+|||++.+..++..   +|+|++|+
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  202 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTK---SDVWSFGI  202 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             ---ccCCCccccccCHHHhCCCCCCch---hcHHHHHH
Confidence               123457889999999976655543   55666664

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.94  E-value=2.3e-27  Score=267.79  Aligned_cols=182  Identities=25%  Similarity=0.274  Sum_probs=143.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  849 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999864 5899999999753  2344567889999999999999999999987654      


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..++||||+++ ++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78888753   3789999999999999999999   99999999999999999999999999999986


Q ss_pred             ecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ...   ........||+.|+|||++.+..++..   +|+|++|+
T Consensus       177 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwslG~  214 (371)
T 2xrw_A          177 AGT---SFMMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVGC  214 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTT---HHHHHHHH
T ss_pred             ccc---ccccCCceecCCccCHHHhcCCCCCch---HhHHHHHH
Confidence            532   122345679999999999977655543   55566663

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.94  E-value=9.7e-28  Score=261.39  Aligned_cols=186  Identities=25%  Similarity=0.258  Sum_probs=139.6

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc--hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|+++....  ...+.+..+...++.++||||+++++++.+++..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            357899999999999999999986 4699999999975422  2223344455557888999999999999999999999


Q ss_pred             EEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          855 LEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      |||+++ ++.+++..   ....+++..+..++.|++.||+|||   ++ ||+||||||+||+++.++.+||+|||+|+..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 88777653   4556899999999999999999999   87 9999999999999999999999999999876


Q ss_pred             cCCCCceeecccccccccccCceee----eeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFH----VKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~~~d~~~~~~  973 (982)
                      ...   .......||+.|+|||++.    +..++   ..+|+|++|+
T Consensus       161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~---~~~Di~slG~  201 (290)
T 3fme_A          161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYS---VKSDIWSLGI  201 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CC---HHHHHHHHHH
T ss_pred             ccc---ccccccCCCccccChhhcChhhcCcCCC---cHHHHHHHHH
Confidence            332   2223457999999999973    33333   3355666664

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.94  E-value=6.1e-28  Score=271.48  Aligned_cols=181  Identities=25%  Similarity=0.319  Sum_probs=134.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCC------C
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE------E  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~  849 (982)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...  .....+++.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999985 46999999998643  233456788999999999999999999998654      5


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..|+||||+ +++|.+++..  ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 7899998865  35899999999999999999999   99999999999999999999999999999986


Q ss_pred             ecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      ...     ......||+.|+|||++.+ ..++..   +|+|++|+
T Consensus       182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwslG~  218 (367)
T 2fst_X          182 TAD-----EMTGYVATRWYRAPEIMLNWMHYNQT---VDIWSVGC  218 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTT---HHHHHHHH
T ss_pred             ccc-----cCCCcCcCcCccChHHHcCCcCCCch---hhHHHHHH
Confidence            532     1345679999999999865 344433   45556553

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=7.5e-28  Score=265.29  Aligned_cols=189  Identities=24%  Similarity=0.302  Sum_probs=146.1

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc------hhhhhHHHHHHHhhhc----CCccceeEE
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG------RAFKSFDVECEMMKSI----RHRNLIKVI  842 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~nIv~l~  842 (982)
                      +.....++|++.+.||+|+||.||+|+. .+++.||+|+++....      .....+.+|+++++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4455678899999999999999999985 4689999999965422      2334566799999998    899999999


Q ss_pred             eeecCCCeeEEEEEe-ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEE
Q 036229          843 SSCSTEEFKALILEY-MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAH  920 (982)
Q Consensus       843 ~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~k  920 (982)
                      +++...+..++|||| +.+++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999997644 4899999999999999999999   99999999999999999 889999


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      |+|||++......    ......||+.|+|||++.+..+...  .+|+|++|
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~--~~Di~slG  226 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHAL--PATVWSLG  226 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHH--HHHHHHHH
T ss_pred             EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCc--cchHHHHH
Confidence            9999999876432    2234669999999999866544321  24556655

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.94  E-value=1.7e-27  Score=286.11  Aligned_cols=181  Identities=24%  Similarity=0.350  Sum_probs=145.1

Q ss_pred             ceeeeeceEEEEEEEe---CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARI---GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      +.||+|+||.||+|.+   ..++.||||+++...  ....+++.+|++++++++||||+++++++..+ ..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            5799999999999964   246889999997542  23457899999999999999999999999754 57899999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC-ceee
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ-SITQ  939 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~  939 (982)
                      |+|.+++... ..+++..+..++.||+.||+|||   ++|||||||||+||+++.++.+||+|||+|+.+..... ....
T Consensus       454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999754 45899999999999999999999   99999999999999999999999999999987643322 1222


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....+|+.|+|||++.+..++..   +|+|++|++
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~---sDvwSlGv~  561 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSK---SDVWSFGVL  561 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             cCCCCceeeeChhhhcCCCCCcH---HHHHHHHHH
Confidence            34457889999999977666543   556666643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.94  E-value=4.5e-28  Score=267.23  Aligned_cols=181  Identities=21%  Similarity=0.371  Sum_probs=145.6

Q ss_pred             CCHHHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcC--CccceeEEeee
Q 036229          770 FSYLELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIR--HRNLIKVISSC  845 (982)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~  845 (982)
                      +.+..+....++|++.+.||+|+||.||+|+..+++.||+|++...  .....+.+.+|++++++++  ||||+++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            3333344456789999999999999999999888999999999754  2345678899999999997  59999999999


Q ss_pred             cCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          846 STEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       846 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      ..++..++||| +.+++|.+++.... .+++..+..++.|++.||.|||   ++||+||||||+||++++ +.+||+|||
T Consensus        98 ~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             ecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecc
Confidence            99999999999 55789999997654 5889999999999999999999   999999999999999964 899999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                      ++................||+.|+|||++.+
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKD  202 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTT
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhh
Confidence            9987644333333345679999999999864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.94  E-value=3.8e-27  Score=273.05  Aligned_cols=185  Identities=20%  Similarity=0.250  Sum_probs=154.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCC-ccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH-RNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....  ...++..|+++++.++| ++|..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999986 569999999987543  23568899999999977 566666667778889999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE---cCCCcEEEEeecCceeecCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~  933 (982)
                      |+ +++|.+++......+++.++..|+.||+.||+|||   ++|||||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 89999999876677999999999999999999999   9999999999999999   58889999999999987543


Q ss_pred             CCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          934 DQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       934 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ...     .......||+.|+|||++.+..++..   .|+|++|
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~---sDvwSlG  200 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRR---DDLESLG  200 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH---HHHHHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChH---HHHHHHH
Confidence            321     12235679999999999987766544   4455555

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.94  E-value=2.3e-27  Score=270.99  Aligned_cols=182  Identities=22%  Similarity=0.250  Sum_probs=150.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC--------CccceeEEeeec---
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR--------HRNLIKVISSCS---  846 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~---  846 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999985 45899999999743 344577889999999985        788999999987   


Q ss_pred             -CCCeeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCC------
Q 036229          847 -TEEFKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNM------  917 (982)
Q Consensus       847 -~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~------  917 (982)
                       .....++||||+ ++++.+.+... ...+++..+..++.||+.||+|||   ++ ||+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             566899999999 55666666543 356899999999999999999999   88 999999999999999775      


Q ss_pred             -------------------------------------------cEEEEeecCceeecCCCCceeecccccccccccCcee
Q 036229          918 -------------------------------------------VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF  954 (982)
Q Consensus       918 -------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  954 (982)
                                                                 .+||+|||.|......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999875321     2345799999999999


Q ss_pred             eeeeeeeEEeeEeeeeeee
Q 036229          955 HVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       955 ~~~~~~~~~~~~d~~~~~~  973 (982)
                      .+..++..   +|+|++|+
T Consensus       266 ~~~~~~~~---~DiwslG~  281 (397)
T 1wak_A          266 IGSGYNTP---ADIWSTAC  281 (397)
T ss_dssp             HTSCCCTH---HHHHHHHH
T ss_pred             cCCCCCcH---HHHHHHHH
Confidence            87766544   45566653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=1.2e-27  Score=273.75  Aligned_cols=184  Identities=22%  Similarity=0.301  Sum_probs=134.7

Q ss_pred             cCCCc-cceeeeeceEEEEEEEeC---CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeee--cCCCeeEE
Q 036229          780 NRFSE-NNLIGRGGFGSVYKARIG---EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC--STEEFKAL  853 (982)
Q Consensus       780 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~--~~~~~~~l  853 (982)
                      +.|++ +++||+|+||.||+|+..   +++.||+|+++...  ....+.+|++++++++||||+++++++  ......++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44655 568999999999999864   47899999987432  235688999999999999999999999  45778999


Q ss_pred             EEEeccCCChHHHHhcC--------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----cCCCcEEE
Q 036229          854 ILEYMPHGSLEKSLYSS--------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHL  921 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl----~~~~~~kL  921 (982)
                      ||||++ ++|.+++...        ...+++..++.++.||+.||+|||   ++||+||||||+||++    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 4888877522        124889999999999999999999   9999999999999999    67789999


Q ss_pred             EeecCceeecCCCC-ceeecccccccccccCceeeeee-eeeEEeeEeeeeee
Q 036229          922 SDFGIAKLLIGEDQ-SITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL  972 (982)
Q Consensus       922 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~  972 (982)
                      +|||+|+.+..... ........||+.|+|||++.+.. ++..   +|+|++|
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~---~DiwSlG  223 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA---IDIWAIG  223 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHH---HHHHHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccch---hhhHHHH
Confidence            99999987643221 12234567999999999997643 4433   4455555

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.93  E-value=2.6e-27  Score=261.90  Aligned_cols=186  Identities=25%  Similarity=0.327  Sum_probs=146.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeec-----------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS-----------  846 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-----------  846 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........+++.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999975 49999999998766666788999999999999999999999873           


Q ss_pred             ---CCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEE
Q 036229          847 ---TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLS  922 (982)
Q Consensus       847 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~  922 (982)
                         ..+..++||||++ |+|.+++..  ..+++..+..++.|++.||+|||   ++||+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 599999864  34889999999999999999999   99999999999999997 56799999


Q ss_pred             eecCceeecCCCC-ceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          923 DFGIAKLLIGEDQ-SITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       923 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      |||+++....... ........+|+.|+|||++.+ ..++.   .+|+|++|+
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~~Di~slG~  213 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK---AIDMWAAGC  213 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCH---HHHHHHHHH
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCc---hhhhHhHHH
Confidence            9999987532211 122234567999999999854 33433   345566663

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.93  E-value=4.5e-27  Score=263.93  Aligned_cols=186  Identities=24%  Similarity=0.306  Sum_probs=150.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCC-----Cee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~  851 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++... .....++.+|++++++++||||+++++++..+     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            578999999999999999999865 59999999996432 33456788999999999999999999987654     678


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 5999988763  4899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCce--------eecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          932 GEDQSI--------TQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       932 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      ......        ......||+.|+|||++.+ ..++.   .+|+|++|+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~~Di~slG~  211 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR---AMDVWSCGC  211 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCH---HHHHHHHHH
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccc---hhhHHHHHH
Confidence            321111        1223578999999998754 33433   355666664

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.93  E-value=2.9e-27  Score=285.25  Aligned_cols=188  Identities=24%  Similarity=0.349  Sum_probs=153.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC----CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG----EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ..++|++.+.||+|+||.||+|++.    .+..||+|+++.. .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            3467999999999999999999863    2578999998654 3344578899999999999999999999985 45689


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|+|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            999999999999999877667899999999999999999999   99999999999999999999999999999987633


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .. ........+|+.|||||++.+..++..   +|+|++|+
T Consensus       544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~---~DiwSlG~  580 (656)
T 2j0j_A          544 ST-YYKASKGKLPIKWMAPESINFRRFTSA---SDVWMFGV  580 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             Cc-ceeccCCCCCcceeCHHHhcCCCCCch---hhHHHHHH
Confidence            22 222234557889999999977665543   55666664

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.93  E-value=1.4e-27  Score=274.11  Aligned_cols=189  Identities=22%  Similarity=0.370  Sum_probs=145.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..+|...+.||+|+||+||.....+++.||||++....   ...+.+|+++++++ +||||+++++++.+.+..|+||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            35688999999999999665555678999999986432   24467899999999 899999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-----CCcEEEEeecCceeecC
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kL~DFGla~~~~~  932 (982)
                      ++ |+|.+++........+.++..++.||+.||+|||   ++||+||||||+||+++.     ...+||+|||+|+....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 5999999876655566667889999999999999   999999999999999953     23688999999987643


Q ss_pred             CCCc-eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          933 EDQS-ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       933 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .... .......||+.|+|||++.+......+..+|+|++|++
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~i  218 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV  218 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHH
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHH
Confidence            3211 23345679999999999974322222334566777643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=3.2e-27  Score=287.96  Aligned_cols=180  Identities=21%  Similarity=0.316  Sum_probs=150.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC--CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCe-----
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG--EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF-----  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----  850 (982)
                      .++|++.+.||+|+||.||+|++.  +++.||||++... .......+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999875  5899999998643 23445678899999999999999999999977654     


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||+++++|.+++..   .+++.++..++.||+.||.|||   ++|||||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999987754   5899999999999999999999   9999999999999999875 8999999999875


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ...      ....||+.|+|||++.+.+    +..+|+|++|+++
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~~----~~~sDi~slG~~l  266 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTGP----TVATDIYTVGRTL  266 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHCS----CHHHHHHHHHHHH
T ss_pred             ccC------CccCCCccccCHHHHcCCC----CCceehhhhHHHH
Confidence            322      3467999999999997654    3446677777443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=2.7e-27  Score=279.99  Aligned_cols=164  Identities=19%  Similarity=0.144  Sum_probs=125.7

Q ss_pred             eeeeeceEEEEEEE-eCCCeEEEEEEeeccc----------chhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEE
Q 036229          787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC----------GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       787 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ..+.|+.|.++.++ ...|+.||+|++....          ....+++.+|+++|+++ .|+||+++++++++++..|+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34566666666654 3358889999996541          23346799999999999 799999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||++|++|.+++.+.+ .++..   +|+.||+.||+|+|   ++|||||||||+|||++++|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999997654 45543   58999999999999   9999999999999999999999999999999763322


Q ss_pred             CceeecccccccccccCceeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYI  959 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~  959 (982)
                        ......+||+.|||||++.+...
T Consensus       394 --~~~~t~vGTp~YmAPE~l~g~~~  416 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVNELFAENKS  416 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC-----
T ss_pred             --ccccCceechhhccHHHhCCCCC
Confidence              23345789999999999987643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.93  E-value=5.6e-27  Score=269.44  Aligned_cols=183  Identities=21%  Similarity=0.280  Sum_probs=153.1

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhc------CCccceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSI------RHRNLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~  850 (982)
                      ...+|++.+.||+|+||.||+|+.. +++.||||+++.. .....++.+|+++++.+      +|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3567999999999999999999864 5899999999754 33446778899888877      57799999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc--EEEEeecCc
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIA  927 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~--~kL~DFGla  927 (982)
                      .++||||++ ++|.+++.... ..+++..+..++.||+.||+|||   ++||+||||||+||+++.++.  +||+|||+|
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 69999887654 35899999999999999999999   999999999999999998887  999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +....     ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       250 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlG~  287 (429)
T 3kvw_A          250 CYEHQ-----RVYTYIQSRFYRAPEVILGARYGMP---IDMWSLGC  287 (429)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHHTBCCCTH---HHHHHHHH
T ss_pred             eecCC-----cccccCCCCCccChHHHhCCCCCch---HHHHhHHH
Confidence            86421     2234679999999999987766544   45566663

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.93  E-value=3.7e-27  Score=266.19  Aligned_cols=180  Identities=23%  Similarity=0.302  Sum_probs=147.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCee----
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK----  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----  851 (982)
                      .++|...+.||+|+||.||+|+.. +++.||||++...  .....+++.+|+++++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999864 5999999999754  233457788999999999999999999999877654    


Q ss_pred             --EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          852 --ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       852 --~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                        ++||||++ ++|.+++..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 588887733   3899999999999999999999   99999999999999999999999999999986


Q ss_pred             ecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      ...     ......||+.|+|||++.+ ..++.   .+|+|++|+
T Consensus       194 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~---~~DiwslG~  230 (371)
T 4exu_A          194 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQ---TVDIWSVGC  230 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCT---THHHHHHHH
T ss_pred             ccc-----CcCCcccCccccCHHHhcCCCCCCc---HHhHHHHHH
Confidence            522     2235678999999999866 34443   345566663

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.93  E-value=7.1e-27  Score=260.63  Aligned_cols=183  Identities=20%  Similarity=0.277  Sum_probs=153.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEe--CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCcc------ceeEEeeecCCCe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI--GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN------LIKVISSCSTEEF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~  850 (982)
                      .++|++.+.||+|+||.||+|..  .+++.||+|+++.. ....+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986  35899999999743 344577889999999887654      9999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC--------------
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD--------------  915 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~--------------  915 (982)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999987654 35789999999999999999999   999999999999999987              


Q ss_pred             -----CCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          916 -----NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       916 -----~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                           ++.+||+|||+++.....     .....||+.|+|||++.+..++..   +|+|++|++
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~i  223 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQP---CDVWSIGCI  223 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTH---HHHHHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcc---hhhHHHHHH
Confidence                 668999999999864221     234678999999999977665543   556666643

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=9.6e-26  Score=243.66  Aligned_cols=225  Identities=21%  Similarity=0.181  Sum_probs=197.7

Q ss_pred             EEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeec
Q 036229          428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLED  507 (982)
Q Consensus       428 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  507 (982)
                      .++.++..+..++..     ++..+++|++++|++++..+..|.++++|+.|++++|++++..+..|.++++|++|+|++
T Consensus        11 ~~~c~~~~l~~ip~~-----l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~   85 (276)
T 2z62_A           11 TYQCMELNFYKIPDN-----LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG   85 (276)
T ss_dssp             EEECTTSCCSSCCSS-----SCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             eEEecCCCccccCCC-----CCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCC
Confidence            455556656555443     235688888888899888888899999999999999999988888999999999999999


Q ss_pred             cCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccc--cccccccccCceEEecCCCcccCCC
Q 036229          508 NKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTS--IPLTIWNLKGMLYLNFSSNFFTGPL  585 (982)
Q Consensus       508 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~--ip~~~~~l~~L~~L~Ls~N~l~~~~  585 (982)
                      |++++..+..|.++++|++|++++|++++..+..+.++++|++|++++|+++.  +|..+..+++|++|++++|++++..
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~  165 (276)
T 2z62_A           86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (276)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEEC
T ss_pred             CccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCC
Confidence            99998888899999999999999999998888789999999999999999996  6888899999999999999999888


Q ss_pred             ccccccccccc----eeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCC
Q 036229          586 PLDIGNLKVLI----GIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIP  658 (982)
Q Consensus       586 ~~~~~~l~~L~----~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  658 (982)
                      +..+..++.|+    .|++++|.+++..+..+.. .+|++|+|++|++++.++..|.++++|+.|+|++|++++..|
T Consensus       166 ~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             GGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             HHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            88888888887    8999999999877766655 489999999999998888889999999999999999997554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.93  E-value=6e-27  Score=259.83  Aligned_cols=186  Identities=26%  Similarity=0.360  Sum_probs=153.3

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe--CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhc---CCccceeEEeeec----
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI--GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSI---RHRNLIKVISSCS----  846 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~----  846 (982)
                      ..++|++.+.||+|+||.||+|+.  .+++.||+|+++...  ......+.+|+++++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            467899999999999999999997  458999999987542  22345677888888776   8999999999986    


Q ss_pred             -CCCeeEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEee
Q 036229          847 -TEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF  924 (982)
Q Consensus       847 -~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DF  924 (982)
                       .....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5668899999997 59999987643 34899999999999999999999   999999999999999999999999999


Q ss_pred             cCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          925 GIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       925 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |+++....   ........||+.|+|||++.+..++..   +|+|++|+
T Consensus       165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~---~Di~slG~  207 (326)
T 1blx_A          165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATP---VDLWSVGC  207 (326)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTH---HHHHHHHH
T ss_pred             cccccccC---CCCccccccccceeCHHHHhcCCCCcc---hhHHHHHH
Confidence            99986532   122345678999999999977655543   55666663

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.93  E-value=9.4e-29  Score=298.32  Aligned_cols=421  Identities=15%  Similarity=0.131  Sum_probs=211.6

Q ss_pred             CEEEcCCCCccccCcc-hhhhccCCcEEEccCCcccCc---cC------------ccccCcCCCCccccccCcccccCch
Q 036229          108 QSLNLGFNRLSGSIPS-AIFTLYTLKYVNFRGNQLSGA---FP------------SFIFNKSSLQHLDFSYNALSGEIPA  171 (982)
Q Consensus       108 ~~L~L~~n~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~~---~p------------~~~~~l~~L~~L~Ls~N~l~~~ip~  171 (982)
                      +.+++++...  ..|. .+..+++|++|+|+++.....   .|            .....+++|++|+|++|.+++..+.
T Consensus        46 ~~l~~~~~~~--~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~  123 (594)
T 2p1m_B           46 RKVFIGNCYA--VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLE  123 (594)
T ss_dssp             CEEEESSTTS--SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHH
T ss_pred             eEEeeccccc--cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHH
Confidence            3566655432  2333 456789999999999863211   12            1134577888888888888766666


Q ss_pred             hhhcCCCCCCeeeecce-eeecc-cCCCccCcCcccEEEeeccccccccccccc----cccchhhhhccCCC--CCCc-h
Q 036229          172 NICSNLPFLESISLSQN-MFHGR-IPSALSNCKYLEILSLSINNLLGAIPKEIG----NLTKLKELYLGYSG--LQGE-I  242 (982)
Q Consensus       172 ~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~~L~~L~L~~N~--l~~~-~  242 (982)
                      .+...+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+.++.    .+++|++|++++|.  ++.. +
T Consensus       124 ~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l  203 (594)
T 2p1m_B          124 LIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSAL  203 (594)
T ss_dssp             HHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHH
T ss_pred             HHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHH
Confidence            66446788888888888 45433 333445778888888888887765544443    45577777777775  2211 1


Q ss_pred             hhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCC-------ccccCCCccccccCCCcEE-EccCccccccC
Q 036229          243 PREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKN-------FLTGEIPPEIHNLHNLKLL-DLSHNKLVGAV  314 (982)
Q Consensus       243 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N-------~l~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~  314 (982)
                      +..+.++++|+.|++++|...+.+|..+..+++|++|+++.+       .+++ ++..+.++++|+.| ++.+... +.+
T Consensus       204 ~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l  281 (594)
T 2p1m_B          204 ERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYL  281 (594)
T ss_dssp             HHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGG
T ss_pred             HHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhH
Confidence            222234567777777766222235566666777777764433       3332 22355566666666 3333222 233


Q ss_pred             cccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCccccc-ccccccCCCCCCEEEecc---------ccCc
Q 036229          315 PATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGT-IPRFIFNASKLSVLELGR---------NSFS  384 (982)
Q Consensus       315 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~---------N~i~  384 (982)
                      +..+..+++|+.|+|++|.+.+.........+++|++|++++| +... ++.....+++|++|++++         +.++
T Consensus       282 ~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~  360 (594)
T 2p1m_B          282 PAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALT  360 (594)
T ss_dssp             GGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCC
T ss_pred             HHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCC
Confidence            4333445566666666665432211111224455555655555 2211 122222345555555522         2232


Q ss_pred             cccCCccc-cCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccc
Q 036229          385 GFIPNTFG-NLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVS  463 (982)
Q Consensus       385 ~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~  463 (982)
                      +.....+. .+++|+.|.++.|.++......    ....+++|+.|+++.|...+                    .++++
T Consensus       361 ~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~----l~~~~~~L~~L~L~~~~~~~--------------------~~~l~  416 (594)
T 2p1m_B          361 EQGLVSVSMGCPKLESVLYFCRQMTNAALIT----IARNRPNMTRFRLCIIEPKA--------------------PDYLT  416 (594)
T ss_dssp             HHHHHHHHHHCTTCCEEEEEESCCCHHHHHH----HHHHCTTCCEEEEEESSTTC--------------------CCTTT
T ss_pred             HHHHHHHHHhchhHHHHHHhcCCcCHHHHHH----HHhhCCCcceeEeecccCCC--------------------ccccc
Confidence            22111111 2344444444444333211110    00123334444443110000                    02222


Q ss_pred             cC-----CCcccccccccceEEecCCCCCCCCCccccC-cCCCCeEEeeccCCCCCCCccc-CCCccccEEEccCCcCCc
Q 036229          464 GG-----FPKEIGNLTNLIGIYLGGNKLNGSIPITLGK-LQKLQGLHLEDNKLEGPIPDDI-CRLTKLYELGLSGNKLSG  536 (982)
Q Consensus       464 ~~-----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~  536 (982)
                      +.     ++..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++
T Consensus       417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~  495 (594)
T 2p1m_B          417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD  495 (594)
T ss_dssp             CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred             CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence            11     111244555666666655 444433334433 5566666666666654333333 345566666666666543


Q ss_pred             CCCc-cccCCCcccccccCCCcc
Q 036229          537 SIPA-CFSNLASLGTLSLGSNKL  558 (982)
Q Consensus       537 ~~p~-~~~~l~~L~~L~L~~N~l  558 (982)
                      .... ....+++|++|++++|++
T Consensus       496 ~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          496 KALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHHHHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHHHHHhCCCCCEEeeeCCCC
Confidence            3222 223355566666666655

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=4.7e-27  Score=255.56  Aligned_cols=186  Identities=22%  Similarity=0.356  Sum_probs=155.7

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999975 68999999997542  2345778999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC---CcEEEEeecCceee
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLL  930 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~---~~~kL~DFGla~~~  930 (982)
                      ||||+++++|.+++.... .+++.++..++.|++.||+|||   ++||+||||||+||+++.+   +.+||+|||++...
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999999999887544 4899999999999999999999   9999999999999999754   47999999999865


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ....   ......||+.|+|||++.+. ++   ..+|+|++|+
T Consensus       175 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~---~~~Di~slG~  210 (287)
T 2wei_A          175 QQNT---KMKDRIGTAYYIAPEVLRGT-YD---EKCDVWSAGV  210 (287)
T ss_dssp             CCCS---SCSCHHHHHTTCCHHHHTTC-CC---THHHHHHHHH
T ss_pred             cCCC---ccccccCcccccChHHhcCC-CC---CchhhHhHHH
Confidence            3222   22345689999999998764 33   3456666664

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=2.3e-27  Score=262.28  Aligned_cols=186  Identities=22%  Similarity=0.255  Sum_probs=154.1

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc------hhhhhHHHHHHHhhhcC--CccceeEEeeecC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG------RAFKSFDVECEMMKSIR--HRNLIKVISSCST  847 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~  847 (982)
                      ...++|++.+.||+|+||.||+|+. .+++.||||+++....      ...+.+.+|++++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3467899999999999999999985 4689999999975422      12356778999999996  5999999999999


Q ss_pred             CCeeEEEEEeccC-CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc-CCCcEEEEeec
Q 036229          848 EEFKALILEYMPH-GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFG  925 (982)
Q Consensus       848 ~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~-~~~~~kL~DFG  925 (982)
                      ++..++||||+.+ ++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++ +++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999976 89999987643 5889999999999999999999   99999999999999999 78999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      +++.....    ......||+.|+|||++.+..+...  .+|+|++|
T Consensus       196 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~--~~Di~slG  236 (320)
T 3a99_A          196 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGR--SAAVWSLG  236 (320)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHH--HHHHHHHH
T ss_pred             cccccccc----cccCCCCCccCCChHHhccCCCCCc--cchHHhHH
Confidence            99876322    2234579999999999866544222  23455555

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=4.6e-25  Score=237.35  Aligned_cols=206  Identities=29%  Similarity=0.319  Sum_probs=168.2

Q ss_pred             ccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccC
Q 036229          475 NLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLG  554 (982)
Q Consensus       475 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  554 (982)
                      +.+.+++++|+++. +|..+.  ++++.|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            45677777777773 454443  567788888888877666677778888888888888876666667778888888888


Q ss_pred             CCccccccccc-ccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCc
Q 036229          555 SNKLTSIPLTI-WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI  633 (982)
Q Consensus       555 ~N~l~~ip~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  633 (982)
                      +|+++.+|... ..+++|++|++++|++++..+..++.+++|+.|++++|++++..+..|+.+++|++|+|++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  173 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP  173 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence            88888777654 46778888888888888877778888999999999999998887778999999999999999999888


Q ss_pred             cccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCC
Q 036229          634 SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       634 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  683 (982)
                      +..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|++.+.++.
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            88899999999999999999987777788999999999999999887753

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=1.3e-25  Score=243.85  Aligned_cols=207  Identities=24%  Similarity=0.238  Sum_probs=184.3

Q ss_pred             ccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcc
Q 036229          469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL  548 (982)
Q Consensus       469 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  548 (982)
                      .+.++++++.+++++|+++. +|..+.  ++++.|+|++|+|++..|..|..+++|+.|+|++|+|++..+.  ..+++|
T Consensus         5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            35677889999999999984 454443  6899999999999988888899999999999999999865443  788999


Q ss_pred             cccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc
Q 036229          549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR  628 (982)
Q Consensus       549 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  628 (982)
                      ++|+|++|+++.+|..+..+++|++|++++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        80 ~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             CEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             CEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            99999999999999988889999999999999998888899999999999999999999888889999999999999999


Q ss_pred             ccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccC
Q 036229          629 LQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       629 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~  681 (982)
                      |++..+..|.++++|+.|+|++|+|+ .+|..+...++|+.++|++|++.+.+
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            99877788899999999999999998 67888888889999999999998765

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=1.4e-26  Score=256.82  Aligned_cols=185  Identities=25%  Similarity=0.293  Sum_probs=133.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHH-HhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECE-MMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|+..+.||+|+||.||+|+.. +++.||||+++... .....++..|+. +++.++||||+++++++..++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999974 69999999997543 233445566666 677889999999999999999999999


Q ss_pred             EeccCCChHHHHhc----CCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          856 EYMPHGSLEKSLYS----SNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       856 E~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||   +. ||+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88777753    2456899999999999999999999   88 9999999999999999999999999999876


Q ss_pred             cCCCCceeecccccccccccCceee----eeeeeeEEeeEeeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFH----VKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~~~d~~~~~~  973 (982)
                      ...   .......||+.|+|||++.    +..++   ..+|+|++|+
T Consensus       177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~---~~~Di~slG~  217 (327)
T 3aln_A          177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYD---VRSDVWSLGI  217 (327)
T ss_dssp             --------------------------------CC---SHHHHHHHHH
T ss_pred             ccc---cccccCCCCccccCceeeccccCcCCCC---chhhHHHHHH
Confidence            322   1223447999999999984    33333   3355666663

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.93  E-value=8.8e-27  Score=262.32  Aligned_cols=192  Identities=23%  Similarity=0.292  Sum_probs=142.0

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC--
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE--  849 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--  849 (982)
                      .+.....++|++.+.||+|+||.||+|+.. +++.||||++... .....+..+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455677889999999999999999999964 5899999998644 233456677888889999999999999985433  


Q ss_pred             -----eeEEEEEeccCCChHHHHh---cCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEE
Q 036229          850 -----FKALILEYMPHGSLEKSLY---SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAH  920 (982)
Q Consensus       850 -----~~~lv~E~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~k  920 (982)
                           ..++||||+++ ++.+.+.   .....+++..+..++.|++.|+.||| .+++||+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 37899999976 5554443   24456889999999999999999999 55789999999999999996 89999


Q ss_pred             EEeecCceeecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          921 LSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       921 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                      |+|||+|+......   ......||+.|+|||++.+.. ++.   .+|+|++|+
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~---~~Di~slG~  220 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTT---AVDIWSVGC  220 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCT---HHHHHHHHH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCc---HHHHHHHHH
Confidence            99999998764322   233567899999999985543 343   345566663

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.93  E-value=2e-26  Score=256.37  Aligned_cols=181  Identities=22%  Similarity=0.290  Sum_probs=129.0

Q ss_pred             HhcCCCccc-eeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHH-HHhhhcCCccceeEEeeecC----CCe
Q 036229          778 ATNRFSENN-LIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVEC-EMMKSIRHRNLIKVISSCST----EEF  850 (982)
Q Consensus       778 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~----~~~  850 (982)
                      ..++|.+.+ .||+|+||.||+|+.. +++.||||++....     ...+|+ ..++.++||||+++++++..    +..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            457898854 6999999999999865 58999999986431     122233 33566799999999999865    456


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecC
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGI  926 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGl  926 (982)
                      .++||||+++|+|.+++.... ..+++.++..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+|||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            899999999999999998653 36899999999999999999999   999999999999999975   45699999999


Q ss_pred             ceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          927 AKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       927 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ++.....    ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  217 (336)
T 3fhr_A          178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKS---CDMWSLGV  217 (336)
T ss_dssp             CEEC--------------------------CHHHHH---HHHHHHHH
T ss_pred             ceecccc----ccccCCCCcCccChhhhCCCCCCch---hhHHHHHH
Confidence            9865322    2234578999999999977666543   45566663

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=8.2e-27  Score=261.72  Aligned_cols=180  Identities=23%  Similarity=0.300  Sum_probs=146.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCe-----
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF-----  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----  850 (982)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  .....+++.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999864 5999999999653  22345678899999999999999999999987654     


Q ss_pred             -eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          851 -KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       851 -~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                       .++||||++ ++|.+++..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887743   4899999999999999999999   99999999999999999999999999999986


Q ss_pred             ecCCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeeee
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~  973 (982)
                      ...     ......||+.|+|||++.+ ..++.   .+|+|++|+
T Consensus       176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~---~~Di~slG~  212 (353)
T 3coi_A          176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQ---TVDIWSVGC  212 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCT---THHHHHHHH
T ss_pred             CCC-----CccccccCcCcCCHHHHhCcCCCCc---hhhHHHHHH
Confidence            422     1234678999999999866 33333   345566653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.93  E-value=6.9e-27  Score=276.17  Aligned_cols=187  Identities=27%  Similarity=0.400  Sum_probs=153.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecC------CC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCST------EE  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~  849 (982)
                      ..++|++.+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|++++++++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999986 45899999998754 33446778999999999999999999998765      66


Q ss_pred             eeEEEEEeccCCChHHHHhcCCC--cCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCc---EEEEee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNY--ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV---AHLSDF  924 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~---~kL~DF  924 (982)
                      ..++||||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            78999999999999999986432  5788899999999999999999   999999999999999997664   999999


Q ss_pred             cCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          925 GIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       925 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |.+.......   ......||+.|+|||++.+..++..   +|+|++|+
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~k---sDIwSLGv  211 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVT---VDYWSFGT  211 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTT---HHHHHHHH
T ss_pred             cccccccccc---ccccccCCcccCChHHhccCCCCch---hHHHHHHH
Confidence            9998763322   2345679999999999987766544   45566653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.93  E-value=1.4e-26  Score=266.78  Aligned_cols=188  Identities=25%  Similarity=0.330  Sum_probs=139.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEEEEec
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      +.|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+++..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345567889999999998776668999999998743   235678899999886 8999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcC------CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC-------------CcE
Q 036229          859 PHGSLEKSLYSSNYIL------DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN-------------MVA  919 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~------~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~-------------~~~  919 (982)
                      + |+|.+++.......      ++..+..++.||+.||+|||   ++||+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999997643211      22345679999999999999   9999999999999999754             489


Q ss_pred             EEEeecCceeecCCCCce--eecccccccccccCceeeeee----eeeEEeeEeeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSI--TQTQTLATIGYMAPGLFHVKY----ILFVVNFLTSYSFLMI  974 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~~~~~~d~~~~~~~  974 (982)
                      ||+|||+|+.........  ......||+.|+|||++.+..    ....+..+|+|++|++
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~i  228 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV  228 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHH
Confidence            999999999864432211  223467999999999996511    1112234556666643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.93  E-value=1.1e-27  Score=264.76  Aligned_cols=178  Identities=24%  Similarity=0.392  Sum_probs=146.4

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCe
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEF  850 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  850 (982)
                      .++....++|++.+.||+|+||.||+|+...  .||+|+++...  ....+.+.+|++++++++||||+++++++..++.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            3344456889999999999999999998754  49999986442  3344677889999999999999999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++||||+++++|.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++ ++.+||+|||++...
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            99999999999999999877667899999999999999999999   99999999999999998 679999999998764


Q ss_pred             cCCC---CceeecccccccccccCceeee
Q 036229          931 IGED---QSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       931 ~~~~---~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                      ....   .........||+.|+|||++.+
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSC
T ss_pred             ccccccccccccccCCCcccccChHHhhh
Confidence            3211   1122234568999999999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.92  E-value=4.4e-26  Score=258.50  Aligned_cols=184  Identities=23%  Similarity=0.314  Sum_probs=151.7

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcC-Cc-----cceeEEeeecCCCe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HR-----NLIKVISSCSTEEF  850 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~~  850 (982)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++.. .....++..|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            4678999999999999999999864 5899999999743 334567788999988874 44     59999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCc
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIA  927 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGla  927 (982)
                      .++||||++ ++|.+++.... ..+++..+..++.|++.||.||| .++.|||||||||+||+++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHT-STTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhc-cCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999988654 45899999999999999999999 2247999999999999995  5778999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      +....     ......||+.|+|||++.+..++..   +|+|++|
T Consensus       209 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~---~DiwSlG  245 (382)
T 2vx3_A          209 CQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLA---IDMWSLG  245 (382)
T ss_dssp             EETTC-----CCCSSCSCGGGCCHHHHTTCCCCTH---HHHHHHH
T ss_pred             eeccc-----ccccccCCccccChHHHcCCCCCcH---HHHHHHH
Confidence            87532     1235679999999999987766543   4556665

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.92  E-value=2.2e-26  Score=260.47  Aligned_cols=182  Identities=18%  Similarity=0.262  Sum_probs=150.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-----------CccceeEEeeec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-----------HRNLIKVISSCS  846 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~  846 (982)
                      .++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46899999999999999999986 46999999999743 334567888999998886           899999999987


Q ss_pred             CCC----eeEEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEc------
Q 036229          847 TEE----FKALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLD------  914 (982)
Q Consensus       847 ~~~----~~~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~------  914 (982)
                      ..+    ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||   ++ ||+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 88999999764 345899999999999999999999   88 999999999999994      


Q ss_pred             CCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          915 DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       915 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..+.+||+|||+|+.....     .....||+.|+|||++.+..++..   +|+|++|+
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~---~Di~slG~  223 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCG---ADIWSTAC  223 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTH---HHHHHHHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCch---HhHHHHHH
Confidence            4458999999999875321     234578999999999987765543   45566663

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=4.7e-25  Score=237.42  Aligned_cols=206  Identities=26%  Similarity=0.278  Sum_probs=176.4

Q ss_pred             ccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcc
Q 036229          469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL  548 (982)
Q Consensus       469 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  548 (982)
                      ....+++|+.|++++|.++..  ..+..+++|++|+|++|++++.  ..+..+++|++|+|++|++++..+..|.++++|
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  111 (272)
T 3rfs_A           36 TQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL  111 (272)
T ss_dssp             CHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             ccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence            355677888888888888742  3477888888888888888863  478888888888888888888777778888888


Q ss_pred             cccccCCCcccccccc-cccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccc
Q 036229          549 GTLSLGSNKLTSIPLT-IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYN  627 (982)
Q Consensus       549 ~~L~L~~N~l~~ip~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N  627 (982)
                      ++|+|++|+++.+|.. +..+++|++|++++|++++..+..++.+++|+.|++++|++++..+..|+.+++|++|+|++|
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            8888888888887765 457888999999999988887878899999999999999999988888999999999999999


Q ss_pred             cccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCCC
Q 036229          628 RLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGG  685 (982)
Q Consensus       628 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~  685 (982)
                      ++++.+|..|..+++|+.|+|++|.+.+..       +.|+.++++.|.++|.+|...
T Consensus       192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~-------~~l~~l~~~~n~~~g~ip~~~  242 (272)
T 3rfs_A          192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCTC-------PGIRYLSEWINKHSGVVRNSA  242 (272)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCCT-------TTTHHHHHHHHHTGGGBBCTT
T ss_pred             cCCccCHHHHhCCcCCCEEEccCCCccccC-------cHHHHHHHHHHhCCCcccCcc
Confidence            999988888999999999999999998654       468899999999999999763

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.92  E-value=6.8e-26  Score=254.45  Aligned_cols=182  Identities=20%  Similarity=0.267  Sum_probs=150.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-C-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCcc------ceeEEeeecCCCe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-E-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN------LIKVISSCSTEEF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~~  850 (982)
                      .++|++.+.||+|+||.||+|+.. + ++.||+|+++.. ....+.+.+|+++++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            478999999999999999999864 3 478999999743 344567888999999997766      9999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEE----------------
Q 036229          851 KALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLL----------------  913 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl----------------  913 (982)
                      .++||||+ ++++.+++.... ..+++.++..++.|++.||+|||   ++||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 567777766543 46899999999999999999999   9999999999999999                


Q ss_pred             ---cCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          914 ---DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       914 ---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         +.++.+||+|||+++.....     .....||+.|+|||++.+..++..   +|+|++|+
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~---~Di~slG~  227 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQP---CDVWSIGC  227 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTH---HHHHHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCc---cchHHHHH
Confidence               56789999999999864221     234679999999999977665543   55666664

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=3.7e-26  Score=252.49  Aligned_cols=185  Identities=24%  Similarity=0.269  Sum_probs=134.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccch--hhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGR--AFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .++|+..+.||+|+||.||+|+.. +++.||||++......  ..+.+..+..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467899999999999999999975 6899999999754322  2233444555678889999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||+ ++.+..+.......+++..+..++.|++.||.|||   ++ ||+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666666554567899999999999999999999   85 99999999999999999999999999998653322


Q ss_pred             CceeecccccccccccCceeee-----eeeeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHV-----KYILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~~~d~~~~~~  973 (982)
                         ......||+.|+|||++..     ..++   ..+|+|++|+
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~---~~~Di~slG~  217 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYD---IRADVWSLGI  217 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CC---THHHHHHHHH
T ss_pred             ---cccccCCCccccChhhcccccccccCCc---cccchhhHHH
Confidence               2234579999999999853     2233   3355666663

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=4.2e-24  Score=231.81  Aligned_cols=206  Identities=28%  Similarity=0.287  Sum_probs=183.7

Q ss_pred             cccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCce
Q 036229          493 TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGML  572 (982)
Q Consensus       493 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~  572 (982)
                      .++++++++++++++|.++ .+|..+.  ++++.|+|++|+|++..|..|.++++|++|+|++|+++.+|.. ..+++|+
T Consensus         5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~   80 (290)
T 1p9a_G            5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLG   80 (290)
T ss_dssp             EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCC
T ss_pred             cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCC
Confidence            4678899999999999999 5666553  6899999999999998899999999999999999999998875 7789999


Q ss_pred             EEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCc
Q 036229          573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNN  652 (982)
Q Consensus       573 ~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  652 (982)
                      +|++++|+++ .+|..+..+++|+.|++++|+|++..|..|..+++|++|+|++|+|++.++..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            9999999998 678889999999999999999999888999999999999999999998888899999999999999999


Q ss_pred             CCCCCCcccccccccceeecCCCcccccCCCCC-CCCCCCCcccccCcccCCC
Q 036229          653 LSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGG-SFGNFSAKSFEGNELLCGS  704 (982)
Q Consensus       653 l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~-~~~~~~~~~~~gn~~lc~~  704 (982)
                      |++..+..|..+++|++|+|++|+++ .+|.+. ...........|||+.|..
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            99776677889999999999999999 666553 2334455667899999974

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.2e-24  Score=234.15  Aligned_cols=212  Identities=23%  Similarity=0.259  Sum_probs=159.6

Q ss_pred             cccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCC
Q 036229          100 QLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPF  179 (982)
Q Consensus       100 ~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~  179 (982)
                      .+..+++|+.|++++|.++ .++ .+..+++|++|+|++|++++.  +.+..+++|++|+|++|.++ .+|+..|..+++
T Consensus        36 ~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~  110 (272)
T 3rfs_A           36 TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTN  110 (272)
T ss_dssp             CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCC-CCCTTTTTTCTT
T ss_pred             ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccC-ccChhHhcCCcC
Confidence            3556777888888887775 333 477788888888888887752  46777888888888888877 456555577888


Q ss_pred             CCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccc
Q 036229          180 LESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQV  259 (982)
Q Consensus       180 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  259 (982)
                      |++|+|++|++++..+..|+++++|++|+|++|++++..+..++.+++|++|++++|++++..+..|+.+++|+.|++++
T Consensus       111 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~  190 (272)
T 3rfs_A          111 LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ  190 (272)
T ss_dssp             CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCC
Confidence            88888888888877777778888888888888888766666677788888888888888877777777788888888888


Q ss_pred             cccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCC
Q 036229          260 SNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST  323 (982)
Q Consensus       260 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  323 (982)
                      |++++..|..+..+++|++|++++|.+++.       +++|+.|+++.|+++|.+|..++.+..
T Consensus       191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             CcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccccCC
Confidence            888877777777888888888888877643       446777888888888888877665543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=2.3e-24  Score=229.20  Aligned_cols=191  Identities=22%  Similarity=0.274  Sum_probs=135.2

Q ss_pred             CCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccC
Q 036229           67 PVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFP  146 (982)
Q Consensus        67 ~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  146 (982)
                      +||.|.|++|..   ..+.+++++++++ .+|..+.  ++++.|+|++|++++..|.++..+++|++|+|++|++++..|
T Consensus         3 ~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            588999999962   2346788888888 6776665  578888888888887777778888888888888888887777


Q ss_pred             ccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeecccccccccccccccc
Q 036229          147 SFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLT  226 (982)
Q Consensus       147 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  226 (982)
                      ..+.++++|++|+|++|.++ .+|...|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  155 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT  155 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             hHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc
Confidence            77778888888888888877 56666667777777777777777766666667777777777777777655555566666


Q ss_pred             chhhhhccCCCCCCchhhhcCCCcccceEeccccccCC
Q 036229          227 KLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQG  264 (982)
Q Consensus       227 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  264 (982)
                      +|++|+|++|++++..+..|..+++|+.|++++|.+..
T Consensus       156 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            66666666666665544455555555555555554443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.91  E-value=1.4e-24  Score=238.53  Aligned_cols=229  Identities=16%  Similarity=0.161  Sum_probs=134.0

Q ss_pred             cccEEEccCCCCCCCCC-ccccccccccccEEeccCCccccCCCccc--ccccccceEEecCCCCCCCCC----ccccCc
Q 036229          425 SLTYIGLSNNPLDGILP-RMSMGNLSHSLEYFDMSYCNVSGGFPKEI--GNLTNLIGIYLGGNKLNGSIP----ITLGKL  497 (982)
Q Consensus       425 ~L~~L~Ls~N~l~~~~~-~~~~~~~~~~L~~Ldls~n~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l  497 (982)
                      .++.+.+.++.+....- ..........|++|++++|++++..|..+  ..+++|++|+|++|++++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            45677777765532100 00000011236666666666666666665  666666666666666665443    333456


Q ss_pred             CCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcC--C--CccccCCCcccccccCCCcccccccccccccCceE
Q 036229          498 QKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGS--I--PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLY  573 (982)
Q Consensus       498 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~  573 (982)
                      ++|++|+|++|++++..|..|..+++|++|+|++|++.+.  +  +..+..+++|++|+|++|+++.+|.....      
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~------  218 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAA------  218 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHH------
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHH------
Confidence            6666666666666666666666666666666666665431  1  22235566666666666666554432100      


Q ss_pred             EecCCCcccCCCccccccccccceeecccccccccccccccCc---cCcceEecccccccCCccccccCCCCCCeeeCCC
Q 036229          574 LNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGL---TNLQYLFLGYNRLQGSISESFGDLISLKSLNLSN  650 (982)
Q Consensus       574 L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  650 (982)
                                    .++.+++|+.|||++|++++..|..+..+   ++|++|+|++|+|+ .+|..+.  ++|+.|||++
T Consensus       219 --------------l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~  281 (310)
T 4glp_A          219 --------------LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSS  281 (310)
T ss_dssp             --------------HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCS
T ss_pred             --------------HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCC
Confidence                          12344555666666666666555555554   57777777777777 4555553  6777788888


Q ss_pred             CcCCCCCCcccccccccceeecCCCccc
Q 036229          651 NNLSRSIPISLEKLSYLEDLDLSFNKLK  678 (982)
Q Consensus       651 N~l~~~~p~~l~~l~~L~~l~ls~N~l~  678 (982)
                      |+|++. |. +..+++|++|+|++|+++
T Consensus       282 N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          282 NRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             CcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            877753 33 566777788888888776

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.91  E-value=6.5e-26  Score=252.61  Aligned_cols=269  Identities=18%  Similarity=0.223  Sum_probs=146.0

Q ss_pred             CCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCC--CCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccC
Q 036229           66 TPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNL--SSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG  143 (982)
Q Consensus        66 ~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l--~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~  143 (982)
                      .-|.+|.++.|+  ...++.++++++.+.   +..+..+  ++++.|++++|.+.+..|. ++.+++|++|+|++|.+++
T Consensus        34 ~vc~~W~~~~~~--~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~  107 (336)
T 2ast_B           34 GVCKRWYRLASD--ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEV  107 (336)
T ss_dssp             SSCHHHHHHHTC--STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECH
T ss_pred             HHHHHHHHHhcC--chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCH
Confidence            346689999886  334556666666554   3344444  5666666666666544443 4455666666666666554


Q ss_pred             c-cCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecce-eeecc-cCCCccCcCcccEEEeecc-ccccccc
Q 036229          144 A-FPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN-MFHGR-IPSALSNCKYLEILSLSIN-NLLGAIP  219 (982)
Q Consensus       144 ~-~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p  219 (982)
                      . +|..+..+++|++|+|++|.+++..|..+ ..+++|++|+|++| .+++. ++..+.++++|++|++++| ++++.  
T Consensus       108 ~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l-~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~--  184 (336)
T 2ast_B          108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTL-AKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK--  184 (336)
T ss_dssp             HHHHHHHTTBCCCSEEECTTCBCCHHHHHHH-TTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH--
T ss_pred             HHHHHHHhhCCCCCEEeCcCcccCHHHHHHH-hcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH--
Confidence            3 55555555555555555555554444443 44555555555555 34431 3333444455555555555 44432  


Q ss_pred             cccccccchhhhhccCCCCCCchhhhcCCCc-ccceEecccc--ccC-CcCChhhhccCCCcEEEccCCc-cccCCCccc
Q 036229          220 KEIGNLTKLKELYLGYSGLQGEIPREFGNLA-ELELMALQVS--NLQ-GEIPQELANLTGLEVLKLGKNF-LTGEIPPEI  294 (982)
Q Consensus       220 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~n--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~  294 (982)
                                           .++..+..++ +|+.|++++|  .++ +.+|..+.++++|++|++++|. +++..+..+
T Consensus       185 ---------------------~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l  243 (336)
T 2ast_B          185 ---------------------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF  243 (336)
T ss_dssp             ---------------------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred             ---------------------HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHH
Confidence                                 1344444444 5555555555  233 2344455566666666666666 555555566


Q ss_pred             cccCCCcEEEccCcc-ccccCcccccCCCCCceeecCCCcCCCCcCccccccC-CCccEEEccCCcccccccccccC
Q 036229          295 HNLHNLKLLDLSHNK-LVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQL-PNLEELRLWSNNFSGTIPRFIFN  369 (982)
Q Consensus       295 ~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~  369 (982)
                      ..+++|++|++++|. +.......+..+++|+.|++++| +..    .....+ .++..|++++|++++..|..+..
T Consensus       244 ~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~----~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          244 FQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD----GTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             GGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT----TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             hCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH----HHHHHHHhhCcceEEecccCccccCCcccc
Confidence            666666666666663 22111124555666666666666 321    111112 23566678888888888776653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=2.6e-24  Score=227.01  Aligned_cols=196  Identities=17%  Similarity=0.212  Sum_probs=134.2

Q ss_pred             ccceEEecCCCCCCCCCccccCcCCCCeEEeeccC-CCCCCCcccCCCccccEEEccC-CcCCcCCCccccCCCcccccc
Q 036229          475 NLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK-LEGPIPDDICRLTKLYELGLSG-NKLSGSIPACFSNLASLGTLS  552 (982)
Q Consensus       475 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~  552 (982)
                      +|+.|++++|+++++.+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |+|+++.+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            56666666666665555566666666666666665 6655555666666666666666 666655556666666666666


Q ss_pred             cCCCcccccccccccccCce---EEecCCC-cccCCCccccccccccc-eeecccccccccccccccCccCcceEecccc
Q 036229          553 LGSNKLTSIPLTIWNLKGML---YLNFSSN-FFTGPLPLDIGNLKVLI-GIDFSTNNFSDVIPTVIGGLTNLQYLFLGYN  627 (982)
Q Consensus       553 L~~N~l~~ip~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N  627 (982)
                      +++|+++.+|. +..+++|+   +|++++| ++++..+..|.++++|+ .|++++|+++.+.+..|.. ++|++|+|++|
T Consensus       112 l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n  189 (239)
T 2xwt_C          112 IFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN  189 (239)
T ss_dssp             EEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred             CCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence            66666666665 44555555   7777777 66666666677778888 8888888887554445555 78888888888


Q ss_pred             c-ccCCccccccCC-CCCCeeeCCCCcCCCCCCcccccccccceeecCCC
Q 036229          628 R-LQGSISESFGDL-ISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFN  675 (982)
Q Consensus       628 ~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N  675 (982)
                      + +++..+..|.++ ++|+.|+|++|++++ +|..  .+++|+.|+++++
T Consensus       190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             TTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred             CCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence            4 887667788888 888888888888875 4443  5667888888766

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.90  E-value=1.4e-24  Score=235.42  Aligned_cols=141  Identities=17%  Similarity=0.094  Sum_probs=125.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            368999999999999999999975 48999999997542   23347789999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      |||++|++|.+++...   ....++.+++.|++.||+|||   ++||+||||||+||+++.++.+||+++|
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc
Confidence            9999999999999543   355678899999999999999   9999999999999999999999998554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=3.8e-25  Score=248.74  Aligned_cols=110  Identities=16%  Similarity=0.157  Sum_probs=61.8

Q ss_pred             EEEcCCCCccccCcchhhhccCCcEEEccCCcccCccC----ccccCcC-CCCccccccCcccccCchhhhcCC-----C
Q 036229          109 SLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFP----SFIFNKS-SLQHLDFSYNALSGEIPANICSNL-----P  178 (982)
Q Consensus       109 ~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~ip~~~~~~l-----~  178 (982)
                      .++++.|.++|.+|..+...++|++|+|++|.+++..+    ..+.+++ +|++|+|++|.+++..+..+ ..+     +
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l-~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDEL-VQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHH-HHHHHTSCT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHH-HHHHhccCC
Confidence            35666677776666666656667777777777665444    4555565 66666666666664434333 222     5


Q ss_pred             CCCeeeecceeeecccCCCccC----c-CcccEEEeeccccccccc
Q 036229          179 FLESISLSQNMFHGRIPSALSN----C-KYLEILSLSINNLLGAIP  219 (982)
Q Consensus       179 ~L~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~~p  219 (982)
                      +|++|+|++|++++..+..+..    + ++|++|+|++|++++..+
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  126 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSS  126 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCH
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHH
Confidence            5555555555555444433222    2 455555555555554433

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.90  E-value=8.8e-25  Score=249.99  Aligned_cols=182  Identities=18%  Similarity=0.200  Sum_probs=134.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCC-ccce--------------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRH-RNLI--------------  839 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv--------------  839 (982)
                      ...|...+.||+|+||.||+|++ .+|+.||||++....   ....+.+.+|+.+++.++| ++..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34577889999999999999995 469999999987432   2336788999999999977 2111              


Q ss_pred             -------eEEeeecC-----CCeeEEEEEeccCCChHHHHh------cCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 036229          840 -------KVISSCST-----EEFKALILEYMPHGSLEKSLY------SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV  901 (982)
Q Consensus       840 -------~l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~------~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~i  901 (982)
                             .++.++..     ....+++|+++ +++|.+++.      .....+++..+..++.|++.||+|||   ++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                   11111111     12356777766 679999884      22445778889999999999999999   9999


Q ss_pred             EEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCcee----------eeeeeeeEEeeEeeeee
Q 036229          902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF----------HVKYILFVVNFLTSYSF  971 (982)
Q Consensus       902 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~~~d~~~~  971 (982)
                      |||||||+|||++.++.+||+|||+|+....     .....+| +.|+|||++          .+..++   ..+|+|++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~---~~~DvwSl  303 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMT---FAFDTWTL  303 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC---HHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCC---chhhHHHH
Confidence            9999999999999999999999999986421     1345567 999999999          333333   34566666


Q ss_pred             ee
Q 036229          972 LM  973 (982)
Q Consensus       972 ~~  973 (982)
                      |+
T Consensus       304 Gv  305 (413)
T 3dzo_A          304 GL  305 (413)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=1.9e-23  Score=229.61  Aligned_cols=207  Identities=15%  Similarity=0.142  Sum_probs=154.5

Q ss_pred             CCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCC----cccccccccceEEecCCCCCCCCCccccCc
Q 036229          422 NCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFP----KEIGNLTNLIGIYLGGNKLNGSIPITLGKL  497 (982)
Q Consensus       422 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  497 (982)
                      .+++|++|++++|.+.+..+...+......|++|++++|++++..+    ..+..+++|+.|+|++|++++..|..|+.+
T Consensus        89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l  168 (310)
T 4glp_A           89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF  168 (310)
T ss_dssp             HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred             ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence            4567999999999999887765432345689999999999998666    345679999999999999999999999999


Q ss_pred             CCCCeEEeeccCCCCC---C-CcccCCCccccEEEccCCcCCcCCCc----cccCCCcccccccCCCccccc-ccccccc
Q 036229          498 QKLQGLHLEDNKLEGP---I-PDDICRLTKLYELGLSGNKLSGSIPA----CFSNLASLGTLSLGSNKLTSI-PLTIWNL  568 (982)
Q Consensus       498 ~~L~~L~Ls~N~l~~~---~-p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~i-p~~~~~l  568 (982)
                      ++|++|+|++|++.+.   . +..+..+++|++|+|++|+|+. +|.    .+.++++|++|+|++|+++.+ |..+..+
T Consensus       169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  247 (310)
T 4glp_A          169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC  247 (310)
T ss_dssp             TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred             CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence            9999999999998752   2 2334789999999999999973 333    356778888888888887754 5544432


Q ss_pred             cCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeC
Q 036229          569 KGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNL  648 (982)
Q Consensus       569 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  648 (982)
                      .                     .+++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +..+++|+.|+|
T Consensus       248 ~---------------------~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L  301 (310)
T 4glp_A          248 M---------------------WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTL  301 (310)
T ss_dssp             C---------------------CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEEC
T ss_pred             c---------------------CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEEC
Confidence            1                     1245556666666665 3444443  6777778888877754 33 567778888888


Q ss_pred             CCCcCCC
Q 036229          649 SNNNLSR  655 (982)
Q Consensus       649 s~N~l~~  655 (982)
                      ++|+|+.
T Consensus       302 ~~N~l~~  308 (310)
T 4glp_A          302 DGNPFLV  308 (310)
T ss_dssp             SSTTTSC
T ss_pred             cCCCCCC
Confidence            8887763

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=4.4e-25  Score=248.23  Aligned_cols=230  Identities=17%  Similarity=0.149  Sum_probs=178.2

Q ss_pred             EEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCc----chhhhcc-CCcEEEccCCcccCccCccccCc-----CC
Q 036229           85 VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIP----SAIFTLY-TLKYVNFRGNQLSGAFPSFIFNK-----SS  154 (982)
Q Consensus        85 ~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~  154 (982)
                      ..++++++++|.+|..+...++|++|||++|.+++..+    .++..++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            36789999999999888888889999999999987666    6777888 99999999999998888877775     99


Q ss_pred             CCccccccCcccccCchhh---hcCC-CCCCeeeecceeeecccCCCcc----C-cCcccEEEeeccccccccc----cc
Q 036229          155 LQHLDFSYNALSGEIPANI---CSNL-PFLESISLSQNMFHGRIPSALS----N-CKYLEILSLSINNLLGAIP----KE  221 (982)
Q Consensus       155 L~~L~Ls~N~l~~~ip~~~---~~~l-~~L~~L~Ls~N~l~~~~p~~~~----~-l~~L~~L~Ls~N~l~~~~p----~~  221 (982)
                      |++|||++|.+++..+..+   +..+ ++|++|+|++|++++..+..+.    . .++|++|+|++|++++..+    ..
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            9999999999996665543   2444 8999999999999877665543    3 3699999999999986443    34


Q ss_pred             ccccc-chhhhhccCCCCCCchhhhcC----CC-cccceEeccccccCCc----CChhhhcc-CCCcEEEccCCccccCC
Q 036229          222 IGNLT-KLKELYLGYSGLQGEIPREFG----NL-AELELMALQVSNLQGE----IPQELANL-TGLEVLKLGKNFLTGEI  290 (982)
Q Consensus       222 ~~~l~-~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~L~~n~l~~~----~p~~l~~l-~~L~~L~Ls~N~l~~~~  290 (982)
                      +..++ +|++|+|++|++++..+..+.    .+ ++|+.|++++|.+.+.    ++..+..+ ++|++|+|++|.|++..
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            45554 899999999998877665444    34 5888888888888763    34455553 48888888888887654


Q ss_pred             C----ccccccCCCcEEEccCccccccC
Q 036229          291 P----PEIHNLHNLKLLDLSHNKLVGAV  314 (982)
Q Consensus       291 p----~~~~~l~~L~~L~Ls~N~l~~~~  314 (982)
                      +    ..+..+++|++|+|++|.+.+..
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~  269 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDIVKNMS  269 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHHHTTCC
T ss_pred             HHHHHHHHhcCCCccEEEeccCCccccC
Confidence            4    33456677888888888855443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=2.2e-23  Score=219.88  Aligned_cols=203  Identities=20%  Similarity=0.215  Sum_probs=132.4

Q ss_pred             cCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCc-ccCccCccccCcCCCCcccccc-CcccccCchhh
Q 036229           96 TIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQ-LSGAFPSFIFNKSSLQHLDFSY-NALSGEIPANI  173 (982)
Q Consensus        96 ~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ip~~~  173 (982)
                      .+|. +.  .+|++|++++|++++..+.++..+++|++|+|++|+ +++..+..|.++++|++|++++ |.++ .+|+..
T Consensus        25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~  100 (239)
T 2xwt_C           25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDA  100 (239)
T ss_dssp             SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTS
T ss_pred             ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHH
Confidence            5665 33  378889998888886656678888888888888886 7755555778888888888887 7877 566666


Q ss_pred             hcCCCCCCeeeecceeeecccCCCccCcCccc---EEEeecc-ccccccccccccccchh-hhhccCCCCCCchhhhcCC
Q 036229          174 CSNLPFLESISLSQNMFHGRIPSALSNCKYLE---ILSLSIN-NLLGAIPKEIGNLTKLK-ELYLGYSGLQGEIPREFGN  248 (982)
Q Consensus       174 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~  248 (982)
                      |.++++|++|++++|++++ +|. |..+++|+   +|++++| ++++..+..|..+++|+ +|++++|+++...+..|..
T Consensus       101 f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~  178 (239)
T 2xwt_C          101 LKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG  178 (239)
T ss_dssp             EECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT
T ss_pred             hCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC
Confidence            6778888888888888775 554 77777776   7777777 77755555677777777 7777777776322223333


Q ss_pred             CcccceEeccccc-cCCcCChhhhcc-CCCcEEEccCCccccCCCccccccCCCcEEEccCc
Q 036229          249 LAELELMALQVSN-LQGEIPQELANL-TGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHN  308 (982)
Q Consensus       249 l~~L~~L~L~~n~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  308 (982)
                       ++|+.|++++|+ +++..+..|.++ ++|++|++++|++++..+.   .+++|+.|+++++
T Consensus       179 -~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          179 -TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             -CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             -CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence             555555555552 554444445555 5555555555555533222   3344555554443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.90  E-value=1.4e-24  Score=241.92  Aligned_cols=254  Identities=20%  Similarity=0.261  Sum_probs=173.6

Q ss_pred             CCEEEcCCCCccccCcchhhhc--cCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeee
Q 036229          107 LQSLNLGFNRLSGSIPSAIFTL--YTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESIS  184 (982)
Q Consensus       107 L~~L~L~~n~~~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~  184 (982)
                      ++.+|+++|.+.   |..+..+  +++++|++++|.+++..+. +.++++|++|+|++|.+++..               
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~---------------  109 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST---------------  109 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH---------------
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH---------------
Confidence            456666666554   3445555  5666666666666544333 334555555555555544320               


Q ss_pred             ecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCC-CCCC-chhhhcCCCcccceEecccc-c
Q 036229          185 LSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYS-GLQG-EIPREFGNLAELELMALQVS-N  261 (982)
Q Consensus       185 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~~~~~~~l~~L~~L~L~~n-~  261 (982)
                               +|..+..+++|++|+|++|++++..|..++.+++|++|+|++| .+++ .++..+.++++|+.|++++| .
T Consensus       110 ---------~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~  180 (336)
T 2ast_B          110 ---------LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD  180 (336)
T ss_dssp             ---------HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred             ---------HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCC
Confidence                     3444445555555555555555555555555666666666666 4554 25666777888888888888 8


Q ss_pred             cCCc-CChhhhccC-CCcEEEccCC--ccc-cCCCccccccCCCcEEEccCcc-ccccCcccccCCCCCceeecCCCc-C
Q 036229          262 LQGE-IPQELANLT-GLEVLKLGKN--FLT-GEIPPEIHNLHNLKLLDLSHNK-LVGAVPATIFNMSTLTGLGLQSNS-L  334 (982)
Q Consensus       262 l~~~-~p~~l~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l  334 (982)
                      +++. ++..+..++ +|++|++++|  .++ +.+|..+.++++|++|++++|. +++..+..+..+++|+.|++++|. +
T Consensus       181 l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~  260 (336)
T 2ast_B          181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI  260 (336)
T ss_dssp             CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTC
T ss_pred             cChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCC
Confidence            8764 577799999 9999999999  555 4567778899999999999999 777788899999999999999996 2


Q ss_pred             CCCcCccccccCCCccEEEccCCcccccccccccCC-CCCCEEEeccccCccccCCcccc
Q 036229          335 SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA-SKLSVLELGRNSFSGFIPNTFGN  393 (982)
Q Consensus       335 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~  393 (982)
                      .. ..-.....+++|++|++++| +..   ..+..+ ..++.|+++.|++++..|..++.
T Consensus       261 ~~-~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          261 IP-ETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             CG-GGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CH-HHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence            21 11123457899999999999 443   233333 34778889999999999988775

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=2.7e-25  Score=252.59  Aligned_cols=256  Identities=24%  Similarity=0.259  Sum_probs=137.0

Q ss_pred             cCcchhhhccCCcEEEccCCcccCccC----ccccCcCCCCccccccC---cccccCchhh------hcCCCCCCeeeec
Q 036229          120 SIPSAIFTLYTLKYVNFRGNQLSGAFP----SFIFNKSSLQHLDFSYN---ALSGEIPANI------CSNLPFLESISLS  186 (982)
Q Consensus       120 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N---~l~~~ip~~~------~~~l~~L~~L~Ls  186 (982)
                      .++..+..+++|++|+|++|++++..+    ..+..+++|++|+|++|   .+++.+|..+      +..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            345555666666666666666654422    33556666666666664   3444555443      2456666666666


Q ss_pred             ceeeec----ccCCCccCcCcccEEEeeccccccccccccccc-cchhhhhccCCCCCCchhhhcCCCcccceEeccccc
Q 036229          187 QNMFHG----RIPSALSNCKYLEILSLSINNLLGAIPKEIGNL-TKLKELYLGYSGLQGEIPREFGNLAELELMALQVSN  261 (982)
Q Consensus       187 ~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~  261 (982)
                      +|.+++    .+|..+..+++|++|+|++|++++..+..+... ..+..     |++++       ..++|+.|++++|+
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~-----~~~~~-------~~~~L~~L~L~~n~  170 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV-----NKKAK-------NAPPLRSIICGRNR  170 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHH-----HHHHH-------TCCCCCEEECCSSC
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhh-----hhhcc-------cCCCCcEEECCCCC
Confidence            666665    355566666677777777776654333333221 00000     00000       00334444444444


Q ss_pred             cC-CcCC---hhhhccCCCcEEEccCCcccc-----CCCccccccCCCcEEEccCcccc----ccCcccccCCCCCceee
Q 036229          262 LQ-GEIP---QELANLTGLEVLKLGKNFLTG-----EIPPEIHNLHNLKLLDLSHNKLV----GAVPATIFNMSTLTGLG  328 (982)
Q Consensus       262 l~-~~~p---~~l~~l~~L~~L~Ls~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~  328 (982)
                      ++ +.+|   ..+..+++|++|+|++|+|+.     ..|..+..+++|++|+|++|.++    +.+|..+..+++|+.|+
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~  250 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG  250 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence            43 1222   234455555555555555541     22224555555555555555553    34455555555555555


Q ss_pred             cCCCcCCCCc-----CccccccCCCccEEEccCCcccc----cccccc-cCCCCCCEEEeccccCcccc
Q 036229          329 LQSNSLSGSL-----SSIADVQLPNLEELRLWSNNFSG----TIPRFI-FNASKLSVLELGRNSFSGFI  387 (982)
Q Consensus       329 L~~N~l~~~~-----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~i~~~~  387 (982)
                      |++|.+++..     .......+++|++|+|++|.+++    .+|..+ .++++|++|++++|++++..
T Consensus       251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            5555554321     11111235677888888888876    466666 55788888888888888654

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=2.1e-25  Score=253.53  Aligned_cols=240  Identities=18%  Similarity=0.214  Sum_probs=177.0

Q ss_pred             cCCccccCCCCCCEEEcCCCCccccCcc----hhhhccCCcEEEccCC---cccCccCccc-------cCcCCCCccccc
Q 036229           96 TIPSQLWNLSSLQSLNLGFNRLSGSIPS----AIFTLYTLKYVNFRGN---QLSGAFPSFI-------FNKSSLQHLDFS  161 (982)
Q Consensus        96 ~~~~~l~~l~~L~~L~L~~n~~~~~~p~----~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls  161 (982)
                      .++..+..+++|++|+|++|.+++..+.    .+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            5667788889999999999998866443    4668899999999995   4556667655       688999999999


Q ss_pred             cCcccc----cCchhhhcCCCCCCeeeecceeeecccCCCcc----Cc---------CcccEEEeeccccc-cccc---c
Q 036229          162 YNALSG----EIPANICSNLPFLESISLSQNMFHGRIPSALS----NC---------KYLEILSLSINNLL-GAIP---K  220 (982)
Q Consensus       162 ~N~l~~----~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~Ls~N~l~-~~~p---~  220 (982)
                      +|.+++    .+|..+ ..+++|++|+|++|.+++..+..+.    .+         ++|++|+|++|+++ +.+|   .
T Consensus       103 ~n~l~~~~~~~l~~~l-~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~  181 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFL-SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK  181 (386)
T ss_dssp             SCCCCTTTHHHHHHHH-HHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred             CCcCCHHHHHHHHHHH-HhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHH
Confidence            999986    366565 7889999999999999755444443    33         88999999999987 3444   4


Q ss_pred             ccccccchhhhhccCCCCCC-----chhhhcCCCcccceEeccccccC----CcCChhhhccCCCcEEEccCCccccC--
Q 036229          221 EIGNLTKLKELYLGYSGLQG-----EIPREFGNLAELELMALQVSNLQ----GEIPQELANLTGLEVLKLGKNFLTGE--  289 (982)
Q Consensus       221 ~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~~--  289 (982)
                      .+..+++|++|+|++|+++.     ..|..+..+++|+.|+|++|.++    +.+|..+..+++|++|+|++|+|++.  
T Consensus       182 ~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  261 (386)
T 2ca6_A          182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA  261 (386)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred             HHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhH
Confidence            66778888888888888872     34446777788888888888775    55667777778888888888887754  


Q ss_pred             --CCcccc--ccCCCcEEEccCccccc----cCcccc-cCCCCCceeecCCCcCCC
Q 036229          290 --IPPEIH--NLHNLKLLDLSHNKLVG----AVPATI-FNMSTLTGLGLQSNSLSG  336 (982)
Q Consensus       290 --~p~~~~--~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~  336 (982)
                        ++..+.  .+++|++|+|++|.+++    .+|..+ .++++|+.|++++|.+++
T Consensus       262 ~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          262 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             HHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence              345553  37777888888887776    355555 446666666666665553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=9.7e-25  Score=256.79  Aligned_cols=161  Identities=17%  Similarity=0.207  Sum_probs=122.0

Q ss_pred             CCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--------chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          781 RFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--------GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      .+...+.||+|+||.||+|+. .++.+|+|+.....        ....+++.+|++++++++||||+++..++...+..|
T Consensus       337 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          337 RKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             -----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             cCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            335567999999999999965 57788888864321        112356899999999999999995555555666779


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++++|.+++..         +..++.|+++||+|||   ++||+||||||+||++++  .+||+|||+|+....
T Consensus       416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            99999999999999865         4679999999999999   999999999999999998  999999999998643


Q ss_pred             CCCce-----eecccccccccccCceeee
Q 036229          933 EDQSI-----TQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       933 ~~~~~-----~~~~~~gt~~y~aPE~~~~  956 (982)
                      .....     ......||+.|||||++..
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~  510 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWER  510 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence            22111     1235689999999999976

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=3.8e-23  Score=226.56  Aligned_cols=195  Identities=27%  Similarity=0.358  Sum_probs=148.7

Q ss_pred             cccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccc
Q 036229          470 IGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLG  549 (982)
Q Consensus       470 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  549 (982)
                      +..+++|+.|++++|.++. +| .+..+++|++|+|++|++++..+  +..+++|++|+|++|++++. + .+..+++|+
T Consensus        37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~  110 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK  110 (308)
T ss_dssp             HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred             HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence            3456677777777777764 33 46777777888888877775433  77777788888888877753 3 577777888


Q ss_pred             ccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccc
Q 036229          550 TLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRL  629 (982)
Q Consensus       550 ~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  629 (982)
                      +|+|++|+++.+|. +..+++|++|++++|++++..+  ++.+++|+.|++++|++++..+  +..+++|++|+|++|++
T Consensus       111 ~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          111 TLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             EEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEECCCCCCCCchh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence            88888888877765 6677788888888888776544  7788888888888888877544  88888888999998888


Q ss_pred             cCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccc
Q 036229          630 QGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKG  679 (982)
Q Consensus       630 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  679 (982)
                      ++..+  +..+++|+.|+|++|++++..  .+..+++|++|++++|++++
T Consensus       186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          186 SDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred             CcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence            86544  788888999999999888654  37888889999999998875

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=7.8e-23  Score=217.30  Aligned_cols=182  Identities=28%  Similarity=0.343  Sum_probs=124.1

Q ss_pred             cccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccccccc
Q 036229          474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL  553 (982)
Q Consensus       474 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  553 (982)
                      .+.+.++++++.++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L   90 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL   90 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence            45677888888887 4554444  57888888888888777777888888888888888888777777777777777777


Q ss_pred             CCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCc
Q 036229          554 GSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI  633 (982)
Q Consensus       554 ~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  633 (982)
                      ++|+++.+|..                       .+..+++|+.|+|++|+|++..+..|+.+++|++|+|++|+|++..
T Consensus        91 ~~n~l~~~~~~-----------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  147 (251)
T 3m19_A           91 ANNQLASLPLG-----------------------VFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP  147 (251)
T ss_dssp             TTSCCCCCCTT-----------------------TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCCcccccChh-----------------------HhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence            77777766543                       3444455555555555555555555666666666666666666555


Q ss_pred             cccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccC
Q 036229          634 SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       634 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~  681 (982)
                      +..|+++++|+.|+|++|++++..|..+..+++|++|+|++|+++|..
T Consensus       148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~  195 (251)
T 3m19_A          148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSR  195 (251)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred             HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence            556666666666666666666655556666666666666666666553

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=1.5e-23  Score=229.28  Aligned_cols=144  Identities=21%  Similarity=0.357  Sum_probs=126.5

Q ss_pred             hcCCCcc-ceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHh-hhcCCccceeEEeeecC----CCee
Q 036229          779 TNRFSEN-NLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMM-KSIRHRNLIKVISSCST----EEFK  851 (982)
Q Consensus       779 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~  851 (982)
                      .++|.+. +.||+|+||.||+|+. .+++.||+|+++..     ..+.+|++++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4667776 7899999999999986 46899999998632     4567888888 56699999999999876    6788


Q ss_pred             EEEEEeccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla  927 (982)
                      ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+|||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998653 36899999999999999999999   999999999999999997   789999999999


Q ss_pred             eee
Q 036229          928 KLL  930 (982)
Q Consensus       928 ~~~  930 (982)
                      ...
T Consensus       168 ~~~  170 (299)
T 3m2w_A          168 KET  170 (299)
T ss_dssp             EEC
T ss_pred             ccc
Confidence            865

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.88  E-value=1.5e-22  Score=221.88  Aligned_cols=179  Identities=26%  Similarity=0.414  Sum_probs=140.7

Q ss_pred             ccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcc
Q 036229          469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL  548 (982)
Q Consensus       469 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  548 (982)
                      .+..+++|+.|++++|++++..+  +..+++|++|+|++|++++.  +.+..+++|+.|++++|++++. + .+..+++|
T Consensus        58 ~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L  131 (308)
T 1h6u_A           58 GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNL  131 (308)
T ss_dssp             TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTC
T ss_pred             hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCC
Confidence            46677788888888888876554  78888888888888888753  3677888888888888888754 3 27888888


Q ss_pred             cccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc
Q 036229          549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR  628 (982)
Q Consensus       549 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  628 (982)
                      ++|++++|+++.+|. +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|+|++|+
T Consensus       132 ~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~  206 (308)
T 1h6u_A          132 QVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ  206 (308)
T ss_dssp             CEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred             CEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence            888888888887776 6678888888888888886544  7888888888888888877654  7888889999999999


Q ss_pred             ccCCccccccCCCCCCeeeCCCCcCCCCCCccc
Q 036229          629 LQGSISESFGDLISLKSLNLSNNNLSRSIPISL  661 (982)
Q Consensus       629 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  661 (982)
                      +++..+  +..+++|+.|+|++|++++ .|..+
T Consensus       207 l~~~~~--l~~l~~L~~L~l~~N~i~~-~~~~~  236 (308)
T 1h6u_A          207 ISDVSP--LANTSNLFIVTLTNQTITN-QPVFY  236 (308)
T ss_dssp             CCBCGG--GTTCTTCCEEEEEEEEEEC-CCEEC
T ss_pred             cCcccc--ccCCCCCCEEEccCCeeec-CCeee
Confidence            886553  8888899999999999875 44433

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=3.2e-22  Score=223.67  Aligned_cols=138  Identities=17%  Similarity=0.068  Sum_probs=89.3

Q ss_pred             ccccccccce-EEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccC-CcCCcCCCccccCCC
Q 036229          469 EIGNLTNLIG-IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG-NKLSGSIPACFSNLA  546 (982)
Q Consensus       469 ~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~  546 (982)
                      .|.+++++.. +.+++|+++.+.|..|..+++|++|++++|+|++..+..+....++..|++++ |++..+.+..|..+.
T Consensus        74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~  153 (350)
T 4ay9_X           74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS  153 (350)
T ss_dssp             SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred             HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence            4555666553 55666777777778888888888888888888876666777777778888755 667766666777664


Q ss_pred             -cccccccCCCcccccccccccccCceEEecCC-CcccCCCccccccccccceeeccccccc
Q 036229          547 -SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSS-NFFTGPLPLDIGNLKVLIGIDFSTNNFS  606 (982)
Q Consensus       547 -~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~Ldls~N~l~  606 (982)
                       .++.|+|++|+|++||...+...+++.|++++ |.++...+..|.++++|+.||+|+|+|+
T Consensus       154 ~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~  215 (350)
T 4ay9_X          154 FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  215 (350)
T ss_dssp             SSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred             hhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence             57778888888888877776666666666653 3333222223334444444444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.88  E-value=1.3e-23  Score=246.88  Aligned_cols=213  Identities=24%  Similarity=0.334  Sum_probs=149.0

Q ss_pred             CCCCCCCCCC-----ceeeE-EecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcE
Q 036229           60 KNWNTSTPVC-----NWTGV-TCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKY  133 (982)
Q Consensus        60 ~~w~~~~~~c-----~w~gv-~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~  133 (982)
                      .+|..+.++|     .|.|+ .|.  .++++.|+|+++++++ +|..+.  ++|++|+|++|+++ .+|   ..+++|++
T Consensus        34 ~~W~~~~~~~~~~~~~~~~l~~C~--~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~  104 (571)
T 3cvr_A           34 DKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY  104 (571)
T ss_dssp             HHHHTTCCTTCCHHHHHHHHHHHH--HTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred             HHHhccCCccccccchhhhccccc--cCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence            4565555667     79999 787  3578999999999986 787664  78999999999998 778   45789999


Q ss_pred             EEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccc
Q 036229          134 VNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINN  213 (982)
Q Consensus       134 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  213 (982)
                      |+|++|+|++ +|. +.+  +|++|+|++|.+++ +|.    .+++|+.|+|++|+|++ +|.   .+++|++|+|++|+
T Consensus       105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~  171 (571)
T 3cvr_A          105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ  171 (571)
T ss_dssp             EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred             EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence            9999999986 777 655  89999999999885 776    47888888888888886 554   56788888888888


Q ss_pred             cccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCcc
Q 036229          214 LLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE  293 (982)
Q Consensus       214 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~  293 (982)
                      +++ +|. |.  ++|++|+|++|+|+ .+|. |..  +|                 +...+.|++|+|++|+|+ .+|..
T Consensus       172 L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L-----------------~~~~~~L~~L~Ls~N~l~-~lp~~  225 (571)
T 3cvr_A          172 LTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN-----------------HHSEETEIFFRCRENRIT-HIPEN  225 (571)
T ss_dssp             CSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------------------------CCEEEECCSSCCC-CCCGG
T ss_pred             CCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh-----------------hcccccceEEecCCCcce-ecCHH
Confidence            875 665 55  77888888888877 4444 433  33                 011122355555555555 34444


Q ss_pred             ccccCCCcEEEccCccccccCcccccC
Q 036229          294 IHNLHNLKLLDLSHNKLVGAVPATIFN  320 (982)
Q Consensus       294 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~  320 (982)
                      +..+++|+.|+|++|++++..|..+..
T Consensus       226 l~~l~~L~~L~L~~N~l~~~~p~~l~~  252 (571)
T 3cvr_A          226 ILSLDPTCTIILEDNPLSSRIRESLSQ  252 (571)
T ss_dssp             GGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred             HhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence            445555555555555555555555444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=3e-22  Score=223.92  Aligned_cols=243  Identities=17%  Similarity=0.115  Sum_probs=186.2

Q ss_pred             cEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCC-ccccCcCCCCe-EE
Q 036229          427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP-ITLGKLQKLQG-LH  504 (982)
Q Consensus       427 ~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~  504 (982)
                      ++++.++|+++.++...     +.++++|++++|+|+...+..|.++++|+.|+|++|++.+.+| .+|.+++++++ +.
T Consensus        12 ~~v~C~~~~Lt~iP~~l-----~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~   86 (350)
T 4ay9_X           12 RVFLCQESKVTEIPSDL-----PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   86 (350)
T ss_dssp             TEEEEESTTCCSCCTTC-----CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred             CEEEecCCCCCccCcCc-----CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence            46777777777765433     3567888888888887777789999999999999999866554 67889988775 66


Q ss_pred             eeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCC-Ccccccccccc-cc-cCceEEecCCCcc
Q 036229          505 LEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS-NKLTSIPLTIW-NL-KGMLYLNFSSNFF  581 (982)
Q Consensus       505 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~ip~~~~-~l-~~L~~L~Ls~N~l  581 (982)
                      ++.|+|++..|+.|..+++|++|++++|+|++..+..+....++..|++.+ |+++.+|...+ .+ ..+++|++++|++
T Consensus        87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i  166 (350)
T 4ay9_X           87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  166 (350)
T ss_dssp             EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence            778999988889999999999999999999988777888888888898865 68888886543 33 4688899999999


Q ss_pred             cCCCccccccccccceeeccc-ccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcc
Q 036229          582 TGPLPLDIGNLKVLIGIDFST-NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS  660 (982)
Q Consensus       582 ~~~~~~~~~~l~~L~~Ldls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  660 (982)
                      +...+ ......+|+.+++++ |.++.+.+..|+++++|++|+|++|+|+..++..|.++++|+.+++  ++++ .+| .
T Consensus       167 ~~i~~-~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP-~  241 (350)
T 4ay9_X          167 QEIHN-SAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP-T  241 (350)
T ss_dssp             CEECT-TSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCC-C
T ss_pred             cCCCh-hhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCC-C
Confidence            85444 444556788899875 6676655567899999999999999998666656655554444333  3343 566 4


Q ss_pred             cccccccceeecCCCcccc
Q 036229          661 LEKLSYLEDLDLSFNKLKG  679 (982)
Q Consensus       661 l~~l~~L~~l~ls~N~l~~  679 (982)
                      +.++++|+.++++++.-++
T Consensus       242 l~~l~~L~~l~l~~~~~c~  260 (350)
T 4ay9_X          242 LEKLVALMEASLTYPSHCC  260 (350)
T ss_dssp             TTTCCSCCEEECSCHHHHH
T ss_pred             chhCcChhhCcCCCCcccc
Confidence            7888999999998765543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=4.6e-22  Score=204.89  Aligned_cols=183  Identities=20%  Similarity=0.258  Sum_probs=122.6

Q ss_pred             CceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCcc
Q 036229           69 CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSF  148 (982)
Q Consensus        69 c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  148 (982)
                      |.|.+|.|+.            ++++ .+|..+  .++|++|++++|++++..+..+..+++|++|+|++|++++..+..
T Consensus         7 C~~~~v~c~~------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (208)
T 2o6s_A            7 CSGTTVECYS------------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV   71 (208)
T ss_dssp             EETTEEECCS------------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             ECCCEEEecC------------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhh
Confidence            7899999972            2233 344433  347788888888887555556677888888888888887555555


Q ss_pred             ccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccch
Q 036229          149 IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKL  228 (982)
Q Consensus       149 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  228 (982)
                      +..+++|++|+|++|.++ .+|...|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|
T Consensus        72 ~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  150 (208)
T 2o6s_A           72 FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL  150 (208)
T ss_dssp             TTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             cCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCc
Confidence            677777777777777777 5565555777777777777777776666667777777777777777775555556666677


Q ss_pred             hhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccC
Q 036229          229 KELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLT  274 (982)
Q Consensus       229 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~  274 (982)
                      ++|++++|.+.+       .+++|+.|+++.|+++|.+|++++.++
T Consensus       151 ~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          151 QYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             CEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             cEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            777777666553       233455556666666666655555443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=4.8e-22  Score=214.15  Aligned_cols=153  Identities=16%  Similarity=0.135  Sum_probs=121.5

Q ss_pred             HHHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccc------------------hhhhhHHHHHHHhhhcC
Q 036229          773 LELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG------------------RAFKSFDVECEMMKSIR  834 (982)
Q Consensus       773 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  834 (982)
                      ..+......|.+.+.||+|+||.||+|+..+|+.||+|+++....                  .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344455667788899999999999999997799999999864321                  13456889999999998


Q ss_pred             CccceeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc
Q 036229          835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD  914 (982)
Q Consensus       835 h~nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~  914 (982)
                      |   +++.+++.. +..++||||++|++|.+ +..       .....++.|++.|++|||   ++||+||||||+||+++
T Consensus       163 ~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             C---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence            5   444444432 55699999999999988 422       124569999999999999   99999999999999999


Q ss_pred             CCCcEEEEeecCceeecCCCCceeecccccccccccCceeee
Q 036229          915 DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV  956 (982)
Q Consensus       915 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  956 (982)
                       ++.+||+|||+|+..               ..|+|||++..
T Consensus       228 -~~~vkl~DFG~a~~~---------------~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVEV---------------GEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEET---------------TSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeEC---------------CCCCHHHHHHH
Confidence             999999999998742               34788888753

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=1.1e-21  Score=230.50  Aligned_cols=169  Identities=26%  Similarity=0.303  Sum_probs=94.4

Q ss_pred             cccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccccccc
Q 036229          474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL  553 (982)
Q Consensus       474 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  553 (982)
                      ++|+.|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +..  +|+.|+|++|+|++ +|.   .+++|+.|+|
T Consensus        80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  147 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA  147 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred             CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence            34555555555555 233   234555555555555554 444 433  55555555555554 333   3455555555


Q ss_pred             CCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCc-------ceEeccc
Q 036229          554 GSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNL-------QYLFLGY  626 (982)
Q Consensus       554 ~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L-------~~L~Ls~  626 (982)
                      ++|+|+.+|.   .+++|++|++++|++++ +|. +.  ++|+.|||++|+|+. +|. |..  +|       +.|+|++
T Consensus       148 s~N~l~~lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~-lp~-~~~--~L~~~~~~L~~L~Ls~  216 (571)
T 3cvr_A          148 DNNQLTMLPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLES-LPA-VPV--RNHHSEETEIFFRCRE  216 (571)
T ss_dssp             CSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSS-CCC-CC----------CCEEEECCS
T ss_pred             CCCccCcCCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCc-hhh-HHH--hhhcccccceEEecCC
Confidence            5555555554   34455555555555554 333 43  556666666666653 343 433  55       7777777


Q ss_pred             ccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccc
Q 036229          627 NRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY  666 (982)
Q Consensus       627 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  666 (982)
                      |+|+ .+|..+..+++|+.|+|++|+|++.+|..+..++.
T Consensus       217 N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             SCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             Ccce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            7776 45666666777777777777777777766665543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=1.1e-20  Score=194.62  Aligned_cols=161  Identities=27%  Similarity=0.263  Sum_probs=77.7

Q ss_pred             ccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccC
Q 036229          475 NLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLG  554 (982)
Q Consensus       475 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  554 (982)
                      +|+.|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            44555555555554444445555555555555555554444444555555555555555554444444445555555555


Q ss_pred             CCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCcc
Q 036229          555 SNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSIS  634 (982)
Q Consensus       555 ~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  634 (982)
                      +|+++.+|.                       ..+..+++|+.|++++|++++..+..|..+++|++|+|++|.+.+.  
T Consensus       109 ~N~l~~~~~-----------------------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--  163 (208)
T 2o6s_A          109 TNQLQSLPD-----------------------GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--  163 (208)
T ss_dssp             SSCCCCCCT-----------------------TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC--
T ss_pred             CCcCcccCH-----------------------hHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC--
Confidence            554444443                       3333444444444444444444444444455555555555544322  


Q ss_pred             ccccCCCCCCeeeCCCCcCCCCCCccccccc
Q 036229          635 ESFGDLISLKSLNLSNNNLSRSIPISLEKLS  665 (982)
Q Consensus       635 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  665 (982)
                           +++|+.|+++.|+++|.+|..++.++
T Consensus       164 -----~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          164 -----CPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             -----TTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             -----CCCHHHHHHHHHhCCceeeccCcccc
Confidence                 23445555555555555555444443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=3.5e-21  Score=199.76  Aligned_cols=157  Identities=25%  Similarity=0.318  Sum_probs=114.7

Q ss_pred             CeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCC-ccccCCCcccccccCCCcccccccccccccCceEEecCCC
Q 036229          501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIP-ACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSN  579 (982)
Q Consensus       501 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N  579 (982)
                      +.+++++|.++. +|..+.  ..+++|+|++|+|++..| ..|.++++|++|+|++|+|+.+                  
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i------------------   72 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI------------------   72 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEE------------------
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEE------------------
Confidence            366777777763 454442  234666666666665533 3355555555555555555544                  


Q ss_pred             cccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCc
Q 036229          580 FFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI  659 (982)
Q Consensus       580 ~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  659 (982)
                           .+..|.++++|+.|+|++|++++..|..|+.+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|.
T Consensus        73 -----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  147 (220)
T 2v70_A           73 -----EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG  147 (220)
T ss_dssp             -----CTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred             -----CHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence                 445566677777778888888777777888888888888888888888888888888899999999999888888


Q ss_pred             ccccccccceeecCCCcccccCCC
Q 036229          660 SLEKLSYLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       660 ~l~~l~~L~~l~ls~N~l~~~~p~  683 (982)
                      .|..+++|++|+|++|++.|.++-
T Consensus       148 ~~~~l~~L~~L~L~~N~l~c~c~l  171 (220)
T 2v70_A          148 AFDTLHSLSTLNLLANPFNCNCYL  171 (220)
T ss_dssp             TTTTCTTCCEEECCSCCEECSGGG
T ss_pred             HhcCCCCCCEEEecCcCCcCCCch
Confidence            888888899999999999887764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=8.4e-21  Score=206.03  Aligned_cols=189  Identities=25%  Similarity=0.347  Sum_probs=121.7

Q ss_pred             cceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCC
Q 036229          476 LIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS  555 (982)
Q Consensus       476 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  555 (982)
                      +..+.++.+.+++..+  +..+++|+.|++++|.+++. + .+..+++|+.|+|++|++++..+  +.++++|++|+|++
T Consensus        26 ~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~   99 (291)
T 1h6t_A           26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDE   99 (291)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCC
Confidence            3334444555443222  33455566666666666533 2 35556666666666666654433  56666666666666


Q ss_pred             CcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccc
Q 036229          556 NKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISE  635 (982)
Q Consensus       556 N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  635 (982)
                      |+++.+|. +..+++|++|++++|++++.  ..+..+++|+.|++++|++++.  ..++.+++|++|+|++|++++..| 
T Consensus       100 n~l~~~~~-l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-  173 (291)
T 1h6t_A          100 NKVKDLSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-  173 (291)
T ss_dssp             SCCCCGGG-GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred             CcCCCChh-hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence            66666553 55566666666666666653  3466677777777777777665  467778888888888888876554 


Q ss_pred             cccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccc
Q 036229          636 SFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKG  679 (982)
Q Consensus       636 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  679 (982)
                       +..+++|+.|+|++|++++ +| .+..+++|+.|++++|+++.
T Consensus       174 -l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          174 -LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             -GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             -hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence             7788888888888888875 44 47778888888888888764

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=1.2e-21  Score=239.02  Aligned_cols=235  Identities=19%  Similarity=0.217  Sum_probs=125.8

Q ss_pred             CCChhHHHHHHHHHHHhcCCCCccccCCCC-CCCCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCE---
Q 036229           34 SSITTDQDALLALKAHITHDPTNFLAKNWN-TSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQS---  109 (982)
Q Consensus        34 ~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~---  109 (982)
                      +....++++|.++....... ....-..|. ..+..+.|.++.++  .++++.|+|.++++.. ++..+....+|..   
T Consensus       128 s~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i  203 (727)
T 4b8c_D          128 SLVDCTKQALMEMADTLTDS-KTAKKQQPTGDSTPSGTATNSAVS--TPLTPKIELFANGKDE-ANQALLQHKKLSQYSI  203 (727)
T ss_dssp             ----CCCHHHHHHHHHHHHH-HTTC-------------------------------------------------------
T ss_pred             hccccchhhhhhhhhhcccc-cCcccCCCcCCCCccccCCCceec--CCccceEEeeCCCCCc-chhhHhhcCccCcccc
Confidence            45577889999998877542 111223453 34556789999887  5789999999999885 4444433332322   


Q ss_pred             --EEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecc
Q 036229          110 --LNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQ  187 (982)
Q Consensus       110 --L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~  187 (982)
                        ++++.|.+. ..|..+..+++|+.|+|++|.+. .+|..++++++|++|+|++|.|+ .+|..+ .++++|+.|+|++
T Consensus       204 ~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~Ls~  279 (727)
T 4b8c_D          204 DEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEI-KNLSNLRVLDLSH  279 (727)
T ss_dssp             -------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGG-GGGTTCCEEECTT
T ss_pred             cCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhh-hCCCCCCEEeCcC
Confidence              233334443 45677888888899999988888 77887888888888888888888 788776 7888888888888


Q ss_pred             eeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcc-cceEeccccccCCcC
Q 036229          188 NMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAE-LELMALQVSNLQGEI  266 (982)
Q Consensus       188 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~n~l~~~~  266 (982)
                      |+|+ .+|..|+++++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..+++++|.+++.+
T Consensus       280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~  357 (727)
T 4b8c_D          280 NRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL  357 (727)
T ss_dssp             SCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred             CcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence            8888 67888888888888888888887 67777888888888888888888888887765432 234677788887777


Q ss_pred             ChhhhccCCCcEEEccCC
Q 036229          267 PQELANLTGLEVLKLGKN  284 (982)
Q Consensus       267 p~~l~~l~~L~~L~Ls~N  284 (982)
                      |..      |+.|++++|
T Consensus       358 p~~------l~~l~l~~n  369 (727)
T 4b8c_D          358 PHE------RRFIEINTD  369 (727)
T ss_dssp             CCC---------------
T ss_pred             ccc------cceeEeecc
Confidence            653      455566666

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=2.8e-20  Score=194.36  Aligned_cols=163  Identities=22%  Similarity=0.262  Sum_probs=104.2

Q ss_pred             CCCCCCCCCCceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCC
Q 036229           60 KNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGN  139 (982)
Q Consensus        60 ~~w~~~~~~c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N  139 (982)
                      .-|..++..|+|.+|.|+            +++++ .+|..+.  ++|+.|+|++|++++..|..+..+++|++|+|++|
T Consensus        10 ~~~~~~~~~Cs~~~v~c~------------~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N   74 (229)
T 3e6j_A           10 SAACPSQCSCSGTTVDCR------------SKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN   74 (229)
T ss_dssp             -CCCCTTCEEETTEEECT------------TSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             hccCCCCCEEeCCEeEcc------------CCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCC
Confidence            345567788999999998            22333 5565443  67777888877777766777777777777777777


Q ss_pred             cccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccc
Q 036229          140 QLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIP  219 (982)
Q Consensus       140 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  219 (982)
                      +|+...+..|..+++|++|+|++|.++ .+|+..|..+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..+
T Consensus        75 ~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~  152 (229)
T 3e6j_A           75 QLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH  152 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred             CCCCcChhhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence            776444445566666666666666666 455555566666666666666665 455555666666666666666654444


Q ss_pred             cccccccchhhhhccCCCCC
Q 036229          220 KEIGNLTKLKELYLGYSGLQ  239 (982)
Q Consensus       220 ~~~~~l~~L~~L~L~~N~l~  239 (982)
                      ..|..+++|++|+|++|.++
T Consensus       153 ~~~~~l~~L~~L~l~~N~~~  172 (229)
T 3e6j_A          153 GAFDRLSSLTHAYLFGNPWD  172 (229)
T ss_dssp             TTTTTCTTCCEEECTTSCBC
T ss_pred             HHHhCCCCCCEEEeeCCCcc
Confidence            44555555555555555554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=1.2e-20  Score=195.65  Aligned_cols=156  Identities=22%  Similarity=0.337  Sum_probs=110.7

Q ss_pred             CeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCc
Q 036229          501 QGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNF  580 (982)
Q Consensus       501 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~  580 (982)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|+++.+..|.++++|++|+|++|+++.+                   
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~-------------------   71 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-------------------   71 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE-------------------
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc-------------------
Confidence            45677777776 4454443  5666777777777666555666666666666666665544                   


Q ss_pred             ccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcc
Q 036229          581 FTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS  660 (982)
Q Consensus       581 l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  660 (982)
                          .|..|.++++|+.|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..
T Consensus        72 ----~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  147 (220)
T 2v9t_B           72 ----APDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT  147 (220)
T ss_dssp             ----CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred             ----CHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence                4455666666777777777776666666777888888888888888777788888888888888888888777777


Q ss_pred             cccccccceeecCCCcccccCC
Q 036229          661 LEKLSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       661 l~~l~~L~~l~ls~N~l~~~~p  682 (982)
                      |..+++|++|+|++|++.+..+
T Consensus       148 ~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          148 FSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             TTTCTTCCEEECCSSCEECSGG
T ss_pred             HhCCCCCCEEEeCCCCcCCCCc
Confidence            8888888888888888877554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=3.4e-20  Score=208.08  Aligned_cols=180  Identities=26%  Similarity=0.237  Sum_probs=127.3

Q ss_pred             ceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccC-CCccccEEEccCCcCCcCCCccccCCCcccccccCC
Q 036229          477 IGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDIC-RLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGS  555 (982)
Q Consensus       477 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  555 (982)
                      +.+++++|+++. +|..+.  +.++.|+|++|+|++..+..|. .+++|+.|+|++|+|+++.|..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            567777777774 444443  3467777777777766666666 677777777777777766666677777776666666


Q ss_pred             CcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccc
Q 036229          556 NKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISE  635 (982)
Q Consensus       556 N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  635 (982)
                      |+|+.+|.                       ..|.++++|+.|+|++|+|+++.|..|..+++|++|+|++|+|++..+.
T Consensus        98 N~l~~~~~-----------------------~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~  154 (361)
T 2xot_A           98 NHLHTLDE-----------------------FLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE  154 (361)
T ss_dssp             SCCCEECT-----------------------TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred             CcCCcCCH-----------------------HHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence            66665543                       3455666677777777777777777888888888888888888865555


Q ss_pred             cc---cCCCCCCeeeCCCCcCCCCCCcccccccc--cceeecCCCcccccCC
Q 036229          636 SF---GDLISLKSLNLSNNNLSRSIPISLEKLSY--LEDLDLSFNKLKGEIP  682 (982)
Q Consensus       636 ~~---~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~--L~~l~ls~N~l~~~~p  682 (982)
                      .|   ..+++|+.|||++|+|++..+..+..++.  |+.|+|++|++.+.+.
T Consensus       155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            56   56888888888888888665567777776  4788899988887653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.82  E-value=2.6e-22  Score=237.29  Aligned_cols=188  Identities=20%  Similarity=0.155  Sum_probs=95.9

Q ss_pred             cCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCc-------------ccCccCccccCcCCCCccc-cccCcccc
Q 036229          102 WNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQ-------------LSGAFPSFIFNKSSLQHLD-FSYNALSG  167 (982)
Q Consensus       102 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~  167 (982)
                      +..++|+.|+|++|+++ .+|.+++++++|++|++++|.             +.+..|..++++++|++|| ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            45666666666666665 666666666666666665554             3444455555555555555 4444332 


Q ss_pred             cCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcC
Q 036229          168 EIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFG  247 (982)
Q Consensus       168 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  247 (982)
                                 .|+.+.+++|.++...+.      .|+.|+|++|++++ +|. |+.+++|+.|+|++|+|+ .+|..|+
T Consensus       424 -----------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~  483 (567)
T 1dce_A          424 -----------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA  483 (567)
T ss_dssp             -----------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred             -----------hhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence                       122333444444432211      24555555555553 343 555555555555555555 3444455


Q ss_pred             CCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCC-CccccccCCCcEEEccCcccccc
Q 036229          248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEI-PPEIHNLHNLKLLDLSHNKLVGA  313 (982)
Q Consensus       248 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~  313 (982)
                      ++++|+.|+|++|++++ +| .++++++|++|+|++|+|++.. |..|..+++|+.|+|++|++++.
T Consensus       484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence            55555555555555543 33 4455555555555555555443 44555555555555555555433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=6.6e-20  Score=198.92  Aligned_cols=174  Identities=25%  Similarity=0.352  Sum_probs=139.6

Q ss_pred             cccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccc
Q 036229          470 IGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLG  549 (982)
Q Consensus       470 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  549 (982)
                      +..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|++++|++++ +| .+..+++|+
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~  115 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK  115 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred             hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence            34667788888888888754 3 37778888888888888886544  7788888888888888875 33 378888888


Q ss_pred             ccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccc
Q 036229          550 TLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRL  629 (982)
Q Consensus       550 ~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  629 (982)
                      +|+|++|+++.++ .+..+++|++|++++|++++.  ..++.+++|+.|++++|++++..|  +..+++|++|+|++|++
T Consensus       116 ~L~L~~n~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          116 SLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             EEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEECCCCcCCCCh-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcC
Confidence            8888888888774 566788888888888888865  568888999999999999988765  88999999999999999


Q ss_pred             cCCccccccCCCCCCeeeCCCCcCCCC
Q 036229          630 QGSISESFGDLISLKSLNLSNNNLSRS  656 (982)
Q Consensus       630 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~  656 (982)
                      ++. | .+..+++|+.|++++|+++..
T Consensus       191 ~~l-~-~l~~l~~L~~L~l~~n~i~~~  215 (291)
T 1h6t_A          191 SDL-R-ALAGLKNLDVLELFSQECLNK  215 (291)
T ss_dssp             CBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred             CCC-h-hhccCCCCCEEECcCCcccCC
Confidence            864 4 489999999999999999853

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=3.5e-20  Score=220.29  Aligned_cols=188  Identities=24%  Similarity=0.322  Sum_probs=104.2

Q ss_pred             cEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCC
Q 036229          453 EYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGN  532 (982)
Q Consensus       453 ~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  532 (982)
                      ..++++.+.+.+..+  +..+++|+.|++++|.++.. | .+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|
T Consensus        24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N   97 (605)
T 1m9s_A           24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDEN   97 (605)
T ss_dssp             HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             HHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCC
Confidence            334445555544332  34556666666666666533 2 35666666666666666664433  556666666666666


Q ss_pred             cCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccccccccccccc
Q 036229          533 KLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTV  612 (982)
Q Consensus       533 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~  612 (982)
                      +|++ +| .+..+++|++|+|++|+++.+| .+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|+|++..|  
T Consensus        98 ~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--  170 (605)
T 1m9s_A           98 KIKD-LS-SLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--  170 (605)
T ss_dssp             CCCC-CT-TSTTCTTCCEEECTTSCCCCCG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--
T ss_pred             CCCC-Ch-hhccCCCCCEEEecCCCCCCCc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--
Confidence            6653 22 4566666666666666666553 344555566666666655543  345555555555555555555444  


Q ss_pred             ccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCC
Q 036229          613 IGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR  655 (982)
Q Consensus       613 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  655 (982)
                      +..+++|+.|+|++|+|++.  +.+..+++|+.|+|++|++++
T Consensus       171 l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          171 LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence            55555555555555555542  235555555555555555554

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=1.1e-19  Score=216.19  Aligned_cols=169  Identities=29%  Similarity=0.410  Sum_probs=87.8

Q ss_pred             cccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEcc
Q 036229          451 SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLS  530 (982)
Q Consensus       451 ~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  530 (982)
                      .|+.|++++|.+... | .+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus        44 ~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls  117 (605)
T 1m9s_A           44 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLE  117 (605)
T ss_dssp             TCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECT
T ss_pred             CCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEec
Confidence            455555555555432 1 35555555555555555554433  5555555555555555553 22 45555555555555


Q ss_pred             CCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccccccccccc
Q 036229          531 GNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP  610 (982)
Q Consensus       531 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p  610 (982)
                      +|+|++.  ..+..+++|+.|+|++|+|+.+ ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|+|++.  
T Consensus       118 ~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--  190 (605)
T 1m9s_A          118 HNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--  190 (605)
T ss_dssp             TSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--
T ss_pred             CCCCCCC--ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--
Confidence            5555532  2355555555555555555554 334455555555555555554444  55555555555555555543  


Q ss_pred             ccccCccCcceEecccccccCC
Q 036229          611 TVIGGLTNLQYLFLGYNRLQGS  632 (982)
Q Consensus       611 ~~~~~l~~L~~L~Ls~N~l~~~  632 (982)
                      ..+..+++|+.|+|++|++++.
T Consensus       191 ~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          191 RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             GGGTTCTTCSEEECCSEEEECC
T ss_pred             hHHccCCCCCEEEccCCcCcCC
Confidence            2355555555555555555543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=2.2e-19  Score=186.23  Aligned_cols=152  Identities=20%  Similarity=0.274  Sum_probs=86.5

Q ss_pred             ccccccCcccccCchhhhcCCCCCCeeeecceeeecccC-CCccCcCcccEEEeeccccccccccccccccchhhhhccC
Q 036229          157 HLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP-SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGY  235 (982)
Q Consensus       157 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  235 (982)
                      ++++++|.++ .+|..+   .+.+++|+|++|++++..| ..|..+++|++|+|++|++++..+..|..+++|++|+|++
T Consensus        15 ~l~~s~n~l~-~iP~~~---~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           15 TVDCSNQKLN-KIPEHI---PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             EEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             EeEeCCCCcc-cCccCC---CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            4455555544 344433   1234555555555554433 3355555556666655555554444555555555555555


Q ss_pred             CCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccc
Q 036229          236 SGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVG  312 (982)
Q Consensus       236 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  312 (982)
                      |++++..+..|.++++|+.|++++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+..
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            55555555555555555555555555555555566666666666666666666666666666666666666666654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=4.3e-19  Score=184.01  Aligned_cols=153  Identities=27%  Similarity=0.356  Sum_probs=123.9

Q ss_pred             ceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCC
Q 036229          477 IGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN  556 (982)
Q Consensus       477 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  556 (982)
                      +.+++++|.++. +|..+.  ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+++.|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            679999999984 565554  68999999999999888889999999999999999999999999999999999999999


Q ss_pred             cccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCcccc
Q 036229          557 KLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES  636 (982)
Q Consensus       557 ~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  636 (982)
                      +|+.+|...                       |.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..
T Consensus        91 ~l~~l~~~~-----------------------f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  147 (220)
T 2v9t_B           91 KITELPKSL-----------------------FEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT  147 (220)
T ss_dssp             CCCCCCTTT-----------------------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred             cCCccCHhH-----------------------ccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence            999887654                       334455555666666666666667777777777777777777777777


Q ss_pred             ccCCCCCCeeeCCCCcCCC
Q 036229          637 FGDLISLKSLNLSNNNLSR  655 (982)
Q Consensus       637 ~~~l~~L~~L~Ls~N~l~~  655 (982)
                      |..+++|+.|+|++|.+..
T Consensus       148 ~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          148 FSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             TTTCTTCCEEECCSSCEEC
T ss_pred             HhCCCCCCEEEeCCCCcCC
Confidence            7778888888888887764

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.79  E-value=5.3e-20  Score=196.46  Aligned_cols=171  Identities=25%  Similarity=0.334  Sum_probs=113.4

Q ss_pred             cccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccccc
Q 036229          472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTL  551 (982)
Q Consensus       472 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  551 (982)
                      .+.++..+++++|.+++..  .+..+++|+.|++++|+|+. +| .+..+++|+.|+|++|+|++..+  +.++++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            5667777788888887544  57778888888888888874 44 67778888888888888876544  7788888888


Q ss_pred             ccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccC
Q 036229          552 SLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG  631 (982)
Q Consensus       552 ~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  631 (982)
                      +|++|+++.+|....  ++|++|++++                        |++++.  +.++.+++|++|+|++|++++
T Consensus        91 ~L~~N~l~~l~~~~~--~~L~~L~L~~------------------------N~l~~~--~~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A           91 SVNRNRLKNLNGIPS--ACLSRLFLDN------------------------NELRDT--DSLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             ECCSSCCSCCTTCCC--SSCCEEECCS------------------------SCCSBS--GGGTTCTTCCEEECTTSCCCB
T ss_pred             ECCCCccCCcCcccc--CcccEEEccC------------------------CccCCC--hhhcCcccccEEECCCCcCCC
Confidence            888888877664322  4444444444                        444432  235556666666666666654


Q ss_pred             CccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCccccc
Q 036229          632 SISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGE  680 (982)
Q Consensus       632 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~  680 (982)
                      . + .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|++++.
T Consensus       143 ~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          143 I-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             C-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             C-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            3 2 466666666666666666654  4556666666666666666644

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=1.3e-19  Score=203.20  Aligned_cols=175  Identities=24%  Similarity=0.228  Sum_probs=93.2

Q ss_pred             ccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCcc-CcCcccEEEeeccccccccccccccccchhhhhccC
Q 036229          157 HLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALS-NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGY  235 (982)
Q Consensus       157 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  235 (982)
                      ++++++|.++ .+|..+.   +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        22 ~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           22 ILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             EEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             EEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            3444444444 3444331   2344455555555544444444 555555555555555544444455555555555555


Q ss_pred             CCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccc---cccCCCcEEEccCccccc
Q 036229          236 SGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEI---HNLHNLKLLDLSHNKLVG  312 (982)
Q Consensus       236 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~  312 (982)
                      |+|++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|   ..+++|+.|||++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            55554444455555555555555555555555666666666666666666665444444   456677777777777765


Q ss_pred             cCcccccCCCCC--ceeecCCCcCC
Q 036229          313 AVPATIFNMSTL--TGLGLQSNSLS  335 (982)
Q Consensus       313 ~~p~~~~~l~~L--~~L~L~~N~l~  335 (982)
                      ..+..+..++.+  +.|+|++|++.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             cCHHHhhhccHhhcceEEecCCCcc
Confidence            555555555542  44555555443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=6.6e-20  Score=185.82  Aligned_cols=155  Identities=26%  Similarity=0.330  Sum_probs=91.8

Q ss_pred             cccccCCCcccccccccccccCceEEecCCCcccCCCcc-ccccccccceeecccccccccccccccCccCcceEecccc
Q 036229          549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPL-DIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYN  627 (982)
Q Consensus       549 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N  627 (982)
                      +.+++++|.++++|..++.  ++++|++++|++++..+. .++.+++|+.|+|++|+|++..|..|+.+++|++|+|++|
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            3455555555555544432  555555666655544443 3566666666666666666666666666667777777777


Q ss_pred             cccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCCCCCCCCCCcccccCcccCCCC
Q 036229          628 RLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       628 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~gn~~lc~~~  705 (982)
                      +|++..|..|.++++|++|+|++|+|++.+|..+..+++|++|+|++|+++|.+|......-+....+.++...|+.|
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            776666666666777777777777776666666666667777777777776666532211011122334455556554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=8.6e-19  Score=183.01  Aligned_cols=156  Identities=26%  Similarity=0.349  Sum_probs=109.9

Q ss_pred             CCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCC
Q 036229          500 LQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSN  579 (982)
Q Consensus       500 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N  579 (982)
                      .+.++.+++.++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|+.+|...              
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~--------------   83 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV--------------   83 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTT--------------
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhh--------------
Confidence            456888888887 5665553  78888888888888888888888888888888888887776443              


Q ss_pred             cccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCc
Q 036229          580 FFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI  659 (982)
Q Consensus       580 ~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  659 (982)
                               +..+++|+.|||++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus        84 ---------~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~  153 (229)
T 3e6j_A           84 ---------FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG  153 (229)
T ss_dssp             ---------TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred             ---------cccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence                     344455555555555555555556666677777777777776 5566667777777777777777765555


Q ss_pred             ccccccccceeecCCCcccccCC
Q 036229          660 SLEKLSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       660 ~l~~l~~L~~l~ls~N~l~~~~p  682 (982)
                      .+..+++|+.|++++|++.|.++
T Consensus       154 ~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          154 AFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTTTCTTCCEEECTTSCBCTTBG
T ss_pred             HHhCCCCCCEEEeeCCCccCCcc
Confidence            66677777777777777776655

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=2.8e-21  Score=228.41  Aligned_cols=218  Identities=20%  Similarity=0.114  Sum_probs=128.9

Q ss_pred             hhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCccc
Q 036229          126 FTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLE  205 (982)
Q Consensus       126 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  205 (982)
                      +.+++|+.|+|++|+++ .+|+.++++++|++|++++|.....+|..            +..+.+.+.+|..++.+++|+
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l------------l~~~~~~~~~~~~l~~l~~L~  412 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL------------MRALDPLLYEKETLQYFSTLK  412 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH------------HHHHCTGGGHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH------------HHhcccccCCHHHHHHHHhcc
Confidence            56777888888888876 67888888888888887666421111111            011223345555666666666


Q ss_pred             EEE-eeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCC
Q 036229          206 ILS-LSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKN  284 (982)
Q Consensus       206 ~L~-Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N  284 (982)
                      .|+ ++.|.+           .+|..+.+++|.++...+.      .|+.|++++|++++ +|. ++++++|++|+|++|
T Consensus       413 ~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N  473 (567)
T 1dce_A          413 AVDPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN  473 (567)
T ss_dssp             HHCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred             cCcchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence            666 454433           2455555555555432221      35666666666664 344 666666666666666


Q ss_pred             ccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCccccccc
Q 036229          285 FLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIP  364 (982)
Q Consensus       285 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  364 (982)
                      +|+ .+|..|.++++|+.|+|++|+|++ +| .+..+++|+.|+|++|.|++......+..+++|+.|+|++|++++.+|
T Consensus       474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            666 456666666666666666666664 44 566666666666666666655322233456667777777777776544


Q ss_pred             cc---ccCCCCCCEEEe
Q 036229          365 RF---IFNASKLSVLEL  378 (982)
Q Consensus       365 ~~---~~~l~~L~~L~L  378 (982)
                      ..   +..+++|+.|++
T Consensus       551 ~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          551 IQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CTTHHHHHCTTCSEEEC
T ss_pred             HHHHHHHHCcccCccCC
Confidence            21   233677777754

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.78  E-value=4.8e-20  Score=224.90  Aligned_cols=184  Identities=24%  Similarity=0.277  Sum_probs=70.6

Q ss_pred             CCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccccccccccccc
Q 036229          490 IPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLK  569 (982)
Q Consensus       490 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~  569 (982)
                      .|..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+.||..+..++
T Consensus       216 ~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~  293 (727)
T 4b8c_D          216 PKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCF  293 (727)
T ss_dssp             ------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGT
T ss_pred             ChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCC
Confidence            3444444444444444444444 33333334444444444444444 344444444445555555555444444444444


Q ss_pred             CceEEecCCCcccCCCccccccccccceeecccccccccccccccCccC-cceEecccccccCCccccccCCCCCCeeeC
Q 036229          570 GMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTN-LQYLFLGYNRLQGSISESFGDLISLKSLNL  648 (982)
Q Consensus       570 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  648 (982)
                      +|++|+|++|.++ .+|..|+++++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..      |+.|++
T Consensus       294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l  366 (727)
T 4b8c_D          294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEI  366 (727)
T ss_dssp             TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC------------
T ss_pred             CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEe
Confidence            5555555555444 33444555555555555555555555554443321 123555666665555542      334444


Q ss_pred             CCC--------cCCCCCCcccccccccceeecCCCcccccCC
Q 036229          649 SNN--------NLSRSIPISLEKLSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       649 s~N--------~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  682 (982)
                      ++|        .|.+..+..+..+..++...+++|-+.+...
T Consensus       367 ~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~  408 (727)
T 4b8c_D          367 NTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYA  408 (727)
T ss_dssp             -----------------------------------CCCGGGC
T ss_pred             ecccccccccCCccccccchhhcccccceeeeeccccccccC
Confidence            444        3444444445556666666777777664433

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=3.9e-19  Score=189.71  Aligned_cols=165  Identities=20%  Similarity=0.271  Sum_probs=115.5

Q ss_pred             EEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCc
Q 036229          454 YFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNK  533 (982)
Q Consensus       454 ~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  533 (982)
                      .+++++|.+++..  .+..+++|+.|++++|+++. +| .+..+++|++|+|++|+|++..+  +..+++|+.|+|++|+
T Consensus        23 ~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~   96 (263)
T 1xeu_A           23 KQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNR   96 (263)
T ss_dssp             HHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSC
T ss_pred             HHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCc
Confidence            3444444444332  46677788888888888874 34 67778888888888888886544  7888888888888888


Q ss_pred             CCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccc
Q 036229          534 LSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVI  613 (982)
Q Consensus       534 l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~  613 (982)
                      |++. |. +.. ++|++|+|++|+++.+| .+..+++|++|++++|++++. + .++.+++|+.|++++|++++.  ..+
T Consensus        97 l~~l-~~-~~~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l  168 (263)
T 1xeu_A           97 LKNL-NG-IPS-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGL  168 (263)
T ss_dssp             CSCC-TT-CCC-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTS
T ss_pred             cCCc-Cc-ccc-CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHh
Confidence            8754 33 222 78888888888888775 366677777777777777654 2 466677777777777777665  556


Q ss_pred             cCccCcceEecccccccCC
Q 036229          614 GGLTNLQYLFLGYNRLQGS  632 (982)
Q Consensus       614 ~~l~~L~~L~Ls~N~l~~~  632 (982)
                      ..+++|++|++++|++++.
T Consensus       169 ~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          169 TRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TTCCCCCEEEEEEEEEECC
T ss_pred             ccCCCCCEEeCCCCcccCC
Confidence            6777777777777777654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=1.2e-18  Score=177.45  Aligned_cols=156  Identities=21%  Similarity=0.267  Sum_probs=106.0

Q ss_pred             cccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCce
Q 036229          493 TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGML  572 (982)
Q Consensus       493 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~  572 (982)
                      ....+++|+.|++++|.|+ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|+++             
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~-------------  101 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVT-------------  101 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCB-------------
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccC-------------
Confidence            3456677777777777777 344 46667777777777775542  224555555555555555544             


Q ss_pred             EEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc-ccCCccccccCCCCCCeeeCCCC
Q 036229          573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR-LQGSISESFGDLISLKSLNLSNN  651 (982)
Q Consensus       573 ~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N  651 (982)
                                +..+..++.+++|+.|++++|++++..|..++.+++|++|+|++|+ ++ .+| .+.++++|+.|++++|
T Consensus       102 ----------~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n  169 (197)
T 4ezg_A          102 ----------SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFD  169 (197)
T ss_dssp             ----------GGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTB
T ss_pred             ----------cccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCC
Confidence                      4445556666777777777777777777778888888888888887 54 455 6888888888888888


Q ss_pred             cCCCCCCcccccccccceeecCCCcccc
Q 036229          652 NLSRSIPISLEKLSYLEDLDLSFNKLKG  679 (982)
Q Consensus       652 ~l~~~~p~~l~~l~~L~~l~ls~N~l~~  679 (982)
                      ++++ ++ .+..+++|++|++++|++.+
T Consensus       170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          170 GVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             CCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             CCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            8875 44 67788888888888888753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=9.1e-19  Score=186.27  Aligned_cols=138  Identities=20%  Similarity=0.253  Sum_probs=107.7

Q ss_pred             CCCccceeeeeceEEEEEEEe-CCCeE--EEEEEeecccch------------------------hhhhHHHHHHHhhhc
Q 036229          781 RFSENNLIGRGGFGSVYKARI-GEGME--VAVKVFDLQCGR------------------------AFKSFDVECEMMKSI  833 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  833 (982)
                      -|++.+.||+|+||.||+|+. .+|+.  ||||+++.....                        ....+.+|+++++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999987 67888  999997543111                        113678899999999


Q ss_pred             CCccc--eeEEeeecCCCeeEEEEEeccC-C----ChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC
Q 036229          834 RHRNL--IKVISSCSTEEFKALILEYMPH-G----SLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL  906 (982)
Q Consensus       834 ~h~nI--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDl  906 (982)
                      +|+++  +.++++    +..++||||+.+ |    +|.+....    .++..+..++.|++.|+.|||.  +.||+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            88754  445543    356899999942 3    67665432    2234567899999999999994  689999999


Q ss_pred             CCCCEEEcCCCcEEEEeecCceee
Q 036229          907 KPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       907 kp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ||+|||+++  .+||+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999988  9999999999865

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=3.5e-18  Score=173.96  Aligned_cols=153  Identities=15%  Similarity=0.159  Sum_probs=83.0

Q ss_pred             CcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhh
Q 036229          151 NKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKE  230 (982)
Q Consensus       151 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  230 (982)
                      .+++|++|++++|.++ .+| .+ ..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..++.+++|++
T Consensus        42 ~l~~L~~L~l~~n~i~-~l~-~l-~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           42 QMNSLTYITLANINVT-DLT-GI-EYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHTCCEEEEESSCCS-CCT-TG-GGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hcCCccEEeccCCCcc-ChH-HH-hcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            3444444444444444 333 22 44555555555555332  2234555555666666666555555555555555555


Q ss_pred             hhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccc
Q 036229          231 LYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL  310 (982)
Q Consensus       231 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  310 (982)
                      |+|++|++++..|..++.+++|+.|++++|+..+.+| .+..+++|++|++++|++++. + .+..+++|++|++++|+|
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence            5555555555555555556666666666665222333 466667777777777777643 2 566667777777777766


Q ss_pred             c
Q 036229          311 V  311 (982)
Q Consensus       311 ~  311 (982)
                      .
T Consensus       194 ~  194 (197)
T 4ezg_A          194 G  194 (197)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=4.2e-18  Score=188.47  Aligned_cols=59  Identities=8%  Similarity=-0.116  Sum_probs=30.4

Q ss_pred             ccccccccc-eEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEE
Q 036229          469 EIGNLTNLI-GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELG  528 (982)
Q Consensus       469 ~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  528 (982)
                      .|.++++|+ .+++.+ +++.+.+.+|.++++|+.+++++|+++.+.+.+|.++++|+.++
T Consensus       268 aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          268 VFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             TTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             HhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence            344444444 444444 44444445555555555555555555544455555555555554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=8.3e-18  Score=170.29  Aligned_cols=175  Identities=22%  Similarity=0.278  Sum_probs=118.1

Q ss_pred             cEEEccCCcCCcCCCccccCCCcccccccCCCcccccccc--cccccCceEEecCCCcccCCCccccccccccceeeccc
Q 036229          525 YELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLT--IWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFST  602 (982)
Q Consensus       525 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~  602 (982)
                      +.+++++|+++ .+|..+..  +|++|+|++|+++.+|..  +..+++|++|+|++|++++..|..|.++++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            34444444443 33333221  455555555555555432  44566666666777777766777788888888899999


Q ss_pred             ccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCC
Q 036229          603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       603 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  682 (982)
                      |+|++..|..|+++++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++..+... -...++...+..+...+.-|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCC
Confidence            99988888889999999999999999999889999999999999999999998765321 11224445566666666666


Q ss_pred             CCCCCCCCCCcccccCcccCCCC
Q 036229          683 KGGSFGNFSAKSFEGNELLCGSP  705 (982)
Q Consensus       683 ~~~~~~~~~~~~~~gn~~lc~~~  705 (982)
                      ...  ....-.....+...|..+
T Consensus       167 ~~l--~~~~l~~l~~~~~~C~~~  187 (192)
T 1w8a_A          167 SKV--RDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             TTT--TTSBGGGSCTTTCCCCCC
T ss_pred             hHH--cCCChhhCcHhhcCcCCC
Confidence            542  233334455566667654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.73  E-value=2.1e-18  Score=190.90  Aligned_cols=282  Identities=16%  Similarity=0.137  Sum_probs=162.2

Q ss_pred             CCCCCEEEcCCCCccccCcchhhh-ccCCcEEEccCCccc--CccCccccCcCCCCccccccCcccccCchhhhcC----
Q 036229          104 LSSLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLS--GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSN----  176 (982)
Q Consensus       104 l~~L~~L~L~~n~~~~~~p~~~~~-l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~----  176 (982)
                      +.+++.|+++++ +.+.--..+.. +++|+.|||++|+++  ...+   +.++.+..+++..|    .||+..|.+    
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~---~~~~~~~~~~~~~~----~I~~~aF~~~~~~   95 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA---GTYPNGKFYIYMAN----FVPAYAFSNVVNG   95 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS---SSSGGGCCEEECTT----EECTTTTEEEETT
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc---cccccccccccccc----ccCHHHhcccccc
Confidence            667888888764 22111123344 788999999999987  2222   12233455555555    567777788    


Q ss_pred             ----CCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCC----CCCCchhhhcCC
Q 036229          177 ----LPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYS----GLQGEIPREFGN  248 (982)
Q Consensus       177 ----l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N----~l~~~~~~~~~~  248 (982)
                          +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++...+.+|..+.++..+.++.+    ........+|.+
T Consensus        96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~  174 (329)
T 3sb4_A           96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIE  174 (329)
T ss_dssp             EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEE
T ss_pred             cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccc
Confidence                89999999988 888777788888999999999988887677778888777777766552    223333445656


Q ss_pred             Ccccc-eEeccccccCCcCChhhh----ccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCC
Q 036229          249 LAELE-LMALQVSNLQGEIPQELA----NLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST  323 (982)
Q Consensus       249 l~~L~-~L~L~~n~l~~~~p~~l~----~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  323 (982)
                      +..|+ .+.+....   .++..+.    ...+++.+.+.++-...........+++|+.|+|++|+++.+.+.+|.++.+
T Consensus       175 ~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~  251 (329)
T 3sb4_A          175 GEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY  251 (329)
T ss_dssp             SCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT
T ss_pred             ccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC
Confidence            66665 34443221   2222211    2445555555544222111111123567777777777776555556666666


Q ss_pred             CceeecCCCcCCCCcCccccccCCCcc-EEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCcccee
Q 036229          324 LTGLGLQSNSLSGSLSSIADVQLPNLE-ELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM  400 (982)
Q Consensus       324 L~~L~L~~N~l~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  400 (982)
                      |+.++|++| +. .++..+|..+++|+ .+++.+ +++.+.+.+|.++++|+.++++.|+++.+.+.+|.++++|+.+
T Consensus       252 L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          252 LLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             CCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             CCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            655555554 22 23333444444445 555544 4444444555555555555555555555555555555555443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=5.1e-18  Score=171.84  Aligned_cols=131  Identities=29%  Similarity=0.362  Sum_probs=102.5

Q ss_pred             cccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc
Q 036229          549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR  628 (982)
Q Consensus       549 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  628 (982)
                      +.+++++|.++++|..+.  +++++|++++|+++ .+|..+.++++|+.|||++|+|+++.+..|.++++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            345666666666665543  35666777777766 455677777788888888888888777888888899999999999


Q ss_pred             ccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCC
Q 036229          629 LQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       629 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  682 (982)
                      |++..|.+|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+.++
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            988888889999999999999999987666678888999999999999987664

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.68  E-value=7.9e-17  Score=160.90  Aligned_cols=134  Identities=26%  Similarity=0.276  Sum_probs=111.0

Q ss_pred             ccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccc
Q 036229          548 LGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYN  627 (982)
Q Consensus       548 L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N  627 (982)
                      .+.+++++|.++.+|..+.  +++++|++++|++++..+..++.+++|+.|++++|++++..+..|+.+++|++|+|++|
T Consensus         9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            3556677777777775543  57778888888888776777788888999999999998877778899999999999999


Q ss_pred             cccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCC
Q 036229          628 RLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       628 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  683 (982)
                      +|++.++..|.++++|++|+|++|++++..+..+..+++|++|++++|++.|.+|.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            99988888889999999999999999876666678899999999999999988774

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=1.2e-16  Score=158.17  Aligned_cols=60  Identities=23%  Similarity=0.280  Sum_probs=27.9

Q ss_pred             CCCCeEEeeccCCC-CCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccc
Q 036229          498 QKLQGLHLEDNKLE-GPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLT  559 (982)
Q Consensus       498 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  559 (982)
                      ++|+.|++++|+++ +.+|..+..+++|+.|++++|+|++.  ..|..+++|++|+|++|+++
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~   84 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIF   84 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCC
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCc
Confidence            44555555555554 34444444455555555555554433  33444444444444444443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=2.5e-16  Score=155.78  Aligned_cols=107  Identities=26%  Similarity=0.285  Sum_probs=74.5

Q ss_pred             cccceEEecCCCCC-CCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccc
Q 036229          474 TNLIGIYLGGNKLN-GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS  552 (982)
Q Consensus       474 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  552 (982)
                      ++|+.|++++|+++ +.+|..+..+++|+.|+|++|.|++.  ..+..+++|++|+|++|++++.+|..+.++++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56777777777776 56677777777788888888887755  6677778888888888888766777777777777777


Q ss_pred             cCCCcccccc--cccccccCceEEecCCCccc
Q 036229          553 LGSNKLTSIP--LTIWNLKGMLYLNFSSNFFT  582 (982)
Q Consensus       553 L~~N~l~~ip--~~~~~l~~L~~L~Ls~N~l~  582 (982)
                      |++|+++.+|  ..+..+++|++|++++|.++
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~  133 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT  133 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence            7777777765  33444444444444444444

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.65  E-value=4.9e-17  Score=178.80  Aligned_cols=137  Identities=15%  Similarity=0.179  Sum_probs=100.9

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccc--------------hhhh--------hHHHHHHHhhhcCCcc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG--------------RAFK--------SFDVECEMMKSIRHRN  837 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~n  837 (982)
                      .-|++.+.||+|++|.||+|...+|+.||||+++....              ....        ...+|...+.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34899999999999999999988899999999753210              0001        1234566666664443


Q ss_pred             c--eeEEeeecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC
Q 036229          838 L--IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD  915 (982)
Q Consensus       838 I--v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~  915 (982)
                      +  ...+++.    ..++||||++|+++.++...       .....++.|++.++.|+|   +.|||||||||.|||+++
T Consensus       175 v~vp~p~~~~----~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          175 FPVPEPIAQS----RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             CSCCCEEEEE----TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred             CCCCeeeecc----CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence            3  2223221    23799999999888654321       134568899999999999   999999999999999987


Q ss_pred             CC----------cEEEEeecCceee
Q 036229          916 NM----------VAHLSDFGIAKLL  930 (982)
Q Consensus       916 ~~----------~~kL~DFGla~~~  930 (982)
                      ++          .+.|+||+-+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999988764

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.64  E-value=5.2e-16  Score=156.97  Aligned_cols=129  Identities=23%  Similarity=0.305  Sum_probs=101.2

Q ss_pred             cEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccccc
Q 036229          525 YELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNN  604 (982)
Q Consensus       525 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~  604 (982)
                      +.+++++|+|+ .+|..+.  ++|++|+|++|+++.+|..+..+++|++|+|++|++++..+..|.++++|+.|||++|+
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            34555666655 3343332  45666666666666666666667777777777777777777788888999999999999


Q ss_pred             ccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCC
Q 036229          605 FSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRS  656 (982)
Q Consensus       605 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  656 (982)
                      |+++.|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            9998888999999999999999999987777899999999999999999753

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.64  E-value=1e-15  Score=172.94  Aligned_cols=217  Identities=12%  Similarity=0.096  Sum_probs=117.6

Q ss_pred             ccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccC
Q 036229          452 LEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG  531 (982)
Q Consensus       452 L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  531 (982)
                      |+.+++.. .+..+.+..|.++++|+.+++++|+++.+...+|. ..+|+.+.|.+| ++.+...+|.++++|+.+++..
T Consensus       159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~  235 (401)
T 4fdw_A          159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE  235 (401)
T ss_dssp             CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred             ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence            33444432 34444455566666666666666666655555555 356666666533 5545555666666666666665


Q ss_pred             CcCCcCCCccccCCCcccccccCCCccccccccc-ccccCceEEecCCCccc-----CCCccccccccccceeecccccc
Q 036229          532 NKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTI-WNLKGMLYLNFSSNFFT-----GPLPLDIGNLKVLIGIDFSTNNF  605 (982)
Q Consensus       532 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~-~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~Ldls~N~l  605 (982)
                      | ++.+...+|.+ .+|+.+.+ .|.++.|+... .++.+|+.+++.+|.+.     ...+..|.++++|+.+++. |.+
T Consensus       236 ~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i  311 (401)
T 4fdw_A          236 N-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESI  311 (401)
T ss_dssp             T-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTC
T ss_pred             C-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-Cce
Confidence            4 44455556655 56666666 34455555433 34566666666555543     2333455555555555555 335


Q ss_pred             cccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccccccc-ccceeecCCCcc
Q 036229          606 SDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLS-YLEDLDLSFNKL  677 (982)
Q Consensus       606 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~l~ls~N~l  677 (982)
                      +.+...+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|..++ .++.|++..|.+
T Consensus       312 ~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          312 RILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             CEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             EEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            4444455555556666665433 444444555555 566666665555544444454442 445555544443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=2.4e-16  Score=152.50  Aligned_cols=81  Identities=26%  Similarity=0.228  Sum_probs=37.2

Q ss_pred             cccceeecccccccccccccccCccCcceEecccccccCC-ccccccCCCCCCeeeCCCCcCCCCCC---cccccccccc
Q 036229          593 KVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS-ISESFGDLISLKSLNLSNNNLSRSIP---ISLEKLSYLE  668 (982)
Q Consensus       593 ~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~l~~l~~L~  668 (982)
                      ++|+.||+++|.+++.+|..++.+++|++|++++|++++. .+..++.+++|++|++++|++++..+   ..+..+++|+
T Consensus        64 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~  143 (149)
T 2je0_A           64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLT  143 (149)
T ss_dssp             TTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCC
T ss_pred             CCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcc
Confidence            3333334444444333444444444455555555554432 22445555555555555555554333   2445555555


Q ss_pred             eeecC
Q 036229          669 DLDLS  673 (982)
Q Consensus       669 ~l~ls  673 (982)
                      +||++
T Consensus       144 ~L~l~  148 (149)
T 2je0_A          144 YLDGY  148 (149)
T ss_dssp             EETTB
T ss_pred             cccCC
Confidence            55544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.63  E-value=7.8e-16  Score=153.63  Aligned_cols=135  Identities=21%  Similarity=0.275  Sum_probs=105.7

Q ss_pred             CceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCcc
Q 036229           69 CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSF  148 (982)
Q Consensus        69 c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  148 (982)
                      |.|.++.|+            +++++ .+|..+.  ++|+.|++++|++++..+..+..+++|++|+|++|++++..+..
T Consensus         7 C~~~~l~~~------------~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~   71 (177)
T 2o6r_A            7 CSGTEIRCN------------SKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV   71 (177)
T ss_dssp             EETTEEECC------------SSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred             eCCCEEEec------------CCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence            678888776            33444 4554443  68899999999998666666788999999999999998666666


Q ss_pred             ccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccc
Q 036229          149 IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIP  219 (982)
Q Consensus       149 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  219 (982)
                      +..+++|++|++++|.++ .+|...|..+++|++|+|++|++++..+..|..+++|++|+|++|.+.+..|
T Consensus        72 ~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           72 FDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCCccCEEECCCCCcc-ccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            788889999999999888 5666666888888888888888887666667888888888888888876543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=5.5e-16  Score=149.92  Aligned_cols=107  Identities=21%  Similarity=0.299  Sum_probs=64.3

Q ss_pred             cccceEEecCCCCC-CCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccc
Q 036229          474 TNLIGIYLGGNKLN-GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS  552 (982)
Q Consensus       474 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  552 (982)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|++++.  ..+..+++|++|++++|+|++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45666666666665 55566666666666666666666654  5566666666666666666655666666666666666


Q ss_pred             cCCCcccccc--cccccccCceEEecCCCccc
Q 036229          553 LGSNKLTSIP--LTIWNLKGMLYLNFSSNFFT  582 (982)
Q Consensus       553 L~~N~l~~ip--~~~~~l~~L~~L~Ls~N~l~  582 (982)
                      +++|+++.+|  ..+..+++|++|++++|.++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            6666666544  33444444444444444444

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.59  E-value=1.7e-14  Score=163.64  Aligned_cols=158  Identities=15%  Similarity=0.064  Sum_probs=79.7

Q ss_pred             cCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcC
Q 036229          168 EIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFG  247 (982)
Q Consensus       168 ~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~  247 (982)
                      .|+...|.++.+|+++.+..+ ++.+...+|.++++|+.+++..+ ++......|.++++|+.+.+..+ ++.....+|.
T Consensus        61 sIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~  137 (394)
T 4fs7_A           61 SIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFK  137 (394)
T ss_dssp             EECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTT
T ss_pred             EhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeee
Confidence            455555555555555555432 44444455666666666665533 33233345555555655555432 3323344455


Q ss_pred             CCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCcee
Q 036229          248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGL  327 (982)
Q Consensus       248 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  327 (982)
                      +...++........  .....+|.++++|+.+.+.++. +.+....|.++.+|+.+++..| ++......+.++..|+.+
T Consensus       138 ~~~~~~~~~~~~~~--~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i  213 (394)
T 4fs7_A          138 GCDFKEITIPEGVT--VIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENM  213 (394)
T ss_dssp             TCCCSEEECCTTCC--EECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBC
T ss_pred             cccccccccCcccc--ccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhcccccccee
Confidence            44433322222221  1223456666777777765543 3355556666666776666655 333444455555555555


Q ss_pred             ecCCC
Q 036229          328 GLQSN  332 (982)
Q Consensus       328 ~L~~N  332 (982)
                      .+..+
T Consensus       214 ~~~~~  218 (394)
T 4fs7_A          214 EFPNS  218 (394)
T ss_dssp             CCCTT
T ss_pred             ecCCC
Confidence            44443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.59  E-value=2.3e-14  Score=161.76  Aligned_cols=256  Identities=14%  Similarity=0.131  Sum_probs=144.2

Q ss_pred             hhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCC
Q 036229          243 PREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMS  322 (982)
Q Consensus       243 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  322 (982)
                      ..+|.+. +|+.+.+..+ ++.....+|.+ .+|+.+.+.+ .++.+.+.+|.++++|+.+++++|+++......|. ..
T Consensus       129 ~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~  203 (401)
T 4fdw_A          129 KDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YA  203 (401)
T ss_dssp             TTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TC
T ss_pred             HhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ec
Confidence            3444442 4555554433 33333344444 2455555553 44444555555556666666655555533333332 34


Q ss_pred             CCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecc
Q 036229          323 TLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL  402 (982)
Q Consensus       323 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  402 (982)
                      +|+.+.|..+                          ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+
T Consensus       204 ~L~~l~lp~~--------------------------l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l  255 (401)
T 4fdw_A          204 GIEEVLLPVT--------------------------LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL  255 (401)
T ss_dssp             CCSEEECCTT--------------------------CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred             ccCEEEeCCc--------------------------hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence            4433333322                          33333344444444555554442 34444444444 44555555


Q ss_pred             cccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEec
Q 036229          403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLG  482 (982)
Q Consensus       403 ~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~  482 (982)
                       .+.++.++.     .+|.+|++|+.+++.+|.+..                     +.+..+.+..|.++++|+.+.+.
T Consensus       256 -p~~i~~I~~-----~aF~~c~~L~~l~l~~~~~~~---------------------~~~~~I~~~aF~~c~~L~~l~l~  308 (401)
T 4fdw_A          256 -PNGVTNIAS-----RAFYYCPELAEVTTYGSTFND---------------------DPEAMIHPYCLEGCPKLARFEIP  308 (401)
T ss_dssp             -ETTCCEECT-----TTTTTCTTCCEEEEESSCCCC---------------------CTTCEECTTTTTTCTTCCEECCC
T ss_pred             -CCCccEECh-----hHhhCCCCCCEEEeCCccccC---------------------CcccEECHHHhhCCccCCeEEeC
Confidence             223333332     236666666677666664321                     11222345567777778888877


Q ss_pred             CCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCC-cccccccCCCccccc
Q 036229          483 GNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLA-SLGTLSLGSNKLTSI  561 (982)
Q Consensus       483 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~i  561 (982)
                       +.++.+...+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+...
T Consensus       309 -~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~y  385 (401)
T 4fdw_A          309 -ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEKY  385 (401)
T ss_dssp             -TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHHH
T ss_pred             -CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHHh
Confidence             4477677778888888888888554 665667788888 888888888888777777888874 678888877776643

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.58  E-value=1.1e-16  Score=162.92  Aligned_cols=130  Identities=28%  Similarity=0.324  Sum_probs=70.3

Q ss_pred             cCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccce
Q 036229          175 SNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELEL  254 (982)
Q Consensus       175 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  254 (982)
                      ..+++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+..+++|++|+|++|++++ +| .+..+++|+.
T Consensus        45 ~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~  119 (198)
T 1ds9_A           45 STLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRV  119 (198)
T ss_dssp             HHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSE
T ss_pred             hcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCE
Confidence            455556666666665554 34 5555566666666666655 445555555556666665555553 23 3445555555


Q ss_pred             EeccccccCCcCC-hhhhccCCCcEEEccCCccccCCCcc----------ccccCCCcEEEccCcccc
Q 036229          255 MALQVSNLQGEIP-QELANLTGLEVLKLGKNFLTGEIPPE----------IHNLHNLKLLDLSHNKLV  311 (982)
Q Consensus       255 L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~  311 (982)
                      |++++|++++..+ ..+..+++|++|++++|.+++..|..          +..+++|+.||  +|.++
T Consensus       120 L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            5555555543222 34555666666666666665544332          45555555554  44443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.57  E-value=1.6e-15  Score=151.19  Aligned_cols=133  Identities=21%  Similarity=0.191  Sum_probs=95.1

Q ss_pred             ccCCCcccccccCCCcccccccccccc-cCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcc
Q 036229          542 FSNLASLGTLSLGSNKLTSIPLTIWNL-KGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQ  620 (982)
Q Consensus       542 ~~~l~~L~~L~L~~N~l~~ip~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~  620 (982)
                      +.++++|++|++++|+++.+|. +..+ ++|++|++++|.+++.  ..++.+++|+.|++++|+|++..|..|+.+++|+
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             cCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            3444555555555555555543 2222 2566666666666543  4567777888888888888776666668889999


Q ss_pred             eEecccccccCCccc--cccCCCCCCeeeCCCCcCCCCCCcc----cccccccceeecCCCcccc
Q 036229          621 YLFLGYNRLQGSISE--SFGDLISLKSLNLSNNNLSRSIPIS----LEKLSYLEDLDLSFNKLKG  679 (982)
Q Consensus       621 ~L~Ls~N~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~----l~~l~~L~~l~ls~N~l~~  679 (982)
                      +|+|++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..    +..+++|+.||+++|....
T Consensus        92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A           92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            9999999996 4555  7888999999999999997 45664    8889999999999998764

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=1.3e-16  Score=162.38  Aligned_cols=155  Identities=21%  Similarity=0.252  Sum_probs=100.9

Q ss_pred             hhccCCcEEEccCCcccCccCc------cccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCcc
Q 036229          126 FTLYTLKYVNFRGNQLSGAFPS------FIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALS  199 (982)
Q Consensus       126 ~~l~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  199 (982)
                      .....++.++++.+.++|.+|.      .+..+++|++|++++|.+++ +| .+ ..+++|+.|+|++|+++ .+|..+.
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~-~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SL-SGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CH-HHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-cc-ccCCCCCEEECCCCCcc-cccchhh
Confidence            3444555555555555555444      55666666666666666653 55 33 56666666666666666 4555666


Q ss_pred             CcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchh-hhcCCCcccceEeccccccCCcCCh----------
Q 036229          200 NCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIP-REFGNLAELELMALQVSNLQGEIPQ----------  268 (982)
Q Consensus       200 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~----------  268 (982)
                      .+++|++|+|++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+.+..|.          
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            66777777777777764 34 56677777777777777775333 4677777888888888877665544          


Q ss_pred             hhhccCCCcEEEccCCcccc
Q 036229          269 ELANLTGLEVLKLGKNFLTG  288 (982)
Q Consensus       269 ~l~~l~~L~~L~Ls~N~l~~  288 (982)
                      .+..+++|++||  +|.++.
T Consensus       169 ~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          169 VVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHHCSSCSEEC--CGGGTT
T ss_pred             HHHhCCCcEEEC--CcccCH
Confidence            378889999887  677663

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.55  E-value=3.6e-15  Score=148.58  Aligned_cols=110  Identities=23%  Similarity=0.228  Sum_probs=74.6

Q ss_pred             ccccccccceEEecCCCCCCCCCccccCcC-CCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCc
Q 036229          469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQ-KLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLAS  547 (982)
Q Consensus       469 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  547 (982)
                      .+.++++|+.|++++|+++.. |. +..+. +|+.|+|++|+|++.  ..|..+++|++|+|++|+|++..|..|..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            355667778888888887743 44 33333 788888888877754  56777777777777777777655555677777


Q ss_pred             ccccccCCCccccccc--ccccccCceEEecCCCccc
Q 036229          548 LGTLSLGSNKLTSIPL--TIWNLKGMLYLNFSSNFFT  582 (982)
Q Consensus       548 L~~L~L~~N~l~~ip~--~~~~l~~L~~L~Ls~N~l~  582 (982)
                      |++|+|++|+++.+|.  .+..+++|++|++++|.++
T Consensus        90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence            7777777777777765  4555555555555555554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.54  E-value=1.3e-13  Score=156.32  Aligned_cols=331  Identities=14%  Similarity=0.086  Sum_probs=154.3

Q ss_pred             chhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccC
Q 036229          241 EIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN  320 (982)
Q Consensus       241 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  320 (982)
                      +...+|.++++|+.+.+.. .++.....+|.++++|+.+++.++ ++.+...+|.++.+|+.+.+..+ +......+|.+
T Consensus        62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~  138 (394)
T 4fs7_A           62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG  138 (394)
T ss_dssp             ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred             hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence            3345555666666666542 244333445555555555555433 44344445555555555444433 22122223322


Q ss_pred             CCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCcccee
Q 036229          321 MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM  400 (982)
Q Consensus       321 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  400 (982)
                      +..                         +.....  +.........|.++++|+.+.+.++ +..+...+|.++.+|+.+
T Consensus       139 ~~~-------------------------~~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i  190 (394)
T 4fs7_A          139 CDF-------------------------KEITIP--EGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSI  190 (394)
T ss_dssp             CCC-------------------------SEEECC--TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBC
T ss_pred             ccc-------------------------cccccC--ccccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEE
Confidence            221                         111111  1122233445666677777777644 334556667777777766


Q ss_pred             cccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEE
Q 036229          401 TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIY  480 (982)
Q Consensus       401 ~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~  480 (982)
                      .+..| ++.+..     .+|.++..|+.+.+.++...                            +...+....+|+.+.
T Consensus       191 ~l~~~-~~~I~~-----~~F~~~~~L~~i~~~~~~~~----------------------------i~~~~~~~~~l~~i~  236 (394)
T 4fs7_A          191 KLPRN-LKIIRD-----YCFAECILLENMEFPNSLYY----------------------------LGDFALSKTGVKNII  236 (394)
T ss_dssp             CCCTT-CCEECT-----TTTTTCTTCCBCCCCTTCCE----------------------------ECTTTTTTCCCCEEE
T ss_pred             EcCCC-ceEeCc-----hhhccccccceeecCCCceE----------------------------eehhhcccCCCceEE
Confidence            66554 333322     24666666666665544210                            001111223344444


Q ss_pred             ecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccc
Q 036229          481 LGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTS  560 (982)
Q Consensus       481 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  560 (982)
                      +..+ ++.+....|.+...|+.+.+..+..+ .....|..+..++.+....+.+   ...+|.++.+|+.+.+.++ ++.
T Consensus       237 ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~  310 (394)
T 4fs7_A          237 IPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKF  310 (394)
T ss_dssp             ECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCE
T ss_pred             ECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cce
Confidence            4322 22233344445555555555444332 3344455555555555444332   1234444455555444332 333


Q ss_pred             cccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCC
Q 036229          561 IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDL  640 (982)
Q Consensus       561 ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  640 (982)
                      |+..                       +|.++.+|+.+++..+ ++.+-..+|.++++|+.+++..| ++.+-..+|.++
T Consensus       311 I~~~-----------------------aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C  365 (394)
T 4fs7_A          311 IGEE-----------------------AFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGC  365 (394)
T ss_dssp             ECTT-----------------------TTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTC
T ss_pred             echh-----------------------hhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCC
Confidence            3322                       3333444444444322 33333445666666666666554 444445566666


Q ss_pred             CCCCeeeCCCCcCCCCCCcccccccccce
Q 036229          641 ISLKSLNLSNNNLSRSIPISLEKLSYLED  669 (982)
Q Consensus       641 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  669 (982)
                      .+|+.+++..+ ++ .+..+|.++++|+.
T Consensus       366 ~~L~~i~lp~~-~~-~~~~~F~~c~~L~~  392 (394)
T 4fs7_A          366 INLKKVELPKR-LE-QYRYDFEDTTKFKW  392 (394)
T ss_dssp             TTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred             CCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence            66666666543 22 23445555665554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.52  E-value=2.4e-14  Score=141.58  Aligned_cols=89  Identities=24%  Similarity=0.220  Sum_probs=54.3

Q ss_pred             ccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecC
Q 036229          594 VLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLS  673 (982)
Q Consensus       594 ~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls  673 (982)
                      .|+.|+|++|+|+++.|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus        31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  110 (170)
T 3g39_A           31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL  110 (170)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeC
Confidence            44455555555555555566666666666666666665555556666666666666666665555556666666666666


Q ss_pred             CCcccccCC
Q 036229          674 FNKLKGEIP  682 (982)
Q Consensus       674 ~N~l~~~~p  682 (982)
                      +|++++.++
T Consensus       111 ~N~~~c~c~  119 (170)
T 3g39_A          111 NNPWDCACS  119 (170)
T ss_dssp             SSCBCTTBG
T ss_pred             CCCCCCCch
Confidence            666665554

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.51  E-value=3.3e-14  Score=140.54  Aligned_cols=108  Identities=26%  Similarity=0.239  Sum_probs=97.1

Q ss_pred             ccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccc
Q 036229          548 LGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYN  627 (982)
Q Consensus       548 L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N  627 (982)
                      .+.+++++|.|+++|..+.  +++++|+|++|++++..|..|.++++|+.|||++|+|+++.|..|..+++|++|+|++|
T Consensus        11 ~~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           11 GTTVDCSGKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEeCCCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            4678888888888887664  68889999999999888999999999999999999999988888999999999999999


Q ss_pred             cccCCccccccCCCCCCeeeCCCCcCCCCC
Q 036229          628 RLQGSISESFGDLISLKSLNLSNNNLSRSI  657 (982)
Q Consensus       628 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  657 (982)
                      +|++..+..|.++++|+.|+|++|.++...
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            999888888999999999999999998654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.49  E-value=5.5e-14  Score=139.42  Aligned_cols=107  Identities=25%  Similarity=0.314  Sum_probs=58.3

Q ss_pred             cccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc
Q 036229          549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR  628 (982)
Q Consensus       549 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  628 (982)
                      +.+++++|+++++|..+.  ++|++|+|                        ++|+|++.+|..|+++++|++|+|++|+
T Consensus        15 ~~l~~~~n~l~~iP~~~~--~~L~~L~L------------------------s~N~l~~~~~~~~~~l~~L~~L~Ls~N~   68 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGIP--TDKQRLWL------------------------NNNQITKLEPGVFDHLVNLQQLYFNSNK   68 (174)
T ss_dssp             SEEECCSSCCSSCCSCCC--TTCSEEEC------------------------CSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cEEEeCCCCCCccCCCcC--CCCcEEEe------------------------CCCCccccCHHHhcCCcCCCEEECCCCC
Confidence            456666666666665443  44445554                        4555544445555555555555555555


Q ss_pred             ccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccC
Q 036229          629 LQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       629 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~  681 (982)
                      |++.++..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|++.+.+
T Consensus        69 l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           69 LTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             CCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence            55444444555555555555555555443334555555555555555555443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.48  E-value=5e-14  Score=139.70  Aligned_cols=112  Identities=24%  Similarity=0.241  Sum_probs=85.3

Q ss_pred             ccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccc
Q 036229          524 LYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN  603 (982)
Q Consensus       524 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N  603 (982)
                      -+.+++++|+++ .+|..+.  ++|++|+|++|+|+.++.                       ..|+++++|+.|||++|
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~-----------------------~~~~~l~~L~~L~Ls~N   67 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEP-----------------------GVFDHLVNLQQLYFNSN   67 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCT-----------------------TTTTTCTTCCEEECCSS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCH-----------------------HHhcCCcCCCEEECCCC
Confidence            378999999997 5676664  899999999999997753                       23445556666666677


Q ss_pred             cccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccc
Q 036229          604 NFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLE  662 (982)
Q Consensus       604 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  662 (982)
                      +|+++.+..|..+++|++|+|++|+|++.++..|..+++|+.|+|++|.+.. .|..+.
T Consensus        68 ~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c-~~~~~~  125 (174)
T 2r9u_A           68 KLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC-ECRDIM  125 (174)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT-TBGGGH
T ss_pred             CCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccc-ccccHH
Confidence            7766666667888888888888888887766678888889999999998875 343333

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.38  E-value=8.1e-15  Score=163.96  Aligned_cols=111  Identities=17%  Similarity=0.159  Sum_probs=48.3

Q ss_pred             cCCcEEEccCCcccCccCccccCc-----CCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCc-----
Q 036229          129 YTLKYVNFRGNQLSGAFPSFIFNK-----SSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSAL-----  198 (982)
Q Consensus       129 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----  198 (982)
                      +.|++|+|++|.++......+...     ++|++|||++|.++......++..+++|++|+|++|.++......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            345555555555543222222211     3455555555554432223333334445555555555443322222     


Q ss_pred             cCcCcccEEEeeccccccc----cccccccccchhhhhccCCCCC
Q 036229          199 SNCKYLEILSLSINNLLGA----IPKEIGNLTKLKELYLGYSGLQ  239 (982)
Q Consensus       199 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~  239 (982)
                      ...++|++|+|++|.++..    ++..+..+++|++|+|++|.++
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~  196 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG  196 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence            1234555555555555431    2222334444555555555544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.35  E-value=3.7e-11  Score=136.15  Aligned_cols=159  Identities=13%  Similarity=0.121  Sum_probs=83.2

Q ss_pred             cCchhhhcCCC-CCCeeeecceeeecccCCCccCcCcccEEEeeccc---cccccccccccccchhhhhccCCCCCCchh
Q 036229          168 EIPANICSNLP-FLESISLSQNMFHGRIPSALSNCKYLEILSLSINN---LLGAIPKEIGNLTKLKELYLGYSGLQGEIP  243 (982)
Q Consensus       168 ~ip~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  243 (982)
                      .|+...|.+.. .|+++.+-.+ ++.+...+|.++++|+.+.++.|.   ++.....+|..+.+|+.+.+..+ ++....
T Consensus        53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~  130 (394)
T 4gt6_A           53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS  130 (394)
T ss_dssp             EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred             EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence            34444444442 3555555433 444455566666666666665553   33333445666666666655433 443444


Q ss_pred             hhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCC
Q 036229          244 REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMST  323 (982)
Q Consensus       244 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  323 (982)
                      .+|..+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+-.. .....+.++..
T Consensus       131 ~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~  206 (394)
T 4gt6_A          131 EAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFA  206 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTT
T ss_pred             hhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccc
Confidence            56666666666666532 23233445666677777766544 34344455543 45666666544322 33445555555


Q ss_pred             CceeecCCC
Q 036229          324 LTGLGLQSN  332 (982)
Q Consensus       324 L~~L~L~~N  332 (982)
                      ++......+
T Consensus       207 l~~~~~~~~  215 (394)
T 4gt6_A          207 LSTITSDSE  215 (394)
T ss_dssp             CCEEEECCS
T ss_pred             cceeccccc
Confidence            555444443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=1.7e-12  Score=144.52  Aligned_cols=103  Identities=20%  Similarity=0.181  Sum_probs=59.4

Q ss_pred             cccCCC-cccccccccccccCceEEecCC-CcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc
Q 036229          551 LSLGSN-KLTSIPLTIWNLKGMLYLNFSS-NFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR  628 (982)
Q Consensus       551 L~L~~N-~l~~ip~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  628 (982)
                      ++++++ .|+.||. +..+++|++|+|++ |++++..+..|+++++|+.|||++|+|++++|..|+++++|++|+|++|+
T Consensus        13 v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~   91 (347)
T 2ifg_A           13 LRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (347)
T ss_dssp             EECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence            455555 5555555 55555555555553 55555445555556666666666666666555566666666666666666


Q ss_pred             ccCCccccccCCCCCCeeeCCCCcCCC
Q 036229          629 LQGSISESFGDLISLKSLNLSNNNLSR  655 (982)
Q Consensus       629 l~~~~~~~~~~l~~L~~L~Ls~N~l~~  655 (982)
                      |++.++..|..+. |+.|+|++|.+..
T Consensus        92 l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           92 LESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             CSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             cceeCHHHcccCC-ceEEEeeCCCccC
Confidence            6655555555444 6666666666553

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.31  E-value=7.2e-14  Score=156.21  Aligned_cols=188  Identities=21%  Similarity=0.190  Sum_probs=108.5

Q ss_pred             CCCCCEEEcCCCCccccCcchhhhc-----cCCcEEEccCCcccCccCccc-cCcCCCCccccccCcccccCchhhh---
Q 036229          104 LSSLQSLNLGFNRLSGSIPSAIFTL-----YTLKYVNFRGNQLSGAFPSFI-FNKSSLQHLDFSYNALSGEIPANIC---  174 (982)
Q Consensus       104 l~~L~~L~L~~n~~~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~ip~~~~---  174 (982)
                      .+.|+.|+|++|.++......+...     ++|++|+|++|.++......+ ..+++|++|||++|.++......+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            3567788888887765444444433     578888888887764433333 3456788888888877643222221   


Q ss_pred             -cCCCCCCeeeecceeeecc----cCCCccCcCcccEEEeecccccccc----ccccccccchhhhhccCCCCCCchhhh
Q 036229          175 -SNLPFLESISLSQNMFHGR----IPSALSNCKYLEILSLSINNLLGAI----PKEIGNLTKLKELYLGYSGLQGEIPRE  245 (982)
Q Consensus       175 -~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~  245 (982)
                       ...++|++|+|++|.|+..    ++..+..+++|++|+|++|++++..    +..+...++|++|+|++|.|+......
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence             3457788888888888643    3444567788899999999887532    344555556666666666665322211


Q ss_pred             cCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccC-----CCcEEE--ccCcccc
Q 036229          246 FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLH-----NLKLLD--LSHNKLV  311 (982)
Q Consensus       246 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-----~L~~L~--Ls~N~l~  311 (982)
                                          ++..+...++|++|||++|.|+......+..+.     .|+.+.  +..|.+.
T Consensus       231 --------------------l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          231 --------------------LARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             --------------------HHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             --------------------HHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence                                123344456666666666666543333332221     155555  5555554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=1.2e-12  Score=145.73  Aligned_cols=108  Identities=22%  Similarity=0.175  Sum_probs=97.9

Q ss_pred             eEEecCCC-cccCCCccccccccccceeeccc-ccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCC
Q 036229          572 LYLNFSSN-FFTGPLPLDIGNLKVLIGIDFST-NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLS  649 (982)
Q Consensus       572 ~~L~Ls~N-~l~~~~~~~~~~l~~L~~Ldls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  649 (982)
                      ..++++++ .+++ +|. +..+++|+.|+|++ |+|+++.|..|+++++|++|+|++|+|++.+|..|.++++|+.|||+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35688988 8885 677 99999999999996 99999988999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCCcccccccccceeecCCCcccccCC
Q 036229          650 NNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       650 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p  682 (982)
                      +|+|++..|..+..++ |+.|+|++|+|.+.++
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCA  120 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence            9999987766777776 9999999999998765

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.29  E-value=9.9e-11  Score=132.58  Aligned_cols=109  Identities=11%  Similarity=0.200  Sum_probs=57.3

Q ss_pred             CcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCC
Q 036229          467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLA  546 (982)
Q Consensus       467 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  546 (982)
                      ...|.++.+|+.+.+.++..+ +...+|.++++|+.+.+. +.++.+...+|.++++|+.+++..+ ++.+...+|.+++
T Consensus       258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~  334 (394)
T 4gt6_A          258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE  334 (394)
T ss_dssp             TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred             cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence            345555666666666544332 444556666666666664 3444344455666666666666543 4444555666666


Q ss_pred             cccccccCCCcccccccccc-cccCceEEecCCC
Q 036229          547 SLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSN  579 (982)
Q Consensus       547 ~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~Ls~N  579 (982)
                      +|+.+.+.++ ++.|+...| ++.+|+.+++.+|
T Consensus       335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~  367 (394)
T 4gt6_A          335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGS  367 (394)
T ss_dssp             TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred             CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence            6666666433 555544322 3444444444443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=7.7e-12  Score=133.26  Aligned_cols=147  Identities=16%  Similarity=0.092  Sum_probs=116.8

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEE
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ....+.|+.....+.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..++++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            345567888888898999999999854 6889999987533233457899999999984 67888999999888899999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc--------------------------------------
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG--------------------------------------  896 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~--------------------------------------  896 (982)
                      |||++|.++.+....      ......++.++++++..||..                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999775321      122346889999999999941                                      


Q ss_pred             ------------------CCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          897 ------------------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       897 ------------------~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                                        ....++|+|++|.||++++++.+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              015699999999999998766678999998875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.08  E-value=1.4e-10  Score=123.34  Aligned_cols=139  Identities=14%  Similarity=0.071  Sum_probs=103.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCcc--ceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN--LIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~E~  857 (982)
                      .+|.+....+.|..+.||++...+|+.+++|+....   ....+..|+++++.+.+.+  +++++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            345443333456669999998777888999997643   3367889999999985444  56788888888889999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccC----------------------------------------
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY----------------------------------------  897 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~----------------------------------------  897 (982)
                      ++|.++.  ...    .+   ...++.++++.+..+|...                                        
T Consensus        97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9998884  211    11   2357788888888888311                                        


Q ss_pred             ---------------CCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          898 ---------------SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       898 ---------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                                     ..+++|+|++|.||++++++.++|+|||.|..-
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                           123999999999999988777789999998753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.04  E-value=9.1e-09  Score=115.76  Aligned_cols=97  Identities=18%  Similarity=0.147  Sum_probs=67.0

Q ss_pred             CcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCC
Q 036229          467 PKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLA  546 (982)
Q Consensus       467 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  546 (982)
                      ...|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+...+|.++++|+.++|..+ ++.+...+|.+++
T Consensus       256 ~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~  333 (379)
T 4h09_A          256 SFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCK  333 (379)
T ss_dssp             TTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred             ccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCC
Confidence            445666677777777543 55455667777777888888777777666677777888888888654 5556667788888


Q ss_pred             cccccccCCCcccccccccc
Q 036229          547 SLGTLSLGSNKLTSIPLTIW  566 (982)
Q Consensus       547 ~L~~L~L~~N~l~~ip~~~~  566 (982)
                      +|+.+.+..+ ++.|....|
T Consensus       334 ~L~~i~ip~~-v~~I~~~aF  352 (379)
T 4h09_A          334 ALSTISYPKS-ITLIESGAF  352 (379)
T ss_dssp             TCCCCCCCTT-CCEECTTTT
T ss_pred             CCCEEEECCc-cCEEchhHh
Confidence            8888877654 666665444

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.02  E-value=1.3e-10  Score=128.73  Aligned_cols=205  Identities=16%  Similarity=0.223  Sum_probs=115.1

Q ss_pred             CCcEEEEEeCCCCccc-c-------CCccccCCCCCCEEEcCCCCcc---------ccCcchhhhccCCcEEEccCCccc
Q 036229           80 SHRVKVLNISHLNLTG-T-------IPSQLWNLSSLQSLNLGFNRLS---------GSIPSAIFTLYTLKYVNFRGNQLS  142 (982)
Q Consensus        80 ~~~v~~L~l~~~~l~g-~-------~~~~l~~l~~L~~L~L~~n~~~---------~~~p~~~~~l~~L~~L~Ls~N~l~  142 (982)
                      ..+|+.|.+......| .       +.+++..+++|+.|.+..+...         +.++..+..+++|+.|+|++|.-.
T Consensus       106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l  185 (362)
T 2ra8_A          106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL  185 (362)
T ss_dssp             GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred             chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence            3578888888666553 2       2344667889999988765331         234555667788888888887311


Q ss_pred             CccCccccCcCCCCccccccCcccccCchhhh-cCCCCCCeeeecc--eeeecc-----cCCCc--cCcCcccEEEeecc
Q 036229          143 GAFPSFIFNKSSLQHLDFSYNALSGEIPANIC-SNLPFLESISLSQ--NMFHGR-----IPSAL--SNCKYLEILSLSIN  212 (982)
Q Consensus       143 ~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~-~~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N  212 (982)
                       .++. + .+++|++|+|..|.++......+. ..+|+|++|+|+.  |...+.     +...+  ..+++|++|+|++|
T Consensus       186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~  262 (362)
T 2ra8_A          186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA  262 (362)
T ss_dssp             -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred             -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence             2333 3 377888888888777543333332 2678888888753  221111     01112  23567777777777


Q ss_pred             ccccccccccc---cccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccC
Q 036229          213 NLLGAIPKEIG---NLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGE  289 (982)
Q Consensus       213 ~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  289 (982)
                      .+.+..+..+.   .+++|++|+|+.|.+++..+..                    ++..+..+++|+.|+|++|.|+..
T Consensus       263 ~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~--------------------L~~~L~~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL--------------------LLDHVDKIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             TTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHH--------------------HHTTHHHHTTCSEEECCSBBCCHH
T ss_pred             CCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHH--------------------HHhhcccCCcceEEECCCCcCCHH
Confidence            66543332222   3445555555555554322111                    122334567777777777776643


Q ss_pred             CCccccc-cCCCcEEEccCcc
Q 036229          290 IPPEIHN-LHNLKLLDLSHNK  309 (982)
Q Consensus       290 ~p~~~~~-l~~L~~L~Ls~N~  309 (982)
                      .-..+.. +  ...+|+++|+
T Consensus       323 ~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          323 MKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHC--CSEEECCSBC
T ss_pred             HHHHHHHHc--CCEEEecCCc
Confidence            2223332 1  3557777776

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.98  E-value=1.5e-08  Score=113.91  Aligned_cols=59  Identities=14%  Similarity=0.153  Sum_probs=26.3

Q ss_pred             cccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCC
Q 036229          591 NLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSN  650 (982)
Q Consensus       591 ~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  650 (982)
                      ++.+|+.+++.++.++.+.+.+|.++.+|+.+.|..+ ++.+-..+|.++.+|+.+.+..
T Consensus       284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~  342 (379)
T 4h09_A          284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK  342 (379)
T ss_dssp             TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             cccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence            3333334444433343333344555555555555432 3333344555555555555543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.93  E-value=2.6e-10  Score=126.15  Aligned_cols=208  Identities=14%  Similarity=0.233  Sum_probs=116.3

Q ss_pred             CCCCEEEcCCCCccc-c-------CcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcC
Q 036229          105 SSLQSLNLGFNRLSG-S-------IPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSN  176 (982)
Q Consensus       105 ~~L~~L~L~~n~~~~-~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~  176 (982)
                      ..++.|.+....+.| .       +..++..+++|+.|.+..+....              .+++...- +.++. ++..
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~--------------~~is~~~~-~~L~~-ll~~  170 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEE--------------QEISWIEQ-VDLSP-VLDA  170 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTT--------------CCGGGCBC-CBCHH-HHHT
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhh--------------cccccccc-cCHHH-HHhc
Confidence            356777777655542 1       23445678888888887653310              00111100 11222 2244


Q ss_pred             CCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccc--cccchhhhhccC--CCCCCc-----hhhhc-
Q 036229          177 LPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIG--NLTKLKELYLGY--SGLQGE-----IPREF-  246 (982)
Q Consensus       177 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~~~~~-  246 (982)
                      +|+|++|+|++|.-. .++. +. +++|++|+|..+.++......+.  .+++|++|+|+.  |...+.     +...+ 
T Consensus       171 ~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~  247 (362)
T 2ra8_A          171 MPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS  247 (362)
T ss_dssp             CTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred             CCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence            555555555554211 1222 22 45566666665555433222332  455566665532  111110     11112 


Q ss_pred             -CCCcccceEeccccccCCcCChhhh---ccCCCcEEEccCCccccC----CCccccccCCCcEEEccCccccccCcccc
Q 036229          247 -GNLAELELMALQVSNLQGEIPQELA---NLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKLVGAVPATI  318 (982)
Q Consensus       247 -~~l~~L~~L~L~~n~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  318 (982)
                       ..+++|+.|+|.+|.+.+..+..+.   .+++|++|+|+.|.|++.    ++..+..+++|+.|+|++|.|+...-..+
T Consensus       248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l  327 (362)
T 2ra8_A          248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL  327 (362)
T ss_dssp             TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHH
T ss_pred             cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHH
Confidence             2468899999988888755544444   478999999999999864    23344567999999999999875444334


Q ss_pred             cC-CCCCceeecCCCc
Q 036229          319 FN-MSTLTGLGLQSNS  333 (982)
Q Consensus       319 ~~-l~~L~~L~L~~N~  333 (982)
                      .. +  ...++++.++
T Consensus       328 ~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          328 QKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHC--CSEEECCSBC
T ss_pred             HHHc--CCEEEecCCc
Confidence            33 2  3568888887

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.93  E-value=1.8e-09  Score=120.44  Aligned_cols=143  Identities=13%  Similarity=0.140  Sum_probs=107.2

Q ss_pred             CccceeeeeceEEEEEEEeCCCeEEEEEEee--ccc-chhhhhHHHHHHHhhhcC--CccceeEEeeecCC---CeeEEE
Q 036229          783 SENNLIGRGGFGSVYKARIGEGMEVAVKVFD--LQC-GRAFKSFDVECEMMKSIR--HRNLIKVISSCSTE---EFKALI  854 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv  854 (982)
                      ...+.++.|.++.||++...+ ..+++|+..  ... ......+.+|+++++.+.  +..+++++.++.+.   +..|+|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            346788999999999998754 578888775  322 123457889999999996  45688899988776   458999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccC-------------------------------------
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY-------------------------------------  897 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~-------------------------------------  897 (982)
                      |||++|..+.+..   ...++..++..++.+++++|..||...                                     
T Consensus       120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999998774321   123567788889999999999999420                                     


Q ss_pred             ------------------CCCeEEcCCCCCCEEEcCCCc--EEEEeecCcee
Q 036229          898 ------------------SAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKL  929 (982)
Q Consensus       898 ------------------~~~ivHrDlkp~NILl~~~~~--~kL~DFGla~~  929 (982)
                                        ..+++|+|++|.||++++++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999987653  69999999875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.88  E-value=1.3e-11  Score=129.31  Aligned_cols=23  Identities=13%  Similarity=0.055  Sum_probs=16.9

Q ss_pred             CCceeeEEecCCCCcEEEEEeCC
Q 036229           68 VCNWTGVTCDVHSHRVKVLNISH   90 (982)
Q Consensus        68 ~c~w~gv~c~~~~~~v~~L~l~~   90 (982)
                      -|+|.|+.|+.+..+|..+...+
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~   99 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSS   99 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEEC
T ss_pred             HHhcCcEEECCCCCEEEEEEecC
Confidence            47899999996666776665544

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.48  E-value=1.3e-08  Score=101.48  Aligned_cols=119  Identities=14%  Similarity=0.149  Sum_probs=66.1

Q ss_pred             cCCccccCCCCCCEEEcCCC-Ccccc----CcchhhhccCCcEEEccCCcccCc----cCccccCcCCCCccccccCccc
Q 036229           96 TIPSQLWNLSSLQSLNLGFN-RLSGS----IPSAIFTLYTLKYVNFRGNQLSGA----FPSFIFNKSSLQHLDFSYNALS  166 (982)
Q Consensus        96 ~~~~~l~~l~~L~~L~L~~n-~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  166 (982)
                      .+...+...+.|++|+|++| .+...    +...+...++|++|+|++|+++..    +...+...++|++|+|++|.|.
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34455666777888888887 77532    333445567777788877777532    3333445566777777777665


Q ss_pred             cc----CchhhhcCCCCCCeeee--cceeeeccc----CCCccCcCcccEEEeeccccc
Q 036229          167 GE----IPANICSNLPFLESISL--SQNMFHGRI----PSALSNCKYLEILSLSINNLL  215 (982)
Q Consensus       167 ~~----ip~~~~~~l~~L~~L~L--s~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~  215 (982)
                      ..    +...+ ...+.|++|+|  ++|.|....    ...+...+.|++|+|++|.+.
T Consensus       107 ~~g~~~l~~~L-~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          107 GSGILALVEAL-QSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHHHGG-GGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHH-HhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            32    12222 34445555555  555554322    222333345555555555553

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.46  E-value=3.3e-07  Score=99.46  Aligned_cols=137  Identities=21%  Similarity=0.225  Sum_probs=101.0

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCcc--ceeEEeeecCCC---eeEEEEEec
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRN--LIKVISSCSTEE---FKALILEYM  858 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~l~~~~~~~~---~~~lv~E~~  858 (982)
                      .+.++.|....||++.    ..+++|+....  .....+.+|+++++.+ .+..  +++++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4678999999999864    45888886532  3456788999999887 3332  456666554433   458999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc------------------------------------------
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG------------------------------------------  896 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~------------------------------------------  896 (982)
                      +|.++.+....   .++..++..++.+++..+..||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888654322   256677778888888888888831                                          


Q ss_pred             -------------CCCCeEEcCCCCCCEEEcC--CCcEEEEeecCceee
Q 036229          897 -------------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLL  930 (982)
Q Consensus       897 -------------~~~~ivHrDlkp~NILl~~--~~~~kL~DFGla~~~  930 (982)
                                   ....++|+|++|.||++++  ...+.++||+.+..-
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                         1146899999999999997  567899999998753

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.44  E-value=2.9e-08  Score=103.98  Aligned_cols=90  Identities=31%  Similarity=0.300  Sum_probs=60.1

Q ss_pred             cccccce--eeccccccc---ccccccccCccCcceEecccccccC--CccccccCCCCCCeeeCCCCcCCCCCCccccc
Q 036229          591 NLKVLIG--IDFSTNNFS---DVIPTVIGGLTNLQYLFLGYNRLQG--SISESFGDLISLKSLNLSNNNLSRSIPISLEK  663 (982)
Q Consensus       591 ~l~~L~~--Ldls~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  663 (982)
                      ..+.|+.  ++++.|+..   ..++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..
T Consensus       139 ~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~  216 (267)
T 3rw6_A          139 SDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDK  216 (267)
T ss_dssp             GCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGG
T ss_pred             CCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhh
Confidence            3344444  566666432   2222233457788888888888887  3456777788888888888888764  34555


Q ss_pred             cc--ccceeecCCCcccccCC
Q 036229          664 LS--YLEDLDLSFNKLKGEIP  682 (982)
Q Consensus       664 l~--~L~~l~ls~N~l~~~~p  682 (982)
                      +.  +|++|+|++|++++.+|
T Consensus       217 l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          217 IKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             GTTSCCSEEECTTSTTGGGCS
T ss_pred             cccCCcceEEccCCcCccccC
Confidence            55  78888888888887666

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=2.2e-06  Score=92.91  Aligned_cols=136  Identities=14%  Similarity=0.133  Sum_probs=95.9

Q ss_pred             cceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCc---cceeEEeeec-CCCeeEEEEEeccC
Q 036229          785 NNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR---NLIKVISSCS-TEEFKALILEYMPH  860 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~E~~~~  860 (982)
                      .+.++.|....||+.    +..+++|+..  .......+.+|+++++.+.+.   .+++++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            467888999999988    4668888843  223456789999999999642   3667777763 45678899999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc--------------------------------------------
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG--------------------------------------------  896 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~--------------------------------------------  896 (982)
                      .++.+....   .++..+...++.++++.+..||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888653211   123444455555555555555521                                            


Q ss_pred             -------------CCCCeEEcCCCCCCEEEcC---CCc-EEEEeecCcee
Q 036229          897 -------------YSAPVIHCDLKPSNVLLDD---NMV-AHLSDFGIAKL  929 (982)
Q Consensus       897 -------------~~~~ivHrDlkp~NILl~~---~~~-~kL~DFGla~~  929 (982)
                                   ....++|+|++|.||++++   ++. +.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         2346799999999999987   455 58999998875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.33  E-value=8.4e-08  Score=95.61  Aligned_cols=42  Identities=17%  Similarity=0.121  Sum_probs=20.4

Q ss_pred             hhccCCCcEEEc--cCCccccC----CCccccccCCCcEEEccCcccc
Q 036229          270 LANLTGLEVLKL--GKNFLTGE----IPPEIHNLHNLKLLDLSHNKLV  311 (982)
Q Consensus       270 l~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  311 (982)
                      +...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       117 L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          117 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            334445555555  44555432    1223333455666666666553

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.31  E-value=3.1e-06  Score=90.02  Aligned_cols=142  Identities=17%  Similarity=0.081  Sum_probs=102.0

Q ss_pred             cCCCccceeeeeceE-EEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFG-SVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ..|+. +.+..|..| .||+.... ++..+++|+-+..   ....+.+|.+.++.+. +--+.++++++.+.+..++|||
T Consensus        25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            34433 345556555 69998754 4677899986533   3457888999998874 4457889999988899999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccC---------------------------------------
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY---------------------------------------  897 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------  897 (982)
                      +++|.++.+.....     ......+..+++..+..||...                                       
T Consensus       101 ~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             CCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             eeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            99998887655322     1223446667777777777210                                       


Q ss_pred             ----------------CCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          898 ----------------SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       898 ----------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                                      ...++|+|+.+.||++++++.+-|+||+.+..-
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                            114899999999999998877789999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.18  E-value=2.6e-06  Score=94.61  Aligned_cols=80  Identities=9%  Similarity=-0.014  Sum_probs=57.6

Q ss_pred             ccee-eeeceEEEEEEEeC-------CCeEEEEEEeeccc---chhhhhHHHHHHHhhhcC-C--ccceeEEeeecCC--
Q 036229          785 NNLI-GRGGFGSVYKARIG-------EGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIR-H--RNLIKVISSCSTE--  848 (982)
Q Consensus       785 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~--  848 (982)
                      .+.| +.|....+|++...       +++.+++|+.....   ......+.+|+++++.+. +  ..+++++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78889999998754       26788999865432   112357888999998884 2  3577888887655  


Q ss_pred             -CeeEEEEEeccCCChH
Q 036229          849 -EFKALILEYMPHGSLE  864 (982)
Q Consensus       849 -~~~~lv~E~~~~gsL~  864 (982)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             4578999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.86  E-value=4e-05  Score=84.35  Aligned_cols=139  Identities=15%  Similarity=0.173  Sum_probs=80.7

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCC--ccceeEEee------ecCCCeeEEEEEe
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH--RNLIKVISS------CSTEEFKALILEY  857 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~------~~~~~~~~lv~E~  857 (982)
                      +.++.|..+.||++...++ .+++|+....    ..++..|.++++.+..  -.+++++..      ....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4455577889999987554 5899988642    2344456666665531  133444431      1245678899999


Q ss_pred             ccCCChH-----H---------HHhc--CCC-----------cCCHHHH-------------------------------
Q 036229          858 MPHGSLE-----K---------SLYS--SNY-----------ILDIFQR-------------------------------  879 (982)
Q Consensus       858 ~~~gsL~-----~---------~l~~--~~~-----------~~~~~~~-------------------------------  879 (982)
                      ++|.++.     +         .++.  ...           ...|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0         1111  000           0122110                               


Q ss_pred             HHHHHHHHHHHHHHHc----------cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          880 LNIMVDVATTLEYLHF----------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       880 ~~i~~qi~~~L~yLH~----------~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..+..++..++++++.          ....+++|+|+++.||+++.++.+.++||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111223345566641          0267899999999999998788999999998864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.81  E-value=4.2e-05  Score=86.20  Aligned_cols=75  Identities=15%  Similarity=0.119  Sum_probs=50.8

Q ss_pred             cceeeeeceEEEEEEEeC-CCeEEEEEEeecccc-------hhhhhHHHHHHHhhhcCC--c-cceeEEeeecCCCeeEE
Q 036229          785 NNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCG-------RAFKSFDVECEMMKSIRH--R-NLIKVISSCSTEEFKAL  853 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~l~~~~~~~~~~~l  853 (982)
                      .+.+|.|..+.||+++.. +++.|++|.......       ...+++..|.++++.+..  | .+++++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            467899999999999754 467899998653211       223567889999988732  3 455666553  344689


Q ss_pred             EEEeccCC
Q 036229          854 ILEYMPHG  861 (982)
Q Consensus       854 v~E~~~~g  861 (982)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.57  E-value=0.00042  Score=74.02  Aligned_cols=80  Identities=13%  Similarity=0.107  Sum_probs=60.4

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCC---ccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH---RNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ......+.+|.|..+.||+.+..+|+.|++|+...........+..|++.|+.+.-   -.+++++++.    ..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            34556788999999999999999999999998765544445678899999988842   2456666653    2478999


Q ss_pred             eccCCCh
Q 036229          857 YMPHGSL  863 (982)
Q Consensus       857 ~~~~gsL  863 (982)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.56  E-value=0.00034  Score=75.25  Aligned_cols=137  Identities=14%  Similarity=0.127  Sum_probs=92.6

Q ss_pred             ccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcC---CccceeEEeeecCCCeeEEEEEeccC
Q 036229          784 ENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR---HRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       784 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      ..+.++.|....+|+... ++..+++|+....   ....+..|.+.++.+.   ...++++++++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456789999999999986 4677888987633   3567888999998883   36788999988888889999999998


Q ss_pred             CChHH-----------HHhcCCC---------------------cCCHHHHH---HHHHH----------------HHHH
Q 036229          861 GSLEK-----------SLYSSNY---------------------ILDIFQRL---NIMVD----------------VATT  889 (982)
Q Consensus       861 gsL~~-----------~l~~~~~---------------------~~~~~~~~---~i~~q----------------i~~~  889 (982)
                      ..+..           .++....                     .-+|....   ++..+                ++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76421           1111110                     01343221   11111                1111


Q ss_pred             H-HHHH-ccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          890 L-EYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       890 L-~yLH-~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      + ..|. ......+||+|+.+.|++++.++ +.|+||+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 2232 12257899999999999999887 8999984

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.51  E-value=4.1e-05  Score=74.11  Aligned_cols=34  Identities=12%  Similarity=0.143  Sum_probs=15.3

Q ss_pred             CCCeeeecceeeecccCCCccCcCcccEEEeecc
Q 036229          179 FLESISLSQNMFHGRIPSALSNCKYLEILSLSIN  212 (982)
Q Consensus       179 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  212 (982)
                      +|++|||+++.++...-..+.++++|++|+|++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            3444455444444333333444444444444444

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.42  E-value=4.6e-05  Score=73.76  Aligned_cols=82  Identities=10%  Similarity=0.098  Sum_probs=34.6

Q ss_pred             cccEEEeeccccccccccccccccchhhhhccCCC-CCCchhhhcCCC----cccceEeccccc-cCCcCChhhhccCCC
Q 036229          203 YLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSG-LQGEIPREFGNL----AELELMALQVSN-LQGEIPQELANLTGL  276 (982)
Q Consensus       203 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~L~~n~-l~~~~p~~l~~l~~L  276 (982)
                      +|++|||+++.++...-..+..+++|++|+|++|. ++...-..++.+    ++|+.|+++++. ++...-..+.++++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34444444444443333334444444444444442 333222233332    234444444442 333222334445555


Q ss_pred             cEEEccCC
Q 036229          277 EVLKLGKN  284 (982)
Q Consensus       277 ~~L~Ls~N  284 (982)
                      ++|+|+++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.33  E-value=0.00046  Score=78.16  Aligned_cols=74  Identities=11%  Similarity=0.085  Sum_probs=46.2

Q ss_pred             ccceeeeeceEEEEEEEeCCCeEEEEEEeeccc----ch-----hhhhHHHHHHHhh-hcCCccceeEEeeecCCCeeEE
Q 036229          784 ENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC----GR-----AFKSFDVECEMMK-SIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       784 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~-----~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ..+.+|.|..+.||++.. +++.++||......    ..     ....++.|+..+. ......+++++.+.  ++..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            356789999999999965 46789999432110    00     1223333433322 22345677888776  456789


Q ss_pred             EEEec-cC
Q 036229          854 ILEYM-PH  860 (982)
Q Consensus       854 v~E~~-~~  860 (982)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.31  E-value=0.00075  Score=73.34  Aligned_cols=158  Identities=15%  Similarity=0.158  Sum_probs=90.2

Q ss_pred             cCCHHHHHHHhcCCCcc-----ceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCcc--ceeE
Q 036229          769 RFSYLELCRATNRFSEN-----NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN--LIKV  841 (982)
Q Consensus       769 ~~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l  841 (982)
                      .++.+++.....+|...     +.|+.|....+|++...++ .+++|+....  ...+.+..|+++++.+....  ++++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            34556666666667542     3456688889999987555 6788988642  12345667888887763222  3444


Q ss_pred             Eeee------cCCCeeEEEEEeccCCChHH--------------HHhcC--C--Cc----C---CHHHHHH---------
Q 036229          842 ISSC------STEEFKALILEYMPHGSLEK--------------SLYSS--N--YI----L---DIFQRLN---------  881 (982)
Q Consensus       842 ~~~~------~~~~~~~lv~E~~~~gsL~~--------------~l~~~--~--~~----~---~~~~~~~---------  881 (982)
                      +...      ...+..+++|||++|..+..              .++..  .  ..    .   .|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            4321      12356789999998865311              01110  0  00    0   1211000         


Q ss_pred             ---HHHHHHHHHHHHHc----cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          882 ---IMVDVATTLEYLHF----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       882 ---i~~qi~~~L~yLH~----~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                         +...+...+++++.    ....+++|+|+.+.||++++++.+.++||+.+..
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               01123444555542    1246899999999999999876668999998874

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.26  E-value=0.001  Score=72.76  Aligned_cols=139  Identities=12%  Similarity=0.079  Sum_probs=75.9

Q ss_pred             ceeeeeceEE-EEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCC--ccceeEEeeecCCCeeEEEEEeccCCC
Q 036229          786 NLIGRGGFGS-VYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH--RNLIKVISSCSTEEFKALILEYMPHGS  862 (982)
Q Consensus       786 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~E~~~~gs  862 (982)
                      +.++.|.... +|+....+++.+++|......   ...+..|+.+++.+..  -.+++++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565565554 667765446777777654321   1445667887777632  34567777654444  68999997766


Q ss_pred             hHHHHhcCC-------------------------CcCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 036229          863 LEKSLYSSN-------------------------YILDIFQRL-------N-I------------MVDVATTLEYLH---  894 (982)
Q Consensus       863 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~qi~~~L~yLH---  894 (982)
                      +.+.+....                         ...+.....       . +            ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654332110                         011111000       0 0            011111222221   


Q ss_pred             ccCCCCeEEcCCCCCCEEEcCC----CcEEEEeecCcee
Q 036229          895 FGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL  929 (982)
Q Consensus       895 ~~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~  929 (982)
                      ......++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125689999999999999874    6899999999875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.14  E-value=0.00084  Score=72.21  Aligned_cols=139  Identities=14%  Similarity=0.180  Sum_probs=78.0

Q ss_pred             CCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccc-eeEEeeecCCCeeEEEEEec-c
Q 036229          782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSTEEFKALILEYM-P  859 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~-~  859 (982)
                      +.-.+.++.|....+|++     +.+++|+....... .....+|+.+++.+....+ ++++++..+  .-++++||+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCC
Confidence            333678999999999999     45888887643222 2334668888877742222 566665433  346899999 6


Q ss_pred             CCChHHH------------------HhcCCCc----CCHH-HHHHHHH--------------HHHHHHH----HHH-ccC
Q 036229          860 HGSLEKS------------------LYSSNYI----LDIF-QRLNIMV--------------DVATTLE----YLH-FGY  897 (982)
Q Consensus       860 ~gsL~~~------------------l~~~~~~----~~~~-~~~~i~~--------------qi~~~L~----yLH-~~~  897 (982)
                      |.++...                  ++.....    .+.. ....+..              .+...+.    .+. ...
T Consensus        92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~  171 (301)
T 3dxq_A           92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL  171 (301)
T ss_dssp             CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence            6544210                  0011100    0111 1111100              0111111    111 112


Q ss_pred             CCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       898 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ...++|+|+.|.||+ ..++.+.++||..|..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            456899999999999 5667889999998875

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.96  E-value=0.00099  Score=61.40  Aligned_cols=59  Identities=25%  Similarity=0.308  Sum_probs=34.2

Q ss_pred             eEeccccccc-CCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccC
Q 036229          621 YLFLGYNRLQ-GSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       621 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~  681 (982)
                      .++.+++.|+ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+..
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC   71 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC   71 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence            4555555554 12332221  24667777777776555556666777777777777776543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.92  E-value=0.0018  Score=71.51  Aligned_cols=139  Identities=14%  Similarity=0.156  Sum_probs=83.7

Q ss_pred             ceeeeeceEEEEEEEeC--------CCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEEE
Q 036229          786 NLIGRGGFGSVYKARIG--------EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      +.+..|-...+|++...        +++.|++|+.... ........+|.++++.+. +.-.+++++++..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56767878889999864        2478999986332 223456678999998873 3334677777654    29999


Q ss_pred             eccCCChHHH-----------------HhcC----CCcCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 036229          857 YMPHGSLEKS-----------------LYSS----NYILD--IFQRLNIMVDVAT-------------------TLEYLH  894 (982)
Q Consensus       857 ~~~~gsL~~~-----------------l~~~----~~~~~--~~~~~~i~~qi~~-------------------~L~yLH  894 (982)
                      |++|.++..-                 ++..    .....  +.++.++..++..                   .++.|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9988655210                 1111    11122  3444445443322                   223332


Q ss_pred             -----ccCCCCeEEcCCCCCCEEEcCC----CcEEEEeecCcee
Q 036229          895 -----FGYSAPVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL  929 (982)
Q Consensus       895 -----~~~~~~ivHrDlkp~NILl~~~----~~~kL~DFGla~~  929 (982)
                           ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                 1224579999999999999876    7899999999875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.91  E-value=0.0022  Score=69.72  Aligned_cols=140  Identities=9%  Similarity=0.104  Sum_probs=81.8

Q ss_pred             ceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCc--cceeEEee-----ecCCCeeEEEEEec
Q 036229          786 NLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHR--NLIKVISS-----CSTEEFKALILEYM  858 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~~~~lv~E~~  858 (982)
                      +.++ |....||++...+|+.+++|+..... .....+..|..+++.+...  .+++++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 77889999887677789999986331 2345677788888777422  24444443     11245667899999


Q ss_pred             cCCChH-----HH---------Hhc----C----CCcCCHHHH----HHH---------------HHHHHHHHHHHHc--
Q 036229          859 PHGSLE-----KS---------LYS----S----NYILDIFQR----LNI---------------MVDVATTLEYLHF--  895 (982)
Q Consensus       859 ~~gsL~-----~~---------l~~----~----~~~~~~~~~----~~i---------------~~qi~~~L~yLH~--  895 (982)
                      +|..+.     ..         ++.    .    ....++...    ..+               ...+...++.+..  
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875431     10         110    0    011121110    001               1111122223221  


Q ss_pred             --cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          896 --GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       896 --~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                        .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence              1256789999999999998 4 899999988764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.85  E-value=0.0033  Score=71.38  Aligned_cols=74  Identities=14%  Similarity=0.144  Sum_probs=49.1

Q ss_pred             cceeeeeceEEEEEEEeCC-CeEEEEEEeecccchhhhhHHHHHHHhhhcCCccc-eeEEeeecCCCeeEEEEEeccCCC
Q 036229          785 NNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSTEEFKALILEYMPHGS  862 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E~~~~gs  862 (982)
                      .+.|+.|-...+|++...+ +..+++|+....... ..+-.+|..+++.+...++ +++++.+.  +  ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4578888889999998765 588999987543221 1223679999988864444 57777763  2  35999998754


Q ss_pred             h
Q 036229          863 L  863 (982)
Q Consensus       863 L  863 (982)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.75  E-value=0.00041  Score=68.44  Aligned_cols=42  Identities=21%  Similarity=0.166  Sum_probs=20.5

Q ss_pred             ccCcCcccEEEeeccccccccc----cccccccchhhhhccCCCCC
Q 036229          198 LSNCKYLEILSLSINNLLGAIP----KEIGNLTKLKELYLGYSGLQ  239 (982)
Q Consensus       198 ~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~  239 (982)
                      +..-+.|+.|+|++|+|....-    +.+..-+.|++|+|+.|.|.
T Consensus        66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            3344556666666666553222    22233344555555555554

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.69  E-value=0.0026  Score=71.88  Aligned_cols=73  Identities=18%  Similarity=0.180  Sum_probs=49.9

Q ss_pred             cceeeeeceEEEEEEEeCC--------CeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEE
Q 036229          785 NNLIGRGGFGSVYKARIGE--------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .+.|+.|....||++...+        ++.+++|+....  ...+.+..|..+++.+. +.-.+++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4577888889999998653        578999988432  11145557999888874 3234677776543    3899


Q ss_pred             EeccCCCh
Q 036229          856 EYMPHGSL  863 (982)
Q Consensus       856 E~~~~gsL  863 (982)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.61  E-value=0.00072  Score=66.68  Aligned_cols=18  Identities=39%  Similarity=0.606  Sum_probs=9.0

Q ss_pred             hhccCCCcEEEccCCccc
Q 036229          270 LANLTGLEVLKLGKNFLT  287 (982)
Q Consensus       270 l~~l~~L~~L~Ls~N~l~  287 (982)
                      +..-+.|++|+|++|+|+
T Consensus        94 L~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           94 IETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             HHHCSSCCEEECCSSBCC
T ss_pred             HhcCCccCeEecCCCcCC
Confidence            333445555555555554

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.57  E-value=0.0025  Score=58.67  Aligned_cols=56  Identities=20%  Similarity=0.236  Sum_probs=43.7

Q ss_pred             eeeccccccc-ccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCC
Q 036229          597 GIDFSTNNFS-DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       597 ~Ldls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  654 (982)
                      .+|-+++.++ ..+|..+.  ++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5677777775 23454432  46899999999999877888999999999999999875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.55  E-value=0.0047  Score=68.46  Aligned_cols=74  Identities=14%  Similarity=0.194  Sum_probs=45.7

Q ss_pred             cceeeeeceEEEEEEEeCC---------CeEEEEEEeecccchhhhhHHHHHHHhhhcCCcc-ceeEEeeecCCCeeEEE
Q 036229          785 NNLIGRGGFGSVYKARIGE---------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN-LIKVISSCSTEEFKALI  854 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv  854 (982)
                      .+.++.|....+|++...+         ++.+++|+...... ...+...|.++++.+...+ .+++++...    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            3567778888999998643         26888998754322 2223467888888874323 456776542    2689


Q ss_pred             EEeccCCCh
Q 036229          855 LEYMPHGSL  863 (982)
Q Consensus       855 ~E~~~~gsL  863 (982)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.41  E-value=0.012  Score=64.34  Aligned_cols=33  Identities=21%  Similarity=0.308  Sum_probs=29.1

Q ss_pred             CCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       898 ~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ...++|+|+.+.||++++++.+.++||+.+..-
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            457999999999999998888999999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.99  E-value=0.075  Score=59.43  Aligned_cols=139  Identities=14%  Similarity=0.170  Sum_probs=84.6

Q ss_pred             cceeeeeceEEEEEEEeCC--------CeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEE
Q 036229          785 NNLIGRGGFGSVYKARIGE--------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .+.+..|-...+|++...+        ++.|++|+..... ....+..+|.++++.+. +.-.+++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567678888999998653        5789999865432 22234467888888874 333466666443    26899


Q ss_pred             EeccCCChHH-------H-------Hh------c-----C---C-CcCCHHHHHHHHHHH-------------------H
Q 036229          856 EYMPHGSLEK-------S-------LY------S-----S---N-YILDIFQRLNIMVDV-------------------A  887 (982)
Q Consensus       856 E~~~~gsL~~-------~-------l~------~-----~---~-~~~~~~~~~~i~~qi-------------------~  887 (982)
                      ||++|.++..       .       +.      .     .   . .+.-+.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999865411       0       00      0     0   1 111133333333222                   2


Q ss_pred             HHHHHHH---------------------ccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          888 TTLEYLH---------------------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       888 ~~L~yLH---------------------~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ..+++|.                     ......++|+|+.+.||+ +.++.+.++||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2233332                     111357899999999999 7788999999999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.42  E-value=0.31  Score=54.19  Aligned_cols=30  Identities=27%  Similarity=0.371  Sum_probs=25.6

Q ss_pred             CeEEcCCCCCCEEE------cCCCcEEEEeecCcee
Q 036229          900 PVIHCDLKPSNVLL------DDNMVAHLSDFGIAKL  929 (982)
Q Consensus       900 ~ivHrDlkp~NILl------~~~~~~kL~DFGla~~  929 (982)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      3456899999999875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	982
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-40
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-40
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-39
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-38
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-36
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-36
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-35
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-35
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-35
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-34
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-31
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-30
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-29
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-28
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-28
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-28
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-08
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-28
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-28
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-28
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-09
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-27
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-27
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-26
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-26
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-25
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-07
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-20
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-04
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-19
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-13
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-10
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-09
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.004
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	8e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-44
 Identities = 44/174 (25%), Positives = 84/174 (48%), Gaps = 8/174 (4%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRN 837
            + +    IG G FG+VYK +     +VAVK+ ++     +  ++F  E  +++  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++  +    T    A++ ++    SL   L+      ++ + ++I    A  ++YLH   
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +IH DLK +N+ L +++   + DFG+A +      S    Q   +I +MAP
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (383), Expect = 2e-41
 Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 20/199 (10%)

Query: 770 FSYLELCRATNRFSEN---------NLIGRGGFGSVYKARI----GEGMEVAVKVFDLQ- 815
           F++ +   A   F++           +IG G FG V    +       + VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 816 CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILD 875
             +  + F  E  +M    H N+I +    +      +I E+M +GSL+  L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 876 IFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
           + Q + ++  +A  ++YL        +H DL   N+L++ N+V  +SDFG+++ L  +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 936 SITQTQTL---ATIGYMAP 951
             T T  L     I + AP
Sbjct: 184 DPTYTSALGGKIPIRWTAP 202

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 3e-40
 Identities = 46/173 (26%), Positives = 85/173 (49%), Gaps = 7/173 (4%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
                   +G G FG V+        +VAVK    Q   +  +F  E  +MK ++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI-LDIFQRLNIMVDVATTLEYLHFGYS 898
           ++ +  + E    +I EYM +GSL   L + + I L I + L++   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              IH DL+ +N+L+ D +   ++DFG+A+ LI +++   +      I + AP
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 9e-40
 Identities = 41/185 (22%), Positives = 81/185 (43%), Gaps = 11/185 (5%)

Query: 773 LELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKS-FDVECEMM 830
           +EL    + F + + +G G  G V+K      G+ +A K+  L+   A ++    E +++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 831 KSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
                  ++    +  ++   ++ +E+M  GSL++ L  +   +       + + V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
            YL       ++H D+KPSN+L++      L DFG++  LI           + T  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171

Query: 951 PGLFH 955
           P    
Sbjct: 172 PERLQ 176

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (367), Expect = 4e-39
 Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 14/177 (7%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL---QCGRAFKSFDVECEMMKSIR 834
              FS+   IG G FG+VY AR +     VA+K       Q    ++    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H N I+       E    L++EY    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              S  +IH D+K  N+LL +  +  L DFG A ++            + T  +MAP
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAP 180

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 4e-39
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 6/167 (3%)

Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISS 844
             +G G FG VYKA+     +  A KV D +     + + VE +++ S  H N++K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 845 CSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHC 904
              E    +++E+   G+++  +      L   Q   +       L YLH      +IH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 905 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           DLK  N+L   +    L+DFG++       Q   +   + T  +MAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAP 179

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 5e-39
 Identities = 44/188 (23%), Positives = 81/188 (43%), Gaps = 10/188 (5%)

Query: 774 ELCRATNRFS-ENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCGRAF-KSFDVECE 828
           +L    +     +  +G G FGSV +       + ++VA+KV      +A  +    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 829 MMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVAT 888
           +M  + +  ++++I  C  E    L++E    G L K L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 889 TLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIG 947
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 948 YMAPGLFH 955
           + AP   +
Sbjct: 178 WYAPECIN 185

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 5e-38
 Identities = 43/173 (24%), Positives = 82/173 (47%), Gaps = 7/173 (4%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
                   +G+G FG V+         VA+K        + ++F  E ++MK +RH  L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIF-QRLNIMVDVATTLEYLHFGYS 898
           ++ +  S E    ++ EYM  GSL   L           Q +++   +A+ + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              +H DL+ +N+L+ +N+V  ++DFG+A+ LI +++   +      I + AP
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAP 183

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 8e-38
 Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 5/174 (2%)

Query: 782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKV 841
            +    +G G FG V   +     +VA+K+   +   +   F  E ++M ++ H  L+++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
              C+ +    +I EYM +G L   L    +     Q L +  DV   +EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
           +H DL   N L++D  V  +SDFG+++ ++ +D+  +   +   + +  P +  
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 7/186 (3%)

Query: 768 RRFSYLELCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVE 826
              +Y +        +  + +G G +G VY+       + VAVK          + F  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63

Query: 827 CEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN-YILDIFQRLNIMVD 885
             +MK I+H NL++++  C+ E    +I E+M +G+L   L   N   +     L +   
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 886 VATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLAT 945
           +++ +EYL        IH DL   N L+ +N +  ++DFG+++L+ G D           
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFP 179

Query: 946 IGYMAP 951
           I + AP
Sbjct: 180 IKWTAP 185

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 8e-37
 Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 5/172 (2%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           +  +    IG G FG V+        +VA+K        + + F  E E+M  + H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
           ++   C  +    L+ E+M HG L   L +   +      L + +DV    E + +   A
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC---EGMAYLEEA 120

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            VIH DL   N L+ +N V  +SDFG+ + ++ +  + +   T   + + +P
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASP 171

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-36
 Identities = 45/202 (22%), Positives = 79/202 (39%), Gaps = 33/202 (16%)

Query: 780 NRFSENNLIGRGGFGSVYKA------RIGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKS 832
                  ++G G FG V  A      + G  ++VAVK+   +   +  ++   E +MM  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 833 I-RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSN-------------------- 871
           +  H N++ ++ +C+      LI EY  +G L   L S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 872 --YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 929
              +L     L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 930 LIGEDQSITQTQTLATIGYMAP 951
           ++ +   + +      + +MAP
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAP 235

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 6/174 (3%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL-QCGRAFKSFDVECEMMKSIRHRN 837
             +     +G G +G V  A        VAVK+ D+ +     ++   E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++K          + L LEY   G L   +   +  +           +   + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              + H D+KP N+LLD+     +SDFG+A +    ++     +   T+ Y+AP
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 4e-36
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 18/202 (8%)

Query: 788 IGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST 847
           IG+G FG V++ +   G EVAVK+F  +  R++   + E      +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 848 EEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH-----FGYS 898
           +        L+ +Y  HGSL   L  + Y + +   + + +  A+ L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ--SITQTQTLATIGYMAPGLFHV 956
             + H DLK  N+L+  N    ++D G+A           I     + T  YMAP +   
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 957 KYILFVVNFLTS---YSFLMIF 975
              +           Y+  ++F
Sbjct: 187 SINMKHFESFKRADIYAMGLVF 208

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 8e-36
 Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 10/179 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKARI-----GEGMEVAVKVFDLQCG-RAFKSFDVECEMMKSI 833
           +  +   +IG G FG VYK  +      + + VA+K        +    F  E  +M   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 834 RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYL 893
            H N+I++    S  +   +I EYM +G+L+K L   +    + Q + ++  +A  ++YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 894 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAP 951
               +   +H DL   N+L++ N+V  +SDFG++++L    + + T +     I + AP
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 9e-36
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 11/174 (6%)

Query: 784 ENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNL 838
           E+  +G G FG+V K           VAVK+   +            E  +M+ + +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           +++I  C  E +  L++E    G L K L  + + +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYMAP 951
           +  +H DL   NVLL     A +SDFG++K L  ++            + + AP
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-35
 Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 8/182 (4%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKS 832
           +    F    ++G G F +V  AR +    E A+K+ +   +           E ++M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           + H   +K+  +   +E     L Y  +G L K +       D         ++ + LEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPG 952
           LH      +IH DLKP N+LL+++M   ++DFG AK+L  E +       + T  Y++P 
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 953 LF 954
           L 
Sbjct: 181 LL 182

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  135 bits (342), Expect = 2e-35
 Identities = 37/179 (20%), Positives = 69/179 (38%), Gaps = 9/179 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           + +  +  +G G FG V++      G   A K          ++   E + M  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           + +  +   +    +I E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 899 APVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
              +H DLKP N++     +    L DFG+   L  +      T T     + AP +  
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAE 198

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-35
 Identities = 52/177 (29%), Positives = 76/177 (42%), Gaps = 13/177 (7%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
                   IG+G FG V       G +VAVK          ++F  E  +M  +RH NL+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 840 KVISSCSTEEFK-ALILEYMPHGSLEKSLYSSNY-ILDIFQRLNIMVDVATTLEYLHFGY 897
           +++     E+    ++ EYM  GSL   L S    +L     L   +DV   +EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
               +H DL   NVL+ ++ VA +SDFG+ K       S TQ      + + AP   
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEAL 172

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 3e-35
 Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 35/213 (16%)

Query: 769 RFSYLELCRATNRFSENNLIGRGGFGSVYKAR------IGEGMEVAVKVFDLQCGRAF-K 821
           +   LE  R  N       IG G FG V++AR            VAVK+   +       
Sbjct: 4   KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 822 SFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNY--------- 872
            F  E  +M    + N++K++  C+  +   L+ EYM +G L + L S +          
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121

Query: 873 --------------ILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMV 918
                          L   ++L I   VA  + YL        +H DL   N L+ +NMV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178

Query: 919 AHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             ++DFG+++ +   D           I +M P
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 211

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 4e-35
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 15/187 (8%)

Query: 781 RFSE-NNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHR 836
           RF + +  IGRG F +VYK       +EVA      +       + F  E EM+K ++H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 837 NLIKVISSCST----EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           N+++   S  +    ++   L+ E M  G+L+  L     ++ I    +    +   L++
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQF 127

Query: 893 LHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           LH   + P+IH DLK  N+ +        + D G+A L      S  +   + T  +MAP
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFMAP 182

Query: 952 GLFHVKY 958
            ++  KY
Sbjct: 183 EMYEEKY 189

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 7e-35
 Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 12/176 (6%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRH 835
             F     +G+G FG+VY AR       +A+KV     L+          E E+   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
            N++++           LILEY P G++ + L   +   D  +    + ++A  L Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
             S  VIH D+KP N+LL       ++DFG +           +T    T+ Y+ P
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPP 173

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 8e-35
 Identities = 47/189 (24%), Positives = 75/189 (39%), Gaps = 13/189 (6%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSI 833
           RA + +     IG G +G   K R   +G  +  K  D         +    E  +++ +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 834 RHRNLIKVISSCSTEEFKAL--ILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVAT 888
           +H N+++            L  ++EY   G L   +         LD    L +M  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 889 TLEYLH--FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATI 946
            L+  H        V+H DLKP+NV LD      L DFG+A++L   D S  +     T 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFV-GTP 178

Query: 947 GYMAPGLFH 955
            YM+P   +
Sbjct: 179 YYMSPEQMN 187

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-34
 Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 28/201 (13%)

Query: 780 NRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQCGRAF-KSFDVECEMMKS 832
           NR S    +G G FG V +A           M VAVK+          ++   E +++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 833 I-RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSS-----------------NYIL 874
           +  H N++ ++ +C+      +I EY  +G L   L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 875 DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
           D+   L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 935 QSITQTQTLATIGYMAPGLFH 955
             + +      + +MAP    
Sbjct: 200 NYVVKGNARLPVKWMAPESIF 220

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 8/174 (4%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN 837
             +++    IG+G  G+VY A  +  G EVA++  +LQ     +    E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++  + S    +   +++EY+  GSL   +  +    D  Q   +  +    LE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH--- 133

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           S  VIH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAP 185

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-34
 Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 10/176 (5%)

Query: 782 FSENNLIGRGGFGSVYKAR-IGEGMEVAVKV-----FDLQCGRAFKSFDVECEMMKSIRH 835
           F +  ++G G FG+VYK   I EG +V + V      +    +A K    E  +M S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
            ++ +++  C T   + LI + MP G L   +      +     LN  V +A  + YL  
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
                ++H DL   NVL+       ++DFG+AKLL  E++          I +MA 
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 5e-34
 Identities = 50/179 (27%), Positives = 70/179 (39%), Gaps = 12/179 (6%)

Query: 788 IGRGGFGSVYKARI----GEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIK 840
           +G G FG V +       G+ + VAVK      L    A   F  E   M S+ HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 841 VISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
           +     T   K ++ E  P GSL   L        +       V VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 901 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAPGLFHVKY 958
            IH DL   N+LL    +  + DFG+ + L   +D  + Q        + AP     + 
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  130 bits (328), Expect = 2e-33
 Identities = 38/183 (20%), Positives = 74/183 (40%), Gaps = 9/183 (4%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
           + +     +G G FG V++      G     K  +        +   E  +M  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           I +  +   +    LILE++  G L   + + +Y +   + +N M      L+++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145

Query: 899 APVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV 956
             ++H D+KP N++ +        + DFG+A  L   +       T AT  + AP +   
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDR 202

Query: 957 KYI 959
           + +
Sbjct: 203 EPV 205

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 5e-33
 Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 26/192 (13%)

Query: 780 NRFSENNLIGRGGFGSVYKARI---GEGMEVAVKVFDLQCGR-AFKSFDVECEMMKSI-R 834
           N     ++IG G FG V KARI   G  M+ A+K       +   + F  E E++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------------LDIFQR 879
           H N+I ++ +C    +  L +EY PHG+L   L  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 880 LNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ 939
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++   G++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 940 TQTLATIGYMAP 951
           T     + +MA 
Sbjct: 184 TMGRLPVRWMAI 195

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 9e-33
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 10/181 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQCGRAFKS-FDVECEMMKSIR 834
            R      IG G FG V++          + VA+K        + +  F  E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H +++K+I    TE    +I+E    G L   L    Y LD+   +     ++T L YL 
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
              S   +H D+   NVL+  N    L DFG+++ +  +      ++    I +MAP   
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 181

Query: 955 H 955
           +
Sbjct: 182 N 182

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  123 bits (310), Expect = 7e-32
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 13/182 (7%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGR---AFKSFDVECEMMKSIR 834
           ++R+    ++G GG   V+ AR +    +VAVKV      R    +  F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 835 HRNLIKVISSCSTEEFKA----LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           H  ++ V  +   E        +++EY+   +L   +++    +   + + ++ D    L
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLA-TIGYM 949
            + H      +IH D+KP+N+++       + DFGIA+ +     S+TQT  +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 950 AP 951
           +P
Sbjct: 182 SP 183

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 11/175 (6%)

Query: 785 NNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHRNLI 839
           N +IGRG FG VY   +    G+ +  AVK  +          F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 840 KVISSCSTEEFKA-LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
            ++  C   E    ++L YM HG L   + +  +   +   +   + VA   + + F  S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA---KGMKFLAS 148

Query: 899 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ--TQTLATIGYMAP 951
              +H DL   N +LD+     ++DFG+A+ +  ++       T     + +MA 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-31
 Identities = 36/188 (19%), Positives = 78/188 (41%), Gaps = 19/188 (10%)

Query: 780 NRFSENNLIGRGGFGSVYKA------RIGEGMEVAVKVFDLQCG-RAFKSFDVECEMMKS 832
            + + +  +G+G FG VY+       +      VA+K  +     R    F  E  +MK 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYI---------LDIFQRLNIM 883
               ++++++   S  +   +I+E M  G L+  L S               + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTL 943
            ++A  + YL+   +   +H DL   N ++ ++    + DFG+ + +   D      + L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 944 ATIGYMAP 951
             + +M+P
Sbjct: 197 LPVRWMSP 204

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  123 bits (309), Expect = 5e-31
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 15/178 (8%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL------QCGRAFKSFDVECEMMKS 832
           N FS + +IGRGGFG VY  R    G   A+K  D       Q      +  +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
                ++ +  +  T +  + IL+ M  G L   L S + +           ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           +H   +  V++ DLKP+N+LLD++    +SD G+A              ++ T GYMA
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMA 173

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-30
 Identities = 45/185 (24%), Positives = 78/185 (42%), Gaps = 8/185 (4%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHR 836
             R++  + IG G +G V  A      + VA+K       + + +    E +++   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYS--SNYILDIFQRLNIMVDVATTLEYLH 894
           N+I +         + +   Y+    +   LY       L        +  +   L+Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSITQTQTLATIGYMAPGL 953
              SA V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT  Y AP +
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 954 FHVKY 958
                
Sbjct: 184 MLNSK 188

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (304), Expect = 1e-30
 Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 13/174 (7%)

Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRHRNLIKV 841
             +G G FG V+  R    G   A+KV     +   +  +  + E  M+  + H  +I++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 842 ISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPV 901
             +    +   +I++Y+  G    SL   +             +V   LEYLH   S  +
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 902 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
           I+ DLKP N+LLD N    ++DFG AK +     ++       T  Y+AP +  
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVS 174

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  119 bits (298), Expect = 3e-30
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 18/182 (9%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDV---------ECEMM 830
            +    ++GRG    V +        E AVK+ D+  G +F + +V         E +++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 831 KSIR-HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATT 889
           + +  H N+I++  +  T  F  L+ + M  G L   L +    L   +   IM  +   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEV 122

Query: 890 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
           +  LH      ++H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y+
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYL 176

Query: 950 AP 951
           AP
Sbjct: 177 AP 178

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (293), Expect = 2e-29
 Identities = 36/181 (19%), Positives = 69/181 (38%), Gaps = 6/181 (3%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAF-KSFDVECEMMKSIRHR 836
            + +   +++G G F  V  A        VA+K    +       S + E  ++  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           N++ +     +     LI++ +  G L   +    +         ++  V   ++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHV 956
                           LD++    +SDFG++K+   ED     +    T GY+AP +   
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 957 K 957
           K
Sbjct: 184 K 184

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-29
 Identities = 33/165 (20%), Positives = 70/165 (42%), Gaps = 7/165 (4%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
           ++     +GRG FG V++            K   ++ G        E  ++   RHRN++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNIL 64

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            +  S  + E   +I E++    + + + +S + L+  + ++ +  V   L++LH   S 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SH 121

Query: 900 PVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQSITQTQT 942
            + H D++P N++     +    + +FG A+ L   D        
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-28
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 28/197 (14%)

Query: 780 NRFSENNLIGRGGFGSVYKAR--------IGEGMEVAVKVFDLQCG-RAFKSFDVECEMM 830
           +R      +G G FG V  A              +VAVK+       +       E EMM
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 831 KSI-RHRNLIKVISSCSTEEFKALILEYMPHGSLEKSL---------------YSSNYIL 874
           K I +H+N+I ++ +C+ +    +I+EY   G+L + L               ++    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 875 DIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 934
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 935 QSITQTQTLATIGYMAP 951
                T     + +MAP
Sbjct: 190 YYKKTTNGRLPVKWMAP 206

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-28
 Identities = 44/196 (22%), Positives = 75/196 (38%), Gaps = 27/196 (13%)

Query: 780 NRFSENNLIGRGGFGSVYKAR------IGEGMEVAVKVFDLQCGRA-FKSFDVECEMMKS 832
           +R      +GRG FG V +A             VAVK+       +  ++   E +++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 833 IRHRNLIKVISSCSTEEFKAL--ILEYMPHGSLEKSLYSSNY---------------ILD 875
           I H   +  +    T+    L  I+E+   G+L   L S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 876 IFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 935
           +   +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 936 SITQTQTLATIGYMAP 951
            + +      + +MAP
Sbjct: 190 YVRKGDARLPLKWMAP 205

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 8/178 (4%)

Query: 780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRN 837
            ++     IG G +G VYKA+   G   A+K   L+        +   E  ++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++K+     T++   L+ E++    L+K L      L+     + ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
              V+H DLKP N+L++      ++DFG+A+           T  + T+ Y AP +  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLM 173

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  114 bits (285), Expect = 2e-28
 Identities = 96/308 (31%), Positives = 139/308 (45%), Gaps = 14/308 (4%)

Query: 38  TDQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVTCD--VHSHRVKVLNISHLNL 93
            D+ ALL +K  +  +PT     +W  +T  CN  W GV CD    ++RV  L++S LNL
Sbjct: 6   QDKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62

Query: 94  TG--TIPSQLWNLSSLQSLNL-GFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIF 150
                IPS L NL  L  L + G N L G IP AI  L  L Y+      +SGA P F+ 
Sbjct: 63  PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122

Query: 151 NKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLS 210
              +L  LDFSYNALSG +P +I  +LP L  I+   N   G IP +  +   L      
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSIS-SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181

Query: 211 INNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQEL 270
             N L            L  + L  + L+G+    FG+    + + L  ++L  ++ +  
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241

Query: 271 ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQ 330
            +     +  L  N + G +P  +  L  L  L++S N L G +P    N+         
Sbjct: 242 LSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYA 299

Query: 331 SNS-LSGS 337
           +N  L GS
Sbjct: 300 NNKCLCGS 307

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 87.5 bits (215), Expect = 3e-19
 Identities = 72/296 (24%), Positives = 111/296 (37%), Gaps = 28/296 (9%)

Query: 418 SSFSNCKSLTYIGLSNNPLDGILP-RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNL 476
            + +    +  + LS   L    P   S+ NL +    +     N+ G  P  I  LT L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 477 IGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSG 536
             +Y+    ++G+IP  L +++ L  L    N L G +P  I  L  L  +   GN++SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 537 SIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLI 596
           +IP  + + + L T    S    +  +        L     S          +       
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 597 GIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRS 656
                  N        +G   NL  L L  NR+ G++ +    L  L SLN+S NNL   
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC-- 281

Query: 657 IPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPPC 712
                                 GEIP+GG+   F   ++  N+ LCGSP   +P C
Sbjct: 282 ----------------------GEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 73.2 bits (178), Expect = 2e-14
 Identities = 65/287 (22%), Positives = 99/287 (34%), Gaps = 29/287 (10%)

Query: 343 DVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL 402
           D Q   +  L L   N     P                      IP++  NL  L  + +
Sbjct: 46  DTQTYRVNNLDLSGLNLPKPYP----------------------IPSSLANLPYLNFLYI 83

Query: 403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNV 462
                   NL      + +    L Y+ +++  + G +P         +L   D SY  +
Sbjct: 84  GGIN----NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI--KTLVTLDFSYNAL 137

Query: 463 SGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLT 522
           SG  P  I +L NL+GI   GN+++G+IP + G   KL                      
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197

Query: 523 KLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFT 582
            L  + LS N L G     F +  +   + L  N L      +   K +  L+  +N   
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257

Query: 583 GPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRL 629
           G LP  +  LK L  ++ S NN    IP   G L          N+ 
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 67.1 bits (162), Expect = 2e-12
 Identities = 48/266 (18%), Positives = 81/266 (30%), Gaps = 10/266 (3%)

Query: 324 LTGLGLQSNSLSGSLSSIADV-QLPNLEELRLWSN-NFSGTIPRFIFNASKLSVLELGRN 381
           +  L L   +L       + +  LP L  L +    N  G IP  I   ++L  L +   
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 382 SFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILP 441
           + SG IP+    ++ L  +   YN      L  +   S S+  +L  I    N + G + 
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYN-----ALSGTLPPSISSLPNLVGITFDGNRISGAI- 165

Query: 442 RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQ 501
                     L        N               +        +       L    K  
Sbjct: 166 -PDSYGSFSKLFTSMTISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 502 GLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSI 561
                           +     L  L L  N++ G++P   + L  L +L++  N L   
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 562 PLTIWNLKGMLYLNFSSNFFTGPLPL 587
                NL+      +++N      PL
Sbjct: 284 IPQGGNLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.1 bits (144), Expect = 4e-10
 Identities = 20/78 (25%), Positives = 30/78 (38%), Gaps = 1/78 (1%)

Query: 69  CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTL 128
                +     S  +  L++ +  + GT+P  L  L  L SLN+ FN L G IP     L
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNL 290

Query: 129 YTLKYVNFRGNQLSGAFP 146
                  +  N+     P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.0 bits (128), Expect = 4e-08
 Identities = 19/69 (27%), Positives = 29/69 (42%), Gaps = 4/69 (5%)

Query: 133 YVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHG 192
            ++ R N++ G  P  +     L  L+ S+N L GEIP     NL   +  + + N    
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLC 305

Query: 193 RIPSALSNC 201
             P  L  C
Sbjct: 306 GSP--LPAC 312

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 4e-28
 Identities = 41/177 (23%), Positives = 75/177 (42%), Gaps = 11/177 (6%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECE-MMKSIR 834
             F  + ++G+G FG V+ A         A+K      +      +   VE   +  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 835 HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLH 894
           H  L  +  +  T+E    ++EY+  G L   + S +   D+ +      ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 895 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
              S  +++ DLK  N+LLD +    ++DFG+ K  +  D          T  Y+AP
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAP 172

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-28
 Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 12/172 (6%)

Query: 786 NLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC-----GRAFKSFDVECEMMKSIRHRNLI 839
           + +G G F +VYKAR       VA+K   L           ++   E ++++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 840 KVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA 899
            ++ +   +   +L+ ++M        +  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 900 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
            ++H DLKP+N+LLD+N V  L+DFG+AK       +   T  + T  Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAP 169

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 5e-28
 Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 20/185 (10%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLI 839
            +++  +IG G FG VY+A+    G  VA+K          +  + E ++M+ + H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 840 KVISSCST------EEFKALILEYMPHGSLE--KSLYSSNYILDIFQRLNIMVDVATTLE 891
           ++     +      E +  L+L+Y+P       +    +   L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 892 YLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           Y+H   S  + H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRA 190

Query: 951 PGLFH 955
           P L  
Sbjct: 191 PELIF 195

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 6e-28
 Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 18/193 (9%)

Query: 775 LCRATNRFSENNLIGRGGFGSVYKAR--IGEGMEVAVKVFDLQCGRAFKSFDVECE---- 828
           LCRA  ++     IG G +G V+KAR     G  VA+K   +Q G          E    
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 829 -MMKSIRHRNLIKVISSCSTEEFKA-----LILEYMPHGSLEKSLYSSNYILDIFQRLNI 882
             +++  H N++++   C+           L+ E++               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 883 MVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT 942
           M  +   L++LH   S  V+H DLKP N+L+  +    L+DFG+A++       +  T  
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175

Query: 943 LATIGYMAPGLFH 955
           + T+ Y AP +  
Sbjct: 176 VVTLWYRAPEVLL 188

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 9e-28
 Identities = 43/193 (22%), Positives = 85/193 (44%), Gaps = 17/193 (8%)

Query: 775 LCRATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMK 831
            C   +++ +   IG+G FG V+KAR    G +VA+K   ++        +   E ++++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 832 SIRHRNLIKVISSCSTEEFKA--------LILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            ++H N++ +I  C T+            L+ ++  H               + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQT- 942
             +   L  L++ +   ++H D+K +NVL+  + V  L+DFG+A+       S     T 
Sbjct: 124 QML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 943 -LATIGYMAPGLF 954
            + T+ Y  P L 
Sbjct: 181 RVVTLWYRPPELL 193

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  113 bits (283), Expect = 2e-27
 Identities = 77/386 (19%), Positives = 144/386 (37%), Gaps = 28/386 (7%)

Query: 296 NLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLW 355
            L       L    +   V  +  ++  +T L      +  S+  +    L NL ++   
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGVE--YLNNLTQINFS 74

Query: 356 SNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELS 415
           +N  +   P  + N +KL  + +  N  +   P           +  +          L+
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 416 FLSSFSNCKSLTYIGLSNNPLDGILPRMSMGN------LSHSLEYFDMSYCNVSGGFPKE 469
            L+      +      + + L  +              L++      +   +        
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 470 IGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGL 529
           +  LTNL  +    N+++   P+ +     L  L L  N+L+      +  LT L +L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDLDL 248

Query: 530 SGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDI 589
           + N++S   P   S L  L  L LG+N++++I   +  L  +  L  + N      P  I
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLEDISP--I 303

Query: 590 GNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLS 649
            NLK L  +    NN SD+ P  +  LT LQ LF   N++      S  +L ++  L+  
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAG 359

Query: 650 NNNLSRSIPISLEKLSYLEDLDLSFN 675
           +N +S   P++   L+ +  L L+  
Sbjct: 360 HNQISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 97.4 bits (241), Expect = 5e-22
 Identities = 79/395 (20%), Positives = 127/395 (32%), Gaps = 43/395 (10%)

Query: 175 SNLPFLESISLSQNMFHGRIP-SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYL 233
           + L       L +      +  + L     L+   L I ++ G     +  L  L ++  
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINF 73

Query: 234 GYSGLQGEIPREFGNLAELEL------------MALQVSNLQGEIPQELANLTGLEVLKL 281
             + L    P    NL +L                  ++NL G             +  L
Sbjct: 74  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 282 GKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSI 341
                       I ++  L  L        G     +  ++ LT L     S +      
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 342 ADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMT 401
              +L NLE L   +N  S   P  I   + L  L L  N        T  +L NL  + 
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 402 LHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCN 461
           L  N +++       L+  S    LT + L  N +  I P   +  L++     +     
Sbjct: 248 LANNQISN-------LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI 300

Query: 462 VSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRL 521
                   I NL NL  + L  N ++   P+    L KLQ L   +NK+       +  L
Sbjct: 301 ------SPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANL 350

Query: 522 TKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSN 556
           T +  L    N++S   P   +NL  +  L L   
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 92.4 bits (228), Expect = 2e-20
 Identities = 70/386 (18%), Positives = 140/386 (36%), Gaps = 28/386 (7%)

Query: 224 NLTKLKELYLGYSGLQGEIP-REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
            L +  +  LG + +   +   +   +  L+   L + ++ G     +  L  L  +   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIA 342
            N LT   P  + NL  L  + +++N++    P       T   L     +    L ++ 
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 343 DVQLP-----NLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNL 397
           ++         + ++   S   S     F    + L  L          I +   +  ++
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 398 RLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDM 457
                +   L ++N ++S ++      +L  + L+ N L  I    S+ NL+      D+
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTD----LDL 248

Query: 458 SYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDD 517
           +   +S   P  +  LT L  + LG N+++   P+          L+             
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL----EDISP 302

Query: 518 ICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFS 577
           I  L  L  L L  N +S   P   S+L  L  L   +NK++ +  ++ NL  + +L+  
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAG 359

Query: 578 SNFFTGPLPLDIGNLKVLIGIDFSTN 603
            N  +   PL   NL  +  +  +  
Sbjct: 360 HNQISDLTPL--ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.9 bits (219), Expect = 3e-19
 Identities = 82/406 (20%), Positives = 146/406 (35%), Gaps = 42/406 (10%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
            L+      LG   ++ ++      L  +  +      +       +   ++L  ++FS 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
           N L+   P    + L  +   +                   L    ++  + L  +    
Sbjct: 76  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
                   +    +       ++                 Q    + LANLT LE L + 
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSF------------GNQVTDLKPLANLTTLERLDIS 183

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIA 342
            N         +  L NL+ L  ++N++    P  +  ++ L  L L  N L   + ++A
Sbjct: 184 SNK--VSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLA 238

Query: 343 DVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL 402
              L NL +L L +N  S   P  +   +KL+ L+LG N  S   P     L  L  + L
Sbjct: 239 --SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 292

Query: 403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNV 462
           + N L   +         SN K+LTY+ L  N +  I P   + +L+  L+    +   V
Sbjct: 293 NENQLEDIS-------PISNLKNLTYLTLYFNNISDISP---VSSLT-KLQRLFFANNKV 341

Query: 463 SGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDN 508
           S      + NLTN+  +  G N+++   P  L  L ++  L L D 
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.7 bits (216), Expect = 6e-19
 Identities = 79/390 (20%), Positives = 135/390 (34%), Gaps = 40/390 (10%)

Query: 58  LAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRL 117
           LA+   T     N T         +V  L    L +       +  L++L  +N   N+L
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQL 78

Query: 118 SGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNL 177
           +   P  +  L  L  +    NQ++   P       +   L  +       +      N 
Sbjct: 79  TDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136

Query: 178 PFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI------------GNL 225
             L S ++S       + S        ++  L     L  + +                L
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196

Query: 226 TKLKELYLGYSGLQGEIPREFG-NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKN 284
           T L+ L    + +    P     NL EL L   Q+ +        LA+LT L  L L  N
Sbjct: 197 TNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-----IGTLASLTNLTDLDLANN 251

Query: 285 FLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADV 344
            ++   P  +  L  L  L L  N++       I  ++ LT L     + +         
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISN-----ISPLAGLTALTNLELNENQLEDISPIS 304

Query: 345 QLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHY 404
            L NL  L L+ NN S   P  + + +KL  L    N  S    ++  NL N+  ++  +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 405 NYLTSSNLELSFLSSFSNCKSLTYIGLSNN 434
           N ++        L+  +N   +T +GL++ 
Sbjct: 361 NQISD-------LTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 82.0 bits (201), Expect = 5e-17
 Identities = 52/260 (20%), Positives = 93/260 (35%), Gaps = 41/260 (15%)

Query: 49  HITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQ 108
                P   L             + ++       ++ L  ++  ++   P  +   ++L 
Sbjct: 165 VTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLD 222

Query: 109 SLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGE 168
            L+L  N+L       + +L  L  ++   NQ+S   P  +   + L  L    N +S  
Sbjct: 223 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 278

Query: 169 IPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKL 228
            P    + L  L ++ L++N      P   SN K L  L+L  NN+    P  + +LTKL
Sbjct: 279 SP---LAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKL 331

Query: 229 KELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTG 288
           + L+   + +                               LANLT +  L  G N ++ 
Sbjct: 332 QRLFFANNKVSD--------------------------VSSLANLTNINWLSAGHNQISD 365

Query: 289 EIPPEIHNLHNLKLLDLSHN 308
             P  + NL  +  L L+  
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.6 bits (200), Expect = 7e-17
 Identities = 74/385 (19%), Positives = 136/385 (35%), Gaps = 54/385 (14%)

Query: 86  LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAF 145
             +   N+T T+     +L  + +L      +  SI   +  L  L  +NF  NQL+   
Sbjct: 27  TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDIT 82

Query: 146 PSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLE 205
           P  + N + L  +  + N ++   P    +N      ++      +              
Sbjct: 83  P--LKNLTKLVDILMNNNQIADITPLANLTN------LTGLTLFNNQITDIDPLKNLTNL 134

Query: 206 ILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGE 265
                 +N +  I    G  +  +  +           +   NL  LE +   +S+ +  
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQV----TDLKPLANLTTLERL--DISSNKVS 188

Query: 266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLT 325
               LA LT LE L    N ++   P  I    NL  L L+ N+L      T+ +++ LT
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLT 244

Query: 326 GLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASK------------- 372
            L L +N +S          L  L EL+L +N  S   P     A               
Sbjct: 245 DLDLANNQISNL---APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 301

Query: 373 -------LSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKS 425
                  L+ L L  N+ S   P    +L  L+ +    N ++        +SS +N  +
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-------VSSLANLTN 352

Query: 426 LTYIGLSNNPLDGILPRMSMGNLSH 450
           + ++   +N +  + P  ++  ++ 
Sbjct: 353 INWLSAGHNQISDLTPLANLTRITQ 377

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 80.4 bits (197), Expect = 1e-16
 Identities = 69/369 (18%), Positives = 118/369 (31%), Gaps = 75/369 (20%)

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY 428
             ++     LG+ + +  +  +  +L  +  +      + S       +       +LT 
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 70

Query: 429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFP--------------------- 467
           I  SNN L  I P  ++  L   L   +                                
Sbjct: 71  INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 468 --------------KEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGP 513
                          +I  L+ L  +         +    L  L  L+ L +  NK    
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VS 188

Query: 514 IPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLY 573
               + +LT L  L  + N++S   P       +L  LSL  N+L  I  T+ +L  +  
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDIG-TLASLTNLTD 245

Query: 574 LNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP--------------------TVI 613
           L+ ++N  +   PL    L  L  +    N  S++ P                    + I
Sbjct: 246 LDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303

Query: 614 GGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLS 673
             L NL YL L +N +          L  L+ L  +NN +  S   SL  L+ +  L   
Sbjct: 304 SNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAG 359

Query: 674 FNKLKGEIP 682
            N++    P
Sbjct: 360 HNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.9 bits (141), Expect = 1e-09
 Identities = 21/111 (18%), Positives = 44/111 (39%), Gaps = 6/111 (5%)

Query: 54  PTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLG 113
           P   L    N          ++   +   +  L +   N++   P  + +L+ LQ L   
Sbjct: 280 PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFA 337

Query: 114 FNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA 164
            N++S    S++  L  + +++   NQ+S   P  + N + +  L  +  A
Sbjct: 338 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (277), Expect = 2e-27
 Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 14/184 (7%)

Query: 777 RATNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH 835
           R  NR+     IG G FG +Y    I  G EVA+K+  ++         +E ++ K ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQG 61

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
              I  I  C  E    +++  +   SLE      +    +   L +   + + +EY+H 
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH- 120

Query: 896 GYSAPVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLIGED-----QSITQTQTLATIG 947
             S   IH D+KP N L        + ++ DFG+AK                     T  
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 948 YMAP 951
           Y + 
Sbjct: 179 YASI 182

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-27
 Identities = 40/182 (21%), Positives = 68/182 (37%), Gaps = 17/182 (9%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF------DLQCGRAFKSFDVECEMMKS 832
           +++    L+G GGFGSVY    + + + VA+K        D           +E  ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 833 IR--HRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           +      +I+++      +   LILE            +    L      +    V   +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYM 949
            + H   +  V+H D+K  N+L+D +     L DFG   LL    +    T    T  Y 
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYS 176

Query: 950 AP 951
            P
Sbjct: 177 PP 178

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 5e-27
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 8/174 (4%)

Query: 781 RFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRN 837
            F +   IG G +G VYKAR    G  VA+K   L         +   E  ++K + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 838 LIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY 897
           ++K++    TE    L+ E++     +    S+   + +    + +  +   L + H   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119

Query: 898 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           S  V+H DLKP N+L++      L+DFG+A+      ++ T      T+ Y AP
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 171

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-26
 Identities = 44/191 (23%), Positives = 77/191 (40%), Gaps = 18/191 (9%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDL------QCGRAFKSFDVECEMMKS 832
           + +     +G G F  V K R    G++ A K          + G + +  + E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 833 IRHRNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEY 892
           I+H N+I +      +    LILE +  G L     +    L   +    +  +   + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128

Query: 893 LHFGYSAPVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLIGEDQSITQTQTLATIGY 948
           LH   S  + H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 949 MAPGLFHVKYI 959
           +AP + + + +
Sbjct: 183 VAPEIVNYEPL 193

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 1e-26
 Identities = 35/178 (19%), Positives = 74/178 (41%), Gaps = 19/178 (10%)

Query: 787 LIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC 845
           ++G G  G V +        + A+K+    C +A +  ++     ++ +  ++++++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVY 74

Query: 846 ----STEEFKALILEYMPHGSLEKSLYS-SNYILDIFQRLNIMVDVATTLEYLHFGYSAP 900
               +  +   +++E +  G L   +    +      +   IM  +   ++YLH   S  
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SIN 131

Query: 901 VIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
           + H D+KP N+L      N +  L+DFG AK     +   T      T  Y+AP +  
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLG 186

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 3e-26
 Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 10/180 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRA---FKSFDVECEMMKSIRH 835
           N F    L+G+G FG V   R    G   A+K+   +   A         E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L  +  +  T +    ++EY   G L   L S   +    +      ++   +  L +
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEI---VSALEY 120

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
            +S  V++ D+K  N++LD +    ++DFG+ K  I +    T      T  Y+AP +  
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE 178

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (270), Expect = 5e-26
 Identities = 41/180 (22%), Positives = 74/180 (41%), Gaps = 13/180 (7%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFD---LQCGRAFKSFDVECEMMKSIRH 835
           ++F     +G G FG V   +    G   A+K+ D   +   +  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 836 RNLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
             L+K+  S        +++EY+  G +   L                  +  T EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 896 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
             S  +I+ DLKP N+L+D      ++DFG AK + G   ++       T   +AP +  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (261), Expect = 2e-25
 Identities = 37/179 (20%), Positives = 79/179 (44%), Gaps = 9/179 (5%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCG--RAFKSFDVECEMMKSIRHR 836
            ++ +   IG G +G+V+KA+       VA+K   L         S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 837 NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG 896
           N++++     +++   L+ E+      +     +  + D     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS- 119

Query: 897 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFH 955
               V+H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P +  
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLF 174

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (259), Expect = 6e-25
 Identities = 29/190 (15%), Positives = 58/190 (30%), Gaps = 16/190 (8%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
             +     IG G FG +++   +    +VA+K    +          E    K +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 839 IKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS 898
           I  +     E    +++  +   SLE  L        +         +   ++ +H    
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 899 APVIHCDLKPSNVLLDDNMVAH-----LSDFGIAKLLIGEDQSITQ-----TQTLATIGY 948
             +++ D+KP N L+      +     + DFG+ K                     T  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 949 MAPGLFHVKY 958
           M+      + 
Sbjct: 180 MSINTHLGRE 189

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  100 bits (249), Expect = 2e-23
 Identities = 37/181 (20%), Positives = 79/181 (43%), Gaps = 18/181 (9%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRN 837
           + +     +GRG +  V++A  I    +V VK+      +  K    E ++++++R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPN 91

Query: 838 LIKVISSCSTEEFK--ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHF 895
           +I +         +  AL+ E++ +   ++   +    L  +     M ++   L+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146

Query: 896 GYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLF 954
             S  ++H D+KP NV++D ++    L D+G+A+              +A+  +  P L 
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELL 201

Query: 955 H 955
            
Sbjct: 202 V 202

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 3e-23
 Identities = 40/188 (21%), Positives = 72/188 (38%), Gaps = 13/188 (6%)

Query: 780 NRFSENNLIGRGGFGSVYKAR----IGEGMEVAVKVFD----LQCGRAFKSFDVECEMMK 831
             F    ++G G +G V+  R       G   A+KV      +Q  +  +    E ++++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 832 SIRHR-NLIKVISSCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
            IR    L+ +  +  TE    LIL+Y+  G L   L         F    + + V   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
             L   +   +I+ D+K  N+LLD N    L+DFG++K  + ++                
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 951 PGLFHVKY 958
             +     
Sbjct: 200 DIVRGGDS 207

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 98.6 bits (244), Expect = 5e-23
 Identities = 61/316 (19%), Positives = 99/316 (31%), Gaps = 31/316 (9%)

Query: 335 SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNL 394
              L  +     P+   L L +N  +        N   L  L L  N  S   P  F  L
Sbjct: 19  DLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPL 78

Query: 395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEY 454
             L  + L  N L                K+L  + +  N +  +   +  G     +  
Sbjct: 79  VKLERLYLSKNQLKE--------LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 455 FDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPI 514
              +    SG        +  L  I +    +     I  G    L  LHL+ NK+    
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVD 187

Query: 515 PDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL 574
              +  L  L +LGLS N +S       +N   L  L L +NKL  +P  + + K +  +
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247

Query: 575 NFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS-- 632
              +N           N+  +   DF         P       +   + L  N +Q    
Sbjct: 248 YLHNN-----------NISAIGSNDFC-------PPGYNTKKASYSGVSLFSNPVQYWEI 289

Query: 633 ISESFGDLISLKSLNL 648
              +F  +    ++ L
Sbjct: 290 QPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.8 bits (229), Expect = 5e-21
 Identities = 51/296 (17%), Positives = 97/296 (32%), Gaps = 16/296 (5%)

Query: 69  CNWTGVTCDVHSHR---------VKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSG 119
           C+   V C                 +L++ +  +T        NL +L +L L  N++S 
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 120 SIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPF 179
             P A   L  L+ +    NQL             L+  +     +   +      N   
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN--GLNQMI 127

Query: 180 LESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQ 239
           +  +  +     G    A    K L  + ++  N +  IP+  G    L EL+L  + + 
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQ--GLPPSLTELHLDGNKIT 184

Query: 240 GEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHN 299
                    L  L  + L  +++       LAN   L  L L  N L  ++P  + +   
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243

Query: 300 LKLLDLSHNKLVGAVPATIFNMSTLTGL-GLQSNSLSGSLSSIADVQLPNLEELRL 354
           ++++ L +N +              T        SL  +     ++Q      + +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 88.9 bits (219), Expect = 1e-19
 Identities = 54/261 (20%), Positives = 93/261 (35%), Gaps = 12/261 (4%)

Query: 424 KSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGG 483
                + L NN +  I       NL + L    +    +S   P     L  L  +YL  
Sbjct: 31  PDTALLDLQNNKITEIKDG-DFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSK 88

Query: 484 NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFS 543
           N+L          LQ+L+    E  K+   + + + ++  +  LG +  K SG     F 
Sbjct: 89  NQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQ 147

Query: 544 NLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTN 603
            +  L  + +    +T+IP        +  L+   N  T      +  L  L  +  S N
Sbjct: 148 GMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 604 NFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR------SI 657
           + S V    +    +L+ L L  N+L         D   ++ + L NNN+S         
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 658 PISLEKLSYLEDLDLSFNKLK 678
           P    K +    + L  N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.5 bits (205), Expect = 5e-18
 Identities = 53/238 (22%), Positives = 80/238 (33%), Gaps = 3/238 (1%)

Query: 474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNK 533
            +   + L  NK+          L+ L  L L +NK+    P     L KL  L LS N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 534 LSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLK 593
           L          L  L        K+        N   ++ L  +    +G        +K
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 594 VLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNL 653
            L  I  +  N + +     G   +L  L L  N++    + S   L +L  L LS N++
Sbjct: 151 KLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207

Query: 654 SRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPNLQVPP 711
           S     SL    +L +L L+ NKL                    N +     N   PP
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.2 bits (204), Expect = 8e-18
 Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 5/218 (2%)

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
            +P  L        L L++NK+      D   L  L+ L L  NK+S   P  F+ L  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDV 608
             L L  N+L  +P  +      L ++ +          +  N  +++ +  +    S +
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 609 IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLE 668
                 G+  L Y+ +    +    +   G   SL  L+L  N +++    SL+ L+ L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 669 DLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSPN 706
            L LSFN +        +      +    N  L   P 
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 51.6 bits (122), Expect = 2e-07
 Identities = 26/140 (18%), Positives = 46/140 (32%), Gaps = 4/140 (2%)

Query: 585 LPLDIG-NLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISL 643
           +P D+  +  +L   D   N  +++       L NL  L L  N++      +F  L+ L
Sbjct: 25  VPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 644 KSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCG 703
           + L LS N L        + L  L   +    K++  +  G +            +    
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 704 SPNLQVPPCKTSIHHKSRKN 723
                    K S    +  N
Sbjct: 142 ENGAFQGMKKLSYIRIADTN 161

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 5e-23
 Identities = 41/181 (22%), Positives = 77/181 (42%), Gaps = 20/181 (11%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRHR 836
             + +   +G G +G+V  A     G +VA+K      Q     K    E  ++K +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 837 NLIKVISSCSTEEFKA------LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           N+I ++   + +E         L++ +M     +      +  L   +   ++  +   L
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGEDRIQFLVYQMLKGL 134

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
            Y+H   +A +IH DLKP N+ ++++    + DFG+A+           T  + T  Y A
Sbjct: 135 RYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRA 186

Query: 951 P 951
           P
Sbjct: 187 P 187

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 1e-21
 Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 16/183 (8%)

Query: 779 TNRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRH 835
             R+   + +G G +GSV  A     G+ VAVK      Q     K    E  ++K ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 836 RNLIKVISSCSTE----EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE 891
            N+I ++   +      EF  + L     G+   ++      L       ++  +   L+
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLK 135

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAP 951
           Y+H   SA +IH DLKPSN+ ++++    + DFG+A+           T  +AT  Y AP
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAP 187

Query: 952 GLF 954
            + 
Sbjct: 188 EIM 190

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 3e-21
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 19/181 (10%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVF--DLQCGRAFKSFDVECEMMKSIRHR 836
            R+     IG G  G V  A        VA+K      Q     K    E  +MK + H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 837 NLIKVISSCSTEEFK------ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTL 890
           N+I +++  + ++         L++E M     +          D  +   ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132

Query: 891 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMA 950
           ++LH   SA +IH DLKPSN+++  +    + DFG+A+       S   T  + T  Y A
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRA 186

Query: 951 P 951
           P
Sbjct: 187 P 187

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.0 bits (212), Expect = 8e-20
 Identities = 23/157 (14%), Positives = 50/157 (31%), Gaps = 26/157 (16%)

Query: 786 NLIGRGGFGSVYKARIGEGMEVAVKVFDL----------QCGRAFKSFDVECEMMKSIRH 835
            L+G G   +V+     +  E  VK   +          +       F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 836 RNLIKVISSCSTEEF----KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLE 891
           R L K+      + +     A+++E +             Y + +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117

Query: 892 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 928
             +      ++H DL   NVL+ +  +  + DF  + 
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (215), Expect = 2e-19
 Identities = 58/286 (20%), Positives = 99/286 (34%), Gaps = 8/286 (2%)

Query: 76  CDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVN 135
           C  ++      +     L   +P  +   ++ Q + L  NR+S    ++      L  + 
Sbjct: 6   CVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILW 62

Query: 136 FRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIP 195
              N L+    +     + L+ LD S NA    +       L  L ++ L +       P
Sbjct: 63  LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122

Query: 196 SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELM 255
                   L+ L L  N L         +L  L  L+L  + +     R F  L  L+ +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182

Query: 256 ALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVP 315
            L  + +    P    +L  L  L L  N L+      +  L  L+ L L+ N  V    
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242

Query: 316 ATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSG 361
           A     + L      S+ +  SL      +L   +  RL +N+  G
Sbjct: 243 ARPL-WAWLQKFRGSSSEVPCSLPQ----RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (207), Expect = 2e-18
 Identities = 56/257 (21%), Positives = 85/257 (33%), Gaps = 6/257 (2%)

Query: 424 KSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGG 483
            +   I L  N +  + P  S     +    +  S            G            
Sbjct: 32  AASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 484 NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFS 543
            +L    P T   L +L  LHL+   L+   P     L  L  L L  N L       F 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 544 NLASLGTLSLGSNKLTSIPL-TIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFST 602
           +L +L  L L  N+++S+P      L  +  L    N      P    +L  L+ +    
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLE 662
           NN S +    +  L  LQYL L  N        +      L+    S++ +  S+P  L 
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 663 KLSYLEDLDLSFNKLKG 679
                    L+ N L+G
Sbjct: 270 GRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.2 bits (188), Expect = 6e-16
 Identities = 49/272 (18%), Positives = 83/272 (30%), Gaps = 9/272 (3%)

Query: 335 SGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNL 394
              L ++        + + L  N  S            L++L L  N  +      F  L
Sbjct: 20  QQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79

Query: 395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEY 454
             L  + L  N      L     ++F     L  + L    L  +     +     +L+Y
Sbjct: 80  ALLEQLDLSDNA----QLRSVDPATFHGLGRLHTLHLDRCGLQEL--GPGLFRGLAALQY 133

Query: 455 FDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPI 514
             +    +         +L NL  ++L GN+++         L  L  L L  N++    
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193

Query: 515 PDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL 574
           P     L +L  L L  N LS       + L +L  L L  N              +   
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKF 253

Query: 575 NFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
             SS+     LP  +    +      + N+  
Sbjct: 254 RGSSSEVPCSLPQRLAGRDLK---RLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.5 bits (163), Expect = 9e-13
 Identities = 52/231 (22%), Positives = 81/231 (35%), Gaps = 5/231 (2%)

Query: 58  LAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRL 117
           L   W  S  +           +   ++    +  L    P+    L  L +L+L    L
Sbjct: 58  LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117

Query: 118 SGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNL 177
               P     L  L+Y+  + N L         +  +L HL    N +S  +P      L
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGL 176

Query: 178 PFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSG 237
             L+ + L QN      P A  +   L  L L  NNL     + +  L  L+ L L  + 
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236

Query: 238 LQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTG 288
              +  R     A L+      S +   +PQ LA   G ++ +L  N L G
Sbjct: 237 WVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (155), Expect = 1e-11
 Identities = 60/242 (24%), Positives = 85/242 (35%), Gaps = 4/242 (1%)

Query: 466 FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLY 525
            P  I        I+L GN+++     +    + L  L L  N L          L  L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 526 ELGLSGNKLSGSI-PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNF-SSNFFTG 583
           +L LS N    S+ PA F  L  L TL L    L  +   ++     L   +   N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 584 PLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISL 643
                  +L  L  +    N  S V      GL +L  L L  NR+      +F DL  L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 644 KSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCG 703
            +L L  NNLS     +L  L  L+ L L+ N    +      +          +E+ C 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263

Query: 704 SP 705
            P
Sbjct: 264 LP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (93), Expect = 6e-04
 Identities = 30/169 (17%), Positives = 46/169 (27%), Gaps = 27/169 (15%)

Query: 539 PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGI 598
            AC        T S     L ++P+ I        +    N  +          + L  +
Sbjct: 4   GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 599 DFSTNNFSDVI-------------------------PTVIGGLTNLQYLFLGYNRLQGSI 633
              +N  + +                          P    GL  L  L L    LQ   
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 634 SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIP 682
              F  L +L+ L L +N L      +   L  L  L L  N++     
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.8 bits (216), Expect = 5e-19
 Identities = 38/217 (17%), Positives = 78/217 (35%), Gaps = 21/217 (9%)

Query: 780 NRFSENNLIGRGGFGSVYKAR-IGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL 838
            R+     +G G F +V+ A+ +     VA+K+         ++ + E ++++ +   + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADN 71

Query: 839 IKVISSCSTEEFK---------------ALILEYMPHGSLEKSLYSSNYILDIFQRLNIM 883
            K  S  +    K                ++ E +    L       +  + +     I 
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 884 VDVATTLEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSITQTQT 942
             +   L+Y+H      +IH D+KP NVL++  +   +L    IA L          T +
Sbjct: 132 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 943 LATIGYMAPG-LFHVKYILFVVNFLTSYSFLMIFIGR 978
           + T  Y +P  L    +      + T+     +  G 
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.7 bits (169), Expect = 2e-13
 Identities = 50/209 (23%), Positives = 78/209 (37%), Gaps = 6/209 (2%)

Query: 469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELG 528
           E+  + + + +      L  ++P  L K      LHL +N L       +   T+L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 529 LSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLD 588
           L   +   +       L  LGTL L  N+L S+PL    L  +  L+ S N  T      
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 589 IGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNL 648
           +  L  L  +    N    + P ++     L+ L L  N L    +     L +L +L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 649 SNNNLSRSIPISLEKLSYLEDLDLSFNKL 677
             N+L  +IP        L    L  N  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 46/217 (21%), Positives = 66/217 (30%), Gaps = 13/217 (5%)

Query: 221 EIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLK 280
           E+  +    E+      L   +P +     +  ++ L  + L       L   T L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 281 LGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSS 340
           L +             L  L  LDLSHN+L           +        +   S  L  
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS--LPL 117

Query: 341 IADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM 400
            A   L  L+EL L  N      P  +    KL  L L  N+ +         L NL  +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 401 TLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLD 437
            L  N L +          F     L +  L  NP  
Sbjct: 178 LLQENSLYT------IPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.6 bits (127), Expect = 3e-08
 Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 10/187 (5%)

Query: 395 RNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEY 454
           ++  ++ L  N L + +L     ++      LT + L    L  +    ++  L      
Sbjct: 31  KDTTILHLSENLLYTFSL-----ATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLS 85

Query: 455 FDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPI 514
            +        G       + ++    L            L  L +LQ L+L+ N+L+   
Sbjct: 86  HNQLQSLPLLGQTLPALTVLDVSFNRL-----TSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 515 PDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL 574
           P  +    KL +L L+ N L+       + L +L TL L  N L +IP   +    + + 
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFA 200

Query: 575 NFSSNFF 581
               N +
Sbjct: 201 FLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 41/244 (16%), Positives = 66/244 (27%), Gaps = 38/244 (15%)

Query: 67  PVCNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIF 126
           P+C          +  ++V N    NLT  +P  L        L+L  N L     + + 
Sbjct: 2   PIC-----EVSKVASHLEV-NCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLM 52

Query: 127 TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
               L  +N     L  A  + +    +L  L     + +      +        ++   
Sbjct: 53  PYTRLTQLN-----LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV 107

Query: 187 QNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREF 246
                  +P                 N L  +P  +   T                    
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL----------------- 150

Query: 247 GNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLS 306
                 E ++L  +NL       L  L  L+ L L +N L   IP      H L    L 
Sbjct: 151 ------EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203

Query: 307 HNKL 310
            N  
Sbjct: 204 GNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 9e-08
 Identities = 52/210 (24%), Positives = 80/210 (38%), Gaps = 8/210 (3%)

Query: 174 CSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYL 233
            S +     ++  +      +P  L   K   IL LS N L       +   T+L +L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 234 GYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPE 293
                +    +  G L  L  + L  + LQ         L  L VL +  N LT      
Sbjct: 63  --DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGA 119

Query: 294 IHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELR 353
           +  L  L+ L L  N+L    P  +     L  L L +N+L+   + + +  L NL+ L 
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLN-GLENLDTLL 178

Query: 354 LWSNNFSGTIPRFIFNASKLSVLELGRNSF 383
           L  N+   TIP+  F +  L    L  N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (116), Expect = 7e-07
 Identities = 34/212 (16%), Positives = 56/212 (26%), Gaps = 8/212 (3%)

Query: 419 SFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIG 478
             S   S   +      L  + P     +L        +S   +       +   T L  
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPP-----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSI 538
           + L   +L          L  L  L L  N+L+                       S  +
Sbjct: 60  LNLDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 539 PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGI 598
            A             G+   T  P  +     +  L+ ++N  T      +  L+ L  +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 599 DFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ 630
               N+    IP    G   L + FL  N   
Sbjct: 178 LLQENSLYT-IPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 41/246 (16%), Positives = 66/246 (26%), Gaps = 8/246 (3%)

Query: 199 SNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQ 258
           S       ++    NL  A+P ++        L+L  + L             L    L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQ--LN 61

Query: 259 VSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATI 318
           +   +    Q    L  L  L L  N L                        + ++P   
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTV--LDVSFNRLTSLPLGA 119

Query: 319 FNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLEL 378
                         +   +L        P LE+L L +NN +      +     L  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 379 GRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDG 438
             NS    IP  F     L    LH N    +   L F     +     Y+      +  
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKA 238

Query: 439 ILPRMS 444
           +   ++
Sbjct: 239 MTSNVA 244

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (148), Expect = 9e-11
 Identities = 54/301 (17%), Positives = 101/301 (33%), Gaps = 29/301 (9%)

Query: 101 LWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSF-IFNKSSLQHLD 159
           LW     Q+L+L    L   +   + +   +    FR  +     P    F+   +QH+D
Sbjct: 1   LW-----QTLDLTGKNLHPDVTGRLLSQGVI---AFRCPRSFMDQPLAEHFSPFRVQHMD 52

Query: 160 FSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIP 219
            S + +       I S    L+++SL        I + L+    L  L+LS  +      
Sbjct: 53  LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA 112

Query: 220 KEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVL 279
            +    +  +   L  S       +            +   NL G               
Sbjct: 113 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG--------------- 157

Query: 280 KLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLV-GAVPATIFNMSTLTGLGLQSNSLSGSL 338
              KN    ++   +    NL  LDLS + ++        F ++ L  L L         
Sbjct: 158 -YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 216

Query: 339 SSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLR 398
           + +   ++P L+ L+++     GT+         L  L++  + F+     T GN +N  
Sbjct: 217 TLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIARPTIGNKKNQE 273

Query: 399 L 399
           +
Sbjct: 274 I 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 1e-07
 Identities = 38/279 (13%), Positives = 79/279 (28%), Gaps = 13/279 (4%)

Query: 156 QHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLL 215
           Q LD +   L  ++   + S    + +    ++     +    S  + ++ + LS + + 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59

Query: 216 G-AIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELE-LMALQVSNLQGEIPQE---- 269
              +   +   +KL+ L L    L   I       + L  L     S       Q     
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 270 ---LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTG 326
              L  L         +  +   +      +  L L     N     +   +     L  
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 327 LGLQSNSLSGSLSSIADVQLPNLEELRLWS-NNFSGTIPRFIFNASKLSVLELGRNSFSG 385
           L L  + +  +       QL  L+ L L    +        +     L  L++      G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 386 FIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCK 424
            +      L +L++   H+  +    +           K
Sbjct: 240 TLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 3e-06
 Identities = 42/268 (15%), Positives = 89/268 (33%), Gaps = 14/268 (5%)

Query: 72  TGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFT-LYT 130
             VT  + S  V         +   +     +   +Q ++L  + +  S    I +    
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSK 72

Query: 131 LKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA----LSGEIPANICSNLPFLESISLS 186
           L+ ++  G +LS    + +   S+L  L+ S  +     + +   + CS L  L      
Sbjct: 73  LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 132

Query: 187 QNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYS----GLQGEI 242
                    +     + +  L+LS              + +   L          L+ + 
Sbjct: 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC 192

Query: 243 PREFGNLAELELMAL-QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLK 301
            +EF  L  L+ ++L +  ++  E   EL  +  L+ L++      G +      L +L+
Sbjct: 193 FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ 252

Query: 302 LLDLSHNKLVGAVPATIFNMSTLTGLGL 329
           +     +        TI N       G+
Sbjct: 253 INC---SHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 2e-05
 Identities = 38/255 (14%), Positives = 82/255 (32%), Gaps = 18/255 (7%)

Query: 427 TYIGLSNNPL-DGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNK 485
             + L+   L   +  R+    LS  +  F      +      E  +   +  + L  + 
Sbjct: 3   QTLDLTGKNLHPDVTGRL----LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSV 57

Query: 486 LNG-SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYEL--GLSGNKLSGSIPACF 542
           +   ++   L +  KLQ L LE  +L  PI + + + + L  L           ++    
Sbjct: 58  IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 543 SNLASLGTLSLGSNKLTSIPLTIWNLKG--------MLYLNFSSNFFTGPLPLDIGNLKV 594
           S+ + L  L+L      +       +           L     +   +    L      +
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 595 LIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGY-NRLQGSISESFGDLISLKSLNLSNNNL 653
           +      +    +        L  LQ+L L     +        G++ +LK+L +     
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237

Query: 654 SRSIPISLEKLSYLE 668
             ++ +  E L +L+
Sbjct: 238 DGTLQLLKEALPHLQ 252

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 36/256 (14%), Positives = 80/256 (31%), Gaps = 19/256 (7%)

Query: 376 LELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNP 435
           L+L   +     P+  G L +  ++         S ++      FS  + + ++ LSN+ 
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFR---CPRSFMDQPLAEHFSPFR-VQHMDLSNSV 57

Query: 436 LDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNL--------IGIYLGGNKLN 487
           ++       +   S  L+   +    +S      +   +NL         G      +  
Sbjct: 58  IEVSTLHGILSQCSK-LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116

Query: 488 GSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLAS 547
            S    L +L         +  ++  +      +T+L   G   N     +        +
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176

Query: 548 LGTLSLGSNKLTS--IPLTIWNLKGMLYLNFSS-NFFTGPLPLDIGNLKVLIGIDFSTNN 604
           L  L L  + +         + L  + +L+ S          L++G +  L  +      
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236

Query: 605 FSDVIPTVIGGLTNLQ 620
               +  +   L +LQ
Sbjct: 237 PDGTLQLLKEALPHLQ 252

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 61.0 bits (146), Expect = 3e-10
 Identities = 62/331 (18%), Positives = 106/331 (32%), Gaps = 20/331 (6%)

Query: 248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
              ELEL  L +S+L    P        LE L    N LT E+P    +L +L + + + 
Sbjct: 39  QAHELELNNLGLSSLPELPPH-------LESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90

Query: 308 NKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFI 367
             L    P   +   +   L       + S   I DV   +L++L     +         
Sbjct: 91  KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150

Query: 368 FNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSN---CK 424
                  +  L   +      N+   L +L L         +   EL  L +        
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210

Query: 425 SLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGN 484
           +   +  +   L   L  +++ +   +                     L+ L       N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270

Query: 485 KLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSN 544
             +  I         L+ L++ +NKL   +P    RL +L     S N L+  +P    N
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLA-EVPELPQN 325

Query: 545 LASLGTLSLGSNKLTSIPLTIWNLKGMLYLN 575
           L     L +  N L   P    +++  L +N
Sbjct: 326 LK---QLHVEYNPLREFPDIPESVED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.1 bits (141), Expect = 9e-10
 Identities = 56/327 (17%), Positives = 94/327 (28%), Gaps = 19/327 (5%)

Query: 274 TGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNS 333
                L+L    L+  +P    +L +L     S N L   +P    ++ +L        +
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 334 LSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGN 393
           LS     +  + + N +  +L     S  +     + + L  L     S           
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 394 LRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLE 453
                L  L +     ++   S         SL  I   NN L+ +    ++  L+    
Sbjct: 153 EELPELQNLPFLTAIYADNN-SLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211

Query: 454 YF----DMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK 509
                  +     S        N    +                   L +L       N 
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271

Query: 510 LEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLK 569
               I         L EL +S NKL   +PA    L     L    N L  +P    NLK
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAEVPELPQNLK 327

Query: 570 GMLYLNFSSNFFTG--PLPLDIGNLKV 594
               L+   N       +P  + +L++
Sbjct: 328 ---QLHVEYNPLREFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 2e-08
 Identities = 57/337 (16%), Positives = 96/337 (28%), Gaps = 29/337 (8%)

Query: 341 IADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLM 400
           + D       EL L +N    ++P    +   L  L    NS +  +P    +L++L + 
Sbjct: 32  LRDCLDRQAHELEL-NNLGLSSLPELPPH---LESLVASCNSLTE-LPELPQSLKSLLVD 86

Query: 401 TLHYNYLT----------SSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSH 450
             +   L+           SN +L  L    N   L  I + NN L  +           
Sbjct: 87  NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA 146

Query: 451 SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKL 510
           +          +            N     L    L+    +    + +          L
Sbjct: 147 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206

Query: 511 EGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKG 570
                D+    T       S   L+              +L+                  
Sbjct: 207 TTIYADNNLLKTLPDL-PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265

Query: 571 MLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ 630
           + YLN SSN           +L+ L   + S N   + +P        L+ L   +N L 
Sbjct: 266 LYYLNASSNEIRSL-CDLPPSLEEL---NVSNNKLIE-LP---ALPPRLERLIASFNHLA 317

Query: 631 GSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYL 667
             + E      +LK L++  N L    P   E +  L
Sbjct: 318 -EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.8 bits (130), Expect = 3e-08
 Identities = 45/325 (13%), Positives = 95/325 (29%), Gaps = 16/325 (4%)

Query: 299 NLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNN 358
               L+L++  L  ++P    +   L  L    NSL+        ++   ++   L + +
Sbjct: 39  QAHELELNNLGL-SSLPELPPH---LESLVASCNSLTELPELPQSLKSLLVDNNNLKALS 94

Query: 359 FSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLS 418
               +       S   + +L     S F+     +  +L+ +      L       + L 
Sbjct: 95  DLPPL-LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 419 SFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPK---EIGNLTN 475
                ++L ++       + +     +     S+   +     +               N
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 476 LIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS 535
            +   L     +                  +         +    L++L       N  S
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 536 GSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVL 595
             I +      SL  L++ +NKL  +P     L+    L  S N     +P    NLK L
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPELPQNLKQL 329

Query: 596 IGIDFSTNNFSDVIPTVIGGLTNLQ 620
                  N   +  P +   + +L+
Sbjct: 330 ---HVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.5 bits (124), Expect = 1e-07
 Identities = 49/325 (15%), Positives = 96/325 (29%), Gaps = 25/325 (7%)

Query: 85  VLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGA 144
            L +++L L+ ++P        L+SL    N L+  +P    +L +L   N     LS  
Sbjct: 42  ELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 96

Query: 145 FPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYL 204
            P   +   S   L+      +      I  +   L+ +                  +  
Sbjct: 97  PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELP 156

Query: 205 EILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQG 264
           E+ +L     + A    +  L  L             +           L  +   N   
Sbjct: 157 ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 216

Query: 265 EIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLL----------DLSHNKLVGAV 314
           +   +L        ++        E+P  +  L   + +              N     +
Sbjct: 217 KTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEI 276

Query: 315 PATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLS 374
            +      +L  L + +N L    +       P LE L    N+ +  +P    N   L 
Sbjct: 277 RSLCDLPPSLEELNVSNNKLIELPALP-----PRLERLIASFNHLA-EVPELPQN---LK 327

Query: 375 VLELGRNSFSGFIPNTFGNLRNLRL 399
            L +  N      P+   ++ +LR+
Sbjct: 328 QLHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.1 bits (123), Expect = 2e-07
 Identities = 58/349 (16%), Positives = 107/349 (30%), Gaps = 37/349 (10%)

Query: 201 CKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVS 260
            +    L L+ N  L ++P+   +L     L    + L  E+P    +L  L +    + 
Sbjct: 37  DRQAHELELN-NLGLSSLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91

Query: 261 NLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFN 320
            L    P          +  LG +    E  PE+ N   LK++D+ +N L          
Sbjct: 92  ALSDLPPL---------LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142

Query: 321 MSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGR 380
                           +  +    +LP L+ L   +  ++            LS+  +  
Sbjct: 143 EFI-------------AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA 189

Query: 381 NSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGIL 440
            +          NL  L  +    N L +       L + +   +              L
Sbjct: 190 GNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFL 249

Query: 441 PRMSMGNLSHSLEYFDMSYCNVSGG-FPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQK 499
                     S    ++ Y N S            +L  + +  NKL   +P    +L++
Sbjct: 250 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER 308

Query: 500 LQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
              L    N L   +P+    L +L+   +  N L    P    ++  L
Sbjct: 309 ---LIASFNHLAE-VPELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 5e-06
 Identities = 20/83 (24%), Positives = 37/83 (44%), Gaps = 9/83 (10%)

Query: 600 FSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPI 659
           +  N  S+ I ++     +L+ L +  N+L   +         L+ L  S N+L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVP- 320

Query: 660 SLEKLSYLEDLDLSFNKLKGEIP 682
             E    L+ L + +N L+ E P
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.8 bits (104), Expect = 4e-05
 Identities = 23/112 (20%), Positives = 36/112 (32%), Gaps = 10/112 (8%)

Query: 69  CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTL 128
                         +          +  I S      SL+ LN+  N+L   +P+    L
Sbjct: 248 FLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL 306

Query: 129 YTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFL 180
             L       N L+   P       +L+ L   YN L  E P +I  ++  L
Sbjct: 307 ERL---IASFNHLA-EVPELP---QNLKQLHVEYNPLR-EFP-DIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 24/78 (30%), Positives = 30/78 (38%), Gaps = 7/78 (8%)

Query: 623 FLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIP 682
               N     I        SL+ LN+SNN L   +P    +   LE L  SFN L  E+P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 683 KGGSFGNFSAKSFEGNEL 700
           +     N      E N L
Sbjct: 321 E--LPQNLKQLHVEYNPL 336

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 58.3 bits (139), Expect = 3e-10
 Identities = 36/177 (20%), Positives = 61/177 (34%), Gaps = 7/177 (3%)

Query: 134 VNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR 193
           V+  G  L    P  I        L  + N L       +   LP L  + L +N   G 
Sbjct: 13  VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELE 253
            P+A     +++ L L  N +     K    L +LK L L  + +   +P  F +L  L 
Sbjct: 70  EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129

Query: 254 LMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL 310
            + L  +               L    L         P +   + ++++ DL H++ 
Sbjct: 130 SLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.0 bits (107), Expect = 5e-06
 Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 1/159 (0%)

Query: 547 SLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS 606
              T+      L  IP  I      L LN +            G L  L+ ++   N  +
Sbjct: 9   EGTTVDCTGRGLKEIPRDIPLHTTELLLNDN-ELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSY 666
            + P    G +++Q L LG N+++   ++ F  L  LK+LNL +N +S  +P S E L+ 
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 667 LEDLDLSFNKLKGEIPKGGSFGNFSAKSFEGNELLCGSP 705
           L  L+L+ N                 KS  G    CG+P
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 42.9 bits (99), Expect = 6e-05
 Identities = 38/187 (20%), Positives = 71/187 (37%), Gaps = 10/187 (5%)

Query: 421 SNCK-SLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGG-FPKEIGNLTNLIG 478
           + C    T +  +   L  I PR    ++        ++   +         G L +L+ 
Sbjct: 4   AMCHCEGTTVDCTGRGLKEI-PR----DIPLHTTELLLNDNELGRISSDGLFGRLPHLVK 58

Query: 479 IYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSI 538
           + L  N+L G  P        +Q L L +NK++         L +L  L L  N++S  +
Sbjct: 59  LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118

Query: 539 PACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGI 598
           P  F +L SL +L+L SN         W  + +   + +        P  + ++++    
Sbjct: 119 PGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIK--- 175

Query: 599 DFSTNNF 605
           D   + F
Sbjct: 176 DLPHSEF 182

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.6 bits (135), Expect = 2e-09
 Identities = 33/202 (16%), Positives = 60/202 (29%), Gaps = 15/202 (7%)

Query: 472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG 531
                I   L    +     +T  +L  +  +   ++ ++      I  L  + +L L+G
Sbjct: 22  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 532 NKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGN 591
           NKL+   P        L  L                          S         DI  
Sbjct: 78  NKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129

Query: 592 LKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
           L  L  ++      + +    +             +     I      L  L++L LS N
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN 188

Query: 652 NLSRSIPISLEKLSYLEDLDLS 673
           ++S  +  +L  L  L+ L+L 
Sbjct: 189 HIS-DLR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 9e-06
 Identities = 32/204 (15%), Positives = 68/204 (33%), Gaps = 17/204 (8%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
             +     NL    ++ ++      L ++  +    + +       I    ++  L  + 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
           N L+        +NL  L  + L +N                  L  +  + +  +    
Sbjct: 78  NKLTDI---KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
                     L     +         L +L+ ++L+ + +   +P  LA LT L+ L L 
Sbjct: 135 QL------ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLS 306
           KN ++      +  L NL +L+L 
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 30/199 (15%), Positives = 56/199 (28%), Gaps = 24/199 (12%)

Query: 248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
             AE     L+  ++   + Q    L  ++ +    + +       I  L N+  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 308 NKLVGAVPATIFNMSTLTGLGLQSN-----------SLSGSLSSIADVQLPNLEELRLWS 356
           NKL    P           L                  S SL       +  L  L    
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 357 NNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN--TFGNLRNLRLMTLHYNYLTSSNLEL 414
           + + G                   +     I +      L  L+ + L  N+++      
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD----- 192

Query: 415 SFLSSFSNCKSLTYIGLSN 433
             L + +  K+L  + L +
Sbjct: 193 --LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 9e-05
 Identities = 23/187 (12%), Positives = 62/187 (33%), Gaps = 12/187 (6%)

Query: 272 NLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQS 331
                    L K  +T  +      L+++  +  +++ +       I  +  +T L L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 332 NSLSGS--LSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN 389
           N L+    L+++ ++    L+E ++   +    + +    + + + +             
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 390 TFGNLRNLRLMTLHYNYLTSS------NLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
           +     N        + LT        + ++S +   +    L  + LS N +  +    
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALA 197

Query: 444 SMGNLSH 450
            + NL  
Sbjct: 198 GLKNLDV 204

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 34/200 (17%), Positives = 67/200 (33%), Gaps = 25/200 (12%)

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY 428
             ++     L + S +  +      L ++  +  + + + S       +       ++T 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72

Query: 429 IGLSNNPLDGILP-------------RMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTN 475
           + L+ N L  I P                + +LS   +   +   ++      +I  L +
Sbjct: 73  LFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132

Query: 476 LIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS 535
           L  +       N    IT+            ++     I   +  LTKL  L LS N +S
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHIS 191

Query: 536 GSIPACFSNLASLGTLSLGS 555
             + A  + L +L  L L S
Sbjct: 192 -DLRA-LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 23/166 (13%), Positives = 54/166 (32%), Gaps = 17/166 (10%)

Query: 81  HRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQ 140
           + +  +  ++ ++       +  L ++  L L  N+L+   P A        +++    +
Sbjct: 46  NSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVK 103

Query: 141 LSGAFPSFIFNKSS---------LQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFH 191
              +       KS          +  L       S  +  N  +++  L  ++    +  
Sbjct: 104 DLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSL 163

Query: 192 GRI----PSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYL 233
                     L+    L+ L LS N++     + +  L  L  L L
Sbjct: 164 EDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 32/210 (15%), Positives = 64/210 (30%), Gaps = 24/210 (11%)

Query: 296 NLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLW 355
                   +L    +  AV  T   ++++  +   ++ +  S+  I    LPN+ +L L 
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQGIQ--YLPNVTKLFLN 76

Query: 356 SNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELS 415
            N  +      I   + L  L       +     +              +          
Sbjct: 77  GNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN--------- 122

Query: 416 FLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTN 475
                S+   L ++    +   G      +  LS   +   +S  +        +  LT 
Sbjct: 123 ---GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTK 179

Query: 476 LIGIYLGGNKLNGSIPITLGKLQKLQGLHL 505
           L  +YL  N ++  +   L  L+ L  L L
Sbjct: 180 LQNLYLSKNHIS-DLR-ALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 38/204 (18%), Positives = 74/204 (36%), Gaps = 17/204 (8%)

Query: 480 YLGGNKLNGSIPI----TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS 535
            LG   +    PI    +     +    +L+   +   +  +   L  + ++  + + + 
Sbjct: 2   PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59

Query: 536 GSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVL 595
                    L ++  L L  NKLT I   + NLK + +L    N       L        
Sbjct: 60  SVQG--IQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLSSLKDLK---- 112

Query: 596 IGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSR 655
                S +   + I  + G +   Q   L     + +       L  L +L+L +N +S 
Sbjct: 113 --KLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD 170

Query: 656 SIPISLEKLSYLEDLDLSFNKLKG 679
            +P++   L+ L++L LS N +  
Sbjct: 171 IVPLA--GLTKLQNLYLSKNHISD 192

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (130), Expect = 3e-08
 Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 9/89 (10%)

Query: 154 SLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGR----IPSALSNCKYLEILSL 209
            +Q LD     LS    A +   L   + + L            I SAL     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 210 SINNLLGAIPKEIG-----NLTKLKELYL 233
             N L       +         K+++L L
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 6e-07
 Identities = 14/71 (19%), Positives = 28/71 (39%), Gaps = 5/71 (7%)

Query: 618 NLQYLFLGYNRLQGS-ISESFGDLISLKSLNLSNNNLS----RSIPISLEKLSYLEDLDL 672
           ++Q L +    L  +  +E    L   + + L +  L+    + I  +L     L +L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 673 SFNKLKGEIPK 683
             N+L      
Sbjct: 63  RSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 16/95 (16%), Positives = 31/95 (32%), Gaps = 9/95 (9%)

Query: 106 SLQSLNLGFNRLSGSIPSAIFT-LYTLKYVNFRGNQLSG----AFPSFIFNKSSLQHLDF 160
            +QSL++    LS +  + +   L   + V      L+        S +    +L  L+ 
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 161 SYNALSGEIPANICSNL----PFLESISLSQNMFH 191
             N L       +   L      ++ +SL      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 18/93 (19%), Positives = 30/93 (32%), Gaps = 13/93 (13%)

Query: 591 NLKVLIGIDFSTNNFSDV-IPTVIGGLTNLQYLFLGYNRLQG----SISESFGDLISLKS 645
           +++ L   D      SD     ++  L   Q + L    L       IS +     +L  
Sbjct: 3   DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 646 LNLSNNNLSRSIPISL-----EKLSYLEDLDLS 673
           LNL +N L       +          ++ L L 
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 6e-06
 Identities = 24/171 (14%), Positives = 48/171 (28%), Gaps = 31/171 (18%)

Query: 49  HITHDPTNFLAKNWNTSTPVCNWTGVTCDVHSHRVKVLNISHLNLTGTI---PSQLWNLS 105
                 + ++     T+    +++ V           ++ + L   G            S
Sbjct: 310 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 369

Query: 106 SLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNAL 165
            L+ L L    +S S  S++                     + +    SL+ LD S N L
Sbjct: 370 VLRVLWLADCDVSDSSCSSL--------------------AATLLANHSLRELDLSNNCL 409

Query: 166 SGEIPANICS----NLPFLESISLSQNMFHGRIPSALS----NCKYLEILS 208
                  +          LE + L    +   +   L     +   L ++S
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 6e-06
 Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 9/76 (11%)

Query: 617 TNLQYLFLGYNRLQG----SISESFGDLISLKSLNLSNNNLSRSIPISL-----EKLSYL 667
           + L+ L+L    +      S++ +     SL+ L+LSNN L  +  + L     +    L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 668 EDLDLSFNKLKGEIPK 683
           E L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 4/97 (4%)

Query: 299 NLKLLDLSHNKLVGAVPATIF-NMSTLTGLGLQSNSLSG-SLSSIADV--QLPNLEELRL 354
           +++ LD+   +L  A  A +   +     + L    L+      I+      P L EL L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 355 WSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTF 391
            SN         +    +    ++ + S         
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 16/83 (19%), Positives = 30/83 (36%), Gaps = 12/83 (14%)

Query: 591 NLKVLIGIDFSTNNFSDV----IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLI----- 641
            L+VL     +  + SD     +   +    +L+ L L  N L  +      + +     
Sbjct: 370 VLRVL---WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 642 SLKSLNLSNNNLSRSIPISLEKL 664
            L+ L L +   S  +   L+ L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 17/93 (18%), Positives = 34/93 (36%), Gaps = 6/93 (6%)

Query: 248 NLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLL 303
           ++  L++   ++S+ +    + L  L   +V++L    LT      I   +     L  L
Sbjct: 3   DIQSLDIQCEELSDAR--WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 304 DLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSG 336
           +L  N+L       +          +Q  SL  
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 7e-05
 Identities = 15/87 (17%), Positives = 25/87 (28%), Gaps = 9/87 (10%)

Query: 174 CSNLPFLESISLSQNMFHGR----IPSALSNCKYLEILSLSINNLLGAIPKEIG-----N 224
                 L  + L+           + + L     L  L LS N L  A   ++       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 225 LTKLKELYLGYSGLQGEIPREFGNLAE 251
              L++L L       E+      L +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 16/81 (19%), Positives = 31/81 (38%), Gaps = 8/81 (9%)

Query: 295 HNLHNLKLLDLSHNKL----VGAVPATIFNMSTLTGLGLQSNSLSGS----LSSIADVQL 346
                L++L L+   +      ++ AT+    +L  L L +N L  +    L        
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 347 PNLEELRLWSNNFSGTIPRFI 367
             LE+L L+   +S  +   +
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 14/119 (11%), Positives = 32/119 (26%), Gaps = 5/119 (4%)

Query: 348 NLEELRLWSNNFSGT-IPRFIFNASKLSVLELGRNSFSG----FIPNTFGNLRNLRLMTL 402
           +++ L +     S       +    +  V+ L     +      I +       L  + L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCN 461
             N L    +        +    +  + L N  L G    +    L       ++   +
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 121

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 4e-04
 Identities = 10/87 (11%), Positives = 22/87 (25%), Gaps = 5/87 (5%)

Query: 573 YLNFSSNFFT-GPLPLDIGNLKVLIGIDFSTNNFSDV----IPTVIGGLTNLQYLFLGYN 627
            L+      +       +  L+    +       ++     I + +     L  L L  N
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65

Query: 628 RLQGSISESFGDLISLKSLNLSNNNLS 654
            L           +   S  +   +L 
Sbjct: 66  ELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 19/89 (21%), Positives = 28/89 (31%), Gaps = 8/89 (8%)

Query: 315 PATIFNMSTLTGLGLQSNSLSG-SLSSIADV--QLPNLEELRLWSNNFSGTIPRFIFNA- 370
                  S L  L L    +S  S SS+A       +L EL L +N         +  + 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 371 ----SKLSVLELGRNSFSGFIPNTFGNLR 395
                 L  L L    +S  + +    L 
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 19/98 (19%), Positives = 34/98 (34%), Gaps = 5/98 (5%)

Query: 475 NLIGIYLGGNKLNGS-IPITLGKLQKLQGLHLEDNKLEG----PIPDDICRLTKLYELGL 529
           ++  + +   +L+ +     L  LQ+ Q + L+D  L       I   +     L EL L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 530 SGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWN 567
             N+L      C        +  +    L +  LT   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 16/94 (17%), Positives = 30/94 (31%), Gaps = 10/94 (10%)

Query: 449 SHSLEYFDMSYCNVS-GGFPKEIGNLTNLIGIYLGGNKLNG----SIPITLGKLQKLQGL 503
           S  ++  D+    +S   + + +  L     + L    L       I   L     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 504 HLEDNKLEGPIPDDICRL-----TKLYELGLSGN 532
           +L  N+L       + +       K+ +L L   
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 14/112 (12%), Positives = 31/112 (27%), Gaps = 23/112 (20%)

Query: 190 FHGRIPSALSNCKYLEILSLSINNL----LGAIPKEIGNLTKLKELYLGYSGLQGEIPRE 245
                         L +L L+  ++      ++   +     L+EL L  + L      +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416

Query: 246 FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNL 297
                     +++                 LE L L   + + E+   +  L
Sbjct: 417 LVE-------SVRQ------------PGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 15/93 (16%), Positives = 23/93 (24%), Gaps = 4/93 (4%)

Query: 355 WSNNFSGTIPRFIFNASKLSVLELGRNSFSG----FIPNTFGNLRNLRLMTLHYNYLTSS 410
                           S L VL L     S      +  T     +LR + L  N L  +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 411 NLELSFLSSFSNCKSLTYIGLSNNPLDGILPRM 443
            +     S       L  + L +      +   
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.7 bits (125), Expect = 5e-08
 Identities = 35/217 (16%), Positives = 66/217 (30%), Gaps = 23/217 (10%)

Query: 472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG 531
            L N I I  G + +     +T   L  +  L      +     + +  L  L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 532 NKL-SGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIG 590
           N++   +     + +  L         +++I          L     ++        ++ 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 591 NLKVLIGI--------------DFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISES 636
            L + +                  S  N      T +  L+ L  L    N++       
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 637 FGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLS 673
              L +L  ++L NN +S   P  L   S L  + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 6e-07
 Identities = 37/218 (16%), Positives = 73/218 (33%), Gaps = 15/218 (6%)

Query: 343 DVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL 402
           D  L N  ++    +N + T+     +   ++ L       +         L NL  + L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70

Query: 403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNV 462
             N +T      +         S   +   +        +      +   +   ++  + 
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 463 SGGFPKEIGNLTNLIGI-------YLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIP 515
                 ++  +TN+  +       YL       S    L  L KL  L  +DNK+    P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 516 DDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSL 553
             +  L  L E+ L  N++S   P   +N ++L  ++L
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 40/260 (15%), Positives = 81/260 (31%), Gaps = 50/260 (19%)

Query: 271 ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQ 330
             L     +  GK+ +T  +     +L  +  L      +           +T+ G+   
Sbjct: 16  PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV-----------TTIEGVQ-- 60

Query: 331 SNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNT 390
                          L NL  L L  N         I + + L  L           P  
Sbjct: 61  --------------YLNNLIGLELKDN--------QITDLAPLKNLTKITELELSGNPLK 98

Query: 391 FGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSH 450
             +           +  ++   +++ L+  SN + L            +    ++  L+ 
Sbjct: 99  NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD---------LNQITNISPLAG 149

Query: 451 SLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKL 510
                 +S  N        + NL+ L  +    NK++   P  L  L  L  +HL++N++
Sbjct: 150 LTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI 207

Query: 511 EGPIPDDICRLTKLYELGLS 530
               P  +   + L+ + L+
Sbjct: 208 SDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 27/221 (12%), Positives = 71/221 (32%), Gaps = 24/221 (10%)

Query: 369 NASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTY 428
             +    +  G+++ +  +  T  +L  +  ++     +T+       +       +L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 429 IGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNG 488
           + L +N +  + P  ++  ++      +      +    + I  L            L G
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 489 S------------IPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSG 536
                        I             +L     +      +  L+KL  L    NK+S 
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 537 SIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFS 577
             P   ++L +L  + L +N+++ +   + N   +  +  +
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 32/218 (14%), Positives = 69/218 (31%), Gaps = 21/218 (9%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
            L++   +  G + ++ ++  A   L  +  ++  G  ++      +   ++L  L+   
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGA----- 217
           N ++   P    + +  LE                      L    ++    L       
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 218 --------IPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQE 269
                   I             YL     Q        NL++L  +    + +    P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 270 LANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSH 307
           LA+L  L  + L  N ++   P  + N  NL ++ L++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 8e-05
 Identities = 38/236 (16%), Positives = 76/236 (32%), Gaps = 28/236 (11%)

Query: 224 NLTKLKELYLGYSGLQGEIP-REFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
            L    ++  G S +   +   +   +  L      V+ ++G     +  L  L  L+L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71

Query: 283 KNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIA 342
            N +T      + NL  +  L+LS N L                L     +    L+ ++
Sbjct: 72  DNQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129

Query: 343 DVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTL 402
           ++Q                 I      A   ++  L   +          NL  L  +  
Sbjct: 130 NLQ---------VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180

Query: 403 HYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMS 458
             N ++        +S  ++  +L  + L NN +  + P   + N S +L    ++
Sbjct: 181 DDNKISD-------ISPLASLPNLIEVHLKNNQISDVSP---LANTS-NLFIVTLT 225

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.4 bits (121), Expect = 1e-07
 Identities = 35/226 (15%), Positives = 66/226 (29%), Gaps = 5/226 (2%)

Query: 337 SLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRN 396
            ++ I      N  ELR                   L  +E+ +N     I     +   
Sbjct: 19  KVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78

Query: 397 LRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFD 456
                       ++NL      +F N  +L Y+ +SN  +  +     + +L   L    
Sbjct: 79  ---KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135

Query: 457 MSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPD 516
            +    +      +G     + ++L  N +           Q  +    ++N LE    D
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195

Query: 517 DICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIP 562
                +    L +S  ++         NL  L   S     L  +P
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.9 bits (117), Expect = 4e-07
 Identities = 40/244 (16%), Positives = 69/244 (28%), Gaps = 18/244 (7%)

Query: 69  CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTL 128
           C+     C                +T  IPS L    +   L     +L      A    
Sbjct: 8   CSNRVFLC------------QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52

Query: 129 YTLKYVNFRGNQLS---GAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISL 185
             L+ +    N +     A       K     ++ + N L     A           IS 
Sbjct: 53  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112

Query: 186 SQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPRE 245
           +       +    S  K L  +  +IN         +G   +   L+L  +G+Q      
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172

Query: 246 FGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDL 305
           F      EL     +NL+          +G  +L + +  +       + NL  L+    
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

Query: 306 SHNK 309
            + K
Sbjct: 233 YNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 4e-05
 Identities = 15/97 (15%), Positives = 31/97 (31%), Gaps = 4/97 (4%)

Query: 566 WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLG 625
                 + L  + N             ++        NN  ++   V  G +    L + 
Sbjct: 150 GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 209

Query: 626 YNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLE 662
             R+    S    +L  L++ +  N    + +P +LE
Sbjct: 210 RTRIHSLPSYGLENLKKLRARSTYNL---KKLP-TLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 7e-04
 Identities = 8/44 (18%), Positives = 13/44 (29%)

Query: 633 ISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNK 676
            ++ F        L++S   +       LE L  L        K
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 29/221 (13%), Positives = 59/221 (26%), Gaps = 6/221 (2%)

Query: 289 EIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPN 348
           EIP ++    N   L     KL             L  + +  N +   + +     LP 
Sbjct: 22  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 349 LEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLT 408
           L E+R+   N    I    F               S        ++  +  +      + 
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQ----YLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135

Query: 409 SSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPK 468
            +    +   +     S   + L  N            N +   E       N+      
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195

Query: 469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNK 509
                +  + + +   +++      L  L+KL+     + K
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 38/213 (17%), Positives = 69/213 (32%), Gaps = 5/213 (2%)

Query: 194 IPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELE 253
           IPS L   +    L   +  L             L+++ +  + +   I  +  +     
Sbjct: 23  IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 254 LMAL--QVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLV 311
                 + +NL    P+   NL  L+ L +    +         +     LLD+  N  +
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 312 GAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIF-NA 370
             +    F   +   + L  N                L+EL L  NN    +P  +F  A
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 371 SKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLH 403
           S   +L++ R            NL+ LR  + +
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 3e-07
 Identities = 30/122 (24%), Positives = 44/122 (36%), Gaps = 5/122 (4%)

Query: 550 TLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVI 609
            L L    LT +   +  L  + +L+ S N      P  +  L+ L  +  S N   +V 
Sbjct: 2   VLHLAHKDLTVLC-HLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 610 PTVIGGLTNLQYLFLGYNRLQG-SISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLE 668
                    LQ L L  NRLQ  +  +       L  LNL  N+L +   I       L 
Sbjct: 60  GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 669 DL 670
            +
Sbjct: 118 SV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 4e-07
 Identities = 26/109 (23%), Positives = 42/109 (38%), Gaps = 5/109 (4%)

Query: 84  KVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSG 143
           +VL+++H +LT  +   L  L  +  L+L  NRL    P+ +  L  L+ +    N    
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55

Query: 144 AFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHG 192
                + N   LQ L    N L          + P L  ++L  N    
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 26/118 (22%), Positives = 43/118 (36%), Gaps = 6/118 (5%)

Query: 456 DMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIP 515
            +++ +++      +  L  +  + L  N+L    P  L  L+ L+ L   DN LE    
Sbjct: 4   HLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG 60

Query: 516 DDICRLTKLYELGLSGNKL-SGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGML 572
                  +  EL L  N+L   +      +   L  L+L  N L         L  ML
Sbjct: 61  VANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 7e-06
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 6/108 (5%)

Query: 206 ILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGE 265
           +L L+  +L   +   +  L  +  L L ++ L+   P     L  LE++  Q S+   E
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVL--QASDNALE 56

Query: 266 IPQELANLTGLEVLKLGKNFLTG-EIPPEIHNLHNLKLLDLSHNKLVG 312
               +ANL  L+ L L  N L        + +   L LL+L  N L  
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.6 bits (102), Expect = 1e-05
 Identities = 20/118 (16%), Positives = 34/118 (28%), Gaps = 6/118 (5%)

Query: 527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLP 586
           L L+   L+  +      L  +  L L  N+L ++P  +  L+ +  L  S N       
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 587 LDIGNLKVLIGIDFSTNNFSDV-IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISL 643
           +          +    N          +     L  L L  N L          L  +
Sbjct: 61  VANLPRLQE--LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 2e-05
 Identities = 25/128 (19%), Positives = 41/128 (32%), Gaps = 8/128 (6%)

Query: 301 KLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFS 360
           ++L L+H  L   V   +  +  +T L L  N L     ++A   L  LE L+   N   
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALA--ALRCLEVLQASDNALE 56

Query: 361 GTIPRFIFNASKLSVLELGRNSFSGF-IPNTFGNLRNLRLMTLHYNYLTS-SNLELSFLS 418
                      +   L L  N            +   L L+ L  N L     ++     
Sbjct: 57  NVDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 419 SFSNCKSL 426
              +  S+
Sbjct: 115 MLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 2e-05
 Identities = 24/116 (20%), Positives = 45/116 (38%), Gaps = 7/116 (6%)

Query: 410 SNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE 469
           ++ +L+ L        +T++ LS+N L  +        L+       +   + +      
Sbjct: 6   AHKDLTVLCHLEQLLLVTHLDLSHNRLRAL-----PPALAALRCLEVLQASDNALENVDG 60

Query: 470 IGNLTNLIGIYLGGNKLNGSIPI-TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKL 524
           + NL  L  + L  N+L  S  I  L    +L  L+L+ N L         RL ++
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 5e-05
 Identities = 30/121 (24%), Positives = 48/121 (39%), Gaps = 8/121 (6%)

Query: 278 VLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGS 337
           VL L    LT  +   +  L  +  LDLSHN+L    P     ++ L  L +   S +  
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55

Query: 338 LSSIADVQLPNLEELRLWSNNFSGT-IPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRN 396
            +      LP L+EL L +N    +   + + +  +L +L L  NS           L  
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114

Query: 397 L 397
           +
Sbjct: 115 M 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 3e-04
 Identities = 27/109 (24%), Positives = 41/109 (37%), Gaps = 6/109 (5%)

Query: 573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS 632
            L+ +    T    L    L ++  +D S N    + P  +  L  L+ L    +     
Sbjct: 2   VLHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNALE 56

Query: 633 ISESFGDLISLKSLNLSNNNLSRSIPI-SLEKLSYLEDLDLSFNKLKGE 680
             +   +L  L+ L L NN L +S  I  L     L  L+L  N L  E
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.9 bits (117), Expect = 8e-07
 Identities = 41/336 (12%), Positives = 88/336 (26%), Gaps = 32/336 (9%)

Query: 252 LELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSH 307
           L+L A+   + +  +   L     ++ + L  N +  E    +   I +  +L++ + S 
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 308 NKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFI 367
                        +  L                 A ++ P L  +RL  N F  T    +
Sbjct: 69  IFTGRVKDEIPEALRLL---------------LQALLKCPKLHTVRLSDNAFGPTAQEPL 113

Query: 368 FNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLT 427
            +              +  +    G      L  L  N    +   L  +    N     
Sbjct: 114 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 173

Query: 428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLN 487
            +             +    +  +    +     +  G           +      +  +
Sbjct: 174 SMKEWAKT-FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232

Query: 488 GSIPITLGKLQKLQGLHLEDNKLEGPIPDDI------CRLTKLYELGLSGNKLSGSIP-- 539
            ++ I L     L+ L L D  L       +           L  L L  N++       
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 292

Query: 540 ---ACFSNLASLGTLSLGSNKLTSIPLTIWNLKGML 572
                   +  L  L L  N+ +     +  ++ + 
Sbjct: 293 LKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 328

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.9 bits (104), Expect = 3e-05
 Identities = 35/319 (10%), Positives = 84/319 (26%), Gaps = 26/319 (8%)

Query: 194 IPSALSNCKYLEILSLSINNL----LGAIPKEIGNLTKLKELYL---GYSGLQGEIPREF 246
           + + L     ++ + LS N +       + + I +   L+           ++ EIP   
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 247 GNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLS 306
             L +  L   ++  ++              +  L K+     +    + L       ++
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 307 HNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF 366
                 AV     N   L  +    N L             +   L       +G  P  
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202

Query: 367 IFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSL 426
           I             +     +                 +  +S+               L
Sbjct: 203 IE------------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250

Query: 427 TYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEI-----GNLTNLIGIYL 481
               LS      ++   S       L+   + Y  +     + +       + +L+ + L
Sbjct: 251 NDCLLSARGAAAVVDAFSKLEN-IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 482 GGNKLNGSIPITLGKLQKL 500
            GN+        + +++++
Sbjct: 310 NGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.7 bits (101), Expect = 7e-05
 Identities = 43/329 (13%), Positives = 86/329 (26%), Gaps = 26/329 (7%)

Query: 365 RFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCK 424
           RF      L +  +        +        +++ + L  N + +         + ++ K
Sbjct: 2   RFSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKK 59

Query: 425 SLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMS-YCNVSGGFPKEIGNLTNLIGIYLGG 483
            L     S+     +   +                   V              +  +L  
Sbjct: 60  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119

Query: 484 NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS-GSIPACF 542
           +     + +    L    G  +     E  +         L  +    N+L  GS+    
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179

Query: 543 SNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFST 602
               S   L         I         +  L +                   +  +  T
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD-----------LQDNTFT 228

Query: 603 NNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGD------LISLKSLNLSNNNLSRS 656
           +  S  +   +    NL+ L L    L    + +  D       I L++L L  N +   
Sbjct: 229 HLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELD 288

Query: 657 IPISL-----EKLSYLEDLDLSFNKLKGE 680
              +L     EK+  L  L+L+ N+   E
Sbjct: 289 AVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 0.001
 Identities = 39/315 (12%), Positives = 77/315 (24%), Gaps = 17/315 (5%)

Query: 131 LKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANIC---SNLPFLESISLSQ 187
           LK           +  + +    S++ +  S N +  E    +    ++   LE    S 
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 188 NMFHGRIPSALSNCKYLEILSLSINNLL---GAIPKEIGNLTKLKELYLGYSGLQGEIPR 244
                         + L    L    L     +         +    +L        +  
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 245 EFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLD 304
               L       +  +  +  + ++  N   L  +  G+N L      E           
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ----- 183

Query: 305 LSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIP 364
              ++L+  V      +       L    L+            N       S        
Sbjct: 184 --SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 365 RFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLH--YNYLTSSNLELSFLSSFSN 422
                   L+   L     +  + + F  L N+ L TL   YN +    +          
Sbjct: 242 WPNLRELGLNDCLLSARGAA-AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 423 CKSLTYIGLSNNPLD 437
              L ++ L+ N   
Sbjct: 301 MPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 41/327 (12%), Positives = 82/327 (25%), Gaps = 20/327 (6%)

Query: 84  KVLNISHLNLTG--TIPSQLWNLSSLQSLNLGFNRLSG----SIPSAIFTLYTLKYVNFR 137
           K L +  +      ++ + L    S++ + L  N +       +   I +   L+   F 
Sbjct: 8   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 138 GNQLSGAFPSFIFNKSSLQHLDFSYNALS--GEIPANICSNLPFLESISLSQNMFHGRIP 195
                            L         L                     LS++     + 
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 196 SALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELM 255
              +         ++      A+ K+  N   L+ +  G + L+    +E+         
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK-TFQSHR 186

Query: 256 ALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVP 315
            L    +     +       L         L      +    H          K      
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK-----S 241

Query: 316 ATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNA----- 370
                   L    L +   +  + + + ++   L+ LRL  N       R +        
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 371 SKLSVLELGRNSFSGFIPNTFGNLRNL 397
             L  LEL  N FS    +    +R +
Sbjct: 302 PDLLFLELNGNRFSE-EDDVVDEIREV 327

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 3e-06
 Identities = 37/199 (18%), Positives = 74/199 (37%), Gaps = 15/199 (7%)

Query: 472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSG 531
            L   +   LG   +     ++   L ++  L  +   ++    D +  L  L ++  S 
Sbjct: 16  ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 532 NKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGN 591
           N+L+        NL  L  + + +N++  I              F++         ++ N
Sbjct: 72  NQLTDIT--PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129

Query: 592 LKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN 651
           L  L          S+ I  +           L ++  Q +  +   +L +L+ L++S+N
Sbjct: 130 LNRL-------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSN 182

Query: 652 NLSRSIPISLEKLSYLEDL 670
            +S  I   L KL+ LE L
Sbjct: 183 KVS-DIS-VLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 27/188 (14%), Positives = 59/188 (31%), Gaps = 12/188 (6%)

Query: 271 ANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQ 330
             L       LGK  +T  +     +L  +  L      +       +  ++ LT +   
Sbjct: 15  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFS 70

Query: 331 SNSLSG--------SLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNS 382
           +N L+          L  I        +   L +      +  F    + +  L+   N 
Sbjct: 71  NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130

Query: 383 FSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPR 442
               + +   +  +          L  S+ +++ L   +N  +L  + +S+N +  I   
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVL 190

Query: 443 MSMGNLSH 450
             + NL  
Sbjct: 191 AKLTNLES 198

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 30/188 (15%), Positives = 62/188 (32%), Gaps = 19/188 (10%)

Query: 506 EDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTI 565
           +D  +     D    L +  +  L    ++ ++    ++L  + TL      + SI   +
Sbjct: 4   QDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID-GV 58

Query: 566 WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLG 625
             L  +  +NFS+N  T   PL      V I ++ +       +  +        +    
Sbjct: 59  EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 118

Query: 626 YNRLQGSISESFGDLISLKSL--------------NLSNNNLSRSIPISLEKLSYLEDLD 671
            +        +   L    +                L+ ++   +    L  L+ LE LD
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLD 178

Query: 672 LSFNKLKG 679
           +S NK+  
Sbjct: 179 ISSNKVSD 186

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 35/208 (16%), Positives = 69/208 (33%), Gaps = 24/208 (11%)

Query: 296 NLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLW 355
            L       L    +   V  +  ++  +T L      +  S+  +    L NL ++   
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDGVE--YLNNLTQINFS 70

Query: 356 SNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELS 415
           +N  +   P           L+         + N             +   LT  N +++
Sbjct: 71  NNQLTDITP-----------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119

Query: 416 FLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTN 475
            +    N  +L  + LS+N +        +  LS       +++ +      K + NLT 
Sbjct: 120 DIDPLKNLTNLNRLELSSNTI------SDISALSGLTSLQQLNFSSNQVTDLKPLANLTT 173

Query: 476 LIGIYLGGNKLNGSIPITLGKLQKLQGL 503
           L  + +  NK++      L KL  L+ L
Sbjct: 174 LERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 29/201 (14%), Positives = 61/201 (30%), Gaps = 17/201 (8%)

Query: 103 NLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSY 162
            L+      LG   ++ ++      L  +  +      +       +   ++L  ++FS 
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 163 NALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
           N           +++  L++++   ++       A             +      I    
Sbjct: 72  N---------QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLG 282
                     L  S            L  L+ +    + +    P  LANLT LE L + 
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180

Query: 283 KNFLTGEIPPEIHNLHNLKLL 303
            N ++      +  L NL+ L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (106), Expect = 7e-06
 Identities = 30/152 (19%), Positives = 58/152 (38%), Gaps = 8/152 (5%)

Query: 529 LSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLD 588
           L   ++   +    S        +L    L S P  +      + LN  S+     L + 
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLRSDP-DLVAQNIDVVLNRRSSMAAT-LRII 60

Query: 589 IGNLKVLIGIDFSTNNFSDV--IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSL 646
             N+  L+ ++ S N    +  + +++    NL+ L L  N L+          + L+ L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 647 NLSNNNLSRSIPISLEKLSYLEDLDLSFNKLK 678
            L  N+LS +     ++ +Y+  +   F KL 
Sbjct: 121 WLDGNSLSDTFR---DQSTYISAIRERFPKLL 149

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 23/144 (15%), Positives = 44/144 (30%), Gaps = 13/144 (9%)

Query: 489 SIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL 548
            + + + K        L+   L      D+        L    + ++ ++     N+  L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPEL 67

Query: 549 GTLSLGSNKLTS---IPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNF 605
            +L+L +N+L     +   +     +  LN S N       LD      L  +    N+ 
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 606 SDVIP-------TVIGGLTNLQYL 622
           SD           +      L  L
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRL 151

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 28/134 (20%), Positives = 44/134 (32%), Gaps = 9/134 (6%)

Query: 553 LGSNKLTSIPLTIWNLKG--MLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIP 610
           L   ++  + L +          L+         L +      VL       ++ +  + 
Sbjct: 4   LKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDL-VAQNIDVVL----NRRSSMAATLR 58

Query: 611 TVIGGLTNLQYLFLGYNRLQG--SISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLE 668
            +   +  L  L L  NRL     +S       +LK LNLS N L     +   K   LE
Sbjct: 59  IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118

Query: 669 DLDLSFNKLKGEIP 682
           +L L  N L     
Sbjct: 119 ELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 22/134 (16%), Positives = 39/134 (29%), Gaps = 5/134 (3%)

Query: 193 RIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQG--EIPREFGNLA 250
           ++   +S        +L +  L      ++        L    S       I      L 
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68

Query: 251 ELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKL 310
            L L   ++  L   +   +     L++L L  N L  E   +      L+ L L  N L
Sbjct: 69  SLNLSNNRLYRLDD-MSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 311 VGAVPATIFNMSTL 324
                     +S +
Sbjct: 128 SDTFRDQSTYISAI 141

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 2e-04
 Identities = 19/133 (14%), Positives = 43/133 (32%), Gaps = 6/133 (4%)

Query: 521 LTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNF 580
             +  EL L G K+   I    + L     +    N++  +      L+ +  L  ++N 
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD-GFPLLRRLKTLLVNNNR 74

Query: 581 FTGPLPLDIGNLKVLIGIDFSTNNFSDV-IPTVIGGLTNLQYLFLG---YNRLQGSISES 636
                      L  L  +  + N+  ++     +  L +L YL +        +      
Sbjct: 75  ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYV 134

Query: 637 FGDLISLKSLNLS 649
              +  ++ L+  
Sbjct: 135 IYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 7/44 (15%), Positives = 18/44 (40%), Gaps = 1/44 (2%)

Query: 634 SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKL 677
           +  + + +  + L+L    +   I      L   + +D S N++
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 23/148 (15%), Positives = 50/148 (33%), Gaps = 9/148 (6%)

Query: 165 LSGEIPANICS--NLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEI 222
           L+ E+        N      + L        I +  +     + +  S +N +  +    
Sbjct: 3   LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFS-DNEIRKLDG-F 59

Query: 223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQG----EIPQELANLTGLEV 278
             L +LK L +  + +          L +L  + L  ++L      +    L +LT L +
Sbjct: 60  PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119

Query: 279 LKLGKNFLTGEIPPEIHNLHNLKLLDLS 306
           L+             I+ +  +++LD  
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 27/136 (19%), Positives = 43/136 (31%), Gaps = 6/136 (4%)

Query: 542 FSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFS 601
           ++N      L L   K+  I      L     ++FS N     L      L+ L  +  +
Sbjct: 14  YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVN 71

Query: 602 TNNFSDVIPTVIGGLTNLQYLFLGYNRLQG-SISESFGDLISLKSLNLSNNN---LSRSI 657
            N    +   +   L +L  L L  N L      +    L SL  L +  N         
Sbjct: 72  NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131

Query: 658 PISLEKLSYLEDLDLS 673
              + K+  +  LD  
Sbjct: 132 LYVIYKVPQVRVLDFQ 147

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 8e-04
 Identities = 22/147 (14%), Positives = 42/147 (28%), Gaps = 1/147 (0%)

Query: 127 TLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS 186
             +    +    +         +    +L  L          +       L  L ++++ 
Sbjct: 6   CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64

Query: 187 QNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREF 246
           ++      P A      L  L+LS N L     K +  L+  + +  G         R  
Sbjct: 65  KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124

Query: 247 GNLAELELMALQVSNLQGEIPQELANL 273
               E  L  +    LQ      LA++
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHM 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	982
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.98
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.98
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.98
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.98
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.89
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.83
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.71
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.61
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.52
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.5
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.5
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.48
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.47
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.4
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.35
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.29
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.56
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.49
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.39
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.33
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.64
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.61
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.46
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.37
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.28

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.6e-43  Score=385.42  Aligned_cols=293  Identities=34%  Similarity=0.513  Sum_probs=267.9

Q ss_pred             CCChhHHHHHHHHHHHhcCCCCccccCCCCCCCCCCc--eeeEEecCCC--CcEEEEEeCCCCccc--cCCccccCCCCC
Q 036229           34 SSITTDQDALLALKAHITHDPTNFLAKNWNTSTPVCN--WTGVTCDVHS--HRVKVLNISHLNLTG--TIPSQLWNLSSL  107 (982)
Q Consensus        34 ~~~~~~~~~ll~~k~~~~~~~~~~~~~~w~~~~~~c~--w~gv~c~~~~--~~v~~L~l~~~~l~g--~~~~~l~~l~~L  107 (982)
                      .|.++|++||++||+++.++   ..+++|+.++|||.  |.||+|+..+  +||++|+|++++++|  .+|+++++|++|
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~---~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNP---TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCC---GGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHHCCCC---CcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence            59999999999999999764   35899999999995  9999998543  389999999999998  589999999999


Q ss_pred             CEEEcCC-CCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeec
Q 036229          108 QSLNLGF-NRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLS  186 (982)
Q Consensus       108 ~~L~L~~-n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls  186 (982)
                      ++|||++ |+++|.+|++|+++++|++|+|++|++.+..|..+..+++|+++++++|.+.+.+|..+ .++++|+.++++
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l-~~l~~L~~l~l~  157 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI-SSLPNLVGITFD  157 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGG-GGCTTCCEEECC
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhh-ccCcccceeecc
Confidence            9999997 89999999999999999999999999999999999999999999999999999999887 899999999999


Q ss_pred             ceeeecccCCCccCcCcc-cEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCc
Q 036229          187 QNMFHGRIPSALSNCKYL-EILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGE  265 (982)
Q Consensus       187 ~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  265 (982)
                      +|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .++++.+...+.+|..+..+++++.+++++|.+.+.
T Consensus       158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~  236 (313)
T d1ogqa_         158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD  236 (313)
T ss_dssp             SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence            999999999999988876 889999999999999988887654 699999999999999999999999999999999887


Q ss_pred             CChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCc
Q 036229          266 IPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNS  333 (982)
Q Consensus       266 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  333 (982)
                      +| .+..+++|++|+|++|++++.+|..|.++++|++|||++|+|+|.+|. +.++++|+.+++++|+
T Consensus       237 ~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         237 LG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             GG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             cc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            65 688899999999999999999999999999999999999999998885 5677788777777776

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-39  Score=341.35  Aligned_cols=197  Identities=22%  Similarity=0.306  Sum_probs=162.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            367999999999999999999864 69999999997543 3345678999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      ||++|+|.+++... ..+++.++..++.|++.||+|||   ++||+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999998654 46899999999999999999999   999999999999999999999999999999987544444


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ......+||+.|||||++.+..+.....|+|++|+.++.+.+|
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence            4445678999999999997765532323333444444544554

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-38  Score=335.04  Aligned_cols=190  Identities=26%  Similarity=0.358  Sum_probs=163.9

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            5799999999999999999985 469999999998766556678999999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      +||+|.+++.+.  .+++.++..++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--cc
Confidence            999999988654  4899999999999999999999   9999999999999999999999999999999874332  23


Q ss_pred             ecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          939 QTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ....+||+.|||||++.++.++..   +|+|++|  ++.+.+|
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~---~DiwSlGvilyemltG  212 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPK---VDIWSLGIMAIEMIEG  212 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTH---HHHHHHHHHHHHHHHS
T ss_pred             ccccccCCCccChhhhcCCCCCch---hceehHhHHHHHHhhC
Confidence            345689999999999988777644   4455555  4444443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=336.55  Aligned_cols=190  Identities=24%  Similarity=0.402  Sum_probs=154.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..++|++.+.||+|+||+||+|+.+  ..||||+++..  .....+.+.+|++++++++||||+++++++.. +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            4578999999999999999999864  35999998644  34456789999999999999999999998755 5689999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||++|+|.+++...+..+++..+..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+.......
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999877777999999999999999999999   99999999999999999999999999999987654433


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ........||+.|||||++.+......+..+|+||+|+
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv  197 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGI  197 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHH
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHH
Confidence            34445678999999999996543222334466777774

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-37  Score=332.24  Aligned_cols=186  Identities=26%  Similarity=0.387  Sum_probs=156.9

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++..   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999986 46999999999753   2334567899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||++|+|.+++...+ .+++..+..++.|++.||+|||   ++|||||||||+||++++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887654 5899999999999999999999   99999999999999999999999999999998754444


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .......+||+.|||||++.+..++..   +|+||+|
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~---~DiwSlG  197 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKS---SDLWALG  197 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHH---HHHHHHH
T ss_pred             ccccccccCCccccCceeeccCCCCcc---cceehhh
Confidence            444456789999999999988777654   4455555

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=333.23  Aligned_cols=185  Identities=23%  Similarity=0.343  Sum_probs=160.5

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      +.|++.+.||+|+||+||+|+.. +++.||||+++.......+++.+|++++++++||||+++++++.+++..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999864 68999999998776677789999999999999999999999999999999999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCcee
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSIT  938 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  938 (982)
                      ++|+|.+++.+....+++.++..++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999998776667999999999999999999999   999999999999999999999999999999865321  122


Q ss_pred             ecccccccccccCceeee-----eeeeeEEeeEeeeeee
Q 036229          939 QTQTLATIGYMAPGLFHV-----KYILFVVNFLTSYSFL  972 (982)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~-----~~~~~~~~~~d~~~~~  972 (982)
                      .....||+.|||||++..     ..++.   .+|+||+|
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~---k~DiwSlG  202 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDY---KADVWSLG  202 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTT---HHHHHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCCh---hhhHHHHH
Confidence            345689999999999842     23333   35566666

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-37  Score=326.58  Aligned_cols=183  Identities=26%  Similarity=0.388  Sum_probs=158.8

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++...   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999964 5899999998743   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||++|+|.+++.+.+ .+++..+..++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999997644 4899999999999999999999   999999999999999999999999999999865322  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......||+.|||||++.+..++..   +|+||+|+
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~---~DiwSlGv  192 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEK---VDLWSLGV  192 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTT---HHHHHHHH
T ss_pred             --cccccCCCCcccCHHHHcCCCCCch---hhhhhHhH
Confidence              2235679999999999988776644   45566663

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-37  Score=338.17  Aligned_cols=183  Identities=21%  Similarity=0.301  Sum_probs=157.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|+++.. .....+++.+|++++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57899999999999999999996 46999999999755 33445788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~-~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++ ||+||||||+|||+++++.+||+|||+|+.+.+.  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999997654 4899999999999999999999   74 9999999999999999999999999999976321  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                        .....+||+.|||||++.+..++..   +|+||+|
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~---~DiWSlG  190 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQ---SDIWSMG  190 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTT---HHHHHHH
T ss_pred             --ccccccCCccccCchHHcCCCCCcH---HHHHHHH
Confidence              2245689999999999988877654   4455555

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-37  Score=325.48  Aligned_cols=187  Identities=26%  Similarity=0.391  Sum_probs=153.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      ++|+..+.||+|+||+||+|++.+++.||||+++.. ....+++.+|++++++++||||++++++|..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578899999999999999999988999999999754 3345789999999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +|+|.+++......+++..+..++.|++.||+|+|   +++|+||||||+||++++++.+||+|||+|+....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999877777899999999999999999999   99999999999999999999999999999987643322 223


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....||+.|||||++.+..++.   .+|+||+|++
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~---k~DVwS~Gvi  191 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSS---KSDVWSFGVL  191 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCH---HHHHHHHHHH
T ss_pred             cceecCcccCChHHhcCCCCCc---hhhhcchHHH
Confidence            4467999999999998776654   4566777744

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-37  Score=331.67  Aligned_cols=191  Identities=24%  Similarity=0.407  Sum_probs=163.6

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      +...++|++.+.||+|+||+||+|++. +++.||||+++... ...+++.+|++++++++|||||+++++|.+++..++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            344578999999999999999999865 58999999997543 3457899999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          855 LEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||++|++.+++... ...+++..+..++.||+.||+|||   ++||+||||||+|||+++++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            9999999999998753 456899999999999999999999   999999999999999999999999999999876433


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                       .........|++.|||||++.++.++..   +|+||+|++
T Consensus       169 -~~~~~~~~~g~~~y~aPE~~~~~~~~~k---~DiwS~Gv~  205 (287)
T d1opja_         169 -TYTAHAGAKFPIKWTAPESLAYNKFSIK---SDVWAFGVL  205 (287)
T ss_dssp             -SSEEETTEEECGGGCCHHHHHHCCCSHH---HHHHHHHHH
T ss_pred             -CceeeccccccccccChHHHcCCCCCch---hhhhhHHHH
Confidence             2333445668999999999987766643   566777753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-37  Score=325.15  Aligned_cols=188  Identities=24%  Similarity=0.406  Sum_probs=159.4

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++|++.+.||+|+||+||+|++++++.||||+++... ...+++.+|++++++++|||||++++++.+ +..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            456899999999999999999999888999999997543 345789999999999999999999998865 457899999


Q ss_pred             ccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++|+|.+++.... ..+++..+.+|+.||++||+|||   +++|+||||||+||++++++.+||+|||+|+..... ..
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-cc
Confidence            99999999876433 35899999999999999999999   999999999999999999999999999999976432 22


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      .......||+.|||||++.++.++.   .+|+||+|++
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~---~sDvwS~Gvv  199 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTI---KSDVWSFGIL  199 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECH---HHHHHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCCCCc---hhhhhhhHHH
Confidence            3334567999999999998766653   4566777743

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-37  Score=323.93  Aligned_cols=186  Identities=23%  Similarity=0.338  Sum_probs=146.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC--CCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST--EEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l  853 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++..  .+...+.+.+|++++++++||||+++++++.+  ++..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36799999999999999999986 46899999999754  23445678999999999999999999999854  456899


Q ss_pred             EEEeccCCChHHHHhc---CCCcCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          854 ILEYMPHGSLEKSLYS---SNYILDIFQRLNIMVDVATTLEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~-----ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                      |||||++|+|.+++.+   .+..+++..+..++.|++.||+|||   +++     ||||||||+|||++.++.+||+|||
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            9999999999999864   3456899999999999999999999   654     9999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      +|+.+....  .......||+.|||||++.+..++..   +|+||+|
T Consensus       160 ~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~---~DIwSlG  201 (269)
T d2java1         160 LARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEK---SDIWSLG  201 (269)
T ss_dssp             HHHHC-------------CCCSCCCHHHHTTCCCCHH---HHHHHHH
T ss_pred             ceeecccCC--CccccCCCCcccCCHHHHcCCCCChH---HHHHhhC
Confidence            999764322  22345789999999999987766644   4556666

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-36  Score=332.43  Aligned_cols=186  Identities=21%  Similarity=0.308  Sum_probs=162.9

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999986 46999999999876666677899999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+||+|.+++.+....+++..+..++.||+.||+|||   ++|||||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999776667999999999999999999999   99999999999999996  46799999999999864332 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......||+.|||||++.+..++..   +|+|++|+
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~---~DiwSlGv  213 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVGV  213 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHH---HHHHHHHH
T ss_pred             --ccceecCcccccCHHHHcCCCCChh---HhhhhhhH
Confidence              2345689999999999988776644   45566663

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-36  Score=329.39  Aligned_cols=194  Identities=24%  Similarity=0.297  Sum_probs=163.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      .++|++.+.||+|+||+||+|+. .+++.||||++++.   .....+++.+|++++++++||||+++++++++++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999996 46999999999754   233457788999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||||+||+|.+++.+.+ .+++..++.++.|++.||+|||   ++|||||||||+|||++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999987654 4899999999999999999999   9999999999999999999999999999998753322


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                        ......+||+.|||||++.+..++.. .++|++|+.++.+.+|
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G  201 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCG  201 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHS
T ss_pred             --cccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHC
Confidence              23346789999999999988877654 2333444444444444

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-36  Score=330.80  Aligned_cols=186  Identities=21%  Similarity=0.340  Sum_probs=163.1

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46799999999999999999986 46999999999876555667889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc--CCCcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~--~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |+||+|.+++......+++.++..++.||+.||+|||   ++|||||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999988777767999999999999999999999   99999999999999998  67899999999999874332 


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                        ......||+.|||||++.+..++..   +|+|++|+
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlGv  216 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFY---TDMWAIGV  216 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHH---HHHHHHHH
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCc---cchHHHHH
Confidence              2345679999999999988777654   45566653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-36  Score=328.55  Aligned_cols=184  Identities=25%  Similarity=0.313  Sum_probs=154.4

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      +.|+..+.||+|+||+||+|+. .+++.||||+++...   ....+++.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4589999999999999999985 468999999997543   234467889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||++|++..++.. +..+++.++..++.||+.||.|||   ++|||||||||+|||++.++.+||+|||+|+....   
T Consensus        95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            99999998766654 346899999999999999999999   99999999999999999999999999999986422   


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                         .....||+.|||||++.+......+..+|+||+|+
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGv  202 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  202 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHH
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHH
Confidence               23467999999999985432222223456666664

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.5e-36  Score=323.97  Aligned_cols=181  Identities=28%  Similarity=0.342  Sum_probs=157.6

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..   .....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999996 45999999999753   2334567899999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      |||+||++.+++.... ..++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999998887654 4788889999999999999999   999999999999999999999999999999976322  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                         ....+||+.|||||++.++.++..   +|+||+|
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~---~DiwSlG  188 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKS---IDWWSFG  188 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTT---HHHHHHH
T ss_pred             ---cccccCcccccCHHHHcCCCCCch---hhccccc
Confidence               235689999999999988777654   4455555

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-36  Score=314.08  Aligned_cols=187  Identities=22%  Similarity=0.373  Sum_probs=163.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEecc
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMP  859 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~  859 (982)
                      ++|+..+.||+|+||+||+|++++++.||||+++... ...+++.+|++++++++||||++++++|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999889999999998643 345789999999999999999999999999999999999999


Q ss_pred             CCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCceee
Q 036229          860 HGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQ  939 (982)
Q Consensus       860 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  939 (982)
                      +|++.+++......+++..+.+++.|+++||+|||   ++||+||||||+||++++++.+||+|||+|+.+.... ....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence            99999998877777899999999999999999999   9999999999999999999999999999998764332 2233


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....||+.|||||++.+..++.   .+|+||+|++
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~---ksDiwS~G~~  190 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSS---KSDIWAFGVL  190 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCH---HHHHHHHHHH
T ss_pred             cccCCCCCcCCcHHhcCCCCCc---ceeecccchh
Confidence            4567999999999998776654   3556666643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-36  Score=323.93  Aligned_cols=189  Identities=22%  Similarity=0.388  Sum_probs=148.9

Q ss_pred             cCCCccceeeeeceEEEEEEEeCC----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ++|++.+.||+|+||+||+|++..    ...||||++... .....+++.+|++++++++|||||++++++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            457778999999999999998642    236899988654 334567899999999999999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      ||||++|+|.+++......+++.++..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887777999999999999999999999   9999999999999999999999999999999764432


Q ss_pred             Cce---eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          935 QSI---TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       935 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ...   ......||+.|||||++.++.++..   +|+||+|++
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~---sDvwS~Gvv  222 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSA---SDVWSYGIV  222 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHH---HHHHHHHHH
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcc---cccccchHH
Confidence            221   1223467999999999987766544   566777744

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-36  Score=326.00  Aligned_cols=186  Identities=22%  Similarity=0.319  Sum_probs=143.5

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ..+.|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3467999999999999999999864 58999999997543 233456789999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEc---CCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~---~~~~~kL~DFGla~~~~~  932 (982)
                      |||+||+|.+++.+. ..+++.++..++.||+.||+|||   ++|||||||||+||++.   +++.+||+|||+|+....
T Consensus        87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            999999999999764 45899999999999999999999   99999999999999995   578999999999986532


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .   ......+||+.|||||++.+..++..   +|+||+|+
T Consensus       163 ~---~~~~~~~GT~~y~APE~~~~~~~~~~---~DiwSlGv  197 (307)
T d1a06a_         163 G---SVLSTACGTPGYVAPEVLAQKPYSKA---VDCWSIGV  197 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTH---HHHHHHHH
T ss_pred             C---CeeeeeeeCccccCcHHHcCCCCCcH---HHhhhhhH
Confidence            2   22345679999999999988776644   55666663

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-35  Score=316.83  Aligned_cols=188  Identities=22%  Similarity=0.357  Sum_probs=157.8

Q ss_pred             cCCCccc-eeeeeceEEEEEEEeC---CCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEE
Q 036229          780 NRFSENN-LIGRGGFGSVYKARIG---EGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       780 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ++|.+.+ +||+|+||+||+|.+.   ++..||||+++... ....+++.+|++++++++|||||++++++.++ ..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            4566667 4999999999999753   36689999997543 34567899999999999999999999999754 57899


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++...+..+++.++..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877777999999999999999999999   9999999999999999999999999999999875443


Q ss_pred             Cce-eecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          935 QSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       935 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ... ......||+.|||||++.++.++.   .+|+||+|++
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDVwS~Gv~  201 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSS---RSDVWSYGVT  201 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECH---HHHHHHHHHH
T ss_pred             cccccccccccCccccChHHHhCCCCCc---cchhhcchHH
Confidence            222 223456899999999997776654   4667777753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=323.88  Aligned_cols=190  Identities=24%  Similarity=0.391  Sum_probs=158.2

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC------CeEEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE------GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEE  849 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  849 (982)
                      ..++|++.+.||+|+||+||+|++..      ...||+|++... .......+.+|+++++++ +|||||++++++.+++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44689999999999999999998532      247999998643 334456789999999998 8999999999999999


Q ss_pred             eeEEEEEeccCCChHHHHhcCC----------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 036229          850 FKALILEYMPHGSLEKSLYSSN----------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLK  907 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlk  907 (982)
                      ..++|||||++|+|.++++..+                      ..+++..+..++.||++||+|||   +++|||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            9999999999999999997643                      24788999999999999999999   9999999999


Q ss_pred             CCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          908 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       908 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      |+||+++.++.+||+|||+|+...............||+.|||||++.++.++..   +|+||+|+
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~---~DiwS~Gv  254 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK---SDVWSYGI  254 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH---HHHHHHHH
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc---eeccchhH
Confidence            9999999999999999999998765555445556778999999999987776644   45566663

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-35  Score=316.28  Aligned_cols=185  Identities=24%  Similarity=0.341  Sum_probs=158.6

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc------chhhhhHHHHHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC------GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++...      ....+.+.+|++++++++||||+++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46899999999999999999996 469999999997432      12356789999999999999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC----cEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~----~~kL~DFGla  927 (982)
                      |+|||||++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++|||||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999997654 5899999999999999999999   99999999999999998776    5999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      +.....   .......||+.|||||++.+..++..   +|+||+|+
T Consensus       165 ~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~---~DiwSlGv  204 (293)
T d1jksa_         165 HKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGV  204 (293)
T ss_dssp             EECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTH---HHHHHHHH
T ss_pred             hhcCCC---ccccccCCCCcccCHHHHcCCCCCCc---ccchhhhH
Confidence            976332   22345679999999999987766544   55666663

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-35  Score=312.36  Aligned_cols=178  Identities=26%  Similarity=0.380  Sum_probs=148.8

Q ss_pred             CccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC----CCeeEEEE
Q 036229          783 SENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST----EEFKALIL  855 (982)
Q Consensus       783 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~  855 (982)
                      +..++||+|+||+||+|++. +++.||+|++...  .....+++.+|++++++++||||+++++++.+    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999864 5889999998754  33445678999999999999999999999854    45689999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCCEEEc-CCCcEEEEeecCceeecC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~  932 (982)
                      ||+++|+|.+++.+.. .+++..+..++.||+.||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999997643 5899999999999999999999   888  99999999999996 578999999999986422


Q ss_pred             CCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          933 EDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .    .....+||+.|||||++.++ ++.   .+|+||+|
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~~-~~~---~~DIwSlG  199 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEEK-YDE---SVDVYAFG  199 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGTC-CCT---HHHHHHHH
T ss_pred             C----ccCCcccCccccCHHHhCCC-CCC---cCchhhHH
Confidence            1    22356899999999999764 443   35566666

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-35  Score=316.95  Aligned_cols=190  Identities=25%  Similarity=0.437  Sum_probs=153.7

Q ss_pred             cCCCccceeeeeceEEEEEEEeCC-----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGE-----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      +.|+..+.||+|+||+||+|+++.     ...||||+++.. ......++.+|++++++++|||||++++++.+++..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            568889999999999999998643     247999999754 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+.++++.+++......+++.++..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999998887778999999999999999999999   999999999999999999999999999999876433


Q ss_pred             CC-ceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          934 DQ-SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       934 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .. ........||+.|||||++.++.++..   +|+||+|+++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~---sDI~S~Gvil  203 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSA---SDVWSFGIVM  203 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHH---HHHHHHHHHH
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCc---ccccccHHHH
Confidence            22 223344568999999999987766644   5667777443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-35  Score=323.16  Aligned_cols=188  Identities=23%  Similarity=0.312  Sum_probs=161.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      ++|++.+.||+|+||+||+|+.. +|+.||||+++..   .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999864 6999999999743   2334567889999999999999999999999999999999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~  935 (982)
                      ||+.+|++.+++.+.+ .+++..+..++.||+.||.|||   ++|||||||||+|||++.+|.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987654 5899999999999999999999   999999999999999999999999999999986332  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                         .....||+.|||||++.++.++..   +|+|++|  ++.+.+|
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~---~DiwSlGvilyemltG  234 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAG  234 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTH---HHHHHHHHHHHHHHHS
T ss_pred             ---cccccCccccCCHHHHcCCCCCcc---ccccchhHHHHHHHhC
Confidence               234679999999999988877654   3445555  4444433

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-35  Score=311.75  Aligned_cols=181  Identities=24%  Similarity=0.347  Sum_probs=148.9

Q ss_pred             ceeeeeceEEEEEEEeC---CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEeccC
Q 036229          786 NLIGRGGFGSVYKARIG---EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYMPH  860 (982)
Q Consensus       786 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~~~  860 (982)
                      ++||+|+||+||+|.+.   .++.||||+++..  .....+++.+|++++++++|||||+++++|..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999753   3578999999643  334457899999999999999999999999755 56899999999


Q ss_pred             CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce-ee
Q 036229          861 GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI-TQ  939 (982)
Q Consensus       861 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~  939 (982)
                      |+|.+++.+.. .+++.++..++.||+.||+|||   +++||||||||+||+++.++.+||+|||+|+.+....... ..
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999987644 5899999999999999999999   9999999999999999999999999999999865443322 23


Q ss_pred             cccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          940 TQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ....||+.|||||++.+..++.   .+|+||+|++
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~---~sDiwS~Gv~  199 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSS---KSDVWSFGVL  199 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEH---HHHHHHHHHH
T ss_pred             cccCCCceecCchhhcCCCCCc---hhhhccchhh
Confidence            4567899999999997776654   4667777753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=314.72  Aligned_cols=191  Identities=19%  Similarity=0.292  Sum_probs=161.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      .++|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++++.++||||+++++++++++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999864 68999999997653 3345688999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCC--CcEEEEeecCceeecCCCC
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDN--MVAHLSDFGIAKLLIGEDQ  935 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~--~~~kL~DFGla~~~~~~~~  935 (982)
                      |+||+|.+++...+..+++.++..++.||+.||+|||   ++||+||||||+|||++.+  ..+||+|||+++.....  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999999999877667999999999999999999999   9999999999999999844  58999999999976332  


Q ss_pred             ceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          936 SITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                       .......||+.|+|||.+.+..++..   +|+|++|  ++.+.+|
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~~~---~DiWSlGvily~ll~G  199 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVSTA---TDMWSLGTLVYVLLSG  199 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHH---HHHHHHHHHHHHHHHS
T ss_pred             -CcccccccccccccchhccCCCCCch---hhcccHHHHHHHHHhC
Confidence             22344679999999999988777654   4445555  4444443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-35  Score=315.34  Aligned_cols=188  Identities=24%  Similarity=0.401  Sum_probs=153.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEec
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEYM  858 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~~  858 (982)
                      .++|++.+.||+|+||+||+|+++++++||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46899999999999999999999888899999997543 345789999999999999999999999865 4578999999


Q ss_pred             cCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          859 PHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       859 ~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++|++..++... ...+++.++..++.||+.||+|||   ++||+||||||+|||+++++.+||+|||+|+...... ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            999999888743 345899999999999999999999   9999999999999999999999999999998764322 22


Q ss_pred             eecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ......||+.|+|||++..+.++.   .+|+||+|+++
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~---ksDI~S~Giil  204 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTI---KSDVWSFGILL  204 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCH---HHHHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCc---HHhhhcchHHH
Confidence            334567999999999997776664   45667777443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-34  Score=321.08  Aligned_cols=192  Identities=26%  Similarity=0.322  Sum_probs=154.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeeccc---chhhhhHHH---HHHHhhhcCCccceeEEeeecCCCee
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQC---GRAFKSFDV---ECEMMKSIRHRNLIKVISSCSTEEFK  851 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~  851 (982)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++...   ......+.+   |+++++.++||||+++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999964 69999999996432   112223333   46677788999999999999999999


Q ss_pred             EEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeec
Q 036229          852 ALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI  931 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~  931 (982)
                      |+|||||+||+|.+++.+.. .+++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999997654 4789999999999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCceeecccccccccccCceeee-eeeeeEEeeEeeeeeeeeecccC
Q 036229          932 GEDQSITQTQTLATIGYMAPGLFHV-KYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      ..    ......||+.|||||++.. ..++.. .|+|++|+.++.+.+|
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~-~DiwSlGvilyemltG  202 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRG  202 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHS
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcc-cchhHHHHHHHHHHhC
Confidence            32    2345679999999999964 445544 2233444444444433

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-34  Score=313.43  Aligned_cols=191  Identities=23%  Similarity=0.333  Sum_probs=159.3

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc---cchhhhhHHHHHHHhh-hcCCccceeEEeeecCCCeeEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ---CGRAFKSFDVECEMMK-SIRHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++..   .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            67999999999999999999864 6999999999754   2233456677777765 68999999999999999999999


Q ss_pred             EEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCC
Q 036229          855 LEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED  934 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  934 (982)
                      |||+++|+|.+++.... .+++.++..++.||+.||+|||   ++||+||||||+|||+++++.+||+|||+|+..... 
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence            99999999999997654 4889999999999999999999   999999999999999999999999999999865332 


Q ss_pred             CceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                       ........||+.|||||++.+..++..   +|+||+|  ++.+.+|
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlGvilyemltG  199 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAPEILLGQKYNHS---VDWWSFGVLLYEMLIG  199 (320)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTH---HHHHHHHHHHHHHHHS
T ss_pred             -cccccccCCCCCcCCHHHHcCCCCCch---hhhhhhhHHHHHHHhC
Confidence             223345689999999999988877754   4445555  4444443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.9e-33  Score=307.43  Aligned_cols=257  Identities=32%  Similarity=0.571  Sum_probs=238.7

Q ss_pred             cccEEeccCCcccc--CCCcccccccccceEEecC-CCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEE
Q 036229          451 SLEYFDMSYCNVSG--GFPKEIGNLTNLIGIYLGG-NKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYEL  527 (982)
Q Consensus       451 ~L~~Ldls~n~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  527 (982)
                      +++.|||++|++++  .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|+|++..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46677777777776  4789999999999999997 89999999999999999999999999999999999999999999


Q ss_pred             EccCCcCCcCCCccccCCCcccccccCCCccc-ccccccccccCc-eEEecCCCcccCCCccccccccccceeecccccc
Q 036229          528 GLSGNKLSGSIPACFSNLASLGTLSLGSNKLT-SIPLTIWNLKGM-LYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNF  605 (982)
Q Consensus       528 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~ip~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l  605 (982)
                      ++++|++.+.+|..+.++++|+++++++|+++ .+|..++.+..+ +.+++++|++++..|..+..+..+ .+++++|..
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            99999999999999999999999999999999 799998888776 789999999999999999888665 699999999


Q ss_pred             cccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCCCC
Q 036229          606 SDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPKGG  685 (982)
Q Consensus       606 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~  685 (982)
                      .+.+|..++.+++|+.+++++|.+++.+| .++.+++|+.|+|++|+|+|.+|..+.++++|++|||++|+|+|.+|+.+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            99999999999999999999999997665 68999999999999999999999999999999999999999999999988


Q ss_pred             CCCCCCCcccccCcccCCCCCCCCCCC
Q 036229          686 SFGNFSAKSFEGNELLCGSPNLQVPPC  712 (982)
Q Consensus       686 ~~~~~~~~~~~gn~~lc~~~~~~~~~c  712 (982)
                      .+..+...++.||+.+||.|   .|+|
T Consensus       289 ~L~~L~~l~l~~N~~l~g~p---lp~c  312 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSP---LPAC  312 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTT---SSCC
T ss_pred             cCCCCCHHHhCCCccccCCC---CCCC
Confidence            88888899999999999998   4677

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-35  Score=314.77  Aligned_cols=195  Identities=26%  Similarity=0.393  Sum_probs=163.1

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecccc-hhhhhHHHHHHHhhhcCCccceeEEeeec
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCS  846 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  846 (982)
                      +++...++|++.+.||+|+||+||+|++.      +++.||||+++.... ...+++.+|++++++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999853      367899999975433 34678999999999999999999999999


Q ss_pred             CCCeeEEEEEeccCCChHHHHhcCC-----------------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 036229          847 TEEFKALILEYMPHGSLEKSLYSSN-----------------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIH  903 (982)
Q Consensus       847 ~~~~~~lv~E~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivH  903 (982)
                      +++..++||||+++|+|.++++...                       ..+++..+..|+.|++.||+|||   +++|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence            9999999999999999999987432                       24788899999999999999999   999999


Q ss_pred             cCCCCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          904 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       904 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      |||||+|||++.++.+||+|||+|+...+.......+...||+.|||||++.+..++.   .+|+||||++
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~---ksDVwS~Gvv  231 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT---ESDVWAYGVV  231 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH---HHHHHHHHHH
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh---hhhhccchhh
Confidence            9999999999999999999999998765444444445677899999999998876663   4667777744

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.6e-34  Score=304.85  Aligned_cols=186  Identities=25%  Similarity=0.347  Sum_probs=156.8

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc---------hhhhhHHHHHHHhhhcC-CccceeEEeeecCC
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG---------RAFKSFDVECEMMKSIR-HRNLIKVISSCSTE  848 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~  848 (982)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++....         ...+++.+|++++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999986 4699999999975421         22346889999999997 99999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCce
Q 036229          849 EFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK  928 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~  928 (982)
                      +..|+||||+++|+|.++++... .+++.+++.++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997654 5899999999999999999999   9999999999999999999999999999999


Q ss_pred             eecCCCCceeecccccccccccCceeeeeeee---eEEeeEeeeeee
Q 036229          929 LLIGEDQSITQTQTLATIGYMAPGLFHVKYIL---FVVNFLTSYSFL  972 (982)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~d~~~~~  972 (982)
                      .+....   ......||+.|+|||++.+....   ..+..+|+|++|
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslG  202 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG  202 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccc
Confidence            864322   23457899999999998643211   112335556666

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-34  Score=313.26  Aligned_cols=188  Identities=27%  Similarity=0.369  Sum_probs=153.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCe----EEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGM----EVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      ++|++.+.||+|+||+||+|++. +|+    +||+|+++.. ..+..+++.+|++++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999853 343    6888888643 344567899999999999999999999999875 4678


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      +|||+.+|+|.+++......+++..+..++.||+.||+|||   ++|||||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999888888999999999999999999999   999999999999999999999999999999987554


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ..........||+.|||||++.++.++.   .+|+||+|++
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~---~sDvwS~Gvi  202 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTH---QSDVWSYGVT  202 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCH---HHHHHHHHHH
T ss_pred             cccccccccccCccccChHHHhcCCCCh---hhhhhhHHHH
Confidence            4444445567899999999998776654   3566777754

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-34  Score=312.17  Aligned_cols=199  Identities=23%  Similarity=0.365  Sum_probs=155.0

Q ss_pred             CHHHHHHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEE
Q 036229          771 SYLELCRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVI  842 (982)
Q Consensus       771 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~  842 (982)
                      +..+++...++|++.+.||+|+||.||+|++.      +++.||||+++.. .....+.+.+|.+++.++ +|+||++++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            44555555678999999999999999999842      3578999998754 234456778888888777 689999999


Q ss_pred             eeecCC-CeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC
Q 036229          843 SSCSTE-EFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDL  906 (982)
Q Consensus       843 ~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDl  906 (982)
                      +++..+ +..++|||||++|+|.++++...               ..+++.++..++.||+.||+|||   +++||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcC
Confidence            987654 56899999999999999997532               34789999999999999999999   999999999


Q ss_pred             CCCCEEEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          907 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       907 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      ||+|||+++++.+||+|||+|+...............||+.|||||++.++.++..   +|+||+|+++
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~---sDiwS~Gvil  226 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ---SDVWSFGVLL  226 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH---HHHHHHHHHH
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc---cceeehHHHH
Confidence            99999999999999999999987655444444556789999999999987766644   5667777543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.4e-34  Score=305.95  Aligned_cols=188  Identities=21%  Similarity=0.364  Sum_probs=150.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc---chhhhhHHHHHHHhhhcCCccceeEEeeecCCC----e
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----F  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~  850 (982)
                      .++|++.+.||+|+||+||+|+. .+++.||||+++...   ....+++.+|+++++.++||||+++++++..++    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46899999999999999999986 469999999997542   334567899999999999999999999986543    4


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||++|++|.+++...+ .+++.++..++.||+.||+|||   ++|||||||||+||+++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999887654 5899999999999999999999   999999999999999999999999999998865


Q ss_pred             cCCC-CceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          931 IGED-QSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       931 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      .... ........+||+.|||||++.+..++..   +|+||+|+
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~---~DiwSlGv  202 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR---SDVYSLGC  202 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHH---HHHHHHHH
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcc---eecccchH
Confidence            3322 2223355689999999999988766644   55666663

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-34  Score=311.77  Aligned_cols=186  Identities=26%  Similarity=0.321  Sum_probs=152.4

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++...  ....+++.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999996 569999999996542  2345788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      |+.++.+..........+++..+..++.|++.||+|||   ++|||||||||+|||++.++.+||+|||.|+.....  .
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--S
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC--c
Confidence            99765444443444566899999999999999999999   999999999999999999999999999999876332  2


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .......||+.|+|||++....+...  .+|+||+|
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~--~~DiwSlG  190 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYST--AVDIWSLG  190 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCT--HHHHHHHH
T ss_pred             ccceeecccceeeehhhhccccCCCc--cccccccc
Confidence            33445689999999999866544322  24455555

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.9e-34  Score=307.85  Aligned_cols=187  Identities=24%  Similarity=0.354  Sum_probs=147.2

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCC----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l  853 (982)
                      .++|++.+.||+|+||+||+|++..    +..||||.++.. .....+.+.+|++++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999998532    467899988644 3344677999999999999999999999996 467899


Q ss_pred             EEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCC
Q 036229          854 ILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       854 v~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  933 (982)
                      ||||+++|++.+++......+++..+..++.||+.||+|||   +++||||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998877778999999999999999999999   999999999999999999999999999999876432


Q ss_pred             CCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          934 DQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      . ........||+.|+|||++.+..++..   +|+||+|+
T Consensus       162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~---~DiwSlGv  197 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAPESINFRRFTSA---SDVWMFGV  197 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHH---HHHHHHHH
T ss_pred             c-ceeccceecCcccchhhHhccCCCCCc---cccccchH
Confidence            2 223345678999999999987766644   55666664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.6e-34  Score=310.42  Aligned_cols=187  Identities=26%  Similarity=0.339  Sum_probs=149.2

Q ss_pred             ccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc-----hhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          784 ENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG-----RAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       784 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ..++||+|+||+||+|+. .+|+.||||+++....     ...+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999996 4599999999864422     2245788999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      ++++++..+. ..+..+++.++..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+......  .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~  155 (299)
T d1ua2a_          82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R  155 (299)
T ss_dssp             CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred             hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence            9887665554 44556888999999999999999999   9999999999999999999999999999998753322  2


Q ss_pred             eecccccccccccCceeeee-eeeeEEeeEeeeeee--eeecccC
Q 036229          938 TQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .....+||+.|||||++.+. .++..   +|+||+|  ++.+.+|
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~---~DiwSlGvil~el~~g  197 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVG---VDMWAVGCILAELLLR  197 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHH---HHHHHHHHHHHHHHHS
T ss_pred             cccceecChhhccHHHHccCCCCChh---hhhhhcchHHHHHHhC
Confidence            33456799999999998544 34433   4455555  4444444

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.1e-33  Score=309.86  Aligned_cols=187  Identities=20%  Similarity=0.294  Sum_probs=153.5

Q ss_pred             hcCCCccc-eeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhc-CCccceeEEeeecC----CCee
Q 036229          779 TNRFSENN-LIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCST----EEFK  851 (982)
Q Consensus       779 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~~  851 (982)
                      .++|.+.+ .||+|+||+||+|+. .+++.||||+++..     ..+.+|++++.++ +||||+++++++++    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46888764 699999999999986 56999999998632     4577899987654 89999999999865    4678


Q ss_pred             EEEEEeccCCChHHHHhcC-CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCc
Q 036229          852 ALILEYMPHGSLEKSLYSS-NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA  927 (982)
Q Consensus       852 ~lv~E~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla  927 (982)
                      |+|||||+||+|.+++.+. ...+++.++..|+.|++.||+|||   ++||+||||||+||++++   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            9999999999999999765 346899999999999999999999   999999999999999985   567999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      +......   ......||+.|||||++.+..++..   +|+||+|  ++.+.+|
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~---~DiwSlGvily~lltg  209 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKS---CDMWSLGVIMYILLCG  209 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHH---HHHHHHHHHHHHHTTS
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHH---HHHHhhchhHHHHhhC
Confidence            9764322   2345689999999999988777654   4455555  4444444

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=5.5e-34  Score=303.95  Aligned_cols=191  Identities=22%  Similarity=0.239  Sum_probs=154.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccc------hhhhhHHHHHHHhhhcC--CccceeEEeeecCCC
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCG------RAFKSFDVECEMMKSIR--HRNLIKVISSCSTEE  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~  849 (982)
                      .++|++.+.||+|+||+||+|+. .+++.||||+++....      ....++.+|++++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36899999999999999999986 4689999999975421      12345678999999996  899999999999999


Q ss_pred             eeEEEEEeccC-CChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-CCcEEEEeecCc
Q 036229          850 FKALILEYMPH-GSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIA  927 (982)
Q Consensus       850 ~~~lv~E~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-~~~~kL~DFGla  927 (982)
                      ..++||||+.+ +++.+++... ..+++.++..++.|++.||+|||   ++||+||||||+||+++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 5777777654 35899999999999999999999   999999999999999985 579999999999


Q ss_pred             eeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          928 KLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       928 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      +.....    ..+...||+.|||||++.+..+....  +|+||+|  ++.+.+|
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~--~DiwSlGvilyell~g  206 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRS--AAVWSLGILLYDMVCG  206 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHH--HHHHHHHHHHHHHHHS
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcc--cccccceeeehhHhhC
Confidence            875322    23456899999999999766543222  3445555  4434444

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-33  Score=300.76  Aligned_cols=187  Identities=26%  Similarity=0.348  Sum_probs=148.4

Q ss_pred             cCCCccceeeeeceEEEEEEEeC--C--CeEEEEEEeecc---cchhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG--E--GMEVAVKVFDLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  852 (982)
                      ++|++.+.||+|+||+||+|+..  +  ...||||+++..   .....+++.+|++++++++||||+++++++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56899999999999999999852  2  347899998643   334457899999999999999999999999764 678


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      +||||+++|++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988877777999999999999999999999   99999999999999999999999999999998754


Q ss_pred             CCCce-eecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          933 EDQSI-TQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       933 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ..... ......|+..|+|||++.++.++..   +|+||||+
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~---~Di~S~Gv  202 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHA---SDTWMFGV  202 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHH---HHHHHHHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcc---hhhhhhHH
Confidence            43322 2334567889999999987766543   56777775

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.4e-33  Score=302.13  Aligned_cols=191  Identities=24%  Similarity=0.347  Sum_probs=149.1

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecCCC----eeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----FKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~  855 (982)
                      ++|...+.||+|+||.||+|++ +|+.||||+++.... .....+.|+..+++++||||+++++++.+++    ..|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4677889999999999999997 689999999974422 1222334555567789999999999997543    679999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~-----~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      ||+++|+|.+++++.  .+++.++.+++.|++.||+|+|..     +++|||||||||+|||+++++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999765  489999999999999999999931     2479999999999999999999999999999987


Q ss_pred             cCCCCce--eecccccccccccCceeeeeee---eeEEeeEeeeeeeee
Q 036229          931 IGEDQSI--TQTQTLATIGYMAPGLFHVKYI---LFVVNFLTSYSFLMI  974 (982)
Q Consensus       931 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~d~~~~~~~  974 (982)
                      .......  ......||+.|||||++.+...   ...+..+|+|+||++
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvv  207 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  207 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHH
Confidence            5443322  2345689999999999865421   112344567777744

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.5e-33  Score=303.65  Aligned_cols=193  Identities=24%  Similarity=0.381  Sum_probs=164.8

Q ss_pred             HHhcCCCccceeeeeceEEEEEEEe------CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhc-CCccceeEEeeecCC
Q 036229          777 RATNRFSENNLIGRGGFGSVYKARI------GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSTE  848 (982)
Q Consensus       777 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  848 (982)
                      ...++|+..+.||+|+||.||+|++      .+++.||||+++... .....++.+|+.+++++ +|||||++++++.++
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            3457899999999999999999974      346889999997543 34456788999999999 699999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC-----------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCE
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN-----------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNV  911 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NI  911 (982)
                      +..++|||||++|+|.++++...                 ..+++..+..++.||++|++|||   +++||||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence            99999999999999999987543                 25889999999999999999999   99999999999999


Q ss_pred             EEcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          912 LLDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       912 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      +++.++.+|++|||.++...............||+.|+|||++.+..++.   .+|+||+|+++
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DIwS~G~~l  237 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF---ESDVWSYGIFL  237 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH---HHHHHHHHHHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC---cccccchHHHH
Confidence            99999999999999999876555555556678999999999997766654   35667777443

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-33  Score=297.62  Aligned_cols=181  Identities=29%  Similarity=0.406  Sum_probs=146.4

Q ss_pred             hcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC-CCeeEEEEEe
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST-EEFKALILEY  857 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E~  857 (982)
                      .++|+..+.||+|+||.||+|++ .|++||||+++.+  ...+++.+|++++++++||||+++++++.+ ++..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45788899999999999999998 5789999999743  345789999999999999999999998854 5678999999


Q ss_pred             ccCCChHHHHhcCC-CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          858 MPHGSLEKSLYSSN-YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       858 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      +++|+|.+++.... ..+++..+.+++.||+.||.|||   +++|+||||||+||+++.++.+|++|||+++....    
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----  155 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----  155 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC----
Confidence            99999999997543 35899999999999999999999   99999999999999999999999999999986532    


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                       ......+|+.|+|||++.++.++.   .+|+||||+
T Consensus       156 -~~~~~~~~~~y~aPE~l~~~~~t~---~sDIwSfG~  188 (262)
T d1byga_         156 -TQDTGKLPVKWTAPEALREKKFST---KSDVWSFGI  188 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCH---HHHHHHHHH
T ss_pred             -CCccccccccCCChHHHhCCCCCh---HHHHHhHHH
Confidence             223456889999999997776654   355666663

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=2.9e-33  Score=301.36  Aligned_cols=184  Identities=22%  Similarity=0.315  Sum_probs=151.2

Q ss_pred             cCCCccceeeeeceEEEEEEEeCCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEEe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILEY  857 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E~  857 (982)
                      ++|++.++||+|+||+||+|++++++.||||+++...  ....+++.+|+.++++++||||+++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999889999999996542  33357889999999999999999999999999999999999


Q ss_pred             ccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCce
Q 036229          858 MPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSI  937 (982)
Q Consensus       858 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  937 (982)
                      +.++.+..+ ......+++..+..++.||+.||+|||   ++|||||||||+|||++.++.+|++|||.|......  ..
T Consensus        82 ~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~  155 (286)
T d1ob3a_          82 LDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR  155 (286)
T ss_dssp             CSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC--cc
Confidence            977655554 455567999999999999999999999   999999999999999999999999999999876322  22


Q ss_pred             eecccccccccccCceeeeee-eeeEEeeEeeeeee
Q 036229          938 TQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL  972 (982)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~  972 (982)
                      ......|++.|+|||.+.+.. ++..   +|+|++|
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~---~DiwslG  188 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTT---IDIWSVG  188 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTH---HHHHHHH
T ss_pred             ccceecccchhhhHHHHhCCCCCCcc---eeehhcC
Confidence            334557899999999986543 3333   4455555

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-33  Score=305.37  Aligned_cols=193  Identities=20%  Similarity=0.339  Sum_probs=162.6

Q ss_pred             HHHhcCCCccceeeeeceEEEEEEEeC------CCeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecCC
Q 036229          776 CRATNRFSENNLIGRGGFGSVYKARIG------EGMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTE  848 (982)
Q Consensus       776 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  848 (982)
                      +...++|+..+.||+|+||.||+|++.      +++.||||+++.. .......+.+|++++++++||||+++++++..+
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            334578999999999999999999753      2578999999754 334456789999999999999999999999999


Q ss_pred             CeeEEEEEeccCCChHHHHhcCC---------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          849 EFKALILEYMPHGSLEKSLYSSN---------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       849 ~~~~lv~E~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                      +..++||||+++|+|.+++...+         ...++..+.+++.|+++||.|||   +++|+||||||+|||+++++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceE
Confidence            99999999999999999886421         34688899999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ||+|||+|+...............||+.|+|||.+.++.++..   +|+|++|++
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~---~Dv~S~G~i  224 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY---SDVWSFGVV  224 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc---cccccHHHH
Confidence            9999999997755444444556679999999999987766643   566777644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-32  Score=298.75  Aligned_cols=185  Identities=24%  Similarity=0.409  Sum_probs=154.8

Q ss_pred             cceeeeeceEEEEEEEeCC----CeEEEEEEeecc-cchhhhhHHHHHHHhhhcCCccceeEEeeecC-CCeeEEEEEec
Q 036229          785 NNLIGRGGFGSVYKARIGE----GMEVAVKVFDLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCST-EEFKALILEYM  858 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~E~~  858 (982)
                      .++||+|+||+||+|++..    ...||||+++.. .....+++.+|++++++++||||+++++++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999998643    246899998743 44556789999999999999999999999864 56889999999


Q ss_pred             cCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc--
Q 036229          859 PHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS--  936 (982)
Q Consensus       859 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~--  936 (982)
                      ++|+|.+++.......++..+.+++.|++.||.|+|   +++|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777889999999999999999999   999999999999999999999999999999976433221  


Q ss_pred             eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIF  975 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l  975 (982)
                      .......||+.|+|||.+....++..   +|+||||+++
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~k---sDI~SfGivl  224 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTK---SDVWSFGVLL  224 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHH---HHHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCCh---hHhhhhHHHH
Confidence            22234578999999999977666544   5677777433

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.6e-33  Score=300.70  Aligned_cols=185  Identities=29%  Similarity=0.469  Sum_probs=151.6

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCe--EEEEEEeecc-cchhhhhHHHHHHHhhhc-CCccceeEEeeecCCCeeEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGM--EVAVKVFDLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSTEEFKALI  854 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  854 (982)
                      ++|++.+.||+|+||+||+|++. ++.  .||||+++.. .....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            68899999999999999999864 444  4778887543 344567899999999998 799999999999999999999


Q ss_pred             EEeccCCChHHHHhcC---------------CCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcE
Q 036229          855 LEYMPHGSLEKSLYSS---------------NYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVA  919 (982)
Q Consensus       855 ~E~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~  919 (982)
                      |||+++|+|.++++..               ...+++..+.+++.||+.|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999743               356899999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeee
Q 036229          920 HLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLM  973 (982)
Q Consensus       920 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~  973 (982)
                      ||+|||+|+....   ........||+.|+|||.+.++.++..   +|+||||+
T Consensus       167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~---sDvwSfGv  214 (309)
T d1fvra_         167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTN---SDVWSYGV  214 (309)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHH---HHHHHHHH
T ss_pred             EEccccccccccc---cccccceecCCcccchHHhccCCCCcc---ceeehhHH
Confidence            9999999986422   222234568999999999987766543   56666664

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.2e-33  Score=301.28  Aligned_cols=191  Identities=28%  Similarity=0.412  Sum_probs=158.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEeCC--------CeEEEEEEeecccc-hhhhhHHHHHHHhhhc-CCccceeEEeeecC
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARIGE--------GMEVAVKVFDLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCST  847 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  847 (982)
                      ..++|++.+.||+|+||.||+|+...        +..||||+++.+.. ....++.+|...++++ +||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34689999999999999999997422        35799999976533 4457788899999888 89999999999999


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCC---------------CcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEE
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSN---------------YILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVL  912 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NIL  912 (982)
                      ++..++||||+++|+|.+++....               ..+++.+++.++.|++.||+|||   +++||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccccee
Confidence            999999999999999999997543               34799999999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          913 LDDNMVAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       913 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                      ++.++.+||+|||+++...............||+.|+|||++.++.++..   +|+|++|++
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k---~DiwS~Gvv  226 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ---SDVWSFGVL  226 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH---HHHHHHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch---hhhHHhHHH
Confidence            99999999999999998765554445566789999999999987776644   667777753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-32  Score=299.90  Aligned_cols=186  Identities=25%  Similarity=0.343  Sum_probs=153.0

Q ss_pred             HhcCCCccceeeeeceEEEEEEEe-CC-CeEEEEEEeeccc--chhhhhHHHHHHHhhhc---CCccceeEEeeec----
Q 036229          778 ATNRFSENNLIGRGGFGSVYKARI-GE-GMEVAVKVFDLQC--GRAFKSFDVECEMMKSI---RHRNLIKVISSCS----  846 (982)
Q Consensus       778 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~----  846 (982)
                      ..++|++.+.||+|+||+||+|+. .+ ++.||||+++...  ......+.+|+++++.+   +||||+++++++.    
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            457999999999999999999986 34 6789999997542  23345677888887766   7999999999884    


Q ss_pred             -CCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeec
Q 036229          847 -TEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG  925 (982)
Q Consensus       847 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFG  925 (982)
                       .....+++|||++++.+..........+++..++.++.|++.||+|||   ++|||||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             345789999999988776666666667899999999999999999999   9999999999999999999999999999


Q ss_pred             CceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          926 IAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       926 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      +++...   .........||+.|||||++.+..++..   +|+||+|
T Consensus       162 ~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~---~DiwSlG  202 (305)
T d1blxa_         162 LARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATP---VDLWSVG  202 (305)
T ss_dssp             SCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTH---HHHHHHH
T ss_pred             hhhhhc---ccccCCCcccChhhcCcchhcCCCCChh---ehhhchH
Confidence            988642   2223356789999999999988777644   4555555

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=1e-31  Score=289.29  Aligned_cols=194  Identities=16%  Similarity=0.200  Sum_probs=159.3

Q ss_pred             hcCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCC-ccceeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRH-RNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++...  ..+.+.+|+++++.++| ++++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            468999999999999999999964 69999999986442  34567889999999965 899999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC-----CCcEEEEeecCceeec
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLI  931 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~-----~~~~kL~DFGla~~~~  931 (982)
                      |+ +++|.+++......+++.++..++.|++.||+|||   ++||+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 68999999877778999999999999999999999   999999999999999974     5789999999999865


Q ss_pred             CCCCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          932 GEDQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       932 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      .....     ......+||+.|||||++.+..++..+ |+|++|+.++.+.+|
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~-DiwSlG~~l~elltg  209 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD-DLEALGHVFMYFLRG  209 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHH-HHHHHHHHHHHHHHS
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHH-HHHHhhHHHHHHHhC
Confidence            43221     123356799999999999887766553 233444444444444

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=3e-29  Score=282.45  Aligned_cols=359  Identities=26%  Similarity=0.385  Sum_probs=224.4

Q ss_pred             hhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCcc
Q 036229          230 ELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNK  309 (982)
Q Consensus       230 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  309 (982)
                      ...++.+.+++.+..  ..+.+|+.|+++++.++..  +.+..+++|++|+|++|+|++..  .+.++++|++|++++|+
T Consensus        26 ~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          26 KTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HHHTTCSSTTSEECH--HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccCH--HHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccc
Confidence            445666666654432  2344566666666666532  34555666666666666666432  25566666666666666


Q ss_pred             ccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCC
Q 036229          310 LVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPN  389 (982)
Q Consensus       310 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~  389 (982)
                      +++..|  +..+++|                         +.|++++|.+++..+  ......+..+....|.+....+.
T Consensus       100 i~~i~~--l~~l~~L-------------------------~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~  150 (384)
T d2omza2         100 IADITP--LANLTNL-------------------------TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISAL  150 (384)
T ss_dssp             CCCCGG--GTTCTTC-------------------------CEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGG
T ss_pred             cccccc--ccccccc-------------------------ccccccccccccccc--ccccccccccccccccccccccc
Confidence            653322  3444444                         555555555543322  22334455555555555433222


Q ss_pred             ccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcc
Q 036229          390 TFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKE  469 (982)
Q Consensus       390 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~  469 (982)
                      .................+.          .+.............|                          ..  ..+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~--------------------------~~--~~~~~  192 (384)
T d2omza2         151 SGLTSLQQLSFGNQVTDLK----------PLANLTTLERLDISSN--------------------------KV--SDISV  192 (384)
T ss_dssp             TTCTTCSEEEEEESCCCCG----------GGTTCTTCCEEECCSS--------------------------CC--CCCGG
T ss_pred             cccccccccccccccchhh----------hhcccccccccccccc--------------------------cc--ccccc
Confidence            2211111111111100000          1111122222222222                          22  12344


Q ss_pred             cccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccc
Q 036229          470 IGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLG  549 (982)
Q Consensus       470 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  549 (982)
                      +..+++++.+++++|.+++..|  +...++|++|++++|+++..  +.+..+++|+.|++++|++++..+  +..+++|+
T Consensus       193 ~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~  266 (384)
T d2omza2         193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLT  266 (384)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred             cccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCC
Confidence            5667778888888888876654  45567888888888888742  357778888888888888876543  67788888


Q ss_pred             ccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccc
Q 036229          550 TLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRL  629 (982)
Q Consensus       550 ~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  629 (982)
                      +|++++|+++.++. +..+..++.++++.|.+++.  ..+..+++++.|++++|++++..|  +..+++|++|+|++|+|
T Consensus       267 ~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l  341 (384)
T d2omza2         267 ELKLGANQISNISP-LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV  341 (384)
T ss_dssp             EEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCC
T ss_pred             EeeccCcccCCCCc-cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCC
Confidence            88888888887764 55677788888888888753  347778888899999999987643  78899999999999999


Q ss_pred             cCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCc
Q 036229          630 QGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNK  676 (982)
Q Consensus       630 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~  676 (982)
                      ++ ++ .|+++++|++|+|++|+|++.+|  +.++++|++|+|++|.
T Consensus       342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         342 SD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            85 44 68999999999999999987654  8889999999999883

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.6e-32  Score=297.80  Aligned_cols=193  Identities=23%  Similarity=0.262  Sum_probs=150.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc-chhhhhHHHHHHHhhhcCCccceeEEeeecCCC----eeE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE----FKA  852 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~  852 (982)
                      +++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++||||+++++++..+.    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999985 579999999997543 344568899999999999999999999986653    234


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecC
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG  932 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  932 (982)
                      ++++|+.+|+|.+++...  .+++..++.++.|++.||+|||   ++|||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            555667799999999754  4899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCc-eeecccccccccccCceeeee-eeeeEEeeEeeeeee--eeecccC
Q 036229          933 EDQS-ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       933 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      .... ......+||+.|+|||++... .+..+   +|+|++|  ++.+.+|
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~---~DiwSlG~il~eml~g  209 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS---IDIWSVGCILAEMLSN  209 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTH---HHHHHHHHHHHHHHHS
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCch---hhhhccCceehHHhhC
Confidence            3221 223456799999999998544 33333   3445555  4444333

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.9e-32  Score=297.90  Aligned_cols=187  Identities=25%  Similarity=0.316  Sum_probs=147.8

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecCCC------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSTEE------  849 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------  849 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++..  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999986 45999999999754  2344567889999999999999999999997654      


Q ss_pred             eeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          850 FKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       850 ~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      +.|+||||+ +.++.++.+..  .+++..++.++.|++.||+|||   ++|||||||||+|||++.++.+|++|||.|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 66888877543  4899999999999999999999   99999999999999999999999999999997


Q ss_pred             ecCCCCceeecccccccccccCceeeeee-eeeEEeeEeeeeee--eeecccC
Q 036229          930 LIGEDQSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ....     .+...||+.|+|||++.+.. ++..   +|+||+|  ++.+.+|
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwSlGvil~ell~g  215 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQT---VDIWSVGCIMAEMITG  215 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTT---HHHHHHHHHHHHHHHS
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCcc---chhhcchHHHHHHHHC
Confidence            5322     24567999999999986543 3333   3445555  4444444

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-31  Score=295.18  Aligned_cols=186  Identities=26%  Similarity=0.405  Sum_probs=145.6

Q ss_pred             CCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccceeEEeeecC------CCeeEE
Q 036229          781 RFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCST------EEFKAL  853 (982)
Q Consensus       781 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~~~l  853 (982)
                      +|+..++||+|+||+||+|++. +|+.||||+++.+.    ....+|++++++++||||+++++++..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888999999999999999964 59999999997543    223479999999999999999998843      335789


Q ss_pred             EEEeccCCChHHHHh--cCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceee
Q 036229          854 ILEYMPHGSLEKSLY--SSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLL  930 (982)
Q Consensus       854 v~E~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~  930 (982)
                      |||||+++....+..  .....+++.+++.++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998754433322  34556899999999999999999999   99999999999999999765 8999999999876


Q ss_pred             cCCCCceeecccccccccccCceeeee-eeeeEEeeEeeeeee--eeecccC
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ....   ......||+.|+|||.+.+. .++..   +|+|++|  ++.+.+|
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~---~DIwSlG~il~el~~g  219 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSS---IDVWSAGCVLAELLLG  219 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTH---HHHHHHHHHHHHHHHT
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcc---eeecccceEEEehhhC
Confidence            4332   23346899999999998654 44433   3445444  4444443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=5.8e-29  Score=280.05  Aligned_cols=357  Identities=27%  Similarity=0.363  Sum_probs=230.6

Q ss_pred             EEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCcc
Q 036229          207 LSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFL  286 (982)
Q Consensus       207 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l  286 (982)
                      .+++.+.+++.+.  ...+.+|++|++++|+++..  +.+..+++|++|++++|++++..  .++++++|++|++++|++
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccc
Confidence            4566677776554  35678899999999999853  46888999999999999999753  399999999999999999


Q ss_pred             ccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEccCCccccccccc
Q 036229          287 TGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRF  366 (982)
Q Consensus       287 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  366 (982)
                      ++..  .+.++++|+.|++++|.+++..+  ......+.......|.+...                         .+..
T Consensus       101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~-------------------------~~~~  151 (384)
T d2omza2         101 ADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-------------------------SALS  151 (384)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-------------------------GGGT
T ss_pred             cccc--ccccccccccccccccccccccc--cccccccccccccccccccc-------------------------cccc
Confidence            8653  38899999999999999986543  23344554555555444321                         1111


Q ss_pred             ccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCCCCCCCCCccccc
Q 036229          367 IFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMG  446 (982)
Q Consensus       367 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  446 (982)
                      ................+     ..+...+.........|....       ...+..+++++.+++++|.++++.+     
T Consensus       152 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~~~~l~l~~n~i~~~~~-----  214 (384)
T d2omza2         152 GLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQISDITP-----  214 (384)
T ss_dssp             TCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCCC-------CGGGGGCTTCSEEECCSSCCCCCGG-----
T ss_pred             ccccccccccccccchh-----hhhcccccccccccccccccc-------ccccccccccceeeccCCccCCCCc-----
Confidence            11111111111111111     112222222222333332221       1224455666677777776654422     


Q ss_pred             cccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccE
Q 036229          447 NLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYE  526 (982)
Q Consensus       447 ~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  526 (982)
                                             +...++|+.|++++|+++..  ..+..+++|+.|++++|++++..  .+..+++|+.
T Consensus       215 -----------------------~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~  267 (384)
T d2omza2         215 -----------------------LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTE  267 (384)
T ss_dssp             -----------------------GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred             -----------------------ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCE
Confidence                                   22344556666666666532  34556666666666666666433  2556666777


Q ss_pred             EEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeeccccccc
Q 036229          527 LGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFS  606 (982)
Q Consensus       527 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~  606 (982)
                      |++++|++++..  .+.+++.++.++++.|+++.++ .+..+++++.|++++|++++..+  +..+++|+.|++++|+|+
T Consensus       268 L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~  342 (384)
T d2omza2         268 LKLGANQISNIS--PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS  342 (384)
T ss_dssp             EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             eeccCcccCCCC--cccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCC
Confidence            777777766443  2556667777777777776654 35556677777777777776532  677888888888888887


Q ss_pred             ccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCC
Q 036229          607 DVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNN  651 (982)
Q Consensus       607 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  651 (982)
                      ++ | .++++++|++|+|++|+|++.+|  +.++++|++|+|++|
T Consensus       343 ~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         343 DV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            63 3 58888999999999999987654  888999999999988

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-31  Score=285.63  Aligned_cols=185  Identities=22%  Similarity=0.292  Sum_probs=155.8

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCCCeeEEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTEEFKALILE  856 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~E  856 (982)
                      ++|++.++||+|+||+||+|++ .+++.||||+++...  ....+++.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999996 468999999997542  3456788999999999999999999999999999999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceeecCCCCc
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS  936 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~  936 (982)
                      ++.++++..++.. .+.+++..+..++.|++.||+|||   ++|||||||||+||+++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            9999888777654 456889999999999999999999   99999999999999999999999999999997643322 


Q ss_pred             eeecccccccccccCceeeeeee-eeEEeeEeeeeeee
Q 036229          937 ITQTQTLATIGYMAPGLFHVKYI-LFVVNFLTSYSFLM  973 (982)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~d~~~~~~  973 (982)
                       ......+++.|+|||++....+ +..   +|+|++|+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~---~DiwSlG~  190 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTS---IDMWSAGC  190 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTH---HHHHHHHH
T ss_pred             -cceeeccccchhhhhHhccCCCCCch---hhccccch
Confidence             2334567889999999865543 322   45555553

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=2.3e-31  Score=292.30  Aligned_cols=178  Identities=21%  Similarity=0.339  Sum_probs=147.9

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecC--CCeeEEEE
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCST--EEFKALIL  855 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~  855 (982)
                      ++|++.++||+|+||+||+|+. .+++.||||+++..   ..+++.+|+++++.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6799999999999999999996 46999999998743   3467889999999995 9999999999864  45689999


Q ss_pred             EeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCC-cEEEEeecCceeecCCC
Q 036229          856 EYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGED  934 (982)
Q Consensus       856 E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~  934 (982)
                      ||+++++|.++.    +.+++.+++.++.||+.||+|||   ++|||||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999997654    34899999999999999999999   99999999999999998654 69999999998764322


Q ss_pred             CceeecccccccccccCceeeeee-eeeEEeeEeeeeeee
Q 036229          935 QSITQTQTLATIGYMAPGLFHVKY-ILFVVNFLTSYSFLM  973 (982)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~d~~~~~~  973 (982)
                         ......||+.|+|||++.+.. ++..   +|+|++|+
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~---~DiwslG~  218 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYS---LDMWSLGC  218 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTH---HHHHHHHH
T ss_pred             ---cccccccCccccCcccccCCCCCCcc---cchhhhhh
Confidence               234567999999999986543 3433   44555553

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.2e-31  Score=289.97  Aligned_cols=194  Identities=23%  Similarity=0.319  Sum_probs=151.5

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC--------
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST--------  847 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------  847 (982)
                      .++|++.++||+|+||+||+|+. .+|+.||||++...  ......++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57899999999999999999996 46999999998644  23345678899999999999999999998754        


Q ss_pred             CCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCc
Q 036229          848 EEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA  927 (982)
Q Consensus       848 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla  927 (982)
                      ++..|+||||++++.+. ........+++..++.++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34689999999876554 44445556899999999999999999999   999999999999999999999999999999


Q ss_pred             eeecCCCCc--eeecccccccccccCceeeee-eeeeEEeeEeeeeee--eeecccC
Q 036229          928 KLLIGEDQS--ITQTQTLATIGYMAPGLFHVK-YILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       928 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      +.+......  ......+||+.|+|||++.+. .++..   +|+||+|  ++.+.+|
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k---~DiwSlGvil~el~~g  218 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP---IDLWGAGCIMAEMWTR  218 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTH---HHHHHHHHHHHHHHHS
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcH---HHcccCCceeeeHhhC
Confidence            876433211  222345799999999998654 34433   4445555  4444444

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.9e-31  Score=290.57  Aligned_cols=187  Identities=25%  Similarity=0.334  Sum_probs=154.2

Q ss_pred             cCCCccceeeeeceEEEEEEEe----CCCeEEEEEEeecc----cchhhhhHHHHHHHhhhcCC-ccceeEEeeecCCCe
Q 036229          780 NRFSENNLIGRGGFGSVYKARI----GEGMEVAVKVFDLQ----CGRAFKSFDVECEMMKSIRH-RNLIKVISSCSTEEF  850 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~  850 (982)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999974    24899999998643    22345678899999999976 899999999999999


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .++||||+.+|+|.+++...+ ..++..+..++.|++.|++|+|   +++||||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999987655 4678889999999999999999   999999999999999999999999999999876


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      .... ........|++.|+|||.+.+.... .+..+|+||+|
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~-~~~ksDIWSlG  219 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAPDIVRGGDSG-HDKAVDWWSLG  219 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC----CTHHHHHHHH
T ss_pred             cccc-cccccccccccccchhHHhhcCCcC-CCchhhhHHHH
Confidence            4322 2223456799999999999654322 12335556665

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=9.6e-31  Score=283.36  Aligned_cols=192  Identities=21%  Similarity=0.278  Sum_probs=153.7

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccc-eeEEeeecCCCeeEEEEE
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSTEEFKALILE  856 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~E  856 (982)
                      .++|++.+.||+|+||+||+|++ .+++.||||++....  ..+++.+|+++++.++|+++ +.+.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            46799999999999999999986 468999999987543  34578899999999987765 455566677888999999


Q ss_pred             eccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcC---CCcEEEEeecCceeecCC
Q 036229          857 YMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGE  933 (982)
Q Consensus       857 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~---~~~~kL~DFGla~~~~~~  933 (982)
                      |+ ++++.+.+......+++..+..++.|++.||+|||   ++|||||||||+||+++.   +..+|++|||+|+.+...
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 56787777776777999999999999999999999   999999999999999863   457999999999987543


Q ss_pred             CCc-----eeecccccccccccCceeeeeeeeeEEeeEeeeeee--eeecccC
Q 036229          934 DQS-----ITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL--MIFIGRG  979 (982)
Q Consensus       934 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~--~~l~~~~  979 (982)
                      ...     .......||+.|||||++.+..++..   +|+||+|  ++.+.+|
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlG~~l~el~tg  209 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRR---DDLESLGYVLMYFNLG  209 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHH---HHHHHHHHHHHHHHHS
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCCh---hhEEecCHHHHHHHhC
Confidence            321     22345679999999999988776654   4445555  4444443

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-30  Score=288.98  Aligned_cols=191  Identities=24%  Similarity=0.279  Sum_probs=149.0

Q ss_pred             hcCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeeccc--chhhhhHHHHHHHhhhcCCccceeEEeeecCC-----Ce
Q 036229          779 TNRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSTE-----EF  850 (982)
Q Consensus       779 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~  850 (982)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++...  ....+++.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            57899999999999999999985 469999999997542  33456788999999999999999999998543     34


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .+++|||+.+|+|.+++...  .+++.+++.++.||+.||+|||   ++||+||||||+||+++.++.+|++|||.|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46677788899999998643  4899999999999999999999   999999999999999999999999999999864


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeeeecccC
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMIFIGRG  979 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~l~~~~  979 (982)
                      .     .......||+.|+|||++.+..+.....++|++|+.++.+.+|
T Consensus       172 ~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g  215 (348)
T d2gfsa1         172 D-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG  215 (348)
T ss_dssp             T-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred             C-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhC
Confidence            2     2234567999999999976543322223333344444444444

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=8.8e-30  Score=282.29  Aligned_cols=180  Identities=26%  Similarity=0.279  Sum_probs=140.0

Q ss_pred             cCCCccceeeeeceEEEEEEEeC-CCeEEEEEEeecc--cchhhhhHHHHHHHhhhcCCccceeEEeeecC------CCe
Q 036229          780 NRFSENNLIGRGGFGSVYKARIG-EGMEVAVKVFDLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCST------EEF  850 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~  850 (982)
                      ++|++.++||+|+||+||+|++. +|+.||||+++..  ......++.+|+.++++++||||+++++++..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999965 6999999999754  23445678899999999999999999999853      468


Q ss_pred             eEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCceee
Q 036229          851 KALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  930 (982)
Q Consensus       851 ~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~~  930 (982)
                      .|+||||+.++ +.+.+.   ..+++..++.++.|++.||+|||   ++||+||||||+|||++.++.+|++|||.++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999765 444443   34789999999999999999999   999999999999999999999999999998865


Q ss_pred             cCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeee
Q 036229          931 IGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFL  972 (982)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~  972 (982)
                      ..   ........||+.|+|||++.+..++..   +|+|++|
T Consensus       170 ~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~---~DiwSlG  205 (355)
T d2b1pa1         170 GT---SFMMTPYVVTRYYRAPEVILGMGYKEN---VDIWSVG  205 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTT---HHHHHHH
T ss_pred             cc---ccccccccccccccChhhhcCCCCCCC---ccccccc
Confidence            32   233345679999999999987766644   4455555

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.3e-26  Score=251.69  Aligned_cols=244  Identities=22%  Similarity=0.294  Sum_probs=192.7

Q ss_pred             CceeeEEecCCCCcEEEEEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCcc
Q 036229           69 CNWTGVTCDVHSHRVKVLNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSF  148 (982)
Q Consensus        69 c~w~gv~c~~~~~~v~~L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  148 (982)
                      |.|++|.|+            +.+++ .+|+.+.  +++++|||++|+++...+.+|.++++|++|++++|.++...|..
T Consensus        10 c~~~~~~C~------------~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~   74 (305)
T d1xkua_          10 CHLRVVQCS------------DLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   74 (305)
T ss_dssp             EETTEEECT------------TSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             ecCCEEEec------------CCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence            567777776            34566 6777664  68999999999998444457889999999999999999877888


Q ss_pred             ccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccc--ccccccccccc
Q 036229          149 IFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLL--GAIPKEIGNLT  226 (982)
Q Consensus       149 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~  226 (982)
                      |.++++|++|++++|+++ .+|...   .+.++.|++++|.+.+..+..+.....++.++...|...  ...+..+..++
T Consensus        75 f~~l~~L~~L~l~~n~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~  150 (305)
T d1xkua_          75 FAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK  150 (305)
T ss_dssp             TTTCTTCCEEECCSSCCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT
T ss_pred             hhCCCccCEecccCCccC-cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccccc
Confidence            999999999999999998 788655   467889999999998777667777888888888887543  33455677888


Q ss_pred             chhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEcc
Q 036229          227 KLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLS  306 (982)
Q Consensus       227 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  306 (982)
                      +|+.+++++|+++. +|..+  +++|+.|++++|...+..+..|.+++.+++|++++|.+++..+..|.++++|++|+|+
T Consensus       151 ~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~  227 (305)
T d1xkua_         151 KLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN  227 (305)
T ss_dssp             TCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred             ccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence            88888888888874 34332  5678888888888887777888888888888888888888778888888888888888


Q ss_pred             CccccccCcccccCCCCCceeecCCCcCC
Q 036229          307 HNKLVGAVPATIFNMSTLTGLGLQSNSLS  335 (982)
Q Consensus       307 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  335 (982)
                      +|+|+ .+|..+.++++|+.|+|++|+|+
T Consensus       228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         228 NNKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             SSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             ccccc-ccccccccccCCCEEECCCCccC
Confidence            88887 45667777777766666666665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.4e-25  Score=243.65  Aligned_cols=248  Identities=24%  Similarity=0.309  Sum_probs=133.2

Q ss_pred             cceEeccccccCCcCChhhhccCCCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCC
Q 036229          252 LELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQS  331 (982)
Q Consensus       252 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  331 (982)
                      ++.++.++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.+++.|+.|++++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            344555555554 3344432  4566677777776655555666666777777777776665566666666666666666


Q ss_pred             CcCCCCcCccccccCCCccEEEccCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCc
Q 036229          332 NSLSGSLSSIADVQLPNLEELRLWSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSN  411 (982)
Q Consensus       332 N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  411 (982)
                      |+++.....    ..+.+..|++++|.+.+..+..+.....+..++...|......                        
T Consensus        89 n~l~~l~~~----~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~------------------------  140 (305)
T d1xkua_          89 NQLKELPEK----MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG------------------------  140 (305)
T ss_dssp             SCCSBCCSS----CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG------------------------
T ss_pred             CccCcCccc----hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccC------------------------
Confidence            655432211    1235566666777666555555555566666666665433211                        


Q ss_pred             ccccccccCCCCccccEEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCC
Q 036229          412 LELSFLSSFSNCKSLTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIP  491 (982)
Q Consensus       412 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  491 (982)
                         .....|..+++|+++++++|.+..+...                             .+++|+.|++++|.+++..+
T Consensus       141 ---~~~~~~~~l~~L~~l~l~~n~l~~l~~~-----------------------------~~~~L~~L~l~~n~~~~~~~  188 (305)
T d1xkua_         141 ---IENGAFQGMKKLSYIRIADTNITTIPQG-----------------------------LPPSLTELHLDGNKITKVDA  188 (305)
T ss_dssp             ---BCTTGGGGCTTCCEEECCSSCCCSCCSS-----------------------------CCTTCSEEECTTSCCCEECT
T ss_pred             ---CCccccccccccCccccccCCccccCcc-----------------------------cCCccCEEECCCCcCCCCCh
Confidence               0011244455555666666654432111                             12344555555555555555


Q ss_pred             ccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCccccccc
Q 036229          492 ITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPL  563 (982)
Q Consensus       492 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~  563 (982)
                      ..|.+++.++.|++++|++++..+..+.++++|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+.|+.
T Consensus       189 ~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~  259 (305)
T d1xkua_         189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS  259 (305)
T ss_dssp             GGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             hHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccCh
Confidence            55555555555555555555554555555555555555555554 334455555555555555555555543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.9e-26  Score=245.11  Aligned_cols=209  Identities=27%  Similarity=0.267  Sum_probs=126.5

Q ss_pred             ccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEcc-CCcCCcCCCccccCCCccccccc
Q 036229          475 NLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLS-GNKLSGSIPACFSNLASLGTLSL  553 (982)
Q Consensus       475 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~L  553 (982)
                      ++++|+|++|+|+++.+.+|.++++|++|++++|+|.+..+..+..++.++.++.. .|.++...|..|.++++|++|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            34455555555554444455555555555555555555555555555555555432 34454444555555555555555


Q ss_pred             CCCccccccccc-ccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCC
Q 036229          554 GSNKLTSIPLTI-WNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS  632 (982)
Q Consensus       554 ~~N~l~~ip~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  632 (982)
                      ++|.+..++... ....+|+++++++|++++..+..|..++.|+.|++++|+++++.+.+|.++++|+++++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            555555444332 2345555556666665555555566666667777777777666666777777777777777777766


Q ss_pred             ccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccCCC
Q 036229          633 ISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEIPK  683 (982)
Q Consensus       633 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  683 (982)
                      .|.+|.++++|++||+++|++++..|..|..+++|++|++++|++.|.++.
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~  243 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA  243 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred             ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence            677777777777777777777766666677777777777777777766553

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.7e-25  Score=240.05  Aligned_cols=251  Identities=20%  Similarity=0.204  Sum_probs=219.5

Q ss_pred             EEEccCCCCCCCCCccccccccccccEEeccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEee-
Q 036229          428 YIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLE-  506 (982)
Q Consensus       428 ~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-  506 (982)
                      .++.+++.++.++..     ++..+++||+++|+|+...+..|.++++|+.|++++|++.++.+..+..+..++.++.. 
T Consensus        15 ~v~c~~~~L~~iP~~-----ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~   89 (284)
T d1ozna_          15 TTSCPQQGLQAVPVG-----IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (284)
T ss_dssp             EEECCSSCCSSCCTT-----CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             EEEcCCCCCCccCCC-----CCCCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc
Confidence            556777777766443     23568899999999998888889999999999999999999999999999999998865 


Q ss_pred             ccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccc-cccCceEEecCCCcccCCC
Q 036229          507 DNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW-NLKGMLYLNFSSNFFTGPL  585 (982)
Q Consensus       507 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~-~l~~L~~L~Ls~N~l~~~~  585 (982)
                      .|.++...|..|.++++|++|++++|.+.+..+..+...++|+.+++++|+|+.+|...+ .+++|+.|++++|++++..
T Consensus        90 ~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~  169 (284)
T d1ozna_          90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (284)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence            678888888899999999999999999998888889999999999999999999986544 6889999999999999988


Q ss_pred             ccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCccccccc
Q 036229          586 PLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLS  665 (982)
Q Consensus       586 ~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  665 (982)
                      +..|.++++|+.+++++|+++++.|..|.++++|++|++++|++++..|.+|+++++|+.|+|++|.+...-+. ..-..
T Consensus       170 ~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~  248 (284)
T d1ozna_         170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWA  248 (284)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHH
T ss_pred             hhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999875432 12234


Q ss_pred             ccceeecCCCcccccCCCC
Q 036229          666 YLEDLDLSFNKLKGEIPKG  684 (982)
Q Consensus       666 ~L~~l~ls~N~l~~~~p~~  684 (982)
                      .++.+....+++.|..|..
T Consensus       249 ~l~~~~~~~~~~~C~~p~~  267 (284)
T d1ozna_         249 WLQKFRGSSSEVPCSLPQR  267 (284)
T ss_dssp             HHHHCCSEECCCBEEESGG
T ss_pred             HHHhCcCCCCceEeCCchH
Confidence            5778888888888877754

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=6.2e-25  Score=232.96  Aligned_cols=204  Identities=24%  Similarity=0.228  Sum_probs=167.0

Q ss_pred             cccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccccc
Q 036229          472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTL  551 (982)
Q Consensus       472 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  551 (982)
                      +...+.+++.++++++. +|..+.  +++++|+|++|+|++..+.+|.++++|++|+|++|+|+.+ | .+..+++|++|
T Consensus         8 ~~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L   82 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL   82 (266)
T ss_dssp             CSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred             ccCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence            34455566777777773 454443  4677888888888766666777888888888888888743 3 35677888888


Q ss_pred             ccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccC
Q 036229          552 SLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG  631 (982)
Q Consensus       552 ~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  631 (982)
                      +|++|+++.+|..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.+++..+..+..+++|+.|++++|+|++
T Consensus        83 ~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~  162 (266)
T d1p9ag_          83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (266)
T ss_dssp             ECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             ccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence            88888888777777778888888888888888778888889999999999999998888889999999999999999998


Q ss_pred             CccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccccC
Q 036229          632 SISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       632 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~  681 (982)
                      ..+..|..+++|++|||++|+|+ .+|+.+..+++|+.|+|++|++.|.+
T Consensus       163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            88889999999999999999998 78888889999999999999998754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.91  E-value=6.6e-26  Score=252.54  Aligned_cols=183  Identities=17%  Similarity=0.209  Sum_probs=142.2

Q ss_pred             cCCCccceeeeeceEEEEEEEe-CCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-----------CccceeEEeeecC
Q 036229          780 NRFSENNLIGRGGFGSVYKARI-GEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-----------HRNLIKVISSCST  847 (982)
Q Consensus       780 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~  847 (982)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++.+. ...+.+.+|+++++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4699999999999999999986 469999999997542 33467788999988775           5789999988754


Q ss_pred             --CCeeEEEEEeccCCChHH--HHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCCEEEcCCC-----
Q 036229          848 --EEFKALILEYMPHGSLEK--SLYSSNYILDIFQRLNIMVDVATTLEYLHFGYS-APVIHCDLKPSNVLLDDNM-----  917 (982)
Q Consensus       848 --~~~~~lv~E~~~~gsL~~--~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~-~~ivHrDlkp~NILl~~~~-----  917 (982)
                        ....+++|+++..+....  .........++..++.++.|++.|++|||   + .||+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence              356667777765543322  22234456889999999999999999999   6 8999999999999998654     


Q ss_pred             -cEEEEeecCceeecCCCCceeecccccccccccCceeeeeeeeeEEeeEeeeeeeee
Q 036229          918 -VAHLSDFGIAKLLIGEDQSITQTQTLATIGYMAPGLFHVKYILFVVNFLTSYSFLMI  974 (982)
Q Consensus       918 -~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~d~~~~~~~  974 (982)
                       .+|++|||.|.....     .....+||+.|+|||++.+..++..   +|+|++|++
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~---~DiwSlG~i  218 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCG---ADIWSTACL  218 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTH---HHHHHHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCcc---ccccchHHH
Confidence             499999999986522     2245679999999999987766543   556666643

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=7e-23  Score=216.94  Aligned_cols=204  Identities=28%  Similarity=0.281  Sum_probs=181.9

Q ss_pred             cCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEE
Q 036229          495 GKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYL  574 (982)
Q Consensus       495 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L  574 (982)
                      .+...+.+.|.+++.|+ .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+++|. +..+++|++|
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~-~~~l~~L~~L   82 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTL   82 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEE
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc-cccccccccc
Confidence            45567778899999999 5677664  589999999999998888899999999999999999999985 4678999999


Q ss_pred             ecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCC
Q 036229          575 NFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       575 ~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  654 (982)
                      ++++|++++ .+..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++|+.|++++|+|+
T Consensus        83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_          83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             ccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            999999985 4668899999999999999999999999999999999999999999888899999999999999999999


Q ss_pred             CCCCcccccccccceeecCCCcccccCCCCC-CCCCCCCcccccCcccCCC
Q 036229          655 RSIPISLEKLSYLEDLDLSFNKLKGEIPKGG-SFGNFSAKSFEGNELLCGS  704 (982)
Q Consensus       655 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~-~~~~~~~~~~~gn~~lc~~  704 (982)
                      +..|..|..+++|++|||++|+|+ .+|.+. ...........|||+.|+.
T Consensus       162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            988888999999999999999999 788754 3344556778999999984

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=2.2e-21  Score=194.12  Aligned_cols=133  Identities=17%  Similarity=0.200  Sum_probs=106.7

Q ss_pred             CCccceeeeeceEEEEEEEeCCCeEEEEEEeecccc------------------hhhhhHHHHHHHhhhcCCccceeEEe
Q 036229          782 FSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCG------------------RAFKSFDVECEMMKSIRHRNLIKVIS  843 (982)
Q Consensus       782 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~nIv~l~~  843 (982)
                      +.++++||+|+||+||+|+..+|++||||+++....                  .......+|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            356789999999999999988899999998753210                  11234456888999999999999887


Q ss_pred             eecCCCeeEEEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCCEEEcCCCcEEEEe
Q 036229          844 SCSTEEFKALILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD  923 (982)
Q Consensus       844 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~~~~ivHrDlkp~NILl~~~~~~kL~D  923 (982)
                      +..    .+++|||++++...+        ++...+..++.|++.|++|||   ++||+||||||+|||++++ .++|+|
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence            642    379999998865533        233445679999999999999   9999999999999999965 589999


Q ss_pred             ecCceee
Q 036229          924 FGIAKLL  930 (982)
Q Consensus       924 FGla~~~  930 (982)
                      ||.|...
T Consensus       146 FG~a~~~  152 (191)
T d1zara2         146 FPQSVEV  152 (191)
T ss_dssp             CTTCEET
T ss_pred             CCCcccC
Confidence            9999865

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=3e-19  Score=197.04  Aligned_cols=96  Identities=25%  Similarity=0.330  Sum_probs=56.7

Q ss_pred             cCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEE
Q 036229          129 YTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILS  208 (982)
Q Consensus       129 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  208 (982)
                      .+|++|||++|+++ .+|+.   .++|++|+|++|+|+ .+|..    +.+|+.|++++|+++. +++.   .+.|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccch-hhhh---cccccccc
Confidence            46778888888877 46653   356777777777777 66643    3466677777766652 2211   12466666


Q ss_pred             eeccccccccccccccccchhhhhccCCCCC
Q 036229          209 LSINNLLGAIPKEIGNLTKLKELYLGYSGLQ  239 (982)
Q Consensus       209 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  239 (982)
                      +++|++. .+|. ++.+++|++|++++|.++
T Consensus       105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~  133 (353)
T d1jl5a_         105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK  133 (353)
T ss_dssp             CCSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred             ccccccc-cccc-hhhhccceeecccccccc
Confidence            6666655 3332 345555555555555544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.83  E-value=7.3e-19  Score=193.90  Aligned_cols=137  Identities=26%  Similarity=0.308  Sum_probs=72.8

Q ss_pred             CCcEEEccCCccccCCCccccccCCCcEEEccCccccccCcccccCCCCCceeecCCCcCCCCcCccccccCCCccEEEc
Q 036229          275 GLEVLKLGKNFLTGEIPPEIHNLHNLKLLDLSHNKLVGAVPATIFNMSTLTGLGLQSNSLSGSLSSIADVQLPNLEELRL  354 (982)
Q Consensus       275 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L  354 (982)
                      ++++|||++|.++. +|+.   .++|++|+|++|+|+ .+|+.   ..+|+.|++++|.++.. +..    .+.|++|++
T Consensus        39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~l----p~~L~~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SDL----PPLLEYLGV  105 (353)
T ss_dssp             TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CSC----CTTCCEEEC
T ss_pred             CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hhh----ccccccccc
Confidence            46666666666663 4432   346666677777666 44543   23566666666665422 111    134677777


Q ss_pred             cCCcccccccccccCCCCCCEEEeccccCccccCCccccCCccceecccccccccCcccccccccCCCCccccEEEccCC
Q 036229          355 WSNNFSGTIPRFIFNASKLSVLELGRNSFSGFIPNTFGNLRNLRLMTLHYNYLTSSNLELSFLSSFSNCKSLTYIGLSNN  434 (982)
Q Consensus       355 s~N~l~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N  434 (982)
                      ++|.+.. +|. +..+++|++|++++|.+.... ..   ...+..+.+..+.....       ..+..++.++.+++++|
T Consensus       106 ~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~-~~---~~~l~~l~~~~~~~~~~-------~~l~~l~~l~~L~l~~n  172 (353)
T d1jl5a_         106 SNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLEEL-------PELQNLPFLTAIYADNN  172 (353)
T ss_dssp             CSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSSC-------CCCTTCTTCCEEECCSS
T ss_pred             ccccccc-ccc-hhhhccceeeccccccccccc-cc---cccccchhhcccccccc-------ccccccccceecccccc
Confidence            7777763 343 456677777777777766432 22   22333343333333221       12344555555666555


Q ss_pred             CCC
Q 036229          435 PLD  437 (982)
Q Consensus       435 ~l~  437 (982)
                      ...
T Consensus       173 ~~~  175 (353)
T d1jl5a_         173 SLK  175 (353)
T ss_dssp             CCS
T ss_pred             ccc
Confidence            443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=1.7e-19  Score=187.97  Aligned_cols=200  Identities=18%  Similarity=0.149  Sum_probs=134.3

Q ss_pred             ccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCC-CcccCCCccccEEEccC-CcCCcCCCccccCCCcccccc
Q 036229          475 NLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPI-PDDICRLTKLYELGLSG-NKLSGSIPACFSNLASLGTLS  552 (982)
Q Consensus       475 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~  552 (982)
                      ++++|++++|+|+.+.+.+|.++++|++|+|++|.+...+ +.+|.++++++++++.. |.+....+..|.++++|++|+
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            5666666666666555556666777777777777665433 34566666666666543 566656666677777777777


Q ss_pred             cCCCcccccccc--cccccCceEEecCCCcccCCCcccccccc-ccceeecccccccccccccccCccCcceEecccccc
Q 036229          553 LGSNKLTSIPLT--IWNLKGMLYLNFSSNFFTGPLPLDIGNLK-VLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRL  629 (982)
Q Consensus       553 L~~N~l~~ip~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  629 (982)
                      +++|.++.+|..  ...+..+..+..+++.+....+..+.++. .++.+++++|+++++.+..+....-++.+++++|+|
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l  189 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL  189 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTC
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccccc
Confidence            777777655432  22455566666666666655555565554 677788888888766555555433344446788888


Q ss_pred             cCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCC
Q 036229          630 QGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF  674 (982)
Q Consensus       630 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~  674 (982)
                      +...+..|.++++|++|||++|+|+...+..|.++++|+.+++++
T Consensus       190 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             ccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            866666788899999999999999866566788888888877744

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=3.7e-19  Score=183.15  Aligned_cols=202  Identities=26%  Similarity=0.322  Sum_probs=154.6

Q ss_pred             eccCCccccCCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCC
Q 036229          456 DMSYCNVSGGFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLS  535 (982)
Q Consensus       456 dls~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  535 (982)
                      +++.+++++..  .+..+.+|+.|++.+|+|+..  ..+..+++|++|++++|+|++..|  +..+++|+.+++++|.++
T Consensus        25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~   98 (227)
T d1h6ua2          25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK   98 (227)
T ss_dssp             HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred             HhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence            33444444432  346677888888888888754  357888888888888888885433  788888888888888887


Q ss_pred             cCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccC
Q 036229          536 GSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGG  615 (982)
Q Consensus       536 ~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~  615 (982)
                      . ++ .+.++++|+.++++++....++. +...+.+..+.++++.+....  .+.+.++|+.|++++|.+++..  .+++
T Consensus        99 ~-i~-~l~~l~~L~~l~l~~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~  171 (227)
T d1h6ua2          99 N-VS-AIAGLQSIKTLDLTSTQITDVTP-LAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLAN  171 (227)
T ss_dssp             C-CG-GGTTCTTCCEEECTTSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTT
T ss_pred             c-cc-cccccccccccccccccccccch-hccccchhhhhchhhhhchhh--hhccccccccccccccccccch--hhcc
Confidence            4 33 47788888888888888876543 445677888888888876543  3677888999999999887643  4888


Q ss_pred             ccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCC
Q 036229          616 LTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF  674 (982)
Q Consensus       616 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~  674 (982)
                      +++|++|+|++|++++. + .|+++++|++|+|++|++++. | .+.++++|+.|++++
T Consensus       172 l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         172 LSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             CTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred             cccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence            99999999999999864 3 388999999999999999864 4 388999999999874

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1.5e-19  Score=188.22  Aligned_cols=150  Identities=17%  Similarity=0.149  Sum_probs=82.2

Q ss_pred             EEeCCCCccccCCccccCCCCCCEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCc-cccCcCCCCcccccc-C
Q 036229           86 LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPS-FIFNKSSLQHLDFSY-N  163 (982)
Q Consensus        86 L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~-N  163 (982)
                      ++.++.+++ .+|+.+.  +++++|||++|+++...+.+|.++++|++|+|++|.+...+|. .|.+++++++++++. |
T Consensus        13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n   89 (242)
T d1xwdc1          13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   89 (242)
T ss_dssp             EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred             EEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence            344456666 6666553  4677777777777633333566777777777777776654433 456666666666543 4


Q ss_pred             cccccCchhhhcCCCCCCeeeecceeeecccCC-CccCcCcccEEEeecccccccccccccccc-chhhhhccCCCCC
Q 036229          164 ALSGEIPANICSNLPFLESISLSQNMFHGRIPS-ALSNCKYLEILSLSINNLLGAIPKEIGNLT-KLKELYLGYSGLQ  239 (982)
Q Consensus       164 ~l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~  239 (982)
                      .+. .++...|..+++|++|++++|++....+. .+..+..+..+..+++++....+..|.+++ .++.|++++|+++
T Consensus        90 ~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          90 NLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             TCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence            444 44444446666666666666665533221 223344444445555555433333444332 3444455544444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=8.4e-22  Score=226.17  Aligned_cols=38  Identities=32%  Similarity=0.409  Sum_probs=21.9

Q ss_pred             CCCcEEEccCCccccC----CCccccccCCCcEEEccCcccc
Q 036229          274 TGLEVLKLGKNFLTGE----IPPEIHNLHNLKLLDLSHNKLV  311 (982)
Q Consensus       274 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  311 (982)
                      ++|++|+|++|+++..    ++..+..+++|++|+|++|.++
T Consensus        84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            3566666666666532    2334555666666666666654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1.1e-21  Score=225.21  Aligned_cols=111  Identities=21%  Similarity=0.258  Sum_probs=73.1

Q ss_pred             cCCcEEEccCCcccCc-cCccccCcCCCCccccccCcccc----cCchhhhcCCCCCCeeeecceeeecc----cCCCcc
Q 036229          129 YTLKYVNFRGNQLSGA-FPSFIFNKSSLQHLDFSYNALSG----EIPANICSNLPFLESISLSQNMFHGR----IPSALS  199 (982)
Q Consensus       129 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~----~ip~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~  199 (982)
                      .+|++||+++|++++. +...+..++++++|+|++|.++.    .++..+ ...++|++|||++|.|+..    +...+.
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L-~~~~~L~~LdLs~N~i~~~~~~~l~~~l~   80 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL-RVNPALAELNLRSNELGDVGVHCVLQGLQ   80 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHH-HTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHH-hcCCCCCEEECcCCcCChHHHHHHHHHHh
Confidence            3678888888888753 23345667888888888887762    222223 6778888888888877532    222232


Q ss_pred             -CcCcccEEEeeccccccc----cccccccccchhhhhccCCCCCC
Q 036229          200 -NCKYLEILSLSINNLLGA----IPKEIGNLTKLKELYLGYSGLQG  240 (982)
Q Consensus       200 -~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~  240 (982)
                       ...+|++|+|++|+++..    ++..+..+++|++|+|++|.++.
T Consensus        81 ~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          81 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             cCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence             234688888888877643    34556667777777777777764

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=5.7e-19  Score=181.79  Aligned_cols=169  Identities=25%  Similarity=0.391  Sum_probs=132.3

Q ss_pred             ccccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcc
Q 036229          469 EIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASL  548 (982)
Q Consensus       469 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  548 (982)
                      .+..+++|+.|++++|++++..|  +..+++|+.+++++|.++. + ..+.++++|+.+++++|...+.  ..+...+.+
T Consensus        58 ~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~  131 (227)
T d1h6ua2          58 GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNL  131 (227)
T ss_dssp             TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTC
T ss_pred             hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-cccccccccccccccccccccc--chhccccch
Confidence            36677888888888888876544  7788888888888888874 3 3577888888888888887644  335667888


Q ss_pred             cccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccc
Q 036229          549 GTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNR  628 (982)
Q Consensus       549 ~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  628 (982)
                      +.+.++++.+...+. +...++|++|++++|.+++..  .++++++|+.|||++|+++++.  .++++++|++|+|++|+
T Consensus       132 ~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~  206 (227)
T d1h6ua2         132 QVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQ  206 (227)
T ss_dssp             CEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSC
T ss_pred             hhhhchhhhhchhhh-hccccccccccccccccccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCc
Confidence            888888888875543 556778888899888887543  3788899999999999998753  38889999999999999


Q ss_pred             ccCCccccccCCCCCCeeeCCC
Q 036229          629 LQGSISESFGDLISLKSLNLSN  650 (982)
Q Consensus       629 l~~~~~~~~~~l~~L~~L~Ls~  650 (982)
                      |++..|  ++++++|+.|++++
T Consensus       207 lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         207 ISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             CCBCGG--GTTCTTCCEEEEEE
T ss_pred             CCCCcc--cccCCCCCEEEeeC
Confidence            986543  88999999999973

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=4.8e-19  Score=179.67  Aligned_cols=182  Identities=25%  Similarity=0.341  Sum_probs=120.1

Q ss_pred             eEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCc
Q 036229          478 GIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNK  557 (982)
Q Consensus       478 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  557 (982)
                      ...++.+.+++.++.  ..+.+|+.|++++|.+++..  .+..+++|++|+|++|+|++..  .+.++++|++|++++|+
T Consensus        28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~  101 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK  101 (210)
T ss_dssp             HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence            344555555544432  23456666666666666432  3556666666666666666433  24566667777777776


Q ss_pred             ccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccc
Q 036229          558 LTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESF  637 (982)
Q Consensus       558 l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  637 (982)
                      ++.+| .+..+++|+.|++++|.+..  ...+..++.++.+++++|.+++.  ..+..+++|+++++++|++++..  .+
T Consensus       102 i~~l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l  174 (210)
T d1h6ta2         102 VKDLS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PL  174 (210)
T ss_dssp             CCCGG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred             ccccc-cccccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccc--cc
Confidence            66666 35566667777777776653  23466677777777777777653  34667788888888888887543  37


Q ss_pred             cCCCCCCeeeCCCCcCCCCCCcccccccccceeecCC
Q 036229          638 GDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSF  674 (982)
Q Consensus       638 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~  674 (982)
                      .++++|+.|+|++|+|+. +| .+..+++|++|+|++
T Consensus       175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred             cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence            888888888888888874 44 578888888888864

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=6.1e-19  Score=177.28  Aligned_cols=183  Identities=27%  Similarity=0.411  Sum_probs=134.3

Q ss_pred             ccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccc
Q 036229          473 LTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS  552 (982)
Q Consensus       473 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  552 (982)
                      +.+.....++.+.+++.++  ...++++++|++++|.|+..  +.+..+++|++|++++|+|++..|  +.++++|++|+
T Consensus        17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~   90 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL   90 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence            3444455666777665443  34567777888888877743  346777888888888888875433  77788888888


Q ss_pred             cCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCC
Q 036229          553 LGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGS  632 (982)
Q Consensus       553 L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  632 (982)
                      +++|.+..+|. +..++.|++|++++|.+...  ..+..+++|+.|++++|++...  +.+..+++|++|++++|++++.
T Consensus        91 l~~n~~~~~~~-l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l  165 (199)
T d2omxa2          91 MNNNQIADITP-LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL  165 (199)
T ss_dssp             CCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC
T ss_pred             ccccccccccc-cccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC
Confidence            88888877764 66777888888888877653  2467788888888888888653  3578888999999999999864


Q ss_pred             ccccccCCCCCCeeeCCCCcCCCCCCccccccccccee
Q 036229          633 ISESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDL  670 (982)
Q Consensus       633 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l  670 (982)
                      .  .++++++|++|++++|++++ +| .+..+++|++|
T Consensus       166 ~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         166 K--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             G--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             c--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            3  48889999999999999885 44 57788888765

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=7.2e-19  Score=175.67  Aligned_cols=169  Identities=20%  Similarity=0.210  Sum_probs=132.0

Q ss_pred             EEeCCCCccccCCccccCCCCCCEEEcCCCCccccC-cchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCc
Q 036229           86 LNISHLNLTGTIPSQLWNLSSLQSLNLGFNRLSGSI-PSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNA  164 (982)
Q Consensus        86 L~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  164 (982)
                      ++.++++++ .+|+.+.  +++++|+|++|+|++.+ +..|..+++|++|+|++|++.+..+..+..+++|++|+|++|+
T Consensus        13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~   89 (192)
T d1w8aa_          13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence            455677787 7887764  68999999999998655 5567889999999999999998888999999999999999999


Q ss_pred             ccccCchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhh
Q 036229          165 LSGEIPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPR  244 (982)
Q Consensus       165 l~~~ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  244 (982)
                      |+ .+|+..|.++++|++|+|++|+|++..|++|.++++|++|+|++|.+....+. ..-...++.+.+..|.++...|.
T Consensus        90 l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          90 IK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCCh
Confidence            98 78888889999999999999999998899999999999999999998744321 11123466667777766654443


Q ss_pred             hcCCCcccceEecccccc
Q 036229          245 EFGNLAELELMALQVSNL  262 (982)
Q Consensus       245 ~~~~l~~L~~L~L~~n~l  262 (982)
                      .+   ..++.++++.|.+
T Consensus       168 ~l---~~~~l~~L~~n~l  182 (192)
T d1w8aa_         168 KV---RDVQIKDLPHSEF  182 (192)
T ss_dssp             TT---TTSBGGGSCTTTC
T ss_pred             hh---cCCEeeecCHhhC
Confidence            32   3334445554444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.75  E-value=8e-19  Score=175.30  Aligned_cols=132  Identities=23%  Similarity=0.275  Sum_probs=93.9

Q ss_pred             ccEEEccCCCCCCCCCccccccccccccEEeccCCcccc-CCCcccccccccceEEecCCCCCCCCCccccCcCCCCeEE
Q 036229          426 LTYIGLSNNPLDGILPRMSMGNLSHSLEYFDMSYCNVSG-GFPKEIGNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLH  504 (982)
Q Consensus       426 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~Ldls~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  504 (982)
                      .++++.++|+++.+++..     +..+++|+|++|+|++ ..+..|.++++|+.|+|++|++++..+..|..+++|++|+
T Consensus        10 ~~~v~Cs~~~L~~iP~~l-----p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~   84 (192)
T d1w8aa_          10 GTTVDCTGRGLKEIPRDI-----PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ   84 (192)
T ss_dssp             TTEEECTTSCCSSCCSCC-----CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCEEEEeCCCcCccCCCC-----CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceee
Confidence            346777777777665432     3456677777777765 3355667777777777777777777777777777777777


Q ss_pred             eeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccc
Q 036229          505 LEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIP  562 (982)
Q Consensus       505 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip  562 (982)
                      |++|+|+++.|++|.++++|++|+|++|+|+++.|++|..+++|++|+|++|.+...+
T Consensus        85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence            7777777766777777777777777777777777777777777777777777776433

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=2.2e-18  Score=174.75  Aligned_cols=166  Identities=25%  Similarity=0.346  Sum_probs=129.6

Q ss_pred             cccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCccccc
Q 036229          472 NLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTL  551 (982)
Q Consensus       472 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  551 (982)
                      .+.+|+.|++++|.++...  .+..+++|++|+|++|+|++..  .++.+++|++|++++|+|++ +| .+.++++|+.|
T Consensus        44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L  117 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence            4667788888888887543  3677888888888888887543  36778888888888888874 34 47788888888


Q ss_pred             ccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccC
Q 036229          552 SLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQG  631 (982)
Q Consensus       552 ~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  631 (982)
                      ++++|.++.++ .+..+++++.+++++|.+++  +..+..+++|+.+++++|+++++.  .++++++|++|+|++|+|+.
T Consensus       118 ~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~  192 (210)
T d1h6ta2         118 SLEHNGISDIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD  192 (210)
T ss_dssp             ECTTSCCCCCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB
T ss_pred             ccccccccccc-cccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC
Confidence            88888887765 46677888888888888875  335677888999999999998753  38889999999999999984


Q ss_pred             CccccccCCCCCCeeeCCC
Q 036229          632 SISESFGDLISLKSLNLSN  650 (982)
Q Consensus       632 ~~~~~~~~l~~L~~L~Ls~  650 (982)
                       +| .|.++++|++|+|++
T Consensus       193 -l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         193 -LR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -CG-GGTTCTTCSEEEEEE
T ss_pred             -Ch-hhcCCCCCCEEEccC
Confidence             44 589999999999874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.71  E-value=2.2e-17  Score=165.75  Aligned_cols=163  Identities=26%  Similarity=0.370  Sum_probs=119.6

Q ss_pred             ccccccceEEecCCCCCCCCCccccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccc
Q 036229          471 GNLTNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGT  550 (982)
Q Consensus       471 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  550 (982)
                      ..+.+++.|++++|.++..  +.+..+++|++|++++|+|++..|  +.++++|++|++++|.+... + .+.++++|+.
T Consensus        37 ~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~  110 (199)
T d2omxa2          37 TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTG  110 (199)
T ss_dssp             HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSE
T ss_pred             HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccccc-c-cccccccccc
Confidence            3566777777777777643  246677778888888888775432  77777888888888877643 3 3677778888


Q ss_pred             cccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEeccccccc
Q 036229          551 LSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQ  630 (982)
Q Consensus       551 L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  630 (982)
                      |++++|.+..++ .+..+++|++|++++|++...  ..+..+++|+.|++++|++++..  .++++++|++|++++|+++
T Consensus       111 L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         111 LTLFNNQITDID-PLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             EECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccccc-ccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence            888877777654 355677788888888877642  34777888888888888887753  4788999999999999998


Q ss_pred             CCccccccCCCCCCee
Q 036229          631 GSISESFGDLISLKSL  646 (982)
Q Consensus       631 ~~~~~~~~~l~~L~~L  646 (982)
                      + ++ .++++++|++|
T Consensus       186 ~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         186 D-IS-VLAKLTNLESL  199 (199)
T ss_dssp             C-CG-GGGGCTTCSEE
T ss_pred             C-Cc-cccCCCCCCcC
Confidence            5 43 57888888876

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=1.6e-16  Score=168.82  Aligned_cols=223  Identities=18%  Similarity=0.211  Sum_probs=137.1

Q ss_pred             CEEEcCCCCccccCcchhhhccCCcEEEccCCcccCccCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecc
Q 036229          108 QSLNLGFNRLSGSIPSAIFTLYTLKYVNFRGNQLSGAFPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQ  187 (982)
Q Consensus       108 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~  187 (982)
                      +.+||+++.+.......+.. .....+.++.......+. ......+|++||++++.++......++.++++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            46777776664222222221 234556666655553322 2334567888888888776555556668888888888888


Q ss_pred             eeeecccCCCccCcCcccEEEeecc-ccccc-cccccccccchhhhhccCC-CCCCc-hhhhcCC-CcccceEecccc--
Q 036229          188 NMFHGRIPSALSNCKYLEILSLSIN-NLLGA-IPKEIGNLTKLKELYLGYS-GLQGE-IPREFGN-LAELELMALQVS--  260 (982)
Q Consensus       188 N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~-l~~L~~L~L~~n--  260 (982)
                      |.+++..+..++.+++|++|+++++ .++.. +..-..++++|++|+++++ .++.. +...+.. .+.|+.|++++.  
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~  160 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK  160 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence            8887777777778888888888874 55532 2222356778888888875 44422 2222333 356777777753  


Q ss_pred             ccCCc-CChhhhccCCCcEEEccCC-ccccCCCccccccCCCcEEEccCc-cccccCcccccCCCCCceeecCCC
Q 036229          261 NLQGE-IPQELANLTGLEVLKLGKN-FLTGEIPPEIHNLHNLKLLDLSHN-KLVGAVPATIFNMSTLTGLGLQSN  332 (982)
Q Consensus       261 ~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N  332 (982)
                      .++.. +...+.++++|++|++++| .+++.....+.++++|++|+|+++ .+++.....+.++++|+.|+++++
T Consensus       161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            33322 2223456778888888775 466666667777778888888873 566555555555566655555544

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=3.1e-15  Score=143.74  Aligned_cols=127  Identities=20%  Similarity=0.207  Sum_probs=75.8

Q ss_pred             cCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccce
Q 036229          518 ICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIG  597 (982)
Q Consensus       518 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  597 (982)
                      |.+..++++|+|++|+|+. +|..+..+++|+.|+|++|+|++++                         .+..+++|+.
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l~-------------------------~~~~l~~L~~   67 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLD-------------------------GFPLLRRLKT   67 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEEC-------------------------CCCCCSSCCE
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCccC-------------------------CcccCcchhh
Confidence            4455556666666666653 3444555566666666666655543                         2444555666


Q ss_pred             eecccccccccccccccCccCcceEecccccccCCcc-ccccCCCCCCeeeCCCCcCCCCCCc----ccccccccceee
Q 036229          598 IDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSIS-ESFGDLISLKSLNLSNNNLSRSIPI----SLEKLSYLEDLD  671 (982)
Q Consensus       598 Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~l~  671 (982)
                      |++++|+++++.+..+..+++|+.|+|++|+|+.... ..+.++++|++|++++|.++. .|.    .+..+++|++||
T Consensus        68 L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred             hhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence            6666666655555555666777777777777764322 356667777777777777753 332    356677777766

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=4e-15  Score=142.94  Aligned_cols=129  Identities=18%  Similarity=0.163  Sum_probs=95.2

Q ss_pred             cccCcCCCCeEEeeccCCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccc-cccCc
Q 036229          493 TLGKLQKLQGLHLEDNKLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIW-NLKGM  571 (982)
Q Consensus       493 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~-~l~~L  571 (982)
                      .|.+..++++|+|++|+|+. ++..+..+++|+.|+|++|+|+.. + .|..+++|++|++++|+++.+|..++ .+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            46778899999999999994 577778899999999999999954 3 58999999999999999999987654 47777


Q ss_pred             eEEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCc---cccccCCCCCCeee
Q 036229          572 LYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSI---SESFGDLISLKSLN  647 (982)
Q Consensus       572 ~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~  647 (982)
                      +.|++++|+++....                       -..+..+++|++|++++|+++...   +..+..+++|+.||
T Consensus        90 ~~L~L~~N~i~~~~~-----------------------l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGD-----------------------LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGG-----------------------GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccceecccccccccc-----------------------ccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            777777776653211                       023455566666666666665322   12456667777666

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=1.6e-14  Score=131.81  Aligned_cols=101  Identities=30%  Similarity=0.349  Sum_probs=49.0

Q ss_pred             EEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccccceeecccccc
Q 036229          526 ELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNF  605 (982)
Q Consensus       526 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l  605 (982)
                      .|+|++|+|+ .++ .+.++++|++|++++|+|+++|..+..+++|+.|++++|+++                       
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-----------------------   56 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-----------------------   56 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-----------------------
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-----------------------
Confidence            4555555554 222 245555555555555555555444444444444444444433                       


Q ss_pred             cccccccccCccCcceEecccccccCCc-cccccCCCCCCeeeCCCCcCC
Q 036229          606 SDVIPTVIGGLTNLQYLFLGYNRLQGSI-SESFGDLISLKSLNLSNNNLS  654 (982)
Q Consensus       606 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  654 (982)
                       +. | .++.+++|++|++++|+|++.. ...++.+++|+.|++++|+++
T Consensus        57 -~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          57 -NV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             -CC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             -cc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence             22 1 2444555555555555555332 134555556666666666554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.50  E-value=1.3e-15  Score=166.89  Aligned_cols=246  Identities=21%  Similarity=0.203  Sum_probs=118.1

Q ss_pred             CCccccCCCCCCEEEcCCCCcccc----CcchhhhccCCcEEEccCCcccCc----------cCccccCcCCCCcccccc
Q 036229           97 IPSQLWNLSSLQSLNLGFNRLSGS----IPSAIFTLYTLKYVNFRGNQLSGA----------FPSFIFNKSSLQHLDFSY  162 (982)
Q Consensus        97 ~~~~l~~l~~L~~L~L~~n~~~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~Ls~  162 (982)
                      +..++.+...|+.|+|++|.+...    +-..+...++|+.|+++++.....          +...+...++|++|||++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            445566677777788877776432    223345567777777777654321          112234456666666666


Q ss_pred             CcccccCch---hhhcCCCCCCeeeecceeeecccCCCc-------------cCcCcccEEEeeccccccc----ccccc
Q 036229          163 NALSGEIPA---NICSNLPFLESISLSQNMFHGRIPSAL-------------SNCKYLEILSLSINNLLGA----IPKEI  222 (982)
Q Consensus       163 N~l~~~ip~---~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------------~~l~~L~~L~Ls~N~l~~~----~p~~~  222 (982)
                      |.+...-..   ..+...++|++|++++|.+.......+             ...+.|+.|++++|+++..    +...+
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l  182 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  182 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence            666532111   111345566666666665532111111             1234455555555554321    11222


Q ss_pred             ccccchhhhhccCCCCCCchhhhcCCCcccceEeccccccCCcCChhhhccCCCcEEEccCCccccC----CCccccccC
Q 036229          223 GNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNLQGEIPQELANLTGLEVLKLGKNFLTGE----IPPEIHNLH  298 (982)
Q Consensus       223 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~  298 (982)
                      ...+.|++|+|++|+++.....                   ..+...+...++|+.|+|++|.++..    +...+...+
T Consensus       183 ~~~~~L~~L~L~~n~i~~~g~~-------------------~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~  243 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGIRPEGIE-------------------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP  243 (344)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHH-------------------HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred             hhhhhhcccccccccccccccc-------------------cchhhhhcchhhhcccccccccccccccccccccccccc
Confidence            3334444555554444321000                   00112244455555566655555422    223344555


Q ss_pred             CCcEEEccCccccccCcccc----c--CCCCCceeecCCCcCCCC----cCccccccCCCccEEEccCCcccc
Q 036229          299 NLKLLDLSHNKLVGAVPATI----F--NMSTLTGLGLQSNSLSGS----LSSIADVQLPNLEELRLWSNNFSG  361 (982)
Q Consensus       299 ~L~~L~Ls~N~l~~~~p~~~----~--~l~~L~~L~L~~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~l~~  361 (982)
                      +|++|+|++|.|++.....+    .  ....|+.|++++|.|...    +........++|++|+|++|++..
T Consensus       244 ~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             TCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             cchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            56666666665543222111    1  124566666666665421    111111235667777887777753

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.50  E-value=2.6e-14  Score=130.25  Aligned_cols=103  Identities=26%  Similarity=0.305  Sum_probs=85.2

Q ss_pred             EEecCCCcccCCCccccccccccceeecccccccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCc
Q 036229          573 YLNFSSNFFTGPLPLDIGNLKVLIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNN  652 (982)
Q Consensus       573 ~L~Ls~N~l~~~~~~~~~~l~~L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  652 (982)
                      +|+|++|+++.. + .++.++.|+.||+++|+|++ +|..|+.+++|+.|++++|+|++ +| .++++++|+.|++++|+
T Consensus         2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            566677766633 2 36778888888999999975 57789999999999999999985 44 59999999999999999


Q ss_pred             CCCCCC-cccccccccceeecCCCccccc
Q 036229          653 LSRSIP-ISLEKLSYLEDLDLSFNKLKGE  680 (982)
Q Consensus       653 l~~~~p-~~l~~l~~L~~l~ls~N~l~~~  680 (982)
                      |+...+ ..+..+++|++|++++|++++.
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            986432 5788999999999999999853

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=6e-15  Score=156.46  Aligned_cols=181  Identities=20%  Similarity=0.225  Sum_probs=91.1

Q ss_pred             hccCCcEEEccCCcccCc-cCccccCcCCCCccccccCcccccCchhhhcCCCCCCeeeecce-eeecc-cCCCccCcCc
Q 036229          127 TLYTLKYVNFRGNQLSGA-FPSFIFNKSSLQHLDFSYNALSGEIPANICSNLPFLESISLSQN-MFHGR-IPSALSNCKY  203 (982)
Q Consensus       127 ~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~  203 (982)
                      ...+|++|||+++.++.. ++..+.++++|++|+|+++.+++..+..+ ..+++|++|+|+++ .++.. +..-+.++++
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l-~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~  122 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTL-AKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  122 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHH-TTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHH-hcCCCCcCccccccccccccccchhhHHHHh
Confidence            334555555555555432 23334455555555555555554444444 44555555555553 33321 1111234555


Q ss_pred             ccEEEeecc-ccccc-ccccccc-ccchhhhhccCC--CCCCc-hhhhcCCCcccceEecccc-ccCCcCChhhhccCCC
Q 036229          204 LEILSLSIN-NLLGA-IPKEIGN-LTKLKELYLGYS--GLQGE-IPREFGNLAELELMALQVS-NLQGEIPQELANLTGL  276 (982)
Q Consensus       204 L~~L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L  276 (982)
                      |++|+++++ +++.. +...+.. .++|+.|+++++  .++.. +...+.++++|+.|++++| .+++.....+.++++|
T Consensus       123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L  202 (284)
T d2astb2         123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL  202 (284)
T ss_dssp             CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence            666666553 23211 1112222 245566666543  23321 2222344566666666654 3555555566666777


Q ss_pred             cEEEccC-CccccCCCccccccCCCcEEEccCc
Q 036229          277 EVLKLGK-NFLTGEIPPEIHNLHNLKLLDLSHN  308 (982)
Q Consensus       277 ~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N  308 (982)
                      ++|+|++ +.+++.....++++++|+.|+++++
T Consensus       203 ~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             CEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            7777776 3565554555666677777777665

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.47  E-value=3.1e-15  Score=163.88  Aligned_cols=254  Identities=24%  Similarity=0.267  Sum_probs=155.0

Q ss_pred             cCcchhhhccCCcEEEccCCcccCc----cCccccCcCCCCccccccCcccc---cCch------hhhcCCCCCCeeeec
Q 036229          120 SIPSAIFTLYTLKYVNFRGNQLSGA----FPSFIFNKSSLQHLDFSYNALSG---EIPA------NICSNLPFLESISLS  186 (982)
Q Consensus       120 ~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~---~ip~------~~~~~l~~L~~L~Ls  186 (982)
                      .+..++.+.++|++|+|++|.++..    +...+...++|+.|+++++....   ..|.      ..+...++|++|+|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            4566778889999999999998642    33456677899999998875431   1121      112456778888888


Q ss_pred             ceeeecc----cCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCCCcccceEecccccc
Q 036229          187 QNMFHGR----IPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGNLAELELMALQVSNL  262 (982)
Q Consensus       187 ~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l  262 (982)
                      +|.+...    +...+...++|++|++++|.+.......+..  .+..+...         ......+.|+.++++.|++
T Consensus       102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~---------~~~~~~~~L~~l~l~~n~i  170 (344)
T d2ca6a1         102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVN---------KKAKNAPPLRSIICGRNRL  170 (344)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHH---------HHHHTCCCCCEEECCSSCC
T ss_pred             ccccccccccchhhhhcccccchheecccccccccccccccc--cccccccc---------cccccCcccceeecccccc
Confidence            7777643    2223445667777777777765322111111  12222111         1123445677778887776


Q ss_pred             CCc----CChhhhccCCCcEEEccCCccccC-----CCccccccCCCcEEEccCcccccc----CcccccCCCCCceeec
Q 036229          263 QGE----IPQELANLTGLEVLKLGKNFLTGE-----IPPEIHNLHNLKLLDLSHNKLVGA----VPATIFNMSTLTGLGL  329 (982)
Q Consensus       263 ~~~----~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L  329 (982)
                      ...    +...+...+.|++|+|++|+|+..     +...+...++|+.|+|++|.++..    +...+..+++|+.|+|
T Consensus       171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L  250 (344)
T d2ca6a1         171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  250 (344)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence            533    233466778899999999988742     234567788899999999988643    3345567778888888


Q ss_pred             CCCcCCCCcC-----ccccccCCCccEEEccCCcccccc----ccccc-CCCCCCEEEeccccCc
Q 036229          330 QSNSLSGSLS-----SIADVQLPNLEELRLWSNNFSGTI----PRFIF-NASKLSVLELGRNSFS  384 (982)
Q Consensus       330 ~~N~l~~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~L~~N~i~  384 (982)
                      ++|.|.+.-.     .......+.|++|++++|++....    ...+. +.++|++|+|++|++.
T Consensus       251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            8887753211     011112345677777777765422    22221 3456677777777665

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.40  E-value=3.8e-15  Score=148.38  Aligned_cols=129  Identities=26%  Similarity=0.300  Sum_probs=64.6

Q ss_pred             CcccCCCccccEEEccCCcCCcCCCccccCCCcccccccCCCcccccccccccccCceEEecCCCcccCCCccccccccc
Q 036229          515 PDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLSLGSNKLTSIPLTIWNLKGMLYLNFSSNFFTGPLPLDIGNLKV  594 (982)
Q Consensus       515 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  594 (982)
                      +.++..+++|++|+|++|+|+. ++ .|.++++|++|+|++|+|+++|.....+++|++|++++|+++            
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~------------  106 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA------------  106 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC------------
T ss_pred             hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhccccccccccccccccccccccccccccc------------
Confidence            3455556666666666666653 22 355666666666666666665543333334444444444444            


Q ss_pred             cceeecccccccccccccccCccCcceEecccccccCCcc-ccccCCCCCCeeeCCCCcCCCCCCcc----------ccc
Q 036229          595 LIGIDFSTNNFSDVIPTVIGGLTNLQYLFLGYNRLQGSIS-ESFGDLISLKSLNLSNNNLSRSIPIS----------LEK  663 (982)
Q Consensus       595 L~~Ldls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------l~~  663 (982)
                                  .+  +.+..+++|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+..          +..
T Consensus       107 ------------~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~  172 (198)
T d1m9la_         107 ------------SL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR  172 (198)
T ss_dssp             ------------CH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHH
T ss_pred             ------------cc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHH
Confidence                        21  123344455555555555542211 24455555555555555554322221          345


Q ss_pred             ccccceee
Q 036229          664 LSYLEDLD  671 (982)
Q Consensus       664 l~~L~~l~  671 (982)
                      +++|+.||
T Consensus       173 lp~L~~LD  180 (198)
T d1m9la_         173 LPNLKKLD  180 (198)
T ss_dssp             CSSCCEES
T ss_pred             CCCcCEeC
Confidence            66666665

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=2.4e-14  Score=142.49  Aligned_cols=115  Identities=27%  Similarity=0.333  Sum_probs=69.8

Q ss_pred             CchhhhcCCCCCCeeeecceeeecccCCCccCcCcccEEEeeccccccccccccccccchhhhhccCCCCCCchhhhcCC
Q 036229          169 IPANICSNLPFLESISLSQNMFHGRIPSALSNCKYLEILSLSINNLLGAIPKEIGNLTKLKELYLGYSGLQGEIPREFGN  248 (982)
Q Consensus       169 ip~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  248 (982)
                      +|.++ +.+++|++|+|++|+|+. ++ .|.++++|++|+|++|+++ .+|..+..+++|++|++++|+++. + ..+..
T Consensus        40 l~~sl-~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~  113 (198)
T d1m9la_          40 MDATL-STLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK  113 (198)
T ss_dssp             CHHHH-HHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred             hhhHH-hcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence            44444 567777777777777763 33 4667777777777777776 445444555566777777776663 2 23555


Q ss_pred             CcccceEeccccccCCcCC-hhhhccCCCcEEEccCCccccC
Q 036229          249 LAELELMALQVSNLQGEIP-QELANLTGLEVLKLGKNFLTGE  289 (982)
Q Consensus       249 l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~  289 (982)
                      +++|+.|++++|+++.... ..+..+++|++|+|++|.++..
T Consensus       114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_         114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             cccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence            5666666666666653221 3466666666666666666543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=6.4e-13  Score=126.33  Aligned_cols=108  Identities=20%  Similarity=0.150  Sum_probs=83.2

Q ss_pred             cccceEEecCCCCCCCCCccccCcCCCCeEEeecc-CCCCCCCcccCCCccccEEEccCCcCCcCCCccccCCCcccccc
Q 036229          474 TNLIGIYLGGNKLNGSIPITLGKLQKLQGLHLEDN-KLEGPIPDDICRLTKLYELGLSGNKLSGSIPACFSNLASLGTLS  552 (982)
Q Consensus       474 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  552 (982)
                      ...+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.|.+|.++++|++|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34455677777776 45666777888888888655 47766667788888888888888888877788888888888888


Q ss_pred             cCCCcccccccccccccCceEEecCCCccc
Q 036229          553 LGSNKLTSIPLTIWNLKGMLYLNFSSNFFT  582 (982)
Q Consensus       553 L~~N~l~~ip~~~~~l~~L~~L~Ls~N~l~  582 (982)
                      |++|+|+++|...+...+|+.|+|++|.+.
T Consensus        87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccCCCCcccChhhhccccccccccCCCccc
Confidence            888888888887776667788888888764

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.29  E-value=3.2e-12  Score=121.46  Aligned_cols=95  Identities=21%  Similarity=0.142  Sum_probs=69.6

Q ss_pred             ccccccccccceeecccc-cccccccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcccccc
Q 036229          586 PLDIGNLKVLIGIDFSTN-NFSDVIPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPISLEKL  664 (982)
Q Consensus       586 ~~~~~~l~~L~~Ldls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  664 (982)
                      |..+..+++|+.|++++| .|+.+.+.+|.++++|+.|+|++|+|+...|.+|.++++|++|+|++|+|+...+..+.. 
T Consensus        24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-  102 (156)
T d2ifga3          24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-  102 (156)
T ss_dssp             TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-
T ss_pred             cccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc-
Confidence            334445556666666554 466666677888888888888888888777888888888888888888888544444444 


Q ss_pred             cccceeecCCCcccccC
Q 036229          665 SYLEDLDLSFNKLKGEI  681 (982)
Q Consensus       665 ~~L~~l~ls~N~l~~~~  681 (982)
                      ..|+.|+|++|+|.+..
T Consensus       103 ~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3         103 LSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             CCCCEEECCSSCCCCCG
T ss_pred             ccccccccCCCcccCCc
Confidence            46888888888886544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=4.2e-09  Score=100.17  Aligned_cols=78  Identities=24%  Similarity=0.293  Sum_probs=39.0

Q ss_pred             ccceeeccccccccc--ccccccCccCcceEecccccccCCccccccCCCCCCeeeCCCCcCCCCCCcc-------cccc
Q 036229          594 VLIGIDFSTNNFSDV--IPTVIGGLTNLQYLFLGYNRLQGSISESFGDLISLKSLNLSNNNLSRSIPIS-------LEKL  664 (982)
Q Consensus       594 ~L~~Ldls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-------l~~l  664 (982)
                      .|+.||||+|+|+.+  ++..+..+++|+.|+|++|+|+...+-.+.....|+.|++++|.++......       +..+
T Consensus        66 ~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~  145 (162)
T d1koha1          66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERF  145 (162)
T ss_dssp             TCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTS
T ss_pred             CCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHC
Confidence            333444444444332  1233445556666666666665433333334445666666666665443321       3456


Q ss_pred             cccceee
Q 036229          665 SYLEDLD  671 (982)
Q Consensus       665 ~~L~~l~  671 (982)
                      |+|+.||
T Consensus       146 P~L~~LD  152 (162)
T d1koha1         146 PKLLRLD  152 (162)
T ss_dssp             TTCCEET
T ss_pred             CCCCEEC
Confidence            6666665

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.49  E-value=6.3e-09  Score=98.91  Aligned_cols=69  Identities=32%  Similarity=0.215  Sum_probs=35.2

Q ss_pred             ccccCccCcceEecccccccCCc--cccccCCCCCCeeeCCCCcCCCCCCcccccccccceeecCCCcccc
Q 036229          611 TVIGGLTNLQYLFLGYNRLQGSI--SESFGDLISLKSLNLSNNNLSRSIPISLEKLSYLEDLDLSFNKLKG  679 (982)
Q Consensus       611 ~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  679 (982)
                      ..+..+++|++|+|++|+|+...  +..+..+++|+.|||++|+|+...+-.+.....|+++++++|++++
T Consensus        59 ~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             HHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             HHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence            33344555666666666665432  2344555666666666666653322222233345666666666554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=2.3e-07  Score=95.80  Aligned_cols=149  Identities=17%  Similarity=0.123  Sum_probs=105.9

Q ss_pred             HHHHHhcCCCccceeeeeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeE
Q 036229          774 ELCRATNRFSENNLIGRGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKA  852 (982)
Q Consensus       774 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  852 (982)
                      ++....+.|+..+..+-++.+.||+... +++.+++|+...........+.+|...++.+. +--+++++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555567777666555455678999875 45667888887555555567888999988774 445778888888888999


Q ss_pred             EEEEeccCCChHHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHccC-----------------------------------
Q 036229          853 LILEYMPHGSLEKSLYSSNYILDIFQRLNIMVDVATTLEYLHFGY-----------------------------------  897 (982)
Q Consensus       853 lv~E~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~~~-----------------------------------  897 (982)
                      +|||+++|.++.+.....      .....++.++++.+..||...                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999998876544221      112334556666666666210                                   


Q ss_pred             ---------------------CCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          898 ---------------------SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       898 ---------------------~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                                           ...++|+|+.|.||++++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 12489999999999999877778999998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=5.1e-06  Score=84.81  Aligned_cols=131  Identities=18%  Similarity=0.127  Sum_probs=88.3

Q ss_pred             eeeeec-eEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcC--CccceeEEeeecCCCeeEEEEEeccCCCh
Q 036229          787 LIGRGG-FGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIR--HRNLIKVISSCSTEEFKALILEYMPHGSL  863 (982)
Q Consensus       787 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~E~~~~gsL  863 (982)
                      .+..|. -+.||+...+++..+++|.....   ....+..|++.++.+.  .-.+++++++..+++..++|||+++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344444 36799999877888899986543   2346778888888773  33467788888888889999999988665


Q ss_pred             HHHHhcCCCcCCHHHHHHHHHHHHHHHHHHHc------------------------------------------------
Q 036229          864 EKSLYSSNYILDIFQRLNIMVDVATTLEYLHF------------------------------------------------  895 (982)
Q Consensus       864 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~yLH~------------------------------------------------  895 (982)
                      .+..      ...   ...+.++...+.-||.                                                
T Consensus        94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            3210      111   1112233333333331                                                


Q ss_pred             -------cCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          896 -------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       896 -------~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                             .....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                   0123589999999999999877778999999875

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.39  E-value=3e-05  Score=73.13  Aligned_cols=41  Identities=22%  Similarity=0.156  Sum_probs=17.9

Q ss_pred             cCcCcccEEEeecccccccc----ccccccccchhhhhccCCCCC
Q 036229          199 SNCKYLEILSLSINNLLGAI----PKEIGNLTKLKELYLGYSGLQ  239 (982)
Q Consensus       199 ~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~  239 (982)
                      ...++|++|+|++|.+....    .+.+...+.|++|+|++|.++
T Consensus        41 ~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~   85 (167)
T d1pgva_          41 CNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT   85 (167)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             hhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence            33444555555555554221    112223344455555555444

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.36  E-value=4.1e-05  Score=72.11  Aligned_cols=43  Identities=19%  Similarity=0.234  Sum_probs=21.9

Q ss_pred             hhhccCCCcEEEccCCccccCC----CccccccCCCcEEEccCcccc
Q 036229          269 ELANLTGLEVLKLGKNFLTGEI----PPEIHNLHNLKLLDLSHNKLV  311 (982)
Q Consensus       269 ~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~  311 (982)
                      .+...+.|++|+|++|.|+...    -..+...+.|++|+|++|++.
T Consensus        67 ~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          67 LIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             hhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            3444555666666666665321    123334455666666655443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.33  E-value=0.0002  Score=77.54  Aligned_cols=76  Identities=17%  Similarity=0.161  Sum_probs=50.4

Q ss_pred             cceeeeeceEEEEEEEeCC-CeEEEEEEeeccc-------chhhhhHHHHHHHhhhcC-C--ccceeEEeeecCCCeeEE
Q 036229          785 NNLIGRGGFGSVYKARIGE-GMEVAVKVFDLQC-------GRAFKSFDVECEMMKSIR-H--RNLIKVISSCSTEEFKAL  853 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~l  853 (982)
                      .+.||.|....||++...+ ++.|+||......       ....++...|.+.++.+. +  ..+++++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            4578999999999998654 6789999754211       122345677888887662 2  4567777664  344578


Q ss_pred             EEEeccCCC
Q 036229          854 ILEYMPHGS  862 (982)
Q Consensus       854 v~E~~~~gs  862 (982)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.64  E-value=0.003  Score=65.70  Aligned_cols=157  Identities=15%  Similarity=0.095  Sum_probs=86.8

Q ss_pred             CCHHHHHHHhcCCCccceee-----eeceEEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCcc--ceeEE
Q 036229          770 FSYLELCRATNRFSENNLIG-----RGGFGSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRN--LIKVI  842 (982)
Q Consensus       770 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~  842 (982)
                      .+.+|+.....+|..++...     .|---+.|+.+.++|+ +++|++...  ...+++..|.+++..+...+  ++...
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence            46678888888897765544     4555678999876654 889998643  23355666777777764222  22221


Q ss_pred             ee------ecCCCeeEEEEEeccCCChHH--------------HHhc--C----C--CcCC------------------H
Q 036229          843 SS------CSTEEFKALILEYMPHGSLEK--------------SLYS--S----N--YILD------------------I  876 (982)
Q Consensus       843 ~~------~~~~~~~~lv~E~~~~gsL~~--------------~l~~--~----~--~~~~------------------~  876 (982)
                      ..      ....+....++.+..+.....              .++.  .    .  ....                  .
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            11      122345566777766543311              0000  0    0  0000                  0


Q ss_pred             HHHHHHHHHHHHHHHHHH-ccCCCCeEEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          877 FQRLNIMVDVATTLEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       877 ~~~~~i~~qi~~~L~yLH-~~~~~~ivHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ......+......+.-.+ .....|+||+|+.+.||+++++...-++||+.|..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            001112222222222222 12367999999999999999887778999999874

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.61  E-value=0.0021  Score=67.20  Aligned_cols=133  Identities=11%  Similarity=0.129  Sum_probs=77.6

Q ss_pred             EEEEEEEeCCCeEEEEEEeecccchhhhhHHHHHHHhhhcCCccc--eeEEe-----eecCCCeeEEEEEeccCCChH--
Q 036229          794 GSVYKARIGEGMEVAVKVFDLQCGRAFKSFDVECEMMKSIRHRNL--IKVIS-----SCSTEEFKALILEYMPHGSLE--  864 (982)
Q Consensus       794 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~lv~E~~~~gsL~--  864 (982)
                      -.||+++.++|+.|++|+.+.. ....+++..|.+.+..+....+  +....     .+...+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999989999999998754 2345677889988877742222  11111     123455778899999764331  


Q ss_pred             ---HHH---------h----c----CCCcCCHH-------------------HHHHHHHHHHHHHHHHH----ccCCCCe
Q 036229          865 ---KSL---------Y----S----SNYILDIF-------------------QRLNIMVDVATTLEYLH----FGYSAPV  901 (982)
Q Consensus       865 ---~~l---------~----~----~~~~~~~~-------------------~~~~i~~qi~~~L~yLH----~~~~~~i  901 (982)
                         ..-         +    .    .+...+..                   ....+...+...++.+.    .....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               110         0    0    01111111                   11112222222333332    1224689


Q ss_pred             EEcCCCCCCEEEcCCCcEEEEeecCcee
Q 036229          902 IHCDLKPSNVLLDDNMVAHLSDFGIAKL  929 (982)
Q Consensus       902 vHrDlkp~NILl~~~~~~kL~DFGla~~  929 (982)
                      ||+|+.|.||+++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999744  45899998874

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.46  E-value=0.00025  Score=66.47  Aligned_cols=16  Identities=13%  Similarity=0.100  Sum_probs=8.0

Q ss_pred             CcCcccEEEeeccccc
Q 036229          200 NCKYLEILSLSINNLL  215 (982)
Q Consensus       200 ~l~~L~~L~Ls~N~l~  215 (982)
                      ..++|++|+|++|.++
T Consensus        44 ~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TCCSCCEEECTTSCCC
T ss_pred             cCCccCeeeccCCccc
Confidence            4445555555555443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.37  E-value=0.00028  Score=66.12  Aligned_cols=18  Identities=28%  Similarity=0.427  Sum_probs=9.8

Q ss_pred             hhccCCCcEEEccCCccc
Q 036229          270 LANLTGLEVLKLGKNFLT  287 (982)
Q Consensus       270 l~~l~~L~~L~Ls~N~l~  287 (982)
                      +...++++.+++++|.++
T Consensus        70 l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          70 LKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HHHCSSCCEEECCSSCCC
T ss_pred             Hhhcccchhhhhcccccc
Confidence            344455556666555554

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.28  E-value=0.0037  Score=67.27  Aligned_cols=73  Identities=18%  Similarity=0.178  Sum_probs=50.3

Q ss_pred             cceeeeeceEEEEEEEeCC--------CeEEEEEEeecccchhhhhHHHHHHHhhhcC-CccceeEEeeecCCCeeEEEE
Q 036229          785 NNLIGRGGFGSVYKARIGE--------GMEVAVKVFDLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSTEEFKALIL  855 (982)
Q Consensus       785 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  855 (982)
                      .+.|+.|---.+|++..++        .+.|++++.. ... ......+|..+++.+. +.-.+++++++..    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4678888888999998643        3567777764 222 2345567999988874 4445678887753    5899


Q ss_pred             EeccCCCh
Q 036229          856 EYMPHGSL  863 (982)
Q Consensus       856 E~~~~gsL  863 (982)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544